data_6f99_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6f99 _Structure_validation_residue.Date_analyzed 2019-01-25 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.463 0.191 0 CA-C-O 118.817 -0.611 . . . . 0.0 112.078 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.71 -50.26 74.56 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 61.1 tp -69.54 -34.61 74.48 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 118.33 -0.843 . . . . 0.0 110.748 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 17.3 mt -61.38 -54.38 44.39 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.8 m -57.52 -50.52 72.79 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.157 0.983 . . . . 0.0 110.368 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.7 -50.29 72.61 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 118.651 -0.69 . . . . 0.0 111.038 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 21.9 m -52.2 -45.21 65.13 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 124.282 1.033 . . . . 0.0 110.309 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -60.56 -51.38 69.67 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.356 0.98 . . . . 0.0 108.767 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -59.03 -60.25 4.17 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.44 -30.92 67.89 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.199 -176.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.76 -52.29 51.64 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 42.1 t -56.75 -48.62 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 118.361 1.08 . . . . 0.0 109.794 179.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.43 -30.92 70.87 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 119.037 -1.065 . . . . 0.0 113.487 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 44.4 m -78.19 -34.2 49.62 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 21.7 mt -60.02 -54.74 30.63 Favored 'Isoleucine or valine' 0 C--O 1.23 0.072 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -58.11 -29.85 65.82 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.781 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -69.75 -39.81 76.5 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.294 0.952 . . . . 0.0 112.189 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.414 ' HZ3' ' CD ' ' A' ' 237' ' ' GLU . 11.2 tptt -84.77 -34.2 22.85 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 120.744 -1.223 . . . . 0.0 110.426 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 15.9 mt -65.95 -30.28 70.82 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 118.497 -0.763 . . . . 0.0 109.802 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -48.36 -35.05 11.75 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.466 1.107 . . . . 0.0 112.209 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -49.0 -66.07 0.46 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.51 1.524 . . . . 0.0 113.328 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -158.0 -177.85 6.87 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 128.178 2.591 . . . . 0.0 108.777 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 58.5 m -86.67 167.21 14.71 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 42.3 pt -115.69 156.99 16.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -154.18 141.76 19.85 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 122.555 0.342 . . . . 0.0 111.225 -178.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -140.44 125.75 18.78 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.649 0.78 . . . . 0.0 111.205 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -84.27 105.76 15.37 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.64 80.23 4.79 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.27 -103.24 0.98 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -93.2 -23.08 18.67 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.457 1.103 . . . . 0.0 113.742 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -100.58 156.9 17.04 Favored 'General case' 0 CA--C 1.517 -0.326 0 O-C-N 121.606 -0.684 . . . . 0.0 110.111 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.8 mp -127.89 135.33 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -115.5 124.87 52.17 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -120.9 120.07 34.45 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 123.291 0.636 . . . . 0.0 110.301 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -110.9 131.2 55.25 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.657 0.741 . . . . 0.0 109.922 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 36.1 m -110.08 157.24 38.43 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 124.398 1.079 . . . . 0.0 112.697 -178.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -63.6 76.68 0.14 Allowed 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 125.042 3.828 . . . . 0.0 113.612 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 66.18 60.66 6.15 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 125.01 1.291 . . . . 0.0 112.228 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 3.2 mp -130.57 -71.46 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -164.88 164.71 20.82 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 126.455 1.902 . . . . 0.0 110.278 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -131.18 119.35 21.75 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 22.5 m -143.92 164.89 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 123.899 0.88 . . . . 0.0 110.761 -178.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -120.59 129.48 53.77 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.632 1.173 . . . . 0.0 109.014 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -138.93 162.87 33.81 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.19 1.396 . . . . 0.0 112.089 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -89.09 160.91 16.81 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 176.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.486 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -179.767 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -147.03 129.21 15.62 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 54.3 mt -112.94 -21.98 10.85 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.828 0.74 . . . . 0.0 109.753 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 155.98 157.8 8.48 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -126.46 117.73 23.07 Favored Pre-proline 0 CA--C 1.536 0.41 0 O-C-N 122.044 -0.68 . . . . 0.0 111.003 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -77.01 -171.17 1.07 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 1 C-N-CA 126.316 4.677 . . . . 0.0 108.845 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -129.5 152.86 48.57 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.312 1.045 . . . . 0.0 109.04 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -73.76 -29.71 62.37 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.26 1.024 . . . . 0.0 110.578 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -88.28 64.66 7.71 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 124.708 1.203 . . . . 0.0 108.361 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.6 p -50.07 -31.59 7.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 124.92 1.288 . . . . 0.0 112.093 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -61.5 -32.89 72.94 Favored 'General case' 0 CA--C 1.522 -0.116 0 C-N-CA 123.931 0.892 . . . . 0.0 111.986 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -80.64 -28.28 36.98 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.338 1.055 . . . . 0.0 110.82 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 9.4 mtp-105 -72.92 137.3 45.48 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -99.12 144.75 27.9 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -128.7 173.89 9.91 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 126.326 1.85 . . . . 0.0 108.639 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -131.71 154.09 49.36 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.375 0.67 . . . . 0.0 109.389 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 23.1 tp -118.27 100.65 7.64 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.344 1.058 . . . . 0.0 109.061 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -109.24 -179.89 3.97 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -149.95 163.51 37.9 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 121.142 -0.974 . . . . 0.0 108.978 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -140.58 -178.14 5.38 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -59.33 -22.52 61.39 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.694 1.198 . . . . 0.0 111.729 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 48.3 t -88.85 -35.86 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 125.762 1.625 . . . . 0.0 111.965 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 160.19 178.95 34.64 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 121.743 -0.265 . . . . 0.0 112.789 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -78.01 155.71 30.56 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 123.893 0.877 . . . . 0.0 108.98 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -155.72 156.72 35.37 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.31 0.644 . . . . 0.0 111.395 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 92.7 mt -97.15 133.82 37.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 12.3 t -101.32 127.14 48.07 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.495 1.518 . . . . 0.0 108.294 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -122.54 107.28 11.82 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.604 1.562 . . . . 0.0 107.807 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -93.3 115.47 32.19 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.5 mt -99.64 106.59 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 104.778 -2.305 . . . . 0.0 104.778 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -99.72 -152.86 27.24 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 108.771 -1.731 . . . . 0.0 108.771 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 69.66 47.7 0.63 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-O 123.049 1.404 . . . . 0.0 107.875 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -116.79 158.24 14.59 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 107.803 -2.119 . . . . 0.0 107.803 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -74.42 159.15 32.69 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.168 0.987 . . . . 0.0 108.704 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 34.1 mm -83.03 126.38 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 177.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.2 m -75.37 111.75 10.97 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 127.065 2.146 . . . . 0.0 107.072 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -56.23 -27.45 54.93 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.626 1.17 . . . . 0.0 112.49 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 57.9 t -49.3 -50.67 15.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 125.036 1.334 . . . . 0.0 110.847 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 6.5 t -125.57 -32.35 2.89 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 116.644 2.09 . . . . 0.0 116.644 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 106.9 35.86 2.68 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -178.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -116.68 152.14 34.89 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 118.261 1.03 . . . . 0.0 111.764 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -74.81 146.45 42.03 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.571 0.748 . . . . 0.0 112.908 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -72.6 29.11 0.06 Allowed 'General case' 0 C--O 1.223 -0.322 1 C-N-CA 132.055 4.142 . . . . 0.0 112.308 178.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 5.8 ptm -75.77 177.52 6.83 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 120.197 -1.565 . . . . 0.0 110.341 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 5.9 p -147.94 148.85 15.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 125.158 1.383 . . . . 0.0 108.452 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -104.73 121.97 44.71 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 177.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 17.7 mm -114.1 131.22 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -114.54 125.0 53.3 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.304 1.042 . . . . 0.0 109.068 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -97.77 112.72 24.51 Favored 'General case' 0 C--O 1.239 0.553 0 C-N-CA 123.685 0.794 . . . . 0.0 109.72 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 5.1 m -124.08 161.46 26.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 44.1 t -90.25 142.68 27.48 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -84.4 2.39 87.93 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-O 117.753 -1.581 . . . . 0.0 114.906 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.719 0 N-CA-C 106.97 -2.452 . . . . 0.0 106.97 -178.132 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo . . . . . 0 CA--C 1.545 1.065 0 N-CA-C 107.733 -1.68 . . . . 0.0 107.733 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.6 p -150.33 142.11 23.72 Favored 'General case' 0 C--O 1.237 0.405 0 O-C-N 120.047 -1.658 . . . . 0.0 111.554 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 40.7 p -147.86 160.98 42.19 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.776 1.23 . . . . 0.0 110.244 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 4.0 mt -100.08 153.71 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 126.536 1.935 . . . . 0.0 107.865 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -97.62 -48.55 5.2 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 124.492 1.117 . . . . 0.0 112.618 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 52.8 p-90 -163.96 159.46 20.83 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 91.0 t -152.8 129.15 1.84 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.586 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.14 167.35 29.39 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.289 0.95 . . . . 0.0 112.547 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -77.41 132.63 38.6 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.581 1.552 . . . . 0.0 107.653 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 7.5 t -110.84 -33.74 6.44 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.573 1.149 . . . . 0.0 110.918 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -132.53 -175.18 3.67 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 124.645 1.178 . . . . 0.0 108.985 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 60.9 mt -56.64 -45.05 82.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -125.58 18.33 8.1 Favored 'General case' 0 C--N 1.334 -0.108 0 C-N-CA 124.185 0.994 . . . . 0.0 111.102 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 15.8 t -121.65 143.3 34.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 CA-C-N 118.309 0.504 . . . . 0.0 110.387 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -124.47 161.32 26.32 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.152 1.381 . . . . 0.0 107.666 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -132.07 134.49 45.57 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 126.04 1.736 . . . . 0.0 106.534 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -140.22 145.3 37.22 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.919 1.688 . . . . 0.0 109.07 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -133.69 128.62 35.37 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 119.263 -0.398 . . . . 0.0 111.57 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 3.8 m -112.35 152.69 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.57 115.36 20.71 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.808 1.243 . . . . 0.0 107.775 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 18.5 pt -127.14 152.25 75.61 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.879 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.63 -45.43 0.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.819 2.346 . . . . 0.0 112.366 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . 0.414 ' CD ' ' HZ3' ' A' ' 112' ' ' LYS . 4.3 mm-40 -53.32 -28.51 28.77 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 116.751 2.13 . . . . 0.0 116.751 -176.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 59.2 mt -64.42 -28.98 70.05 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 120.33 1.423 . . . . 0.0 110.323 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 12.3 m -60.61 -11.72 8.04 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -69.85 -31.52 69.41 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.96 121.63 25.71 Favored 'General case' 0 C--O 1.225 -0.199 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -47.13 -42.6 19.63 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.906 1.683 . . . . 0.0 113.47 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.86 -29.57 64.51 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 17.3 mt -96.49 -5.45 39.45 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.299 1.04 . . . . 0.0 111.832 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -64.3 116.77 6.36 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.895 1.678 . . . . 0.0 108.577 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm . . . . . 0 N--CA 1.451 -0.399 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 178.217 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.536 0.406 0 CA-C-O 118.916 -0.564 . . . . 0.0 110.955 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.56 -43.15 97.57 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 119.119 0.872 . . . . 0.0 109.395 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 65.7 tp -64.2 -32.36 73.91 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-O 118.406 -0.807 . . . . 0.0 109.61 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.04 -54.36 39.3 Favored 'General case' 0 C--N 1.345 0.377 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 25.3 m -60.79 -48.14 83.13 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.159 0.984 . . . . 0.0 110.877 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.86 -48.84 79.95 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 121.024 -1.048 . . . . 0.0 110.036 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 53.8 m -54.11 -46.09 72.03 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 123.535 0.734 . . . . 0.0 110.055 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -56.22 -48.47 76.41 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.515 0.326 . . . . 0.0 110.432 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.16 -52.96 16.26 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -58.14 -40.29 80.95 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.344 1.058 . . . . 0.0 110.983 -178.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -66.58 -52.35 35.34 Favored Glycine 0 C--O 1.223 -0.537 0 N-CA-C 108.776 -1.729 . . . . 0.0 108.776 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 24.5 t -53.25 -46.88 57.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 118.76 1.28 . . . . 0.0 110.988 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.6 ptmm? -62.44 -34.2 76.32 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.1 m -77.66 -36.45 51.34 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.916 0.887 . . . . 0.0 110.371 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 23.5 mt -60.22 -54.71 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -61.53 -28.19 69.14 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.112 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -66.29 -45.41 80.5 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 120.586 -1.321 . . . . 0.0 113.0 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -76.92 -39.43 50.84 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 18.3 mt -66.22 -28.41 68.72 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-O 118.721 -0.657 . . . . 0.0 112.147 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -56.77 -18.57 13.16 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.54 0.736 . . . . 0.0 112.607 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -68.01 -74.71 0.11 Allowed 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 7.1 mmm180 -143.06 -179.65 6.5 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.281 1.432 . . . . 0.0 111.402 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 85.3 m -86.59 174.91 8.6 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 32.7 pt -128.67 159.99 39.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 127.043 2.137 . . . . 0.0 107.299 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -155.81 135.25 12.39 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.855 1.262 . . . . 0.0 108.975 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -130.79 126.16 35.62 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.666 1.186 . . . . 0.0 109.076 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -88.88 104.15 16.67 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.26 1.024 . . . . 0.0 109.365 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.59 80.74 4.3 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 128.337 2.655 . . . . 0.0 106.552 178.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 59.97 -113.34 5.24 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -78.0 -22.54 49.18 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.192 0.997 . . . . 0.0 112.835 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -105.15 161.72 14.01 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 123.625 0.77 . . . . 0.0 111.917 -178.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.4 mp -135.61 134.75 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 104.131 -2.544 . . . . 0.0 104.131 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -114.86 119.65 37.29 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 103.991 -2.596 . . . . 0.0 103.991 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -111.02 116.46 31.22 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.382 0.673 . . . . 0.0 109.396 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -106.66 129.23 54.6 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 20.8 m -114.75 155.49 46.17 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 126.665 1.986 . . . . 0.0 113.835 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.27 80.73 1.57 Allowed 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 124.115 3.21 . . . . 0.0 113.37 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.44 45.31 18.93 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-O 118.2 -1.333 . . . . 0.0 112.961 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 3.0 mp -120.84 -72.3 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 119.459 1.63 . . . . 0.0 109.913 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -179.2 141.91 0.18 Allowed 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -109.17 125.69 52.46 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -177.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 33.3 m -144.61 164.33 13.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 114.123 -1.399 . . . . 0.0 111.575 -177.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -123.0 130.57 52.97 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.649 1.179 . . . . 0.0 108.286 178.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -138.25 162.89 33.15 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.402 1.481 . . . . 0.0 111.338 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 74.3 t60 -91.06 161.56 15.06 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.916 1.686 . . . . 0.0 107.391 178.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.72 0 CA-C-N 120.099 1.318 . . . . 0.0 110.769 -179.35 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 . . . . . 0 N--CA 1.451 -0.394 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 9.6 tpp180 -143.36 110.46 5.68 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.9 mp -98.43 -34.46 10.63 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 177.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 160.05 163.92 14.34 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 119.266 0.939 . . . . 0.0 111.537 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -118.82 109.78 39.25 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 124.264 1.026 . . . . 0.0 110.201 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -77.93 174.93 11.81 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 123.298 2.665 . . . . 0.0 111.118 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -126.35 146.23 50.13 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.25 -37.93 75.04 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 126.664 1.985 . . . . 0.0 111.428 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -73.25 65.36 0.83 Allowed 'General case' 0 C--O 1.233 0.227 0 C-N-CA 126.098 1.759 . . . . 0.0 109.967 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.4 p -48.84 -31.22 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 125.048 1.339 . . . . 0.0 112.206 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -71.18 -31.61 67.85 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 124.899 1.28 . . . . 0.0 112.862 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -76.65 -12.95 60.08 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.715 1.206 . . . . 0.0 113.167 -178.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -107.63 152.54 24.15 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.598 1.159 . . . . 0.0 110.526 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -105.02 156.61 17.89 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.267 1.427 . . . . 0.0 108.306 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -136.83 163.91 29.53 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.46 1.504 . . . . 0.0 108.738 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -114.72 153.7 29.81 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.236 0.614 . . . . 0.0 110.106 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 16.9 tp -118.39 98.79 6.44 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.432 1.493 . . . . 0.0 107.79 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -110.35 -178.99 3.65 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 126.875 2.07 . . . . 0.0 108.564 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -144.88 163.31 34.5 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 121.35 0.595 . . . . 0.0 110.057 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -137.69 -177.59 4.87 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.791 1.636 . . . . 0.0 108.046 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -60.55 -17.54 46.67 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.164 1.386 . . . . 0.0 111.56 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 87.7 t -86.0 -56.98 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 128.511 2.724 . . . . 0.0 110.484 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 168.76 -165.17 38.68 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -78.39 166.49 22.58 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 117.523 0.662 . . . . 0.0 109.683 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -159.85 171.59 19.18 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.167 0.987 . . . . 0.0 110.384 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 79.7 mt -107.42 138.11 35.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 32.9 t -107.07 134.11 50.69 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 125.393 1.477 . . . . 0.0 108.408 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -130.23 111.45 12.42 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.369 1.068 . . . . 0.0 108.214 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.6 mp -93.41 132.17 38.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 10.3 mt -122.18 115.2 45.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -110.68 -152.52 13.01 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 125.796 1.665 . . . . 0.0 111.603 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 4.6 t 71.58 35.25 1.49 Allowed 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.65 1.58 . . . . 0.0 114.434 178.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -87.58 -112.42 1.02 Allowed Glycine 0 CA--C 1.526 0.768 0 N-CA-C 108.44 -1.864 . . . . 0.0 108.44 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -154.55 150.83 28.17 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 129.825 3.25 . . . . 0.0 103.589 178.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.8 mm -72.9 137.57 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 O-C-N 120.053 -1.654 . . . . 0.0 111.999 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.6 m -81.4 116.08 21.05 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 128.489 2.716 . . . . 0.0 107.001 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -57.72 -29.16 64.51 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 124.624 1.17 . . . . 0.0 112.105 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 14.5 t -51.81 -50.67 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 126.423 1.889 . . . . 0.0 113.878 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 14.7 t -124.0 -31.97 3.31 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.15 34.74 3.86 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 -178.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -109.14 155.64 20.78 Favored 'General case' 0 C--N 1.343 0.324 0 C-N-CA 123.957 0.903 . . . . 0.0 110.182 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -75.72 144.4 41.55 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 125.197 1.399 . . . . 0.0 110.832 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . 0.269 26.1 mtp85 -69.04 29.18 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 130.053 3.341 . . . . 0.0 112.524 178.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 8.4 ptm -74.71 177.99 5.75 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.141 0.976 . . . . 0.0 112.022 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.3 p -145.78 152.72 13.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 125.504 1.522 . . . . 0.0 109.174 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -112.18 101.81 10.03 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 126.938 2.095 . . . . 0.0 106.921 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 9.1 mm -94.36 146.31 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . 0.412 HE22 ' HG2' ' A' ' 230' ' ' GLU . 16.2 mp0 -126.32 114.43 18.24 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 127.298 2.239 . . . . 0.0 109.574 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -93.62 115.71 28.19 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 12.5 m -125.02 165.62 21.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 42.1 t -87.04 140.68 29.31 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -95.47 18.06 58.12 Favored Glycine 0 CA--C 1.523 0.532 0 CA-C-O 118.596 -1.114 . . . . 0.0 112.706 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.985 0 N-CA-C 107.771 -2.131 . . . . 0.0 107.771 -178.241 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.453 ' HG2' ' H ' ' A' ' 216' ' ' SER . 59.5 Cg_endo . . . . . 0 N--CA 1.452 -0.958 0 N-CA-C 110.488 -0.62 . . . . 0.0 110.488 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' SER . . . . . 0.453 ' H ' ' HG2' ' A' ' 215' ' ' PRO . 3.8 p -173.05 152.42 2.32 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.863 1.665 . . . . 0.0 110.914 -178.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 4.7 p -150.85 166.36 30.79 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.533 1.533 . . . . 0.0 109.108 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 5.1 mt -108.68 153.73 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 126.098 1.759 . . . . 0.0 110.614 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -94.44 -56.29 2.86 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 124.46 1.104 . . . . 0.0 111.155 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 -160.73 156.05 24.76 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 126.324 1.85 . . . . 0.0 106.903 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 58.0 t -151.33 125.94 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 125.731 1.612 . . . . 0.0 108.369 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -162.54 164.18 27.01 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 118.21 0.459 . . . . 0.0 110.874 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -65.81 141.9 58.13 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 1.8 t -123.79 -30.64 3.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 118.457 0.571 . . . . 0.0 111.897 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 11.3 mttt -124.4 -175.87 3.37 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 77.0 mt -59.28 -47.36 90.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.88 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 1.8 t -118.93 15.02 13.37 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.651 0.78 . . . . 0.0 112.703 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 14.2 t -122.38 148.7 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.705 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.546 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -125.42 166.1 17.21 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . 0.412 ' HG2' HE22 ' A' ' 205' ' ' GLN . 4.3 mt-10 -133.02 144.47 50.1 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 124.667 1.187 . . . . 0.0 108.464 178.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -144.96 118.95 9.35 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.19 1.396 . . . . 0.0 109.915 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -106.13 124.11 49.06 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 104.98 -2.23 . . . . 0.0 104.98 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 3.0 m -119.38 153.76 21.92 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 2.1 p -122.55 138.27 54.63 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 122.236 1.017 . . . . 0.0 110.856 -178.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -143.69 148.14 41.86 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 114.609 -1.178 . . . . 0.0 108.142 178.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.28 -36.11 3.44 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 121.597 1.531 . . . . 0.0 112.208 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -59.86 -20.74 58.85 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 116.618 2.081 . . . . 0.0 116.618 -177.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 32.9 mt -71.24 -26.64 63.0 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.899 1.681 . . . . 0.0 110.52 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 27.5 m -59.57 -12.52 6.73 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.877 0.871 . . . . 0.0 111.845 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -62.39 -35.77 80.23 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.772 0.829 . . . . 0.0 110.171 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -87.87 130.9 34.75 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -47.81 -48.64 30.43 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.516 1.926 . . . . 0.0 112.779 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 66.0 mt -65.34 -25.67 67.7 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 15.4 mt -99.74 -7.54 25.42 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.746 0.818 . . . . 0.0 113.175 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -62.54 112.86 2.65 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 128.212 2.605 . . . . 0.0 112.743 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.237 0.42 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 C--O 1.237 0.417 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.09 -38.97 93.3 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 22.8 tp -74.0 -40.96 62.57 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 117.519 -1.229 . . . . 0.0 109.367 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 36.2 mt -57.87 -54.09 50.88 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.738 1.154 . . . . 0.0 110.407 -177.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 78.2 m -61.81 -38.07 86.73 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.503 -0.748 . . . . 0.0 111.215 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.39 -48.2 76.35 Favored 'General case' 0 C--N 1.341 0.201 0 O-C-N 120.091 -1.631 . . . . 0.0 109.424 178.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 77.2 m -52.82 -48.43 66.97 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.12 1.368 . . . . 0.0 109.941 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -59.38 -43.92 92.84 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.797 0.439 . . . . 0.0 111.933 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -71.98 -52.79 15.36 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -63.22 -41.22 99.09 Favored 'General case' 0 C--O 1.216 -0.698 0 C-N-CA 124.856 1.263 . . . . 0.0 109.661 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.04 -50.9 62.32 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 36.4 t -58.24 -45.88 88.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 118.591 1.195 . . . . 0.0 110.425 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 8.0 ptmt -61.92 -34.66 76.47 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.783 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 99.6 m -77.67 -28.53 51.16 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.679 0.792 . . . . 0.0 109.783 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 19.8 mt -69.61 -55.03 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 178.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -55.7 -36.99 67.76 Favored 'General case' 0 CA--C 1.527 0.083 0 O-C-N 123.644 0.59 . . . . 0.0 110.565 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -63.25 -38.66 92.02 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.258 1.023 . . . . 0.0 111.95 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.0 tptp -82.63 -38.78 23.04 Favored 'General case' 0 CA--C 1.518 -0.273 0 O-C-N 121.149 -0.969 . . . . 0.0 111.114 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 31.8 mt -70.26 -24.6 63.09 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 122.437 0.295 . . . . 0.0 111.305 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -50.93 -29.71 12.87 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.132 1.373 . . . . 0.0 111.096 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -64.87 -64.51 0.85 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.315 1.046 . . . . 0.0 113.176 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 86.7 mmt-85 -150.46 177.17 10.25 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.684 1.194 . . . . 0.0 110.479 -177.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 74.4 m -86.47 175.99 8.08 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 46.2 pt -129.33 157.74 42.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 124.926 1.29 . . . . 0.0 108.473 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -156.46 139.79 15.7 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.014 0.926 . . . . 0.0 110.668 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -136.84 124.14 21.9 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -81.07 98.79 8.15 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.997 1.719 . . . . 0.0 108.24 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.86 79.76 5.28 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.19 -85.37 0.06 OUTLIER Glycine 0 CA--C 1.521 0.458 0 C-N-CA 124.67 1.129 . . . . 0.0 113.183 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -106.8 -32.18 8.07 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.447 1.099 . . . . 0.0 112.895 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -104.93 128.24 53.11 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 123.679 0.791 . . . . 0.0 110.96 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.9 mp -98.24 157.1 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 103.794 -2.669 . . . . 0.0 103.794 177.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -135.34 121.95 20.77 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 103.955 -2.609 . . . . 0.0 103.955 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -119.25 117.65 29.18 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.8 1.64 . . . . 0.0 110.741 -178.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -110.67 137.7 48.0 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.415 1.486 . . . . 0.0 109.453 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 11.7 m -120.83 151.81 55.2 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 123.718 0.807 . . . . 0.0 111.506 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -60.53 85.35 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.662 1 C-N-CA 125.767 4.311 . . . . 0.0 115.044 -177.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 74.43 33.05 57.06 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 117.964 -1.464 . . . . 0.0 113.207 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 3.8 mp -115.65 -72.49 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 119.537 1.668 . . . . 0.0 109.222 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -168.88 169.36 9.83 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.12 1.768 . . . . 0.0 109.115 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -134.23 120.79 20.45 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 33.8 m -139.47 163.39 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.807 1.243 . . . . 0.0 110.993 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -118.82 125.07 48.73 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -138.24 162.3 34.66 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.962 0.801 . . . . 0.0 110.704 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -89.96 160.58 16.32 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 177.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.565 0 O-C-N 120.031 -1.668 . . . . 0.0 109.685 -178.341 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 . . . . . 0 CA--C 1.547 0.847 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -149.07 129.52 13.88 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.047 -1.658 . . . . 0.0 110.7 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 43.4 mt -109.02 -30.63 7.98 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 120.053 1.297 . . . . 0.0 108.525 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 165.68 164.36 20.99 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -128.66 109.63 18.87 Favored Pre-proline 0 C--O 1.236 0.356 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -73.36 176.72 8.85 Favored 'Trans proline' 0 C--O 1.236 0.39 1 C-N-CA 125.458 4.105 . . . . 0.0 110.783 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -123.13 144.39 49.37 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 124.114 0.966 . . . . 0.0 109.58 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -67.11 -43.53 82.23 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 124.953 1.408 . . . . 0.0 109.6 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -74.3 64.81 1.14 Allowed 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.285 1.434 . . . . 0.0 110.411 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.2 p -50.95 -28.83 6.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 126.855 2.062 . . . . 0.0 111.333 178.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -72.97 -30.44 63.84 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.497 1.119 . . . . 0.0 112.524 -178.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -75.98 -23.01 55.29 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -96.58 173.6 7.26 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -133.31 165.39 24.92 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -135.71 169.79 16.99 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.743 1.217 . . . . 0.0 110.245 -177.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -113.23 153.65 28.01 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 48.7 tp -123.11 99.07 6.18 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.009 1.723 . . . . 0.0 106.784 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -108.36 175.56 5.43 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -140.5 160.56 39.73 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 123.001 1.382 . . . . 0.0 109.609 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -140.79 178.23 7.49 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 126.294 1.838 . . . . 0.0 106.544 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -73.2 10.78 0.87 Allowed 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 125.479 1.512 . . . . 0.0 114.199 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 59.6 t -116.76 -37.25 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 125.879 1.672 . . . . 0.0 109.827 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 164.04 -176.04 40.09 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -86.68 163.19 17.5 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -156.36 161.52 40.14 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.633 0.773 . . . . 0.0 110.667 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 86.6 mt -102.08 130.74 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 12.9 t -97.38 126.9 42.91 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.485 1.114 . . . . 0.0 108.704 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -122.13 108.89 13.86 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -90.28 108.88 20.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 N-CA-C 103.68 -2.711 . . . . 0.0 103.68 178.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 12.2 mt -94.62 105.92 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 103.331 -2.841 . . . . 0.0 103.331 177.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -99.28 -152.72 27.52 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 107.765 -2.134 . . . . 0.0 107.765 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 5.2 t 70.22 51.64 0.38 Allowed 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -178.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -93.29 -162.78 36.62 Favored Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 106.375 -2.69 . . . . 0.0 106.375 177.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . 0.405 ' H ' ' HB3' ' A' ' 200' ' ' ARG . 62.7 m-20 -127.64 136.17 51.26 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 100.585 -3.858 . . . . 0.0 100.585 177.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 33.2 mm -60.36 138.95 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 119.552 1.069 . . . . 0.0 109.924 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.06 112.01 24.25 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.829 2.052 . . . . 0.0 106.376 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -51.12 -29.02 12.14 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.183 1.793 . . . . 0.0 115.795 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 24.5 t -42.22 -51.92 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.126 1.37 . . . . 0.0 111.108 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 13.2 t -123.76 -34.07 3.08 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.532 0.733 . . . . 0.0 109.334 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 106.48 35.46 2.86 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -112.51 158.86 19.39 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-N 118.852 1.326 . . . . 0.0 110.689 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -68.12 143.53 55.39 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.649 1.58 . . . . 0.0 114.869 -178.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . 0.405 ' HB3' ' H ' ' A' ' 191' ' ' ASP 0.258 24.1 ttp180 -77.22 28.76 0.14 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 130.508 3.523 . . . . 0.0 113.524 179.033 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 8.1 ptm -73.82 176.91 5.9 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.072 -1.017 . . . . 0.0 111.365 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.46 149.27 19.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 125.801 1.64 . . . . 0.0 106.733 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -111.39 114.19 27.16 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 9.5 mm -102.26 138.99 24.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -118.15 96.93 5.54 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 126.729 2.011 . . . . 0.0 107.698 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -80.83 111.13 17.01 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.247 1.019 . . . . 0.0 108.545 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 33.5 m -124.53 164.98 22.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 124.653 1.181 . . . . 0.0 108.383 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . 0.424 ' O ' ' HE2' ' A' ' 246' ' ' LYS . 41.8 t -85.8 142.22 29.1 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -90.54 16.99 56.57 Favored Glycine 0 C--O 1.227 -0.294 0 CA-C-O 118.067 -1.407 . . . . 0.0 115.15 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.318 0 C-N-CA 125.812 1.673 . . . . 0.0 117.071 179.489 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo . . . . . 0 CA--C 1.545 1.072 0 N-CA-C 110.983 -0.43 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 3.8 p -156.01 148.61 23.86 Favored 'General case' 0 C--O 1.237 0.442 0 O-C-N 120.094 -1.629 . . . . 0.0 109.853 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.7 p -151.01 168.5 24.38 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.895 0.878 . . . . 0.0 112.122 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 3.2 mt -109.63 152.01 11.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 126.505 1.922 . . . . 0.0 109.465 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -98.42 -51.83 3.84 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 126.063 1.745 . . . . 0.0 109.592 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 65.3 p-90 -159.87 158.67 31.34 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.607 1.163 . . . . 0.0 109.306 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 97.1 t -153.42 134.9 5.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 126.153 1.781 . . . . 0.0 107.459 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -165.7 162.64 18.86 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.367 0.667 . . . . 0.0 111.662 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -68.48 140.87 55.72 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 178.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 13.1 t -120.65 -30.07 4.57 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.865 1.266 . . . . 0.0 112.681 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 43.2 mttt -131.25 -175.63 3.76 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 72.8 mt -46.68 -49.49 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 6.8 t -133.25 17.82 4.06 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.986 0.514 . . . . 0.0 111.276 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 23.1 t -109.62 143.31 19.97 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -122.68 161.95 22.89 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -131.69 144.55 51.08 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 178.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -144.77 141.33 29.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.893 1.277 . . . . 0.0 109.585 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -124.01 116.26 22.55 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 1.1 m -110.36 144.54 18.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -121.83 123.6 42.16 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.666 1.586 . . . . 0.0 110.757 -178.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 3.6 pt -131.65 147.62 66.77 Favored Pre-proline 0 C--N 1.331 -0.231 0 C-N-CA 123.892 0.877 . . . . 0.0 108.695 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -70.18 -43.04 2.51 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.766 1.644 . . . . 0.0 111.924 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -55.77 -23.85 32.17 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -177.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 20.1 mt -65.28 -26.71 68.2 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 116.982 -1.887 . . . . 0.0 111.07 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 18.9 m -61.7 -11.75 13.35 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.618 0.645 . . . . 0.0 112.29 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -61.08 -22.89 65.04 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.718 0.807 . . . . 0.0 109.798 177.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -98.11 130.58 44.89 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 126.594 1.958 . . . . 0.0 109.743 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -51.65 -47.76 63.62 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.844 1.258 . . . . 0.0 112.637 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.59 -35.85 80.85 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.104 -0.998 . . . . 0.0 113.438 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 17.9 mt -89.89 -14.94 33.17 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -58.68 112.72 1.72 Allowed 'General case' 0 C--O 1.236 0.345 0 C-N-CA 128.204 2.601 . . . . 0.0 111.731 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.424 ' HE2' ' O ' ' A' ' 208' ' ' CYS . 39.2 mmtt . . . . . 0 C--O 1.235 0.29 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.465 0.323 0 CA-C-O 120.472 0.177 . . . . 0.0 110.708 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.5 -42.61 95.72 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 32.5 tp -69.85 -36.89 75.91 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.44 1.096 . . . . 0.0 110.507 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 22.4 mt -61.41 -54.89 37.67 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 119.005 0.821 . . . . 0.0 109.083 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 56.1 m -65.38 -40.26 93.26 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 121.453 -0.779 . . . . 0.0 111.257 -179.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -45.37 93.89 Favored 'General case' 0 C--O 1.222 -0.382 0 O-C-N 121.207 -0.933 . . . . 0.0 109.169 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 42.2 m -52.28 -48.9 65.05 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.171 0.989 . . . . 0.0 109.741 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -58.3 -48.9 79.02 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.886 0.474 . . . . 0.0 110.863 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -67.82 -56.33 9.57 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -177.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.414 ' HA ' ' HE3' ' A' ' 107' ' ' LYS . 2.8 mm-40 -55.83 -44.25 77.75 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.806 1.642 . . . . 0.0 109.678 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.34 -52.99 49.29 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-O 118.001 -1.444 . . . . 0.0 110.212 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 43.0 t -55.85 -43.36 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-N 119.893 1.846 . . . . 0.0 110.91 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.414 ' HE3' ' HA ' ' A' ' 104' ' ' GLN . 6.6 ptpt -66.01 -33.81 76.65 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 119.38 -0.928 . . . . 0.0 111.165 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 65.5 m -72.9 -39.24 66.51 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 22.7 mt -61.06 -55.76 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -61.29 -35.42 77.29 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 118.292 -0.861 . . . . 0.0 112.67 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -62.21 -33.85 75.34 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.813 0.733 . . . . 0.0 111.887 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.456 ' HA ' ' HE2' ' A' ' 112' ' ' LYS . 0.6 OUTLIER -87.62 -38.27 16.06 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 117.87 -1.062 . . . . 0.0 110.333 179.047 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 29.5 mt -65.74 -25.17 67.16 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.904 1.229 . . . . 0.0 110.338 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -51.47 -30.08 18.54 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.119 1.768 . . . . 0.0 111.558 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -65.51 -66.75 0.51 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.426 1.49 . . . . 0.0 113.083 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.6 mmt180 -144.56 173.36 11.87 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 124.456 1.102 . . . . 0.0 110.743 -178.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 78.6 m -86.07 163.34 17.97 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 48.3 pt -118.92 154.5 21.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -178.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -151.87 144.49 24.24 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.909 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -140.74 122.34 15.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.425 178.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -81.6 100.07 9.2 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.69 80.03 6.67 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 104.389 -2.449 . . . . 0.0 104.389 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 65.97 -109.02 2.65 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -81.32 -36.36 29.84 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -99.84 146.0 27.11 Favored 'General case' 0 CA--C 1.512 -0.486 0 O-C-N 121.635 -0.666 . . . . 0.0 110.388 -178.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.5 mp -110.21 153.4 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -131.9 119.3 20.98 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -121.15 120.49 35.4 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.315 1.046 . . . . 0.0 111.676 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -111.27 140.66 45.66 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.003 1.321 . . . . 0.0 111.065 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 50.3 m -123.12 152.77 64.06 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.497 1.119 . . . . 0.0 111.371 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -63.73 86.28 0.14 Allowed 'Trans proline' 0 C--N 1.35 0.649 1 C-N-CA 125.548 4.165 . . . . 0.0 115.7 -178.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 72.51 34.96 59.84 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 118.751 -1.027 . . . . 0.0 112.278 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 4.4 mp -118.59 -71.62 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.344 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -168.81 172.65 7.66 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.523 1.529 . . . . 0.0 110.314 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -137.21 119.75 15.99 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 31.8 m -139.22 163.54 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 124.528 1.131 . . . . 0.0 111.059 -178.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -121.05 124.43 44.8 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.968 1.307 . . . . 0.0 107.92 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -138.65 162.28 35.03 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.961 0.904 . . . . 0.0 111.469 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -92.08 160.91 14.99 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 176.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.479 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -179.419 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 33.1 ttt85 -148.49 102.14 3.3 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 81.6 mt -79.37 -30.8 42.71 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 119.387 0.994 . . . . 0.0 108.495 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 169.45 156.35 10.74 Favored Glycine 0 N--CA 1.439 -1.129 0 CA-C-O 121.899 0.721 . . . . 0.0 111.345 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.62 109.04 44.05 Favored Pre-proline 0 N--CA 1.444 -0.76 0 C-N-CA 124.481 1.112 . . . . 0.0 108.674 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -77.22 -168.36 0.58 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.438 2.759 . . . . 0.0 109.038 178.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -126.5 151.09 48.28 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 124.724 1.21 . . . . 0.0 108.047 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -74.81 -28.69 60.81 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.973 0.892 . . . . 0.0 109.445 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -89.32 65.24 7.15 Favored 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 126.148 1.779 . . . . 0.0 106.297 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.2 p -45.22 -32.79 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 123.911 0.884 . . . . 0.0 111.973 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -65.48 -26.34 67.89 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.996 2.119 . . . . 0.0 112.875 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.68 -25.83 49.79 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.742 0.817 . . . . 0.0 110.337 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -75.96 177.74 6.79 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.725 0.81 . . . . 0.0 109.267 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -131.52 155.74 46.91 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -139.73 160.15 40.54 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.993 0.917 . . . . 0.0 109.49 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -117.24 153.57 32.67 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 18.5 tp -119.84 98.34 6.05 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -106.05 172.53 6.76 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -147.21 162.76 38.24 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.934 0.873 . . . . 0.0 109.021 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -139.54 178.17 7.41 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 125.682 1.593 . . . . 0.0 109.44 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -68.38 2.2 2.47 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.081 1.353 . . . . 0.0 111.928 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 90.8 t -109.66 -38.96 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 126.14 1.776 . . . . 0.0 110.177 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 166.37 -175.81 41.73 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -88.33 164.86 15.35 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 117.962 0.881 . . . . 0.0 109.327 178.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -158.92 163.7 36.31 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.704 0.802 . . . . 0.0 109.965 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 95.2 mt -107.21 131.8 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 22.6 t -100.69 137.34 39.22 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.405 0.682 . . . . 0.0 109.312 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -131.22 116.05 17.14 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.513 1.125 . . . . 0.0 108.082 178.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -92.84 120.75 42.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 178.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.1 mt -107.66 106.7 21.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -108.92 -152.68 15.28 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 125.977 1.751 . . . . 0.0 109.199 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 80.42 22.8 0.41 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.956 1.702 . . . . 0.0 112.634 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -91.89 -154.05 30.41 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.24 166.15 10.85 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 179.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 36.7 mm -88.7 140.74 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.235 1.414 . . . . 0.0 108.982 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.2 m -88.94 115.14 26.28 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 127.816 2.446 . . . . 0.0 106.612 178.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -57.91 -16.96 13.83 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.211 1.404 . . . . 0.0 113.586 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 61.8 t -53.32 -56.06 9.98 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 CA-C-N 118.913 0.779 . . . . 0.0 110.663 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 1.9 t -124.66 -23.12 4.43 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -177.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.87 35.35 4.03 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 108.395 -1.882 . . . . 0.0 108.395 -178.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -111.0 147.59 34.4 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 119.054 1.427 . . . . 0.0 113.563 -178.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -68.34 144.51 54.76 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.992 0.917 . . . . 0.0 112.657 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -70.1 26.77 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.499 1 C-N-CA 131.862 4.065 . . . . 0.0 111.471 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 7.0 ptm -74.08 176.3 6.66 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.767 1.167 . . . . 0.0 112.814 -177.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.3 p -141.18 148.33 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 125.1 1.36 . . . . 0.0 107.981 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -110.59 109.32 19.57 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.484 1.913 . . . . 0.0 106.477 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 9.2 mm -99.29 150.06 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 O-C-N 121.055 -1.028 . . . . 0.0 111.191 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -125.67 106.52 9.78 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.206 2.202 . . . . 0.0 110.077 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -87.46 110.25 20.17 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 177.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 31.3 m -125.17 168.42 17.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 C-N-CA 125.186 1.394 . . . . 0.0 109.041 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 51.6 t -89.07 146.5 24.79 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 104.432 -2.432 . . . . 0.0 104.432 177.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -91.19 18.74 50.43 Favored Glycine 0 C--O 1.226 -0.401 0 CA-C-O 117.023 -1.987 . . . . 0.0 116.688 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.722 0 CA-C-N 119.433 1.617 . . . . 0.0 109.075 -179.308 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo . . . . . 0 CA--C 1.542 0.899 0 CA-C-O 119.905 -0.123 . . . . 0.0 112.033 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 14.7 p -147.34 145.97 29.51 Favored 'General case' 0 C--O 1.239 0.52 0 O-C-N 120.482 -1.387 . . . . 0.0 112.369 -177.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 81.3 p -149.91 166.14 30.47 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.163 0.985 . . . . 0.0 110.99 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.9 mp -104.07 154.36 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 126.072 1.749 . . . . 0.0 108.118 178.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 43.4 mm-40 -103.11 -49.98 3.61 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 125.202 1.401 . . . . 0.0 110.66 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 59.8 p-90 -158.04 155.88 30.1 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.572 1.149 . . . . 0.0 109.109 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 60.9 t -153.97 132.64 2.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 125.809 1.644 . . . . 0.0 107.411 179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.3 167.34 17.98 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.851 0.86 . . . . 0.0 111.342 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -75.96 132.99 40.56 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 4.6 t -112.42 -31.36 6.84 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.463 1.505 . . . . 0.0 112.705 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -132.49 -175.75 3.86 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 124.249 1.02 . . . . 0.0 108.357 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 55.1 mt -47.26 -47.87 9.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 123.567 0.747 . . . . 0.0 112.631 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -132.88 19.34 4.16 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.229 1.012 . . . . 0.0 111.2 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 18.4 t -116.75 145.33 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.813 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -177.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -125.02 164.53 19.96 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -136.18 148.19 48.02 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.48 146.53 30.58 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.387 1.475 . . . . 0.0 108.942 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -129.63 120.12 24.69 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 2.4 m -115.98 143.51 25.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.8 p -119.91 127.51 52.76 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 127.175 2.19 . . . . 0.0 111.911 -176.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 15.1 pt -134.04 146.64 60.72 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 177.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -71.45 -36.42 6.84 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 123.151 2.567 . . . . 0.0 111.323 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -59.02 -28.23 66.2 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.81 1.244 . . . . 0.0 114.304 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 3.1 tp -60.83 -32.49 71.88 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 121.45 -0.781 . . . . 0.0 111.367 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 7.3 m -59.56 -13.64 10.05 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.587 1.155 . . . . 0.0 113.448 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.88 -35.59 75.13 Favored 'General case' 0 C--O 1.227 -0.095 0 CA-C-N 119.58 1.082 . . . . 0.0 110.307 179.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.18 125.63 29.7 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -48.27 -42.29 30.26 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.128 1.371 . . . . 0.0 112.459 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.57 -32.27 73.76 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.415 -0.803 . . . . 0.0 112.496 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 25.4 mt -96.14 -7.63 35.38 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.835 1.654 . . . . 0.0 113.298 -178.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -67.52 108.53 2.88 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.094 2.158 . . . . 0.0 110.172 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 9.9 mmmt . . . . . 0 N--CA 1.47 0.543 0 CA-C-N 118.945 0.793 . . . . 0.0 110.246 -179.729 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.466 0.34 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.52 -38.32 80.69 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.212 0.46 . . . . 0.0 110.221 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 23.1 tp -73.94 -34.96 64.51 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.377 1.071 . . . . 0.0 109.383 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 28.6 mt -60.16 -55.18 37.03 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.23 0.923 . . . . 0.0 110.049 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 96.3 m -67.09 -40.34 86.95 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.295 -0.878 . . . . 0.0 111.018 -178.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.2 ttpt -59.38 -43.94 92.85 Favored 'General case' 0 C--O 1.226 -0.159 0 O-C-N 121.081 -1.012 . . . . 0.0 109.984 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 55.3 m -54.02 -43.92 70.53 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 124.352 1.061 . . . . 0.0 110.347 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -57.02 -50.33 73.06 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.522 0.601 . . . . 0.0 109.924 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.47 -54.69 21.13 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.565 0.697 . . . . 0.0 111.735 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -55.12 -44.4 74.96 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.224 1.01 . . . . 0.0 110.914 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.48 -51.87 48.39 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-O 117.797 -1.557 . . . . 0.0 109.366 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 41.0 t -54.86 -45.16 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 119.966 1.883 . . . . 0.0 109.683 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.0 pttm -61.83 -34.85 76.69 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 119.804 -0.759 . . . . 0.0 111.183 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 39.0 m -71.28 -44.17 65.74 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.579 0.752 . . . . 0.0 109.558 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 22.3 mt -57.49 -55.53 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -63.27 -29.24 70.61 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 118.782 -0.628 . . . . 0.0 112.348 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -70.18 -48.95 55.03 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.354 0.979 . . . . 0.0 111.898 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.428 ' HA ' ' HE2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -75.71 -43.91 44.71 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 123.562 0.745 . . . . 0.0 112.129 -178.037 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 14.2 mt -65.27 -28.25 69.21 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 118.193 -0.908 . . . . 0.0 112.671 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -51.91 -28.8 17.55 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -48.88 -69.86 0.11 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -146.48 179.01 7.84 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 126.152 1.781 . . . . 0.0 108.454 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 59.8 m -87.14 166.67 14.8 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 35.4 pt -120.39 155.95 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.446 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -148.22 139.79 23.66 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 123.61 0.764 . . . . 0.0 110.383 -178.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.451 ' CZ ' ' HA ' ' A' ' 220' ' ' TRP . 7.1 t80 -137.07 120.88 17.46 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.58 1.152 . . . . 0.0 110.304 178.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -82.97 101.94 11.4 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.513 1.525 . . . . 0.0 109.509 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -87.86 81.15 7.63 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 127.956 2.502 . . . . 0.0 106.794 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.52 -90.49 0.38 Allowed Glycine 0 CA--C 1.534 1.24 0 O-C-N 121.301 -0.874 . . . . 0.0 111.926 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -107.68 -28.57 9.64 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 127.053 2.141 . . . . 0.0 112.844 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -99.55 157.65 16.3 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.1 mp -126.88 128.4 70.78 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -101.43 119.03 38.14 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -116.21 123.24 47.27 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -115.92 132.48 56.63 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.556 0.743 . . . . 0.0 110.302 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 66.7 m -112.27 148.18 38.57 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 124.247 1.019 . . . . 0.0 109.145 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.78 85.96 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 124.38 3.387 . . . . 0.0 115.151 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.21 30.76 40.57 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-O 117.944 -1.476 . . . . 0.0 112.981 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 3.9 mp -117.15 -73.62 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.455 0 CA-C-N 119.191 1.495 . . . . 0.0 110.247 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -163.39 166.25 23.09 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.03 2.132 . . . . 0.0 108.583 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -135.6 123.6 22.79 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.568 1.547 . . . . 0.0 107.568 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 17.8 m -144.47 164.04 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 126.8 2.04 . . . . 0.0 111.103 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -117.84 127.19 53.63 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 177.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -136.53 162.41 33.19 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 125.39 1.476 . . . . 0.0 111.224 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -92.63 160.56 14.95 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.751 0 CA-C-N 119.185 0.902 . . . . 0.0 111.722 -179.294 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 . . . . . 0 CA--C 1.532 0.284 0 CA-C-O 121.174 0.512 . . . . 0.0 109.626 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -149.04 112.0 4.87 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 126.268 1.827 . . . . 0.0 108.471 178.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 82.6 mt -99.07 -26.89 14.07 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 160.96 161.01 11.13 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -127.34 108.53 21.26 Favored Pre-proline 0 C--O 1.239 0.509 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -72.32 -179.62 4.18 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 124.447 3.432 . . . . 0.0 109.825 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -122.39 159.76 26.85 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.063 0.545 . . . . 0.0 110.851 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.62 -54.0 11.85 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -68.72 64.6 0.12 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 126.751 2.02 . . . . 0.0 112.71 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 5.6 p -47.02 -34.34 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 C-N-CA 125.759 1.624 . . . . 0.0 111.846 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -63.84 -32.98 74.68 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.022 1.329 . . . . 0.0 112.026 -178.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -80.69 -14.21 58.34 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 122.748 0.419 . . . . 0.0 110.096 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 44.4 mtp180 -83.3 177.97 8.28 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 121.071 -1.018 . . . . 0.0 109.509 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -132.85 150.36 52.17 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.381 1.072 . . . . 0.0 108.201 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -138.22 161.2 37.47 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.193 1.797 . . . . 0.0 107.688 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -126.87 149.99 49.48 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 122.889 0.476 . . . . 0.0 110.606 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 32.1 tp -107.47 111.01 23.1 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.876 1.271 . . . . 0.0 108.659 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -118.47 -179.75 3.88 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.944 1.298 . . . . 0.0 110.45 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -137.84 154.4 49.51 Favored 'General case' 0 N--CA 1.458 -0.037 0 C-N-CA 124.875 1.27 . . . . 0.0 109.467 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -140.45 -178.16 5.37 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 126.678 1.991 . . . . 0.0 107.421 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -66.11 -5.71 10.83 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.868 1.267 . . . . 0.0 113.417 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 56.0 t -107.6 -24.49 4.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 126.794 2.038 . . . . 0.0 113.656 -178.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 144.24 -173.02 25.12 Favored Glycine 0 N--CA 1.444 -0.774 0 O-C-N 121.841 -0.537 . . . . 0.0 112.052 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -79.06 158.42 27.86 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 121.716 0.769 . . . . 0.0 109.297 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -155.74 162.85 40.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.331 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 96.7 mt -104.23 136.42 37.62 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.073 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 46.2 t -102.22 129.34 48.59 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 125.414 1.485 . . . . 0.0 108.374 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -121.33 113.98 20.68 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.88 119.0 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 104.512 -2.403 . . . . 0.0 104.512 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 9.0 mt -109.2 105.63 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 177.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -101.32 -153.43 26.03 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 23.1 t 67.86 26.65 7.55 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.993 0.917 . . . . 0.0 111.932 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -82.2 -60.32 2.16 Favored Glycine 0 CA--C 1.525 0.691 0 O-C-N 120.51 -1.369 . . . . 0.0 110.543 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 153.83 -174.14 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.608 1 C-N-CA 131.893 4.077 . . . . 0.0 106.384 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 51.8 mm -105.9 143.3 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 129.561 3.144 . . . . 0.0 112.205 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.2 m -93.56 118.15 30.98 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 128.345 2.658 . . . . 0.0 107.207 177.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.5 -30.89 54.77 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.818 1.247 . . . . 0.0 113.331 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 44.1 t -45.32 -56.28 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 125.019 1.328 . . . . 0.0 113.031 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 6.6 t -123.46 -23.02 4.89 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 124.701 1.201 . . . . 0.0 113.85 -177.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 94.97 34.66 6.1 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 107.263 -2.335 . . . . 0.0 107.263 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -103.09 150.38 23.67 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 117.998 0.899 . . . . 0.0 110.922 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -74.03 139.65 44.88 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 122.544 0.337 . . . . 0.0 111.697 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -67.47 29.0 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.559 1 C-N-CA 135.799 5.64 . . . . 0.0 110.208 177.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 1.9 ptm -74.46 -176.81 2.85 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.17 1.388 . . . . 0.0 111.955 -177.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.2 p -153.6 146.69 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 O-C-N 121.087 -1.008 . . . . 0.0 110.753 -178.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -104.32 104.77 14.71 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.595 1.558 . . . . 0.0 109.522 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 8.7 mm -93.8 123.1 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -105.15 99.61 9.22 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 127.312 2.245 . . . . 0.0 109.333 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -82.17 110.72 17.63 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.76 1.224 . . . . 0.0 108.849 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 19.0 m -124.72 164.73 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 125.456 1.502 . . . . 0.0 107.46 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 46.3 t -83.91 146.09 28.23 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 119.909 -1.745 . . . . 0.0 107.562 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -86.75 3.76 86.77 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-O 118.774 -1.015 . . . . 0.0 113.108 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.726 0 N-CA-C 107.905 -2.078 . . . . 0.0 107.905 -179.069 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 N--CA 1.455 -0.774 0 N-CA-C 111.598 -0.193 . . . . 0.0 111.598 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 5.0 p -151.74 146.5 25.8 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.654 1.182 . . . . 0.0 109.086 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 17.0 p -149.89 172.23 15.5 Favored 'General case' 0 C--O 1.225 -0.201 0 O-C-N 121.757 -0.589 . . . . 0.0 112.246 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 5.8 mt -122.14 146.06 27.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 126.863 2.065 . . . . 0.0 106.555 177.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -95.35 -47.67 6.2 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.343 1.457 . . . . 0.0 110.525 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . 0.451 ' HA ' ' CZ ' ' A' ' 120' ' ' TYR . 56.2 p-90 -162.88 158.51 22.62 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 125.459 1.504 . . . . 0.0 108.948 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 49.7 t -152.94 135.02 5.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 126.189 1.796 . . . . 0.0 106.366 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.79 168.76 17.5 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.006 1.322 . . . . 0.0 110.347 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -75.61 141.67 42.82 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 124.104 0.962 . . . . 0.0 108.638 178.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 10.2 t -118.83 -31.98 4.64 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.955 1.302 . . . . 0.0 112.3 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 4.8 mttm -135.22 -176.59 4.31 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 120.806 -1.184 . . . . 0.0 109.067 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 36.5 mt -48.15 -47.22 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 123.864 0.866 . . . . 0.0 112.29 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -130.62 21.47 5.09 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.265 1.026 . . . . 0.0 111.894 -178.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 16.6 t -122.62 143.0 36.95 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.584 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -178.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -121.68 162.52 20.59 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.57 1.548 . . . . 0.0 107.131 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -131.46 138.28 48.95 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 125.416 1.486 . . . . 0.0 107.209 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -135.78 132.39 36.69 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.569 1.148 . . . . 0.0 109.522 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -109.08 108.0 18.53 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 48.3 t -100.73 138.23 25.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.3 p -120.94 130.29 53.8 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 126.286 1.835 . . . . 0.0 112.427 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -138.67 143.34 37.5 Favored Pre-proline 0 N--CA 1.467 0.394 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 176.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -73.3 -33.32 7.27 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.948 2.432 . . . . 0.0 112.963 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -64.25 -17.77 63.92 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.56 0.744 . . . . 0.0 112.811 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 5.9 tp -68.16 -29.51 68.42 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 121.174 -0.954 . . . . 0.0 110.044 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 14.4 m -62.99 -9.98 12.05 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.664 0.786 . . . . 0.0 112.961 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -60.89 -31.24 70.73 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.196 0.907 . . . . 0.0 109.721 178.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -88.64 127.22 35.56 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 124.196 0.998 . . . . 0.0 109.331 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -47.0 -49.33 21.04 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 126.047 1.739 . . . . 0.0 113.475 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 41.8 mt -65.05 -28.81 69.73 Favored 'General case' 0 C--O 1.231 0.115 0 O-C-N 121.332 -0.855 . . . . 0.0 112.983 -178.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 11.5 mt -95.75 -17.52 21.16 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.101 0.96 . . . . 0.0 112.7 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -62.31 135.53 57.5 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 129.321 3.048 . . . . 0.0 109.445 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt . . . . . 0 CA--C 1.513 -0.474 0 C-N-CA 124.154 0.982 . . . . 0.0 112.12 -179.711 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.311 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.07 -50.97 69.82 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 57.2 tp -63.79 -39.86 95.26 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.569 1.148 . . . . 0.0 110.678 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.8 mt -60.1 -54.28 47.76 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 119.277 0.944 . . . . 0.0 108.65 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.3 m -58.31 -49.32 77.58 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.121 0.486 . . . . 0.0 110.152 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -60.88 -40.74 94.16 Favored 'General case' 0 C--O 1.232 0.164 0 O-C-N 121.206 -0.934 . . . . 0.0 111.776 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 54.4 m -52.3 -48.74 65.21 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.574 0.75 . . . . 0.0 110.842 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -58.89 -47.6 84.38 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 117.966 0.348 . . . . 0.0 110.659 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.45 -55.81 24.11 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 122.504 1.145 . . . . 0.0 113.876 -177.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -64.34 -38.44 91.05 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-N 113.645 -1.616 . . . . 0.0 111.521 -177.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.25 -52.78 41.15 Favored Glycine 0 N--CA 1.44 -1.045 0 N-CA-C 107.95 -2.06 . . . . 0.0 107.95 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 56.0 t -56.92 -47.92 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 119.306 1.553 . . . . 0.0 110.541 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.6 pttm -59.1 -35.52 73.56 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.847 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 52.5 m -79.29 -36.36 39.85 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.308 1.043 . . . . 0.0 111.067 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 21.8 mt -57.85 -54.27 34.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -60.84 -29.39 69.47 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.481 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -68.24 -41.05 81.74 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 120.144 1.338 . . . . 0.0 111.593 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.435 ' HZ2' ' HA ' ' A' ' 215' ' ' PRO . 0.0 OUTLIER -79.07 -37.42 38.9 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 117.991 0.36 . . . . 0.0 111.75 -179.371 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 17.2 mt -74.17 -25.83 59.95 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 118.685 -0.674 . . . . 0.0 111.903 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -54.82 -20.12 7.95 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.454 0.57 . . . . 0.0 112.167 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -64.62 -72.77 0.14 Allowed 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.694 1.197 . . . . 0.0 109.036 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -147.42 -175.55 4.89 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.386 1.474 . . . . 0.0 111.522 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 62.6 m -87.71 175.4 7.89 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.604 -0.685 . . . . 0.0 109.439 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 27.4 pt -132.73 161.22 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 126.324 1.85 . . . . 0.0 108.774 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -154.74 142.73 20.15 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 122.759 0.423 . . . . 0.0 110.401 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -134.37 123.74 24.61 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.478 0.711 . . . . 0.0 110.499 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -86.66 98.7 11.26 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.19 81.06 5.56 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 128.407 2.683 . . . . 0.0 107.336 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 58.47 -112.93 4.39 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 124.388 0.994 . . . . 0.0 111.054 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -77.28 -12.8 59.99 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.852 1.261 . . . . 0.0 113.375 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -115.74 158.24 23.12 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 124.414 1.086 . . . . 0.0 112.642 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.532 HD13 ' H ' ' A' ' 140' ' ' GLY . 4.8 mp -133.38 126.36 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 N-CA-C 103.577 -2.749 . . . . 0.0 103.577 177.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -110.54 123.36 49.79 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -117.96 129.63 55.72 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.714 0.806 . . . . 0.0 110.008 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -119.52 133.2 55.79 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 123.722 0.809 . . . . 0.0 110.923 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 16.3 m -112.41 156.1 42.7 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 123.737 0.815 . . . . 0.0 111.075 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -63.77 78.46 0.15 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 125.084 3.856 . . . . 0.0 114.203 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 67.51 60.19 6.06 Favored Glycine 0 CA--C 1.525 0.677 0 O-C-N 120.971 -1.081 . . . . 0.0 111.688 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 3.5 mp -130.86 -71.44 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -165.73 168.95 15.65 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 125.45 1.5 . . . . 0.0 109.449 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -130.81 121.95 26.25 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 176.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.8 m -144.76 164.94 12.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 118.916 0.78 . . . . 0.0 111.083 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -120.95 132.2 54.79 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.726 1.211 . . . . 0.0 108.727 178.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -138.51 162.74 33.77 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.122 1.369 . . . . 0.0 112.437 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 55.5 t60 -103.15 108.8 20.14 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.532 ' H ' HD13 ' A' ' 126' ' ' ILE . . . . . . . . 0 C--N 1.331 0.301 0 O-C-N 121.603 -0.686 . . . . 0.0 112.107 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 . . . . . 0 N--CA 1.449 -0.487 0 CA-C-O 122.795 1.283 . . . . 0.0 108.436 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.439 ' N ' HH21 ' A' ' 200' ' ' ARG . 0.0 OUTLIER -149.38 110.35 4.34 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 179.005 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mp -93.92 -27.53 16.32 Favored 'General case' 0 C--O 1.219 -0.55 0 O-C-N 125.794 1.934 . . . . 0.0 107.315 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 163.63 163.23 15.97 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 5.4 mtpt -127.66 110.13 20.68 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -78.04 -173.08 1.68 Allowed 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 124.954 3.769 . . . . 0.0 110.4 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -129.32 149.18 51.22 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 125.277 1.431 . . . . 0.0 109.58 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.74 -41.4 71.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.668 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 31.4 m-20 -71.7 65.02 0.48 Allowed 'General case' 0 C--O 1.236 0.383 0 C-N-CA 126.383 1.873 . . . . 0.0 110.977 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.4 p -52.3 -32.0 15.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 124.904 1.282 . . . . 0.0 110.663 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -63.93 -22.39 66.9 Favored 'General case' 0 N--CA 1.461 0.105 0 C-N-CA 124.695 1.198 . . . . 0.0 112.544 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -97.85 -18.27 18.82 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.522 1.129 . . . . 0.0 110.877 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.4 mtp-105 -81.02 142.21 33.61 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -103.73 148.98 25.42 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 178.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -134.25 -176.47 4.21 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.48 1.512 . . . . 0.0 109.587 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -135.41 153.46 51.79 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.329 1.051 . . . . 0.0 109.331 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 22.9 tp -115.05 98.97 7.11 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.697 1.599 . . . . 0.0 106.861 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -105.33 -179.8 4.05 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 181' ' ' TYR . 2.5 p90 -145.65 163.01 36.2 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -140.75 -178.44 5.54 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.406 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -62.07 -14.41 36.01 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.528 1.131 . . . . 0.0 111.107 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 57.9 t -98.04 -39.12 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 125.495 1.518 . . . . 0.0 111.395 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 161.3 -173.83 37.77 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 123.431 0.539 . . . . 0.0 112.152 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 176' ' ' TYR . 25.9 m-85 -77.72 160.34 28.5 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 118.387 1.094 . . . . 0.0 110.72 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -158.84 168.5 26.64 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.325 1.45 . . . . 0.0 110.813 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 89.1 mt -108.89 141.46 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 15.6 t -111.41 137.32 49.35 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.394 1.077 . . . . 0.0 109.585 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -129.13 111.53 13.04 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.482 1.513 . . . . 0.0 108.381 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.2 mp -94.93 116.7 36.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 103.928 -2.619 . . . . 0.0 103.928 178.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 12.4 mt -105.1 106.95 21.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -103.66 -152.22 22.85 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 75.19 33.39 0.71 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.218 1.007 . . . . 0.0 110.127 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -113.87 159.18 13.83 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 107.615 -2.194 . . . . 0.0 107.615 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -66.72 167.82 10.55 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.354 1.062 . . . . 0.0 109.892 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.0 mm -87.13 142.33 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 C-N-CA 124.282 1.033 . . . . 0.0 108.795 178.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.1 m -88.81 110.76 21.31 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 104.204 -2.517 . . . . 0.0 104.204 177.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -47.68 -40.02 18.92 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 125.503 1.521 . . . . 0.0 111.637 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 33.4 t -38.45 -56.62 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.228 -0.055 0 C-N-CA 128.024 2.53 . . . . 0.0 113.366 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 10.8 t -124.42 -28.86 3.58 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 105.23 35.31 3.17 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -107.35 149.95 27.27 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 118.278 1.039 . . . . 0.0 110.23 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -77.48 152.25 34.26 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 119.02 0.827 . . . . 0.0 111.176 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . 0.439 HH21 ' N ' ' A' ' 159' ' ' ARG . 30.7 mmm-85 -71.1 27.78 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 131.471 3.908 . . . . 0.0 110.795 177.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 8.1 ptm -75.59 178.43 6.02 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.343 1.057 . . . . 0.0 111.312 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.33 151.28 14.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 125.22 1.408 . . . . 0.0 108.745 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -107.45 106.38 16.75 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.937 2.095 . . . . 0.0 106.703 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 16.2 mm -101.29 144.58 12.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -125.48 121.22 33.11 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.441 1.496 . . . . 0.0 108.914 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -99.04 108.76 21.5 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.658 1.183 . . . . 0.0 108.985 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 3.8 m -126.91 169.77 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 122.101 0.953 . . . . 0.0 109.506 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 42.0 t -95.25 144.08 26.13 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 104.39 -2.448 . . . . 0.0 104.39 177.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -99.85 10.0 60.35 Favored Glycine 0 N--CA 1.461 0.324 0 CA-C-O 117.736 -1.591 . . . . 0.0 115.016 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.497 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.595 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.435 ' HA ' ' HZ2' ' A' ' 112' ' ' LYS . 60.4 Cg_endo . . . . . 0 CA--C 1.542 0.912 0 CA-C-O 119.657 -0.226 . . . . 0.0 111.95 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 4.8 p -161.8 147.06 13.28 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 120.45 -1.406 . . . . 0.0 112.809 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 19.2 p -151.22 160.23 43.95 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.501 1.12 . . . . 0.0 110.37 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 4.3 mt -100.75 153.55 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 125.894 1.678 . . . . 0.0 108.018 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -98.93 -50.21 4.27 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.184 0.994 . . . . 0.0 111.798 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 63.9 p-90 -159.11 154.52 25.7 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.142 1.377 . . . . 0.0 107.353 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 59.7 t -150.2 130.09 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.03 167.83 26.98 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 118.147 0.43 . . . . 0.0 111.086 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -80.77 137.32 36.24 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 1.8 t -112.96 -39.32 4.26 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.705 -0.622 . . . . 0.0 110.74 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -121.65 -174.82 2.95 Favored 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 124.185 0.994 . . . . 0.0 109.595 -177.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 72.8 mt -56.51 -41.73 73.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.528 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -131.52 12.3 4.93 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.15 1.78 . . . . 0.0 112.815 -178.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 21.0 t -116.59 146.19 21.34 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 CA-C-N 118.72 0.691 . . . . 0.0 109.611 -178.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -123.5 161.64 24.47 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -127.99 142.13 51.33 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 106.376 -1.712 . . . . 0.0 106.376 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -150.78 131.82 14.32 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.465 1.106 . . . . 0.0 109.013 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -121.17 122.65 40.46 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.3 0.64 . . . . 0.0 109.635 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 4.6 m -106.47 156.44 7.06 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-N 118.676 0.671 . . . . 0.0 109.339 178.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.54 115.62 19.8 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 125.584 1.554 . . . . 0.0 109.166 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 10.6 pt -128.26 145.22 54.79 Favored Pre-proline 0 N--CA 1.448 -0.536 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.05 -41.43 5.19 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.004 1.803 . . . . 0.0 111.128 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -55.69 -17.57 6.14 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 117.589 2.44 . . . . 0.0 117.589 -177.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 44.2 mt -72.84 -30.12 63.76 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 120.781 1.628 . . . . 0.0 108.912 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 22.3 m -61.65 -11.65 12.61 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.563 0.745 . . . . 0.0 112.649 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 -67.53 -18.08 64.9 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-O 122.222 1.011 . . . . 0.0 109.664 177.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 29.8 mt -101.01 118.64 37.41 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 127.97 2.508 . . . . 0.0 106.787 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -46.75 -46.46 20.41 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.141 1.376 . . . . 0.0 112.732 -178.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 1.1 mp -65.59 -27.24 68.28 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 9.4 mt -102.39 -3.78 26.52 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.381 1.073 . . . . 0.0 111.609 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -68.94 113.71 6.59 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 127.84 2.456 . . . . 0.0 110.689 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.226 -0.178 0 CA-C-O 118.746 -0.645 . . . . 0.0 110.7 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.17 -47.98 71.4 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 42.3 tp -65.44 -37.44 86.91 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 117.645 -1.169 . . . . 0.0 110.662 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 64.1 mt -61.95 -55.01 33.91 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.55 1.068 . . . . 0.0 109.678 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 89.8 m -57.99 -49.59 76.32 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.389 1.875 . . . . 0.0 110.168 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 23.6 ttpt -62.09 -47.55 84.11 Favored 'General case' 0 N--CA 1.444 -0.741 0 O-C-N 121.341 -0.85 . . . . 0.0 109.698 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.6 m -52.74 -47.14 67.59 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 118.726 0.693 . . . . 0.0 110.765 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -58.7 -50.46 73.81 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 118.228 0.467 . . . . 0.0 109.971 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.83 -61.19 2.45 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -61.25 -38.32 86.26 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.641 0.776 . . . . 0.0 110.99 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.6 -53.24 45.35 Favored Glycine 0 CA--C 1.52 0.376 0 CA-C-O 117.904 -1.498 . . . . 0.0 109.401 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 39.3 t -57.74 -40.76 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 119.434 1.617 . . . . 0.0 109.251 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -58.69 -41.39 86.15 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 28.2 m -70.76 -40.1 72.87 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 125.133 1.373 . . . . 0.0 110.557 -177.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.459 HG21 ' CZ ' ' A' ' 206' ' ' TYR . 18.0 mt -61.48 -55.95 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -62.55 -32.39 73.34 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.821 -0.609 . . . . 0.0 111.488 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -60.83 -40.12 91.61 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 118.632 0.651 . . . . 0.0 111.029 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.3 tptm -81.13 -37.99 27.94 Favored 'General case' 0 CA--C 1.519 -0.247 0 O-C-N 122.064 -0.398 . . . . 0.0 110.793 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 40.4 mt -69.12 -26.61 64.99 Favored 'General case' 0 C--O 1.221 -0.412 0 O-C-N 121.443 -0.786 . . . . 0.0 109.992 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.16 -30.87 50.85 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.628 1.171 . . . . 0.0 111.339 179.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -56.24 -63.9 1.04 Allowed 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.489 1.116 . . . . 0.0 111.946 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -151.37 175.59 12.09 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 126.319 1.848 . . . . 0.0 110.336 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 85.7 m -87.53 161.4 17.8 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 106.959 -1.496 . . . . 0.0 106.959 178.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 42.3 pt -112.42 155.01 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 124.846 1.258 . . . . 0.0 108.143 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -148.98 137.37 21.0 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 125.185 1.394 . . . . 0.0 108.27 -178.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -140.85 126.94 19.51 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.307 1.043 . . . . 0.0 111.652 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -80.39 99.46 7.96 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.047 1.339 . . . . 0.0 109.122 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.98 79.97 5.79 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 178.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 58.71 -119.83 19.53 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -63.74 -35.91 82.12 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.91 0.884 . . . . 0.0 112.955 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -99.86 164.36 12.06 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 119.126 0.875 . . . . 0.0 111.651 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.427 HD12 ' H ' ' A' ' 140' ' ' GLY . 4.2 mp -129.43 129.13 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 103.824 -2.658 . . . . 0.0 103.824 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -105.39 122.95 47.02 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 125.634 1.574 . . . . 0.0 106.871 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -118.5 126.49 52.13 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -122.88 137.37 54.96 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.531 0.732 . . . . 0.0 111.26 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 27.4 m -117.12 153.37 49.7 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.613 1.165 . . . . 0.0 111.488 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -62.61 84.53 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.643 1 C-N-CA 125.428 4.085 . . . . 0.0 116.266 -177.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.36 32.56 55.14 Favored Glycine 0 CA--C 1.531 1.093 0 O-C-N 120.749 -1.22 . . . . 0.0 112.853 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 4.5 mp -115.56 -69.92 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.306 0 CA-C-N 117.956 0.878 . . . . 0.0 109.104 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -168.44 168.34 11.25 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.533 1.133 . . . . 0.0 110.632 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -132.38 120.22 21.74 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 177.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.2 m -140.56 163.85 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 124.924 1.29 . . . . 0.0 110.575 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -135.04 126.55 28.68 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -138.08 162.86 33.07 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 126.604 1.962 . . . . 0.0 109.08 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -102.87 120.02 39.87 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.427 ' H ' HD12 ' A' ' 126' ' ' ILE . . . . . . . . 0 CA--C 1.534 1.231 0 C-N-CA 127.21 2.338 . . . . 0.0 107.919 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 . . . . . 0 C--O 1.226 -0.147 0 CA-C-O 121.675 0.75 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 5.8 mpp_? -149.37 133.33 17.09 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 48.3 mt -110.87 -21.75 11.88 Favored 'General case' 0 C--O 1.22 -0.476 0 O-C-N 124.181 0.926 . . . . 0.0 109.195 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 155.53 163.97 12.69 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -126.63 114.3 22.8 Favored Pre-proline 0 C--O 1.236 0.352 0 CA-C-O 118.849 -0.595 . . . . 0.0 109.914 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -71.24 -173.89 1.05 Allowed 'Trans proline' 0 CA--C 1.544 1.004 0 C-N-CA 125.091 3.861 . . . . 0.0 109.567 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -120.8 163.83 17.54 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.932 0.872 . . . . 0.0 111.974 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.75 -36.56 59.85 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.116 177.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -89.57 65.71 7.05 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.476 1.91 . . . . 0.0 110.895 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.9 p -45.76 -36.72 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 123.146 0.578 . . . . 0.0 111.851 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -61.86 -37.9 86.24 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 125.488 1.515 . . . . 0.0 112.532 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -71.56 -23.61 61.78 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 124.972 1.309 . . . . 0.0 110.671 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 9.5 mtp-105 -79.53 138.92 37.67 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -101.41 139.78 36.61 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -122.89 -178.32 3.91 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 126.493 1.917 . . . . 0.0 111.802 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -131.49 154.01 49.18 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.908 1.283 . . . . 0.0 109.968 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 28.4 tp -116.75 107.69 14.96 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.264 1.826 . . . . 0.0 106.368 178.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -118.58 -178.25 3.49 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 126.258 1.823 . . . . 0.0 109.564 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -145.33 164.81 30.3 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.236 0.615 . . . . 0.0 111.27 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.7 178.56 7.06 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 128.005 2.522 . . . . 0.0 107.417 178.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -59.69 -18.9 46.01 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.489 1.116 . . . . 0.0 111.822 -177.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 76.8 t -92.05 -38.6 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 125.429 1.491 . . . . 0.0 111.297 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 163.46 -168.06 37.94 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 118.764 0.711 . . . . 0.0 112.194 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 6.4 m-30 -78.48 161.92 26.73 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.579 0.704 . . . . 0.0 110.234 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -159.32 161.87 35.89 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.25 1.42 . . . . 0.0 110.38 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 95.3 mt -100.96 146.08 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 6.7 t -119.7 132.88 55.77 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.492 1.117 . . . . 0.0 108.364 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -126.79 107.71 10.38 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.978 2.111 . . . . 0.0 108.939 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -90.6 114.14 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 104.481 -2.415 . . . . 0.0 104.481 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 7.2 mt -98.1 106.68 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.49 -153.49 24.82 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 77.07 20.85 1.17 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.585 1.154 . . . . 0.0 109.58 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -84.95 146.16 21.95 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.12 137.71 58.04 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 125.851 1.66 . . . . 0.0 108.44 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 25.3 mm -62.37 139.32 21.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 CA-C-O 122.218 1.009 . . . . 0.0 112.227 -178.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 5.6 t -79.2 116.35 19.42 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 128.381 2.672 . . . . 0.0 109.802 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.08 -17.0 56.16 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.904 0.881 . . . . 0.0 112.907 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 42.0 t -69.11 -52.47 33.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 125.742 1.617 . . . . 0.0 112.235 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 3.8 t -123.38 -40.44 2.37 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.971 1.308 . . . . 0.0 113.832 -178.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 117.03 21.66 4.46 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.301 1.429 . . . . 0.0 110.596 -178.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -88.7 151.31 22.51 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.868 1.834 . . . . 0.0 110.729 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -71.59 153.61 42.01 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 5.8 ttt-85 -74.52 28.58 0.08 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 127.519 2.328 . . . . 0.0 110.011 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 7.6 ptm -73.03 172.17 11.5 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 122.424 1.106 . . . . 0.0 111.315 -176.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.2 p -143.17 143.95 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 C-N-CA 124.414 1.086 . . . . 0.0 108.092 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -100.56 106.96 18.53 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 23.6 mm -100.98 146.25 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 O-C-N 120.756 -1.215 . . . . 0.0 108.713 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -125.48 134.53 52.02 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.796 -1.186 . . . . 0.0 107.796 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . 0.459 ' CZ ' HG21 ' A' ' 109' ' ' ILE . 43.4 m-85 -106.06 110.05 22.19 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 29.9 m -124.7 162.58 26.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 45.5 t -83.03 143.51 30.56 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -87.48 23.67 11.9 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-O 117.285 -1.842 . . . . 0.0 113.187 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.341 0.83 0 C-N-CA 126.256 1.884 . . . . 0.0 109.911 -179.643 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo . . . . . 0 CA--C 1.547 1.13 0 N-CA-C 109.97 -0.819 . . . . 0.0 109.97 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.2 p -163.9 139.3 6.22 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 129.731 3.212 . . . . 0.0 105.409 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 77.4 p -151.3 175.46 12.19 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.536 1.062 . . . . 0.0 110.819 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . 0.419 ' HA ' ' HA ' ' A' ' 233' ' ' VAL . 3.2 mt -115.48 143.05 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 104.073 -2.565 . . . . 0.0 104.073 176.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -94.35 -48.31 6.21 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.722 1.209 . . . . 0.0 112.421 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 -156.84 151.85 26.11 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.815 1.646 . . . . 0.0 108.499 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 6.8 p -155.71 120.44 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -148.85 158.38 44.12 Favored 'General case' 0 C--O 1.235 0.342 0 O-C-N 121.563 -0.711 . . . . 0.0 110.849 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -65.84 130.44 43.29 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 12.1 t -107.96 -33.61 7.16 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 125.842 1.657 . . . . 0.0 112.605 -178.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 7.1 mttt -132.17 -175.88 3.89 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 1.1 mm -38.72 -56.92 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 124.896 1.278 . . . . 0.0 113.319 -177.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 2.5 m -133.32 17.61 4.04 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.775 1.63 . . . . 0.0 109.81 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.64 141.75 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -121.53 163.7 18.43 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.457 1.103 . . . . 0.0 108.474 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -138.16 132.36 31.81 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 178.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -136.57 140.04 42.61 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.158 1.383 . . . . 0.0 108.141 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -118.92 116.98 27.62 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 218' ' ' ILE . 1.3 m -107.0 151.85 8.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.8 p -126.75 136.83 52.94 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 123.461 0.704 . . . . 0.0 111.857 -178.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -141.21 142.55 27.48 Favored Pre-proline 0 N--CA 1.452 -0.336 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -66.79 -47.54 2.62 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.855 2.37 . . . . 0.0 112.002 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -53.41 -24.48 12.61 Favored 'General case' 0 CA--C 1.527 0.091 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 10.7 tp -61.11 -29.9 70.04 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 119.266 0.939 . . . . 0.0 111.409 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 9.2 m -62.0 -12.26 17.75 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.999 0.919 . . . . 0.0 112.602 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.99 -24.65 66.06 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.245 0.93 . . . . 0.0 110.121 178.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -89.14 117.21 27.96 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 178.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 -46.79 -44.18 18.93 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 126.281 1.833 . . . . 0.0 114.105 -178.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 60.2 mt -70.23 -31.43 68.83 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.448 -1.407 . . . . 0.0 113.017 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 14.3 mt -84.29 -20.7 31.69 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.124 0.97 . . . . 0.0 112.583 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -55.72 141.16 39.28 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 128.914 2.886 . . . . 0.0 111.538 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 34.5 mmtt . . . . . 0 C--O 1.236 0.39 0 C-N-CA 125.378 1.471 . . . . 0.0 109.616 179.233 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.531 0.216 0 CA-C-O 119.385 -0.341 . . . . 0.0 111.035 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.43 -45.96 92.1 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 55.3 tp -66.38 -38.07 86.71 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 118.396 -0.811 . . . . 0.0 109.905 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 20.7 mt -59.74 -54.81 41.98 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 24.5 m -60.7 -38.53 85.34 Favored 'General case' 0 C--O 1.239 0.551 0 O-C-N 121.449 -0.782 . . . . 0.0 111.77 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -65.28 -48.19 74.04 Favored 'General case' 0 CA--C 1.519 -0.247 0 O-C-N 121.056 -1.027 . . . . 0.0 109.993 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 69.2 m -51.95 -47.81 64.59 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.352 1.061 . . . . 0.0 110.667 -178.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -58.51 -49.48 77.21 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 117.847 0.294 . . . . 0.0 110.912 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -62.89 -57.35 11.09 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 122.243 1.02 . . . . 0.0 113.153 -177.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -60.41 -41.6 94.22 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.797 -178.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -62.71 -53.21 42.9 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-O 117.781 -1.566 . . . . 0.0 111.418 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 47.8 t -58.34 -42.53 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 120.562 2.181 . . . . 0.0 109.0 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.84 -30.98 71.69 Favored 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 119.181 -1.007 . . . . 0.0 112.499 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 52.6 m -72.32 -40.75 67.24 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 126.042 1.737 . . . . 0.0 108.385 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 18.1 mt -60.66 -55.06 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -60.91 -28.0 68.6 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-O 117.876 -1.059 . . . . 0.0 111.657 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -62.07 -49.38 76.17 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.22 1.008 . . . . 0.0 111.337 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.438 ' HA ' ' HE2' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -85.26 -39.28 17.93 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -177.765 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 16.2 mt -66.38 -25.78 66.95 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 119.009 -0.519 . . . . 0.0 112.26 -179.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -52.44 -28.75 21.3 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -51.18 -74.77 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.821 1.648 . . . . 0.0 111.67 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -147.68 176.68 9.9 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.804 1.642 . . . . 0.0 109.126 -178.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 33.4 m -86.21 163.06 18.0 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.635 0.731 . . . . 0.0 109.147 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 37.6 pt -118.63 160.29 18.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 126.134 1.774 . . . . 0.0 109.395 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -158.05 139.62 13.7 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -130.54 127.2 38.61 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 123.584 0.753 . . . . 0.0 110.052 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -85.39 101.66 12.78 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.26 1.024 . . . . 0.0 108.439 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.26 80.07 7.65 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 104.681 -2.34 . . . . 0.0 104.681 178.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.73 -99.63 0.37 Allowed Glycine 0 CA--C 1.531 1.08 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -95.25 -25.85 16.19 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.742 1.617 . . . . 0.0 114.031 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -99.01 152.35 19.91 Favored 'General case' 0 CA--C 1.513 -0.451 0 O-C-N 121.302 -0.874 . . . . 0.0 108.752 -178.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.442 HD13 ' H ' ' A' ' 140' ' ' GLY . 5.2 mp -124.67 124.6 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -100.99 119.3 38.54 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 103.212 -2.884 . . . . 0.0 103.212 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -118.4 124.7 48.33 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.157 0.983 . . . . 0.0 110.891 -177.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -124.03 135.03 53.32 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -178.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 16.1 m -111.18 155.97 41.79 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 125.546 1.538 . . . . 0.0 112.808 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -67.97 81.31 0.49 Allowed 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 124.864 3.71 . . . . 0.0 114.474 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 72.98 54.55 7.0 Favored Glycine 0 CA--C 1.529 0.922 0 O-C-N 121.207 -0.933 . . . . 0.0 112.862 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 3.6 mp -131.04 -72.02 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -167.16 167.82 14.02 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.757 1.623 . . . . 0.0 109.068 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -128.54 126.14 39.75 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 176.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.8 m -141.53 164.0 19.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 124.591 1.157 . . . . 0.0 110.55 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -126.36 125.81 42.85 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -139.4 162.96 33.77 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.091 0.957 . . . . 0.0 110.636 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 61.8 t60 -110.19 109.35 19.81 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 101.993 -3.336 . . . . 0.0 101.993 177.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.442 ' H ' HD13 ' A' ' 126' ' ' ILE . . . . . . . . 0 CA--C 1.53 1.012 0 C-N-CA 126.191 1.853 . . . . 0.0 109.959 -178.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 . . . . . 0 N--CA 1.445 -0.692 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -134.59 141.78 46.74 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 177.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 59.7 mt -120.17 -29.06 4.96 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 125.454 1.721 . . . . 0.0 107.042 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 160.62 159.18 9.73 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 36.1 mtmt -128.57 114.66 19.49 Favored Pre-proline 0 CA--C 1.537 0.444 0 O-C-N 122.021 -0.694 . . . . 0.0 109.998 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -75.6 -167.98 0.49 Allowed 'Trans proline' 0 CA--C 1.537 0.63 1 C-N-CA 125.806 4.338 . . . . 0.0 110.336 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -131.93 157.56 43.7 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.328 1.451 . . . . 0.0 108.91 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.89 -38.29 73.05 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.878 0.371 . . . . 0.0 110.503 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 33.7 m-20 -76.15 64.73 2.03 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.703 1.601 . . . . 0.0 110.293 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 6.1 p -52.04 -30.32 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 124.212 1.005 . . . . 0.0 111.172 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -71.32 -26.03 62.66 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.531 1.132 . . . . 0.0 113.804 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -77.32 -23.68 50.95 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 122.901 0.481 . . . . 0.0 112.174 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -92.42 160.32 15.14 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.964 0.411 . . . . 0.0 109.909 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -114.38 161.48 17.87 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -138.11 170.43 16.05 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.738 1.215 . . . . 0.0 109.621 -177.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -112.57 151.32 30.19 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 21.9 tp -121.3 98.35 5.94 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -110.16 178.46 4.39 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -155.0 163.3 40.51 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -141.08 -171.03 3.18 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -55.27 -23.82 25.02 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.087 1.355 . . . . 0.0 112.406 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.5 t -81.87 -65.91 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 177.48 -170.58 43.1 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -77.55 157.62 30.26 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.566 0.746 . . . . 0.0 111.838 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -156.09 173.77 16.34 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 126.735 2.014 . . . . 0.0 108.585 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 93.8 mt -114.29 141.69 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 177.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 21.3 t -109.91 128.71 55.53 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.059 1.343 . . . . 0.0 107.923 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -124.07 107.39 11.23 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.862 1.265 . . . . 0.0 108.459 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.6 mp -91.05 128.65 42.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 7.6 mt -118.9 106.72 19.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -93.88 -152.56 29.41 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 108.443 -1.863 . . . . 0.0 108.443 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 69.7 m 79.15 25.49 0.46 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.201 2.2 . . . . 0.0 115.768 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -89.64 -156.02 31.44 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 107.58 -2.208 . . . . 0.0 107.58 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -123.17 144.13 49.56 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 39.8 mm -60.82 134.55 26.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -79.62 109.63 14.18 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 127.131 2.172 . . . . 0.0 105.489 177.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -55.04 -19.5 7.2 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.847 2.059 . . . . 0.0 113.189 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 50.1 t -60.47 -54.52 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 126.968 2.107 . . . . 0.0 111.567 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 4.8 t -124.09 -25.42 4.18 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -177.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 99.59 35.72 4.55 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 108.239 -1.945 . . . . 0.0 108.239 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -113.27 151.29 31.29 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 117.933 0.867 . . . . 0.0 110.669 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 57.5 mp0 -75.26 141.41 43.49 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 123.976 0.91 . . . . 0.0 112.735 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . 0.297 7.9 ttt85 -70.05 30.98 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 130.885 3.674 . . . . 0.0 112.797 178.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 5.1 ptm -74.75 177.36 6.22 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.125 0.97 . . . . 0.0 110.472 -179.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.2 p -143.65 152.97 16.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 125.283 1.433 . . . . 0.0 107.98 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -114.65 112.57 23.08 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 15.7 mm -98.24 141.96 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -124.62 111.46 15.66 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.663 1.585 . . . . 0.0 107.985 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -92.56 109.03 20.43 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.701 1.6 . . . . 0.0 110.369 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 34.9 m -124.79 167.82 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.211 1.005 . . . . 0.0 109.837 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 45.5 t -96.46 132.73 41.72 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 103.541 -2.763 . . . . 0.0 103.541 177.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -98.36 32.49 6.89 Favored Glycine 0 N--CA 1.463 0.456 0 C-N-CA 124.541 1.067 . . . . 0.0 111.01 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.169 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.276 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo . . . . . 0 N--CA 1.456 -0.731 0 N-CA-C 115.429 1.281 . . . . 0.0 115.429 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -164.12 151.03 11.63 Favored 'General case' 0 C--O 1.241 0.624 0 O-C-N 120.863 -1.148 . . . . 0.0 109.1 -178.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 36.7 p -151.81 160.64 43.49 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.839 0.855 . . . . 0.0 110.579 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 4.1 mt -106.48 148.55 10.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -93.82 -53.98 3.8 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.672 0.789 . . . . 0.0 110.95 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 63.4 p-90 -155.17 155.03 33.2 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.859 1.264 . . . . 0.0 108.113 -178.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 56.3 t -150.58 129.66 3.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.84 162.18 32.15 Favored 'General case' 0 C--O 1.233 0.209 0 O-C-N 122.19 -0.319 . . . . 0.0 111.174 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -72.53 128.79 36.66 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 104.574 -2.38 . . . . 0.0 104.574 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 9.9 t -106.15 -37.17 6.68 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 124.833 1.253 . . . . 0.0 109.981 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 34.2 mttt -133.31 -176.45 4.14 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 123.782 0.833 . . . . 0.0 109.975 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 69.3 mt -46.38 -49.43 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.188 0.995 . . . . 0.0 112.322 -178.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.99 21.23 5.83 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 124.112 0.965 . . . . 0.0 110.362 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 7.9 t -120.1 141.4 40.49 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.61 0 CA-C-N 118.64 0.654 . . . . 0.0 111.61 -177.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -122.97 158.37 30.61 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -129.73 134.46 47.63 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -137.32 119.33 15.38 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 125.427 1.491 . . . . 0.0 109.932 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -108.42 124.66 50.74 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 12.5 m -116.31 156.58 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.481 0 C-N-CA 122.47 0.308 . . . . 0.0 110.665 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.3 p -123.85 123.89 41.45 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 124.39 1.076 . . . . 0.0 110.263 -178.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 2.2 pt -133.44 134.52 23.92 Favored Pre-proline 0 C--O 1.237 0.4 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 177.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.54 -27.82 45.83 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.233 2.622 . . . . 0.0 113.304 -178.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 28.2 mp0 -64.59 -28.65 69.78 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 -178.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 66.6 mt -61.23 -29.23 69.7 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 118.587 -1.245 . . . . 0.0 110.652 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 21.7 m -58.86 -16.35 16.95 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 118.806 0.73 . . . . 0.0 112.256 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -60.11 -38.4 82.91 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 118.91 0.777 . . . . 0.0 109.663 178.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -79.61 122.47 26.56 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -47.33 -44.88 24.05 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 126.26 1.824 . . . . 0.0 113.34 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.43 -33.59 76.05 Favored 'General case' 0 C--O 1.226 -0.176 0 O-C-N 121.341 -0.849 . . . . 0.0 112.694 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 27.2 mt -92.88 -4.99 51.89 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.231 1.012 . . . . 0.0 113.054 -178.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -71.61 117.06 12.71 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 127.625 2.37 . . . . 0.0 112.978 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 32.6 mmtm . . . . . 0 CA--C 1.516 -0.352 0 C-N-CA 123.216 0.606 . . . . 0.0 110.709 178.424 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.171 0 CA-C-O 118.554 -0.736 . . . . 0.0 112.078 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.82 -49.23 76.01 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 52.8 tp -65.1 -35.6 81.64 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.492 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 43.3 mt -63.24 -55.01 28.48 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.44 1.018 . . . . 0.0 108.791 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 88.9 m -57.25 -46.36 83.1 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 125.045 1.338 . . . . 0.0 110.254 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.71 -50.2 70.08 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 118.231 -0.89 . . . . 0.0 109.666 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 47.6 m -52.53 -46.9 66.94 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 124.159 0.984 . . . . 0.0 110.532 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -59.49 -50.33 74.33 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 118.3 0.5 . . . . 0.0 110.003 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.1 -61.5 2.22 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.219 0.608 . . . . 0.0 112.313 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.44 -37.98 79.5 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.487 0.315 . . . . 0.0 110.231 -178.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.09 -53.25 38.16 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-O 117.583 -1.676 . . . . 0.0 110.706 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 37.3 t -57.12 -45.19 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 119.671 1.736 . . . . 0.0 109.087 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -62.96 -34.36 77.33 Favored 'General case' 0 C--O 1.223 -0.311 0 C-N-CA 118.815 -1.154 . . . . 0.0 111.573 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 86.2 m -70.89 -36.96 72.97 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.444 0.698 . . . . 0.0 109.53 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.7 mt -61.81 -55.4 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -64.3 -27.85 69.32 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -64.51 -30.82 71.85 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.443 1.02 . . . . 0.0 111.646 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.68 -46.61 6.54 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 123.835 0.854 . . . . 0.0 110.56 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.9 mt -59.98 -27.58 66.97 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -55.03 -24.83 26.63 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -62.85 -62.44 1.72 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.48 0.712 . . . . 0.0 110.872 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -148.42 171.03 16.7 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 123.97 0.908 . . . . 0.0 110.868 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 69.8 m -87.07 166.14 15.25 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 35.4 pt -117.92 156.44 19.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 125.372 1.469 . . . . 0.0 108.613 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.3 138.29 21.27 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 125.389 1.475 . . . . 0.0 109.278 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -136.7 113.36 10.21 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 123.634 0.773 . . . . 0.0 111.44 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -79.82 99.59 7.58 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.29 79.62 8.99 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 178.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 60.13 -105.83 0.87 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -77.99 -34.32 50.87 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.685 0.794 . . . . 0.0 112.981 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 52.4 m95 -99.79 167.82 10.3 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 118.952 0.797 . . . . 0.0 110.293 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.3 mp -136.88 153.81 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -133.68 120.15 20.27 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.766 2.027 . . . . 0.0 106.221 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -117.15 121.29 40.85 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -119.06 139.43 51.76 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 124.216 1.007 . . . . 0.0 109.895 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 20.8 m -115.77 157.38 44.73 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 126.663 1.985 . . . . 0.0 111.687 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -64.21 76.68 0.17 Allowed 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 124.723 3.615 . . . . 0.0 114.626 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 68.54 56.87 8.92 Favored Glycine 0 CA--C 1.533 1.161 0 O-C-N 120.72 -1.238 . . . . 0.0 112.792 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 3.9 mp -128.12 -71.24 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.131 0 C-N-CA 126.198 1.799 . . . . 0.0 106.153 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -164.42 169.97 16.61 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 126.963 2.105 . . . . 0.0 109.521 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -133.38 124.84 27.89 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 178.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 33.9 m -142.65 163.71 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 123.99 0.916 . . . . 0.0 112.043 -178.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -125.43 124.67 41.95 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.757 1.623 . . . . 0.0 107.017 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -139.34 162.45 34.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 119.451 1.023 . . . . 0.0 111.43 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 63.1 t60 -85.37 160.97 19.66 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 177.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.595 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -178.674 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 . . . . . 0 CA--C 1.532 0.271 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -148.7 134.18 18.61 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.5 mp -109.85 -23.73 11.22 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 160.79 159.22 9.78 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-N 119.436 1.016 . . . . 0.0 111.891 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.38 108.46 41.71 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 123.918 0.887 . . . . 0.0 109.631 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.4 166.73 23.88 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.286 2.657 . . . . 0.0 110.058 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -96.75 156.55 16.3 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -76.02 -35.14 59.65 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.728 1.211 . . . . 0.0 113.149 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -84.85 66.73 9.83 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 124.369 1.068 . . . . 0.0 110.534 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.5 p -46.04 -28.6 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -71.16 -31.2 67.4 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 124.823 1.249 . . . . 0.0 111.737 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -87.84 -14.1 40.4 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.138 1.775 . . . . 0.0 110.24 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -75.97 158.38 32.02 Favored 'General case' 0 CA--C 1.521 -0.165 0 O-C-N 120.921 -1.112 . . . . 0.0 108.865 178.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -109.9 149.25 30.18 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -143.37 169.28 17.96 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 127.025 2.13 . . . . 0.0 108.606 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -128.13 154.01 46.23 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.082 0.953 . . . . 0.0 110.043 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 23.9 tp -114.25 108.52 17.05 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -118.2 -179.83 3.89 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.226 1.41 . . . . 0.0 109.297 -178.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -149.33 156.79 42.62 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -141.52 -178.12 5.48 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 177.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -60.86 -13.13 13.58 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.331 -0.856 . . . . 0.0 111.464 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 69.0 t -83.09 -45.25 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 O-C-N 120.796 -1.19 . . . . 0.0 110.435 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 154.53 -165.56 31.99 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 108.082 -2.007 . . . . 0.0 108.082 -178.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.405 ' CD2' ' HB3' ' A' ' 243' ' ' LEU . 3.4 m-30 -78.56 160.72 27.46 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 118.239 1.019 . . . . 0.0 110.22 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -158.64 161.72 37.2 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.503 1.121 . . . . 0.0 111.371 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 95.8 mt -101.4 144.1 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 29.7 t -114.29 133.01 55.95 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -123.46 108.55 12.8 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -85.84 127.61 40.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.8 mt -115.59 105.23 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 102.874 -3.01 . . . . 0.0 102.874 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -110.76 -152.04 12.74 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 108.379 -1.888 . . . . 0.0 108.379 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 75.26 23.74 1.52 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.389 1.076 . . . . 0.0 110.945 178.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -95.08 173.64 31.89 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.98 163.88 26.72 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 44.0 mm -86.23 141.43 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 125.619 1.568 . . . . 0.0 111.623 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.2 m -87.23 118.75 26.86 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 127.724 2.41 . . . . 0.0 108.383 178.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -54.06 -32.24 54.02 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.075 2.15 . . . . 0.0 113.335 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 43.8 t -50.91 -55.42 7.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 125.542 1.537 . . . . 0.0 112.772 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 13.6 t -123.93 -33.28 3.16 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 108.05 34.73 2.69 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -178.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -104.82 152.65 22.33 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.916 1.358 . . . . 0.0 110.438 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -76.96 146.2 37.65 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 118.773 0.715 . . . . 0.0 109.559 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . 0.373 4.8 ptp180 -71.62 29.34 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 128.176 2.59 . . . . 0.0 113.558 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 7.8 ptm -72.59 174.31 7.7 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 122.15 0.976 . . . . 0.0 111.643 -176.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.4 p -142.25 150.17 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 124.065 0.946 . . . . 0.0 109.346 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -111.06 106.23 15.23 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 17.0 mm -90.31 150.59 3.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -125.76 100.03 6.23 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 126.916 2.087 . . . . 0.0 110.173 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -84.81 108.68 17.6 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 178.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 26.1 m -125.38 164.11 25.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 124.243 1.017 . . . . 0.0 108.674 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 42.6 t -82.92 146.51 28.8 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 177.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -93.04 13.42 67.74 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-O 118.997 -0.891 . . . . 0.0 112.456 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.977 0 N-CA-C 106.443 -2.663 . . . . 0.0 106.443 -177.239 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo . . . . . 0 N--CA 1.456 -0.731 0 N-CA-C 114.305 0.848 . . . . 0.0 114.305 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 2.9 p -164.33 142.7 7.1 Favored 'General case' 0 N--CA 1.463 0.201 0 O-C-N 120.934 -1.104 . . . . 0.0 109.678 -178.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 7.9 p -148.8 165.5 31.29 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.47 0.577 . . . . 0.0 111.132 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 3.4 mt -101.96 154.48 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 125.298 1.439 . . . . 0.0 107.372 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -105.0 -44.86 4.69 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.121 0.968 . . . . 0.0 113.573 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 67.0 p-90 -163.68 151.88 13.31 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.999 1.319 . . . . 0.0 107.718 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 87.9 t -151.89 129.2 2.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 C-N-CA 124.879 1.272 . . . . 0.0 109.22 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 1.5 ppt_? -163.48 160.5 23.34 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.752 0.706 . . . . 0.0 110.495 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -67.09 131.25 45.45 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 14.9 t -104.07 -33.15 8.87 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.948 1.299 . . . . 0.0 111.361 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 56.8 mttt -131.36 -175.04 3.57 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 125.049 1.34 . . . . 0.0 108.332 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 67.5 mt -52.27 -43.88 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -129.95 8.3 5.22 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.649 0.78 . . . . 0.0 112.227 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 21.5 t -105.81 142.34 19.07 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -178.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -121.55 166.36 14.31 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 124.72 1.208 . . . . 0.0 108.104 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -136.91 144.29 43.39 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -148.65 119.02 7.33 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 123.364 0.666 . . . . 0.0 109.608 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -103.5 123.07 46.22 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 2.3 m -119.98 152.44 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 2.8 p -126.6 135.93 51.87 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 3.9 pt -139.82 146.17 46.02 Favored Pre-proline 0 C--O 1.236 0.362 0 C-N-CA 125.564 1.545 . . . . 0.0 107.029 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -74.03 -24.82 14.63 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.201 1.934 . . . . 0.0 112.973 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 49.6 mp0 -66.02 -28.18 68.68 Favored 'General case' 0 CA--C 1.518 -0.286 0 O-C-N 120.43 -1.418 . . . . 0.0 114.355 -178.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 58.9 mt -63.32 -25.13 68.16 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 118.902 -1.119 . . . . 0.0 110.682 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 20.9 m -63.0 -15.12 55.27 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 119.163 0.892 . . . . 0.0 111.051 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -69.5 -31.77 70.22 Favored 'General case' 0 C--N 1.341 0.206 0 O-C-N 121.186 -0.946 . . . . 0.0 109.358 178.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -78.21 120.75 23.44 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 33.0 tp10 -46.05 -48.47 16.86 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.766 2.026 . . . . 0.0 115.795 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . 0.405 ' HB3' ' CD2' ' A' ' 181' ' ' TYR . 20.0 mt -69.52 -34.44 74.27 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.148 -0.97 . . . . 0.0 112.786 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 3.2 mt -84.71 -10.35 57.36 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.266 1.026 . . . . 0.0 112.717 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -61.25 123.73 18.56 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.179 2.192 . . . . 0.0 111.015 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 16.2 mmtp . . . . . 0 C--O 1.237 0.443 0 C-N-CA 123.319 0.648 . . . . 0.0 109.677 178.759 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.462 0.138 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.88 -52.64 64.86 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 42.0 tp -68.36 -34.95 77.0 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 118.416 -0.802 . . . . 0.0 110.373 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 31.8 mt -60.36 -54.37 46.42 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 60.4 m -61.9 -45.26 94.5 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.656 -0.652 . . . . 0.0 109.8 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.9 -47.31 83.16 Favored 'General case' 0 C--N 1.346 0.415 0 O-C-N 120.854 -1.154 . . . . 0.0 109.416 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 72.3 m -54.14 -51.17 65.13 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.579 1.152 . . . . 0.0 110.323 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -57.98 -47.92 81.54 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 123.288 0.367 . . . . 0.0 110.56 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -69.17 -59.58 2.93 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -177.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.46 -37.32 85.46 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -56.15 -52.65 47.99 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 41.3 t -56.69 -46.02 82.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 119.381 1.59 . . . . 0.0 110.475 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.3 ptmt -63.61 -31.63 72.86 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 118.714 -0.66 . . . . 0.0 111.878 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.3 m -76.43 -37.89 56.36 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.38 1.072 . . . . 0.0 109.104 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 24.6 mt -62.16 -55.34 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -62.15 -28.37 69.6 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 118.272 -0.87 . . . . 0.0 111.497 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -68.67 -50.3 52.16 Favored 'General case' 0 N--CA 1.457 -0.085 0 CA-C-N 119.028 0.831 . . . . 0.0 111.135 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.05 -44.8 45.64 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 30.8 mt -64.33 -26.12 68.34 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-O 119.068 -0.491 . . . . 0.0 111.929 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -51.63 -27.06 10.26 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.3 1.04 . . . . 0.0 112.872 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -52.58 -68.09 0.2 Allowed 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.544 1.538 . . . . 0.0 112.489 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -152.9 -179.13 7.38 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.597 1.559 . . . . 0.0 111.536 -178.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 64.1 m -86.65 175.42 8.29 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 35.7 pt -140.73 160.19 24.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 125.306 1.442 . . . . 0.0 109.746 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.32 144.2 25.38 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 123.878 0.871 . . . . 0.0 110.081 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.462 ' CE1' ' HA ' ' A' ' 220' ' ' TRP . 8.8 t80 -135.04 131.16 36.71 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.091 0.956 . . . . 0.0 109.461 178.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -91.43 109.71 21.0 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 124.915 1.286 . . . . 0.0 108.029 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -102.39 80.09 1.91 Allowed 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.15 1.78 . . . . 0.0 110.86 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.82 -85.99 0.07 OUTLIER Glycine 0 CA--C 1.529 0.913 0 O-C-N 120.711 -1.243 . . . . 0.0 113.1 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -109.77 -32.62 7.01 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.407 1.083 . . . . 0.0 111.235 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 69.2 m95 -99.81 152.76 19.76 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 118.933 0.788 . . . . 0.0 110.323 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.434 HD12 ' H ' ' A' ' 140' ' ' GLY . 4.8 mp -122.19 138.22 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -113.97 130.62 56.51 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -132.86 125.04 29.09 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.358 0.526 . . . . 0.0 110.57 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -116.06 140.65 49.06 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.823 1.249 . . . . 0.0 110.82 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 6.5 m -121.37 151.9 56.9 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 124.354 1.062 . . . . 0.0 109.925 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -65.69 84.86 0.23 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 124.374 3.383 . . . . 0.0 116.108 -177.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.21 32.07 36.38 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-O 118.041 -1.422 . . . . 0.0 112.714 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.8 mp -114.67 -72.59 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -172.05 173.74 4.28 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.737 1.215 . . . . 0.0 109.364 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -129.47 126.9 39.74 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.0 m -142.05 163.97 18.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 124.383 1.073 . . . . 0.0 111.487 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -123.93 118.93 28.17 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -137.78 163.43 31.39 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 125.869 1.667 . . . . 0.0 111.361 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -94.77 135.39 36.31 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 177.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.434 ' H ' HD12 ' A' ' 126' ' ' ILE . . . . . . . . 0 CA--C 1.529 0.914 0 O-C-N 121.126 -0.984 . . . . 0.0 111.89 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 . . . . . 0 C--O 1.236 0.385 0 CA-C-O 120.587 0.232 . . . . 0.0 110.513 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 19.2 tpp180 -148.11 113.19 5.5 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.425 1.49 . . . . 0.0 110.527 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 60.3 mt -97.91 -41.59 7.94 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 157.89 175.06 28.39 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 6.0 ptmm? -130.36 127.83 22.54 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -70.35 179.1 4.27 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.036 3.157 . . . . 0.0 108.771 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -123.47 162.06 23.62 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 121.321 -0.862 . . . . 0.0 110.425 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -73.04 -50.06 25.17 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.126 0.97 . . . . 0.0 111.037 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -77.55 64.96 2.98 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 126.072 1.749 . . . . 0.0 111.734 -177.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.4 p -50.14 -32.43 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.464 1.105 . . . . 0.0 111.133 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -62.38 -37.24 84.98 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.402 1.481 . . . . 0.0 110.752 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -84.54 -15.21 46.6 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.849 1.26 . . . . 0.0 112.018 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 67.4 mtp180 -79.65 134.29 36.42 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -89.96 149.55 22.53 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -135.65 166.3 23.55 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.913 1.685 . . . . 0.0 107.149 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -122.79 153.57 39.36 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 48.1 tp -116.63 100.74 8.04 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.58 1.552 . . . . 0.0 109.524 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -117.67 178.68 4.31 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 125.175 1.39 . . . . 0.0 107.449 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -153.98 161.09 42.23 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 121.85 -0.531 . . . . 0.0 111.048 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.431 ' CG ' ' H ' ' A' ' 178' ' ' ASP . 23.2 t70 -138.78 176.24 8.86 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 126.649 1.98 . . . . 0.0 107.501 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . 0.431 ' H ' ' CG ' ' A' ' 177' ' ' ASP . 68.2 m-20 -59.91 -16.87 33.0 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 126.169 1.788 . . . . 0.0 111.987 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.457 ' CG1' ' HE3' ' A' ' 246' ' ' LYS . 99.3 t -86.41 -37.55 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 124.293 1.037 . . . . 0.0 110.196 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 155.51 -178.94 31.85 Favored Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -78.43 165.53 23.68 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.222 1.009 . . . . 0.0 108.718 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -158.95 169.75 23.63 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 122.779 0.431 . . . . 0.0 109.922 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 96.7 mt -109.48 124.74 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 35.3 t -91.54 129.52 37.5 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -125.64 107.26 10.4 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -90.15 125.68 43.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 103.711 -2.7 . . . . 0.0 103.711 177.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 6.3 mt -113.74 112.75 41.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.73 -160.3 25.76 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 124.945 1.26 . . . . 0.0 112.554 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 84.25 56.64 0.01 OUTLIER 'General case' 0 C--O 1.239 0.529 0 C-N-CA 128.291 2.636 . . . . 0.0 108.421 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -134.05 149.62 19.8 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-O 121.651 0.584 . . . . 0.0 112.773 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -58.68 140.01 55.25 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 128.325 2.65 . . . . 0.0 109.995 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 21.7 mm -69.16 137.03 25.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 121.16 0.505 . . . . 0.0 111.21 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.3 m -85.33 104.06 14.82 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -53.99 -28.87 40.58 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.123 0.969 . . . . 0.0 112.593 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 45.5 t -42.95 -48.76 1.2 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 125.882 1.673 . . . . 0.0 111.207 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 10.0 t -124.36 -35.21 2.81 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.294 1.038 . . . . 0.0 113.241 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 105.94 36.15 2.82 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.564 1.554 . . . . 0.0 109.238 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -114.37 152.24 31.79 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 118.463 1.131 . . . . 0.0 111.535 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -66.1 163.29 17.82 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 4.9 mmt85 -89.29 28.4 1.25 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 130.648 3.579 . . . . 0.0 112.452 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 6.1 ptm -73.32 175.31 7.01 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 121.763 2.074 . . . . 0.0 111.042 -177.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.81 153.01 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 125.289 1.436 . . . . 0.0 107.24 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -115.48 114.65 25.3 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.798 1.639 . . . . 0.0 106.951 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 12.0 mm -106.07 144.79 14.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.324 1.049 . . . . 0.0 109.138 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -125.65 98.46 5.58 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.609 1.564 . . . . 0.0 112.601 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -73.06 111.48 8.21 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.571 1.148 . . . . 0.0 108.003 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 25.4 m -125.24 163.63 25.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 C-N-CA 124.932 1.293 . . . . 0.0 109.018 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 48.7 t -85.12 146.7 27.0 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -102.03 22.39 38.28 Favored Glycine 0 N--CA 1.463 0.443 0 C-N-CA 124.361 0.981 . . . . 0.0 112.042 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.833 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 -178.283 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo . . . . . 0 N--CA 1.458 -0.601 0 N-CA-C 109.866 -0.859 . . . . 0.0 109.866 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 2.3 p -171.19 145.57 2.24 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 126.961 2.104 . . . . 0.0 108.317 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 13.9 p -149.88 172.42 15.2 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.849 0.86 . . . . 0.0 110.207 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 233' ' ' VAL . 4.1 mt -122.36 136.08 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 125.997 1.719 . . . . 0.0 107.27 177.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -77.61 -59.37 2.81 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.425 1.49 . . . . 0.0 107.94 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . 0.462 ' HA ' ' CE1' ' A' ' 120' ' ' TYR . 68.1 p-90 -159.88 162.57 34.62 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.38 1.472 . . . . 0.0 109.259 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 47.3 t -154.43 138.67 9.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.27 163.3 20.09 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.998 0.919 . . . . 0.0 110.474 178.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -71.53 143.12 50.05 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 178.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 9.4 t -118.67 -35.95 3.59 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.541 1.136 . . . . 0.0 111.547 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -129.51 -175.98 3.76 Favored 'General case' 0 C--O 1.22 -0.485 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 56.5 mt -53.35 -43.31 51.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -129.56 14.54 6.0 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.512 0.725 . . . . 0.0 112.159 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 15.8 t -115.84 142.7 28.03 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -177.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -123.76 159.8 28.69 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.362 1.065 . . . . 0.0 109.037 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -126.77 136.74 52.81 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.885 1.674 . . . . 0.0 107.824 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -137.27 146.66 45.0 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 125.814 1.646 . . . . 0.0 109.038 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -135.5 108.04 7.4 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 218' ' ' ILE . 2.8 m -101.15 149.63 6.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 124.542 1.137 . . . . 0.0 108.622 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.12 128.6 46.45 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.94 0.896 . . . . 0.0 112.39 -178.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -131.83 147.88 67.71 Favored Pre-proline 0 C--O 1.234 0.249 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 177.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -72.45 -43.55 0.97 Allowed 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.225 1.95 . . . . 0.0 110.512 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -54.46 -23.92 18.12 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 125.424 1.49 . . . . 0.0 113.39 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 5.4 tp -62.24 -32.8 73.53 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 121.229 -0.919 . . . . 0.0 110.432 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 9.0 m -61.6 -12.3 15.18 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.666 1.186 . . . . 0.0 112.469 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.83 -31.28 70.7 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 123.391 0.676 . . . . 0.0 109.344 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.49 122.15 27.68 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -47.35 -44.36 23.88 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.823 1.649 . . . . 0.0 112.841 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 1.1 tp -68.06 -30.71 69.98 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 120.975 -1.078 . . . . 0.0 113.704 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 19.2 mt -93.61 -5.0 49.77 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.876 1.671 . . . . 0.0 111.841 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -67.22 119.77 12.66 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.004 1.321 . . . . 0.0 109.944 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.457 ' HE3' ' CG1' ' A' ' 179' ' ' VAL . 13.3 mmmm . . . . . 0 CA--C 1.532 0.276 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.462 0.159 0 CA-C-O 119.468 -0.301 . . . . 0.0 110.353 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.22 -51.17 69.06 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.782 0.833 . . . . 0.0 108.942 178.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 35.4 tp -67.22 -40.03 86.36 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.826 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 41.4 mt -59.66 -54.55 45.07 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 119.514 1.052 . . . . 0.0 109.889 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 52.5 m -62.68 -44.84 95.23 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.132 0.973 . . . . 0.0 110.358 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.4 tmmm? -60.83 -50.92 71.47 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.713 -0.617 . . . . 0.0 109.934 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.1 m -53.82 -44.29 70.11 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 123.873 0.869 . . . . 0.0 109.862 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.12 -45.9 92.78 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.689 0.677 . . . . 0.0 109.76 178.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.87 -61.7 2.32 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 124.573 1.149 . . . . 0.0 113.71 -178.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.98 -34.46 78.15 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 119.118 -0.468 . . . . 0.0 110.558 -178.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.34 -53.08 48.58 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 40.3 t -57.52 -51.57 68.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-N 118.909 1.355 . . . . 0.0 111.471 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 7.6 pttp -60.39 -33.68 72.82 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.849 -179.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 35.5 m -76.33 -30.89 57.84 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 122.235 0.214 . . . . 0.0 111.095 -178.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 16.1 mt -61.83 -54.97 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -62.45 -33.5 74.94 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.901 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -60.23 -35.56 75.73 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.178 0.899 . . . . 0.0 110.942 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.1 tptp -80.27 -53.67 6.43 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 28.8 mt -57.02 -28.79 62.8 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -178.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -49.35 -26.0 2.84 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.881 1.272 . . . . 0.0 112.908 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -61.33 -63.3 1.33 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.181 0.992 . . . . 0.0 112.511 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.7 mmm-85 -154.62 178.82 9.67 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.088 1.755 . . . . 0.0 110.049 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 63.4 m -86.62 174.05 9.14 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 38.5 pt -127.92 157.54 39.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 125.762 1.625 . . . . 0.0 108.778 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -151.57 145.23 24.98 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.847 1.259 . . . . 0.0 109.609 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -140.23 120.91 14.31 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.191 0.596 . . . . 0.0 111.551 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -79.22 104.61 9.96 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 178.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.06 79.97 3.6 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 57.8 -109.14 1.66 Allowed Glycine 0 CA--C 1.53 1.023 0 C-N-CA 123.992 0.806 . . . . 0.0 111.121 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -72.27 -35.96 68.87 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 118.704 -0.665 . . . . 0.0 112.281 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -99.8 168.68 9.75 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 119.336 0.971 . . . . 0.0 112.702 -177.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.4 mp -136.51 133.82 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 N-CA-C 104.059 -2.571 . . . . 0.0 104.059 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -111.68 119.98 40.49 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -117.88 124.78 49.15 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.256 0.622 . . . . 0.0 109.437 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -117.78 136.22 53.54 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.436 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 17.8 m -113.78 154.61 45.79 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 124.184 0.994 . . . . 0.0 111.241 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -61.99 80.56 0.09 OUTLIER 'Trans proline' 0 C--N 1.351 0.661 1 C-N-CA 125.409 4.072 . . . . 0.0 116.383 -177.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 72.95 41.74 47.57 Favored Glycine 0 CA--C 1.529 0.934 0 O-C-N 120.836 -1.165 . . . . 0.0 111.258 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 3.9 mp -122.93 -69.43 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.32 0 CA-C-N 118.207 1.004 . . . . 0.0 108.553 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -164.29 169.62 17.28 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.235 1.014 . . . . 0.0 109.849 -178.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -133.06 118.32 18.63 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 176.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.7 m -135.85 164.63 31.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 125.229 1.412 . . . . 0.0 112.327 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -125.23 123.29 39.22 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.546 1.938 . . . . 0.0 108.514 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -138.31 162.56 34.06 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.561 1.145 . . . . 0.0 110.987 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -105.54 130.59 53.56 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 178.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.512 0 N-CA-C 108.476 -1.85 . . . . 0.0 108.476 -178.605 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 . . . . . 0 N--CA 1.452 -0.363 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -149.36 115.95 5.88 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 178.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 26.5 mt -100.14 -24.81 14.48 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 159.89 161.72 11.59 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-O 122.545 1.081 . . . . 0.0 112.199 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -124.02 109.46 29.67 Favored Pre-proline 0 N--CA 1.43 -1.429 0 C-N-CA 125.01 1.324 . . . . 0.0 111.737 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -74.86 157.23 43.49 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 123.726 2.951 . . . . 0.0 109.223 177.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -92.73 157.54 16.39 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.791 -0.568 . . . . 0.0 109.54 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.62 -47.8 74.38 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.3 0.64 . . . . 0.0 111.572 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -74.74 64.89 1.29 Allowed 'General case' 0 N--CA 1.461 0.102 0 C-N-CA 126.701 2.001 . . . . 0.0 113.162 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.4 p -47.55 -31.82 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 124.382 1.073 . . . . 0.0 112.969 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -64.85 -32.44 74.15 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 122.401 1.095 . . . . 0.0 112.283 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -87.78 -15.1 37.88 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.165 1.386 . . . . 0.0 111.173 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -80.74 133.58 35.69 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -98.78 149.2 23.11 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -134.41 169.98 16.43 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.087 1.355 . . . . 0.0 108.565 -178.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -120.77 152.97 37.65 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 122.908 0.483 . . . . 0.0 109.791 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 14.2 tp -110.59 110.62 21.4 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 125.417 1.487 . . . . 0.0 107.384 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -123.65 -179.23 4.28 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 127.316 2.246 . . . . 0.0 108.595 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -144.69 167.97 21.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.435 0.636 . . . . 0.0 111.005 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -140.64 -176.11 4.53 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 126.734 2.014 . . . . 0.0 107.646 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -64.04 -11.87 33.36 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 121.386 -0.821 . . . . 0.0 112.965 -177.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 85.0 t -106.23 -36.42 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 124.62 1.168 . . . . 0.0 112.485 -178.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 169.4 -173.62 43.74 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 119.389 0.995 . . . . 0.0 112.476 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 5.1 m-30 -79.97 162.97 24.62 Favored 'General case' 0 C--O 1.241 0.654 0 O-C-N 122.107 -0.643 . . . . 0.0 110.125 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -159.22 168.96 25.18 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.501 -1.227 . . . . 0.0 112.053 -179.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 92.1 mt -104.74 127.5 59.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 22.5 t -100.07 115.08 28.93 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.915 1.286 . . . . 0.0 108.802 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -111.83 107.01 15.91 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -89.54 111.84 23.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.447 0 N-CA-C 103.455 -2.795 . . . . 0.0 103.455 177.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 6.7 mt -95.87 106.64 18.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.01 -157.42 26.29 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.0 t 85.29 3.61 0.62 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 127.667 2.387 . . . . 0.0 108.679 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -63.74 136.78 41.5 Favored Glycine 0 N--CA 1.435 -1.411 0 N-CA-C 108.256 -1.937 . . . . 0.0 108.256 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.26 148.25 27.9 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.469 1.108 . . . . 0.0 108.842 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.8 mm -70.37 130.76 34.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 122.863 1.316 . . . . 0.0 113.893 -177.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.3 m -85.46 107.5 17.45 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 128.448 2.699 . . . . 0.0 108.171 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -53.74 -18.38 3.09 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 127.963 2.505 . . . . 0.0 113.436 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 18.0 t -56.24 -54.77 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 125.935 1.694 . . . . 0.0 109.805 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 13.3 t -123.75 -29.68 3.67 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.189 0.996 . . . . 0.0 112.49 -178.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 104.6 35.75 3.21 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -115.48 160.1 20.35 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.282 1.541 . . . . 0.0 111.9 -178.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -77.54 151.43 34.53 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 118.867 0.758 . . . . 0.0 112.996 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -71.0 28.65 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.667 1 C-N-CA 132.129 4.172 . . . . 0.0 109.988 177.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 7.0 ptm -73.47 173.78 9.15 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 122.617 1.199 . . . . 0.0 112.002 -176.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.08 147.04 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 124.488 1.115 . . . . 0.0 108.733 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -106.83 104.37 14.04 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 125.635 1.574 . . . . 0.0 107.241 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 12.6 mm -93.24 147.21 5.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -126.84 101.75 6.73 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.008 1.723 . . . . 0.0 107.638 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -84.34 111.15 19.17 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 6.4 m -125.13 168.13 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.718 0.77 . . . . 0.0 109.605 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 49.8 t -87.88 142.15 28.03 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -88.49 -0.69 81.89 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-O 118.464 -1.187 . . . . 0.0 113.07 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.739 0 N-CA-C 107.31 -2.316 . . . . 0.0 107.31 -178.234 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo . . . . . 0 N--CA 1.451 -0.987 0 N-CA-C 110.973 -0.433 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 19.0 p -160.21 147.7 16.34 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 120.624 -1.298 . . . . 0.0 108.951 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 82.8 p -148.04 166.43 27.79 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.632 0.773 . . . . 0.0 109.31 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 3.4 mt -105.47 149.51 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 177.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -99.1 -44.95 6.09 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.653 0.781 . . . . 0.0 112.29 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 66.9 p-90 -163.63 155.12 16.79 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.15 1.78 . . . . 0.0 107.51 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 59.1 t -151.96 131.54 3.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 C-N-CA 125.565 1.546 . . . . 0.0 107.479 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.78 163.43 36.73 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.185 0.902 . . . . 0.0 111.848 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -77.74 129.07 35.03 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 104.02 -2.585 . . . . 0.0 104.02 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 9.8 t -108.55 -28.33 9.37 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.886 1.275 . . . . 0.0 113.089 -178.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 59.1 mttt -135.9 -176.05 4.17 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 124.468 1.107 . . . . 0.0 108.621 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 68.9 mt -47.86 -47.49 12.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.591 -0.732 . . . . 0.0 112.365 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 3.7 t -133.06 18.08 4.11 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.131 1.373 . . . . 0.0 111.372 -178.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 22.0 t -114.96 142.48 27.64 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -178.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -121.29 162.94 19.38 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.202 1.401 . . . . 0.0 107.226 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -135.47 143.57 45.93 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 179.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -142.8 150.14 39.57 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -137.6 122.41 18.79 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 104.33 -2.47 . . . . 0.0 104.33 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 3.5 m -119.09 150.74 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -178.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.3 p -120.94 132.82 55.17 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.149 0.98 . . . . 0.0 111.608 -178.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 6.6 pt -138.32 154.85 74.09 Favored Pre-proline 0 N--CA 1.453 -0.278 0 C-N-CA 125.317 1.447 . . . . 0.0 109.205 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -76.08 -49.93 0.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.256 2.638 . . . . 0.0 112.296 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -53.01 -15.83 0.9 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 118.002 2.593 . . . . 0.0 118.002 -176.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 22.9 mt -77.52 -26.89 51.51 Favored 'General case' 0 CA--C 1.517 -0.308 0 O-C-N 120.958 -1.089 . . . . 0.0 109.648 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 5.8 m -56.13 -21.37 22.07 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.112 0.965 . . . . 0.0 111.724 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -59.49 -36.07 75.34 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.635 1.174 . . . . 0.0 109.347 178.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.58 125.2 30.24 Favored 'General case' 0 CA--C 1.521 -0.164 0 O-C-N 120.941 -1.1 . . . . 0.0 108.322 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -47.49 -48.83 26.94 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -178.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 22.5 mt -68.58 -26.87 65.6 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 13.8 mt -91.97 -13.47 31.02 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.219 0.608 . . . . 0.0 112.291 -178.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -58.15 141.83 49.15 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 128.283 2.633 . . . . 0.0 113.061 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp . . . . . 0 C--N 1.33 -0.257 0 C-N-CA 127.659 2.383 . . . . 0.0 110.093 179.532 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.233 0.222 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.89 -39.26 93.78 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 56.4 tp -63.58 -38.26 90.46 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 64.8 mt -59.37 -54.55 45.45 Favored 'General case' 0 C--N 1.345 0.381 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.0 m -64.06 -45.98 86.38 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.889 0.476 . . . . 0.0 111.755 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.54 -47.61 79.07 Favored 'General case' 0 CA--C 1.516 -0.362 0 O-C-N 121.397 -0.815 . . . . 0.0 109.632 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 91.7 m -55.15 -47.3 75.31 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.358 0.663 . . . . 0.0 110.703 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -56.73 -47.0 80.97 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 123.438 0.462 . . . . 0.0 110.007 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.37 -56.93 6.05 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.854 0.835 . . . . 0.0 112.52 -178.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -56.96 -42.04 79.41 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 125.058 1.343 . . . . 0.0 110.651 -178.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.68 -52.79 39.53 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-O 117.673 -1.626 . . . . 0.0 109.594 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 50.8 t -55.89 -45.62 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 120.155 1.978 . . . . 0.0 110.485 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.2 pttp -61.3 -35.83 78.43 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.193 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 51.8 m -75.14 -36.69 61.54 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.898 0.879 . . . . 0.0 110.301 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 20.0 mt -59.17 -55.04 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 178.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -60.0 -34.22 73.03 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 124.066 0.854 . . . . 0.0 111.726 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -63.42 -37.75 88.51 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -178.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.8 mmmt -86.07 -42.79 13.64 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 19.2 mt -61.73 -29.19 69.95 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-O 117.808 -1.092 . . . . 0.0 111.685 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -47.83 -30.79 4.32 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.704 2.002 . . . . 0.0 111.807 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -64.85 -70.34 0.24 Allowed 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 122.813 0.445 . . . . 0.0 111.544 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -145.35 -178.62 6.16 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.628 1.171 . . . . 0.0 112.275 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 60.2 m -86.82 171.2 11.05 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 27.3 pt -121.91 160.35 23.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 127.087 2.155 . . . . 0.0 107.41 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -156.4 134.8 11.47 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.043 0.537 . . . . 0.0 111.957 -178.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -132.09 121.21 23.45 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.65 0.78 . . . . 0.0 110.562 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -87.95 99.44 12.14 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.41 80.71 6.72 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 127.363 2.265 . . . . 0.0 108.952 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.17 -111.53 4.08 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 108.158 -1.977 . . . . 0.0 108.158 -179.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -85.88 -24.4 26.67 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -100.53 159.4 15.18 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 119.551 1.069 . . . . 0.0 111.851 -178.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.2 mp -132.73 140.9 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -121.72 119.55 32.09 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -179.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -107.5 116.44 31.94 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.189 0.595 . . . . 0.0 110.087 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -109.27 129.19 55.52 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 122.03 -0.419 . . . . 0.0 110.673 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 52.3 m -110.95 155.9 41.68 Favored Pre-proline 0 N--CA 1.446 -0.641 0 C-N-CA 127.266 2.226 . . . . 0.0 113.312 -178.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.26 70.75 0.15 Allowed 'Trans proline' 0 CA--C 1.542 0.904 1 C-N-CA 125.647 4.231 . . . . 0.0 114.717 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 68.57 57.51 8.06 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 120.466 -1.396 . . . . 0.0 110.911 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.0 mp -124.65 -71.72 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.303 0 CA-C-N 118.333 1.067 . . . . 0.0 109.251 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -175.21 138.29 0.42 Allowed 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -109.8 125.22 52.5 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.984 0.811 . . . . 0.0 109.722 -176.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 20.0 m -142.9 163.97 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.795 1.238 . . . . 0.0 111.637 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -122.13 129.6 52.48 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.222 1.409 . . . . 0.0 108.266 178.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -139.13 162.96 33.67 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.017 0.927 . . . . 0.0 112.074 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 53.1 t60 -84.85 160.87 20.1 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 177.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.653 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 -179.517 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 . . . . . 0 CA--C 1.516 -0.335 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -140.86 134.01 29.46 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 58.7 mt -119.92 -26.25 5.65 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 125.286 1.616 . . . . 0.0 108.031 178.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 156.13 154.61 7.05 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 119.543 1.065 . . . . 0.0 111.096 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -117.57 109.95 41.23 Favored Pre-proline 0 C--O 1.236 0.347 0 C-N-CA 124.138 0.975 . . . . 0.0 108.412 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -73.3 -169.44 0.52 Allowed 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 124.003 3.135 . . . . 0.0 109.445 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -126.86 156.32 41.55 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.833 1.253 . . . . 0.0 108.549 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.44 -45.29 39.61 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.361 0.664 . . . . 0.0 111.247 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -74.9 65.75 1.45 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.602 1.561 . . . . 0.0 111.518 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.3 p -45.55 -35.09 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 124.762 1.225 . . . . 0.0 112.52 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -63.9 -36.43 83.91 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -178.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -74.31 -15.84 60.95 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.746 0.819 . . . . 0.0 113.046 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 20.5 mtp-105 -78.22 178.17 7.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 122.096 0.951 . . . . 0.0 110.097 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -127.27 144.6 51.01 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 178.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -132.22 165.95 22.97 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -123.89 147.74 47.42 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 16.0 tp -114.58 98.06 6.66 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -112.25 -179.26 3.63 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 127.856 2.463 . . . . 0.0 106.757 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -149.4 165.22 32.72 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.617 0.722 . . . . 0.0 109.446 178.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -135.88 179.64 6.22 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 126.654 1.981 . . . . 0.0 110.513 -178.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.26 -18.75 63.89 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.904 1.282 . . . . 0.0 109.656 178.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 25.6 t -87.24 -25.3 6.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 129.771 3.228 . . . . 0.0 111.805 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 132.87 -167.95 23.07 Favored Glycine 0 N--CA 1.444 -0.779 0 O-C-N 121.279 -0.888 . . . . 0.0 111.701 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -77.71 163.31 26.29 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 121.841 -0.8 . . . . 0.0 110.367 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -160.73 167.36 27.03 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.635 1.174 . . . . 0.0 111.082 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 83.9 mt -106.15 138.28 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 17.4 t -113.01 135.15 54.09 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.041 0.937 . . . . 0.0 109.052 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -127.22 110.88 13.32 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 125.815 1.646 . . . . 0.0 108.57 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -93.52 111.49 24.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 7.5 mt -98.45 108.28 21.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 179.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -94.63 -153.28 30.14 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 66.6 m 66.19 54.73 0.94 Allowed 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.208 1.003 . . . . 0.0 112.912 178.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -102.02 -137.84 9.83 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -140.58 128.8 22.32 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 177.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 28.8 mm -60.21 132.3 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 121.911 0.862 . . . . 0.0 111.743 -178.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 3.0 m -84.92 111.34 19.58 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 128.101 2.56 . . . . 0.0 109.245 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.76 -19.58 11.73 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.125 1.77 . . . . 0.0 113.774 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 60.9 t -56.62 -51.75 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 124.652 1.181 . . . . 0.0 110.33 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 13.9 t -125.12 -25.1 3.89 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 99.0 35.51 4.79 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 107.556 -2.218 . . . . 0.0 107.556 -178.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -103.98 152.52 21.91 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 118.519 1.16 . . . . 0.0 113.732 -178.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -78.42 138.94 38.74 Favored 'General case' 0 C--N 1.335 -0.052 0 C-N-CA 124.025 0.93 . . . . 0.0 109.152 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . 0.3 34.3 ttt180 -69.94 30.52 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 130.705 3.602 . . . . 0.0 113.598 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 5.2 ptm -74.18 171.92 12.71 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.056 -1.028 . . . . 0.0 109.216 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.77 148.79 22.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 C-N-CA 124.679 1.191 . . . . 0.0 107.819 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -110.17 116.39 31.43 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 14.4 mm -103.97 141.08 20.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -124.43 110.09 14.1 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 126.067 1.747 . . . . 0.0 109.774 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -87.31 110.85 20.51 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.479 1.111 . . . . 0.0 108.875 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 11.2 m -123.11 163.66 21.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 46.1 t -88.07 146.58 25.38 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -97.86 16.91 59.62 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-O 117.914 -1.492 . . . . 0.0 113.057 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.077 0 C-N-CA 126.646 2.07 . . . . 0.0 113.875 179.507 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo . . . . . 0 CA--C 1.539 0.753 0 N-CA-C 110.145 -0.752 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 4.6 p -166.88 148.27 6.02 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 127.055 2.142 . . . . 0.0 107.34 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 10.4 p -154.39 165.97 34.72 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.182 1.393 . . . . 0.0 109.556 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 4.9 mt -108.54 153.81 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 126.567 1.947 . . . . 0.0 106.592 178.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -101.1 -52.21 3.33 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 123.44 0.696 . . . . 0.0 110.484 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 58.9 p-90 -157.07 157.32 34.36 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -178.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 91.3 t -153.16 122.56 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -178.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.22 167.5 29.6 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.511 1.05 . . . . 0.0 110.784 178.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -73.07 132.05 42.85 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 6.7 t -109.35 -38.59 5.45 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.427 1.091 . . . . 0.0 110.22 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 6.7 mttt -130.92 178.57 6.57 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 73.1 mt -49.51 -46.98 20.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -126.19 22.32 7.24 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 6.5 t -122.86 138.64 52.25 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.545 0 O-C-N 121.191 -0.943 . . . . 0.0 110.081 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -120.97 162.26 20.2 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -132.53 145.71 51.35 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.24 119.36 8.26 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.218 1.007 . . . . 0.0 108.471 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -107.36 126.93 53.08 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 4.0 m -118.14 154.38 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-N 117.717 0.235 . . . . 0.0 110.797 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 2.3 p -121.56 124.82 45.31 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.33 1.052 . . . . 0.0 110.911 -177.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 2.3 pt -136.84 129.49 17.29 Favored Pre-proline 0 N--CA 1.444 -0.728 0 CA-C-N 114.922 -1.035 . . . . 0.0 108.831 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -64.85 -31.12 57.82 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.065 2.51 . . . . 0.0 113.388 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -64.25 -14.13 53.74 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -177.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 44.6 mt -76.88 -31.03 56.48 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 120.475 -1.391 . . . . 0.0 109.908 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 15.6 m -55.88 -12.06 1.24 Allowed 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -70.42 -32.04 69.48 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 121.497 -0.752 . . . . 0.0 110.043 179.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.9 mt -80.71 123.16 27.96 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.669 1.988 . . . . 0.0 106.671 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -47.51 -48.09 27.44 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.074 1.349 . . . . 0.0 114.081 -178.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 56.1 mt -66.65 -32.53 73.91 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 119.298 0.954 . . . . 0.0 112.847 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 15.9 mt -91.68 -5.57 53.53 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -65.31 134.42 53.54 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 127.55 2.34 . . . . 0.0 110.3 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt . . . . . 0 CA--C 1.511 -0.554 0 C-N-CA 125.214 1.406 . . . . 0.0 111.146 179.872 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 CA--C 1.522 -0.133 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.54 -43.63 84.53 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 53.1 tp -68.28 -36.7 79.79 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-O 118.459 -0.782 . . . . 0.0 109.401 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.5 mt -60.26 -54.69 42.78 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 118.935 0.789 . . . . 0.0 109.694 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 50.9 m -58.78 -49.12 78.87 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.314 1.046 . . . . 0.0 109.845 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.22 -44.69 96.86 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 118.095 -0.955 . . . . 0.0 110.905 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 63.0 m -52.33 -49.3 64.54 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 119.286 0.948 . . . . 0.0 110.682 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -55.38 -50.73 68.94 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 122.744 0.417 . . . . 0.0 110.101 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.36 -55.49 15.63 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 115.151 1.538 . . . . 0.0 115.151 -178.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -64.94 -38.1 89.84 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.497 1.119 . . . . 0.0 110.648 -177.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.03 -52.57 51.42 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 54.2 t -57.37 -44.88 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 118.671 1.236 . . . . 0.0 109.72 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -61.7 -35.78 79.02 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 118.53 -1.268 . . . . 0.0 111.643 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 59.3 m -65.64 -46.43 79.22 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -178.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 19.3 mt -56.92 -54.96 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 CA-C-O 121.568 0.699 . . . . 0.0 109.738 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -64.61 -27.81 69.19 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -62.61 -42.73 99.75 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -83.25 -43.16 16.37 Favored 'General case' 0 C--N 1.341 0.234 0 O-C-N 121.278 -0.889 . . . . 0.0 113.038 -179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.4 mt -62.87 -27.38 69.31 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.099 0.863 . . . . 0.0 113.243 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -44.38 -33.86 1.8 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.484 1.514 . . . . 0.0 113.825 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -64.43 -69.5 0.28 Allowed 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.909 1.283 . . . . 0.0 113.944 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 -140.07 172.58 12.55 Favored 'General case' 0 CA--C 1.518 -0.27 0 O-C-N 121.097 -1.002 . . . . 0.0 112.979 -177.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 37.7 m -87.13 160.7 18.45 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 178.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 34.9 pt -114.37 157.03 15.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 124.906 1.282 . . . . 0.0 107.544 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -151.4 134.29 15.75 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 123.801 0.84 . . . . 0.0 109.263 -178.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -133.16 120.95 21.87 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 123.741 0.817 . . . . 0.0 111.615 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -84.48 101.41 12.02 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.542 1.137 . . . . 0.0 108.614 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.75 80.34 3.76 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.04 -124.65 20.51 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -70.97 -31.2 67.69 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 48.0 m95 -99.83 152.02 20.61 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 118.546 0.612 . . . . 0.0 110.344 -178.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.7 mp -125.15 144.73 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 104.481 -2.415 . . . . 0.0 104.481 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -122.12 119.68 32.04 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -178.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -113.63 126.51 55.35 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.918 0.887 . . . . 0.0 109.091 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -124.98 126.77 45.97 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.424 0.69 . . . . 0.0 109.801 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 15.0 m -104.46 155.96 36.57 Favored Pre-proline 0 CA--C 1.532 0.257 0 C-N-CA 123.929 0.892 . . . . 0.0 111.47 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -63.13 83.25 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 124.385 3.39 . . . . 0.0 114.597 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.38 42.96 63.81 Favored Glycine 0 CA--C 1.526 0.77 0 O-C-N 120.776 -1.202 . . . . 0.0 113.079 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 3.6 mp -122.7 -70.25 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -161.86 168.52 22.9 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.849 1.259 . . . . 0.0 110.611 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -132.42 126.84 34.07 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 104.459 -2.422 . . . . 0.0 104.459 177.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.2 m -144.81 164.17 13.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 124.999 1.32 . . . . 0.0 112.321 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -130.24 118.77 21.86 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -137.9 162.82 33.04 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.871 1.668 . . . . 0.0 111.23 -178.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -94.08 148.29 22.32 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.524 0 C-N-CA 125.301 1.429 . . . . 0.0 110.343 -179.69 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 . . . . . 0 C--O 1.235 0.298 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -145.45 136.87 25.08 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 124.69 1.196 . . . . 0.0 107.926 178.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.1 mp -116.15 -27.74 6.8 Favored 'General case' 0 C--O 1.221 -0.444 0 O-C-N 125.486 1.741 . . . . 0.0 107.277 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 157.3 163.45 12.55 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -126.97 110.24 21.92 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 124.03 0.932 . . . . 0.0 111.428 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -71.96 177.57 6.91 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.907 3.071 . . . . 0.0 109.274 178.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -121.1 146.67 46.49 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.31 -45.94 76.3 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.171 1.388 . . . . 0.0 112.178 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.441 HD21 ' CD ' ' A' ' 169' ' ' GLU . 48.8 m-20 -73.41 67.13 1.0 Allowed 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 127.581 2.353 . . . . 0.0 110.249 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.5 p -44.82 -32.74 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 O-C-N 121.196 -0.94 . . . . 0.0 113.385 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -65.25 -31.74 73.05 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 119.186 0.903 . . . . 0.0 111.671 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.441 ' CD ' HD21 ' A' ' 166' ' ' ASN . 98.0 mt-10 -71.74 -30.56 65.74 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 124.03 0.932 . . . . 0.0 110.049 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 25.7 mtt180 -69.08 152.46 45.17 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -114.06 143.12 45.29 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -129.63 168.06 17.02 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.159 1.384 . . . . 0.0 112.072 -177.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -133.62 154.67 50.71 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 124.884 1.274 . . . . 0.0 111.265 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 57.5 tp -109.23 98.63 8.03 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 127.28 2.232 . . . . 0.0 110.252 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -112.17 -179.26 3.63 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 127.649 2.38 . . . . 0.0 108.581 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -141.7 166.29 25.15 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.188 0.518 . . . . 0.0 111.461 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -139.28 179.99 6.21 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 127.313 2.245 . . . . 0.0 108.39 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -57.4 -19.25 22.11 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.477 1.111 . . . . 0.0 112.389 -178.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 40.7 t -92.6 -54.84 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 O-C-N 120.651 -1.281 . . . . 0.0 110.43 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 178.7 -153.52 12.78 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -178.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -86.64 168.79 13.29 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 122.43 1.109 . . . . 0.0 110.772 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -158.57 176.09 12.84 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.014 1.725 . . . . 0.0 109.559 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 89.3 mt -110.95 138.27 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 176.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 14.2 t -100.96 128.53 46.95 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -129.15 110.03 11.66 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -92.42 135.66 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 104.604 -2.369 . . . . 0.0 104.604 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 3.8 mt -112.74 106.2 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 104.782 -2.303 . . . . 0.0 104.782 176.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -99.32 -155.49 28.65 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.5 t 68.72 56.19 0.45 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-O 122.516 1.151 . . . . 0.0 111.766 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -131.82 157.07 22.23 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 128.401 2.905 . . . . 0.0 106.396 177.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -72.62 150.91 42.64 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.219 1.007 . . . . 0.0 112.273 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.9 mm -65.99 136.23 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-O 121.274 0.559 . . . . 0.0 110.379 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.5 m -79.87 115.52 19.5 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.707 2.003 . . . . 0.0 106.979 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -55.06 -21.7 13.39 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.863 1.265 . . . . 0.0 112.957 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 31.6 t -51.44 -61.16 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.205 0 C-N-CA 126.966 2.106 . . . . 0.0 112.24 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 5.1 t -125.69 -24.12 3.9 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.318 1.047 . . . . 0.0 113.762 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 105.61 34.87 3.2 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -178.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -98.91 149.72 22.65 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 118.851 1.326 . . . . 0.0 112.112 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -74.71 141.04 44.52 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.942 0.897 . . . . 0.0 110.737 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -66.64 27.71 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 131.269 3.828 . . . . 0.0 113.882 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 8.2 ptm -75.14 177.09 6.7 Favored 'General case' 0 C--N 1.319 -0.743 0 O-C-N 120.788 -1.195 . . . . 0.0 111.787 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.0 p -147.18 153.62 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 126.612 1.965 . . . . 0.0 106.408 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -116.77 117.63 30.3 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.801 1.24 . . . . 0.0 108.324 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 9.2 mm -102.25 148.53 7.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -126.09 103.73 7.87 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 128.274 2.63 . . . . 0.0 108.97 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -83.25 109.8 17.54 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.967 1.307 . . . . 0.0 108.706 178.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 5.8 m -125.17 163.4 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 47.5 t -84.76 139.83 31.69 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 178.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -86.97 -0.07 85.87 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 118.369 -1.239 . . . . 0.0 112.7 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.678 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 -178.72 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo . . . . . 0 N--CA 1.454 -0.806 0 CA-C-O 120.085 -0.048 . . . . 0.0 112.003 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.7 p -158.66 148.94 19.78 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.283 1.433 . . . . 0.0 108.751 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 1.7 p -152.62 170.51 20.04 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.423 1.089 . . . . 0.0 110.365 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 4.8 mt -113.17 154.37 14.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 126.406 1.883 . . . . 0.0 107.291 178.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -104.38 -46.6 4.35 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.886 0.875 . . . . 0.0 111.527 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -160.93 155.63 23.71 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.972 1.709 . . . . 0.0 107.781 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 59.9 t -154.05 123.56 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 125.68 1.592 . . . . 0.0 106.999 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -154.13 161.68 41.71 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 118.913 0.779 . . . . 0.0 111.21 179.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -69.18 136.99 52.9 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 2.0 t -119.2 -28.75 5.37 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.199 1.0 . . . . 0.0 111.866 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -134.98 -176.66 4.32 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 124.123 0.969 . . . . 0.0 108.709 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 1.9 mm -50.41 -48.98 25.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 123.346 0.659 . . . . 0.0 112.133 -178.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -128.13 23.56 6.04 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.373 1.469 . . . . 0.0 111.63 -178.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 14.1 t -127.47 146.37 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 CA-C-O 122.045 0.926 . . . . 0.0 110.367 -178.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -126.14 161.84 26.73 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -134.35 141.32 46.85 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -140.09 140.12 36.01 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 125.31 1.444 . . . . 0.0 110.233 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -120.47 114.35 21.65 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 2.5 m -107.87 148.1 12.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.4 p -122.17 135.93 54.84 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 123.567 0.747 . . . . 0.0 111.927 -178.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -140.6 152.25 65.68 Favored Pre-proline 0 N--CA 1.451 -0.402 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.074 177.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -74.91 -50.86 0.13 Allowed 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.496 2.797 . . . . 0.0 111.995 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -52.98 -27.13 17.69 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 117.606 -1.188 . . . . 0.0 113.911 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 9.8 tp -59.23 -25.39 63.98 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 120.538 1.517 . . . . 0.0 112.258 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 3.4 m -64.74 -9.2 18.47 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.805 0.842 . . . . 0.0 111.963 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 42.5 p-10 -60.29 -40.3 89.95 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 125.337 1.455 . . . . 0.0 109.418 178.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -83.7 123.91 30.32 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 124.78 1.232 . . . . 0.0 108.591 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -47.18 -47.89 23.93 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.749 2.02 . . . . 0.0 113.31 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 40.6 mt -65.6 -20.09 66.17 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -178.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 5.2 mt -107.1 -11.75 15.56 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.176 1.39 . . . . 0.0 112.249 -178.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -63.29 131.12 47.3 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 128.479 2.712 . . . . 0.0 110.082 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt . . . . . 0 N--CA 1.465 0.285 0 C-N-CA 124.237 1.015 . . . . 0.0 110.017 179.764 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.211 0.053 . . . . 0.0 111.012 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.54 -43.4 89.24 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 13.0 tp -69.71 -36.18 75.7 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.239 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 62.3 mt -59.13 -54.72 43.83 Favored 'General case' 0 C--N 1.343 0.288 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 20.7 m -65.37 -42.29 92.88 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 121.559 -0.713 . . . . 0.0 110.938 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.29 -42.4 95.39 Favored 'General case' 0 C--N 1.341 0.214 0 O-C-N 120.874 -1.141 . . . . 0.0 110.472 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 80.3 m -56.59 -46.45 80.81 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.776 0.83 . . . . 0.0 109.805 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -59.79 -45.14 93.25 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 118.233 0.47 . . . . 0.0 110.604 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -65.19 -61.11 2.33 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 122.26 1.029 . . . . 0.0 112.013 -178.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -62.3 -36.89 83.53 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.369 -178.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -65.6 -53.35 32.18 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-O 118.114 -1.381 . . . . 0.0 110.149 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 45.4 t -58.28 -44.16 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 119.913 1.857 . . . . 0.0 109.957 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.7 ptmt -64.74 -32.94 74.85 Favored 'General case' 0 C--O 1.226 -0.168 0 C-N-CA 119.604 -0.839 . . . . 0.0 111.695 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.6 m -76.08 -33.78 59.53 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 123.441 0.696 . . . . 0.0 109.738 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 16.6 mt -62.75 -55.52 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 178.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -61.92 -28.57 69.62 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 117.948 -1.025 . . . . 0.0 112.39 -179.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.64 -38.16 86.68 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.963 1.256 . . . . 0.0 112.656 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.411 ' HE3' ' CD ' ' A' ' 237' ' ' GLU . 0.6 OUTLIER -95.48 -37.48 10.88 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.491 -0.755 . . . . 0.0 110.847 179.538 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.654 ' CD2' ' HG ' ' A' ' 216' ' ' SER . 15.8 mt -62.64 -28.35 69.86 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 118.66 0.664 . . . . 0.0 110.734 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -50.15 -34.71 23.23 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.613 1.165 . . . . 0.0 113.536 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -55.5 -61.74 2.15 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.735 1.214 . . . . 0.0 112.554 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -151.61 174.59 13.27 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.86 1.664 . . . . 0.0 110.761 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 56.7 m -86.61 170.94 11.4 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 114.006 -1.452 . . . . 0.0 108.684 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 29.6 pt -127.78 162.82 32.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 126.272 1.829 . . . . 0.0 109.004 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.72 145.28 22.24 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -136.87 125.7 24.09 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -88.88 108.04 19.32 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.075 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.37 80.3 3.93 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 178.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 58.75 -107.92 1.35 Allowed Glycine 0 CA--C 1.53 0.989 0 O-C-N 121.807 -0.558 . . . . 0.0 111.713 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -81.47 -17.88 47.2 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.546 1.938 . . . . 0.0 113.715 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 65.8 m95 -111.88 157.39 20.68 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 123.406 0.682 . . . . 0.0 110.121 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.2 mp -133.3 136.84 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -113.33 129.95 56.4 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -121.55 125.61 47.19 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 123.682 0.793 . . . . 0.0 110.885 -178.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -124.77 129.94 51.43 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.899 0.857 . . . . 0.0 110.63 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 2.1 m -111.18 156.41 41.07 Favored Pre-proline 0 C--N 1.33 -0.262 0 C-N-CA 125.303 1.441 . . . . 0.0 110.314 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -64.36 82.04 0.16 Allowed 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.775 2.983 . . . . 0.0 114.097 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 69.79 50.14 31.8 Favored Glycine 0 CA--C 1.533 1.209 0 O-C-N 120.785 -1.197 . . . . 0.0 113.683 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 3.4 mp -125.18 -68.28 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 119.042 1.421 . . . . 0.0 108.508 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -165.72 159.3 16.14 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 124.906 1.282 . . . . 0.0 109.213 179.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -122.96 123.07 40.08 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 104.554 -2.387 . . . . 0.0 104.554 176.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 16.6 m -143.37 163.98 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 123.485 0.714 . . . . 0.0 110.654 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -123.77 117.91 25.99 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -139.76 163.37 32.79 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 118.937 0.79 . . . . 0.0 112.039 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -90.07 154.99 19.37 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.273 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.468 0 O-C-N 120.674 -1.266 . . . . 0.0 111.583 179.61 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 . . . . . 0 N--CA 1.466 0.363 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.96 104.94 3.48 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.697 1.199 . . . . 0.0 109.414 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.3 mp -90.99 -28.59 17.91 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 162.76 156.77 8.68 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.7 mtpt -122.29 110.06 32.77 Favored Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 123.697 0.799 . . . . 0.0 108.997 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -79.73 170.12 17.34 Favored 'Trans proline' 0 N--CA 1.456 -0.698 1 C-N-CA 125.736 4.291 . . . . 0.0 109.133 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -105.7 159.72 15.76 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 123.036 0.534 . . . . 0.0 110.703 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -72.99 -43.39 62.25 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -73.39 64.01 0.8 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.416 1.486 . . . . 0.0 110.279 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.4 p -53.51 -29.48 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 O-C-N 120.653 -1.279 . . . . 0.0 110.821 178.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -63.13 -28.04 69.79 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.897 1.679 . . . . 0.0 112.748 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -88.57 -19.78 25.88 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 125.405 1.482 . . . . 0.0 112.462 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -77.77 154.68 31.74 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -107.85 149.45 28.25 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -137.13 173.99 11.09 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 126.681 1.992 . . . . 0.0 109.24 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -132.99 153.93 50.99 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.411 1.085 . . . . 0.0 110.455 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 25.1 tp -115.05 98.55 6.87 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 127.03 2.132 . . . . 0.0 108.53 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -110.09 -178.88 3.63 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.33 1.452 . . . . 0.0 110.079 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -135.22 153.85 51.79 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.952 0.901 . . . . 0.0 109.04 177.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.468 ' CG ' ' H ' ' A' ' 178' ' ' ASP . 15.1 t70 -130.46 175.41 8.99 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 128.087 2.555 . . . . 0.0 107.866 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . 0.468 ' H ' ' CG ' ' A' ' 177' ' ' ASP . 19.9 t0 -56.76 -16.86 7.26 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 129.099 2.96 . . . . 0.0 111.252 179.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 67.4 t -99.55 -50.42 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 126.803 2.041 . . . . 0.0 108.859 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 170.04 -161.46 34.65 Favored Glycine 0 C--N 1.336 0.553 0 CA-C-N 119.1 0.864 . . . . 0.0 112.339 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 -77.16 156.0 31.89 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 117.751 0.776 . . . . 0.0 110.891 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -157.35 166.63 32.54 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.21 1.004 . . . . 0.0 112.03 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 96.6 mt -105.34 142.06 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 15.9 t -111.24 138.58 47.52 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.238 1.415 . . . . 0.0 107.849 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -130.06 109.3 10.74 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 124.606 1.162 . . . . 0.0 108.402 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.8 mp -93.77 117.47 37.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 6.4 mt -108.12 106.38 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -125.01 142.82 14.14 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 108.111 -1.996 . . . . 0.0 108.111 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 22.7 t 162.83 25.21 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 129.949 3.3 . . . . 0.0 106.968 -178.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -99.0 159.31 20.12 Favored Glycine 0 CA--C 1.505 -0.549 0 O-C-N 120.328 -1.482 . . . . 0.0 111.55 -178.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.44 167.17 15.28 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 178.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 35.0 mm -84.07 135.82 24.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 O-C-N 121.177 -0.952 . . . . 0.0 111.955 -178.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -81.51 104.32 11.85 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 177.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -50.94 -31.69 18.51 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.553 1.141 . . . . 0.0 111.593 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 18.8 t -47.77 -47.33 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 128.72 2.808 . . . . 0.0 112.752 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 7.5 t -124.51 -39.69 2.29 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 110.57 36.16 1.95 Allowed Glycine 0 C--N 1.335 0.512 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -178.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -128.24 154.16 46.16 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 118.995 1.397 . . . . 0.0 110.567 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -66.16 168.26 8.79 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.102 0.561 . . . . 0.0 110.204 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -87.75 30.8 0.8 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 130.259 3.424 . . . . 0.0 110.335 177.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 5.9 ptm -72.58 175.42 6.36 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 120.576 -1.327 . . . . 0.0 111.815 -177.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.1 p -139.93 152.04 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 125.215 1.406 . . . . 0.0 109.19 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -114.27 104.08 11.72 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.511 1.924 . . . . 0.0 107.179 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 13.4 mm -91.69 143.7 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -124.72 99.31 6.1 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.624 1.57 . . . . 0.0 107.118 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -78.86 110.2 13.83 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 4.5 m -123.8 160.58 27.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 124.649 1.18 . . . . 0.0 108.678 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 53.5 t -82.41 141.26 32.92 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 179.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -90.16 3.34 82.33 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-O 118.421 -1.21 . . . . 0.0 114.916 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.585 0 C-N-CA 124.688 1.137 . . . . 0.0 111.967 -179.204 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo . . . . . 0 CA--C 1.536 0.585 0 N-CA-C 114.624 0.971 . . . . 0.0 114.624 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' SER . . . . . 0.654 ' HG ' ' CD2' ' A' ' 113' ' ' LEU . 4.9 p -173.46 156.28 3.0 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.021 -1.049 . . . . 0.0 113.245 -177.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 20.5 p -155.31 172.95 17.34 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.892 1.277 . . . . 0.0 108.255 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 7.5 mt -114.77 148.12 17.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 126.399 1.88 . . . . 0.0 108.465 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -89.37 -51.69 5.42 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.959 0.903 . . . . 0.0 110.961 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 64.8 p-90 -161.53 160.81 29.52 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.42 1.888 . . . . 0.0 107.189 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 88.0 t -148.92 127.89 3.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 125.586 1.555 . . . . 0.0 107.361 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -158.77 159.4 35.13 Favored 'General case' 0 C--O 1.239 0.522 0 O-C-N 121.392 -0.818 . . . . 0.0 112.012 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -67.48 135.12 52.56 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 177.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 8.8 t -109.51 -36.64 5.92 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.86 -0.525 . . . . 0.0 111.138 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 14.5 mttt -129.22 -175.48 3.58 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 124.274 1.03 . . . . 0.0 108.625 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 73.3 mt -51.19 -41.9 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -133.1 9.89 4.14 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.154 0.982 . . . . 0.0 112.453 -178.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 15.0 t -109.28 142.49 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.683 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -177.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -119.76 158.91 25.56 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.216 1.406 . . . . 0.0 107.586 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -136.38 141.86 43.71 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -144.61 121.04 10.99 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.339 1.056 . . . . 0.0 111.337 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -95.05 110.08 22.05 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 105.523 -2.029 . . . . 0.0 105.523 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 61.9 t -101.41 129.5 52.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -114.73 122.02 45.13 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.101 1.36 . . . . 0.0 111.913 -178.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 10.8 pt -132.3 139.26 34.3 Favored Pre-proline 0 N--CA 1.453 -0.312 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -66.84 -34.63 29.91 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 121.762 1.641 . . . . 0.0 111.37 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . 0.411 ' CD ' ' HE3' ' A' ' 112' ' ' LYS . 75.4 mm-40 -54.53 -32.66 58.64 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 126.571 1.949 . . . . 0.0 115.023 -178.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 43.5 mt -59.91 -29.47 68.38 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.766 1.166 . . . . 0.0 112.353 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 33.8 m -59.04 -11.85 4.01 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.938 0.895 . . . . 0.0 112.471 179.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -59.87 -25.68 65.25 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 118.668 -0.682 . . . . 0.0 111.106 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -97.27 132.24 43.21 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.904 1.282 . . . . 0.0 108.15 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -46.99 -46.89 21.99 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.297 1.839 . . . . 0.0 112.062 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 69.1 mt -58.13 -45.25 87.66 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 6.0 mt -91.32 1.19 57.29 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.478 1.511 . . . . 0.0 113.221 -177.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -71.24 111.76 6.84 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.311 1.044 . . . . 0.0 108.935 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 5.5 mmmt . . . . . 0 C--O 1.24 0.586 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.543 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 C--O 1.235 0.331 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.0 -35.94 80.03 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 42.1 tp -74.72 -36.79 62.69 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 121.281 -0.887 . . . . 0.0 109.425 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 86.9 mt -59.53 -55.66 31.71 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.433 1.093 . . . . 0.0 111.048 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 37.0 m -68.69 -40.89 79.83 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.29 -0.881 . . . . 0.0 111.007 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.12 -42.95 91.81 Favored 'General case' 0 C--N 1.341 0.201 0 O-C-N 121.579 -0.701 . . . . 0.0 109.681 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 53.7 m -56.18 -49.19 74.73 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 123.848 0.859 . . . . 0.0 109.904 178.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -57.97 -49.22 77.57 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 122.405 0.282 . . . . 0.0 110.643 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -66.59 -59.61 3.46 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -177.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -60.37 -37.8 81.9 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 123.079 0.552 . . . . 0.0 110.415 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.98 -51.97 55.23 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 39.0 t -56.93 -43.64 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 119.538 1.669 . . . . 0.0 108.081 177.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.4 tttt -57.76 -39.05 76.49 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 122.11 -0.368 . . . . 0.0 110.583 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.6 m -70.37 -37.41 74.58 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 126.149 1.78 . . . . 0.0 110.342 -178.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.2 mt -63.92 -55.02 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -61.45 -28.23 69.13 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.801 -0.619 . . . . 0.0 112.48 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -64.26 -53.82 43.07 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.036 1.334 . . . . 0.0 109.962 178.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -80.36 -39.52 28.37 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.4 mt -61.04 -28.59 69.17 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 118.534 0.606 . . . . 0.0 112.338 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -51.34 -31.05 20.59 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -49.32 -72.01 0.06 Allowed 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.131 1.372 . . . . 0.0 112.92 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -149.06 178.67 8.5 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.529 1.532 . . . . 0.0 109.846 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 86.3 m -86.72 159.17 19.25 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 40.5 pt -115.44 160.65 14.69 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 C-N-CA 124.806 1.243 . . . . 0.0 110.021 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -156.07 149.03 24.21 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.649 -178.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -141.14 136.52 31.96 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.71 1.204 . . . . 0.0 110.633 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -95.04 102.37 14.17 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.733 1.213 . . . . 0.0 108.194 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.69 80.71 8.46 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 127.746 2.418 . . . . 0.0 106.622 179.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.65 -102.11 0.59 Allowed Glycine 0 CA--C 1.528 0.864 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -93.6 -20.15 20.48 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.667 1.187 . . . . 0.0 112.376 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 56.6 m95 -99.49 158.4 15.76 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 123.823 0.849 . . . . 0.0 111.0 -178.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.468 HD13 ' H ' ' A' ' 140' ' ' GLY . 4.6 mp -131.59 141.57 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 N-CA-C 104.912 -2.255 . . . . 0.0 104.912 178.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -124.38 121.31 34.57 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 126.188 1.795 . . . . 0.0 107.983 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -114.81 119.44 36.64 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 125.887 1.675 . . . . 0.0 110.716 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -111.54 135.74 51.7 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 13.3 m -117.18 153.76 49.88 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 123.69 0.796 . . . . 0.0 109.928 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -67.17 74.1 0.5 Allowed 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 125.142 3.895 . . . . 0.0 115.877 -177.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.35 39.11 9.29 Favored Glycine 0 CA--C 1.526 0.764 0 O-C-N 121.465 -0.772 . . . . 0.0 113.32 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 3.1 mp -121.06 -66.96 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 118.199 1.0 . . . . 0.0 109.239 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -167.46 169.12 12.45 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.19 1.396 . . . . 0.0 109.525 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -135.49 117.18 14.99 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 104.245 -2.502 . . . . 0.0 104.245 176.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 31.8 m -145.15 165.48 11.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 126.529 1.932 . . . . 0.0 109.644 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -124.22 130.38 52.42 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 177.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -138.82 163.15 32.98 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.503 1.521 . . . . 0.0 109.373 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -93.59 108.41 20.13 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.468 ' H ' HD13 ' A' ' 126' ' ' ILE . . . . . . . . 0 CA--C 1.523 0.573 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 -179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 . . . . . 0 CA--C 1.528 0.103 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -147.73 137.14 22.46 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.2 mp -120.22 -30.93 4.52 Favored 'General case' 0 C--O 1.221 -0.4 0 C-N-CA 125.525 1.53 . . . . 0.0 108.315 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 167.28 162.41 18.96 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-N 119.61 1.095 . . . . 0.0 111.39 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm -125.54 108.31 26.34 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 124.78 1.232 . . . . 0.0 108.516 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -81.64 167.05 17.17 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.83 3.02 . . . . 0.0 110.92 178.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -110.56 145.1 38.39 Favored 'General case' 0 CA--C 1.513 -0.481 0 C-N-CA 124.752 1.221 . . . . 0.0 112.036 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.4 -40.33 90.55 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 124.356 1.035 . . . . 0.0 109.596 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -76.4 64.34 2.11 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 126.173 1.789 . . . . 0.0 109.348 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.9 p -47.06 -32.46 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 119.763 1.165 . . . . 0.0 111.91 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -63.99 -26.67 68.68 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.899 1.68 . . . . 0.0 112.619 -178.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.0 -25.91 56.21 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.428 0.691 . . . . 0.0 110.568 178.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 65.4 mtp180 -81.04 165.24 21.85 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 122.067 0.937 . . . . 0.0 110.884 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -123.46 147.68 46.93 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -130.42 165.44 22.58 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 125.318 1.447 . . . . 0.0 107.866 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -130.83 153.36 49.17 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 118.012 0.369 . . . . 0.0 110.447 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 45.9 tp -108.41 103.23 12.33 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.305 1.442 . . . . 0.0 108.471 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -114.63 -179.51 3.65 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 126.653 1.981 . . . . 0.0 109.073 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -142.17 160.47 40.17 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.693 0.797 . . . . 0.0 110.824 179.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -139.97 -175.46 4.24 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.368 2.267 . . . . 0.0 108.084 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -58.48 -18.49 29.33 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 120.292 -1.505 . . . . 0.0 114.361 -178.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 42.4 t -98.84 -44.99 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 122.964 0.506 . . . . 0.0 111.648 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 175.2 -159.86 28.29 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 118.659 0.663 . . . . 0.0 111.729 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -85.38 158.76 20.16 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -154.97 166.41 33.65 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.61 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 98.2 mt -105.77 128.7 59.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 43.8 t -92.95 130.71 38.44 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.216 1.406 . . . . 0.0 108.299 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -126.0 112.77 16.29 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 177.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.14 112.2 26.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 11.1 mt -99.84 106.53 19.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 103.426 -2.805 . . . . 0.0 103.426 178.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -101.37 -153.18 25.88 Favored Glycine 0 CA--C 1.52 0.364 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 60.96 43.18 11.86 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.499 0.72 . . . . 0.0 112.153 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -86.56 -106.59 0.8 Allowed Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 105.027 -3.229 . . . . 0.0 105.027 178.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -157.9 162.63 38.33 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 129.095 2.958 . . . . 0.0 104.545 178.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.6 mm -85.62 142.28 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.3 m -97.97 105.6 17.77 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 127.746 2.418 . . . . 0.0 104.584 177.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -50.39 -27.0 5.58 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.311 1.844 . . . . 0.0 112.902 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 21.6 t -43.0 -56.55 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 126.819 2.048 . . . . 0.0 110.866 179.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 9.2 t -123.65 -25.61 4.31 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.867 1.267 . . . . 0.0 112.774 -178.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 99.27 35.04 4.87 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 107.541 -2.224 . . . . 0.0 107.541 -178.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -106.62 150.46 26.18 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 118.851 1.326 . . . . 0.0 112.747 -178.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -78.91 141.97 37.16 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.274 0.559 . . . . 0.0 109.722 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 -67.56 29.71 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.519 1 C-N-CA 133.64 4.776 . . . . 0.0 114.625 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 9.5 ptm -74.43 178.99 4.87 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.433 1.493 . . . . 0.0 112.051 -178.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.23 150.46 15.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 124.853 1.261 . . . . 0.0 109.199 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -110.74 103.58 12.14 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.445 2.298 . . . . 0.0 107.553 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 9.4 mm -93.48 146.8 6.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -125.58 105.34 8.95 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.952 2.101 . . . . 0.0 108.004 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -84.77 110.58 18.9 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 12.5 m -125.36 167.19 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 124.015 0.926 . . . . 0.0 109.101 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 36.7 t -93.69 135.21 35.21 Favored 'General case' 0 C--N 1.333 -0.127 0 O-C-N 120.153 -1.592 . . . . 0.0 107.233 178.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -83.84 8.65 65.39 Favored Glycine 0 N--CA 1.464 0.509 0 CA-C-O 118.77 -1.017 . . . . 0.0 114.349 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.954 0 CA-C-O 118.23 -1.317 . . . . 0.0 114.273 -179.584 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 CA--C 1.535 0.541 0 N-CA-C 110.778 -0.508 . . . . 0.0 110.778 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 11.2 p -162.13 154.17 19.06 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 120.645 -1.284 . . . . 0.0 109.686 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 41.7 p -151.38 163.79 38.16 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.392 0.677 . . . . 0.0 110.426 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 4.1 mt -110.54 143.03 21.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 125.145 1.378 . . . . 0.0 107.423 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -95.11 -51.72 4.52 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.199 1.4 . . . . 0.0 110.786 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 -161.21 156.57 24.41 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.429 1.491 . . . . 0.0 109.658 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 7.3 t -151.03 144.98 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 C-N-CA 127.894 2.478 . . . . 0.0 106.228 -178.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.24 168.47 15.18 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.602 1.161 . . . . 0.0 109.146 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -83.57 131.12 35.0 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 103.383 -2.821 . . . . 0.0 103.383 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 9.8 t -109.87 -28.68 8.64 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 124.245 1.018 . . . . 0.0 113.177 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -133.92 -175.6 3.89 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 70.0 mt -54.39 -49.52 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -123.01 20.56 9.94 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 124.042 0.937 . . . . 0.0 110.76 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 13.5 t -121.73 144.73 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 CA-C-N 118.578 0.626 . . . . 0.0 110.38 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -123.33 165.47 16.93 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 125.983 1.713 . . . . 0.0 108.434 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -131.31 147.01 52.53 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 126.086 1.754 . . . . 0.0 106.981 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -151.35 120.6 6.79 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.84 0.856 . . . . 0.0 109.373 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -108.79 113.45 26.41 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 123.588 0.755 . . . . 0.0 109.389 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 6.7 m -104.12 152.2 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -118.91 116.34 26.26 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.68 -1.145 . . . . 0.0 108.452 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -124.83 122.47 25.6 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-O 117.935 -1.031 . . . . 0.0 109.282 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -57.38 -38.45 94.47 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.249 2.633 . . . . 0.0 111.427 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -59.18 -28.66 66.83 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 10.2 tp -58.59 -33.25 69.77 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 121.48 -0.762 . . . . 0.0 111.638 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 15.3 m -59.21 -11.13 3.47 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.141 0.976 . . . . 0.0 112.996 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -61.79 -32.01 72.27 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 120.128 1.331 . . . . 0.0 109.877 178.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -85.05 124.5 31.81 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -47.73 -48.11 29.83 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.239 2.215 . . . . 0.0 113.101 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 59.7 mt -67.97 -19.41 64.94 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.061 -1.025 . . . . 0.0 113.185 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 11.4 mt -105.36 -5.91 20.04 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.82 1.248 . . . . 0.0 111.686 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -71.64 139.69 49.38 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 128.606 2.762 . . . . 0.0 112.189 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 16.8 mmtm . . . . . 0 N--CA 1.463 0.187 0 C-N-CA 127.894 2.478 . . . . 0.0 112.698 179.598 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.52 -0.183 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.03 -40.84 95.11 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 35.6 tp -67.98 -35.99 79.27 Favored 'General case' 0 C--N 1.343 0.306 0 CA-C-O 117.514 -1.232 . . . . 0.0 109.233 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.7 mt -62.05 -55.04 33.14 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.942 1.246 . . . . 0.0 107.963 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 53.5 m -60.05 -47.16 87.01 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.097 0.959 . . . . 0.0 110.346 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.16 -45.25 94.25 Favored 'General case' 0 N--CA 1.462 0.128 0 O-C-N 121.099 -1.001 . . . . 0.0 109.808 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.5 m -53.92 -43.11 69.46 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 124.706 1.202 . . . . 0.0 109.684 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.22 -52.08 67.2 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 118.341 0.519 . . . . 0.0 110.218 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -64.95 -51.47 61.61 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -178.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -63.14 -42.08 99.41 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.777 -178.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.38 -52.51 52.18 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 107.872 -2.091 . . . . 0.0 107.872 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 17.9 t -54.81 -51.99 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 124.614 1.166 . . . . 0.0 110.954 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 31.5 pttt -62.33 -32.2 72.94 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 119.966 -0.693 . . . . 0.0 111.484 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 59.9 m -76.61 -33.2 58.42 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 19.6 mt -63.49 -56.03 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -60.36 -36.92 79.15 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 118.063 -0.97 . . . . 0.0 111.669 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -54.86 -43.83 73.45 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.832 0.742 . . . . 0.0 111.806 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.9 tptt -82.38 -40.95 20.6 Favored 'General case' 0 CA--C 1.517 -0.326 0 O-C-N 122.027 -0.421 . . . . 0.0 111.566 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 44.5 mt -60.65 -29.47 69.29 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 119.135 -0.46 . . . . 0.0 111.512 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -55.38 -15.66 2.82 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.038 0.935 . . . . 0.0 112.729 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -64.63 -66.85 0.49 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.253 1.021 . . . . 0.0 109.676 178.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 18.6 mmt85 -151.47 -179.49 7.43 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.894 1.678 . . . . 0.0 111.85 -178.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 64.9 m -86.12 161.32 18.94 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 38.7 pt -121.63 162.68 20.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 125.722 1.609 . . . . 0.0 108.281 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -156.89 142.62 17.7 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.374 1.07 . . . . 0.0 109.433 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -136.38 132.6 35.75 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.213 1.005 . . . . 0.0 110.65 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -81.44 98.44 8.23 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.66 83.04 4.8 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.122 1.369 . . . . 0.0 107.78 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.12 -98.15 0.18 Allowed Glycine 0 C--N 1.336 0.53 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -100.45 -26.56 13.82 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.349 1.06 . . . . 0.0 113.716 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -103.1 132.2 49.53 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 118.932 0.787 . . . . 0.0 110.467 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.437 HD11 ' H ' ' A' ' 140' ' ' GLY . 3.3 mp -96.2 127.86 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 103.643 -2.725 . . . . 0.0 103.643 178.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -100.84 120.35 40.0 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -116.11 125.07 51.87 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 125.167 1.387 . . . . 0.0 110.394 -178.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -121.51 129.07 52.69 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.508 0.723 . . . . 0.0 112.018 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 22.7 m -107.76 151.01 40.96 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 123.624 0.77 . . . . 0.0 111.301 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -66.23 80.25 0.3 Allowed 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 125.275 3.983 . . . . 0.0 116.82 -177.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.87 31.19 27.07 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 117.803 -1.554 . . . . 0.0 112.007 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 3.0 mp -117.18 -71.99 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 119.444 1.622 . . . . 0.0 109.817 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -163.22 166.63 23.03 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.927 1.691 . . . . 0.0 110.435 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -130.56 119.91 23.25 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 105.731 -1.952 . . . . 0.0 105.731 177.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.7 m -144.22 164.08 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 125.109 1.364 . . . . 0.0 110.724 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -125.65 122.84 37.56 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -138.72 162.15 35.42 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 123.924 0.89 . . . . 0.0 108.907 178.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -96.04 118.45 32.66 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.437 ' H ' HD11 ' A' ' 126' ' ' ILE . . . . . . . . 0 CA--C 1.528 0.904 0 C-N-CA 125.026 1.298 . . . . 0.0 110.267 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 122.504 1.145 . . . . 0.0 110.029 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -148.65 143.81 26.76 Favored 'General case' 0 CA--C 1.512 -0.484 0 C-N-CA 126.371 1.868 . . . . 0.0 107.046 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 42.7 mt -129.79 -31.67 1.95 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.566 1.547 . . . . 0.0 107.689 177.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 159.34 158.66 9.24 Favored Glycine 0 C--N 1.341 0.823 0 O-C-N 120.587 -1.32 . . . . 0.0 113.459 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -117.41 108.93 42.7 Favored Pre-proline 0 C--O 1.239 0.529 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.04 165.09 33.65 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 124.16 3.24 . . . . 0.0 109.371 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -109.99 148.82 30.94 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 123.476 0.71 . . . . 0.0 110.281 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -68.15 -48.46 65.3 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 125.777 1.923 . . . . 0.0 109.788 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -74.98 65.47 1.44 Allowed 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.207 1.403 . . . . 0.0 113.443 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.0 p -47.8 -31.66 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.29 1.036 . . . . 0.0 111.925 178.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -72.65 -30.11 64.01 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -178.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -73.66 -18.16 61.06 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.963 0.505 . . . . 0.0 109.842 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -105.81 165.47 11.16 Favored 'General case' 0 C--N 1.342 0.268 0 O-C-N 121.603 -0.686 . . . . 0.0 109.824 178.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -120.84 156.3 32.24 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -130.0 171.14 13.1 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.405 1.482 . . . . 0.0 108.715 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -113.7 153.44 28.97 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 123.691 0.796 . . . . 0.0 110.057 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 56.8 tp -121.63 102.51 8.28 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.594 1.558 . . . . 0.0 107.759 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -112.5 -178.6 3.44 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 127.299 2.24 . . . . 0.0 109.996 -178.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -142.57 161.14 38.82 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.599 0.76 . . . . 0.0 110.346 177.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -140.92 178.68 7.19 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 127.637 2.375 . . . . 0.0 106.909 178.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.29 -17.81 22.32 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.435 1.494 . . . . 0.0 113.337 -178.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 90.0 t -93.92 -31.83 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 124.787 1.235 . . . . 0.0 111.917 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 156.19 -170.46 33.86 Favored Glycine 0 N--CA 1.448 -0.553 0 O-C-N 121.305 -0.872 . . . . 0.0 112.762 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.46 ' CE2' ' HG ' ' A' ' 243' ' ' LEU . 3.7 m-30 -78.76 160.73 27.28 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 30.7 p90 -164.33 157.96 18.18 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.273 1.029 . . . . 0.0 111.831 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 76.2 mt -96.03 138.82 20.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.899 1.28 . . . . 0.0 107.8 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 30.1 t -105.12 120.89 42.62 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 126.087 1.755 . . . . 0.0 107.973 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -114.89 107.49 15.48 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.905 1.682 . . . . 0.0 108.355 179.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -89.79 124.14 42.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 178.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.7 mt -114.27 105.69 19.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 104.94 -2.244 . . . . 0.0 104.94 177.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -98.18 -152.22 27.86 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 105.99 -2.844 . . . . 0.0 105.99 178.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 20.1 m 81.33 18.51 0.44 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 177.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -90.58 -142.19 9.78 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 108.354 -1.899 . . . . 0.0 108.354 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -124.5 163.82 21.05 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.4 mm -81.41 142.71 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.191 0.996 . . . . 0.0 112.012 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -85.93 122.63 30.25 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.722 1.609 . . . . 0.0 109.129 178.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.45 -28.4 63.29 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.761 1.225 . . . . 0.0 111.896 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 58.6 t -57.62 -54.95 24.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.549 1.139 . . . . 0.0 113.165 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 14.0 t -122.72 -36.64 2.87 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 116.164 1.912 . . . . 0.0 116.164 -176.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 111.81 23.51 5.58 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -99.07 150.95 21.48 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.763 0.825 . . . . 0.0 109.742 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -74.91 151.88 38.88 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.955 0.883 . . . . 0.0 108.922 178.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -71.27 29.75 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 130.021 3.329 . . . . 0.0 110.276 177.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 8.0 ptm -73.84 175.58 7.15 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.284 1.834 . . . . 0.0 111.778 -177.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.52 150.34 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 124.294 1.038 . . . . 0.0 108.628 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -111.93 104.17 12.44 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.242 1.817 . . . . 0.0 106.412 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 10.2 mm -96.75 144.02 11.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 O-C-N 120.848 -1.157 . . . . 0.0 109.289 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -124.29 127.67 47.99 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.292 1.037 . . . . 0.0 109.22 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -102.43 113.11 26.17 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 118.565 -0.731 . . . . 0.0 110.823 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 4.5 m -127.61 162.26 33.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 16.2 t -91.89 138.26 31.7 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 104.381 -2.451 . . . . 0.0 104.381 177.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -95.33 12.97 67.5 Favored Glycine 0 CA--C 1.522 0.483 0 CA-C-O 118.726 -1.041 . . . . 0.0 112.462 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.171 0 CA-C-N 118.16 0.98 . . . . 0.0 111.666 -178.721 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo . . . . . 0 N--CA 1.451 -0.98 0 N-CA-C 110.879 -0.469 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 18.2 p -170.8 146.94 2.67 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.171 1.788 . . . . 0.0 109.842 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 29.3 p -154.84 147.7 24.5 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.504 1.122 . . . . 0.0 110.487 178.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 3.2 mt -85.64 144.85 8.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -90.34 -55.75 3.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.869 1.267 . . . . 0.0 108.683 178.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 66.1 p-90 -154.63 158.14 39.23 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.328 1.051 . . . . 0.0 110.105 -178.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 7.2 p -156.16 134.91 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 177.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -159.64 159.91 33.64 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 118.545 0.611 . . . . 0.0 110.683 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -67.59 133.36 49.27 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 178.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 2.3 t -111.82 -34.32 6.05 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.937 1.295 . . . . 0.0 111.592 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 7.7 mttm -134.73 -176.5 4.25 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 97.6 mt -50.06 -47.67 23.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 C-N-CA 124.681 1.192 . . . . 0.0 111.669 -178.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -127.7 20.5 6.58 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.582 0.753 . . . . 0.0 110.232 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 13.6 t -122.75 147.71 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 O-C-N 120.925 -1.109 . . . . 0.0 110.067 -177.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -127.92 163.58 24.16 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -135.35 133.05 38.36 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 178.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -135.91 149.08 48.82 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.208 1.803 . . . . 0.0 107.981 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -135.72 124.36 23.73 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 118.862 0.756 . . . . 0.0 110.049 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 15.3 m -106.97 153.08 8.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 121.338 0.59 . . . . 0.0 109.682 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.02 121.62 39.32 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 178.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -132.82 145.36 56.77 Favored Pre-proline 0 N--CA 1.45 -0.432 0 O-C-N 124.469 1.106 . . . . 0.0 110.809 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.71 -42.26 1.24 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.812 2.341 . . . . 0.0 112.317 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -56.89 -25.48 57.03 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -178.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 9.6 tp -64.58 -29.69 70.71 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 121.403 -0.811 . . . . 0.0 112.374 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 11.4 m -58.39 -12.47 3.85 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.464 1.106 . . . . 0.0 112.449 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -64.11 -27.02 68.8 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 119.42 1.009 . . . . 0.0 111.239 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.27 124.86 35.79 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 -47.85 -48.35 31.07 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.706 1.203 . . . . 0.0 113.904 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . 0.46 ' HG ' ' CE2' ' A' ' 181' ' ' TYR . 1.6 mp -61.12 -31.84 71.54 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 13.4 mt -93.73 -17.9 22.68 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.859 1.264 . . . . 0.0 113.167 -178.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -61.4 146.83 46.97 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 128.18 2.592 . . . . 0.0 110.411 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt . . . . . 0 C--N 1.328 -0.352 0 C-N-CA 125.361 1.464 . . . . 0.0 111.977 -179.16 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.45 -44.35 89.16 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 118.809 -0.615 . . . . 0.0 110.759 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 58.6 tp -74.26 -38.35 63.47 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-O 117.913 -1.041 . . . . 0.0 109.416 178.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 16.1 mt -58.92 -54.51 46.29 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.597 1.089 . . . . 0.0 110.746 -177.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 16.9 m -64.54 -36.18 83.37 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 118.703 -1.199 . . . . 0.0 110.762 -179.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.74 -49.86 76.06 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 89.6 m -51.44 -46.52 63.03 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.345 1.058 . . . . 0.0 110.586 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -58.77 -50.08 75.27 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.82 0.737 . . . . 0.0 110.524 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -67.95 -59.1 3.53 Favored 'General case' 0 C--O 1.227 -0.114 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -58.89 -38.14 78.18 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.21 1.004 . . . . 0.0 110.392 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.22 -52.65 50.47 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 51.6 t -57.72 -44.53 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 118.882 1.341 . . . . 0.0 109.974 179.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -60.47 -35.49 76.01 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.458 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 88.4 m -75.74 -34.95 60.34 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 122.771 0.428 . . . . 0.0 110.335 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 26.1 mt -63.36 -55.59 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -62.04 -33.51 74.51 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 118.433 -0.794 . . . . 0.0 112.753 -178.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -65.8 -37.95 87.66 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 118.834 0.743 . . . . 0.0 111.354 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.8 tptt -84.76 -38.46 19.6 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 118.761 -0.638 . . . . 0.0 111.157 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 16.8 mt -65.06 -25.81 67.97 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.845 0.748 . . . . 0.0 111.256 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -53.17 -24.66 11.27 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.059 1.344 . . . . 0.0 111.459 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -65.96 -65.79 0.63 Allowed 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 118.132 -0.937 . . . . 0.0 111.71 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -147.43 175.32 10.91 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 120.276 1.398 . . . . 0.0 112.863 -178.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 79.0 m -86.44 163.9 17.3 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 43.1 pt -121.8 159.46 24.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 124.587 1.155 . . . . 0.0 109.86 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -157.06 140.22 15.48 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 122.914 0.486 . . . . 0.0 111.847 -178.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -138.73 129.9 26.94 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 119.804 -0.759 . . . . 0.0 109.995 176.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -83.46 98.56 9.59 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.996 1.319 . . . . 0.0 107.547 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -85.95 80.56 8.84 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.494 1.918 . . . . 0.0 106.545 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.44 -99.42 0.33 Allowed Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -92.38 -30.75 15.62 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 118.423 1.112 . . . . 0.0 113.43 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -100.21 155.18 17.9 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 119.109 0.868 . . . . 0.0 110.548 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.488 HD11 ' H ' ' A' ' 140' ' ' GLY . 4.0 mp -122.13 144.59 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 104.003 -2.591 . . . . 0.0 104.003 179.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -128.88 120.0 25.43 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -110.06 126.02 53.56 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.966 1.706 . . . . 0.0 109.423 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -115.13 136.09 53.49 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 17.1 m -118.97 148.8 45.46 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 123.528 0.731 . . . . 0.0 111.066 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -64.63 91.33 0.19 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 125.079 3.853 . . . . 0.0 114.586 -178.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.82 28.44 58.98 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-O 118.045 -1.42 . . . . 0.0 114.265 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 4.1 mp -115.14 -71.58 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 119.654 1.727 . . . . 0.0 108.43 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -171.43 174.6 4.4 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.449 1.5 . . . . 0.0 110.072 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.425 ' CD1' HD13 ' A' ' 160' ' ' LEU . 1.2 t80 -136.54 120.26 17.3 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 177.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.9 m -145.41 164.99 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 126.494 1.917 . . . . 0.0 110.336 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -117.37 131.97 56.68 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 119.461 1.028 . . . . 0.0 110.498 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -137.68 162.31 34.19 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.547 1.067 . . . . 0.0 108.781 176.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -102.24 109.93 21.75 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.488 ' H ' HD11 ' A' ' 126' ' ' ILE . . . . . . . . 0 CA--C 1.528 0.888 0 C-N-CA 125.426 1.489 . . . . 0.0 109.788 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 . . . . . 0 CA--C 1.531 0.225 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.27 113.06 5.41 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 117.37 -1.3 . . . . 0.0 109.248 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.425 HD13 ' CD1' ' A' ' 135' ' ' PHE . 43.4 mt -102.02 -30.46 11.18 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.936 1.244 . . . . 0.0 108.982 178.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 161.99 161.31 11.81 Favored Glycine 0 CA--C 1.503 -0.668 0 CA-C-O 122.396 0.998 . . . . 0.0 110.758 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -123.91 109.39 29.95 Favored Pre-proline 0 N--CA 1.426 -1.631 0 C-N-CA 125.262 1.425 . . . . 0.0 109.307 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -70.52 177.77 5.75 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.664 2.909 . . . . 0.0 108.745 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -120.55 152.11 38.52 Favored 'General case' 0 CA--C 1.517 -0.312 0 O-C-N 121.64 -0.663 . . . . 0.0 111.363 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -67.04 -49.69 64.37 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 122.945 0.498 . . . . 0.0 110.142 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -79.18 65.02 4.24 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.606 0.763 . . . . 0.0 110.47 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.3 p -48.8 -33.35 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 125.26 1.424 . . . . 0.0 111.229 179.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -65.5 -30.93 71.75 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 126.131 1.773 . . . . 0.0 111.621 -178.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -88.76 -11.3 45.38 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.698 1.199 . . . . 0.0 111.692 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 50.6 ttt180 -81.53 177.23 9.06 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.025 1.33 . . . . 0.0 108.686 178.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -133.29 149.8 51.92 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 121.261 -0.9 . . . . 0.0 109.34 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -136.63 169.87 17.01 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 127.592 2.357 . . . . 0.0 110.091 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -123.62 154.63 39.05 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.806 0.842 . . . . 0.0 110.349 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 12.4 tp -119.09 105.1 11.08 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 122.383 1.087 . . . . 0.0 109.621 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 3.4 mt -119.09 176.67 5.19 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 128.227 2.611 . . . . 0.0 107.738 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -154.68 164.36 38.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.714 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.71 -175.43 3.82 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.388 1.875 . . . . 0.0 110.313 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -66.81 -1.81 4.34 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.875 1.67 . . . . 0.0 113.442 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 30.6 t -112.82 -44.21 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 124.741 1.216 . . . . 0.0 109.519 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 175.56 -175.52 47.26 Favored Glycine 0 N--CA 1.446 -0.67 0 O-C-N 121.274 -0.891 . . . . 0.0 111.943 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -82.17 163.71 21.75 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -154.4 172.37 17.84 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 74.6 mt -113.9 129.81 69.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 35.0 t -91.59 124.22 35.59 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -123.15 107.54 11.85 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.5 mp -93.39 117.89 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 104.281 -2.488 . . . . 0.0 104.281 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.3 mt -104.89 105.83 19.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 178.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -104.19 -156.38 23.82 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.793 1.664 . . . . 0.0 109.409 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.1 t 64.02 43.47 5.16 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.586 1.155 . . . . 0.0 110.36 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -91.57 -64.09 1.16 Allowed Glycine 0 CA--C 1.529 0.937 0 N-CA-C 107.987 -2.045 . . . . 0.0 107.987 179.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 157.29 179.98 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.379 1 C-N-CA 132.086 4.155 . . . . 0.0 105.792 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.5 mm -105.59 143.39 16.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 127.756 2.423 . . . . 0.0 112.107 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.4 m -95.73 101.13 12.78 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 128.11 2.564 . . . . 0.0 104.312 176.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -48.73 -31.32 6.73 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.258 1.823 . . . . 0.0 112.658 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 60.0 t -39.16 -54.11 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 127.268 2.227 . . . . 0.0 110.574 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 11.3 t -123.5 -26.95 4.13 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.404 1.082 . . . . 0.0 111.787 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.33 35.18 4.24 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 -178.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -110.67 148.69 31.74 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 118.498 1.149 . . . . 0.0 113.108 -178.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -73.8 148.09 42.8 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.274 0.559 . . . . 0.0 112.156 179.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -70.06 27.01 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.425 1 C-N-CA 134.844 5.258 . . . . 0.0 109.87 177.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 2.8 ptm -74.64 178.78 5.14 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.383 1.473 . . . . 0.0 113.336 -176.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.1 p -150.74 136.45 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 123.279 0.631 . . . . 0.0 110.642 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -98.79 109.22 22.01 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.744 1.217 . . . . 0.0 109.213 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 11.1 mm -97.49 147.88 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 O-C-N 121.627 -0.671 . . . . 0.0 109.853 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -125.7 105.4 8.96 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 128.092 2.557 . . . . 0.0 109.106 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -87.76 114.17 24.12 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 120.65 -1.281 . . . . 0.0 108.951 178.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 4.6 m -124.49 165.01 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 41.9 t -84.63 145.86 27.79 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 120.418 -1.426 . . . . 0.0 107.36 178.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -90.89 6.14 81.91 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-O 117.341 -1.81 . . . . 0.0 115.362 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.957 0 CA-C-N 119.026 1.413 . . . . 0.0 114.952 179.542 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo . . . . . 0 N--CA 1.452 -0.913 0 N-CA-C 109.575 -0.971 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 28.1 p -154.68 147.61 24.56 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 119.992 -1.693 . . . . 0.0 111.374 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 20.6 p -151.05 161.59 42.44 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.541 1.136 . . . . 0.0 110.145 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 3.6 mt -100.64 154.53 4.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 125.311 1.444 . . . . 0.0 109.386 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -102.27 -51.69 3.31 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 124.783 1.233 . . . . 0.0 109.844 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 64.5 p-90 -155.92 154.09 30.65 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.067 0.947 . . . . 0.0 109.255 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 90.9 t -147.73 137.7 16.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.63 168.53 19.8 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 122.842 0.457 . . . . 0.0 111.207 -178.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -86.86 133.67 33.6 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 177.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 14.8 t -109.21 -32.22 7.28 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.528 1.131 . . . . 0.0 112.214 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -136.86 -175.97 4.21 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.668 1.187 . . . . 0.0 108.84 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 78.3 mt -48.76 -45.05 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.585 0.754 . . . . 0.0 112.479 -178.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -130.19 12.54 5.59 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.112 0.965 . . . . 0.0 112.265 -178.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 17.5 t -114.14 140.29 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 O-C-N 122.116 -0.365 . . . . 0.0 110.127 -176.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -120.66 166.97 12.95 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 125.18 1.392 . . . . 0.0 108.445 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -137.89 148.65 45.54 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.505 1.522 . . . . 0.0 108.822 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -148.93 145.49 27.42 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 125.789 1.636 . . . . 0.0 110.273 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -132.84 122.89 25.11 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 178.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 5.5 m -116.29 154.81 17.8 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.1 p -120.76 124.05 44.17 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.517 1.127 . . . . 0.0 110.302 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -132.8 122.98 17.97 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 124.238 1.015 . . . . 0.0 109.261 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -58.19 -40.83 73.07 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 124.014 3.143 . . . . 0.0 113.406 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -61.05 -19.62 61.6 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.615 0.766 . . . . 0.0 112.101 -178.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 8.6 tp -66.94 -28.87 68.64 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 120.432 -1.418 . . . . 0.0 110.715 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 21.4 m -62.33 -11.85 17.69 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.746 0.818 . . . . 0.0 111.942 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.08 -21.39 66.14 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.046 0.839 . . . . 0.0 110.122 178.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -98.12 121.01 39.53 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 177.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -47.99 -46.13 32.35 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 126.071 1.749 . . . . 0.0 112.704 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.42 -37.54 87.23 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 120.809 -1.182 . . . . 0.0 112.127 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 22.1 mt -85.21 -5.73 59.31 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.32 1.048 . . . . 0.0 112.252 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -68.95 156.41 38.62 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.822 1.249 . . . . 0.0 110.428 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 2.9 mmmt . . . . . 0 C--N 1.325 -0.498 0 C-N-CA 126.225 1.81 . . . . 0.0 109.279 179.813 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.384 0 CA-C-O 118.777 -0.63 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.55 -42.65 92.89 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.505 1.048 . . . . 0.0 109.481 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.5 tp -68.88 -36.8 78.51 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-O 117.276 -1.345 . . . . 0.0 109.28 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 98.8 mt -58.67 -54.55 45.82 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 120.265 1.393 . . . . 0.0 108.533 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.2 m -58.93 -46.88 86.88 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.808 0.843 . . . . 0.0 111.457 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.09 -41.94 94.51 Favored 'General case' 0 N--CA 1.463 0.197 0 O-C-N 120.343 -1.473 . . . . 0.0 111.014 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 37.6 m -52.4 -46.94 66.51 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.135 1.374 . . . . 0.0 110.771 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -56.51 -50.99 70.19 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.309 0.504 . . . . 0.0 110.098 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -63.02 -58.0 8.78 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -178.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.09 -39.33 78.32 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.343 -177.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.78 -52.57 41.19 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 43.6 t -54.46 -51.07 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-N 119.032 1.416 . . . . 0.0 110.682 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.6 pttp -56.86 -35.14 68.52 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.448 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 77.2 m -80.34 -29.03 37.97 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.113 0.965 . . . . 0.0 111.947 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 16.7 mt -63.27 -54.39 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 104.677 -2.342 . . . . 0.0 104.677 177.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -61.13 -30.69 70.53 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 118.44 -0.79 . . . . 0.0 111.199 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -56.37 -47.57 78.62 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.478 1.036 . . . . 0.0 111.084 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -84.14 -37.9 21.36 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 24.9 mt -65.97 -26.56 67.62 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 118.931 -0.557 . . . . 0.0 112.161 -179.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -56.83 -20.9 25.17 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -64.64 -66.81 0.49 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.517 0.727 . . . . 0.0 109.485 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -153.51 -179.7 8.01 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.04 1.736 . . . . 0.0 110.306 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 56.0 m -86.63 172.82 9.95 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.287 0.635 . . . . 0.0 109.694 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 34.0 pt -129.8 164.37 32.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 126.654 1.982 . . . . 0.0 109.046 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -158.74 150.33 20.86 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 122.831 0.452 . . . . 0.0 110.225 -179.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -141.5 127.38 19.32 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.631 0.772 . . . . 0.0 109.882 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -84.07 102.23 12.37 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 122.054 0.93 . . . . 0.0 109.404 179.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.27 80.57 6.84 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 127.864 2.466 . . . . 0.0 107.15 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 60.75 -114.69 6.85 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -76.74 -28.81 55.9 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.829 0.852 . . . . 0.0 112.548 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -99.95 163.46 12.43 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 119.073 0.851 . . . . 0.0 110.89 -178.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.502 HD12 ' H ' ' A' ' 140' ' ' GLY . 4.5 mp -136.55 130.56 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -110.05 119.99 41.05 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -108.04 126.42 52.71 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 118.437 -0.792 . . . . 0.0 109.909 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -117.55 130.49 56.44 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.292 0.951 . . . . 0.0 110.094 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 21.4 m -110.83 156.6 40.44 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 128.427 2.691 . . . . 0.0 113.937 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -68.19 72.42 0.83 Allowed 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 124.79 3.66 . . . . 0.0 114.404 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.84 62.06 3.77 Favored Glycine 0 N--CA 1.448 -0.517 0 O-C-N 121.186 -0.947 . . . . 0.0 111.285 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.5 mp -131.03 -72.31 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-O 118.325 -0.845 . . . . 0.0 109.235 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -173.65 136.9 0.59 Allowed 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 119.646 1.112 . . . . 0.0 108.15 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -108.27 124.3 50.1 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 121.04 1.745 . . . . 0.0 106.32 -175.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 18.3 m -145.04 165.06 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 125.257 1.423 . . . . 0.0 111.428 -178.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -122.02 133.4 54.8 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.479 1.512 . . . . 0.0 108.193 178.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -138.96 162.87 33.82 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.127 1.371 . . . . 0.0 112.667 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 42.6 t60 -92.76 122.66 35.38 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.502 ' H ' HD12 ' A' ' 126' ' ' ILE . . . . . . . . 0 N--CA 1.454 -0.145 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 -178.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 . . . . . 0 CA--C 1.52 -0.197 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.67 135.86 23.84 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 178.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.1 mp -125.7 -36.36 2.43 Favored 'General case' 0 C--O 1.221 -0.445 0 C-N-CA 126.478 1.911 . . . . 0.0 106.905 177.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 172.75 152.43 8.65 Favored Glycine 0 C--N 1.34 0.795 0 CA-C-N 119.391 0.996 . . . . 0.0 112.705 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 29.3 mtmt -123.28 109.33 31.32 Favored Pre-proline 0 C--O 1.239 0.513 0 N-CA-C 106.125 -1.805 . . . . 0.0 106.125 177.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -75.35 -172.95 1.43 Allowed 'Trans proline' 0 N--CA 1.459 -0.519 1 C-N-CA 126.174 4.583 . . . . 0.0 111.425 -178.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -124.39 152.41 43.25 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 123.762 0.825 . . . . 0.0 108.965 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.11 -46.18 65.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.066 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 -68.88 65.36 0.13 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 127.366 2.267 . . . . 0.0 111.166 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.8 p -48.51 -34.06 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 124.662 1.185 . . . . 0.0 111.746 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -59.64 -32.21 70.24 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 125.46 1.504 . . . . 0.0 113.184 -178.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -84.61 -22.61 29.91 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.767 1.227 . . . . 0.0 112.787 -178.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.409 HH22 ' HG3' ' A' ' 185' ' ' GLU . 66.6 mtp180 -74.82 139.71 43.43 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -97.22 143.3 28.15 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 179.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -133.59 165.84 23.97 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 124.21 1.004 . . . . 0.0 109.777 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -123.45 142.73 50.7 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.944 0.897 . . . . 0.0 109.965 -178.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 58.9 tp -102.28 100.95 11.18 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.062 1.745 . . . . 0.0 107.584 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -107.78 -178.84 3.74 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.301 1.44 . . . . 0.0 109.147 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 181' ' ' TYR . 1.7 p90 -139.97 156.88 46.43 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -134.97 175.0 9.98 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 126.879 2.072 . . . . 0.0 107.446 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -64.21 -13.97 52.36 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 124.548 1.139 . . . . 0.0 112.699 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 99.6 t -97.65 -34.93 4.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 125.856 1.662 . . . . 0.0 112.459 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 163.93 -174.65 40.09 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 176' ' ' TYR . 3.6 m-30 -78.41 166.21 22.9 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -165.66 164.19 19.08 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.354 0.662 . . . . 0.0 111.395 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 67.7 mt -102.43 132.41 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 23.3 t -100.81 127.27 47.33 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.581 1.553 . . . . 0.0 107.954 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.409 ' HG3' HH22 ' A' ' 170' ' ' ARG . 26.4 tt0 -124.21 112.47 17.09 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.39 1.876 . . . . 0.0 109.617 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -96.94 116.23 38.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 178.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 5.3 mt -105.22 108.64 25.44 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -106.58 -153.21 19.83 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 108.023 -2.031 . . . . 0.0 108.023 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 85.44 32.13 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.352 1.861 . . . . 0.0 111.237 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -111.53 165.17 12.09 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 125.537 1.541 . . . . 0.0 111.093 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.62 157.17 38.45 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.7 mm -78.1 134.87 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 C-N-CA 125.387 1.475 . . . . 0.0 110.769 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.35 115.03 18.75 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.918 1.687 . . . . 0.0 106.685 178.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -60.37 -22.21 63.03 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.161 1.384 . . . . 0.0 112.219 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 59.8 t -53.73 -48.51 60.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 C-N-CA 125.192 1.397 . . . . 0.0 111.249 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 11.7 t -125.2 -43.27 1.95 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 117.62 35.15 1.1 Allowed Glycine 0 CA--C 1.532 1.139 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 -177.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -111.08 150.67 29.05 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.612 1.706 . . . . 0.0 111.598 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -73.03 143.3 47.57 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.446 0.641 . . . . 0.0 109.388 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 7.0 ttp180 -67.6 29.45 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.4 1 C-N-CA 132.184 4.194 . . . . 0.0 113.564 179.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 6.0 ptm -73.51 175.78 6.72 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.216 -0.927 . . . . 0.0 113.062 -177.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 8.8 p -142.13 151.41 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 124.7 1.2 . . . . 0.0 108.483 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -110.78 115.25 29.23 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 179.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 8.5 mm -106.12 140.06 25.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -125.44 109.0 12.21 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.604 1.562 . . . . 0.0 109.108 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -89.48 115.27 26.78 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 120.636 -1.29 . . . . 0.0 110.413 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 5.2 m -124.62 165.99 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 124.015 0.926 . . . . 0.0 108.525 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 48.8 t -85.39 143.09 28.83 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 121.033 -1.042 . . . . 0.0 108.331 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -86.91 7.18 81.28 Favored Glycine 0 CA--C 1.52 0.395 0 CA-C-O 116.831 -2.094 . . . . 0.0 116.829 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.827 0 CA-C-N 120.249 2.024 . . . . 0.0 111.593 -178.579 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo . . . . . 0 N--CA 1.45 -1.031 0 N-CA-C 109.047 -1.174 . . . . 0.0 109.047 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.5 p -171.42 150.39 2.86 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 121.021 -1.049 . . . . 0.0 110.078 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.9 p -151.85 159.1 43.97 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.862 1.265 . . . . 0.0 109.325 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 4.3 mt -102.31 152.56 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 126.416 1.886 . . . . 0.0 107.996 178.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -97.6 -50.95 4.29 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.467 1.107 . . . . 0.0 111.447 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 58.2 p-90 -160.02 155.24 25.02 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.336 1.454 . . . . 0.0 107.84 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 52.9 t -151.46 118.75 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 125.672 1.589 . . . . 0.0 106.769 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.98 167.49 26.54 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 118.51 0.596 . . . . 0.0 111.459 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -73.81 134.69 43.41 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 1.4 t -112.34 -37.36 5.01 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.172 0.989 . . . . 0.0 110.732 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 16.4 mttm -131.61 -175.19 3.63 Favored 'General case' 0 CA--C 1.506 -0.749 0 C-N-CA 124.054 0.942 . . . . 0.0 109.689 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 71.0 mt -53.16 -48.51 54.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.923 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -126.84 22.56 6.78 Favored 'General case' 0 C--O 1.226 -0.135 0 C-N-CA 124.66 1.184 . . . . 0.0 110.777 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 12.3 t -123.38 144.33 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.518 0 C-N-CA 120.328 -0.549 . . . . 0.0 109.57 -178.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -125.15 158.93 32.7 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.496 1.519 . . . . 0.0 107.379 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -127.72 137.47 52.48 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -142.34 125.64 16.54 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.88 1.672 . . . . 0.0 110.686 -177.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -118.97 116.96 27.55 Favored 'General case' 0 C--O 1.237 0.436 0 O-C-N 121.721 -0.612 . . . . 0.0 110.659 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 3.6 m -101.5 154.3 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.1 p -124.01 125.57 44.79 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 1.2 pt -136.5 141.03 34.12 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -67.68 -43.34 5.57 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.831 2.354 . . . . 0.0 112.386 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -56.69 -18.23 11.64 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -178.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 3.9 tp -70.18 -22.16 62.98 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 120.06 -1.65 . . . . 0.0 112.171 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 15.9 m -70.48 -9.31 56.23 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.623 1.169 . . . . 0.0 112.259 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -57.29 -35.86 70.34 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.203 1.001 . . . . 0.0 108.535 178.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -92.55 124.33 36.5 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -46.89 -47.92 21.3 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 128.416 2.686 . . . . 0.0 111.815 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 25.3 mt -62.09 -44.46 96.61 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.752 -178.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 8.2 mp -78.66 -8.33 58.56 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -70.02 141.39 52.91 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.688 1.595 . . . . 0.0 110.722 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 10.3 mmmm . . . . . 0 C--N 1.328 -0.33 0 C-N-CA 124.126 0.971 . . . . 0.0 109.409 179.489 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 118.661 -0.685 . . . . 0.0 111.552 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.42 -51.22 69.63 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.651 -1.241 . . . . 0.0 107.651 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 53.7 tp -61.35 -38.25 86.27 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 117.728 -1.13 . . . . 0.0 110.383 179.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.6 mt -60.94 -54.37 45.87 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 119.627 1.103 . . . . 0.0 109.365 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 26.4 m -58.86 -49.01 79.34 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.241 1.416 . . . . 0.0 110.303 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.4 ttmm -58.7 -49.85 76.07 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 52.9 m -52.61 -45.34 66.52 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 123.964 0.905 . . . . 0.0 110.127 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -57.32 -49.8 74.96 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.711 0.687 . . . . 0.0 109.482 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.17 -61.38 2.17 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.904 0.881 . . . . 0.0 112.5 -178.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.25 -39.03 78.11 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 125.153 1.381 . . . . 0.0 111.739 -178.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -65.32 -52.72 37.79 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-O 117.985 -1.453 . . . . 0.0 109.935 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 52.2 t -58.77 -42.89 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 119.689 1.745 . . . . 0.0 110.691 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.9 ptmm? -62.06 -35.9 80.02 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.968 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.4 m -72.89 -40.13 65.81 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.317 1.047 . . . . 0.0 109.67 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 20.4 mt -58.48 -54.71 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -57.18 -37.73 72.58 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 118.011 -0.995 . . . . 0.0 111.432 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -63.69 -37.41 87.26 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.102 0.865 . . . . 0.0 111.399 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.43 -32.56 62.68 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.768 -0.582 . . . . 0.0 111.636 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.0 mt -83.73 -25.11 30.85 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 117.884 0.311 . . . . 0.0 111.362 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -47.82 -35.45 10.18 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.185 1.394 . . . . 0.0 111.552 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -60.62 -67.04 0.44 Allowed 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 125.329 1.452 . . . . 0.0 111.928 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 77.5 mmt-85 -150.05 171.73 16.39 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.815 1.189 . . . . 0.0 111.936 -178.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 62.1 m -86.71 152.62 22.38 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 178.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 28.7 pt -106.41 161.32 5.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 125.779 1.632 . . . . 0.0 109.74 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -151.73 134.57 15.64 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.635 1.574 . . . . 0.0 108.694 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.403 ' CB ' ' HB ' ' A' ' 218' ' ' ILE . 12.2 t80 -138.61 127.6 23.91 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.114 0.966 . . . . 0.0 111.139 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -81.99 106.78 14.18 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.533 1.133 . . . . 0.0 108.83 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -100.54 79.99 2.16 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 178.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.66 -125.59 20.24 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -67.05 -34.59 78.03 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.308 0.643 . . . . 0.0 112.046 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -99.96 163.88 12.25 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 119.132 0.878 . . . . 0.0 111.637 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.1 mp -128.98 140.92 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 104.886 -2.264 . . . . 0.0 104.886 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -114.82 120.07 38.76 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 125.841 1.656 . . . . 0.0 107.961 -177.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -113.46 122.66 47.99 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -122.25 135.13 54.7 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 123.855 0.862 . . . . 0.0 110.7 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 16.4 m -109.09 158.25 34.84 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 126.675 1.99 . . . . 0.0 112.59 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -63.9 74.46 0.17 Allowed 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 124.738 3.625 . . . . 0.0 114.457 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 72.78 50.68 13.18 Favored Glycine 0 CA--C 1.532 1.126 0 O-C-N 120.093 -1.63 . . . . 0.0 114.085 179.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 3.6 mp -124.31 -65.98 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 125.352 1.461 . . . . 0.0 108.091 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -166.64 168.48 14.44 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 127.416 2.286 . . . . 0.0 110.837 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -134.57 121.72 21.35 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 19.5 m -143.03 163.79 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 125.008 1.323 . . . . 0.0 111.821 -178.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -126.19 128.07 46.67 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.608 1.163 . . . . 0.0 110.124 178.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -138.09 162.92 32.93 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.555 1.942 . . . . 0.0 110.929 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -91.69 160.76 15.2 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 120.867 -1.146 . . . . 0.0 109.357 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.953 0 C-N-CA 124.842 1.21 . . . . 0.0 111.045 -179.128 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 . . . . . 0 C--O 1.228 -0.033 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -148.93 140.28 23.26 Favored 'General case' 0 CA--C 1.507 -0.697 0 O-C-N 120.819 -1.176 . . . . 0.0 109.474 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 41.0 mt -118.07 -24.37 7.05 Favored 'General case' 0 C--O 1.219 -0.51 0 O-C-N 125.391 1.682 . . . . 0.0 109.378 179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 163.38 164.12 17.72 Favored Glycine 0 C--N 1.34 0.757 0 O-C-N 121.056 -1.028 . . . . 0.0 111.1 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -127.89 109.58 20.25 Favored Pre-proline 0 CA--C 1.533 0.31 0 C-N-CA 124.374 1.07 . . . . 0.0 110.519 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -72.09 172.58 14.44 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 123.945 3.097 . . . . 0.0 111.127 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -111.43 152.32 27.52 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.705 0.802 . . . . 0.0 111.083 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -68.01 -44.25 76.97 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.807 1.243 . . . . 0.0 111.986 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -78.15 65.36 3.51 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.482 1.113 . . . . 0.0 111.456 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.8 p -47.23 -33.91 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 124.532 1.133 . . . . 0.0 111.86 178.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -67.45 -36.19 80.69 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.951 1.3 . . . . 0.0 112.726 -178.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -86.28 -1.39 57.45 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 125.503 1.521 . . . . 0.0 110.917 -178.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 18.3 ttt-85 -93.24 146.94 23.32 Favored 'General case' 0 N--CA 1.441 -0.876 0 O-C-N 120.399 -1.438 . . . . 0.0 110.634 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -102.69 147.85 26.32 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.597 0.759 . . . . 0.0 110.656 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -138.04 175.48 9.54 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.873 2.069 . . . . 0.0 109.371 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -137.6 133.68 34.68 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.513 0.725 . . . . 0.0 112.52 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 35.1 tp -92.07 106.36 18.4 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.633 1.173 . . . . 0.0 109.377 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -113.38 -179.25 3.59 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 125.775 1.63 . . . . 0.0 109.412 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -136.42 162.74 32.2 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.098 0.959 . . . . 0.0 110.092 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -138.89 178.81 6.88 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 127.666 2.386 . . . . 0.0 107.711 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -63.46 -14.31 49.4 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 121.706 -0.621 . . . . 0.0 111.659 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 5.0 t -97.5 -47.72 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 125.279 1.432 . . . . 0.0 112.101 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 172.6 -162.29 33.98 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.281 -1.127 . . . . 0.0 110.281 -178.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -84.32 163.33 19.67 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 117.993 0.897 . . . . 0.0 110.359 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -156.88 165.14 37.04 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.29 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 62.7 mt -105.26 120.2 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 39.8 t -89.93 136.31 33.12 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 124.707 1.203 . . . . 0.0 107.931 178.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -131.44 113.16 13.37 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 125.129 1.372 . . . . 0.0 107.652 178.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.48 107.03 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 7.2 mt -94.01 105.81 17.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -111.57 -152.34 12.17 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 126.676 2.084 . . . . 0.0 109.715 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 76.73 40.54 0.2 Allowed 'General case' 0 C--O 1.237 0.416 0 C-N-CA 127.166 2.186 . . . . 0.0 108.305 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -108.7 173.25 17.43 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-O 121.978 0.766 . . . . 0.0 112.793 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . 0.498 ' H ' ' NE ' ' A' ' 200' ' ' ARG . 30.6 m-20 -80.97 141.28 34.61 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 179.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 43.5 mm -69.2 136.53 26.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 124.951 1.3 . . . . 0.0 112.046 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -87.52 110.33 20.26 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 128.335 2.654 . . . . 0.0 107.744 178.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -55.94 -18.49 9.25 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 127.691 2.396 . . . . 0.0 114.101 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 25.3 t -60.48 -46.28 95.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 124.985 1.314 . . . . 0.0 110.575 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 5.7 t -123.1 -37.52 2.7 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.514 1.126 . . . . 0.0 113.133 -178.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 104.12 35.89 3.29 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 108.079 -2.008 . . . . 0.0 108.079 -178.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -122.18 163.45 19.53 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.71 1.255 . . . . 0.0 110.813 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -77.2 151.71 35.1 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -178.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . 0.498 ' NE ' ' H ' ' A' ' 191' ' ' ASP . 27.0 ptt85 -76.61 28.71 0.13 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 129.352 3.061 . . . . 0.0 111.852 177.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 6.6 ptm -72.77 175.52 6.4 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.956 0.903 . . . . 0.0 112.286 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.2 p -142.34 146.86 21.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 124.977 1.311 . . . . 0.0 109.978 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -105.18 104.04 13.69 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.831 1.652 . . . . 0.0 107.678 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 24.4 mm -91.26 152.01 3.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 O-C-N 120.896 -1.127 . . . . 0.0 109.432 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -127.36 104.83 8.13 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.342 1.857 . . . . 0.0 110.586 178.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -84.48 108.59 17.35 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 177.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 11.6 m -125.01 166.88 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 48.0 t -91.77 138.35 31.63 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 178.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -87.4 3.26 86.6 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-O 118.56 -1.133 . . . . 0.0 112.601 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.686 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -178.802 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo . . . . . 0 N--CA 1.449 -1.138 0 N-CA-C 109.401 -1.038 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.1 146.38 26.89 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.864 1.666 . . . . 0.0 108.782 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 80.4 p -147.18 162.3 39.16 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 118.784 0.72 . . . . 0.0 110.357 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . 0.403 ' HB ' ' CB ' ' A' ' 120' ' ' TYR . 3.4 mt -107.28 139.63 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 105.013 -2.218 . . . . 0.0 105.013 177.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -88.48 -47.71 8.13 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.417 1.087 . . . . 0.0 111.45 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 68.6 p-90 -159.25 154.21 24.93 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 126.047 1.739 . . . . 0.0 108.66 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 6.1 p -155.78 128.82 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -156.3 162.54 40.09 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 122.895 0.478 . . . . 0.0 111.119 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -68.76 133.42 48.33 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 178.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 12.0 t -109.48 -31.11 7.63 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 123.909 0.884 . . . . 0.0 111.882 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 7.1 mttm -138.65 -175.85 4.27 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.043 1.337 . . . . 0.0 108.024 178.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 76.3 mt -45.1 -49.39 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 1.8 t -132.96 18.96 4.12 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.169 0.988 . . . . 0.0 111.168 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 18.5 t -113.79 141.69 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -123.96 163.62 20.97 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.805 1.242 . . . . 0.0 107.725 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -142.76 133.55 25.4 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -134.89 145.26 48.07 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 125.669 1.588 . . . . 0.0 107.986 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -124.29 123.29 39.9 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 6.3 m -113.92 154.81 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 2.1 p -125.37 126.3 44.8 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 123.76 0.824 . . . . 0.0 112.079 -178.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -131.38 145.94 59.81 Favored Pre-proline 0 C--O 1.234 0.254 0 O-C-N 124.357 1.035 . . . . 0.0 108.258 176.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -66.52 -47.85 2.71 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.786 2.324 . . . . 0.0 109.255 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -53.31 -23.61 9.64 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 -178.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 7.4 tp -66.39 -30.27 70.61 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 121.11 -0.994 . . . . 0.0 111.147 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 2.8 m -60.25 -13.08 10.72 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.058 0.943 . . . . 0.0 112.706 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.33 -25.79 67.76 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 118.901 0.773 . . . . 0.0 111.389 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -88.94 126.42 35.39 Favored 'General case' 0 C--O 1.225 -0.229 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -47.4 -44.65 24.59 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.631 1.972 . . . . 0.0 113.064 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 48.1 mt -72.93 -21.72 60.84 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 120.681 -1.262 . . . . 0.0 113.864 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 13.2 mt -100.46 -13.14 18.82 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.538 1.535 . . . . 0.0 112.654 -178.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -61.25 136.29 58.01 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 129.263 3.025 . . . . 0.0 110.742 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt . . . . . 0 N--CA 1.464 0.236 0 C-N-CA 125.703 1.601 . . . . 0.0 110.079 179.238 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 CA--C 1.517 -0.296 0 CA-C-O 118.755 -0.64 . . . . 0.0 112.089 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.91 -38.61 79.3 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 49.9 tp -70.25 -38.24 75.1 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 117.865 -1.064 . . . . 0.0 109.519 177.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.5 mt -61.75 -55.24 32.33 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.94 1.245 . . . . 0.0 109.376 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 18.3 m -60.12 -46.45 89.59 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.93 1.692 . . . . 0.0 111.211 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.9 ttpt -66.84 -41.9 86.66 Favored 'General case' 0 C--N 1.341 0.208 0 O-C-N 120.103 -1.623 . . . . 0.0 110.544 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 27.0 m -53.73 -50.49 65.83 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.795 0.838 . . . . 0.0 110.028 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -55.05 -50.38 69.26 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.133 0.573 . . . . 0.0 111.015 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.77 -58.49 7.82 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 122.487 1.136 . . . . 0.0 112.807 -178.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.0 mm100 -58.87 -40.63 84.92 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.915 1.286 . . . . 0.0 111.27 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.0 -53.03 39.86 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 109.171 -1.571 . . . . 0.0 109.171 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 42.3 t -55.12 -47.58 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 119.46 1.63 . . . . 0.0 110.482 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.4 pttm -62.1 -34.23 75.94 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.364 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 84.0 m -75.63 -35.96 60.33 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 21.0 mt -59.24 -54.3 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -58.45 -34.14 70.51 Favored 'General case' 0 C--O 1.225 -0.198 0 O-C-N 123.852 0.72 . . . . 0.0 111.447 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -56.18 -48.13 76.95 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.181 0.593 . . . . 0.0 111.496 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.414 ' HE3' ' HA ' ' A' ' 215' ' ' PRO . 27.0 mmmt -80.96 -40.8 23.86 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 121.565 -0.709 . . . . 0.0 111.255 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 13.0 mt -61.59 -31.62 71.69 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-O 118.364 -0.827 . . . . 0.0 112.25 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -51.53 -28.14 12.81 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.031 0.932 . . . . 0.0 113.337 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -59.65 -63.11 1.42 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.981 0.912 . . . . 0.0 111.72 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 7.3 mmt85 -154.65 -176.95 6.16 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.395 1.478 . . . . 0.0 110.805 -178.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 67.3 m -86.29 174.32 9.15 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 177.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 30.9 pt -129.47 161.42 38.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 126.573 1.949 . . . . 0.0 107.246 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -153.35 142.62 21.52 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -136.97 117.23 13.52 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.346 0.659 . . . . 0.0 109.892 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -85.24 98.43 10.49 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.83 80.77 7.09 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 128.634 2.774 . . . . 0.0 108.02 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 60.16 -112.09 4.17 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 108.581 -1.808 . . . . 0.0 108.581 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -80.77 -24.65 38.47 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -100.45 159.33 15.23 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 119.957 1.253 . . . . 0.0 111.031 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.0 mp -134.88 132.22 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 N-CA-C 103.904 -2.628 . . . . 0.0 103.904 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -118.59 121.3 39.87 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -109.26 121.1 44.45 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -111.25 128.3 55.89 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.196 0.522 . . . . 0.0 110.669 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 54.7 m -110.14 153.21 43.37 Favored Pre-proline 0 N--CA 1.439 -1.002 0 C-N-CA 126.894 2.077 . . . . 0.0 113.308 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -68.96 74.34 0.95 Allowed 'Trans proline' 0 C--N 1.349 0.573 1 C-N-CA 125.356 4.037 . . . . 0.0 113.692 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.13 51.77 6.65 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-O 119.04 -0.866 . . . . 0.0 113.812 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.6 mp -124.83 -72.16 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.299 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 177.73 145.28 0.11 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -109.87 131.98 54.57 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 124.757 1.223 . . . . 0.0 109.098 -175.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.5 m -144.82 164.53 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 125.318 1.447 . . . . 0.0 111.581 -177.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -123.19 126.29 46.71 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 105.25 -2.129 . . . . 0.0 105.25 177.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -138.36 162.99 32.98 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.87 1.214 . . . . 0.0 111.235 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -84.98 157.73 20.7 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 177.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.926 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -179.439 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 . . . . . 0 CA--C 1.512 -0.499 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.3 116.18 12.3 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 49.0 mt -98.05 -26.81 14.48 Favored 'General case' 0 C--O 1.22 -0.448 0 O-C-N 124.413 1.07 . . . . 0.0 110.91 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 155.17 155.17 7.2 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 119.028 0.831 . . . . 0.0 111.54 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -114.74 109.97 47.17 Favored Pre-proline 0 N--CA 1.451 -0.4 0 C-N-CA 125.246 1.418 . . . . 0.0 108.766 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -74.52 -177.55 3.41 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.801 2.334 . . . . 0.0 107.319 178.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -128.95 134.67 48.29 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-N 118.819 0.736 . . . . 0.0 110.532 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -49.61 -45.98 48.71 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 125.869 1.98 . . . . 0.0 109.808 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -73.21 65.05 0.8 Allowed 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.522 1.529 . . . . 0.0 110.297 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 5.9 p -50.76 -31.23 9.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 121.035 -1.041 . . . . 0.0 112.659 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -63.42 -26.88 68.94 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -177.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -86.74 -23.09 25.62 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.67 1.588 . . . . 0.0 112.826 -179.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 30.2 mtp85 -73.34 150.71 41.65 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -103.71 144.19 31.79 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -138.93 159.26 42.57 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.96 1.304 . . . . 0.0 108.749 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -120.11 153.74 35.72 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.738 0.815 . . . . 0.0 109.994 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 35.5 tp -114.26 98.01 6.68 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.777 1.631 . . . . 0.0 106.995 179.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -107.92 -178.54 3.64 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.693 1.997 . . . . 0.0 108.547 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -141.22 158.06 44.4 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.024 0.53 . . . . 0.0 110.853 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -132.09 -178.7 5.02 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.681 1.992 . . . . 0.0 108.435 179.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.14 -14.42 17.05 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.186 1.394 . . . . 0.0 113.136 -178.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 16.0 t -107.24 -41.87 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 124.37 1.068 . . . . 0.0 111.279 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 177.34 -172.34 45.15 Favored Glycine 0 C--N 1.336 0.537 0 O-C-N 121.104 -0.998 . . . . 0.0 114.573 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 5.0 m-30 -77.28 158.36 30.26 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 122.337 1.065 . . . . 0.0 108.514 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -157.04 160.5 39.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.2 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 92.5 mt -100.19 132.11 46.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 22.7 t -102.06 126.15 48.92 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 125.406 1.482 . . . . 0.0 111.971 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -123.17 111.6 16.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.725 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -93.26 119.04 40.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 177.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 9.1 mt -104.7 106.55 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 178.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.63 -153.1 24.54 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 124.771 1.177 . . . . 0.0 110.57 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 71.3 47.87 0.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.716 2.006 . . . . 0.0 107.946 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -115.04 162.91 12.27 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 108.886 -1.685 . . . . 0.0 108.886 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.05 159.11 30.11 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.0 mm -79.6 137.84 20.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 124.674 1.19 . . . . 0.0 110.604 178.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.3 m -90.09 108.65 19.86 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 128.047 2.539 . . . . 0.0 106.635 178.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -53.93 -25.88 22.62 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.051 1.34 . . . . 0.0 113.486 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 40.0 t -49.6 -47.26 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 125.254 1.422 . . . . 0.0 112.024 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 11.2 t -124.3 -38.99 2.37 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.278 1.031 . . . . 0.0 111.653 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 110.5 34.96 2.16 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 107.923 -2.071 . . . . 0.0 107.923 -177.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -106.28 154.8 20.23 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 120.175 1.988 . . . . 0.0 111.403 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -76.25 148.41 37.63 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 123.523 0.729 . . . . 0.0 111.723 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 38.6 mtt180 -69.91 27.23 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 130.564 3.546 . . . . 0.0 112.442 178.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 6.4 ptm -74.38 175.29 7.82 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.473 1.033 . . . . 0.0 110.683 -178.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.13 149.84 18.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 124.972 1.309 . . . . 0.0 107.484 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -109.19 112.79 25.15 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.355 1.462 . . . . 0.0 107.345 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 13.3 mm -105.99 139.49 27.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 39.1 mm-40 -124.73 126.71 46.11 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.479 1.112 . . . . 0.0 109.88 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -100.41 111.2 23.44 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.301 1.04 . . . . 0.0 110.512 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 3.5 m -124.21 163.43 24.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 123.742 0.817 . . . . 0.0 109.769 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 52.7 t -88.87 134.21 34.02 Favored 'General case' 0 N--CA 1.461 0.09 0 O-C-N 120.633 -1.292 . . . . 0.0 110.204 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -84.59 10.37 62.19 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 124.34 0.971 . . . . 0.0 114.032 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.17 0 N-CA-C 106.965 -2.454 . . . . 0.0 106.965 -177.988 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.414 ' HA ' ' HE3' ' A' ' 112' ' ' LYS . 55.4 Cg_endo . . . . . 0 N--CA 1.451 -1.024 0 N-CA-C 111.102 -0.384 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 4.2 p -174.85 151.83 1.46 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.212 1.405 . . . . 0.0 110.66 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.4 p -151.09 158.58 44.22 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.865 1.266 . . . . 0.0 109.222 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 4.3 mt -98.1 151.93 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 125.65 1.58 . . . . 0.0 110.084 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -97.07 -50.34 4.64 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 124.691 1.197 . . . . 0.0 112.031 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 63.9 p-90 -159.69 156.09 27.17 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -178.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 61.7 t -153.76 129.16 1.59 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 125.792 1.637 . . . . 0.0 107.198 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -160.62 163.68 32.42 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.198 0.599 . . . . 0.0 111.189 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -69.39 144.21 53.45 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 9.0 t -119.18 -35.8 3.53 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 121.084 -1.01 . . . . 0.0 110.521 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -127.65 -175.11 3.37 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 83.3 mt -55.7 -44.63 77.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.731 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 1.1 t -125.16 10.16 8.08 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.579 0.752 . . . . 0.0 112.492 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 10.6 t -114.74 143.77 23.76 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.793 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -177.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -122.39 162.22 22.01 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -132.54 143.53 49.79 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -145.89 146.27 31.03 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.638 1.575 . . . . 0.0 108.842 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -135.44 130.25 34.49 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 8.8 m -114.43 155.6 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.627 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 178.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.04 125.27 44.25 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 1.5 pt -134.72 146.22 58.06 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -75.22 -35.98 2.68 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.413 2.076 . . . . 0.0 112.566 -178.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -62.89 -17.58 61.84 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 -177.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 18.4 mt -73.18 -29.31 62.75 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.88 1.218 . . . . 0.0 110.264 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 10.1 m -57.1 -15.86 6.32 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.11 0.964 . . . . 0.0 112.903 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -62.01 -31.05 71.39 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.139 0.975 . . . . 0.0 109.173 177.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -86.34 124.28 32.52 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 106.052 -1.832 . . . . 0.0 106.052 178.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -47.23 -48.67 24.19 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 127.003 2.121 . . . . 0.0 113.608 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 32.9 mt -67.01 -26.18 66.67 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 12.8 mt -99.31 2.64 45.63 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.095 1.758 . . . . 0.0 111.582 -178.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -77.67 114.56 16.63 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.614 1.566 . . . . 0.0 111.733 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp . . . . . 0 N--CA 1.465 0.279 0 C-N-CA 124.018 0.927 . . . . 0.0 109.529 178.208 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.55 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -148.78 76.74 1.36 Allowed 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 73.8 m -139.33 147.77 42.01 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 123.141 0.576 . . . . 0.0 111.625 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -87.13 168.36 13.33 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.194 0.998 . . . . 0.0 110.572 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.3 t -70.93 -41.37 71.26 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 117.696 -1.145 . . . . 0.0 113.945 -178.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -54.4 -40.36 68.15 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 120.297 1.408 . . . . 0.0 110.225 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.1 tmtm? -54.26 -55.16 30.9 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.631 1.172 . . . . 0.0 108.025 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.53 -37.17 86.61 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 124.06 0.944 . . . . 0.0 112.078 179.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.71 -50.26 74.56 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 61.1 tp -69.54 -34.61 74.48 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 118.33 -0.843 . . . . 0.0 110.748 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 17.3 mt -61.38 -54.38 44.39 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.8 m -57.52 -50.52 72.79 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.157 0.983 . . . . 0.0 110.368 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.7 -50.29 72.61 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 118.651 -0.69 . . . . 0.0 111.038 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 21.9 m -52.2 -45.21 65.13 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 124.282 1.033 . . . . 0.0 110.309 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -60.56 -51.38 69.67 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.356 0.98 . . . . 0.0 108.767 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -59.03 -60.25 4.17 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.44 -30.92 67.89 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.199 -176.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.76 -52.29 51.64 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 42.1 t -56.75 -48.62 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 118.361 1.08 . . . . 0.0 109.794 179.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.43 -30.92 70.87 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 119.037 -1.065 . . . . 0.0 113.487 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 44.4 m -78.19 -34.2 49.62 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 21.7 mt -60.02 -54.74 30.63 Favored 'Isoleucine or valine' 0 C--O 1.23 0.072 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -58.11 -29.85 65.82 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.781 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -69.75 -39.81 76.5 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.294 0.952 . . . . 0.0 112.189 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.414 ' HZ3' ' CD ' ' A' ' 237' ' ' GLU . 11.2 tptt -84.77 -34.2 22.85 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 120.744 -1.223 . . . . 0.0 110.426 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 15.9 mt -65.95 -30.28 70.82 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 118.497 -0.763 . . . . 0.0 109.802 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -48.36 -35.05 11.75 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.466 1.107 . . . . 0.0 112.209 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -49.0 -66.07 0.46 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.51 1.524 . . . . 0.0 113.328 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -158.0 -177.85 6.87 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 128.178 2.591 . . . . 0.0 108.777 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 58.5 m -86.67 167.21 14.71 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 42.3 pt -115.69 156.99 16.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -154.18 141.76 19.85 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 122.555 0.342 . . . . 0.0 111.225 -178.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -140.44 125.75 18.78 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.649 0.78 . . . . 0.0 111.205 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -84.27 105.76 15.37 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.64 80.23 4.79 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.27 -103.24 0.98 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -93.2 -23.08 18.67 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.457 1.103 . . . . 0.0 113.742 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -100.58 156.9 17.04 Favored 'General case' 0 CA--C 1.517 -0.326 0 O-C-N 121.606 -0.684 . . . . 0.0 110.111 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.8 mp -127.89 135.33 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -115.5 124.87 52.17 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -120.9 120.07 34.45 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 123.291 0.636 . . . . 0.0 110.301 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -110.9 131.2 55.25 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.657 0.741 . . . . 0.0 109.922 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 36.1 m -110.08 157.24 38.43 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 124.398 1.079 . . . . 0.0 112.697 -178.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -63.6 76.68 0.14 Allowed 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 125.042 3.828 . . . . 0.0 113.612 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 66.18 60.66 6.15 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 125.01 1.291 . . . . 0.0 112.228 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 3.2 mp -130.57 -71.46 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -164.88 164.71 20.82 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 126.455 1.902 . . . . 0.0 110.278 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -131.18 119.35 21.75 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 22.5 m -143.92 164.89 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 123.899 0.88 . . . . 0.0 110.761 -178.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -120.59 129.48 53.77 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.632 1.173 . . . . 0.0 109.014 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -138.93 162.87 33.81 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.19 1.396 . . . . 0.0 112.089 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -89.09 160.91 16.81 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 176.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 138.68 -161.81 25.81 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -149.06 167.55 25.56 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 126.495 1.918 . . . . 0.0 108.579 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.5 p -127.96 149.31 32.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -105.2 104.39 14.12 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 103.624 -2.732 . . . . 0.0 103.624 177.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.8 p -53.86 -31.85 51.02 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 120.744 1.611 . . . . 0.0 112.125 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -53.09 -46.28 68.59 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.25 1.42 . . . . 0.0 111.051 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 40.3 p -97.77 -33.95 11.08 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 123.835 0.854 . . . . 0.0 112.043 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 86.94 22.32 46.2 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 127.74 2.591 . . . . 0.0 111.763 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -124.32 154.77 39.8 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 119.082 1.441 . . . . 0.0 112.229 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 9.5 mm -70.51 166.45 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 125.128 1.371 . . . . 0.0 108.907 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 12.4 m -60.78 -55.52 24.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 178.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -164.41 157.51 17.49 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 127.884 2.474 . . . . 0.0 107.124 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 39.6 mtm-85 -74.68 176.78 6.64 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -140.99 103.72 4.53 Favored 'General case' 0 C--O 1.232 0.165 0 O-C-N 120.954 -1.091 . . . . 0.0 112.73 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -77.85 -19.5 54.75 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.413 1.085 . . . . 0.0 112.878 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 16.0 m -82.58 -41.16 19.91 Favored 'General case' 0 C--O 1.238 0.458 0 O-C-N 121.286 -0.884 . . . . 0.0 110.464 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 94.4 mt -77.36 72.96 3.93 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.883 1.673 . . . . 0.0 109.75 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 57.4 t -75.08 120.01 23.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 123.674 0.79 . . . . 0.0 109.895 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -146.96 151.74 37.49 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.971 1.708 . . . . 0.0 108.374 178.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -147.03 129.21 15.62 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 54.3 mt -112.94 -21.98 10.85 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.828 0.74 . . . . 0.0 109.753 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 155.98 157.8 8.48 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -126.46 117.73 23.07 Favored Pre-proline 0 CA--C 1.536 0.41 0 O-C-N 122.044 -0.68 . . . . 0.0 111.003 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -77.01 -171.17 1.07 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 1 C-N-CA 126.316 4.677 . . . . 0.0 108.845 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -129.5 152.86 48.57 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.312 1.045 . . . . 0.0 109.04 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -73.76 -29.71 62.37 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.26 1.024 . . . . 0.0 110.578 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -88.28 64.66 7.71 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 124.708 1.203 . . . . 0.0 108.361 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.6 p -50.07 -31.59 7.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 124.92 1.288 . . . . 0.0 112.093 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -61.5 -32.89 72.94 Favored 'General case' 0 CA--C 1.522 -0.116 0 C-N-CA 123.931 0.892 . . . . 0.0 111.986 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -80.64 -28.28 36.98 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.338 1.055 . . . . 0.0 110.82 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 9.4 mtp-105 -72.92 137.3 45.48 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -99.12 144.75 27.9 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -128.7 173.89 9.91 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 126.326 1.85 . . . . 0.0 108.639 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -131.71 154.09 49.36 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.375 0.67 . . . . 0.0 109.389 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 23.1 tp -118.27 100.65 7.64 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.344 1.058 . . . . 0.0 109.061 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -109.24 -179.89 3.97 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -149.95 163.51 37.9 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 121.142 -0.974 . . . . 0.0 108.978 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -140.58 -178.14 5.38 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -59.33 -22.52 61.39 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.694 1.198 . . . . 0.0 111.729 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 48.3 t -88.85 -35.86 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 125.762 1.625 . . . . 0.0 111.965 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 160.19 178.95 34.64 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 121.743 -0.265 . . . . 0.0 112.789 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -78.01 155.71 30.56 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 123.893 0.877 . . . . 0.0 108.98 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -155.72 156.72 35.37 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.31 0.644 . . . . 0.0 111.395 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 92.7 mt -97.15 133.82 37.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 12.3 t -101.32 127.14 48.07 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.495 1.518 . . . . 0.0 108.294 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -122.54 107.28 11.82 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.604 1.562 . . . . 0.0 107.807 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -93.3 115.47 32.19 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.5 mt -99.64 106.59 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 104.778 -2.305 . . . . 0.0 104.778 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -99.72 -152.86 27.24 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 108.771 -1.731 . . . . 0.0 108.771 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 69.66 47.7 0.63 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-O 123.049 1.404 . . . . 0.0 107.875 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -116.79 158.24 14.59 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 107.803 -2.119 . . . . 0.0 107.803 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -74.42 159.15 32.69 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.168 0.987 . . . . 0.0 108.704 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 34.1 mm -83.03 126.38 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 177.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.2 m -75.37 111.75 10.97 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 127.065 2.146 . . . . 0.0 107.072 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -56.23 -27.45 54.93 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.626 1.17 . . . . 0.0 112.49 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 57.9 t -49.3 -50.67 15.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 125.036 1.334 . . . . 0.0 110.847 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 6.5 t -125.57 -32.35 2.89 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 116.644 2.09 . . . . 0.0 116.644 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 106.9 35.86 2.68 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -178.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -116.68 152.14 34.89 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 118.261 1.03 . . . . 0.0 111.764 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -74.81 146.45 42.03 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.571 0.748 . . . . 0.0 112.908 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -72.6 29.11 0.06 Allowed 'General case' 0 C--O 1.223 -0.322 1 C-N-CA 132.055 4.142 . . . . 0.0 112.308 178.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 5.8 ptm -75.77 177.52 6.83 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 120.197 -1.565 . . . . 0.0 110.341 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 5.9 p -147.94 148.85 15.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 125.158 1.383 . . . . 0.0 108.452 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -104.73 121.97 44.71 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 177.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 17.7 mm -114.1 131.22 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -114.54 125.0 53.3 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.304 1.042 . . . . 0.0 109.068 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -97.77 112.72 24.51 Favored 'General case' 0 C--O 1.239 0.553 0 C-N-CA 123.685 0.794 . . . . 0.0 109.72 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 5.1 m -124.08 161.46 26.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 44.1 t -90.25 142.68 27.48 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -84.4 2.39 87.93 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-O 117.753 -1.581 . . . . 0.0 114.906 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 62.6 56.5 21.09 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 106.97 -2.452 . . . . 0.0 106.97 -178.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.93 137.37 29.4 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -179.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -82.18 -13.04 57.75 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.503 0.668 . . . . 0.0 110.653 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 50.5 p -156.23 172.26 18.77 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 119.845 -1.784 . . . . 0.0 111.682 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 125.57 174.22 13.86 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 127.041 2.258 . . . . 0.0 112.221 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -85.43 -113.85 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 124.194 3.263 . . . . 0.0 107.733 178.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.6 p -150.33 142.11 23.72 Favored 'General case' 0 C--O 1.237 0.405 0 O-C-N 120.047 -1.658 . . . . 0.0 111.554 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 40.7 p -147.86 160.98 42.19 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.776 1.23 . . . . 0.0 110.244 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 4.0 mt -100.08 153.71 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 126.536 1.935 . . . . 0.0 107.865 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -97.62 -48.55 5.2 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 124.492 1.117 . . . . 0.0 112.618 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 52.8 p-90 -163.96 159.46 20.83 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 91.0 t -152.8 129.15 1.84 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.586 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.14 167.35 29.39 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.289 0.95 . . . . 0.0 112.547 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -77.41 132.63 38.6 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.581 1.552 . . . . 0.0 107.653 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 7.5 t -110.84 -33.74 6.44 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.573 1.149 . . . . 0.0 110.918 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -132.53 -175.18 3.67 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 124.645 1.178 . . . . 0.0 108.985 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 60.9 mt -56.64 -45.05 82.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -125.58 18.33 8.1 Favored 'General case' 0 C--N 1.334 -0.108 0 C-N-CA 124.185 0.994 . . . . 0.0 111.102 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 15.8 t -121.65 143.3 34.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 CA-C-N 118.309 0.504 . . . . 0.0 110.387 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -124.47 161.32 26.32 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.152 1.381 . . . . 0.0 107.666 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -132.07 134.49 45.57 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 126.04 1.736 . . . . 0.0 106.534 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -140.22 145.3 37.22 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.919 1.688 . . . . 0.0 109.07 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -133.69 128.62 35.37 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 119.263 -0.398 . . . . 0.0 111.57 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 3.8 m -112.35 152.69 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.57 115.36 20.71 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.808 1.243 . . . . 0.0 107.775 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 18.5 pt -127.14 152.25 75.61 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.879 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.63 -45.43 0.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.819 2.346 . . . . 0.0 112.366 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . 0.414 ' CD ' ' HZ3' ' A' ' 112' ' ' LYS . 4.3 mm-40 -53.32 -28.51 28.77 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 116.751 2.13 . . . . 0.0 116.751 -176.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 59.2 mt -64.42 -28.98 70.05 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 120.33 1.423 . . . . 0.0 110.323 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 12.3 m -60.61 -11.72 8.04 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -69.85 -31.52 69.41 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.96 121.63 25.71 Favored 'General case' 0 C--O 1.225 -0.199 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -47.13 -42.6 19.63 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.906 1.683 . . . . 0.0 113.47 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.86 -29.57 64.51 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 17.3 mt -96.49 -5.45 39.45 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.299 1.04 . . . . 0.0 111.832 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -64.3 116.77 6.36 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.895 1.678 . . . . 0.0 108.577 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -77.26 161.21 28.31 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 178.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.3 -11.5 59.57 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -127.71 33.12 4.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.104 1.362 . . . . 0.0 110.552 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.017 0 C-N-CA 125.615 1.566 . . . . 0.0 109.043 178.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.706 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.09 126.51 18.8 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.888 0.875 . . . . 0.0 110.141 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.2 t -151.39 109.44 3.71 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 50.84 31.63 6.29 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.523 1.129 . . . . 0.0 110.824 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.5 m -46.23 -54.17 9.3 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 127.343 2.257 . . . . 0.0 113.702 -177.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -64.51 -38.21 90.21 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 118.33 0.514 . . . . 0.0 111.555 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -61.05 -46.29 91.32 Favored 'General case' 0 C--N 1.342 0.265 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.85 -34.04 73.97 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.754 0.706 . . . . 0.0 110.955 178.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.56 -43.15 97.57 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 119.119 0.872 . . . . 0.0 109.395 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 65.7 tp -64.2 -32.36 73.91 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-O 118.406 -0.807 . . . . 0.0 109.61 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.04 -54.36 39.3 Favored 'General case' 0 C--N 1.345 0.377 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 25.3 m -60.79 -48.14 83.13 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.159 0.984 . . . . 0.0 110.877 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.86 -48.84 79.95 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 121.024 -1.048 . . . . 0.0 110.036 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 53.8 m -54.11 -46.09 72.03 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 123.535 0.734 . . . . 0.0 110.055 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -56.22 -48.47 76.41 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.515 0.326 . . . . 0.0 110.432 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.16 -52.96 16.26 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -58.14 -40.29 80.95 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.344 1.058 . . . . 0.0 110.983 -178.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -66.58 -52.35 35.34 Favored Glycine 0 C--O 1.223 -0.537 0 N-CA-C 108.776 -1.729 . . . . 0.0 108.776 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 24.5 t -53.25 -46.88 57.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 118.76 1.28 . . . . 0.0 110.988 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.6 ptmm? -62.44 -34.2 76.32 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.1 m -77.66 -36.45 51.34 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.916 0.887 . . . . 0.0 110.371 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 23.5 mt -60.22 -54.71 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -61.53 -28.19 69.14 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.112 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -66.29 -45.41 80.5 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 120.586 -1.321 . . . . 0.0 113.0 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -76.92 -39.43 50.84 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 18.3 mt -66.22 -28.41 68.72 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-O 118.721 -0.657 . . . . 0.0 112.147 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -56.77 -18.57 13.16 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.54 0.736 . . . . 0.0 112.607 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -68.01 -74.71 0.11 Allowed 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 7.1 mmm180 -143.06 -179.65 6.5 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.281 1.432 . . . . 0.0 111.402 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 85.3 m -86.59 174.91 8.6 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 32.7 pt -128.67 159.99 39.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 127.043 2.137 . . . . 0.0 107.299 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -155.81 135.25 12.39 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.855 1.262 . . . . 0.0 108.975 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -130.79 126.16 35.62 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.666 1.186 . . . . 0.0 109.076 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -88.88 104.15 16.67 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.26 1.024 . . . . 0.0 109.365 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.59 80.74 4.3 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 128.337 2.655 . . . . 0.0 106.552 178.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 59.97 -113.34 5.24 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -78.0 -22.54 49.18 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.192 0.997 . . . . 0.0 112.835 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -105.15 161.72 14.01 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 123.625 0.77 . . . . 0.0 111.917 -178.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.4 mp -135.61 134.75 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 104.131 -2.544 . . . . 0.0 104.131 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -114.86 119.65 37.29 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 103.991 -2.596 . . . . 0.0 103.991 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -111.02 116.46 31.22 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.382 0.673 . . . . 0.0 109.396 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -106.66 129.23 54.6 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 20.8 m -114.75 155.49 46.17 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 126.665 1.986 . . . . 0.0 113.835 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.27 80.73 1.57 Allowed 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 124.115 3.21 . . . . 0.0 113.37 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.44 45.31 18.93 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-O 118.2 -1.333 . . . . 0.0 112.961 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 3.0 mp -120.84 -72.3 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 119.459 1.63 . . . . 0.0 109.913 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -179.2 141.91 0.18 Allowed 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -109.17 125.69 52.46 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -177.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 33.3 m -144.61 164.33 13.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 114.123 -1.399 . . . . 0.0 111.575 -177.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -123.0 130.57 52.97 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.649 1.179 . . . . 0.0 108.286 178.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -138.25 162.89 33.15 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.402 1.481 . . . . 0.0 111.338 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.4 ' H ' ' CD1' ' A' ' 156' ' ' LEU . 74.3 t60 -91.06 161.56 15.06 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.916 1.686 . . . . 0.0 107.391 178.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 126.57 -158.65 20.71 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-N 120.099 1.318 . . . . 0.0 110.769 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.57 167.26 28.62 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 121.668 -0.901 . . . . 0.0 109.488 177.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.8 p -123.16 141.15 44.54 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 C-N-CA 124.034 0.934 . . . . 0.0 108.79 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -86.72 113.94 22.99 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 13.5 p -59.86 -17.72 38.85 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.831 1.252 . . . . 0.0 112.799 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -68.8 -35.37 76.93 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 126.984 2.114 . . . . 0.0 113.399 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 30.6 p -124.88 -36.29 2.58 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 93.92 34.82 6.33 Favored Glycine 0 C--N 1.334 0.447 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -124.36 141.96 51.66 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 125.166 1.386 . . . . 0.0 108.863 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 9.4 mm -71.73 161.24 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 8.6 m -58.8 -42.23 84.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 O-C-N 121.505 -0.747 . . . . 0.0 110.672 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -172.91 164.1 5.01 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 126.596 1.959 . . . . 0.0 107.383 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -75.75 167.78 21.25 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 178.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -127.27 99.54 5.7 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -84.35 -20.03 32.68 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 118.514 -0.755 . . . . 0.0 112.121 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 6.0 t -75.02 -42.52 57.21 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 120.349 1.431 . . . . 0.0 109.462 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.4 ' CD1' ' H ' ' A' ' 139' ' ' HIS . 54.5 mt -72.6 123.3 22.92 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 15.7 m -131.56 105.03 9.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -124.09 160.76 27.03 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.491 1.516 . . . . 0.0 107.275 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 9.6 tpp180 -143.36 110.46 5.68 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.9 mp -98.43 -34.46 10.63 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 177.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 160.05 163.92 14.34 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 119.266 0.939 . . . . 0.0 111.537 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -118.82 109.78 39.25 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 124.264 1.026 . . . . 0.0 110.201 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -77.93 174.93 11.81 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 123.298 2.665 . . . . 0.0 111.118 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -126.35 146.23 50.13 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.25 -37.93 75.04 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 126.664 1.985 . . . . 0.0 111.428 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -73.25 65.36 0.83 Allowed 'General case' 0 C--O 1.233 0.227 0 C-N-CA 126.098 1.759 . . . . 0.0 109.967 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.4 p -48.84 -31.22 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 125.048 1.339 . . . . 0.0 112.206 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -71.18 -31.61 67.85 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 124.899 1.28 . . . . 0.0 112.862 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -76.65 -12.95 60.08 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.715 1.206 . . . . 0.0 113.167 -178.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -107.63 152.54 24.15 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.598 1.159 . . . . 0.0 110.526 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -105.02 156.61 17.89 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.267 1.427 . . . . 0.0 108.306 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -136.83 163.91 29.53 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.46 1.504 . . . . 0.0 108.738 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -114.72 153.7 29.81 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.236 0.614 . . . . 0.0 110.106 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 16.9 tp -118.39 98.79 6.44 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.432 1.493 . . . . 0.0 107.79 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -110.35 -178.99 3.65 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 126.875 2.07 . . . . 0.0 108.564 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -144.88 163.31 34.5 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 121.35 0.595 . . . . 0.0 110.057 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -137.69 -177.59 4.87 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.791 1.636 . . . . 0.0 108.046 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -60.55 -17.54 46.67 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.164 1.386 . . . . 0.0 111.56 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 87.7 t -86.0 -56.98 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 128.511 2.724 . . . . 0.0 110.484 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 168.76 -165.17 38.68 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -78.39 166.49 22.58 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 117.523 0.662 . . . . 0.0 109.683 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -159.85 171.59 19.18 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.167 0.987 . . . . 0.0 110.384 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 79.7 mt -107.42 138.11 35.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 32.9 t -107.07 134.11 50.69 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 125.393 1.477 . . . . 0.0 108.408 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -130.23 111.45 12.42 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.369 1.068 . . . . 0.0 108.214 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.6 mp -93.41 132.17 38.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 10.3 mt -122.18 115.2 45.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -110.68 -152.52 13.01 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 125.796 1.665 . . . . 0.0 111.603 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 4.6 t 71.58 35.25 1.49 Allowed 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.65 1.58 . . . . 0.0 114.434 178.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -87.58 -112.42 1.02 Allowed Glycine 0 CA--C 1.526 0.768 0 N-CA-C 108.44 -1.864 . . . . 0.0 108.44 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -154.55 150.83 28.17 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 129.825 3.25 . . . . 0.0 103.589 178.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.8 mm -72.9 137.57 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 O-C-N 120.053 -1.654 . . . . 0.0 111.999 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.6 m -81.4 116.08 21.05 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 128.489 2.716 . . . . 0.0 107.001 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -57.72 -29.16 64.51 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 124.624 1.17 . . . . 0.0 112.105 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 14.5 t -51.81 -50.67 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 126.423 1.889 . . . . 0.0 113.878 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 14.7 t -124.0 -31.97 3.31 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.15 34.74 3.86 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 -178.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -109.14 155.64 20.78 Favored 'General case' 0 C--N 1.343 0.324 0 C-N-CA 123.957 0.903 . . . . 0.0 110.182 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -75.72 144.4 41.55 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 125.197 1.399 . . . . 0.0 110.832 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . 0.269 26.1 mtp85 -69.04 29.18 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 130.053 3.341 . . . . 0.0 112.524 178.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 8.4 ptm -74.71 177.99 5.75 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.141 0.976 . . . . 0.0 112.022 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.3 p -145.78 152.72 13.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 125.504 1.522 . . . . 0.0 109.174 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -112.18 101.81 10.03 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 126.938 2.095 . . . . 0.0 106.921 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 9.1 mm -94.36 146.31 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . 0.412 HE22 ' HG2' ' A' ' 230' ' ' GLU . 16.2 mp0 -126.32 114.43 18.24 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 127.298 2.239 . . . . 0.0 109.574 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -93.62 115.71 28.19 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 12.5 m -125.02 165.62 21.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 42.1 t -87.04 140.68 29.31 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -95.47 18.06 58.12 Favored Glycine 0 CA--C 1.523 0.532 0 CA-C-O 118.596 -1.114 . . . . 0.0 112.706 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 68.13 -149.18 49.87 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 107.771 -2.131 . . . . 0.0 107.771 -178.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 41.5 m -73.49 81.35 1.45 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.236 1.018 . . . . 0.0 108.33 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -132.02 60.67 1.67 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 12.6 m -52.97 123.62 12.06 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 123.882 0.873 . . . . 0.0 109.929 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 163.52 -168.25 38.07 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.453 ' HG2' ' H ' ' A' ' 216' ' ' SER . 59.5 Cg_endo -72.68 -75.37 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 123.553 2.835 . . . . 0.0 110.488 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' SER . . . . . 0.453 ' H ' ' HG2' ' A' ' 215' ' ' PRO . 3.8 p -173.05 152.42 2.32 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.863 1.665 . . . . 0.0 110.914 -178.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 4.7 p -150.85 166.36 30.79 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.533 1.533 . . . . 0.0 109.108 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 5.1 mt -108.68 153.73 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 126.098 1.759 . . . . 0.0 110.614 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -94.44 -56.29 2.86 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 124.46 1.104 . . . . 0.0 111.155 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 -160.73 156.05 24.76 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 126.324 1.85 . . . . 0.0 106.903 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 58.0 t -151.33 125.94 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 125.731 1.612 . . . . 0.0 108.369 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -162.54 164.18 27.01 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 118.21 0.459 . . . . 0.0 110.874 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -65.81 141.9 58.13 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 1.8 t -123.79 -30.64 3.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 118.457 0.571 . . . . 0.0 111.897 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 11.3 mttt -124.4 -175.87 3.37 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 77.0 mt -59.28 -47.36 90.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.88 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 1.8 t -118.93 15.02 13.37 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.651 0.78 . . . . 0.0 112.703 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 14.2 t -122.38 148.7 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.705 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.546 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -125.42 166.1 17.21 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . 0.412 ' HG2' HE22 ' A' ' 205' ' ' GLN . 4.3 mt-10 -133.02 144.47 50.1 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 124.667 1.187 . . . . 0.0 108.464 178.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -144.96 118.95 9.35 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.19 1.396 . . . . 0.0 109.915 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -106.13 124.11 49.06 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 104.98 -2.23 . . . . 0.0 104.98 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 3.0 m -119.38 153.76 21.92 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 2.1 p -122.55 138.27 54.63 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 122.236 1.017 . . . . 0.0 110.856 -178.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -143.69 148.14 41.86 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 114.609 -1.178 . . . . 0.0 108.142 178.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.28 -36.11 3.44 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 121.597 1.531 . . . . 0.0 112.208 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -59.86 -20.74 58.85 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 116.618 2.081 . . . . 0.0 116.618 -177.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 32.9 mt -71.24 -26.64 63.0 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.899 1.681 . . . . 0.0 110.52 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 27.5 m -59.57 -12.52 6.73 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.877 0.871 . . . . 0.0 111.845 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -62.39 -35.77 80.23 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.772 0.829 . . . . 0.0 110.171 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -87.87 130.9 34.75 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -47.81 -48.64 30.43 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.516 1.926 . . . . 0.0 112.779 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 66.0 mt -65.34 -25.67 67.7 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 15.4 mt -99.74 -7.54 25.42 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.746 0.818 . . . . 0.0 113.175 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -62.54 112.86 2.65 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 128.212 2.605 . . . . 0.0 112.743 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -66.69 151.71 46.85 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -94.5 -22.34 18.3 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.52 0.728 . . . . 0.0 111.521 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.29 35.36 4.56 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 129.117 2.967 . . . . 0.0 109.935 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 C--O 1.247 0.967 0 C-N-CA 125.917 1.687 . . . . 0.0 110.326 179.426 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.935 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.66 161.24 23.5 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.129 0.965 . . . . 0.0 109.785 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.9 p -154.09 107.56 2.93 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.759 1.224 . . . . 0.0 109.423 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -72.42 121.71 20.01 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 177.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.9 m -70.15 -20.91 63.13 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.119 1.368 . . . . 0.0 114.511 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -75.37 -49.68 18.27 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 120.702 -1.249 . . . . 0.0 108.663 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -53.65 -50.85 64.88 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.1 p -66.75 -36.17 81.83 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 123.256 0.622 . . . . 0.0 112.524 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.09 -38.97 93.3 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 22.8 tp -74.0 -40.96 62.57 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 117.519 -1.229 . . . . 0.0 109.367 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 36.2 mt -57.87 -54.09 50.88 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.738 1.154 . . . . 0.0 110.407 -177.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 78.2 m -61.81 -38.07 86.73 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.503 -0.748 . . . . 0.0 111.215 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.39 -48.2 76.35 Favored 'General case' 0 C--N 1.341 0.201 0 O-C-N 120.091 -1.631 . . . . 0.0 109.424 178.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 77.2 m -52.82 -48.43 66.97 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.12 1.368 . . . . 0.0 109.941 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -59.38 -43.92 92.84 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.797 0.439 . . . . 0.0 111.933 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -71.98 -52.79 15.36 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -63.22 -41.22 99.09 Favored 'General case' 0 C--O 1.216 -0.698 0 C-N-CA 124.856 1.263 . . . . 0.0 109.661 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.04 -50.9 62.32 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 36.4 t -58.24 -45.88 88.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 118.591 1.195 . . . . 0.0 110.425 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 8.0 ptmt -61.92 -34.66 76.47 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.783 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 99.6 m -77.67 -28.53 51.16 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.679 0.792 . . . . 0.0 109.783 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 19.8 mt -69.61 -55.03 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 178.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -55.7 -36.99 67.76 Favored 'General case' 0 CA--C 1.527 0.083 0 O-C-N 123.644 0.59 . . . . 0.0 110.565 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -63.25 -38.66 92.02 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.258 1.023 . . . . 0.0 111.95 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.0 tptp -82.63 -38.78 23.04 Favored 'General case' 0 CA--C 1.518 -0.273 0 O-C-N 121.149 -0.969 . . . . 0.0 111.114 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 31.8 mt -70.26 -24.6 63.09 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 122.437 0.295 . . . . 0.0 111.305 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -50.93 -29.71 12.87 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.132 1.373 . . . . 0.0 111.096 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -64.87 -64.51 0.85 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.315 1.046 . . . . 0.0 113.176 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 86.7 mmt-85 -150.46 177.17 10.25 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.684 1.194 . . . . 0.0 110.479 -177.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 74.4 m -86.47 175.99 8.08 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 46.2 pt -129.33 157.74 42.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 124.926 1.29 . . . . 0.0 108.473 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -156.46 139.79 15.7 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.014 0.926 . . . . 0.0 110.668 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -136.84 124.14 21.9 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -81.07 98.79 8.15 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.997 1.719 . . . . 0.0 108.24 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.86 79.76 5.28 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.19 -85.37 0.06 OUTLIER Glycine 0 CA--C 1.521 0.458 0 C-N-CA 124.67 1.129 . . . . 0.0 113.183 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -106.8 -32.18 8.07 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.447 1.099 . . . . 0.0 112.895 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -104.93 128.24 53.11 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 123.679 0.791 . . . . 0.0 110.96 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.9 mp -98.24 157.1 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 103.794 -2.669 . . . . 0.0 103.794 177.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -135.34 121.95 20.77 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 103.955 -2.609 . . . . 0.0 103.955 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -119.25 117.65 29.18 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.8 1.64 . . . . 0.0 110.741 -178.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -110.67 137.7 48.0 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.415 1.486 . . . . 0.0 109.453 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 11.7 m -120.83 151.81 55.2 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 123.718 0.807 . . . . 0.0 111.506 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -60.53 85.35 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.662 1 C-N-CA 125.767 4.311 . . . . 0.0 115.044 -177.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 74.43 33.05 57.06 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 117.964 -1.464 . . . . 0.0 113.207 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 3.8 mp -115.65 -72.49 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 119.537 1.668 . . . . 0.0 109.222 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -168.88 169.36 9.83 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.12 1.768 . . . . 0.0 109.115 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -134.23 120.79 20.45 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 33.8 m -139.47 163.39 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.807 1.243 . . . . 0.0 110.993 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -118.82 125.07 48.73 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -138.24 162.3 34.66 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.962 0.801 . . . . 0.0 110.704 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -89.96 160.58 16.32 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 177.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 143.13 -158.59 27.26 Favored Glycine 0 N--CA 1.464 0.565 0 O-C-N 120.031 -1.668 . . . . 0.0 109.685 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.11 159.99 32.49 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.777 1.231 . . . . 0.0 108.671 177.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.7 p -110.24 149.06 13.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -103.61 101.59 11.45 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 17.7 p -48.25 -25.94 1.75 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 127.836 2.454 . . . . 0.0 114.209 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 39.8 mmtt -68.42 -32.22 72.11 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.299 1.44 . . . . 0.0 113.096 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.564 ' HG1' ' HG2' ' A' ' 148' ' ' GLU . 23.8 p -118.91 -27.77 5.7 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -178.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 84.29 31.63 24.79 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 124.67 1.129 . . . . 0.0 112.243 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.564 ' HG2' ' HG1' ' A' ' 146' ' ' THR . 3.2 pt-20 -125.8 156.06 40.1 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.597 1.159 . . . . 0.0 111.055 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 15.0 mm -76.55 149.49 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 29.3 m -62.9 -43.97 99.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -149.42 -171.77 3.97 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.786 1.634 . . . . 0.0 107.755 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.22 105.48 5.04 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 178.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.83 120.45 16.44 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 120.768 -1.208 . . . . 0.0 108.881 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -79.66 -24.44 41.83 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.269 0.628 . . . . 0.0 110.869 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 2.6 p -74.0 -21.47 59.97 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 126.004 1.722 . . . . 0.0 112.642 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 29.3 mt -96.1 83.45 3.63 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 122.598 1.19 . . . . 0.0 109.413 -178.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 65.1 t -84.66 124.07 39.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 125.249 1.42 . . . . 0.0 107.346 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -154.6 156.8 37.19 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.544 1.537 . . . . 0.0 108.221 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -149.07 129.52 13.88 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.047 -1.658 . . . . 0.0 110.7 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 43.4 mt -109.02 -30.63 7.98 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 120.053 1.297 . . . . 0.0 108.525 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 165.68 164.36 20.99 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -128.66 109.63 18.87 Favored Pre-proline 0 C--O 1.236 0.356 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -73.36 176.72 8.85 Favored 'Trans proline' 0 C--O 1.236 0.39 1 C-N-CA 125.458 4.105 . . . . 0.0 110.783 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -123.13 144.39 49.37 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 124.114 0.966 . . . . 0.0 109.58 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -67.11 -43.53 82.23 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 124.953 1.408 . . . . 0.0 109.6 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -74.3 64.81 1.14 Allowed 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.285 1.434 . . . . 0.0 110.411 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.2 p -50.95 -28.83 6.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 126.855 2.062 . . . . 0.0 111.333 178.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -72.97 -30.44 63.84 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.497 1.119 . . . . 0.0 112.524 -178.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -75.98 -23.01 55.29 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -96.58 173.6 7.26 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -133.31 165.39 24.92 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -135.71 169.79 16.99 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.743 1.217 . . . . 0.0 110.245 -177.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -113.23 153.65 28.01 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 48.7 tp -123.11 99.07 6.18 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.009 1.723 . . . . 0.0 106.784 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -108.36 175.56 5.43 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -140.5 160.56 39.73 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 123.001 1.382 . . . . 0.0 109.609 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -140.79 178.23 7.49 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 126.294 1.838 . . . . 0.0 106.544 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -73.2 10.78 0.87 Allowed 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 125.479 1.512 . . . . 0.0 114.199 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 59.6 t -116.76 -37.25 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 125.879 1.672 . . . . 0.0 109.827 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 164.04 -176.04 40.09 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -86.68 163.19 17.5 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -156.36 161.52 40.14 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.633 0.773 . . . . 0.0 110.667 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 86.6 mt -102.08 130.74 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 12.9 t -97.38 126.9 42.91 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.485 1.114 . . . . 0.0 108.704 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -122.13 108.89 13.86 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -90.28 108.88 20.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 N-CA-C 103.68 -2.711 . . . . 0.0 103.68 178.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 12.2 mt -94.62 105.92 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 103.331 -2.841 . . . . 0.0 103.331 177.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -99.28 -152.72 27.52 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 107.765 -2.134 . . . . 0.0 107.765 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 5.2 t 70.22 51.64 0.38 Allowed 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -178.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -93.29 -162.78 36.62 Favored Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 106.375 -2.69 . . . . 0.0 106.375 177.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . 0.405 ' H ' ' HB3' ' A' ' 200' ' ' ARG . 62.7 m-20 -127.64 136.17 51.26 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 100.585 -3.858 . . . . 0.0 100.585 177.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 33.2 mm -60.36 138.95 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 119.552 1.069 . . . . 0.0 109.924 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.06 112.01 24.25 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.829 2.052 . . . . 0.0 106.376 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -51.12 -29.02 12.14 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.183 1.793 . . . . 0.0 115.795 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 24.5 t -42.22 -51.92 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.126 1.37 . . . . 0.0 111.108 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 13.2 t -123.76 -34.07 3.08 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.532 0.733 . . . . 0.0 109.334 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 106.48 35.46 2.86 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -112.51 158.86 19.39 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-N 118.852 1.326 . . . . 0.0 110.689 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -68.12 143.53 55.39 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.649 1.58 . . . . 0.0 114.869 -178.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.405 ' HB3' ' H ' ' A' ' 191' ' ' ASP 0.258 24.1 ttp180 -77.22 28.76 0.14 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 130.508 3.523 . . . . 0.0 113.524 179.033 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 8.1 ptm -73.82 176.91 5.9 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.072 -1.017 . . . . 0.0 111.365 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.46 149.27 19.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 125.801 1.64 . . . . 0.0 106.733 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -111.39 114.19 27.16 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 9.5 mm -102.26 138.99 24.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -118.15 96.93 5.54 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 126.729 2.011 . . . . 0.0 107.698 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -80.83 111.13 17.01 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.247 1.019 . . . . 0.0 108.545 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 33.5 m -124.53 164.98 22.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 124.653 1.181 . . . . 0.0 108.383 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . 0.424 ' O ' ' HE2' ' A' ' 246' ' ' LYS . 41.8 t -85.8 142.22 29.1 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -90.54 16.99 56.57 Favored Glycine 0 C--O 1.227 -0.294 0 CA-C-O 118.067 -1.407 . . . . 0.0 115.15 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 57.57 -5.08 0.04 OUTLIER Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.812 1.673 . . . . 0.0 117.071 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 7.6 t -82.69 160.54 22.37 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 119.702 1.751 . . . . 0.0 108.88 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -73.57 -53.59 10.16 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.659 0.783 . . . . 0.0 111.821 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.85 163.01 38.39 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.662 0.744 . . . . 0.0 111.497 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 150.05 -174.27 29.53 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 128.181 2.8 . . . . 0.0 107.287 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -75.85 -110.3 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 124.085 3.19 . . . . 0.0 110.983 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 3.8 p -156.01 148.61 23.86 Favored 'General case' 0 C--O 1.237 0.442 0 O-C-N 120.094 -1.629 . . . . 0.0 109.853 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.7 p -151.01 168.5 24.38 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.895 0.878 . . . . 0.0 112.122 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 3.2 mt -109.63 152.01 11.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 126.505 1.922 . . . . 0.0 109.465 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -98.42 -51.83 3.84 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 126.063 1.745 . . . . 0.0 109.592 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 65.3 p-90 -159.87 158.67 31.34 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.607 1.163 . . . . 0.0 109.306 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 97.1 t -153.42 134.9 5.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 126.153 1.781 . . . . 0.0 107.459 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -165.7 162.64 18.86 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.367 0.667 . . . . 0.0 111.662 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -68.48 140.87 55.72 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 178.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 13.1 t -120.65 -30.07 4.57 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.865 1.266 . . . . 0.0 112.681 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 43.2 mttt -131.25 -175.63 3.76 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 72.8 mt -46.68 -49.49 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 6.8 t -133.25 17.82 4.06 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.986 0.514 . . . . 0.0 111.276 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 23.1 t -109.62 143.31 19.97 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -122.68 161.95 22.89 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -131.69 144.55 51.08 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 178.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -144.77 141.33 29.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.893 1.277 . . . . 0.0 109.585 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -124.01 116.26 22.55 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 1.1 m -110.36 144.54 18.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -121.83 123.6 42.16 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.666 1.586 . . . . 0.0 110.757 -178.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 3.6 pt -131.65 147.62 66.77 Favored Pre-proline 0 C--N 1.331 -0.231 0 C-N-CA 123.892 0.877 . . . . 0.0 108.695 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -70.18 -43.04 2.51 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.766 1.644 . . . . 0.0 111.924 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -55.77 -23.85 32.17 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -177.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 20.1 mt -65.28 -26.71 68.2 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 116.982 -1.887 . . . . 0.0 111.07 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 18.9 m -61.7 -11.75 13.35 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.618 0.645 . . . . 0.0 112.29 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -61.08 -22.89 65.04 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.718 0.807 . . . . 0.0 109.798 177.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -98.11 130.58 44.89 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 126.594 1.958 . . . . 0.0 109.743 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -51.65 -47.76 63.62 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.844 1.258 . . . . 0.0 112.637 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.59 -35.85 80.85 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.104 -0.998 . . . . 0.0 113.438 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 17.9 mt -89.89 -14.94 33.17 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -58.68 112.72 1.72 Allowed 'General case' 0 C--O 1.236 0.345 0 C-N-CA 128.204 2.601 . . . . 0.0 111.731 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.424 ' HE2' ' O ' ' A' ' 208' ' ' CYS . 39.2 mmtt -79.3 159.51 27.19 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -88.62 -64.57 1.13 Allowed 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -142.07 59.32 1.47 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.428 0.632 . . . . 0.0 111.034 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 30.5 t70 . . . . . 0 C--O 1.246 0.889 0 C-N-CA 125.175 1.39 . . . . 0.0 109.58 178.199 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.175 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.46 120.98 13.83 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 54.6 p -160.47 134.78 7.33 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 50.71 22.99 1.23 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.716 1.206 . . . . 0.0 113.504 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.7 m -48.27 -39.81 22.72 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 129.374 3.07 . . . . 0.0 114.202 -178.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -66.69 -44.99 80.25 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 123.788 0.835 . . . . 0.0 109.169 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.49 -43.9 96.5 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.1 -34.66 78.56 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.776 1.171 . . . . 0.0 110.708 177.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.5 -42.61 95.72 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 32.5 tp -69.85 -36.89 75.91 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.44 1.096 . . . . 0.0 110.507 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 22.4 mt -61.41 -54.89 37.67 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 119.005 0.821 . . . . 0.0 109.083 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 56.1 m -65.38 -40.26 93.26 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 121.453 -0.779 . . . . 0.0 111.257 -179.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -45.37 93.89 Favored 'General case' 0 C--O 1.222 -0.382 0 O-C-N 121.207 -0.933 . . . . 0.0 109.169 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 42.2 m -52.28 -48.9 65.05 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.171 0.989 . . . . 0.0 109.741 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -58.3 -48.9 79.02 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.886 0.474 . . . . 0.0 110.863 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -67.82 -56.33 9.57 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -177.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.414 ' HA ' ' HE3' ' A' ' 107' ' ' LYS . 2.8 mm-40 -55.83 -44.25 77.75 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.806 1.642 . . . . 0.0 109.678 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.34 -52.99 49.29 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-O 118.001 -1.444 . . . . 0.0 110.212 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 43.0 t -55.85 -43.36 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-N 119.893 1.846 . . . . 0.0 110.91 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.414 ' HE3' ' HA ' ' A' ' 104' ' ' GLN . 6.6 ptpt -66.01 -33.81 76.65 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 119.38 -0.928 . . . . 0.0 111.165 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 65.5 m -72.9 -39.24 66.51 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 22.7 mt -61.06 -55.76 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -61.29 -35.42 77.29 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 118.292 -0.861 . . . . 0.0 112.67 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -62.21 -33.85 75.34 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.813 0.733 . . . . 0.0 111.887 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.456 ' HA ' ' HE2' ' A' ' 112' ' ' LYS . 0.6 OUTLIER -87.62 -38.27 16.06 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 117.87 -1.062 . . . . 0.0 110.333 179.047 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 29.5 mt -65.74 -25.17 67.16 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.904 1.229 . . . . 0.0 110.338 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -51.47 -30.08 18.54 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.119 1.768 . . . . 0.0 111.558 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -65.51 -66.75 0.51 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.426 1.49 . . . . 0.0 113.083 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.6 mmt180 -144.56 173.36 11.87 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 124.456 1.102 . . . . 0.0 110.743 -178.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 78.6 m -86.07 163.34 17.97 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 48.3 pt -118.92 154.5 21.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -178.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -151.87 144.49 24.24 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.909 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -140.74 122.34 15.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.425 178.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -81.6 100.07 9.2 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.69 80.03 6.67 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 104.389 -2.449 . . . . 0.0 104.389 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 65.97 -109.02 2.65 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -81.32 -36.36 29.84 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -99.84 146.0 27.11 Favored 'General case' 0 CA--C 1.512 -0.486 0 O-C-N 121.635 -0.666 . . . . 0.0 110.388 -178.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.5 mp -110.21 153.4 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -131.9 119.3 20.98 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -121.15 120.49 35.4 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.315 1.046 . . . . 0.0 111.676 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -111.27 140.66 45.66 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.003 1.321 . . . . 0.0 111.065 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 50.3 m -123.12 152.77 64.06 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.497 1.119 . . . . 0.0 111.371 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -63.73 86.28 0.14 Allowed 'Trans proline' 0 C--N 1.35 0.649 1 C-N-CA 125.548 4.165 . . . . 0.0 115.7 -178.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 72.51 34.96 59.84 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 118.751 -1.027 . . . . 0.0 112.278 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 4.4 mp -118.59 -71.62 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.344 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -168.81 172.65 7.66 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.523 1.529 . . . . 0.0 110.314 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -137.21 119.75 15.99 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 31.8 m -139.22 163.54 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 124.528 1.131 . . . . 0.0 111.059 -178.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -121.05 124.43 44.8 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.968 1.307 . . . . 0.0 107.92 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -138.65 162.28 35.03 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.961 0.904 . . . . 0.0 111.469 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.54 ' H ' ' CD1' ' A' ' 156' ' ' LEU . 60.1 t60 -92.08 160.91 14.99 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 176.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 138.14 -160.19 25.34 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -148.98 162.21 40.36 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 125.418 1.487 . . . . 0.0 110.182 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 p -131.97 146.95 32.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 C-N-CA 125.277 1.431 . . . . 0.0 107.487 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -106.02 121.82 44.89 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 177.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 35.6 p -54.07 -13.34 0.78 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 127.487 2.315 . . . . 0.0 115.559 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt -78.98 -24.9 43.48 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -178.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 26.8 p -128.77 -33.64 2.02 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 123.936 0.895 . . . . 0.0 111.971 -178.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.86 31.16 36.49 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.632 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 -121.59 146.24 47.17 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 21.9 mm -65.23 152.41 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 26.6 m -58.45 -45.84 89.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 122.877 0.471 . . . . 0.0 109.759 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -164.32 108.58 0.96 Allowed 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -56.12 126.55 26.53 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.565 0.62 . . . . 0.0 110.394 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.96 104.84 5.71 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 126.488 1.915 . . . . 0.0 108.058 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -81.96 -23.88 35.83 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.026 0.931 . . . . 0.0 113.497 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 66.5 m -67.81 -36.53 80.57 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.469 -0.769 . . . . 0.0 112.63 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.54 ' CD1' ' H ' ' A' ' 139' ' ' HIS . 44.9 mt -72.66 132.79 44.16 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.599 1.159 . . . . 0.0 108.933 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 25.7 m -128.95 119.84 50.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 123.149 0.579 . . . . 0.0 109.489 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -149.45 155.36 40.28 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.84 1.656 . . . . 0.0 108.084 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 33.1 ttt85 -148.49 102.14 3.3 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 81.6 mt -79.37 -30.8 42.71 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 119.387 0.994 . . . . 0.0 108.495 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 169.45 156.35 10.74 Favored Glycine 0 N--CA 1.439 -1.129 0 CA-C-O 121.899 0.721 . . . . 0.0 111.345 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.62 109.04 44.05 Favored Pre-proline 0 N--CA 1.444 -0.76 0 C-N-CA 124.481 1.112 . . . . 0.0 108.674 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -77.22 -168.36 0.58 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.438 2.759 . . . . 0.0 109.038 178.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -126.5 151.09 48.28 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 124.724 1.21 . . . . 0.0 108.047 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -74.81 -28.69 60.81 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.973 0.892 . . . . 0.0 109.445 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -89.32 65.24 7.15 Favored 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 126.148 1.779 . . . . 0.0 106.297 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.2 p -45.22 -32.79 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 123.911 0.884 . . . . 0.0 111.973 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -65.48 -26.34 67.89 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.996 2.119 . . . . 0.0 112.875 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.68 -25.83 49.79 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.742 0.817 . . . . 0.0 110.337 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -75.96 177.74 6.79 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.725 0.81 . . . . 0.0 109.267 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -131.52 155.74 46.91 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -139.73 160.15 40.54 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.993 0.917 . . . . 0.0 109.49 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -117.24 153.57 32.67 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 18.5 tp -119.84 98.34 6.05 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -106.05 172.53 6.76 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -147.21 162.76 38.24 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.934 0.873 . . . . 0.0 109.021 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -139.54 178.17 7.41 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 125.682 1.593 . . . . 0.0 109.44 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -68.38 2.2 2.47 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.081 1.353 . . . . 0.0 111.928 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 90.8 t -109.66 -38.96 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 126.14 1.776 . . . . 0.0 110.177 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 166.37 -175.81 41.73 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -88.33 164.86 15.35 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 117.962 0.881 . . . . 0.0 109.327 178.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -158.92 163.7 36.31 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.704 0.802 . . . . 0.0 109.965 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 95.2 mt -107.21 131.8 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 22.6 t -100.69 137.34 39.22 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.405 0.682 . . . . 0.0 109.312 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -131.22 116.05 17.14 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.513 1.125 . . . . 0.0 108.082 178.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -92.84 120.75 42.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 178.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.1 mt -107.66 106.7 21.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -108.92 -152.68 15.28 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 125.977 1.751 . . . . 0.0 109.199 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 80.42 22.8 0.41 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.956 1.702 . . . . 0.0 112.634 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -91.89 -154.05 30.41 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.24 166.15 10.85 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 179.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 36.7 mm -88.7 140.74 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.235 1.414 . . . . 0.0 108.982 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.2 m -88.94 115.14 26.28 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 127.816 2.446 . . . . 0.0 106.612 178.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -57.91 -16.96 13.83 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.211 1.404 . . . . 0.0 113.586 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 61.8 t -53.32 -56.06 9.98 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 CA-C-N 118.913 0.779 . . . . 0.0 110.663 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 1.9 t -124.66 -23.12 4.43 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -177.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.87 35.35 4.03 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 108.395 -1.882 . . . . 0.0 108.395 -178.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -111.0 147.59 34.4 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 119.054 1.427 . . . . 0.0 113.563 -178.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -68.34 144.51 54.76 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.992 0.917 . . . . 0.0 112.657 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -70.1 26.77 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.499 1 C-N-CA 131.862 4.065 . . . . 0.0 111.471 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 7.0 ptm -74.08 176.3 6.66 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.767 1.167 . . . . 0.0 112.814 -177.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.3 p -141.18 148.33 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 125.1 1.36 . . . . 0.0 107.981 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -110.59 109.32 19.57 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.484 1.913 . . . . 0.0 106.477 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 9.2 mm -99.29 150.06 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 O-C-N 121.055 -1.028 . . . . 0.0 111.191 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -125.67 106.52 9.78 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.206 2.202 . . . . 0.0 110.077 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -87.46 110.25 20.17 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 177.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 31.3 m -125.17 168.42 17.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 C-N-CA 125.186 1.394 . . . . 0.0 109.041 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 51.6 t -89.07 146.5 24.79 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 104.432 -2.432 . . . . 0.0 104.432 177.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -91.19 18.74 50.43 Favored Glycine 0 C--O 1.226 -0.401 0 CA-C-O 117.023 -1.987 . . . . 0.0 116.688 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 58.5 48.62 83.25 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-N 119.433 1.617 . . . . 0.0 109.075 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 71.5 m -149.13 166.52 28.53 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.52 1.528 . . . . 0.0 108.57 -178.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -123.87 -3.28 8.18 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 8.7 t -150.74 148.54 28.67 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 118.816 0.734 . . . . 0.0 109.695 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 125.79 175.43 14.19 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.263 0.935 . . . . 0.0 114.286 178.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -81.23 -115.83 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 124.536 3.491 . . . . 0.0 112.033 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 14.7 p -147.34 145.97 29.51 Favored 'General case' 0 C--O 1.239 0.52 0 O-C-N 120.482 -1.387 . . . . 0.0 112.369 -177.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 81.3 p -149.91 166.14 30.47 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.163 0.985 . . . . 0.0 110.99 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.9 mp -104.07 154.36 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 126.072 1.749 . . . . 0.0 108.118 178.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 43.4 mm-40 -103.11 -49.98 3.61 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 125.202 1.401 . . . . 0.0 110.66 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 59.8 p-90 -158.04 155.88 30.1 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.572 1.149 . . . . 0.0 109.109 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 60.9 t -153.97 132.64 2.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 125.809 1.644 . . . . 0.0 107.411 179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.3 167.34 17.98 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.851 0.86 . . . . 0.0 111.342 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -75.96 132.99 40.56 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 4.6 t -112.42 -31.36 6.84 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.463 1.505 . . . . 0.0 112.705 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -132.49 -175.75 3.86 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 124.249 1.02 . . . . 0.0 108.357 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 55.1 mt -47.26 -47.87 9.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 123.567 0.747 . . . . 0.0 112.631 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -132.88 19.34 4.16 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.229 1.012 . . . . 0.0 111.2 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 18.4 t -116.75 145.33 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.813 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -177.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -125.02 164.53 19.96 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -136.18 148.19 48.02 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.48 146.53 30.58 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.387 1.475 . . . . 0.0 108.942 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -129.63 120.12 24.69 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 2.4 m -115.98 143.51 25.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.8 p -119.91 127.51 52.76 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 127.175 2.19 . . . . 0.0 111.911 -176.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 15.1 pt -134.04 146.64 60.72 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 177.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -71.45 -36.42 6.84 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 123.151 2.567 . . . . 0.0 111.323 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -59.02 -28.23 66.2 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.81 1.244 . . . . 0.0 114.304 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 3.1 tp -60.83 -32.49 71.88 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 121.45 -0.781 . . . . 0.0 111.367 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 7.3 m -59.56 -13.64 10.05 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.587 1.155 . . . . 0.0 113.448 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.88 -35.59 75.13 Favored 'General case' 0 C--O 1.227 -0.095 0 CA-C-N 119.58 1.082 . . . . 0.0 110.307 179.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.18 125.63 29.7 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -48.27 -42.29 30.26 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.128 1.371 . . . . 0.0 112.459 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.57 -32.27 73.76 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.415 -0.803 . . . . 0.0 112.496 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 25.4 mt -96.14 -7.63 35.38 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.835 1.654 . . . . 0.0 113.298 -178.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -67.52 108.53 2.88 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.094 2.158 . . . . 0.0 110.172 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 9.9 mmmt -71.45 159.43 34.52 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.945 0.793 . . . . 0.0 110.246 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -97.34 -76.16 0.52 Allowed 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.866 0.866 . . . . 0.0 109.059 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -144.89 39.18 1.22 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.632 1.173 . . . . 0.0 110.243 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.011 0 CA-C-O 116.779 -1.581 . . . . 0.0 110.607 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.059 0 N-CA-C 106.805 -2.518 . . . . 0.0 106.805 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.96 -173.76 1.67 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 p -66.34 93.3 0.22 Allowed 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.642 1.177 . . . . 0.0 108.675 179.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -62.54 -49.7 74.26 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.162 1.385 . . . . 0.0 110.87 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.3 m -52.57 -47.9 66.55 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.346 1.059 . . . . 0.0 111.775 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -57.11 -48.78 77.79 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 123.973 0.909 . . . . 0.0 110.553 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.65 -57.43 11.98 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 118.107 -0.949 . . . . 0.0 108.648 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.28 -40.76 68.14 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 119.05 0.841 . . . . 0.0 112.134 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.52 -38.32 80.69 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.212 0.46 . . . . 0.0 110.221 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 23.1 tp -73.94 -34.96 64.51 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.377 1.071 . . . . 0.0 109.383 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 28.6 mt -60.16 -55.18 37.03 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.23 0.923 . . . . 0.0 110.049 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 96.3 m -67.09 -40.34 86.95 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.295 -0.878 . . . . 0.0 111.018 -178.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.2 ttpt -59.38 -43.94 92.85 Favored 'General case' 0 C--O 1.226 -0.159 0 O-C-N 121.081 -1.012 . . . . 0.0 109.984 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 55.3 m -54.02 -43.92 70.53 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 124.352 1.061 . . . . 0.0 110.347 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -57.02 -50.33 73.06 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.522 0.601 . . . . 0.0 109.924 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.47 -54.69 21.13 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.565 0.697 . . . . 0.0 111.735 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -55.12 -44.4 74.96 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.224 1.01 . . . . 0.0 110.914 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.48 -51.87 48.39 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-O 117.797 -1.557 . . . . 0.0 109.366 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 41.0 t -54.86 -45.16 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 119.966 1.883 . . . . 0.0 109.683 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.0 pttm -61.83 -34.85 76.69 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 119.804 -0.759 . . . . 0.0 111.183 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 39.0 m -71.28 -44.17 65.74 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.579 0.752 . . . . 0.0 109.558 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 22.3 mt -57.49 -55.53 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -63.27 -29.24 70.61 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 118.782 -0.628 . . . . 0.0 112.348 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -70.18 -48.95 55.03 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.354 0.979 . . . . 0.0 111.898 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.428 ' HA ' ' HE2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -75.71 -43.91 44.71 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 123.562 0.745 . . . . 0.0 112.129 -178.037 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 14.2 mt -65.27 -28.25 69.21 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 118.193 -0.908 . . . . 0.0 112.671 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -51.91 -28.8 17.55 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -48.88 -69.86 0.11 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -146.48 179.01 7.84 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 126.152 1.781 . . . . 0.0 108.454 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 59.8 m -87.14 166.67 14.8 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 35.4 pt -120.39 155.95 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.446 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -148.22 139.79 23.66 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 123.61 0.764 . . . . 0.0 110.383 -178.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.451 ' CZ ' ' HA ' ' A' ' 220' ' ' TRP . 7.1 t80 -137.07 120.88 17.46 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.58 1.152 . . . . 0.0 110.304 178.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -82.97 101.94 11.4 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.513 1.525 . . . . 0.0 109.509 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -87.86 81.15 7.63 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 127.956 2.502 . . . . 0.0 106.794 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.52 -90.49 0.38 Allowed Glycine 0 CA--C 1.534 1.24 0 O-C-N 121.301 -0.874 . . . . 0.0 111.926 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -107.68 -28.57 9.64 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 127.053 2.141 . . . . 0.0 112.844 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -99.55 157.65 16.3 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.1 mp -126.88 128.4 70.78 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -101.43 119.03 38.14 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -116.21 123.24 47.27 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -115.92 132.48 56.63 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.556 0.743 . . . . 0.0 110.302 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 66.7 m -112.27 148.18 38.57 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 124.247 1.019 . . . . 0.0 109.145 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.78 85.96 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 124.38 3.387 . . . . 0.0 115.151 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.21 30.76 40.57 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-O 117.944 -1.476 . . . . 0.0 112.981 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 3.9 mp -117.15 -73.62 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.455 0 CA-C-N 119.191 1.495 . . . . 0.0 110.247 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -163.39 166.25 23.09 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.03 2.132 . . . . 0.0 108.583 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -135.6 123.6 22.79 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.568 1.547 . . . . 0.0 107.568 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 17.8 m -144.47 164.04 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 126.8 2.04 . . . . 0.0 111.103 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -117.84 127.19 53.63 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 177.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -136.53 162.41 33.19 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 125.39 1.476 . . . . 0.0 111.224 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.47 ' H ' ' CD1' ' A' ' 156' ' ' LEU . 80.9 t60 -92.63 160.56 14.95 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 177.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 135.44 -159.13 24.01 Favored Glycine 0 C--N 1.34 0.751 0 CA-C-N 119.185 0.902 . . . . 0.0 111.722 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.33 167.25 30.82 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 128.37 2.668 . . . . 0.0 105.527 177.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.6 p -114.41 152.33 16.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -100.2 103.33 14.78 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 178.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 39.6 p -51.13 -24.19 3.88 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 115.825 1.787 . . . . 0.0 115.825 -178.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 38.9 mmtt -66.55 -27.44 67.75 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.976 0.91 . . . . 0.0 113.171 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.405 ' HG1' ' HG2' ' A' ' 148' ' ' GLU . 7.9 p -126.42 -40.93 1.92 Allowed 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.283 1.433 . . . . 0.0 112.524 -178.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 96.41 29.69 8.19 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 125.544 1.545 . . . . 0.0 110.609 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.405 ' HG2' ' HG1' ' A' ' 146' ' ' THR . 0.9 OUTLIER -102.66 140.52 36.82 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.393 1.077 . . . . 0.0 109.909 -179.464 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 14.5 mm -81.04 134.28 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 20.4 m -65.57 -10.83 11.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 -178.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -138.51 105.72 5.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 119.174 0.897 . . . . 0.0 111.063 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -82.7 65.9 8.05 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.325 0.512 . . . . 0.0 110.655 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 27.1 53.58 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 129.017 2.927 . . . . 0.0 114.788 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -60.55 -35.03 75.03 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.363 -1.29 . . . . 0.0 111.732 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 5.8 m -125.44 -21.01 4.62 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 115.478 1.658 . . . . 0.0 115.478 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.47 ' CD1' ' H ' ' A' ' 139' ' ' HIS . 9.2 mt -82.53 153.44 25.54 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 120.497 1.499 . . . . 0.0 109.382 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 44.7 t -147.25 119.38 1.72 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 124.336 1.054 . . . . 0.0 109.494 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -147.09 165.84 28.7 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.221 1.809 . . . . 0.0 109.626 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -149.04 112.0 4.87 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 126.268 1.827 . . . . 0.0 108.471 178.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 82.6 mt -99.07 -26.89 14.07 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 160.96 161.01 11.13 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -127.34 108.53 21.26 Favored Pre-proline 0 C--O 1.239 0.509 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -72.32 -179.62 4.18 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 124.447 3.432 . . . . 0.0 109.825 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -122.39 159.76 26.85 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.063 0.545 . . . . 0.0 110.851 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.62 -54.0 11.85 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -68.72 64.6 0.12 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 126.751 2.02 . . . . 0.0 112.71 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 5.6 p -47.02 -34.34 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 C-N-CA 125.759 1.624 . . . . 0.0 111.846 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -63.84 -32.98 74.68 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.022 1.329 . . . . 0.0 112.026 -178.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -80.69 -14.21 58.34 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 122.748 0.419 . . . . 0.0 110.096 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 44.4 mtp180 -83.3 177.97 8.28 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 121.071 -1.018 . . . . 0.0 109.509 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -132.85 150.36 52.17 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.381 1.072 . . . . 0.0 108.201 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -138.22 161.2 37.47 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.193 1.797 . . . . 0.0 107.688 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -126.87 149.99 49.48 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 122.889 0.476 . . . . 0.0 110.606 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 32.1 tp -107.47 111.01 23.1 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.876 1.271 . . . . 0.0 108.659 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -118.47 -179.75 3.88 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.944 1.298 . . . . 0.0 110.45 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -137.84 154.4 49.51 Favored 'General case' 0 N--CA 1.458 -0.037 0 C-N-CA 124.875 1.27 . . . . 0.0 109.467 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -140.45 -178.16 5.37 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 126.678 1.991 . . . . 0.0 107.421 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -66.11 -5.71 10.83 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.868 1.267 . . . . 0.0 113.417 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 56.0 t -107.6 -24.49 4.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 126.794 2.038 . . . . 0.0 113.656 -178.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 144.24 -173.02 25.12 Favored Glycine 0 N--CA 1.444 -0.774 0 O-C-N 121.841 -0.537 . . . . 0.0 112.052 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -79.06 158.42 27.86 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 121.716 0.769 . . . . 0.0 109.297 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -155.74 162.85 40.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.331 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 96.7 mt -104.23 136.42 37.62 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.073 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 46.2 t -102.22 129.34 48.59 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 125.414 1.485 . . . . 0.0 108.374 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -121.33 113.98 20.68 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.88 119.0 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 104.512 -2.403 . . . . 0.0 104.512 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 9.0 mt -109.2 105.63 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 177.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -101.32 -153.43 26.03 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 23.1 t 67.86 26.65 7.55 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.993 0.917 . . . . 0.0 111.932 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -82.2 -60.32 2.16 Favored Glycine 0 CA--C 1.525 0.691 0 O-C-N 120.51 -1.369 . . . . 0.0 110.543 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 153.83 -174.14 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.608 1 C-N-CA 131.893 4.077 . . . . 0.0 106.384 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 51.8 mm -105.9 143.3 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 129.561 3.144 . . . . 0.0 112.205 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.2 m -93.56 118.15 30.98 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 128.345 2.658 . . . . 0.0 107.207 177.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.5 -30.89 54.77 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.818 1.247 . . . . 0.0 113.331 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 44.1 t -45.32 -56.28 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 125.019 1.328 . . . . 0.0 113.031 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 6.6 t -123.46 -23.02 4.89 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 124.701 1.201 . . . . 0.0 113.85 -177.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 94.97 34.66 6.1 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 107.263 -2.335 . . . . 0.0 107.263 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -103.09 150.38 23.67 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 117.998 0.899 . . . . 0.0 110.922 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -74.03 139.65 44.88 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 122.544 0.337 . . . . 0.0 111.697 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -67.47 29.0 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.559 1 C-N-CA 135.799 5.64 . . . . 0.0 110.208 177.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 1.9 ptm -74.46 -176.81 2.85 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.17 1.388 . . . . 0.0 111.955 -177.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.2 p -153.6 146.69 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 O-C-N 121.087 -1.008 . . . . 0.0 110.753 -178.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -104.32 104.77 14.71 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.595 1.558 . . . . 0.0 109.522 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 8.7 mm -93.8 123.1 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -105.15 99.61 9.22 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 127.312 2.245 . . . . 0.0 109.333 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -82.17 110.72 17.63 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.76 1.224 . . . . 0.0 108.849 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 19.0 m -124.72 164.73 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 125.456 1.502 . . . . 0.0 107.46 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 46.3 t -83.91 146.09 28.23 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 119.909 -1.745 . . . . 0.0 107.562 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -86.75 3.76 86.77 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-O 118.774 -1.015 . . . . 0.0 113.108 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 70.23 -126.05 15.75 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 107.905 -2.078 . . . . 0.0 107.905 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 12.6 m -73.06 -163.51 0.14 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.705 0.765 . . . . 0.0 109.981 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 2.6 m120 58.54 57.82 3.63 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.056 1.343 . . . . 0.0 109.814 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 1.3 p -64.68 93.85 0.11 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.345 0.658 . . . . 0.0 110.886 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -118.79 -162.53 12.14 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 127.376 2.417 . . . . 0.0 108.206 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -68.87 -91.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 124.073 3.182 . . . . 0.0 111.598 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 5.0 p -151.74 146.5 25.8 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.654 1.182 . . . . 0.0 109.086 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 17.0 p -149.89 172.23 15.5 Favored 'General case' 0 C--O 1.225 -0.201 0 O-C-N 121.757 -0.589 . . . . 0.0 112.246 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 5.8 mt -122.14 146.06 27.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 126.863 2.065 . . . . 0.0 106.555 177.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -95.35 -47.67 6.2 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.343 1.457 . . . . 0.0 110.525 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . 0.451 ' HA ' ' CZ ' ' A' ' 120' ' ' TYR . 56.2 p-90 -162.88 158.51 22.62 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 125.459 1.504 . . . . 0.0 108.948 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 49.7 t -152.94 135.02 5.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 126.189 1.796 . . . . 0.0 106.366 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.79 168.76 17.5 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.006 1.322 . . . . 0.0 110.347 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -75.61 141.67 42.82 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 124.104 0.962 . . . . 0.0 108.638 178.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 10.2 t -118.83 -31.98 4.64 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.955 1.302 . . . . 0.0 112.3 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 4.8 mttm -135.22 -176.59 4.31 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 120.806 -1.184 . . . . 0.0 109.067 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 36.5 mt -48.15 -47.22 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 123.864 0.866 . . . . 0.0 112.29 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -130.62 21.47 5.09 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.265 1.026 . . . . 0.0 111.894 -178.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 16.6 t -122.62 143.0 36.95 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.584 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -178.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -121.68 162.52 20.59 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.57 1.548 . . . . 0.0 107.131 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -131.46 138.28 48.95 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 125.416 1.486 . . . . 0.0 107.209 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -135.78 132.39 36.69 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.569 1.148 . . . . 0.0 109.522 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -109.08 108.0 18.53 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 48.3 t -100.73 138.23 25.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.3 p -120.94 130.29 53.8 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 126.286 1.835 . . . . 0.0 112.427 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -138.67 143.34 37.5 Favored Pre-proline 0 N--CA 1.467 0.394 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 176.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -73.3 -33.32 7.27 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.948 2.432 . . . . 0.0 112.963 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -64.25 -17.77 63.92 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.56 0.744 . . . . 0.0 112.811 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 5.9 tp -68.16 -29.51 68.42 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 121.174 -0.954 . . . . 0.0 110.044 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 14.4 m -62.99 -9.98 12.05 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.664 0.786 . . . . 0.0 112.961 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -60.89 -31.24 70.73 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.196 0.907 . . . . 0.0 109.721 178.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -88.64 127.22 35.56 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 124.196 0.998 . . . . 0.0 109.331 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -47.0 -49.33 21.04 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 126.047 1.739 . . . . 0.0 113.475 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 41.8 mt -65.05 -28.81 69.73 Favored 'General case' 0 C--O 1.231 0.115 0 O-C-N 121.332 -0.855 . . . . 0.0 112.983 -178.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 11.5 mt -95.75 -17.52 21.16 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.101 0.96 . . . . 0.0 112.7 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -62.31 135.53 57.5 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 129.321 3.048 . . . . 0.0 109.445 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -101.69 155.75 17.92 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 124.154 0.982 . . . . 0.0 112.12 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -70.68 -60.46 2.24 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 123.781 0.675 . . . . 0.0 109.337 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 50.02 29.67 3.62 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.634 1.574 . . . . 0.0 111.738 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 21.7 t70 . . . . . 0 C--O 1.261 1.695 0 C-N-CA 129.382 3.073 . . . . 0.0 106.464 -179.163 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.99 0 N-CA-C 108.2 -1.96 . . . . 0.0 108.2 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.54 -59.32 5.41 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 119.081 1.441 . . . . 0.0 109.99 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.1 t -167.33 166.46 14.6 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 126.209 1.804 . . . . 0.0 106.29 178.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 61.4 m-80 54.22 7.5 0.14 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.172 2.189 . . . . 0.0 114.529 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.8 m -56.1 -30.51 62.17 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.993 1.317 . . . . 0.0 113.64 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -70.7 -24.7 62.71 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.648 -0.658 . . . . 0.0 111.085 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.87 -47.55 65.63 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 105.585 -2.005 . . . . 0.0 105.585 177.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -32.92 74.51 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 118.887 0.767 . . . . 0.0 110.262 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.07 -50.97 69.82 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 57.2 tp -63.79 -39.86 95.26 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.569 1.148 . . . . 0.0 110.678 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.8 mt -60.1 -54.28 47.76 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 119.277 0.944 . . . . 0.0 108.65 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.3 m -58.31 -49.32 77.58 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.121 0.486 . . . . 0.0 110.152 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -60.88 -40.74 94.16 Favored 'General case' 0 C--O 1.232 0.164 0 O-C-N 121.206 -0.934 . . . . 0.0 111.776 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 54.4 m -52.3 -48.74 65.21 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.574 0.75 . . . . 0.0 110.842 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -58.89 -47.6 84.38 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 117.966 0.348 . . . . 0.0 110.659 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.45 -55.81 24.11 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 122.504 1.145 . . . . 0.0 113.876 -177.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -64.34 -38.44 91.05 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-N 113.645 -1.616 . . . . 0.0 111.521 -177.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.25 -52.78 41.15 Favored Glycine 0 N--CA 1.44 -1.045 0 N-CA-C 107.95 -2.06 . . . . 0.0 107.95 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 56.0 t -56.92 -47.92 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 119.306 1.553 . . . . 0.0 110.541 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.6 pttm -59.1 -35.52 73.56 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.847 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 52.5 m -79.29 -36.36 39.85 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.308 1.043 . . . . 0.0 111.067 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 21.8 mt -57.85 -54.27 34.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -60.84 -29.39 69.47 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.481 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -68.24 -41.05 81.74 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 120.144 1.338 . . . . 0.0 111.593 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.435 ' HZ2' ' HA ' ' A' ' 215' ' ' PRO . 0.0 OUTLIER -79.07 -37.42 38.9 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 117.991 0.36 . . . . 0.0 111.75 -179.371 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 17.2 mt -74.17 -25.83 59.95 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 118.685 -0.674 . . . . 0.0 111.903 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -54.82 -20.12 7.95 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.454 0.57 . . . . 0.0 112.167 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -64.62 -72.77 0.14 Allowed 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.694 1.197 . . . . 0.0 109.036 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -147.42 -175.55 4.89 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.386 1.474 . . . . 0.0 111.522 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 62.6 m -87.71 175.4 7.89 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.604 -0.685 . . . . 0.0 109.439 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 27.4 pt -132.73 161.22 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 126.324 1.85 . . . . 0.0 108.774 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -154.74 142.73 20.15 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 122.759 0.423 . . . . 0.0 110.401 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -134.37 123.74 24.61 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.478 0.711 . . . . 0.0 110.499 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -86.66 98.7 11.26 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.19 81.06 5.56 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 128.407 2.683 . . . . 0.0 107.336 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 58.47 -112.93 4.39 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 124.388 0.994 . . . . 0.0 111.054 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -77.28 -12.8 59.99 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.852 1.261 . . . . 0.0 113.375 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -115.74 158.24 23.12 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 124.414 1.086 . . . . 0.0 112.642 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.532 HD13 ' H ' ' A' ' 140' ' ' GLY . 4.8 mp -133.38 126.36 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 N-CA-C 103.577 -2.749 . . . . 0.0 103.577 177.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -110.54 123.36 49.79 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -117.96 129.63 55.72 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.714 0.806 . . . . 0.0 110.008 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -119.52 133.2 55.79 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 123.722 0.809 . . . . 0.0 110.923 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 16.3 m -112.41 156.1 42.7 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 123.737 0.815 . . . . 0.0 111.075 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -63.77 78.46 0.15 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 125.084 3.856 . . . . 0.0 114.203 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 67.51 60.19 6.06 Favored Glycine 0 CA--C 1.525 0.677 0 O-C-N 120.971 -1.081 . . . . 0.0 111.688 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 3.5 mp -130.86 -71.44 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -165.73 168.95 15.65 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 125.45 1.5 . . . . 0.0 109.449 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -130.81 121.95 26.25 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 176.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.8 m -144.76 164.94 12.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 118.916 0.78 . . . . 0.0 111.083 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -120.95 132.2 54.79 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.726 1.211 . . . . 0.0 108.727 178.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -138.51 162.74 33.77 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.122 1.369 . . . . 0.0 112.437 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 55.5 t60 -103.15 108.8 20.14 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.532 ' H ' HD13 ' A' ' 126' ' ' ILE . . . -176.12 -160.21 23.14 Favored Glycine 0 C--N 1.331 0.301 0 O-C-N 121.603 -0.686 . . . . 0.0 112.107 -179.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -141.99 157.48 44.89 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.764 1.225 . . . . 0.0 108.072 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.6 p -121.15 152.35 24.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -104.89 120.25 40.98 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 119.096 0.862 . . . . 0.0 108.982 178.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.8 p -58.06 -8.61 1.1 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.032 1.733 . . . . 0.0 114.065 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 30.7 mmtt -88.21 -29.59 20.36 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.271 1.029 . . . . 0.0 112.936 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.7 p -117.98 -48.29 2.56 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.088 0.555 . . . . 0.0 110.603 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 95.38 33.12 6.64 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 123.948 0.785 . . . . 0.0 111.783 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -125.1 161.18 27.37 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 126.879 2.072 . . . . 0.0 107.46 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 20.8 mm -85.31 142.75 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 124.234 1.013 . . . . 0.0 109.32 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 30.5 m -57.91 -38.72 67.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 117.857 -1.068 . . . . 0.0 113.755 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 38.8 p-10 159.7 177.79 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 130.149 3.38 . . . . 0.0 109.561 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 49.0 ttt180 81.56 70.05 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 128.993 2.917 . . . . 0.0 111.263 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -101.23 -82.12 0.47 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.812 2.445 . . . . 0.0 112.732 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -51.5 -34.41 35.81 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 117.857 2.54 . . . . 0.0 117.857 -178.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.51 -19.46 57.03 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -177.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 75.4 mt -113.76 91.53 3.67 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 15.4 m -74.62 108.34 6.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 C-N-CA 124.604 1.162 . . . . 0.0 111.613 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -141.27 151.48 43.71 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 122.795 1.283 . . . . 0.0 108.436 178.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.439 ' N ' HH21 ' A' ' 200' ' ' ARG . 0.0 OUTLIER -149.38 110.35 4.34 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 179.005 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mp -93.92 -27.53 16.32 Favored 'General case' 0 C--O 1.219 -0.55 0 O-C-N 125.794 1.934 . . . . 0.0 107.315 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 163.63 163.23 15.97 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 5.4 mtpt -127.66 110.13 20.68 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -78.04 -173.08 1.68 Allowed 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 124.954 3.769 . . . . 0.0 110.4 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -129.32 149.18 51.22 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 125.277 1.431 . . . . 0.0 109.58 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.74 -41.4 71.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.668 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 31.4 m-20 -71.7 65.02 0.48 Allowed 'General case' 0 C--O 1.236 0.383 0 C-N-CA 126.383 1.873 . . . . 0.0 110.977 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.4 p -52.3 -32.0 15.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 124.904 1.282 . . . . 0.0 110.663 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -63.93 -22.39 66.9 Favored 'General case' 0 N--CA 1.461 0.105 0 C-N-CA 124.695 1.198 . . . . 0.0 112.544 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -97.85 -18.27 18.82 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.522 1.129 . . . . 0.0 110.877 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.4 mtp-105 -81.02 142.21 33.61 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -103.73 148.98 25.42 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 178.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -134.25 -176.47 4.21 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.48 1.512 . . . . 0.0 109.587 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -135.41 153.46 51.79 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.329 1.051 . . . . 0.0 109.331 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 22.9 tp -115.05 98.97 7.11 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.697 1.599 . . . . 0.0 106.861 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -105.33 -179.8 4.05 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 181' ' ' TYR . 2.5 p90 -145.65 163.01 36.2 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -140.75 -178.44 5.54 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.406 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -62.07 -14.41 36.01 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.528 1.131 . . . . 0.0 111.107 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 57.9 t -98.04 -39.12 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 125.495 1.518 . . . . 0.0 111.395 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 161.3 -173.83 37.77 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 123.431 0.539 . . . . 0.0 112.152 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 176' ' ' TYR . 25.9 m-85 -77.72 160.34 28.5 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 118.387 1.094 . . . . 0.0 110.72 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -158.84 168.5 26.64 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.325 1.45 . . . . 0.0 110.813 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 89.1 mt -108.89 141.46 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 15.6 t -111.41 137.32 49.35 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.394 1.077 . . . . 0.0 109.585 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -129.13 111.53 13.04 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.482 1.513 . . . . 0.0 108.381 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.2 mp -94.93 116.7 36.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 103.928 -2.619 . . . . 0.0 103.928 178.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 12.4 mt -105.1 106.95 21.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -103.66 -152.22 22.85 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 75.19 33.39 0.71 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.218 1.007 . . . . 0.0 110.127 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -113.87 159.18 13.83 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 107.615 -2.194 . . . . 0.0 107.615 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -66.72 167.82 10.55 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.354 1.062 . . . . 0.0 109.892 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.0 mm -87.13 142.33 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 C-N-CA 124.282 1.033 . . . . 0.0 108.795 178.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.1 m -88.81 110.76 21.31 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 104.204 -2.517 . . . . 0.0 104.204 177.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -47.68 -40.02 18.92 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 125.503 1.521 . . . . 0.0 111.637 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 33.4 t -38.45 -56.62 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.228 -0.055 0 C-N-CA 128.024 2.53 . . . . 0.0 113.366 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 10.8 t -124.42 -28.86 3.58 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 105.23 35.31 3.17 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -107.35 149.95 27.27 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 118.278 1.039 . . . . 0.0 110.23 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -77.48 152.25 34.26 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 119.02 0.827 . . . . 0.0 111.176 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.439 HH21 ' N ' ' A' ' 159' ' ' ARG . 30.7 mmm-85 -71.1 27.78 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 131.471 3.908 . . . . 0.0 110.795 177.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 8.1 ptm -75.59 178.43 6.02 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.343 1.057 . . . . 0.0 111.312 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.33 151.28 14.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 125.22 1.408 . . . . 0.0 108.745 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -107.45 106.38 16.75 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.937 2.095 . . . . 0.0 106.703 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 16.2 mm -101.29 144.58 12.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -125.48 121.22 33.11 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.441 1.496 . . . . 0.0 108.914 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -99.04 108.76 21.5 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.658 1.183 . . . . 0.0 108.985 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 3.8 m -126.91 169.77 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 122.101 0.953 . . . . 0.0 109.506 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 42.0 t -95.25 144.08 26.13 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 104.39 -2.448 . . . . 0.0 104.39 177.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -99.85 10.0 60.35 Favored Glycine 0 N--CA 1.461 0.324 0 CA-C-O 117.736 -1.591 . . . . 0.0 115.016 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 66.69 54.18 23.79 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.5 m -132.35 128.81 38.46 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -73.11 -19.38 61.16 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.801 0.728 . . . . 0.0 112.819 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 6.3 t -157.72 177.31 11.52 Favored 'General case' 0 C--O 1.242 0.661 0 O-C-N 121.22 -0.925 . . . . 0.0 110.725 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.88 178.4 16.35 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 126.195 1.855 . . . . 0.0 115.941 178.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.435 ' HA ' ' HZ2' ' A' ' 112' ' ' LYS . 60.4 Cg_endo -78.93 -104.96 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.912 1 C-N-CA 126.03 4.487 . . . . 0.0 111.95 179.783 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 4.8 p -161.8 147.06 13.28 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 120.45 -1.406 . . . . 0.0 112.809 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 19.2 p -151.22 160.23 43.95 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.501 1.12 . . . . 0.0 110.37 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 4.3 mt -100.75 153.55 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 125.894 1.678 . . . . 0.0 108.018 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -98.93 -50.21 4.27 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.184 0.994 . . . . 0.0 111.798 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 63.9 p-90 -159.11 154.52 25.7 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.142 1.377 . . . . 0.0 107.353 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 59.7 t -150.2 130.09 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.03 167.83 26.98 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 118.147 0.43 . . . . 0.0 111.086 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -80.77 137.32 36.24 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 1.8 t -112.96 -39.32 4.26 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.705 -0.622 . . . . 0.0 110.74 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -121.65 -174.82 2.95 Favored 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 124.185 0.994 . . . . 0.0 109.595 -177.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 72.8 mt -56.51 -41.73 73.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.528 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -131.52 12.3 4.93 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.15 1.78 . . . . 0.0 112.815 -178.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 21.0 t -116.59 146.19 21.34 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 CA-C-N 118.72 0.691 . . . . 0.0 109.611 -178.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -123.5 161.64 24.47 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -127.99 142.13 51.33 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 106.376 -1.712 . . . . 0.0 106.376 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -150.78 131.82 14.32 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.465 1.106 . . . . 0.0 109.013 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -121.17 122.65 40.46 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.3 0.64 . . . . 0.0 109.635 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 4.6 m -106.47 156.44 7.06 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-N 118.676 0.671 . . . . 0.0 109.339 178.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.54 115.62 19.8 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 125.584 1.554 . . . . 0.0 109.166 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 10.6 pt -128.26 145.22 54.79 Favored Pre-proline 0 N--CA 1.448 -0.536 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.05 -41.43 5.19 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.004 1.803 . . . . 0.0 111.128 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -55.69 -17.57 6.14 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 117.589 2.44 . . . . 0.0 117.589 -177.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 44.2 mt -72.84 -30.12 63.76 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 120.781 1.628 . . . . 0.0 108.912 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 22.3 m -61.65 -11.65 12.61 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.563 0.745 . . . . 0.0 112.649 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 -67.53 -18.08 64.9 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-O 122.222 1.011 . . . . 0.0 109.664 177.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 29.8 mt -101.01 118.64 37.41 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 127.97 2.508 . . . . 0.0 106.787 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -46.75 -46.46 20.41 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.141 1.376 . . . . 0.0 112.732 -178.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 1.1 mp -65.59 -27.24 68.28 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 9.4 mt -102.39 -3.78 26.52 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.381 1.073 . . . . 0.0 111.609 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -68.94 113.71 6.59 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 127.84 2.456 . . . . 0.0 110.689 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.49 170.15 16.74 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -62.63 -29.21 70.45 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.122 0.487 . . . . 0.0 109.748 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -87.12 54.9 3.33 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.735 1.614 . . . . 0.0 108.478 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.257 1.483 0 C-N-CA 125.242 1.417 . . . . 0.0 111.823 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.751 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.88 127.37 32.39 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.9 t -164.22 175.62 9.95 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.715 1.206 . . . . 0.0 108.265 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.4 m120 54.73 37.79 28.97 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.916 1.686 . . . . 0.0 110.139 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.3 m -53.0 -35.11 59.02 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 120.947 -1.096 . . . . 0.0 113.48 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -72.03 -21.21 61.57 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.123 -0.985 . . . . 0.0 111.017 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.45 ' HE3' ' HA ' ' A' ' 94' ' ' LYS . 0.1 OUTLIER -73.02 -57.08 4.29 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 178.043 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -55.75 -39.41 71.15 Favored 'General case' 0 C--O 1.226 -0.178 0 O-C-N 123.797 0.686 . . . . 0.0 110.7 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.17 -47.98 71.4 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 42.3 tp -65.44 -37.44 86.91 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 117.645 -1.169 . . . . 0.0 110.662 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 64.1 mt -61.95 -55.01 33.91 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.55 1.068 . . . . 0.0 109.678 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 89.8 m -57.99 -49.59 76.32 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.389 1.875 . . . . 0.0 110.168 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 23.6 ttpt -62.09 -47.55 84.11 Favored 'General case' 0 N--CA 1.444 -0.741 0 O-C-N 121.341 -0.85 . . . . 0.0 109.698 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.6 m -52.74 -47.14 67.59 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 118.726 0.693 . . . . 0.0 110.765 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -58.7 -50.46 73.81 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 118.228 0.467 . . . . 0.0 109.971 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.83 -61.19 2.45 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -61.25 -38.32 86.26 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.641 0.776 . . . . 0.0 110.99 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.6 -53.24 45.35 Favored Glycine 0 CA--C 1.52 0.376 0 CA-C-O 117.904 -1.498 . . . . 0.0 109.401 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 39.3 t -57.74 -40.76 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 119.434 1.617 . . . . 0.0 109.251 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -58.69 -41.39 86.15 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 28.2 m -70.76 -40.1 72.87 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 125.133 1.373 . . . . 0.0 110.557 -177.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.459 HG21 ' CZ ' ' A' ' 206' ' ' TYR . 18.0 mt -61.48 -55.95 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -62.55 -32.39 73.34 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.821 -0.609 . . . . 0.0 111.488 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -60.83 -40.12 91.61 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 118.632 0.651 . . . . 0.0 111.029 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.3 tptm -81.13 -37.99 27.94 Favored 'General case' 0 CA--C 1.519 -0.247 0 O-C-N 122.064 -0.398 . . . . 0.0 110.793 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 40.4 mt -69.12 -26.61 64.99 Favored 'General case' 0 C--O 1.221 -0.412 0 O-C-N 121.443 -0.786 . . . . 0.0 109.992 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.16 -30.87 50.85 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.628 1.171 . . . . 0.0 111.339 179.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -56.24 -63.9 1.04 Allowed 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.489 1.116 . . . . 0.0 111.946 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -151.37 175.59 12.09 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 126.319 1.848 . . . . 0.0 110.336 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 85.7 m -87.53 161.4 17.8 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 106.959 -1.496 . . . . 0.0 106.959 178.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 42.3 pt -112.42 155.01 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 124.846 1.258 . . . . 0.0 108.143 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -148.98 137.37 21.0 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 125.185 1.394 . . . . 0.0 108.27 -178.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -140.85 126.94 19.51 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.307 1.043 . . . . 0.0 111.652 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -80.39 99.46 7.96 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.047 1.339 . . . . 0.0 109.122 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.98 79.97 5.79 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 178.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 58.71 -119.83 19.53 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -63.74 -35.91 82.12 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.91 0.884 . . . . 0.0 112.955 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -99.86 164.36 12.06 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 119.126 0.875 . . . . 0.0 111.651 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.427 HD12 ' H ' ' A' ' 140' ' ' GLY . 4.2 mp -129.43 129.13 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 103.824 -2.658 . . . . 0.0 103.824 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -105.39 122.95 47.02 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 125.634 1.574 . . . . 0.0 106.871 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -118.5 126.49 52.13 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -122.88 137.37 54.96 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.531 0.732 . . . . 0.0 111.26 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 27.4 m -117.12 153.37 49.7 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.613 1.165 . . . . 0.0 111.488 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -62.61 84.53 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.643 1 C-N-CA 125.428 4.085 . . . . 0.0 116.266 -177.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.36 32.56 55.14 Favored Glycine 0 CA--C 1.531 1.093 0 O-C-N 120.749 -1.22 . . . . 0.0 112.853 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 4.5 mp -115.56 -69.92 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.306 0 CA-C-N 117.956 0.878 . . . . 0.0 109.104 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -168.44 168.34 11.25 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.533 1.133 . . . . 0.0 110.632 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -132.38 120.22 21.74 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 177.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.2 m -140.56 163.85 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 124.924 1.29 . . . . 0.0 110.575 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -135.04 126.55 28.68 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -138.08 162.86 33.07 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 126.604 1.962 . . . . 0.0 109.08 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -102.87 120.02 39.87 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.427 ' H ' HD12 ' A' ' 126' ' ' ILE . . . -178.76 -159.87 23.84 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 127.21 2.338 . . . . 0.0 107.919 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.07 159.05 42.77 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.957 1.879 . . . . 0.0 111.933 178.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.2 p -94.75 155.91 3.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 124.69 1.196 . . . . 0.0 109.611 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 48.2 m-20 -101.48 97.95 8.35 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 101.031 -3.692 . . . . 0.0 101.031 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 82.6 p -57.99 -19.4 30.55 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 40.5 mmtt -67.66 -45.9 73.92 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 121.137 -0.977 . . . . 0.0 110.961 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 35.0 p -99.51 -38.33 8.82 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 125.329 1.452 . . . . 0.0 112.512 -178.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 95.28 32.25 7.13 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 126.079 1.8 . . . . 0.0 112.108 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -125.35 160.94 28.12 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.914 1.686 . . . . 0.0 110.332 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 11.4 mm -86.18 146.1 6.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 123.202 0.601 . . . . 0.0 110.04 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 32.8 m -61.13 -20.22 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.408 1.483 . . . . 0.0 113.877 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -169.5 -179.36 3.39 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 127.735 2.414 . . . . 0.0 108.356 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -102.33 -77.61 0.55 Allowed 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 103.011 -2.959 . . . . 0.0 103.011 176.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -156.25 133.99 11.03 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.888 0.875 . . . . 0.0 108.659 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -85.03 -62.36 1.56 Allowed 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.5 m -126.7 32.68 5.1 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.886 2.074 . . . . 0.0 112.512 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 34.9 mt -120.54 138.48 53.83 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 120.266 -1.521 . . . . 0.0 110.785 -177.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.3 p -143.97 121.49 5.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 118.863 0.756 . . . . 0.0 109.386 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -148.39 160.39 43.07 Favored 'General case' 0 C--O 1.226 -0.147 0 C-N-CA 123.883 0.873 . . . . 0.0 110.867 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 5.8 mpp_? -149.37 133.33 17.09 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 48.3 mt -110.87 -21.75 11.88 Favored 'General case' 0 C--O 1.22 -0.476 0 O-C-N 124.181 0.926 . . . . 0.0 109.195 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 155.53 163.97 12.69 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -126.63 114.3 22.8 Favored Pre-proline 0 C--O 1.236 0.352 0 CA-C-O 118.849 -0.595 . . . . 0.0 109.914 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -71.24 -173.89 1.05 Allowed 'Trans proline' 0 CA--C 1.544 1.004 0 C-N-CA 125.091 3.861 . . . . 0.0 109.567 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -120.8 163.83 17.54 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.932 0.872 . . . . 0.0 111.974 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.75 -36.56 59.85 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.116 177.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -89.57 65.71 7.05 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.476 1.91 . . . . 0.0 110.895 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.9 p -45.76 -36.72 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 123.146 0.578 . . . . 0.0 111.851 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -61.86 -37.9 86.24 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 125.488 1.515 . . . . 0.0 112.532 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -71.56 -23.61 61.78 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 124.972 1.309 . . . . 0.0 110.671 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 9.5 mtp-105 -79.53 138.92 37.67 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -101.41 139.78 36.61 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -122.89 -178.32 3.91 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 126.493 1.917 . . . . 0.0 111.802 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -131.49 154.01 49.18 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.908 1.283 . . . . 0.0 109.968 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 28.4 tp -116.75 107.69 14.96 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.264 1.826 . . . . 0.0 106.368 178.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -118.58 -178.25 3.49 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 126.258 1.823 . . . . 0.0 109.564 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -145.33 164.81 30.3 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.236 0.615 . . . . 0.0 111.27 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.7 178.56 7.06 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 128.005 2.522 . . . . 0.0 107.417 178.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -59.69 -18.9 46.01 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.489 1.116 . . . . 0.0 111.822 -177.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 76.8 t -92.05 -38.6 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 125.429 1.491 . . . . 0.0 111.297 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 163.46 -168.06 37.94 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 118.764 0.711 . . . . 0.0 112.194 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 6.4 m-30 -78.48 161.92 26.73 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.579 0.704 . . . . 0.0 110.234 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -159.32 161.87 35.89 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.25 1.42 . . . . 0.0 110.38 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 95.3 mt -100.96 146.08 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 6.7 t -119.7 132.88 55.77 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.492 1.117 . . . . 0.0 108.364 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -126.79 107.71 10.38 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.978 2.111 . . . . 0.0 108.939 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -90.6 114.14 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 104.481 -2.415 . . . . 0.0 104.481 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 7.2 mt -98.1 106.68 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.49 -153.49 24.82 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 77.07 20.85 1.17 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.585 1.154 . . . . 0.0 109.58 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -84.95 146.16 21.95 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.12 137.71 58.04 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 125.851 1.66 . . . . 0.0 108.44 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 25.3 mm -62.37 139.32 21.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 CA-C-O 122.218 1.009 . . . . 0.0 112.227 -178.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 5.6 t -79.2 116.35 19.42 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 128.381 2.672 . . . . 0.0 109.802 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.08 -17.0 56.16 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.904 0.881 . . . . 0.0 112.907 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 42.0 t -69.11 -52.47 33.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 125.742 1.617 . . . . 0.0 112.235 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 3.8 t -123.38 -40.44 2.37 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.971 1.308 . . . . 0.0 113.832 -178.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 117.03 21.66 4.46 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.301 1.429 . . . . 0.0 110.596 -178.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -88.7 151.31 22.51 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.868 1.834 . . . . 0.0 110.729 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -71.59 153.61 42.01 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 5.8 ttt-85 -74.52 28.58 0.08 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 127.519 2.328 . . . . 0.0 110.011 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 7.6 ptm -73.03 172.17 11.5 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 122.424 1.106 . . . . 0.0 111.315 -176.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.2 p -143.17 143.95 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 C-N-CA 124.414 1.086 . . . . 0.0 108.092 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -100.56 106.96 18.53 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 23.6 mm -100.98 146.25 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 O-C-N 120.756 -1.215 . . . . 0.0 108.713 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -125.48 134.53 52.02 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.796 -1.186 . . . . 0.0 107.796 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . 0.459 ' CZ ' HG21 ' A' ' 109' ' ' ILE . 43.4 m-85 -106.06 110.05 22.19 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 29.9 m -124.7 162.58 26.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 45.5 t -83.03 143.51 30.56 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -87.48 23.67 11.9 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-O 117.285 -1.842 . . . . 0.0 113.187 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 71.2 -74.19 0.68 Allowed Glycine 0 C--N 1.341 0.83 0 C-N-CA 126.256 1.884 . . . . 0.0 109.911 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 60.8 m -51.6 123.45 9.99 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.377 1.871 . . . . 0.0 107.09 178.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -74.68 2.78 9.11 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.049 1.339 . . . . 0.0 113.22 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 4.0 t -131.26 154.95 47.94 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.021 1.328 . . . . 0.0 109.495 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 132.28 177.72 15.08 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.68 1.61 . . . . 0.0 112.1 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -80.15 -101.97 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.13 0 C-N-CA 123.743 2.962 . . . . 0.0 109.97 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.2 p -163.9 139.3 6.22 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 129.731 3.212 . . . . 0.0 105.409 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 77.4 p -151.3 175.46 12.19 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.536 1.062 . . . . 0.0 110.819 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . 0.419 ' HA ' ' HA ' ' A' ' 233' ' ' VAL . 3.2 mt -115.48 143.05 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 104.073 -2.565 . . . . 0.0 104.073 176.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -94.35 -48.31 6.21 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.722 1.209 . . . . 0.0 112.421 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 -156.84 151.85 26.11 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.815 1.646 . . . . 0.0 108.499 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 6.8 p -155.71 120.44 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -148.85 158.38 44.12 Favored 'General case' 0 C--O 1.235 0.342 0 O-C-N 121.563 -0.711 . . . . 0.0 110.849 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -65.84 130.44 43.29 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 12.1 t -107.96 -33.61 7.16 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 125.842 1.657 . . . . 0.0 112.605 -178.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 7.1 mttt -132.17 -175.88 3.89 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 1.1 mm -38.72 -56.92 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 124.896 1.278 . . . . 0.0 113.319 -177.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 2.5 m -133.32 17.61 4.04 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.775 1.63 . . . . 0.0 109.81 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.64 141.75 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -121.53 163.7 18.43 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.457 1.103 . . . . 0.0 108.474 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -138.16 132.36 31.81 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 178.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -136.57 140.04 42.61 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.158 1.383 . . . . 0.0 108.141 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -118.92 116.98 27.62 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 218' ' ' ILE . 1.3 m -107.0 151.85 8.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.8 p -126.75 136.83 52.94 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 123.461 0.704 . . . . 0.0 111.857 -178.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -141.21 142.55 27.48 Favored Pre-proline 0 N--CA 1.452 -0.336 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -66.79 -47.54 2.62 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.855 2.37 . . . . 0.0 112.002 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -53.41 -24.48 12.61 Favored 'General case' 0 CA--C 1.527 0.091 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 10.7 tp -61.11 -29.9 70.04 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 119.266 0.939 . . . . 0.0 111.409 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 9.2 m -62.0 -12.26 17.75 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.999 0.919 . . . . 0.0 112.602 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.99 -24.65 66.06 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.245 0.93 . . . . 0.0 110.121 178.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -89.14 117.21 27.96 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 178.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 -46.79 -44.18 18.93 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 126.281 1.833 . . . . 0.0 114.105 -178.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 60.2 mt -70.23 -31.43 68.83 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.448 -1.407 . . . . 0.0 113.017 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 14.3 mt -84.29 -20.7 31.69 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.124 0.97 . . . . 0.0 112.583 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -55.72 141.16 39.28 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 128.914 2.886 . . . . 0.0 111.538 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 34.5 mmtt -103.5 176.49 5.13 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.378 1.471 . . . . 0.0 109.616 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -101.77 -69.63 0.78 Allowed 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 53.03 25.44 4.08 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.356 1.463 . . . . 0.0 110.94 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 3.0 t70 . . . . . 0 C--O 1.246 0.88 0 C-N-CA 127.096 2.158 . . . . 0.0 108.057 179.745 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.366 0 N-CA-C 108.149 -1.981 . . . . 0.0 108.149 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.5 -29.81 68.11 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 119.443 1.621 . . . . 0.0 109.216 178.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 70.6 m -142.14 164.38 30.33 Favored 'General case' 0 C--O 1.246 0.909 0 C-N-CA 131.658 3.983 . . . . 0.0 102.953 177.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -120.63 118.06 29.17 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 58.6 m -52.41 -37.4 56.56 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 124.396 1.078 . . . . 0.0 109.077 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -58.82 -40.63 84.74 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 127.757 2.423 . . . . 0.0 110.746 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? -62.33 -50.49 71.43 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.52 -37.24 85.28 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.021 0.528 . . . . 0.0 111.035 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.43 -45.96 92.1 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 55.3 tp -66.38 -38.07 86.71 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 118.396 -0.811 . . . . 0.0 109.905 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 20.7 mt -59.74 -54.81 41.98 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 24.5 m -60.7 -38.53 85.34 Favored 'General case' 0 C--O 1.239 0.551 0 O-C-N 121.449 -0.782 . . . . 0.0 111.77 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -65.28 -48.19 74.04 Favored 'General case' 0 CA--C 1.519 -0.247 0 O-C-N 121.056 -1.027 . . . . 0.0 109.993 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 69.2 m -51.95 -47.81 64.59 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.352 1.061 . . . . 0.0 110.667 -178.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -58.51 -49.48 77.21 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 117.847 0.294 . . . . 0.0 110.912 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -62.89 -57.35 11.09 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 122.243 1.02 . . . . 0.0 113.153 -177.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -60.41 -41.6 94.22 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.797 -178.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -62.71 -53.21 42.9 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-O 117.781 -1.566 . . . . 0.0 111.418 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 47.8 t -58.34 -42.53 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 120.562 2.181 . . . . 0.0 109.0 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.84 -30.98 71.69 Favored 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 119.181 -1.007 . . . . 0.0 112.499 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 52.6 m -72.32 -40.75 67.24 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 126.042 1.737 . . . . 0.0 108.385 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 18.1 mt -60.66 -55.06 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -60.91 -28.0 68.6 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-O 117.876 -1.059 . . . . 0.0 111.657 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -62.07 -49.38 76.17 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.22 1.008 . . . . 0.0 111.337 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.438 ' HA ' ' HE2' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -85.26 -39.28 17.93 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -177.765 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 16.2 mt -66.38 -25.78 66.95 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 119.009 -0.519 . . . . 0.0 112.26 -179.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -52.44 -28.75 21.3 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -51.18 -74.77 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.821 1.648 . . . . 0.0 111.67 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -147.68 176.68 9.9 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.804 1.642 . . . . 0.0 109.126 -178.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 33.4 m -86.21 163.06 18.0 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.635 0.731 . . . . 0.0 109.147 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 37.6 pt -118.63 160.29 18.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 126.134 1.774 . . . . 0.0 109.395 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -158.05 139.62 13.7 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -130.54 127.2 38.61 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 123.584 0.753 . . . . 0.0 110.052 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -85.39 101.66 12.78 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.26 1.024 . . . . 0.0 108.439 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.26 80.07 7.65 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 104.681 -2.34 . . . . 0.0 104.681 178.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.73 -99.63 0.37 Allowed Glycine 0 CA--C 1.531 1.08 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -95.25 -25.85 16.19 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.742 1.617 . . . . 0.0 114.031 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -99.01 152.35 19.91 Favored 'General case' 0 CA--C 1.513 -0.451 0 O-C-N 121.302 -0.874 . . . . 0.0 108.752 -178.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.442 HD13 ' H ' ' A' ' 140' ' ' GLY . 5.2 mp -124.67 124.6 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -100.99 119.3 38.54 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 103.212 -2.884 . . . . 0.0 103.212 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -118.4 124.7 48.33 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.157 0.983 . . . . 0.0 110.891 -177.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -124.03 135.03 53.32 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -178.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 16.1 m -111.18 155.97 41.79 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 125.546 1.538 . . . . 0.0 112.808 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -67.97 81.31 0.49 Allowed 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 124.864 3.71 . . . . 0.0 114.474 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 72.98 54.55 7.0 Favored Glycine 0 CA--C 1.529 0.922 0 O-C-N 121.207 -0.933 . . . . 0.0 112.862 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 3.6 mp -131.04 -72.02 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -167.16 167.82 14.02 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.757 1.623 . . . . 0.0 109.068 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -128.54 126.14 39.75 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 176.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.8 m -141.53 164.0 19.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 124.591 1.157 . . . . 0.0 110.55 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -126.36 125.81 42.85 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -139.4 162.96 33.77 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.091 0.957 . . . . 0.0 110.636 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.491 ' H ' ' CD1' ' A' ' 156' ' ' LEU . 61.8 t60 -110.19 109.35 19.81 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 101.993 -3.336 . . . . 0.0 101.993 177.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.442 ' H ' HD13 ' A' ' 126' ' ' ILE . . . -168.78 -159.64 14.92 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.191 1.853 . . . . 0.0 109.959 -178.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -141.02 167.26 22.61 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 118.856 1.328 . . . . 0.0 112.684 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 8.9 p -133.16 150.42 32.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 125.747 1.619 . . . . 0.0 107.878 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 63.2 t-20 -103.49 121.75 43.49 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 16.6 p -60.9 -27.4 68.14 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 33.3 mmtt -61.29 -33.12 73.05 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -178.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.8 p -110.05 -47.33 3.33 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 125.025 1.33 . . . . 0.0 109.497 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 90.56 32.22 9.59 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 125.325 1.44 . . . . 0.0 110.793 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -124.68 145.62 49.57 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 125.668 1.587 . . . . 0.0 108.881 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 6.5 mm -66.0 149.26 11.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 125.299 1.439 . . . . 0.0 110.464 -177.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 24.3 m -59.98 -43.39 92.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 124.197 0.999 . . . . 0.0 111.096 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 74.3 m-80 -151.52 151.29 31.41 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 125.005 1.322 . . . . 0.0 108.103 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -79.75 -155.97 0.11 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.553 1.141 . . . . 0.0 109.725 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -67.04 90.53 0.19 Allowed 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.651 -1.281 . . . . 0.0 111.06 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -76.54 -67.1 0.73 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 49.8 m -126.54 -15.53 5.55 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.742 1.217 . . . . 0.0 113.479 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.491 ' CD1' ' H ' ' A' ' 139' ' ' HIS . 56.7 mt -83.45 81.8 8.56 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 120.743 -1.223 . . . . 0.0 109.995 -178.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 71.4 t -77.06 110.05 12.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -145.72 137.26 25.06 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.639 1.176 . . . . 0.0 109.029 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -134.59 141.78 46.74 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 177.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 59.7 mt -120.17 -29.06 4.96 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 125.454 1.721 . . . . 0.0 107.042 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 160.62 159.18 9.73 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 36.1 mtmt -128.57 114.66 19.49 Favored Pre-proline 0 CA--C 1.537 0.444 0 O-C-N 122.021 -0.694 . . . . 0.0 109.998 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -75.6 -167.98 0.49 Allowed 'Trans proline' 0 CA--C 1.537 0.63 1 C-N-CA 125.806 4.338 . . . . 0.0 110.336 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -131.93 157.56 43.7 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.328 1.451 . . . . 0.0 108.91 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.89 -38.29 73.05 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.878 0.371 . . . . 0.0 110.503 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 33.7 m-20 -76.15 64.73 2.03 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.703 1.601 . . . . 0.0 110.293 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 6.1 p -52.04 -30.32 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 124.212 1.005 . . . . 0.0 111.172 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -71.32 -26.03 62.66 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.531 1.132 . . . . 0.0 113.804 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -77.32 -23.68 50.95 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 122.901 0.481 . . . . 0.0 112.174 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -92.42 160.32 15.14 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.964 0.411 . . . . 0.0 109.909 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -114.38 161.48 17.87 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -138.11 170.43 16.05 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.738 1.215 . . . . 0.0 109.621 -177.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -112.57 151.32 30.19 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 21.9 tp -121.3 98.35 5.94 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -110.16 178.46 4.39 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -155.0 163.3 40.51 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -141.08 -171.03 3.18 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -55.27 -23.82 25.02 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.087 1.355 . . . . 0.0 112.406 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.5 t -81.87 -65.91 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 177.48 -170.58 43.1 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -77.55 157.62 30.26 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.566 0.746 . . . . 0.0 111.838 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -156.09 173.77 16.34 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 126.735 2.014 . . . . 0.0 108.585 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 93.8 mt -114.29 141.69 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 177.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 21.3 t -109.91 128.71 55.53 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.059 1.343 . . . . 0.0 107.923 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -124.07 107.39 11.23 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.862 1.265 . . . . 0.0 108.459 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.6 mp -91.05 128.65 42.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 7.6 mt -118.9 106.72 19.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -93.88 -152.56 29.41 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 108.443 -1.863 . . . . 0.0 108.443 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 69.7 m 79.15 25.49 0.46 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.201 2.2 . . . . 0.0 115.768 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -89.64 -156.02 31.44 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 107.58 -2.208 . . . . 0.0 107.58 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -123.17 144.13 49.56 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 39.8 mm -60.82 134.55 26.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -79.62 109.63 14.18 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 127.131 2.172 . . . . 0.0 105.489 177.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -55.04 -19.5 7.2 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.847 2.059 . . . . 0.0 113.189 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 50.1 t -60.47 -54.52 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 126.968 2.107 . . . . 0.0 111.567 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 4.8 t -124.09 -25.42 4.18 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -177.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 99.59 35.72 4.55 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 108.239 -1.945 . . . . 0.0 108.239 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -113.27 151.29 31.29 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 117.933 0.867 . . . . 0.0 110.669 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 57.5 mp0 -75.26 141.41 43.49 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 123.976 0.91 . . . . 0.0 112.735 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . 0.297 7.9 ttt85 -70.05 30.98 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 130.885 3.674 . . . . 0.0 112.797 178.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 5.1 ptm -74.75 177.36 6.22 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.125 0.97 . . . . 0.0 110.472 -179.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.2 p -143.65 152.97 16.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 125.283 1.433 . . . . 0.0 107.98 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -114.65 112.57 23.08 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 15.7 mm -98.24 141.96 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -124.62 111.46 15.66 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.663 1.585 . . . . 0.0 107.985 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -92.56 109.03 20.43 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.701 1.6 . . . . 0.0 110.369 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 34.9 m -124.79 167.82 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.211 1.005 . . . . 0.0 109.837 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 45.5 t -96.46 132.73 41.72 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 103.541 -2.763 . . . . 0.0 103.541 177.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -98.36 32.49 6.89 Favored Glycine 0 N--CA 1.463 0.456 0 C-N-CA 124.541 1.067 . . . . 0.0 111.01 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 58.14 -147.44 38.26 Favored Glycine 0 CA--C 1.533 1.169 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 25.6 m -63.16 80.16 0.02 OUTLIER 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.659 1.584 . . . . 0.0 113.871 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.29 59.4 1.56 Allowed 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.119 1.367 . . . . 0.0 108.421 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 9.6 m -54.21 147.22 13.53 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 121.377 -0.827 . . . . 0.0 109.145 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 131.96 -161.06 23.77 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-O 119.163 -0.798 . . . . 0.0 112.525 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -67.1 -95.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 124.483 3.455 . . . . 0.0 115.429 -178.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -164.12 151.03 11.63 Favored 'General case' 0 C--O 1.241 0.624 0 O-C-N 120.863 -1.148 . . . . 0.0 109.1 -178.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 36.7 p -151.81 160.64 43.49 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.839 0.855 . . . . 0.0 110.579 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 4.1 mt -106.48 148.55 10.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -93.82 -53.98 3.8 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.672 0.789 . . . . 0.0 110.95 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 63.4 p-90 -155.17 155.03 33.2 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.859 1.264 . . . . 0.0 108.113 -178.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 56.3 t -150.58 129.66 3.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.84 162.18 32.15 Favored 'General case' 0 C--O 1.233 0.209 0 O-C-N 122.19 -0.319 . . . . 0.0 111.174 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -72.53 128.79 36.66 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 104.574 -2.38 . . . . 0.0 104.574 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 9.9 t -106.15 -37.17 6.68 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 124.833 1.253 . . . . 0.0 109.981 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 34.2 mttt -133.31 -176.45 4.14 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 123.782 0.833 . . . . 0.0 109.975 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 69.3 mt -46.38 -49.43 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.188 0.995 . . . . 0.0 112.322 -178.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.99 21.23 5.83 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 124.112 0.965 . . . . 0.0 110.362 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 7.9 t -120.1 141.4 40.49 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.61 0 CA-C-N 118.64 0.654 . . . . 0.0 111.61 -177.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -122.97 158.37 30.61 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -129.73 134.46 47.63 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -137.32 119.33 15.38 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 125.427 1.491 . . . . 0.0 109.932 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -108.42 124.66 50.74 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 12.5 m -116.31 156.58 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.481 0 C-N-CA 122.47 0.308 . . . . 0.0 110.665 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.3 p -123.85 123.89 41.45 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 124.39 1.076 . . . . 0.0 110.263 -178.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 2.2 pt -133.44 134.52 23.92 Favored Pre-proline 0 C--O 1.237 0.4 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 177.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.54 -27.82 45.83 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.233 2.622 . . . . 0.0 113.304 -178.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 28.2 mp0 -64.59 -28.65 69.78 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 -178.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 66.6 mt -61.23 -29.23 69.7 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 118.587 -1.245 . . . . 0.0 110.652 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 21.7 m -58.86 -16.35 16.95 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 118.806 0.73 . . . . 0.0 112.256 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -60.11 -38.4 82.91 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 118.91 0.777 . . . . 0.0 109.663 178.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -79.61 122.47 26.56 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -47.33 -44.88 24.05 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 126.26 1.824 . . . . 0.0 113.34 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.43 -33.59 76.05 Favored 'General case' 0 C--O 1.226 -0.176 0 O-C-N 121.341 -0.849 . . . . 0.0 112.694 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 27.2 mt -92.88 -4.99 51.89 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.231 1.012 . . . . 0.0 113.054 -178.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -71.61 117.06 12.71 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 127.625 2.37 . . . . 0.0 112.978 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 32.6 mmtm -79.54 150.56 31.1 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 123.216 0.606 . . . . 0.0 110.709 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -144.05 -13.89 0.62 Allowed 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 124.865 1.266 . . . . 0.0 111.56 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -120.64 21.32 11.57 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 127.206 2.202 . . . . 0.0 110.183 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 . . . . . 0 C--O 1.252 1.189 0 CA-C-O 116.613 -1.661 . . . . 0.0 111.126 179.642 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.658 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -147.37 -143.69 0.14 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 128.885 2.874 . . . . 0.0 104.583 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.0 t -79.21 63.6 3.89 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 120.008 1.276 . . . . 0.0 107.69 178.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -65.76 -53.35 41.66 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.825 1.65 . . . . 0.0 109.888 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.9 m -50.79 -43.09 58.61 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.475 1.91 . . . . 0.0 112.947 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -60.96 -50.02 75.08 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 118.528 0.604 . . . . 0.0 110.234 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -52.99 -53.43 50.14 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -178.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.37 -37.63 65.19 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 118.554 -0.736 . . . . 0.0 112.078 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.82 -49.23 76.01 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 52.8 tp -65.1 -35.6 81.64 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.492 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 43.3 mt -63.24 -55.01 28.48 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.44 1.018 . . . . 0.0 108.791 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 88.9 m -57.25 -46.36 83.1 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 125.045 1.338 . . . . 0.0 110.254 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.71 -50.2 70.08 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 118.231 -0.89 . . . . 0.0 109.666 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 47.6 m -52.53 -46.9 66.94 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 124.159 0.984 . . . . 0.0 110.532 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -59.49 -50.33 74.33 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 118.3 0.5 . . . . 0.0 110.003 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.1 -61.5 2.22 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.219 0.608 . . . . 0.0 112.313 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.44 -37.98 79.5 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.487 0.315 . . . . 0.0 110.231 -178.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.09 -53.25 38.16 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-O 117.583 -1.676 . . . . 0.0 110.706 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 37.3 t -57.12 -45.19 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 119.671 1.736 . . . . 0.0 109.087 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -62.96 -34.36 77.33 Favored 'General case' 0 C--O 1.223 -0.311 0 C-N-CA 118.815 -1.154 . . . . 0.0 111.573 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 86.2 m -70.89 -36.96 72.97 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.444 0.698 . . . . 0.0 109.53 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.7 mt -61.81 -55.4 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -64.3 -27.85 69.32 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -64.51 -30.82 71.85 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.443 1.02 . . . . 0.0 111.646 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.68 -46.61 6.54 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 123.835 0.854 . . . . 0.0 110.56 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.9 mt -59.98 -27.58 66.97 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -55.03 -24.83 26.63 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -62.85 -62.44 1.72 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.48 0.712 . . . . 0.0 110.872 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -148.42 171.03 16.7 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 123.97 0.908 . . . . 0.0 110.868 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 69.8 m -87.07 166.14 15.25 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 35.4 pt -117.92 156.44 19.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 125.372 1.469 . . . . 0.0 108.613 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.3 138.29 21.27 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 125.389 1.475 . . . . 0.0 109.278 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -136.7 113.36 10.21 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 123.634 0.773 . . . . 0.0 111.44 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -79.82 99.59 7.58 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.29 79.62 8.99 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 178.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 60.13 -105.83 0.87 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -77.99 -34.32 50.87 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.685 0.794 . . . . 0.0 112.981 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 52.4 m95 -99.79 167.82 10.3 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 118.952 0.797 . . . . 0.0 110.293 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.3 mp -136.88 153.81 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -133.68 120.15 20.27 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.766 2.027 . . . . 0.0 106.221 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -117.15 121.29 40.85 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -119.06 139.43 51.76 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 124.216 1.007 . . . . 0.0 109.895 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 20.8 m -115.77 157.38 44.73 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 126.663 1.985 . . . . 0.0 111.687 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -64.21 76.68 0.17 Allowed 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 124.723 3.615 . . . . 0.0 114.626 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 68.54 56.87 8.92 Favored Glycine 0 CA--C 1.533 1.161 0 O-C-N 120.72 -1.238 . . . . 0.0 112.792 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 3.9 mp -128.12 -71.24 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.131 0 C-N-CA 126.198 1.799 . . . . 0.0 106.153 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -164.42 169.97 16.61 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 126.963 2.105 . . . . 0.0 109.521 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -133.38 124.84 27.89 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 178.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 33.9 m -142.65 163.71 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 123.99 0.916 . . . . 0.0 112.043 -178.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -125.43 124.67 41.95 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.757 1.623 . . . . 0.0 107.017 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -139.34 162.45 34.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 119.451 1.023 . . . . 0.0 111.43 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 63.1 t60 -85.37 160.97 19.66 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 177.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 133.09 -159.06 23.43 Favored Glycine 0 N--CA 1.465 0.595 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.97 167.54 29.1 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 124.949 1.3 . . . . 0.0 109.584 178.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.0 p -112.66 148.95 15.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.3 113.01 26.28 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 178.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 58.9 p -53.77 -30.82 46.31 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.918 1.287 . . . . 0.0 112.972 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp -47.04 -45.12 21.24 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 127.79 2.436 . . . . 0.0 112.965 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.7 p -120.22 -41.27 2.64 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 127.331 2.252 . . . . 0.0 112.926 -177.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 100.04 35.47 4.51 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 125.871 1.701 . . . . 0.0 110.467 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.1 148.63 41.37 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.755 1.222 . . . . 0.0 111.503 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 34.2 mm -78.73 144.68 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 103.24 -2.874 . . . . 0.0 103.24 177.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 32.5 m -66.66 -6.46 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 36.61 84.1 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 128.978 2.911 . . . . 0.0 110.471 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -140.85 -34.64 0.5 Allowed 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -178.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -93.28 66.97 4.07 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -60.37 -57.02 14.56 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.162 1.385 . . . . 0.0 112.641 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 4.5 m -59.54 -15.41 17.95 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 115.764 1.765 . . . . 0.0 115.764 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 13.8 mt -84.23 57.32 4.17 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.252 0.933 . . . . 0.0 108.921 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 10.8 m -85.48 148.08 5.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 124.005 0.922 . . . . 0.0 109.61 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -151.85 176.98 10.89 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 128.561 2.744 . . . . 0.0 107.477 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -148.7 134.18 18.61 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.5 mp -109.85 -23.73 11.22 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 160.79 159.22 9.78 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-N 119.436 1.016 . . . . 0.0 111.891 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.38 108.46 41.71 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 123.918 0.887 . . . . 0.0 109.631 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.4 166.73 23.88 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.286 2.657 . . . . 0.0 110.058 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -96.75 156.55 16.3 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -76.02 -35.14 59.65 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.728 1.211 . . . . 0.0 113.149 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -84.85 66.73 9.83 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 124.369 1.068 . . . . 0.0 110.534 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.5 p -46.04 -28.6 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -71.16 -31.2 67.4 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 124.823 1.249 . . . . 0.0 111.737 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -87.84 -14.1 40.4 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.138 1.775 . . . . 0.0 110.24 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -75.97 158.38 32.02 Favored 'General case' 0 CA--C 1.521 -0.165 0 O-C-N 120.921 -1.112 . . . . 0.0 108.865 178.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -109.9 149.25 30.18 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -143.37 169.28 17.96 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 127.025 2.13 . . . . 0.0 108.606 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -128.13 154.01 46.23 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.082 0.953 . . . . 0.0 110.043 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 23.9 tp -114.25 108.52 17.05 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -118.2 -179.83 3.89 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.226 1.41 . . . . 0.0 109.297 -178.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -149.33 156.79 42.62 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -141.52 -178.12 5.48 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 177.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -60.86 -13.13 13.58 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.331 -0.856 . . . . 0.0 111.464 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 69.0 t -83.09 -45.25 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 O-C-N 120.796 -1.19 . . . . 0.0 110.435 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 154.53 -165.56 31.99 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 108.082 -2.007 . . . . 0.0 108.082 -178.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.405 ' CD2' ' HB3' ' A' ' 243' ' ' LEU . 3.4 m-30 -78.56 160.72 27.46 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 118.239 1.019 . . . . 0.0 110.22 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -158.64 161.72 37.2 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.503 1.121 . . . . 0.0 111.371 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 95.8 mt -101.4 144.1 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 29.7 t -114.29 133.01 55.95 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -123.46 108.55 12.8 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -85.84 127.61 40.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.8 mt -115.59 105.23 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 102.874 -3.01 . . . . 0.0 102.874 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -110.76 -152.04 12.74 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 108.379 -1.888 . . . . 0.0 108.379 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 75.26 23.74 1.52 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.389 1.076 . . . . 0.0 110.945 178.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -95.08 173.64 31.89 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.98 163.88 26.72 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 44.0 mm -86.23 141.43 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 125.619 1.568 . . . . 0.0 111.623 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.2 m -87.23 118.75 26.86 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 127.724 2.41 . . . . 0.0 108.383 178.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -54.06 -32.24 54.02 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.075 2.15 . . . . 0.0 113.335 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 43.8 t -50.91 -55.42 7.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 125.542 1.537 . . . . 0.0 112.772 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 13.6 t -123.93 -33.28 3.16 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 108.05 34.73 2.69 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -178.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -104.82 152.65 22.33 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.916 1.358 . . . . 0.0 110.438 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -76.96 146.2 37.65 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 118.773 0.715 . . . . 0.0 109.559 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . 0.373 4.8 ptp180 -71.62 29.34 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 128.176 2.59 . . . . 0.0 113.558 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 7.8 ptm -72.59 174.31 7.7 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 122.15 0.976 . . . . 0.0 111.643 -176.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.4 p -142.25 150.17 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 124.065 0.946 . . . . 0.0 109.346 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -111.06 106.23 15.23 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 17.0 mm -90.31 150.59 3.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -125.76 100.03 6.23 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 126.916 2.087 . . . . 0.0 110.173 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -84.81 108.68 17.6 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 178.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 26.1 m -125.38 164.11 25.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 124.243 1.017 . . . . 0.0 108.674 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 42.6 t -82.92 146.51 28.8 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 177.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -93.04 13.42 67.74 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-O 118.997 -0.891 . . . . 0.0 112.456 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 68.85 -155.97 53.49 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 106.443 -2.663 . . . . 0.0 106.443 -177.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 16.0 m -70.43 85.48 0.6 Allowed 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.15 0.98 . . . . 0.0 109.393 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -145.74 60.65 1.27 Allowed 'General case' 0 C--O 1.233 0.22 0 C-N-CA 126.418 1.887 . . . . 0.0 108.02 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 12.8 m -59.72 104.84 0.31 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.319 1.448 . . . . 0.0 111.506 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.417 ' H ' ' HG3' ' A' ' 236' ' ' PRO . . . -175.21 -163.39 28.14 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 125.284 1.421 . . . . 0.0 110.426 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -68.95 -92.5 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.641 2.894 . . . . 0.0 114.305 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 2.9 p -164.33 142.7 7.1 Favored 'General case' 0 N--CA 1.463 0.201 0 O-C-N 120.934 -1.104 . . . . 0.0 109.678 -178.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 7.9 p -148.8 165.5 31.29 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.47 0.577 . . . . 0.0 111.132 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 3.4 mt -101.96 154.48 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 125.298 1.439 . . . . 0.0 107.372 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -105.0 -44.86 4.69 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.121 0.968 . . . . 0.0 113.573 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 67.0 p-90 -163.68 151.88 13.31 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.999 1.319 . . . . 0.0 107.718 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 87.9 t -151.89 129.2 2.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 C-N-CA 124.879 1.272 . . . . 0.0 109.22 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 1.5 ppt_? -163.48 160.5 23.34 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.752 0.706 . . . . 0.0 110.495 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -67.09 131.25 45.45 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 14.9 t -104.07 -33.15 8.87 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.948 1.299 . . . . 0.0 111.361 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 56.8 mttt -131.36 -175.04 3.57 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 125.049 1.34 . . . . 0.0 108.332 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 67.5 mt -52.27 -43.88 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -129.95 8.3 5.22 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.649 0.78 . . . . 0.0 112.227 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 21.5 t -105.81 142.34 19.07 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -178.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -121.55 166.36 14.31 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 124.72 1.208 . . . . 0.0 108.104 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -136.91 144.29 43.39 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -148.65 119.02 7.33 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 123.364 0.666 . . . . 0.0 109.608 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -103.5 123.07 46.22 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 2.3 m -119.98 152.44 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 2.8 p -126.6 135.93 51.87 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 3.9 pt -139.82 146.17 46.02 Favored Pre-proline 0 C--O 1.236 0.362 0 C-N-CA 125.564 1.545 . . . . 0.0 107.029 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.417 ' HG3' ' H ' ' A' ' 214' ' ' GLY . 97.4 Cg_endo -74.03 -24.82 14.63 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.201 1.934 . . . . 0.0 112.973 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 49.6 mp0 -66.02 -28.18 68.68 Favored 'General case' 0 CA--C 1.518 -0.286 0 O-C-N 120.43 -1.418 . . . . 0.0 114.355 -178.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 58.9 mt -63.32 -25.13 68.16 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 118.902 -1.119 . . . . 0.0 110.682 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 20.9 m -63.0 -15.12 55.27 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 119.163 0.892 . . . . 0.0 111.051 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -69.5 -31.77 70.22 Favored 'General case' 0 C--N 1.341 0.206 0 O-C-N 121.186 -0.946 . . . . 0.0 109.358 178.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -78.21 120.75 23.44 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 33.0 tp10 -46.05 -48.47 16.86 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.766 2.026 . . . . 0.0 115.795 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . 0.405 ' HB3' ' CD2' ' A' ' 181' ' ' TYR . 20.0 mt -69.52 -34.44 74.27 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.148 -0.97 . . . . 0.0 112.786 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 3.2 mt -84.71 -10.35 57.36 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.266 1.026 . . . . 0.0 112.717 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -61.25 123.73 18.56 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.179 2.192 . . . . 0.0 111.015 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 16.2 mmtp -78.52 167.26 21.55 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.319 0.648 . . . . 0.0 109.677 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -65.99 -48.26 71.8 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 123.704 0.802 . . . . 0.0 111.183 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 48.0 48.72 17.89 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 126.299 1.84 . . . . 0.0 110.788 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 0.989 0 C-N-CA 126.351 1.86 . . . . 0.0 110.004 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.673 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -140.63 157.43 45.47 Favored 'General case' 0 CA--C 1.523 -0.077 0 CA-C-N 118.58 1.19 . . . . 0.0 110.258 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.2 p -112.12 15.97 20.34 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.177 2.191 . . . . 0.0 111.211 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -60.21 90.45 0.02 OUTLIER 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.677 1.591 . . . . 0.0 111.286 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.6 t -77.93 -41.6 35.86 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 118.808 0.731 . . . . 0.0 109.778 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.515 ' CD ' ' H ' ' A' ' 93' ' ' GLU . 8.8 mp0 -53.27 -41.58 65.68 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 127.095 2.158 . . . . 0.0 110.887 -178.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.8 tmtm? -60.56 -59.17 5.82 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -59.48 -36.89 76.88 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.88 -52.64 64.86 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 42.0 tp -68.36 -34.95 77.0 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 118.416 -0.802 . . . . 0.0 110.373 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 31.8 mt -60.36 -54.37 46.42 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 60.4 m -61.9 -45.26 94.5 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.656 -0.652 . . . . 0.0 109.8 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.9 -47.31 83.16 Favored 'General case' 0 C--N 1.346 0.415 0 O-C-N 120.854 -1.154 . . . . 0.0 109.416 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 72.3 m -54.14 -51.17 65.13 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.579 1.152 . . . . 0.0 110.323 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -57.98 -47.92 81.54 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 123.288 0.367 . . . . 0.0 110.56 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -69.17 -59.58 2.93 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -177.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.46 -37.32 85.46 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -56.15 -52.65 47.99 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 41.3 t -56.69 -46.02 82.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 119.381 1.59 . . . . 0.0 110.475 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.3 ptmt -63.61 -31.63 72.86 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 118.714 -0.66 . . . . 0.0 111.878 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.3 m -76.43 -37.89 56.36 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.38 1.072 . . . . 0.0 109.104 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 24.6 mt -62.16 -55.34 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -62.15 -28.37 69.6 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 118.272 -0.87 . . . . 0.0 111.497 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -68.67 -50.3 52.16 Favored 'General case' 0 N--CA 1.457 -0.085 0 CA-C-N 119.028 0.831 . . . . 0.0 111.135 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.05 -44.8 45.64 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 30.8 mt -64.33 -26.12 68.34 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-O 119.068 -0.491 . . . . 0.0 111.929 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -51.63 -27.06 10.26 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.3 1.04 . . . . 0.0 112.872 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -52.58 -68.09 0.2 Allowed 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.544 1.538 . . . . 0.0 112.489 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -152.9 -179.13 7.38 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.597 1.559 . . . . 0.0 111.536 -178.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 64.1 m -86.65 175.42 8.29 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 35.7 pt -140.73 160.19 24.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 125.306 1.442 . . . . 0.0 109.746 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.32 144.2 25.38 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 123.878 0.871 . . . . 0.0 110.081 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.462 ' CE1' ' HA ' ' A' ' 220' ' ' TRP . 8.8 t80 -135.04 131.16 36.71 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.091 0.956 . . . . 0.0 109.461 178.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -91.43 109.71 21.0 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 124.915 1.286 . . . . 0.0 108.029 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -102.39 80.09 1.91 Allowed 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.15 1.78 . . . . 0.0 110.86 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.82 -85.99 0.07 OUTLIER Glycine 0 CA--C 1.529 0.913 0 O-C-N 120.711 -1.243 . . . . 0.0 113.1 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -109.77 -32.62 7.01 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.407 1.083 . . . . 0.0 111.235 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 69.2 m95 -99.81 152.76 19.76 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 118.933 0.788 . . . . 0.0 110.323 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.434 HD12 ' H ' ' A' ' 140' ' ' GLY . 4.8 mp -122.19 138.22 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -113.97 130.62 56.51 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -132.86 125.04 29.09 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.358 0.526 . . . . 0.0 110.57 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -116.06 140.65 49.06 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.823 1.249 . . . . 0.0 110.82 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 6.5 m -121.37 151.9 56.9 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 124.354 1.062 . . . . 0.0 109.925 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -65.69 84.86 0.23 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 124.374 3.383 . . . . 0.0 116.108 -177.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.21 32.07 36.38 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-O 118.041 -1.422 . . . . 0.0 112.714 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.8 mp -114.67 -72.59 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -172.05 173.74 4.28 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.737 1.215 . . . . 0.0 109.364 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -129.47 126.9 39.74 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.0 m -142.05 163.97 18.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 124.383 1.073 . . . . 0.0 111.487 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -123.93 118.93 28.17 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -137.78 163.43 31.39 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 125.869 1.667 . . . . 0.0 111.361 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -94.77 135.39 36.31 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 177.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.434 ' H ' HD12 ' A' ' 126' ' ' ILE . . . 148.84 141.27 3.43 Favored Glycine 0 CA--C 1.529 0.914 0 O-C-N 121.126 -0.984 . . . . 0.0 111.89 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -91.13 167.94 11.99 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.715 0.806 . . . . 0.0 111.524 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.4 p -131.9 150.48 33.87 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 C-N-CA 124.7 1.2 . . . . 0.0 108.316 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -105.04 111.11 23.77 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 30.9 p -52.77 -29.13 25.54 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.18 1.392 . . . . 0.0 113.052 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 39.3 mmtt -59.59 -30.4 68.65 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.312 1.445 . . . . 0.0 113.056 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 25.5 p -124.99 -47.45 1.79 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.068 0.947 . . . . 0.0 112.39 -177.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 102.44 35.03 3.97 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.056 1.312 . . . . 0.0 110.987 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -120.56 149.88 41.75 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.273 1.029 . . . . 0.0 109.638 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 8.7 mm -79.14 157.92 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 179.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 15.6 m -65.53 -42.95 94.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 123.882 0.873 . . . . 0.0 110.218 179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -157.43 154.43 28.78 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.484 2.313 . . . . 0.0 107.009 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 15.1 mmt180 -103.07 95.96 6.48 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 104.528 -2.397 . . . . 0.0 104.528 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -70.92 92.11 0.9 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 122.61 1.195 . . . . 0.0 114.097 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -71.81 -17.35 62.16 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.119 0.968 . . . . 0.0 112.476 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.52 -10.69 59.17 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.272 1.429 . . . . 0.0 110.371 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 69.8 mt -111.26 101.49 9.97 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 126.949 2.1 . . . . 0.0 108.041 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.6 m -97.54 119.22 45.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -142.58 162.87 34.36 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.268 0.627 . . . . 0.0 110.513 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 19.2 tpp180 -148.11 113.19 5.5 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.425 1.49 . . . . 0.0 110.527 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 60.3 mt -97.91 -41.59 7.94 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 157.89 175.06 28.39 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 6.0 ptmm? -130.36 127.83 22.54 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -70.35 179.1 4.27 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.036 3.157 . . . . 0.0 108.771 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -123.47 162.06 23.62 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 121.321 -0.862 . . . . 0.0 110.425 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -73.04 -50.06 25.17 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.126 0.97 . . . . 0.0 111.037 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -77.55 64.96 2.98 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 126.072 1.749 . . . . 0.0 111.734 -177.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.4 p -50.14 -32.43 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.464 1.105 . . . . 0.0 111.133 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -62.38 -37.24 84.98 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.402 1.481 . . . . 0.0 110.752 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -84.54 -15.21 46.6 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.849 1.26 . . . . 0.0 112.018 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 67.4 mtp180 -79.65 134.29 36.42 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -89.96 149.55 22.53 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -135.65 166.3 23.55 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.913 1.685 . . . . 0.0 107.149 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -122.79 153.57 39.36 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 48.1 tp -116.63 100.74 8.04 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.58 1.552 . . . . 0.0 109.524 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -117.67 178.68 4.31 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 125.175 1.39 . . . . 0.0 107.449 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -153.98 161.09 42.23 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 121.85 -0.531 . . . . 0.0 111.048 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.431 ' CG ' ' H ' ' A' ' 178' ' ' ASP . 23.2 t70 -138.78 176.24 8.86 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 126.649 1.98 . . . . 0.0 107.501 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.431 ' H ' ' CG ' ' A' ' 177' ' ' ASP . 68.2 m-20 -59.91 -16.87 33.0 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 126.169 1.788 . . . . 0.0 111.987 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.457 ' CG1' ' HE3' ' A' ' 246' ' ' LYS . 99.3 t -86.41 -37.55 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 124.293 1.037 . . . . 0.0 110.196 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 155.51 -178.94 31.85 Favored Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -78.43 165.53 23.68 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.222 1.009 . . . . 0.0 108.718 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -158.95 169.75 23.63 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 122.779 0.431 . . . . 0.0 109.922 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 96.7 mt -109.48 124.74 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 35.3 t -91.54 129.52 37.5 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -125.64 107.26 10.4 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -90.15 125.68 43.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 103.711 -2.7 . . . . 0.0 103.711 177.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 6.3 mt -113.74 112.75 41.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.73 -160.3 25.76 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 124.945 1.26 . . . . 0.0 112.554 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 84.25 56.64 0.01 OUTLIER 'General case' 0 C--O 1.239 0.529 0 C-N-CA 128.291 2.636 . . . . 0.0 108.421 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -134.05 149.62 19.8 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-O 121.651 0.584 . . . . 0.0 112.773 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -58.68 140.01 55.25 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 128.325 2.65 . . . . 0.0 109.995 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 21.7 mm -69.16 137.03 25.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 121.16 0.505 . . . . 0.0 111.21 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.3 m -85.33 104.06 14.82 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -53.99 -28.87 40.58 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.123 0.969 . . . . 0.0 112.593 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 45.5 t -42.95 -48.76 1.2 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 125.882 1.673 . . . . 0.0 111.207 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 10.0 t -124.36 -35.21 2.81 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.294 1.038 . . . . 0.0 113.241 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 105.94 36.15 2.82 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.564 1.554 . . . . 0.0 109.238 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -114.37 152.24 31.79 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 118.463 1.131 . . . . 0.0 111.535 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -66.1 163.29 17.82 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 4.9 mmt85 -89.29 28.4 1.25 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 130.648 3.579 . . . . 0.0 112.452 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 6.1 ptm -73.32 175.31 7.01 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 121.763 2.074 . . . . 0.0 111.042 -177.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.81 153.01 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 125.289 1.436 . . . . 0.0 107.24 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -115.48 114.65 25.3 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.798 1.639 . . . . 0.0 106.951 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 12.0 mm -106.07 144.79 14.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.324 1.049 . . . . 0.0 109.138 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -125.65 98.46 5.58 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.609 1.564 . . . . 0.0 112.601 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -73.06 111.48 8.21 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.571 1.148 . . . . 0.0 108.003 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 25.4 m -125.24 163.63 25.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 C-N-CA 124.932 1.293 . . . . 0.0 109.018 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 48.7 t -85.12 146.7 27.0 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -102.03 22.39 38.28 Favored Glycine 0 N--CA 1.463 0.443 0 C-N-CA 124.361 0.981 . . . . 0.0 112.042 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 67.53 -142.0 39.78 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 50.9 m -74.48 -149.71 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 127.206 2.202 . . . . 0.0 111.066 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 15.9 m120 53.55 51.62 14.84 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.991 1.716 . . . . 0.0 110.777 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -41.39 100.14 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 128.107 2.563 . . . . 0.0 111.867 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -118.99 175.96 15.9 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 126.824 2.154 . . . . 0.0 110.138 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -64.18 -67.9 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.822 2.348 . . . . 0.0 109.866 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 2.3 p -171.19 145.57 2.24 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 126.961 2.104 . . . . 0.0 108.317 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 13.9 p -149.88 172.42 15.2 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.849 0.86 . . . . 0.0 110.207 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 233' ' ' VAL . 4.1 mt -122.36 136.08 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 125.997 1.719 . . . . 0.0 107.27 177.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -77.61 -59.37 2.81 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.425 1.49 . . . . 0.0 107.94 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . 0.462 ' HA ' ' CE1' ' A' ' 120' ' ' TYR . 68.1 p-90 -159.88 162.57 34.62 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.38 1.472 . . . . 0.0 109.259 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 47.3 t -154.43 138.67 9.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.27 163.3 20.09 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.998 0.919 . . . . 0.0 110.474 178.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -71.53 143.12 50.05 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 178.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 9.4 t -118.67 -35.95 3.59 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.541 1.136 . . . . 0.0 111.547 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -129.51 -175.98 3.76 Favored 'General case' 0 C--O 1.22 -0.485 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 56.5 mt -53.35 -43.31 51.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -129.56 14.54 6.0 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.512 0.725 . . . . 0.0 112.159 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 15.8 t -115.84 142.7 28.03 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -177.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -123.76 159.8 28.69 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.362 1.065 . . . . 0.0 109.037 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -126.77 136.74 52.81 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.885 1.674 . . . . 0.0 107.824 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -137.27 146.66 45.0 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 125.814 1.646 . . . . 0.0 109.038 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -135.5 108.04 7.4 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 218' ' ' ILE . 2.8 m -101.15 149.63 6.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 124.542 1.137 . . . . 0.0 108.622 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.12 128.6 46.45 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.94 0.896 . . . . 0.0 112.39 -178.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -131.83 147.88 67.71 Favored Pre-proline 0 C--O 1.234 0.249 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 177.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -72.45 -43.55 0.97 Allowed 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.225 1.95 . . . . 0.0 110.512 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -54.46 -23.92 18.12 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 125.424 1.49 . . . . 0.0 113.39 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 5.4 tp -62.24 -32.8 73.53 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 121.229 -0.919 . . . . 0.0 110.432 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 9.0 m -61.6 -12.3 15.18 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.666 1.186 . . . . 0.0 112.469 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.83 -31.28 70.7 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 123.391 0.676 . . . . 0.0 109.344 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.49 122.15 27.68 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -47.35 -44.36 23.88 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.823 1.649 . . . . 0.0 112.841 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 1.1 tp -68.06 -30.71 69.98 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 120.975 -1.078 . . . . 0.0 113.704 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 19.2 mt -93.61 -5.0 49.77 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.876 1.671 . . . . 0.0 111.841 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -67.22 119.77 12.66 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.004 1.321 . . . . 0.0 109.944 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.457 ' HE3' ' CG1' ' A' ' 179' ' ' VAL . 13.3 mmmm -71.3 174.27 6.69 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -78.31 -10.48 59.69 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.597 -0.689 . . . . 0.0 110.062 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -129.17 34.86 4.35 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 129.663 3.185 . . . . 0.0 110.148 -178.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 . . . . . 0 C--O 1.245 0.865 0 C-N-CA 125.65 1.58 . . . . 0.0 111.823 179.002 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.145 0 N-CA-C 108.841 -1.704 . . . . 0.0 108.841 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -117.94 90.4 3.32 Favored 'General case' 0 C--N 1.334 -0.09 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.0 m 60.43 24.6 14.17 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.757 0.823 . . . . 0.0 112.316 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 21.4 m120 51.8 47.39 24.88 Favored 'General case' 0 C--N 1.344 0.342 0 C-N-CA 125.736 1.614 . . . . 0.0 107.701 -177.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.9 p -47.17 -38.04 11.17 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 126.576 1.95 . . . . 0.0 112.334 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -68.86 -32.21 71.72 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.641 1.576 . . . . 0.0 110.79 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.06 -52.76 9.51 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 178.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.86 -39.35 74.14 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 119.767 1.167 . . . . 0.0 110.353 179.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.22 -51.17 69.06 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.782 0.833 . . . . 0.0 108.942 178.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 35.4 tp -67.22 -40.03 86.36 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.826 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 41.4 mt -59.66 -54.55 45.07 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 119.514 1.052 . . . . 0.0 109.889 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 52.5 m -62.68 -44.84 95.23 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.132 0.973 . . . . 0.0 110.358 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.4 tmmm? -60.83 -50.92 71.47 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.713 -0.617 . . . . 0.0 109.934 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.1 m -53.82 -44.29 70.11 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 123.873 0.869 . . . . 0.0 109.862 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.12 -45.9 92.78 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.689 0.677 . . . . 0.0 109.76 178.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.87 -61.7 2.32 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 124.573 1.149 . . . . 0.0 113.71 -178.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.98 -34.46 78.15 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 119.118 -0.468 . . . . 0.0 110.558 -178.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.34 -53.08 48.58 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 40.3 t -57.52 -51.57 68.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-N 118.909 1.355 . . . . 0.0 111.471 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 7.6 pttp -60.39 -33.68 72.82 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.849 -179.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 35.5 m -76.33 -30.89 57.84 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 122.235 0.214 . . . . 0.0 111.095 -178.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 16.1 mt -61.83 -54.97 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -62.45 -33.5 74.94 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.901 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -60.23 -35.56 75.73 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.178 0.899 . . . . 0.0 110.942 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.1 tptp -80.27 -53.67 6.43 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 28.8 mt -57.02 -28.79 62.8 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -178.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -49.35 -26.0 2.84 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.881 1.272 . . . . 0.0 112.908 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -61.33 -63.3 1.33 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.181 0.992 . . . . 0.0 112.511 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.7 mmm-85 -154.62 178.82 9.67 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.088 1.755 . . . . 0.0 110.049 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 63.4 m -86.62 174.05 9.14 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 38.5 pt -127.92 157.54 39.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 125.762 1.625 . . . . 0.0 108.778 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -151.57 145.23 24.98 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.847 1.259 . . . . 0.0 109.609 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -140.23 120.91 14.31 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.191 0.596 . . . . 0.0 111.551 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -79.22 104.61 9.96 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 178.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.06 79.97 3.6 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 57.8 -109.14 1.66 Allowed Glycine 0 CA--C 1.53 1.023 0 C-N-CA 123.992 0.806 . . . . 0.0 111.121 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -72.27 -35.96 68.87 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 118.704 -0.665 . . . . 0.0 112.281 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -99.8 168.68 9.75 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 119.336 0.971 . . . . 0.0 112.702 -177.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.4 mp -136.51 133.82 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 N-CA-C 104.059 -2.571 . . . . 0.0 104.059 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -111.68 119.98 40.49 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -117.88 124.78 49.15 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.256 0.622 . . . . 0.0 109.437 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -117.78 136.22 53.54 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.436 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 17.8 m -113.78 154.61 45.79 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 124.184 0.994 . . . . 0.0 111.241 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -61.99 80.56 0.09 OUTLIER 'Trans proline' 0 C--N 1.351 0.661 1 C-N-CA 125.409 4.072 . . . . 0.0 116.383 -177.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 72.95 41.74 47.57 Favored Glycine 0 CA--C 1.529 0.934 0 O-C-N 120.836 -1.165 . . . . 0.0 111.258 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 3.9 mp -122.93 -69.43 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.32 0 CA-C-N 118.207 1.004 . . . . 0.0 108.553 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -164.29 169.62 17.28 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.235 1.014 . . . . 0.0 109.849 -178.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -133.06 118.32 18.63 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 176.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.7 m -135.85 164.63 31.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 125.229 1.412 . . . . 0.0 112.327 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -125.23 123.29 39.22 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.546 1.938 . . . . 0.0 108.514 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -138.31 162.56 34.06 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.561 1.145 . . . . 0.0 110.987 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -105.54 130.59 53.56 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 178.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 164.28 -159.15 31.99 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 108.476 -1.85 . . . . 0.0 108.476 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.89 159.72 43.55 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 118.757 1.279 . . . . 0.0 109.916 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.2 p -115.26 160.2 14.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 124.498 1.119 . . . . 0.0 108.578 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -105.49 110.06 22.26 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 104.24 -2.504 . . . . 0.0 104.24 177.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 17.5 p -55.27 -26.23 38.76 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 120.367 1.44 . . . . 0.0 112.762 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -61.43 -56.42 20.43 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 123.863 0.865 . . . . 0.0 111.694 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 36.6 p -93.54 -30.21 15.11 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.686 1.594 . . . . 0.0 113.332 -177.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.87 27.22 51.19 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 126.027 1.775 . . . . 0.0 112.604 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.54 151.8 38.02 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.42 1.088 . . . . 0.0 109.579 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 12.4 mm -71.23 150.97 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 29.3 m -66.5 -22.69 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 176.08 149.31 0.12 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.632 2.773 . . . . 0.0 107.519 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -88.23 114.5 24.91 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 119.443 1.019 . . . . 0.0 108.516 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.62 82.74 5.69 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -65.09 -17.4 64.43 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.344 0.657 . . . . 0.0 112.052 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 19.1 m -67.22 -10.21 48.19 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.842 1.657 . . . . 0.0 112.117 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 71.1 mt -104.3 133.01 49.93 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 104.268 -2.493 . . . . 0.0 104.268 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.9 m -128.88 116.39 40.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -144.51 154.92 43.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.073 1.349 . . . . 0.0 109.163 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -149.36 115.95 5.88 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 178.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 26.5 mt -100.14 -24.81 14.48 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 159.89 161.72 11.59 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-O 122.545 1.081 . . . . 0.0 112.199 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -124.02 109.46 29.67 Favored Pre-proline 0 N--CA 1.43 -1.429 0 C-N-CA 125.01 1.324 . . . . 0.0 111.737 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -74.86 157.23 43.49 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 123.726 2.951 . . . . 0.0 109.223 177.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -92.73 157.54 16.39 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.791 -0.568 . . . . 0.0 109.54 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.62 -47.8 74.38 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.3 0.64 . . . . 0.0 111.572 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -74.74 64.89 1.29 Allowed 'General case' 0 N--CA 1.461 0.102 0 C-N-CA 126.701 2.001 . . . . 0.0 113.162 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.4 p -47.55 -31.82 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 124.382 1.073 . . . . 0.0 112.969 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -64.85 -32.44 74.15 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 122.401 1.095 . . . . 0.0 112.283 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -87.78 -15.1 37.88 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.165 1.386 . . . . 0.0 111.173 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -80.74 133.58 35.69 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -98.78 149.2 23.11 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -134.41 169.98 16.43 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.087 1.355 . . . . 0.0 108.565 -178.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -120.77 152.97 37.65 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 122.908 0.483 . . . . 0.0 109.791 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 14.2 tp -110.59 110.62 21.4 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 125.417 1.487 . . . . 0.0 107.384 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -123.65 -179.23 4.28 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 127.316 2.246 . . . . 0.0 108.595 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -144.69 167.97 21.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.435 0.636 . . . . 0.0 111.005 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -140.64 -176.11 4.53 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 126.734 2.014 . . . . 0.0 107.646 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -64.04 -11.87 33.36 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 121.386 -0.821 . . . . 0.0 112.965 -177.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 85.0 t -106.23 -36.42 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 124.62 1.168 . . . . 0.0 112.485 -178.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 169.4 -173.62 43.74 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 119.389 0.995 . . . . 0.0 112.476 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 5.1 m-30 -79.97 162.97 24.62 Favored 'General case' 0 C--O 1.241 0.654 0 O-C-N 122.107 -0.643 . . . . 0.0 110.125 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -159.22 168.96 25.18 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.501 -1.227 . . . . 0.0 112.053 -179.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 92.1 mt -104.74 127.5 59.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 22.5 t -100.07 115.08 28.93 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.915 1.286 . . . . 0.0 108.802 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -111.83 107.01 15.91 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -89.54 111.84 23.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.447 0 N-CA-C 103.455 -2.795 . . . . 0.0 103.455 177.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 6.7 mt -95.87 106.64 18.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.01 -157.42 26.29 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.0 t 85.29 3.61 0.62 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 127.667 2.387 . . . . 0.0 108.679 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -63.74 136.78 41.5 Favored Glycine 0 N--CA 1.435 -1.411 0 N-CA-C 108.256 -1.937 . . . . 0.0 108.256 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.26 148.25 27.9 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.469 1.108 . . . . 0.0 108.842 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.8 mm -70.37 130.76 34.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 122.863 1.316 . . . . 0.0 113.893 -177.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.3 m -85.46 107.5 17.45 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 128.448 2.699 . . . . 0.0 108.171 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -53.74 -18.38 3.09 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 127.963 2.505 . . . . 0.0 113.436 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 18.0 t -56.24 -54.77 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 125.935 1.694 . . . . 0.0 109.805 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 13.3 t -123.75 -29.68 3.67 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.189 0.996 . . . . 0.0 112.49 -178.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 104.6 35.75 3.21 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -115.48 160.1 20.35 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.282 1.541 . . . . 0.0 111.9 -178.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -77.54 151.43 34.53 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 118.867 0.758 . . . . 0.0 112.996 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -71.0 28.65 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.667 1 C-N-CA 132.129 4.172 . . . . 0.0 109.988 177.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 7.0 ptm -73.47 173.78 9.15 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 122.617 1.199 . . . . 0.0 112.002 -176.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.08 147.04 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 124.488 1.115 . . . . 0.0 108.733 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -106.83 104.37 14.04 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 125.635 1.574 . . . . 0.0 107.241 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 12.6 mm -93.24 147.21 5.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -126.84 101.75 6.73 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.008 1.723 . . . . 0.0 107.638 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -84.34 111.15 19.17 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 6.4 m -125.13 168.13 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.718 0.77 . . . . 0.0 109.605 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 49.8 t -87.88 142.15 28.03 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -88.49 -0.69 81.89 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-O 118.464 -1.187 . . . . 0.0 113.07 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 61.11 57.33 19.09 Favored Glycine 0 C--N 1.339 0.739 0 N-CA-C 107.31 -2.316 . . . . 0.0 107.31 -178.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 11.7 m -135.62 143.54 45.61 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -73.38 -37.46 65.99 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 119.566 -0.254 . . . . 0.0 111.255 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 75.8 p -148.78 -176.02 5.17 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 118.53 0.604 . . . . 0.0 110.693 -178.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 121.94 -179.82 16.14 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 124.047 0.832 . . . . 0.0 115.087 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -78.88 -113.67 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 124.053 3.169 . . . . 0.0 110.973 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 19.0 p -160.21 147.7 16.34 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 120.624 -1.298 . . . . 0.0 108.951 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 82.8 p -148.04 166.43 27.79 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.632 0.773 . . . . 0.0 109.31 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 3.4 mt -105.47 149.51 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 177.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -99.1 -44.95 6.09 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.653 0.781 . . . . 0.0 112.29 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 66.9 p-90 -163.63 155.12 16.79 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.15 1.78 . . . . 0.0 107.51 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 59.1 t -151.96 131.54 3.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 C-N-CA 125.565 1.546 . . . . 0.0 107.479 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.78 163.43 36.73 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.185 0.902 . . . . 0.0 111.848 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -77.74 129.07 35.03 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 104.02 -2.585 . . . . 0.0 104.02 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 9.8 t -108.55 -28.33 9.37 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.886 1.275 . . . . 0.0 113.089 -178.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 59.1 mttt -135.9 -176.05 4.17 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 124.468 1.107 . . . . 0.0 108.621 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 68.9 mt -47.86 -47.49 12.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.591 -0.732 . . . . 0.0 112.365 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 3.7 t -133.06 18.08 4.11 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.131 1.373 . . . . 0.0 111.372 -178.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 22.0 t -114.96 142.48 27.64 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -178.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -121.29 162.94 19.38 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.202 1.401 . . . . 0.0 107.226 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -135.47 143.57 45.93 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 179.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -142.8 150.14 39.57 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -137.6 122.41 18.79 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 104.33 -2.47 . . . . 0.0 104.33 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 3.5 m -119.09 150.74 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -178.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.3 p -120.94 132.82 55.17 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.149 0.98 . . . . 0.0 111.608 -178.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 6.6 pt -138.32 154.85 74.09 Favored Pre-proline 0 N--CA 1.453 -0.278 0 C-N-CA 125.317 1.447 . . . . 0.0 109.205 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -76.08 -49.93 0.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.256 2.638 . . . . 0.0 112.296 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -53.01 -15.83 0.9 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 118.002 2.593 . . . . 0.0 118.002 -176.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 22.9 mt -77.52 -26.89 51.51 Favored 'General case' 0 CA--C 1.517 -0.308 0 O-C-N 120.958 -1.089 . . . . 0.0 109.648 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 5.8 m -56.13 -21.37 22.07 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.112 0.965 . . . . 0.0 111.724 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -59.49 -36.07 75.34 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.635 1.174 . . . . 0.0 109.347 178.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.58 125.2 30.24 Favored 'General case' 0 CA--C 1.521 -0.164 0 O-C-N 120.941 -1.1 . . . . 0.0 108.322 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -47.49 -48.83 26.94 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -178.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 22.5 mt -68.58 -26.87 65.6 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 13.8 mt -91.97 -13.47 31.02 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.219 0.608 . . . . 0.0 112.291 -178.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -58.15 141.83 49.15 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 128.283 2.633 . . . . 0.0 113.061 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp -115.72 172.02 7.39 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 127.659 2.383 . . . . 0.0 110.093 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -70.04 -33.01 71.41 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.658 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -87.4 55.22 3.43 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.813 1.645 . . . . 0.0 107.4 179.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 38.2 t70 . . . . . 0 C--O 1.249 1.027 0 C-N-CA 124.775 1.23 . . . . 0.0 110.489 179.851 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.884 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.13 -161.7 0.43 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.3 m -57.65 164.41 2.06 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.048 0.939 . . . . 0.0 110.813 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -56.29 142.76 36.55 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.51 1.124 . . . . 0.0 108.193 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.3 m -52.62 -30.68 32.64 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.241 1.016 . . . . 0.0 113.106 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -70.54 -51.44 28.65 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 123.872 0.869 . . . . 0.0 108.952 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -54.06 -50.89 65.73 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.72 -32.72 74.42 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.89 -39.26 93.78 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 56.4 tp -63.58 -38.26 90.46 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 64.8 mt -59.37 -54.55 45.45 Favored 'General case' 0 C--N 1.345 0.381 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.0 m -64.06 -45.98 86.38 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.889 0.476 . . . . 0.0 111.755 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.54 -47.61 79.07 Favored 'General case' 0 CA--C 1.516 -0.362 0 O-C-N 121.397 -0.815 . . . . 0.0 109.632 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 91.7 m -55.15 -47.3 75.31 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.358 0.663 . . . . 0.0 110.703 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -56.73 -47.0 80.97 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 123.438 0.462 . . . . 0.0 110.007 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.37 -56.93 6.05 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.854 0.835 . . . . 0.0 112.52 -178.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -56.96 -42.04 79.41 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 125.058 1.343 . . . . 0.0 110.651 -178.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.68 -52.79 39.53 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-O 117.673 -1.626 . . . . 0.0 109.594 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 50.8 t -55.89 -45.62 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 120.155 1.978 . . . . 0.0 110.485 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.2 pttp -61.3 -35.83 78.43 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.193 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 51.8 m -75.14 -36.69 61.54 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.898 0.879 . . . . 0.0 110.301 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 20.0 mt -59.17 -55.04 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 178.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -60.0 -34.22 73.03 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 124.066 0.854 . . . . 0.0 111.726 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -63.42 -37.75 88.51 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -178.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.8 mmmt -86.07 -42.79 13.64 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 19.2 mt -61.73 -29.19 69.95 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-O 117.808 -1.092 . . . . 0.0 111.685 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -47.83 -30.79 4.32 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.704 2.002 . . . . 0.0 111.807 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -64.85 -70.34 0.24 Allowed 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 122.813 0.445 . . . . 0.0 111.544 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -145.35 -178.62 6.16 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.628 1.171 . . . . 0.0 112.275 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 60.2 m -86.82 171.2 11.05 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 27.3 pt -121.91 160.35 23.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 127.087 2.155 . . . . 0.0 107.41 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -156.4 134.8 11.47 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.043 0.537 . . . . 0.0 111.957 -178.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -132.09 121.21 23.45 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.65 0.78 . . . . 0.0 110.562 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -87.95 99.44 12.14 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.41 80.71 6.72 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 127.363 2.265 . . . . 0.0 108.952 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.17 -111.53 4.08 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 108.158 -1.977 . . . . 0.0 108.158 -179.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -85.88 -24.4 26.67 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -100.53 159.4 15.18 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 119.551 1.069 . . . . 0.0 111.851 -178.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.2 mp -132.73 140.9 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -121.72 119.55 32.09 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -179.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -107.5 116.44 31.94 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.189 0.595 . . . . 0.0 110.087 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -109.27 129.19 55.52 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 122.03 -0.419 . . . . 0.0 110.673 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 52.3 m -110.95 155.9 41.68 Favored Pre-proline 0 N--CA 1.446 -0.641 0 C-N-CA 127.266 2.226 . . . . 0.0 113.312 -178.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.26 70.75 0.15 Allowed 'Trans proline' 0 CA--C 1.542 0.904 1 C-N-CA 125.647 4.231 . . . . 0.0 114.717 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 68.57 57.51 8.06 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 120.466 -1.396 . . . . 0.0 110.911 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.0 mp -124.65 -71.72 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.303 0 CA-C-N 118.333 1.067 . . . . 0.0 109.251 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -175.21 138.29 0.42 Allowed 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -109.8 125.22 52.5 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.984 0.811 . . . . 0.0 109.722 -176.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 20.0 m -142.9 163.97 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.795 1.238 . . . . 0.0 111.637 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -122.13 129.6 52.48 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.222 1.409 . . . . 0.0 108.266 178.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -139.13 162.96 33.67 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.017 0.927 . . . . 0.0 112.074 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 53.1 t60 -84.85 160.87 20.1 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 177.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 136.62 -159.42 24.49 Favored Glycine 0 C--N 1.338 0.653 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -152.24 167.12 29.61 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 128.126 2.57 . . . . 0.0 106.792 178.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.4 p -128.32 150.92 34.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 119.456 1.025 . . . . 0.0 109.544 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -106.03 106.89 17.62 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 178.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 13.5 p -52.22 -29.29 21.99 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.676 1.191 . . . . 0.0 112.597 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 43.2 mmtt -57.12 -27.93 62.25 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 127.465 2.306 . . . . 0.0 113.044 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.2 p -122.98 -47.73 2.03 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 124.609 1.164 . . . . 0.0 110.075 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 100.84 28.16 7.11 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.404 1.478 . . . . 0.0 110.15 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -124.83 147.44 48.75 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 124.688 1.195 . . . . 0.0 110.317 -179.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 9.4 mm -70.4 148.26 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 21.6 m -70.62 -10.75 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 121.57 -0.706 . . . . 0.0 112.517 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -161.29 169.29 22.4 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 125.976 1.71 . . . . 0.0 109.38 -179.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 89.2 mtm-85 -94.32 -31.71 13.93 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 120.412 1.46 . . . . 0.0 108.379 177.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 56.49 36.47 27.61 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.596 1.558 . . . . 0.0 109.066 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -47.87 -27.89 2.35 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 128.025 2.53 . . . . 0.0 114.495 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 49.5 m -59.57 -34.46 72.73 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.497 -0.752 . . . . 0.0 111.136 178.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 69.1 mt -81.23 66.28 6.7 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.453 1.501 . . . . 0.0 108.703 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 3.0 p -74.08 107.75 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -122.71 158.36 30.27 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 125.703 1.601 . . . . 0.0 107.395 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -140.86 134.01 29.46 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 58.7 mt -119.92 -26.25 5.65 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 125.286 1.616 . . . . 0.0 108.031 178.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 156.13 154.61 7.05 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 119.543 1.065 . . . . 0.0 111.096 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -117.57 109.95 41.23 Favored Pre-proline 0 C--O 1.236 0.347 0 C-N-CA 124.138 0.975 . . . . 0.0 108.412 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -73.3 -169.44 0.52 Allowed 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 124.003 3.135 . . . . 0.0 109.445 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -126.86 156.32 41.55 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.833 1.253 . . . . 0.0 108.549 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.44 -45.29 39.61 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.361 0.664 . . . . 0.0 111.247 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -74.9 65.75 1.45 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.602 1.561 . . . . 0.0 111.518 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.3 p -45.55 -35.09 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 124.762 1.225 . . . . 0.0 112.52 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -63.9 -36.43 83.91 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -178.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -74.31 -15.84 60.95 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.746 0.819 . . . . 0.0 113.046 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 20.5 mtp-105 -78.22 178.17 7.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 122.096 0.951 . . . . 0.0 110.097 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -127.27 144.6 51.01 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 178.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -132.22 165.95 22.97 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -123.89 147.74 47.42 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 16.0 tp -114.58 98.06 6.66 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -112.25 -179.26 3.63 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 127.856 2.463 . . . . 0.0 106.757 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -149.4 165.22 32.72 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.617 0.722 . . . . 0.0 109.446 178.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -135.88 179.64 6.22 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 126.654 1.981 . . . . 0.0 110.513 -178.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.26 -18.75 63.89 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.904 1.282 . . . . 0.0 109.656 178.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 25.6 t -87.24 -25.3 6.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 129.771 3.228 . . . . 0.0 111.805 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 132.87 -167.95 23.07 Favored Glycine 0 N--CA 1.444 -0.779 0 O-C-N 121.279 -0.888 . . . . 0.0 111.701 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -77.71 163.31 26.29 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 121.841 -0.8 . . . . 0.0 110.367 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -160.73 167.36 27.03 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.635 1.174 . . . . 0.0 111.082 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 83.9 mt -106.15 138.28 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 17.4 t -113.01 135.15 54.09 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.041 0.937 . . . . 0.0 109.052 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -127.22 110.88 13.32 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 125.815 1.646 . . . . 0.0 108.57 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -93.52 111.49 24.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 7.5 mt -98.45 108.28 21.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 179.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -94.63 -153.28 30.14 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 66.6 m 66.19 54.73 0.94 Allowed 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.208 1.003 . . . . 0.0 112.912 178.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -102.02 -137.84 9.83 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -140.58 128.8 22.32 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 177.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 28.8 mm -60.21 132.3 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 121.911 0.862 . . . . 0.0 111.743 -178.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 3.0 m -84.92 111.34 19.58 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 128.101 2.56 . . . . 0.0 109.245 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.76 -19.58 11.73 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.125 1.77 . . . . 0.0 113.774 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 60.9 t -56.62 -51.75 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 124.652 1.181 . . . . 0.0 110.33 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 13.9 t -125.12 -25.1 3.89 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 99.0 35.51 4.79 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 107.556 -2.218 . . . . 0.0 107.556 -178.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -103.98 152.52 21.91 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 118.519 1.16 . . . . 0.0 113.732 -178.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -78.42 138.94 38.74 Favored 'General case' 0 C--N 1.335 -0.052 0 C-N-CA 124.025 0.93 . . . . 0.0 109.152 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . 0.3 34.3 ttt180 -69.94 30.52 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 130.705 3.602 . . . . 0.0 113.598 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 5.2 ptm -74.18 171.92 12.71 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.056 -1.028 . . . . 0.0 109.216 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.77 148.79 22.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 C-N-CA 124.679 1.191 . . . . 0.0 107.819 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -110.17 116.39 31.43 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 14.4 mm -103.97 141.08 20.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -124.43 110.09 14.1 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 126.067 1.747 . . . . 0.0 109.774 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -87.31 110.85 20.51 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.479 1.111 . . . . 0.0 108.875 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 11.2 m -123.11 163.66 21.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 46.1 t -88.07 146.58 25.38 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -97.86 16.91 59.62 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-O 117.914 -1.492 . . . . 0.0 113.057 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 45.5 28.39 2.33 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 126.646 2.07 . . . . 0.0 113.875 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.0 151.49 19.49 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.08 -1.247 . . . . 0.0 108.375 -179.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -61.22 -42.46 98.64 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 122.983 0.513 . . . . 0.0 111.613 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 57.7 m -161.91 176.93 10.3 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 128.862 2.865 . . . . 0.0 107.474 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 149.1 176.41 22.36 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 121.071 -1.018 . . . . 0.0 113.018 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -79.1 -99.14 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 124.322 3.348 . . . . 0.0 110.145 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 4.6 p -166.88 148.27 6.02 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 127.055 2.142 . . . . 0.0 107.34 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 10.4 p -154.39 165.97 34.72 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.182 1.393 . . . . 0.0 109.556 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 4.9 mt -108.54 153.81 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 126.567 1.947 . . . . 0.0 106.592 178.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -101.1 -52.21 3.33 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 123.44 0.696 . . . . 0.0 110.484 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 58.9 p-90 -157.07 157.32 34.36 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -178.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 91.3 t -153.16 122.56 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -178.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.22 167.5 29.6 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.511 1.05 . . . . 0.0 110.784 178.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -73.07 132.05 42.85 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 6.7 t -109.35 -38.59 5.45 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.427 1.091 . . . . 0.0 110.22 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 6.7 mttt -130.92 178.57 6.57 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 73.1 mt -49.51 -46.98 20.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -126.19 22.32 7.24 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 6.5 t -122.86 138.64 52.25 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.545 0 O-C-N 121.191 -0.943 . . . . 0.0 110.081 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -120.97 162.26 20.2 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -132.53 145.71 51.35 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.24 119.36 8.26 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.218 1.007 . . . . 0.0 108.471 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -107.36 126.93 53.08 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 4.0 m -118.14 154.38 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-N 117.717 0.235 . . . . 0.0 110.797 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 2.3 p -121.56 124.82 45.31 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.33 1.052 . . . . 0.0 110.911 -177.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 2.3 pt -136.84 129.49 17.29 Favored Pre-proline 0 N--CA 1.444 -0.728 0 CA-C-N 114.922 -1.035 . . . . 0.0 108.831 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -64.85 -31.12 57.82 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.065 2.51 . . . . 0.0 113.388 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -64.25 -14.13 53.74 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -177.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 44.6 mt -76.88 -31.03 56.48 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 120.475 -1.391 . . . . 0.0 109.908 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 15.6 m -55.88 -12.06 1.24 Allowed 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -70.42 -32.04 69.48 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 121.497 -0.752 . . . . 0.0 110.043 179.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.9 mt -80.71 123.16 27.96 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.669 1.988 . . . . 0.0 106.671 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -47.51 -48.09 27.44 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.074 1.349 . . . . 0.0 114.081 -178.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 56.1 mt -66.65 -32.53 73.91 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 119.298 0.954 . . . . 0.0 112.847 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 15.9 mt -91.68 -5.57 53.53 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -65.31 134.42 53.54 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 127.55 2.34 . . . . 0.0 110.3 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -107.24 152.45 24.08 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 125.214 1.406 . . . . 0.0 111.146 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -89.98 -47.27 7.96 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.231 -0.895 . . . . 0.0 113.211 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -146.43 26.59 1.16 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -177.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 30.0 t70 . . . . . 0 C--O 1.242 0.675 0 CA-C-O 117.869 -1.062 . . . . 0.0 108.342 179.04 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.373 0 N-CA-C 106.675 -2.57 . . . . 0.0 106.675 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.75 57.72 3.52 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 104.535 -2.395 . . . . 0.0 104.535 177.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . 0.273 14.4 m -58.12 -11.41 2.56 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.996 2.118 . . . . 0.0 115.765 -177.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -68.55 -48.8 63.32 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 176.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 75.4 m -62.05 -35.87 79.9 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 125.053 1.341 . . . . 0.0 110.41 178.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -62.98 -34.85 78.4 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.547 -0.721 . . . . 0.0 111.004 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -78.12 -48.12 16.68 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 118.303 -0.856 . . . . 0.0 109.319 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.2 p -57.15 -31.62 65.55 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-N 118.999 0.818 . . . . 0.0 111.632 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.54 -43.63 84.53 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 53.1 tp -68.28 -36.7 79.79 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-O 118.459 -0.782 . . . . 0.0 109.401 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.5 mt -60.26 -54.69 42.78 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 118.935 0.789 . . . . 0.0 109.694 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 50.9 m -58.78 -49.12 78.87 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.314 1.046 . . . . 0.0 109.845 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.22 -44.69 96.86 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 118.095 -0.955 . . . . 0.0 110.905 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 63.0 m -52.33 -49.3 64.54 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 119.286 0.948 . . . . 0.0 110.682 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -55.38 -50.73 68.94 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 122.744 0.417 . . . . 0.0 110.101 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.36 -55.49 15.63 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 115.151 1.538 . . . . 0.0 115.151 -178.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -64.94 -38.1 89.84 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.497 1.119 . . . . 0.0 110.648 -177.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.03 -52.57 51.42 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 54.2 t -57.37 -44.88 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 118.671 1.236 . . . . 0.0 109.72 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -61.7 -35.78 79.02 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 118.53 -1.268 . . . . 0.0 111.643 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 59.3 m -65.64 -46.43 79.22 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -178.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 19.3 mt -56.92 -54.96 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 CA-C-O 121.568 0.699 . . . . 0.0 109.738 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -64.61 -27.81 69.19 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -62.61 -42.73 99.75 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -83.25 -43.16 16.37 Favored 'General case' 0 C--N 1.341 0.234 0 O-C-N 121.278 -0.889 . . . . 0.0 113.038 -179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.4 mt -62.87 -27.38 69.31 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.099 0.863 . . . . 0.0 113.243 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -44.38 -33.86 1.8 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.484 1.514 . . . . 0.0 113.825 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -64.43 -69.5 0.28 Allowed 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.909 1.283 . . . . 0.0 113.944 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 -140.07 172.58 12.55 Favored 'General case' 0 CA--C 1.518 -0.27 0 O-C-N 121.097 -1.002 . . . . 0.0 112.979 -177.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 37.7 m -87.13 160.7 18.45 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 178.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 34.9 pt -114.37 157.03 15.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 124.906 1.282 . . . . 0.0 107.544 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -151.4 134.29 15.75 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 123.801 0.84 . . . . 0.0 109.263 -178.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -133.16 120.95 21.87 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 123.741 0.817 . . . . 0.0 111.615 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -84.48 101.41 12.02 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.542 1.137 . . . . 0.0 108.614 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.75 80.34 3.76 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.04 -124.65 20.51 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -70.97 -31.2 67.69 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 48.0 m95 -99.83 152.02 20.61 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 118.546 0.612 . . . . 0.0 110.344 -178.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.7 mp -125.15 144.73 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 104.481 -2.415 . . . . 0.0 104.481 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -122.12 119.68 32.04 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -178.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -113.63 126.51 55.35 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.918 0.887 . . . . 0.0 109.091 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -124.98 126.77 45.97 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.424 0.69 . . . . 0.0 109.801 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 15.0 m -104.46 155.96 36.57 Favored Pre-proline 0 CA--C 1.532 0.257 0 C-N-CA 123.929 0.892 . . . . 0.0 111.47 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -63.13 83.25 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 124.385 3.39 . . . . 0.0 114.597 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.38 42.96 63.81 Favored Glycine 0 CA--C 1.526 0.77 0 O-C-N 120.776 -1.202 . . . . 0.0 113.079 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 3.6 mp -122.7 -70.25 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -161.86 168.52 22.9 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.849 1.259 . . . . 0.0 110.611 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -132.42 126.84 34.07 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 104.459 -2.422 . . . . 0.0 104.459 177.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.2 m -144.81 164.17 13.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 124.999 1.32 . . . . 0.0 112.321 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -130.24 118.77 21.86 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -137.9 162.82 33.04 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.871 1.668 . . . . 0.0 111.23 -178.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -94.08 148.29 22.32 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 142.18 -170.62 24.92 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 125.301 1.429 . . . . 0.0 110.343 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.93 167.51 21.96 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 121.082 -1.246 . . . . 0.0 109.492 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.2 p -107.67 132.75 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 178.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -87.37 115.03 24.5 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 67.2 p -57.06 -22.41 38.95 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.018 0.927 . . . . 0.0 113.376 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.54 -49.42 76.4 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 124.344 1.058 . . . . 0.0 111.332 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 49.2 p -113.57 -22.64 10.2 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -176.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 79.31 34.78 31.63 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.453 1.025 . . . . 0.0 111.374 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -122.06 148.39 44.91 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.469 1.108 . . . . 0.0 109.742 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 24.0 mm -75.62 153.89 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 15.9 m -58.69 -34.76 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.315 1.046 . . . . 0.0 113.042 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 61.7 m-80 -155.18 152.69 29.69 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.77 1.628 . . . . 0.0 109.657 -179.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 -106.57 103.99 13.57 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 177.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 38.58 81.57 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 127.737 2.415 . . . . 0.0 111.729 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -60.95 -79.65 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 65.8 p -126.83 -1.42 6.64 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.753 1.621 . . . . 0.0 110.418 177.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 67.6 mt -82.18 74.63 9.15 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 126.855 2.062 . . . . 0.0 111.135 -177.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 16.4 m -74.79 116.91 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 178.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -148.56 151.51 35.19 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.603 1.161 . . . . 0.0 108.691 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -145.45 136.87 25.08 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 124.69 1.196 . . . . 0.0 107.926 178.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.1 mp -116.15 -27.74 6.8 Favored 'General case' 0 C--O 1.221 -0.444 0 O-C-N 125.486 1.741 . . . . 0.0 107.277 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 157.3 163.45 12.55 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -126.97 110.24 21.92 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 124.03 0.932 . . . . 0.0 111.428 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -71.96 177.57 6.91 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.907 3.071 . . . . 0.0 109.274 178.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -121.1 146.67 46.49 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.31 -45.94 76.3 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.171 1.388 . . . . 0.0 112.178 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.441 HD21 ' CD ' ' A' ' 169' ' ' GLU . 48.8 m-20 -73.41 67.13 1.0 Allowed 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 127.581 2.353 . . . . 0.0 110.249 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.5 p -44.82 -32.74 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 O-C-N 121.196 -0.94 . . . . 0.0 113.385 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -65.25 -31.74 73.05 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 119.186 0.903 . . . . 0.0 111.671 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.441 ' CD ' HD21 ' A' ' 166' ' ' ASN . 98.0 mt-10 -71.74 -30.56 65.74 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 124.03 0.932 . . . . 0.0 110.049 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 25.7 mtt180 -69.08 152.46 45.17 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -114.06 143.12 45.29 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -129.63 168.06 17.02 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.159 1.384 . . . . 0.0 112.072 -177.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -133.62 154.67 50.71 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 124.884 1.274 . . . . 0.0 111.265 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 57.5 tp -109.23 98.63 8.03 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 127.28 2.232 . . . . 0.0 110.252 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -112.17 -179.26 3.63 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 127.649 2.38 . . . . 0.0 108.581 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -141.7 166.29 25.15 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.188 0.518 . . . . 0.0 111.461 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -139.28 179.99 6.21 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 127.313 2.245 . . . . 0.0 108.39 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -57.4 -19.25 22.11 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.477 1.111 . . . . 0.0 112.389 -178.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 40.7 t -92.6 -54.84 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 O-C-N 120.651 -1.281 . . . . 0.0 110.43 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 178.7 -153.52 12.78 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -178.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -86.64 168.79 13.29 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 122.43 1.109 . . . . 0.0 110.772 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -158.57 176.09 12.84 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.014 1.725 . . . . 0.0 109.559 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 89.3 mt -110.95 138.27 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 176.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 14.2 t -100.96 128.53 46.95 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -129.15 110.03 11.66 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -92.42 135.66 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 104.604 -2.369 . . . . 0.0 104.604 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 3.8 mt -112.74 106.2 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 104.782 -2.303 . . . . 0.0 104.782 176.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -99.32 -155.49 28.65 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.5 t 68.72 56.19 0.45 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-O 122.516 1.151 . . . . 0.0 111.766 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -131.82 157.07 22.23 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 128.401 2.905 . . . . 0.0 106.396 177.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -72.62 150.91 42.64 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.219 1.007 . . . . 0.0 112.273 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.9 mm -65.99 136.23 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-O 121.274 0.559 . . . . 0.0 110.379 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.5 m -79.87 115.52 19.5 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.707 2.003 . . . . 0.0 106.979 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -55.06 -21.7 13.39 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.863 1.265 . . . . 0.0 112.957 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 31.6 t -51.44 -61.16 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.205 0 C-N-CA 126.966 2.106 . . . . 0.0 112.24 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 5.1 t -125.69 -24.12 3.9 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.318 1.047 . . . . 0.0 113.762 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 105.61 34.87 3.2 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -178.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -98.91 149.72 22.65 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 118.851 1.326 . . . . 0.0 112.112 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -74.71 141.04 44.52 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.942 0.897 . . . . 0.0 110.737 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -66.64 27.71 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 131.269 3.828 . . . . 0.0 113.882 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 8.2 ptm -75.14 177.09 6.7 Favored 'General case' 0 C--N 1.319 -0.743 0 O-C-N 120.788 -1.195 . . . . 0.0 111.787 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.0 p -147.18 153.62 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 126.612 1.965 . . . . 0.0 106.408 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -116.77 117.63 30.3 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.801 1.24 . . . . 0.0 108.324 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 9.2 mm -102.25 148.53 7.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -126.09 103.73 7.87 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 128.274 2.63 . . . . 0.0 108.97 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -83.25 109.8 17.54 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.967 1.307 . . . . 0.0 108.706 178.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 5.8 m -125.17 163.4 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 47.5 t -84.76 139.83 31.69 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 178.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -86.97 -0.07 85.87 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 118.369 -1.239 . . . . 0.0 112.7 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 58.71 59.24 11.15 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 3.6 m -138.3 148.73 44.96 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -64.17 -47.51 79.55 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -178.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 85.3 p -151.0 -176.15 5.42 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.06 0.944 . . . . 0.0 109.497 -179.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 129.95 172.55 13.17 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 124.804 1.192 . . . . 0.0 112.673 178.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -75.63 -104.06 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.745 2.963 . . . . 0.0 112.003 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.7 p -158.66 148.94 19.78 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.283 1.433 . . . . 0.0 108.751 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 1.7 p -152.62 170.51 20.04 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.423 1.089 . . . . 0.0 110.365 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 4.8 mt -113.17 154.37 14.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 126.406 1.883 . . . . 0.0 107.291 178.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -104.38 -46.6 4.35 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.886 0.875 . . . . 0.0 111.527 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -160.93 155.63 23.71 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.972 1.709 . . . . 0.0 107.781 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 59.9 t -154.05 123.56 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 125.68 1.592 . . . . 0.0 106.999 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -154.13 161.68 41.71 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 118.913 0.779 . . . . 0.0 111.21 179.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -69.18 136.99 52.9 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 2.0 t -119.2 -28.75 5.37 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.199 1.0 . . . . 0.0 111.866 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -134.98 -176.66 4.32 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 124.123 0.969 . . . . 0.0 108.709 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 1.9 mm -50.41 -48.98 25.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 123.346 0.659 . . . . 0.0 112.133 -178.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -128.13 23.56 6.04 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.373 1.469 . . . . 0.0 111.63 -178.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 14.1 t -127.47 146.37 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 CA-C-O 122.045 0.926 . . . . 0.0 110.367 -178.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -126.14 161.84 26.73 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -134.35 141.32 46.85 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -140.09 140.12 36.01 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 125.31 1.444 . . . . 0.0 110.233 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -120.47 114.35 21.65 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 2.5 m -107.87 148.1 12.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.4 p -122.17 135.93 54.84 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 123.567 0.747 . . . . 0.0 111.927 -178.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -140.6 152.25 65.68 Favored Pre-proline 0 N--CA 1.451 -0.402 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.074 177.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -74.91 -50.86 0.13 Allowed 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.496 2.797 . . . . 0.0 111.995 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -52.98 -27.13 17.69 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 117.606 -1.188 . . . . 0.0 113.911 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 9.8 tp -59.23 -25.39 63.98 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 120.538 1.517 . . . . 0.0 112.258 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 3.4 m -64.74 -9.2 18.47 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.805 0.842 . . . . 0.0 111.963 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 42.5 p-10 -60.29 -40.3 89.95 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 125.337 1.455 . . . . 0.0 109.418 178.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -83.7 123.91 30.32 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 124.78 1.232 . . . . 0.0 108.591 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -47.18 -47.89 23.93 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.749 2.02 . . . . 0.0 113.31 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 40.6 mt -65.6 -20.09 66.17 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -178.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 5.2 mt -107.1 -11.75 15.56 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.176 1.39 . . . . 0.0 112.249 -178.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -63.29 131.12 47.3 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 128.479 2.712 . . . . 0.0 110.082 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt -100.5 166.48 10.9 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.237 1.015 . . . . 0.0 110.017 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -81.27 -8.83 59.82 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -178.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.17 30.52 4.77 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.67 1.188 . . . . 0.0 112.294 -177.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.252 1.198 0 C-N-CA 125.036 1.334 . . . . 0.0 107.423 177.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.917 0 CA-C-O 119.196 -0.78 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -118.16 -30.38 5.31 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.439 ' C ' ' H ' ' A' ' 92' ' ' SER . 13.5 p -149.85 -74.29 0.17 Allowed 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -76.77 37.2 0.18 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.679 1.592 . . . . 0.0 109.57 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.439 ' H ' ' C ' ' A' ' 90' ' ' SER . 4.7 t -64.5 -42.23 95.95 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 128.159 2.583 . . . . 0.0 110.607 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -65.36 -22.68 66.83 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 121.785 -0.572 . . . . 0.0 111.97 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.67 -56.39 14.09 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 178.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.72 -34.6 78.23 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 123.199 0.6 . . . . 0.0 111.012 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.54 -43.4 89.24 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 13.0 tp -69.71 -36.18 75.7 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.239 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 62.3 mt -59.13 -54.72 43.83 Favored 'General case' 0 C--N 1.343 0.288 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 20.7 m -65.37 -42.29 92.88 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 121.559 -0.713 . . . . 0.0 110.938 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.29 -42.4 95.39 Favored 'General case' 0 C--N 1.341 0.214 0 O-C-N 120.874 -1.141 . . . . 0.0 110.472 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 80.3 m -56.59 -46.45 80.81 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.776 0.83 . . . . 0.0 109.805 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -59.79 -45.14 93.25 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 118.233 0.47 . . . . 0.0 110.604 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -65.19 -61.11 2.33 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 122.26 1.029 . . . . 0.0 112.013 -178.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -62.3 -36.89 83.53 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.369 -178.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -65.6 -53.35 32.18 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-O 118.114 -1.381 . . . . 0.0 110.149 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 45.4 t -58.28 -44.16 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 119.913 1.857 . . . . 0.0 109.957 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.7 ptmt -64.74 -32.94 74.85 Favored 'General case' 0 C--O 1.226 -0.168 0 C-N-CA 119.604 -0.839 . . . . 0.0 111.695 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.6 m -76.08 -33.78 59.53 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 123.441 0.696 . . . . 0.0 109.738 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 16.6 mt -62.75 -55.52 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 178.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -61.92 -28.57 69.62 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 117.948 -1.025 . . . . 0.0 112.39 -179.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.64 -38.16 86.68 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.963 1.256 . . . . 0.0 112.656 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.411 ' HE3' ' CD ' ' A' ' 237' ' ' GLU . 0.6 OUTLIER -95.48 -37.48 10.88 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.491 -0.755 . . . . 0.0 110.847 179.538 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.654 ' CD2' ' HG ' ' A' ' 216' ' ' SER . 15.8 mt -62.64 -28.35 69.86 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 118.66 0.664 . . . . 0.0 110.734 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -50.15 -34.71 23.23 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.613 1.165 . . . . 0.0 113.536 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -55.5 -61.74 2.15 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.735 1.214 . . . . 0.0 112.554 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -151.61 174.59 13.27 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.86 1.664 . . . . 0.0 110.761 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 56.7 m -86.61 170.94 11.4 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 114.006 -1.452 . . . . 0.0 108.684 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 29.6 pt -127.78 162.82 32.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 126.272 1.829 . . . . 0.0 109.004 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.72 145.28 22.24 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -136.87 125.7 24.09 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -88.88 108.04 19.32 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.075 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.37 80.3 3.93 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 178.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 58.75 -107.92 1.35 Allowed Glycine 0 CA--C 1.53 0.989 0 O-C-N 121.807 -0.558 . . . . 0.0 111.713 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -81.47 -17.88 47.2 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.546 1.938 . . . . 0.0 113.715 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 65.8 m95 -111.88 157.39 20.68 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 123.406 0.682 . . . . 0.0 110.121 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.2 mp -133.3 136.84 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -113.33 129.95 56.4 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -121.55 125.61 47.19 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 123.682 0.793 . . . . 0.0 110.885 -178.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -124.77 129.94 51.43 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.899 0.857 . . . . 0.0 110.63 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 2.1 m -111.18 156.41 41.07 Favored Pre-proline 0 C--N 1.33 -0.262 0 C-N-CA 125.303 1.441 . . . . 0.0 110.314 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -64.36 82.04 0.16 Allowed 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.775 2.983 . . . . 0.0 114.097 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 69.79 50.14 31.8 Favored Glycine 0 CA--C 1.533 1.209 0 O-C-N 120.785 -1.197 . . . . 0.0 113.683 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 3.4 mp -125.18 -68.28 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 119.042 1.421 . . . . 0.0 108.508 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -165.72 159.3 16.14 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 124.906 1.282 . . . . 0.0 109.213 179.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -122.96 123.07 40.08 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 104.554 -2.387 . . . . 0.0 104.554 176.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 16.6 m -143.37 163.98 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 123.485 0.714 . . . . 0.0 110.654 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -123.77 117.91 25.99 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -139.76 163.37 32.79 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 118.937 0.79 . . . . 0.0 112.039 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -90.07 154.99 19.37 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.273 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 144.19 -162.95 27.85 Favored Glycine 0 C--N 1.334 0.468 0 O-C-N 120.674 -1.266 . . . . 0.0 111.583 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -145.35 160.78 41.01 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 126.601 1.96 . . . . 0.0 107.013 178.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.6 p -126.97 156.57 38.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -100.56 109.79 21.9 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 2.0 p -60.92 -7.85 2.71 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.783 0.833 . . . . 0.0 113.079 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -83.15 -26.99 30.41 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 125.808 1.643 . . . . 0.0 112.095 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.7 p -121.67 -48.65 2.15 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 124.154 0.982 . . . . 0.0 112.482 -178.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 108.1 21.98 7.45 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.963 1.268 . . . . 0.0 113.08 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -124.51 152.25 43.65 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 119.275 1.537 . . . . 0.0 112.069 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 5.5 mm -69.19 153.87 8.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 C-N-CA 124.96 1.304 . . . . 0.0 108.853 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 12.7 m -60.0 -53.63 45.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.97 1.308 . . . . 0.0 109.542 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -158.59 159.92 35.99 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.08 1.752 . . . . 0.0 109.623 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 -83.37 153.68 24.43 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 178.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 28.7 p-10 -128.05 81.65 2.04 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 127.375 2.27 . . . . 0.0 111.555 -178.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -50.64 -38.08 44.15 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.615 1.566 . . . . 0.0 114.546 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 16.5 m -73.24 -5.82 41.9 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 33.3 mt -124.26 37.21 4.46 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.755 1.222 . . . . 0.0 112.161 -177.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 8.1 p -74.81 138.63 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-O 121.89 0.852 . . . . 0.0 110.15 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -135.56 172.08 13.52 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 128.327 2.651 . . . . 0.0 108.051 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.96 104.94 3.48 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.697 1.199 . . . . 0.0 109.414 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.3 mp -90.99 -28.59 17.91 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 162.76 156.77 8.68 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.7 mtpt -122.29 110.06 32.77 Favored Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 123.697 0.799 . . . . 0.0 108.997 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -79.73 170.12 17.34 Favored 'Trans proline' 0 N--CA 1.456 -0.698 1 C-N-CA 125.736 4.291 . . . . 0.0 109.133 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -105.7 159.72 15.76 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 123.036 0.534 . . . . 0.0 110.703 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -72.99 -43.39 62.25 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -73.39 64.01 0.8 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.416 1.486 . . . . 0.0 110.279 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.4 p -53.51 -29.48 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 O-C-N 120.653 -1.279 . . . . 0.0 110.821 178.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -63.13 -28.04 69.79 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.897 1.679 . . . . 0.0 112.748 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -88.57 -19.78 25.88 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 125.405 1.482 . . . . 0.0 112.462 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -77.77 154.68 31.74 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -107.85 149.45 28.25 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -137.13 173.99 11.09 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 126.681 1.992 . . . . 0.0 109.24 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -132.99 153.93 50.99 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.411 1.085 . . . . 0.0 110.455 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 25.1 tp -115.05 98.55 6.87 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 127.03 2.132 . . . . 0.0 108.53 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -110.09 -178.88 3.63 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.33 1.452 . . . . 0.0 110.079 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -135.22 153.85 51.79 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.952 0.901 . . . . 0.0 109.04 177.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.468 ' CG ' ' H ' ' A' ' 178' ' ' ASP . 15.1 t70 -130.46 175.41 8.99 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 128.087 2.555 . . . . 0.0 107.866 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.468 ' H ' ' CG ' ' A' ' 177' ' ' ASP . 19.9 t0 -56.76 -16.86 7.26 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 129.099 2.96 . . . . 0.0 111.252 179.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 67.4 t -99.55 -50.42 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 126.803 2.041 . . . . 0.0 108.859 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 170.04 -161.46 34.65 Favored Glycine 0 C--N 1.336 0.553 0 CA-C-N 119.1 0.864 . . . . 0.0 112.339 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 -77.16 156.0 31.89 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 117.751 0.776 . . . . 0.0 110.891 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -157.35 166.63 32.54 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.21 1.004 . . . . 0.0 112.03 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 96.6 mt -105.34 142.06 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 15.9 t -111.24 138.58 47.52 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.238 1.415 . . . . 0.0 107.849 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -130.06 109.3 10.74 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 124.606 1.162 . . . . 0.0 108.402 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.8 mp -93.77 117.47 37.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 6.4 mt -108.12 106.38 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -125.01 142.82 14.14 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 108.111 -1.996 . . . . 0.0 108.111 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 22.7 t 162.83 25.21 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 129.949 3.3 . . . . 0.0 106.968 -178.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -99.0 159.31 20.12 Favored Glycine 0 CA--C 1.505 -0.549 0 O-C-N 120.328 -1.482 . . . . 0.0 111.55 -178.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.44 167.17 15.28 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 178.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 35.0 mm -84.07 135.82 24.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 O-C-N 121.177 -0.952 . . . . 0.0 111.955 -178.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -81.51 104.32 11.85 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 177.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -50.94 -31.69 18.51 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.553 1.141 . . . . 0.0 111.593 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 18.8 t -47.77 -47.33 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 128.72 2.808 . . . . 0.0 112.752 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 7.5 t -124.51 -39.69 2.29 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 110.57 36.16 1.95 Allowed Glycine 0 C--N 1.335 0.512 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -178.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -128.24 154.16 46.16 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 118.995 1.397 . . . . 0.0 110.567 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -66.16 168.26 8.79 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.102 0.561 . . . . 0.0 110.204 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -87.75 30.8 0.8 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 130.259 3.424 . . . . 0.0 110.335 177.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 5.9 ptm -72.58 175.42 6.36 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 120.576 -1.327 . . . . 0.0 111.815 -177.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.1 p -139.93 152.04 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 125.215 1.406 . . . . 0.0 109.19 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -114.27 104.08 11.72 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.511 1.924 . . . . 0.0 107.179 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 13.4 mm -91.69 143.7 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -124.72 99.31 6.1 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.624 1.57 . . . . 0.0 107.118 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -78.86 110.2 13.83 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 4.5 m -123.8 160.58 27.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 124.649 1.18 . . . . 0.0 108.678 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 53.5 t -82.41 141.26 32.92 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 179.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -90.16 3.34 82.33 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-O 118.421 -1.21 . . . . 0.0 114.916 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 56.5 75.52 0.24 Allowed Glycine 0 CA--C 1.523 0.585 0 C-N-CA 124.688 1.137 . . . . 0.0 111.967 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 6.7 t -157.29 163.52 38.63 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 178.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -63.91 -61.28 2.39 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.111 0.965 . . . . 0.0 113.148 -178.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 3.3 t -158.12 163.06 37.98 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 149.34 167.53 14.08 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 126.013 1.768 . . . . 0.0 111.261 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -65.08 -92.22 0.0 OUTLIER 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 124.882 3.721 . . . . 0.0 114.624 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' SER . . . . . 0.654 ' HG ' ' CD2' ' A' ' 113' ' ' LEU . 4.9 p -173.46 156.28 3.0 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.021 -1.049 . . . . 0.0 113.245 -177.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 20.5 p -155.31 172.95 17.34 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.892 1.277 . . . . 0.0 108.255 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 7.5 mt -114.77 148.12 17.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 126.399 1.88 . . . . 0.0 108.465 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -89.37 -51.69 5.42 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.959 0.903 . . . . 0.0 110.961 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 64.8 p-90 -161.53 160.81 29.52 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.42 1.888 . . . . 0.0 107.189 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 88.0 t -148.92 127.89 3.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 125.586 1.555 . . . . 0.0 107.361 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -158.77 159.4 35.13 Favored 'General case' 0 C--O 1.239 0.522 0 O-C-N 121.392 -0.818 . . . . 0.0 112.012 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -67.48 135.12 52.56 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 177.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 8.8 t -109.51 -36.64 5.92 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.86 -0.525 . . . . 0.0 111.138 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 14.5 mttt -129.22 -175.48 3.58 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 124.274 1.03 . . . . 0.0 108.625 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 73.3 mt -51.19 -41.9 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -133.1 9.89 4.14 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.154 0.982 . . . . 0.0 112.453 -178.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 15.0 t -109.28 142.49 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.683 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -177.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -119.76 158.91 25.56 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.216 1.406 . . . . 0.0 107.586 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -136.38 141.86 43.71 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -144.61 121.04 10.99 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.339 1.056 . . . . 0.0 111.337 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -95.05 110.08 22.05 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 105.523 -2.029 . . . . 0.0 105.523 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 61.9 t -101.41 129.5 52.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -114.73 122.02 45.13 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.101 1.36 . . . . 0.0 111.913 -178.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 10.8 pt -132.3 139.26 34.3 Favored Pre-proline 0 N--CA 1.453 -0.312 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -66.84 -34.63 29.91 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 121.762 1.641 . . . . 0.0 111.37 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . 0.411 ' CD ' ' HE3' ' A' ' 112' ' ' LYS . 75.4 mm-40 -54.53 -32.66 58.64 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 126.571 1.949 . . . . 0.0 115.023 -178.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 43.5 mt -59.91 -29.47 68.38 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.766 1.166 . . . . 0.0 112.353 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 33.8 m -59.04 -11.85 4.01 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.938 0.895 . . . . 0.0 112.471 179.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -59.87 -25.68 65.25 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 118.668 -0.682 . . . . 0.0 111.106 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -97.27 132.24 43.21 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.904 1.282 . . . . 0.0 108.15 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -46.99 -46.89 21.99 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.297 1.839 . . . . 0.0 112.062 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 69.1 mt -58.13 -45.25 87.66 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 6.0 mt -91.32 1.19 57.29 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.478 1.511 . . . . 0.0 113.221 -177.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -71.24 111.76 6.84 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.311 1.044 . . . . 0.0 108.935 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 5.5 mmmt -63.7 146.47 53.76 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -92.49 -55.73 3.29 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-O 117.279 -1.343 . . . . 0.0 110.702 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 46.18 58.55 4.39 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.198 1.399 . . . . 0.0 107.468 -177.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 9.4 t0 . . . . . 0 C--O 1.248 1.015 0 CA-C-N 112.399 -2.182 . . . . 0.0 110.795 -177.969 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.451 ' C ' ' H ' ' A' ' 90' ' ' SER . . . . . . . . 0 N--CA 1.477 1.406 0 N-CA-C 108.121 -1.991 . . . . 0.0 108.121 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 65.02 -16.63 0.09 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 127.053 2.141 . . . . 0.0 113.929 -178.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.451 ' H ' ' C ' ' A' ' 88' ' ' GLY . 5.5 p -63.97 83.59 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 130.817 3.647 . . . . 0.0 109.785 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -114.09 -18.83 11.58 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.854 1.261 . . . . 0.0 111.622 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 70.0 m -56.23 -26.35 51.0 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.921 1.289 . . . . 0.0 114.291 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -78.72 -44.2 24.05 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 120.426 -1.422 . . . . 0.0 107.185 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.5 tptm -56.8 -53.54 56.69 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.1 p -60.94 -38.89 87.42 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 119.613 1.097 . . . . 0.0 112.12 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.0 -35.94 80.03 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 42.1 tp -74.72 -36.79 62.69 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 121.281 -0.887 . . . . 0.0 109.425 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 86.9 mt -59.53 -55.66 31.71 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.433 1.093 . . . . 0.0 111.048 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 37.0 m -68.69 -40.89 79.83 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.29 -0.881 . . . . 0.0 111.007 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.12 -42.95 91.81 Favored 'General case' 0 C--N 1.341 0.201 0 O-C-N 121.579 -0.701 . . . . 0.0 109.681 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 53.7 m -56.18 -49.19 74.73 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 123.848 0.859 . . . . 0.0 109.904 178.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -57.97 -49.22 77.57 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 122.405 0.282 . . . . 0.0 110.643 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -66.59 -59.61 3.46 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -177.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -60.37 -37.8 81.9 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 123.079 0.552 . . . . 0.0 110.415 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.98 -51.97 55.23 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 39.0 t -56.93 -43.64 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 119.538 1.669 . . . . 0.0 108.081 177.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.4 tttt -57.76 -39.05 76.49 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 122.11 -0.368 . . . . 0.0 110.583 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.6 m -70.37 -37.41 74.58 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 126.149 1.78 . . . . 0.0 110.342 -178.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.2 mt -63.92 -55.02 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -61.45 -28.23 69.13 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.801 -0.619 . . . . 0.0 112.48 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -64.26 -53.82 43.07 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.036 1.334 . . . . 0.0 109.962 178.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -80.36 -39.52 28.37 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.4 mt -61.04 -28.59 69.17 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 118.534 0.606 . . . . 0.0 112.338 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -51.34 -31.05 20.59 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -49.32 -72.01 0.06 Allowed 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.131 1.372 . . . . 0.0 112.92 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -149.06 178.67 8.5 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.529 1.532 . . . . 0.0 109.846 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 86.3 m -86.72 159.17 19.25 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 40.5 pt -115.44 160.65 14.69 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 C-N-CA 124.806 1.243 . . . . 0.0 110.021 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -156.07 149.03 24.21 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.649 -178.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -141.14 136.52 31.96 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.71 1.204 . . . . 0.0 110.633 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -95.04 102.37 14.17 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.733 1.213 . . . . 0.0 108.194 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.69 80.71 8.46 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 127.746 2.418 . . . . 0.0 106.622 179.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.65 -102.11 0.59 Allowed Glycine 0 CA--C 1.528 0.864 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -93.6 -20.15 20.48 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.667 1.187 . . . . 0.0 112.376 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 56.6 m95 -99.49 158.4 15.76 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 123.823 0.849 . . . . 0.0 111.0 -178.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.468 HD13 ' H ' ' A' ' 140' ' ' GLY . 4.6 mp -131.59 141.57 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 N-CA-C 104.912 -2.255 . . . . 0.0 104.912 178.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -124.38 121.31 34.57 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 126.188 1.795 . . . . 0.0 107.983 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -114.81 119.44 36.64 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 125.887 1.675 . . . . 0.0 110.716 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -111.54 135.74 51.7 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 13.3 m -117.18 153.76 49.88 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 123.69 0.796 . . . . 0.0 109.928 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -67.17 74.1 0.5 Allowed 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 125.142 3.895 . . . . 0.0 115.877 -177.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.35 39.11 9.29 Favored Glycine 0 CA--C 1.526 0.764 0 O-C-N 121.465 -0.772 . . . . 0.0 113.32 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 3.1 mp -121.06 -66.96 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 118.199 1.0 . . . . 0.0 109.239 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -167.46 169.12 12.45 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.19 1.396 . . . . 0.0 109.525 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -135.49 117.18 14.99 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 104.245 -2.502 . . . . 0.0 104.245 176.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 31.8 m -145.15 165.48 11.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 126.529 1.932 . . . . 0.0 109.644 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -124.22 130.38 52.42 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 177.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -138.82 163.15 32.98 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.503 1.521 . . . . 0.0 109.373 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -93.59 108.41 20.13 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.468 ' H ' HD13 ' A' ' 126' ' ' ILE . . . 175.08 151.56 8.61 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.78 167.0 15.79 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.452 1.126 . . . . 0.0 111.578 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.3 p -95.68 150.89 4.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 C-N-CA 124.948 1.299 . . . . 0.0 110.965 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -105.57 132.59 51.54 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 104.459 -2.422 . . . . 0.0 104.459 176.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 19.2 p -69.76 -13.57 62.35 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -71.22 -49.28 45.0 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 119.163 0.892 . . . . 0.0 111.52 -177.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 67.7 p -108.29 -21.34 12.8 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.791 0.836 . . . . 0.0 112.384 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.34 29.75 43.76 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.634 -0.537 . . . . 0.0 113.372 179.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -124.65 160.2 29.03 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.762 1.225 . . . . 0.0 110.105 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.8 mp -84.11 159.0 3.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 29.4 m -68.96 -58.22 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.641 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -164.2 169.35 17.77 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 127.674 2.39 . . . . 0.0 106.681 178.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -127.85 104.57 7.89 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 103.808 -2.664 . . . . 0.0 103.808 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -63.83 113.25 3.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 126.198 1.799 . . . . 0.0 112.217 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -63.82 -6.36 5.7 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.805 1.642 . . . . 0.0 112.631 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.6 t -87.93 -15.93 35.25 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.645 1.978 . . . . 0.0 110.348 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 26.9 mt -125.41 53.22 1.56 Allowed 'General case' 0 C--N 1.338 0.081 0 C-N-CA 125.78 1.632 . . . . 0.0 109.172 -178.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 15.0 m -86.03 145.96 7.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 C-N-CA 124.486 1.114 . . . . 0.0 110.681 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -151.03 175.43 12.1 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 126.223 1.809 . . . . 0.0 108.581 -179.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -147.73 137.14 22.46 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.2 mp -120.22 -30.93 4.52 Favored 'General case' 0 C--O 1.221 -0.4 0 C-N-CA 125.525 1.53 . . . . 0.0 108.315 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 167.28 162.41 18.96 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-N 119.61 1.095 . . . . 0.0 111.39 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm -125.54 108.31 26.34 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 124.78 1.232 . . . . 0.0 108.516 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -81.64 167.05 17.17 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.83 3.02 . . . . 0.0 110.92 178.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -110.56 145.1 38.39 Favored 'General case' 0 CA--C 1.513 -0.481 0 C-N-CA 124.752 1.221 . . . . 0.0 112.036 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.4 -40.33 90.55 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 124.356 1.035 . . . . 0.0 109.596 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -76.4 64.34 2.11 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 126.173 1.789 . . . . 0.0 109.348 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.9 p -47.06 -32.46 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 119.763 1.165 . . . . 0.0 111.91 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -63.99 -26.67 68.68 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.899 1.68 . . . . 0.0 112.619 -178.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.0 -25.91 56.21 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.428 0.691 . . . . 0.0 110.568 178.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 65.4 mtp180 -81.04 165.24 21.85 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 122.067 0.937 . . . . 0.0 110.884 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -123.46 147.68 46.93 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -130.42 165.44 22.58 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 125.318 1.447 . . . . 0.0 107.866 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -130.83 153.36 49.17 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 118.012 0.369 . . . . 0.0 110.447 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 45.9 tp -108.41 103.23 12.33 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.305 1.442 . . . . 0.0 108.471 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -114.63 -179.51 3.65 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 126.653 1.981 . . . . 0.0 109.073 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -142.17 160.47 40.17 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.693 0.797 . . . . 0.0 110.824 179.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -139.97 -175.46 4.24 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.368 2.267 . . . . 0.0 108.084 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -58.48 -18.49 29.33 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 120.292 -1.505 . . . . 0.0 114.361 -178.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 42.4 t -98.84 -44.99 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 122.964 0.506 . . . . 0.0 111.648 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 175.2 -159.86 28.29 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 118.659 0.663 . . . . 0.0 111.729 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -85.38 158.76 20.16 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -154.97 166.41 33.65 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.61 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 98.2 mt -105.77 128.7 59.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 43.8 t -92.95 130.71 38.44 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.216 1.406 . . . . 0.0 108.299 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -126.0 112.77 16.29 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 177.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.14 112.2 26.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 11.1 mt -99.84 106.53 19.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 103.426 -2.805 . . . . 0.0 103.426 178.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -101.37 -153.18 25.88 Favored Glycine 0 CA--C 1.52 0.364 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 60.96 43.18 11.86 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.499 0.72 . . . . 0.0 112.153 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -86.56 -106.59 0.8 Allowed Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 105.027 -3.229 . . . . 0.0 105.027 178.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -157.9 162.63 38.33 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 129.095 2.958 . . . . 0.0 104.545 178.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.6 mm -85.62 142.28 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.3 m -97.97 105.6 17.77 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 127.746 2.418 . . . . 0.0 104.584 177.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -50.39 -27.0 5.58 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.311 1.844 . . . . 0.0 112.902 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 21.6 t -43.0 -56.55 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 126.819 2.048 . . . . 0.0 110.866 179.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 9.2 t -123.65 -25.61 4.31 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.867 1.267 . . . . 0.0 112.774 -178.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 99.27 35.04 4.87 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 107.541 -2.224 . . . . 0.0 107.541 -178.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -106.62 150.46 26.18 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 118.851 1.326 . . . . 0.0 112.747 -178.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -78.91 141.97 37.16 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.274 0.559 . . . . 0.0 109.722 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 -67.56 29.71 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.519 1 C-N-CA 133.64 4.776 . . . . 0.0 114.625 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 9.5 ptm -74.43 178.99 4.87 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.433 1.493 . . . . 0.0 112.051 -178.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.23 150.46 15.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 124.853 1.261 . . . . 0.0 109.199 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -110.74 103.58 12.14 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.445 2.298 . . . . 0.0 107.553 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 9.4 mm -93.48 146.8 6.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -125.58 105.34 8.95 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.952 2.101 . . . . 0.0 108.004 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -84.77 110.58 18.9 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 12.5 m -125.36 167.19 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 124.015 0.926 . . . . 0.0 109.101 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 36.7 t -93.69 135.21 35.21 Favored 'General case' 0 C--N 1.333 -0.127 0 O-C-N 120.153 -1.592 . . . . 0.0 107.233 178.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -83.84 8.65 65.39 Favored Glycine 0 N--CA 1.464 0.509 0 CA-C-O 118.77 -1.017 . . . . 0.0 114.349 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 73.33 -6.77 13.92 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-O 118.23 -1.317 . . . . 0.0 114.273 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 2.8 p -79.82 156.88 27.2 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 119.368 1.584 . . . . 0.0 108.798 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -83.7 -29.31 27.67 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.231 1.013 . . . . 0.0 112.427 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 9.4 m -156.81 168.81 26.33 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 120.126 -1.609 . . . . 0.0 111.731 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 132.3 170.62 12.58 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 128.373 2.892 . . . . 0.0 111.168 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.06 -94.34 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 124.19 3.26 . . . . 0.0 110.778 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 11.2 p -162.13 154.17 19.06 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 120.645 -1.284 . . . . 0.0 109.686 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 41.7 p -151.38 163.79 38.16 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.392 0.677 . . . . 0.0 110.426 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 4.1 mt -110.54 143.03 21.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 125.145 1.378 . . . . 0.0 107.423 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -95.11 -51.72 4.52 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.199 1.4 . . . . 0.0 110.786 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 -161.21 156.57 24.41 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.429 1.491 . . . . 0.0 109.658 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 7.3 t -151.03 144.98 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 C-N-CA 127.894 2.478 . . . . 0.0 106.228 -178.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.24 168.47 15.18 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.602 1.161 . . . . 0.0 109.146 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -83.57 131.12 35.0 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 103.383 -2.821 . . . . 0.0 103.383 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 9.8 t -109.87 -28.68 8.64 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 124.245 1.018 . . . . 0.0 113.177 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -133.92 -175.6 3.89 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 70.0 mt -54.39 -49.52 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -123.01 20.56 9.94 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 124.042 0.937 . . . . 0.0 110.76 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 13.5 t -121.73 144.73 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 CA-C-N 118.578 0.626 . . . . 0.0 110.38 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -123.33 165.47 16.93 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 125.983 1.713 . . . . 0.0 108.434 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -131.31 147.01 52.53 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 126.086 1.754 . . . . 0.0 106.981 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -151.35 120.6 6.79 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.84 0.856 . . . . 0.0 109.373 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -108.79 113.45 26.41 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 123.588 0.755 . . . . 0.0 109.389 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 6.7 m -104.12 152.2 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -118.91 116.34 26.26 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.68 -1.145 . . . . 0.0 108.452 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -124.83 122.47 25.6 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-O 117.935 -1.031 . . . . 0.0 109.282 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -57.38 -38.45 94.47 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.249 2.633 . . . . 0.0 111.427 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -59.18 -28.66 66.83 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 10.2 tp -58.59 -33.25 69.77 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 121.48 -0.762 . . . . 0.0 111.638 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 15.3 m -59.21 -11.13 3.47 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.141 0.976 . . . . 0.0 112.996 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -61.79 -32.01 72.27 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 120.128 1.331 . . . . 0.0 109.877 178.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -85.05 124.5 31.81 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -47.73 -48.11 29.83 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.239 2.215 . . . . 0.0 113.101 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 59.7 mt -67.97 -19.41 64.94 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.061 -1.025 . . . . 0.0 113.185 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 11.4 mt -105.36 -5.91 20.04 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.82 1.248 . . . . 0.0 111.686 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -71.64 139.69 49.38 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 128.606 2.762 . . . . 0.0 112.189 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 16.8 mmtm -111.74 163.3 14.3 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 127.894 2.478 . . . . 0.0 112.698 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -124.64 -39.36 2.3 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -140.97 51.18 1.62 Allowed 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.149 0.98 . . . . 0.0 109.848 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.254 1.309 0 C-N-CA 125.431 1.492 . . . . 0.0 108.21 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.68 0 CA-C-O 118.746 -1.03 . . . . 0.0 112.669 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 51.31 7.64 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 128.641 2.776 . . . . 0.0 118.201 178.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.0 m -63.76 157.88 23.19 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 120.859 1.663 . . . . 0.0 112.057 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -54.15 -58.19 8.3 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.768 1.227 . . . . 0.0 110.642 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.6 m -62.68 -28.93 70.27 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.337 1.055 . . . . 0.0 112.245 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -69.19 -26.24 64.74 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 118.44 -0.791 . . . . 0.0 111.559 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 42.3 tptt -66.9 -55.26 15.43 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.28 -39.96 94.67 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 123.043 0.537 . . . . 0.0 110.103 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.03 -40.84 95.11 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 35.6 tp -67.98 -35.99 79.27 Favored 'General case' 0 C--N 1.343 0.306 0 CA-C-O 117.514 -1.232 . . . . 0.0 109.233 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.7 mt -62.05 -55.04 33.14 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.942 1.246 . . . . 0.0 107.963 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 53.5 m -60.05 -47.16 87.01 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.097 0.959 . . . . 0.0 110.346 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.16 -45.25 94.25 Favored 'General case' 0 N--CA 1.462 0.128 0 O-C-N 121.099 -1.001 . . . . 0.0 109.808 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.5 m -53.92 -43.11 69.46 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 124.706 1.202 . . . . 0.0 109.684 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.22 -52.08 67.2 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 118.341 0.519 . . . . 0.0 110.218 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -64.95 -51.47 61.61 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -178.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -63.14 -42.08 99.41 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.777 -178.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.38 -52.51 52.18 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 107.872 -2.091 . . . . 0.0 107.872 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 17.9 t -54.81 -51.99 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 124.614 1.166 . . . . 0.0 110.954 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 31.5 pttt -62.33 -32.2 72.94 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 119.966 -0.693 . . . . 0.0 111.484 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 59.9 m -76.61 -33.2 58.42 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 19.6 mt -63.49 -56.03 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -60.36 -36.92 79.15 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 118.063 -0.97 . . . . 0.0 111.669 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -54.86 -43.83 73.45 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.832 0.742 . . . . 0.0 111.806 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.9 tptt -82.38 -40.95 20.6 Favored 'General case' 0 CA--C 1.517 -0.326 0 O-C-N 122.027 -0.421 . . . . 0.0 111.566 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 44.5 mt -60.65 -29.47 69.29 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 119.135 -0.46 . . . . 0.0 111.512 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -55.38 -15.66 2.82 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.038 0.935 . . . . 0.0 112.729 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -64.63 -66.85 0.49 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.253 1.021 . . . . 0.0 109.676 178.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 18.6 mmt85 -151.47 -179.49 7.43 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.894 1.678 . . . . 0.0 111.85 -178.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 64.9 m -86.12 161.32 18.94 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 38.7 pt -121.63 162.68 20.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 125.722 1.609 . . . . 0.0 108.281 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -156.89 142.62 17.7 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.374 1.07 . . . . 0.0 109.433 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -136.38 132.6 35.75 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.213 1.005 . . . . 0.0 110.65 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -81.44 98.44 8.23 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.66 83.04 4.8 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.122 1.369 . . . . 0.0 107.78 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.12 -98.15 0.18 Allowed Glycine 0 C--N 1.336 0.53 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -100.45 -26.56 13.82 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.349 1.06 . . . . 0.0 113.716 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -103.1 132.2 49.53 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 118.932 0.787 . . . . 0.0 110.467 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.437 HD11 ' H ' ' A' ' 140' ' ' GLY . 3.3 mp -96.2 127.86 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 103.643 -2.725 . . . . 0.0 103.643 178.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -100.84 120.35 40.0 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -116.11 125.07 51.87 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 125.167 1.387 . . . . 0.0 110.394 -178.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -121.51 129.07 52.69 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.508 0.723 . . . . 0.0 112.018 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 22.7 m -107.76 151.01 40.96 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 123.624 0.77 . . . . 0.0 111.301 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -66.23 80.25 0.3 Allowed 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 125.275 3.983 . . . . 0.0 116.82 -177.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.87 31.19 27.07 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 117.803 -1.554 . . . . 0.0 112.007 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 3.0 mp -117.18 -71.99 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 119.444 1.622 . . . . 0.0 109.817 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -163.22 166.63 23.03 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.927 1.691 . . . . 0.0 110.435 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -130.56 119.91 23.25 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 105.731 -1.952 . . . . 0.0 105.731 177.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.7 m -144.22 164.08 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 125.109 1.364 . . . . 0.0 110.724 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -125.65 122.84 37.56 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -138.72 162.15 35.42 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 123.924 0.89 . . . . 0.0 108.907 178.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.408 ' H ' HD13 ' A' ' 156' ' ' LEU . 76.4 t60 -96.04 118.45 32.66 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.437 ' H ' HD11 ' A' ' 126' ' ' ILE . . . -169.15 -167.51 29.84 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.026 1.298 . . . . 0.0 110.267 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -138.99 142.92 38.32 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.673 1.589 . . . . 0.0 107.783 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.5 p -94.91 149.94 4.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 119.633 1.106 . . . . 0.0 108.308 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -98.06 92.88 5.99 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 102.377 -3.194 . . . . 0.0 102.377 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 27.8 p -52.5 -25.37 10.08 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.82 1.248 . . . . 0.0 114.117 -178.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -52.5 -40.33 62.28 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 125.09 1.356 . . . . 0.0 111.124 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.0 p -117.81 -48.07 2.58 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.896 1.279 . . . . 0.0 112.045 -178.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 118.11 24.91 3.14 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 117.979 -1.456 . . . . 0.0 113.84 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -124.77 155.54 39.19 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 121.163 2.481 . . . . 0.0 111.963 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 10.7 mm -69.31 158.05 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 123.919 0.888 . . . . 0.0 109.532 -179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 7.6 m -66.68 -33.21 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 125.09 1.356 . . . . 0.0 113.701 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -145.5 159.1 43.6 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.127 1.371 . . . . 0.0 110.03 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -113.68 124.79 53.15 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.451 1.5 . . . . 0.0 111.737 -178.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 8.68 61.32 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.172 1 C-N-CA 131.728 4.011 . . . . 0.0 113.904 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -59.72 -79.98 0.02 OUTLIER 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.882 1.673 . . . . 0.0 112.866 -178.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 42.3 m -112.31 -29.51 7.51 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.04 0.936 . . . . 0.0 110.7 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.408 HD13 ' H ' ' A' ' 139' ' ' HIS . 68.8 mt -61.35 133.62 56.04 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.3 p -127.64 119.79 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 123.887 0.875 . . . . 0.0 110.957 -178.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -154.82 155.56 34.65 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 124.707 1.203 . . . . 0.0 110.029 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -148.65 143.81 26.76 Favored 'General case' 0 CA--C 1.512 -0.484 0 C-N-CA 126.371 1.868 . . . . 0.0 107.046 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 42.7 mt -129.79 -31.67 1.95 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.566 1.547 . . . . 0.0 107.689 177.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 159.34 158.66 9.24 Favored Glycine 0 C--N 1.341 0.823 0 O-C-N 120.587 -1.32 . . . . 0.0 113.459 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -117.41 108.93 42.7 Favored Pre-proline 0 C--O 1.239 0.529 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.04 165.09 33.65 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 124.16 3.24 . . . . 0.0 109.371 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -109.99 148.82 30.94 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 123.476 0.71 . . . . 0.0 110.281 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -68.15 -48.46 65.3 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 125.777 1.923 . . . . 0.0 109.788 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -74.98 65.47 1.44 Allowed 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.207 1.403 . . . . 0.0 113.443 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.0 p -47.8 -31.66 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.29 1.036 . . . . 0.0 111.925 178.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -72.65 -30.11 64.01 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -178.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -73.66 -18.16 61.06 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.963 0.505 . . . . 0.0 109.842 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -105.81 165.47 11.16 Favored 'General case' 0 C--N 1.342 0.268 0 O-C-N 121.603 -0.686 . . . . 0.0 109.824 178.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -120.84 156.3 32.24 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -130.0 171.14 13.1 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.405 1.482 . . . . 0.0 108.715 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -113.7 153.44 28.97 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 123.691 0.796 . . . . 0.0 110.057 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 56.8 tp -121.63 102.51 8.28 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.594 1.558 . . . . 0.0 107.759 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -112.5 -178.6 3.44 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 127.299 2.24 . . . . 0.0 109.996 -178.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -142.57 161.14 38.82 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.599 0.76 . . . . 0.0 110.346 177.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -140.92 178.68 7.19 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 127.637 2.375 . . . . 0.0 106.909 178.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.29 -17.81 22.32 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.435 1.494 . . . . 0.0 113.337 -178.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 90.0 t -93.92 -31.83 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 124.787 1.235 . . . . 0.0 111.917 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 156.19 -170.46 33.86 Favored Glycine 0 N--CA 1.448 -0.553 0 O-C-N 121.305 -0.872 . . . . 0.0 112.762 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.46 ' CE2' ' HG ' ' A' ' 243' ' ' LEU . 3.7 m-30 -78.76 160.73 27.28 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 30.7 p90 -164.33 157.96 18.18 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.273 1.029 . . . . 0.0 111.831 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 76.2 mt -96.03 138.82 20.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.899 1.28 . . . . 0.0 107.8 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 30.1 t -105.12 120.89 42.62 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 126.087 1.755 . . . . 0.0 107.973 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -114.89 107.49 15.48 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.905 1.682 . . . . 0.0 108.355 179.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -89.79 124.14 42.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 178.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.7 mt -114.27 105.69 19.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 104.94 -2.244 . . . . 0.0 104.94 177.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -98.18 -152.22 27.86 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 105.99 -2.844 . . . . 0.0 105.99 178.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 20.1 m 81.33 18.51 0.44 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 177.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -90.58 -142.19 9.78 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 108.354 -1.899 . . . . 0.0 108.354 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -124.5 163.82 21.05 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.4 mm -81.41 142.71 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.191 0.996 . . . . 0.0 112.012 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -85.93 122.63 30.25 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.722 1.609 . . . . 0.0 109.129 178.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.45 -28.4 63.29 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.761 1.225 . . . . 0.0 111.896 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 58.6 t -57.62 -54.95 24.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.549 1.139 . . . . 0.0 113.165 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 14.0 t -122.72 -36.64 2.87 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 116.164 1.912 . . . . 0.0 116.164 -176.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 111.81 23.51 5.58 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -99.07 150.95 21.48 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.763 0.825 . . . . 0.0 109.742 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -74.91 151.88 38.88 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.955 0.883 . . . . 0.0 108.922 178.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -71.27 29.75 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 130.021 3.329 . . . . 0.0 110.276 177.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 8.0 ptm -73.84 175.58 7.15 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.284 1.834 . . . . 0.0 111.778 -177.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.52 150.34 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 124.294 1.038 . . . . 0.0 108.628 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -111.93 104.17 12.44 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.242 1.817 . . . . 0.0 106.412 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 10.2 mm -96.75 144.02 11.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 O-C-N 120.848 -1.157 . . . . 0.0 109.289 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -124.29 127.67 47.99 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.292 1.037 . . . . 0.0 109.22 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -102.43 113.11 26.17 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 118.565 -0.731 . . . . 0.0 110.823 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 4.5 m -127.61 162.26 33.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 16.2 t -91.89 138.26 31.7 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 104.381 -2.451 . . . . 0.0 104.381 177.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -95.33 12.97 67.5 Favored Glycine 0 CA--C 1.522 0.483 0 CA-C-O 118.726 -1.041 . . . . 0.0 112.462 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 71.31 -0.91 29.86 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-N 118.16 0.98 . . . . 0.0 111.666 -178.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 9.4 m -68.67 130.33 42.53 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -74.39 -19.72 60.32 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -155.63 175.07 14.39 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.214 1.406 . . . . 0.0 110.306 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 123.3 173.49 14.04 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.5 1.524 . . . . 0.0 113.861 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -79.93 -89.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 123.824 3.016 . . . . 0.0 110.879 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 18.2 p -170.8 146.94 2.67 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.171 1.788 . . . . 0.0 109.842 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 29.3 p -154.84 147.7 24.5 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.504 1.122 . . . . 0.0 110.487 178.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 3.2 mt -85.64 144.85 8.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -90.34 -55.75 3.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.869 1.267 . . . . 0.0 108.683 178.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 66.1 p-90 -154.63 158.14 39.23 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.328 1.051 . . . . 0.0 110.105 -178.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 7.2 p -156.16 134.91 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 177.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -159.64 159.91 33.64 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 118.545 0.611 . . . . 0.0 110.683 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -67.59 133.36 49.27 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 178.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 2.3 t -111.82 -34.32 6.05 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.937 1.295 . . . . 0.0 111.592 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 7.7 mttm -134.73 -176.5 4.25 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 97.6 mt -50.06 -47.67 23.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 C-N-CA 124.681 1.192 . . . . 0.0 111.669 -178.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -127.7 20.5 6.58 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.582 0.753 . . . . 0.0 110.232 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 13.6 t -122.75 147.71 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 O-C-N 120.925 -1.109 . . . . 0.0 110.067 -177.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -127.92 163.58 24.16 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -135.35 133.05 38.36 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 178.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -135.91 149.08 48.82 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.208 1.803 . . . . 0.0 107.981 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -135.72 124.36 23.73 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 118.862 0.756 . . . . 0.0 110.049 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 15.3 m -106.97 153.08 8.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 121.338 0.59 . . . . 0.0 109.682 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.02 121.62 39.32 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 178.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -132.82 145.36 56.77 Favored Pre-proline 0 N--CA 1.45 -0.432 0 O-C-N 124.469 1.106 . . . . 0.0 110.809 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.71 -42.26 1.24 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.812 2.341 . . . . 0.0 112.317 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -56.89 -25.48 57.03 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -178.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 9.6 tp -64.58 -29.69 70.71 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 121.403 -0.811 . . . . 0.0 112.374 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 11.4 m -58.39 -12.47 3.85 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.464 1.106 . . . . 0.0 112.449 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -64.11 -27.02 68.8 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 119.42 1.009 . . . . 0.0 111.239 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.27 124.86 35.79 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 -47.85 -48.35 31.07 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.706 1.203 . . . . 0.0 113.904 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . 0.46 ' HG ' ' CE2' ' A' ' 181' ' ' TYR . 1.6 mp -61.12 -31.84 71.54 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 13.4 mt -93.73 -17.9 22.68 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.859 1.264 . . . . 0.0 113.167 -178.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -61.4 146.83 46.97 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 128.18 2.592 . . . . 0.0 110.411 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -105.2 169.57 8.37 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.361 1.464 . . . . 0.0 111.977 -179.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -106.17 -5.83 19.01 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 125.376 1.471 . . . . 0.0 111.142 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -112.6 24.21 12.72 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.202 1.801 . . . . 0.0 109.784 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 12.1 t70 . . . . . 0 C--O 1.259 1.557 0 C-N-CA 126.868 2.067 . . . . 0.0 109.941 -179.495 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.874 0 N-CA-C 108.468 -1.853 . . . . 0.0 108.468 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.02 177.99 10.18 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.496 1.518 . . . . 0.0 107.943 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.2 m -71.81 82.25 0.89 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.843 0.857 . . . . 0.0 110.179 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -63.05 -40.38 97.52 Favored 'General case' 0 C--O 1.225 -0.234 0 O-C-N 120.819 -1.175 . . . . 0.0 110.828 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.1 m -60.07 -49.49 77.43 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.041 1.336 . . . . 0.0 111.566 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -61.05 -45.07 96.26 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.0 tptm -54.29 -52.99 59.71 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 118.452 -0.785 . . . . 0.0 109.379 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.5 p -58.52 -40.72 83.67 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.45 -44.35 89.16 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 118.809 -0.615 . . . . 0.0 110.759 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 58.6 tp -74.26 -38.35 63.47 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-O 117.913 -1.041 . . . . 0.0 109.416 178.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 16.1 mt -58.92 -54.51 46.29 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.597 1.089 . . . . 0.0 110.746 -177.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 16.9 m -64.54 -36.18 83.37 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 118.703 -1.199 . . . . 0.0 110.762 -179.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.74 -49.86 76.06 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 89.6 m -51.44 -46.52 63.03 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.345 1.058 . . . . 0.0 110.586 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -58.77 -50.08 75.27 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.82 0.737 . . . . 0.0 110.524 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -67.95 -59.1 3.53 Favored 'General case' 0 C--O 1.227 -0.114 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -58.89 -38.14 78.18 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.21 1.004 . . . . 0.0 110.392 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.22 -52.65 50.47 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 51.6 t -57.72 -44.53 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 118.882 1.341 . . . . 0.0 109.974 179.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -60.47 -35.49 76.01 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.458 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 88.4 m -75.74 -34.95 60.34 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 122.771 0.428 . . . . 0.0 110.335 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 26.1 mt -63.36 -55.59 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -62.04 -33.51 74.51 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 118.433 -0.794 . . . . 0.0 112.753 -178.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -65.8 -37.95 87.66 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 118.834 0.743 . . . . 0.0 111.354 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.8 tptt -84.76 -38.46 19.6 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 118.761 -0.638 . . . . 0.0 111.157 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 16.8 mt -65.06 -25.81 67.97 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.845 0.748 . . . . 0.0 111.256 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -53.17 -24.66 11.27 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.059 1.344 . . . . 0.0 111.459 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -65.96 -65.79 0.63 Allowed 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 118.132 -0.937 . . . . 0.0 111.71 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -147.43 175.32 10.91 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 120.276 1.398 . . . . 0.0 112.863 -178.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 79.0 m -86.44 163.9 17.3 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 43.1 pt -121.8 159.46 24.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 124.587 1.155 . . . . 0.0 109.86 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -157.06 140.22 15.48 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 122.914 0.486 . . . . 0.0 111.847 -178.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -138.73 129.9 26.94 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 119.804 -0.759 . . . . 0.0 109.995 176.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -83.46 98.56 9.59 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.996 1.319 . . . . 0.0 107.547 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -85.95 80.56 8.84 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.494 1.918 . . . . 0.0 106.545 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.44 -99.42 0.33 Allowed Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -92.38 -30.75 15.62 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 118.423 1.112 . . . . 0.0 113.43 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -100.21 155.18 17.9 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 119.109 0.868 . . . . 0.0 110.548 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.488 HD11 ' H ' ' A' ' 140' ' ' GLY . 4.0 mp -122.13 144.59 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 104.003 -2.591 . . . . 0.0 104.003 179.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -128.88 120.0 25.43 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -110.06 126.02 53.56 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.966 1.706 . . . . 0.0 109.423 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -115.13 136.09 53.49 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 17.1 m -118.97 148.8 45.46 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 123.528 0.731 . . . . 0.0 111.066 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -64.63 91.33 0.19 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 125.079 3.853 . . . . 0.0 114.586 -178.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.82 28.44 58.98 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-O 118.045 -1.42 . . . . 0.0 114.265 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 4.1 mp -115.14 -71.58 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 119.654 1.727 . . . . 0.0 108.43 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -171.43 174.6 4.4 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.449 1.5 . . . . 0.0 110.072 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.425 ' CD1' HD13 ' A' ' 160' ' ' LEU . 1.2 t80 -136.54 120.26 17.3 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 177.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.9 m -145.41 164.99 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 126.494 1.917 . . . . 0.0 110.336 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -117.37 131.97 56.68 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 119.461 1.028 . . . . 0.0 110.498 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -137.68 162.31 34.19 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.547 1.067 . . . . 0.0 108.781 176.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.485 ' H ' ' CD1' ' A' ' 156' ' ' LEU . 72.1 t60 -102.24 109.93 21.75 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.488 ' H ' HD11 ' A' ' 126' ' ' ILE . . . -170.42 -178.25 41.09 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.426 1.489 . . . . 0.0 109.788 -179.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -126.01 160.71 29.32 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.39 1.595 . . . . 0.0 110.886 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.6 p -117.41 157.42 18.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 C-N-CA 124.082 0.953 . . . . 0.0 108.572 179.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -105.26 99.81 9.42 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 177.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 40.0 p -53.25 -17.03 1.48 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.518 1.527 . . . . 0.0 113.558 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.79 -39.13 83.91 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 125.395 1.478 . . . . 0.0 111.835 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 44.3 p -132.23 -28.01 1.74 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 105.99 18.2 11.79 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.958 1.266 . . . . 0.0 115.501 179.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -97.41 147.81 23.83 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 118.85 1.325 . . . . 0.0 111.833 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 13.8 mm -74.12 154.64 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 178.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 27.1 m -68.73 -38.0 78.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.162 0.985 . . . . 0.0 110.753 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 26.2 t30 -175.75 148.78 0.9 Allowed 'General case' 0 C--O 1.235 0.313 0 C-N-CA 129.114 2.965 . . . . 0.0 106.45 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 30.4 mtp180 -97.19 155.08 17.0 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.029 0.832 . . . . 0.0 109.323 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -114.91 112.16 22.29 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -83.16 -13.59 55.22 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.914 0.864 . . . . 0.0 112.594 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 4.6 p -69.27 -42.33 75.68 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 127.994 2.518 . . . . 0.0 111.071 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.485 ' CD1' ' H ' ' A' ' 139' ' ' HIS . 34.2 mt -77.5 67.57 3.44 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 127.708 2.403 . . . . 0.0 110.582 -178.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 4.3 p -79.77 130.93 35.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -150.55 166.78 29.2 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 126.55 1.94 . . . . 0.0 107.859 178.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.27 113.06 5.41 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 117.37 -1.3 . . . . 0.0 109.248 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.425 HD13 ' CD1' ' A' ' 135' ' ' PHE . 43.4 mt -102.02 -30.46 11.18 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.936 1.244 . . . . 0.0 108.982 178.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 161.99 161.31 11.81 Favored Glycine 0 CA--C 1.503 -0.668 0 CA-C-O 122.396 0.998 . . . . 0.0 110.758 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -123.91 109.39 29.95 Favored Pre-proline 0 N--CA 1.426 -1.631 0 C-N-CA 125.262 1.425 . . . . 0.0 109.307 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -70.52 177.77 5.75 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.664 2.909 . . . . 0.0 108.745 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -120.55 152.11 38.52 Favored 'General case' 0 CA--C 1.517 -0.312 0 O-C-N 121.64 -0.663 . . . . 0.0 111.363 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -67.04 -49.69 64.37 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 122.945 0.498 . . . . 0.0 110.142 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -79.18 65.02 4.24 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.606 0.763 . . . . 0.0 110.47 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.3 p -48.8 -33.35 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 125.26 1.424 . . . . 0.0 111.229 179.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -65.5 -30.93 71.75 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 126.131 1.773 . . . . 0.0 111.621 -178.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -88.76 -11.3 45.38 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.698 1.199 . . . . 0.0 111.692 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 50.6 ttt180 -81.53 177.23 9.06 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.025 1.33 . . . . 0.0 108.686 178.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -133.29 149.8 51.92 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 121.261 -0.9 . . . . 0.0 109.34 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -136.63 169.87 17.01 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 127.592 2.357 . . . . 0.0 110.091 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -123.62 154.63 39.05 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.806 0.842 . . . . 0.0 110.349 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 12.4 tp -119.09 105.1 11.08 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 122.383 1.087 . . . . 0.0 109.621 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 3.4 mt -119.09 176.67 5.19 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 128.227 2.611 . . . . 0.0 107.738 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -154.68 164.36 38.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.714 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.71 -175.43 3.82 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.388 1.875 . . . . 0.0 110.313 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -66.81 -1.81 4.34 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.875 1.67 . . . . 0.0 113.442 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 30.6 t -112.82 -44.21 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 124.741 1.216 . . . . 0.0 109.519 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 175.56 -175.52 47.26 Favored Glycine 0 N--CA 1.446 -0.67 0 O-C-N 121.274 -0.891 . . . . 0.0 111.943 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -82.17 163.71 21.75 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -154.4 172.37 17.84 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 74.6 mt -113.9 129.81 69.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 35.0 t -91.59 124.22 35.59 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -123.15 107.54 11.85 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.5 mp -93.39 117.89 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 104.281 -2.488 . . . . 0.0 104.281 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 4.3 mt -104.89 105.83 19.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 178.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -104.19 -156.38 23.82 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.793 1.664 . . . . 0.0 109.409 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.1 t 64.02 43.47 5.16 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.586 1.155 . . . . 0.0 110.36 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -91.57 -64.09 1.16 Allowed Glycine 0 CA--C 1.529 0.937 0 N-CA-C 107.987 -2.045 . . . . 0.0 107.987 179.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 157.29 179.98 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.379 1 C-N-CA 132.086 4.155 . . . . 0.0 105.792 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.5 mm -105.59 143.39 16.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 127.756 2.423 . . . . 0.0 112.107 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.4 m -95.73 101.13 12.78 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 128.11 2.564 . . . . 0.0 104.312 176.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -48.73 -31.32 6.73 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.258 1.823 . . . . 0.0 112.658 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 60.0 t -39.16 -54.11 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 127.268 2.227 . . . . 0.0 110.574 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 11.3 t -123.5 -26.95 4.13 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.404 1.082 . . . . 0.0 111.787 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.33 35.18 4.24 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 -178.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -110.67 148.69 31.74 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 118.498 1.149 . . . . 0.0 113.108 -178.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -73.8 148.09 42.8 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.274 0.559 . . . . 0.0 112.156 179.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -70.06 27.01 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.425 1 C-N-CA 134.844 5.258 . . . . 0.0 109.87 177.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 2.8 ptm -74.64 178.78 5.14 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.383 1.473 . . . . 0.0 113.336 -176.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.1 p -150.74 136.45 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 123.279 0.631 . . . . 0.0 110.642 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -98.79 109.22 22.01 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.744 1.217 . . . . 0.0 109.213 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 11.1 mm -97.49 147.88 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 O-C-N 121.627 -0.671 . . . . 0.0 109.853 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -125.7 105.4 8.96 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 128.092 2.557 . . . . 0.0 109.106 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -87.76 114.17 24.12 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 120.65 -1.281 . . . . 0.0 108.951 178.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 4.6 m -124.49 165.01 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 41.9 t -84.63 145.86 27.79 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 120.418 -1.426 . . . . 0.0 107.36 178.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -90.89 6.14 81.91 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-O 117.341 -1.81 . . . . 0.0 115.362 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 62.96 13.75 49.38 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-N 119.026 1.413 . . . . 0.0 114.952 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 46.8 m -96.79 153.84 17.64 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.139 1.376 . . . . 0.0 107.935 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -72.46 -35.48 68.25 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 115.273 1.583 . . . . 0.0 115.273 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 18.6 m -157.95 166.17 33.28 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.52 1.528 . . . . 0.0 109.273 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 144.42 175.05 17.21 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 115.647 1.019 . . . . 0.0 115.647 178.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -78.37 -118.26 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.913 1 C-N-CA 125.38 4.054 . . . . 0.0 109.575 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 28.1 p -154.68 147.61 24.56 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 119.992 -1.693 . . . . 0.0 111.374 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 20.6 p -151.05 161.59 42.44 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.541 1.136 . . . . 0.0 110.145 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 3.6 mt -100.64 154.53 4.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 125.311 1.444 . . . . 0.0 109.386 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -102.27 -51.69 3.31 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 124.783 1.233 . . . . 0.0 109.844 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 64.5 p-90 -155.92 154.09 30.65 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.067 0.947 . . . . 0.0 109.255 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 90.9 t -147.73 137.7 16.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.63 168.53 19.8 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 122.842 0.457 . . . . 0.0 111.207 -178.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -86.86 133.67 33.6 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 177.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 14.8 t -109.21 -32.22 7.28 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.528 1.131 . . . . 0.0 112.214 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -136.86 -175.97 4.21 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.668 1.187 . . . . 0.0 108.84 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 78.3 mt -48.76 -45.05 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.585 0.754 . . . . 0.0 112.479 -178.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -130.19 12.54 5.59 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.112 0.965 . . . . 0.0 112.265 -178.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 17.5 t -114.14 140.29 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 O-C-N 122.116 -0.365 . . . . 0.0 110.127 -176.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -120.66 166.97 12.95 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 125.18 1.392 . . . . 0.0 108.445 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -137.89 148.65 45.54 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.505 1.522 . . . . 0.0 108.822 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -148.93 145.49 27.42 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 125.789 1.636 . . . . 0.0 110.273 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -132.84 122.89 25.11 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 178.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 5.5 m -116.29 154.81 17.8 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.1 p -120.76 124.05 44.17 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.517 1.127 . . . . 0.0 110.302 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -132.8 122.98 17.97 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 124.238 1.015 . . . . 0.0 109.261 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -58.19 -40.83 73.07 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 124.014 3.143 . . . . 0.0 113.406 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -61.05 -19.62 61.6 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.615 0.766 . . . . 0.0 112.101 -178.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 8.6 tp -66.94 -28.87 68.64 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 120.432 -1.418 . . . . 0.0 110.715 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 21.4 m -62.33 -11.85 17.69 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.746 0.818 . . . . 0.0 111.942 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.08 -21.39 66.14 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.046 0.839 . . . . 0.0 110.122 178.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -98.12 121.01 39.53 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 177.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -47.99 -46.13 32.35 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 126.071 1.749 . . . . 0.0 112.704 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.42 -37.54 87.23 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 120.809 -1.182 . . . . 0.0 112.127 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 22.1 mt -85.21 -5.73 59.31 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.32 1.048 . . . . 0.0 112.252 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -68.95 156.41 38.62 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.822 1.249 . . . . 0.0 110.428 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 2.9 mmmt -96.35 -166.87 1.48 Allowed 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 126.225 1.81 . . . . 0.0 109.279 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -67.0 -27.99 67.88 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 53.45 31.78 12.79 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 128.19 2.596 . . . . 0.0 111.989 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 33.7 t70 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.739 -0.648 . . . . 0.0 112.598 -179.281 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.936 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 35.16 66.14 0.33 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 127.106 2.163 . . . . 0.0 114.018 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 71.6 m -140.16 147.1 39.65 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.728 1.211 . . . . 0.0 108.689 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -65.72 107.17 1.69 Allowed 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.8 m -50.69 -50.37 55.1 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 119.758 1.163 . . . . 0.0 112.531 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -63.92 -33.63 76.15 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.385 0.674 . . . . 0.0 112.241 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -59.24 -51.37 70.28 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 178.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.46 -37.15 74.87 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.043 0.937 . . . . 0.0 110.874 178.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.55 -42.65 92.89 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.505 1.048 . . . . 0.0 109.481 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.5 tp -68.88 -36.8 78.51 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-O 117.276 -1.345 . . . . 0.0 109.28 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 98.8 mt -58.67 -54.55 45.82 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 120.265 1.393 . . . . 0.0 108.533 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.2 m -58.93 -46.88 86.88 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.808 0.843 . . . . 0.0 111.457 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.09 -41.94 94.51 Favored 'General case' 0 N--CA 1.463 0.197 0 O-C-N 120.343 -1.473 . . . . 0.0 111.014 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 37.6 m -52.4 -46.94 66.51 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.135 1.374 . . . . 0.0 110.771 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -56.51 -50.99 70.19 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.309 0.504 . . . . 0.0 110.098 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -63.02 -58.0 8.78 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -178.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.09 -39.33 78.32 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.343 -177.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.78 -52.57 41.19 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 43.6 t -54.46 -51.07 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-N 119.032 1.416 . . . . 0.0 110.682 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.6 pttp -56.86 -35.14 68.52 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.448 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 77.2 m -80.34 -29.03 37.97 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.113 0.965 . . . . 0.0 111.947 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 16.7 mt -63.27 -54.39 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 104.677 -2.342 . . . . 0.0 104.677 177.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -61.13 -30.69 70.53 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 118.44 -0.79 . . . . 0.0 111.199 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -56.37 -47.57 78.62 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.478 1.036 . . . . 0.0 111.084 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -84.14 -37.9 21.36 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 24.9 mt -65.97 -26.56 67.62 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 118.931 -0.557 . . . . 0.0 112.161 -179.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -56.83 -20.9 25.17 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -64.64 -66.81 0.49 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.517 0.727 . . . . 0.0 109.485 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -153.51 -179.7 8.01 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.04 1.736 . . . . 0.0 110.306 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 56.0 m -86.63 172.82 9.95 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.287 0.635 . . . . 0.0 109.694 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 34.0 pt -129.8 164.37 32.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 126.654 1.982 . . . . 0.0 109.046 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.425 ' CE2' HG21 ' A' ' 142' ' ' VAL . 0.5 OUTLIER -158.74 150.33 20.86 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 122.831 0.452 . . . . 0.0 110.225 -179.222 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -141.5 127.38 19.32 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.631 0.772 . . . . 0.0 109.882 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -84.07 102.23 12.37 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 122.054 0.93 . . . . 0.0 109.404 179.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.27 80.57 6.84 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 127.864 2.466 . . . . 0.0 107.15 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 60.75 -114.69 6.85 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -76.74 -28.81 55.9 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.829 0.852 . . . . 0.0 112.548 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -99.95 163.46 12.43 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 119.073 0.851 . . . . 0.0 110.89 -178.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.502 HD12 ' H ' ' A' ' 140' ' ' GLY . 4.5 mp -136.55 130.56 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -110.05 119.99 41.05 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -108.04 126.42 52.71 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 118.437 -0.792 . . . . 0.0 109.909 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -117.55 130.49 56.44 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.292 0.951 . . . . 0.0 110.094 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 21.4 m -110.83 156.6 40.44 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 128.427 2.691 . . . . 0.0 113.937 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -68.19 72.42 0.83 Allowed 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 124.79 3.66 . . . . 0.0 114.404 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.84 62.06 3.77 Favored Glycine 0 N--CA 1.448 -0.517 0 O-C-N 121.186 -0.947 . . . . 0.0 111.285 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.5 mp -131.03 -72.31 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-O 118.325 -0.845 . . . . 0.0 109.235 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -173.65 136.9 0.59 Allowed 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 119.646 1.112 . . . . 0.0 108.15 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -108.27 124.3 50.1 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 121.04 1.745 . . . . 0.0 106.32 -175.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 18.3 m -145.04 165.06 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 125.257 1.423 . . . . 0.0 111.428 -178.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -122.02 133.4 54.8 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.479 1.512 . . . . 0.0 108.193 178.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -138.96 162.87 33.82 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.127 1.371 . . . . 0.0 112.667 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 42.6 t60 -92.76 122.66 35.38 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.502 ' H ' HD12 ' A' ' 126' ' ' ILE . . . 169.97 -158.78 31.07 Favored Glycine 0 N--CA 1.454 -0.145 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 -178.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.6 165.59 34.12 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.425 HG21 ' CE2' ' A' ' 119' ' ' PHE . 5.3 p -107.11 154.52 8.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 178.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -106.16 102.18 11.61 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 104.14 -2.541 . . . . 0.0 104.14 176.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 2.3 p -47.58 -39.67 17.29 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 119.812 1.187 . . . . 0.0 113.205 -178.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 53.3 mmtt -56.3 -30.34 62.4 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 126.093 1.757 . . . . 0.0 114.488 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 29.2 p -113.14 -32.67 6.25 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.106 0.962 . . . . 0.0 110.593 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 84.1 26.54 40.3 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 126.015 1.769 . . . . 0.0 112.719 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -125.45 159.63 31.45 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.948 1.299 . . . . 0.0 110.996 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 24.3 mm -75.25 150.78 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 106.816 -1.549 . . . . 0.0 106.816 178.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 30.3 m -65.45 -29.61 47.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -165.61 174.87 9.39 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.925 1.29 . . . . 0.0 110.392 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -113.6 157.38 22.18 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -123.09 109.13 13.67 Favored 'General case' 0 CA--C 1.516 -0.337 0 O-C-N 120.853 -1.154 . . . . 0.0 113.337 -175.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 -83.11 -17.89 41.49 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.905 -0.497 . . . . 0.0 111.133 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 16.0 m -89.54 -42.53 11.38 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 120.874 -1.141 . . . . 0.0 111.004 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 72.9 mt -79.33 93.2 5.27 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.9 m -110.93 117.66 55.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 123.691 0.797 . . . . 0.0 111.127 -178.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -132.81 163.86 28.12 Favored 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 125.122 1.369 . . . . 0.0 109.181 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.67 135.86 23.84 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 178.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.1 mp -125.7 -36.36 2.43 Favored 'General case' 0 C--O 1.221 -0.445 0 C-N-CA 126.478 1.911 . . . . 0.0 106.905 177.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 172.75 152.43 8.65 Favored Glycine 0 C--N 1.34 0.795 0 CA-C-N 119.391 0.996 . . . . 0.0 112.705 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 29.3 mtmt -123.28 109.33 31.32 Favored Pre-proline 0 C--O 1.239 0.513 0 N-CA-C 106.125 -1.805 . . . . 0.0 106.125 177.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -75.35 -172.95 1.43 Allowed 'Trans proline' 0 N--CA 1.459 -0.519 1 C-N-CA 126.174 4.583 . . . . 0.0 111.425 -178.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -124.39 152.41 43.25 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 123.762 0.825 . . . . 0.0 108.965 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.11 -46.18 65.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.066 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 -68.88 65.36 0.13 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 127.366 2.267 . . . . 0.0 111.166 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.8 p -48.51 -34.06 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 124.662 1.185 . . . . 0.0 111.746 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -59.64 -32.21 70.24 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 125.46 1.504 . . . . 0.0 113.184 -178.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -84.61 -22.61 29.91 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.767 1.227 . . . . 0.0 112.787 -178.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.409 HH22 ' HG3' ' A' ' 185' ' ' GLU . 66.6 mtp180 -74.82 139.71 43.43 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -97.22 143.3 28.15 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 179.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -133.59 165.84 23.97 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 124.21 1.004 . . . . 0.0 109.777 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -123.45 142.73 50.7 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.944 0.897 . . . . 0.0 109.965 -178.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 58.9 tp -102.28 100.95 11.18 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.062 1.745 . . . . 0.0 107.584 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -107.78 -178.84 3.74 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.301 1.44 . . . . 0.0 109.147 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 181' ' ' TYR . 1.7 p90 -139.97 156.88 46.43 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -134.97 175.0 9.98 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 126.879 2.072 . . . . 0.0 107.446 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -64.21 -13.97 52.36 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 124.548 1.139 . . . . 0.0 112.699 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 99.6 t -97.65 -34.93 4.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 125.856 1.662 . . . . 0.0 112.459 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 163.93 -174.65 40.09 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 176' ' ' TYR . 3.6 m-30 -78.41 166.21 22.9 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -165.66 164.19 19.08 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.354 0.662 . . . . 0.0 111.395 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 67.7 mt -102.43 132.41 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 23.3 t -100.81 127.27 47.33 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.581 1.553 . . . . 0.0 107.954 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.409 ' HG3' HH22 ' A' ' 170' ' ' ARG . 26.4 tt0 -124.21 112.47 17.09 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.39 1.876 . . . . 0.0 109.617 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -96.94 116.23 38.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 178.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 5.3 mt -105.22 108.64 25.44 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -106.58 -153.21 19.83 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 108.023 -2.031 . . . . 0.0 108.023 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 85.44 32.13 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.352 1.861 . . . . 0.0 111.237 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -111.53 165.17 12.09 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 125.537 1.541 . . . . 0.0 111.093 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.62 157.17 38.45 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.7 mm -78.1 134.87 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 C-N-CA 125.387 1.475 . . . . 0.0 110.769 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.35 115.03 18.75 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.918 1.687 . . . . 0.0 106.685 178.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -60.37 -22.21 63.03 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.161 1.384 . . . . 0.0 112.219 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 59.8 t -53.73 -48.51 60.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 C-N-CA 125.192 1.397 . . . . 0.0 111.249 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 11.7 t -125.2 -43.27 1.95 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 117.62 35.15 1.1 Allowed Glycine 0 CA--C 1.532 1.139 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 -177.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -111.08 150.67 29.05 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.612 1.706 . . . . 0.0 111.598 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -73.03 143.3 47.57 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.446 0.641 . . . . 0.0 109.388 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 7.0 ttp180 -67.6 29.45 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.4 1 C-N-CA 132.184 4.194 . . . . 0.0 113.564 179.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 6.0 ptm -73.51 175.78 6.72 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.216 -0.927 . . . . 0.0 113.062 -177.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 8.8 p -142.13 151.41 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 124.7 1.2 . . . . 0.0 108.483 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -110.78 115.25 29.23 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 179.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 8.5 mm -106.12 140.06 25.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -125.44 109.0 12.21 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.604 1.562 . . . . 0.0 109.108 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -89.48 115.27 26.78 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 120.636 -1.29 . . . . 0.0 110.413 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 5.2 m -124.62 165.99 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 124.015 0.926 . . . . 0.0 108.525 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 48.8 t -85.39 143.09 28.83 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 121.033 -1.042 . . . . 0.0 108.331 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -86.91 7.18 81.28 Favored Glycine 0 CA--C 1.52 0.395 0 CA-C-O 116.831 -2.094 . . . . 0.0 116.829 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 54.29 60.85 7.89 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 120.249 2.024 . . . . 0.0 111.593 -178.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.3 t -157.47 160.06 37.91 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.788 0.835 . . . . 0.0 109.76 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -70.31 -57.21 5.12 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 124.831 1.253 . . . . 0.0 114.259 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 91.9 p -149.84 167.88 25.33 Favored 'General case' 0 C--O 1.233 0.229 0 O-C-N 121.227 -0.921 . . . . 0.0 111.45 -178.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 152.55 168.61 16.87 Favored Glycine 0 CA--C 1.522 0.508 0 CA-C-O 119.161 -0.799 . . . . 0.0 111.352 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -70.91 -90.67 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 123.186 2.591 . . . . 0.0 109.047 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.5 p -171.42 150.39 2.86 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 121.021 -1.049 . . . . 0.0 110.078 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.9 p -151.85 159.1 43.97 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.862 1.265 . . . . 0.0 109.325 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 4.3 mt -102.31 152.56 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 126.416 1.886 . . . . 0.0 107.996 178.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -97.6 -50.95 4.29 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.467 1.107 . . . . 0.0 111.447 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 58.2 p-90 -160.02 155.24 25.02 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.336 1.454 . . . . 0.0 107.84 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 52.9 t -151.46 118.75 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 125.672 1.589 . . . . 0.0 106.769 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.98 167.49 26.54 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 118.51 0.596 . . . . 0.0 111.459 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -73.81 134.69 43.41 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 1.4 t -112.34 -37.36 5.01 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.172 0.989 . . . . 0.0 110.732 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 16.4 mttm -131.61 -175.19 3.63 Favored 'General case' 0 CA--C 1.506 -0.749 0 C-N-CA 124.054 0.942 . . . . 0.0 109.689 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 71.0 mt -53.16 -48.51 54.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.923 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -126.84 22.56 6.78 Favored 'General case' 0 C--O 1.226 -0.135 0 C-N-CA 124.66 1.184 . . . . 0.0 110.777 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 12.3 t -123.38 144.33 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.518 0 C-N-CA 120.328 -0.549 . . . . 0.0 109.57 -178.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -125.15 158.93 32.7 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.496 1.519 . . . . 0.0 107.379 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -127.72 137.47 52.48 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -142.34 125.64 16.54 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.88 1.672 . . . . 0.0 110.686 -177.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -118.97 116.96 27.55 Favored 'General case' 0 C--O 1.237 0.436 0 O-C-N 121.721 -0.612 . . . . 0.0 110.659 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 3.6 m -101.5 154.3 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.1 p -124.01 125.57 44.79 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 1.2 pt -136.5 141.03 34.12 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -67.68 -43.34 5.57 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.831 2.354 . . . . 0.0 112.386 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -56.69 -18.23 11.64 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -178.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 3.9 tp -70.18 -22.16 62.98 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 120.06 -1.65 . . . . 0.0 112.171 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 15.9 m -70.48 -9.31 56.23 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.623 1.169 . . . . 0.0 112.259 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -57.29 -35.86 70.34 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.203 1.001 . . . . 0.0 108.535 178.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -92.55 124.33 36.5 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -46.89 -47.92 21.3 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 128.416 2.686 . . . . 0.0 111.815 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 25.3 mt -62.09 -44.46 96.61 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.752 -178.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 8.2 mp -78.66 -8.33 58.56 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -70.02 141.39 52.91 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.688 1.595 . . . . 0.0 110.722 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 10.3 mmmm -85.89 174.35 9.34 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.126 0.971 . . . . 0.0 109.409 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -102.98 -16.67 15.75 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.534 0.734 . . . . 0.0 111.754 179.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -123.15 50.15 1.59 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.403 1.481 . . . . 0.0 107.963 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 . . . . . 0 C--O 1.248 1.016 0 CA-C-N 114.219 -1.355 . . . . 0.0 108.78 178.679 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.672 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.78 179.1 6.87 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.202 1.001 . . . . 0.0 109.461 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.7 m -137.9 80.98 1.83 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 178.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.58 71.67 1.47 Allowed 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 17.1 m -54.9 -27.5 43.45 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.872 0.869 . . . . 0.0 112.979 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -70.93 -40.89 71.83 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.948 0.795 . . . . 0.0 110.412 179.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 43.9 tptt -65.67 -54.67 24.27 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.19 -34.29 70.21 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 118.661 -0.685 . . . . 0.0 111.552 179.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.42 -51.22 69.63 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.651 -1.241 . . . . 0.0 107.651 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 53.7 tp -61.35 -38.25 86.27 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 117.728 -1.13 . . . . 0.0 110.383 179.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.6 mt -60.94 -54.37 45.87 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 119.627 1.103 . . . . 0.0 109.365 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 26.4 m -58.86 -49.01 79.34 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.241 1.416 . . . . 0.0 110.303 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.4 ttmm -58.7 -49.85 76.07 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 52.9 m -52.61 -45.34 66.52 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 123.964 0.905 . . . . 0.0 110.127 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -57.32 -49.8 74.96 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.711 0.687 . . . . 0.0 109.482 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.17 -61.38 2.17 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.904 0.881 . . . . 0.0 112.5 -178.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.25 -39.03 78.11 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 125.153 1.381 . . . . 0.0 111.739 -178.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -65.32 -52.72 37.79 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-O 117.985 -1.453 . . . . 0.0 109.935 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 52.2 t -58.77 -42.89 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 119.689 1.745 . . . . 0.0 110.691 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.9 ptmm? -62.06 -35.9 80.02 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.968 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.4 m -72.89 -40.13 65.81 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.317 1.047 . . . . 0.0 109.67 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 20.4 mt -58.48 -54.71 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -57.18 -37.73 72.58 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 118.011 -0.995 . . . . 0.0 111.432 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -63.69 -37.41 87.26 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.102 0.865 . . . . 0.0 111.399 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.43 -32.56 62.68 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.768 -0.582 . . . . 0.0 111.636 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.0 mt -83.73 -25.11 30.85 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 117.884 0.311 . . . . 0.0 111.362 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -47.82 -35.45 10.18 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.185 1.394 . . . . 0.0 111.552 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -60.62 -67.04 0.44 Allowed 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 125.329 1.452 . . . . 0.0 111.928 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 77.5 mmt-85 -150.05 171.73 16.39 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.815 1.189 . . . . 0.0 111.936 -178.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 62.1 m -86.71 152.62 22.38 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 178.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 28.7 pt -106.41 161.32 5.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 125.779 1.632 . . . . 0.0 109.74 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -151.73 134.57 15.64 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.635 1.574 . . . . 0.0 108.694 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.403 ' CB ' ' HB ' ' A' ' 218' ' ' ILE . 12.2 t80 -138.61 127.6 23.91 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.114 0.966 . . . . 0.0 111.139 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -81.99 106.78 14.18 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.533 1.133 . . . . 0.0 108.83 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -100.54 79.99 2.16 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 178.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.66 -125.59 20.24 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -67.05 -34.59 78.03 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.308 0.643 . . . . 0.0 112.046 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -99.96 163.88 12.25 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 119.132 0.878 . . . . 0.0 111.637 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.1 mp -128.98 140.92 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 104.886 -2.264 . . . . 0.0 104.886 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -114.82 120.07 38.76 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 125.841 1.656 . . . . 0.0 107.961 -177.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -113.46 122.66 47.99 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -122.25 135.13 54.7 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 123.855 0.862 . . . . 0.0 110.7 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 16.4 m -109.09 158.25 34.84 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 126.675 1.99 . . . . 0.0 112.59 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -63.9 74.46 0.17 Allowed 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 124.738 3.625 . . . . 0.0 114.457 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 72.78 50.68 13.18 Favored Glycine 0 CA--C 1.532 1.126 0 O-C-N 120.093 -1.63 . . . . 0.0 114.085 179.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 3.6 mp -124.31 -65.98 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 125.352 1.461 . . . . 0.0 108.091 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -166.64 168.48 14.44 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 127.416 2.286 . . . . 0.0 110.837 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -134.57 121.72 21.35 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 19.5 m -143.03 163.79 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 125.008 1.323 . . . . 0.0 111.821 -178.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -126.19 128.07 46.67 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.608 1.163 . . . . 0.0 110.124 178.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -138.09 162.92 32.93 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.555 1.942 . . . . 0.0 110.929 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.426 ' H ' HD11 ' A' ' 156' ' ' LEU . 13.1 t60 -91.69 160.76 15.2 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 120.867 -1.146 . . . . 0.0 109.357 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 135.52 -160.62 24.54 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.842 1.21 . . . . 0.0 111.045 -179.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.414 ' H ' HG23 ' A' ' 150' ' ' VAL . 0.4 OUTLIER -142.47 167.72 21.43 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.004 1.322 . . . . 0.0 110.183 179.462 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.9 p -128.75 146.29 34.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 CA-C-N 119.645 1.111 . . . . 0.0 111.198 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -95.12 106.39 18.4 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 25.7 p -60.06 -25.48 65.4 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.437 1.017 . . . . 0.0 113.299 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -55.75 -49.3 73.47 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.615 0.766 . . . . 0.0 112.077 -179.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 24.9 p -102.68 -36.17 8.41 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.798 1.239 . . . . 0.0 112.443 -178.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 92.12 35.96 6.5 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -179.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -124.14 148.34 47.27 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 118.266 1.033 . . . . 0.0 110.337 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 14.3 mm -69.95 156.14 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 179.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.414 HG23 ' H ' ' A' ' 141' ' ' ARG . 6.3 m -56.71 -29.32 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 124.705 1.202 . . . . 0.0 112.077 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -169.48 176.42 5.06 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 126.826 2.05 . . . . 0.0 107.168 179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -109.34 101.07 10.09 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 104.975 -2.231 . . . . 0.0 104.975 178.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.39 88.34 1.19 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -73.14 -23.57 60.48 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.187 -0.946 . . . . 0.0 110.516 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 3.8 m -71.85 3.74 3.95 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.141 1.776 . . . . 0.0 113.237 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.426 HD11 ' H ' ' A' ' 139' ' ' HIS . 43.1 mt -125.23 123.48 39.64 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.6 126.81 61.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 124.681 1.192 . . . . 0.0 108.028 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -151.53 162.6 40.68 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 126.798 2.039 . . . . 0.0 107.863 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -148.93 140.28 23.26 Favored 'General case' 0 CA--C 1.507 -0.697 0 O-C-N 120.819 -1.176 . . . . 0.0 109.474 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 41.0 mt -118.07 -24.37 7.05 Favored 'General case' 0 C--O 1.219 -0.51 0 O-C-N 125.391 1.682 . . . . 0.0 109.378 179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 163.38 164.12 17.72 Favored Glycine 0 C--N 1.34 0.757 0 O-C-N 121.056 -1.028 . . . . 0.0 111.1 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -127.89 109.58 20.25 Favored Pre-proline 0 CA--C 1.533 0.31 0 C-N-CA 124.374 1.07 . . . . 0.0 110.519 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -72.09 172.58 14.44 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 123.945 3.097 . . . . 0.0 111.127 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -111.43 152.32 27.52 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.705 0.802 . . . . 0.0 111.083 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -68.01 -44.25 76.97 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.807 1.243 . . . . 0.0 111.986 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -78.15 65.36 3.51 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.482 1.113 . . . . 0.0 111.456 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.8 p -47.23 -33.91 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 124.532 1.133 . . . . 0.0 111.86 178.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -67.45 -36.19 80.69 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.951 1.3 . . . . 0.0 112.726 -178.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -86.28 -1.39 57.45 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 125.503 1.521 . . . . 0.0 110.917 -178.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 18.3 ttt-85 -93.24 146.94 23.32 Favored 'General case' 0 N--CA 1.441 -0.876 0 O-C-N 120.399 -1.438 . . . . 0.0 110.634 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -102.69 147.85 26.32 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.597 0.759 . . . . 0.0 110.656 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -138.04 175.48 9.54 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.873 2.069 . . . . 0.0 109.371 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -137.6 133.68 34.68 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.513 0.725 . . . . 0.0 112.52 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 35.1 tp -92.07 106.36 18.4 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.633 1.173 . . . . 0.0 109.377 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -113.38 -179.25 3.59 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 125.775 1.63 . . . . 0.0 109.412 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -136.42 162.74 32.2 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.098 0.959 . . . . 0.0 110.092 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -138.89 178.81 6.88 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 127.666 2.386 . . . . 0.0 107.711 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -63.46 -14.31 49.4 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 121.706 -0.621 . . . . 0.0 111.659 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 5.0 t -97.5 -47.72 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 125.279 1.432 . . . . 0.0 112.101 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 172.6 -162.29 33.98 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.281 -1.127 . . . . 0.0 110.281 -178.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -84.32 163.33 19.67 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 117.993 0.897 . . . . 0.0 110.359 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -156.88 165.14 37.04 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.29 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 62.7 mt -105.26 120.2 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 39.8 t -89.93 136.31 33.12 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 124.707 1.203 . . . . 0.0 107.931 178.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -131.44 113.16 13.37 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 125.129 1.372 . . . . 0.0 107.652 178.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.48 107.03 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 7.2 mt -94.01 105.81 17.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -111.57 -152.34 12.17 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 126.676 2.084 . . . . 0.0 109.715 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 76.73 40.54 0.2 Allowed 'General case' 0 C--O 1.237 0.416 0 C-N-CA 127.166 2.186 . . . . 0.0 108.305 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -108.7 173.25 17.43 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-O 121.978 0.766 . . . . 0.0 112.793 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . 0.498 ' H ' ' NE ' ' A' ' 200' ' ' ARG . 30.6 m-20 -80.97 141.28 34.61 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 179.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 43.5 mm -69.2 136.53 26.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 124.951 1.3 . . . . 0.0 112.046 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -87.52 110.33 20.26 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 128.335 2.654 . . . . 0.0 107.744 178.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -55.94 -18.49 9.25 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 127.691 2.396 . . . . 0.0 114.101 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 25.3 t -60.48 -46.28 95.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 124.985 1.314 . . . . 0.0 110.575 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 5.7 t -123.1 -37.52 2.7 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.514 1.126 . . . . 0.0 113.133 -178.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 104.12 35.89 3.29 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 108.079 -2.008 . . . . 0.0 108.079 -178.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -122.18 163.45 19.53 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.71 1.255 . . . . 0.0 110.813 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -77.2 151.71 35.1 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -178.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.498 ' NE ' ' H ' ' A' ' 191' ' ' ASP . 27.0 ptt85 -76.61 28.71 0.13 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 129.352 3.061 . . . . 0.0 111.852 177.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 6.6 ptm -72.77 175.52 6.4 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.956 0.903 . . . . 0.0 112.286 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.2 p -142.34 146.86 21.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 124.977 1.311 . . . . 0.0 109.978 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -105.18 104.04 13.69 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.831 1.652 . . . . 0.0 107.678 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 24.4 mm -91.26 152.01 3.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 O-C-N 120.896 -1.127 . . . . 0.0 109.432 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -127.36 104.83 8.13 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.342 1.857 . . . . 0.0 110.586 178.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -84.48 108.59 17.35 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 177.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 11.6 m -125.01 166.88 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 48.0 t -91.77 138.35 31.63 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 178.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -87.4 3.26 86.6 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-O 118.56 -1.133 . . . . 0.0 112.601 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 60.48 63.42 5.02 Favored Glycine 0 C--N 1.338 0.686 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 5.8 p -143.3 151.58 40.68 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 55.0 p30 -81.06 -19.27 44.13 Favored 'General case' 0 CA--C 1.522 -0.115 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -179.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 54.1 p -163.72 170.99 16.22 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 119.255 0.934 . . . . 0.0 110.697 -178.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 132.95 176.76 14.55 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 124.217 0.913 . . . . 0.0 113.708 178.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -80.02 -114.89 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 124.075 3.183 . . . . 0.0 109.401 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.1 146.38 26.89 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.864 1.666 . . . . 0.0 108.782 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 80.4 p -147.18 162.3 39.16 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 118.784 0.72 . . . . 0.0 110.357 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . 0.403 ' HB ' ' CB ' ' A' ' 120' ' ' TYR . 3.4 mt -107.28 139.63 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 105.013 -2.218 . . . . 0.0 105.013 177.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -88.48 -47.71 8.13 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.417 1.087 . . . . 0.0 111.45 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 68.6 p-90 -159.25 154.21 24.93 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 126.047 1.739 . . . . 0.0 108.66 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 6.1 p -155.78 128.82 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -156.3 162.54 40.09 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 122.895 0.478 . . . . 0.0 111.119 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -68.76 133.42 48.33 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 178.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 12.0 t -109.48 -31.11 7.63 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 123.909 0.884 . . . . 0.0 111.882 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 7.1 mttm -138.65 -175.85 4.27 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.043 1.337 . . . . 0.0 108.024 178.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 76.3 mt -45.1 -49.39 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 1.8 t -132.96 18.96 4.12 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.169 0.988 . . . . 0.0 111.168 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 18.5 t -113.79 141.69 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -123.96 163.62 20.97 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.805 1.242 . . . . 0.0 107.725 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -142.76 133.55 25.4 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -134.89 145.26 48.07 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 125.669 1.588 . . . . 0.0 107.986 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -124.29 123.29 39.9 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 6.3 m -113.92 154.81 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 2.1 p -125.37 126.3 44.8 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 123.76 0.824 . . . . 0.0 112.079 -178.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -131.38 145.94 59.81 Favored Pre-proline 0 C--O 1.234 0.254 0 O-C-N 124.357 1.035 . . . . 0.0 108.258 176.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -66.52 -47.85 2.71 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.786 2.324 . . . . 0.0 109.255 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -53.31 -23.61 9.64 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 -178.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 7.4 tp -66.39 -30.27 70.61 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 121.11 -0.994 . . . . 0.0 111.147 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 2.8 m -60.25 -13.08 10.72 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.058 0.943 . . . . 0.0 112.706 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.33 -25.79 67.76 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 118.901 0.773 . . . . 0.0 111.389 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -88.94 126.42 35.39 Favored 'General case' 0 C--O 1.225 -0.229 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -47.4 -44.65 24.59 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.631 1.972 . . . . 0.0 113.064 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 48.1 mt -72.93 -21.72 60.84 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 120.681 -1.262 . . . . 0.0 113.864 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 13.2 mt -100.46 -13.14 18.82 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.538 1.535 . . . . 0.0 112.654 -178.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -61.25 136.29 58.01 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 129.263 3.025 . . . . 0.0 110.742 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -112.9 -176.0 2.8 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.703 1.601 . . . . 0.0 110.079 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -69.53 -8.99 52.0 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.033 1.333 . . . . 0.0 111.31 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -122.7 31.36 6.11 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 127.382 2.273 . . . . 0.0 109.959 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.247 0.971 0 CA-C-O 117.345 -1.312 . . . . 0.0 111.711 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.037 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -99.89 -111.99 0.18 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 104.262 -2.496 . . . . 0.0 104.262 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.9 m -58.01 -13.12 4.04 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.479 1.112 . . . . 0.0 113.515 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -59.88 -37.64 79.92 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 177.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.3 t -72.79 -37.78 67.48 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 128.73 2.812 . . . . 0.0 110.101 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -63.59 -46.12 87.28 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -55.95 -55.19 35.65 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.1 p -62.7 -37.38 86.23 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 123.307 0.643 . . . . 0.0 112.089 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.91 -38.61 79.3 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 49.9 tp -70.25 -38.24 75.1 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 117.865 -1.064 . . . . 0.0 109.519 177.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.5 mt -61.75 -55.24 32.33 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.94 1.245 . . . . 0.0 109.376 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 18.3 m -60.12 -46.45 89.59 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.93 1.692 . . . . 0.0 111.211 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.9 ttpt -66.84 -41.9 86.66 Favored 'General case' 0 C--N 1.341 0.208 0 O-C-N 120.103 -1.623 . . . . 0.0 110.544 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 27.0 m -53.73 -50.49 65.83 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.795 0.838 . . . . 0.0 110.028 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -55.05 -50.38 69.26 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.133 0.573 . . . . 0.0 111.015 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.77 -58.49 7.82 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 122.487 1.136 . . . . 0.0 112.807 -178.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.0 mm100 -58.87 -40.63 84.92 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.915 1.286 . . . . 0.0 111.27 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.0 -53.03 39.86 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 109.171 -1.571 . . . . 0.0 109.171 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 42.3 t -55.12 -47.58 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 119.46 1.63 . . . . 0.0 110.482 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.4 pttm -62.1 -34.23 75.94 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.364 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 84.0 m -75.63 -35.96 60.33 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 21.0 mt -59.24 -54.3 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -58.45 -34.14 70.51 Favored 'General case' 0 C--O 1.225 -0.198 0 O-C-N 123.852 0.72 . . . . 0.0 111.447 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -56.18 -48.13 76.95 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.181 0.593 . . . . 0.0 111.496 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.414 ' HE3' ' HA ' ' A' ' 215' ' ' PRO . 27.0 mmmt -80.96 -40.8 23.86 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 121.565 -0.709 . . . . 0.0 111.255 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 13.0 mt -61.59 -31.62 71.69 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-O 118.364 -0.827 . . . . 0.0 112.25 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -51.53 -28.14 12.81 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.031 0.932 . . . . 0.0 113.337 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -59.65 -63.11 1.42 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.981 0.912 . . . . 0.0 111.72 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 7.3 mmt85 -154.65 -176.95 6.16 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.395 1.478 . . . . 0.0 110.805 -178.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 67.3 m -86.29 174.32 9.15 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 177.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 30.9 pt -129.47 161.42 38.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 126.573 1.949 . . . . 0.0 107.246 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -153.35 142.62 21.52 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -136.97 117.23 13.52 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.346 0.659 . . . . 0.0 109.892 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -85.24 98.43 10.49 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.83 80.77 7.09 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 128.634 2.774 . . . . 0.0 108.02 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 60.16 -112.09 4.17 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 108.581 -1.808 . . . . 0.0 108.581 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -80.77 -24.65 38.47 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -100.45 159.33 15.23 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 119.957 1.253 . . . . 0.0 111.031 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.0 mp -134.88 132.22 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 N-CA-C 103.904 -2.628 . . . . 0.0 103.904 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -118.59 121.3 39.87 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -109.26 121.1 44.45 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -111.25 128.3 55.89 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.196 0.522 . . . . 0.0 110.669 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 54.7 m -110.14 153.21 43.37 Favored Pre-proline 0 N--CA 1.439 -1.002 0 C-N-CA 126.894 2.077 . . . . 0.0 113.308 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -68.96 74.34 0.95 Allowed 'Trans proline' 0 C--N 1.349 0.573 1 C-N-CA 125.356 4.037 . . . . 0.0 113.692 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.13 51.77 6.65 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-O 119.04 -0.866 . . . . 0.0 113.812 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.6 mp -124.83 -72.16 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.299 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 177.73 145.28 0.11 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -109.87 131.98 54.57 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 124.757 1.223 . . . . 0.0 109.098 -175.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.5 m -144.82 164.53 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 125.318 1.447 . . . . 0.0 111.581 -177.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -123.19 126.29 46.71 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 105.25 -2.129 . . . . 0.0 105.25 177.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -138.36 162.99 32.98 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.87 1.214 . . . . 0.0 111.235 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -84.98 157.73 20.7 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 177.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 136.76 -163.63 25.24 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -152.67 167.62 28.34 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 128.966 2.906 . . . . 0.0 107.137 178.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.2 p -122.32 146.56 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 123.721 0.809 . . . . 0.0 109.212 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -89.71 108.95 19.98 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 179.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 46.2 p -48.38 -33.15 8.63 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -178.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -66.31 -39.47 89.32 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -178.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 45.2 p -110.18 -21.92 12.02 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -177.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.25 35.54 70.07 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.064 1.316 . . . . 0.0 110.494 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -117.05 150.41 38.68 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 118.811 1.305 . . . . 0.0 109.288 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 12.2 mm -74.91 159.69 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 123.77 0.828 . . . . 0.0 109.166 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 17.9 m -69.78 -37.42 73.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 125.446 1.498 . . . . 0.0 111.641 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -162.1 174.78 12.5 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 128.372 2.669 . . . . 0.0 107.298 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.37 124.57 45.85 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 101.464 -3.532 . . . . 0.0 101.464 176.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.44 89.26 7.79 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.575 0.703 . . . . 0.0 110.0 -177.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -57.72 -24.7 58.27 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.45 1.1 . . . . 0.0 110.059 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 5.5 m -80.5 -22.23 41.16 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 127.403 2.281 . . . . 0.0 113.63 -179.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 93.9 mt -98.13 89.36 4.49 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 19.6 m -95.54 105.07 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.189 -178.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -130.41 143.09 50.55 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 125.594 1.558 . . . . 0.0 106.921 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.3 116.18 12.3 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 49.0 mt -98.05 -26.81 14.48 Favored 'General case' 0 C--O 1.22 -0.448 0 O-C-N 124.413 1.07 . . . . 0.0 110.91 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 155.17 155.17 7.2 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 119.028 0.831 . . . . 0.0 111.54 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -114.74 109.97 47.17 Favored Pre-proline 0 N--CA 1.451 -0.4 0 C-N-CA 125.246 1.418 . . . . 0.0 108.766 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -74.52 -177.55 3.41 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.801 2.334 . . . . 0.0 107.319 178.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -128.95 134.67 48.29 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-N 118.819 0.736 . . . . 0.0 110.532 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -49.61 -45.98 48.71 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 125.869 1.98 . . . . 0.0 109.808 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -73.21 65.05 0.8 Allowed 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.522 1.529 . . . . 0.0 110.297 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 5.9 p -50.76 -31.23 9.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 121.035 -1.041 . . . . 0.0 112.659 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -63.42 -26.88 68.94 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -177.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -86.74 -23.09 25.62 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.67 1.588 . . . . 0.0 112.826 -179.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 30.2 mtp85 -73.34 150.71 41.65 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -103.71 144.19 31.79 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -138.93 159.26 42.57 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.96 1.304 . . . . 0.0 108.749 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -120.11 153.74 35.72 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.738 0.815 . . . . 0.0 109.994 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 35.5 tp -114.26 98.01 6.68 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.777 1.631 . . . . 0.0 106.995 179.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -107.92 -178.54 3.64 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.693 1.997 . . . . 0.0 108.547 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -141.22 158.06 44.4 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.024 0.53 . . . . 0.0 110.853 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -132.09 -178.7 5.02 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.681 1.992 . . . . 0.0 108.435 179.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.14 -14.42 17.05 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.186 1.394 . . . . 0.0 113.136 -178.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 16.0 t -107.24 -41.87 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 124.37 1.068 . . . . 0.0 111.279 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 177.34 -172.34 45.15 Favored Glycine 0 C--N 1.336 0.537 0 O-C-N 121.104 -0.998 . . . . 0.0 114.573 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 5.0 m-30 -77.28 158.36 30.26 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 122.337 1.065 . . . . 0.0 108.514 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -157.04 160.5 39.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.2 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 92.5 mt -100.19 132.11 46.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 22.7 t -102.06 126.15 48.92 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 125.406 1.482 . . . . 0.0 111.971 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -123.17 111.6 16.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.725 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -93.26 119.04 40.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 177.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 9.1 mt -104.7 106.55 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 178.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.63 -153.1 24.54 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 124.771 1.177 . . . . 0.0 110.57 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 71.3 47.87 0.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.716 2.006 . . . . 0.0 107.946 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -115.04 162.91 12.27 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 108.886 -1.685 . . . . 0.0 108.886 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.05 159.11 30.11 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.0 mm -79.6 137.84 20.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 124.674 1.19 . . . . 0.0 110.604 178.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.3 m -90.09 108.65 19.86 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 128.047 2.539 . . . . 0.0 106.635 178.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -53.93 -25.88 22.62 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.051 1.34 . . . . 0.0 113.486 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 40.0 t -49.6 -47.26 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 125.254 1.422 . . . . 0.0 112.024 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 11.2 t -124.3 -38.99 2.37 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.278 1.031 . . . . 0.0 111.653 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 110.5 34.96 2.16 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 107.923 -2.071 . . . . 0.0 107.923 -177.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -106.28 154.8 20.23 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 120.175 1.988 . . . . 0.0 111.403 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -76.25 148.41 37.63 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 123.523 0.729 . . . . 0.0 111.723 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 38.6 mtt180 -69.91 27.23 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 130.564 3.546 . . . . 0.0 112.442 178.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 6.4 ptm -74.38 175.29 7.82 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.473 1.033 . . . . 0.0 110.683 -178.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.13 149.84 18.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 124.972 1.309 . . . . 0.0 107.484 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -109.19 112.79 25.15 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.355 1.462 . . . . 0.0 107.345 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 13.3 mm -105.99 139.49 27.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 39.1 mm-40 -124.73 126.71 46.11 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.479 1.112 . . . . 0.0 109.88 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -100.41 111.2 23.44 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.301 1.04 . . . . 0.0 110.512 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 3.5 m -124.21 163.43 24.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 123.742 0.817 . . . . 0.0 109.769 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 52.7 t -88.87 134.21 34.02 Favored 'General case' 0 N--CA 1.461 0.09 0 O-C-N 120.633 -1.292 . . . . 0.0 110.204 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -84.59 10.37 62.19 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 124.34 0.971 . . . . 0.0 114.032 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 63.03 -143.05 48.3 Favored Glycine 0 CA--C 1.533 1.17 0 N-CA-C 106.965 -2.454 . . . . 0.0 106.965 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 40.7 m -69.72 78.75 0.44 Allowed 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -140.93 64.9 1.41 Allowed 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 177.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 2.9 m -58.68 138.43 57.02 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 149.59 -167.08 29.76 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.238 0.923 . . . . 0.0 112.074 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.414 ' HA ' ' HE3' ' A' ' 112' ' ' LYS . 55.4 Cg_endo -67.22 -82.64 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 124.234 3.289 . . . . 0.0 111.102 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 4.2 p -174.85 151.83 1.46 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.212 1.405 . . . . 0.0 110.66 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.4 p -151.09 158.58 44.22 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.865 1.266 . . . . 0.0 109.222 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 4.3 mt -98.1 151.93 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 125.65 1.58 . . . . 0.0 110.084 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -97.07 -50.34 4.64 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 124.691 1.197 . . . . 0.0 112.031 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 63.9 p-90 -159.69 156.09 27.17 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -178.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 61.7 t -153.76 129.16 1.59 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 125.792 1.637 . . . . 0.0 107.198 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -160.62 163.68 32.42 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.198 0.599 . . . . 0.0 111.189 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -69.39 144.21 53.45 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 9.0 t -119.18 -35.8 3.53 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 121.084 -1.01 . . . . 0.0 110.521 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -127.65 -175.11 3.37 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 83.3 mt -55.7 -44.63 77.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.731 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 1.1 t -125.16 10.16 8.08 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.579 0.752 . . . . 0.0 112.492 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 10.6 t -114.74 143.77 23.76 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.793 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -177.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -122.39 162.22 22.01 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -132.54 143.53 49.79 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -145.89 146.27 31.03 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.638 1.575 . . . . 0.0 108.842 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -135.44 130.25 34.49 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 8.8 m -114.43 155.6 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.627 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 178.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.04 125.27 44.25 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 1.5 pt -134.72 146.22 58.06 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -75.22 -35.98 2.68 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.413 2.076 . . . . 0.0 112.566 -178.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -62.89 -17.58 61.84 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 -177.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 18.4 mt -73.18 -29.31 62.75 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.88 1.218 . . . . 0.0 110.264 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 10.1 m -57.1 -15.86 6.32 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.11 0.964 . . . . 0.0 112.903 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -62.01 -31.05 71.39 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.139 0.975 . . . . 0.0 109.173 177.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -86.34 124.28 32.52 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 106.052 -1.832 . . . . 0.0 106.052 178.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -47.23 -48.67 24.19 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 127.003 2.121 . . . . 0.0 113.608 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 32.9 mt -67.01 -26.18 66.67 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 12.8 mt -99.31 2.64 45.63 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.095 1.758 . . . . 0.0 111.582 -178.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -77.67 114.56 16.63 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.614 1.566 . . . . 0.0 111.733 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -69.2 173.44 5.64 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.018 0.927 . . . . 0.0 109.529 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . 0.491 ' C ' ' H ' ' A' ' 249' ' ' ASP . 36.9 t30 63.11 -13.01 0.08 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 127.793 2.437 . . . . 0.0 115.635 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -72.58 22.4 0.06 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 126.727 2.011 . . . . 0.0 111.729 178.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . 0.491 ' H ' ' C ' ' A' ' 247' ' ' ASN . 16.9 t70 . . . . . 0 C--O 1.244 0.776 0 C-N-CA 128.623 2.769 . . . . 0.0 109.552 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.428 ' HA ' HD12 ' A' ' 98' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.463 0.191 0 CA-C-O 118.817 -0.611 . . . . 0.0 112.078 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.71 -50.26 74.56 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 61.1 tp -69.54 -34.61 74.48 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 118.33 -0.843 . . . . 0.0 110.748 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 95' ' ' THR . 17.3 mt -61.38 -54.38 44.39 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.8 m -57.52 -50.52 72.79 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.157 0.983 . . . . 0.0 110.368 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.7 -50.29 72.61 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 118.651 -0.69 . . . . 0.0 111.038 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 21.9 m -52.2 -45.21 65.13 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 124.282 1.033 . . . . 0.0 110.309 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -60.56 -51.38 69.67 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.356 0.98 . . . . 0.0 108.767 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -59.03 -60.25 4.17 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.44 -30.92 67.89 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.199 -176.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.76 -52.29 51.64 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.506 ' HA ' HD12 ' A' ' 109' ' ' ILE . 42.1 t -56.75 -48.62 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 118.361 1.08 . . . . 0.0 109.794 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.43 -30.92 70.87 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 119.037 -1.065 . . . . 0.0 113.487 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 44.4 m -78.19 -34.2 49.62 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.506 HD12 ' HA ' ' A' ' 106' ' ' VAL . 21.7 mt -60.02 -54.74 30.63 Favored 'Isoleucine or valine' 0 C--O 1.23 0.072 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -58.11 -29.85 65.82 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.781 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -69.75 -39.81 76.5 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.294 0.952 . . . . 0.0 112.189 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.2 tptt -84.77 -34.2 22.85 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 120.744 -1.223 . . . . 0.0 110.426 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 15.9 mt -65.95 -30.28 70.82 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 118.497 -0.763 . . . . 0.0 109.802 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -48.36 -35.05 11.75 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.466 1.107 . . . . 0.0 112.209 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -49.0 -66.07 0.46 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.51 1.524 . . . . 0.0 113.328 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -158.0 -177.85 6.87 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 128.178 2.591 . . . . 0.0 108.777 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 58.5 m -86.67 167.21 14.71 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 42.3 pt -115.69 156.99 16.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -154.18 141.76 19.85 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 122.555 0.342 . . . . 0.0 111.225 -178.004 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -140.44 125.75 18.78 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.649 0.78 . . . . 0.0 111.205 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -84.27 105.76 15.37 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.64 80.23 4.79 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.27 -103.24 0.98 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -93.2 -23.08 18.67 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.457 1.103 . . . . 0.0 113.742 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -100.58 156.9 17.04 Favored 'General case' 0 CA--C 1.517 -0.326 0 O-C-N 121.606 -0.684 . . . . 0.0 110.111 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.8 mp -127.89 135.33 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.43 ' CD1' HG11 ' A' ' 221' ' ' VAL . 63.1 m-85 -115.5 124.87 52.17 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -120.9 120.07 34.45 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 123.291 0.636 . . . . 0.0 110.301 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -110.9 131.2 55.25 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.657 0.741 . . . . 0.0 109.922 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.45 ' HB3' HD13 ' A' ' 133' ' ' ILE . 36.1 m -110.08 157.24 38.43 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 124.398 1.079 . . . . 0.0 112.697 -178.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -63.6 76.68 0.14 Allowed 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 125.042 3.828 . . . . 0.0 113.612 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 66.18 60.66 6.15 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 125.01 1.291 . . . . 0.0 112.228 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.45 HD13 ' HB3' ' A' ' 130' ' ' CYS . 3.2 mp -130.57 -71.46 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -164.88 164.71 20.82 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 126.455 1.902 . . . . 0.0 110.278 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -131.18 119.35 21.75 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 22.5 m -143.92 164.89 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 123.899 0.88 . . . . 0.0 110.761 -178.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -120.59 129.48 53.77 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.632 1.173 . . . . 0.0 109.014 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -138.93 162.87 33.81 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.19 1.396 . . . . 0.0 112.089 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -89.09 160.91 16.81 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 176.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.486 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -179.767 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -147.03 129.21 15.62 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 54.3 mt -112.94 -21.98 10.85 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.828 0.74 . . . . 0.0 109.753 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 155.98 157.8 8.48 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -126.46 117.73 23.07 Favored Pre-proline 0 CA--C 1.536 0.41 0 O-C-N 122.044 -0.68 . . . . 0.0 111.003 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -77.01 -171.17 1.07 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 1 C-N-CA 126.316 4.677 . . . . 0.0 108.845 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -129.5 152.86 48.57 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.312 1.045 . . . . 0.0 109.04 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -73.76 -29.71 62.37 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.26 1.024 . . . . 0.0 110.578 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -88.28 64.66 7.71 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 124.708 1.203 . . . . 0.0 108.361 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.6 p -50.07 -31.59 7.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 124.92 1.288 . . . . 0.0 112.093 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -61.5 -32.89 72.94 Favored 'General case' 0 CA--C 1.522 -0.116 0 C-N-CA 123.931 0.892 . . . . 0.0 111.986 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -80.64 -28.28 36.98 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.338 1.055 . . . . 0.0 110.82 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 9.4 mtp-105 -72.92 137.3 45.48 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -99.12 144.75 27.9 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -128.7 173.89 9.91 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 126.326 1.85 . . . . 0.0 108.639 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -131.71 154.09 49.36 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.375 0.67 . . . . 0.0 109.389 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 23.1 tp -118.27 100.65 7.64 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.344 1.058 . . . . 0.0 109.061 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -109.24 -179.89 3.97 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 181' ' ' TYR . 4.0 p90 -149.95 163.51 37.9 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 121.142 -0.974 . . . . 0.0 108.978 177.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -140.58 -178.14 5.38 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -59.33 -22.52 61.39 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.694 1.198 . . . . 0.0 111.729 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.449 HG12 ' HE3' ' A' ' 246' ' ' LYS . 48.3 t -88.85 -35.86 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 125.762 1.625 . . . . 0.0 111.965 -178.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 160.19 178.95 34.64 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 121.743 -0.265 . . . . 0.0 112.789 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 176' ' ' TYR . 20.1 m-85 -78.01 155.71 30.56 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 123.893 0.877 . . . . 0.0 108.98 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -155.72 156.72 35.37 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.31 0.644 . . . . 0.0 111.395 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 92.7 mt -97.15 133.82 37.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 12.3 t -101.32 127.14 48.07 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.495 1.518 . . . . 0.0 108.294 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -122.54 107.28 11.82 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.604 1.562 . . . . 0.0 107.807 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -93.3 115.47 32.19 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.5 mt -99.64 106.59 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 104.778 -2.305 . . . . 0.0 104.778 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -99.72 -152.86 27.24 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 108.771 -1.731 . . . . 0.0 108.771 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 69.66 47.7 0.63 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-O 123.049 1.404 . . . . 0.0 107.875 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -116.79 158.24 14.59 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 107.803 -2.119 . . . . 0.0 107.803 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -74.42 159.15 32.69 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.168 0.987 . . . . 0.0 108.704 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 34.1 mm -83.03 126.38 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 177.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.2 m -75.37 111.75 10.97 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 127.065 2.146 . . . . 0.0 107.072 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -56.23 -27.45 54.93 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.626 1.17 . . . . 0.0 112.49 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 57.9 t -49.3 -50.67 15.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 125.036 1.334 . . . . 0.0 110.847 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 6.5 t -125.57 -32.35 2.89 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 116.644 2.09 . . . . 0.0 116.644 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 106.9 35.86 2.68 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -178.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -116.68 152.14 34.89 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 118.261 1.03 . . . . 0.0 111.764 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -74.81 146.45 42.03 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.571 0.748 . . . . 0.0 112.908 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -72.6 29.11 0.06 Allowed 'General case' 0 C--O 1.223 -0.322 1 C-N-CA 132.055 4.142 . . . . 0.0 112.308 178.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 5.8 ptm -75.77 177.52 6.83 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 120.197 -1.565 . . . . 0.0 110.341 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 5.9 p -147.94 148.85 15.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 125.158 1.383 . . . . 0.0 108.452 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -104.73 121.97 44.71 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 177.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 17.7 mm -114.1 131.22 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -114.54 125.0 53.3 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.304 1.042 . . . . 0.0 109.068 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -97.77 112.72 24.51 Favored 'General case' 0 C--O 1.239 0.553 0 C-N-CA 123.685 0.794 . . . . 0.0 109.72 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 5.1 m -124.08 161.46 26.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 44.1 t -90.25 142.68 27.48 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -84.4 2.39 87.93 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-O 117.753 -1.581 . . . . 0.0 114.906 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.719 0 N-CA-C 106.97 -2.452 . . . . 0.0 106.97 -178.132 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo . . . . . 0 CA--C 1.545 1.065 0 N-CA-C 107.733 -1.68 . . . . 0.0 107.733 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.6 p -150.33 142.11 23.72 Favored 'General case' 0 C--O 1.237 0.405 0 O-C-N 120.047 -1.658 . . . . 0.0 111.554 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 40.7 p -147.86 160.98 42.19 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.776 1.23 . . . . 0.0 110.244 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 4.0 mt -100.08 153.71 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 126.536 1.935 . . . . 0.0 107.865 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -97.62 -48.55 5.2 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 124.492 1.117 . . . . 0.0 112.618 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 52.8 p-90 -163.96 159.46 20.83 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.43 HG11 ' CD1' ' A' ' 127' ' ' TYR . 91.0 t -152.8 129.15 1.84 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.586 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.14 167.35 29.39 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.289 0.95 . . . . 0.0 112.547 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -77.41 132.63 38.6 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.581 1.552 . . . . 0.0 107.653 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 7.5 t -110.84 -33.74 6.44 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.573 1.149 . . . . 0.0 110.918 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -132.53 -175.18 3.67 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 124.645 1.178 . . . . 0.0 108.985 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 60.9 mt -56.64 -45.05 82.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -125.58 18.33 8.1 Favored 'General case' 0 C--N 1.334 -0.108 0 C-N-CA 124.185 0.994 . . . . 0.0 111.102 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 15.8 t -121.65 143.3 34.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 CA-C-N 118.309 0.504 . . . . 0.0 110.387 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -124.47 161.32 26.32 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.152 1.381 . . . . 0.0 107.666 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -132.07 134.49 45.57 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 126.04 1.736 . . . . 0.0 106.534 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -140.22 145.3 37.22 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.919 1.688 . . . . 0.0 109.07 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -133.69 128.62 35.37 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 119.263 -0.398 . . . . 0.0 111.57 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 3.8 m -112.35 152.69 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.57 115.36 20.71 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.808 1.243 . . . . 0.0 107.775 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 18.5 pt -127.14 152.25 75.61 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.879 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.63 -45.43 0.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.819 2.346 . . . . 0.0 112.366 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -53.32 -28.51 28.77 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 116.751 2.13 . . . . 0.0 116.751 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.4 HD22 ' CD1' ' A' ' 244' ' ' LEU . 59.2 mt -64.42 -28.98 70.05 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 120.33 1.423 . . . . 0.0 110.323 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 12.3 m -60.61 -11.72 8.04 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -69.85 -31.52 69.41 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.96 121.63 25.71 Favored 'General case' 0 C--O 1.225 -0.199 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -47.13 -42.6 19.63 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.906 1.683 . . . . 0.0 113.47 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.86 -29.57 64.51 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.4 ' CD1' HD22 ' A' ' 238' ' ' LEU . 17.3 mt -96.49 -5.45 39.45 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.299 1.04 . . . . 0.0 111.832 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -64.3 116.77 6.36 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.895 1.678 . . . . 0.0 108.577 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.449 ' HE3' HG12 ' A' ' 179' ' ' VAL . 3.8 mmmm . . . . . 0 N--CA 1.451 -0.399 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 178.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.536 0.406 0 CA-C-O 118.916 -0.564 . . . . 0.0 110.955 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.56 -43.15 97.57 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 119.119 0.872 . . . . 0.0 109.395 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 65.7 tp -64.2 -32.36 73.91 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-O 118.406 -0.807 . . . . 0.0 109.61 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.04 -54.36 39.3 Favored 'General case' 0 C--N 1.345 0.377 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 25.3 m -60.79 -48.14 83.13 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.159 0.984 . . . . 0.0 110.877 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.86 -48.84 79.95 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 121.024 -1.048 . . . . 0.0 110.036 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 53.8 m -54.11 -46.09 72.03 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 123.535 0.734 . . . . 0.0 110.055 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -56.22 -48.47 76.41 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.515 0.326 . . . . 0.0 110.432 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.16 -52.96 16.26 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -58.14 -40.29 80.95 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.344 1.058 . . . . 0.0 110.983 -178.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -66.58 -52.35 35.34 Favored Glycine 0 C--O 1.223 -0.537 0 N-CA-C 108.776 -1.729 . . . . 0.0 108.776 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.415 ' HA ' HD12 ' A' ' 109' ' ' ILE . 24.5 t -53.25 -46.88 57.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 118.76 1.28 . . . . 0.0 110.988 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.6 ptmm? -62.44 -34.2 76.32 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.1 m -77.66 -36.45 51.34 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.916 0.887 . . . . 0.0 110.371 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.415 HD12 ' HA ' ' A' ' 106' ' ' VAL . 23.5 mt -60.22 -54.71 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -61.53 -28.19 69.14 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.112 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -66.29 -45.41 80.5 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 120.586 -1.321 . . . . 0.0 113.0 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -76.92 -39.43 50.84 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 18.3 mt -66.22 -28.41 68.72 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-O 118.721 -0.657 . . . . 0.0 112.147 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -56.77 -18.57 13.16 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.54 0.736 . . . . 0.0 112.607 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -68.01 -74.71 0.11 Allowed 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 7.1 mmm180 -143.06 -179.65 6.5 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.281 1.432 . . . . 0.0 111.402 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 85.3 m -86.59 174.91 8.6 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 32.7 pt -128.67 159.99 39.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 127.043 2.137 . . . . 0.0 107.299 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -155.81 135.25 12.39 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.855 1.262 . . . . 0.0 108.975 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -130.79 126.16 35.62 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.666 1.186 . . . . 0.0 109.076 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -88.88 104.15 16.67 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.26 1.024 . . . . 0.0 109.365 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.59 80.74 4.3 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 128.337 2.655 . . . . 0.0 106.552 178.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 59.97 -113.34 5.24 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -78.0 -22.54 49.18 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.192 0.997 . . . . 0.0 112.835 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -105.15 161.72 14.01 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 123.625 0.77 . . . . 0.0 111.917 -178.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.4 mp -135.61 134.75 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 104.131 -2.544 . . . . 0.0 104.131 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.405 ' CD1' ' HB3' ' A' ' 137' ' ' GLN . 94.4 m-85 -114.86 119.65 37.29 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 103.991 -2.596 . . . . 0.0 103.991 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -111.02 116.46 31.22 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.382 0.673 . . . . 0.0 109.396 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -106.66 129.23 54.6 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.52 ' HB3' HD13 ' A' ' 133' ' ' ILE . 20.8 m -114.75 155.49 46.17 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 126.665 1.986 . . . . 0.0 113.835 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.27 80.73 1.57 Allowed 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 124.115 3.21 . . . . 0.0 113.37 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.44 45.31 18.93 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-O 118.2 -1.333 . . . . 0.0 112.961 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.52 HD13 ' HB3' ' A' ' 130' ' ' CYS . 3.0 mp -120.84 -72.3 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 119.459 1.63 . . . . 0.0 109.913 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -179.2 141.91 0.18 Allowed 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -109.17 125.69 52.46 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -177.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 33.3 m -144.61 164.33 13.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 114.123 -1.399 . . . . 0.0 111.575 -177.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.405 ' HB3' ' CD1' ' A' ' 127' ' ' TYR . 6.6 pt20 -123.0 130.57 52.97 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.649 1.179 . . . . 0.0 108.286 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -138.25 162.89 33.15 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.402 1.481 . . . . 0.0 111.338 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 74.3 t60 -91.06 161.56 15.06 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.916 1.686 . . . . 0.0 107.391 178.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.72 0 CA-C-N 120.099 1.318 . . . . 0.0 110.769 -179.35 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 . . . . . 0 N--CA 1.451 -0.394 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 9.6 tpp180 -143.36 110.46 5.68 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.9 mp -98.43 -34.46 10.63 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 177.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 160.05 163.92 14.34 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 119.266 0.939 . . . . 0.0 111.537 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -118.82 109.78 39.25 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 124.264 1.026 . . . . 0.0 110.201 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -77.93 174.93 11.81 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 123.298 2.665 . . . . 0.0 111.118 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -126.35 146.23 50.13 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.25 -37.93 75.04 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 126.664 1.985 . . . . 0.0 111.428 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -73.25 65.36 0.83 Allowed 'General case' 0 C--O 1.233 0.227 0 C-N-CA 126.098 1.759 . . . . 0.0 109.967 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.4 p -48.84 -31.22 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 125.048 1.339 . . . . 0.0 112.206 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -71.18 -31.61 67.85 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 124.899 1.28 . . . . 0.0 112.862 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -76.65 -12.95 60.08 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.715 1.206 . . . . 0.0 113.167 -178.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -107.63 152.54 24.15 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.598 1.159 . . . . 0.0 110.526 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -105.02 156.61 17.89 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.267 1.427 . . . . 0.0 108.306 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -136.83 163.91 29.53 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.46 1.504 . . . . 0.0 108.738 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -114.72 153.7 29.81 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.236 0.614 . . . . 0.0 110.106 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 16.9 tp -118.39 98.79 6.44 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.432 1.493 . . . . 0.0 107.79 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -110.35 -178.99 3.65 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 126.875 2.07 . . . . 0.0 108.564 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -144.88 163.31 34.5 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 121.35 0.595 . . . . 0.0 110.057 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -137.69 -177.59 4.87 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.791 1.636 . . . . 0.0 108.046 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -60.55 -17.54 46.67 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.164 1.386 . . . . 0.0 111.56 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 87.7 t -86.0 -56.98 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 128.511 2.724 . . . . 0.0 110.484 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 168.76 -165.17 38.68 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -78.39 166.49 22.58 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 117.523 0.662 . . . . 0.0 109.683 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -159.85 171.59 19.18 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.167 0.987 . . . . 0.0 110.384 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 79.7 mt -107.42 138.11 35.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 32.9 t -107.07 134.11 50.69 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 125.393 1.477 . . . . 0.0 108.408 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -130.23 111.45 12.42 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.369 1.068 . . . . 0.0 108.214 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.6 mp -93.41 132.17 38.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 10.3 mt -122.18 115.2 45.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -110.68 -152.52 13.01 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 125.796 1.665 . . . . 0.0 111.603 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 4.6 t 71.58 35.25 1.49 Allowed 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.65 1.58 . . . . 0.0 114.434 178.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -87.58 -112.42 1.02 Allowed Glycine 0 CA--C 1.526 0.768 0 N-CA-C 108.44 -1.864 . . . . 0.0 108.44 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -154.55 150.83 28.17 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 129.825 3.25 . . . . 0.0 103.589 178.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.8 mm -72.9 137.57 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 O-C-N 120.053 -1.654 . . . . 0.0 111.999 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.6 m -81.4 116.08 21.05 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 128.489 2.716 . . . . 0.0 107.001 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -57.72 -29.16 64.51 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 124.624 1.17 . . . . 0.0 112.105 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 14.5 t -51.81 -50.67 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 126.423 1.889 . . . . 0.0 113.878 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 14.7 t -124.0 -31.97 3.31 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.15 34.74 3.86 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 -178.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -109.14 155.64 20.78 Favored 'General case' 0 C--N 1.343 0.324 0 C-N-CA 123.957 0.903 . . . . 0.0 110.182 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -75.72 144.4 41.55 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 125.197 1.399 . . . . 0.0 110.832 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . 0.269 26.1 mtp85 -69.04 29.18 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 130.053 3.341 . . . . 0.0 112.524 178.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 8.4 ptm -74.71 177.99 5.75 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.141 0.976 . . . . 0.0 112.022 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.3 p -145.78 152.72 13.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 125.504 1.522 . . . . 0.0 109.174 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -112.18 101.81 10.03 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 126.938 2.095 . . . . 0.0 106.921 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 9.1 mm -94.36 146.31 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -126.32 114.43 18.24 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 127.298 2.239 . . . . 0.0 109.574 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -93.62 115.71 28.19 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 12.5 m -125.02 165.62 21.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 42.1 t -87.04 140.68 29.31 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -95.47 18.06 58.12 Favored Glycine 0 CA--C 1.523 0.532 0 CA-C-O 118.596 -1.114 . . . . 0.0 112.706 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.985 0 N-CA-C 107.771 -2.131 . . . . 0.0 107.771 -178.241 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 N--CA 1.452 -0.958 0 N-CA-C 110.488 -0.62 . . . . 0.0 110.488 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 3.8 p -173.05 152.42 2.32 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.863 1.665 . . . . 0.0 110.914 -178.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 4.7 p -150.85 166.36 30.79 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.533 1.533 . . . . 0.0 109.108 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.476 HG12 HG12 ' A' ' 233' ' ' VAL . 5.1 mt -108.68 153.73 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 126.098 1.759 . . . . 0.0 110.614 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -94.44 -56.29 2.86 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 124.46 1.104 . . . . 0.0 111.155 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 -160.73 156.05 24.76 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 126.324 1.85 . . . . 0.0 106.903 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 58.0 t -151.33 125.94 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 125.731 1.612 . . . . 0.0 108.369 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -162.54 164.18 27.01 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 118.21 0.459 . . . . 0.0 110.874 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -65.81 141.9 58.13 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' THR . . . . . 0.486 HG23 ' HG3' ' A' ' 225' ' ' LYS . 1.8 t -123.79 -30.64 3.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 118.457 0.571 . . . . 0.0 111.897 179.27 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.486 ' HG3' HG23 ' A' ' 224' ' ' THR . 11.3 mttt -124.4 -175.87 3.37 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 77.0 mt -59.28 -47.36 90.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.88 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 1.8 t -118.93 15.02 13.37 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.651 0.78 . . . . 0.0 112.703 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 14.2 t -122.38 148.7 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.705 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.546 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -125.42 166.1 17.21 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -133.02 144.47 50.1 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 124.667 1.187 . . . . 0.0 108.464 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -144.96 118.95 9.35 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.19 1.396 . . . . 0.0 109.915 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -106.13 124.11 49.06 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 104.98 -2.23 . . . . 0.0 104.98 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' VAL . . . . . 0.476 HG12 HG12 ' A' ' 218' ' ' ILE . 3.0 m -119.38 153.76 21.92 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 2.1 p -122.55 138.27 54.63 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 122.236 1.017 . . . . 0.0 110.856 -178.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -143.69 148.14 41.86 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 114.609 -1.178 . . . . 0.0 108.142 178.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.28 -36.11 3.44 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 121.597 1.531 . . . . 0.0 112.208 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -59.86 -20.74 58.85 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 116.618 2.081 . . . . 0.0 116.618 -177.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 32.9 mt -71.24 -26.64 63.0 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.899 1.681 . . . . 0.0 110.52 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 27.5 m -59.57 -12.52 6.73 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.877 0.871 . . . . 0.0 111.845 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -62.39 -35.77 80.23 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.772 0.829 . . . . 0.0 110.171 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -87.87 130.9 34.75 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -47.81 -48.64 30.43 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.516 1.926 . . . . 0.0 112.779 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 66.0 mt -65.34 -25.67 67.7 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 15.4 mt -99.74 -7.54 25.42 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.746 0.818 . . . . 0.0 113.175 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -62.54 112.86 2.65 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 128.212 2.605 . . . . 0.0 112.743 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.237 0.42 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.45 ' HA ' HD12 ' A' ' 98' ' ' LEU . 1.1 p . . . . . 0 C--O 1.237 0.417 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.09 -38.97 93.3 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 22.8 tp -74.0 -40.96 62.57 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 117.519 -1.229 . . . . 0.0 109.367 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' ' 95' ' ' THR . 36.2 mt -57.87 -54.09 50.88 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.738 1.154 . . . . 0.0 110.407 -177.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 78.2 m -61.81 -38.07 86.73 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.503 -0.748 . . . . 0.0 111.215 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.39 -48.2 76.35 Favored 'General case' 0 C--N 1.341 0.201 0 O-C-N 120.091 -1.631 . . . . 0.0 109.424 178.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 77.2 m -52.82 -48.43 66.97 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.12 1.368 . . . . 0.0 109.941 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -59.38 -43.92 92.84 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.797 0.439 . . . . 0.0 111.933 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -71.98 -52.79 15.36 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -63.22 -41.22 99.09 Favored 'General case' 0 C--O 1.216 -0.698 0 C-N-CA 124.856 1.263 . . . . 0.0 109.661 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.04 -50.9 62.32 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.435 ' HA ' HD12 ' A' ' 109' ' ' ILE . 36.4 t -58.24 -45.88 88.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 118.591 1.195 . . . . 0.0 110.425 179.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 8.0 ptmt -61.92 -34.66 76.47 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.783 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 99.6 m -77.67 -28.53 51.16 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.679 0.792 . . . . 0.0 109.783 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.435 HD12 ' HA ' ' A' ' 106' ' ' VAL . 19.8 mt -69.61 -55.03 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 178.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -55.7 -36.99 67.76 Favored 'General case' 0 CA--C 1.527 0.083 0 O-C-N 123.644 0.59 . . . . 0.0 110.565 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -63.25 -38.66 92.02 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.258 1.023 . . . . 0.0 111.95 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.0 tptp -82.63 -38.78 23.04 Favored 'General case' 0 CA--C 1.518 -0.273 0 O-C-N 121.149 -0.969 . . . . 0.0 111.114 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 31.8 mt -70.26 -24.6 63.09 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 122.437 0.295 . . . . 0.0 111.305 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -50.93 -29.71 12.87 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.132 1.373 . . . . 0.0 111.096 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -64.87 -64.51 0.85 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.315 1.046 . . . . 0.0 113.176 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 86.7 mmt-85 -150.46 177.17 10.25 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.684 1.194 . . . . 0.0 110.479 -177.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 74.4 m -86.47 175.99 8.08 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 46.2 pt -129.33 157.74 42.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 124.926 1.29 . . . . 0.0 108.473 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -156.46 139.79 15.7 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.014 0.926 . . . . 0.0 110.668 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.476 ' CE1' ' HB2' ' A' ' 122' ' ' ALA . 4.9 t80 -136.84 124.14 21.9 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -81.07 98.79 8.15 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.997 1.719 . . . . 0.0 108.24 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.476 ' HB2' ' CE1' ' A' ' 120' ' ' TYR . . . -91.86 79.76 5.28 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.19 -85.37 0.06 OUTLIER Glycine 0 CA--C 1.521 0.458 0 C-N-CA 124.67 1.129 . . . . 0.0 113.183 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -106.8 -32.18 8.07 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.447 1.099 . . . . 0.0 112.895 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -104.93 128.24 53.11 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 123.679 0.791 . . . . 0.0 110.96 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.9 mp -98.24 157.1 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 103.794 -2.669 . . . . 0.0 103.794 177.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -135.34 121.95 20.77 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 103.955 -2.609 . . . . 0.0 103.955 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -119.25 117.65 29.18 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.8 1.64 . . . . 0.0 110.741 -178.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -110.67 137.7 48.0 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.415 1.486 . . . . 0.0 109.453 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.489 ' HB3' HD13 ' A' ' 133' ' ' ILE . 11.7 m -120.83 151.81 55.2 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 123.718 0.807 . . . . 0.0 111.506 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -60.53 85.35 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.662 1 C-N-CA 125.767 4.311 . . . . 0.0 115.044 -177.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 74.43 33.05 57.06 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 117.964 -1.464 . . . . 0.0 113.207 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.489 HD13 ' HB3' ' A' ' 130' ' ' CYS . 3.8 mp -115.65 -72.49 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 119.537 1.668 . . . . 0.0 109.222 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.489 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 9.1 pt-20 -168.88 169.36 9.83 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.12 1.768 . . . . 0.0 109.115 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -134.23 120.79 20.45 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 33.8 m -139.47 163.39 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.807 1.243 . . . . 0.0 110.993 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -118.82 125.07 48.73 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -138.24 162.3 34.66 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.962 0.801 . . . . 0.0 110.704 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -89.96 160.58 16.32 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 177.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.565 0 O-C-N 120.031 -1.668 . . . . 0.0 109.685 -178.341 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 . . . . . 0 CA--C 1.547 0.847 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -149.07 129.52 13.88 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.047 -1.658 . . . . 0.0 110.7 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 43.4 mt -109.02 -30.63 7.98 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 120.053 1.297 . . . . 0.0 108.525 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 165.68 164.36 20.99 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -128.66 109.63 18.87 Favored Pre-proline 0 C--O 1.236 0.356 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.489 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 69.2 Cg_endo -73.36 176.72 8.85 Favored 'Trans proline' 0 C--O 1.236 0.39 1 C-N-CA 125.458 4.105 . . . . 0.0 110.783 -179.542 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -123.13 144.39 49.37 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 124.114 0.966 . . . . 0.0 109.58 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -67.11 -43.53 82.23 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 124.953 1.408 . . . . 0.0 109.6 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -74.3 64.81 1.14 Allowed 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.285 1.434 . . . . 0.0 110.411 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.2 p -50.95 -28.83 6.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 126.855 2.062 . . . . 0.0 111.333 178.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -72.97 -30.44 63.84 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.497 1.119 . . . . 0.0 112.524 -178.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -75.98 -23.01 55.29 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -96.58 173.6 7.26 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -133.31 165.39 24.92 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -135.71 169.79 16.99 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.743 1.217 . . . . 0.0 110.245 -177.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -113.23 153.65 28.01 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 48.7 tp -123.11 99.07 6.18 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.009 1.723 . . . . 0.0 106.784 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -108.36 175.56 5.43 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -140.5 160.56 39.73 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 123.001 1.382 . . . . 0.0 109.609 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -140.79 178.23 7.49 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 126.294 1.838 . . . . 0.0 106.544 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -73.2 10.78 0.87 Allowed 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 125.479 1.512 . . . . 0.0 114.199 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 59.6 t -116.76 -37.25 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 125.879 1.672 . . . . 0.0 109.827 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 164.04 -176.04 40.09 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -86.68 163.19 17.5 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.534 ' HB3' HG12 ' A' ' 207' ' ' VAL . 43.5 p90 -156.36 161.52 40.14 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.633 0.773 . . . . 0.0 110.667 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 86.6 mt -102.08 130.74 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 12.9 t -97.38 126.9 42.91 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.485 1.114 . . . . 0.0 108.704 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -122.13 108.89 13.86 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -90.28 108.88 20.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 N-CA-C 103.68 -2.711 . . . . 0.0 103.68 178.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 12.2 mt -94.62 105.92 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 103.331 -2.841 . . . . 0.0 103.331 177.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -99.28 -152.72 27.52 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 107.765 -2.134 . . . . 0.0 107.765 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 5.2 t 70.22 51.64 0.38 Allowed 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -178.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -93.29 -162.78 36.62 Favored Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 106.375 -2.69 . . . . 0.0 106.375 177.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -127.64 136.17 51.26 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 100.585 -3.858 . . . . 0.0 100.585 177.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 33.2 mm -60.36 138.95 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 119.552 1.069 . . . . 0.0 109.924 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.06 112.01 24.25 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.829 2.052 . . . . 0.0 106.376 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -51.12 -29.02 12.14 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.183 1.793 . . . . 0.0 115.795 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 24.5 t -42.22 -51.92 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.126 1.37 . . . . 0.0 111.108 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 13.2 t -123.76 -34.07 3.08 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.532 0.733 . . . . 0.0 109.334 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 106.48 35.46 2.86 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -112.51 158.86 19.39 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-N 118.852 1.326 . . . . 0.0 110.689 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -68.12 143.53 55.39 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.649 1.58 . . . . 0.0 114.869 -178.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . 0.258 24.1 ttp180 -77.22 28.76 0.14 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 130.508 3.523 . . . . 0.0 113.524 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 8.1 ptm -73.82 176.91 5.9 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.072 -1.017 . . . . 0.0 111.365 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.46 149.27 19.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 125.801 1.64 . . . . 0.0 106.733 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -111.39 114.19 27.16 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 9.5 mm -102.26 138.99 24.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -118.15 96.93 5.54 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 126.729 2.011 . . . . 0.0 107.698 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -80.83 111.13 17.01 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.247 1.019 . . . . 0.0 108.545 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.534 HG12 ' HB3' ' A' ' 182' ' ' TYR . 33.5 m -124.53 164.98 22.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 124.653 1.181 . . . . 0.0 108.383 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' CYS . . . . . 0.439 ' O ' ' HE2' ' A' ' 246' ' ' LYS . 41.8 t -85.8 142.22 29.1 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -90.54 16.99 56.57 Favored Glycine 0 C--O 1.227 -0.294 0 CA-C-O 118.067 -1.407 . . . . 0.0 115.15 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.318 0 C-N-CA 125.812 1.673 . . . . 0.0 117.071 179.489 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo . . . . . 0 CA--C 1.545 1.072 0 N-CA-C 110.983 -0.43 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 216' ' ' SER . . . . . 0.405 ' CB ' HG22 ' A' ' 235' ' ' ILE . 3.8 p -156.01 148.61 23.86 Favored 'General case' 0 C--O 1.237 0.442 0 O-C-N 120.094 -1.629 . . . . 0.0 109.853 -178.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.7 p -151.01 168.5 24.38 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.895 0.878 . . . . 0.0 112.122 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.436 HG12 HG12 ' A' ' 233' ' ' VAL . 3.2 mt -109.63 152.01 11.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 126.505 1.922 . . . . 0.0 109.465 178.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -98.42 -51.83 3.84 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 126.063 1.745 . . . . 0.0 109.592 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 65.3 p-90 -159.87 158.67 31.34 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.607 1.163 . . . . 0.0 109.306 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 97.1 t -153.42 134.9 5.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 126.153 1.781 . . . . 0.0 107.459 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -165.7 162.64 18.86 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.367 0.667 . . . . 0.0 111.662 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -68.48 140.87 55.72 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 178.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 13.1 t -120.65 -30.07 4.57 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.865 1.266 . . . . 0.0 112.681 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 43.2 mttt -131.25 -175.63 3.76 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 72.8 mt -46.68 -49.49 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 6.8 t -133.25 17.82 4.06 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.986 0.514 . . . . 0.0 111.276 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 23.1 t -109.62 143.31 19.97 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -122.68 161.95 22.89 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -131.69 144.55 51.08 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 178.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -144.77 141.33 29.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.893 1.277 . . . . 0.0 109.585 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -124.01 116.26 22.55 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' VAL . . . . . 0.436 HG12 HG12 ' A' ' 218' ' ' ILE . 1.1 m -110.36 144.54 18.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -121.83 123.6 42.16 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.666 1.586 . . . . 0.0 110.757 -178.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.405 HG22 ' CB ' ' A' ' 216' ' ' SER . 3.6 pt -131.65 147.62 66.77 Favored Pre-proline 0 C--N 1.331 -0.231 0 C-N-CA 123.892 0.877 . . . . 0.0 108.695 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -70.18 -43.04 2.51 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.766 1.644 . . . . 0.0 111.924 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -55.77 -23.85 32.17 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -177.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.613 HD22 ' CD1' ' A' ' 244' ' ' LEU . 20.1 mt -65.28 -26.71 68.2 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 116.982 -1.887 . . . . 0.0 111.07 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 18.9 m -61.7 -11.75 13.35 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.618 0.645 . . . . 0.0 112.29 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -61.08 -22.89 65.04 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.718 0.807 . . . . 0.0 109.798 177.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -98.11 130.58 44.89 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 126.594 1.958 . . . . 0.0 109.743 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -51.65 -47.76 63.62 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.844 1.258 . . . . 0.0 112.637 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.59 -35.85 80.85 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.104 -0.998 . . . . 0.0 113.438 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.613 ' CD1' HD22 ' A' ' 238' ' ' LEU . 17.9 mt -89.89 -14.94 33.17 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -178.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -58.68 112.72 1.72 Allowed 'General case' 0 C--O 1.236 0.345 0 C-N-CA 128.204 2.601 . . . . 0.0 111.731 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.439 ' HE2' ' O ' ' A' ' 208' ' ' CYS . 39.2 mmtt . . . . . 0 C--O 1.235 0.29 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.531 ' HA ' HD12 ' A' ' 98' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.465 0.323 0 CA-C-O 120.472 0.177 . . . . 0.0 110.708 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.5 -42.61 95.72 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 32.5 tp -69.85 -36.89 75.91 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.44 1.096 . . . . 0.0 110.507 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.531 HD12 ' HA ' ' A' ' 95' ' ' THR . 22.4 mt -61.41 -54.89 37.67 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 119.005 0.821 . . . . 0.0 109.083 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 56.1 m -65.38 -40.26 93.26 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 121.453 -0.779 . . . . 0.0 111.257 -179.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -45.37 93.89 Favored 'General case' 0 C--O 1.222 -0.382 0 O-C-N 121.207 -0.933 . . . . 0.0 109.169 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 42.2 m -52.28 -48.9 65.05 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.171 0.989 . . . . 0.0 109.741 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -58.3 -48.9 79.02 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.886 0.474 . . . . 0.0 110.863 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -67.82 -56.33 9.57 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -177.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.427 ' HA ' ' HE3' ' A' ' 107' ' ' LYS . 2.8 mm-40 -55.83 -44.25 77.75 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.806 1.642 . . . . 0.0 109.678 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.34 -52.99 49.29 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-O 118.001 -1.444 . . . . 0.0 110.212 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.412 ' HA ' HD12 ' A' ' 109' ' ' ILE . 43.0 t -55.85 -43.36 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-N 119.893 1.846 . . . . 0.0 110.91 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.427 ' HE3' ' HA ' ' A' ' 104' ' ' GLN . 6.6 ptpt -66.01 -33.81 76.65 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 119.38 -0.928 . . . . 0.0 111.165 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 65.5 m -72.9 -39.24 66.51 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 106' ' ' VAL . 22.7 mt -61.06 -55.76 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -61.29 -35.42 77.29 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 118.292 -0.861 . . . . 0.0 112.67 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -62.21 -33.85 75.34 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.813 0.733 . . . . 0.0 111.887 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.527 ' HA ' ' HE2' ' A' ' 112' ' ' LYS . 0.6 OUTLIER -87.62 -38.27 16.06 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 117.87 -1.062 . . . . 0.0 110.333 179.047 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 29.5 mt -65.74 -25.17 67.16 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.904 1.229 . . . . 0.0 110.338 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -51.47 -30.08 18.54 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.119 1.768 . . . . 0.0 111.558 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -65.51 -66.75 0.51 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.426 1.49 . . . . 0.0 113.083 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.6 mmt180 -144.56 173.36 11.87 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 124.456 1.102 . . . . 0.0 110.743 -178.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 78.6 m -86.07 163.34 17.97 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 48.3 pt -118.92 154.5 21.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -178.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -151.87 144.49 24.24 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.909 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -140.74 122.34 15.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.425 178.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -81.6 100.07 9.2 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.69 80.03 6.67 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 104.389 -2.449 . . . . 0.0 104.389 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 65.97 -109.02 2.65 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -81.32 -36.36 29.84 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -99.84 146.0 27.11 Favored 'General case' 0 CA--C 1.512 -0.486 0 O-C-N 121.635 -0.666 . . . . 0.0 110.388 -178.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.5 mp -110.21 153.4 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -131.9 119.3 20.98 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -121.15 120.49 35.4 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.315 1.046 . . . . 0.0 111.676 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -111.27 140.66 45.66 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.003 1.321 . . . . 0.0 111.065 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.507 ' HB3' HD13 ' A' ' 133' ' ' ILE . 50.3 m -123.12 152.77 64.06 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.497 1.119 . . . . 0.0 111.371 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -63.73 86.28 0.14 Allowed 'Trans proline' 0 C--N 1.35 0.649 1 C-N-CA 125.548 4.165 . . . . 0.0 115.7 -178.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 72.51 34.96 59.84 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 118.751 -1.027 . . . . 0.0 112.278 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.507 HD13 ' HB3' ' A' ' 130' ' ' CYS . 4.4 mp -118.59 -71.62 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.344 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -168.81 172.65 7.66 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.523 1.529 . . . . 0.0 110.314 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -137.21 119.75 15.99 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 31.8 m -139.22 163.54 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 124.528 1.131 . . . . 0.0 111.059 -178.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -121.05 124.43 44.8 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.968 1.307 . . . . 0.0 107.92 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -138.65 162.28 35.03 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.961 0.904 . . . . 0.0 111.469 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -92.08 160.91 14.99 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 176.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.479 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -179.419 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 33.1 ttt85 -148.49 102.14 3.3 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 81.6 mt -79.37 -30.8 42.71 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 119.387 0.994 . . . . 0.0 108.495 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 169.45 156.35 10.74 Favored Glycine 0 N--CA 1.439 -1.129 0 CA-C-O 121.899 0.721 . . . . 0.0 111.345 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.62 109.04 44.05 Favored Pre-proline 0 N--CA 1.444 -0.76 0 C-N-CA 124.481 1.112 . . . . 0.0 108.674 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -77.22 -168.36 0.58 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.438 2.759 . . . . 0.0 109.038 178.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -126.5 151.09 48.28 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 124.724 1.21 . . . . 0.0 108.047 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -74.81 -28.69 60.81 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.973 0.892 . . . . 0.0 109.445 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -89.32 65.24 7.15 Favored 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 126.148 1.779 . . . . 0.0 106.297 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.2 p -45.22 -32.79 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 123.911 0.884 . . . . 0.0 111.973 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -65.48 -26.34 67.89 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.996 2.119 . . . . 0.0 112.875 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.68 -25.83 49.79 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.742 0.817 . . . . 0.0 110.337 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -75.96 177.74 6.79 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.725 0.81 . . . . 0.0 109.267 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -131.52 155.74 46.91 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -139.73 160.15 40.54 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.993 0.917 . . . . 0.0 109.49 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -117.24 153.57 32.67 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 18.5 tp -119.84 98.34 6.05 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -106.05 172.53 6.76 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 181' ' ' TYR . 2.5 p90 -147.21 162.76 38.24 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.934 0.873 . . . . 0.0 109.021 178.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -139.54 178.17 7.41 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 125.682 1.593 . . . . 0.0 109.44 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -68.38 2.2 2.47 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.081 1.353 . . . . 0.0 111.928 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 90.8 t -109.66 -38.96 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 126.14 1.776 . . . . 0.0 110.177 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 166.37 -175.81 41.73 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 176' ' ' TYR . 16.6 m-85 -88.33 164.86 15.35 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 117.962 0.881 . . . . 0.0 109.327 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.468 ' HB3' HG12 ' A' ' 207' ' ' VAL . 46.6 p90 -158.92 163.7 36.31 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.704 0.802 . . . . 0.0 109.965 179.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 95.2 mt -107.21 131.8 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 22.6 t -100.69 137.34 39.22 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.405 0.682 . . . . 0.0 109.312 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -131.22 116.05 17.14 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.513 1.125 . . . . 0.0 108.082 178.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -92.84 120.75 42.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 178.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.1 mt -107.66 106.7 21.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -108.92 -152.68 15.28 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 125.977 1.751 . . . . 0.0 109.199 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 80.42 22.8 0.41 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.956 1.702 . . . . 0.0 112.634 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -91.89 -154.05 30.41 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.24 166.15 10.85 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 179.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 36.7 mm -88.7 140.74 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.235 1.414 . . . . 0.0 108.982 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.2 m -88.94 115.14 26.28 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 127.816 2.446 . . . . 0.0 106.612 178.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -57.91 -16.96 13.83 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.211 1.404 . . . . 0.0 113.586 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 61.8 t -53.32 -56.06 9.98 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 CA-C-N 118.913 0.779 . . . . 0.0 110.663 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 1.9 t -124.66 -23.12 4.43 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -177.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.87 35.35 4.03 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 108.395 -1.882 . . . . 0.0 108.395 -178.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -111.0 147.59 34.4 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 119.054 1.427 . . . . 0.0 113.563 -178.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -68.34 144.51 54.76 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.992 0.917 . . . . 0.0 112.657 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -70.1 26.77 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.499 1 C-N-CA 131.862 4.065 . . . . 0.0 111.471 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 7.0 ptm -74.08 176.3 6.66 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.767 1.167 . . . . 0.0 112.814 -177.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.3 p -141.18 148.33 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 125.1 1.36 . . . . 0.0 107.981 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -110.59 109.32 19.57 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.484 1.913 . . . . 0.0 106.477 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 9.2 mm -99.29 150.06 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 O-C-N 121.055 -1.028 . . . . 0.0 111.191 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -125.67 106.52 9.78 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.206 2.202 . . . . 0.0 110.077 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -87.46 110.25 20.17 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 177.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.468 HG12 ' HB3' ' A' ' 182' ' ' TYR . 31.3 m -125.17 168.42 17.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 C-N-CA 125.186 1.394 . . . . 0.0 109.041 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 51.6 t -89.07 146.5 24.79 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 104.432 -2.432 . . . . 0.0 104.432 177.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -91.19 18.74 50.43 Favored Glycine 0 C--O 1.226 -0.401 0 CA-C-O 117.023 -1.987 . . . . 0.0 116.688 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.722 0 CA-C-N 119.433 1.617 . . . . 0.0 109.075 -179.308 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo . . . . . 0 CA--C 1.542 0.899 0 CA-C-O 119.905 -0.123 . . . . 0.0 112.033 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 216' ' ' SER . . . . . 0.438 ' CB ' HG22 ' A' ' 235' ' ' ILE . 14.7 p -147.34 145.97 29.51 Favored 'General case' 0 C--O 1.239 0.52 0 O-C-N 120.482 -1.387 . . . . 0.0 112.369 -177.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 81.3 p -149.91 166.14 30.47 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.163 0.985 . . . . 0.0 110.99 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.9 mp -104.07 154.36 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 126.072 1.749 . . . . 0.0 108.118 178.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 43.4 mm-40 -103.11 -49.98 3.61 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 125.202 1.401 . . . . 0.0 110.66 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 59.8 p-90 -158.04 155.88 30.1 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.572 1.149 . . . . 0.0 109.109 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 60.9 t -153.97 132.64 2.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 125.809 1.644 . . . . 0.0 107.411 179.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.3 167.34 17.98 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.851 0.86 . . . . 0.0 111.342 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -75.96 132.99 40.56 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 4.6 t -112.42 -31.36 6.84 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.463 1.505 . . . . 0.0 112.705 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -132.49 -175.75 3.86 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 124.249 1.02 . . . . 0.0 108.357 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 55.1 mt -47.26 -47.87 9.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 123.567 0.747 . . . . 0.0 112.631 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -132.88 19.34 4.16 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.229 1.012 . . . . 0.0 111.2 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 18.4 t -116.75 145.33 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.813 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -177.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -125.02 164.53 19.96 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -136.18 148.19 48.02 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.48 146.53 30.58 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.387 1.475 . . . . 0.0 108.942 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -129.63 120.12 24.69 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 2.4 m -115.98 143.51 25.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.8 p -119.91 127.51 52.76 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 127.175 2.19 . . . . 0.0 111.911 -176.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.513 HD11 HD13 ' A' ' 238' ' ' LEU . 15.1 pt -134.04 146.64 60.72 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 177.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -71.45 -36.42 6.84 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 123.151 2.567 . . . . 0.0 111.323 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -59.02 -28.23 66.2 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.81 1.244 . . . . 0.0 114.304 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.513 HD13 HD11 ' A' ' 235' ' ' ILE . 3.1 tp -60.83 -32.49 71.88 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 121.45 -0.781 . . . . 0.0 111.367 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 7.3 m -59.56 -13.64 10.05 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.587 1.155 . . . . 0.0 113.448 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.88 -35.59 75.13 Favored 'General case' 0 C--O 1.227 -0.095 0 CA-C-N 119.58 1.082 . . . . 0.0 110.307 179.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.18 125.63 29.7 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -48.27 -42.29 30.26 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.128 1.371 . . . . 0.0 112.459 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.57 -32.27 73.76 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.415 -0.803 . . . . 0.0 112.496 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 25.4 mt -96.14 -7.63 35.38 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.835 1.654 . . . . 0.0 113.298 -178.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -67.52 108.53 2.88 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.094 2.158 . . . . 0.0 110.172 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 9.9 mmmt . . . . . 0 N--CA 1.47 0.543 0 CA-C-N 118.945 0.793 . . . . 0.0 110.246 -179.729 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.466 0.34 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.52 -38.32 80.69 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.212 0.46 . . . . 0.0 110.221 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 23.1 tp -73.94 -34.96 64.51 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.377 1.071 . . . . 0.0 109.383 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.63 HD23 HD11 ' A' ' 243' ' ' LEU . 28.6 mt -60.16 -55.18 37.03 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.23 0.923 . . . . 0.0 110.049 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 96.3 m -67.09 -40.34 86.95 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.295 -0.878 . . . . 0.0 111.018 -178.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.2 ttpt -59.38 -43.94 92.85 Favored 'General case' 0 C--O 1.226 -0.159 0 O-C-N 121.081 -1.012 . . . . 0.0 109.984 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 55.3 m -54.02 -43.92 70.53 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 124.352 1.061 . . . . 0.0 110.347 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -57.02 -50.33 73.06 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.522 0.601 . . . . 0.0 109.924 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.47 -54.69 21.13 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.565 0.697 . . . . 0.0 111.735 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -55.12 -44.4 74.96 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.224 1.01 . . . . 0.0 110.914 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.48 -51.87 48.39 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-O 117.797 -1.557 . . . . 0.0 109.366 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.469 ' HA ' HD12 ' A' ' 109' ' ' ILE . 41.0 t -54.86 -45.16 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 119.966 1.883 . . . . 0.0 109.683 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.0 pttm -61.83 -34.85 76.69 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 119.804 -0.759 . . . . 0.0 111.183 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 39.0 m -71.28 -44.17 65.74 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.579 0.752 . . . . 0.0 109.558 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.469 HD12 ' HA ' ' A' ' 106' ' ' VAL . 22.3 mt -57.49 -55.53 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -63.27 -29.24 70.61 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 118.782 -0.628 . . . . 0.0 112.348 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -70.18 -48.95 55.03 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.354 0.979 . . . . 0.0 111.898 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.46 ' HA ' ' HE2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -75.71 -43.91 44.71 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 123.562 0.745 . . . . 0.0 112.129 -178.037 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 14.2 mt -65.27 -28.25 69.21 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 118.193 -0.908 . . . . 0.0 112.671 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -51.91 -28.8 17.55 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -48.88 -69.86 0.11 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -146.48 179.01 7.84 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 126.152 1.781 . . . . 0.0 108.454 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 59.8 m -87.14 166.67 14.8 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 35.4 pt -120.39 155.95 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.446 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -148.22 139.79 23.66 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 123.61 0.764 . . . . 0.0 110.383 -178.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.461 ' CZ ' ' HA ' ' A' ' 220' ' ' TRP . 7.1 t80 -137.07 120.88 17.46 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.58 1.152 . . . . 0.0 110.304 178.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -82.97 101.94 11.4 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.513 1.525 . . . . 0.0 109.509 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.419 ' HB2' ' CE1' ' A' ' 120' ' ' TYR . . . -87.86 81.15 7.63 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 127.956 2.502 . . . . 0.0 106.794 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.52 -90.49 0.38 Allowed Glycine 0 CA--C 1.534 1.24 0 O-C-N 121.301 -0.874 . . . . 0.0 111.926 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -107.68 -28.57 9.64 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 127.053 2.141 . . . . 0.0 112.844 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -99.55 157.65 16.3 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.1 mp -126.88 128.4 70.78 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.424 ' CD1' HG11 ' A' ' 221' ' ' VAL . 44.0 m-85 -101.43 119.03 38.14 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -116.21 123.24 47.27 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -115.92 132.48 56.63 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.556 0.743 . . . . 0.0 110.302 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 66.7 m -112.27 148.18 38.57 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 124.247 1.019 . . . . 0.0 109.145 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.78 85.96 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 124.38 3.387 . . . . 0.0 115.151 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.21 30.76 40.57 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-O 117.944 -1.476 . . . . 0.0 112.981 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 3.9 mp -117.15 -73.62 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.455 0 CA-C-N 119.191 1.495 . . . . 0.0 110.247 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.406 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 37.4 mt-10 -163.39 166.25 23.09 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.03 2.132 . . . . 0.0 108.583 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -135.6 123.6 22.79 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.568 1.547 . . . . 0.0 107.568 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 17.8 m -144.47 164.04 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 126.8 2.04 . . . . 0.0 111.103 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -117.84 127.19 53.63 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 177.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -136.53 162.41 33.19 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 125.39 1.476 . . . . 0.0 111.224 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -92.63 160.56 14.95 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.751 0 CA-C-N 119.185 0.902 . . . . 0.0 111.722 -179.294 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 . . . . . 0 CA--C 1.532 0.284 0 CA-C-O 121.174 0.512 . . . . 0.0 109.626 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -149.04 112.0 4.87 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 126.268 1.827 . . . . 0.0 108.471 178.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 82.6 mt -99.07 -26.89 14.07 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 160.96 161.01 11.13 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -127.34 108.53 21.26 Favored Pre-proline 0 C--O 1.239 0.509 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 86.2 Cg_endo -72.32 -179.62 4.18 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 124.447 3.432 . . . . 0.0 109.825 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -122.39 159.76 26.85 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.063 0.545 . . . . 0.0 110.851 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.62 -54.0 11.85 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -68.72 64.6 0.12 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 126.751 2.02 . . . . 0.0 112.71 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 5.6 p -47.02 -34.34 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 C-N-CA 125.759 1.624 . . . . 0.0 111.846 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -63.84 -32.98 74.68 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.022 1.329 . . . . 0.0 112.026 -178.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -80.69 -14.21 58.34 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 122.748 0.419 . . . . 0.0 110.096 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 44.4 mtp180 -83.3 177.97 8.28 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 121.071 -1.018 . . . . 0.0 109.509 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -132.85 150.36 52.17 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.381 1.072 . . . . 0.0 108.201 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -138.22 161.2 37.47 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.193 1.797 . . . . 0.0 107.688 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -126.87 149.99 49.48 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 122.889 0.476 . . . . 0.0 110.606 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 32.1 tp -107.47 111.01 23.1 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.876 1.271 . . . . 0.0 108.659 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.46 HD23 ' HB2' ' A' ' 184' ' ' SER . 2.9 mm? -118.47 -179.75 3.88 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.944 1.298 . . . . 0.0 110.45 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -137.84 154.4 49.51 Favored 'General case' 0 N--CA 1.458 -0.037 0 C-N-CA 124.875 1.27 . . . . 0.0 109.467 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -140.45 -178.16 5.37 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 126.678 1.991 . . . . 0.0 107.421 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -66.11 -5.71 10.83 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.868 1.267 . . . . 0.0 113.417 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 56.0 t -107.6 -24.49 4.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 126.794 2.038 . . . . 0.0 113.656 -178.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 144.24 -173.02 25.12 Favored Glycine 0 N--CA 1.444 -0.774 0 O-C-N 121.841 -0.537 . . . . 0.0 112.052 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -79.06 158.42 27.86 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 121.716 0.769 . . . . 0.0 109.297 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.452 ' HB3' HG12 ' A' ' 207' ' ' VAL . 42.0 p90 -155.74 162.85 40.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.331 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 96.7 mt -104.23 136.42 37.62 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.073 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.46 ' HB2' HD23 ' A' ' 175' ' ' LEU . 46.2 t -102.22 129.34 48.59 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 125.414 1.485 . . . . 0.0 108.374 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -121.33 113.98 20.68 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.88 119.0 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 104.512 -2.403 . . . . 0.0 104.512 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 9.0 mt -109.2 105.63 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 177.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -101.32 -153.43 26.03 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 23.1 t 67.86 26.65 7.55 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.993 0.917 . . . . 0.0 111.932 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -82.2 -60.32 2.16 Favored Glycine 0 CA--C 1.525 0.691 0 O-C-N 120.51 -1.369 . . . . 0.0 110.543 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 153.83 -174.14 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.608 1 C-N-CA 131.893 4.077 . . . . 0.0 106.384 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 51.8 mm -105.9 143.3 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 129.561 3.144 . . . . 0.0 112.205 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.2 m -93.56 118.15 30.98 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 128.345 2.658 . . . . 0.0 107.207 177.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.5 -30.89 54.77 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.818 1.247 . . . . 0.0 113.331 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 44.1 t -45.32 -56.28 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 125.019 1.328 . . . . 0.0 113.031 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 6.6 t -123.46 -23.02 4.89 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 124.701 1.201 . . . . 0.0 113.85 -177.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 94.97 34.66 6.1 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 107.263 -2.335 . . . . 0.0 107.263 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -103.09 150.38 23.67 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 117.998 0.899 . . . . 0.0 110.922 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -74.03 139.65 44.88 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 122.544 0.337 . . . . 0.0 111.697 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -67.47 29.0 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.559 1 C-N-CA 135.799 5.64 . . . . 0.0 110.208 177.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 1.9 ptm -74.46 -176.81 2.85 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.17 1.388 . . . . 0.0 111.955 -177.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.2 p -153.6 146.69 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 O-C-N 121.087 -1.008 . . . . 0.0 110.753 -178.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -104.32 104.77 14.71 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.595 1.558 . . . . 0.0 109.522 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 8.7 mm -93.8 123.1 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -105.15 99.61 9.22 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 127.312 2.245 . . . . 0.0 109.333 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -82.17 110.72 17.63 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.76 1.224 . . . . 0.0 108.849 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.452 HG12 ' HB3' ' A' ' 182' ' ' TYR . 19.0 m -124.72 164.73 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 125.456 1.502 . . . . 0.0 107.46 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 46.3 t -83.91 146.09 28.23 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 119.909 -1.745 . . . . 0.0 107.562 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -86.75 3.76 86.77 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-O 118.774 -1.015 . . . . 0.0 113.108 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.726 0 N-CA-C 107.905 -2.078 . . . . 0.0 107.905 -179.069 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 N--CA 1.455 -0.774 0 N-CA-C 111.598 -0.193 . . . . 0.0 111.598 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 5.0 p -151.74 146.5 25.8 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.654 1.182 . . . . 0.0 109.086 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 17.0 p -149.89 172.23 15.5 Favored 'General case' 0 C--O 1.225 -0.201 0 O-C-N 121.757 -0.589 . . . . 0.0 112.246 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.416 HG21 HG23 ' A' ' 221' ' ' VAL . 5.8 mt -122.14 146.06 27.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 126.863 2.065 . . . . 0.0 106.555 177.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -95.35 -47.67 6.2 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.343 1.457 . . . . 0.0 110.525 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' TRP . . . . . 0.461 ' HA ' ' CZ ' ' A' ' 120' ' ' TYR . 56.2 p-90 -162.88 158.51 22.62 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 125.459 1.504 . . . . 0.0 108.948 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.424 HG11 ' CD1' ' A' ' 127' ' ' TYR . 49.7 t -152.94 135.02 5.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 126.189 1.796 . . . . 0.0 106.366 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.79 168.76 17.5 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.006 1.322 . . . . 0.0 110.347 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -75.61 141.67 42.82 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 124.104 0.962 . . . . 0.0 108.638 178.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' THR . . . . . 0.437 HG21 ' HG3' ' A' ' 230' ' ' GLU . 10.2 t -118.83 -31.98 4.64 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.955 1.302 . . . . 0.0 112.3 179.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.429 ' HG3' HG23 ' A' ' 224' ' ' THR . 4.8 mttm -135.22 -176.59 4.31 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 120.806 -1.184 . . . . 0.0 109.067 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 36.5 mt -48.15 -47.22 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 123.864 0.866 . . . . 0.0 112.29 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -130.62 21.47 5.09 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.265 1.026 . . . . 0.0 111.894 -178.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 16.6 t -122.62 143.0 36.95 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.584 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -178.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -121.68 162.52 20.59 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.57 1.548 . . . . 0.0 107.131 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' GLU . . . . . 0.437 ' HG3' HG21 ' A' ' 224' ' ' THR . 13.3 mt-10 -131.46 138.28 48.95 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 125.416 1.486 . . . . 0.0 107.209 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -135.78 132.39 36.69 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.569 1.148 . . . . 0.0 109.522 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -109.08 108.0 18.53 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 48.3 t -100.73 138.23 25.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.3 p -120.94 130.29 53.8 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 126.286 1.835 . . . . 0.0 112.427 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -138.67 143.34 37.5 Favored Pre-proline 0 N--CA 1.467 0.394 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 176.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -73.3 -33.32 7.27 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.948 2.432 . . . . 0.0 112.963 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -64.25 -17.77 63.92 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.56 0.744 . . . . 0.0 112.811 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 5.9 tp -68.16 -29.51 68.42 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 121.174 -0.954 . . . . 0.0 110.044 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 14.4 m -62.99 -9.98 12.05 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.664 0.786 . . . . 0.0 112.961 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -60.89 -31.24 70.73 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.196 0.907 . . . . 0.0 109.721 178.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -88.64 127.22 35.56 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 124.196 0.998 . . . . 0.0 109.331 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -47.0 -49.33 21.04 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 126.047 1.739 . . . . 0.0 113.475 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.63 HD11 HD23 ' A' ' 98' ' ' LEU . 41.8 mt -65.05 -28.81 69.73 Favored 'General case' 0 C--O 1.231 0.115 0 O-C-N 121.332 -0.855 . . . . 0.0 112.983 -178.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 11.5 mt -95.75 -17.52 21.16 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.101 0.96 . . . . 0.0 112.7 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -62.31 135.53 57.5 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 129.321 3.048 . . . . 0.0 109.445 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt . . . . . 0 CA--C 1.513 -0.474 0 C-N-CA 124.154 0.982 . . . . 0.0 112.12 -179.711 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.311 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.07 -50.97 69.82 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 57.2 tp -63.79 -39.86 95.26 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.569 1.148 . . . . 0.0 110.678 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.8 mt -60.1 -54.28 47.76 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 119.277 0.944 . . . . 0.0 108.65 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.3 m -58.31 -49.32 77.58 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.121 0.486 . . . . 0.0 110.152 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -60.88 -40.74 94.16 Favored 'General case' 0 C--O 1.232 0.164 0 O-C-N 121.206 -0.934 . . . . 0.0 111.776 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 54.4 m -52.3 -48.74 65.21 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.574 0.75 . . . . 0.0 110.842 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -58.89 -47.6 84.38 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 117.966 0.348 . . . . 0.0 110.659 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.45 -55.81 24.11 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 122.504 1.145 . . . . 0.0 113.876 -177.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -64.34 -38.44 91.05 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-N 113.645 -1.616 . . . . 0.0 111.521 -177.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.25 -52.78 41.15 Favored Glycine 0 N--CA 1.44 -1.045 0 N-CA-C 107.95 -2.06 . . . . 0.0 107.95 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 56.0 t -56.92 -47.92 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 119.306 1.553 . . . . 0.0 110.541 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.6 pttm -59.1 -35.52 73.56 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.847 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 52.5 m -79.29 -36.36 39.85 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.308 1.043 . . . . 0.0 111.067 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 21.8 mt -57.85 -54.27 34.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -60.84 -29.39 69.47 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.481 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -68.24 -41.05 81.74 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 120.144 1.338 . . . . 0.0 111.593 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.463 ' HA ' ' HE2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -79.07 -37.42 38.9 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 117.991 0.36 . . . . 0.0 111.75 -179.371 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 17.2 mt -74.17 -25.83 59.95 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 118.685 -0.674 . . . . 0.0 111.903 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -54.82 -20.12 7.95 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.454 0.57 . . . . 0.0 112.167 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -64.62 -72.77 0.14 Allowed 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.694 1.197 . . . . 0.0 109.036 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -147.42 -175.55 4.89 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.386 1.474 . . . . 0.0 111.522 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 62.6 m -87.71 175.4 7.89 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.604 -0.685 . . . . 0.0 109.439 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 27.4 pt -132.73 161.22 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 126.324 1.85 . . . . 0.0 108.774 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -154.74 142.73 20.15 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 122.759 0.423 . . . . 0.0 110.401 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -134.37 123.74 24.61 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.478 0.711 . . . . 0.0 110.499 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -86.66 98.7 11.26 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.19 81.06 5.56 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 128.407 2.683 . . . . 0.0 107.336 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 58.47 -112.93 4.39 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 124.388 0.994 . . . . 0.0 111.054 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -77.28 -12.8 59.99 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.852 1.261 . . . . 0.0 113.375 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -115.74 158.24 23.12 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 124.414 1.086 . . . . 0.0 112.642 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.573 HD13 ' H ' ' A' ' 140' ' ' GLY . 4.8 mp -133.38 126.36 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 N-CA-C 103.577 -2.749 . . . . 0.0 103.577 177.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -110.54 123.36 49.79 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -117.96 129.63 55.72 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.714 0.806 . . . . 0.0 110.008 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -119.52 133.2 55.79 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 123.722 0.809 . . . . 0.0 110.923 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.513 ' HB3' HD13 ' A' ' 133' ' ' ILE . 16.3 m -112.41 156.1 42.7 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 123.737 0.815 . . . . 0.0 111.075 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -63.77 78.46 0.15 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 125.084 3.856 . . . . 0.0 114.203 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 67.51 60.19 6.06 Favored Glycine 0 CA--C 1.525 0.677 0 O-C-N 120.971 -1.081 . . . . 0.0 111.688 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.513 HD13 ' HB3' ' A' ' 130' ' ' CYS . 3.5 mp -130.86 -71.44 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -165.73 168.95 15.65 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 125.45 1.5 . . . . 0.0 109.449 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -130.81 121.95 26.25 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 176.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.8 m -144.76 164.94 12.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 118.916 0.78 . . . . 0.0 111.083 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -120.95 132.2 54.79 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.726 1.211 . . . . 0.0 108.727 178.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -138.51 162.74 33.77 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.122 1.369 . . . . 0.0 112.437 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 55.5 t60 -103.15 108.8 20.14 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.573 ' H ' HD13 ' A' ' 126' ' ' ILE . . . . . . . . 0 C--N 1.331 0.301 0 O-C-N 121.603 -0.686 . . . . 0.0 112.107 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 . . . . . 0 N--CA 1.449 -0.487 0 CA-C-O 122.795 1.283 . . . . 0.0 108.436 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.518 ' N ' HH21 ' A' ' 200' ' ' ARG . 0.0 OUTLIER -149.38 110.35 4.34 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 179.005 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mp -93.92 -27.53 16.32 Favored 'General case' 0 C--O 1.219 -0.55 0 O-C-N 125.794 1.934 . . . . 0.0 107.315 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 163.63 163.23 15.97 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 5.4 mtpt -127.66 110.13 20.68 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -78.04 -173.08 1.68 Allowed 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 124.954 3.769 . . . . 0.0 110.4 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -129.32 149.18 51.22 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 125.277 1.431 . . . . 0.0 109.58 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.74 -41.4 71.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.668 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 31.4 m-20 -71.7 65.02 0.48 Allowed 'General case' 0 C--O 1.236 0.383 0 C-N-CA 126.383 1.873 . . . . 0.0 110.977 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.4 p -52.3 -32.0 15.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 124.904 1.282 . . . . 0.0 110.663 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -63.93 -22.39 66.9 Favored 'General case' 0 N--CA 1.461 0.105 0 C-N-CA 124.695 1.198 . . . . 0.0 112.544 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -97.85 -18.27 18.82 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.522 1.129 . . . . 0.0 110.877 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.4 mtp-105 -81.02 142.21 33.61 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -103.73 148.98 25.42 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 178.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -134.25 -176.47 4.21 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.48 1.512 . . . . 0.0 109.587 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -135.41 153.46 51.79 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.329 1.051 . . . . 0.0 109.331 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 22.9 tp -115.05 98.97 7.11 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.697 1.599 . . . . 0.0 106.861 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.462 HD23 ' HB2' ' A' ' 184' ' ' SER . 2.7 mm? -105.33 -179.8 4.05 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 181' ' ' TYR . 2.5 p90 -145.65 163.01 36.2 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -140.75 -178.44 5.54 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.406 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -62.07 -14.41 36.01 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.528 1.131 . . . . 0.0 111.107 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 57.9 t -98.04 -39.12 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 125.495 1.518 . . . . 0.0 111.395 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 161.3 -173.83 37.77 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 123.431 0.539 . . . . 0.0 112.152 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 176' ' ' TYR . 25.9 m-85 -77.72 160.34 28.5 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 118.387 1.094 . . . . 0.0 110.72 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -158.84 168.5 26.64 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.325 1.45 . . . . 0.0 110.813 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 89.1 mt -108.89 141.46 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.462 ' HB2' HD23 ' A' ' 175' ' ' LEU . 15.6 t -111.41 137.32 49.35 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.394 1.077 . . . . 0.0 109.585 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -129.13 111.53 13.04 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.482 1.513 . . . . 0.0 108.381 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.2 mp -94.93 116.7 36.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 103.928 -2.619 . . . . 0.0 103.928 178.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 12.4 mt -105.1 106.95 21.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -103.66 -152.22 22.85 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 75.19 33.39 0.71 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.218 1.007 . . . . 0.0 110.127 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -113.87 159.18 13.83 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 107.615 -2.194 . . . . 0.0 107.615 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -66.72 167.82 10.55 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.354 1.062 . . . . 0.0 109.892 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.0 mm -87.13 142.33 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 C-N-CA 124.282 1.033 . . . . 0.0 108.795 178.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.1 m -88.81 110.76 21.31 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 104.204 -2.517 . . . . 0.0 104.204 177.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -47.68 -40.02 18.92 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 125.503 1.521 . . . . 0.0 111.637 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 33.4 t -38.45 -56.62 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.228 -0.055 0 C-N-CA 128.024 2.53 . . . . 0.0 113.366 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 10.8 t -124.42 -28.86 3.58 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 105.23 35.31 3.17 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -107.35 149.95 27.27 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 118.278 1.039 . . . . 0.0 110.23 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -77.48 152.25 34.26 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 119.02 0.827 . . . . 0.0 111.176 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.518 HH21 ' N ' ' A' ' 159' ' ' ARG . 30.7 mmm-85 -71.1 27.78 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 131.471 3.908 . . . . 0.0 110.795 177.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 8.1 ptm -75.59 178.43 6.02 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.343 1.057 . . . . 0.0 111.312 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.33 151.28 14.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 125.22 1.408 . . . . 0.0 108.745 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -107.45 106.38 16.75 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.937 2.095 . . . . 0.0 106.703 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 16.2 mm -101.29 144.58 12.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -125.48 121.22 33.11 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.441 1.496 . . . . 0.0 108.914 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -99.04 108.76 21.5 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.658 1.183 . . . . 0.0 108.985 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 3.8 m -126.91 169.77 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 122.101 0.953 . . . . 0.0 109.506 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 42.0 t -95.25 144.08 26.13 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 104.39 -2.448 . . . . 0.0 104.39 177.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -99.85 10.0 60.35 Favored Glycine 0 N--CA 1.461 0.324 0 CA-C-O 117.736 -1.591 . . . . 0.0 115.016 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.497 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.595 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo . . . . . 0 CA--C 1.542 0.912 0 CA-C-O 119.657 -0.226 . . . . 0.0 111.95 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 4.8 p -161.8 147.06 13.28 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 120.45 -1.406 . . . . 0.0 112.809 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 19.2 p -151.22 160.23 43.95 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.501 1.12 . . . . 0.0 110.37 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 233' ' ' VAL . 4.3 mt -100.75 153.55 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 125.894 1.678 . . . . 0.0 108.018 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -98.93 -50.21 4.27 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.184 0.994 . . . . 0.0 111.798 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 63.9 p-90 -159.11 154.52 25.7 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.142 1.377 . . . . 0.0 107.353 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 59.7 t -150.2 130.09 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.03 167.83 26.98 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 118.147 0.43 . . . . 0.0 111.086 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -80.77 137.32 36.24 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 1.8 t -112.96 -39.32 4.26 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.705 -0.622 . . . . 0.0 110.74 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -121.65 -174.82 2.95 Favored 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 124.185 0.994 . . . . 0.0 109.595 -177.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 72.8 mt -56.51 -41.73 73.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.528 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -131.52 12.3 4.93 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.15 1.78 . . . . 0.0 112.815 -178.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 21.0 t -116.59 146.19 21.34 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 CA-C-N 118.72 0.691 . . . . 0.0 109.611 -178.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -123.5 161.64 24.47 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -127.99 142.13 51.33 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 106.376 -1.712 . . . . 0.0 106.376 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -150.78 131.82 14.32 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.465 1.106 . . . . 0.0 109.013 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -121.17 122.65 40.46 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.3 0.64 . . . . 0.0 109.635 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' A' ' 218' ' ' ILE . 4.6 m -106.47 156.44 7.06 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-N 118.676 0.671 . . . . 0.0 109.339 178.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.54 115.62 19.8 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 125.584 1.554 . . . . 0.0 109.166 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 10.6 pt -128.26 145.22 54.79 Favored Pre-proline 0 N--CA 1.448 -0.536 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.05 -41.43 5.19 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.004 1.803 . . . . 0.0 111.128 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -55.69 -17.57 6.14 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 117.589 2.44 . . . . 0.0 117.589 -177.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.443 HD22 ' CD1' ' A' ' 244' ' ' LEU . 44.2 mt -72.84 -30.12 63.76 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 120.781 1.628 . . . . 0.0 108.912 178.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 22.3 m -61.65 -11.65 12.61 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.563 0.745 . . . . 0.0 112.649 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 -67.53 -18.08 64.9 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-O 122.222 1.011 . . . . 0.0 109.664 177.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 29.8 mt -101.01 118.64 37.41 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 127.97 2.508 . . . . 0.0 106.787 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -46.75 -46.46 20.41 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.141 1.376 . . . . 0.0 112.732 -178.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 1.1 mp -65.59 -27.24 68.28 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.443 ' CD1' HD22 ' A' ' 238' ' ' LEU . 9.4 mt -102.39 -3.78 26.52 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.381 1.073 . . . . 0.0 111.609 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -68.94 113.71 6.59 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 127.84 2.456 . . . . 0.0 110.689 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.226 -0.178 0 CA-C-O 118.746 -0.645 . . . . 0.0 110.7 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.17 -47.98 71.4 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 42.3 tp -65.44 -37.44 86.91 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 117.645 -1.169 . . . . 0.0 110.662 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 64.1 mt -61.95 -55.01 33.91 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.55 1.068 . . . . 0.0 109.678 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 89.8 m -57.99 -49.59 76.32 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.389 1.875 . . . . 0.0 110.168 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 23.6 ttpt -62.09 -47.55 84.11 Favored 'General case' 0 N--CA 1.444 -0.741 0 O-C-N 121.341 -0.85 . . . . 0.0 109.698 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.6 m -52.74 -47.14 67.59 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 118.726 0.693 . . . . 0.0 110.765 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -58.7 -50.46 73.81 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 118.228 0.467 . . . . 0.0 109.971 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.83 -61.19 2.45 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -61.25 -38.32 86.26 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.641 0.776 . . . . 0.0 110.99 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.6 -53.24 45.35 Favored Glycine 0 CA--C 1.52 0.376 0 CA-C-O 117.904 -1.498 . . . . 0.0 109.401 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.518 ' HA ' HD12 ' A' ' 109' ' ' ILE . 39.3 t -57.74 -40.76 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 119.434 1.617 . . . . 0.0 109.251 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -58.69 -41.39 86.15 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 28.2 m -70.76 -40.1 72.87 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 125.133 1.373 . . . . 0.0 110.557 -177.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.555 HD13 ' CD1' ' A' ' 206' ' ' TYR . 18.0 mt -61.48 -55.95 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -62.55 -32.39 73.34 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.821 -0.609 . . . . 0.0 111.488 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -60.83 -40.12 91.61 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 118.632 0.651 . . . . 0.0 111.029 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.3 tptm -81.13 -37.99 27.94 Favored 'General case' 0 CA--C 1.519 -0.247 0 O-C-N 122.064 -0.398 . . . . 0.0 110.793 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 40.4 mt -69.12 -26.61 64.99 Favored 'General case' 0 C--O 1.221 -0.412 0 O-C-N 121.443 -0.786 . . . . 0.0 109.992 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.16 -30.87 50.85 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.628 1.171 . . . . 0.0 111.339 179.014 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -56.24 -63.9 1.04 Allowed 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.489 1.116 . . . . 0.0 111.946 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -151.37 175.59 12.09 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 126.319 1.848 . . . . 0.0 110.336 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 85.7 m -87.53 161.4 17.8 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 106.959 -1.496 . . . . 0.0 106.959 178.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 42.3 pt -112.42 155.01 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 124.846 1.258 . . . . 0.0 108.143 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -148.98 137.37 21.0 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 125.185 1.394 . . . . 0.0 108.27 -178.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -140.85 126.94 19.51 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.307 1.043 . . . . 0.0 111.652 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -80.39 99.46 7.96 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.047 1.339 . . . . 0.0 109.122 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.98 79.97 5.79 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 178.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 58.71 -119.83 19.53 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -63.74 -35.91 82.12 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.91 0.884 . . . . 0.0 112.955 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -99.86 164.36 12.06 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 119.126 0.875 . . . . 0.0 111.651 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.516 HD13 ' H ' ' A' ' 140' ' ' GLY . 4.2 mp -129.43 129.13 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 103.824 -2.658 . . . . 0.0 103.824 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.418 ' CG ' HG11 ' A' ' 221' ' ' VAL . 10.6 m-85 -105.39 122.95 47.02 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 125.634 1.574 . . . . 0.0 106.871 -178.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -118.5 126.49 52.13 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -122.88 137.37 54.96 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.531 0.732 . . . . 0.0 111.26 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.554 ' HB3' HD13 ' A' ' 133' ' ' ILE . 27.4 m -117.12 153.37 49.7 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.613 1.165 . . . . 0.0 111.488 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -62.61 84.53 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.643 1 C-N-CA 125.428 4.085 . . . . 0.0 116.266 -177.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.36 32.56 55.14 Favored Glycine 0 CA--C 1.531 1.093 0 O-C-N 120.749 -1.22 . . . . 0.0 112.853 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.554 HD13 ' HB3' ' A' ' 130' ' ' CYS . 4.5 mp -115.56 -69.92 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.306 0 CA-C-N 117.956 0.878 . . . . 0.0 109.104 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -168.44 168.34 11.25 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.533 1.133 . . . . 0.0 110.632 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -132.38 120.22 21.74 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 177.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.2 m -140.56 163.85 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 124.924 1.29 . . . . 0.0 110.575 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -135.04 126.55 28.68 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -138.08 162.86 33.07 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 126.604 1.962 . . . . 0.0 109.08 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -102.87 120.02 39.87 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.516 ' H ' HD13 ' A' ' 126' ' ' ILE . . . . . . . . 0 CA--C 1.534 1.231 0 C-N-CA 127.21 2.338 . . . . 0.0 107.919 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 . . . . . 0 C--O 1.226 -0.147 0 CA-C-O 121.675 0.75 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 5.8 mpp_? -149.37 133.33 17.09 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 48.3 mt -110.87 -21.75 11.88 Favored 'General case' 0 C--O 1.22 -0.476 0 O-C-N 124.181 0.926 . . . . 0.0 109.195 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 155.53 163.97 12.69 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -126.63 114.3 22.8 Favored Pre-proline 0 C--O 1.236 0.352 0 CA-C-O 118.849 -0.595 . . . . 0.0 109.914 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -71.24 -173.89 1.05 Allowed 'Trans proline' 0 CA--C 1.544 1.004 0 C-N-CA 125.091 3.861 . . . . 0.0 109.567 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -120.8 163.83 17.54 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.932 0.872 . . . . 0.0 111.974 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.75 -36.56 59.85 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.116 177.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -89.57 65.71 7.05 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.476 1.91 . . . . 0.0 110.895 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.9 p -45.76 -36.72 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 123.146 0.578 . . . . 0.0 111.851 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -61.86 -37.9 86.24 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 125.488 1.515 . . . . 0.0 112.532 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -71.56 -23.61 61.78 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 124.972 1.309 . . . . 0.0 110.671 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 9.5 mtp-105 -79.53 138.92 37.67 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -101.41 139.78 36.61 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -122.89 -178.32 3.91 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 126.493 1.917 . . . . 0.0 111.802 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -131.49 154.01 49.18 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.908 1.283 . . . . 0.0 109.968 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 28.4 tp -116.75 107.69 14.96 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.264 1.826 . . . . 0.0 106.368 178.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.601 HD23 ' HB2' ' A' ' 184' ' ' SER . 1.7 mm? -118.58 -178.25 3.49 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 126.258 1.823 . . . . 0.0 109.564 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -145.33 164.81 30.3 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.236 0.615 . . . . 0.0 111.27 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.7 178.56 7.06 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 128.005 2.522 . . . . 0.0 107.417 178.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -59.69 -18.9 46.01 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.489 1.116 . . . . 0.0 111.822 -177.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 76.8 t -92.05 -38.6 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 125.429 1.491 . . . . 0.0 111.297 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 163.46 -168.06 37.94 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 118.764 0.711 . . . . 0.0 112.194 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.405 ' CD2' ' HB3' ' A' ' 243' ' ' LEU . 6.4 m-30 -78.48 161.92 26.73 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.579 0.704 . . . . 0.0 110.234 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.402 ' HB3' HG12 ' A' ' 207' ' ' VAL . 32.3 p90 -159.32 161.87 35.89 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.25 1.42 . . . . 0.0 110.38 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 95.3 mt -100.96 146.08 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.601 ' HB2' HD23 ' A' ' 175' ' ' LEU . 6.7 t -119.7 132.88 55.77 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.492 1.117 . . . . 0.0 108.364 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -126.79 107.71 10.38 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.978 2.111 . . . . 0.0 108.939 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.487 HD11 ' HG3' ' A' ' 203' ' ' GLU . 1.7 mp -90.6 114.14 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 104.481 -2.415 . . . . 0.0 104.481 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 7.2 mt -98.1 106.68 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.49 -153.49 24.82 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 77.07 20.85 1.17 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.585 1.154 . . . . 0.0 109.58 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -84.95 146.16 21.95 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.12 137.71 58.04 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 125.851 1.66 . . . . 0.0 108.44 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 25.3 mm -62.37 139.32 21.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 CA-C-O 122.218 1.009 . . . . 0.0 112.227 -178.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 5.6 t -79.2 116.35 19.42 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 128.381 2.672 . . . . 0.0 109.802 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.08 -17.0 56.16 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.904 0.881 . . . . 0.0 112.907 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 42.0 t -69.11 -52.47 33.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 125.742 1.617 . . . . 0.0 112.235 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' THR . . . . . 0.4 HG22 HG21 ' A' ' 226' ' ' ILE . 3.8 t -123.38 -40.44 2.37 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.971 1.308 . . . . 0.0 113.832 -178.001 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 117.03 21.66 4.46 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.301 1.429 . . . . 0.0 110.596 -178.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -88.7 151.31 22.51 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.868 1.834 . . . . 0.0 110.729 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -71.59 153.61 42.01 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 5.8 ttt-85 -74.52 28.58 0.08 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 127.519 2.328 . . . . 0.0 110.011 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 7.6 ptm -73.03 172.17 11.5 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 122.424 1.106 . . . . 0.0 111.315 -176.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.2 p -143.17 143.95 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 C-N-CA 124.414 1.086 . . . . 0.0 108.092 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.487 ' HG3' HD11 ' A' ' 186' ' ' ILE . 11.2 tt0 -100.56 106.96 18.53 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 178.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 23.6 mm -100.98 146.25 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 O-C-N 120.756 -1.215 . . . . 0.0 108.713 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -125.48 134.53 52.02 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.796 -1.186 . . . . 0.0 107.796 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' TYR . . . . . 0.555 ' CD1' HD13 ' A' ' 109' ' ' ILE . 43.4 m-85 -106.06 110.05 22.19 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.402 HG12 ' HB3' ' A' ' 182' ' ' TYR . 29.9 m -124.7 162.58 26.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 45.5 t -83.03 143.51 30.56 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -87.48 23.67 11.9 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-O 117.285 -1.842 . . . . 0.0 113.187 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.341 0.83 0 C-N-CA 126.256 1.884 . . . . 0.0 109.911 -179.643 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo . . . . . 0 CA--C 1.547 1.13 0 N-CA-C 109.97 -0.819 . . . . 0.0 109.97 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.2 p -163.9 139.3 6.22 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 129.731 3.212 . . . . 0.0 105.409 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 77.4 p -151.3 175.46 12.19 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.536 1.062 . . . . 0.0 110.819 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.433 ' HA ' ' HA ' ' A' ' 233' ' ' VAL . 3.2 mt -115.48 143.05 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 104.073 -2.565 . . . . 0.0 104.073 176.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -94.35 -48.31 6.21 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.722 1.209 . . . . 0.0 112.421 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 -156.84 151.85 26.11 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.815 1.646 . . . . 0.0 108.499 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.493 HG23 ' HB2' ' A' ' 231' ' ' ALA . 6.8 p -155.71 120.44 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 177.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -148.85 158.38 44.12 Favored 'General case' 0 C--O 1.235 0.342 0 O-C-N 121.563 -0.711 . . . . 0.0 110.849 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -65.84 130.44 43.29 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 12.1 t -107.96 -33.61 7.16 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 125.842 1.657 . . . . 0.0 112.605 -178.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 7.1 mttt -132.17 -175.88 3.89 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.4 HG21 HG22 ' A' ' 196' ' ' THR . 1.1 mm -38.72 -56.92 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 124.896 1.278 . . . . 0.0 113.319 -177.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 2.5 m -133.32 17.61 4.04 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.775 1.63 . . . . 0.0 109.81 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.64 141.75 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -121.53 163.7 18.43 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.457 1.103 . . . . 0.0 108.474 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -138.16 132.36 31.81 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 178.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.493 ' HB2' HG23 ' A' ' 221' ' ' VAL . . . -136.57 140.04 42.61 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.158 1.383 . . . . 0.0 108.141 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -118.92 116.98 27.62 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 218' ' ' ILE . 1.3 m -107.0 151.85 8.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.8 p -126.75 136.83 52.94 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 123.461 0.704 . . . . 0.0 111.857 -178.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -141.21 142.55 27.48 Favored Pre-proline 0 N--CA 1.452 -0.336 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -66.79 -47.54 2.62 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.855 2.37 . . . . 0.0 112.002 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -53.41 -24.48 12.61 Favored 'General case' 0 CA--C 1.527 0.091 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 10.7 tp -61.11 -29.9 70.04 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 119.266 0.939 . . . . 0.0 111.409 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 9.2 m -62.0 -12.26 17.75 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.999 0.919 . . . . 0.0 112.602 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.99 -24.65 66.06 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.245 0.93 . . . . 0.0 110.121 178.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -89.14 117.21 27.96 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 178.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 -46.79 -44.18 18.93 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 126.281 1.833 . . . . 0.0 114.105 -178.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.405 ' HB3' ' CD2' ' A' ' 181' ' ' TYR . 60.2 mt -70.23 -31.43 68.83 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.448 -1.407 . . . . 0.0 113.017 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 14.3 mt -84.29 -20.7 31.69 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.124 0.97 . . . . 0.0 112.583 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -55.72 141.16 39.28 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 128.914 2.886 . . . . 0.0 111.538 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 34.5 mmtt . . . . . 0 C--O 1.236 0.39 0 C-N-CA 125.378 1.471 . . . . 0.0 109.616 179.233 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.527 ' HA ' HD12 ' A' ' 98' ' ' LEU . 0.3 OUTLIER . . . . . 0 CA--C 1.531 0.216 0 CA-C-O 119.385 -0.341 . . . . 0.0 111.035 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.43 -45.96 92.1 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 55.3 tp -66.38 -38.07 86.71 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 118.396 -0.811 . . . . 0.0 109.905 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.527 HD12 ' HA ' ' A' ' 95' ' ' THR . 20.7 mt -59.74 -54.81 41.98 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 24.5 m -60.7 -38.53 85.34 Favored 'General case' 0 C--O 1.239 0.551 0 O-C-N 121.449 -0.782 . . . . 0.0 111.77 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -65.28 -48.19 74.04 Favored 'General case' 0 CA--C 1.519 -0.247 0 O-C-N 121.056 -1.027 . . . . 0.0 109.993 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 69.2 m -51.95 -47.81 64.59 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.352 1.061 . . . . 0.0 110.667 -178.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.411 HD21 ' HB2' ' A' ' 172' ' ' PHE . 3.4 tm? -58.51 -49.48 77.21 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 117.847 0.294 . . . . 0.0 110.912 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -62.89 -57.35 11.09 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 122.243 1.02 . . . . 0.0 113.153 -177.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -60.41 -41.6 94.22 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.797 -178.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -62.71 -53.21 42.9 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-O 117.781 -1.566 . . . . 0.0 111.418 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.515 ' HA ' HD12 ' A' ' 109' ' ' ILE . 47.8 t -58.34 -42.53 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 120.562 2.181 . . . . 0.0 109.0 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.84 -30.98 71.69 Favored 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 119.181 -1.007 . . . . 0.0 112.499 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.429 ' CG2' ' HB3' ' A' ' 237' ' ' GLU . 52.6 m -72.32 -40.75 67.24 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 126.042 1.737 . . . . 0.0 108.385 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.515 HD12 ' HA ' ' A' ' 106' ' ' VAL . 18.1 mt -60.66 -55.06 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 178.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -60.91 -28.0 68.6 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-O 117.876 -1.059 . . . . 0.0 111.657 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -62.07 -49.38 76.17 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.22 1.008 . . . . 0.0 111.337 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.473 ' HA ' ' HE2' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -85.26 -39.28 17.93 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -177.765 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 16.2 mt -66.38 -25.78 66.95 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 119.009 -0.519 . . . . 0.0 112.26 -179.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -52.44 -28.75 21.3 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -51.18 -74.77 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.821 1.648 . . . . 0.0 111.67 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -147.68 176.68 9.9 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.804 1.642 . . . . 0.0 109.126 -178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 33.4 m -86.21 163.06 18.0 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.635 0.731 . . . . 0.0 109.147 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 37.6 pt -118.63 160.29 18.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 126.134 1.774 . . . . 0.0 109.395 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -158.05 139.62 13.7 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -130.54 127.2 38.61 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 123.584 0.753 . . . . 0.0 110.052 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -85.39 101.66 12.78 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.26 1.024 . . . . 0.0 108.439 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.26 80.07 7.65 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 104.681 -2.34 . . . . 0.0 104.681 178.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.73 -99.63 0.37 Allowed Glycine 0 CA--C 1.531 1.08 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -95.25 -25.85 16.19 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.742 1.617 . . . . 0.0 114.031 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -99.01 152.35 19.91 Favored 'General case' 0 CA--C 1.513 -0.451 0 O-C-N 121.302 -0.874 . . . . 0.0 108.752 -178.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.465 HD13 ' H ' ' A' ' 140' ' ' GLY . 5.2 mp -124.67 124.6 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -100.99 119.3 38.54 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 103.212 -2.884 . . . . 0.0 103.212 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -118.4 124.7 48.33 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.157 0.983 . . . . 0.0 110.891 -177.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -124.03 135.03 53.32 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -178.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.578 ' HB3' HD13 ' A' ' 133' ' ' ILE . 16.1 m -111.18 155.97 41.79 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 125.546 1.538 . . . . 0.0 112.808 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -67.97 81.31 0.49 Allowed 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 124.864 3.71 . . . . 0.0 114.474 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 72.98 54.55 7.0 Favored Glycine 0 CA--C 1.529 0.922 0 O-C-N 121.207 -0.933 . . . . 0.0 112.862 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.578 HD13 ' HB3' ' A' ' 130' ' ' CYS . 3.6 mp -131.04 -72.02 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -167.16 167.82 14.02 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.757 1.623 . . . . 0.0 109.068 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -128.54 126.14 39.75 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 176.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.8 m -141.53 164.0 19.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 124.591 1.157 . . . . 0.0 110.55 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -126.36 125.81 42.85 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -139.4 162.96 33.77 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.091 0.957 . . . . 0.0 110.636 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 61.8 t60 -110.19 109.35 19.81 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 101.993 -3.336 . . . . 0.0 101.993 177.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.465 ' H ' HD13 ' A' ' 126' ' ' ILE . . . . . . . . 0 CA--C 1.53 1.012 0 C-N-CA 126.191 1.853 . . . . 0.0 109.959 -178.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 . . . . . 0 N--CA 1.445 -0.692 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -134.59 141.78 46.74 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 177.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 59.7 mt -120.17 -29.06 4.96 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 125.454 1.721 . . . . 0.0 107.042 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 160.62 159.18 9.73 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 36.1 mtmt -128.57 114.66 19.49 Favored Pre-proline 0 CA--C 1.537 0.444 0 O-C-N 122.021 -0.694 . . . . 0.0 109.998 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -75.6 -167.98 0.49 Allowed 'Trans proline' 0 CA--C 1.537 0.63 1 C-N-CA 125.806 4.338 . . . . 0.0 110.336 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -131.93 157.56 43.7 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.328 1.451 . . . . 0.0 108.91 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.89 -38.29 73.05 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.878 0.371 . . . . 0.0 110.503 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 33.7 m-20 -76.15 64.73 2.03 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.703 1.601 . . . . 0.0 110.293 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 6.1 p -52.04 -30.32 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 124.212 1.005 . . . . 0.0 111.172 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -71.32 -26.03 62.66 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.531 1.132 . . . . 0.0 113.804 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -77.32 -23.68 50.95 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 122.901 0.481 . . . . 0.0 112.174 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -92.42 160.32 15.14 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.964 0.411 . . . . 0.0 109.909 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -114.38 161.48 17.87 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.411 ' HB2' HD21 ' A' ' 102' ' ' LEU . 49.4 m-85 -138.11 170.43 16.05 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.738 1.215 . . . . 0.0 109.621 -177.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -112.57 151.32 30.19 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 21.9 tp -121.3 98.35 5.94 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -110.16 178.46 4.39 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -155.0 163.3 40.51 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -141.08 -171.03 3.18 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -55.27 -23.82 25.02 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.087 1.355 . . . . 0.0 112.406 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.5 t -81.87 -65.91 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 177.48 -170.58 43.1 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -77.55 157.62 30.26 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.566 0.746 . . . . 0.0 111.838 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.452 ' HB3' HG12 ' A' ' 207' ' ' VAL . 48.7 p90 -156.09 173.77 16.34 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 126.735 2.014 . . . . 0.0 108.585 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 93.8 mt -114.29 141.69 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 177.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 21.3 t -109.91 128.71 55.53 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.059 1.343 . . . . 0.0 107.923 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -124.07 107.39 11.23 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.862 1.265 . . . . 0.0 108.459 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.6 mp -91.05 128.65 42.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 7.6 mt -118.9 106.72 19.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -93.88 -152.56 29.41 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 108.443 -1.863 . . . . 0.0 108.443 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 69.7 m 79.15 25.49 0.46 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.201 2.2 . . . . 0.0 115.768 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -89.64 -156.02 31.44 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 107.58 -2.208 . . . . 0.0 107.58 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -123.17 144.13 49.56 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 39.8 mm -60.82 134.55 26.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -79.62 109.63 14.18 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 127.131 2.172 . . . . 0.0 105.489 177.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -55.04 -19.5 7.2 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.847 2.059 . . . . 0.0 113.189 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 50.1 t -60.47 -54.52 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 126.968 2.107 . . . . 0.0 111.567 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 4.8 t -124.09 -25.42 4.18 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -177.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 99.59 35.72 4.55 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 108.239 -1.945 . . . . 0.0 108.239 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -113.27 151.29 31.29 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 117.933 0.867 . . . . 0.0 110.669 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 57.5 mp0 -75.26 141.41 43.49 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 123.976 0.91 . . . . 0.0 112.735 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . 0.297 7.9 ttt85 -70.05 30.98 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 130.885 3.674 . . . . 0.0 112.797 178.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 5.1 ptm -74.75 177.36 6.22 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.125 0.97 . . . . 0.0 110.472 -179.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.2 p -143.65 152.97 16.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 125.283 1.433 . . . . 0.0 107.98 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -114.65 112.57 23.08 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 15.7 mm -98.24 141.96 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -124.62 111.46 15.66 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.663 1.585 . . . . 0.0 107.985 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -92.56 109.03 20.43 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.701 1.6 . . . . 0.0 110.369 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.452 HG12 ' HB3' ' A' ' 182' ' ' TYR . 34.9 m -124.79 167.82 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.211 1.005 . . . . 0.0 109.837 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 45.5 t -96.46 132.73 41.72 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 103.541 -2.763 . . . . 0.0 103.541 177.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -98.36 32.49 6.89 Favored Glycine 0 N--CA 1.463 0.456 0 C-N-CA 124.541 1.067 . . . . 0.0 111.01 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.169 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.276 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo . . . . . 0 N--CA 1.456 -0.731 0 N-CA-C 115.429 1.281 . . . . 0.0 115.429 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -164.12 151.03 11.63 Favored 'General case' 0 C--O 1.241 0.624 0 O-C-N 120.863 -1.148 . . . . 0.0 109.1 -178.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 36.7 p -151.81 160.64 43.49 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.839 0.855 . . . . 0.0 110.579 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 4.1 mt -106.48 148.55 10.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -93.82 -53.98 3.8 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.672 0.789 . . . . 0.0 110.95 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 63.4 p-90 -155.17 155.03 33.2 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.859 1.264 . . . . 0.0 108.113 -178.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 56.3 t -150.58 129.66 3.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.84 162.18 32.15 Favored 'General case' 0 C--O 1.233 0.209 0 O-C-N 122.19 -0.319 . . . . 0.0 111.174 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -72.53 128.79 36.66 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 104.574 -2.38 . . . . 0.0 104.574 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 9.9 t -106.15 -37.17 6.68 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 124.833 1.253 . . . . 0.0 109.981 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 34.2 mttt -133.31 -176.45 4.14 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 123.782 0.833 . . . . 0.0 109.975 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 69.3 mt -46.38 -49.43 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.188 0.995 . . . . 0.0 112.322 -178.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.99 21.23 5.83 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 124.112 0.965 . . . . 0.0 110.362 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 7.9 t -120.1 141.4 40.49 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.61 0 CA-C-N 118.64 0.654 . . . . 0.0 111.61 -177.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -122.97 158.37 30.61 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -129.73 134.46 47.63 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -137.32 119.33 15.38 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 125.427 1.491 . . . . 0.0 109.932 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -108.42 124.66 50.74 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 12.5 m -116.31 156.58 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.481 0 C-N-CA 122.47 0.308 . . . . 0.0 110.665 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.3 p -123.85 123.89 41.45 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 124.39 1.076 . . . . 0.0 110.263 -178.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 2.2 pt -133.44 134.52 23.92 Favored Pre-proline 0 C--O 1.237 0.4 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 177.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.54 -27.82 45.83 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.233 2.622 . . . . 0.0 113.304 -178.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' GLU . . . . . 0.429 ' HB3' ' CG2' ' A' ' 108' ' ' THR . 28.2 mp0 -64.59 -28.65 69.78 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 -178.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 66.6 mt -61.23 -29.23 69.7 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 118.587 -1.245 . . . . 0.0 110.652 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 21.7 m -58.86 -16.35 16.95 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 118.806 0.73 . . . . 0.0 112.256 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -60.11 -38.4 82.91 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 118.91 0.777 . . . . 0.0 109.663 178.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -79.61 122.47 26.56 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -47.33 -44.88 24.05 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 126.26 1.824 . . . . 0.0 113.34 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.43 -33.59 76.05 Favored 'General case' 0 C--O 1.226 -0.176 0 O-C-N 121.341 -0.849 . . . . 0.0 112.694 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 27.2 mt -92.88 -4.99 51.89 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.231 1.012 . . . . 0.0 113.054 -178.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -71.61 117.06 12.71 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 127.625 2.37 . . . . 0.0 112.978 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 32.6 mmtm . . . . . 0 CA--C 1.516 -0.352 0 C-N-CA 123.216 0.606 . . . . 0.0 110.709 178.424 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.171 0 CA-C-O 118.554 -0.736 . . . . 0.0 112.078 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.82 -49.23 76.01 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 52.8 tp -65.1 -35.6 81.64 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.492 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.498 HD23 HD11 ' A' ' 243' ' ' LEU . 43.3 mt -63.24 -55.01 28.48 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.44 1.018 . . . . 0.0 108.791 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 88.9 m -57.25 -46.36 83.1 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 125.045 1.338 . . . . 0.0 110.254 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.71 -50.2 70.08 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 118.231 -0.89 . . . . 0.0 109.666 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 47.6 m -52.53 -46.9 66.94 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 124.159 0.984 . . . . 0.0 110.532 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -59.49 -50.33 74.33 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 118.3 0.5 . . . . 0.0 110.003 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.1 -61.5 2.22 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.219 0.608 . . . . 0.0 112.313 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.44 -37.98 79.5 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.487 0.315 . . . . 0.0 110.231 -178.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.09 -53.25 38.16 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-O 117.583 -1.676 . . . . 0.0 110.706 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.55 ' HA ' HD12 ' A' ' 109' ' ' ILE . 37.3 t -57.12 -45.19 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 119.671 1.736 . . . . 0.0 109.087 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -62.96 -34.36 77.33 Favored 'General case' 0 C--O 1.223 -0.311 0 C-N-CA 118.815 -1.154 . . . . 0.0 111.573 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 86.2 m -70.89 -36.96 72.97 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.444 0.698 . . . . 0.0 109.53 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.55 HD12 ' HA ' ' A' ' 106' ' ' VAL . 13.7 mt -61.81 -55.4 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 179.121 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -64.3 -27.85 69.32 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -64.51 -30.82 71.85 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.443 1.02 . . . . 0.0 111.646 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.68 -46.61 6.54 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 123.835 0.854 . . . . 0.0 110.56 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.9 mt -59.98 -27.58 66.97 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -55.03 -24.83 26.63 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -62.85 -62.44 1.72 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.48 0.712 . . . . 0.0 110.872 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -148.42 171.03 16.7 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 123.97 0.908 . . . . 0.0 110.868 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 69.8 m -87.07 166.14 15.25 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 35.4 pt -117.92 156.44 19.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 125.372 1.469 . . . . 0.0 108.613 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.3 138.29 21.27 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 125.389 1.475 . . . . 0.0 109.278 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -136.7 113.36 10.21 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 123.634 0.773 . . . . 0.0 111.44 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -79.82 99.59 7.58 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.29 79.62 8.99 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 178.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 60.13 -105.83 0.87 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -77.99 -34.32 50.87 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.685 0.794 . . . . 0.0 112.981 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 52.4 m95 -99.79 167.82 10.3 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 118.952 0.797 . . . . 0.0 110.293 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.3 mp -136.88 153.81 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.503 ' CD1' HG11 ' A' ' 221' ' ' VAL . 98.9 m-85 -133.68 120.15 20.27 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.766 2.027 . . . . 0.0 106.221 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -117.15 121.29 40.85 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -119.06 139.43 51.76 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 124.216 1.007 . . . . 0.0 109.895 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.607 ' HB3' HD13 ' A' ' 133' ' ' ILE . 20.8 m -115.77 157.38 44.73 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 126.663 1.985 . . . . 0.0 111.687 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -64.21 76.68 0.17 Allowed 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 124.723 3.615 . . . . 0.0 114.626 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 68.54 56.87 8.92 Favored Glycine 0 CA--C 1.533 1.161 0 O-C-N 120.72 -1.238 . . . . 0.0 112.792 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.607 HD13 ' HB3' ' A' ' 130' ' ' CYS . 3.9 mp -128.12 -71.24 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.131 0 C-N-CA 126.198 1.799 . . . . 0.0 106.153 179.265 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -164.42 169.97 16.61 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 126.963 2.105 . . . . 0.0 109.521 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -133.38 124.84 27.89 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 178.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 33.9 m -142.65 163.71 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 123.99 0.916 . . . . 0.0 112.043 -178.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -125.43 124.67 41.95 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.757 1.623 . . . . 0.0 107.017 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -139.34 162.45 34.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 119.451 1.023 . . . . 0.0 111.43 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 63.1 t60 -85.37 160.97 19.66 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 177.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.595 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -178.674 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 . . . . . 0 CA--C 1.532 0.271 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -148.7 134.18 18.61 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.5 mp -109.85 -23.73 11.22 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 160.79 159.22 9.78 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-N 119.436 1.016 . . . . 0.0 111.891 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.38 108.46 41.71 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 123.918 0.887 . . . . 0.0 109.631 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.4 166.73 23.88 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.286 2.657 . . . . 0.0 110.058 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -96.75 156.55 16.3 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -76.02 -35.14 59.65 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.728 1.211 . . . . 0.0 113.149 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -84.85 66.73 9.83 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 124.369 1.068 . . . . 0.0 110.534 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.5 p -46.04 -28.6 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -71.16 -31.2 67.4 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 124.823 1.249 . . . . 0.0 111.737 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -87.84 -14.1 40.4 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.138 1.775 . . . . 0.0 110.24 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -75.97 158.38 32.02 Favored 'General case' 0 CA--C 1.521 -0.165 0 O-C-N 120.921 -1.112 . . . . 0.0 108.865 178.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -109.9 149.25 30.18 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -143.37 169.28 17.96 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 127.025 2.13 . . . . 0.0 108.606 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -128.13 154.01 46.23 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.082 0.953 . . . . 0.0 110.043 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 23.9 tp -114.25 108.52 17.05 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.555 HD23 ' HB2' ' A' ' 184' ' ' SER . 1.9 mm? -118.2 -179.83 3.89 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.226 1.41 . . . . 0.0 109.297 -178.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -149.33 156.79 42.62 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.067 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -141.52 -178.12 5.48 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 177.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -60.86 -13.13 13.58 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.331 -0.856 . . . . 0.0 111.464 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 69.0 t -83.09 -45.25 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 O-C-N 120.796 -1.19 . . . . 0.0 110.435 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 154.53 -165.56 31.99 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 108.082 -2.007 . . . . 0.0 108.082 -178.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.441 ' CD2' ' HB3' ' A' ' 243' ' ' LEU . 3.4 m-30 -78.56 160.72 27.46 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 118.239 1.019 . . . . 0.0 110.22 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.439 ' CB ' HG12 ' A' ' 207' ' ' VAL . 45.7 p90 -158.64 161.72 37.2 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.503 1.121 . . . . 0.0 111.371 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 95.8 mt -101.4 144.1 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.555 ' HB2' HD23 ' A' ' 175' ' ' LEU . 29.7 t -114.29 133.01 55.95 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -123.46 108.55 12.8 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -85.84 127.61 40.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.8 mt -115.59 105.23 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 102.874 -3.01 . . . . 0.0 102.874 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -110.76 -152.04 12.74 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 108.379 -1.888 . . . . 0.0 108.379 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 75.26 23.74 1.52 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.389 1.076 . . . . 0.0 110.945 178.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -95.08 173.64 31.89 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.98 163.88 26.72 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 44.0 mm -86.23 141.43 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 125.619 1.568 . . . . 0.0 111.623 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.2 m -87.23 118.75 26.86 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 127.724 2.41 . . . . 0.0 108.383 178.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -54.06 -32.24 54.02 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.075 2.15 . . . . 0.0 113.335 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 43.8 t -50.91 -55.42 7.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 125.542 1.537 . . . . 0.0 112.772 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 13.6 t -123.93 -33.28 3.16 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 108.05 34.73 2.69 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -178.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -104.82 152.65 22.33 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.916 1.358 . . . . 0.0 110.438 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -76.96 146.2 37.65 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 118.773 0.715 . . . . 0.0 109.559 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . 0.373 4.8 ptp180 -71.62 29.34 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 128.176 2.59 . . . . 0.0 113.558 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 7.8 ptm -72.59 174.31 7.7 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 122.15 0.976 . . . . 0.0 111.643 -176.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.4 p -142.25 150.17 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 124.065 0.946 . . . . 0.0 109.346 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -111.06 106.23 15.23 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 17.0 mm -90.31 150.59 3.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -125.76 100.03 6.23 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 126.916 2.087 . . . . 0.0 110.173 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -84.81 108.68 17.6 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 178.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.439 HG12 ' CB ' ' A' ' 182' ' ' TYR . 26.1 m -125.38 164.11 25.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 124.243 1.017 . . . . 0.0 108.674 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 42.6 t -82.92 146.51 28.8 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 177.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -93.04 13.42 67.74 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-O 118.997 -0.891 . . . . 0.0 112.456 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.977 0 N-CA-C 106.443 -2.663 . . . . 0.0 106.443 -177.239 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo . . . . . 0 N--CA 1.456 -0.731 0 N-CA-C 114.305 0.848 . . . . 0.0 114.305 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 2.9 p -164.33 142.7 7.1 Favored 'General case' 0 N--CA 1.463 0.201 0 O-C-N 120.934 -1.104 . . . . 0.0 109.678 -178.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 7.9 p -148.8 165.5 31.29 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.47 0.577 . . . . 0.0 111.132 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 3.4 mt -101.96 154.48 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 125.298 1.439 . . . . 0.0 107.372 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -105.0 -44.86 4.69 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.121 0.968 . . . . 0.0 113.573 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 67.0 p-90 -163.68 151.88 13.31 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.999 1.319 . . . . 0.0 107.718 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.503 HG11 ' CD1' ' A' ' 127' ' ' TYR . 87.9 t -151.89 129.2 2.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 C-N-CA 124.879 1.272 . . . . 0.0 109.22 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 1.5 ppt_? -163.48 160.5 23.34 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.752 0.706 . . . . 0.0 110.495 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -67.09 131.25 45.45 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 14.9 t -104.07 -33.15 8.87 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.948 1.299 . . . . 0.0 111.361 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 56.8 mttt -131.36 -175.04 3.57 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 125.049 1.34 . . . . 0.0 108.332 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 67.5 mt -52.27 -43.88 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -129.95 8.3 5.22 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.649 0.78 . . . . 0.0 112.227 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 21.5 t -105.81 142.34 19.07 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -178.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -121.55 166.36 14.31 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 124.72 1.208 . . . . 0.0 108.104 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -136.91 144.29 43.39 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -148.65 119.02 7.33 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 123.364 0.666 . . . . 0.0 109.608 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -103.5 123.07 46.22 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 2.3 m -119.98 152.44 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 2.8 p -126.6 135.93 51.87 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 3.9 pt -139.82 146.17 46.02 Favored Pre-proline 0 C--O 1.236 0.362 0 C-N-CA 125.564 1.545 . . . . 0.0 107.029 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -74.03 -24.82 14.63 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.201 1.934 . . . . 0.0 112.973 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 49.6 mp0 -66.02 -28.18 68.68 Favored 'General case' 0 CA--C 1.518 -0.286 0 O-C-N 120.43 -1.418 . . . . 0.0 114.355 -178.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.409 HD22 ' CD1' ' A' ' 244' ' ' LEU . 58.9 mt -63.32 -25.13 68.16 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 118.902 -1.119 . . . . 0.0 110.682 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 20.9 m -63.0 -15.12 55.27 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 119.163 0.892 . . . . 0.0 111.051 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -69.5 -31.77 70.22 Favored 'General case' 0 C--N 1.341 0.206 0 O-C-N 121.186 -0.946 . . . . 0.0 109.358 178.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.445 HD13 ' HA ' ' A' ' 241' ' ' LEU . 3.1 mm? -78.21 120.75 23.44 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 178.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 33.0 tp10 -46.05 -48.47 16.86 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.766 2.026 . . . . 0.0 115.795 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.498 HD11 HD23 ' A' ' 98' ' ' LEU . 20.0 mt -69.52 -34.44 74.27 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.148 -0.97 . . . . 0.0 112.786 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.409 ' CD1' HD22 ' A' ' 238' ' ' LEU . 3.2 mt -84.71 -10.35 57.36 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.266 1.026 . . . . 0.0 112.717 -178.281 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -61.25 123.73 18.56 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.179 2.192 . . . . 0.0 111.015 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 16.2 mmtp . . . . . 0 C--O 1.237 0.443 0 C-N-CA 123.319 0.648 . . . . 0.0 109.677 178.759 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.468 ' HA ' HD12 ' A' ' 98' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.462 0.138 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.88 -52.64 64.86 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 42.0 tp -68.36 -34.95 77.0 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 118.416 -0.802 . . . . 0.0 110.373 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.468 HD12 ' HA ' ' A' ' 95' ' ' THR . 31.8 mt -60.36 -54.37 46.42 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 60.4 m -61.9 -45.26 94.5 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.656 -0.652 . . . . 0.0 109.8 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.9 -47.31 83.16 Favored 'General case' 0 C--N 1.346 0.415 0 O-C-N 120.854 -1.154 . . . . 0.0 109.416 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.405 ' HA ' HD12 ' A' ' 241' ' ' LEU . 72.3 m -54.14 -51.17 65.13 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.579 1.152 . . . . 0.0 110.323 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -57.98 -47.92 81.54 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 123.288 0.367 . . . . 0.0 110.56 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -69.17 -59.58 2.93 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -177.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.46 -37.32 85.46 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.451 ' HA3' HD11 ' A' ' 183' ' ' ILE . . . -56.15 -52.65 47.99 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.519 ' HA ' HD12 ' A' ' 109' ' ' ILE . 41.3 t -56.69 -46.02 82.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 119.381 1.59 . . . . 0.0 110.475 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.3 ptmt -63.61 -31.63 72.86 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 118.714 -0.66 . . . . 0.0 111.878 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.3 m -76.43 -37.89 56.36 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.38 1.072 . . . . 0.0 109.104 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.558 HD13 ' CD1' ' A' ' 206' ' ' TYR . 24.6 mt -62.16 -55.34 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -62.15 -28.37 69.6 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 118.272 -0.87 . . . . 0.0 111.497 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -68.67 -50.3 52.16 Favored 'General case' 0 N--CA 1.457 -0.085 0 CA-C-N 119.028 0.831 . . . . 0.0 111.135 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.05 -44.8 45.64 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 30.8 mt -64.33 -26.12 68.34 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-O 119.068 -0.491 . . . . 0.0 111.929 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -51.63 -27.06 10.26 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.3 1.04 . . . . 0.0 112.872 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -52.58 -68.09 0.2 Allowed 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.544 1.538 . . . . 0.0 112.489 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -152.9 -179.13 7.38 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.597 1.559 . . . . 0.0 111.536 -178.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 64.1 m -86.65 175.42 8.29 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 35.7 pt -140.73 160.19 24.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 125.306 1.442 . . . . 0.0 109.746 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.32 144.2 25.38 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 123.878 0.871 . . . . 0.0 110.081 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.537 ' CE1' ' HB2' ' A' ' 122' ' ' ALA . 8.8 t80 -135.04 131.16 36.71 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.091 0.956 . . . . 0.0 109.461 178.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.4 ' HA ' HG13 ' A' ' 126' ' ' ILE . 57.0 tt0 -91.43 109.71 21.0 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 124.915 1.286 . . . . 0.0 108.029 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.537 ' HB2' ' CE1' ' A' ' 120' ' ' TYR . . . -102.39 80.09 1.91 Allowed 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.15 1.78 . . . . 0.0 110.86 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.82 -85.99 0.07 OUTLIER Glycine 0 CA--C 1.529 0.913 0 O-C-N 120.711 -1.243 . . . . 0.0 113.1 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -109.77 -32.62 7.01 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.407 1.083 . . . . 0.0 111.235 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 69.2 m95 -99.81 152.76 19.76 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 118.933 0.788 . . . . 0.0 110.323 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.483 HD13 ' H ' ' A' ' 140' ' ' GLY . 4.8 mp -122.19 138.22 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -113.97 130.62 56.51 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -132.86 125.04 29.09 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.358 0.526 . . . . 0.0 110.57 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -116.06 140.65 49.06 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.823 1.249 . . . . 0.0 110.82 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 6.5 m -121.37 151.9 56.9 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 124.354 1.062 . . . . 0.0 109.925 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -65.69 84.86 0.23 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 124.374 3.383 . . . . 0.0 116.108 -177.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.21 32.07 36.38 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-O 118.041 -1.422 . . . . 0.0 112.714 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.8 mp -114.67 -72.59 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -172.05 173.74 4.28 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.737 1.215 . . . . 0.0 109.364 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -129.47 126.9 39.74 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.0 m -142.05 163.97 18.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 124.383 1.073 . . . . 0.0 111.487 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -123.93 118.93 28.17 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -137.78 163.43 31.39 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 125.869 1.667 . . . . 0.0 111.361 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -94.77 135.39 36.31 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 177.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.483 ' H ' HD13 ' A' ' 126' ' ' ILE . . . . . . . . 0 CA--C 1.529 0.914 0 O-C-N 121.126 -0.984 . . . . 0.0 111.89 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 . . . . . 0 C--O 1.236 0.385 0 CA-C-O 120.587 0.232 . . . . 0.0 110.513 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 19.2 tpp180 -148.11 113.19 5.5 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.425 1.49 . . . . 0.0 110.527 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 60.3 mt -97.91 -41.59 7.94 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 157.89 175.06 28.39 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.439 ' N ' HG22 ' A' ' 187' ' ' ILE . 6.0 ptmm? -130.36 127.83 22.54 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -70.35 179.1 4.27 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.036 3.157 . . . . 0.0 108.771 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -123.47 162.06 23.62 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 121.321 -0.862 . . . . 0.0 110.425 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -73.04 -50.06 25.17 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.126 0.97 . . . . 0.0 111.037 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -77.55 64.96 2.98 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 126.072 1.749 . . . . 0.0 111.734 -177.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.4 p -50.14 -32.43 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.464 1.105 . . . . 0.0 111.133 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -62.38 -37.24 84.98 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.402 1.481 . . . . 0.0 110.752 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -84.54 -15.21 46.6 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.849 1.26 . . . . 0.0 112.018 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 67.4 mtp180 -79.65 134.29 36.42 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -89.96 149.55 22.53 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -135.65 166.3 23.55 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.913 1.685 . . . . 0.0 107.149 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -122.79 153.57 39.36 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 48.1 tp -116.63 100.74 8.04 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.58 1.552 . . . . 0.0 109.524 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -117.67 178.68 4.31 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 125.175 1.39 . . . . 0.0 107.449 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -153.98 161.09 42.23 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 121.85 -0.531 . . . . 0.0 111.048 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -138.78 176.24 8.86 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 126.649 1.98 . . . . 0.0 107.501 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -59.91 -16.87 33.0 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 126.169 1.788 . . . . 0.0 111.987 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.469 ' CG1' ' HE3' ' A' ' 246' ' ' LYS . 99.3 t -86.41 -37.55 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 124.293 1.037 . . . . 0.0 110.196 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 155.51 -178.94 31.85 Favored Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -78.43 165.53 23.68 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.222 1.009 . . . . 0.0 108.718 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.479 ' HB3' HG12 ' A' ' 207' ' ' VAL . 36.8 p90 -158.95 169.75 23.63 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 122.779 0.431 . . . . 0.0 109.922 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.451 HD11 ' HA3' ' A' ' 105' ' ' GLY . 96.7 mt -109.48 124.74 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 35.3 t -91.54 129.52 37.5 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -125.64 107.26 10.4 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -90.15 125.68 43.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 103.711 -2.7 . . . . 0.0 103.711 177.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.439 HG22 ' N ' ' A' ' 162' ' ' LYS . 6.3 mt -113.74 112.75 41.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.73 -160.3 25.76 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 124.945 1.26 . . . . 0.0 112.554 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 84.25 56.64 0.01 OUTLIER 'General case' 0 C--O 1.239 0.529 0 C-N-CA 128.291 2.636 . . . . 0.0 108.421 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -134.05 149.62 19.8 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-O 121.651 0.584 . . . . 0.0 112.773 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -58.68 140.01 55.25 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 128.325 2.65 . . . . 0.0 109.995 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 21.7 mm -69.16 137.03 25.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 121.16 0.505 . . . . 0.0 111.21 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.3 m -85.33 104.06 14.82 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -53.99 -28.87 40.58 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.123 0.969 . . . . 0.0 112.593 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 45.5 t -42.95 -48.76 1.2 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 125.882 1.673 . . . . 0.0 111.207 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 10.0 t -124.36 -35.21 2.81 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.294 1.038 . . . . 0.0 113.241 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 105.94 36.15 2.82 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.564 1.554 . . . . 0.0 109.238 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -114.37 152.24 31.79 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 118.463 1.131 . . . . 0.0 111.535 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -66.1 163.29 17.82 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 4.9 mmt85 -89.29 28.4 1.25 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 130.648 3.579 . . . . 0.0 112.452 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 6.1 ptm -73.32 175.31 7.01 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 121.763 2.074 . . . . 0.0 111.042 -177.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.81 153.01 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 125.289 1.436 . . . . 0.0 107.24 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -115.48 114.65 25.3 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.798 1.639 . . . . 0.0 106.951 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 12.0 mm -106.07 144.79 14.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.324 1.049 . . . . 0.0 109.138 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -125.65 98.46 5.58 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.609 1.564 . . . . 0.0 112.601 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' TYR . . . . . 0.558 ' CD1' HD13 ' A' ' 109' ' ' ILE . 54.4 m-85 -73.06 111.48 8.21 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.571 1.148 . . . . 0.0 108.003 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.479 HG12 ' HB3' ' A' ' 182' ' ' TYR . 25.4 m -125.24 163.63 25.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 C-N-CA 124.932 1.293 . . . . 0.0 109.018 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 48.7 t -85.12 146.7 27.0 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -102.03 22.39 38.28 Favored Glycine 0 N--CA 1.463 0.443 0 C-N-CA 124.361 0.981 . . . . 0.0 112.042 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.833 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 -178.283 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo . . . . . 0 N--CA 1.458 -0.601 0 N-CA-C 109.866 -0.859 . . . . 0.0 109.866 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 2.3 p -171.19 145.57 2.24 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 126.961 2.104 . . . . 0.0 108.317 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 13.9 p -149.88 172.42 15.2 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.849 0.86 . . . . 0.0 110.207 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.462 HG21 HG23 ' A' ' 221' ' ' VAL . 4.1 mt -122.36 136.08 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 125.997 1.719 . . . . 0.0 107.27 177.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -77.61 -59.37 2.81 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.425 1.49 . . . . 0.0 107.94 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' TRP . . . . . 0.473 ' HA ' ' CE1' ' A' ' 120' ' ' TYR . 68.1 p-90 -159.88 162.57 34.62 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.38 1.472 . . . . 0.0 109.259 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.462 HG23 HG21 ' A' ' 218' ' ' ILE . 47.3 t -154.43 138.67 9.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 178.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.27 163.3 20.09 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.998 0.919 . . . . 0.0 110.474 178.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -71.53 143.12 50.05 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 178.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' THR . . . . . 0.516 HG21 ' HG3' ' A' ' 230' ' ' GLU . 9.4 t -118.67 -35.95 3.59 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.541 1.136 . . . . 0.0 111.547 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.423 ' HG3' HG23 ' A' ' 224' ' ' THR . 10.7 mttt -129.51 -175.98 3.76 Favored 'General case' 0 C--O 1.22 -0.485 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 56.5 mt -53.35 -43.31 51.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -129.56 14.54 6.0 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.512 0.725 . . . . 0.0 112.159 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 15.8 t -115.84 142.7 28.03 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -177.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -123.76 159.8 28.69 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.362 1.065 . . . . 0.0 109.037 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' GLU . . . . . 0.516 ' HG3' HG21 ' A' ' 224' ' ' THR . 25.3 mt-10 -126.77 136.74 52.81 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.885 1.674 . . . . 0.0 107.824 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -137.27 146.66 45.0 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 125.814 1.646 . . . . 0.0 109.038 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -135.5 108.04 7.4 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' A' ' 218' ' ' ILE . 2.8 m -101.15 149.63 6.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 124.542 1.137 . . . . 0.0 108.622 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.12 128.6 46.45 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.94 0.896 . . . . 0.0 112.39 -178.077 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -131.83 147.88 67.71 Favored Pre-proline 0 C--O 1.234 0.249 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 177.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -72.45 -43.55 0.97 Allowed 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.225 1.95 . . . . 0.0 110.512 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -54.46 -23.92 18.12 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 125.424 1.49 . . . . 0.0 113.39 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 5.4 tp -62.24 -32.8 73.53 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 121.229 -0.919 . . . . 0.0 110.432 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 9.0 m -61.6 -12.3 15.18 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.666 1.186 . . . . 0.0 112.469 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.83 -31.28 70.7 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 123.391 0.676 . . . . 0.0 109.344 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 101' ' ' THR . 4.3 mm? -82.49 122.15 27.68 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 177.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -47.35 -44.36 23.88 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.823 1.649 . . . . 0.0 112.841 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 1.1 tp -68.06 -30.71 69.98 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 120.975 -1.078 . . . . 0.0 113.704 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 19.2 mt -93.61 -5.0 49.77 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.876 1.671 . . . . 0.0 111.841 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -67.22 119.77 12.66 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.004 1.321 . . . . 0.0 109.944 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.469 ' HE3' ' CG1' ' A' ' 179' ' ' VAL . 13.3 mmmm . . . . . 0 CA--C 1.532 0.276 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.421 ' HA ' HD12 ' A' ' 98' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.462 0.159 0 CA-C-O 119.468 -0.301 . . . . 0.0 110.353 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.22 -51.17 69.06 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.782 0.833 . . . . 0.0 108.942 178.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 35.4 tp -67.22 -40.03 86.36 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.826 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 95' ' ' THR . 41.4 mt -59.66 -54.55 45.07 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 119.514 1.052 . . . . 0.0 109.889 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 52.5 m -62.68 -44.84 95.23 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.132 0.973 . . . . 0.0 110.358 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.4 tmmm? -60.83 -50.92 71.47 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.713 -0.617 . . . . 0.0 109.934 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.1 m -53.82 -44.29 70.11 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 123.873 0.869 . . . . 0.0 109.862 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.12 -45.9 92.78 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.689 0.677 . . . . 0.0 109.76 178.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -61.87 -61.7 2.32 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 124.573 1.149 . . . . 0.0 113.71 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.98 -34.46 78.15 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 119.118 -0.468 . . . . 0.0 110.558 -178.017 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.34 -53.08 48.58 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.595 ' HA ' HD12 ' A' ' 109' ' ' ILE . 40.3 t -57.52 -51.57 68.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-N 118.909 1.355 . . . . 0.0 111.471 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 7.6 pttp -60.39 -33.68 72.82 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.849 -179.019 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 35.5 m -76.33 -30.89 57.84 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 122.235 0.214 . . . . 0.0 111.095 -178.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.595 HD12 ' HA ' ' A' ' 106' ' ' VAL . 16.1 mt -61.83 -54.97 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -62.45 -33.5 74.94 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.901 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -60.23 -35.56 75.73 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.178 0.899 . . . . 0.0 110.942 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.1 tptp -80.27 -53.67 6.43 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 28.8 mt -57.02 -28.79 62.8 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -178.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -49.35 -26.0 2.84 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.881 1.272 . . . . 0.0 112.908 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -61.33 -63.3 1.33 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.181 0.992 . . . . 0.0 112.511 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.7 mmm-85 -154.62 178.82 9.67 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.088 1.755 . . . . 0.0 110.049 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 63.4 m -86.62 174.05 9.14 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 38.5 pt -127.92 157.54 39.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 125.762 1.625 . . . . 0.0 108.778 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -151.57 145.23 24.98 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.847 1.259 . . . . 0.0 109.609 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -140.23 120.91 14.31 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.191 0.596 . . . . 0.0 111.551 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -79.22 104.61 9.96 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 178.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.06 79.97 3.6 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 57.8 -109.14 1.66 Allowed Glycine 0 CA--C 1.53 1.023 0 C-N-CA 123.992 0.806 . . . . 0.0 111.121 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -72.27 -35.96 68.87 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 118.704 -0.665 . . . . 0.0 112.281 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -99.8 168.68 9.75 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 119.336 0.971 . . . . 0.0 112.702 -177.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.4 mp -136.51 133.82 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 N-CA-C 104.059 -2.571 . . . . 0.0 104.059 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -111.68 119.98 40.49 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -117.88 124.78 49.15 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.256 0.622 . . . . 0.0 109.437 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -117.78 136.22 53.54 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.436 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.451 ' HB3' HD13 ' A' ' 133' ' ' ILE . 17.8 m -113.78 154.61 45.79 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 124.184 0.994 . . . . 0.0 111.241 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -61.99 80.56 0.09 OUTLIER 'Trans proline' 0 C--N 1.351 0.661 1 C-N-CA 125.409 4.072 . . . . 0.0 116.383 -177.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 72.95 41.74 47.57 Favored Glycine 0 CA--C 1.529 0.934 0 O-C-N 120.836 -1.165 . . . . 0.0 111.258 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.451 HD13 ' HB3' ' A' ' 130' ' ' CYS . 3.9 mp -122.93 -69.43 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.32 0 CA-C-N 118.207 1.004 . . . . 0.0 108.553 179.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -164.29 169.62 17.28 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.235 1.014 . . . . 0.0 109.849 -178.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -133.06 118.32 18.63 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 176.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.7 m -135.85 164.63 31.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 125.229 1.412 . . . . 0.0 112.327 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -125.23 123.29 39.22 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.546 1.938 . . . . 0.0 108.514 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -138.31 162.56 34.06 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.561 1.145 . . . . 0.0 110.987 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -105.54 130.59 53.56 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 178.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.512 0 N-CA-C 108.476 -1.85 . . . . 0.0 108.476 -178.605 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 . . . . . 0 N--CA 1.452 -0.363 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -149.36 115.95 5.88 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 178.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 26.5 mt -100.14 -24.81 14.48 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 159.89 161.72 11.59 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-O 122.545 1.081 . . . . 0.0 112.199 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.416 ' N ' HG22 ' A' ' 187' ' ' ILE . 38.9 ttpt -124.02 109.46 29.67 Favored Pre-proline 0 N--CA 1.43 -1.429 0 C-N-CA 125.01 1.324 . . . . 0.0 111.737 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -74.86 157.23 43.49 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 123.726 2.951 . . . . 0.0 109.223 177.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -92.73 157.54 16.39 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.791 -0.568 . . . . 0.0 109.54 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.62 -47.8 74.38 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.3 0.64 . . . . 0.0 111.572 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -74.74 64.89 1.29 Allowed 'General case' 0 N--CA 1.461 0.102 0 C-N-CA 126.701 2.001 . . . . 0.0 113.162 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.4 p -47.55 -31.82 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 124.382 1.073 . . . . 0.0 112.969 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -64.85 -32.44 74.15 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 122.401 1.095 . . . . 0.0 112.283 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -87.78 -15.1 37.88 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.165 1.386 . . . . 0.0 111.173 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -80.74 133.58 35.69 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -98.78 149.2 23.11 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -134.41 169.98 16.43 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.087 1.355 . . . . 0.0 108.565 -178.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -120.77 152.97 37.65 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 122.908 0.483 . . . . 0.0 109.791 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 14.2 tp -110.59 110.62 21.4 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 125.417 1.487 . . . . 0.0 107.384 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.575 HD23 ' HB2' ' A' ' 184' ' ' SER . 2.6 mm? -123.65 -179.23 4.28 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 127.316 2.246 . . . . 0.0 108.595 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -144.69 167.97 21.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.435 0.636 . . . . 0.0 111.005 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -140.64 -176.11 4.53 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 126.734 2.014 . . . . 0.0 107.646 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -64.04 -11.87 33.36 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 121.386 -0.821 . . . . 0.0 112.965 -177.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 85.0 t -106.23 -36.42 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 124.62 1.168 . . . . 0.0 112.485 -178.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 169.4 -173.62 43.74 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 119.389 0.995 . . . . 0.0 112.476 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.419 ' CD2' ' HB3' ' A' ' 243' ' ' LEU . 5.1 m-30 -79.97 162.97 24.62 Favored 'General case' 0 C--O 1.241 0.654 0 O-C-N 122.107 -0.643 . . . . 0.0 110.125 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -159.22 168.96 25.18 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.501 -1.227 . . . . 0.0 112.053 -179.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 92.1 mt -104.74 127.5 59.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.575 ' HB2' HD23 ' A' ' 175' ' ' LEU . 22.5 t -100.07 115.08 28.93 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.915 1.286 . . . . 0.0 108.802 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -111.83 107.01 15.91 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -89.54 111.84 23.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.447 0 N-CA-C 103.455 -2.795 . . . . 0.0 103.455 177.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.416 HG22 ' N ' ' A' ' 162' ' ' LYS . 6.7 mt -95.87 106.64 18.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.01 -157.42 26.29 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.0 t 85.29 3.61 0.62 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 127.667 2.387 . . . . 0.0 108.679 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -63.74 136.78 41.5 Favored Glycine 0 N--CA 1.435 -1.411 0 N-CA-C 108.256 -1.937 . . . . 0.0 108.256 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.26 148.25 27.9 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.469 1.108 . . . . 0.0 108.842 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.8 mm -70.37 130.76 34.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 122.863 1.316 . . . . 0.0 113.893 -177.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.3 m -85.46 107.5 17.45 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 128.448 2.699 . . . . 0.0 108.171 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -53.74 -18.38 3.09 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 127.963 2.505 . . . . 0.0 113.436 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 18.0 t -56.24 -54.77 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 125.935 1.694 . . . . 0.0 109.805 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 13.3 t -123.75 -29.68 3.67 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.189 0.996 . . . . 0.0 112.49 -178.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 104.6 35.75 3.21 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -115.48 160.1 20.35 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.282 1.541 . . . . 0.0 111.9 -178.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -77.54 151.43 34.53 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 118.867 0.758 . . . . 0.0 112.996 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -71.0 28.65 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.667 1 C-N-CA 132.129 4.172 . . . . 0.0 109.988 177.414 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 7.0 ptm -73.47 173.78 9.15 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 122.617 1.199 . . . . 0.0 112.002 -176.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.08 147.04 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 124.488 1.115 . . . . 0.0 108.733 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -106.83 104.37 14.04 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 125.635 1.574 . . . . 0.0 107.241 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 12.6 mm -93.24 147.21 5.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -126.84 101.75 6.73 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.008 1.723 . . . . 0.0 107.638 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' TYR . . . . . 0.509 ' CD1' HD13 ' A' ' 109' ' ' ILE . 40.9 m-85 -84.34 111.15 19.17 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 6.4 m -125.13 168.13 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.718 0.77 . . . . 0.0 109.605 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 49.8 t -87.88 142.15 28.03 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -88.49 -0.69 81.89 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-O 118.464 -1.187 . . . . 0.0 113.07 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.739 0 N-CA-C 107.31 -2.316 . . . . 0.0 107.31 -178.234 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo . . . . . 0 N--CA 1.451 -0.987 0 N-CA-C 110.973 -0.433 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 19.0 p -160.21 147.7 16.34 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 120.624 -1.298 . . . . 0.0 108.951 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 82.8 p -148.04 166.43 27.79 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.632 0.773 . . . . 0.0 109.31 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 3.4 mt -105.47 149.51 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 177.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -99.1 -44.95 6.09 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.653 0.781 . . . . 0.0 112.29 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 66.9 p-90 -163.63 155.12 16.79 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.15 1.78 . . . . 0.0 107.51 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 59.1 t -151.96 131.54 3.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 C-N-CA 125.565 1.546 . . . . 0.0 107.479 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.78 163.43 36.73 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.185 0.902 . . . . 0.0 111.848 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -77.74 129.07 35.03 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 104.02 -2.585 . . . . 0.0 104.02 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' THR . . . . . 0.435 HG23 ' HG3' ' A' ' 225' ' ' LYS . 9.8 t -108.55 -28.33 9.37 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.886 1.275 . . . . 0.0 113.089 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.435 ' HG3' HG23 ' A' ' 224' ' ' THR . 59.1 mttt -135.9 -176.05 4.17 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 124.468 1.107 . . . . 0.0 108.621 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 68.9 mt -47.86 -47.49 12.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.591 -0.732 . . . . 0.0 112.365 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 3.7 t -133.06 18.08 4.11 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.131 1.373 . . . . 0.0 111.372 -178.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 22.0 t -114.96 142.48 27.64 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -178.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -121.29 162.94 19.38 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.202 1.401 . . . . 0.0 107.226 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -135.47 143.57 45.93 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 179.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -142.8 150.14 39.57 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -137.6 122.41 18.79 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 104.33 -2.47 . . . . 0.0 104.33 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 3.5 m -119.09 150.74 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -178.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.3 p -120.94 132.82 55.17 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.149 0.98 . . . . 0.0 111.608 -178.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 6.6 pt -138.32 154.85 74.09 Favored Pre-proline 0 N--CA 1.453 -0.278 0 C-N-CA 125.317 1.447 . . . . 0.0 109.205 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -76.08 -49.93 0.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.256 2.638 . . . . 0.0 112.296 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -53.01 -15.83 0.9 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 118.002 2.593 . . . . 0.0 118.002 -176.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 22.9 mt -77.52 -26.89 51.51 Favored 'General case' 0 CA--C 1.517 -0.308 0 O-C-N 120.958 -1.089 . . . . 0.0 109.648 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 5.8 m -56.13 -21.37 22.07 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.112 0.965 . . . . 0.0 111.724 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -59.49 -36.07 75.34 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.635 1.174 . . . . 0.0 109.347 178.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.58 125.2 30.24 Favored 'General case' 0 CA--C 1.521 -0.164 0 O-C-N 120.941 -1.1 . . . . 0.0 108.322 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -47.49 -48.83 26.94 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -178.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.419 ' HB3' ' CD2' ' A' ' 181' ' ' TYR . 22.5 mt -68.58 -26.87 65.6 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -178.22 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 13.8 mt -91.97 -13.47 31.02 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.219 0.608 . . . . 0.0 112.291 -178.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -58.15 141.83 49.15 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 128.283 2.633 . . . . 0.0 113.061 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp . . . . . 0 C--N 1.33 -0.257 0 C-N-CA 127.659 2.383 . . . . 0.0 110.093 179.532 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.549 HG22 HD12 ' A' ' 98' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--O 1.233 0.222 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.89 -39.26 93.78 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 56.4 tp -63.58 -38.26 90.46 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.549 HD12 HG22 ' A' ' 95' ' ' THR . 64.8 mt -59.37 -54.55 45.45 Favored 'General case' 0 C--N 1.345 0.381 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.0 m -64.06 -45.98 86.38 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.889 0.476 . . . . 0.0 111.755 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.54 -47.61 79.07 Favored 'General case' 0 CA--C 1.516 -0.362 0 O-C-N 121.397 -0.815 . . . . 0.0 109.632 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 91.7 m -55.15 -47.3 75.31 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.358 0.663 . . . . 0.0 110.703 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -56.73 -47.0 80.97 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 123.438 0.462 . . . . 0.0 110.007 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.37 -56.93 6.05 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.854 0.835 . . . . 0.0 112.52 -178.386 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -56.96 -42.04 79.41 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 125.058 1.343 . . . . 0.0 110.651 -178.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.68 -52.79 39.53 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-O 117.673 -1.626 . . . . 0.0 109.594 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.452 ' HA ' HD12 ' A' ' 109' ' ' ILE . 50.8 t -55.89 -45.62 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 120.155 1.978 . . . . 0.0 110.485 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.2 pttp -61.3 -35.83 78.43 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.193 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 51.8 m -75.14 -36.69 61.54 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.898 0.879 . . . . 0.0 110.301 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.452 HD12 ' HA ' ' A' ' 106' ' ' VAL . 20.0 mt -59.17 -55.04 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -60.0 -34.22 73.03 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 124.066 0.854 . . . . 0.0 111.726 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -63.42 -37.75 88.51 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -178.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.8 mmmt -86.07 -42.79 13.64 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 19.2 mt -61.73 -29.19 69.95 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-O 117.808 -1.092 . . . . 0.0 111.685 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -47.83 -30.79 4.32 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.704 2.002 . . . . 0.0 111.807 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -64.85 -70.34 0.24 Allowed 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 122.813 0.445 . . . . 0.0 111.544 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -145.35 -178.62 6.16 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.628 1.171 . . . . 0.0 112.275 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 60.2 m -86.82 171.2 11.05 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 27.3 pt -121.91 160.35 23.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 127.087 2.155 . . . . 0.0 107.41 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -156.4 134.8 11.47 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.043 0.537 . . . . 0.0 111.957 -178.094 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -132.09 121.21 23.45 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.65 0.78 . . . . 0.0 110.562 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -87.95 99.44 12.14 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.41 80.71 6.72 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 127.363 2.265 . . . . 0.0 108.952 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.17 -111.53 4.08 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 108.158 -1.977 . . . . 0.0 108.158 -179.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -85.88 -24.4 26.67 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -100.53 159.4 15.18 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 119.551 1.069 . . . . 0.0 111.851 -178.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.2 mp -132.73 140.9 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.456 ' CD1' HG11 ' A' ' 221' ' ' VAL . 88.5 m-85 -121.72 119.55 32.09 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -107.5 116.44 31.94 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.189 0.595 . . . . 0.0 110.087 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -109.27 129.19 55.52 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 122.03 -0.419 . . . . 0.0 110.673 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.41 ' HB3' HD13 ' A' ' 133' ' ' ILE . 52.3 m -110.95 155.9 41.68 Favored Pre-proline 0 N--CA 1.446 -0.641 0 C-N-CA 127.266 2.226 . . . . 0.0 113.312 -178.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.26 70.75 0.15 Allowed 'Trans proline' 0 CA--C 1.542 0.904 1 C-N-CA 125.647 4.231 . . . . 0.0 114.717 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 68.57 57.51 8.06 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 120.466 -1.396 . . . . 0.0 110.911 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.41 HD13 ' HB3' ' A' ' 130' ' ' CYS . 2.0 mp -124.65 -71.72 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.303 0 CA-C-N 118.333 1.067 . . . . 0.0 109.251 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -175.21 138.29 0.42 Allowed 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -109.8 125.22 52.5 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.984 0.811 . . . . 0.0 109.722 -176.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 20.0 m -142.9 163.97 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.795 1.238 . . . . 0.0 111.637 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -122.13 129.6 52.48 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.222 1.409 . . . . 0.0 108.266 178.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -139.13 162.96 33.67 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.017 0.927 . . . . 0.0 112.074 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 53.1 t60 -84.85 160.87 20.1 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 177.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.653 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 -179.517 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 . . . . . 0 CA--C 1.516 -0.335 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -140.86 134.01 29.46 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 58.7 mt -119.92 -26.25 5.65 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 125.286 1.616 . . . . 0.0 108.031 178.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 156.13 154.61 7.05 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 119.543 1.065 . . . . 0.0 111.096 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -117.57 109.95 41.23 Favored Pre-proline 0 C--O 1.236 0.347 0 C-N-CA 124.138 0.975 . . . . 0.0 108.412 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -73.3 -169.44 0.52 Allowed 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 124.003 3.135 . . . . 0.0 109.445 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -126.86 156.32 41.55 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.833 1.253 . . . . 0.0 108.549 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.44 -45.29 39.61 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.361 0.664 . . . . 0.0 111.247 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -74.9 65.75 1.45 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.602 1.561 . . . . 0.0 111.518 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.3 p -45.55 -35.09 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 124.762 1.225 . . . . 0.0 112.52 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -63.9 -36.43 83.91 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -178.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -74.31 -15.84 60.95 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.746 0.819 . . . . 0.0 113.046 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 20.5 mtp-105 -78.22 178.17 7.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 122.096 0.951 . . . . 0.0 110.097 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -127.27 144.6 51.01 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 178.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -132.22 165.95 22.97 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -123.89 147.74 47.42 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 16.0 tp -114.58 98.06 6.66 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -112.25 -179.26 3.63 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 127.856 2.463 . . . . 0.0 106.757 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -149.4 165.22 32.72 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.617 0.722 . . . . 0.0 109.446 178.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -135.88 179.64 6.22 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 126.654 1.981 . . . . 0.0 110.513 -178.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.26 -18.75 63.89 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.904 1.282 . . . . 0.0 109.656 178.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 25.6 t -87.24 -25.3 6.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 129.771 3.228 . . . . 0.0 111.805 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 132.87 -167.95 23.07 Favored Glycine 0 N--CA 1.444 -0.779 0 O-C-N 121.279 -0.888 . . . . 0.0 111.701 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -77.71 163.31 26.29 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 121.841 -0.8 . . . . 0.0 110.367 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -160.73 167.36 27.03 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.635 1.174 . . . . 0.0 111.082 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 83.9 mt -106.15 138.28 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 17.4 t -113.01 135.15 54.09 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.041 0.937 . . . . 0.0 109.052 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -127.22 110.88 13.32 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 125.815 1.646 . . . . 0.0 108.57 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -93.52 111.49 24.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 7.5 mt -98.45 108.28 21.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 179.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -94.63 -153.28 30.14 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 66.6 m 66.19 54.73 0.94 Allowed 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.208 1.003 . . . . 0.0 112.912 178.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.423 ' HA3' ' HB3' ' A' ' 200' ' ' ARG . . . -102.02 -137.84 9.83 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.066 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -140.58 128.8 22.32 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 177.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 28.8 mm -60.21 132.3 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 121.911 0.862 . . . . 0.0 111.743 -178.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 3.0 m -84.92 111.34 19.58 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 128.101 2.56 . . . . 0.0 109.245 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.76 -19.58 11.73 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.125 1.77 . . . . 0.0 113.774 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 60.9 t -56.62 -51.75 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 124.652 1.181 . . . . 0.0 110.33 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 13.9 t -125.12 -25.1 3.89 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 99.0 35.51 4.79 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 107.556 -2.218 . . . . 0.0 107.556 -178.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -103.98 152.52 21.91 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 118.519 1.16 . . . . 0.0 113.732 -178.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -78.42 138.94 38.74 Favored 'General case' 0 C--N 1.335 -0.052 0 C-N-CA 124.025 0.93 . . . . 0.0 109.152 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.423 ' HB3' ' HA3' ' A' ' 190' ' ' GLY 0.3 34.3 ttt180 -69.94 30.52 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 130.705 3.602 . . . . 0.0 113.598 178.953 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 5.2 ptm -74.18 171.92 12.71 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.056 -1.028 . . . . 0.0 109.216 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.77 148.79 22.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 C-N-CA 124.679 1.191 . . . . 0.0 107.819 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -110.17 116.39 31.43 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 14.4 mm -103.97 141.08 20.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -124.43 110.09 14.1 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 126.067 1.747 . . . . 0.0 109.774 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -87.31 110.85 20.51 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.479 1.111 . . . . 0.0 108.875 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 11.2 m -123.11 163.66 21.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 46.1 t -88.07 146.58 25.38 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -97.86 16.91 59.62 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-O 117.914 -1.492 . . . . 0.0 113.057 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.077 0 C-N-CA 126.646 2.07 . . . . 0.0 113.875 179.507 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo . . . . . 0 CA--C 1.539 0.753 0 N-CA-C 110.145 -0.752 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 4.6 p -166.88 148.27 6.02 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 127.055 2.142 . . . . 0.0 107.34 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 10.4 p -154.39 165.97 34.72 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.182 1.393 . . . . 0.0 109.556 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 4.9 mt -108.54 153.81 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 126.567 1.947 . . . . 0.0 106.592 178.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -101.1 -52.21 3.33 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 123.44 0.696 . . . . 0.0 110.484 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 58.9 p-90 -157.07 157.32 34.36 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -178.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.456 HG11 ' CD1' ' A' ' 127' ' ' TYR . 91.3 t -153.16 122.56 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -178.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.22 167.5 29.6 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.511 1.05 . . . . 0.0 110.784 178.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -73.07 132.05 42.85 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 6.7 t -109.35 -38.59 5.45 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.427 1.091 . . . . 0.0 110.22 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 6.7 mttt -130.92 178.57 6.57 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 73.1 mt -49.51 -46.98 20.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -126.19 22.32 7.24 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 6.5 t -122.86 138.64 52.25 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.545 0 O-C-N 121.191 -0.943 . . . . 0.0 110.081 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -120.97 162.26 20.2 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -132.53 145.71 51.35 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.24 119.36 8.26 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.218 1.007 . . . . 0.0 108.471 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -107.36 126.93 53.08 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 4.0 m -118.14 154.38 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-N 117.717 0.235 . . . . 0.0 110.797 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 2.3 p -121.56 124.82 45.31 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.33 1.052 . . . . 0.0 110.911 -177.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 2.3 pt -136.84 129.49 17.29 Favored Pre-proline 0 N--CA 1.444 -0.728 0 CA-C-N 114.922 -1.035 . . . . 0.0 108.831 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -64.85 -31.12 57.82 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.065 2.51 . . . . 0.0 113.388 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -64.25 -14.13 53.74 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -177.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 44.6 mt -76.88 -31.03 56.48 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 120.475 -1.391 . . . . 0.0 109.908 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 15.6 m -55.88 -12.06 1.24 Allowed 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -70.42 -32.04 69.48 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 121.497 -0.752 . . . . 0.0 110.043 179.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.9 mt -80.71 123.16 27.96 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.669 1.988 . . . . 0.0 106.671 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -47.51 -48.09 27.44 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.074 1.349 . . . . 0.0 114.081 -178.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 56.1 mt -66.65 -32.53 73.91 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 119.298 0.954 . . . . 0.0 112.847 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 15.9 mt -91.68 -5.57 53.53 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -65.31 134.42 53.54 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 127.55 2.34 . . . . 0.0 110.3 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt . . . . . 0 CA--C 1.511 -0.554 0 C-N-CA 125.214 1.406 . . . . 0.0 111.146 179.872 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 CA--C 1.522 -0.133 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.54 -43.63 84.53 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 53.1 tp -68.28 -36.7 79.79 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-O 118.459 -0.782 . . . . 0.0 109.401 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.456 HD23 HD11 ' A' ' 243' ' ' LEU . 60.5 mt -60.26 -54.69 42.78 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 118.935 0.789 . . . . 0.0 109.694 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 50.9 m -58.78 -49.12 78.87 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.314 1.046 . . . . 0.0 109.845 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.22 -44.69 96.86 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 118.095 -0.955 . . . . 0.0 110.905 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 63.0 m -52.33 -49.3 64.54 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 119.286 0.948 . . . . 0.0 110.682 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -55.38 -50.73 68.94 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 122.744 0.417 . . . . 0.0 110.101 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.36 -55.49 15.63 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 115.151 1.538 . . . . 0.0 115.151 -178.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -64.94 -38.1 89.84 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.497 1.119 . . . . 0.0 110.648 -177.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.551 ' HA3' HD11 ' A' ' 183' ' ' ILE . . . -61.03 -52.57 51.42 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.526 ' HA ' HD12 ' A' ' 109' ' ' ILE . 54.2 t -57.37 -44.88 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 118.671 1.236 . . . . 0.0 109.72 178.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -61.7 -35.78 79.02 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 118.53 -1.268 . . . . 0.0 111.643 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 59.3 m -65.64 -46.43 79.22 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -178.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 106' ' ' VAL . 19.3 mt -56.92 -54.96 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 CA-C-O 121.568 0.699 . . . . 0.0 109.738 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -64.61 -27.81 69.19 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -62.61 -42.73 99.75 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -83.25 -43.16 16.37 Favored 'General case' 0 C--N 1.341 0.234 0 O-C-N 121.278 -0.889 . . . . 0.0 113.038 -179.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.4 mt -62.87 -27.38 69.31 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.099 0.863 . . . . 0.0 113.243 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -44.38 -33.86 1.8 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.484 1.514 . . . . 0.0 113.825 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -64.43 -69.5 0.28 Allowed 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.909 1.283 . . . . 0.0 113.944 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 -140.07 172.58 12.55 Favored 'General case' 0 CA--C 1.518 -0.27 0 O-C-N 121.097 -1.002 . . . . 0.0 112.979 -177.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 37.7 m -87.13 160.7 18.45 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 178.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 34.9 pt -114.37 157.03 15.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 124.906 1.282 . . . . 0.0 107.544 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -151.4 134.29 15.75 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 123.801 0.84 . . . . 0.0 109.263 -178.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.615 ' CE1' ' HB2' ' A' ' 122' ' ' ALA . 21.7 t80 -133.16 120.95 21.87 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 123.741 0.817 . . . . 0.0 111.615 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -84.48 101.41 12.02 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.542 1.137 . . . . 0.0 108.614 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.615 ' HB2' ' CE1' ' A' ' 120' ' ' TYR . . . -94.75 80.34 3.76 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.04 -124.65 20.51 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -70.97 -31.2 67.69 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 48.0 m95 -99.83 152.02 20.61 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 118.546 0.612 . . . . 0.0 110.344 -178.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.7 mp -125.15 144.73 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 104.481 -2.415 . . . . 0.0 104.481 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -122.12 119.68 32.04 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -178.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -113.63 126.51 55.35 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.918 0.887 . . . . 0.0 109.091 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -124.98 126.77 45.97 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.424 0.69 . . . . 0.0 109.801 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.461 ' HB3' HD13 ' A' ' 133' ' ' ILE . 15.0 m -104.46 155.96 36.57 Favored Pre-proline 0 CA--C 1.532 0.257 0 C-N-CA 123.929 0.892 . . . . 0.0 111.47 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -63.13 83.25 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 124.385 3.39 . . . . 0.0 114.597 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.38 42.96 63.81 Favored Glycine 0 CA--C 1.526 0.77 0 O-C-N 120.776 -1.202 . . . . 0.0 113.079 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.461 HD13 ' HB3' ' A' ' 130' ' ' CYS . 3.6 mp -122.7 -70.25 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -161.86 168.52 22.9 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.849 1.259 . . . . 0.0 110.611 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -132.42 126.84 34.07 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 104.459 -2.422 . . . . 0.0 104.459 177.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.2 m -144.81 164.17 13.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 124.999 1.32 . . . . 0.0 112.321 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -130.24 118.77 21.86 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -137.9 162.82 33.04 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.871 1.668 . . . . 0.0 111.23 -178.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -94.08 148.29 22.32 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.524 0 C-N-CA 125.301 1.429 . . . . 0.0 110.343 -179.69 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 . . . . . 0 C--O 1.235 0.298 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -145.45 136.87 25.08 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 124.69 1.196 . . . . 0.0 107.926 178.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.1 mp -116.15 -27.74 6.8 Favored 'General case' 0 C--O 1.221 -0.444 0 O-C-N 125.486 1.741 . . . . 0.0 107.277 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 157.3 163.45 12.55 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -126.97 110.24 21.92 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 124.03 0.932 . . . . 0.0 111.428 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -71.96 177.57 6.91 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.907 3.071 . . . . 0.0 109.274 178.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -121.1 146.67 46.49 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.31 -45.94 76.3 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.171 1.388 . . . . 0.0 112.178 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -73.41 67.13 1.0 Allowed 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 127.581 2.353 . . . . 0.0 110.249 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.5 p -44.82 -32.74 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 O-C-N 121.196 -0.94 . . . . 0.0 113.385 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -65.25 -31.74 73.05 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 119.186 0.903 . . . . 0.0 111.671 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -71.74 -30.56 65.74 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 124.03 0.932 . . . . 0.0 110.049 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 25.7 mtt180 -69.08 152.46 45.17 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -114.06 143.12 45.29 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -129.63 168.06 17.02 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.159 1.384 . . . . 0.0 112.072 -177.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -133.62 154.67 50.71 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 124.884 1.274 . . . . 0.0 111.265 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 57.5 tp -109.23 98.63 8.03 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 127.28 2.232 . . . . 0.0 110.252 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.42 HD23 ' HB2' ' A' ' 184' ' ' SER . 2.1 mm? -112.17 -179.26 3.63 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 127.649 2.38 . . . . 0.0 108.581 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -141.7 166.29 25.15 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.188 0.518 . . . . 0.0 111.461 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -139.28 179.99 6.21 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 127.313 2.245 . . . . 0.0 108.39 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -57.4 -19.25 22.11 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.477 1.111 . . . . 0.0 112.389 -178.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 40.7 t -92.6 -54.84 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 O-C-N 120.651 -1.281 . . . . 0.0 110.43 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 178.7 -153.52 12.78 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -178.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.405 ' CD2' HD13 ' A' ' 243' ' ' LEU . 6.3 m-30 -86.64 168.79 13.29 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 122.43 1.109 . . . . 0.0 110.772 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -158.57 176.09 12.84 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.014 1.725 . . . . 0.0 109.559 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.551 HD11 ' HA3' ' A' ' 105' ' ' GLY . 89.3 mt -110.95 138.27 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 176.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.42 ' HB2' HD23 ' A' ' 175' ' ' LEU . 14.2 t -100.96 128.53 46.95 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -129.15 110.03 11.66 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -92.42 135.66 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 104.604 -2.369 . . . . 0.0 104.604 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 3.8 mt -112.74 106.2 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 104.782 -2.303 . . . . 0.0 104.782 176.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -99.32 -155.49 28.65 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.5 t 68.72 56.19 0.45 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-O 122.516 1.151 . . . . 0.0 111.766 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -131.82 157.07 22.23 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 128.401 2.905 . . . . 0.0 106.396 177.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -72.62 150.91 42.64 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.219 1.007 . . . . 0.0 112.273 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.9 mm -65.99 136.23 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-O 121.274 0.559 . . . . 0.0 110.379 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.5 m -79.87 115.52 19.5 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.707 2.003 . . . . 0.0 106.979 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -55.06 -21.7 13.39 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.863 1.265 . . . . 0.0 112.957 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 31.6 t -51.44 -61.16 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.205 0 C-N-CA 126.966 2.106 . . . . 0.0 112.24 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' THR . . . . . 0.544 HG22 HG21 ' A' ' 226' ' ' ILE . 5.1 t -125.69 -24.12 3.9 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.318 1.047 . . . . 0.0 113.762 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 105.61 34.87 3.2 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -178.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -98.91 149.72 22.65 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 118.851 1.326 . . . . 0.0 112.112 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -74.71 141.04 44.52 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.942 0.897 . . . . 0.0 110.737 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -66.64 27.71 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 131.269 3.828 . . . . 0.0 113.882 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 8.2 ptm -75.14 177.09 6.7 Favored 'General case' 0 C--N 1.319 -0.743 0 O-C-N 120.788 -1.195 . . . . 0.0 111.787 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.0 p -147.18 153.62 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 126.612 1.965 . . . . 0.0 106.408 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -116.77 117.63 30.3 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.801 1.24 . . . . 0.0 108.324 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 9.2 mm -102.25 148.53 7.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -126.09 103.73 7.87 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 128.274 2.63 . . . . 0.0 108.97 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' TYR . . . . . 0.432 ' CD1' HD13 ' A' ' 109' ' ' ILE . 35.0 m-85 -83.25 109.8 17.54 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.967 1.307 . . . . 0.0 108.706 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 5.8 m -125.17 163.4 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 47.5 t -84.76 139.83 31.69 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 178.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -86.97 -0.07 85.87 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 118.369 -1.239 . . . . 0.0 112.7 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.678 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 -178.72 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo . . . . . 0 N--CA 1.454 -0.806 0 CA-C-O 120.085 -0.048 . . . . 0.0 112.003 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.7 p -158.66 148.94 19.78 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.283 1.433 . . . . 0.0 108.751 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 1.7 p -152.62 170.51 20.04 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.423 1.089 . . . . 0.0 110.365 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 4.8 mt -113.17 154.37 14.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 126.406 1.883 . . . . 0.0 107.291 178.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -104.38 -46.6 4.35 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.886 0.875 . . . . 0.0 111.527 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -160.93 155.63 23.71 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.972 1.709 . . . . 0.0 107.781 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 59.9 t -154.05 123.56 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 125.68 1.592 . . . . 0.0 106.999 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -154.13 161.68 41.71 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 118.913 0.779 . . . . 0.0 111.21 179.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -69.18 136.99 52.9 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' THR . . . . . 0.636 HG23 ' HG3' ' A' ' 225' ' ' LYS . 2.0 t -119.2 -28.75 5.37 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.199 1.0 . . . . 0.0 111.866 -179.041 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.636 ' HG3' HG23 ' A' ' 224' ' ' THR . 7.5 mttm -134.98 -176.66 4.32 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 124.123 0.969 . . . . 0.0 108.709 178.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.544 HG21 HG22 ' A' ' 196' ' ' THR . 1.9 mm -50.41 -48.98 25.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 123.346 0.659 . . . . 0.0 112.133 -178.264 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -128.13 23.56 6.04 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.373 1.469 . . . . 0.0 111.63 -178.162 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 14.1 t -127.47 146.37 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 CA-C-O 122.045 0.926 . . . . 0.0 110.367 -178.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -126.14 161.84 26.73 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 230' ' ' GLU . . . . . 0.48 ' CD ' HG21 ' A' ' 224' ' ' THR . 10.9 mt-10 -134.35 141.32 46.85 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -140.09 140.12 36.01 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 125.31 1.444 . . . . 0.0 110.233 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -120.47 114.35 21.65 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 2.5 m -107.87 148.1 12.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.4 p -122.17 135.93 54.84 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 123.567 0.747 . . . . 0.0 111.927 -178.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -140.6 152.25 65.68 Favored Pre-proline 0 N--CA 1.451 -0.402 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.074 177.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -74.91 -50.86 0.13 Allowed 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.496 2.797 . . . . 0.0 111.995 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -52.98 -27.13 17.69 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 117.606 -1.188 . . . . 0.0 113.911 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 238' ' ' LEU . 9.8 tp -59.23 -25.39 63.98 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 120.538 1.517 . . . . 0.0 112.258 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 3.4 m -64.74 -9.2 18.47 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.805 0.842 . . . . 0.0 111.963 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 42.5 p-10 -60.29 -40.3 89.95 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 125.337 1.455 . . . . 0.0 109.418 178.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -83.7 123.91 30.32 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 124.78 1.232 . . . . 0.0 108.591 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -47.18 -47.89 23.93 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.749 2.02 . . . . 0.0 113.31 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.456 HD11 HD23 ' A' ' 98' ' ' LEU . 40.6 mt -65.6 -20.09 66.17 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -178.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 5.2 mt -107.1 -11.75 15.56 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.176 1.39 . . . . 0.0 112.249 -178.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -63.29 131.12 47.3 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 128.479 2.712 . . . . 0.0 110.082 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt . . . . . 0 N--CA 1.465 0.285 0 C-N-CA 124.237 1.015 . . . . 0.0 110.017 179.764 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.211 0.053 . . . . 0.0 111.012 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.54 -43.4 89.24 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 13.0 tp -69.71 -36.18 75.7 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.239 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.561 HD23 HD11 ' A' ' 243' ' ' LEU . 62.3 mt -59.13 -54.72 43.83 Favored 'General case' 0 C--N 1.343 0.288 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 20.7 m -65.37 -42.29 92.88 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 121.559 -0.713 . . . . 0.0 110.938 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.29 -42.4 95.39 Favored 'General case' 0 C--N 1.341 0.214 0 O-C-N 120.874 -1.141 . . . . 0.0 110.472 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 80.3 m -56.59 -46.45 80.81 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.776 0.83 . . . . 0.0 109.805 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -59.79 -45.14 93.25 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 118.233 0.47 . . . . 0.0 110.604 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -65.19 -61.11 2.33 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 122.26 1.029 . . . . 0.0 112.013 -178.304 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -62.3 -36.89 83.53 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.369 -178.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -65.6 -53.35 32.18 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-O 118.114 -1.381 . . . . 0.0 110.149 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.646 ' HA ' HD12 ' A' ' 109' ' ' ILE . 45.4 t -58.28 -44.16 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 119.913 1.857 . . . . 0.0 109.957 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.7 ptmt -64.74 -32.94 74.85 Favored 'General case' 0 C--O 1.226 -0.168 0 C-N-CA 119.604 -0.839 . . . . 0.0 111.695 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.6 m -76.08 -33.78 59.53 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 123.441 0.696 . . . . 0.0 109.738 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.646 HD12 ' HA ' ' A' ' 106' ' ' VAL . 16.6 mt -62.75 -55.52 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 178.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -61.92 -28.57 69.62 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 117.948 -1.025 . . . . 0.0 112.39 -179.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.64 -38.16 86.68 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.963 1.256 . . . . 0.0 112.656 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.416 ' HE3' ' CD ' ' A' ' 237' ' ' GLU . 0.6 OUTLIER -95.48 -37.48 10.88 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.491 -0.755 . . . . 0.0 110.847 179.538 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 15.8 mt -62.64 -28.35 69.86 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 118.66 0.664 . . . . 0.0 110.734 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -50.15 -34.71 23.23 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.613 1.165 . . . . 0.0 113.536 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -55.5 -61.74 2.15 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.735 1.214 . . . . 0.0 112.554 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -151.61 174.59 13.27 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.86 1.664 . . . . 0.0 110.761 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 56.7 m -86.61 170.94 11.4 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 114.006 -1.452 . . . . 0.0 108.684 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 29.6 pt -127.78 162.82 32.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 126.272 1.829 . . . . 0.0 109.004 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.72 145.28 22.24 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -136.87 125.7 24.09 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -88.88 108.04 19.32 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.075 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.37 80.3 3.93 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 178.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 58.75 -107.92 1.35 Allowed Glycine 0 CA--C 1.53 0.989 0 O-C-N 121.807 -0.558 . . . . 0.0 111.713 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -81.47 -17.88 47.2 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.546 1.938 . . . . 0.0 113.715 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 65.8 m95 -111.88 157.39 20.68 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 123.406 0.682 . . . . 0.0 110.121 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.2 mp -133.3 136.84 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -113.33 129.95 56.4 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -121.55 125.61 47.19 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 123.682 0.793 . . . . 0.0 110.885 -178.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -124.77 129.94 51.43 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.899 0.857 . . . . 0.0 110.63 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.524 ' HB3' HD13 ' A' ' 133' ' ' ILE . 2.1 m -111.18 156.41 41.07 Favored Pre-proline 0 C--N 1.33 -0.262 0 C-N-CA 125.303 1.441 . . . . 0.0 110.314 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -64.36 82.04 0.16 Allowed 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.775 2.983 . . . . 0.0 114.097 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 69.79 50.14 31.8 Favored Glycine 0 CA--C 1.533 1.209 0 O-C-N 120.785 -1.197 . . . . 0.0 113.683 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.524 HD13 ' HB3' ' A' ' 130' ' ' CYS . 3.4 mp -125.18 -68.28 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 119.042 1.421 . . . . 0.0 108.508 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -165.72 159.3 16.14 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 124.906 1.282 . . . . 0.0 109.213 179.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -122.96 123.07 40.08 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 104.554 -2.387 . . . . 0.0 104.554 176.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 16.6 m -143.37 163.98 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 123.485 0.714 . . . . 0.0 110.654 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -123.77 117.91 25.99 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -139.76 163.37 32.79 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 118.937 0.79 . . . . 0.0 112.039 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -90.07 154.99 19.37 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.273 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.468 0 O-C-N 120.674 -1.266 . . . . 0.0 111.583 179.61 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 . . . . . 0 N--CA 1.466 0.363 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.96 104.94 3.48 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.697 1.199 . . . . 0.0 109.414 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.3 mp -90.99 -28.59 17.91 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 162.76 156.77 8.68 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.7 mtpt -122.29 110.06 32.77 Favored Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 123.697 0.799 . . . . 0.0 108.997 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -79.73 170.12 17.34 Favored 'Trans proline' 0 N--CA 1.456 -0.698 1 C-N-CA 125.736 4.291 . . . . 0.0 109.133 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -105.7 159.72 15.76 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 123.036 0.534 . . . . 0.0 110.703 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -72.99 -43.39 62.25 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -73.39 64.01 0.8 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.416 1.486 . . . . 0.0 110.279 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.4 p -53.51 -29.48 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 O-C-N 120.653 -1.279 . . . . 0.0 110.821 178.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -63.13 -28.04 69.79 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.897 1.679 . . . . 0.0 112.748 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -88.57 -19.78 25.88 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 125.405 1.482 . . . . 0.0 112.462 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -77.77 154.68 31.74 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -107.85 149.45 28.25 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -137.13 173.99 11.09 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 126.681 1.992 . . . . 0.0 109.24 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -132.99 153.93 50.99 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.411 1.085 . . . . 0.0 110.455 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 25.1 tp -115.05 98.55 6.87 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 127.03 2.132 . . . . 0.0 108.53 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -110.09 -178.88 3.63 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.33 1.452 . . . . 0.0 110.079 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -135.22 153.85 51.79 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.952 0.901 . . . . 0.0 109.04 177.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -130.46 175.41 8.99 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 128.087 2.555 . . . . 0.0 107.866 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -56.76 -16.86 7.26 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 129.099 2.96 . . . . 0.0 111.252 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 67.4 t -99.55 -50.42 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 126.803 2.041 . . . . 0.0 108.859 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 170.04 -161.46 34.65 Favored Glycine 0 C--N 1.336 0.553 0 CA-C-N 119.1 0.864 . . . . 0.0 112.339 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 -77.16 156.0 31.89 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 117.751 0.776 . . . . 0.0 110.891 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -157.35 166.63 32.54 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.21 1.004 . . . . 0.0 112.03 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 96.6 mt -105.34 142.06 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 15.9 t -111.24 138.58 47.52 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.238 1.415 . . . . 0.0 107.849 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -130.06 109.3 10.74 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 124.606 1.162 . . . . 0.0 108.402 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.8 mp -93.77 117.47 37.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 6.4 mt -108.12 106.38 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -125.01 142.82 14.14 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 108.111 -1.996 . . . . 0.0 108.111 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 22.7 t 162.83 25.21 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 129.949 3.3 . . . . 0.0 106.968 -178.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -99.0 159.31 20.12 Favored Glycine 0 CA--C 1.505 -0.549 0 O-C-N 120.328 -1.482 . . . . 0.0 111.55 -178.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.44 167.17 15.28 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 178.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 35.0 mm -84.07 135.82 24.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 O-C-N 121.177 -0.952 . . . . 0.0 111.955 -178.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -81.51 104.32 11.85 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 177.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -50.94 -31.69 18.51 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.553 1.141 . . . . 0.0 111.593 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.441 HG23 ' H ' ' A' ' 195' ' ' VAL . 18.8 t -47.77 -47.33 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 128.72 2.808 . . . . 0.0 112.752 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 7.5 t -124.51 -39.69 2.29 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 110.57 36.16 1.95 Allowed Glycine 0 C--N 1.335 0.512 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -178.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -128.24 154.16 46.16 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 118.995 1.397 . . . . 0.0 110.567 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -66.16 168.26 8.79 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.102 0.561 . . . . 0.0 110.204 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -87.75 30.8 0.8 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 130.259 3.424 . . . . 0.0 110.335 177.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 5.9 ptm -72.58 175.42 6.36 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 120.576 -1.327 . . . . 0.0 111.815 -177.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.1 p -139.93 152.04 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 125.215 1.406 . . . . 0.0 109.19 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -114.27 104.08 11.72 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.511 1.924 . . . . 0.0 107.179 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 13.4 mm -91.69 143.7 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -124.72 99.31 6.1 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.624 1.57 . . . . 0.0 107.118 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' TYR . . . . . 0.52 ' CD1' HD13 ' A' ' 109' ' ' ILE . 25.8 m-85 -78.86 110.2 13.83 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 179.165 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 4.5 m -123.8 160.58 27.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 124.649 1.18 . . . . 0.0 108.678 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 53.5 t -82.41 141.26 32.92 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 179.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -90.16 3.34 82.33 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-O 118.421 -1.21 . . . . 0.0 114.916 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.585 0 C-N-CA 124.688 1.137 . . . . 0.0 111.967 -179.204 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo . . . . . 0 CA--C 1.536 0.585 0 N-CA-C 114.624 0.971 . . . . 0.0 114.624 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 216' ' ' SER . . . . . 0.431 ' CB ' HG22 ' A' ' 235' ' ' ILE . 4.9 p -173.46 156.28 3.0 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.021 -1.049 . . . . 0.0 113.245 -177.393 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 20.5 p -155.31 172.95 17.34 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.892 1.277 . . . . 0.0 108.255 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 7.5 mt -114.77 148.12 17.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 126.399 1.88 . . . . 0.0 108.465 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -89.37 -51.69 5.42 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.959 0.903 . . . . 0.0 110.961 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 64.8 p-90 -161.53 160.81 29.52 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.42 1.888 . . . . 0.0 107.189 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 88.0 t -148.92 127.89 3.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 125.586 1.555 . . . . 0.0 107.361 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -158.77 159.4 35.13 Favored 'General case' 0 C--O 1.239 0.522 0 O-C-N 121.392 -0.818 . . . . 0.0 112.012 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -67.48 135.12 52.56 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 177.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 8.8 t -109.51 -36.64 5.92 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.86 -0.525 . . . . 0.0 111.138 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 14.5 mttt -129.22 -175.48 3.58 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 124.274 1.03 . . . . 0.0 108.625 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 73.3 mt -51.19 -41.9 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -133.1 9.89 4.14 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.154 0.982 . . . . 0.0 112.453 -178.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 15.0 t -109.28 142.49 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.683 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -177.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -119.76 158.91 25.56 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.216 1.406 . . . . 0.0 107.586 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -136.38 141.86 43.71 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -144.61 121.04 10.99 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.339 1.056 . . . . 0.0 111.337 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -95.05 110.08 22.05 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 105.523 -2.029 . . . . 0.0 105.523 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 61.9 t -101.41 129.5 52.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -114.73 122.02 45.13 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.101 1.36 . . . . 0.0 111.913 -178.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.431 HG22 ' CB ' ' A' ' 216' ' ' SER . 10.8 pt -132.3 139.26 34.3 Favored Pre-proline 0 N--CA 1.453 -0.312 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -66.84 -34.63 29.91 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 121.762 1.641 . . . . 0.0 111.37 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' GLU . . . . . 0.416 ' CD ' ' HE3' ' A' ' 112' ' ' LYS . 75.4 mm-40 -54.53 -32.66 58.64 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 126.571 1.949 . . . . 0.0 115.023 -178.203 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.427 HD11 ' HB3' ' A' ' 206' ' ' TYR . 43.5 mt -59.91 -29.47 68.38 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.766 1.166 . . . . 0.0 112.353 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 33.8 m -59.04 -11.85 4.01 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.938 0.895 . . . . 0.0 112.471 179.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -59.87 -25.68 65.25 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 118.668 -0.682 . . . . 0.0 111.106 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -97.27 132.24 43.21 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.904 1.282 . . . . 0.0 108.15 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -46.99 -46.89 21.99 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.297 1.839 . . . . 0.0 112.062 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.561 HD11 HD23 ' A' ' 98' ' ' LEU . 69.1 mt -58.13 -45.25 87.66 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.512 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 6.0 mt -91.32 1.19 57.29 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.478 1.511 . . . . 0.0 113.221 -177.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -71.24 111.76 6.84 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.311 1.044 . . . . 0.0 108.935 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 5.5 mmmt . . . . . 0 C--O 1.24 0.586 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.543 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.407 ' HA ' HD12 ' A' ' 98' ' ' LEU . 1.1 p . . . . . 0 C--O 1.235 0.331 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.0 -35.94 80.03 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 42.1 tp -74.72 -36.79 62.69 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 121.281 -0.887 . . . . 0.0 109.425 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 95' ' ' THR . 86.9 mt -59.53 -55.66 31.71 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.433 1.093 . . . . 0.0 111.048 -179.024 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 37.0 m -68.69 -40.89 79.83 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.29 -0.881 . . . . 0.0 111.007 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.12 -42.95 91.81 Favored 'General case' 0 C--N 1.341 0.201 0 O-C-N 121.579 -0.701 . . . . 0.0 109.681 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 53.7 m -56.18 -49.19 74.73 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 123.848 0.859 . . . . 0.0 109.904 178.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -57.97 -49.22 77.57 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 122.405 0.282 . . . . 0.0 110.643 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -66.59 -59.61 3.46 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -177.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -60.37 -37.8 81.9 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 123.079 0.552 . . . . 0.0 110.415 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.98 -51.97 55.23 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.542 ' HA ' HD12 ' A' ' 109' ' ' ILE . 39.0 t -56.93 -43.64 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 119.538 1.669 . . . . 0.0 108.081 177.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.4 tttt -57.76 -39.05 76.49 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 122.11 -0.368 . . . . 0.0 110.583 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.6 m -70.37 -37.41 74.58 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 126.149 1.78 . . . . 0.0 110.342 -178.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.542 HD12 ' HA ' ' A' ' 106' ' ' VAL . 12.2 mt -63.92 -55.02 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -61.45 -28.23 69.13 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.801 -0.619 . . . . 0.0 112.48 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -64.26 -53.82 43.07 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.036 1.334 . . . . 0.0 109.962 178.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -80.36 -39.52 28.37 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.4 mt -61.04 -28.59 69.17 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 118.534 0.606 . . . . 0.0 112.338 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -51.34 -31.05 20.59 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -49.32 -72.01 0.06 Allowed 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.131 1.372 . . . . 0.0 112.92 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -149.06 178.67 8.5 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.529 1.532 . . . . 0.0 109.846 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 86.3 m -86.72 159.17 19.25 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 40.5 pt -115.44 160.65 14.69 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 C-N-CA 124.806 1.243 . . . . 0.0 110.021 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -156.07 149.03 24.21 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.649 -178.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.445 ' CE1' ' HB2' ' A' ' 122' ' ' ALA . 6.0 t80 -141.14 136.52 31.96 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.71 1.204 . . . . 0.0 110.633 178.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -95.04 102.37 14.17 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.733 1.213 . . . . 0.0 108.194 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.445 ' HB2' ' CE1' ' A' ' 120' ' ' TYR . . . -86.69 80.71 8.46 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 127.746 2.418 . . . . 0.0 106.622 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.65 -102.11 0.59 Allowed Glycine 0 CA--C 1.528 0.864 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -93.6 -20.15 20.48 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.667 1.187 . . . . 0.0 112.376 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 56.6 m95 -99.49 158.4 15.76 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 123.823 0.849 . . . . 0.0 111.0 -178.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.584 HD13 ' H ' ' A' ' 140' ' ' GLY . 4.6 mp -131.59 141.57 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 N-CA-C 104.912 -2.255 . . . . 0.0 104.912 178.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.5 ' CD1' HG11 ' A' ' 221' ' ' VAL . 68.9 m-85 -124.38 121.31 34.57 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 126.188 1.795 . . . . 0.0 107.983 -179.22 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -114.81 119.44 36.64 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 125.887 1.675 . . . . 0.0 110.716 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -111.54 135.74 51.7 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 13.3 m -117.18 153.76 49.88 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 123.69 0.796 . . . . 0.0 109.928 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -67.17 74.1 0.5 Allowed 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 125.142 3.895 . . . . 0.0 115.877 -177.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.35 39.11 9.29 Favored Glycine 0 CA--C 1.526 0.764 0 O-C-N 121.465 -0.772 . . . . 0.0 113.32 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 3.1 mp -121.06 -66.96 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 118.199 1.0 . . . . 0.0 109.239 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -167.46 169.12 12.45 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.19 1.396 . . . . 0.0 109.525 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -135.49 117.18 14.99 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 104.245 -2.502 . . . . 0.0 104.245 176.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 31.8 m -145.15 165.48 11.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 126.529 1.932 . . . . 0.0 109.644 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.41 ' HB3' ' CD1' ' A' ' 127' ' ' TYR . 18.0 pt20 -124.22 130.38 52.42 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 177.029 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -138.82 163.15 32.98 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.503 1.521 . . . . 0.0 109.373 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -93.59 108.41 20.13 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.584 ' H ' HD13 ' A' ' 126' ' ' ILE . . . . . . . . 0 CA--C 1.523 0.573 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 -179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 . . . . . 0 CA--C 1.528 0.103 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -147.73 137.14 22.46 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.2 mp -120.22 -30.93 4.52 Favored 'General case' 0 C--O 1.221 -0.4 0 C-N-CA 125.525 1.53 . . . . 0.0 108.315 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 167.28 162.41 18.96 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-N 119.61 1.095 . . . . 0.0 111.39 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm -125.54 108.31 26.34 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 124.78 1.232 . . . . 0.0 108.516 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -81.64 167.05 17.17 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.83 3.02 . . . . 0.0 110.92 178.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -110.56 145.1 38.39 Favored 'General case' 0 CA--C 1.513 -0.481 0 C-N-CA 124.752 1.221 . . . . 0.0 112.036 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.4 -40.33 90.55 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 124.356 1.035 . . . . 0.0 109.596 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -76.4 64.34 2.11 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 126.173 1.789 . . . . 0.0 109.348 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.9 p -47.06 -32.46 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 119.763 1.165 . . . . 0.0 111.91 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -63.99 -26.67 68.68 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.899 1.68 . . . . 0.0 112.619 -178.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.0 -25.91 56.21 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.428 0.691 . . . . 0.0 110.568 178.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 65.4 mtp180 -81.04 165.24 21.85 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 122.067 0.937 . . . . 0.0 110.884 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -123.46 147.68 46.93 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -130.42 165.44 22.58 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 125.318 1.447 . . . . 0.0 107.866 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -130.83 153.36 49.17 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 118.012 0.369 . . . . 0.0 110.447 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 45.9 tp -108.41 103.23 12.33 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.305 1.442 . . . . 0.0 108.471 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.525 HD23 ' HB2' ' A' ' 184' ' ' SER . 2.9 mm? -114.63 -179.51 3.65 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 126.653 1.981 . . . . 0.0 109.073 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -142.17 160.47 40.17 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.693 0.797 . . . . 0.0 110.824 179.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -139.97 -175.46 4.24 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.368 2.267 . . . . 0.0 108.084 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -58.48 -18.49 29.33 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 120.292 -1.505 . . . . 0.0 114.361 -178.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 42.4 t -98.84 -44.99 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 122.964 0.506 . . . . 0.0 111.648 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 175.2 -159.86 28.29 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 118.659 0.663 . . . . 0.0 111.729 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -85.38 158.76 20.16 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -154.97 166.41 33.65 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.61 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 98.2 mt -105.77 128.7 59.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.525 ' HB2' HD23 ' A' ' 175' ' ' LEU . 43.8 t -92.95 130.71 38.44 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.216 1.406 . . . . 0.0 108.299 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -126.0 112.77 16.29 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 177.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.14 112.2 26.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 11.1 mt -99.84 106.53 19.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 103.426 -2.805 . . . . 0.0 103.426 178.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -101.37 -153.18 25.88 Favored Glycine 0 CA--C 1.52 0.364 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 60.96 43.18 11.86 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.499 0.72 . . . . 0.0 112.153 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -86.56 -106.59 0.8 Allowed Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 105.027 -3.229 . . . . 0.0 105.027 178.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -157.9 162.63 38.33 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 129.095 2.958 . . . . 0.0 104.545 178.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.6 mm -85.62 142.28 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.3 m -97.97 105.6 17.77 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 127.746 2.418 . . . . 0.0 104.584 177.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -50.39 -27.0 5.58 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.311 1.844 . . . . 0.0 112.902 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 21.6 t -43.0 -56.55 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 126.819 2.048 . . . . 0.0 110.866 179.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 9.2 t -123.65 -25.61 4.31 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.867 1.267 . . . . 0.0 112.774 -178.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 99.27 35.04 4.87 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 107.541 -2.224 . . . . 0.0 107.541 -178.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -106.62 150.46 26.18 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 118.851 1.326 . . . . 0.0 112.747 -178.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -78.91 141.97 37.16 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.274 0.559 . . . . 0.0 109.722 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 -67.56 29.71 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.519 1 C-N-CA 133.64 4.776 . . . . 0.0 114.625 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 9.5 ptm -74.43 178.99 4.87 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.433 1.493 . . . . 0.0 112.051 -178.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.23 150.46 15.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 124.853 1.261 . . . . 0.0 109.199 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -110.74 103.58 12.14 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.445 2.298 . . . . 0.0 107.553 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 9.4 mm -93.48 146.8 6.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -125.58 105.34 8.95 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.952 2.101 . . . . 0.0 108.004 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' TYR . . . . . 0.431 ' CE2' HG21 ' A' ' 233' ' ' VAL . 58.4 m-85 -84.77 110.58 18.9 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 12.5 m -125.36 167.19 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 124.015 0.926 . . . . 0.0 109.101 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 36.7 t -93.69 135.21 35.21 Favored 'General case' 0 C--N 1.333 -0.127 0 O-C-N 120.153 -1.592 . . . . 0.0 107.233 178.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -83.84 8.65 65.39 Favored Glycine 0 N--CA 1.464 0.509 0 CA-C-O 118.77 -1.017 . . . . 0.0 114.349 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.954 0 CA-C-O 118.23 -1.317 . . . . 0.0 114.273 -179.584 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 CA--C 1.535 0.541 0 N-CA-C 110.778 -0.508 . . . . 0.0 110.778 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 11.2 p -162.13 154.17 19.06 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 120.645 -1.284 . . . . 0.0 109.686 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 41.7 p -151.38 163.79 38.16 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.392 0.677 . . . . 0.0 110.426 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.438 HG13 HG12 ' A' ' 233' ' ' VAL . 4.1 mt -110.54 143.03 21.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 125.145 1.378 . . . . 0.0 107.423 178.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -95.11 -51.72 4.52 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.199 1.4 . . . . 0.0 110.786 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 -161.21 156.57 24.41 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.429 1.491 . . . . 0.0 109.658 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.5 HG11 ' CD1' ' A' ' 127' ' ' TYR . 7.3 t -151.03 144.98 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 C-N-CA 127.894 2.478 . . . . 0.0 106.228 -178.336 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.24 168.47 15.18 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.602 1.161 . . . . 0.0 109.146 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -83.57 131.12 35.0 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 103.383 -2.821 . . . . 0.0 103.383 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' THR . . . . . 0.478 HG23 ' HG3' ' A' ' 225' ' ' LYS . 9.8 t -109.87 -28.68 8.64 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 124.245 1.018 . . . . 0.0 113.177 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.515 ' HE3' HG11 ' A' ' 228' ' ' VAL . 10.2 mttt -133.92 -175.6 3.89 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 70.0 mt -54.39 -49.52 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -123.01 20.56 9.94 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 124.042 0.937 . . . . 0.0 110.76 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.515 HG11 ' HE3' ' A' ' 225' ' ' LYS . 13.5 t -121.73 144.73 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 CA-C-N 118.578 0.626 . . . . 0.0 110.38 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -123.33 165.47 16.93 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 125.983 1.713 . . . . 0.0 108.434 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 230' ' ' GLU . . . . . 0.42 ' HG3' HG21 ' A' ' 224' ' ' THR . 25.7 mt-10 -131.31 147.01 52.53 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 126.086 1.754 . . . . 0.0 106.981 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -151.35 120.6 6.79 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.84 0.856 . . . . 0.0 109.373 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -108.79 113.45 26.41 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 123.588 0.755 . . . . 0.0 109.389 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 233' ' ' VAL . . . . . 0.438 HG12 HG13 ' A' ' 218' ' ' ILE . 6.7 m -104.12 152.2 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -118.91 116.34 26.26 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.68 -1.145 . . . . 0.0 108.452 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -124.83 122.47 25.6 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-O 117.935 -1.031 . . . . 0.0 109.282 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -57.38 -38.45 94.47 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.249 2.633 . . . . 0.0 111.427 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -59.18 -28.66 66.83 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 10.2 tp -58.59 -33.25 69.77 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 121.48 -0.762 . . . . 0.0 111.638 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 15.3 m -59.21 -11.13 3.47 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.141 0.976 . . . . 0.0 112.996 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -61.79 -32.01 72.27 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 120.128 1.331 . . . . 0.0 109.877 178.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -85.05 124.5 31.81 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -47.73 -48.11 29.83 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.239 2.215 . . . . 0.0 113.101 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 59.7 mt -67.97 -19.41 64.94 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.061 -1.025 . . . . 0.0 113.185 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 11.4 mt -105.36 -5.91 20.04 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.82 1.248 . . . . 0.0 111.686 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -71.64 139.69 49.38 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 128.606 2.762 . . . . 0.0 112.189 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 16.8 mmtm . . . . . 0 N--CA 1.463 0.187 0 C-N-CA 127.894 2.478 . . . . 0.0 112.698 179.598 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.52 -0.183 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.03 -40.84 95.11 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 35.6 tp -67.98 -35.99 79.27 Favored 'General case' 0 C--N 1.343 0.306 0 CA-C-O 117.514 -1.232 . . . . 0.0 109.233 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.7 mt -62.05 -55.04 33.14 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.942 1.246 . . . . 0.0 107.963 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 53.5 m -60.05 -47.16 87.01 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.097 0.959 . . . . 0.0 110.346 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.16 -45.25 94.25 Favored 'General case' 0 N--CA 1.462 0.128 0 O-C-N 121.099 -1.001 . . . . 0.0 109.808 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.5 m -53.92 -43.11 69.46 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 124.706 1.202 . . . . 0.0 109.684 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.22 -52.08 67.2 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 118.341 0.519 . . . . 0.0 110.218 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -64.95 -51.47 61.61 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -178.06 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -63.14 -42.08 99.41 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.777 -178.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.38 -52.51 52.18 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 107.872 -2.091 . . . . 0.0 107.872 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.415 HG23 HD13 ' A' ' 183' ' ' ILE . 17.9 t -54.81 -51.99 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 124.614 1.166 . . . . 0.0 110.954 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 31.5 pttt -62.33 -32.2 72.94 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 119.966 -0.693 . . . . 0.0 111.484 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 59.9 m -76.61 -33.2 58.42 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 19.6 mt -63.49 -56.03 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -60.36 -36.92 79.15 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 118.063 -0.97 . . . . 0.0 111.669 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -54.86 -43.83 73.45 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.832 0.742 . . . . 0.0 111.806 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.9 tptt -82.38 -40.95 20.6 Favored 'General case' 0 CA--C 1.517 -0.326 0 O-C-N 122.027 -0.421 . . . . 0.0 111.566 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 44.5 mt -60.65 -29.47 69.29 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 119.135 -0.46 . . . . 0.0 111.512 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -55.38 -15.66 2.82 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.038 0.935 . . . . 0.0 112.729 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -64.63 -66.85 0.49 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.253 1.021 . . . . 0.0 109.676 178.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 18.6 mmt85 -151.47 -179.49 7.43 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.894 1.678 . . . . 0.0 111.85 -178.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 64.9 m -86.12 161.32 18.94 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 38.7 pt -121.63 162.68 20.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 125.722 1.609 . . . . 0.0 108.281 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -156.89 142.62 17.7 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.374 1.07 . . . . 0.0 109.433 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -136.38 132.6 35.75 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.213 1.005 . . . . 0.0 110.65 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -81.44 98.44 8.23 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.66 83.04 4.8 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.122 1.369 . . . . 0.0 107.78 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.12 -98.15 0.18 Allowed Glycine 0 C--N 1.336 0.53 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -100.45 -26.56 13.82 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.349 1.06 . . . . 0.0 113.716 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -103.1 132.2 49.53 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 118.932 0.787 . . . . 0.0 110.467 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.488 HD13 ' H ' ' A' ' 140' ' ' GLY . 3.3 mp -96.2 127.86 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 103.643 -2.725 . . . . 0.0 103.643 178.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.401 ' CG ' HG11 ' A' ' 221' ' ' VAL . 11.3 m-85 -100.84 120.35 40.0 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -179.195 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -116.11 125.07 51.87 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 125.167 1.387 . . . . 0.0 110.394 -178.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -121.51 129.07 52.69 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.508 0.723 . . . . 0.0 112.018 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 22.7 m -107.76 151.01 40.96 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 123.624 0.77 . . . . 0.0 111.301 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -66.23 80.25 0.3 Allowed 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 125.275 3.983 . . . . 0.0 116.82 -177.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.87 31.19 27.07 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 117.803 -1.554 . . . . 0.0 112.007 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 3.0 mp -117.18 -71.99 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 119.444 1.622 . . . . 0.0 109.817 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.507 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 16.2 pt-20 -163.22 166.63 23.03 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.927 1.691 . . . . 0.0 110.435 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -130.56 119.91 23.25 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 105.731 -1.952 . . . . 0.0 105.731 177.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.7 m -144.22 164.08 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 125.109 1.364 . . . . 0.0 110.724 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -125.65 122.84 37.56 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -138.72 162.15 35.42 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 123.924 0.89 . . . . 0.0 108.907 178.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -96.04 118.45 32.66 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.488 ' H ' HD13 ' A' ' 126' ' ' ILE . . . . . . . . 0 CA--C 1.528 0.904 0 C-N-CA 125.026 1.298 . . . . 0.0 110.267 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 122.504 1.145 . . . . 0.0 110.029 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -148.65 143.81 26.76 Favored 'General case' 0 CA--C 1.512 -0.484 0 C-N-CA 126.371 1.868 . . . . 0.0 107.046 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 42.7 mt -129.79 -31.67 1.95 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.566 1.547 . . . . 0.0 107.689 177.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 159.34 158.66 9.24 Favored Glycine 0 C--N 1.341 0.823 0 O-C-N 120.587 -1.32 . . . . 0.0 113.459 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -117.41 108.93 42.7 Favored Pre-proline 0 C--O 1.239 0.529 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.507 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 91.5 Cg_endo -72.04 165.09 33.65 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 124.16 3.24 . . . . 0.0 109.371 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -109.99 148.82 30.94 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 123.476 0.71 . . . . 0.0 110.281 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -68.15 -48.46 65.3 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 125.777 1.923 . . . . 0.0 109.788 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -74.98 65.47 1.44 Allowed 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.207 1.403 . . . . 0.0 113.443 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.0 p -47.8 -31.66 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.29 1.036 . . . . 0.0 111.925 178.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -72.65 -30.11 64.01 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -178.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -73.66 -18.16 61.06 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.963 0.505 . . . . 0.0 109.842 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -105.81 165.47 11.16 Favored 'General case' 0 C--N 1.342 0.268 0 O-C-N 121.603 -0.686 . . . . 0.0 109.824 178.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -120.84 156.3 32.24 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -130.0 171.14 13.1 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.405 1.482 . . . . 0.0 108.715 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -113.7 153.44 28.97 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 123.691 0.796 . . . . 0.0 110.057 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 56.8 tp -121.63 102.51 8.28 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.594 1.558 . . . . 0.0 107.759 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.424 HD23 ' HB2' ' A' ' 184' ' ' SER . 2.3 mm? -112.5 -178.6 3.44 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 127.299 2.24 . . . . 0.0 109.996 -178.648 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -142.57 161.14 38.82 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.599 0.76 . . . . 0.0 110.346 177.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -140.92 178.68 7.19 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 127.637 2.375 . . . . 0.0 106.909 178.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.29 -17.81 22.32 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.435 1.494 . . . . 0.0 113.337 -178.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 90.0 t -93.92 -31.83 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 124.787 1.235 . . . . 0.0 111.917 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 156.19 -170.46 33.86 Favored Glycine 0 N--CA 1.448 -0.553 0 O-C-N 121.305 -0.872 . . . . 0.0 112.762 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.425 ' CE2' ' HG ' ' A' ' 243' ' ' LEU . 3.7 m-30 -78.76 160.73 27.28 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.401 ' HB3' HG12 ' A' ' 207' ' ' VAL . 30.7 p90 -164.33 157.96 18.18 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.273 1.029 . . . . 0.0 111.831 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.415 HD13 HG23 ' A' ' 106' ' ' VAL . 76.2 mt -96.03 138.82 20.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.899 1.28 . . . . 0.0 107.8 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.424 ' HB2' HD23 ' A' ' 175' ' ' LEU . 30.1 t -105.12 120.89 42.62 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 126.087 1.755 . . . . 0.0 107.973 179.204 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -114.89 107.49 15.48 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.905 1.682 . . . . 0.0 108.355 179.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -89.79 124.14 42.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 178.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.7 mt -114.27 105.69 19.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 104.94 -2.244 . . . . 0.0 104.94 177.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -98.18 -152.22 27.86 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 105.99 -2.844 . . . . 0.0 105.99 178.134 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 20.1 m 81.33 18.51 0.44 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 177.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -90.58 -142.19 9.78 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 108.354 -1.899 . . . . 0.0 108.354 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -124.5 163.82 21.05 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.4 mm -81.41 142.71 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.191 0.996 . . . . 0.0 112.012 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -85.93 122.63 30.25 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.722 1.609 . . . . 0.0 109.129 178.337 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.45 -28.4 63.29 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.761 1.225 . . . . 0.0 111.896 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 58.6 t -57.62 -54.95 24.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.549 1.139 . . . . 0.0 113.165 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 14.0 t -122.72 -36.64 2.87 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 116.164 1.912 . . . . 0.0 116.164 -176.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 111.81 23.51 5.58 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -99.07 150.95 21.48 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.763 0.825 . . . . 0.0 109.742 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -74.91 151.88 38.88 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.955 0.883 . . . . 0.0 108.922 178.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -71.27 29.75 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 130.021 3.329 . . . . 0.0 110.276 177.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 8.0 ptm -73.84 175.58 7.15 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.284 1.834 . . . . 0.0 111.778 -177.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.52 150.34 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 124.294 1.038 . . . . 0.0 108.628 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -111.93 104.17 12.44 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.242 1.817 . . . . 0.0 106.412 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 10.2 mm -96.75 144.02 11.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 O-C-N 120.848 -1.157 . . . . 0.0 109.289 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -124.29 127.67 47.99 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.292 1.037 . . . . 0.0 109.22 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -102.43 113.11 26.17 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 118.565 -0.731 . . . . 0.0 110.823 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.401 HG12 ' HB3' ' A' ' 182' ' ' TYR . 4.5 m -127.61 162.26 33.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 16.2 t -91.89 138.26 31.7 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 104.381 -2.451 . . . . 0.0 104.381 177.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -95.33 12.97 67.5 Favored Glycine 0 CA--C 1.522 0.483 0 CA-C-O 118.726 -1.041 . . . . 0.0 112.462 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.171 0 CA-C-N 118.16 0.98 . . . . 0.0 111.666 -178.721 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo . . . . . 0 N--CA 1.451 -0.98 0 N-CA-C 110.879 -0.469 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 18.2 p -170.8 146.94 2.67 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.171 1.788 . . . . 0.0 109.842 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 29.3 p -154.84 147.7 24.5 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.504 1.122 . . . . 0.0 110.487 178.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.447 HG13 HG12 ' A' ' 233' ' ' VAL . 3.2 mt -85.64 144.85 8.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -90.34 -55.75 3.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.869 1.267 . . . . 0.0 108.683 178.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 66.1 p-90 -154.63 158.14 39.23 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.328 1.051 . . . . 0.0 110.105 -178.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.612 HG23 ' HB2' ' A' ' 231' ' ' ALA . 7.2 p -156.16 134.91 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 177.014 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -159.64 159.91 33.64 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 118.545 0.611 . . . . 0.0 110.683 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -67.59 133.36 49.27 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 178.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' THR . . . . . 0.644 HG23 ' HG3' ' A' ' 225' ' ' LYS . 2.3 t -111.82 -34.32 6.05 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.937 1.295 . . . . 0.0 111.592 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.644 ' HG3' HG23 ' A' ' 224' ' ' THR . 7.7 mttm -134.73 -176.5 4.25 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 97.6 mt -50.06 -47.67 23.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 C-N-CA 124.681 1.192 . . . . 0.0 111.669 -178.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -127.7 20.5 6.58 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.582 0.753 . . . . 0.0 110.232 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 13.6 t -122.75 147.71 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 O-C-N 120.925 -1.109 . . . . 0.0 110.067 -177.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -127.92 163.58 24.16 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -135.35 133.05 38.36 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 178.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.612 ' HB2' HG23 ' A' ' 221' ' ' VAL . . . -135.91 149.08 48.82 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.208 1.803 . . . . 0.0 107.981 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -135.72 124.36 23.73 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 118.862 0.756 . . . . 0.0 110.049 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 233' ' ' VAL . . . . . 0.447 HG12 HG13 ' A' ' 218' ' ' ILE . 15.3 m -106.97 153.08 8.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 121.338 0.59 . . . . 0.0 109.682 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.02 121.62 39.32 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 178.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -132.82 145.36 56.77 Favored Pre-proline 0 N--CA 1.45 -0.432 0 O-C-N 124.469 1.106 . . . . 0.0 110.809 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.71 -42.26 1.24 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.812 2.341 . . . . 0.0 112.317 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -56.89 -25.48 57.03 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -178.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 9.6 tp -64.58 -29.69 70.71 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 121.403 -0.811 . . . . 0.0 112.374 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 11.4 m -58.39 -12.47 3.85 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.464 1.106 . . . . 0.0 112.449 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -64.11 -27.02 68.8 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 119.42 1.009 . . . . 0.0 111.239 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.27 124.86 35.79 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 -47.85 -48.35 31.07 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.706 1.203 . . . . 0.0 113.904 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.425 ' HG ' ' CE2' ' A' ' 181' ' ' TYR . 1.6 mp -61.12 -31.84 71.54 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 13.4 mt -93.73 -17.9 22.68 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.859 1.264 . . . . 0.0 113.167 -178.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -61.4 146.83 46.97 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 128.18 2.592 . . . . 0.0 110.411 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt . . . . . 0 C--N 1.328 -0.352 0 C-N-CA 125.361 1.464 . . . . 0.0 111.977 -179.16 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.45 -44.35 89.16 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 118.809 -0.615 . . . . 0.0 110.759 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 58.6 tp -74.26 -38.35 63.47 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-O 117.913 -1.041 . . . . 0.0 109.416 178.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 16.1 mt -58.92 -54.51 46.29 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.597 1.089 . . . . 0.0 110.746 -177.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 16.9 m -64.54 -36.18 83.37 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 118.703 -1.199 . . . . 0.0 110.762 -179.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.74 -49.86 76.06 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.233 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 89.6 m -51.44 -46.52 63.03 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.345 1.058 . . . . 0.0 110.586 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -58.77 -50.08 75.27 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.82 0.737 . . . . 0.0 110.524 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -67.95 -59.1 3.53 Favored 'General case' 0 C--O 1.227 -0.114 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -58.89 -38.14 78.18 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.21 1.004 . . . . 0.0 110.392 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.22 -52.65 50.47 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.478 ' HA ' HD12 ' A' ' 109' ' ' ILE . 51.6 t -57.72 -44.53 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 118.882 1.341 . . . . 0.0 109.974 179.112 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -60.47 -35.49 76.01 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.458 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 88.4 m -75.74 -34.95 60.34 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 122.771 0.428 . . . . 0.0 110.335 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.478 HD12 ' HA ' ' A' ' 106' ' ' VAL . 26.1 mt -63.36 -55.59 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -62.04 -33.51 74.51 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 118.433 -0.794 . . . . 0.0 112.753 -178.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -65.8 -37.95 87.66 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 118.834 0.743 . . . . 0.0 111.354 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.8 tptt -84.76 -38.46 19.6 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 118.761 -0.638 . . . . 0.0 111.157 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 16.8 mt -65.06 -25.81 67.97 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.845 0.748 . . . . 0.0 111.256 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -53.17 -24.66 11.27 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.059 1.344 . . . . 0.0 111.459 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -65.96 -65.79 0.63 Allowed 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 118.132 -0.937 . . . . 0.0 111.71 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -147.43 175.32 10.91 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 120.276 1.398 . . . . 0.0 112.863 -178.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 79.0 m -86.44 163.9 17.3 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 43.1 pt -121.8 159.46 24.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 124.587 1.155 . . . . 0.0 109.86 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -157.06 140.22 15.48 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 122.914 0.486 . . . . 0.0 111.847 -178.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -138.73 129.9 26.94 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 119.804 -0.759 . . . . 0.0 109.995 176.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -83.46 98.56 9.59 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.996 1.319 . . . . 0.0 107.547 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -85.95 80.56 8.84 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.494 1.918 . . . . 0.0 106.545 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.44 -99.42 0.33 Allowed Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -92.38 -30.75 15.62 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 118.423 1.112 . . . . 0.0 113.43 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -100.21 155.18 17.9 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 119.109 0.868 . . . . 0.0 110.548 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.687 HD13 ' H ' ' A' ' 140' ' ' GLY . 4.0 mp -122.13 144.59 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 104.003 -2.591 . . . . 0.0 104.003 179.041 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -128.88 120.0 25.43 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -110.06 126.02 53.56 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.966 1.706 . . . . 0.0 109.423 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -115.13 136.09 53.49 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.498 ' HB3' HD13 ' A' ' 133' ' ' ILE . 17.1 m -118.97 148.8 45.46 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 123.528 0.731 . . . . 0.0 111.066 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -64.63 91.33 0.19 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 125.079 3.853 . . . . 0.0 114.586 -178.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.82 28.44 58.98 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-O 118.045 -1.42 . . . . 0.0 114.265 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.498 HD13 ' HB3' ' A' ' 130' ' ' CYS . 4.1 mp -115.14 -71.58 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 119.654 1.727 . . . . 0.0 108.43 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.406 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 15.8 pt-20 -171.43 174.6 4.4 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.449 1.5 . . . . 0.0 110.072 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.416 ' CD1' HD12 ' A' ' 160' ' ' LEU . 1.2 t80 -136.54 120.26 17.3 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 177.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.9 m -145.41 164.99 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 126.494 1.917 . . . . 0.0 110.336 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -117.37 131.97 56.68 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 119.461 1.028 . . . . 0.0 110.498 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -137.68 162.31 34.19 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.547 1.067 . . . . 0.0 108.781 176.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -102.24 109.93 21.75 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.687 ' H ' HD13 ' A' ' 126' ' ' ILE . . . . . . . . 0 CA--C 1.528 0.888 0 C-N-CA 125.426 1.489 . . . . 0.0 109.788 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 . . . . . 0 CA--C 1.531 0.225 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.27 113.06 5.41 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 117.37 -1.3 . . . . 0.0 109.248 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.416 HD12 ' CD1' ' A' ' 135' ' ' PHE . 43.4 mt -102.02 -30.46 11.18 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.936 1.244 . . . . 0.0 108.982 178.31 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 161.99 161.31 11.81 Favored Glycine 0 CA--C 1.503 -0.668 0 CA-C-O 122.396 0.998 . . . . 0.0 110.758 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -123.91 109.39 29.95 Favored Pre-proline 0 N--CA 1.426 -1.631 0 C-N-CA 125.262 1.425 . . . . 0.0 109.307 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 85.3 Cg_endo -70.52 177.77 5.75 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.664 2.909 . . . . 0.0 108.745 178.129 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -120.55 152.11 38.52 Favored 'General case' 0 CA--C 1.517 -0.312 0 O-C-N 121.64 -0.663 . . . . 0.0 111.363 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -67.04 -49.69 64.37 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 122.945 0.498 . . . . 0.0 110.142 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -79.18 65.02 4.24 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.606 0.763 . . . . 0.0 110.47 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.3 p -48.8 -33.35 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 125.26 1.424 . . . . 0.0 111.229 179.073 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -65.5 -30.93 71.75 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 126.131 1.773 . . . . 0.0 111.621 -178.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -88.76 -11.3 45.38 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.698 1.199 . . . . 0.0 111.692 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.442 HH22 HG12 ' A' ' 187' ' ' ILE . 50.6 ttt180 -81.53 177.23 9.06 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.025 1.33 . . . . 0.0 108.686 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -133.29 149.8 51.92 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 121.261 -0.9 . . . . 0.0 109.34 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -136.63 169.87 17.01 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 127.592 2.357 . . . . 0.0 110.091 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -123.62 154.63 39.05 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.806 0.842 . . . . 0.0 110.349 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 12.4 tp -119.09 105.1 11.08 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 122.383 1.087 . . . . 0.0 109.621 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 3.4 mt -119.09 176.67 5.19 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 128.227 2.611 . . . . 0.0 107.738 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -154.68 164.36 38.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.714 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.71 -175.43 3.82 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.388 1.875 . . . . 0.0 110.313 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -66.81 -1.81 4.34 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.875 1.67 . . . . 0.0 113.442 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.407 ' CG1' ' HE3' ' A' ' 246' ' ' LYS . 30.6 t -112.82 -44.21 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 124.741 1.216 . . . . 0.0 109.519 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 175.56 -175.52 47.26 Favored Glycine 0 N--CA 1.446 -0.67 0 O-C-N 121.274 -0.891 . . . . 0.0 111.943 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -82.17 163.71 21.75 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.455 ' HB3' HG12 ' A' ' 207' ' ' VAL . 45.7 p90 -154.4 172.37 17.84 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 74.6 mt -113.9 129.81 69.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 35.0 t -91.59 124.22 35.59 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -123.15 107.54 11.85 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.5 mp -93.39 117.89 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 104.281 -2.488 . . . . 0.0 104.281 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.442 HG12 HH22 ' A' ' 170' ' ' ARG . 4.3 mt -104.89 105.83 19.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 178.384 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -104.19 -156.38 23.82 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.793 1.664 . . . . 0.0 109.409 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.1 t 64.02 43.47 5.16 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.586 1.155 . . . . 0.0 110.36 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -91.57 -64.09 1.16 Allowed Glycine 0 CA--C 1.529 0.937 0 N-CA-C 107.987 -2.045 . . . . 0.0 107.987 179.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 157.29 179.98 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.379 1 C-N-CA 132.086 4.155 . . . . 0.0 105.792 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.5 mm -105.59 143.39 16.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 127.756 2.423 . . . . 0.0 112.107 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.4 m -95.73 101.13 12.78 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 128.11 2.564 . . . . 0.0 104.312 176.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -48.73 -31.32 6.73 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.258 1.823 . . . . 0.0 112.658 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 60.0 t -39.16 -54.11 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 127.268 2.227 . . . . 0.0 110.574 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 11.3 t -123.5 -26.95 4.13 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.404 1.082 . . . . 0.0 111.787 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.33 35.18 4.24 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 -178.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -110.67 148.69 31.74 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 118.498 1.149 . . . . 0.0 113.108 -178.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -73.8 148.09 42.8 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.274 0.559 . . . . 0.0 112.156 179.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -70.06 27.01 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.425 1 C-N-CA 134.844 5.258 . . . . 0.0 109.87 177.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 2.8 ptm -74.64 178.78 5.14 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.383 1.473 . . . . 0.0 113.336 -176.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.1 p -150.74 136.45 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 123.279 0.631 . . . . 0.0 110.642 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -98.79 109.22 22.01 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.744 1.217 . . . . 0.0 109.213 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 11.1 mm -97.49 147.88 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 O-C-N 121.627 -0.671 . . . . 0.0 109.853 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -125.7 105.4 8.96 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 128.092 2.557 . . . . 0.0 109.106 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -87.76 114.17 24.12 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 120.65 -1.281 . . . . 0.0 108.951 178.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.455 HG12 ' HB3' ' A' ' 182' ' ' TYR . 4.6 m -124.49 165.01 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 41.9 t -84.63 145.86 27.79 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 120.418 -1.426 . . . . 0.0 107.36 178.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -90.89 6.14 81.91 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-O 117.341 -1.81 . . . . 0.0 115.362 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.957 0 CA-C-N 119.026 1.413 . . . . 0.0 114.952 179.542 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo . . . . . 0 N--CA 1.452 -0.913 0 N-CA-C 109.575 -0.971 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 28.1 p -154.68 147.61 24.56 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 119.992 -1.693 . . . . 0.0 111.374 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 20.6 p -151.05 161.59 42.44 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.541 1.136 . . . . 0.0 110.145 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 3.6 mt -100.64 154.53 4.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 125.311 1.444 . . . . 0.0 109.386 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -102.27 -51.69 3.31 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 124.783 1.233 . . . . 0.0 109.844 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 64.5 p-90 -155.92 154.09 30.65 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.067 0.947 . . . . 0.0 109.255 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 90.9 t -147.73 137.7 16.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.63 168.53 19.8 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 122.842 0.457 . . . . 0.0 111.207 -178.716 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -86.86 133.67 33.6 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 177.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 14.8 t -109.21 -32.22 7.28 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.528 1.131 . . . . 0.0 112.214 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -136.86 -175.97 4.21 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.668 1.187 . . . . 0.0 108.84 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 78.3 mt -48.76 -45.05 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.585 0.754 . . . . 0.0 112.479 -178.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -130.19 12.54 5.59 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.112 0.965 . . . . 0.0 112.265 -178.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 17.5 t -114.14 140.29 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 O-C-N 122.116 -0.365 . . . . 0.0 110.127 -176.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -120.66 166.97 12.95 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 125.18 1.392 . . . . 0.0 108.445 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -137.89 148.65 45.54 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.505 1.522 . . . . 0.0 108.822 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -148.93 145.49 27.42 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 125.789 1.636 . . . . 0.0 110.273 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -132.84 122.89 25.11 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 178.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 5.5 m -116.29 154.81 17.8 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.1 p -120.76 124.05 44.17 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.517 1.127 . . . . 0.0 110.302 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -132.8 122.98 17.97 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 124.238 1.015 . . . . 0.0 109.261 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -58.19 -40.83 73.07 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 124.014 3.143 . . . . 0.0 113.406 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -61.05 -19.62 61.6 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.615 0.766 . . . . 0.0 112.101 -178.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 8.6 tp -66.94 -28.87 68.64 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 120.432 -1.418 . . . . 0.0 110.715 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 21.4 m -62.33 -11.85 17.69 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.746 0.818 . . . . 0.0 111.942 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.08 -21.39 66.14 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.046 0.839 . . . . 0.0 110.122 178.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -98.12 121.01 39.53 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 177.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -47.99 -46.13 32.35 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 126.071 1.749 . . . . 0.0 112.704 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.42 -37.54 87.23 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 120.809 -1.182 . . . . 0.0 112.127 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 22.1 mt -85.21 -5.73 59.31 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.32 1.048 . . . . 0.0 112.252 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -68.95 156.41 38.62 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.822 1.249 . . . . 0.0 110.428 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.407 ' HE3' ' CG1' ' A' ' 179' ' ' VAL . 2.9 mmmt . . . . . 0 C--N 1.325 -0.498 0 C-N-CA 126.225 1.81 . . . . 0.0 109.279 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.384 0 CA-C-O 118.777 -0.63 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.55 -42.65 92.89 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.505 1.048 . . . . 0.0 109.481 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.5 tp -68.88 -36.8 78.51 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-O 117.276 -1.345 . . . . 0.0 109.28 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 98.8 mt -58.67 -54.55 45.82 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 120.265 1.393 . . . . 0.0 108.533 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.2 m -58.93 -46.88 86.88 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.808 0.843 . . . . 0.0 111.457 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.09 -41.94 94.51 Favored 'General case' 0 N--CA 1.463 0.197 0 O-C-N 120.343 -1.473 . . . . 0.0 111.014 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 37.6 m -52.4 -46.94 66.51 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.135 1.374 . . . . 0.0 110.771 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -56.51 -50.99 70.19 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.309 0.504 . . . . 0.0 110.098 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -63.02 -58.0 8.78 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -178.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.09 -39.33 78.32 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.343 -177.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.78 -52.57 41.19 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.54 ' HA ' HD12 ' A' ' 109' ' ' ILE . 43.6 t -54.46 -51.07 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-N 119.032 1.416 . . . . 0.0 110.682 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.6 pttp -56.86 -35.14 68.52 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.448 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 77.2 m -80.34 -29.03 37.97 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.113 0.965 . . . . 0.0 111.947 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.54 HD12 ' HA ' ' A' ' 106' ' ' VAL . 16.7 mt -63.27 -54.39 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 104.677 -2.342 . . . . 0.0 104.677 177.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -61.13 -30.69 70.53 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 118.44 -0.79 . . . . 0.0 111.199 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -56.37 -47.57 78.62 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.478 1.036 . . . . 0.0 111.084 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -84.14 -37.9 21.36 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 24.9 mt -65.97 -26.56 67.62 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 118.931 -0.557 . . . . 0.0 112.161 -179.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -56.83 -20.9 25.17 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -64.64 -66.81 0.49 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.517 0.727 . . . . 0.0 109.485 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -153.51 -179.7 8.01 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.04 1.736 . . . . 0.0 110.306 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 56.0 m -86.63 172.82 9.95 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.287 0.635 . . . . 0.0 109.694 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 34.0 pt -129.8 164.37 32.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 126.654 1.982 . . . . 0.0 109.046 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -158.74 150.33 20.86 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 122.831 0.452 . . . . 0.0 110.225 -179.222 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -141.5 127.38 19.32 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.631 0.772 . . . . 0.0 109.882 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -84.07 102.23 12.37 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 122.054 0.93 . . . . 0.0 109.404 179.15 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.27 80.57 6.84 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 127.864 2.466 . . . . 0.0 107.15 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 60.75 -114.69 6.85 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -76.74 -28.81 55.9 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.829 0.852 . . . . 0.0 112.548 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -99.95 163.46 12.43 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 119.073 0.851 . . . . 0.0 110.89 -178.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.524 HD13 ' H ' ' A' ' 140' ' ' GLY . 4.5 mp -136.55 130.56 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -110.05 119.99 41.05 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -108.04 126.42 52.71 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 118.437 -0.792 . . . . 0.0 109.909 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -117.55 130.49 56.44 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.292 0.951 . . . . 0.0 110.094 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.462 ' HB3' HD13 ' A' ' 133' ' ' ILE . 21.4 m -110.83 156.6 40.44 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 128.427 2.691 . . . . 0.0 113.937 -178.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -68.19 72.42 0.83 Allowed 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 124.79 3.66 . . . . 0.0 114.404 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.84 62.06 3.77 Favored Glycine 0 N--CA 1.448 -0.517 0 O-C-N 121.186 -0.947 . . . . 0.0 111.285 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.462 HD13 ' HB3' ' A' ' 130' ' ' CYS . 2.5 mp -131.03 -72.31 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-O 118.325 -0.845 . . . . 0.0 109.235 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -173.65 136.9 0.59 Allowed 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 119.646 1.112 . . . . 0.0 108.15 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -108.27 124.3 50.1 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 121.04 1.745 . . . . 0.0 106.32 -175.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 18.3 m -145.04 165.06 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 125.257 1.423 . . . . 0.0 111.428 -178.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -122.02 133.4 54.8 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.479 1.512 . . . . 0.0 108.193 178.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -138.96 162.87 33.82 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.127 1.371 . . . . 0.0 112.667 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 42.6 t60 -92.76 122.66 35.38 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.524 ' H ' HD13 ' A' ' 126' ' ' ILE . . . . . . . . 0 N--CA 1.454 -0.145 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 -178.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 . . . . . 0 CA--C 1.52 -0.197 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.67 135.86 23.84 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 178.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.1 mp -125.7 -36.36 2.43 Favored 'General case' 0 C--O 1.221 -0.445 0 C-N-CA 126.478 1.911 . . . . 0.0 106.905 177.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 172.75 152.43 8.65 Favored Glycine 0 C--N 1.34 0.795 0 CA-C-N 119.391 0.996 . . . . 0.0 112.705 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 29.3 mtmt -123.28 109.33 31.32 Favored Pre-proline 0 C--O 1.239 0.513 0 N-CA-C 106.125 -1.805 . . . . 0.0 106.125 177.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -75.35 -172.95 1.43 Allowed 'Trans proline' 0 N--CA 1.459 -0.519 1 C-N-CA 126.174 4.583 . . . . 0.0 111.425 -178.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -124.39 152.41 43.25 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 123.762 0.825 . . . . 0.0 108.965 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.11 -46.18 65.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.066 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 -68.88 65.36 0.13 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 127.366 2.267 . . . . 0.0 111.166 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.8 p -48.51 -34.06 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 124.662 1.185 . . . . 0.0 111.746 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -59.64 -32.21 70.24 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 125.46 1.504 . . . . 0.0 113.184 -178.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -84.61 -22.61 29.91 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.767 1.227 . . . . 0.0 112.787 -178.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.404 HH22 ' HG3' ' A' ' 185' ' ' GLU . 66.6 mtp180 -74.82 139.71 43.43 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -97.22 143.3 28.15 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 179.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -133.59 165.84 23.97 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 124.21 1.004 . . . . 0.0 109.777 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -123.45 142.73 50.7 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.944 0.897 . . . . 0.0 109.965 -178.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 58.9 tp -102.28 100.95 11.18 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.062 1.745 . . . . 0.0 107.584 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.584 HD23 ' HB2' ' A' ' 184' ' ' SER . 2.9 mm? -107.78 -178.84 3.74 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.301 1.44 . . . . 0.0 109.147 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 181' ' ' TYR . 1.7 p90 -139.97 156.88 46.43 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.484 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -134.97 175.0 9.98 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 126.879 2.072 . . . . 0.0 107.446 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -64.21 -13.97 52.36 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 124.548 1.139 . . . . 0.0 112.699 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 99.6 t -97.65 -34.93 4.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 125.856 1.662 . . . . 0.0 112.459 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 163.93 -174.65 40.09 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 176' ' ' TYR . 3.6 m-30 -78.41 166.21 22.9 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -165.66 164.19 19.08 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.354 0.662 . . . . 0.0 111.395 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 67.7 mt -102.43 132.41 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.584 ' HB2' HD23 ' A' ' 175' ' ' LEU . 23.3 t -100.81 127.27 47.33 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.581 1.553 . . . . 0.0 107.954 179.048 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.404 ' HG3' HH22 ' A' ' 170' ' ' ARG . 26.4 tt0 -124.21 112.47 17.09 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.39 1.876 . . . . 0.0 109.617 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -96.94 116.23 38.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 178.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 5.3 mt -105.22 108.64 25.44 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -106.58 -153.21 19.83 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 108.023 -2.031 . . . . 0.0 108.023 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 85.44 32.13 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.352 1.861 . . . . 0.0 111.237 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -111.53 165.17 12.09 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 125.537 1.541 . . . . 0.0 111.093 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.62 157.17 38.45 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.7 mm -78.1 134.87 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 C-N-CA 125.387 1.475 . . . . 0.0 110.769 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.35 115.03 18.75 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.918 1.687 . . . . 0.0 106.685 178.155 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -60.37 -22.21 63.03 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.161 1.384 . . . . 0.0 112.219 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 59.8 t -53.73 -48.51 60.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 C-N-CA 125.192 1.397 . . . . 0.0 111.249 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 11.7 t -125.2 -43.27 1.95 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 117.62 35.15 1.1 Allowed Glycine 0 CA--C 1.532 1.139 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 -177.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -111.08 150.67 29.05 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.612 1.706 . . . . 0.0 111.598 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -73.03 143.3 47.57 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.446 0.641 . . . . 0.0 109.388 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 7.0 ttp180 -67.6 29.45 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.4 1 C-N-CA 132.184 4.194 . . . . 0.0 113.564 179.083 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 6.0 ptm -73.51 175.78 6.72 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.216 -0.927 . . . . 0.0 113.062 -177.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 8.8 p -142.13 151.41 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 124.7 1.2 . . . . 0.0 108.483 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -110.78 115.25 29.23 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 179.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 8.5 mm -106.12 140.06 25.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -125.44 109.0 12.21 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.604 1.562 . . . . 0.0 109.108 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -89.48 115.27 26.78 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 120.636 -1.29 . . . . 0.0 110.413 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 5.2 m -124.62 165.99 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 124.015 0.926 . . . . 0.0 108.525 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 48.8 t -85.39 143.09 28.83 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 121.033 -1.042 . . . . 0.0 108.331 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -86.91 7.18 81.28 Favored Glycine 0 CA--C 1.52 0.395 0 CA-C-O 116.831 -2.094 . . . . 0.0 116.829 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.827 0 CA-C-N 120.249 2.024 . . . . 0.0 111.593 -178.579 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo . . . . . 0 N--CA 1.45 -1.031 0 N-CA-C 109.047 -1.174 . . . . 0.0 109.047 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.5 p -171.42 150.39 2.86 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 121.021 -1.049 . . . . 0.0 110.078 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.9 p -151.85 159.1 43.97 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.862 1.265 . . . . 0.0 109.325 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.429 ' HA ' ' HA ' ' A' ' 233' ' ' VAL . 4.3 mt -102.31 152.56 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 126.416 1.886 . . . . 0.0 107.996 178.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -97.6 -50.95 4.29 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.467 1.107 . . . . 0.0 111.447 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 58.2 p-90 -160.02 155.24 25.02 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.336 1.454 . . . . 0.0 107.84 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 52.9 t -151.46 118.75 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 125.672 1.589 . . . . 0.0 106.769 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.98 167.49 26.54 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 118.51 0.596 . . . . 0.0 111.459 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -73.81 134.69 43.41 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 1.4 t -112.34 -37.36 5.01 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.172 0.989 . . . . 0.0 110.732 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 16.4 mttm -131.61 -175.19 3.63 Favored 'General case' 0 CA--C 1.506 -0.749 0 C-N-CA 124.054 0.942 . . . . 0.0 109.689 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 71.0 mt -53.16 -48.51 54.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.923 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -126.84 22.56 6.78 Favored 'General case' 0 C--O 1.226 -0.135 0 C-N-CA 124.66 1.184 . . . . 0.0 110.777 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 12.3 t -123.38 144.33 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.518 0 C-N-CA 120.328 -0.549 . . . . 0.0 109.57 -178.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -125.15 158.93 32.7 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.496 1.519 . . . . 0.0 107.379 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -127.72 137.47 52.48 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -142.34 125.64 16.54 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.88 1.672 . . . . 0.0 110.686 -177.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -118.97 116.96 27.55 Favored 'General case' 0 C--O 1.237 0.436 0 O-C-N 121.721 -0.612 . . . . 0.0 110.659 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 218' ' ' ILE . 3.6 m -101.5 154.3 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.1 p -124.01 125.57 44.79 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 1.2 pt -136.5 141.03 34.12 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -67.68 -43.34 5.57 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.831 2.354 . . . . 0.0 112.386 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -56.69 -18.23 11.64 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -178.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 3.9 tp -70.18 -22.16 62.98 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 120.06 -1.65 . . . . 0.0 112.171 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 15.9 m -70.48 -9.31 56.23 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.623 1.169 . . . . 0.0 112.259 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -57.29 -35.86 70.34 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.203 1.001 . . . . 0.0 108.535 178.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -92.55 124.33 36.5 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -46.89 -47.92 21.3 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 128.416 2.686 . . . . 0.0 111.815 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.432 ' HB3' ' CD2' ' A' ' 181' ' ' TYR . 25.3 mt -62.09 -44.46 96.61 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.752 -178.417 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 8.2 mp -78.66 -8.33 58.56 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -70.02 141.39 52.91 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.688 1.595 . . . . 0.0 110.722 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 10.3 mmmm . . . . . 0 C--N 1.328 -0.33 0 C-N-CA 124.126 0.971 . . . . 0.0 109.409 179.489 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 118.661 -0.685 . . . . 0.0 111.552 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.42 -51.22 69.63 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.651 -1.241 . . . . 0.0 107.651 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 53.7 tp -61.35 -38.25 86.27 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 117.728 -1.13 . . . . 0.0 110.383 179.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.6 mt -60.94 -54.37 45.87 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 119.627 1.103 . . . . 0.0 109.365 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 26.4 m -58.86 -49.01 79.34 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.241 1.416 . . . . 0.0 110.303 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.4 ttmm -58.7 -49.85 76.07 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 52.9 m -52.61 -45.34 66.52 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 123.964 0.905 . . . . 0.0 110.127 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -57.32 -49.8 74.96 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.711 0.687 . . . . 0.0 109.482 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.17 -61.38 2.17 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.904 0.881 . . . . 0.0 112.5 -178.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -58.25 -39.03 78.11 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 125.153 1.381 . . . . 0.0 111.739 -178.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -65.32 -52.72 37.79 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-O 117.985 -1.453 . . . . 0.0 109.935 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.536 ' HA ' HD12 ' A' ' 109' ' ' ILE . 52.2 t -58.77 -42.89 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 119.689 1.745 . . . . 0.0 110.691 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.9 ptmm? -62.06 -35.9 80.02 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.968 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.4 m -72.89 -40.13 65.81 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.317 1.047 . . . . 0.0 109.67 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.536 HD12 ' HA ' ' A' ' 106' ' ' VAL . 20.4 mt -58.48 -54.71 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -57.18 -37.73 72.58 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 118.011 -0.995 . . . . 0.0 111.432 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -63.69 -37.41 87.26 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.102 0.865 . . . . 0.0 111.399 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.43 -32.56 62.68 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.768 -0.582 . . . . 0.0 111.636 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.0 mt -83.73 -25.11 30.85 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 117.884 0.311 . . . . 0.0 111.362 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -47.82 -35.45 10.18 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.185 1.394 . . . . 0.0 111.552 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -60.62 -67.04 0.44 Allowed 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 125.329 1.452 . . . . 0.0 111.928 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 77.5 mmt-85 -150.05 171.73 16.39 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.815 1.189 . . . . 0.0 111.936 -178.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 62.1 m -86.71 152.62 22.38 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 178.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 28.7 pt -106.41 161.32 5.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 125.779 1.632 . . . . 0.0 109.74 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -151.73 134.57 15.64 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.635 1.574 . . . . 0.0 108.694 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.406 ' CB ' ' HB ' ' A' ' 218' ' ' ILE . 12.2 t80 -138.61 127.6 23.91 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.114 0.966 . . . . 0.0 111.139 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -81.99 106.78 14.18 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.533 1.133 . . . . 0.0 108.83 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -100.54 79.99 2.16 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 178.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.66 -125.59 20.24 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -67.05 -34.59 78.03 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.308 0.643 . . . . 0.0 112.046 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -99.96 163.88 12.25 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 119.132 0.878 . . . . 0.0 111.637 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.1 mp -128.98 140.92 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 104.886 -2.264 . . . . 0.0 104.886 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.416 ' CG ' HG11 ' A' ' 221' ' ' VAL . 10.5 m-85 -114.82 120.07 38.76 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 125.841 1.656 . . . . 0.0 107.961 -177.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -113.46 122.66 47.99 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -122.25 135.13 54.7 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 123.855 0.862 . . . . 0.0 110.7 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.506 ' HB3' HD13 ' A' ' 133' ' ' ILE . 16.4 m -109.09 158.25 34.84 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 126.675 1.99 . . . . 0.0 112.59 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -63.9 74.46 0.17 Allowed 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 124.738 3.625 . . . . 0.0 114.457 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 72.78 50.68 13.18 Favored Glycine 0 CA--C 1.532 1.126 0 O-C-N 120.093 -1.63 . . . . 0.0 114.085 179.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.506 HD13 ' HB3' ' A' ' 130' ' ' CYS . 3.6 mp -124.31 -65.98 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 125.352 1.461 . . . . 0.0 108.091 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -166.64 168.48 14.44 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 127.416 2.286 . . . . 0.0 110.837 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -134.57 121.72 21.35 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 19.5 m -143.03 163.79 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 125.008 1.323 . . . . 0.0 111.821 -178.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -126.19 128.07 46.67 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.608 1.163 . . . . 0.0 110.124 178.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -138.09 162.92 32.93 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.555 1.942 . . . . 0.0 110.929 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -91.69 160.76 15.2 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 120.867 -1.146 . . . . 0.0 109.357 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.953 0 C-N-CA 124.842 1.21 . . . . 0.0 111.045 -179.128 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 . . . . . 0 C--O 1.228 -0.033 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -148.93 140.28 23.26 Favored 'General case' 0 CA--C 1.507 -0.697 0 O-C-N 120.819 -1.176 . . . . 0.0 109.474 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 41.0 mt -118.07 -24.37 7.05 Favored 'General case' 0 C--O 1.219 -0.51 0 O-C-N 125.391 1.682 . . . . 0.0 109.378 179.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 163.38 164.12 17.72 Favored Glycine 0 C--N 1.34 0.757 0 O-C-N 121.056 -1.028 . . . . 0.0 111.1 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.414 ' N ' HG22 ' A' ' 187' ' ' ILE . 49.0 mtpt -127.89 109.58 20.25 Favored Pre-proline 0 CA--C 1.533 0.31 0 C-N-CA 124.374 1.07 . . . . 0.0 110.519 178.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -72.09 172.58 14.44 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 123.945 3.097 . . . . 0.0 111.127 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -111.43 152.32 27.52 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.705 0.802 . . . . 0.0 111.083 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -68.01 -44.25 76.97 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.807 1.243 . . . . 0.0 111.986 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -78.15 65.36 3.51 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.482 1.113 . . . . 0.0 111.456 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.8 p -47.23 -33.91 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 124.532 1.133 . . . . 0.0 111.86 178.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -67.45 -36.19 80.69 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.951 1.3 . . . . 0.0 112.726 -178.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -86.28 -1.39 57.45 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 125.503 1.521 . . . . 0.0 110.917 -178.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 18.3 ttt-85 -93.24 146.94 23.32 Favored 'General case' 0 N--CA 1.441 -0.876 0 O-C-N 120.399 -1.438 . . . . 0.0 110.634 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -102.69 147.85 26.32 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.597 0.759 . . . . 0.0 110.656 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -138.04 175.48 9.54 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.873 2.069 . . . . 0.0 109.371 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -137.6 133.68 34.68 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.513 0.725 . . . . 0.0 112.52 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 35.1 tp -92.07 106.36 18.4 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.633 1.173 . . . . 0.0 109.377 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.492 HD23 ' HB2' ' A' ' 184' ' ' SER . 2.8 mm? -113.38 -179.25 3.59 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 125.775 1.63 . . . . 0.0 109.412 179.362 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -136.42 162.74 32.2 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.098 0.959 . . . . 0.0 110.092 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -138.89 178.81 6.88 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 127.666 2.386 . . . . 0.0 107.711 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -63.46 -14.31 49.4 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 121.706 -0.621 . . . . 0.0 111.659 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 5.0 t -97.5 -47.72 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 125.279 1.432 . . . . 0.0 112.101 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 172.6 -162.29 33.98 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.281 -1.127 . . . . 0.0 110.281 -178.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -84.32 163.33 19.67 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 117.993 0.897 . . . . 0.0 110.359 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -156.88 165.14 37.04 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.29 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 62.7 mt -105.26 120.2 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.492 ' HB2' HD23 ' A' ' 175' ' ' LEU . 39.8 t -89.93 136.31 33.12 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 124.707 1.203 . . . . 0.0 107.931 178.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -131.44 113.16 13.37 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 125.129 1.372 . . . . 0.0 107.652 178.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.48 107.03 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.414 HG22 ' N ' ' A' ' 162' ' ' LYS . 7.2 mt -94.01 105.81 17.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 178.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -111.57 -152.34 12.17 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 126.676 2.084 . . . . 0.0 109.715 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 76.73 40.54 0.2 Allowed 'General case' 0 C--O 1.237 0.416 0 C-N-CA 127.166 2.186 . . . . 0.0 108.305 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -108.7 173.25 17.43 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-O 121.978 0.766 . . . . 0.0 112.793 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' ASP . . . . . 0.504 ' H ' ' NE ' ' A' ' 200' ' ' ARG . 30.6 m-20 -80.97 141.28 34.61 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 179.33 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 43.5 mm -69.2 136.53 26.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 124.951 1.3 . . . . 0.0 112.046 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -87.52 110.33 20.26 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 128.335 2.654 . . . . 0.0 107.744 178.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -55.94 -18.49 9.25 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 127.691 2.396 . . . . 0.0 114.101 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 25.3 t -60.48 -46.28 95.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 124.985 1.314 . . . . 0.0 110.575 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 5.7 t -123.1 -37.52 2.7 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.514 1.126 . . . . 0.0 113.133 -178.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 104.12 35.89 3.29 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 108.079 -2.008 . . . . 0.0 108.079 -178.108 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -122.18 163.45 19.53 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.71 1.255 . . . . 0.0 110.813 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -77.2 151.71 35.1 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -178.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.504 ' NE ' ' H ' ' A' ' 191' ' ' ASP . 27.0 ptt85 -76.61 28.71 0.13 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 129.352 3.061 . . . . 0.0 111.852 177.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 6.6 ptm -72.77 175.52 6.4 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.956 0.903 . . . . 0.0 112.286 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.2 p -142.34 146.86 21.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 124.977 1.311 . . . . 0.0 109.978 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -105.18 104.04 13.69 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.831 1.652 . . . . 0.0 107.678 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 24.4 mm -91.26 152.01 3.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 O-C-N 120.896 -1.127 . . . . 0.0 109.432 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -127.36 104.83 8.13 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.342 1.857 . . . . 0.0 110.586 178.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 206' ' ' TYR . . . . . 0.446 ' CD1' HD13 ' A' ' 109' ' ' ILE . 42.9 m-85 -84.48 108.59 17.35 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 177.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 11.6 m -125.01 166.88 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 48.0 t -91.77 138.35 31.63 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 178.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -87.4 3.26 86.6 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-O 118.56 -1.133 . . . . 0.0 112.601 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.686 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -178.802 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo . . . . . 0 N--CA 1.449 -1.138 0 N-CA-C 109.401 -1.038 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.1 146.38 26.89 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.864 1.666 . . . . 0.0 108.782 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 80.4 p -147.18 162.3 39.16 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 118.784 0.72 . . . . 0.0 110.357 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.433 ' CG1' HG12 ' A' ' 233' ' ' VAL . 3.4 mt -107.28 139.63 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 105.013 -2.218 . . . . 0.0 105.013 177.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -88.48 -47.71 8.13 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.417 1.087 . . . . 0.0 111.45 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 68.6 p-90 -159.25 154.21 24.93 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 126.047 1.739 . . . . 0.0 108.66 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.483 HG23 ' HB2' ' A' ' 231' ' ' ALA . 6.1 p -155.78 128.82 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -156.3 162.54 40.09 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 122.895 0.478 . . . . 0.0 111.119 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -68.76 133.42 48.33 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 178.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 224' ' ' THR . . . . . 0.4 HG23 ' HG3' ' A' ' 225' ' ' LYS . 12.0 t -109.48 -31.11 7.63 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 123.909 0.884 . . . . 0.0 111.882 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.4 ' HG3' HG23 ' A' ' 224' ' ' THR . 7.1 mttm -138.65 -175.85 4.27 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.043 1.337 . . . . 0.0 108.024 178.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 76.3 mt -45.1 -49.39 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 1.8 t -132.96 18.96 4.12 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.169 0.988 . . . . 0.0 111.168 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 18.5 t -113.79 141.69 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -123.96 163.62 20.97 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.805 1.242 . . . . 0.0 107.725 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -142.76 133.55 25.4 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.483 ' HB2' HG23 ' A' ' 221' ' ' VAL . . . -134.89 145.26 48.07 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 125.669 1.588 . . . . 0.0 107.986 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -124.29 123.29 39.9 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 233' ' ' VAL . . . . . 0.433 HG12 ' CG1' ' A' ' 218' ' ' ILE . 6.3 m -113.92 154.81 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -179.125 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 2.1 p -125.37 126.3 44.8 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 123.76 0.824 . . . . 0.0 112.079 -178.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -131.38 145.94 59.81 Favored Pre-proline 0 C--O 1.234 0.254 0 O-C-N 124.357 1.035 . . . . 0.0 108.258 176.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -66.52 -47.85 2.71 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.786 2.324 . . . . 0.0 109.255 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -53.31 -23.61 9.64 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 -178.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 7.4 tp -66.39 -30.27 70.61 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 121.11 -0.994 . . . . 0.0 111.147 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 2.8 m -60.25 -13.08 10.72 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.058 0.943 . . . . 0.0 112.706 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.33 -25.79 67.76 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 118.901 0.773 . . . . 0.0 111.389 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' A' ' 241' ' ' LEU . 4.1 mm? -88.94 126.42 35.39 Favored 'General case' 0 C--O 1.225 -0.229 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -47.4 -44.65 24.59 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.631 1.972 . . . . 0.0 113.064 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 48.1 mt -72.93 -21.72 60.84 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 120.681 -1.262 . . . . 0.0 113.864 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 13.2 mt -100.46 -13.14 18.82 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.538 1.535 . . . . 0.0 112.654 -178.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -61.25 136.29 58.01 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 129.263 3.025 . . . . 0.0 110.742 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt . . . . . 0 N--CA 1.464 0.236 0 C-N-CA 125.703 1.601 . . . . 0.0 110.079 179.238 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 CA--C 1.517 -0.296 0 CA-C-O 118.755 -0.64 . . . . 0.0 112.089 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.91 -38.61 79.3 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 49.9 tp -70.25 -38.24 75.1 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 117.865 -1.064 . . . . 0.0 109.519 177.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.5 mt -61.75 -55.24 32.33 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.94 1.245 . . . . 0.0 109.376 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 18.3 m -60.12 -46.45 89.59 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.93 1.692 . . . . 0.0 111.211 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.9 ttpt -66.84 -41.9 86.66 Favored 'General case' 0 C--N 1.341 0.208 0 O-C-N 120.103 -1.623 . . . . 0.0 110.544 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 27.0 m -53.73 -50.49 65.83 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.795 0.838 . . . . 0.0 110.028 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -55.05 -50.38 69.26 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.133 0.573 . . . . 0.0 111.015 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.77 -58.49 7.82 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 122.487 1.136 . . . . 0.0 112.807 -178.55 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.0 mm100 -58.87 -40.63 84.92 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.915 1.286 . . . . 0.0 111.27 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.0 -53.03 39.86 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 109.171 -1.571 . . . . 0.0 109.171 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.472 ' HA ' HD12 ' A' ' 109' ' ' ILE . 42.3 t -55.12 -47.58 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 119.46 1.63 . . . . 0.0 110.482 179.457 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.4 pttm -62.1 -34.23 75.94 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.364 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 84.0 m -75.63 -35.96 60.33 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.472 HD12 ' HA ' ' A' ' 106' ' ' VAL . 21.0 mt -59.24 -54.3 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -58.45 -34.14 70.51 Favored 'General case' 0 C--O 1.225 -0.198 0 O-C-N 123.852 0.72 . . . . 0.0 111.447 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -56.18 -48.13 76.95 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.181 0.593 . . . . 0.0 111.496 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.483 ' HE3' ' HA ' ' A' ' 215' ' ' PRO . 27.0 mmmt -80.96 -40.8 23.86 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 121.565 -0.709 . . . . 0.0 111.255 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 13.0 mt -61.59 -31.62 71.69 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-O 118.364 -0.827 . . . . 0.0 112.25 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -51.53 -28.14 12.81 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.031 0.932 . . . . 0.0 113.337 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -59.65 -63.11 1.42 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.981 0.912 . . . . 0.0 111.72 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 7.3 mmt85 -154.65 -176.95 6.16 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.395 1.478 . . . . 0.0 110.805 -178.121 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 67.3 m -86.29 174.32 9.15 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 177.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 30.9 pt -129.47 161.42 38.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 126.573 1.949 . . . . 0.0 107.246 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -153.35 142.62 21.52 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -136.97 117.23 13.52 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.346 0.659 . . . . 0.0 109.892 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -85.24 98.43 10.49 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.83 80.77 7.09 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 128.634 2.774 . . . . 0.0 108.02 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 60.16 -112.09 4.17 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 108.581 -1.808 . . . . 0.0 108.581 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -80.77 -24.65 38.47 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -100.45 159.33 15.23 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 119.957 1.253 . . . . 0.0 111.031 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.0 mp -134.88 132.22 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 N-CA-C 103.904 -2.628 . . . . 0.0 103.904 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -118.59 121.3 39.87 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -109.26 121.1 44.45 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -111.25 128.3 55.89 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.196 0.522 . . . . 0.0 110.669 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.483 ' HB3' HD13 ' A' ' 133' ' ' ILE . 54.7 m -110.14 153.21 43.37 Favored Pre-proline 0 N--CA 1.439 -1.002 0 C-N-CA 126.894 2.077 . . . . 0.0 113.308 -178.573 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -68.96 74.34 0.95 Allowed 'Trans proline' 0 C--N 1.349 0.573 1 C-N-CA 125.356 4.037 . . . . 0.0 113.692 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.13 51.77 6.65 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-O 119.04 -0.866 . . . . 0.0 113.812 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.483 HD13 ' HB3' ' A' ' 130' ' ' CYS . 2.6 mp -124.83 -72.16 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.299 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 177.73 145.28 0.11 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.172 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -109.87 131.98 54.57 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 124.757 1.223 . . . . 0.0 109.098 -175.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.5 m -144.82 164.53 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 125.318 1.447 . . . . 0.0 111.581 -177.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -123.19 126.29 46.71 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 105.25 -2.129 . . . . 0.0 105.25 177.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -138.36 162.99 32.98 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.87 1.214 . . . . 0.0 111.235 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -84.98 157.73 20.7 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 177.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.926 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -179.439 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 . . . . . 0 CA--C 1.512 -0.499 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.3 116.18 12.3 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 49.0 mt -98.05 -26.81 14.48 Favored 'General case' 0 C--O 1.22 -0.448 0 O-C-N 124.413 1.07 . . . . 0.0 110.91 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 155.17 155.17 7.2 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 119.028 0.831 . . . . 0.0 111.54 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -114.74 109.97 47.17 Favored Pre-proline 0 N--CA 1.451 -0.4 0 C-N-CA 125.246 1.418 . . . . 0.0 108.766 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -74.52 -177.55 3.41 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.801 2.334 . . . . 0.0 107.319 178.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -128.95 134.67 48.29 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-N 118.819 0.736 . . . . 0.0 110.532 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -49.61 -45.98 48.71 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 125.869 1.98 . . . . 0.0 109.808 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -73.21 65.05 0.8 Allowed 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.522 1.529 . . . . 0.0 110.297 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 5.9 p -50.76 -31.23 9.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 121.035 -1.041 . . . . 0.0 112.659 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -63.42 -26.88 68.94 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -177.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -86.74 -23.09 25.62 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.67 1.588 . . . . 0.0 112.826 -179.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 30.2 mtp85 -73.34 150.71 41.65 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -103.71 144.19 31.79 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -138.93 159.26 42.57 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.96 1.304 . . . . 0.0 108.749 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -120.11 153.74 35.72 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.738 0.815 . . . . 0.0 109.994 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 35.5 tp -114.26 98.01 6.68 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.777 1.631 . . . . 0.0 106.995 179.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -107.92 -178.54 3.64 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.693 1.997 . . . . 0.0 108.547 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -141.22 158.06 44.4 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.024 0.53 . . . . 0.0 110.853 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -132.09 -178.7 5.02 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.681 1.992 . . . . 0.0 108.435 179.416 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.14 -14.42 17.05 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.186 1.394 . . . . 0.0 113.136 -178.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 16.0 t -107.24 -41.87 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 124.37 1.068 . . . . 0.0 111.279 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 177.34 -172.34 45.15 Favored Glycine 0 C--N 1.336 0.537 0 O-C-N 121.104 -0.998 . . . . 0.0 114.573 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 5.0 m-30 -77.28 158.36 30.26 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 122.337 1.065 . . . . 0.0 108.514 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -157.04 160.5 39.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.2 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 92.5 mt -100.19 132.11 46.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 22.7 t -102.06 126.15 48.92 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 125.406 1.482 . . . . 0.0 111.971 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -123.17 111.6 16.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.725 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -93.26 119.04 40.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 177.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 9.1 mt -104.7 106.55 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 178.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.63 -153.1 24.54 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 124.771 1.177 . . . . 0.0 110.57 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 71.3 47.87 0.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.716 2.006 . . . . 0.0 107.946 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -115.04 162.91 12.27 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 108.886 -1.685 . . . . 0.0 108.886 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.05 159.11 30.11 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.0 mm -79.6 137.84 20.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 124.674 1.19 . . . . 0.0 110.604 178.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.3 m -90.09 108.65 19.86 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 128.047 2.539 . . . . 0.0 106.635 178.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -53.93 -25.88 22.62 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.051 1.34 . . . . 0.0 113.486 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 40.0 t -49.6 -47.26 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 125.254 1.422 . . . . 0.0 112.024 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 11.2 t -124.3 -38.99 2.37 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.278 1.031 . . . . 0.0 111.653 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 110.5 34.96 2.16 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 107.923 -2.071 . . . . 0.0 107.923 -177.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -106.28 154.8 20.23 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 120.175 1.988 . . . . 0.0 111.403 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -76.25 148.41 37.63 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 123.523 0.729 . . . . 0.0 111.723 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 38.6 mtt180 -69.91 27.23 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 130.564 3.546 . . . . 0.0 112.442 178.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 6.4 ptm -74.38 175.29 7.82 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.473 1.033 . . . . 0.0 110.683 -178.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.13 149.84 18.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 124.972 1.309 . . . . 0.0 107.484 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -109.19 112.79 25.15 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.355 1.462 . . . . 0.0 107.345 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 13.3 mm -105.99 139.49 27.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 39.1 mm-40 -124.73 126.71 46.11 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.479 1.112 . . . . 0.0 109.88 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -100.41 111.2 23.44 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.301 1.04 . . . . 0.0 110.512 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 3.5 m -124.21 163.43 24.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 123.742 0.817 . . . . 0.0 109.769 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 52.7 t -88.87 134.21 34.02 Favored 'General case' 0 N--CA 1.461 0.09 0 O-C-N 120.633 -1.292 . . . . 0.0 110.204 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -84.59 10.37 62.19 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 124.34 0.971 . . . . 0.0 114.032 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.17 0 N-CA-C 106.965 -2.454 . . . . 0.0 106.965 -177.988 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.483 ' HA ' ' HE3' ' A' ' 112' ' ' LYS . 55.4 Cg_endo . . . . . 0 N--CA 1.451 -1.024 0 N-CA-C 111.102 -0.384 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 4.2 p -174.85 151.83 1.46 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.212 1.405 . . . . 0.0 110.66 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.4 p -151.09 158.58 44.22 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.865 1.266 . . . . 0.0 109.222 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 4.3 mt -98.1 151.93 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 125.65 1.58 . . . . 0.0 110.084 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -97.07 -50.34 4.64 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 124.691 1.197 . . . . 0.0 112.031 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 63.9 p-90 -159.69 156.09 27.17 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -178.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 61.7 t -153.76 129.16 1.59 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 125.792 1.637 . . . . 0.0 107.198 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -160.62 163.68 32.42 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.198 0.599 . . . . 0.0 111.189 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -69.39 144.21 53.45 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' THR . . . . . 0.409 HG23 ' HG3' ' A' ' 225' ' ' LYS . 9.0 t -119.18 -35.8 3.53 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 121.084 -1.01 . . . . 0.0 110.521 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.409 ' HG3' HG23 ' A' ' 224' ' ' THR . 21.0 mttm -127.65 -175.11 3.37 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 83.3 mt -55.7 -44.63 77.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.731 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 1.1 t -125.16 10.16 8.08 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.579 0.752 . . . . 0.0 112.492 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 10.6 t -114.74 143.77 23.76 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.793 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -177.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -122.39 162.22 22.01 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -132.54 143.53 49.79 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -145.89 146.27 31.03 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.638 1.575 . . . . 0.0 108.842 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -135.44 130.25 34.49 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 8.8 m -114.43 155.6 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.627 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 178.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.04 125.27 44.25 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 1.5 pt -134.72 146.22 58.06 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -75.22 -35.98 2.68 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.413 2.076 . . . . 0.0 112.566 -178.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -62.89 -17.58 61.84 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 -177.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 18.4 mt -73.18 -29.31 62.75 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.88 1.218 . . . . 0.0 110.264 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 10.1 m -57.1 -15.86 6.32 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.11 0.964 . . . . 0.0 112.903 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -62.01 -31.05 71.39 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.139 0.975 . . . . 0.0 109.173 177.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -86.34 124.28 32.52 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 106.052 -1.832 . . . . 0.0 106.052 178.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -47.23 -48.67 24.19 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 127.003 2.121 . . . . 0.0 113.608 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 32.9 mt -67.01 -26.18 66.67 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 12.8 mt -99.31 2.64 45.63 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.095 1.758 . . . . 0.0 111.582 -178.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -77.67 114.56 16.63 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.614 1.566 . . . . 0.0 111.733 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp . . . . . 0 N--CA 1.465 0.279 0 C-N-CA 124.018 0.927 . . . . 0.0 109.529 178.208 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.55 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -148.78 76.74 1.36 Allowed 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 73.8 m -139.33 147.77 42.01 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 123.141 0.576 . . . . 0.0 111.625 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -87.13 168.36 13.33 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.194 0.998 . . . . 0.0 110.572 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.3 t -70.93 -41.37 71.26 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 117.696 -1.145 . . . . 0.0 113.945 -178.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -54.4 -40.36 68.15 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 120.297 1.408 . . . . 0.0 110.225 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.1 tmtm? -54.26 -55.16 30.9 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.631 1.172 . . . . 0.0 108.025 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.428 ' HA ' HD12 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -64.53 -37.17 86.61 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 124.06 0.944 . . . . 0.0 112.078 179.006 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.71 -50.26 74.56 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 61.1 tp -69.54 -34.61 74.48 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 118.33 -0.843 . . . . 0.0 110.748 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 95' ' ' THR . 17.3 mt -61.38 -54.38 44.39 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.8 m -57.52 -50.52 72.79 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.157 0.983 . . . . 0.0 110.368 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.7 -50.29 72.61 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 118.651 -0.69 . . . . 0.0 111.038 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 21.9 m -52.2 -45.21 65.13 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 124.282 1.033 . . . . 0.0 110.309 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -60.56 -51.38 69.67 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.356 0.98 . . . . 0.0 108.767 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -59.03 -60.25 4.17 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.44 -30.92 67.89 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.199 -176.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.76 -52.29 51.64 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.506 ' HA ' HD12 ' A' ' 109' ' ' ILE . 42.1 t -56.75 -48.62 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 118.361 1.08 . . . . 0.0 109.794 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.43 -30.92 70.87 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 119.037 -1.065 . . . . 0.0 113.487 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 44.4 m -78.19 -34.2 49.62 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.506 HD12 ' HA ' ' A' ' 106' ' ' VAL . 21.7 mt -60.02 -54.74 30.63 Favored 'Isoleucine or valine' 0 C--O 1.23 0.072 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -58.11 -29.85 65.82 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.781 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -69.75 -39.81 76.5 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.294 0.952 . . . . 0.0 112.189 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.2 tptt -84.77 -34.2 22.85 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 120.744 -1.223 . . . . 0.0 110.426 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 15.9 mt -65.95 -30.28 70.82 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 118.497 -0.763 . . . . 0.0 109.802 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -48.36 -35.05 11.75 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.466 1.107 . . . . 0.0 112.209 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -49.0 -66.07 0.46 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.51 1.524 . . . . 0.0 113.328 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -158.0 -177.85 6.87 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 128.178 2.591 . . . . 0.0 108.777 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 58.5 m -86.67 167.21 14.71 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 42.3 pt -115.69 156.99 16.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -154.18 141.76 19.85 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 122.555 0.342 . . . . 0.0 111.225 -178.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -140.44 125.75 18.78 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.649 0.78 . . . . 0.0 111.205 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -84.27 105.76 15.37 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.64 80.23 4.79 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.27 -103.24 0.98 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -93.2 -23.08 18.67 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.457 1.103 . . . . 0.0 113.742 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -100.58 156.9 17.04 Favored 'General case' 0 CA--C 1.517 -0.326 0 O-C-N 121.606 -0.684 . . . . 0.0 110.111 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.8 mp -127.89 135.33 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.43 ' CD1' HG11 ' A' ' 221' ' ' VAL . 63.1 m-85 -115.5 124.87 52.17 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -120.9 120.07 34.45 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 123.291 0.636 . . . . 0.0 110.301 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -110.9 131.2 55.25 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.657 0.741 . . . . 0.0 109.922 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.45 ' HB3' HD13 ' A' ' 133' ' ' ILE . 36.1 m -110.08 157.24 38.43 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 124.398 1.079 . . . . 0.0 112.697 -178.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -63.6 76.68 0.14 Allowed 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 125.042 3.828 . . . . 0.0 113.612 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 66.18 60.66 6.15 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 125.01 1.291 . . . . 0.0 112.228 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.45 HD13 ' HB3' ' A' ' 130' ' ' CYS . 3.2 mp -130.57 -71.46 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -164.88 164.71 20.82 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 126.455 1.902 . . . . 0.0 110.278 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -131.18 119.35 21.75 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 22.5 m -143.92 164.89 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 123.899 0.88 . . . . 0.0 110.761 -178.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -120.59 129.48 53.77 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.632 1.173 . . . . 0.0 109.014 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -138.93 162.87 33.81 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.19 1.396 . . . . 0.0 112.089 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -89.09 160.91 16.81 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 176.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 138.68 -161.81 25.81 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -149.06 167.55 25.56 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 126.495 1.918 . . . . 0.0 108.579 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.5 p -127.96 149.31 32.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -105.2 104.39 14.12 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 103.624 -2.732 . . . . 0.0 103.624 177.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.8 p -53.86 -31.85 51.02 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 120.744 1.611 . . . . 0.0 112.125 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -53.09 -46.28 68.59 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.25 1.42 . . . . 0.0 111.051 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 40.3 p -97.77 -33.95 11.08 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 123.835 0.854 . . . . 0.0 112.043 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 86.94 22.32 46.2 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 127.74 2.591 . . . . 0.0 111.763 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -124.32 154.77 39.8 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 119.082 1.441 . . . . 0.0 112.229 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 9.5 mm -70.51 166.45 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 125.128 1.371 . . . . 0.0 108.907 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 12.4 m -60.78 -55.52 24.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 178.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -164.41 157.51 17.49 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 127.884 2.474 . . . . 0.0 107.124 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 39.6 mtm-85 -74.68 176.78 6.64 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -140.99 103.72 4.53 Favored 'General case' 0 C--O 1.232 0.165 0 O-C-N 120.954 -1.091 . . . . 0.0 112.73 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -77.85 -19.5 54.75 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.413 1.085 . . . . 0.0 112.878 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 16.0 m -82.58 -41.16 19.91 Favored 'General case' 0 C--O 1.238 0.458 0 O-C-N 121.286 -0.884 . . . . 0.0 110.464 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 94.4 mt -77.36 72.96 3.93 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.883 1.673 . . . . 0.0 109.75 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 57.4 t -75.08 120.01 23.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 123.674 0.79 . . . . 0.0 109.895 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -146.96 151.74 37.49 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.971 1.708 . . . . 0.0 108.374 178.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -147.03 129.21 15.62 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 54.3 mt -112.94 -21.98 10.85 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.828 0.74 . . . . 0.0 109.753 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 155.98 157.8 8.48 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -126.46 117.73 23.07 Favored Pre-proline 0 CA--C 1.536 0.41 0 O-C-N 122.044 -0.68 . . . . 0.0 111.003 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -77.01 -171.17 1.07 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 1 C-N-CA 126.316 4.677 . . . . 0.0 108.845 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -129.5 152.86 48.57 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.312 1.045 . . . . 0.0 109.04 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -73.76 -29.71 62.37 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.26 1.024 . . . . 0.0 110.578 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -88.28 64.66 7.71 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 124.708 1.203 . . . . 0.0 108.361 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.6 p -50.07 -31.59 7.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 124.92 1.288 . . . . 0.0 112.093 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -61.5 -32.89 72.94 Favored 'General case' 0 CA--C 1.522 -0.116 0 C-N-CA 123.931 0.892 . . . . 0.0 111.986 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -80.64 -28.28 36.98 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.338 1.055 . . . . 0.0 110.82 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 9.4 mtp-105 -72.92 137.3 45.48 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -99.12 144.75 27.9 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -128.7 173.89 9.91 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 126.326 1.85 . . . . 0.0 108.639 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -131.71 154.09 49.36 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.375 0.67 . . . . 0.0 109.389 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 23.1 tp -118.27 100.65 7.64 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.344 1.058 . . . . 0.0 109.061 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -109.24 -179.89 3.97 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 181' ' ' TYR . 4.0 p90 -149.95 163.51 37.9 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 121.142 -0.974 . . . . 0.0 108.978 177.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -140.58 -178.14 5.38 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -59.33 -22.52 61.39 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.694 1.198 . . . . 0.0 111.729 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.449 HG12 ' HE3' ' A' ' 246' ' ' LYS . 48.3 t -88.85 -35.86 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 125.762 1.625 . . . . 0.0 111.965 -178.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 160.19 178.95 34.64 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 121.743 -0.265 . . . . 0.0 112.789 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 176' ' ' TYR . 20.1 m-85 -78.01 155.71 30.56 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 123.893 0.877 . . . . 0.0 108.98 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -155.72 156.72 35.37 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.31 0.644 . . . . 0.0 111.395 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 92.7 mt -97.15 133.82 37.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 12.3 t -101.32 127.14 48.07 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.495 1.518 . . . . 0.0 108.294 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -122.54 107.28 11.82 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.604 1.562 . . . . 0.0 107.807 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -93.3 115.47 32.19 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.5 mt -99.64 106.59 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 104.778 -2.305 . . . . 0.0 104.778 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -99.72 -152.86 27.24 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 108.771 -1.731 . . . . 0.0 108.771 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 69.66 47.7 0.63 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-O 123.049 1.404 . . . . 0.0 107.875 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -116.79 158.24 14.59 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 107.803 -2.119 . . . . 0.0 107.803 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -74.42 159.15 32.69 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.168 0.987 . . . . 0.0 108.704 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 34.1 mm -83.03 126.38 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 177.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.2 m -75.37 111.75 10.97 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 127.065 2.146 . . . . 0.0 107.072 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -56.23 -27.45 54.93 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.626 1.17 . . . . 0.0 112.49 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 57.9 t -49.3 -50.67 15.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 125.036 1.334 . . . . 0.0 110.847 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 6.5 t -125.57 -32.35 2.89 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 116.644 2.09 . . . . 0.0 116.644 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 106.9 35.86 2.68 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -178.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -116.68 152.14 34.89 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 118.261 1.03 . . . . 0.0 111.764 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -74.81 146.45 42.03 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.571 0.748 . . . . 0.0 112.908 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -72.6 29.11 0.06 Allowed 'General case' 0 C--O 1.223 -0.322 1 C-N-CA 132.055 4.142 . . . . 0.0 112.308 178.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 5.8 ptm -75.77 177.52 6.83 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 120.197 -1.565 . . . . 0.0 110.341 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 5.9 p -147.94 148.85 15.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 125.158 1.383 . . . . 0.0 108.452 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -104.73 121.97 44.71 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 177.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 17.7 mm -114.1 131.22 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -114.54 125.0 53.3 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.304 1.042 . . . . 0.0 109.068 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -97.77 112.72 24.51 Favored 'General case' 0 C--O 1.239 0.553 0 C-N-CA 123.685 0.794 . . . . 0.0 109.72 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 5.1 m -124.08 161.46 26.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 44.1 t -90.25 142.68 27.48 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -84.4 2.39 87.93 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-O 117.753 -1.581 . . . . 0.0 114.906 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 62.6 56.5 21.09 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 106.97 -2.452 . . . . 0.0 106.97 -178.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.93 137.37 29.4 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -179.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -82.18 -13.04 57.75 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.503 0.668 . . . . 0.0 110.653 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 50.5 p -156.23 172.26 18.77 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 119.845 -1.784 . . . . 0.0 111.682 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 125.57 174.22 13.86 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 127.041 2.258 . . . . 0.0 112.221 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -85.43 -113.85 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 124.194 3.263 . . . . 0.0 107.733 178.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.6 p -150.33 142.11 23.72 Favored 'General case' 0 C--O 1.237 0.405 0 O-C-N 120.047 -1.658 . . . . 0.0 111.554 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 40.7 p -147.86 160.98 42.19 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.776 1.23 . . . . 0.0 110.244 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 4.0 mt -100.08 153.71 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 126.536 1.935 . . . . 0.0 107.865 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -97.62 -48.55 5.2 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 124.492 1.117 . . . . 0.0 112.618 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 52.8 p-90 -163.96 159.46 20.83 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.43 HG11 ' CD1' ' A' ' 127' ' ' TYR . 91.0 t -152.8 129.15 1.84 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.586 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.14 167.35 29.39 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.289 0.95 . . . . 0.0 112.547 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -77.41 132.63 38.6 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.581 1.552 . . . . 0.0 107.653 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 7.5 t -110.84 -33.74 6.44 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.573 1.149 . . . . 0.0 110.918 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -132.53 -175.18 3.67 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 124.645 1.178 . . . . 0.0 108.985 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 60.9 mt -56.64 -45.05 82.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -125.58 18.33 8.1 Favored 'General case' 0 C--N 1.334 -0.108 0 C-N-CA 124.185 0.994 . . . . 0.0 111.102 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 15.8 t -121.65 143.3 34.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 CA-C-N 118.309 0.504 . . . . 0.0 110.387 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -124.47 161.32 26.32 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.152 1.381 . . . . 0.0 107.666 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -132.07 134.49 45.57 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 126.04 1.736 . . . . 0.0 106.534 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -140.22 145.3 37.22 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.919 1.688 . . . . 0.0 109.07 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -133.69 128.62 35.37 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 119.263 -0.398 . . . . 0.0 111.57 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 3.8 m -112.35 152.69 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.57 115.36 20.71 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.808 1.243 . . . . 0.0 107.775 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 18.5 pt -127.14 152.25 75.61 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.879 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.63 -45.43 0.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.819 2.346 . . . . 0.0 112.366 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -53.32 -28.51 28.77 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 116.751 2.13 . . . . 0.0 116.751 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.4 HD22 ' CD1' ' A' ' 244' ' ' LEU . 59.2 mt -64.42 -28.98 70.05 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 120.33 1.423 . . . . 0.0 110.323 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 12.3 m -60.61 -11.72 8.04 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -69.85 -31.52 69.41 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.96 121.63 25.71 Favored 'General case' 0 C--O 1.225 -0.199 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -47.13 -42.6 19.63 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.906 1.683 . . . . 0.0 113.47 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.86 -29.57 64.51 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.4 ' CD1' HD22 ' A' ' 238' ' ' LEU . 17.3 mt -96.49 -5.45 39.45 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.299 1.04 . . . . 0.0 111.832 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -64.3 116.77 6.36 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.895 1.678 . . . . 0.0 108.577 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.449 ' HE3' HG12 ' A' ' 179' ' ' VAL . 3.8 mmmm -77.26 161.21 28.31 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 178.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -68.3 -11.5 59.57 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -127.71 33.12 4.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.104 1.362 . . . . 0.0 110.552 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.017 0 C-N-CA 125.615 1.566 . . . . 0.0 109.043 178.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.706 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.09 126.51 18.8 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.888 0.875 . . . . 0.0 110.141 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.2 t -151.39 109.44 3.71 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 50.84 31.63 6.29 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.523 1.129 . . . . 0.0 110.824 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.5 m -46.23 -54.17 9.3 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 127.343 2.257 . . . . 0.0 113.702 -177.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -64.51 -38.21 90.21 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 118.33 0.514 . . . . 0.0 111.555 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -61.05 -46.29 91.32 Favored 'General case' 0 C--N 1.342 0.265 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.85 -34.04 73.97 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.754 0.706 . . . . 0.0 110.955 178.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.56 -43.15 97.57 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 119.119 0.872 . . . . 0.0 109.395 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 65.7 tp -64.2 -32.36 73.91 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-O 118.406 -0.807 . . . . 0.0 109.61 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.04 -54.36 39.3 Favored 'General case' 0 C--N 1.345 0.377 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 25.3 m -60.79 -48.14 83.13 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.159 0.984 . . . . 0.0 110.877 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.86 -48.84 79.95 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 121.024 -1.048 . . . . 0.0 110.036 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 53.8 m -54.11 -46.09 72.03 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 123.535 0.734 . . . . 0.0 110.055 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -56.22 -48.47 76.41 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.515 0.326 . . . . 0.0 110.432 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.16 -52.96 16.26 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -58.14 -40.29 80.95 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.344 1.058 . . . . 0.0 110.983 -178.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -66.58 -52.35 35.34 Favored Glycine 0 C--O 1.223 -0.537 0 N-CA-C 108.776 -1.729 . . . . 0.0 108.776 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.415 ' HA ' HD12 ' A' ' 109' ' ' ILE . 24.5 t -53.25 -46.88 57.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 118.76 1.28 . . . . 0.0 110.988 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.6 ptmm? -62.44 -34.2 76.32 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.1 m -77.66 -36.45 51.34 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.916 0.887 . . . . 0.0 110.371 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.415 HD12 ' HA ' ' A' ' 106' ' ' VAL . 23.5 mt -60.22 -54.71 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -61.53 -28.19 69.14 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.112 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -66.29 -45.41 80.5 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 120.586 -1.321 . . . . 0.0 113.0 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -76.92 -39.43 50.84 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 18.3 mt -66.22 -28.41 68.72 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-O 118.721 -0.657 . . . . 0.0 112.147 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -56.77 -18.57 13.16 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.54 0.736 . . . . 0.0 112.607 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -68.01 -74.71 0.11 Allowed 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 7.1 mmm180 -143.06 -179.65 6.5 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.281 1.432 . . . . 0.0 111.402 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 85.3 m -86.59 174.91 8.6 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 32.7 pt -128.67 159.99 39.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 127.043 2.137 . . . . 0.0 107.299 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -155.81 135.25 12.39 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.855 1.262 . . . . 0.0 108.975 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -130.79 126.16 35.62 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.666 1.186 . . . . 0.0 109.076 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -88.88 104.15 16.67 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.26 1.024 . . . . 0.0 109.365 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.59 80.74 4.3 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 128.337 2.655 . . . . 0.0 106.552 178.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 59.97 -113.34 5.24 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -78.0 -22.54 49.18 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.192 0.997 . . . . 0.0 112.835 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -105.15 161.72 14.01 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 123.625 0.77 . . . . 0.0 111.917 -178.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.4 mp -135.61 134.75 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 104.131 -2.544 . . . . 0.0 104.131 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.405 ' CD1' ' HB3' ' A' ' 137' ' ' GLN . 94.4 m-85 -114.86 119.65 37.29 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 103.991 -2.596 . . . . 0.0 103.991 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -111.02 116.46 31.22 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.382 0.673 . . . . 0.0 109.396 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -106.66 129.23 54.6 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.52 ' HB3' HD13 ' A' ' 133' ' ' ILE . 20.8 m -114.75 155.49 46.17 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 126.665 1.986 . . . . 0.0 113.835 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.27 80.73 1.57 Allowed 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 124.115 3.21 . . . . 0.0 113.37 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.44 45.31 18.93 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-O 118.2 -1.333 . . . . 0.0 112.961 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.52 HD13 ' HB3' ' A' ' 130' ' ' CYS . 3.0 mp -120.84 -72.3 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 119.459 1.63 . . . . 0.0 109.913 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -179.2 141.91 0.18 Allowed 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -109.17 125.69 52.46 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -177.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 33.3 m -144.61 164.33 13.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 114.123 -1.399 . . . . 0.0 111.575 -177.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.405 ' HB3' ' CD1' ' A' ' 127' ' ' TYR . 6.6 pt20 -123.0 130.57 52.97 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.649 1.179 . . . . 0.0 108.286 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -138.25 162.89 33.15 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.402 1.481 . . . . 0.0 111.338 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.495 ' H ' ' CD1' ' A' ' 156' ' ' LEU . 74.3 t60 -91.06 161.56 15.06 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.916 1.686 . . . . 0.0 107.391 178.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 126.57 -158.65 20.71 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-N 120.099 1.318 . . . . 0.0 110.769 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.57 167.26 28.62 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 121.668 -0.901 . . . . 0.0 109.488 177.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.8 p -123.16 141.15 44.54 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 C-N-CA 124.034 0.934 . . . . 0.0 108.79 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -86.72 113.94 22.99 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 13.5 p -59.86 -17.72 38.85 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.831 1.252 . . . . 0.0 112.799 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -68.8 -35.37 76.93 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 126.984 2.114 . . . . 0.0 113.399 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 30.6 p -124.88 -36.29 2.58 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 93.92 34.82 6.33 Favored Glycine 0 C--N 1.334 0.447 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -124.36 141.96 51.66 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 125.166 1.386 . . . . 0.0 108.863 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 9.4 mm -71.73 161.24 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 8.6 m -58.8 -42.23 84.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 O-C-N 121.505 -0.747 . . . . 0.0 110.672 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -172.91 164.1 5.01 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 126.596 1.959 . . . . 0.0 107.383 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -75.75 167.78 21.25 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 178.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -127.27 99.54 5.7 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -84.35 -20.03 32.68 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 118.514 -0.755 . . . . 0.0 112.121 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 6.0 t -75.02 -42.52 57.21 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 120.349 1.431 . . . . 0.0 109.462 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.495 ' CD1' ' H ' ' A' ' 139' ' ' HIS . 54.5 mt -72.6 123.3 22.92 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 15.7 m -131.56 105.03 9.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -124.09 160.76 27.03 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.491 1.516 . . . . 0.0 107.275 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 9.6 tpp180 -143.36 110.46 5.68 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.9 mp -98.43 -34.46 10.63 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 177.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 160.05 163.92 14.34 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 119.266 0.939 . . . . 0.0 111.537 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -118.82 109.78 39.25 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 124.264 1.026 . . . . 0.0 110.201 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -77.93 174.93 11.81 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 123.298 2.665 . . . . 0.0 111.118 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -126.35 146.23 50.13 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.25 -37.93 75.04 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 126.664 1.985 . . . . 0.0 111.428 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -73.25 65.36 0.83 Allowed 'General case' 0 C--O 1.233 0.227 0 C-N-CA 126.098 1.759 . . . . 0.0 109.967 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.4 p -48.84 -31.22 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 125.048 1.339 . . . . 0.0 112.206 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -71.18 -31.61 67.85 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 124.899 1.28 . . . . 0.0 112.862 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -76.65 -12.95 60.08 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.715 1.206 . . . . 0.0 113.167 -178.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -107.63 152.54 24.15 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.598 1.159 . . . . 0.0 110.526 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -105.02 156.61 17.89 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.267 1.427 . . . . 0.0 108.306 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -136.83 163.91 29.53 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.46 1.504 . . . . 0.0 108.738 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -114.72 153.7 29.81 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.236 0.614 . . . . 0.0 110.106 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 16.9 tp -118.39 98.79 6.44 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.432 1.493 . . . . 0.0 107.79 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -110.35 -178.99 3.65 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 126.875 2.07 . . . . 0.0 108.564 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -144.88 163.31 34.5 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 121.35 0.595 . . . . 0.0 110.057 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -137.69 -177.59 4.87 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.791 1.636 . . . . 0.0 108.046 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -60.55 -17.54 46.67 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.164 1.386 . . . . 0.0 111.56 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 87.7 t -86.0 -56.98 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 128.511 2.724 . . . . 0.0 110.484 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 168.76 -165.17 38.68 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -78.39 166.49 22.58 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 117.523 0.662 . . . . 0.0 109.683 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -159.85 171.59 19.18 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.167 0.987 . . . . 0.0 110.384 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 79.7 mt -107.42 138.11 35.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 32.9 t -107.07 134.11 50.69 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 125.393 1.477 . . . . 0.0 108.408 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -130.23 111.45 12.42 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.369 1.068 . . . . 0.0 108.214 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.6 mp -93.41 132.17 38.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 10.3 mt -122.18 115.2 45.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -110.68 -152.52 13.01 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 125.796 1.665 . . . . 0.0 111.603 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 4.6 t 71.58 35.25 1.49 Allowed 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.65 1.58 . . . . 0.0 114.434 178.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -87.58 -112.42 1.02 Allowed Glycine 0 CA--C 1.526 0.768 0 N-CA-C 108.44 -1.864 . . . . 0.0 108.44 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -154.55 150.83 28.17 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 129.825 3.25 . . . . 0.0 103.589 178.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.8 mm -72.9 137.57 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 O-C-N 120.053 -1.654 . . . . 0.0 111.999 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.6 m -81.4 116.08 21.05 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 128.489 2.716 . . . . 0.0 107.001 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -57.72 -29.16 64.51 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 124.624 1.17 . . . . 0.0 112.105 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 14.5 t -51.81 -50.67 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 126.423 1.889 . . . . 0.0 113.878 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 14.7 t -124.0 -31.97 3.31 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.15 34.74 3.86 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 -178.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -109.14 155.64 20.78 Favored 'General case' 0 C--N 1.343 0.324 0 C-N-CA 123.957 0.903 . . . . 0.0 110.182 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -75.72 144.4 41.55 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 125.197 1.399 . . . . 0.0 110.832 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . 0.269 26.1 mtp85 -69.04 29.18 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 130.053 3.341 . . . . 0.0 112.524 178.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 8.4 ptm -74.71 177.99 5.75 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.141 0.976 . . . . 0.0 112.022 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.3 p -145.78 152.72 13.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 125.504 1.522 . . . . 0.0 109.174 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -112.18 101.81 10.03 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 126.938 2.095 . . . . 0.0 106.921 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 9.1 mm -94.36 146.31 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -126.32 114.43 18.24 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 127.298 2.239 . . . . 0.0 109.574 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -93.62 115.71 28.19 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 12.5 m -125.02 165.62 21.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 42.1 t -87.04 140.68 29.31 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -95.47 18.06 58.12 Favored Glycine 0 CA--C 1.523 0.532 0 CA-C-O 118.596 -1.114 . . . . 0.0 112.706 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 68.13 -149.18 49.87 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 107.771 -2.131 . . . . 0.0 107.771 -178.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 41.5 m -73.49 81.35 1.45 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.236 1.018 . . . . 0.0 108.33 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -132.02 60.67 1.67 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 12.6 m -52.97 123.62 12.06 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 123.882 0.873 . . . . 0.0 109.929 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 163.52 -168.25 38.07 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.68 -75.37 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 123.553 2.835 . . . . 0.0 110.488 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 3.8 p -173.05 152.42 2.32 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.863 1.665 . . . . 0.0 110.914 -178.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 4.7 p -150.85 166.36 30.79 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.533 1.533 . . . . 0.0 109.108 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.476 HG12 HG12 ' A' ' 233' ' ' VAL . 5.1 mt -108.68 153.73 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 126.098 1.759 . . . . 0.0 110.614 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -94.44 -56.29 2.86 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 124.46 1.104 . . . . 0.0 111.155 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 -160.73 156.05 24.76 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 126.324 1.85 . . . . 0.0 106.903 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 58.0 t -151.33 125.94 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 125.731 1.612 . . . . 0.0 108.369 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -162.54 164.18 27.01 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 118.21 0.459 . . . . 0.0 110.874 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -65.81 141.9 58.13 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' THR . . . . . 0.486 HG23 ' HG3' ' A' ' 225' ' ' LYS . 1.8 t -123.79 -30.64 3.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 118.457 0.571 . . . . 0.0 111.897 179.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.486 ' HG3' HG23 ' A' ' 224' ' ' THR . 11.3 mttt -124.4 -175.87 3.37 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 77.0 mt -59.28 -47.36 90.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.88 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 1.8 t -118.93 15.02 13.37 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.651 0.78 . . . . 0.0 112.703 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 14.2 t -122.38 148.7 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.705 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.546 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -125.42 166.1 17.21 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -133.02 144.47 50.1 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 124.667 1.187 . . . . 0.0 108.464 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -144.96 118.95 9.35 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.19 1.396 . . . . 0.0 109.915 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -106.13 124.11 49.06 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 104.98 -2.23 . . . . 0.0 104.98 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' VAL . . . . . 0.476 HG12 HG12 ' A' ' 218' ' ' ILE . 3.0 m -119.38 153.76 21.92 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 2.1 p -122.55 138.27 54.63 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 122.236 1.017 . . . . 0.0 110.856 -178.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -143.69 148.14 41.86 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 114.609 -1.178 . . . . 0.0 108.142 178.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.28 -36.11 3.44 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 121.597 1.531 . . . . 0.0 112.208 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -59.86 -20.74 58.85 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 116.618 2.081 . . . . 0.0 116.618 -177.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 32.9 mt -71.24 -26.64 63.0 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.899 1.681 . . . . 0.0 110.52 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 27.5 m -59.57 -12.52 6.73 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.877 0.871 . . . . 0.0 111.845 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -62.39 -35.77 80.23 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.772 0.829 . . . . 0.0 110.171 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -87.87 130.9 34.75 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -47.81 -48.64 30.43 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.516 1.926 . . . . 0.0 112.779 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 66.0 mt -65.34 -25.67 67.7 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 15.4 mt -99.74 -7.54 25.42 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.746 0.818 . . . . 0.0 113.175 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -62.54 112.86 2.65 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 128.212 2.605 . . . . 0.0 112.743 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -66.69 151.71 46.85 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -94.5 -22.34 18.3 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.52 0.728 . . . . 0.0 111.521 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.29 35.36 4.56 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 129.117 2.967 . . . . 0.0 109.935 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 C--O 1.247 0.967 0 C-N-CA 125.917 1.687 . . . . 0.0 110.326 179.426 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.935 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.66 161.24 23.5 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.129 0.965 . . . . 0.0 109.785 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.9 p -154.09 107.56 2.93 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.759 1.224 . . . . 0.0 109.423 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -72.42 121.71 20.01 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 177.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.9 m -70.15 -20.91 63.13 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.119 1.368 . . . . 0.0 114.511 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -75.37 -49.68 18.27 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 120.702 -1.249 . . . . 0.0 108.663 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -53.65 -50.85 64.88 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.45 ' HA ' HD12 ' A' ' 98' ' ' LEU . 1.1 p -66.75 -36.17 81.83 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 123.256 0.622 . . . . 0.0 112.524 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.09 -38.97 93.3 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 22.8 tp -74.0 -40.96 62.57 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 117.519 -1.229 . . . . 0.0 109.367 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' ' 95' ' ' THR . 36.2 mt -57.87 -54.09 50.88 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.738 1.154 . . . . 0.0 110.407 -177.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 78.2 m -61.81 -38.07 86.73 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.503 -0.748 . . . . 0.0 111.215 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.39 -48.2 76.35 Favored 'General case' 0 C--N 1.341 0.201 0 O-C-N 120.091 -1.631 . . . . 0.0 109.424 178.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 77.2 m -52.82 -48.43 66.97 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.12 1.368 . . . . 0.0 109.941 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -59.38 -43.92 92.84 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.797 0.439 . . . . 0.0 111.933 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -71.98 -52.79 15.36 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -63.22 -41.22 99.09 Favored 'General case' 0 C--O 1.216 -0.698 0 C-N-CA 124.856 1.263 . . . . 0.0 109.661 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.04 -50.9 62.32 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.435 ' HA ' HD12 ' A' ' 109' ' ' ILE . 36.4 t -58.24 -45.88 88.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 118.591 1.195 . . . . 0.0 110.425 179.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 8.0 ptmt -61.92 -34.66 76.47 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.783 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 99.6 m -77.67 -28.53 51.16 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.679 0.792 . . . . 0.0 109.783 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.435 HD12 ' HA ' ' A' ' 106' ' ' VAL . 19.8 mt -69.61 -55.03 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 178.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -55.7 -36.99 67.76 Favored 'General case' 0 CA--C 1.527 0.083 0 O-C-N 123.644 0.59 . . . . 0.0 110.565 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -63.25 -38.66 92.02 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.258 1.023 . . . . 0.0 111.95 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.0 tptp -82.63 -38.78 23.04 Favored 'General case' 0 CA--C 1.518 -0.273 0 O-C-N 121.149 -0.969 . . . . 0.0 111.114 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 31.8 mt -70.26 -24.6 63.09 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 122.437 0.295 . . . . 0.0 111.305 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -50.93 -29.71 12.87 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.132 1.373 . . . . 0.0 111.096 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -64.87 -64.51 0.85 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.315 1.046 . . . . 0.0 113.176 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 86.7 mmt-85 -150.46 177.17 10.25 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.684 1.194 . . . . 0.0 110.479 -177.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 74.4 m -86.47 175.99 8.08 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 46.2 pt -129.33 157.74 42.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 124.926 1.29 . . . . 0.0 108.473 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -156.46 139.79 15.7 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.014 0.926 . . . . 0.0 110.668 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.476 ' CE1' ' HB2' ' A' ' 122' ' ' ALA . 4.9 t80 -136.84 124.14 21.9 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -81.07 98.79 8.15 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.997 1.719 . . . . 0.0 108.24 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.476 ' HB2' ' CE1' ' A' ' 120' ' ' TYR . . . -91.86 79.76 5.28 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.19 -85.37 0.06 OUTLIER Glycine 0 CA--C 1.521 0.458 0 C-N-CA 124.67 1.129 . . . . 0.0 113.183 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -106.8 -32.18 8.07 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.447 1.099 . . . . 0.0 112.895 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -104.93 128.24 53.11 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 123.679 0.791 . . . . 0.0 110.96 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.9 mp -98.24 157.1 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 103.794 -2.669 . . . . 0.0 103.794 177.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -135.34 121.95 20.77 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 103.955 -2.609 . . . . 0.0 103.955 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -119.25 117.65 29.18 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.8 1.64 . . . . 0.0 110.741 -178.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -110.67 137.7 48.0 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.415 1.486 . . . . 0.0 109.453 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.489 ' HB3' HD13 ' A' ' 133' ' ' ILE . 11.7 m -120.83 151.81 55.2 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 123.718 0.807 . . . . 0.0 111.506 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -60.53 85.35 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.662 1 C-N-CA 125.767 4.311 . . . . 0.0 115.044 -177.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 74.43 33.05 57.06 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 117.964 -1.464 . . . . 0.0 113.207 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.489 HD13 ' HB3' ' A' ' 130' ' ' CYS . 3.8 mp -115.65 -72.49 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 119.537 1.668 . . . . 0.0 109.222 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.489 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 9.1 pt-20 -168.88 169.36 9.83 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.12 1.768 . . . . 0.0 109.115 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -134.23 120.79 20.45 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 33.8 m -139.47 163.39 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.807 1.243 . . . . 0.0 110.993 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -118.82 125.07 48.73 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -138.24 162.3 34.66 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.962 0.801 . . . . 0.0 110.704 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -89.96 160.58 16.32 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 177.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 143.13 -158.59 27.26 Favored Glycine 0 N--CA 1.464 0.565 0 O-C-N 120.031 -1.668 . . . . 0.0 109.685 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.11 159.99 32.49 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.777 1.231 . . . . 0.0 108.671 177.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.7 p -110.24 149.06 13.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -103.61 101.59 11.45 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 17.7 p -48.25 -25.94 1.75 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 127.836 2.454 . . . . 0.0 114.209 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 39.8 mmtt -68.42 -32.22 72.11 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.299 1.44 . . . . 0.0 113.096 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 23.8 p -118.91 -27.77 5.7 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 84.29 31.63 24.79 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 124.67 1.129 . . . . 0.0 112.243 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -125.8 156.06 40.1 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.597 1.159 . . . . 0.0 111.055 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 15.0 mm -76.55 149.49 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 29.3 m -62.9 -43.97 99.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -149.42 -171.77 3.97 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.786 1.634 . . . . 0.0 107.755 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.22 105.48 5.04 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 178.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.437 ' CG ' HD12 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -70.83 120.45 16.44 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 120.768 -1.208 . . . . 0.0 108.881 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -79.66 -24.44 41.83 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.269 0.628 . . . . 0.0 110.869 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 2.6 p -74.0 -21.47 59.97 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 126.004 1.722 . . . . 0.0 112.642 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.437 HD12 ' CG ' ' A' ' 153' ' ' ASP . 29.3 mt -96.1 83.45 3.63 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 122.598 1.19 . . . . 0.0 109.413 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 65.1 t -84.66 124.07 39.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 125.249 1.42 . . . . 0.0 107.346 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -154.6 156.8 37.19 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.544 1.537 . . . . 0.0 108.221 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -149.07 129.52 13.88 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.047 -1.658 . . . . 0.0 110.7 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 43.4 mt -109.02 -30.63 7.98 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 120.053 1.297 . . . . 0.0 108.525 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 165.68 164.36 20.99 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -128.66 109.63 18.87 Favored Pre-proline 0 C--O 1.236 0.356 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.489 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 69.2 Cg_endo -73.36 176.72 8.85 Favored 'Trans proline' 0 C--O 1.236 0.39 1 C-N-CA 125.458 4.105 . . . . 0.0 110.783 -179.542 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -123.13 144.39 49.37 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 124.114 0.966 . . . . 0.0 109.58 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -67.11 -43.53 82.23 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 124.953 1.408 . . . . 0.0 109.6 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -74.3 64.81 1.14 Allowed 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.285 1.434 . . . . 0.0 110.411 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.2 p -50.95 -28.83 6.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 126.855 2.062 . . . . 0.0 111.333 178.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -72.97 -30.44 63.84 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.497 1.119 . . . . 0.0 112.524 -178.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -75.98 -23.01 55.29 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -96.58 173.6 7.26 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -133.31 165.39 24.92 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -135.71 169.79 16.99 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.743 1.217 . . . . 0.0 110.245 -177.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -113.23 153.65 28.01 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 48.7 tp -123.11 99.07 6.18 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.009 1.723 . . . . 0.0 106.784 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -108.36 175.56 5.43 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -140.5 160.56 39.73 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 123.001 1.382 . . . . 0.0 109.609 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -140.79 178.23 7.49 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 126.294 1.838 . . . . 0.0 106.544 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -73.2 10.78 0.87 Allowed 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 125.479 1.512 . . . . 0.0 114.199 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 59.6 t -116.76 -37.25 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 125.879 1.672 . . . . 0.0 109.827 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 164.04 -176.04 40.09 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -86.68 163.19 17.5 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.534 ' HB3' HG12 ' A' ' 207' ' ' VAL . 43.5 p90 -156.36 161.52 40.14 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.633 0.773 . . . . 0.0 110.667 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 86.6 mt -102.08 130.74 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 12.9 t -97.38 126.9 42.91 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.485 1.114 . . . . 0.0 108.704 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -122.13 108.89 13.86 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -90.28 108.88 20.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 N-CA-C 103.68 -2.711 . . . . 0.0 103.68 178.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 12.2 mt -94.62 105.92 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 103.331 -2.841 . . . . 0.0 103.331 177.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -99.28 -152.72 27.52 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 107.765 -2.134 . . . . 0.0 107.765 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 5.2 t 70.22 51.64 0.38 Allowed 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -178.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -93.29 -162.78 36.62 Favored Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 106.375 -2.69 . . . . 0.0 106.375 177.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -127.64 136.17 51.26 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 100.585 -3.858 . . . . 0.0 100.585 177.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 33.2 mm -60.36 138.95 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 119.552 1.069 . . . . 0.0 109.924 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.06 112.01 24.25 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.829 2.052 . . . . 0.0 106.376 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -51.12 -29.02 12.14 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.183 1.793 . . . . 0.0 115.795 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 24.5 t -42.22 -51.92 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.126 1.37 . . . . 0.0 111.108 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 13.2 t -123.76 -34.07 3.08 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.532 0.733 . . . . 0.0 109.334 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 106.48 35.46 2.86 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -112.51 158.86 19.39 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-N 118.852 1.326 . . . . 0.0 110.689 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -68.12 143.53 55.39 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.649 1.58 . . . . 0.0 114.869 -178.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . 0.258 24.1 ttp180 -77.22 28.76 0.14 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 130.508 3.523 . . . . 0.0 113.524 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 8.1 ptm -73.82 176.91 5.9 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.072 -1.017 . . . . 0.0 111.365 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.46 149.27 19.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 125.801 1.64 . . . . 0.0 106.733 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -111.39 114.19 27.16 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 9.5 mm -102.26 138.99 24.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -118.15 96.93 5.54 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 126.729 2.011 . . . . 0.0 107.698 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -80.83 111.13 17.01 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.247 1.019 . . . . 0.0 108.545 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.534 HG12 ' HB3' ' A' ' 182' ' ' TYR . 33.5 m -124.53 164.98 22.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 124.653 1.181 . . . . 0.0 108.383 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' CYS . . . . . 0.439 ' O ' ' HE2' ' A' ' 246' ' ' LYS . 41.8 t -85.8 142.22 29.1 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -90.54 16.99 56.57 Favored Glycine 0 C--O 1.227 -0.294 0 CA-C-O 118.067 -1.407 . . . . 0.0 115.15 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 57.57 -5.08 0.04 OUTLIER Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.812 1.673 . . . . 0.0 117.071 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 7.6 t -82.69 160.54 22.37 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 119.702 1.751 . . . . 0.0 108.88 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -73.57 -53.59 10.16 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.659 0.783 . . . . 0.0 111.821 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.85 163.01 38.39 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.662 0.744 . . . . 0.0 111.497 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 150.05 -174.27 29.53 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 128.181 2.8 . . . . 0.0 107.287 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -75.85 -110.3 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 124.085 3.19 . . . . 0.0 110.983 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' SER . . . . . 0.405 ' CB ' HG22 ' A' ' 235' ' ' ILE . 3.8 p -156.01 148.61 23.86 Favored 'General case' 0 C--O 1.237 0.442 0 O-C-N 120.094 -1.629 . . . . 0.0 109.853 -178.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.7 p -151.01 168.5 24.38 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.895 0.878 . . . . 0.0 112.122 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.436 HG12 HG12 ' A' ' 233' ' ' VAL . 3.2 mt -109.63 152.01 11.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 126.505 1.922 . . . . 0.0 109.465 178.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -98.42 -51.83 3.84 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 126.063 1.745 . . . . 0.0 109.592 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 65.3 p-90 -159.87 158.67 31.34 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.607 1.163 . . . . 0.0 109.306 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 97.1 t -153.42 134.9 5.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 126.153 1.781 . . . . 0.0 107.459 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -165.7 162.64 18.86 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.367 0.667 . . . . 0.0 111.662 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -68.48 140.87 55.72 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 178.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 13.1 t -120.65 -30.07 4.57 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.865 1.266 . . . . 0.0 112.681 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 43.2 mttt -131.25 -175.63 3.76 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 72.8 mt -46.68 -49.49 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 6.8 t -133.25 17.82 4.06 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.986 0.514 . . . . 0.0 111.276 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 23.1 t -109.62 143.31 19.97 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -122.68 161.95 22.89 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -131.69 144.55 51.08 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 178.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -144.77 141.33 29.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.893 1.277 . . . . 0.0 109.585 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -124.01 116.26 22.55 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' VAL . . . . . 0.436 HG12 HG12 ' A' ' 218' ' ' ILE . 1.1 m -110.36 144.54 18.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -121.83 123.6 42.16 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.666 1.586 . . . . 0.0 110.757 -178.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.405 HG22 ' CB ' ' A' ' 216' ' ' SER . 3.6 pt -131.65 147.62 66.77 Favored Pre-proline 0 C--N 1.331 -0.231 0 C-N-CA 123.892 0.877 . . . . 0.0 108.695 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -70.18 -43.04 2.51 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.766 1.644 . . . . 0.0 111.924 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -55.77 -23.85 32.17 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -177.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.613 HD22 ' CD1' ' A' ' 244' ' ' LEU . 20.1 mt -65.28 -26.71 68.2 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 116.982 -1.887 . . . . 0.0 111.07 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 18.9 m -61.7 -11.75 13.35 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.618 0.645 . . . . 0.0 112.29 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -61.08 -22.89 65.04 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.718 0.807 . . . . 0.0 109.798 177.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -98.11 130.58 44.89 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 126.594 1.958 . . . . 0.0 109.743 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -51.65 -47.76 63.62 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.844 1.258 . . . . 0.0 112.637 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.59 -35.85 80.85 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.104 -0.998 . . . . 0.0 113.438 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.613 ' CD1' HD22 ' A' ' 238' ' ' LEU . 17.9 mt -89.89 -14.94 33.17 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -178.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -58.68 112.72 1.72 Allowed 'General case' 0 C--O 1.236 0.345 0 C-N-CA 128.204 2.601 . . . . 0.0 111.731 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.439 ' HE2' ' O ' ' A' ' 208' ' ' CYS . 39.2 mmtt -79.3 159.51 27.19 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -88.62 -64.57 1.13 Allowed 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -142.07 59.32 1.47 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.428 0.632 . . . . 0.0 111.034 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 30.5 t70 . . . . . 0 C--O 1.246 0.889 0 C-N-CA 125.175 1.39 . . . . 0.0 109.58 178.199 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.175 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.46 120.98 13.83 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 54.6 p -160.47 134.78 7.33 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 50.71 22.99 1.23 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.716 1.206 . . . . 0.0 113.504 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.7 m -48.27 -39.81 22.72 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 129.374 3.07 . . . . 0.0 114.202 -178.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -66.69 -44.99 80.25 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 123.788 0.835 . . . . 0.0 109.169 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.412 ' HE2' HD11 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -60.49 -43.9 96.5 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.482 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.531 ' HA ' HD12 ' A' ' 98' ' ' LEU . 0.6 OUTLIER -64.1 -34.66 78.56 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.776 1.171 . . . . 0.0 110.708 177.979 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.5 -42.61 95.72 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 32.5 tp -69.85 -36.89 75.91 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.44 1.096 . . . . 0.0 110.507 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.531 HD12 ' HA ' ' A' ' 95' ' ' THR . 22.4 mt -61.41 -54.89 37.67 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 119.005 0.821 . . . . 0.0 109.083 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 56.1 m -65.38 -40.26 93.26 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 121.453 -0.779 . . . . 0.0 111.257 -179.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -45.37 93.89 Favored 'General case' 0 C--O 1.222 -0.382 0 O-C-N 121.207 -0.933 . . . . 0.0 109.169 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 42.2 m -52.28 -48.9 65.05 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.171 0.989 . . . . 0.0 109.741 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -58.3 -48.9 79.02 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.886 0.474 . . . . 0.0 110.863 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -67.82 -56.33 9.57 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -177.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.427 ' HA ' ' HE3' ' A' ' 107' ' ' LYS . 2.8 mm-40 -55.83 -44.25 77.75 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.806 1.642 . . . . 0.0 109.678 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.34 -52.99 49.29 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-O 118.001 -1.444 . . . . 0.0 110.212 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.412 ' HA ' HD12 ' A' ' 109' ' ' ILE . 43.0 t -55.85 -43.36 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-N 119.893 1.846 . . . . 0.0 110.91 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.427 ' HE3' ' HA ' ' A' ' 104' ' ' GLN . 6.6 ptpt -66.01 -33.81 76.65 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 119.38 -0.928 . . . . 0.0 111.165 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 65.5 m -72.9 -39.24 66.51 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 106' ' ' VAL . 22.7 mt -61.06 -55.76 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -61.29 -35.42 77.29 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 118.292 -0.861 . . . . 0.0 112.67 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -62.21 -33.85 75.34 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.813 0.733 . . . . 0.0 111.887 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.527 ' HA ' ' HE2' ' A' ' 112' ' ' LYS . 0.6 OUTLIER -87.62 -38.27 16.06 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 117.87 -1.062 . . . . 0.0 110.333 179.047 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 29.5 mt -65.74 -25.17 67.16 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.904 1.229 . . . . 0.0 110.338 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -51.47 -30.08 18.54 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.119 1.768 . . . . 0.0 111.558 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -65.51 -66.75 0.51 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.426 1.49 . . . . 0.0 113.083 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.6 mmt180 -144.56 173.36 11.87 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 124.456 1.102 . . . . 0.0 110.743 -178.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 78.6 m -86.07 163.34 17.97 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 48.3 pt -118.92 154.5 21.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -178.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -151.87 144.49 24.24 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.909 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -140.74 122.34 15.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.425 178.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -81.6 100.07 9.2 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.69 80.03 6.67 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 104.389 -2.449 . . . . 0.0 104.389 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 65.97 -109.02 2.65 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -81.32 -36.36 29.84 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -99.84 146.0 27.11 Favored 'General case' 0 CA--C 1.512 -0.486 0 O-C-N 121.635 -0.666 . . . . 0.0 110.388 -178.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.5 mp -110.21 153.4 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -131.9 119.3 20.98 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -121.15 120.49 35.4 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.315 1.046 . . . . 0.0 111.676 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -111.27 140.66 45.66 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.003 1.321 . . . . 0.0 111.065 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.507 ' HB3' HD13 ' A' ' 133' ' ' ILE . 50.3 m -123.12 152.77 64.06 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.497 1.119 . . . . 0.0 111.371 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -63.73 86.28 0.14 Allowed 'Trans proline' 0 C--N 1.35 0.649 1 C-N-CA 125.548 4.165 . . . . 0.0 115.7 -178.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 72.51 34.96 59.84 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 118.751 -1.027 . . . . 0.0 112.278 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.507 HD13 ' HB3' ' A' ' 130' ' ' CYS . 4.4 mp -118.59 -71.62 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.344 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -168.81 172.65 7.66 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.523 1.529 . . . . 0.0 110.314 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -137.21 119.75 15.99 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 31.8 m -139.22 163.54 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 124.528 1.131 . . . . 0.0 111.059 -178.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -121.05 124.43 44.8 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.968 1.307 . . . . 0.0 107.92 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -138.65 162.28 35.03 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.961 0.904 . . . . 0.0 111.469 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.595 ' H ' ' CD1' ' A' ' 156' ' ' LEU . 60.1 t60 -92.08 160.91 14.99 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 176.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 138.14 -160.19 25.34 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -148.98 162.21 40.36 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 125.418 1.487 . . . . 0.0 110.182 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 p -131.97 146.95 32.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 C-N-CA 125.277 1.431 . . . . 0.0 107.487 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -106.02 121.82 44.89 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 177.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 35.6 p -54.07 -13.34 0.78 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 127.487 2.315 . . . . 0.0 115.559 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt -78.98 -24.9 43.48 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -178.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 26.8 p -128.77 -33.64 2.02 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 123.936 0.895 . . . . 0.0 111.971 -178.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.86 31.16 36.49 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.632 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 -121.59 146.24 47.17 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 21.9 mm -65.23 152.41 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 26.6 m -58.45 -45.84 89.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 122.877 0.471 . . . . 0.0 109.759 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -164.32 108.58 0.96 Allowed 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -56.12 126.55 26.53 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.565 0.62 . . . . 0.0 110.394 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.96 104.84 5.71 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 126.488 1.915 . . . . 0.0 108.058 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -81.96 -23.88 35.83 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.026 0.931 . . . . 0.0 113.497 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 66.5 m -67.81 -36.53 80.57 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.469 -0.769 . . . . 0.0 112.63 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.595 ' CD1' ' H ' ' A' ' 139' ' ' HIS . 44.9 mt -72.66 132.79 44.16 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.599 1.159 . . . . 0.0 108.933 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 25.7 m -128.95 119.84 50.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 123.149 0.579 . . . . 0.0 109.489 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -149.45 155.36 40.28 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.84 1.656 . . . . 0.0 108.084 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 33.1 ttt85 -148.49 102.14 3.3 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 81.6 mt -79.37 -30.8 42.71 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 119.387 0.994 . . . . 0.0 108.495 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 169.45 156.35 10.74 Favored Glycine 0 N--CA 1.439 -1.129 0 CA-C-O 121.899 0.721 . . . . 0.0 111.345 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.62 109.04 44.05 Favored Pre-proline 0 N--CA 1.444 -0.76 0 C-N-CA 124.481 1.112 . . . . 0.0 108.674 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -77.22 -168.36 0.58 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.438 2.759 . . . . 0.0 109.038 178.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -126.5 151.09 48.28 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 124.724 1.21 . . . . 0.0 108.047 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -74.81 -28.69 60.81 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.973 0.892 . . . . 0.0 109.445 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -89.32 65.24 7.15 Favored 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 126.148 1.779 . . . . 0.0 106.297 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.2 p -45.22 -32.79 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 123.911 0.884 . . . . 0.0 111.973 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -65.48 -26.34 67.89 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.996 2.119 . . . . 0.0 112.875 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.68 -25.83 49.79 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.742 0.817 . . . . 0.0 110.337 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -75.96 177.74 6.79 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.725 0.81 . . . . 0.0 109.267 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -131.52 155.74 46.91 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -139.73 160.15 40.54 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.993 0.917 . . . . 0.0 109.49 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -117.24 153.57 32.67 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 18.5 tp -119.84 98.34 6.05 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -106.05 172.53 6.76 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 181' ' ' TYR . 2.5 p90 -147.21 162.76 38.24 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.934 0.873 . . . . 0.0 109.021 178.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -139.54 178.17 7.41 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 125.682 1.593 . . . . 0.0 109.44 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -68.38 2.2 2.47 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.081 1.353 . . . . 0.0 111.928 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 90.8 t -109.66 -38.96 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 126.14 1.776 . . . . 0.0 110.177 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 166.37 -175.81 41.73 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 176' ' ' TYR . 16.6 m-85 -88.33 164.86 15.35 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 117.962 0.881 . . . . 0.0 109.327 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.468 ' HB3' HG12 ' A' ' 207' ' ' VAL . 46.6 p90 -158.92 163.7 36.31 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.704 0.802 . . . . 0.0 109.965 179.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 95.2 mt -107.21 131.8 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 22.6 t -100.69 137.34 39.22 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.405 0.682 . . . . 0.0 109.312 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -131.22 116.05 17.14 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.513 1.125 . . . . 0.0 108.082 178.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -92.84 120.75 42.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 178.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.1 mt -107.66 106.7 21.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -108.92 -152.68 15.28 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 125.977 1.751 . . . . 0.0 109.199 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 80.42 22.8 0.41 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.956 1.702 . . . . 0.0 112.634 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -91.89 -154.05 30.41 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.24 166.15 10.85 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 179.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 36.7 mm -88.7 140.74 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.235 1.414 . . . . 0.0 108.982 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.2 m -88.94 115.14 26.28 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 127.816 2.446 . . . . 0.0 106.612 178.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -57.91 -16.96 13.83 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.211 1.404 . . . . 0.0 113.586 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 61.8 t -53.32 -56.06 9.98 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 CA-C-N 118.913 0.779 . . . . 0.0 110.663 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 1.9 t -124.66 -23.12 4.43 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -177.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.87 35.35 4.03 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 108.395 -1.882 . . . . 0.0 108.395 -178.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -111.0 147.59 34.4 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 119.054 1.427 . . . . 0.0 113.563 -178.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -68.34 144.51 54.76 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.992 0.917 . . . . 0.0 112.657 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -70.1 26.77 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.499 1 C-N-CA 131.862 4.065 . . . . 0.0 111.471 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 7.0 ptm -74.08 176.3 6.66 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.767 1.167 . . . . 0.0 112.814 -177.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.3 p -141.18 148.33 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 125.1 1.36 . . . . 0.0 107.981 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -110.59 109.32 19.57 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.484 1.913 . . . . 0.0 106.477 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 9.2 mm -99.29 150.06 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 O-C-N 121.055 -1.028 . . . . 0.0 111.191 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -125.67 106.52 9.78 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.206 2.202 . . . . 0.0 110.077 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -87.46 110.25 20.17 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 177.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.468 HG12 ' HB3' ' A' ' 182' ' ' TYR . 31.3 m -125.17 168.42 17.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 C-N-CA 125.186 1.394 . . . . 0.0 109.041 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 51.6 t -89.07 146.5 24.79 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 104.432 -2.432 . . . . 0.0 104.432 177.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -91.19 18.74 50.43 Favored Glycine 0 C--O 1.226 -0.401 0 CA-C-O 117.023 -1.987 . . . . 0.0 116.688 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 58.5 48.62 83.25 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-N 119.433 1.617 . . . . 0.0 109.075 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 71.5 m -149.13 166.52 28.53 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.52 1.528 . . . . 0.0 108.57 -178.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -123.87 -3.28 8.18 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 8.7 t -150.74 148.54 28.67 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 118.816 0.734 . . . . 0.0 109.695 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 125.79 175.43 14.19 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.263 0.935 . . . . 0.0 114.286 178.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -81.23 -115.83 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 124.536 3.491 . . . . 0.0 112.033 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' SER . . . . . 0.438 ' CB ' HG22 ' A' ' 235' ' ' ILE . 14.7 p -147.34 145.97 29.51 Favored 'General case' 0 C--O 1.239 0.52 0 O-C-N 120.482 -1.387 . . . . 0.0 112.369 -177.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 81.3 p -149.91 166.14 30.47 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.163 0.985 . . . . 0.0 110.99 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.9 mp -104.07 154.36 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 126.072 1.749 . . . . 0.0 108.118 178.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 43.4 mm-40 -103.11 -49.98 3.61 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 125.202 1.401 . . . . 0.0 110.66 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 59.8 p-90 -158.04 155.88 30.1 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.572 1.149 . . . . 0.0 109.109 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 60.9 t -153.97 132.64 2.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 125.809 1.644 . . . . 0.0 107.411 179.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.3 167.34 17.98 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.851 0.86 . . . . 0.0 111.342 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -75.96 132.99 40.56 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 4.6 t -112.42 -31.36 6.84 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.463 1.505 . . . . 0.0 112.705 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -132.49 -175.75 3.86 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 124.249 1.02 . . . . 0.0 108.357 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 55.1 mt -47.26 -47.87 9.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 123.567 0.747 . . . . 0.0 112.631 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -132.88 19.34 4.16 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.229 1.012 . . . . 0.0 111.2 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 18.4 t -116.75 145.33 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.813 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -177.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -125.02 164.53 19.96 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -136.18 148.19 48.02 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.48 146.53 30.58 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.387 1.475 . . . . 0.0 108.942 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -129.63 120.12 24.69 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 2.4 m -115.98 143.51 25.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.8 p -119.91 127.51 52.76 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 127.175 2.19 . . . . 0.0 111.911 -176.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.513 HD11 HD13 ' A' ' 238' ' ' LEU . 15.1 pt -134.04 146.64 60.72 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 177.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -71.45 -36.42 6.84 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 123.151 2.567 . . . . 0.0 111.323 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -59.02 -28.23 66.2 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.81 1.244 . . . . 0.0 114.304 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.513 HD13 HD11 ' A' ' 235' ' ' ILE . 3.1 tp -60.83 -32.49 71.88 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 121.45 -0.781 . . . . 0.0 111.367 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 7.3 m -59.56 -13.64 10.05 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.587 1.155 . . . . 0.0 113.448 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.88 -35.59 75.13 Favored 'General case' 0 C--O 1.227 -0.095 0 CA-C-N 119.58 1.082 . . . . 0.0 110.307 179.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.18 125.63 29.7 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -48.27 -42.29 30.26 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.128 1.371 . . . . 0.0 112.459 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.57 -32.27 73.76 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.415 -0.803 . . . . 0.0 112.496 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 25.4 mt -96.14 -7.63 35.38 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.835 1.654 . . . . 0.0 113.298 -178.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -67.52 108.53 2.88 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.094 2.158 . . . . 0.0 110.172 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 9.9 mmmt -71.45 159.43 34.52 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.945 0.793 . . . . 0.0 110.246 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -97.34 -76.16 0.52 Allowed 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.866 0.866 . . . . 0.0 109.059 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -144.89 39.18 1.22 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.632 1.173 . . . . 0.0 110.243 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.011 0 CA-C-O 116.779 -1.581 . . . . 0.0 110.607 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.059 0 N-CA-C 106.805 -2.518 . . . . 0.0 106.805 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.96 -173.76 1.67 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 p -66.34 93.3 0.22 Allowed 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.642 1.177 . . . . 0.0 108.675 179.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -62.54 -49.7 74.26 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.162 1.385 . . . . 0.0 110.87 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.3 m -52.57 -47.9 66.55 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.346 1.059 . . . . 0.0 111.775 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -57.11 -48.78 77.79 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 123.973 0.909 . . . . 0.0 110.553 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.65 -57.43 11.98 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 118.107 -0.949 . . . . 0.0 108.648 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.28 -40.76 68.14 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 119.05 0.841 . . . . 0.0 112.134 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.52 -38.32 80.69 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.212 0.46 . . . . 0.0 110.221 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 23.1 tp -73.94 -34.96 64.51 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.377 1.071 . . . . 0.0 109.383 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.63 HD23 HD11 ' A' ' 243' ' ' LEU . 28.6 mt -60.16 -55.18 37.03 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.23 0.923 . . . . 0.0 110.049 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 96.3 m -67.09 -40.34 86.95 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.295 -0.878 . . . . 0.0 111.018 -178.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.2 ttpt -59.38 -43.94 92.85 Favored 'General case' 0 C--O 1.226 -0.159 0 O-C-N 121.081 -1.012 . . . . 0.0 109.984 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 55.3 m -54.02 -43.92 70.53 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 124.352 1.061 . . . . 0.0 110.347 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -57.02 -50.33 73.06 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.522 0.601 . . . . 0.0 109.924 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.47 -54.69 21.13 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.565 0.697 . . . . 0.0 111.735 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -55.12 -44.4 74.96 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.224 1.01 . . . . 0.0 110.914 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.48 -51.87 48.39 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-O 117.797 -1.557 . . . . 0.0 109.366 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.469 ' HA ' HD12 ' A' ' 109' ' ' ILE . 41.0 t -54.86 -45.16 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 119.966 1.883 . . . . 0.0 109.683 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.0 pttm -61.83 -34.85 76.69 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 119.804 -0.759 . . . . 0.0 111.183 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 39.0 m -71.28 -44.17 65.74 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.579 0.752 . . . . 0.0 109.558 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.469 HD12 ' HA ' ' A' ' 106' ' ' VAL . 22.3 mt -57.49 -55.53 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -63.27 -29.24 70.61 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 118.782 -0.628 . . . . 0.0 112.348 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -70.18 -48.95 55.03 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.354 0.979 . . . . 0.0 111.898 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.46 ' HA ' ' HE2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -75.71 -43.91 44.71 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 123.562 0.745 . . . . 0.0 112.129 -178.037 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 14.2 mt -65.27 -28.25 69.21 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 118.193 -0.908 . . . . 0.0 112.671 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -51.91 -28.8 17.55 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -48.88 -69.86 0.11 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -146.48 179.01 7.84 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 126.152 1.781 . . . . 0.0 108.454 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 59.8 m -87.14 166.67 14.8 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 35.4 pt -120.39 155.95 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.446 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -148.22 139.79 23.66 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 123.61 0.764 . . . . 0.0 110.383 -178.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.461 ' CZ ' ' HA ' ' A' ' 220' ' ' TRP . 7.1 t80 -137.07 120.88 17.46 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.58 1.152 . . . . 0.0 110.304 178.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -82.97 101.94 11.4 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.513 1.525 . . . . 0.0 109.509 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.419 ' HB2' ' CE1' ' A' ' 120' ' ' TYR . . . -87.86 81.15 7.63 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 127.956 2.502 . . . . 0.0 106.794 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.52 -90.49 0.38 Allowed Glycine 0 CA--C 1.534 1.24 0 O-C-N 121.301 -0.874 . . . . 0.0 111.926 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -107.68 -28.57 9.64 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 127.053 2.141 . . . . 0.0 112.844 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -99.55 157.65 16.3 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.1 mp -126.88 128.4 70.78 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.424 ' CD1' HG11 ' A' ' 221' ' ' VAL . 44.0 m-85 -101.43 119.03 38.14 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -116.21 123.24 47.27 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -115.92 132.48 56.63 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.556 0.743 . . . . 0.0 110.302 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 66.7 m -112.27 148.18 38.57 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 124.247 1.019 . . . . 0.0 109.145 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.78 85.96 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 124.38 3.387 . . . . 0.0 115.151 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.21 30.76 40.57 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-O 117.944 -1.476 . . . . 0.0 112.981 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 3.9 mp -117.15 -73.62 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.455 0 CA-C-N 119.191 1.495 . . . . 0.0 110.247 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.406 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 37.4 mt-10 -163.39 166.25 23.09 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.03 2.132 . . . . 0.0 108.583 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -135.6 123.6 22.79 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.568 1.547 . . . . 0.0 107.568 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 17.8 m -144.47 164.04 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 126.8 2.04 . . . . 0.0 111.103 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -117.84 127.19 53.63 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 177.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -136.53 162.41 33.19 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 125.39 1.476 . . . . 0.0 111.224 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.546 ' H ' ' CD1' ' A' ' 156' ' ' LEU . 80.9 t60 -92.63 160.56 14.95 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 177.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 135.44 -159.13 24.01 Favored Glycine 0 C--N 1.34 0.751 0 CA-C-N 119.185 0.902 . . . . 0.0 111.722 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.33 167.25 30.82 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 128.37 2.668 . . . . 0.0 105.527 177.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.6 p -114.41 152.33 16.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -100.2 103.33 14.78 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 178.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 39.6 p -51.13 -24.19 3.88 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 115.825 1.787 . . . . 0.0 115.825 -178.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 38.9 mmtt -66.55 -27.44 67.75 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.976 0.91 . . . . 0.0 113.171 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.9 p -126.42 -40.93 1.92 Allowed 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.283 1.433 . . . . 0.0 112.524 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 96.41 29.69 8.19 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 125.544 1.545 . . . . 0.0 110.609 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -102.66 140.52 36.82 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.393 1.077 . . . . 0.0 109.909 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 14.5 mm -81.04 134.28 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 20.4 m -65.57 -10.83 11.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 -178.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -138.51 105.72 5.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 119.174 0.897 . . . . 0.0 111.063 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -82.7 65.9 8.05 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.325 0.512 . . . . 0.0 110.655 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 27.1 53.58 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 129.017 2.927 . . . . 0.0 114.788 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -60.55 -35.03 75.03 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.363 -1.29 . . . . 0.0 111.732 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 5.8 m -125.44 -21.01 4.62 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 115.478 1.658 . . . . 0.0 115.478 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.546 ' CD1' ' H ' ' A' ' 139' ' ' HIS . 9.2 mt -82.53 153.44 25.54 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 120.497 1.499 . . . . 0.0 109.382 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 44.7 t -147.25 119.38 1.72 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 124.336 1.054 . . . . 0.0 109.494 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -147.09 165.84 28.7 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.221 1.809 . . . . 0.0 109.626 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -149.04 112.0 4.87 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 126.268 1.827 . . . . 0.0 108.471 178.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 82.6 mt -99.07 -26.89 14.07 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 160.96 161.01 11.13 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -127.34 108.53 21.26 Favored Pre-proline 0 C--O 1.239 0.509 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 86.2 Cg_endo -72.32 -179.62 4.18 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 124.447 3.432 . . . . 0.0 109.825 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -122.39 159.76 26.85 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.063 0.545 . . . . 0.0 110.851 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.62 -54.0 11.85 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -68.72 64.6 0.12 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 126.751 2.02 . . . . 0.0 112.71 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 5.6 p -47.02 -34.34 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 C-N-CA 125.759 1.624 . . . . 0.0 111.846 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -63.84 -32.98 74.68 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.022 1.329 . . . . 0.0 112.026 -178.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -80.69 -14.21 58.34 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 122.748 0.419 . . . . 0.0 110.096 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 44.4 mtp180 -83.3 177.97 8.28 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 121.071 -1.018 . . . . 0.0 109.509 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -132.85 150.36 52.17 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.381 1.072 . . . . 0.0 108.201 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -138.22 161.2 37.47 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.193 1.797 . . . . 0.0 107.688 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -126.87 149.99 49.48 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 122.889 0.476 . . . . 0.0 110.606 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 32.1 tp -107.47 111.01 23.1 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.876 1.271 . . . . 0.0 108.659 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.46 HD23 ' HB2' ' A' ' 184' ' ' SER . 2.9 mm? -118.47 -179.75 3.88 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.944 1.298 . . . . 0.0 110.45 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -137.84 154.4 49.51 Favored 'General case' 0 N--CA 1.458 -0.037 0 C-N-CA 124.875 1.27 . . . . 0.0 109.467 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -140.45 -178.16 5.37 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 126.678 1.991 . . . . 0.0 107.421 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -66.11 -5.71 10.83 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.868 1.267 . . . . 0.0 113.417 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 56.0 t -107.6 -24.49 4.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 126.794 2.038 . . . . 0.0 113.656 -178.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 144.24 -173.02 25.12 Favored Glycine 0 N--CA 1.444 -0.774 0 O-C-N 121.841 -0.537 . . . . 0.0 112.052 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -79.06 158.42 27.86 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 121.716 0.769 . . . . 0.0 109.297 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.452 ' HB3' HG12 ' A' ' 207' ' ' VAL . 42.0 p90 -155.74 162.85 40.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.331 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 96.7 mt -104.23 136.42 37.62 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.073 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.46 ' HB2' HD23 ' A' ' 175' ' ' LEU . 46.2 t -102.22 129.34 48.59 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 125.414 1.485 . . . . 0.0 108.374 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -121.33 113.98 20.68 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.88 119.0 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 104.512 -2.403 . . . . 0.0 104.512 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 9.0 mt -109.2 105.63 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 177.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -101.32 -153.43 26.03 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 23.1 t 67.86 26.65 7.55 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.993 0.917 . . . . 0.0 111.932 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -82.2 -60.32 2.16 Favored Glycine 0 CA--C 1.525 0.691 0 O-C-N 120.51 -1.369 . . . . 0.0 110.543 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 153.83 -174.14 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.608 1 C-N-CA 131.893 4.077 . . . . 0.0 106.384 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 51.8 mm -105.9 143.3 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 129.561 3.144 . . . . 0.0 112.205 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.2 m -93.56 118.15 30.98 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 128.345 2.658 . . . . 0.0 107.207 177.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.5 -30.89 54.77 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.818 1.247 . . . . 0.0 113.331 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 44.1 t -45.32 -56.28 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 125.019 1.328 . . . . 0.0 113.031 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 6.6 t -123.46 -23.02 4.89 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 124.701 1.201 . . . . 0.0 113.85 -177.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 94.97 34.66 6.1 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 107.263 -2.335 . . . . 0.0 107.263 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -103.09 150.38 23.67 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 117.998 0.899 . . . . 0.0 110.922 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -74.03 139.65 44.88 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 122.544 0.337 . . . . 0.0 111.697 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -67.47 29.0 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.559 1 C-N-CA 135.799 5.64 . . . . 0.0 110.208 177.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 1.9 ptm -74.46 -176.81 2.85 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.17 1.388 . . . . 0.0 111.955 -177.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.2 p -153.6 146.69 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 O-C-N 121.087 -1.008 . . . . 0.0 110.753 -178.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -104.32 104.77 14.71 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.595 1.558 . . . . 0.0 109.522 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 8.7 mm -93.8 123.1 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -105.15 99.61 9.22 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 127.312 2.245 . . . . 0.0 109.333 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -82.17 110.72 17.63 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.76 1.224 . . . . 0.0 108.849 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.452 HG12 ' HB3' ' A' ' 182' ' ' TYR . 19.0 m -124.72 164.73 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 125.456 1.502 . . . . 0.0 107.46 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 46.3 t -83.91 146.09 28.23 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 119.909 -1.745 . . . . 0.0 107.562 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -86.75 3.76 86.77 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-O 118.774 -1.015 . . . . 0.0 113.108 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 70.23 -126.05 15.75 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 107.905 -2.078 . . . . 0.0 107.905 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 12.6 m -73.06 -163.51 0.14 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.705 0.765 . . . . 0.0 109.981 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 2.6 m120 58.54 57.82 3.63 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.056 1.343 . . . . 0.0 109.814 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 1.3 p -64.68 93.85 0.11 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.345 0.658 . . . . 0.0 110.886 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -118.79 -162.53 12.14 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 127.376 2.417 . . . . 0.0 108.206 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -68.87 -91.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 124.073 3.182 . . . . 0.0 111.598 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 5.0 p -151.74 146.5 25.8 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.654 1.182 . . . . 0.0 109.086 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 17.0 p -149.89 172.23 15.5 Favored 'General case' 0 C--O 1.225 -0.201 0 O-C-N 121.757 -0.589 . . . . 0.0 112.246 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.416 HG21 HG23 ' A' ' 221' ' ' VAL . 5.8 mt -122.14 146.06 27.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 126.863 2.065 . . . . 0.0 106.555 177.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -95.35 -47.67 6.2 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.343 1.457 . . . . 0.0 110.525 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' TRP . . . . . 0.461 ' HA ' ' CZ ' ' A' ' 120' ' ' TYR . 56.2 p-90 -162.88 158.51 22.62 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 125.459 1.504 . . . . 0.0 108.948 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.424 HG11 ' CD1' ' A' ' 127' ' ' TYR . 49.7 t -152.94 135.02 5.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 126.189 1.796 . . . . 0.0 106.366 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.79 168.76 17.5 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.006 1.322 . . . . 0.0 110.347 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -75.61 141.67 42.82 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 124.104 0.962 . . . . 0.0 108.638 178.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' THR . . . . . 0.437 HG21 ' HG3' ' A' ' 230' ' ' GLU . 10.2 t -118.83 -31.98 4.64 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.955 1.302 . . . . 0.0 112.3 179.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.429 ' HG3' HG23 ' A' ' 224' ' ' THR . 4.8 mttm -135.22 -176.59 4.31 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 120.806 -1.184 . . . . 0.0 109.067 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 36.5 mt -48.15 -47.22 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 123.864 0.866 . . . . 0.0 112.29 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -130.62 21.47 5.09 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.265 1.026 . . . . 0.0 111.894 -178.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 16.6 t -122.62 143.0 36.95 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.584 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -178.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -121.68 162.52 20.59 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.57 1.548 . . . . 0.0 107.131 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' GLU . . . . . 0.437 ' HG3' HG21 ' A' ' 224' ' ' THR . 13.3 mt-10 -131.46 138.28 48.95 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 125.416 1.486 . . . . 0.0 107.209 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -135.78 132.39 36.69 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.569 1.148 . . . . 0.0 109.522 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -109.08 108.0 18.53 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 48.3 t -100.73 138.23 25.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.3 p -120.94 130.29 53.8 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 126.286 1.835 . . . . 0.0 112.427 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -138.67 143.34 37.5 Favored Pre-proline 0 N--CA 1.467 0.394 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 176.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -73.3 -33.32 7.27 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.948 2.432 . . . . 0.0 112.963 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -64.25 -17.77 63.92 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.56 0.744 . . . . 0.0 112.811 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 5.9 tp -68.16 -29.51 68.42 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 121.174 -0.954 . . . . 0.0 110.044 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 14.4 m -62.99 -9.98 12.05 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.664 0.786 . . . . 0.0 112.961 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -60.89 -31.24 70.73 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.196 0.907 . . . . 0.0 109.721 178.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -88.64 127.22 35.56 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 124.196 0.998 . . . . 0.0 109.331 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -47.0 -49.33 21.04 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 126.047 1.739 . . . . 0.0 113.475 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.63 HD11 HD23 ' A' ' 98' ' ' LEU . 41.8 mt -65.05 -28.81 69.73 Favored 'General case' 0 C--O 1.231 0.115 0 O-C-N 121.332 -0.855 . . . . 0.0 112.983 -178.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 11.5 mt -95.75 -17.52 21.16 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.101 0.96 . . . . 0.0 112.7 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -62.31 135.53 57.5 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 129.321 3.048 . . . . 0.0 109.445 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -101.69 155.75 17.92 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 124.154 0.982 . . . . 0.0 112.12 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -70.68 -60.46 2.24 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 123.781 0.675 . . . . 0.0 109.337 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 50.02 29.67 3.62 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.634 1.574 . . . . 0.0 111.738 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 21.7 t70 . . . . . 0 C--O 1.261 1.695 0 C-N-CA 129.382 3.073 . . . . 0.0 106.464 -179.163 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.99 0 N-CA-C 108.2 -1.96 . . . . 0.0 108.2 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.54 -59.32 5.41 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 119.081 1.441 . . . . 0.0 109.99 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.1 t -167.33 166.46 14.6 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 126.209 1.804 . . . . 0.0 106.29 178.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 61.4 m-80 54.22 7.5 0.14 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.172 2.189 . . . . 0.0 114.529 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.8 m -56.1 -30.51 62.17 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.993 1.317 . . . . 0.0 113.64 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -70.7 -24.7 62.71 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.648 -0.658 . . . . 0.0 111.085 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.87 -47.55 65.63 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 105.585 -2.005 . . . . 0.0 105.585 177.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -32.92 74.51 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 118.887 0.767 . . . . 0.0 110.262 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.07 -50.97 69.82 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 57.2 tp -63.79 -39.86 95.26 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.569 1.148 . . . . 0.0 110.678 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.8 mt -60.1 -54.28 47.76 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 119.277 0.944 . . . . 0.0 108.65 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.3 m -58.31 -49.32 77.58 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.121 0.486 . . . . 0.0 110.152 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -60.88 -40.74 94.16 Favored 'General case' 0 C--O 1.232 0.164 0 O-C-N 121.206 -0.934 . . . . 0.0 111.776 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 54.4 m -52.3 -48.74 65.21 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.574 0.75 . . . . 0.0 110.842 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -58.89 -47.6 84.38 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 117.966 0.348 . . . . 0.0 110.659 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.45 -55.81 24.11 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 122.504 1.145 . . . . 0.0 113.876 -177.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -64.34 -38.44 91.05 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-N 113.645 -1.616 . . . . 0.0 111.521 -177.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.25 -52.78 41.15 Favored Glycine 0 N--CA 1.44 -1.045 0 N-CA-C 107.95 -2.06 . . . . 0.0 107.95 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 56.0 t -56.92 -47.92 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 119.306 1.553 . . . . 0.0 110.541 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.6 pttm -59.1 -35.52 73.56 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.847 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 52.5 m -79.29 -36.36 39.85 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.308 1.043 . . . . 0.0 111.067 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 21.8 mt -57.85 -54.27 34.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -60.84 -29.39 69.47 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.481 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -68.24 -41.05 81.74 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 120.144 1.338 . . . . 0.0 111.593 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.463 ' HA ' ' HE2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -79.07 -37.42 38.9 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 117.991 0.36 . . . . 0.0 111.75 -179.371 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 17.2 mt -74.17 -25.83 59.95 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 118.685 -0.674 . . . . 0.0 111.903 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -54.82 -20.12 7.95 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.454 0.57 . . . . 0.0 112.167 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -64.62 -72.77 0.14 Allowed 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.694 1.197 . . . . 0.0 109.036 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -147.42 -175.55 4.89 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.386 1.474 . . . . 0.0 111.522 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 62.6 m -87.71 175.4 7.89 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.604 -0.685 . . . . 0.0 109.439 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 27.4 pt -132.73 161.22 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 126.324 1.85 . . . . 0.0 108.774 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -154.74 142.73 20.15 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 122.759 0.423 . . . . 0.0 110.401 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -134.37 123.74 24.61 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.478 0.711 . . . . 0.0 110.499 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -86.66 98.7 11.26 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.19 81.06 5.56 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 128.407 2.683 . . . . 0.0 107.336 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 58.47 -112.93 4.39 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 124.388 0.994 . . . . 0.0 111.054 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -77.28 -12.8 59.99 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.852 1.261 . . . . 0.0 113.375 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -115.74 158.24 23.12 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 124.414 1.086 . . . . 0.0 112.642 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.573 HD13 ' H ' ' A' ' 140' ' ' GLY . 4.8 mp -133.38 126.36 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 N-CA-C 103.577 -2.749 . . . . 0.0 103.577 177.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -110.54 123.36 49.79 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -117.96 129.63 55.72 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.714 0.806 . . . . 0.0 110.008 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -119.52 133.2 55.79 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 123.722 0.809 . . . . 0.0 110.923 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.513 ' HB3' HD13 ' A' ' 133' ' ' ILE . 16.3 m -112.41 156.1 42.7 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 123.737 0.815 . . . . 0.0 111.075 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -63.77 78.46 0.15 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 125.084 3.856 . . . . 0.0 114.203 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 67.51 60.19 6.06 Favored Glycine 0 CA--C 1.525 0.677 0 O-C-N 120.971 -1.081 . . . . 0.0 111.688 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.513 HD13 ' HB3' ' A' ' 130' ' ' CYS . 3.5 mp -130.86 -71.44 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -165.73 168.95 15.65 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 125.45 1.5 . . . . 0.0 109.449 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -130.81 121.95 26.25 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 176.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.8 m -144.76 164.94 12.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 118.916 0.78 . . . . 0.0 111.083 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -120.95 132.2 54.79 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.726 1.211 . . . . 0.0 108.727 178.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -138.51 162.74 33.77 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.122 1.369 . . . . 0.0 112.437 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 55.5 t60 -103.15 108.8 20.14 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.573 ' H ' HD13 ' A' ' 126' ' ' ILE . . . -176.12 -160.21 23.14 Favored Glycine 0 C--N 1.331 0.301 0 O-C-N 121.603 -0.686 . . . . 0.0 112.107 -179.052 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -141.99 157.48 44.89 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.764 1.225 . . . . 0.0 108.072 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.6 p -121.15 152.35 24.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -104.89 120.25 40.98 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 119.096 0.862 . . . . 0.0 108.982 178.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.8 p -58.06 -8.61 1.1 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.032 1.733 . . . . 0.0 114.065 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 30.7 mmtt -88.21 -29.59 20.36 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.271 1.029 . . . . 0.0 112.936 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.7 p -117.98 -48.29 2.56 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.088 0.555 . . . . 0.0 110.603 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 95.38 33.12 6.64 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 123.948 0.785 . . . . 0.0 111.783 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -125.1 161.18 27.37 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 126.879 2.072 . . . . 0.0 107.46 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 20.8 mm -85.31 142.75 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 124.234 1.013 . . . . 0.0 109.32 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 30.5 m -57.91 -38.72 67.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 117.857 -1.068 . . . . 0.0 113.755 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 38.8 p-10 159.7 177.79 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 130.149 3.38 . . . . 0.0 109.561 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 49.0 ttt180 81.56 70.05 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 128.993 2.917 . . . . 0.0 111.263 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -101.23 -82.12 0.47 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.812 2.445 . . . . 0.0 112.732 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -51.5 -34.41 35.81 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 117.857 2.54 . . . . 0.0 117.857 -178.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.51 -19.46 57.03 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -177.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 75.4 mt -113.76 91.53 3.67 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 15.4 m -74.62 108.34 6.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 C-N-CA 124.604 1.162 . . . . 0.0 111.613 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -141.27 151.48 43.71 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 122.795 1.283 . . . . 0.0 108.436 178.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.518 ' N ' HH21 ' A' ' 200' ' ' ARG . 0.0 OUTLIER -149.38 110.35 4.34 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 179.005 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mp -93.92 -27.53 16.32 Favored 'General case' 0 C--O 1.219 -0.55 0 O-C-N 125.794 1.934 . . . . 0.0 107.315 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 163.63 163.23 15.97 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 5.4 mtpt -127.66 110.13 20.68 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -78.04 -173.08 1.68 Allowed 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 124.954 3.769 . . . . 0.0 110.4 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -129.32 149.18 51.22 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 125.277 1.431 . . . . 0.0 109.58 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.74 -41.4 71.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.668 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 31.4 m-20 -71.7 65.02 0.48 Allowed 'General case' 0 C--O 1.236 0.383 0 C-N-CA 126.383 1.873 . . . . 0.0 110.977 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.4 p -52.3 -32.0 15.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 124.904 1.282 . . . . 0.0 110.663 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -63.93 -22.39 66.9 Favored 'General case' 0 N--CA 1.461 0.105 0 C-N-CA 124.695 1.198 . . . . 0.0 112.544 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -97.85 -18.27 18.82 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.522 1.129 . . . . 0.0 110.877 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.4 mtp-105 -81.02 142.21 33.61 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -103.73 148.98 25.42 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 178.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -134.25 -176.47 4.21 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.48 1.512 . . . . 0.0 109.587 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -135.41 153.46 51.79 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.329 1.051 . . . . 0.0 109.331 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 22.9 tp -115.05 98.97 7.11 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.697 1.599 . . . . 0.0 106.861 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.462 HD23 ' HB2' ' A' ' 184' ' ' SER . 2.7 mm? -105.33 -179.8 4.05 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 181' ' ' TYR . 2.5 p90 -145.65 163.01 36.2 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -140.75 -178.44 5.54 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.406 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -62.07 -14.41 36.01 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.528 1.131 . . . . 0.0 111.107 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 57.9 t -98.04 -39.12 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 125.495 1.518 . . . . 0.0 111.395 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 161.3 -173.83 37.77 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 123.431 0.539 . . . . 0.0 112.152 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 176' ' ' TYR . 25.9 m-85 -77.72 160.34 28.5 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 118.387 1.094 . . . . 0.0 110.72 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -158.84 168.5 26.64 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.325 1.45 . . . . 0.0 110.813 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 89.1 mt -108.89 141.46 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.462 ' HB2' HD23 ' A' ' 175' ' ' LEU . 15.6 t -111.41 137.32 49.35 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.394 1.077 . . . . 0.0 109.585 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -129.13 111.53 13.04 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.482 1.513 . . . . 0.0 108.381 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.2 mp -94.93 116.7 36.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 103.928 -2.619 . . . . 0.0 103.928 178.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 12.4 mt -105.1 106.95 21.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -103.66 -152.22 22.85 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 75.19 33.39 0.71 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.218 1.007 . . . . 0.0 110.127 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -113.87 159.18 13.83 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 107.615 -2.194 . . . . 0.0 107.615 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -66.72 167.82 10.55 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.354 1.062 . . . . 0.0 109.892 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.0 mm -87.13 142.33 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 C-N-CA 124.282 1.033 . . . . 0.0 108.795 178.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.1 m -88.81 110.76 21.31 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 104.204 -2.517 . . . . 0.0 104.204 177.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -47.68 -40.02 18.92 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 125.503 1.521 . . . . 0.0 111.637 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 33.4 t -38.45 -56.62 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.228 -0.055 0 C-N-CA 128.024 2.53 . . . . 0.0 113.366 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 10.8 t -124.42 -28.86 3.58 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 105.23 35.31 3.17 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -107.35 149.95 27.27 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 118.278 1.039 . . . . 0.0 110.23 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -77.48 152.25 34.26 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 119.02 0.827 . . . . 0.0 111.176 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.518 HH21 ' N ' ' A' ' 159' ' ' ARG . 30.7 mmm-85 -71.1 27.78 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 131.471 3.908 . . . . 0.0 110.795 177.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 8.1 ptm -75.59 178.43 6.02 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.343 1.057 . . . . 0.0 111.312 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.33 151.28 14.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 125.22 1.408 . . . . 0.0 108.745 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -107.45 106.38 16.75 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.937 2.095 . . . . 0.0 106.703 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 16.2 mm -101.29 144.58 12.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -125.48 121.22 33.11 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.441 1.496 . . . . 0.0 108.914 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -99.04 108.76 21.5 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.658 1.183 . . . . 0.0 108.985 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 3.8 m -126.91 169.77 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 122.101 0.953 . . . . 0.0 109.506 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 42.0 t -95.25 144.08 26.13 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 104.39 -2.448 . . . . 0.0 104.39 177.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -99.85 10.0 60.35 Favored Glycine 0 N--CA 1.461 0.324 0 CA-C-O 117.736 -1.591 . . . . 0.0 115.016 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 66.69 54.18 23.79 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.5 m -132.35 128.81 38.46 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -73.11 -19.38 61.16 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.801 0.728 . . . . 0.0 112.819 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 6.3 t -157.72 177.31 11.52 Favored 'General case' 0 C--O 1.242 0.661 0 O-C-N 121.22 -0.925 . . . . 0.0 110.725 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.88 178.4 16.35 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 126.195 1.855 . . . . 0.0 115.941 178.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -78.93 -104.96 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.912 1 C-N-CA 126.03 4.487 . . . . 0.0 111.95 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 4.8 p -161.8 147.06 13.28 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 120.45 -1.406 . . . . 0.0 112.809 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 19.2 p -151.22 160.23 43.95 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.501 1.12 . . . . 0.0 110.37 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 233' ' ' VAL . 4.3 mt -100.75 153.55 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 125.894 1.678 . . . . 0.0 108.018 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -98.93 -50.21 4.27 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.184 0.994 . . . . 0.0 111.798 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 63.9 p-90 -159.11 154.52 25.7 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.142 1.377 . . . . 0.0 107.353 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 59.7 t -150.2 130.09 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.03 167.83 26.98 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 118.147 0.43 . . . . 0.0 111.086 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -80.77 137.32 36.24 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 1.8 t -112.96 -39.32 4.26 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.705 -0.622 . . . . 0.0 110.74 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -121.65 -174.82 2.95 Favored 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 124.185 0.994 . . . . 0.0 109.595 -177.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 72.8 mt -56.51 -41.73 73.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.528 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -131.52 12.3 4.93 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.15 1.78 . . . . 0.0 112.815 -178.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 21.0 t -116.59 146.19 21.34 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 CA-C-N 118.72 0.691 . . . . 0.0 109.611 -178.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -123.5 161.64 24.47 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -127.99 142.13 51.33 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 106.376 -1.712 . . . . 0.0 106.376 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -150.78 131.82 14.32 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.465 1.106 . . . . 0.0 109.013 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -121.17 122.65 40.46 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.3 0.64 . . . . 0.0 109.635 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' A' ' 218' ' ' ILE . 4.6 m -106.47 156.44 7.06 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-N 118.676 0.671 . . . . 0.0 109.339 178.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.54 115.62 19.8 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 125.584 1.554 . . . . 0.0 109.166 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 10.6 pt -128.26 145.22 54.79 Favored Pre-proline 0 N--CA 1.448 -0.536 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.05 -41.43 5.19 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.004 1.803 . . . . 0.0 111.128 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -55.69 -17.57 6.14 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 117.589 2.44 . . . . 0.0 117.589 -177.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.443 HD22 ' CD1' ' A' ' 244' ' ' LEU . 44.2 mt -72.84 -30.12 63.76 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 120.781 1.628 . . . . 0.0 108.912 178.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 22.3 m -61.65 -11.65 12.61 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.563 0.745 . . . . 0.0 112.649 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 -67.53 -18.08 64.9 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-O 122.222 1.011 . . . . 0.0 109.664 177.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 29.8 mt -101.01 118.64 37.41 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 127.97 2.508 . . . . 0.0 106.787 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -46.75 -46.46 20.41 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.141 1.376 . . . . 0.0 112.732 -178.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 1.1 mp -65.59 -27.24 68.28 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.443 ' CD1' HD22 ' A' ' 238' ' ' LEU . 9.4 mt -102.39 -3.78 26.52 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.381 1.073 . . . . 0.0 111.609 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -68.94 113.71 6.59 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 127.84 2.456 . . . . 0.0 110.689 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.49 170.15 16.74 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -62.63 -29.21 70.45 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.122 0.487 . . . . 0.0 109.748 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -87.12 54.9 3.33 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.735 1.614 . . . . 0.0 108.478 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.257 1.483 0 C-N-CA 125.242 1.417 . . . . 0.0 111.823 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.751 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.88 127.37 32.39 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.9 t -164.22 175.62 9.95 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.715 1.206 . . . . 0.0 108.265 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.4 m120 54.73 37.79 28.97 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.916 1.686 . . . . 0.0 110.139 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.3 m -53.0 -35.11 59.02 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 120.947 -1.096 . . . . 0.0 113.48 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -72.03 -21.21 61.57 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.123 -0.985 . . . . 0.0 111.017 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.521 ' HE3' ' HA ' ' A' ' 94' ' ' LYS . 0.1 OUTLIER -73.02 -57.08 4.29 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 178.043 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -55.75 -39.41 71.15 Favored 'General case' 0 C--O 1.226 -0.178 0 O-C-N 123.797 0.686 . . . . 0.0 110.7 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.17 -47.98 71.4 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 42.3 tp -65.44 -37.44 86.91 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 117.645 -1.169 . . . . 0.0 110.662 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 64.1 mt -61.95 -55.01 33.91 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.55 1.068 . . . . 0.0 109.678 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 89.8 m -57.99 -49.59 76.32 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.389 1.875 . . . . 0.0 110.168 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 23.6 ttpt -62.09 -47.55 84.11 Favored 'General case' 0 N--CA 1.444 -0.741 0 O-C-N 121.341 -0.85 . . . . 0.0 109.698 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.6 m -52.74 -47.14 67.59 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 118.726 0.693 . . . . 0.0 110.765 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -58.7 -50.46 73.81 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 118.228 0.467 . . . . 0.0 109.971 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.83 -61.19 2.45 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -61.25 -38.32 86.26 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.641 0.776 . . . . 0.0 110.99 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.6 -53.24 45.35 Favored Glycine 0 CA--C 1.52 0.376 0 CA-C-O 117.904 -1.498 . . . . 0.0 109.401 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.518 ' HA ' HD12 ' A' ' 109' ' ' ILE . 39.3 t -57.74 -40.76 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 119.434 1.617 . . . . 0.0 109.251 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -58.69 -41.39 86.15 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 28.2 m -70.76 -40.1 72.87 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 125.133 1.373 . . . . 0.0 110.557 -177.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.555 HD13 ' CD1' ' A' ' 206' ' ' TYR . 18.0 mt -61.48 -55.95 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -62.55 -32.39 73.34 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.821 -0.609 . . . . 0.0 111.488 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -60.83 -40.12 91.61 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 118.632 0.651 . . . . 0.0 111.029 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.3 tptm -81.13 -37.99 27.94 Favored 'General case' 0 CA--C 1.519 -0.247 0 O-C-N 122.064 -0.398 . . . . 0.0 110.793 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 40.4 mt -69.12 -26.61 64.99 Favored 'General case' 0 C--O 1.221 -0.412 0 O-C-N 121.443 -0.786 . . . . 0.0 109.992 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.16 -30.87 50.85 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.628 1.171 . . . . 0.0 111.339 179.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -56.24 -63.9 1.04 Allowed 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.489 1.116 . . . . 0.0 111.946 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -151.37 175.59 12.09 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 126.319 1.848 . . . . 0.0 110.336 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 85.7 m -87.53 161.4 17.8 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 106.959 -1.496 . . . . 0.0 106.959 178.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 42.3 pt -112.42 155.01 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 124.846 1.258 . . . . 0.0 108.143 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -148.98 137.37 21.0 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 125.185 1.394 . . . . 0.0 108.27 -178.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -140.85 126.94 19.51 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.307 1.043 . . . . 0.0 111.652 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -80.39 99.46 7.96 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.047 1.339 . . . . 0.0 109.122 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.98 79.97 5.79 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 178.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 58.71 -119.83 19.53 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -63.74 -35.91 82.12 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.91 0.884 . . . . 0.0 112.955 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -99.86 164.36 12.06 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 119.126 0.875 . . . . 0.0 111.651 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.516 HD13 ' H ' ' A' ' 140' ' ' GLY . 4.2 mp -129.43 129.13 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 103.824 -2.658 . . . . 0.0 103.824 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.418 ' CG ' HG11 ' A' ' 221' ' ' VAL . 10.6 m-85 -105.39 122.95 47.02 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 125.634 1.574 . . . . 0.0 106.871 -178.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -118.5 126.49 52.13 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -122.88 137.37 54.96 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.531 0.732 . . . . 0.0 111.26 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.554 ' HB3' HD13 ' A' ' 133' ' ' ILE . 27.4 m -117.12 153.37 49.7 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.613 1.165 . . . . 0.0 111.488 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -62.61 84.53 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.643 1 C-N-CA 125.428 4.085 . . . . 0.0 116.266 -177.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.36 32.56 55.14 Favored Glycine 0 CA--C 1.531 1.093 0 O-C-N 120.749 -1.22 . . . . 0.0 112.853 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.554 HD13 ' HB3' ' A' ' 130' ' ' CYS . 4.5 mp -115.56 -69.92 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.306 0 CA-C-N 117.956 0.878 . . . . 0.0 109.104 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -168.44 168.34 11.25 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.533 1.133 . . . . 0.0 110.632 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -132.38 120.22 21.74 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 177.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.2 m -140.56 163.85 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 124.924 1.29 . . . . 0.0 110.575 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -135.04 126.55 28.68 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -138.08 162.86 33.07 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 126.604 1.962 . . . . 0.0 109.08 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.458 ' H ' HD13 ' A' ' 156' ' ' LEU . 78.9 t60 -102.87 120.02 39.87 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.516 ' H ' HD13 ' A' ' 126' ' ' ILE . . . -178.76 -159.87 23.84 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 127.21 2.338 . . . . 0.0 107.919 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.07 159.05 42.77 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.957 1.879 . . . . 0.0 111.933 178.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.2 p -94.75 155.91 3.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 124.69 1.196 . . . . 0.0 109.611 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 48.2 m-20 -101.48 97.95 8.35 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 101.031 -3.692 . . . . 0.0 101.031 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 82.6 p -57.99 -19.4 30.55 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 40.5 mmtt -67.66 -45.9 73.92 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 121.137 -0.977 . . . . 0.0 110.961 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 35.0 p -99.51 -38.33 8.82 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 125.329 1.452 . . . . 0.0 112.512 -178.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 95.28 32.25 7.13 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 126.079 1.8 . . . . 0.0 112.108 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -125.35 160.94 28.12 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.914 1.686 . . . . 0.0 110.332 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 11.4 mm -86.18 146.1 6.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 123.202 0.601 . . . . 0.0 110.04 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 32.8 m -61.13 -20.22 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.408 1.483 . . . . 0.0 113.877 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -169.5 -179.36 3.39 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 127.735 2.414 . . . . 0.0 108.356 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -102.33 -77.61 0.55 Allowed 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 103.011 -2.959 . . . . 0.0 103.011 176.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -156.25 133.99 11.03 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.888 0.875 . . . . 0.0 108.659 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -85.03 -62.36 1.56 Allowed 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.5 m -126.7 32.68 5.1 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.886 2.074 . . . . 0.0 112.512 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.458 HD13 ' H ' ' A' ' 139' ' ' HIS . 34.9 mt -120.54 138.48 53.83 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 120.266 -1.521 . . . . 0.0 110.785 -177.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.3 p -143.97 121.49 5.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 118.863 0.756 . . . . 0.0 109.386 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -148.39 160.39 43.07 Favored 'General case' 0 C--O 1.226 -0.147 0 C-N-CA 123.883 0.873 . . . . 0.0 110.867 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 5.8 mpp_? -149.37 133.33 17.09 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 48.3 mt -110.87 -21.75 11.88 Favored 'General case' 0 C--O 1.22 -0.476 0 O-C-N 124.181 0.926 . . . . 0.0 109.195 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 155.53 163.97 12.69 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -126.63 114.3 22.8 Favored Pre-proline 0 C--O 1.236 0.352 0 CA-C-O 118.849 -0.595 . . . . 0.0 109.914 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -71.24 -173.89 1.05 Allowed 'Trans proline' 0 CA--C 1.544 1.004 0 C-N-CA 125.091 3.861 . . . . 0.0 109.567 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -120.8 163.83 17.54 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.932 0.872 . . . . 0.0 111.974 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.75 -36.56 59.85 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.116 177.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -89.57 65.71 7.05 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.476 1.91 . . . . 0.0 110.895 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.9 p -45.76 -36.72 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 123.146 0.578 . . . . 0.0 111.851 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -61.86 -37.9 86.24 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 125.488 1.515 . . . . 0.0 112.532 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -71.56 -23.61 61.78 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 124.972 1.309 . . . . 0.0 110.671 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 9.5 mtp-105 -79.53 138.92 37.67 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -101.41 139.78 36.61 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -122.89 -178.32 3.91 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 126.493 1.917 . . . . 0.0 111.802 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -131.49 154.01 49.18 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.908 1.283 . . . . 0.0 109.968 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 28.4 tp -116.75 107.69 14.96 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.264 1.826 . . . . 0.0 106.368 178.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.601 HD23 ' HB2' ' A' ' 184' ' ' SER . 1.7 mm? -118.58 -178.25 3.49 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 126.258 1.823 . . . . 0.0 109.564 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -145.33 164.81 30.3 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.236 0.615 . . . . 0.0 111.27 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.7 178.56 7.06 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 128.005 2.522 . . . . 0.0 107.417 178.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -59.69 -18.9 46.01 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.489 1.116 . . . . 0.0 111.822 -177.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 76.8 t -92.05 -38.6 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 125.429 1.491 . . . . 0.0 111.297 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 163.46 -168.06 37.94 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 118.764 0.711 . . . . 0.0 112.194 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.405 ' CD2' ' HB3' ' A' ' 243' ' ' LEU . 6.4 m-30 -78.48 161.92 26.73 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.579 0.704 . . . . 0.0 110.234 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.402 ' HB3' HG12 ' A' ' 207' ' ' VAL . 32.3 p90 -159.32 161.87 35.89 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.25 1.42 . . . . 0.0 110.38 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 95.3 mt -100.96 146.08 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.601 ' HB2' HD23 ' A' ' 175' ' ' LEU . 6.7 t -119.7 132.88 55.77 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.492 1.117 . . . . 0.0 108.364 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -126.79 107.71 10.38 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.978 2.111 . . . . 0.0 108.939 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.487 HD11 ' HG3' ' A' ' 203' ' ' GLU . 1.7 mp -90.6 114.14 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 104.481 -2.415 . . . . 0.0 104.481 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 7.2 mt -98.1 106.68 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.49 -153.49 24.82 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 77.07 20.85 1.17 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.585 1.154 . . . . 0.0 109.58 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -84.95 146.16 21.95 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.12 137.71 58.04 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 125.851 1.66 . . . . 0.0 108.44 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 25.3 mm -62.37 139.32 21.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 CA-C-O 122.218 1.009 . . . . 0.0 112.227 -178.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 5.6 t -79.2 116.35 19.42 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 128.381 2.672 . . . . 0.0 109.802 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.08 -17.0 56.16 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.904 0.881 . . . . 0.0 112.907 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 42.0 t -69.11 -52.47 33.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 125.742 1.617 . . . . 0.0 112.235 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' THR . . . . . 0.4 HG22 HG21 ' A' ' 226' ' ' ILE . 3.8 t -123.38 -40.44 2.37 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.971 1.308 . . . . 0.0 113.832 -178.001 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 117.03 21.66 4.46 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.301 1.429 . . . . 0.0 110.596 -178.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -88.7 151.31 22.51 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.868 1.834 . . . . 0.0 110.729 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -71.59 153.61 42.01 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 5.8 ttt-85 -74.52 28.58 0.08 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 127.519 2.328 . . . . 0.0 110.011 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 7.6 ptm -73.03 172.17 11.5 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 122.424 1.106 . . . . 0.0 111.315 -176.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.2 p -143.17 143.95 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 C-N-CA 124.414 1.086 . . . . 0.0 108.092 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.487 ' HG3' HD11 ' A' ' 186' ' ' ILE . 11.2 tt0 -100.56 106.96 18.53 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 178.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 23.6 mm -100.98 146.25 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 O-C-N 120.756 -1.215 . . . . 0.0 108.713 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -125.48 134.53 52.02 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.796 -1.186 . . . . 0.0 107.796 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' TYR . . . . . 0.555 ' CD1' HD13 ' A' ' 109' ' ' ILE . 43.4 m-85 -106.06 110.05 22.19 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.402 HG12 ' HB3' ' A' ' 182' ' ' TYR . 29.9 m -124.7 162.58 26.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 45.5 t -83.03 143.51 30.56 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -87.48 23.67 11.9 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-O 117.285 -1.842 . . . . 0.0 113.187 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 71.2 -74.19 0.68 Allowed Glycine 0 C--N 1.341 0.83 0 C-N-CA 126.256 1.884 . . . . 0.0 109.911 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 60.8 m -51.6 123.45 9.99 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.377 1.871 . . . . 0.0 107.09 178.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -74.68 2.78 9.11 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.049 1.339 . . . . 0.0 113.22 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 4.0 t -131.26 154.95 47.94 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.021 1.328 . . . . 0.0 109.495 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 132.28 177.72 15.08 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.68 1.61 . . . . 0.0 112.1 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -80.15 -101.97 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.13 0 C-N-CA 123.743 2.962 . . . . 0.0 109.97 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.2 p -163.9 139.3 6.22 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 129.731 3.212 . . . . 0.0 105.409 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 77.4 p -151.3 175.46 12.19 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.536 1.062 . . . . 0.0 110.819 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.433 ' HA ' ' HA ' ' A' ' 233' ' ' VAL . 3.2 mt -115.48 143.05 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 104.073 -2.565 . . . . 0.0 104.073 176.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -94.35 -48.31 6.21 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.722 1.209 . . . . 0.0 112.421 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 -156.84 151.85 26.11 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.815 1.646 . . . . 0.0 108.499 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.493 HG23 ' HB2' ' A' ' 231' ' ' ALA . 6.8 p -155.71 120.44 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 177.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -148.85 158.38 44.12 Favored 'General case' 0 C--O 1.235 0.342 0 O-C-N 121.563 -0.711 . . . . 0.0 110.849 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -65.84 130.44 43.29 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 12.1 t -107.96 -33.61 7.16 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 125.842 1.657 . . . . 0.0 112.605 -178.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 7.1 mttt -132.17 -175.88 3.89 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.4 HG21 HG22 ' A' ' 196' ' ' THR . 1.1 mm -38.72 -56.92 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 124.896 1.278 . . . . 0.0 113.319 -177.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 2.5 m -133.32 17.61 4.04 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.775 1.63 . . . . 0.0 109.81 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.64 141.75 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -121.53 163.7 18.43 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.457 1.103 . . . . 0.0 108.474 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -138.16 132.36 31.81 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 178.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.493 ' HB2' HG23 ' A' ' 221' ' ' VAL . . . -136.57 140.04 42.61 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.158 1.383 . . . . 0.0 108.141 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -118.92 116.98 27.62 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 218' ' ' ILE . 1.3 m -107.0 151.85 8.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.8 p -126.75 136.83 52.94 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 123.461 0.704 . . . . 0.0 111.857 -178.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -141.21 142.55 27.48 Favored Pre-proline 0 N--CA 1.452 -0.336 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -66.79 -47.54 2.62 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.855 2.37 . . . . 0.0 112.002 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -53.41 -24.48 12.61 Favored 'General case' 0 CA--C 1.527 0.091 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 10.7 tp -61.11 -29.9 70.04 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 119.266 0.939 . . . . 0.0 111.409 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 9.2 m -62.0 -12.26 17.75 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.999 0.919 . . . . 0.0 112.602 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.99 -24.65 66.06 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.245 0.93 . . . . 0.0 110.121 178.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -89.14 117.21 27.96 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 178.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 -46.79 -44.18 18.93 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 126.281 1.833 . . . . 0.0 114.105 -178.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.405 ' HB3' ' CD2' ' A' ' 181' ' ' TYR . 60.2 mt -70.23 -31.43 68.83 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.448 -1.407 . . . . 0.0 113.017 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 14.3 mt -84.29 -20.7 31.69 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.124 0.97 . . . . 0.0 112.583 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -55.72 141.16 39.28 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 128.914 2.886 . . . . 0.0 111.538 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 34.5 mmtt -103.5 176.49 5.13 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.378 1.471 . . . . 0.0 109.616 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -101.77 -69.63 0.78 Allowed 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 53.03 25.44 4.08 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.356 1.463 . . . . 0.0 110.94 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 3.0 t70 . . . . . 0 C--O 1.246 0.88 0 C-N-CA 127.096 2.158 . . . . 0.0 108.057 179.745 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.366 0 N-CA-C 108.149 -1.981 . . . . 0.0 108.149 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.5 -29.81 68.11 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 119.443 1.621 . . . . 0.0 109.216 178.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 70.6 m -142.14 164.38 30.33 Favored 'General case' 0 C--O 1.246 0.909 0 C-N-CA 131.658 3.983 . . . . 0.0 102.953 177.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -120.63 118.06 29.17 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 58.6 m -52.41 -37.4 56.56 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 124.396 1.078 . . . . 0.0 109.077 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -58.82 -40.63 84.74 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 127.757 2.423 . . . . 0.0 110.746 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? -62.33 -50.49 71.43 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.527 ' HA ' HD12 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -62.52 -37.24 85.28 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.021 0.528 . . . . 0.0 111.035 178.741 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.43 -45.96 92.1 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 55.3 tp -66.38 -38.07 86.71 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 118.396 -0.811 . . . . 0.0 109.905 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.527 HD12 ' HA ' ' A' ' 95' ' ' THR . 20.7 mt -59.74 -54.81 41.98 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 24.5 m -60.7 -38.53 85.34 Favored 'General case' 0 C--O 1.239 0.551 0 O-C-N 121.449 -0.782 . . . . 0.0 111.77 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -65.28 -48.19 74.04 Favored 'General case' 0 CA--C 1.519 -0.247 0 O-C-N 121.056 -1.027 . . . . 0.0 109.993 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 69.2 m -51.95 -47.81 64.59 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.352 1.061 . . . . 0.0 110.667 -178.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.411 HD21 ' HB2' ' A' ' 172' ' ' PHE . 3.4 tm? -58.51 -49.48 77.21 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 117.847 0.294 . . . . 0.0 110.912 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -62.89 -57.35 11.09 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 122.243 1.02 . . . . 0.0 113.153 -177.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -60.41 -41.6 94.22 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.797 -178.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -62.71 -53.21 42.9 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-O 117.781 -1.566 . . . . 0.0 111.418 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.515 ' HA ' HD12 ' A' ' 109' ' ' ILE . 47.8 t -58.34 -42.53 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 120.562 2.181 . . . . 0.0 109.0 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.84 -30.98 71.69 Favored 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 119.181 -1.007 . . . . 0.0 112.499 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.429 ' CG2' ' HB3' ' A' ' 237' ' ' GLU . 52.6 m -72.32 -40.75 67.24 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 126.042 1.737 . . . . 0.0 108.385 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.515 HD12 ' HA ' ' A' ' 106' ' ' VAL . 18.1 mt -60.66 -55.06 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 178.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -60.91 -28.0 68.6 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-O 117.876 -1.059 . . . . 0.0 111.657 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -62.07 -49.38 76.17 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.22 1.008 . . . . 0.0 111.337 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.473 ' HA ' ' HE2' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -85.26 -39.28 17.93 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -177.765 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 16.2 mt -66.38 -25.78 66.95 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 119.009 -0.519 . . . . 0.0 112.26 -179.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -52.44 -28.75 21.3 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -51.18 -74.77 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.821 1.648 . . . . 0.0 111.67 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -147.68 176.68 9.9 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.804 1.642 . . . . 0.0 109.126 -178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 33.4 m -86.21 163.06 18.0 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.635 0.731 . . . . 0.0 109.147 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 37.6 pt -118.63 160.29 18.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 126.134 1.774 . . . . 0.0 109.395 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -158.05 139.62 13.7 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -130.54 127.2 38.61 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 123.584 0.753 . . . . 0.0 110.052 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -85.39 101.66 12.78 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.26 1.024 . . . . 0.0 108.439 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.26 80.07 7.65 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 104.681 -2.34 . . . . 0.0 104.681 178.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.73 -99.63 0.37 Allowed Glycine 0 CA--C 1.531 1.08 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -95.25 -25.85 16.19 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.742 1.617 . . . . 0.0 114.031 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -99.01 152.35 19.91 Favored 'General case' 0 CA--C 1.513 -0.451 0 O-C-N 121.302 -0.874 . . . . 0.0 108.752 -178.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.465 HD13 ' H ' ' A' ' 140' ' ' GLY . 5.2 mp -124.67 124.6 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -100.99 119.3 38.54 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 103.212 -2.884 . . . . 0.0 103.212 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -118.4 124.7 48.33 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.157 0.983 . . . . 0.0 110.891 -177.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -124.03 135.03 53.32 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -178.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.578 ' HB3' HD13 ' A' ' 133' ' ' ILE . 16.1 m -111.18 155.97 41.79 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 125.546 1.538 . . . . 0.0 112.808 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -67.97 81.31 0.49 Allowed 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 124.864 3.71 . . . . 0.0 114.474 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 72.98 54.55 7.0 Favored Glycine 0 CA--C 1.529 0.922 0 O-C-N 121.207 -0.933 . . . . 0.0 112.862 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.578 HD13 ' HB3' ' A' ' 130' ' ' CYS . 3.6 mp -131.04 -72.02 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -167.16 167.82 14.02 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.757 1.623 . . . . 0.0 109.068 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -128.54 126.14 39.75 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 176.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.8 m -141.53 164.0 19.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 124.591 1.157 . . . . 0.0 110.55 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -126.36 125.81 42.85 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -139.4 162.96 33.77 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.091 0.957 . . . . 0.0 110.636 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.559 ' H ' HD13 ' A' ' 156' ' ' LEU . 61.8 t60 -110.19 109.35 19.81 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 101.993 -3.336 . . . . 0.0 101.993 177.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.465 ' H ' HD13 ' A' ' 126' ' ' ILE . . . -168.78 -159.64 14.92 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.191 1.853 . . . . 0.0 109.959 -178.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -141.02 167.26 22.61 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 118.856 1.328 . . . . 0.0 112.684 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.467 HG23 ' C ' ' A' ' 148' ' ' GLU . 8.9 p -133.16 150.42 32.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 125.747 1.619 . . . . 0.0 107.878 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 63.2 t-20 -103.49 121.75 43.49 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 16.6 p -60.9 -27.4 68.14 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 33.3 mmtt -61.29 -33.12 73.05 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -178.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.8 p -110.05 -47.33 3.33 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 125.025 1.33 . . . . 0.0 109.497 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 90.56 32.22 9.59 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 125.325 1.44 . . . . 0.0 110.793 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.467 ' C ' HG23 ' A' ' 142' ' ' VAL . 11.9 pt-20 -124.68 145.62 49.57 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 125.668 1.587 . . . . 0.0 108.881 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 6.5 mm -66.0 149.26 11.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 125.299 1.439 . . . . 0.0 110.464 -177.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 24.3 m -59.98 -43.39 92.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 124.197 0.999 . . . . 0.0 111.096 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 74.3 m-80 -151.52 151.29 31.41 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 125.005 1.322 . . . . 0.0 108.103 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -79.75 -155.97 0.11 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.553 1.141 . . . . 0.0 109.725 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -67.04 90.53 0.19 Allowed 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.651 -1.281 . . . . 0.0 111.06 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -76.54 -67.1 0.73 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 49.8 m -126.54 -15.53 5.55 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.742 1.217 . . . . 0.0 113.479 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.559 HD13 ' H ' ' A' ' 139' ' ' HIS . 56.7 mt -83.45 81.8 8.56 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 120.743 -1.223 . . . . 0.0 109.995 -178.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 71.4 t -77.06 110.05 12.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -145.72 137.26 25.06 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.639 1.176 . . . . 0.0 109.029 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -134.59 141.78 46.74 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 177.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 59.7 mt -120.17 -29.06 4.96 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 125.454 1.721 . . . . 0.0 107.042 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 160.62 159.18 9.73 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 36.1 mtmt -128.57 114.66 19.49 Favored Pre-proline 0 CA--C 1.537 0.444 0 O-C-N 122.021 -0.694 . . . . 0.0 109.998 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -75.6 -167.98 0.49 Allowed 'Trans proline' 0 CA--C 1.537 0.63 1 C-N-CA 125.806 4.338 . . . . 0.0 110.336 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -131.93 157.56 43.7 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.328 1.451 . . . . 0.0 108.91 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.89 -38.29 73.05 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.878 0.371 . . . . 0.0 110.503 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 33.7 m-20 -76.15 64.73 2.03 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.703 1.601 . . . . 0.0 110.293 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 6.1 p -52.04 -30.32 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 124.212 1.005 . . . . 0.0 111.172 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -71.32 -26.03 62.66 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.531 1.132 . . . . 0.0 113.804 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -77.32 -23.68 50.95 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 122.901 0.481 . . . . 0.0 112.174 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -92.42 160.32 15.14 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.964 0.411 . . . . 0.0 109.909 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -114.38 161.48 17.87 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.411 ' HB2' HD21 ' A' ' 102' ' ' LEU . 49.4 m-85 -138.11 170.43 16.05 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.738 1.215 . . . . 0.0 109.621 -177.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -112.57 151.32 30.19 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 21.9 tp -121.3 98.35 5.94 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -110.16 178.46 4.39 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -155.0 163.3 40.51 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -141.08 -171.03 3.18 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -55.27 -23.82 25.02 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.087 1.355 . . . . 0.0 112.406 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.5 t -81.87 -65.91 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 177.48 -170.58 43.1 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -77.55 157.62 30.26 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.566 0.746 . . . . 0.0 111.838 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.452 ' HB3' HG12 ' A' ' 207' ' ' VAL . 48.7 p90 -156.09 173.77 16.34 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 126.735 2.014 . . . . 0.0 108.585 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 93.8 mt -114.29 141.69 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 177.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 21.3 t -109.91 128.71 55.53 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.059 1.343 . . . . 0.0 107.923 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -124.07 107.39 11.23 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.862 1.265 . . . . 0.0 108.459 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.6 mp -91.05 128.65 42.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 7.6 mt -118.9 106.72 19.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -93.88 -152.56 29.41 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 108.443 -1.863 . . . . 0.0 108.443 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 69.7 m 79.15 25.49 0.46 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.201 2.2 . . . . 0.0 115.768 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -89.64 -156.02 31.44 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 107.58 -2.208 . . . . 0.0 107.58 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -123.17 144.13 49.56 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 39.8 mm -60.82 134.55 26.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -79.62 109.63 14.18 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 127.131 2.172 . . . . 0.0 105.489 177.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -55.04 -19.5 7.2 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.847 2.059 . . . . 0.0 113.189 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 50.1 t -60.47 -54.52 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 126.968 2.107 . . . . 0.0 111.567 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 4.8 t -124.09 -25.42 4.18 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -177.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 99.59 35.72 4.55 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 108.239 -1.945 . . . . 0.0 108.239 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -113.27 151.29 31.29 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 117.933 0.867 . . . . 0.0 110.669 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 57.5 mp0 -75.26 141.41 43.49 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 123.976 0.91 . . . . 0.0 112.735 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . 0.297 7.9 ttt85 -70.05 30.98 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 130.885 3.674 . . . . 0.0 112.797 178.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 5.1 ptm -74.75 177.36 6.22 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.125 0.97 . . . . 0.0 110.472 -179.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.2 p -143.65 152.97 16.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 125.283 1.433 . . . . 0.0 107.98 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -114.65 112.57 23.08 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 15.7 mm -98.24 141.96 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -124.62 111.46 15.66 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.663 1.585 . . . . 0.0 107.985 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -92.56 109.03 20.43 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.701 1.6 . . . . 0.0 110.369 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.452 HG12 ' HB3' ' A' ' 182' ' ' TYR . 34.9 m -124.79 167.82 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.211 1.005 . . . . 0.0 109.837 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 45.5 t -96.46 132.73 41.72 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 103.541 -2.763 . . . . 0.0 103.541 177.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -98.36 32.49 6.89 Favored Glycine 0 N--CA 1.463 0.456 0 C-N-CA 124.541 1.067 . . . . 0.0 111.01 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 58.14 -147.44 38.26 Favored Glycine 0 CA--C 1.533 1.169 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 25.6 m -63.16 80.16 0.02 OUTLIER 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.659 1.584 . . . . 0.0 113.871 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.29 59.4 1.56 Allowed 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.119 1.367 . . . . 0.0 108.421 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 9.6 m -54.21 147.22 13.53 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 121.377 -0.827 . . . . 0.0 109.145 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 131.96 -161.06 23.77 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-O 119.163 -0.798 . . . . 0.0 112.525 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -67.1 -95.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 124.483 3.455 . . . . 0.0 115.429 -178.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -164.12 151.03 11.63 Favored 'General case' 0 C--O 1.241 0.624 0 O-C-N 120.863 -1.148 . . . . 0.0 109.1 -178.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 36.7 p -151.81 160.64 43.49 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.839 0.855 . . . . 0.0 110.579 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 4.1 mt -106.48 148.55 10.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -93.82 -53.98 3.8 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.672 0.789 . . . . 0.0 110.95 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 63.4 p-90 -155.17 155.03 33.2 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.859 1.264 . . . . 0.0 108.113 -178.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 56.3 t -150.58 129.66 3.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.84 162.18 32.15 Favored 'General case' 0 C--O 1.233 0.209 0 O-C-N 122.19 -0.319 . . . . 0.0 111.174 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -72.53 128.79 36.66 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 104.574 -2.38 . . . . 0.0 104.574 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 9.9 t -106.15 -37.17 6.68 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 124.833 1.253 . . . . 0.0 109.981 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 34.2 mttt -133.31 -176.45 4.14 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 123.782 0.833 . . . . 0.0 109.975 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 69.3 mt -46.38 -49.43 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.188 0.995 . . . . 0.0 112.322 -178.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.99 21.23 5.83 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 124.112 0.965 . . . . 0.0 110.362 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 7.9 t -120.1 141.4 40.49 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.61 0 CA-C-N 118.64 0.654 . . . . 0.0 111.61 -177.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -122.97 158.37 30.61 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -129.73 134.46 47.63 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -137.32 119.33 15.38 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 125.427 1.491 . . . . 0.0 109.932 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -108.42 124.66 50.74 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 12.5 m -116.31 156.58 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.481 0 C-N-CA 122.47 0.308 . . . . 0.0 110.665 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.3 p -123.85 123.89 41.45 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 124.39 1.076 . . . . 0.0 110.263 -178.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 2.2 pt -133.44 134.52 23.92 Favored Pre-proline 0 C--O 1.237 0.4 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 177.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.54 -27.82 45.83 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.233 2.622 . . . . 0.0 113.304 -178.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.429 ' HB3' ' CG2' ' A' ' 108' ' ' THR . 28.2 mp0 -64.59 -28.65 69.78 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 -178.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 66.6 mt -61.23 -29.23 69.7 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 118.587 -1.245 . . . . 0.0 110.652 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 21.7 m -58.86 -16.35 16.95 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 118.806 0.73 . . . . 0.0 112.256 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -60.11 -38.4 82.91 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 118.91 0.777 . . . . 0.0 109.663 178.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -79.61 122.47 26.56 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -47.33 -44.88 24.05 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 126.26 1.824 . . . . 0.0 113.34 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.43 -33.59 76.05 Favored 'General case' 0 C--O 1.226 -0.176 0 O-C-N 121.341 -0.849 . . . . 0.0 112.694 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 27.2 mt -92.88 -4.99 51.89 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.231 1.012 . . . . 0.0 113.054 -178.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -71.61 117.06 12.71 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 127.625 2.37 . . . . 0.0 112.978 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 32.6 mmtm -79.54 150.56 31.1 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 123.216 0.606 . . . . 0.0 110.709 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -144.05 -13.89 0.62 Allowed 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 124.865 1.266 . . . . 0.0 111.56 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -120.64 21.32 11.57 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 127.206 2.202 . . . . 0.0 110.183 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 . . . . . 0 C--O 1.252 1.189 0 CA-C-O 116.613 -1.661 . . . . 0.0 111.126 179.642 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.658 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -147.37 -143.69 0.14 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 128.885 2.874 . . . . 0.0 104.583 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.0 t -79.21 63.6 3.89 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 120.008 1.276 . . . . 0.0 107.69 178.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -65.76 -53.35 41.66 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.825 1.65 . . . . 0.0 109.888 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.9 m -50.79 -43.09 58.61 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.475 1.91 . . . . 0.0 112.947 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -60.96 -50.02 75.08 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 118.528 0.604 . . . . 0.0 110.234 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -52.99 -53.43 50.14 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -178.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.37 -37.63 65.19 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 118.554 -0.736 . . . . 0.0 112.078 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.82 -49.23 76.01 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 52.8 tp -65.1 -35.6 81.64 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.492 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.498 HD23 HD11 ' A' ' 243' ' ' LEU . 43.3 mt -63.24 -55.01 28.48 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.44 1.018 . . . . 0.0 108.791 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 88.9 m -57.25 -46.36 83.1 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 125.045 1.338 . . . . 0.0 110.254 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.71 -50.2 70.08 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 118.231 -0.89 . . . . 0.0 109.666 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 47.6 m -52.53 -46.9 66.94 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 124.159 0.984 . . . . 0.0 110.532 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -59.49 -50.33 74.33 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 118.3 0.5 . . . . 0.0 110.003 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.1 -61.5 2.22 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.219 0.608 . . . . 0.0 112.313 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.44 -37.98 79.5 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.487 0.315 . . . . 0.0 110.231 -178.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.09 -53.25 38.16 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-O 117.583 -1.676 . . . . 0.0 110.706 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.55 ' HA ' HD12 ' A' ' 109' ' ' ILE . 37.3 t -57.12 -45.19 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 119.671 1.736 . . . . 0.0 109.087 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -62.96 -34.36 77.33 Favored 'General case' 0 C--O 1.223 -0.311 0 C-N-CA 118.815 -1.154 . . . . 0.0 111.573 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 86.2 m -70.89 -36.96 72.97 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.444 0.698 . . . . 0.0 109.53 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.55 HD12 ' HA ' ' A' ' 106' ' ' VAL . 13.7 mt -61.81 -55.4 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 179.121 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -64.3 -27.85 69.32 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -64.51 -30.82 71.85 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.443 1.02 . . . . 0.0 111.646 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.68 -46.61 6.54 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 123.835 0.854 . . . . 0.0 110.56 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.9 mt -59.98 -27.58 66.97 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -55.03 -24.83 26.63 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -62.85 -62.44 1.72 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.48 0.712 . . . . 0.0 110.872 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -148.42 171.03 16.7 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 123.97 0.908 . . . . 0.0 110.868 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 69.8 m -87.07 166.14 15.25 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 35.4 pt -117.92 156.44 19.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 125.372 1.469 . . . . 0.0 108.613 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.3 138.29 21.27 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 125.389 1.475 . . . . 0.0 109.278 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -136.7 113.36 10.21 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 123.634 0.773 . . . . 0.0 111.44 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -79.82 99.59 7.58 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.29 79.62 8.99 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 178.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 60.13 -105.83 0.87 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -77.99 -34.32 50.87 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.685 0.794 . . . . 0.0 112.981 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 52.4 m95 -99.79 167.82 10.3 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 118.952 0.797 . . . . 0.0 110.293 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.3 mp -136.88 153.81 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.503 ' CD1' HG11 ' A' ' 221' ' ' VAL . 98.9 m-85 -133.68 120.15 20.27 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.766 2.027 . . . . 0.0 106.221 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -117.15 121.29 40.85 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -119.06 139.43 51.76 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 124.216 1.007 . . . . 0.0 109.895 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.607 ' HB3' HD13 ' A' ' 133' ' ' ILE . 20.8 m -115.77 157.38 44.73 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 126.663 1.985 . . . . 0.0 111.687 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -64.21 76.68 0.17 Allowed 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 124.723 3.615 . . . . 0.0 114.626 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 68.54 56.87 8.92 Favored Glycine 0 CA--C 1.533 1.161 0 O-C-N 120.72 -1.238 . . . . 0.0 112.792 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.607 HD13 ' HB3' ' A' ' 130' ' ' CYS . 3.9 mp -128.12 -71.24 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.131 0 C-N-CA 126.198 1.799 . . . . 0.0 106.153 179.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -164.42 169.97 16.61 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 126.963 2.105 . . . . 0.0 109.521 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -133.38 124.84 27.89 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 178.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 33.9 m -142.65 163.71 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 123.99 0.916 . . . . 0.0 112.043 -178.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -125.43 124.67 41.95 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.757 1.623 . . . . 0.0 107.017 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -139.34 162.45 34.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 119.451 1.023 . . . . 0.0 111.43 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 63.1 t60 -85.37 160.97 19.66 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 177.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 133.09 -159.06 23.43 Favored Glycine 0 N--CA 1.465 0.595 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.97 167.54 29.1 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 124.949 1.3 . . . . 0.0 109.584 178.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.0 p -112.66 148.95 15.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -106.3 113.01 26.28 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 178.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 58.9 p -53.77 -30.82 46.31 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.918 1.287 . . . . 0.0 112.972 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp -47.04 -45.12 21.24 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 127.79 2.436 . . . . 0.0 112.965 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.7 p -120.22 -41.27 2.64 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 127.331 2.252 . . . . 0.0 112.926 -177.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 100.04 35.47 4.51 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 125.871 1.701 . . . . 0.0 110.467 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.1 148.63 41.37 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.755 1.222 . . . . 0.0 111.503 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 34.2 mm -78.73 144.68 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 103.24 -2.874 . . . . 0.0 103.24 177.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 32.5 m -66.66 -6.46 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 36.61 84.1 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 128.978 2.911 . . . . 0.0 110.471 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -140.85 -34.64 0.5 Allowed 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -178.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -93.28 66.97 4.07 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -60.37 -57.02 14.56 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.162 1.385 . . . . 0.0 112.641 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 4.5 m -59.54 -15.41 17.95 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 115.764 1.765 . . . . 0.0 115.764 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 13.8 mt -84.23 57.32 4.17 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.252 0.933 . . . . 0.0 108.921 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 10.8 m -85.48 148.08 5.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 124.005 0.922 . . . . 0.0 109.61 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -151.85 176.98 10.89 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 128.561 2.744 . . . . 0.0 107.477 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -148.7 134.18 18.61 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.5 mp -109.85 -23.73 11.22 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 160.79 159.22 9.78 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-N 119.436 1.016 . . . . 0.0 111.891 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.38 108.46 41.71 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 123.918 0.887 . . . . 0.0 109.631 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.4 166.73 23.88 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.286 2.657 . . . . 0.0 110.058 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -96.75 156.55 16.3 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -76.02 -35.14 59.65 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.728 1.211 . . . . 0.0 113.149 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -84.85 66.73 9.83 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 124.369 1.068 . . . . 0.0 110.534 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.5 p -46.04 -28.6 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -71.16 -31.2 67.4 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 124.823 1.249 . . . . 0.0 111.737 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -87.84 -14.1 40.4 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.138 1.775 . . . . 0.0 110.24 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -75.97 158.38 32.02 Favored 'General case' 0 CA--C 1.521 -0.165 0 O-C-N 120.921 -1.112 . . . . 0.0 108.865 178.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -109.9 149.25 30.18 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -143.37 169.28 17.96 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 127.025 2.13 . . . . 0.0 108.606 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -128.13 154.01 46.23 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.082 0.953 . . . . 0.0 110.043 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 23.9 tp -114.25 108.52 17.05 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.555 HD23 ' HB2' ' A' ' 184' ' ' SER . 1.9 mm? -118.2 -179.83 3.89 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.226 1.41 . . . . 0.0 109.297 -178.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -149.33 156.79 42.62 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -141.52 -178.12 5.48 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 177.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -60.86 -13.13 13.58 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.331 -0.856 . . . . 0.0 111.464 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 69.0 t -83.09 -45.25 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 O-C-N 120.796 -1.19 . . . . 0.0 110.435 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 154.53 -165.56 31.99 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 108.082 -2.007 . . . . 0.0 108.082 -178.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.441 ' CD2' ' HB3' ' A' ' 243' ' ' LEU . 3.4 m-30 -78.56 160.72 27.46 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 118.239 1.019 . . . . 0.0 110.22 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.439 ' CB ' HG12 ' A' ' 207' ' ' VAL . 45.7 p90 -158.64 161.72 37.2 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.503 1.121 . . . . 0.0 111.371 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 95.8 mt -101.4 144.1 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.555 ' HB2' HD23 ' A' ' 175' ' ' LEU . 29.7 t -114.29 133.01 55.95 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -123.46 108.55 12.8 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -85.84 127.61 40.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.8 mt -115.59 105.23 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 102.874 -3.01 . . . . 0.0 102.874 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -110.76 -152.04 12.74 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 108.379 -1.888 . . . . 0.0 108.379 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 75.26 23.74 1.52 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.389 1.076 . . . . 0.0 110.945 178.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -95.08 173.64 31.89 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.98 163.88 26.72 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 44.0 mm -86.23 141.43 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 125.619 1.568 . . . . 0.0 111.623 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.2 m -87.23 118.75 26.86 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 127.724 2.41 . . . . 0.0 108.383 178.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -54.06 -32.24 54.02 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.075 2.15 . . . . 0.0 113.335 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 43.8 t -50.91 -55.42 7.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 125.542 1.537 . . . . 0.0 112.772 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 13.6 t -123.93 -33.28 3.16 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 108.05 34.73 2.69 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -178.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -104.82 152.65 22.33 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.916 1.358 . . . . 0.0 110.438 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -76.96 146.2 37.65 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 118.773 0.715 . . . . 0.0 109.559 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . 0.373 4.8 ptp180 -71.62 29.34 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 128.176 2.59 . . . . 0.0 113.558 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 7.8 ptm -72.59 174.31 7.7 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 122.15 0.976 . . . . 0.0 111.643 -176.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.4 p -142.25 150.17 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 124.065 0.946 . . . . 0.0 109.346 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -111.06 106.23 15.23 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 17.0 mm -90.31 150.59 3.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -125.76 100.03 6.23 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 126.916 2.087 . . . . 0.0 110.173 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -84.81 108.68 17.6 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 178.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.439 HG12 ' CB ' ' A' ' 182' ' ' TYR . 26.1 m -125.38 164.11 25.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 124.243 1.017 . . . . 0.0 108.674 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 42.6 t -82.92 146.51 28.8 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 177.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -93.04 13.42 67.74 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-O 118.997 -0.891 . . . . 0.0 112.456 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 68.85 -155.97 53.49 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 106.443 -2.663 . . . . 0.0 106.443 -177.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 16.0 m -70.43 85.48 0.6 Allowed 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.15 0.98 . . . . 0.0 109.393 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -145.74 60.65 1.27 Allowed 'General case' 0 C--O 1.233 0.22 0 C-N-CA 126.418 1.887 . . . . 0.0 108.02 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 12.8 m -59.72 104.84 0.31 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.319 1.448 . . . . 0.0 111.506 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.421 ' H ' ' HG3' ' A' ' 236' ' ' PRO . . . -175.21 -163.39 28.14 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 125.284 1.421 . . . . 0.0 110.426 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -68.95 -92.5 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.641 2.894 . . . . 0.0 114.305 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 2.9 p -164.33 142.7 7.1 Favored 'General case' 0 N--CA 1.463 0.201 0 O-C-N 120.934 -1.104 . . . . 0.0 109.678 -178.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 7.9 p -148.8 165.5 31.29 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.47 0.577 . . . . 0.0 111.132 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 3.4 mt -101.96 154.48 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 125.298 1.439 . . . . 0.0 107.372 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -105.0 -44.86 4.69 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.121 0.968 . . . . 0.0 113.573 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 67.0 p-90 -163.68 151.88 13.31 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.999 1.319 . . . . 0.0 107.718 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.503 HG11 ' CD1' ' A' ' 127' ' ' TYR . 87.9 t -151.89 129.2 2.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 C-N-CA 124.879 1.272 . . . . 0.0 109.22 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 1.5 ppt_? -163.48 160.5 23.34 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.752 0.706 . . . . 0.0 110.495 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -67.09 131.25 45.45 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 14.9 t -104.07 -33.15 8.87 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.948 1.299 . . . . 0.0 111.361 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 56.8 mttt -131.36 -175.04 3.57 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 125.049 1.34 . . . . 0.0 108.332 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 67.5 mt -52.27 -43.88 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -129.95 8.3 5.22 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.649 0.78 . . . . 0.0 112.227 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 21.5 t -105.81 142.34 19.07 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -178.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -121.55 166.36 14.31 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 124.72 1.208 . . . . 0.0 108.104 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -136.91 144.29 43.39 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -148.65 119.02 7.33 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 123.364 0.666 . . . . 0.0 109.608 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -103.5 123.07 46.22 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 2.3 m -119.98 152.44 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 2.8 p -126.6 135.93 51.87 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 3.9 pt -139.82 146.17 46.02 Favored Pre-proline 0 C--O 1.236 0.362 0 C-N-CA 125.564 1.545 . . . . 0.0 107.029 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.421 ' HG3' ' H ' ' A' ' 214' ' ' GLY . 97.4 Cg_endo -74.03 -24.82 14.63 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.201 1.934 . . . . 0.0 112.973 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 49.6 mp0 -66.02 -28.18 68.68 Favored 'General case' 0 CA--C 1.518 -0.286 0 O-C-N 120.43 -1.418 . . . . 0.0 114.355 -178.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.409 HD22 ' CD1' ' A' ' 244' ' ' LEU . 58.9 mt -63.32 -25.13 68.16 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 118.902 -1.119 . . . . 0.0 110.682 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 20.9 m -63.0 -15.12 55.27 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 119.163 0.892 . . . . 0.0 111.051 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -69.5 -31.77 70.22 Favored 'General case' 0 C--N 1.341 0.206 0 O-C-N 121.186 -0.946 . . . . 0.0 109.358 178.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.445 HD13 ' HA ' ' A' ' 241' ' ' LEU . 3.1 mm? -78.21 120.75 23.44 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 178.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 33.0 tp10 -46.05 -48.47 16.86 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.766 2.026 . . . . 0.0 115.795 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.498 HD11 HD23 ' A' ' 98' ' ' LEU . 20.0 mt -69.52 -34.44 74.27 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.148 -0.97 . . . . 0.0 112.786 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.409 ' CD1' HD22 ' A' ' 238' ' ' LEU . 3.2 mt -84.71 -10.35 57.36 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.266 1.026 . . . . 0.0 112.717 -178.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -61.25 123.73 18.56 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.179 2.192 . . . . 0.0 111.015 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 16.2 mmtp -78.52 167.26 21.55 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.319 0.648 . . . . 0.0 109.677 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -65.99 -48.26 71.8 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 123.704 0.802 . . . . 0.0 111.183 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 48.0 48.72 17.89 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 126.299 1.84 . . . . 0.0 110.788 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 0.989 0 C-N-CA 126.351 1.86 . . . . 0.0 110.004 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.673 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -140.63 157.43 45.47 Favored 'General case' 0 CA--C 1.523 -0.077 0 CA-C-N 118.58 1.19 . . . . 0.0 110.258 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.2 p -112.12 15.97 20.34 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.177 2.191 . . . . 0.0 111.211 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -60.21 90.45 0.02 OUTLIER 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.677 1.591 . . . . 0.0 111.286 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.6 t -77.93 -41.6 35.86 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 118.808 0.731 . . . . 0.0 109.778 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.508 ' CD ' ' H ' ' A' ' 93' ' ' GLU . 8.8 mp0 -53.27 -41.58 65.68 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 127.095 2.158 . . . . 0.0 110.887 -178.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.8 tmtm? -60.56 -59.17 5.82 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.468 ' HA ' HD12 ' A' ' 98' ' ' LEU . 0.9 OUTLIER -59.48 -36.89 76.88 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 179.36 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.88 -52.64 64.86 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 42.0 tp -68.36 -34.95 77.0 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 118.416 -0.802 . . . . 0.0 110.373 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.468 HD12 ' HA ' ' A' ' 95' ' ' THR . 31.8 mt -60.36 -54.37 46.42 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 60.4 m -61.9 -45.26 94.5 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.656 -0.652 . . . . 0.0 109.8 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.9 -47.31 83.16 Favored 'General case' 0 C--N 1.346 0.415 0 O-C-N 120.854 -1.154 . . . . 0.0 109.416 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.405 ' HA ' HD12 ' A' ' 241' ' ' LEU . 72.3 m -54.14 -51.17 65.13 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.579 1.152 . . . . 0.0 110.323 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -57.98 -47.92 81.54 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 123.288 0.367 . . . . 0.0 110.56 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -69.17 -59.58 2.93 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -177.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.46 -37.32 85.46 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.451 ' HA3' HD11 ' A' ' 183' ' ' ILE . . . -56.15 -52.65 47.99 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.519 ' HA ' HD12 ' A' ' 109' ' ' ILE . 41.3 t -56.69 -46.02 82.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 119.381 1.59 . . . . 0.0 110.475 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.3 ptmt -63.61 -31.63 72.86 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 118.714 -0.66 . . . . 0.0 111.878 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.3 m -76.43 -37.89 56.36 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.38 1.072 . . . . 0.0 109.104 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.558 HD13 ' CD1' ' A' ' 206' ' ' TYR . 24.6 mt -62.16 -55.34 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -62.15 -28.37 69.6 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 118.272 -0.87 . . . . 0.0 111.497 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -68.67 -50.3 52.16 Favored 'General case' 0 N--CA 1.457 -0.085 0 CA-C-N 119.028 0.831 . . . . 0.0 111.135 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.05 -44.8 45.64 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 30.8 mt -64.33 -26.12 68.34 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-O 119.068 -0.491 . . . . 0.0 111.929 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -51.63 -27.06 10.26 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.3 1.04 . . . . 0.0 112.872 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -52.58 -68.09 0.2 Allowed 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.544 1.538 . . . . 0.0 112.489 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -152.9 -179.13 7.38 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.597 1.559 . . . . 0.0 111.536 -178.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 64.1 m -86.65 175.42 8.29 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 35.7 pt -140.73 160.19 24.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 125.306 1.442 . . . . 0.0 109.746 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.412 ' CD2' HG11 ' A' ' 142' ' ' VAL . 0.2 OUTLIER -150.32 144.2 25.38 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 123.878 0.871 . . . . 0.0 110.081 -179.607 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.537 ' CE1' ' HB2' ' A' ' 122' ' ' ALA . 8.8 t80 -135.04 131.16 36.71 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.091 0.956 . . . . 0.0 109.461 178.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.4 ' HA ' HG13 ' A' ' 126' ' ' ILE . 57.0 tt0 -91.43 109.71 21.0 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 124.915 1.286 . . . . 0.0 108.029 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.537 ' HB2' ' CE1' ' A' ' 120' ' ' TYR . . . -102.39 80.09 1.91 Allowed 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.15 1.78 . . . . 0.0 110.86 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.82 -85.99 0.07 OUTLIER Glycine 0 CA--C 1.529 0.913 0 O-C-N 120.711 -1.243 . . . . 0.0 113.1 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -109.77 -32.62 7.01 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.407 1.083 . . . . 0.0 111.235 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 69.2 m95 -99.81 152.76 19.76 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 118.933 0.788 . . . . 0.0 110.323 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.483 HD13 ' H ' ' A' ' 140' ' ' GLY . 4.8 mp -122.19 138.22 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -113.97 130.62 56.51 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -132.86 125.04 29.09 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.358 0.526 . . . . 0.0 110.57 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -116.06 140.65 49.06 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.823 1.249 . . . . 0.0 110.82 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 6.5 m -121.37 151.9 56.9 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 124.354 1.062 . . . . 0.0 109.925 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -65.69 84.86 0.23 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 124.374 3.383 . . . . 0.0 116.108 -177.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.21 32.07 36.38 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-O 118.041 -1.422 . . . . 0.0 112.714 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.8 mp -114.67 -72.59 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -172.05 173.74 4.28 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.737 1.215 . . . . 0.0 109.364 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -129.47 126.9 39.74 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.0 m -142.05 163.97 18.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 124.383 1.073 . . . . 0.0 111.487 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -123.93 118.93 28.17 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -137.78 163.43 31.39 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 125.869 1.667 . . . . 0.0 111.361 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.443 ' H ' ' CD1' ' A' ' 156' ' ' LEU . 70.5 t60 -94.77 135.39 36.31 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 177.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.483 ' H ' HD13 ' A' ' 126' ' ' ILE . . . 148.84 141.27 3.43 Favored Glycine 0 CA--C 1.529 0.914 0 O-C-N 121.126 -0.984 . . . . 0.0 111.89 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -91.13 167.94 11.99 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.715 0.806 . . . . 0.0 111.524 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.412 HG11 ' CD2' ' A' ' 119' ' ' PHE . 4.4 p -131.9 150.48 33.87 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 C-N-CA 124.7 1.2 . . . . 0.0 108.316 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -105.04 111.11 23.77 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 30.9 p -52.77 -29.13 25.54 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.18 1.392 . . . . 0.0 113.052 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 39.3 mmtt -59.59 -30.4 68.65 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.312 1.445 . . . . 0.0 113.056 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 25.5 p -124.99 -47.45 1.79 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.068 0.947 . . . . 0.0 112.39 -177.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 102.44 35.03 3.97 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.056 1.312 . . . . 0.0 110.987 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -120.56 149.88 41.75 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.273 1.029 . . . . 0.0 109.638 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 8.7 mm -79.14 157.92 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 179.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 15.6 m -65.53 -42.95 94.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 123.882 0.873 . . . . 0.0 110.218 179.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -157.43 154.43 28.78 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.484 2.313 . . . . 0.0 107.009 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 15.1 mmt180 -103.07 95.96 6.48 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 104.528 -2.397 . . . . 0.0 104.528 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -70.92 92.11 0.9 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 122.61 1.195 . . . . 0.0 114.097 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -71.81 -17.35 62.16 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.119 0.968 . . . . 0.0 112.476 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.52 -10.69 59.17 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.272 1.429 . . . . 0.0 110.371 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.443 ' CD1' ' H ' ' A' ' 139' ' ' HIS . 69.8 mt -111.26 101.49 9.97 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 126.949 2.1 . . . . 0.0 108.041 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.6 m -97.54 119.22 45.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -142.58 162.87 34.36 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.268 0.627 . . . . 0.0 110.513 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 19.2 tpp180 -148.11 113.19 5.5 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.425 1.49 . . . . 0.0 110.527 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 60.3 mt -97.91 -41.59 7.94 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 157.89 175.06 28.39 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.439 ' N ' HG22 ' A' ' 187' ' ' ILE . 6.0 ptmm? -130.36 127.83 22.54 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -70.35 179.1 4.27 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.036 3.157 . . . . 0.0 108.771 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -123.47 162.06 23.62 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 121.321 -0.862 . . . . 0.0 110.425 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -73.04 -50.06 25.17 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.126 0.97 . . . . 0.0 111.037 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -77.55 64.96 2.98 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 126.072 1.749 . . . . 0.0 111.734 -177.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.4 p -50.14 -32.43 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.464 1.105 . . . . 0.0 111.133 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -62.38 -37.24 84.98 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.402 1.481 . . . . 0.0 110.752 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -84.54 -15.21 46.6 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.849 1.26 . . . . 0.0 112.018 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 67.4 mtp180 -79.65 134.29 36.42 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -89.96 149.55 22.53 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -135.65 166.3 23.55 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.913 1.685 . . . . 0.0 107.149 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -122.79 153.57 39.36 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 48.1 tp -116.63 100.74 8.04 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.58 1.552 . . . . 0.0 109.524 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -117.67 178.68 4.31 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 125.175 1.39 . . . . 0.0 107.449 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -153.98 161.09 42.23 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 121.85 -0.531 . . . . 0.0 111.048 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -138.78 176.24 8.86 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 126.649 1.98 . . . . 0.0 107.501 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -59.91 -16.87 33.0 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 126.169 1.788 . . . . 0.0 111.987 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.469 ' CG1' ' HE3' ' A' ' 246' ' ' LYS . 99.3 t -86.41 -37.55 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 124.293 1.037 . . . . 0.0 110.196 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 155.51 -178.94 31.85 Favored Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -78.43 165.53 23.68 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.222 1.009 . . . . 0.0 108.718 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.479 ' HB3' HG12 ' A' ' 207' ' ' VAL . 36.8 p90 -158.95 169.75 23.63 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 122.779 0.431 . . . . 0.0 109.922 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.451 HD11 ' HA3' ' A' ' 105' ' ' GLY . 96.7 mt -109.48 124.74 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 35.3 t -91.54 129.52 37.5 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -125.64 107.26 10.4 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -90.15 125.68 43.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 103.711 -2.7 . . . . 0.0 103.711 177.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.439 HG22 ' N ' ' A' ' 162' ' ' LYS . 6.3 mt -113.74 112.75 41.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.73 -160.3 25.76 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 124.945 1.26 . . . . 0.0 112.554 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 84.25 56.64 0.01 OUTLIER 'General case' 0 C--O 1.239 0.529 0 C-N-CA 128.291 2.636 . . . . 0.0 108.421 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -134.05 149.62 19.8 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-O 121.651 0.584 . . . . 0.0 112.773 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -58.68 140.01 55.25 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 128.325 2.65 . . . . 0.0 109.995 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 21.7 mm -69.16 137.03 25.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 121.16 0.505 . . . . 0.0 111.21 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.3 m -85.33 104.06 14.82 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -53.99 -28.87 40.58 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.123 0.969 . . . . 0.0 112.593 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 45.5 t -42.95 -48.76 1.2 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 125.882 1.673 . . . . 0.0 111.207 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 10.0 t -124.36 -35.21 2.81 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.294 1.038 . . . . 0.0 113.241 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 105.94 36.15 2.82 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.564 1.554 . . . . 0.0 109.238 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -114.37 152.24 31.79 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 118.463 1.131 . . . . 0.0 111.535 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -66.1 163.29 17.82 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 4.9 mmt85 -89.29 28.4 1.25 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 130.648 3.579 . . . . 0.0 112.452 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 6.1 ptm -73.32 175.31 7.01 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 121.763 2.074 . . . . 0.0 111.042 -177.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.81 153.01 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 125.289 1.436 . . . . 0.0 107.24 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -115.48 114.65 25.3 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.798 1.639 . . . . 0.0 106.951 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 12.0 mm -106.07 144.79 14.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.324 1.049 . . . . 0.0 109.138 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -125.65 98.46 5.58 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.609 1.564 . . . . 0.0 112.601 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' TYR . . . . . 0.558 ' CD1' HD13 ' A' ' 109' ' ' ILE . 54.4 m-85 -73.06 111.48 8.21 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.571 1.148 . . . . 0.0 108.003 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.479 HG12 ' HB3' ' A' ' 182' ' ' TYR . 25.4 m -125.24 163.63 25.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 C-N-CA 124.932 1.293 . . . . 0.0 109.018 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 48.7 t -85.12 146.7 27.0 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -102.03 22.39 38.28 Favored Glycine 0 N--CA 1.463 0.443 0 C-N-CA 124.361 0.981 . . . . 0.0 112.042 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 67.53 -142.0 39.78 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 50.9 m -74.48 -149.71 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 127.206 2.202 . . . . 0.0 111.066 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 15.9 m120 53.55 51.62 14.84 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.991 1.716 . . . . 0.0 110.777 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -41.39 100.14 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 128.107 2.563 . . . . 0.0 111.867 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -118.99 175.96 15.9 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 126.824 2.154 . . . . 0.0 110.138 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -64.18 -67.9 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.822 2.348 . . . . 0.0 109.866 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 2.3 p -171.19 145.57 2.24 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 126.961 2.104 . . . . 0.0 108.317 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 13.9 p -149.88 172.42 15.2 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.849 0.86 . . . . 0.0 110.207 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.462 HG21 HG23 ' A' ' 221' ' ' VAL . 4.1 mt -122.36 136.08 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 125.997 1.719 . . . . 0.0 107.27 177.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -77.61 -59.37 2.81 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.425 1.49 . . . . 0.0 107.94 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' TRP . . . . . 0.473 ' HA ' ' CE1' ' A' ' 120' ' ' TYR . 68.1 p-90 -159.88 162.57 34.62 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.38 1.472 . . . . 0.0 109.259 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.462 HG23 HG21 ' A' ' 218' ' ' ILE . 47.3 t -154.43 138.67 9.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 178.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.27 163.3 20.09 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.998 0.919 . . . . 0.0 110.474 178.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -71.53 143.12 50.05 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 178.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' THR . . . . . 0.516 HG21 ' HG3' ' A' ' 230' ' ' GLU . 9.4 t -118.67 -35.95 3.59 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.541 1.136 . . . . 0.0 111.547 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.423 ' HG3' HG23 ' A' ' 224' ' ' THR . 10.7 mttt -129.51 -175.98 3.76 Favored 'General case' 0 C--O 1.22 -0.485 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 56.5 mt -53.35 -43.31 51.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -129.56 14.54 6.0 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.512 0.725 . . . . 0.0 112.159 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 15.8 t -115.84 142.7 28.03 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -177.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -123.76 159.8 28.69 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.362 1.065 . . . . 0.0 109.037 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' GLU . . . . . 0.516 ' HG3' HG21 ' A' ' 224' ' ' THR . 25.3 mt-10 -126.77 136.74 52.81 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.885 1.674 . . . . 0.0 107.824 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -137.27 146.66 45.0 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 125.814 1.646 . . . . 0.0 109.038 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -135.5 108.04 7.4 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' A' ' 218' ' ' ILE . 2.8 m -101.15 149.63 6.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 124.542 1.137 . . . . 0.0 108.622 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.12 128.6 46.45 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.94 0.896 . . . . 0.0 112.39 -178.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -131.83 147.88 67.71 Favored Pre-proline 0 C--O 1.234 0.249 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 177.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -72.45 -43.55 0.97 Allowed 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.225 1.95 . . . . 0.0 110.512 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -54.46 -23.92 18.12 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 125.424 1.49 . . . . 0.0 113.39 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 5.4 tp -62.24 -32.8 73.53 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 121.229 -0.919 . . . . 0.0 110.432 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 9.0 m -61.6 -12.3 15.18 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.666 1.186 . . . . 0.0 112.469 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.83 -31.28 70.7 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 123.391 0.676 . . . . 0.0 109.344 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 101' ' ' THR . 4.3 mm? -82.49 122.15 27.68 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 177.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -47.35 -44.36 23.88 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.823 1.649 . . . . 0.0 112.841 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 1.1 tp -68.06 -30.71 69.98 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 120.975 -1.078 . . . . 0.0 113.704 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 19.2 mt -93.61 -5.0 49.77 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.876 1.671 . . . . 0.0 111.841 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -67.22 119.77 12.66 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.004 1.321 . . . . 0.0 109.944 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.469 ' HE3' ' CG1' ' A' ' 179' ' ' VAL . 13.3 mmmm -71.3 174.27 6.69 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -78.31 -10.48 59.69 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.597 -0.689 . . . . 0.0 110.062 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -129.17 34.86 4.35 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 129.663 3.185 . . . . 0.0 110.148 -178.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 . . . . . 0 C--O 1.245 0.865 0 C-N-CA 125.65 1.58 . . . . 0.0 111.823 179.002 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.145 0 N-CA-C 108.841 -1.704 . . . . 0.0 108.841 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -117.94 90.4 3.32 Favored 'General case' 0 C--N 1.334 -0.09 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.0 m 60.43 24.6 14.17 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.757 0.823 . . . . 0.0 112.316 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 21.4 m120 51.8 47.39 24.88 Favored 'General case' 0 C--N 1.344 0.342 0 C-N-CA 125.736 1.614 . . . . 0.0 107.701 -177.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.9 p -47.17 -38.04 11.17 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 126.576 1.95 . . . . 0.0 112.334 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -68.86 -32.21 71.72 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.641 1.576 . . . . 0.0 110.79 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.06 -52.76 9.51 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 178.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.421 ' HA ' HD12 ' A' ' 98' ' ' LEU . 0.6 OUTLIER -56.86 -39.35 74.14 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 119.767 1.167 . . . . 0.0 110.353 179.048 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.22 -51.17 69.06 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.782 0.833 . . . . 0.0 108.942 178.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 35.4 tp -67.22 -40.03 86.36 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.826 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 95' ' ' THR . 41.4 mt -59.66 -54.55 45.07 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 119.514 1.052 . . . . 0.0 109.889 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 52.5 m -62.68 -44.84 95.23 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.132 0.973 . . . . 0.0 110.358 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.4 tmmm? -60.83 -50.92 71.47 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.713 -0.617 . . . . 0.0 109.934 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.1 m -53.82 -44.29 70.11 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 123.873 0.869 . . . . 0.0 109.862 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.12 -45.9 92.78 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.689 0.677 . . . . 0.0 109.76 178.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -61.87 -61.7 2.32 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 124.573 1.149 . . . . 0.0 113.71 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.98 -34.46 78.15 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 119.118 -0.468 . . . . 0.0 110.558 -178.017 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.34 -53.08 48.58 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.595 ' HA ' HD12 ' A' ' 109' ' ' ILE . 40.3 t -57.52 -51.57 68.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-N 118.909 1.355 . . . . 0.0 111.471 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 7.6 pttp -60.39 -33.68 72.82 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.849 -179.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 35.5 m -76.33 -30.89 57.84 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 122.235 0.214 . . . . 0.0 111.095 -178.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.595 HD12 ' HA ' ' A' ' 106' ' ' VAL . 16.1 mt -61.83 -54.97 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -62.45 -33.5 74.94 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.901 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -60.23 -35.56 75.73 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.178 0.899 . . . . 0.0 110.942 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.1 tptp -80.27 -53.67 6.43 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 28.8 mt -57.02 -28.79 62.8 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -178.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -49.35 -26.0 2.84 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.881 1.272 . . . . 0.0 112.908 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -61.33 -63.3 1.33 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.181 0.992 . . . . 0.0 112.511 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.7 mmm-85 -154.62 178.82 9.67 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.088 1.755 . . . . 0.0 110.049 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 63.4 m -86.62 174.05 9.14 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 38.5 pt -127.92 157.54 39.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 125.762 1.625 . . . . 0.0 108.778 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -151.57 145.23 24.98 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.847 1.259 . . . . 0.0 109.609 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -140.23 120.91 14.31 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.191 0.596 . . . . 0.0 111.551 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -79.22 104.61 9.96 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 178.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.06 79.97 3.6 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 57.8 -109.14 1.66 Allowed Glycine 0 CA--C 1.53 1.023 0 C-N-CA 123.992 0.806 . . . . 0.0 111.121 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -72.27 -35.96 68.87 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 118.704 -0.665 . . . . 0.0 112.281 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -99.8 168.68 9.75 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 119.336 0.971 . . . . 0.0 112.702 -177.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.4 mp -136.51 133.82 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 N-CA-C 104.059 -2.571 . . . . 0.0 104.059 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -111.68 119.98 40.49 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -117.88 124.78 49.15 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.256 0.622 . . . . 0.0 109.437 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -117.78 136.22 53.54 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.436 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.451 ' HB3' HD13 ' A' ' 133' ' ' ILE . 17.8 m -113.78 154.61 45.79 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 124.184 0.994 . . . . 0.0 111.241 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -61.99 80.56 0.09 OUTLIER 'Trans proline' 0 C--N 1.351 0.661 1 C-N-CA 125.409 4.072 . . . . 0.0 116.383 -177.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 72.95 41.74 47.57 Favored Glycine 0 CA--C 1.529 0.934 0 O-C-N 120.836 -1.165 . . . . 0.0 111.258 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.451 HD13 ' HB3' ' A' ' 130' ' ' CYS . 3.9 mp -122.93 -69.43 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.32 0 CA-C-N 118.207 1.004 . . . . 0.0 108.553 179.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -164.29 169.62 17.28 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.235 1.014 . . . . 0.0 109.849 -178.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -133.06 118.32 18.63 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 176.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.7 m -135.85 164.63 31.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 125.229 1.412 . . . . 0.0 112.327 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -125.23 123.29 39.22 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.546 1.938 . . . . 0.0 108.514 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -138.31 162.56 34.06 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.561 1.145 . . . . 0.0 110.987 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.457 ' H ' ' CD1' ' A' ' 156' ' ' LEU . 84.0 t60 -105.54 130.59 53.56 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 178.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 164.28 -159.15 31.99 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 108.476 -1.85 . . . . 0.0 108.476 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.89 159.72 43.55 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 118.757 1.279 . . . . 0.0 109.916 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.2 p -115.26 160.2 14.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 124.498 1.119 . . . . 0.0 108.578 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -105.49 110.06 22.26 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 104.24 -2.504 . . . . 0.0 104.24 177.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 17.5 p -55.27 -26.23 38.76 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 120.367 1.44 . . . . 0.0 112.762 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -61.43 -56.42 20.43 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 123.863 0.865 . . . . 0.0 111.694 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 36.6 p -93.54 -30.21 15.11 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.686 1.594 . . . . 0.0 113.332 -177.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.87 27.22 51.19 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 126.027 1.775 . . . . 0.0 112.604 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.54 151.8 38.02 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.42 1.088 . . . . 0.0 109.579 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 12.4 mm -71.23 150.97 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 29.3 m -66.5 -22.69 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 176.08 149.31 0.12 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.632 2.773 . . . . 0.0 107.519 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -88.23 114.5 24.91 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 119.443 1.019 . . . . 0.0 108.516 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.62 82.74 5.69 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -65.09 -17.4 64.43 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.344 0.657 . . . . 0.0 112.052 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 19.1 m -67.22 -10.21 48.19 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.842 1.657 . . . . 0.0 112.117 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.457 ' CD1' ' H ' ' A' ' 139' ' ' HIS . 71.1 mt -104.3 133.01 49.93 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 104.268 -2.493 . . . . 0.0 104.268 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.9 m -128.88 116.39 40.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -144.51 154.92 43.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.073 1.349 . . . . 0.0 109.163 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -149.36 115.95 5.88 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 178.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 26.5 mt -100.14 -24.81 14.48 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 159.89 161.72 11.59 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-O 122.545 1.081 . . . . 0.0 112.199 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.416 ' N ' HG22 ' A' ' 187' ' ' ILE . 38.9 ttpt -124.02 109.46 29.67 Favored Pre-proline 0 N--CA 1.43 -1.429 0 C-N-CA 125.01 1.324 . . . . 0.0 111.737 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -74.86 157.23 43.49 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 123.726 2.951 . . . . 0.0 109.223 177.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -92.73 157.54 16.39 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.791 -0.568 . . . . 0.0 109.54 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.62 -47.8 74.38 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.3 0.64 . . . . 0.0 111.572 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -74.74 64.89 1.29 Allowed 'General case' 0 N--CA 1.461 0.102 0 C-N-CA 126.701 2.001 . . . . 0.0 113.162 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.4 p -47.55 -31.82 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 124.382 1.073 . . . . 0.0 112.969 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -64.85 -32.44 74.15 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 122.401 1.095 . . . . 0.0 112.283 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -87.78 -15.1 37.88 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.165 1.386 . . . . 0.0 111.173 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -80.74 133.58 35.69 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -98.78 149.2 23.11 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -134.41 169.98 16.43 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.087 1.355 . . . . 0.0 108.565 -178.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -120.77 152.97 37.65 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 122.908 0.483 . . . . 0.0 109.791 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 14.2 tp -110.59 110.62 21.4 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 125.417 1.487 . . . . 0.0 107.384 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.575 HD23 ' HB2' ' A' ' 184' ' ' SER . 2.6 mm? -123.65 -179.23 4.28 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 127.316 2.246 . . . . 0.0 108.595 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -144.69 167.97 21.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.435 0.636 . . . . 0.0 111.005 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -140.64 -176.11 4.53 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 126.734 2.014 . . . . 0.0 107.646 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -64.04 -11.87 33.36 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 121.386 -0.821 . . . . 0.0 112.965 -177.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 85.0 t -106.23 -36.42 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 124.62 1.168 . . . . 0.0 112.485 -178.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 169.4 -173.62 43.74 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 119.389 0.995 . . . . 0.0 112.476 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.419 ' CD2' ' HB3' ' A' ' 243' ' ' LEU . 5.1 m-30 -79.97 162.97 24.62 Favored 'General case' 0 C--O 1.241 0.654 0 O-C-N 122.107 -0.643 . . . . 0.0 110.125 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -159.22 168.96 25.18 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.501 -1.227 . . . . 0.0 112.053 -179.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 92.1 mt -104.74 127.5 59.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.575 ' HB2' HD23 ' A' ' 175' ' ' LEU . 22.5 t -100.07 115.08 28.93 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.915 1.286 . . . . 0.0 108.802 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -111.83 107.01 15.91 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -89.54 111.84 23.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.447 0 N-CA-C 103.455 -2.795 . . . . 0.0 103.455 177.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.416 HG22 ' N ' ' A' ' 162' ' ' LYS . 6.7 mt -95.87 106.64 18.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.01 -157.42 26.29 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.0 t 85.29 3.61 0.62 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 127.667 2.387 . . . . 0.0 108.679 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -63.74 136.78 41.5 Favored Glycine 0 N--CA 1.435 -1.411 0 N-CA-C 108.256 -1.937 . . . . 0.0 108.256 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.26 148.25 27.9 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.469 1.108 . . . . 0.0 108.842 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.8 mm -70.37 130.76 34.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 122.863 1.316 . . . . 0.0 113.893 -177.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.3 m -85.46 107.5 17.45 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 128.448 2.699 . . . . 0.0 108.171 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -53.74 -18.38 3.09 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 127.963 2.505 . . . . 0.0 113.436 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 18.0 t -56.24 -54.77 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 125.935 1.694 . . . . 0.0 109.805 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 13.3 t -123.75 -29.68 3.67 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.189 0.996 . . . . 0.0 112.49 -178.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 104.6 35.75 3.21 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -115.48 160.1 20.35 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.282 1.541 . . . . 0.0 111.9 -178.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -77.54 151.43 34.53 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 118.867 0.758 . . . . 0.0 112.996 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -71.0 28.65 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.667 1 C-N-CA 132.129 4.172 . . . . 0.0 109.988 177.414 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 7.0 ptm -73.47 173.78 9.15 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 122.617 1.199 . . . . 0.0 112.002 -176.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.08 147.04 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 124.488 1.115 . . . . 0.0 108.733 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -106.83 104.37 14.04 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 125.635 1.574 . . . . 0.0 107.241 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 12.6 mm -93.24 147.21 5.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -126.84 101.75 6.73 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.008 1.723 . . . . 0.0 107.638 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' TYR . . . . . 0.509 ' CD1' HD13 ' A' ' 109' ' ' ILE . 40.9 m-85 -84.34 111.15 19.17 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 6.4 m -125.13 168.13 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.718 0.77 . . . . 0.0 109.605 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 49.8 t -87.88 142.15 28.03 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -88.49 -0.69 81.89 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-O 118.464 -1.187 . . . . 0.0 113.07 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 61.11 57.33 19.09 Favored Glycine 0 C--N 1.339 0.739 0 N-CA-C 107.31 -2.316 . . . . 0.0 107.31 -178.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 11.7 m -135.62 143.54 45.61 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -73.38 -37.46 65.99 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 119.566 -0.254 . . . . 0.0 111.255 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 75.8 p -148.78 -176.02 5.17 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 118.53 0.604 . . . . 0.0 110.693 -178.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 121.94 -179.82 16.14 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 124.047 0.832 . . . . 0.0 115.087 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -78.88 -113.67 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 124.053 3.169 . . . . 0.0 110.973 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 19.0 p -160.21 147.7 16.34 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 120.624 -1.298 . . . . 0.0 108.951 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 82.8 p -148.04 166.43 27.79 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.632 0.773 . . . . 0.0 109.31 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 3.4 mt -105.47 149.51 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 177.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -99.1 -44.95 6.09 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.653 0.781 . . . . 0.0 112.29 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 66.9 p-90 -163.63 155.12 16.79 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.15 1.78 . . . . 0.0 107.51 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 59.1 t -151.96 131.54 3.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 C-N-CA 125.565 1.546 . . . . 0.0 107.479 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.78 163.43 36.73 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.185 0.902 . . . . 0.0 111.848 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -77.74 129.07 35.03 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 104.02 -2.585 . . . . 0.0 104.02 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' THR . . . . . 0.435 HG23 ' HG3' ' A' ' 225' ' ' LYS . 9.8 t -108.55 -28.33 9.37 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.886 1.275 . . . . 0.0 113.089 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.435 ' HG3' HG23 ' A' ' 224' ' ' THR . 59.1 mttt -135.9 -176.05 4.17 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 124.468 1.107 . . . . 0.0 108.621 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 68.9 mt -47.86 -47.49 12.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.591 -0.732 . . . . 0.0 112.365 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 3.7 t -133.06 18.08 4.11 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.131 1.373 . . . . 0.0 111.372 -178.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 22.0 t -114.96 142.48 27.64 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -178.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -121.29 162.94 19.38 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.202 1.401 . . . . 0.0 107.226 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -135.47 143.57 45.93 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 179.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -142.8 150.14 39.57 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -137.6 122.41 18.79 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 104.33 -2.47 . . . . 0.0 104.33 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 3.5 m -119.09 150.74 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -178.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.3 p -120.94 132.82 55.17 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.149 0.98 . . . . 0.0 111.608 -178.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 6.6 pt -138.32 154.85 74.09 Favored Pre-proline 0 N--CA 1.453 -0.278 0 C-N-CA 125.317 1.447 . . . . 0.0 109.205 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -76.08 -49.93 0.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.256 2.638 . . . . 0.0 112.296 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -53.01 -15.83 0.9 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 118.002 2.593 . . . . 0.0 118.002 -176.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 22.9 mt -77.52 -26.89 51.51 Favored 'General case' 0 CA--C 1.517 -0.308 0 O-C-N 120.958 -1.089 . . . . 0.0 109.648 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 5.8 m -56.13 -21.37 22.07 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.112 0.965 . . . . 0.0 111.724 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -59.49 -36.07 75.34 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.635 1.174 . . . . 0.0 109.347 178.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.58 125.2 30.24 Favored 'General case' 0 CA--C 1.521 -0.164 0 O-C-N 120.941 -1.1 . . . . 0.0 108.322 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -47.49 -48.83 26.94 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -178.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.419 ' HB3' ' CD2' ' A' ' 181' ' ' TYR . 22.5 mt -68.58 -26.87 65.6 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -178.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 13.8 mt -91.97 -13.47 31.02 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.219 0.608 . . . . 0.0 112.291 -178.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -58.15 141.83 49.15 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 128.283 2.633 . . . . 0.0 113.061 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp -115.72 172.02 7.39 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 127.659 2.383 . . . . 0.0 110.093 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -70.04 -33.01 71.41 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.658 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -87.4 55.22 3.43 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.813 1.645 . . . . 0.0 107.4 179.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 38.2 t70 . . . . . 0 C--O 1.249 1.027 0 C-N-CA 124.775 1.23 . . . . 0.0 110.489 179.851 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.884 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.13 -161.7 0.43 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.3 m -57.65 164.41 2.06 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.048 0.939 . . . . 0.0 110.813 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -56.29 142.76 36.55 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.51 1.124 . . . . 0.0 108.193 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.3 m -52.62 -30.68 32.64 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.241 1.016 . . . . 0.0 113.106 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -70.54 -51.44 28.65 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 123.872 0.869 . . . . 0.0 108.952 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -54.06 -50.89 65.73 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.549 HG22 HD12 ' A' ' 98' ' ' LEU . 0.7 OUTLIER -65.72 -32.72 74.42 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 179.844 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.89 -39.26 93.78 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 56.4 tp -63.58 -38.26 90.46 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.549 HD12 HG22 ' A' ' 95' ' ' THR . 64.8 mt -59.37 -54.55 45.45 Favored 'General case' 0 C--N 1.345 0.381 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.0 m -64.06 -45.98 86.38 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.889 0.476 . . . . 0.0 111.755 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.54 -47.61 79.07 Favored 'General case' 0 CA--C 1.516 -0.362 0 O-C-N 121.397 -0.815 . . . . 0.0 109.632 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 91.7 m -55.15 -47.3 75.31 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.358 0.663 . . . . 0.0 110.703 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -56.73 -47.0 80.97 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 123.438 0.462 . . . . 0.0 110.007 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.37 -56.93 6.05 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.854 0.835 . . . . 0.0 112.52 -178.386 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -56.96 -42.04 79.41 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 125.058 1.343 . . . . 0.0 110.651 -178.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.68 -52.79 39.53 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-O 117.673 -1.626 . . . . 0.0 109.594 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.452 ' HA ' HD12 ' A' ' 109' ' ' ILE . 50.8 t -55.89 -45.62 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 120.155 1.978 . . . . 0.0 110.485 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.2 pttp -61.3 -35.83 78.43 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.193 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 51.8 m -75.14 -36.69 61.54 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.898 0.879 . . . . 0.0 110.301 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.452 HD12 ' HA ' ' A' ' 106' ' ' VAL . 20.0 mt -59.17 -55.04 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -60.0 -34.22 73.03 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 124.066 0.854 . . . . 0.0 111.726 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -63.42 -37.75 88.51 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -178.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.8 mmmt -86.07 -42.79 13.64 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 19.2 mt -61.73 -29.19 69.95 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-O 117.808 -1.092 . . . . 0.0 111.685 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -47.83 -30.79 4.32 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.704 2.002 . . . . 0.0 111.807 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -64.85 -70.34 0.24 Allowed 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 122.813 0.445 . . . . 0.0 111.544 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -145.35 -178.62 6.16 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.628 1.171 . . . . 0.0 112.275 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 60.2 m -86.82 171.2 11.05 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 27.3 pt -121.91 160.35 23.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 127.087 2.155 . . . . 0.0 107.41 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -156.4 134.8 11.47 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.043 0.537 . . . . 0.0 111.957 -178.094 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -132.09 121.21 23.45 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.65 0.78 . . . . 0.0 110.562 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -87.95 99.44 12.14 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.41 80.71 6.72 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 127.363 2.265 . . . . 0.0 108.952 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.17 -111.53 4.08 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 108.158 -1.977 . . . . 0.0 108.158 -179.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -85.88 -24.4 26.67 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -100.53 159.4 15.18 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 119.551 1.069 . . . . 0.0 111.851 -178.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.2 mp -132.73 140.9 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.456 ' CD1' HG11 ' A' ' 221' ' ' VAL . 88.5 m-85 -121.72 119.55 32.09 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -107.5 116.44 31.94 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.189 0.595 . . . . 0.0 110.087 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -109.27 129.19 55.52 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 122.03 -0.419 . . . . 0.0 110.673 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.41 ' HB3' HD13 ' A' ' 133' ' ' ILE . 52.3 m -110.95 155.9 41.68 Favored Pre-proline 0 N--CA 1.446 -0.641 0 C-N-CA 127.266 2.226 . . . . 0.0 113.312 -178.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.26 70.75 0.15 Allowed 'Trans proline' 0 CA--C 1.542 0.904 1 C-N-CA 125.647 4.231 . . . . 0.0 114.717 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 68.57 57.51 8.06 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 120.466 -1.396 . . . . 0.0 110.911 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.41 HD13 ' HB3' ' A' ' 130' ' ' CYS . 2.0 mp -124.65 -71.72 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.303 0 CA-C-N 118.333 1.067 . . . . 0.0 109.251 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -175.21 138.29 0.42 Allowed 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -109.8 125.22 52.5 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.984 0.811 . . . . 0.0 109.722 -176.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 20.0 m -142.9 163.97 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.795 1.238 . . . . 0.0 111.637 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -122.13 129.6 52.48 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.222 1.409 . . . . 0.0 108.266 178.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -139.13 162.96 33.67 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.017 0.927 . . . . 0.0 112.074 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 53.1 t60 -84.85 160.87 20.1 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 177.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 136.62 -159.42 24.49 Favored Glycine 0 C--N 1.338 0.653 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -152.24 167.12 29.61 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 128.126 2.57 . . . . 0.0 106.792 178.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.4 p -128.32 150.92 34.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 119.456 1.025 . . . . 0.0 109.544 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -106.03 106.89 17.62 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 178.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 13.5 p -52.22 -29.29 21.99 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.676 1.191 . . . . 0.0 112.597 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 43.2 mmtt -57.12 -27.93 62.25 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 127.465 2.306 . . . . 0.0 113.044 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.2 p -122.98 -47.73 2.03 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 124.609 1.164 . . . . 0.0 110.075 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 100.84 28.16 7.11 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.404 1.478 . . . . 0.0 110.15 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -124.83 147.44 48.75 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 124.688 1.195 . . . . 0.0 110.317 -179.246 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 9.4 mm -70.4 148.26 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 21.6 m -70.62 -10.75 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 121.57 -0.706 . . . . 0.0 112.517 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -161.29 169.29 22.4 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 125.976 1.71 . . . . 0.0 109.38 -179.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 89.2 mtm-85 -94.32 -31.71 13.93 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 120.412 1.46 . . . . 0.0 108.379 177.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 56.49 36.47 27.61 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.596 1.558 . . . . 0.0 109.066 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -47.87 -27.89 2.35 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 128.025 2.53 . . . . 0.0 114.495 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 49.5 m -59.57 -34.46 72.73 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.497 -0.752 . . . . 0.0 111.136 178.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 69.1 mt -81.23 66.28 6.7 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.453 1.501 . . . . 0.0 108.703 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 3.0 p -74.08 107.75 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -122.71 158.36 30.27 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 125.703 1.601 . . . . 0.0 107.395 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -140.86 134.01 29.46 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 58.7 mt -119.92 -26.25 5.65 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 125.286 1.616 . . . . 0.0 108.031 178.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 156.13 154.61 7.05 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 119.543 1.065 . . . . 0.0 111.096 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -117.57 109.95 41.23 Favored Pre-proline 0 C--O 1.236 0.347 0 C-N-CA 124.138 0.975 . . . . 0.0 108.412 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -73.3 -169.44 0.52 Allowed 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 124.003 3.135 . . . . 0.0 109.445 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -126.86 156.32 41.55 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.833 1.253 . . . . 0.0 108.549 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.44 -45.29 39.61 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.361 0.664 . . . . 0.0 111.247 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -74.9 65.75 1.45 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.602 1.561 . . . . 0.0 111.518 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.3 p -45.55 -35.09 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 124.762 1.225 . . . . 0.0 112.52 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -63.9 -36.43 83.91 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -178.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -74.31 -15.84 60.95 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.746 0.819 . . . . 0.0 113.046 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 20.5 mtp-105 -78.22 178.17 7.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 122.096 0.951 . . . . 0.0 110.097 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -127.27 144.6 51.01 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 178.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -132.22 165.95 22.97 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -123.89 147.74 47.42 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 16.0 tp -114.58 98.06 6.66 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -112.25 -179.26 3.63 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 127.856 2.463 . . . . 0.0 106.757 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -149.4 165.22 32.72 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.617 0.722 . . . . 0.0 109.446 178.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -135.88 179.64 6.22 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 126.654 1.981 . . . . 0.0 110.513 -178.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.26 -18.75 63.89 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.904 1.282 . . . . 0.0 109.656 178.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 25.6 t -87.24 -25.3 6.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 129.771 3.228 . . . . 0.0 111.805 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 132.87 -167.95 23.07 Favored Glycine 0 N--CA 1.444 -0.779 0 O-C-N 121.279 -0.888 . . . . 0.0 111.701 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -77.71 163.31 26.29 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 121.841 -0.8 . . . . 0.0 110.367 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -160.73 167.36 27.03 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.635 1.174 . . . . 0.0 111.082 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 83.9 mt -106.15 138.28 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 17.4 t -113.01 135.15 54.09 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.041 0.937 . . . . 0.0 109.052 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -127.22 110.88 13.32 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 125.815 1.646 . . . . 0.0 108.57 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -93.52 111.49 24.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 7.5 mt -98.45 108.28 21.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 179.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -94.63 -153.28 30.14 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 66.6 m 66.19 54.73 0.94 Allowed 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.208 1.003 . . . . 0.0 112.912 178.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.423 ' HA3' ' HB3' ' A' ' 200' ' ' ARG . . . -102.02 -137.84 9.83 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -140.58 128.8 22.32 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 177.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 28.8 mm -60.21 132.3 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 121.911 0.862 . . . . 0.0 111.743 -178.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 3.0 m -84.92 111.34 19.58 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 128.101 2.56 . . . . 0.0 109.245 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.76 -19.58 11.73 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.125 1.77 . . . . 0.0 113.774 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 60.9 t -56.62 -51.75 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 124.652 1.181 . . . . 0.0 110.33 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 13.9 t -125.12 -25.1 3.89 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 99.0 35.51 4.79 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 107.556 -2.218 . . . . 0.0 107.556 -178.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -103.98 152.52 21.91 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 118.519 1.16 . . . . 0.0 113.732 -178.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -78.42 138.94 38.74 Favored 'General case' 0 C--N 1.335 -0.052 0 C-N-CA 124.025 0.93 . . . . 0.0 109.152 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.423 ' HB3' ' HA3' ' A' ' 190' ' ' GLY 0.3 34.3 ttt180 -69.94 30.52 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 130.705 3.602 . . . . 0.0 113.598 178.953 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 5.2 ptm -74.18 171.92 12.71 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.056 -1.028 . . . . 0.0 109.216 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.77 148.79 22.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 C-N-CA 124.679 1.191 . . . . 0.0 107.819 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -110.17 116.39 31.43 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 14.4 mm -103.97 141.08 20.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -124.43 110.09 14.1 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 126.067 1.747 . . . . 0.0 109.774 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -87.31 110.85 20.51 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.479 1.111 . . . . 0.0 108.875 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 11.2 m -123.11 163.66 21.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 46.1 t -88.07 146.58 25.38 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -97.86 16.91 59.62 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-O 117.914 -1.492 . . . . 0.0 113.057 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 45.5 28.39 2.33 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 126.646 2.07 . . . . 0.0 113.875 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.0 151.49 19.49 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.08 -1.247 . . . . 0.0 108.375 -179.04 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -61.22 -42.46 98.64 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 122.983 0.513 . . . . 0.0 111.613 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 57.7 m -161.91 176.93 10.3 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 128.862 2.865 . . . . 0.0 107.474 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 149.1 176.41 22.36 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 121.071 -1.018 . . . . 0.0 113.018 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -79.1 -99.14 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 124.322 3.348 . . . . 0.0 110.145 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 4.6 p -166.88 148.27 6.02 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 127.055 2.142 . . . . 0.0 107.34 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 10.4 p -154.39 165.97 34.72 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.182 1.393 . . . . 0.0 109.556 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 4.9 mt -108.54 153.81 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 126.567 1.947 . . . . 0.0 106.592 178.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -101.1 -52.21 3.33 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 123.44 0.696 . . . . 0.0 110.484 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 58.9 p-90 -157.07 157.32 34.36 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -178.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.456 HG11 ' CD1' ' A' ' 127' ' ' TYR . 91.3 t -153.16 122.56 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -178.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.22 167.5 29.6 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.511 1.05 . . . . 0.0 110.784 178.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -73.07 132.05 42.85 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 6.7 t -109.35 -38.59 5.45 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.427 1.091 . . . . 0.0 110.22 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 6.7 mttt -130.92 178.57 6.57 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 73.1 mt -49.51 -46.98 20.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -126.19 22.32 7.24 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 6.5 t -122.86 138.64 52.25 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.545 0 O-C-N 121.191 -0.943 . . . . 0.0 110.081 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -120.97 162.26 20.2 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -132.53 145.71 51.35 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.24 119.36 8.26 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.218 1.007 . . . . 0.0 108.471 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -107.36 126.93 53.08 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 4.0 m -118.14 154.38 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-N 117.717 0.235 . . . . 0.0 110.797 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 2.3 p -121.56 124.82 45.31 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.33 1.052 . . . . 0.0 110.911 -177.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 2.3 pt -136.84 129.49 17.29 Favored Pre-proline 0 N--CA 1.444 -0.728 0 CA-C-N 114.922 -1.035 . . . . 0.0 108.831 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -64.85 -31.12 57.82 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.065 2.51 . . . . 0.0 113.388 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -64.25 -14.13 53.74 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -177.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 44.6 mt -76.88 -31.03 56.48 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 120.475 -1.391 . . . . 0.0 109.908 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 15.6 m -55.88 -12.06 1.24 Allowed 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -70.42 -32.04 69.48 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 121.497 -0.752 . . . . 0.0 110.043 179.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.9 mt -80.71 123.16 27.96 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.669 1.988 . . . . 0.0 106.671 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -47.51 -48.09 27.44 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.074 1.349 . . . . 0.0 114.081 -178.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 56.1 mt -66.65 -32.53 73.91 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 119.298 0.954 . . . . 0.0 112.847 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 15.9 mt -91.68 -5.57 53.53 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -65.31 134.42 53.54 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 127.55 2.34 . . . . 0.0 110.3 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -107.24 152.45 24.08 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 125.214 1.406 . . . . 0.0 111.146 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -89.98 -47.27 7.96 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.231 -0.895 . . . . 0.0 113.211 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -146.43 26.59 1.16 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -177.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 30.0 t70 . . . . . 0 C--O 1.242 0.675 0 CA-C-O 117.869 -1.062 . . . . 0.0 108.342 179.04 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.373 0 N-CA-C 106.675 -2.57 . . . . 0.0 106.675 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.75 57.72 3.52 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 104.535 -2.395 . . . . 0.0 104.535 177.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . 0.273 14.4 m -58.12 -11.41 2.56 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.996 2.118 . . . . 0.0 115.765 -177.004 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -68.55 -48.8 63.32 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 176.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 75.4 m -62.05 -35.87 79.9 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 125.053 1.341 . . . . 0.0 110.41 178.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -62.98 -34.85 78.4 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.547 -0.721 . . . . 0.0 111.004 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -78.12 -48.12 16.68 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 118.303 -0.856 . . . . 0.0 109.319 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.2 p -57.15 -31.62 65.55 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-N 118.999 0.818 . . . . 0.0 111.632 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.54 -43.63 84.53 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 53.1 tp -68.28 -36.7 79.79 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-O 118.459 -0.782 . . . . 0.0 109.401 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.456 HD23 HD11 ' A' ' 243' ' ' LEU . 60.5 mt -60.26 -54.69 42.78 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 118.935 0.789 . . . . 0.0 109.694 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 50.9 m -58.78 -49.12 78.87 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.314 1.046 . . . . 0.0 109.845 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.22 -44.69 96.86 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 118.095 -0.955 . . . . 0.0 110.905 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 63.0 m -52.33 -49.3 64.54 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 119.286 0.948 . . . . 0.0 110.682 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -55.38 -50.73 68.94 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 122.744 0.417 . . . . 0.0 110.101 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.36 -55.49 15.63 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 115.151 1.538 . . . . 0.0 115.151 -178.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -64.94 -38.1 89.84 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.497 1.119 . . . . 0.0 110.648 -177.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.551 ' HA3' HD11 ' A' ' 183' ' ' ILE . . . -61.03 -52.57 51.42 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.526 ' HA ' HD12 ' A' ' 109' ' ' ILE . 54.2 t -57.37 -44.88 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 118.671 1.236 . . . . 0.0 109.72 178.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -61.7 -35.78 79.02 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 118.53 -1.268 . . . . 0.0 111.643 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 59.3 m -65.64 -46.43 79.22 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -178.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 106' ' ' VAL . 19.3 mt -56.92 -54.96 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 CA-C-O 121.568 0.699 . . . . 0.0 109.738 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -64.61 -27.81 69.19 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -62.61 -42.73 99.75 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -83.25 -43.16 16.37 Favored 'General case' 0 C--N 1.341 0.234 0 O-C-N 121.278 -0.889 . . . . 0.0 113.038 -179.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.4 mt -62.87 -27.38 69.31 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.099 0.863 . . . . 0.0 113.243 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -44.38 -33.86 1.8 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.484 1.514 . . . . 0.0 113.825 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -64.43 -69.5 0.28 Allowed 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.909 1.283 . . . . 0.0 113.944 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 -140.07 172.58 12.55 Favored 'General case' 0 CA--C 1.518 -0.27 0 O-C-N 121.097 -1.002 . . . . 0.0 112.979 -177.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 37.7 m -87.13 160.7 18.45 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 178.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 34.9 pt -114.37 157.03 15.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 124.906 1.282 . . . . 0.0 107.544 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -151.4 134.29 15.75 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 123.801 0.84 . . . . 0.0 109.263 -178.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.615 ' CE1' ' HB2' ' A' ' 122' ' ' ALA . 21.7 t80 -133.16 120.95 21.87 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 123.741 0.817 . . . . 0.0 111.615 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -84.48 101.41 12.02 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.542 1.137 . . . . 0.0 108.614 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.615 ' HB2' ' CE1' ' A' ' 120' ' ' TYR . . . -94.75 80.34 3.76 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.04 -124.65 20.51 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -70.97 -31.2 67.69 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 48.0 m95 -99.83 152.02 20.61 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 118.546 0.612 . . . . 0.0 110.344 -178.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.7 mp -125.15 144.73 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 104.481 -2.415 . . . . 0.0 104.481 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -122.12 119.68 32.04 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -178.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -113.63 126.51 55.35 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.918 0.887 . . . . 0.0 109.091 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -124.98 126.77 45.97 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.424 0.69 . . . . 0.0 109.801 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.461 ' HB3' HD13 ' A' ' 133' ' ' ILE . 15.0 m -104.46 155.96 36.57 Favored Pre-proline 0 CA--C 1.532 0.257 0 C-N-CA 123.929 0.892 . . . . 0.0 111.47 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -63.13 83.25 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 124.385 3.39 . . . . 0.0 114.597 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.38 42.96 63.81 Favored Glycine 0 CA--C 1.526 0.77 0 O-C-N 120.776 -1.202 . . . . 0.0 113.079 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.461 HD13 ' HB3' ' A' ' 130' ' ' CYS . 3.6 mp -122.7 -70.25 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -161.86 168.52 22.9 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.849 1.259 . . . . 0.0 110.611 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -132.42 126.84 34.07 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 104.459 -2.422 . . . . 0.0 104.459 177.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.2 m -144.81 164.17 13.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 124.999 1.32 . . . . 0.0 112.321 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -130.24 118.77 21.86 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -137.9 162.82 33.04 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.871 1.668 . . . . 0.0 111.23 -178.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.453 ' H ' HD13 ' A' ' 156' ' ' LEU . 80.9 t60 -94.08 148.29 22.32 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 142.18 -170.62 24.92 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 125.301 1.429 . . . . 0.0 110.343 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.93 167.51 21.96 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 121.082 -1.246 . . . . 0.0 109.492 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.2 p -107.67 132.75 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 178.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -87.37 115.03 24.5 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 67.2 p -57.06 -22.41 38.95 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.018 0.927 . . . . 0.0 113.376 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.54 -49.42 76.4 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 124.344 1.058 . . . . 0.0 111.332 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 49.2 p -113.57 -22.64 10.2 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -176.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 79.31 34.78 31.63 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.453 1.025 . . . . 0.0 111.374 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -122.06 148.39 44.91 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.469 1.108 . . . . 0.0 109.742 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 24.0 mm -75.62 153.89 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 15.9 m -58.69 -34.76 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.315 1.046 . . . . 0.0 113.042 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 61.7 m-80 -155.18 152.69 29.69 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.77 1.628 . . . . 0.0 109.657 -179.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 -106.57 103.99 13.57 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 177.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 38.58 81.57 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 127.737 2.415 . . . . 0.0 111.729 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -60.95 -79.65 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 65.8 p -126.83 -1.42 6.64 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.753 1.621 . . . . 0.0 110.418 177.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.453 HD13 ' H ' ' A' ' 139' ' ' HIS . 67.6 mt -82.18 74.63 9.15 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 126.855 2.062 . . . . 0.0 111.135 -177.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 16.4 m -74.79 116.91 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 178.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -148.56 151.51 35.19 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.603 1.161 . . . . 0.0 108.691 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -145.45 136.87 25.08 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 124.69 1.196 . . . . 0.0 107.926 178.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.1 mp -116.15 -27.74 6.8 Favored 'General case' 0 C--O 1.221 -0.444 0 O-C-N 125.486 1.741 . . . . 0.0 107.277 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 157.3 163.45 12.55 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -126.97 110.24 21.92 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 124.03 0.932 . . . . 0.0 111.428 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -71.96 177.57 6.91 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.907 3.071 . . . . 0.0 109.274 178.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -121.1 146.67 46.49 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.31 -45.94 76.3 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.171 1.388 . . . . 0.0 112.178 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -73.41 67.13 1.0 Allowed 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 127.581 2.353 . . . . 0.0 110.249 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.5 p -44.82 -32.74 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 O-C-N 121.196 -0.94 . . . . 0.0 113.385 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -65.25 -31.74 73.05 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 119.186 0.903 . . . . 0.0 111.671 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -71.74 -30.56 65.74 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 124.03 0.932 . . . . 0.0 110.049 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 25.7 mtt180 -69.08 152.46 45.17 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -114.06 143.12 45.29 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -129.63 168.06 17.02 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.159 1.384 . . . . 0.0 112.072 -177.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -133.62 154.67 50.71 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 124.884 1.274 . . . . 0.0 111.265 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 57.5 tp -109.23 98.63 8.03 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 127.28 2.232 . . . . 0.0 110.252 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.42 HD23 ' HB2' ' A' ' 184' ' ' SER . 2.1 mm? -112.17 -179.26 3.63 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 127.649 2.38 . . . . 0.0 108.581 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -141.7 166.29 25.15 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.188 0.518 . . . . 0.0 111.461 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -139.28 179.99 6.21 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 127.313 2.245 . . . . 0.0 108.39 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -57.4 -19.25 22.11 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.477 1.111 . . . . 0.0 112.389 -178.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 40.7 t -92.6 -54.84 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 O-C-N 120.651 -1.281 . . . . 0.0 110.43 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 178.7 -153.52 12.78 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -178.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.405 ' CD2' HD13 ' A' ' 243' ' ' LEU . 6.3 m-30 -86.64 168.79 13.29 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 122.43 1.109 . . . . 0.0 110.772 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -158.57 176.09 12.84 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.014 1.725 . . . . 0.0 109.559 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.551 HD11 ' HA3' ' A' ' 105' ' ' GLY . 89.3 mt -110.95 138.27 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 176.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.42 ' HB2' HD23 ' A' ' 175' ' ' LEU . 14.2 t -100.96 128.53 46.95 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -129.15 110.03 11.66 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -92.42 135.66 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 104.604 -2.369 . . . . 0.0 104.604 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 3.8 mt -112.74 106.2 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 104.782 -2.303 . . . . 0.0 104.782 176.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -99.32 -155.49 28.65 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.5 t 68.72 56.19 0.45 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-O 122.516 1.151 . . . . 0.0 111.766 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -131.82 157.07 22.23 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 128.401 2.905 . . . . 0.0 106.396 177.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -72.62 150.91 42.64 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.219 1.007 . . . . 0.0 112.273 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.9 mm -65.99 136.23 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-O 121.274 0.559 . . . . 0.0 110.379 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.5 m -79.87 115.52 19.5 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.707 2.003 . . . . 0.0 106.979 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -55.06 -21.7 13.39 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.863 1.265 . . . . 0.0 112.957 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 31.6 t -51.44 -61.16 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.205 0 C-N-CA 126.966 2.106 . . . . 0.0 112.24 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' THR . . . . . 0.544 HG22 HG21 ' A' ' 226' ' ' ILE . 5.1 t -125.69 -24.12 3.9 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.318 1.047 . . . . 0.0 113.762 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 105.61 34.87 3.2 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -178.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -98.91 149.72 22.65 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 118.851 1.326 . . . . 0.0 112.112 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -74.71 141.04 44.52 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.942 0.897 . . . . 0.0 110.737 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -66.64 27.71 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 131.269 3.828 . . . . 0.0 113.882 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 8.2 ptm -75.14 177.09 6.7 Favored 'General case' 0 C--N 1.319 -0.743 0 O-C-N 120.788 -1.195 . . . . 0.0 111.787 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.0 p -147.18 153.62 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 126.612 1.965 . . . . 0.0 106.408 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -116.77 117.63 30.3 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.801 1.24 . . . . 0.0 108.324 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 9.2 mm -102.25 148.53 7.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -126.09 103.73 7.87 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 128.274 2.63 . . . . 0.0 108.97 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' TYR . . . . . 0.432 ' CD1' HD13 ' A' ' 109' ' ' ILE . 35.0 m-85 -83.25 109.8 17.54 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.967 1.307 . . . . 0.0 108.706 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 5.8 m -125.17 163.4 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 47.5 t -84.76 139.83 31.69 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 178.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -86.97 -0.07 85.87 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 118.369 -1.239 . . . . 0.0 112.7 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 58.71 59.24 11.15 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 3.6 m -138.3 148.73 44.96 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -64.17 -47.51 79.55 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -178.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 85.3 p -151.0 -176.15 5.42 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.06 0.944 . . . . 0.0 109.497 -179.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 129.95 172.55 13.17 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 124.804 1.192 . . . . 0.0 112.673 178.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -75.63 -104.06 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.745 2.963 . . . . 0.0 112.003 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.7 p -158.66 148.94 19.78 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.283 1.433 . . . . 0.0 108.751 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 1.7 p -152.62 170.51 20.04 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.423 1.089 . . . . 0.0 110.365 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 4.8 mt -113.17 154.37 14.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 126.406 1.883 . . . . 0.0 107.291 178.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -104.38 -46.6 4.35 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.886 0.875 . . . . 0.0 111.527 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -160.93 155.63 23.71 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.972 1.709 . . . . 0.0 107.781 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 59.9 t -154.05 123.56 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 125.68 1.592 . . . . 0.0 106.999 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -154.13 161.68 41.71 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 118.913 0.779 . . . . 0.0 111.21 179.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -69.18 136.99 52.9 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' THR . . . . . 0.636 HG23 ' HG3' ' A' ' 225' ' ' LYS . 2.0 t -119.2 -28.75 5.37 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.199 1.0 . . . . 0.0 111.866 -179.041 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.636 ' HG3' HG23 ' A' ' 224' ' ' THR . 7.5 mttm -134.98 -176.66 4.32 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 124.123 0.969 . . . . 0.0 108.709 178.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.544 HG21 HG22 ' A' ' 196' ' ' THR . 1.9 mm -50.41 -48.98 25.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 123.346 0.659 . . . . 0.0 112.133 -178.264 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -128.13 23.56 6.04 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.373 1.469 . . . . 0.0 111.63 -178.162 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 14.1 t -127.47 146.37 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 CA-C-O 122.045 0.926 . . . . 0.0 110.367 -178.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -126.14 161.84 26.73 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' GLU . . . . . 0.48 ' CD ' HG21 ' A' ' 224' ' ' THR . 10.9 mt-10 -134.35 141.32 46.85 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -140.09 140.12 36.01 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 125.31 1.444 . . . . 0.0 110.233 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -120.47 114.35 21.65 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 2.5 m -107.87 148.1 12.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.4 p -122.17 135.93 54.84 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 123.567 0.747 . . . . 0.0 111.927 -178.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -140.6 152.25 65.68 Favored Pre-proline 0 N--CA 1.451 -0.402 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.074 177.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -74.91 -50.86 0.13 Allowed 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.496 2.797 . . . . 0.0 111.995 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -52.98 -27.13 17.69 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 117.606 -1.188 . . . . 0.0 113.911 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 238' ' ' LEU . 9.8 tp -59.23 -25.39 63.98 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 120.538 1.517 . . . . 0.0 112.258 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 3.4 m -64.74 -9.2 18.47 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.805 0.842 . . . . 0.0 111.963 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 42.5 p-10 -60.29 -40.3 89.95 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 125.337 1.455 . . . . 0.0 109.418 178.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -83.7 123.91 30.32 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 124.78 1.232 . . . . 0.0 108.591 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -47.18 -47.89 23.93 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.749 2.02 . . . . 0.0 113.31 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.456 HD11 HD23 ' A' ' 98' ' ' LEU . 40.6 mt -65.6 -20.09 66.17 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -178.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 5.2 mt -107.1 -11.75 15.56 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.176 1.39 . . . . 0.0 112.249 -178.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -63.29 131.12 47.3 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 128.479 2.712 . . . . 0.0 110.082 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt -100.5 166.48 10.9 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.237 1.015 . . . . 0.0 110.017 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -81.27 -8.83 59.82 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -178.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.17 30.52 4.77 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.67 1.188 . . . . 0.0 112.294 -177.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.252 1.198 0 C-N-CA 125.036 1.334 . . . . 0.0 107.423 177.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.917 0 CA-C-O 119.196 -0.78 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -118.16 -30.38 5.31 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 13.5 p -149.85 -74.29 0.17 Allowed 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -76.77 37.2 0.18 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.679 1.592 . . . . 0.0 109.57 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.7 t -64.5 -42.23 95.95 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 128.159 2.583 . . . . 0.0 110.607 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -65.36 -22.68 66.83 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 121.785 -0.572 . . . . 0.0 111.97 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.489 ' HE2' HD21 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -64.67 -56.39 14.09 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 178.14 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.72 -34.6 78.23 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 123.199 0.6 . . . . 0.0 111.012 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.54 -43.4 89.24 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 13.0 tp -69.71 -36.18 75.7 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.239 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.561 HD23 HD11 ' A' ' 243' ' ' LEU . 62.3 mt -59.13 -54.72 43.83 Favored 'General case' 0 C--N 1.343 0.288 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 20.7 m -65.37 -42.29 92.88 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 121.559 -0.713 . . . . 0.0 110.938 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.29 -42.4 95.39 Favored 'General case' 0 C--N 1.341 0.214 0 O-C-N 120.874 -1.141 . . . . 0.0 110.472 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 80.3 m -56.59 -46.45 80.81 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.776 0.83 . . . . 0.0 109.805 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -59.79 -45.14 93.25 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 118.233 0.47 . . . . 0.0 110.604 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -65.19 -61.11 2.33 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 122.26 1.029 . . . . 0.0 112.013 -178.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -62.3 -36.89 83.53 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.369 -178.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -65.6 -53.35 32.18 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-O 118.114 -1.381 . . . . 0.0 110.149 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.646 ' HA ' HD12 ' A' ' 109' ' ' ILE . 45.4 t -58.28 -44.16 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 119.913 1.857 . . . . 0.0 109.957 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.7 ptmt -64.74 -32.94 74.85 Favored 'General case' 0 C--O 1.226 -0.168 0 C-N-CA 119.604 -0.839 . . . . 0.0 111.695 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.6 m -76.08 -33.78 59.53 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 123.441 0.696 . . . . 0.0 109.738 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.646 HD12 ' HA ' ' A' ' 106' ' ' VAL . 16.6 mt -62.75 -55.52 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 178.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -61.92 -28.57 69.62 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 117.948 -1.025 . . . . 0.0 112.39 -179.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.64 -38.16 86.68 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.963 1.256 . . . . 0.0 112.656 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.416 ' HE3' ' CD ' ' A' ' 237' ' ' GLU . 0.6 OUTLIER -95.48 -37.48 10.88 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.491 -0.755 . . . . 0.0 110.847 179.538 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 15.8 mt -62.64 -28.35 69.86 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 118.66 0.664 . . . . 0.0 110.734 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -50.15 -34.71 23.23 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.613 1.165 . . . . 0.0 113.536 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -55.5 -61.74 2.15 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.735 1.214 . . . . 0.0 112.554 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -151.61 174.59 13.27 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.86 1.664 . . . . 0.0 110.761 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 56.7 m -86.61 170.94 11.4 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 114.006 -1.452 . . . . 0.0 108.684 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 29.6 pt -127.78 162.82 32.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 126.272 1.829 . . . . 0.0 109.004 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.72 145.28 22.24 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -136.87 125.7 24.09 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -88.88 108.04 19.32 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.075 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.37 80.3 3.93 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 178.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 58.75 -107.92 1.35 Allowed Glycine 0 CA--C 1.53 0.989 0 O-C-N 121.807 -0.558 . . . . 0.0 111.713 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -81.47 -17.88 47.2 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.546 1.938 . . . . 0.0 113.715 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 65.8 m95 -111.88 157.39 20.68 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 123.406 0.682 . . . . 0.0 110.121 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.2 mp -133.3 136.84 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -113.33 129.95 56.4 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -121.55 125.61 47.19 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 123.682 0.793 . . . . 0.0 110.885 -178.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -124.77 129.94 51.43 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.899 0.857 . . . . 0.0 110.63 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.524 ' HB3' HD13 ' A' ' 133' ' ' ILE . 2.1 m -111.18 156.41 41.07 Favored Pre-proline 0 C--N 1.33 -0.262 0 C-N-CA 125.303 1.441 . . . . 0.0 110.314 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -64.36 82.04 0.16 Allowed 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.775 2.983 . . . . 0.0 114.097 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 69.79 50.14 31.8 Favored Glycine 0 CA--C 1.533 1.209 0 O-C-N 120.785 -1.197 . . . . 0.0 113.683 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.524 HD13 ' HB3' ' A' ' 130' ' ' CYS . 3.4 mp -125.18 -68.28 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 119.042 1.421 . . . . 0.0 108.508 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -165.72 159.3 16.14 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 124.906 1.282 . . . . 0.0 109.213 179.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -122.96 123.07 40.08 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 104.554 -2.387 . . . . 0.0 104.554 176.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 16.6 m -143.37 163.98 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 123.485 0.714 . . . . 0.0 110.654 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -123.77 117.91 25.99 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -139.76 163.37 32.79 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 118.937 0.79 . . . . 0.0 112.039 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -90.07 154.99 19.37 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.273 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 144.19 -162.95 27.85 Favored Glycine 0 C--N 1.334 0.468 0 O-C-N 120.674 -1.266 . . . . 0.0 111.583 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -145.35 160.78 41.01 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 126.601 1.96 . . . . 0.0 107.013 178.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.478 HG23 ' C ' ' A' ' 148' ' ' GLU . 9.6 p -126.97 156.57 38.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -100.56 109.79 21.9 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 2.0 p -60.92 -7.85 2.71 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.783 0.833 . . . . 0.0 113.079 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -83.15 -26.99 30.41 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 125.808 1.643 . . . . 0.0 112.095 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.7 p -121.67 -48.65 2.15 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 124.154 0.982 . . . . 0.0 112.482 -178.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 108.1 21.98 7.45 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.963 1.268 . . . . 0.0 113.08 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.478 ' C ' HG23 ' A' ' 142' ' ' VAL . 8.5 pt-20 -124.51 152.25 43.65 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 119.275 1.537 . . . . 0.0 112.069 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 5.5 mm -69.19 153.87 8.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 C-N-CA 124.96 1.304 . . . . 0.0 108.853 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 12.7 m -60.0 -53.63 45.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.97 1.308 . . . . 0.0 109.542 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -158.59 159.92 35.99 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.08 1.752 . . . . 0.0 109.623 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 -83.37 153.68 24.43 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 178.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 28.7 p-10 -128.05 81.65 2.04 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 127.375 2.27 . . . . 0.0 111.555 -178.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -50.64 -38.08 44.15 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.615 1.566 . . . . 0.0 114.546 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 16.5 m -73.24 -5.82 41.9 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 33.3 mt -124.26 37.21 4.46 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.755 1.222 . . . . 0.0 112.161 -177.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 8.1 p -74.81 138.63 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-O 121.89 0.852 . . . . 0.0 110.15 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -135.56 172.08 13.52 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 128.327 2.651 . . . . 0.0 108.051 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.96 104.94 3.48 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.697 1.199 . . . . 0.0 109.414 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.3 mp -90.99 -28.59 17.91 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 162.76 156.77 8.68 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.7 mtpt -122.29 110.06 32.77 Favored Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 123.697 0.799 . . . . 0.0 108.997 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -79.73 170.12 17.34 Favored 'Trans proline' 0 N--CA 1.456 -0.698 1 C-N-CA 125.736 4.291 . . . . 0.0 109.133 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -105.7 159.72 15.76 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 123.036 0.534 . . . . 0.0 110.703 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -72.99 -43.39 62.25 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -73.39 64.01 0.8 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.416 1.486 . . . . 0.0 110.279 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.4 p -53.51 -29.48 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 O-C-N 120.653 -1.279 . . . . 0.0 110.821 178.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -63.13 -28.04 69.79 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.897 1.679 . . . . 0.0 112.748 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -88.57 -19.78 25.88 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 125.405 1.482 . . . . 0.0 112.462 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -77.77 154.68 31.74 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -107.85 149.45 28.25 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -137.13 173.99 11.09 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 126.681 1.992 . . . . 0.0 109.24 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -132.99 153.93 50.99 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.411 1.085 . . . . 0.0 110.455 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 25.1 tp -115.05 98.55 6.87 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 127.03 2.132 . . . . 0.0 108.53 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -110.09 -178.88 3.63 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.33 1.452 . . . . 0.0 110.079 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -135.22 153.85 51.79 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.952 0.901 . . . . 0.0 109.04 177.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -130.46 175.41 8.99 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 128.087 2.555 . . . . 0.0 107.866 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -56.76 -16.86 7.26 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 129.099 2.96 . . . . 0.0 111.252 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 67.4 t -99.55 -50.42 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 126.803 2.041 . . . . 0.0 108.859 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 170.04 -161.46 34.65 Favored Glycine 0 C--N 1.336 0.553 0 CA-C-N 119.1 0.864 . . . . 0.0 112.339 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 -77.16 156.0 31.89 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 117.751 0.776 . . . . 0.0 110.891 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -157.35 166.63 32.54 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.21 1.004 . . . . 0.0 112.03 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 96.6 mt -105.34 142.06 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 15.9 t -111.24 138.58 47.52 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.238 1.415 . . . . 0.0 107.849 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -130.06 109.3 10.74 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 124.606 1.162 . . . . 0.0 108.402 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.8 mp -93.77 117.47 37.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 6.4 mt -108.12 106.38 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -125.01 142.82 14.14 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 108.111 -1.996 . . . . 0.0 108.111 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 22.7 t 162.83 25.21 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 129.949 3.3 . . . . 0.0 106.968 -178.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -99.0 159.31 20.12 Favored Glycine 0 CA--C 1.505 -0.549 0 O-C-N 120.328 -1.482 . . . . 0.0 111.55 -178.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.44 167.17 15.28 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 178.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 35.0 mm -84.07 135.82 24.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 O-C-N 121.177 -0.952 . . . . 0.0 111.955 -178.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -81.51 104.32 11.85 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 177.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -50.94 -31.69 18.51 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.553 1.141 . . . . 0.0 111.593 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.441 HG23 ' H ' ' A' ' 195' ' ' VAL . 18.8 t -47.77 -47.33 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 128.72 2.808 . . . . 0.0 112.752 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 7.5 t -124.51 -39.69 2.29 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 110.57 36.16 1.95 Allowed Glycine 0 C--N 1.335 0.512 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -178.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -128.24 154.16 46.16 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 118.995 1.397 . . . . 0.0 110.567 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -66.16 168.26 8.79 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.102 0.561 . . . . 0.0 110.204 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -87.75 30.8 0.8 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 130.259 3.424 . . . . 0.0 110.335 177.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 5.9 ptm -72.58 175.42 6.36 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 120.576 -1.327 . . . . 0.0 111.815 -177.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.1 p -139.93 152.04 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 125.215 1.406 . . . . 0.0 109.19 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -114.27 104.08 11.72 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.511 1.924 . . . . 0.0 107.179 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 13.4 mm -91.69 143.7 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -124.72 99.31 6.1 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.624 1.57 . . . . 0.0 107.118 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' TYR . . . . . 0.52 ' CD1' HD13 ' A' ' 109' ' ' ILE . 25.8 m-85 -78.86 110.2 13.83 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 179.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 4.5 m -123.8 160.58 27.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 124.649 1.18 . . . . 0.0 108.678 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 53.5 t -82.41 141.26 32.92 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 179.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -90.16 3.34 82.33 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-O 118.421 -1.21 . . . . 0.0 114.916 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 56.5 75.52 0.24 Allowed Glycine 0 CA--C 1.523 0.585 0 C-N-CA 124.688 1.137 . . . . 0.0 111.967 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 6.7 t -157.29 163.52 38.63 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 178.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -63.91 -61.28 2.39 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.111 0.965 . . . . 0.0 113.148 -178.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 3.3 t -158.12 163.06 37.98 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 149.34 167.53 14.08 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 126.013 1.768 . . . . 0.0 111.261 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -65.08 -92.22 0.0 OUTLIER 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 124.882 3.721 . . . . 0.0 114.624 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' SER . . . . . 0.431 ' CB ' HG22 ' A' ' 235' ' ' ILE . 4.9 p -173.46 156.28 3.0 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.021 -1.049 . . . . 0.0 113.245 -177.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 20.5 p -155.31 172.95 17.34 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.892 1.277 . . . . 0.0 108.255 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 7.5 mt -114.77 148.12 17.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 126.399 1.88 . . . . 0.0 108.465 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -89.37 -51.69 5.42 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.959 0.903 . . . . 0.0 110.961 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 64.8 p-90 -161.53 160.81 29.52 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.42 1.888 . . . . 0.0 107.189 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 88.0 t -148.92 127.89 3.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 125.586 1.555 . . . . 0.0 107.361 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -158.77 159.4 35.13 Favored 'General case' 0 C--O 1.239 0.522 0 O-C-N 121.392 -0.818 . . . . 0.0 112.012 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -67.48 135.12 52.56 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 177.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 8.8 t -109.51 -36.64 5.92 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.86 -0.525 . . . . 0.0 111.138 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 14.5 mttt -129.22 -175.48 3.58 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 124.274 1.03 . . . . 0.0 108.625 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 73.3 mt -51.19 -41.9 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -133.1 9.89 4.14 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.154 0.982 . . . . 0.0 112.453 -178.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 15.0 t -109.28 142.49 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.683 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -177.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -119.76 158.91 25.56 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.216 1.406 . . . . 0.0 107.586 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -136.38 141.86 43.71 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -144.61 121.04 10.99 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.339 1.056 . . . . 0.0 111.337 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -95.05 110.08 22.05 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 105.523 -2.029 . . . . 0.0 105.523 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 61.9 t -101.41 129.5 52.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -114.73 122.02 45.13 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.101 1.36 . . . . 0.0 111.913 -178.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.431 HG22 ' CB ' ' A' ' 216' ' ' SER . 10.8 pt -132.3 139.26 34.3 Favored Pre-proline 0 N--CA 1.453 -0.312 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -66.84 -34.63 29.91 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 121.762 1.641 . . . . 0.0 111.37 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.416 ' CD ' ' HE3' ' A' ' 112' ' ' LYS . 75.4 mm-40 -54.53 -32.66 58.64 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 126.571 1.949 . . . . 0.0 115.023 -178.203 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.427 HD11 ' HB3' ' A' ' 206' ' ' TYR . 43.5 mt -59.91 -29.47 68.38 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.766 1.166 . . . . 0.0 112.353 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 33.8 m -59.04 -11.85 4.01 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.938 0.895 . . . . 0.0 112.471 179.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -59.87 -25.68 65.25 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 118.668 -0.682 . . . . 0.0 111.106 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -97.27 132.24 43.21 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.904 1.282 . . . . 0.0 108.15 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -46.99 -46.89 21.99 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.297 1.839 . . . . 0.0 112.062 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.561 HD11 HD23 ' A' ' 98' ' ' LEU . 69.1 mt -58.13 -45.25 87.66 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 6.0 mt -91.32 1.19 57.29 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.478 1.511 . . . . 0.0 113.221 -177.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -71.24 111.76 6.84 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.311 1.044 . . . . 0.0 108.935 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 5.5 mmmt -63.7 146.47 53.76 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -92.49 -55.73 3.29 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-O 117.279 -1.343 . . . . 0.0 110.702 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 46.18 58.55 4.39 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.198 1.399 . . . . 0.0 107.468 -177.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 9.4 t0 . . . . . 0 C--O 1.248 1.015 0 CA-C-N 112.399 -2.182 . . . . 0.0 110.795 -177.969 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' A' ' 90' ' ' SER . . . . . . . . 0 N--CA 1.477 1.406 0 N-CA-C 108.121 -1.991 . . . . 0.0 108.121 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 65.02 -16.63 0.09 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 127.053 2.141 . . . . 0.0 113.929 -178.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.43 ' H ' ' C ' ' A' ' 88' ' ' GLY . 5.5 p -63.97 83.59 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 130.817 3.647 . . . . 0.0 109.785 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -114.09 -18.83 11.58 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.854 1.261 . . . . 0.0 111.622 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 70.0 m -56.23 -26.35 51.0 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.921 1.289 . . . . 0.0 114.291 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -78.72 -44.2 24.05 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 120.426 -1.422 . . . . 0.0 107.185 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.5 tptm -56.8 -53.54 56.69 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.407 ' HA ' HD12 ' A' ' 98' ' ' LEU . 1.1 p -60.94 -38.89 87.42 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 119.613 1.097 . . . . 0.0 112.12 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.0 -35.94 80.03 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 42.1 tp -74.72 -36.79 62.69 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 121.281 -0.887 . . . . 0.0 109.425 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 95' ' ' THR . 86.9 mt -59.53 -55.66 31.71 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.433 1.093 . . . . 0.0 111.048 -179.024 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 37.0 m -68.69 -40.89 79.83 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.29 -0.881 . . . . 0.0 111.007 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.12 -42.95 91.81 Favored 'General case' 0 C--N 1.341 0.201 0 O-C-N 121.579 -0.701 . . . . 0.0 109.681 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 53.7 m -56.18 -49.19 74.73 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 123.848 0.859 . . . . 0.0 109.904 178.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -57.97 -49.22 77.57 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 122.405 0.282 . . . . 0.0 110.643 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -66.59 -59.61 3.46 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -177.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -60.37 -37.8 81.9 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 123.079 0.552 . . . . 0.0 110.415 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.98 -51.97 55.23 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.542 ' HA ' HD12 ' A' ' 109' ' ' ILE . 39.0 t -56.93 -43.64 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 119.538 1.669 . . . . 0.0 108.081 177.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.4 tttt -57.76 -39.05 76.49 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 122.11 -0.368 . . . . 0.0 110.583 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.6 m -70.37 -37.41 74.58 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 126.149 1.78 . . . . 0.0 110.342 -178.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.542 HD12 ' HA ' ' A' ' 106' ' ' VAL . 12.2 mt -63.92 -55.02 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -61.45 -28.23 69.13 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.801 -0.619 . . . . 0.0 112.48 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -64.26 -53.82 43.07 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.036 1.334 . . . . 0.0 109.962 178.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -80.36 -39.52 28.37 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.4 mt -61.04 -28.59 69.17 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 118.534 0.606 . . . . 0.0 112.338 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -51.34 -31.05 20.59 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -49.32 -72.01 0.06 Allowed 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.131 1.372 . . . . 0.0 112.92 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -149.06 178.67 8.5 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.529 1.532 . . . . 0.0 109.846 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 86.3 m -86.72 159.17 19.25 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 40.5 pt -115.44 160.65 14.69 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 C-N-CA 124.806 1.243 . . . . 0.0 110.021 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -156.07 149.03 24.21 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.649 -178.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.445 ' CE1' ' HB2' ' A' ' 122' ' ' ALA . 6.0 t80 -141.14 136.52 31.96 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.71 1.204 . . . . 0.0 110.633 178.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -95.04 102.37 14.17 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.733 1.213 . . . . 0.0 108.194 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.445 ' HB2' ' CE1' ' A' ' 120' ' ' TYR . . . -86.69 80.71 8.46 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 127.746 2.418 . . . . 0.0 106.622 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.65 -102.11 0.59 Allowed Glycine 0 CA--C 1.528 0.864 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -93.6 -20.15 20.48 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.667 1.187 . . . . 0.0 112.376 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.5 ' HH2' HD22 ' A' ' 156' ' ' LEU . 56.6 m95 -99.49 158.4 15.76 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 123.823 0.849 . . . . 0.0 111.0 -178.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.584 HD13 ' H ' ' A' ' 140' ' ' GLY . 4.6 mp -131.59 141.57 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 N-CA-C 104.912 -2.255 . . . . 0.0 104.912 178.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.5 ' CD1' HG11 ' A' ' 221' ' ' VAL . 68.9 m-85 -124.38 121.31 34.57 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 126.188 1.795 . . . . 0.0 107.983 -179.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -114.81 119.44 36.64 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 125.887 1.675 . . . . 0.0 110.716 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -111.54 135.74 51.7 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 13.3 m -117.18 153.76 49.88 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 123.69 0.796 . . . . 0.0 109.928 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -67.17 74.1 0.5 Allowed 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 125.142 3.895 . . . . 0.0 115.877 -177.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.35 39.11 9.29 Favored Glycine 0 CA--C 1.526 0.764 0 O-C-N 121.465 -0.772 . . . . 0.0 113.32 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 3.1 mp -121.06 -66.96 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 118.199 1.0 . . . . 0.0 109.239 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -167.46 169.12 12.45 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.19 1.396 . . . . 0.0 109.525 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -135.49 117.18 14.99 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 104.245 -2.502 . . . . 0.0 104.245 176.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 31.8 m -145.15 165.48 11.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 126.529 1.932 . . . . 0.0 109.644 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.41 ' HB3' ' CD1' ' A' ' 127' ' ' TYR . 18.0 pt20 -124.22 130.38 52.42 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 177.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -138.82 163.15 32.98 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.503 1.521 . . . . 0.0 109.373 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -93.59 108.41 20.13 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.584 ' H ' HD13 ' A' ' 126' ' ' ILE . . . 175.08 151.56 8.61 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.417 ' HD2' ' H ' ' A' ' 141' ' ' ARG . 0.0 OUTLIER -125.78 167.0 15.79 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.452 1.126 . . . . 0.0 111.578 -179.313 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.3 p -95.68 150.89 4.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 C-N-CA 124.948 1.299 . . . . 0.0 110.965 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -105.57 132.59 51.54 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 104.459 -2.422 . . . . 0.0 104.459 176.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 19.2 p -69.76 -13.57 62.35 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -71.22 -49.28 45.0 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 119.163 0.892 . . . . 0.0 111.52 -177.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 67.7 p -108.29 -21.34 12.8 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.791 0.836 . . . . 0.0 112.384 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.34 29.75 43.76 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.634 -0.537 . . . . 0.0 113.372 179.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -124.65 160.2 29.03 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.762 1.225 . . . . 0.0 110.105 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.8 mp -84.11 159.0 3.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 29.4 m -68.96 -58.22 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.641 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -164.2 169.35 17.77 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 127.674 2.39 . . . . 0.0 106.681 178.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -127.85 104.57 7.89 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 103.808 -2.664 . . . . 0.0 103.808 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -63.83 113.25 3.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 126.198 1.799 . . . . 0.0 112.217 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -63.82 -6.36 5.7 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.805 1.642 . . . . 0.0 112.631 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.6 t -87.93 -15.93 35.25 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.645 1.978 . . . . 0.0 110.348 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.5 HD22 ' HH2' ' A' ' 125' ' ' TRP . 26.9 mt -125.41 53.22 1.56 Allowed 'General case' 0 C--N 1.338 0.081 0 C-N-CA 125.78 1.632 . . . . 0.0 109.172 -178.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 15.0 m -86.03 145.96 7.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 C-N-CA 124.486 1.114 . . . . 0.0 110.681 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -151.03 175.43 12.1 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 126.223 1.809 . . . . 0.0 108.581 -179.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -147.73 137.14 22.46 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.2 mp -120.22 -30.93 4.52 Favored 'General case' 0 C--O 1.221 -0.4 0 C-N-CA 125.525 1.53 . . . . 0.0 108.315 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 167.28 162.41 18.96 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-N 119.61 1.095 . . . . 0.0 111.39 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm -125.54 108.31 26.34 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 124.78 1.232 . . . . 0.0 108.516 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -81.64 167.05 17.17 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.83 3.02 . . . . 0.0 110.92 178.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -110.56 145.1 38.39 Favored 'General case' 0 CA--C 1.513 -0.481 0 C-N-CA 124.752 1.221 . . . . 0.0 112.036 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.4 -40.33 90.55 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 124.356 1.035 . . . . 0.0 109.596 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -76.4 64.34 2.11 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 126.173 1.789 . . . . 0.0 109.348 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.9 p -47.06 -32.46 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 119.763 1.165 . . . . 0.0 111.91 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -63.99 -26.67 68.68 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.899 1.68 . . . . 0.0 112.619 -178.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.0 -25.91 56.21 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.428 0.691 . . . . 0.0 110.568 178.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 65.4 mtp180 -81.04 165.24 21.85 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 122.067 0.937 . . . . 0.0 110.884 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -123.46 147.68 46.93 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -130.42 165.44 22.58 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 125.318 1.447 . . . . 0.0 107.866 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -130.83 153.36 49.17 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 118.012 0.369 . . . . 0.0 110.447 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 45.9 tp -108.41 103.23 12.33 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.305 1.442 . . . . 0.0 108.471 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.525 HD23 ' HB2' ' A' ' 184' ' ' SER . 2.9 mm? -114.63 -179.51 3.65 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 126.653 1.981 . . . . 0.0 109.073 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -142.17 160.47 40.17 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.693 0.797 . . . . 0.0 110.824 179.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -139.97 -175.46 4.24 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.368 2.267 . . . . 0.0 108.084 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -58.48 -18.49 29.33 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 120.292 -1.505 . . . . 0.0 114.361 -178.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 42.4 t -98.84 -44.99 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 122.964 0.506 . . . . 0.0 111.648 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 175.2 -159.86 28.29 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 118.659 0.663 . . . . 0.0 111.729 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -85.38 158.76 20.16 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -154.97 166.41 33.65 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.61 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 98.2 mt -105.77 128.7 59.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.525 ' HB2' HD23 ' A' ' 175' ' ' LEU . 43.8 t -92.95 130.71 38.44 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.216 1.406 . . . . 0.0 108.299 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -126.0 112.77 16.29 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 177.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.14 112.2 26.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 11.1 mt -99.84 106.53 19.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 103.426 -2.805 . . . . 0.0 103.426 178.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -101.37 -153.18 25.88 Favored Glycine 0 CA--C 1.52 0.364 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 60.96 43.18 11.86 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.499 0.72 . . . . 0.0 112.153 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -86.56 -106.59 0.8 Allowed Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 105.027 -3.229 . . . . 0.0 105.027 178.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -157.9 162.63 38.33 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 129.095 2.958 . . . . 0.0 104.545 178.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.6 mm -85.62 142.28 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.3 m -97.97 105.6 17.77 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 127.746 2.418 . . . . 0.0 104.584 177.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -50.39 -27.0 5.58 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.311 1.844 . . . . 0.0 112.902 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 21.6 t -43.0 -56.55 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 126.819 2.048 . . . . 0.0 110.866 179.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 9.2 t -123.65 -25.61 4.31 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.867 1.267 . . . . 0.0 112.774 -178.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 99.27 35.04 4.87 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 107.541 -2.224 . . . . 0.0 107.541 -178.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -106.62 150.46 26.18 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 118.851 1.326 . . . . 0.0 112.747 -178.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -78.91 141.97 37.16 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.274 0.559 . . . . 0.0 109.722 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 -67.56 29.71 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.519 1 C-N-CA 133.64 4.776 . . . . 0.0 114.625 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 9.5 ptm -74.43 178.99 4.87 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.433 1.493 . . . . 0.0 112.051 -178.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.23 150.46 15.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 124.853 1.261 . . . . 0.0 109.199 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -110.74 103.58 12.14 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.445 2.298 . . . . 0.0 107.553 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 9.4 mm -93.48 146.8 6.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -125.58 105.34 8.95 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.952 2.101 . . . . 0.0 108.004 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' TYR . . . . . 0.431 ' CE2' HG21 ' A' ' 233' ' ' VAL . 58.4 m-85 -84.77 110.58 18.9 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 12.5 m -125.36 167.19 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 124.015 0.926 . . . . 0.0 109.101 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 36.7 t -93.69 135.21 35.21 Favored 'General case' 0 C--N 1.333 -0.127 0 O-C-N 120.153 -1.592 . . . . 0.0 107.233 178.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -83.84 8.65 65.39 Favored Glycine 0 N--CA 1.464 0.509 0 CA-C-O 118.77 -1.017 . . . . 0.0 114.349 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 73.33 -6.77 13.92 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-O 118.23 -1.317 . . . . 0.0 114.273 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 2.8 p -79.82 156.88 27.2 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 119.368 1.584 . . . . 0.0 108.798 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -83.7 -29.31 27.67 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.231 1.013 . . . . 0.0 112.427 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 9.4 m -156.81 168.81 26.33 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 120.126 -1.609 . . . . 0.0 111.731 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 132.3 170.62 12.58 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 128.373 2.892 . . . . 0.0 111.168 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.06 -94.34 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 124.19 3.26 . . . . 0.0 110.778 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 11.2 p -162.13 154.17 19.06 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 120.645 -1.284 . . . . 0.0 109.686 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 41.7 p -151.38 163.79 38.16 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.392 0.677 . . . . 0.0 110.426 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.438 HG13 HG12 ' A' ' 233' ' ' VAL . 4.1 mt -110.54 143.03 21.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 125.145 1.378 . . . . 0.0 107.423 178.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -95.11 -51.72 4.52 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.199 1.4 . . . . 0.0 110.786 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 -161.21 156.57 24.41 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.429 1.491 . . . . 0.0 109.658 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.5 HG11 ' CD1' ' A' ' 127' ' ' TYR . 7.3 t -151.03 144.98 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 C-N-CA 127.894 2.478 . . . . 0.0 106.228 -178.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.24 168.47 15.18 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.602 1.161 . . . . 0.0 109.146 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -83.57 131.12 35.0 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 103.383 -2.821 . . . . 0.0 103.383 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' THR . . . . . 0.478 HG23 ' HG3' ' A' ' 225' ' ' LYS . 9.8 t -109.87 -28.68 8.64 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 124.245 1.018 . . . . 0.0 113.177 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.515 ' HE3' HG11 ' A' ' 228' ' ' VAL . 10.2 mttt -133.92 -175.6 3.89 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 70.0 mt -54.39 -49.52 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -123.01 20.56 9.94 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 124.042 0.937 . . . . 0.0 110.76 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.515 HG11 ' HE3' ' A' ' 225' ' ' LYS . 13.5 t -121.73 144.73 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 CA-C-N 118.578 0.626 . . . . 0.0 110.38 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -123.33 165.47 16.93 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 125.983 1.713 . . . . 0.0 108.434 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' GLU . . . . . 0.42 ' HG3' HG21 ' A' ' 224' ' ' THR . 25.7 mt-10 -131.31 147.01 52.53 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 126.086 1.754 . . . . 0.0 106.981 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -151.35 120.6 6.79 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.84 0.856 . . . . 0.0 109.373 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -108.79 113.45 26.41 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 123.588 0.755 . . . . 0.0 109.389 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' VAL . . . . . 0.438 HG12 HG13 ' A' ' 218' ' ' ILE . 6.7 m -104.12 152.2 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -118.91 116.34 26.26 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.68 -1.145 . . . . 0.0 108.452 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -124.83 122.47 25.6 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-O 117.935 -1.031 . . . . 0.0 109.282 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -57.38 -38.45 94.47 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.249 2.633 . . . . 0.0 111.427 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -59.18 -28.66 66.83 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 10.2 tp -58.59 -33.25 69.77 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 121.48 -0.762 . . . . 0.0 111.638 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 15.3 m -59.21 -11.13 3.47 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.141 0.976 . . . . 0.0 112.996 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -61.79 -32.01 72.27 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 120.128 1.331 . . . . 0.0 109.877 178.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -85.05 124.5 31.81 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -47.73 -48.11 29.83 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.239 2.215 . . . . 0.0 113.101 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 59.7 mt -67.97 -19.41 64.94 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.061 -1.025 . . . . 0.0 113.185 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 11.4 mt -105.36 -5.91 20.04 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.82 1.248 . . . . 0.0 111.686 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -71.64 139.69 49.38 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 128.606 2.762 . . . . 0.0 112.189 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 16.8 mmtm -111.74 163.3 14.3 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 127.894 2.478 . . . . 0.0 112.698 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -124.64 -39.36 2.3 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -140.97 51.18 1.62 Allowed 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.149 0.98 . . . . 0.0 109.848 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.254 1.309 0 C-N-CA 125.431 1.492 . . . . 0.0 108.21 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.68 0 CA-C-O 118.746 -1.03 . . . . 0.0 112.669 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 51.31 7.64 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 128.641 2.776 . . . . 0.0 118.201 178.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.0 m -63.76 157.88 23.19 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 120.859 1.663 . . . . 0.0 112.057 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -54.15 -58.19 8.3 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.768 1.227 . . . . 0.0 110.642 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.6 m -62.68 -28.93 70.27 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.337 1.055 . . . . 0.0 112.245 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -69.19 -26.24 64.74 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 118.44 -0.791 . . . . 0.0 111.559 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 42.3 tptt -66.9 -55.26 15.43 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.28 -39.96 94.67 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 123.043 0.537 . . . . 0.0 110.103 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.03 -40.84 95.11 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 35.6 tp -67.98 -35.99 79.27 Favored 'General case' 0 C--N 1.343 0.306 0 CA-C-O 117.514 -1.232 . . . . 0.0 109.233 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.7 mt -62.05 -55.04 33.14 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.942 1.246 . . . . 0.0 107.963 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 53.5 m -60.05 -47.16 87.01 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.097 0.959 . . . . 0.0 110.346 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.16 -45.25 94.25 Favored 'General case' 0 N--CA 1.462 0.128 0 O-C-N 121.099 -1.001 . . . . 0.0 109.808 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.5 m -53.92 -43.11 69.46 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 124.706 1.202 . . . . 0.0 109.684 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.22 -52.08 67.2 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 118.341 0.519 . . . . 0.0 110.218 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -64.95 -51.47 61.61 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -178.06 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -63.14 -42.08 99.41 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.777 -178.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.38 -52.51 52.18 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 107.872 -2.091 . . . . 0.0 107.872 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.415 HG23 HD13 ' A' ' 183' ' ' ILE . 17.9 t -54.81 -51.99 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 124.614 1.166 . . . . 0.0 110.954 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 31.5 pttt -62.33 -32.2 72.94 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 119.966 -0.693 . . . . 0.0 111.484 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 59.9 m -76.61 -33.2 58.42 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 19.6 mt -63.49 -56.03 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -60.36 -36.92 79.15 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 118.063 -0.97 . . . . 0.0 111.669 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -54.86 -43.83 73.45 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.832 0.742 . . . . 0.0 111.806 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.9 tptt -82.38 -40.95 20.6 Favored 'General case' 0 CA--C 1.517 -0.326 0 O-C-N 122.027 -0.421 . . . . 0.0 111.566 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 44.5 mt -60.65 -29.47 69.29 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 119.135 -0.46 . . . . 0.0 111.512 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -55.38 -15.66 2.82 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.038 0.935 . . . . 0.0 112.729 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -64.63 -66.85 0.49 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.253 1.021 . . . . 0.0 109.676 178.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 18.6 mmt85 -151.47 -179.49 7.43 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.894 1.678 . . . . 0.0 111.85 -178.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 64.9 m -86.12 161.32 18.94 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 38.7 pt -121.63 162.68 20.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 125.722 1.609 . . . . 0.0 108.281 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -156.89 142.62 17.7 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.374 1.07 . . . . 0.0 109.433 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -136.38 132.6 35.75 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.213 1.005 . . . . 0.0 110.65 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -81.44 98.44 8.23 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.66 83.04 4.8 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.122 1.369 . . . . 0.0 107.78 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.12 -98.15 0.18 Allowed Glycine 0 C--N 1.336 0.53 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -100.45 -26.56 13.82 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.349 1.06 . . . . 0.0 113.716 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -103.1 132.2 49.53 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 118.932 0.787 . . . . 0.0 110.467 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.488 HD13 ' H ' ' A' ' 140' ' ' GLY . 3.3 mp -96.2 127.86 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 103.643 -2.725 . . . . 0.0 103.643 178.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.401 ' CG ' HG11 ' A' ' 221' ' ' VAL . 11.3 m-85 -100.84 120.35 40.0 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -179.195 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -116.11 125.07 51.87 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 125.167 1.387 . . . . 0.0 110.394 -178.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -121.51 129.07 52.69 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.508 0.723 . . . . 0.0 112.018 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 22.7 m -107.76 151.01 40.96 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 123.624 0.77 . . . . 0.0 111.301 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -66.23 80.25 0.3 Allowed 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 125.275 3.983 . . . . 0.0 116.82 -177.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.87 31.19 27.07 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 117.803 -1.554 . . . . 0.0 112.007 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 3.0 mp -117.18 -71.99 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 119.444 1.622 . . . . 0.0 109.817 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.507 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 16.2 pt-20 -163.22 166.63 23.03 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.927 1.691 . . . . 0.0 110.435 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -130.56 119.91 23.25 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 105.731 -1.952 . . . . 0.0 105.731 177.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.7 m -144.22 164.08 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 125.109 1.364 . . . . 0.0 110.724 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -125.65 122.84 37.56 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.459 ' HE2' HG21 ' A' ' 149' ' ' ILE . 31.2 p90 -138.72 162.15 35.42 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 123.924 0.89 . . . . 0.0 108.907 178.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.547 ' H ' HD13 ' A' ' 156' ' ' LEU . 76.4 t60 -96.04 118.45 32.66 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.488 ' H ' HD13 ' A' ' 126' ' ' ILE . . . -169.15 -167.51 29.84 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.026 1.298 . . . . 0.0 110.267 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -138.99 142.92 38.32 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.673 1.589 . . . . 0.0 107.783 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.5 p -94.91 149.94 4.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 119.633 1.106 . . . . 0.0 108.308 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -98.06 92.88 5.99 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 102.377 -3.194 . . . . 0.0 102.377 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 27.8 p -52.5 -25.37 10.08 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.82 1.248 . . . . 0.0 114.117 -178.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -52.5 -40.33 62.28 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 125.09 1.356 . . . . 0.0 111.124 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.0 p -117.81 -48.07 2.58 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.896 1.279 . . . . 0.0 112.045 -178.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 118.11 24.91 3.14 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 117.979 -1.456 . . . . 0.0 113.84 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -124.77 155.54 39.19 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 121.163 2.481 . . . . 0.0 111.963 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.459 HG21 ' HE2' ' A' ' 138' ' ' PHE . 10.7 mm -69.31 158.05 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 123.919 0.888 . . . . 0.0 109.532 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 7.6 m -66.68 -33.21 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 125.09 1.356 . . . . 0.0 113.701 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -145.5 159.1 43.6 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.127 1.371 . . . . 0.0 110.03 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -113.68 124.79 53.15 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.451 1.5 . . . . 0.0 111.737 -178.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 8.68 61.32 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.172 1 C-N-CA 131.728 4.011 . . . . 0.0 113.904 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -59.72 -79.98 0.02 OUTLIER 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.882 1.673 . . . . 0.0 112.866 -178.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 42.3 m -112.31 -29.51 7.51 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.04 0.936 . . . . 0.0 110.7 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.547 HD13 ' H ' ' A' ' 139' ' ' HIS . 68.8 mt -61.35 133.62 56.04 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.3 p -127.64 119.79 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 123.887 0.875 . . . . 0.0 110.957 -178.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -154.82 155.56 34.65 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 124.707 1.203 . . . . 0.0 110.029 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -148.65 143.81 26.76 Favored 'General case' 0 CA--C 1.512 -0.484 0 C-N-CA 126.371 1.868 . . . . 0.0 107.046 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 42.7 mt -129.79 -31.67 1.95 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.566 1.547 . . . . 0.0 107.689 177.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 159.34 158.66 9.24 Favored Glycine 0 C--N 1.341 0.823 0 O-C-N 120.587 -1.32 . . . . 0.0 113.459 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -117.41 108.93 42.7 Favored Pre-proline 0 C--O 1.239 0.529 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.507 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 91.5 Cg_endo -72.04 165.09 33.65 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 124.16 3.24 . . . . 0.0 109.371 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -109.99 148.82 30.94 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 123.476 0.71 . . . . 0.0 110.281 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -68.15 -48.46 65.3 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 125.777 1.923 . . . . 0.0 109.788 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -74.98 65.47 1.44 Allowed 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.207 1.403 . . . . 0.0 113.443 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.0 p -47.8 -31.66 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.29 1.036 . . . . 0.0 111.925 178.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -72.65 -30.11 64.01 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -178.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -73.66 -18.16 61.06 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.963 0.505 . . . . 0.0 109.842 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -105.81 165.47 11.16 Favored 'General case' 0 C--N 1.342 0.268 0 O-C-N 121.603 -0.686 . . . . 0.0 109.824 178.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -120.84 156.3 32.24 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -130.0 171.14 13.1 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.405 1.482 . . . . 0.0 108.715 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -113.7 153.44 28.97 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 123.691 0.796 . . . . 0.0 110.057 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 56.8 tp -121.63 102.51 8.28 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.594 1.558 . . . . 0.0 107.759 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.424 HD23 ' HB2' ' A' ' 184' ' ' SER . 2.3 mm? -112.5 -178.6 3.44 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 127.299 2.24 . . . . 0.0 109.996 -178.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -142.57 161.14 38.82 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.599 0.76 . . . . 0.0 110.346 177.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -140.92 178.68 7.19 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 127.637 2.375 . . . . 0.0 106.909 178.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.29 -17.81 22.32 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.435 1.494 . . . . 0.0 113.337 -178.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 90.0 t -93.92 -31.83 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 124.787 1.235 . . . . 0.0 111.917 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 156.19 -170.46 33.86 Favored Glycine 0 N--CA 1.448 -0.553 0 O-C-N 121.305 -0.872 . . . . 0.0 112.762 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.425 ' CE2' ' HG ' ' A' ' 243' ' ' LEU . 3.7 m-30 -78.76 160.73 27.28 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.401 ' HB3' HG12 ' A' ' 207' ' ' VAL . 30.7 p90 -164.33 157.96 18.18 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.273 1.029 . . . . 0.0 111.831 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.415 HD13 HG23 ' A' ' 106' ' ' VAL . 76.2 mt -96.03 138.82 20.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.899 1.28 . . . . 0.0 107.8 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.424 ' HB2' HD23 ' A' ' 175' ' ' LEU . 30.1 t -105.12 120.89 42.62 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 126.087 1.755 . . . . 0.0 107.973 179.204 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -114.89 107.49 15.48 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.905 1.682 . . . . 0.0 108.355 179.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -89.79 124.14 42.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 178.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.7 mt -114.27 105.69 19.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 104.94 -2.244 . . . . 0.0 104.94 177.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -98.18 -152.22 27.86 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 105.99 -2.844 . . . . 0.0 105.99 178.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 20.1 m 81.33 18.51 0.44 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 177.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -90.58 -142.19 9.78 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 108.354 -1.899 . . . . 0.0 108.354 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -124.5 163.82 21.05 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.4 mm -81.41 142.71 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.191 0.996 . . . . 0.0 112.012 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -85.93 122.63 30.25 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.722 1.609 . . . . 0.0 109.129 178.337 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.45 -28.4 63.29 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.761 1.225 . . . . 0.0 111.896 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 58.6 t -57.62 -54.95 24.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.549 1.139 . . . . 0.0 113.165 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 14.0 t -122.72 -36.64 2.87 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 116.164 1.912 . . . . 0.0 116.164 -176.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 111.81 23.51 5.58 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -99.07 150.95 21.48 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.763 0.825 . . . . 0.0 109.742 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -74.91 151.88 38.88 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.955 0.883 . . . . 0.0 108.922 178.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -71.27 29.75 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 130.021 3.329 . . . . 0.0 110.276 177.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 8.0 ptm -73.84 175.58 7.15 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.284 1.834 . . . . 0.0 111.778 -177.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.52 150.34 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 124.294 1.038 . . . . 0.0 108.628 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -111.93 104.17 12.44 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.242 1.817 . . . . 0.0 106.412 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 10.2 mm -96.75 144.02 11.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 O-C-N 120.848 -1.157 . . . . 0.0 109.289 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -124.29 127.67 47.99 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.292 1.037 . . . . 0.0 109.22 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -102.43 113.11 26.17 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 118.565 -0.731 . . . . 0.0 110.823 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.401 HG12 ' HB3' ' A' ' 182' ' ' TYR . 4.5 m -127.61 162.26 33.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 16.2 t -91.89 138.26 31.7 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 104.381 -2.451 . . . . 0.0 104.381 177.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -95.33 12.97 67.5 Favored Glycine 0 CA--C 1.522 0.483 0 CA-C-O 118.726 -1.041 . . . . 0.0 112.462 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 71.31 -0.91 29.86 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-N 118.16 0.98 . . . . 0.0 111.666 -178.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 9.4 m -68.67 130.33 42.53 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -74.39 -19.72 60.32 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -155.63 175.07 14.39 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.214 1.406 . . . . 0.0 110.306 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 123.3 173.49 14.04 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.5 1.524 . . . . 0.0 113.861 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -79.93 -89.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 123.824 3.016 . . . . 0.0 110.879 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 18.2 p -170.8 146.94 2.67 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.171 1.788 . . . . 0.0 109.842 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 29.3 p -154.84 147.7 24.5 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.504 1.122 . . . . 0.0 110.487 178.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.447 HG13 HG12 ' A' ' 233' ' ' VAL . 3.2 mt -85.64 144.85 8.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -90.34 -55.75 3.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.869 1.267 . . . . 0.0 108.683 178.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 66.1 p-90 -154.63 158.14 39.23 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.328 1.051 . . . . 0.0 110.105 -178.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.612 HG23 ' HB2' ' A' ' 231' ' ' ALA . 7.2 p -156.16 134.91 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 177.014 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -159.64 159.91 33.64 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 118.545 0.611 . . . . 0.0 110.683 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -67.59 133.36 49.27 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 178.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' THR . . . . . 0.644 HG23 ' HG3' ' A' ' 225' ' ' LYS . 2.3 t -111.82 -34.32 6.05 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.937 1.295 . . . . 0.0 111.592 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.644 ' HG3' HG23 ' A' ' 224' ' ' THR . 7.7 mttm -134.73 -176.5 4.25 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 97.6 mt -50.06 -47.67 23.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 C-N-CA 124.681 1.192 . . . . 0.0 111.669 -178.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -127.7 20.5 6.58 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.582 0.753 . . . . 0.0 110.232 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 13.6 t -122.75 147.71 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 O-C-N 120.925 -1.109 . . . . 0.0 110.067 -177.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -127.92 163.58 24.16 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -135.35 133.05 38.36 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 178.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.612 ' HB2' HG23 ' A' ' 221' ' ' VAL . . . -135.91 149.08 48.82 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.208 1.803 . . . . 0.0 107.981 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -135.72 124.36 23.73 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 118.862 0.756 . . . . 0.0 110.049 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' VAL . . . . . 0.447 HG12 HG13 ' A' ' 218' ' ' ILE . 15.3 m -106.97 153.08 8.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 121.338 0.59 . . . . 0.0 109.682 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.02 121.62 39.32 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 178.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -132.82 145.36 56.77 Favored Pre-proline 0 N--CA 1.45 -0.432 0 O-C-N 124.469 1.106 . . . . 0.0 110.809 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.71 -42.26 1.24 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.812 2.341 . . . . 0.0 112.317 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -56.89 -25.48 57.03 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -178.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 9.6 tp -64.58 -29.69 70.71 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 121.403 -0.811 . . . . 0.0 112.374 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 11.4 m -58.39 -12.47 3.85 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.464 1.106 . . . . 0.0 112.449 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -64.11 -27.02 68.8 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 119.42 1.009 . . . . 0.0 111.239 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.27 124.86 35.79 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 -47.85 -48.35 31.07 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.706 1.203 . . . . 0.0 113.904 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.425 ' HG ' ' CE2' ' A' ' 181' ' ' TYR . 1.6 mp -61.12 -31.84 71.54 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 13.4 mt -93.73 -17.9 22.68 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.859 1.264 . . . . 0.0 113.167 -178.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -61.4 146.83 46.97 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 128.18 2.592 . . . . 0.0 110.411 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -105.2 169.57 8.37 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.361 1.464 . . . . 0.0 111.977 -179.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -106.17 -5.83 19.01 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 125.376 1.471 . . . . 0.0 111.142 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -112.6 24.21 12.72 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.202 1.801 . . . . 0.0 109.784 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 12.1 t70 . . . . . 0 C--O 1.259 1.557 0 C-N-CA 126.868 2.067 . . . . 0.0 109.941 -179.495 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.874 0 N-CA-C 108.468 -1.853 . . . . 0.0 108.468 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.02 177.99 10.18 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.496 1.518 . . . . 0.0 107.943 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.2 m -71.81 82.25 0.89 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.843 0.857 . . . . 0.0 110.179 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -63.05 -40.38 97.52 Favored 'General case' 0 C--O 1.225 -0.234 0 O-C-N 120.819 -1.175 . . . . 0.0 110.828 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.1 m -60.07 -49.49 77.43 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.041 1.336 . . . . 0.0 111.566 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -61.05 -45.07 96.26 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.0 tptm -54.29 -52.99 59.71 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 118.452 -0.785 . . . . 0.0 109.379 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.5 p -58.52 -40.72 83.67 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.45 -44.35 89.16 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 118.809 -0.615 . . . . 0.0 110.759 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 58.6 tp -74.26 -38.35 63.47 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-O 117.913 -1.041 . . . . 0.0 109.416 178.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 16.1 mt -58.92 -54.51 46.29 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.597 1.089 . . . . 0.0 110.746 -177.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 16.9 m -64.54 -36.18 83.37 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 118.703 -1.199 . . . . 0.0 110.762 -179.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.74 -49.86 76.06 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.233 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 89.6 m -51.44 -46.52 63.03 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.345 1.058 . . . . 0.0 110.586 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -58.77 -50.08 75.27 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.82 0.737 . . . . 0.0 110.524 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -67.95 -59.1 3.53 Favored 'General case' 0 C--O 1.227 -0.114 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -58.89 -38.14 78.18 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.21 1.004 . . . . 0.0 110.392 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.22 -52.65 50.47 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.478 ' HA ' HD12 ' A' ' 109' ' ' ILE . 51.6 t -57.72 -44.53 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 118.882 1.341 . . . . 0.0 109.974 179.112 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -60.47 -35.49 76.01 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.458 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 88.4 m -75.74 -34.95 60.34 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 122.771 0.428 . . . . 0.0 110.335 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.478 HD12 ' HA ' ' A' ' 106' ' ' VAL . 26.1 mt -63.36 -55.59 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -62.04 -33.51 74.51 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 118.433 -0.794 . . . . 0.0 112.753 -178.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -65.8 -37.95 87.66 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 118.834 0.743 . . . . 0.0 111.354 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.8 tptt -84.76 -38.46 19.6 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 118.761 -0.638 . . . . 0.0 111.157 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 16.8 mt -65.06 -25.81 67.97 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.845 0.748 . . . . 0.0 111.256 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -53.17 -24.66 11.27 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.059 1.344 . . . . 0.0 111.459 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -65.96 -65.79 0.63 Allowed 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 118.132 -0.937 . . . . 0.0 111.71 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -147.43 175.32 10.91 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 120.276 1.398 . . . . 0.0 112.863 -178.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 79.0 m -86.44 163.9 17.3 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 43.1 pt -121.8 159.46 24.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 124.587 1.155 . . . . 0.0 109.86 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -157.06 140.22 15.48 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 122.914 0.486 . . . . 0.0 111.847 -178.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -138.73 129.9 26.94 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 119.804 -0.759 . . . . 0.0 109.995 176.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -83.46 98.56 9.59 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.996 1.319 . . . . 0.0 107.547 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -85.95 80.56 8.84 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.494 1.918 . . . . 0.0 106.545 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.44 -99.42 0.33 Allowed Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -92.38 -30.75 15.62 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 118.423 1.112 . . . . 0.0 113.43 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -100.21 155.18 17.9 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 119.109 0.868 . . . . 0.0 110.548 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.687 HD13 ' H ' ' A' ' 140' ' ' GLY . 4.0 mp -122.13 144.59 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 104.003 -2.591 . . . . 0.0 104.003 179.041 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -128.88 120.0 25.43 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -110.06 126.02 53.56 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.966 1.706 . . . . 0.0 109.423 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -115.13 136.09 53.49 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.498 ' HB3' HD13 ' A' ' 133' ' ' ILE . 17.1 m -118.97 148.8 45.46 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 123.528 0.731 . . . . 0.0 111.066 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -64.63 91.33 0.19 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 125.079 3.853 . . . . 0.0 114.586 -178.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.82 28.44 58.98 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-O 118.045 -1.42 . . . . 0.0 114.265 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.498 HD13 ' HB3' ' A' ' 130' ' ' CYS . 4.1 mp -115.14 -71.58 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 119.654 1.727 . . . . 0.0 108.43 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.406 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 15.8 pt-20 -171.43 174.6 4.4 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.449 1.5 . . . . 0.0 110.072 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.416 ' CD1' HD12 ' A' ' 160' ' ' LEU . 1.2 t80 -136.54 120.26 17.3 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 177.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.9 m -145.41 164.99 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 126.494 1.917 . . . . 0.0 110.336 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -117.37 131.97 56.68 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 119.461 1.028 . . . . 0.0 110.498 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -137.68 162.31 34.19 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.547 1.067 . . . . 0.0 108.781 176.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.528 ' H ' ' CD1' ' A' ' 156' ' ' LEU . 72.1 t60 -102.24 109.93 21.75 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.687 ' H ' HD13 ' A' ' 126' ' ' ILE . . . -170.42 -178.25 41.09 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.426 1.489 . . . . 0.0 109.788 -179.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -126.01 160.71 29.32 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.39 1.595 . . . . 0.0 110.886 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.6 p -117.41 157.42 18.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 C-N-CA 124.082 0.953 . . . . 0.0 108.572 179.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -105.26 99.81 9.42 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 177.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 40.0 p -53.25 -17.03 1.48 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.518 1.527 . . . . 0.0 113.558 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.79 -39.13 83.91 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 125.395 1.478 . . . . 0.0 111.835 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 44.3 p -132.23 -28.01 1.74 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 105.99 18.2 11.79 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.958 1.266 . . . . 0.0 115.501 179.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -97.41 147.81 23.83 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 118.85 1.325 . . . . 0.0 111.833 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 13.8 mm -74.12 154.64 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 178.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 27.1 m -68.73 -38.0 78.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.162 0.985 . . . . 0.0 110.753 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 26.2 t30 -175.75 148.78 0.9 Allowed 'General case' 0 C--O 1.235 0.313 0 C-N-CA 129.114 2.965 . . . . 0.0 106.45 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 30.4 mtp180 -97.19 155.08 17.0 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.029 0.832 . . . . 0.0 109.323 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -114.91 112.16 22.29 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -83.16 -13.59 55.22 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.914 0.864 . . . . 0.0 112.594 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 4.6 p -69.27 -42.33 75.68 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 127.994 2.518 . . . . 0.0 111.071 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.528 ' CD1' ' H ' ' A' ' 139' ' ' HIS . 34.2 mt -77.5 67.57 3.44 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 127.708 2.403 . . . . 0.0 110.582 -178.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 4.3 p -79.77 130.93 35.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -150.55 166.78 29.2 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 126.55 1.94 . . . . 0.0 107.859 178.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.27 113.06 5.41 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 117.37 -1.3 . . . . 0.0 109.248 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.416 HD12 ' CD1' ' A' ' 135' ' ' PHE . 43.4 mt -102.02 -30.46 11.18 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.936 1.244 . . . . 0.0 108.982 178.31 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 161.99 161.31 11.81 Favored Glycine 0 CA--C 1.503 -0.668 0 CA-C-O 122.396 0.998 . . . . 0.0 110.758 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -123.91 109.39 29.95 Favored Pre-proline 0 N--CA 1.426 -1.631 0 C-N-CA 125.262 1.425 . . . . 0.0 109.307 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 85.3 Cg_endo -70.52 177.77 5.75 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.664 2.909 . . . . 0.0 108.745 178.129 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -120.55 152.11 38.52 Favored 'General case' 0 CA--C 1.517 -0.312 0 O-C-N 121.64 -0.663 . . . . 0.0 111.363 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -67.04 -49.69 64.37 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 122.945 0.498 . . . . 0.0 110.142 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -79.18 65.02 4.24 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.606 0.763 . . . . 0.0 110.47 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.3 p -48.8 -33.35 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 125.26 1.424 . . . . 0.0 111.229 179.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -65.5 -30.93 71.75 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 126.131 1.773 . . . . 0.0 111.621 -178.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -88.76 -11.3 45.38 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.698 1.199 . . . . 0.0 111.692 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.442 HH22 HG12 ' A' ' 187' ' ' ILE . 50.6 ttt180 -81.53 177.23 9.06 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.025 1.33 . . . . 0.0 108.686 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -133.29 149.8 51.92 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 121.261 -0.9 . . . . 0.0 109.34 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -136.63 169.87 17.01 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 127.592 2.357 . . . . 0.0 110.091 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -123.62 154.63 39.05 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.806 0.842 . . . . 0.0 110.349 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 12.4 tp -119.09 105.1 11.08 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 122.383 1.087 . . . . 0.0 109.621 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 3.4 mt -119.09 176.67 5.19 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 128.227 2.611 . . . . 0.0 107.738 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -154.68 164.36 38.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.714 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.71 -175.43 3.82 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.388 1.875 . . . . 0.0 110.313 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -66.81 -1.81 4.34 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.875 1.67 . . . . 0.0 113.442 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.407 ' CG1' ' HE3' ' A' ' 246' ' ' LYS . 30.6 t -112.82 -44.21 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 124.741 1.216 . . . . 0.0 109.519 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 175.56 -175.52 47.26 Favored Glycine 0 N--CA 1.446 -0.67 0 O-C-N 121.274 -0.891 . . . . 0.0 111.943 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -82.17 163.71 21.75 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.455 ' HB3' HG12 ' A' ' 207' ' ' VAL . 45.7 p90 -154.4 172.37 17.84 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 74.6 mt -113.9 129.81 69.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 35.0 t -91.59 124.22 35.59 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -123.15 107.54 11.85 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.5 mp -93.39 117.89 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 104.281 -2.488 . . . . 0.0 104.281 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.442 HG12 HH22 ' A' ' 170' ' ' ARG . 4.3 mt -104.89 105.83 19.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 178.384 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -104.19 -156.38 23.82 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.793 1.664 . . . . 0.0 109.409 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.1 t 64.02 43.47 5.16 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.586 1.155 . . . . 0.0 110.36 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -91.57 -64.09 1.16 Allowed Glycine 0 CA--C 1.529 0.937 0 N-CA-C 107.987 -2.045 . . . . 0.0 107.987 179.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 157.29 179.98 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.379 1 C-N-CA 132.086 4.155 . . . . 0.0 105.792 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.5 mm -105.59 143.39 16.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 127.756 2.423 . . . . 0.0 112.107 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.4 m -95.73 101.13 12.78 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 128.11 2.564 . . . . 0.0 104.312 176.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -48.73 -31.32 6.73 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.258 1.823 . . . . 0.0 112.658 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 60.0 t -39.16 -54.11 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 127.268 2.227 . . . . 0.0 110.574 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 11.3 t -123.5 -26.95 4.13 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.404 1.082 . . . . 0.0 111.787 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.33 35.18 4.24 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 -178.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -110.67 148.69 31.74 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 118.498 1.149 . . . . 0.0 113.108 -178.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -73.8 148.09 42.8 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.274 0.559 . . . . 0.0 112.156 179.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -70.06 27.01 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.425 1 C-N-CA 134.844 5.258 . . . . 0.0 109.87 177.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 2.8 ptm -74.64 178.78 5.14 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.383 1.473 . . . . 0.0 113.336 -176.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.1 p -150.74 136.45 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 123.279 0.631 . . . . 0.0 110.642 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -98.79 109.22 22.01 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.744 1.217 . . . . 0.0 109.213 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 11.1 mm -97.49 147.88 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 O-C-N 121.627 -0.671 . . . . 0.0 109.853 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -125.7 105.4 8.96 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 128.092 2.557 . . . . 0.0 109.106 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -87.76 114.17 24.12 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 120.65 -1.281 . . . . 0.0 108.951 178.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.455 HG12 ' HB3' ' A' ' 182' ' ' TYR . 4.6 m -124.49 165.01 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 41.9 t -84.63 145.86 27.79 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 120.418 -1.426 . . . . 0.0 107.36 178.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -90.89 6.14 81.91 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-O 117.341 -1.81 . . . . 0.0 115.362 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 62.96 13.75 49.38 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-N 119.026 1.413 . . . . 0.0 114.952 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 46.8 m -96.79 153.84 17.64 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.139 1.376 . . . . 0.0 107.935 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -72.46 -35.48 68.25 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 115.273 1.583 . . . . 0.0 115.273 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 18.6 m -157.95 166.17 33.28 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.52 1.528 . . . . 0.0 109.273 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 144.42 175.05 17.21 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 115.647 1.019 . . . . 0.0 115.647 178.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -78.37 -118.26 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.913 1 C-N-CA 125.38 4.054 . . . . 0.0 109.575 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 28.1 p -154.68 147.61 24.56 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 119.992 -1.693 . . . . 0.0 111.374 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 20.6 p -151.05 161.59 42.44 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.541 1.136 . . . . 0.0 110.145 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 3.6 mt -100.64 154.53 4.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 125.311 1.444 . . . . 0.0 109.386 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -102.27 -51.69 3.31 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 124.783 1.233 . . . . 0.0 109.844 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 64.5 p-90 -155.92 154.09 30.65 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.067 0.947 . . . . 0.0 109.255 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 90.9 t -147.73 137.7 16.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.63 168.53 19.8 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 122.842 0.457 . . . . 0.0 111.207 -178.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -86.86 133.67 33.6 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 177.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 14.8 t -109.21 -32.22 7.28 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.528 1.131 . . . . 0.0 112.214 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -136.86 -175.97 4.21 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.668 1.187 . . . . 0.0 108.84 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 78.3 mt -48.76 -45.05 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.585 0.754 . . . . 0.0 112.479 -178.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -130.19 12.54 5.59 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.112 0.965 . . . . 0.0 112.265 -178.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 17.5 t -114.14 140.29 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 O-C-N 122.116 -0.365 . . . . 0.0 110.127 -176.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -120.66 166.97 12.95 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 125.18 1.392 . . . . 0.0 108.445 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -137.89 148.65 45.54 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.505 1.522 . . . . 0.0 108.822 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -148.93 145.49 27.42 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 125.789 1.636 . . . . 0.0 110.273 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -132.84 122.89 25.11 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 178.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 5.5 m -116.29 154.81 17.8 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.1 p -120.76 124.05 44.17 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.517 1.127 . . . . 0.0 110.302 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -132.8 122.98 17.97 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 124.238 1.015 . . . . 0.0 109.261 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -58.19 -40.83 73.07 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 124.014 3.143 . . . . 0.0 113.406 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -61.05 -19.62 61.6 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.615 0.766 . . . . 0.0 112.101 -178.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 8.6 tp -66.94 -28.87 68.64 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 120.432 -1.418 . . . . 0.0 110.715 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 21.4 m -62.33 -11.85 17.69 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.746 0.818 . . . . 0.0 111.942 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.08 -21.39 66.14 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.046 0.839 . . . . 0.0 110.122 178.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -98.12 121.01 39.53 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 177.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -47.99 -46.13 32.35 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 126.071 1.749 . . . . 0.0 112.704 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.42 -37.54 87.23 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 120.809 -1.182 . . . . 0.0 112.127 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 22.1 mt -85.21 -5.73 59.31 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.32 1.048 . . . . 0.0 112.252 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -68.95 156.41 38.62 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.822 1.249 . . . . 0.0 110.428 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.407 ' HE3' ' CG1' ' A' ' 179' ' ' VAL . 2.9 mmmt -96.35 -166.87 1.48 Allowed 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 126.225 1.81 . . . . 0.0 109.279 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -67.0 -27.99 67.88 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 53.45 31.78 12.79 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 128.19 2.596 . . . . 0.0 111.989 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 33.7 t70 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.739 -0.648 . . . . 0.0 112.598 -179.281 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.936 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 35.16 66.14 0.33 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 127.106 2.163 . . . . 0.0 114.018 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 71.6 m -140.16 147.1 39.65 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.728 1.211 . . . . 0.0 108.689 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -65.72 107.17 1.69 Allowed 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.8 m -50.69 -50.37 55.1 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 119.758 1.163 . . . . 0.0 112.531 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -63.92 -33.63 76.15 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.385 0.674 . . . . 0.0 112.241 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -59.24 -51.37 70.28 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 178.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.46 -37.15 74.87 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.043 0.937 . . . . 0.0 110.874 178.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.55 -42.65 92.89 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.505 1.048 . . . . 0.0 109.481 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.5 tp -68.88 -36.8 78.51 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-O 117.276 -1.345 . . . . 0.0 109.28 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 98.8 mt -58.67 -54.55 45.82 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 120.265 1.393 . . . . 0.0 108.533 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.2 m -58.93 -46.88 86.88 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.808 0.843 . . . . 0.0 111.457 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.09 -41.94 94.51 Favored 'General case' 0 N--CA 1.463 0.197 0 O-C-N 120.343 -1.473 . . . . 0.0 111.014 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 37.6 m -52.4 -46.94 66.51 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.135 1.374 . . . . 0.0 110.771 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -56.51 -50.99 70.19 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.309 0.504 . . . . 0.0 110.098 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -63.02 -58.0 8.78 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -178.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.09 -39.33 78.32 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.343 -177.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.78 -52.57 41.19 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.54 ' HA ' HD12 ' A' ' 109' ' ' ILE . 43.6 t -54.46 -51.07 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-N 119.032 1.416 . . . . 0.0 110.682 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.6 pttp -56.86 -35.14 68.52 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.448 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 77.2 m -80.34 -29.03 37.97 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.113 0.965 . . . . 0.0 111.947 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.54 HD12 ' HA ' ' A' ' 106' ' ' VAL . 16.7 mt -63.27 -54.39 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 104.677 -2.342 . . . . 0.0 104.677 177.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -61.13 -30.69 70.53 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 118.44 -0.79 . . . . 0.0 111.199 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -56.37 -47.57 78.62 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.478 1.036 . . . . 0.0 111.084 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -84.14 -37.9 21.36 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 24.9 mt -65.97 -26.56 67.62 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 118.931 -0.557 . . . . 0.0 112.161 -179.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -56.83 -20.9 25.17 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -64.64 -66.81 0.49 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.517 0.727 . . . . 0.0 109.485 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -153.51 -179.7 8.01 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.04 1.736 . . . . 0.0 110.306 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 56.0 m -86.63 172.82 9.95 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.287 0.635 . . . . 0.0 109.694 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 34.0 pt -129.8 164.37 32.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 126.654 1.982 . . . . 0.0 109.046 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.593 ' CE2' HG21 ' A' ' 142' ' ' VAL . 0.5 OUTLIER -158.74 150.33 20.86 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 122.831 0.452 . . . . 0.0 110.225 -179.222 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -141.5 127.38 19.32 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.631 0.772 . . . . 0.0 109.882 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -84.07 102.23 12.37 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 122.054 0.93 . . . . 0.0 109.404 179.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.27 80.57 6.84 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 127.864 2.466 . . . . 0.0 107.15 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 60.75 -114.69 6.85 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -76.74 -28.81 55.9 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.829 0.852 . . . . 0.0 112.548 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -99.95 163.46 12.43 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 119.073 0.851 . . . . 0.0 110.89 -178.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.524 HD13 ' H ' ' A' ' 140' ' ' GLY . 4.5 mp -136.55 130.56 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -110.05 119.99 41.05 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -108.04 126.42 52.71 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 118.437 -0.792 . . . . 0.0 109.909 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -117.55 130.49 56.44 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.292 0.951 . . . . 0.0 110.094 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.462 ' HB3' HD13 ' A' ' 133' ' ' ILE . 21.4 m -110.83 156.6 40.44 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 128.427 2.691 . . . . 0.0 113.937 -178.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -68.19 72.42 0.83 Allowed 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 124.79 3.66 . . . . 0.0 114.404 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.84 62.06 3.77 Favored Glycine 0 N--CA 1.448 -0.517 0 O-C-N 121.186 -0.947 . . . . 0.0 111.285 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.462 HD13 ' HB3' ' A' ' 130' ' ' CYS . 2.5 mp -131.03 -72.31 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-O 118.325 -0.845 . . . . 0.0 109.235 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -173.65 136.9 0.59 Allowed 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 119.646 1.112 . . . . 0.0 108.15 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -108.27 124.3 50.1 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 121.04 1.745 . . . . 0.0 106.32 -175.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 18.3 m -145.04 165.06 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 125.257 1.423 . . . . 0.0 111.428 -178.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -122.02 133.4 54.8 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.479 1.512 . . . . 0.0 108.193 178.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -138.96 162.87 33.82 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.127 1.371 . . . . 0.0 112.667 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 42.6 t60 -92.76 122.66 35.38 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.524 ' H ' HD13 ' A' ' 126' ' ' ILE . . . 169.97 -158.78 31.07 Favored Glycine 0 N--CA 1.454 -0.145 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 -178.324 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.6 165.59 34.12 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.089 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.593 HG21 ' CE2' ' A' ' 119' ' ' PHE . 5.3 p -107.11 154.52 8.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 178.008 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -106.16 102.18 11.61 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 104.14 -2.541 . . . . 0.0 104.14 176.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 2.3 p -47.58 -39.67 17.29 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 119.812 1.187 . . . . 0.0 113.205 -178.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 53.3 mmtt -56.3 -30.34 62.4 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 126.093 1.757 . . . . 0.0 114.488 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 29.2 p -113.14 -32.67 6.25 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.106 0.962 . . . . 0.0 110.593 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 84.1 26.54 40.3 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 126.015 1.769 . . . . 0.0 112.719 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -125.45 159.63 31.45 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.948 1.299 . . . . 0.0 110.996 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 24.3 mm -75.25 150.78 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 106.816 -1.549 . . . . 0.0 106.816 178.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 30.3 m -65.45 -29.61 47.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -165.61 174.87 9.39 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.925 1.29 . . . . 0.0 110.392 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -113.6 157.38 22.18 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -123.09 109.13 13.67 Favored 'General case' 0 CA--C 1.516 -0.337 0 O-C-N 120.853 -1.154 . . . . 0.0 113.337 -175.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 -83.11 -17.89 41.49 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.905 -0.497 . . . . 0.0 111.133 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 16.0 m -89.54 -42.53 11.38 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 120.874 -1.141 . . . . 0.0 111.004 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 72.9 mt -79.33 93.2 5.27 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.9 m -110.93 117.66 55.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 123.691 0.797 . . . . 0.0 111.127 -178.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -132.81 163.86 28.12 Favored 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 125.122 1.369 . . . . 0.0 109.181 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.67 135.86 23.84 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 178.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.1 mp -125.7 -36.36 2.43 Favored 'General case' 0 C--O 1.221 -0.445 0 C-N-CA 126.478 1.911 . . . . 0.0 106.905 177.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 172.75 152.43 8.65 Favored Glycine 0 C--N 1.34 0.795 0 CA-C-N 119.391 0.996 . . . . 0.0 112.705 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 29.3 mtmt -123.28 109.33 31.32 Favored Pre-proline 0 C--O 1.239 0.513 0 N-CA-C 106.125 -1.805 . . . . 0.0 106.125 177.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -75.35 -172.95 1.43 Allowed 'Trans proline' 0 N--CA 1.459 -0.519 1 C-N-CA 126.174 4.583 . . . . 0.0 111.425 -178.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -124.39 152.41 43.25 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 123.762 0.825 . . . . 0.0 108.965 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.11 -46.18 65.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.066 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 -68.88 65.36 0.13 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 127.366 2.267 . . . . 0.0 111.166 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.8 p -48.51 -34.06 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 124.662 1.185 . . . . 0.0 111.746 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -59.64 -32.21 70.24 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 125.46 1.504 . . . . 0.0 113.184 -178.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -84.61 -22.61 29.91 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.767 1.227 . . . . 0.0 112.787 -178.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.404 HH22 ' HG3' ' A' ' 185' ' ' GLU . 66.6 mtp180 -74.82 139.71 43.43 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -97.22 143.3 28.15 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 179.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -133.59 165.84 23.97 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 124.21 1.004 . . . . 0.0 109.777 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -123.45 142.73 50.7 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.944 0.897 . . . . 0.0 109.965 -178.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 58.9 tp -102.28 100.95 11.18 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.062 1.745 . . . . 0.0 107.584 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.584 HD23 ' HB2' ' A' ' 184' ' ' SER . 2.9 mm? -107.78 -178.84 3.74 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.301 1.44 . . . . 0.0 109.147 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 181' ' ' TYR . 1.7 p90 -139.97 156.88 46.43 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -134.97 175.0 9.98 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 126.879 2.072 . . . . 0.0 107.446 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -64.21 -13.97 52.36 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 124.548 1.139 . . . . 0.0 112.699 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 99.6 t -97.65 -34.93 4.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 125.856 1.662 . . . . 0.0 112.459 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 163.93 -174.65 40.09 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 176' ' ' TYR . 3.6 m-30 -78.41 166.21 22.9 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -165.66 164.19 19.08 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.354 0.662 . . . . 0.0 111.395 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 67.7 mt -102.43 132.41 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.584 ' HB2' HD23 ' A' ' 175' ' ' LEU . 23.3 t -100.81 127.27 47.33 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.581 1.553 . . . . 0.0 107.954 179.048 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.404 ' HG3' HH22 ' A' ' 170' ' ' ARG . 26.4 tt0 -124.21 112.47 17.09 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.39 1.876 . . . . 0.0 109.617 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -96.94 116.23 38.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 178.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 5.3 mt -105.22 108.64 25.44 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -106.58 -153.21 19.83 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 108.023 -2.031 . . . . 0.0 108.023 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 85.44 32.13 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.352 1.861 . . . . 0.0 111.237 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -111.53 165.17 12.09 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 125.537 1.541 . . . . 0.0 111.093 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.62 157.17 38.45 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.7 mm -78.1 134.87 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 C-N-CA 125.387 1.475 . . . . 0.0 110.769 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.35 115.03 18.75 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.918 1.687 . . . . 0.0 106.685 178.155 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -60.37 -22.21 63.03 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.161 1.384 . . . . 0.0 112.219 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 59.8 t -53.73 -48.51 60.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 C-N-CA 125.192 1.397 . . . . 0.0 111.249 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 11.7 t -125.2 -43.27 1.95 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 117.62 35.15 1.1 Allowed Glycine 0 CA--C 1.532 1.139 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 -177.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -111.08 150.67 29.05 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.612 1.706 . . . . 0.0 111.598 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -73.03 143.3 47.57 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.446 0.641 . . . . 0.0 109.388 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 7.0 ttp180 -67.6 29.45 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.4 1 C-N-CA 132.184 4.194 . . . . 0.0 113.564 179.083 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 6.0 ptm -73.51 175.78 6.72 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.216 -0.927 . . . . 0.0 113.062 -177.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 8.8 p -142.13 151.41 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 124.7 1.2 . . . . 0.0 108.483 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -110.78 115.25 29.23 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 179.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 8.5 mm -106.12 140.06 25.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -125.44 109.0 12.21 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.604 1.562 . . . . 0.0 109.108 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -89.48 115.27 26.78 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 120.636 -1.29 . . . . 0.0 110.413 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 5.2 m -124.62 165.99 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 124.015 0.926 . . . . 0.0 108.525 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 48.8 t -85.39 143.09 28.83 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 121.033 -1.042 . . . . 0.0 108.331 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -86.91 7.18 81.28 Favored Glycine 0 CA--C 1.52 0.395 0 CA-C-O 116.831 -2.094 . . . . 0.0 116.829 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 54.29 60.85 7.89 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 120.249 2.024 . . . . 0.0 111.593 -178.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.3 t -157.47 160.06 37.91 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.788 0.835 . . . . 0.0 109.76 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -70.31 -57.21 5.12 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 124.831 1.253 . . . . 0.0 114.259 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 91.9 p -149.84 167.88 25.33 Favored 'General case' 0 C--O 1.233 0.229 0 O-C-N 121.227 -0.921 . . . . 0.0 111.45 -178.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 152.55 168.61 16.87 Favored Glycine 0 CA--C 1.522 0.508 0 CA-C-O 119.161 -0.799 . . . . 0.0 111.352 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -70.91 -90.67 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 123.186 2.591 . . . . 0.0 109.047 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.5 p -171.42 150.39 2.86 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 121.021 -1.049 . . . . 0.0 110.078 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.9 p -151.85 159.1 43.97 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.862 1.265 . . . . 0.0 109.325 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.429 ' HA ' ' HA ' ' A' ' 233' ' ' VAL . 4.3 mt -102.31 152.56 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 126.416 1.886 . . . . 0.0 107.996 178.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -97.6 -50.95 4.29 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.467 1.107 . . . . 0.0 111.447 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 58.2 p-90 -160.02 155.24 25.02 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.336 1.454 . . . . 0.0 107.84 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 52.9 t -151.46 118.75 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 125.672 1.589 . . . . 0.0 106.769 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.98 167.49 26.54 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 118.51 0.596 . . . . 0.0 111.459 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -73.81 134.69 43.41 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 1.4 t -112.34 -37.36 5.01 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.172 0.989 . . . . 0.0 110.732 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 16.4 mttm -131.61 -175.19 3.63 Favored 'General case' 0 CA--C 1.506 -0.749 0 C-N-CA 124.054 0.942 . . . . 0.0 109.689 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 71.0 mt -53.16 -48.51 54.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.923 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -126.84 22.56 6.78 Favored 'General case' 0 C--O 1.226 -0.135 0 C-N-CA 124.66 1.184 . . . . 0.0 110.777 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 12.3 t -123.38 144.33 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.518 0 C-N-CA 120.328 -0.549 . . . . 0.0 109.57 -178.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -125.15 158.93 32.7 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.496 1.519 . . . . 0.0 107.379 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -127.72 137.47 52.48 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -142.34 125.64 16.54 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.88 1.672 . . . . 0.0 110.686 -177.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -118.97 116.96 27.55 Favored 'General case' 0 C--O 1.237 0.436 0 O-C-N 121.721 -0.612 . . . . 0.0 110.659 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 218' ' ' ILE . 3.6 m -101.5 154.3 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.1 p -124.01 125.57 44.79 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 1.2 pt -136.5 141.03 34.12 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -67.68 -43.34 5.57 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.831 2.354 . . . . 0.0 112.386 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -56.69 -18.23 11.64 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -178.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 3.9 tp -70.18 -22.16 62.98 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 120.06 -1.65 . . . . 0.0 112.171 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 15.9 m -70.48 -9.31 56.23 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.623 1.169 . . . . 0.0 112.259 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -57.29 -35.86 70.34 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.203 1.001 . . . . 0.0 108.535 178.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -92.55 124.33 36.5 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -46.89 -47.92 21.3 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 128.416 2.686 . . . . 0.0 111.815 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.432 ' HB3' ' CD2' ' A' ' 181' ' ' TYR . 25.3 mt -62.09 -44.46 96.61 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.752 -178.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 8.2 mp -78.66 -8.33 58.56 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -70.02 141.39 52.91 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.688 1.595 . . . . 0.0 110.722 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 10.3 mmmm -85.89 174.35 9.34 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.126 0.971 . . . . 0.0 109.409 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -102.98 -16.67 15.75 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.534 0.734 . . . . 0.0 111.754 179.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -123.15 50.15 1.59 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.403 1.481 . . . . 0.0 107.963 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 . . . . . 0 C--O 1.248 1.016 0 CA-C-N 114.219 -1.355 . . . . 0.0 108.78 178.679 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.672 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.78 179.1 6.87 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.202 1.001 . . . . 0.0 109.461 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.7 m -137.9 80.98 1.83 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 178.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.58 71.67 1.47 Allowed 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 17.1 m -54.9 -27.5 43.45 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.872 0.869 . . . . 0.0 112.979 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -70.93 -40.89 71.83 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.948 0.795 . . . . 0.0 110.412 179.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 43.9 tptt -65.67 -54.67 24.27 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.19 -34.29 70.21 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 118.661 -0.685 . . . . 0.0 111.552 179.3 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.42 -51.22 69.63 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.651 -1.241 . . . . 0.0 107.651 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 53.7 tp -61.35 -38.25 86.27 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 117.728 -1.13 . . . . 0.0 110.383 179.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.6 mt -60.94 -54.37 45.87 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 119.627 1.103 . . . . 0.0 109.365 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 26.4 m -58.86 -49.01 79.34 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.241 1.416 . . . . 0.0 110.303 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.4 ttmm -58.7 -49.85 76.07 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 52.9 m -52.61 -45.34 66.52 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 123.964 0.905 . . . . 0.0 110.127 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -57.32 -49.8 74.96 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.711 0.687 . . . . 0.0 109.482 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.17 -61.38 2.17 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.904 0.881 . . . . 0.0 112.5 -178.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -58.25 -39.03 78.11 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 125.153 1.381 . . . . 0.0 111.739 -178.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -65.32 -52.72 37.79 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-O 117.985 -1.453 . . . . 0.0 109.935 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.536 ' HA ' HD12 ' A' ' 109' ' ' ILE . 52.2 t -58.77 -42.89 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 119.689 1.745 . . . . 0.0 110.691 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.9 ptmm? -62.06 -35.9 80.02 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.968 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.4 m -72.89 -40.13 65.81 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.317 1.047 . . . . 0.0 109.67 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.536 HD12 ' HA ' ' A' ' 106' ' ' VAL . 20.4 mt -58.48 -54.71 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -57.18 -37.73 72.58 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 118.011 -0.995 . . . . 0.0 111.432 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -63.69 -37.41 87.26 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.102 0.865 . . . . 0.0 111.399 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.43 -32.56 62.68 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.768 -0.582 . . . . 0.0 111.636 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.0 mt -83.73 -25.11 30.85 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 117.884 0.311 . . . . 0.0 111.362 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -47.82 -35.45 10.18 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.185 1.394 . . . . 0.0 111.552 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -60.62 -67.04 0.44 Allowed 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 125.329 1.452 . . . . 0.0 111.928 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 77.5 mmt-85 -150.05 171.73 16.39 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.815 1.189 . . . . 0.0 111.936 -178.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 62.1 m -86.71 152.62 22.38 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 178.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 28.7 pt -106.41 161.32 5.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 125.779 1.632 . . . . 0.0 109.74 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -151.73 134.57 15.64 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.635 1.574 . . . . 0.0 108.694 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.406 ' CB ' ' HB ' ' A' ' 218' ' ' ILE . 12.2 t80 -138.61 127.6 23.91 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.114 0.966 . . . . 0.0 111.139 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -81.99 106.78 14.18 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.533 1.133 . . . . 0.0 108.83 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -100.54 79.99 2.16 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 178.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.66 -125.59 20.24 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -67.05 -34.59 78.03 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.308 0.643 . . . . 0.0 112.046 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -99.96 163.88 12.25 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 119.132 0.878 . . . . 0.0 111.637 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.1 mp -128.98 140.92 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 104.886 -2.264 . . . . 0.0 104.886 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.416 ' CG ' HG11 ' A' ' 221' ' ' VAL . 10.5 m-85 -114.82 120.07 38.76 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 125.841 1.656 . . . . 0.0 107.961 -177.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -113.46 122.66 47.99 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -122.25 135.13 54.7 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 123.855 0.862 . . . . 0.0 110.7 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.506 ' HB3' HD13 ' A' ' 133' ' ' ILE . 16.4 m -109.09 158.25 34.84 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 126.675 1.99 . . . . 0.0 112.59 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -63.9 74.46 0.17 Allowed 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 124.738 3.625 . . . . 0.0 114.457 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 72.78 50.68 13.18 Favored Glycine 0 CA--C 1.532 1.126 0 O-C-N 120.093 -1.63 . . . . 0.0 114.085 179.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.506 HD13 ' HB3' ' A' ' 130' ' ' CYS . 3.6 mp -124.31 -65.98 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 125.352 1.461 . . . . 0.0 108.091 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -166.64 168.48 14.44 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 127.416 2.286 . . . . 0.0 110.837 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -134.57 121.72 21.35 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 19.5 m -143.03 163.79 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 125.008 1.323 . . . . 0.0 111.821 -178.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -126.19 128.07 46.67 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.608 1.163 . . . . 0.0 110.124 178.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -138.09 162.92 32.93 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.555 1.942 . . . . 0.0 110.929 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.459 ' H ' HD13 ' A' ' 156' ' ' LEU . 13.1 t60 -91.69 160.76 15.2 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 120.867 -1.146 . . . . 0.0 109.357 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 135.52 -160.62 24.54 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.842 1.21 . . . . 0.0 111.045 -179.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.449 ' H ' HG22 ' A' ' 150' ' ' VAL . 0.4 OUTLIER -142.47 167.72 21.43 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.004 1.322 . . . . 0.0 110.183 179.462 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.9 p -128.75 146.29 34.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 CA-C-N 119.645 1.111 . . . . 0.0 111.198 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -95.12 106.39 18.4 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 25.7 p -60.06 -25.48 65.4 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.437 1.017 . . . . 0.0 113.299 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -55.75 -49.3 73.47 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.615 0.766 . . . . 0.0 112.077 -179.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 24.9 p -102.68 -36.17 8.41 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.798 1.239 . . . . 0.0 112.443 -178.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 92.12 35.96 6.5 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -179.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -124.14 148.34 47.27 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 118.266 1.033 . . . . 0.0 110.337 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 14.3 mm -69.95 156.14 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 179.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.449 HG22 ' H ' ' A' ' 141' ' ' ARG . 6.3 m -56.71 -29.32 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 124.705 1.202 . . . . 0.0 112.077 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -169.48 176.42 5.06 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 126.826 2.05 . . . . 0.0 107.168 179.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -109.34 101.07 10.09 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 104.975 -2.231 . . . . 0.0 104.975 178.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.39 88.34 1.19 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -73.14 -23.57 60.48 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.187 -0.946 . . . . 0.0 110.516 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 3.8 m -71.85 3.74 3.95 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.141 1.776 . . . . 0.0 113.237 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.459 HD13 ' H ' ' A' ' 139' ' ' HIS . 43.1 mt -125.23 123.48 39.64 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.6 126.81 61.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 124.681 1.192 . . . . 0.0 108.028 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -151.53 162.6 40.68 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 126.798 2.039 . . . . 0.0 107.863 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -148.93 140.28 23.26 Favored 'General case' 0 CA--C 1.507 -0.697 0 O-C-N 120.819 -1.176 . . . . 0.0 109.474 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 41.0 mt -118.07 -24.37 7.05 Favored 'General case' 0 C--O 1.219 -0.51 0 O-C-N 125.391 1.682 . . . . 0.0 109.378 179.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 163.38 164.12 17.72 Favored Glycine 0 C--N 1.34 0.757 0 O-C-N 121.056 -1.028 . . . . 0.0 111.1 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.414 ' N ' HG22 ' A' ' 187' ' ' ILE . 49.0 mtpt -127.89 109.58 20.25 Favored Pre-proline 0 CA--C 1.533 0.31 0 C-N-CA 124.374 1.07 . . . . 0.0 110.519 178.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -72.09 172.58 14.44 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 123.945 3.097 . . . . 0.0 111.127 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -111.43 152.32 27.52 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.705 0.802 . . . . 0.0 111.083 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -68.01 -44.25 76.97 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.807 1.243 . . . . 0.0 111.986 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -78.15 65.36 3.51 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.482 1.113 . . . . 0.0 111.456 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.8 p -47.23 -33.91 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 124.532 1.133 . . . . 0.0 111.86 178.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -67.45 -36.19 80.69 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.951 1.3 . . . . 0.0 112.726 -178.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -86.28 -1.39 57.45 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 125.503 1.521 . . . . 0.0 110.917 -178.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 18.3 ttt-85 -93.24 146.94 23.32 Favored 'General case' 0 N--CA 1.441 -0.876 0 O-C-N 120.399 -1.438 . . . . 0.0 110.634 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -102.69 147.85 26.32 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.597 0.759 . . . . 0.0 110.656 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -138.04 175.48 9.54 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.873 2.069 . . . . 0.0 109.371 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -137.6 133.68 34.68 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.513 0.725 . . . . 0.0 112.52 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 35.1 tp -92.07 106.36 18.4 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.633 1.173 . . . . 0.0 109.377 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.492 HD23 ' HB2' ' A' ' 184' ' ' SER . 2.8 mm? -113.38 -179.25 3.59 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 125.775 1.63 . . . . 0.0 109.412 179.362 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -136.42 162.74 32.2 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.098 0.959 . . . . 0.0 110.092 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -138.89 178.81 6.88 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 127.666 2.386 . . . . 0.0 107.711 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -63.46 -14.31 49.4 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 121.706 -0.621 . . . . 0.0 111.659 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 5.0 t -97.5 -47.72 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 125.279 1.432 . . . . 0.0 112.101 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 172.6 -162.29 33.98 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.281 -1.127 . . . . 0.0 110.281 -178.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -84.32 163.33 19.67 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 117.993 0.897 . . . . 0.0 110.359 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -156.88 165.14 37.04 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.29 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 62.7 mt -105.26 120.2 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.492 ' HB2' HD23 ' A' ' 175' ' ' LEU . 39.8 t -89.93 136.31 33.12 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 124.707 1.203 . . . . 0.0 107.931 178.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -131.44 113.16 13.37 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 125.129 1.372 . . . . 0.0 107.652 178.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.48 107.03 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.414 HG22 ' N ' ' A' ' 162' ' ' LYS . 7.2 mt -94.01 105.81 17.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 178.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -111.57 -152.34 12.17 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 126.676 2.084 . . . . 0.0 109.715 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 76.73 40.54 0.2 Allowed 'General case' 0 C--O 1.237 0.416 0 C-N-CA 127.166 2.186 . . . . 0.0 108.305 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -108.7 173.25 17.43 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-O 121.978 0.766 . . . . 0.0 112.793 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' ASP . . . . . 0.504 ' H ' ' NE ' ' A' ' 200' ' ' ARG . 30.6 m-20 -80.97 141.28 34.61 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 179.33 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 43.5 mm -69.2 136.53 26.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 124.951 1.3 . . . . 0.0 112.046 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -87.52 110.33 20.26 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 128.335 2.654 . . . . 0.0 107.744 178.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -55.94 -18.49 9.25 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 127.691 2.396 . . . . 0.0 114.101 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 25.3 t -60.48 -46.28 95.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 124.985 1.314 . . . . 0.0 110.575 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 5.7 t -123.1 -37.52 2.7 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.514 1.126 . . . . 0.0 113.133 -178.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 104.12 35.89 3.29 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 108.079 -2.008 . . . . 0.0 108.079 -178.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -122.18 163.45 19.53 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.71 1.255 . . . . 0.0 110.813 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -77.2 151.71 35.1 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -178.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.504 ' NE ' ' H ' ' A' ' 191' ' ' ASP . 27.0 ptt85 -76.61 28.71 0.13 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 129.352 3.061 . . . . 0.0 111.852 177.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 6.6 ptm -72.77 175.52 6.4 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.956 0.903 . . . . 0.0 112.286 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.2 p -142.34 146.86 21.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 124.977 1.311 . . . . 0.0 109.978 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -105.18 104.04 13.69 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.831 1.652 . . . . 0.0 107.678 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 24.4 mm -91.26 152.01 3.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 O-C-N 120.896 -1.127 . . . . 0.0 109.432 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -127.36 104.83 8.13 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.342 1.857 . . . . 0.0 110.586 178.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' TYR . . . . . 0.446 ' CD1' HD13 ' A' ' 109' ' ' ILE . 42.9 m-85 -84.48 108.59 17.35 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 177.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 11.6 m -125.01 166.88 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 48.0 t -91.77 138.35 31.63 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 178.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -87.4 3.26 86.6 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-O 118.56 -1.133 . . . . 0.0 112.601 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 60.48 63.42 5.02 Favored Glycine 0 C--N 1.338 0.686 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 5.8 p -143.3 151.58 40.68 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 55.0 p30 -81.06 -19.27 44.13 Favored 'General case' 0 CA--C 1.522 -0.115 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -179.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 54.1 p -163.72 170.99 16.22 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 119.255 0.934 . . . . 0.0 110.697 -178.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 132.95 176.76 14.55 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 124.217 0.913 . . . . 0.0 113.708 178.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -80.02 -114.89 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 124.075 3.183 . . . . 0.0 109.401 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.1 146.38 26.89 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.864 1.666 . . . . 0.0 108.782 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 80.4 p -147.18 162.3 39.16 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 118.784 0.72 . . . . 0.0 110.357 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.433 ' CG1' HG12 ' A' ' 233' ' ' VAL . 3.4 mt -107.28 139.63 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 105.013 -2.218 . . . . 0.0 105.013 177.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -88.48 -47.71 8.13 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.417 1.087 . . . . 0.0 111.45 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 68.6 p-90 -159.25 154.21 24.93 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 126.047 1.739 . . . . 0.0 108.66 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.483 HG23 ' HB2' ' A' ' 231' ' ' ALA . 6.1 p -155.78 128.82 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -156.3 162.54 40.09 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 122.895 0.478 . . . . 0.0 111.119 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -68.76 133.42 48.33 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 178.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' THR . . . . . 0.4 HG23 ' HG3' ' A' ' 225' ' ' LYS . 12.0 t -109.48 -31.11 7.63 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 123.909 0.884 . . . . 0.0 111.882 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.4 ' HG3' HG23 ' A' ' 224' ' ' THR . 7.1 mttm -138.65 -175.85 4.27 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.043 1.337 . . . . 0.0 108.024 178.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 76.3 mt -45.1 -49.39 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 1.8 t -132.96 18.96 4.12 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.169 0.988 . . . . 0.0 111.168 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 18.5 t -113.79 141.69 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -123.96 163.62 20.97 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.805 1.242 . . . . 0.0 107.725 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -142.76 133.55 25.4 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.483 ' HB2' HG23 ' A' ' 221' ' ' VAL . . . -134.89 145.26 48.07 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 125.669 1.588 . . . . 0.0 107.986 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -124.29 123.29 39.9 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' VAL . . . . . 0.433 HG12 ' CG1' ' A' ' 218' ' ' ILE . 6.3 m -113.92 154.81 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -179.125 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 2.1 p -125.37 126.3 44.8 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 123.76 0.824 . . . . 0.0 112.079 -178.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -131.38 145.94 59.81 Favored Pre-proline 0 C--O 1.234 0.254 0 O-C-N 124.357 1.035 . . . . 0.0 108.258 176.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -66.52 -47.85 2.71 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.786 2.324 . . . . 0.0 109.255 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -53.31 -23.61 9.64 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 -178.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 7.4 tp -66.39 -30.27 70.61 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 121.11 -0.994 . . . . 0.0 111.147 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 2.8 m -60.25 -13.08 10.72 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.058 0.943 . . . . 0.0 112.706 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.33 -25.79 67.76 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 118.901 0.773 . . . . 0.0 111.389 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' A' ' 241' ' ' LEU . 4.1 mm? -88.94 126.42 35.39 Favored 'General case' 0 C--O 1.225 -0.229 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -47.4 -44.65 24.59 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.631 1.972 . . . . 0.0 113.064 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 48.1 mt -72.93 -21.72 60.84 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 120.681 -1.262 . . . . 0.0 113.864 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 13.2 mt -100.46 -13.14 18.82 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.538 1.535 . . . . 0.0 112.654 -178.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -61.25 136.29 58.01 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 129.263 3.025 . . . . 0.0 110.742 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -112.9 -176.0 2.8 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.703 1.601 . . . . 0.0 110.079 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -69.53 -8.99 52.0 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.033 1.333 . . . . 0.0 111.31 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -122.7 31.36 6.11 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 127.382 2.273 . . . . 0.0 109.959 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.247 0.971 0 CA-C-O 117.345 -1.312 . . . . 0.0 111.711 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.037 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -99.89 -111.99 0.18 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 104.262 -2.496 . . . . 0.0 104.262 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.9 m -58.01 -13.12 4.04 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.479 1.112 . . . . 0.0 113.515 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -59.88 -37.64 79.92 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 177.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.3 t -72.79 -37.78 67.48 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 128.73 2.812 . . . . 0.0 110.101 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -63.59 -46.12 87.28 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -55.95 -55.19 35.65 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.1 p -62.7 -37.38 86.23 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 123.307 0.643 . . . . 0.0 112.089 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.91 -38.61 79.3 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 49.9 tp -70.25 -38.24 75.1 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 117.865 -1.064 . . . . 0.0 109.519 177.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.5 mt -61.75 -55.24 32.33 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.94 1.245 . . . . 0.0 109.376 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 18.3 m -60.12 -46.45 89.59 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.93 1.692 . . . . 0.0 111.211 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.9 ttpt -66.84 -41.9 86.66 Favored 'General case' 0 C--N 1.341 0.208 0 O-C-N 120.103 -1.623 . . . . 0.0 110.544 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 27.0 m -53.73 -50.49 65.83 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.795 0.838 . . . . 0.0 110.028 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -55.05 -50.38 69.26 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.133 0.573 . . . . 0.0 111.015 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.77 -58.49 7.82 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 122.487 1.136 . . . . 0.0 112.807 -178.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.0 mm100 -58.87 -40.63 84.92 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.915 1.286 . . . . 0.0 111.27 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.0 -53.03 39.86 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 109.171 -1.571 . . . . 0.0 109.171 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.472 ' HA ' HD12 ' A' ' 109' ' ' ILE . 42.3 t -55.12 -47.58 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 119.46 1.63 . . . . 0.0 110.482 179.457 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.4 pttm -62.1 -34.23 75.94 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.364 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 84.0 m -75.63 -35.96 60.33 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.472 HD12 ' HA ' ' A' ' 106' ' ' VAL . 21.0 mt -59.24 -54.3 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -58.45 -34.14 70.51 Favored 'General case' 0 C--O 1.225 -0.198 0 O-C-N 123.852 0.72 . . . . 0.0 111.447 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -56.18 -48.13 76.95 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.181 0.593 . . . . 0.0 111.496 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.483 ' HE3' ' HA ' ' A' ' 215' ' ' PRO . 27.0 mmmt -80.96 -40.8 23.86 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 121.565 -0.709 . . . . 0.0 111.255 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 13.0 mt -61.59 -31.62 71.69 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-O 118.364 -0.827 . . . . 0.0 112.25 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -51.53 -28.14 12.81 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.031 0.932 . . . . 0.0 113.337 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -59.65 -63.11 1.42 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.981 0.912 . . . . 0.0 111.72 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 7.3 mmt85 -154.65 -176.95 6.16 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.395 1.478 . . . . 0.0 110.805 -178.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 67.3 m -86.29 174.32 9.15 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 177.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 30.9 pt -129.47 161.42 38.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 126.573 1.949 . . . . 0.0 107.246 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -153.35 142.62 21.52 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -136.97 117.23 13.52 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.346 0.659 . . . . 0.0 109.892 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -85.24 98.43 10.49 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.83 80.77 7.09 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 128.634 2.774 . . . . 0.0 108.02 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 60.16 -112.09 4.17 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 108.581 -1.808 . . . . 0.0 108.581 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -80.77 -24.65 38.47 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -100.45 159.33 15.23 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 119.957 1.253 . . . . 0.0 111.031 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.0 mp -134.88 132.22 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 N-CA-C 103.904 -2.628 . . . . 0.0 103.904 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -118.59 121.3 39.87 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -109.26 121.1 44.45 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -111.25 128.3 55.89 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.196 0.522 . . . . 0.0 110.669 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.483 ' HB3' HD13 ' A' ' 133' ' ' ILE . 54.7 m -110.14 153.21 43.37 Favored Pre-proline 0 N--CA 1.439 -1.002 0 C-N-CA 126.894 2.077 . . . . 0.0 113.308 -178.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -68.96 74.34 0.95 Allowed 'Trans proline' 0 C--N 1.349 0.573 1 C-N-CA 125.356 4.037 . . . . 0.0 113.692 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.13 51.77 6.65 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-O 119.04 -0.866 . . . . 0.0 113.812 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.483 HD13 ' HB3' ' A' ' 130' ' ' CYS . 2.6 mp -124.83 -72.16 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.299 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 177.73 145.28 0.11 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.172 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -109.87 131.98 54.57 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 124.757 1.223 . . . . 0.0 109.098 -175.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.5 m -144.82 164.53 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 125.318 1.447 . . . . 0.0 111.581 -177.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -123.19 126.29 46.71 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 105.25 -2.129 . . . . 0.0 105.25 177.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -138.36 162.99 32.98 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.87 1.214 . . . . 0.0 111.235 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -84.98 157.73 20.7 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 177.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 136.76 -163.63 25.24 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.402 ' H ' HG22 ' A' ' 150' ' ' VAL . 0.6 OUTLIER -152.67 167.62 28.34 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 128.966 2.906 . . . . 0.0 107.137 178.462 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.2 p -122.32 146.56 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 123.721 0.809 . . . . 0.0 109.212 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -89.71 108.95 19.98 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 179.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 46.2 p -48.38 -33.15 8.63 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -178.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -66.31 -39.47 89.32 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -178.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 45.2 p -110.18 -21.92 12.02 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -177.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.25 35.54 70.07 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.064 1.316 . . . . 0.0 110.494 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -117.05 150.41 38.68 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 118.811 1.305 . . . . 0.0 109.288 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 12.2 mm -74.91 159.69 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 123.77 0.828 . . . . 0.0 109.166 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.402 HG22 ' H ' ' A' ' 141' ' ' ARG . 17.9 m -69.78 -37.42 73.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 125.446 1.498 . . . . 0.0 111.641 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -162.1 174.78 12.5 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 128.372 2.669 . . . . 0.0 107.298 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.37 124.57 45.85 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 101.464 -3.532 . . . . 0.0 101.464 176.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.44 89.26 7.79 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.575 0.703 . . . . 0.0 110.0 -177.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -57.72 -24.7 58.27 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.45 1.1 . . . . 0.0 110.059 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 5.5 m -80.5 -22.23 41.16 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 127.403 2.281 . . . . 0.0 113.63 -179.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 93.9 mt -98.13 89.36 4.49 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 19.6 m -95.54 105.07 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.189 -178.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -130.41 143.09 50.55 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 125.594 1.558 . . . . 0.0 106.921 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.3 116.18 12.3 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 49.0 mt -98.05 -26.81 14.48 Favored 'General case' 0 C--O 1.22 -0.448 0 O-C-N 124.413 1.07 . . . . 0.0 110.91 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 155.17 155.17 7.2 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 119.028 0.831 . . . . 0.0 111.54 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -114.74 109.97 47.17 Favored Pre-proline 0 N--CA 1.451 -0.4 0 C-N-CA 125.246 1.418 . . . . 0.0 108.766 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -74.52 -177.55 3.41 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.801 2.334 . . . . 0.0 107.319 178.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -128.95 134.67 48.29 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-N 118.819 0.736 . . . . 0.0 110.532 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -49.61 -45.98 48.71 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 125.869 1.98 . . . . 0.0 109.808 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -73.21 65.05 0.8 Allowed 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.522 1.529 . . . . 0.0 110.297 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 5.9 p -50.76 -31.23 9.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 121.035 -1.041 . . . . 0.0 112.659 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -63.42 -26.88 68.94 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -177.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -86.74 -23.09 25.62 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.67 1.588 . . . . 0.0 112.826 -179.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 30.2 mtp85 -73.34 150.71 41.65 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -103.71 144.19 31.79 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -138.93 159.26 42.57 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.96 1.304 . . . . 0.0 108.749 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -120.11 153.74 35.72 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.738 0.815 . . . . 0.0 109.994 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 35.5 tp -114.26 98.01 6.68 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.777 1.631 . . . . 0.0 106.995 179.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -107.92 -178.54 3.64 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.693 1.997 . . . . 0.0 108.547 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -141.22 158.06 44.4 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.024 0.53 . . . . 0.0 110.853 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -132.09 -178.7 5.02 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.681 1.992 . . . . 0.0 108.435 179.416 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.14 -14.42 17.05 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.186 1.394 . . . . 0.0 113.136 -178.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 16.0 t -107.24 -41.87 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 124.37 1.068 . . . . 0.0 111.279 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 177.34 -172.34 45.15 Favored Glycine 0 C--N 1.336 0.537 0 O-C-N 121.104 -0.998 . . . . 0.0 114.573 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 5.0 m-30 -77.28 158.36 30.26 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 122.337 1.065 . . . . 0.0 108.514 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -157.04 160.5 39.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.2 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 92.5 mt -100.19 132.11 46.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 22.7 t -102.06 126.15 48.92 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 125.406 1.482 . . . . 0.0 111.971 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -123.17 111.6 16.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.725 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -93.26 119.04 40.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 177.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 9.1 mt -104.7 106.55 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 178.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.63 -153.1 24.54 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 124.771 1.177 . . . . 0.0 110.57 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 71.3 47.87 0.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.716 2.006 . . . . 0.0 107.946 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -115.04 162.91 12.27 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 108.886 -1.685 . . . . 0.0 108.886 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.05 159.11 30.11 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.0 mm -79.6 137.84 20.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 124.674 1.19 . . . . 0.0 110.604 178.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.3 m -90.09 108.65 19.86 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 128.047 2.539 . . . . 0.0 106.635 178.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -53.93 -25.88 22.62 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.051 1.34 . . . . 0.0 113.486 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 40.0 t -49.6 -47.26 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 125.254 1.422 . . . . 0.0 112.024 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 11.2 t -124.3 -38.99 2.37 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.278 1.031 . . . . 0.0 111.653 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 110.5 34.96 2.16 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 107.923 -2.071 . . . . 0.0 107.923 -177.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -106.28 154.8 20.23 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 120.175 1.988 . . . . 0.0 111.403 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -76.25 148.41 37.63 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 123.523 0.729 . . . . 0.0 111.723 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 38.6 mtt180 -69.91 27.23 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 130.564 3.546 . . . . 0.0 112.442 178.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 6.4 ptm -74.38 175.29 7.82 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.473 1.033 . . . . 0.0 110.683 -178.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.13 149.84 18.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 124.972 1.309 . . . . 0.0 107.484 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -109.19 112.79 25.15 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.355 1.462 . . . . 0.0 107.345 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 13.3 mm -105.99 139.49 27.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 39.1 mm-40 -124.73 126.71 46.11 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.479 1.112 . . . . 0.0 109.88 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -100.41 111.2 23.44 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.301 1.04 . . . . 0.0 110.512 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 3.5 m -124.21 163.43 24.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 123.742 0.817 . . . . 0.0 109.769 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 52.7 t -88.87 134.21 34.02 Favored 'General case' 0 N--CA 1.461 0.09 0 O-C-N 120.633 -1.292 . . . . 0.0 110.204 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -84.59 10.37 62.19 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 124.34 0.971 . . . . 0.0 114.032 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 63.03 -143.05 48.3 Favored Glycine 0 CA--C 1.533 1.17 0 N-CA-C 106.965 -2.454 . . . . 0.0 106.965 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 40.7 m -69.72 78.75 0.44 Allowed 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -140.93 64.9 1.41 Allowed 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 177.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 2.9 m -58.68 138.43 57.02 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 149.59 -167.08 29.76 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.238 0.923 . . . . 0.0 112.074 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.483 ' HA ' ' HE3' ' A' ' 112' ' ' LYS . 55.4 Cg_endo -67.22 -82.64 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 124.234 3.289 . . . . 0.0 111.102 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 4.2 p -174.85 151.83 1.46 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.212 1.405 . . . . 0.0 110.66 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.4 p -151.09 158.58 44.22 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.865 1.266 . . . . 0.0 109.222 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 4.3 mt -98.1 151.93 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 125.65 1.58 . . . . 0.0 110.084 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -97.07 -50.34 4.64 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 124.691 1.197 . . . . 0.0 112.031 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 63.9 p-90 -159.69 156.09 27.17 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -178.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 61.7 t -153.76 129.16 1.59 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 125.792 1.637 . . . . 0.0 107.198 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -160.62 163.68 32.42 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.198 0.599 . . . . 0.0 111.189 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -69.39 144.21 53.45 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' THR . . . . . 0.409 HG23 ' HG3' ' A' ' 225' ' ' LYS . 9.0 t -119.18 -35.8 3.53 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 121.084 -1.01 . . . . 0.0 110.521 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.409 ' HG3' HG23 ' A' ' 224' ' ' THR . 21.0 mttm -127.65 -175.11 3.37 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 83.3 mt -55.7 -44.63 77.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.731 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 1.1 t -125.16 10.16 8.08 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.579 0.752 . . . . 0.0 112.492 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 10.6 t -114.74 143.77 23.76 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.793 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -177.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -122.39 162.22 22.01 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -132.54 143.53 49.79 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -145.89 146.27 31.03 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.638 1.575 . . . . 0.0 108.842 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -135.44 130.25 34.49 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 8.8 m -114.43 155.6 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.627 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 178.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.04 125.27 44.25 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 1.5 pt -134.72 146.22 58.06 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -75.22 -35.98 2.68 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.413 2.076 . . . . 0.0 112.566 -178.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -62.89 -17.58 61.84 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 -177.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 18.4 mt -73.18 -29.31 62.75 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.88 1.218 . . . . 0.0 110.264 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 10.1 m -57.1 -15.86 6.32 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.11 0.964 . . . . 0.0 112.903 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -62.01 -31.05 71.39 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.139 0.975 . . . . 0.0 109.173 177.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -86.34 124.28 32.52 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 106.052 -1.832 . . . . 0.0 106.052 178.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -47.23 -48.67 24.19 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 127.003 2.121 . . . . 0.0 113.608 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 32.9 mt -67.01 -26.18 66.67 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 12.8 mt -99.31 2.64 45.63 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.095 1.758 . . . . 0.0 111.582 -178.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -77.67 114.56 16.63 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.614 1.566 . . . . 0.0 111.733 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -69.2 173.44 5.64 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.018 0.927 . . . . 0.0 109.529 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' ASN . . . . . 0.42 ' C ' ' H ' ' A' ' 249' ' ' ASP . 36.9 t30 63.11 -13.01 0.08 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 127.793 2.437 . . . . 0.0 115.635 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -72.58 22.4 0.06 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 126.727 2.011 . . . . 0.0 111.729 178.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' ASP . . . . . 0.42 ' H ' ' C ' ' A' ' 247' ' ' ASN . 16.9 t70 . . . . . 0 C--O 1.244 0.776 0 C-N-CA 128.623 2.769 . . . . 0.0 109.552 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.428 ' HA ' HD12 ' A' ' 98' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.463 0.191 0 CA-C-O 118.817 -0.611 . . . . 0.0 112.078 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.71 -50.26 74.56 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 61.1 tp -69.54 -34.61 74.48 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 118.33 -0.843 . . . . 0.0 110.748 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 95' ' ' THR . 17.3 mt -61.38 -54.38 44.39 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.8 m -57.52 -50.52 72.79 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.157 0.983 . . . . 0.0 110.368 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.7 -50.29 72.61 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 118.651 -0.69 . . . . 0.0 111.038 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 21.9 m -52.2 -45.21 65.13 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 124.282 1.033 . . . . 0.0 110.309 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -60.56 -51.38 69.67 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.356 0.98 . . . . 0.0 108.767 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -59.03 -60.25 4.17 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.44 -30.92 67.89 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.199 -176.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.76 -52.29 51.64 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.506 ' HA ' HD12 ' A' ' 109' ' ' ILE . 42.1 t -56.75 -48.62 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 118.361 1.08 . . . . 0.0 109.794 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.43 -30.92 70.87 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 119.037 -1.065 . . . . 0.0 113.487 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 44.4 m -78.19 -34.2 49.62 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.506 HD12 ' HA ' ' A' ' 106' ' ' VAL . 21.7 mt -60.02 -54.74 30.63 Favored 'Isoleucine or valine' 0 C--O 1.23 0.072 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -58.11 -29.85 65.82 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.781 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -69.75 -39.81 76.5 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.294 0.952 . . . . 0.0 112.189 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.2 tptt -84.77 -34.2 22.85 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 120.744 -1.223 . . . . 0.0 110.426 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 15.9 mt -65.95 -30.28 70.82 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 118.497 -0.763 . . . . 0.0 109.802 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -48.36 -35.05 11.75 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.466 1.107 . . . . 0.0 112.209 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -49.0 -66.07 0.46 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.51 1.524 . . . . 0.0 113.328 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -158.0 -177.85 6.87 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 128.178 2.591 . . . . 0.0 108.777 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 58.5 m -86.67 167.21 14.71 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 42.3 pt -115.69 156.99 16.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -154.18 141.76 19.85 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 122.555 0.342 . . . . 0.0 111.225 -178.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -140.44 125.75 18.78 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.649 0.78 . . . . 0.0 111.205 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -84.27 105.76 15.37 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.64 80.23 4.79 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.27 -103.24 0.98 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -93.2 -23.08 18.67 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.457 1.103 . . . . 0.0 113.742 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -100.58 156.9 17.04 Favored 'General case' 0 CA--C 1.517 -0.326 0 O-C-N 121.606 -0.684 . . . . 0.0 110.111 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.8 mp -127.89 135.33 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.43 ' CD1' HG11 ' A' ' 221' ' ' VAL . 63.1 m-85 -115.5 124.87 52.17 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -120.9 120.07 34.45 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 123.291 0.636 . . . . 0.0 110.301 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -110.9 131.2 55.25 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.657 0.741 . . . . 0.0 109.922 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.45 ' HB3' HD13 ' A' ' 133' ' ' ILE . 36.1 m -110.08 157.24 38.43 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 124.398 1.079 . . . . 0.0 112.697 -178.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -63.6 76.68 0.14 Allowed 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 125.042 3.828 . . . . 0.0 113.612 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 66.18 60.66 6.15 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 125.01 1.291 . . . . 0.0 112.228 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.45 HD13 ' HB3' ' A' ' 130' ' ' CYS . 3.2 mp -130.57 -71.46 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -164.88 164.71 20.82 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 126.455 1.902 . . . . 0.0 110.278 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -131.18 119.35 21.75 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 22.5 m -143.92 164.89 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 123.899 0.88 . . . . 0.0 110.761 -178.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -120.59 129.48 53.77 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.632 1.173 . . . . 0.0 109.014 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -138.93 162.87 33.81 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.19 1.396 . . . . 0.0 112.089 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -89.09 160.91 16.81 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 176.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.486 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -179.767 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -147.03 129.21 15.62 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 54.3 mt -112.94 -21.98 10.85 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.828 0.74 . . . . 0.0 109.753 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 155.98 157.8 8.48 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -126.46 117.73 23.07 Favored Pre-proline 0 CA--C 1.536 0.41 0 O-C-N 122.044 -0.68 . . . . 0.0 111.003 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -77.01 -171.17 1.07 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 1 C-N-CA 126.316 4.677 . . . . 0.0 108.845 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -129.5 152.86 48.57 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.312 1.045 . . . . 0.0 109.04 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -73.76 -29.71 62.37 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.26 1.024 . . . . 0.0 110.578 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -88.28 64.66 7.71 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 124.708 1.203 . . . . 0.0 108.361 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.6 p -50.07 -31.59 7.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 124.92 1.288 . . . . 0.0 112.093 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -61.5 -32.89 72.94 Favored 'General case' 0 CA--C 1.522 -0.116 0 C-N-CA 123.931 0.892 . . . . 0.0 111.986 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -80.64 -28.28 36.98 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.338 1.055 . . . . 0.0 110.82 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 9.4 mtp-105 -72.92 137.3 45.48 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -99.12 144.75 27.9 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -128.7 173.89 9.91 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 126.326 1.85 . . . . 0.0 108.639 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -131.71 154.09 49.36 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.375 0.67 . . . . 0.0 109.389 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 23.1 tp -118.27 100.65 7.64 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.344 1.058 . . . . 0.0 109.061 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -109.24 -179.89 3.97 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 181' ' ' TYR . 4.0 p90 -149.95 163.51 37.9 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 121.142 -0.974 . . . . 0.0 108.978 177.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -140.58 -178.14 5.38 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -59.33 -22.52 61.39 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.694 1.198 . . . . 0.0 111.729 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.449 HG12 ' HE3' ' A' ' 246' ' ' LYS . 48.3 t -88.85 -35.86 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 125.762 1.625 . . . . 0.0 111.965 -178.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 160.19 178.95 34.64 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 121.743 -0.265 . . . . 0.0 112.789 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 176' ' ' TYR . 20.1 m-85 -78.01 155.71 30.56 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 123.893 0.877 . . . . 0.0 108.98 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -155.72 156.72 35.37 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.31 0.644 . . . . 0.0 111.395 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 92.7 mt -97.15 133.82 37.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 12.3 t -101.32 127.14 48.07 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.495 1.518 . . . . 0.0 108.294 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -122.54 107.28 11.82 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.604 1.562 . . . . 0.0 107.807 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -93.3 115.47 32.19 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.5 mt -99.64 106.59 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 104.778 -2.305 . . . . 0.0 104.778 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -99.72 -152.86 27.24 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 108.771 -1.731 . . . . 0.0 108.771 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 69.66 47.7 0.63 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-O 123.049 1.404 . . . . 0.0 107.875 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -116.79 158.24 14.59 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 107.803 -2.119 . . . . 0.0 107.803 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -74.42 159.15 32.69 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.168 0.987 . . . . 0.0 108.704 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 34.1 mm -83.03 126.38 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 177.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.2 m -75.37 111.75 10.97 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 127.065 2.146 . . . . 0.0 107.072 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -56.23 -27.45 54.93 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.626 1.17 . . . . 0.0 112.49 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 57.9 t -49.3 -50.67 15.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 125.036 1.334 . . . . 0.0 110.847 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 6.5 t -125.57 -32.35 2.89 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 116.644 2.09 . . . . 0.0 116.644 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 106.9 35.86 2.68 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -178.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -116.68 152.14 34.89 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 118.261 1.03 . . . . 0.0 111.764 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -74.81 146.45 42.03 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.571 0.748 . . . . 0.0 112.908 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -72.6 29.11 0.06 Allowed 'General case' 0 C--O 1.223 -0.322 1 C-N-CA 132.055 4.142 . . . . 0.0 112.308 178.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 5.8 ptm -75.77 177.52 6.83 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 120.197 -1.565 . . . . 0.0 110.341 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 5.9 p -147.94 148.85 15.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 125.158 1.383 . . . . 0.0 108.452 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -104.73 121.97 44.71 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 177.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 17.7 mm -114.1 131.22 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -114.54 125.0 53.3 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.304 1.042 . . . . 0.0 109.068 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -97.77 112.72 24.51 Favored 'General case' 0 C--O 1.239 0.553 0 C-N-CA 123.685 0.794 . . . . 0.0 109.72 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 5.1 m -124.08 161.46 26.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 44.1 t -90.25 142.68 27.48 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -84.4 2.39 87.93 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-O 117.753 -1.581 . . . . 0.0 114.906 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.719 0 N-CA-C 106.97 -2.452 . . . . 0.0 106.97 -178.132 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo . . . . . 0 CA--C 1.545 1.065 0 N-CA-C 107.733 -1.68 . . . . 0.0 107.733 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.6 p -150.33 142.11 23.72 Favored 'General case' 0 C--O 1.237 0.405 0 O-C-N 120.047 -1.658 . . . . 0.0 111.554 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 40.7 p -147.86 160.98 42.19 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.776 1.23 . . . . 0.0 110.244 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 4.0 mt -100.08 153.71 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 126.536 1.935 . . . . 0.0 107.865 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -97.62 -48.55 5.2 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 124.492 1.117 . . . . 0.0 112.618 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 52.8 p-90 -163.96 159.46 20.83 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.43 HG11 ' CD1' ' A' ' 127' ' ' TYR . 91.0 t -152.8 129.15 1.84 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.586 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.14 167.35 29.39 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.289 0.95 . . . . 0.0 112.547 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -77.41 132.63 38.6 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.581 1.552 . . . . 0.0 107.653 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 7.5 t -110.84 -33.74 6.44 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.573 1.149 . . . . 0.0 110.918 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -132.53 -175.18 3.67 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 124.645 1.178 . . . . 0.0 108.985 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 60.9 mt -56.64 -45.05 82.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -125.58 18.33 8.1 Favored 'General case' 0 C--N 1.334 -0.108 0 C-N-CA 124.185 0.994 . . . . 0.0 111.102 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 15.8 t -121.65 143.3 34.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 CA-C-N 118.309 0.504 . . . . 0.0 110.387 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -124.47 161.32 26.32 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.152 1.381 . . . . 0.0 107.666 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -132.07 134.49 45.57 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 126.04 1.736 . . . . 0.0 106.534 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -140.22 145.3 37.22 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.919 1.688 . . . . 0.0 109.07 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -133.69 128.62 35.37 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 119.263 -0.398 . . . . 0.0 111.57 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 3.8 m -112.35 152.69 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.57 115.36 20.71 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.808 1.243 . . . . 0.0 107.775 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 18.5 pt -127.14 152.25 75.61 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.879 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.63 -45.43 0.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.819 2.346 . . . . 0.0 112.366 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -53.32 -28.51 28.77 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 116.751 2.13 . . . . 0.0 116.751 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.4 HD22 ' CD1' ' A' ' 244' ' ' LEU . 59.2 mt -64.42 -28.98 70.05 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 120.33 1.423 . . . . 0.0 110.323 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 12.3 m -60.61 -11.72 8.04 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -69.85 -31.52 69.41 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.96 121.63 25.71 Favored 'General case' 0 C--O 1.225 -0.199 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -47.13 -42.6 19.63 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.906 1.683 . . . . 0.0 113.47 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.86 -29.57 64.51 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.4 ' CD1' HD22 ' A' ' 238' ' ' LEU . 17.3 mt -96.49 -5.45 39.45 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.299 1.04 . . . . 0.0 111.832 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -64.3 116.77 6.36 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.895 1.678 . . . . 0.0 108.577 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.449 ' HE3' HG12 ' A' ' 179' ' ' VAL . 3.8 mmmm . . . . . 0 N--CA 1.451 -0.399 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 178.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.536 0.406 0 CA-C-O 118.916 -0.564 . . . . 0.0 110.955 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.56 -43.15 97.57 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 119.119 0.872 . . . . 0.0 109.395 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 65.7 tp -64.2 -32.36 73.91 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-O 118.406 -0.807 . . . . 0.0 109.61 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.04 -54.36 39.3 Favored 'General case' 0 C--N 1.345 0.377 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 25.3 m -60.79 -48.14 83.13 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.159 0.984 . . . . 0.0 110.877 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.86 -48.84 79.95 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 121.024 -1.048 . . . . 0.0 110.036 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 53.8 m -54.11 -46.09 72.03 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 123.535 0.734 . . . . 0.0 110.055 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -56.22 -48.47 76.41 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.515 0.326 . . . . 0.0 110.432 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.16 -52.96 16.26 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -58.14 -40.29 80.95 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.344 1.058 . . . . 0.0 110.983 -178.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -66.58 -52.35 35.34 Favored Glycine 0 C--O 1.223 -0.537 0 N-CA-C 108.776 -1.729 . . . . 0.0 108.776 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.415 ' HA ' HD12 ' A' ' 109' ' ' ILE . 24.5 t -53.25 -46.88 57.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 118.76 1.28 . . . . 0.0 110.988 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.6 ptmm? -62.44 -34.2 76.32 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.1 m -77.66 -36.45 51.34 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.916 0.887 . . . . 0.0 110.371 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.415 HD12 ' HA ' ' A' ' 106' ' ' VAL . 23.5 mt -60.22 -54.71 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -61.53 -28.19 69.14 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.112 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -66.29 -45.41 80.5 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 120.586 -1.321 . . . . 0.0 113.0 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -76.92 -39.43 50.84 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 18.3 mt -66.22 -28.41 68.72 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-O 118.721 -0.657 . . . . 0.0 112.147 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -56.77 -18.57 13.16 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.54 0.736 . . . . 0.0 112.607 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -68.01 -74.71 0.11 Allowed 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 7.1 mmm180 -143.06 -179.65 6.5 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.281 1.432 . . . . 0.0 111.402 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 85.3 m -86.59 174.91 8.6 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 32.7 pt -128.67 159.99 39.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 127.043 2.137 . . . . 0.0 107.299 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -155.81 135.25 12.39 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.855 1.262 . . . . 0.0 108.975 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -130.79 126.16 35.62 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.666 1.186 . . . . 0.0 109.076 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -88.88 104.15 16.67 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.26 1.024 . . . . 0.0 109.365 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.59 80.74 4.3 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 128.337 2.655 . . . . 0.0 106.552 178.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 59.97 -113.34 5.24 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -78.0 -22.54 49.18 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.192 0.997 . . . . 0.0 112.835 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -105.15 161.72 14.01 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 123.625 0.77 . . . . 0.0 111.917 -178.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.4 mp -135.61 134.75 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 104.131 -2.544 . . . . 0.0 104.131 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.405 ' CD1' ' HB3' ' A' ' 137' ' ' GLN . 94.4 m-85 -114.86 119.65 37.29 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 103.991 -2.596 . . . . 0.0 103.991 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -111.02 116.46 31.22 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.382 0.673 . . . . 0.0 109.396 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -106.66 129.23 54.6 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.52 ' HB3' HD13 ' A' ' 133' ' ' ILE . 20.8 m -114.75 155.49 46.17 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 126.665 1.986 . . . . 0.0 113.835 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.27 80.73 1.57 Allowed 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 124.115 3.21 . . . . 0.0 113.37 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.44 45.31 18.93 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-O 118.2 -1.333 . . . . 0.0 112.961 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.52 HD13 ' HB3' ' A' ' 130' ' ' CYS . 3.0 mp -120.84 -72.3 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 119.459 1.63 . . . . 0.0 109.913 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -179.2 141.91 0.18 Allowed 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -109.17 125.69 52.46 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -177.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 33.3 m -144.61 164.33 13.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 114.123 -1.399 . . . . 0.0 111.575 -177.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.405 ' HB3' ' CD1' ' A' ' 127' ' ' TYR . 6.6 pt20 -123.0 130.57 52.97 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.649 1.179 . . . . 0.0 108.286 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -138.25 162.89 33.15 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.402 1.481 . . . . 0.0 111.338 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 74.3 t60 -91.06 161.56 15.06 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.916 1.686 . . . . 0.0 107.391 178.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.72 0 CA-C-N 120.099 1.318 . . . . 0.0 110.769 -179.35 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 . . . . . 0 N--CA 1.451 -0.394 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 9.6 tpp180 -143.36 110.46 5.68 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.9 mp -98.43 -34.46 10.63 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 177.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 160.05 163.92 14.34 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 119.266 0.939 . . . . 0.0 111.537 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -118.82 109.78 39.25 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 124.264 1.026 . . . . 0.0 110.201 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -77.93 174.93 11.81 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 123.298 2.665 . . . . 0.0 111.118 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -126.35 146.23 50.13 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.25 -37.93 75.04 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 126.664 1.985 . . . . 0.0 111.428 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -73.25 65.36 0.83 Allowed 'General case' 0 C--O 1.233 0.227 0 C-N-CA 126.098 1.759 . . . . 0.0 109.967 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.4 p -48.84 -31.22 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 125.048 1.339 . . . . 0.0 112.206 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -71.18 -31.61 67.85 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 124.899 1.28 . . . . 0.0 112.862 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -76.65 -12.95 60.08 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.715 1.206 . . . . 0.0 113.167 -178.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -107.63 152.54 24.15 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.598 1.159 . . . . 0.0 110.526 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -105.02 156.61 17.89 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.267 1.427 . . . . 0.0 108.306 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -136.83 163.91 29.53 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.46 1.504 . . . . 0.0 108.738 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -114.72 153.7 29.81 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.236 0.614 . . . . 0.0 110.106 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 16.9 tp -118.39 98.79 6.44 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.432 1.493 . . . . 0.0 107.79 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -110.35 -178.99 3.65 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 126.875 2.07 . . . . 0.0 108.564 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -144.88 163.31 34.5 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 121.35 0.595 . . . . 0.0 110.057 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -137.69 -177.59 4.87 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.791 1.636 . . . . 0.0 108.046 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -60.55 -17.54 46.67 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.164 1.386 . . . . 0.0 111.56 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 87.7 t -86.0 -56.98 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 128.511 2.724 . . . . 0.0 110.484 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 168.76 -165.17 38.68 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -78.39 166.49 22.58 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 117.523 0.662 . . . . 0.0 109.683 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -159.85 171.59 19.18 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.167 0.987 . . . . 0.0 110.384 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 79.7 mt -107.42 138.11 35.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 32.9 t -107.07 134.11 50.69 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 125.393 1.477 . . . . 0.0 108.408 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -130.23 111.45 12.42 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.369 1.068 . . . . 0.0 108.214 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.6 mp -93.41 132.17 38.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 10.3 mt -122.18 115.2 45.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -110.68 -152.52 13.01 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 125.796 1.665 . . . . 0.0 111.603 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 4.6 t 71.58 35.25 1.49 Allowed 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.65 1.58 . . . . 0.0 114.434 178.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -87.58 -112.42 1.02 Allowed Glycine 0 CA--C 1.526 0.768 0 N-CA-C 108.44 -1.864 . . . . 0.0 108.44 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -154.55 150.83 28.17 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 129.825 3.25 . . . . 0.0 103.589 178.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.8 mm -72.9 137.57 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 O-C-N 120.053 -1.654 . . . . 0.0 111.999 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.6 m -81.4 116.08 21.05 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 128.489 2.716 . . . . 0.0 107.001 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -57.72 -29.16 64.51 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 124.624 1.17 . . . . 0.0 112.105 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 14.5 t -51.81 -50.67 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 126.423 1.889 . . . . 0.0 113.878 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 14.7 t -124.0 -31.97 3.31 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.15 34.74 3.86 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 -178.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -109.14 155.64 20.78 Favored 'General case' 0 C--N 1.343 0.324 0 C-N-CA 123.957 0.903 . . . . 0.0 110.182 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -75.72 144.4 41.55 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 125.197 1.399 . . . . 0.0 110.832 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . 0.269 26.1 mtp85 -69.04 29.18 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 130.053 3.341 . . . . 0.0 112.524 178.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 8.4 ptm -74.71 177.99 5.75 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.141 0.976 . . . . 0.0 112.022 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.3 p -145.78 152.72 13.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 125.504 1.522 . . . . 0.0 109.174 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -112.18 101.81 10.03 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 126.938 2.095 . . . . 0.0 106.921 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 9.1 mm -94.36 146.31 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.458 HE22 ' HG2' ' A' ' 230' ' ' GLU . 16.2 mp0 -126.32 114.43 18.24 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 127.298 2.239 . . . . 0.0 109.574 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -93.62 115.71 28.19 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 12.5 m -125.02 165.62 21.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 42.1 t -87.04 140.68 29.31 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -95.47 18.06 58.12 Favored Glycine 0 CA--C 1.523 0.532 0 CA-C-O 118.596 -1.114 . . . . 0.0 112.706 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.985 0 N-CA-C 107.771 -2.131 . . . . 0.0 107.771 -178.241 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 N--CA 1.452 -0.958 0 N-CA-C 110.488 -0.62 . . . . 0.0 110.488 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 3.8 p -173.05 152.42 2.32 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.863 1.665 . . . . 0.0 110.914 -178.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 4.7 p -150.85 166.36 30.79 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.533 1.533 . . . . 0.0 109.108 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.476 HG12 HG12 ' A' ' 233' ' ' VAL . 5.1 mt -108.68 153.73 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 126.098 1.759 . . . . 0.0 110.614 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -94.44 -56.29 2.86 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 124.46 1.104 . . . . 0.0 111.155 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 -160.73 156.05 24.76 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 126.324 1.85 . . . . 0.0 106.903 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 58.0 t -151.33 125.94 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 125.731 1.612 . . . . 0.0 108.369 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -162.54 164.18 27.01 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 118.21 0.459 . . . . 0.0 110.874 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -65.81 141.9 58.13 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . 0.486 HG23 ' HG3' ' A' ' 225' ' ' LYS . 1.8 t -123.79 -30.64 3.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 118.457 0.571 . . . . 0.0 111.897 179.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.486 ' HG3' HG23 ' A' ' 224' ' ' THR . 11.3 mttt -124.4 -175.87 3.37 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 77.0 mt -59.28 -47.36 90.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.88 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 1.8 t -118.93 15.02 13.37 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.651 0.78 . . . . 0.0 112.703 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 14.2 t -122.38 148.7 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.705 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.546 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -125.42 166.1 17.21 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . 0.458 ' HG2' HE22 ' A' ' 205' ' ' GLN . 4.3 mt-10 -133.02 144.47 50.1 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 124.667 1.187 . . . . 0.0 108.464 178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -144.96 118.95 9.35 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.19 1.396 . . . . 0.0 109.915 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -106.13 124.11 49.06 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 104.98 -2.23 . . . . 0.0 104.98 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . 0.476 HG12 HG12 ' A' ' 218' ' ' ILE . 3.0 m -119.38 153.76 21.92 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 2.1 p -122.55 138.27 54.63 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 122.236 1.017 . . . . 0.0 110.856 -178.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -143.69 148.14 41.86 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 114.609 -1.178 . . . . 0.0 108.142 178.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.28 -36.11 3.44 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 121.597 1.531 . . . . 0.0 112.208 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -59.86 -20.74 58.85 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 116.618 2.081 . . . . 0.0 116.618 -177.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 32.9 mt -71.24 -26.64 63.0 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.899 1.681 . . . . 0.0 110.52 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 27.5 m -59.57 -12.52 6.73 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.877 0.871 . . . . 0.0 111.845 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -62.39 -35.77 80.23 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.772 0.829 . . . . 0.0 110.171 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -87.87 130.9 34.75 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -47.81 -48.64 30.43 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.516 1.926 . . . . 0.0 112.779 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 66.0 mt -65.34 -25.67 67.7 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 15.4 mt -99.74 -7.54 25.42 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.746 0.818 . . . . 0.0 113.175 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -62.54 112.86 2.65 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 128.212 2.605 . . . . 0.0 112.743 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.237 0.42 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.45 ' HA ' HD12 ' A' ' 98' ' ' LEU . 1.1 p . . . . . 0 C--O 1.237 0.417 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.09 -38.97 93.3 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 22.8 tp -74.0 -40.96 62.57 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 117.519 -1.229 . . . . 0.0 109.367 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' ' 95' ' ' THR . 36.2 mt -57.87 -54.09 50.88 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.738 1.154 . . . . 0.0 110.407 -177.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 78.2 m -61.81 -38.07 86.73 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.503 -0.748 . . . . 0.0 111.215 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.39 -48.2 76.35 Favored 'General case' 0 C--N 1.341 0.201 0 O-C-N 120.091 -1.631 . . . . 0.0 109.424 178.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 77.2 m -52.82 -48.43 66.97 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.12 1.368 . . . . 0.0 109.941 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -59.38 -43.92 92.84 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.797 0.439 . . . . 0.0 111.933 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -71.98 -52.79 15.36 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -63.22 -41.22 99.09 Favored 'General case' 0 C--O 1.216 -0.698 0 C-N-CA 124.856 1.263 . . . . 0.0 109.661 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.04 -50.9 62.32 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.435 ' HA ' HD12 ' A' ' 109' ' ' ILE . 36.4 t -58.24 -45.88 88.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 118.591 1.195 . . . . 0.0 110.425 179.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 8.0 ptmt -61.92 -34.66 76.47 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.783 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 99.6 m -77.67 -28.53 51.16 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.679 0.792 . . . . 0.0 109.783 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.435 HD12 ' HA ' ' A' ' 106' ' ' VAL . 19.8 mt -69.61 -55.03 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 178.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -55.7 -36.99 67.76 Favored 'General case' 0 CA--C 1.527 0.083 0 O-C-N 123.644 0.59 . . . . 0.0 110.565 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -63.25 -38.66 92.02 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.258 1.023 . . . . 0.0 111.95 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.0 tptp -82.63 -38.78 23.04 Favored 'General case' 0 CA--C 1.518 -0.273 0 O-C-N 121.149 -0.969 . . . . 0.0 111.114 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 31.8 mt -70.26 -24.6 63.09 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 122.437 0.295 . . . . 0.0 111.305 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -50.93 -29.71 12.87 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.132 1.373 . . . . 0.0 111.096 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -64.87 -64.51 0.85 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.315 1.046 . . . . 0.0 113.176 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 86.7 mmt-85 -150.46 177.17 10.25 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.684 1.194 . . . . 0.0 110.479 -177.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 74.4 m -86.47 175.99 8.08 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 46.2 pt -129.33 157.74 42.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 124.926 1.29 . . . . 0.0 108.473 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -156.46 139.79 15.7 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.014 0.926 . . . . 0.0 110.668 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.476 ' CE1' ' HB2' ' A' ' 122' ' ' ALA . 4.9 t80 -136.84 124.14 21.9 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -81.07 98.79 8.15 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.997 1.719 . . . . 0.0 108.24 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.476 ' HB2' ' CE1' ' A' ' 120' ' ' TYR . . . -91.86 79.76 5.28 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.19 -85.37 0.06 OUTLIER Glycine 0 CA--C 1.521 0.458 0 C-N-CA 124.67 1.129 . . . . 0.0 113.183 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -106.8 -32.18 8.07 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.447 1.099 . . . . 0.0 112.895 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -104.93 128.24 53.11 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 123.679 0.791 . . . . 0.0 110.96 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.9 mp -98.24 157.1 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 103.794 -2.669 . . . . 0.0 103.794 177.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -135.34 121.95 20.77 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 103.955 -2.609 . . . . 0.0 103.955 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -119.25 117.65 29.18 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.8 1.64 . . . . 0.0 110.741 -178.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -110.67 137.7 48.0 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.415 1.486 . . . . 0.0 109.453 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.489 ' HB3' HD13 ' A' ' 133' ' ' ILE . 11.7 m -120.83 151.81 55.2 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 123.718 0.807 . . . . 0.0 111.506 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -60.53 85.35 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.662 1 C-N-CA 125.767 4.311 . . . . 0.0 115.044 -177.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 74.43 33.05 57.06 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 117.964 -1.464 . . . . 0.0 113.207 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.489 HD13 ' HB3' ' A' ' 130' ' ' CYS . 3.8 mp -115.65 -72.49 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 119.537 1.668 . . . . 0.0 109.222 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.489 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 9.1 pt-20 -168.88 169.36 9.83 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.12 1.768 . . . . 0.0 109.115 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -134.23 120.79 20.45 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 33.8 m -139.47 163.39 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.807 1.243 . . . . 0.0 110.993 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -118.82 125.07 48.73 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -138.24 162.3 34.66 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.962 0.801 . . . . 0.0 110.704 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -89.96 160.58 16.32 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 177.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.565 0 O-C-N 120.031 -1.668 . . . . 0.0 109.685 -178.341 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 . . . . . 0 CA--C 1.547 0.847 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -149.07 129.52 13.88 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.047 -1.658 . . . . 0.0 110.7 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 43.4 mt -109.02 -30.63 7.98 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 120.053 1.297 . . . . 0.0 108.525 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 165.68 164.36 20.99 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -128.66 109.63 18.87 Favored Pre-proline 0 C--O 1.236 0.356 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.489 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 69.2 Cg_endo -73.36 176.72 8.85 Favored 'Trans proline' 0 C--O 1.236 0.39 1 C-N-CA 125.458 4.105 . . . . 0.0 110.783 -179.542 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -123.13 144.39 49.37 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 124.114 0.966 . . . . 0.0 109.58 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -67.11 -43.53 82.23 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 124.953 1.408 . . . . 0.0 109.6 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -74.3 64.81 1.14 Allowed 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.285 1.434 . . . . 0.0 110.411 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.2 p -50.95 -28.83 6.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 126.855 2.062 . . . . 0.0 111.333 178.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -72.97 -30.44 63.84 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.497 1.119 . . . . 0.0 112.524 -178.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -75.98 -23.01 55.29 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -96.58 173.6 7.26 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -133.31 165.39 24.92 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -135.71 169.79 16.99 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.743 1.217 . . . . 0.0 110.245 -177.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -113.23 153.65 28.01 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 48.7 tp -123.11 99.07 6.18 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.009 1.723 . . . . 0.0 106.784 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -108.36 175.56 5.43 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -140.5 160.56 39.73 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 123.001 1.382 . . . . 0.0 109.609 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -140.79 178.23 7.49 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 126.294 1.838 . . . . 0.0 106.544 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -73.2 10.78 0.87 Allowed 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 125.479 1.512 . . . . 0.0 114.199 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 59.6 t -116.76 -37.25 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 125.879 1.672 . . . . 0.0 109.827 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 164.04 -176.04 40.09 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -86.68 163.19 17.5 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.534 ' HB3' HG12 ' A' ' 207' ' ' VAL . 43.5 p90 -156.36 161.52 40.14 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.633 0.773 . . . . 0.0 110.667 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 86.6 mt -102.08 130.74 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 12.9 t -97.38 126.9 42.91 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.485 1.114 . . . . 0.0 108.704 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -122.13 108.89 13.86 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -90.28 108.88 20.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 N-CA-C 103.68 -2.711 . . . . 0.0 103.68 178.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 12.2 mt -94.62 105.92 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 103.331 -2.841 . . . . 0.0 103.331 177.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -99.28 -152.72 27.52 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 107.765 -2.134 . . . . 0.0 107.765 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 5.2 t 70.22 51.64 0.38 Allowed 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -178.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -93.29 -162.78 36.62 Favored Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 106.375 -2.69 . . . . 0.0 106.375 177.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -127.64 136.17 51.26 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 100.585 -3.858 . . . . 0.0 100.585 177.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 33.2 mm -60.36 138.95 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 119.552 1.069 . . . . 0.0 109.924 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.06 112.01 24.25 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.829 2.052 . . . . 0.0 106.376 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -51.12 -29.02 12.14 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.183 1.793 . . . . 0.0 115.795 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 24.5 t -42.22 -51.92 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.126 1.37 . . . . 0.0 111.108 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 13.2 t -123.76 -34.07 3.08 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.532 0.733 . . . . 0.0 109.334 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 106.48 35.46 2.86 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -112.51 158.86 19.39 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-N 118.852 1.326 . . . . 0.0 110.689 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -68.12 143.53 55.39 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.649 1.58 . . . . 0.0 114.869 -178.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . 0.258 24.1 ttp180 -77.22 28.76 0.14 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 130.508 3.523 . . . . 0.0 113.524 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 8.1 ptm -73.82 176.91 5.9 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.072 -1.017 . . . . 0.0 111.365 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.46 149.27 19.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 125.801 1.64 . . . . 0.0 106.733 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -111.39 114.19 27.16 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 9.5 mm -102.26 138.99 24.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -118.15 96.93 5.54 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 126.729 2.011 . . . . 0.0 107.698 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -80.83 111.13 17.01 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.247 1.019 . . . . 0.0 108.545 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.534 HG12 ' HB3' ' A' ' 182' ' ' TYR . 33.5 m -124.53 164.98 22.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 124.653 1.181 . . . . 0.0 108.383 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . 0.439 ' O ' ' HE2' ' A' ' 246' ' ' LYS . 41.8 t -85.8 142.22 29.1 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -90.54 16.99 56.57 Favored Glycine 0 C--O 1.227 -0.294 0 CA-C-O 118.067 -1.407 . . . . 0.0 115.15 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.318 0 C-N-CA 125.812 1.673 . . . . 0.0 117.071 179.489 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo . . . . . 0 CA--C 1.545 1.072 0 N-CA-C 110.983 -0.43 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . 0.405 ' CB ' HG22 ' A' ' 235' ' ' ILE . 3.8 p -156.01 148.61 23.86 Favored 'General case' 0 C--O 1.237 0.442 0 O-C-N 120.094 -1.629 . . . . 0.0 109.853 -178.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.7 p -151.01 168.5 24.38 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.895 0.878 . . . . 0.0 112.122 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.436 HG12 HG12 ' A' ' 233' ' ' VAL . 3.2 mt -109.63 152.01 11.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 126.505 1.922 . . . . 0.0 109.465 178.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -98.42 -51.83 3.84 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 126.063 1.745 . . . . 0.0 109.592 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 65.3 p-90 -159.87 158.67 31.34 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.607 1.163 . . . . 0.0 109.306 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 97.1 t -153.42 134.9 5.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 126.153 1.781 . . . . 0.0 107.459 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -165.7 162.64 18.86 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.367 0.667 . . . . 0.0 111.662 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -68.48 140.87 55.72 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 178.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 13.1 t -120.65 -30.07 4.57 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.865 1.266 . . . . 0.0 112.681 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 43.2 mttt -131.25 -175.63 3.76 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 72.8 mt -46.68 -49.49 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 6.8 t -133.25 17.82 4.06 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.986 0.514 . . . . 0.0 111.276 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 23.1 t -109.62 143.31 19.97 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -122.68 161.95 22.89 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -131.69 144.55 51.08 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 178.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -144.77 141.33 29.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.893 1.277 . . . . 0.0 109.585 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -124.01 116.26 22.55 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . 0.436 HG12 HG12 ' A' ' 218' ' ' ILE . 1.1 m -110.36 144.54 18.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -121.83 123.6 42.16 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.666 1.586 . . . . 0.0 110.757 -178.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.405 HG22 ' CB ' ' A' ' 216' ' ' SER . 3.6 pt -131.65 147.62 66.77 Favored Pre-proline 0 C--N 1.331 -0.231 0 C-N-CA 123.892 0.877 . . . . 0.0 108.695 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -70.18 -43.04 2.51 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.766 1.644 . . . . 0.0 111.924 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -55.77 -23.85 32.17 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -177.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.613 HD22 ' CD1' ' A' ' 244' ' ' LEU . 20.1 mt -65.28 -26.71 68.2 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 116.982 -1.887 . . . . 0.0 111.07 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 18.9 m -61.7 -11.75 13.35 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.618 0.645 . . . . 0.0 112.29 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -61.08 -22.89 65.04 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.718 0.807 . . . . 0.0 109.798 177.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -98.11 130.58 44.89 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 126.594 1.958 . . . . 0.0 109.743 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -51.65 -47.76 63.62 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.844 1.258 . . . . 0.0 112.637 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.59 -35.85 80.85 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.104 -0.998 . . . . 0.0 113.438 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.613 ' CD1' HD22 ' A' ' 238' ' ' LEU . 17.9 mt -89.89 -14.94 33.17 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -178.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -58.68 112.72 1.72 Allowed 'General case' 0 C--O 1.236 0.345 0 C-N-CA 128.204 2.601 . . . . 0.0 111.731 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.439 ' HE2' ' O ' ' A' ' 208' ' ' CYS . 39.2 mmtt . . . . . 0 C--O 1.235 0.29 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.531 ' HA ' HD12 ' A' ' 98' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.465 0.323 0 CA-C-O 120.472 0.177 . . . . 0.0 110.708 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.5 -42.61 95.72 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 32.5 tp -69.85 -36.89 75.91 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.44 1.096 . . . . 0.0 110.507 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.531 HD12 ' HA ' ' A' ' 95' ' ' THR . 22.4 mt -61.41 -54.89 37.67 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 119.005 0.821 . . . . 0.0 109.083 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 56.1 m -65.38 -40.26 93.26 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 121.453 -0.779 . . . . 0.0 111.257 -179.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -45.37 93.89 Favored 'General case' 0 C--O 1.222 -0.382 0 O-C-N 121.207 -0.933 . . . . 0.0 109.169 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 42.2 m -52.28 -48.9 65.05 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.171 0.989 . . . . 0.0 109.741 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -58.3 -48.9 79.02 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.886 0.474 . . . . 0.0 110.863 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -67.82 -56.33 9.57 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -177.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.427 ' HA ' ' HE3' ' A' ' 107' ' ' LYS . 2.8 mm-40 -55.83 -44.25 77.75 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.806 1.642 . . . . 0.0 109.678 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.34 -52.99 49.29 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-O 118.001 -1.444 . . . . 0.0 110.212 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.412 ' HA ' HD12 ' A' ' 109' ' ' ILE . 43.0 t -55.85 -43.36 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-N 119.893 1.846 . . . . 0.0 110.91 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.427 ' HE3' ' HA ' ' A' ' 104' ' ' GLN . 6.6 ptpt -66.01 -33.81 76.65 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 119.38 -0.928 . . . . 0.0 111.165 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 65.5 m -72.9 -39.24 66.51 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 106' ' ' VAL . 22.7 mt -61.06 -55.76 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -61.29 -35.42 77.29 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 118.292 -0.861 . . . . 0.0 112.67 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -62.21 -33.85 75.34 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.813 0.733 . . . . 0.0 111.887 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.527 ' HA ' ' HE2' ' A' ' 112' ' ' LYS . 0.6 OUTLIER -87.62 -38.27 16.06 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 117.87 -1.062 . . . . 0.0 110.333 179.047 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 29.5 mt -65.74 -25.17 67.16 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.904 1.229 . . . . 0.0 110.338 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -51.47 -30.08 18.54 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.119 1.768 . . . . 0.0 111.558 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -65.51 -66.75 0.51 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.426 1.49 . . . . 0.0 113.083 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.6 mmt180 -144.56 173.36 11.87 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 124.456 1.102 . . . . 0.0 110.743 -178.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 78.6 m -86.07 163.34 17.97 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 48.3 pt -118.92 154.5 21.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -178.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -151.87 144.49 24.24 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.909 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -140.74 122.34 15.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.425 178.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -81.6 100.07 9.2 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.69 80.03 6.67 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 104.389 -2.449 . . . . 0.0 104.389 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 65.97 -109.02 2.65 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -81.32 -36.36 29.84 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -99.84 146.0 27.11 Favored 'General case' 0 CA--C 1.512 -0.486 0 O-C-N 121.635 -0.666 . . . . 0.0 110.388 -178.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.5 mp -110.21 153.4 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -131.9 119.3 20.98 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -121.15 120.49 35.4 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.315 1.046 . . . . 0.0 111.676 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -111.27 140.66 45.66 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.003 1.321 . . . . 0.0 111.065 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.507 ' HB3' HD13 ' A' ' 133' ' ' ILE . 50.3 m -123.12 152.77 64.06 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.497 1.119 . . . . 0.0 111.371 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -63.73 86.28 0.14 Allowed 'Trans proline' 0 C--N 1.35 0.649 1 C-N-CA 125.548 4.165 . . . . 0.0 115.7 -178.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 72.51 34.96 59.84 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 118.751 -1.027 . . . . 0.0 112.278 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.507 HD13 ' HB3' ' A' ' 130' ' ' CYS . 4.4 mp -118.59 -71.62 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.344 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -168.81 172.65 7.66 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.523 1.529 . . . . 0.0 110.314 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -137.21 119.75 15.99 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 31.8 m -139.22 163.54 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 124.528 1.131 . . . . 0.0 111.059 -178.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -121.05 124.43 44.8 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.968 1.307 . . . . 0.0 107.92 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -138.65 162.28 35.03 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.961 0.904 . . . . 0.0 111.469 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -92.08 160.91 14.99 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 176.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.479 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -179.419 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 33.1 ttt85 -148.49 102.14 3.3 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 81.6 mt -79.37 -30.8 42.71 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 119.387 0.994 . . . . 0.0 108.495 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 169.45 156.35 10.74 Favored Glycine 0 N--CA 1.439 -1.129 0 CA-C-O 121.899 0.721 . . . . 0.0 111.345 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.62 109.04 44.05 Favored Pre-proline 0 N--CA 1.444 -0.76 0 C-N-CA 124.481 1.112 . . . . 0.0 108.674 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -77.22 -168.36 0.58 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.438 2.759 . . . . 0.0 109.038 178.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -126.5 151.09 48.28 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 124.724 1.21 . . . . 0.0 108.047 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -74.81 -28.69 60.81 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.973 0.892 . . . . 0.0 109.445 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -89.32 65.24 7.15 Favored 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 126.148 1.779 . . . . 0.0 106.297 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.2 p -45.22 -32.79 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 123.911 0.884 . . . . 0.0 111.973 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -65.48 -26.34 67.89 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.996 2.119 . . . . 0.0 112.875 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.68 -25.83 49.79 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.742 0.817 . . . . 0.0 110.337 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -75.96 177.74 6.79 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.725 0.81 . . . . 0.0 109.267 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -131.52 155.74 46.91 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -139.73 160.15 40.54 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.993 0.917 . . . . 0.0 109.49 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -117.24 153.57 32.67 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 18.5 tp -119.84 98.34 6.05 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -106.05 172.53 6.76 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 181' ' ' TYR . 2.5 p90 -147.21 162.76 38.24 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.934 0.873 . . . . 0.0 109.021 178.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -139.54 178.17 7.41 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 125.682 1.593 . . . . 0.0 109.44 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -68.38 2.2 2.47 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.081 1.353 . . . . 0.0 111.928 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 90.8 t -109.66 -38.96 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 126.14 1.776 . . . . 0.0 110.177 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 166.37 -175.81 41.73 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 176' ' ' TYR . 16.6 m-85 -88.33 164.86 15.35 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 117.962 0.881 . . . . 0.0 109.327 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.468 ' HB3' HG12 ' A' ' 207' ' ' VAL . 46.6 p90 -158.92 163.7 36.31 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.704 0.802 . . . . 0.0 109.965 179.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 95.2 mt -107.21 131.8 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 22.6 t -100.69 137.34 39.22 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.405 0.682 . . . . 0.0 109.312 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -131.22 116.05 17.14 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.513 1.125 . . . . 0.0 108.082 178.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -92.84 120.75 42.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 178.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.1 mt -107.66 106.7 21.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -108.92 -152.68 15.28 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 125.977 1.751 . . . . 0.0 109.199 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 80.42 22.8 0.41 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.956 1.702 . . . . 0.0 112.634 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -91.89 -154.05 30.41 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.24 166.15 10.85 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 179.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 36.7 mm -88.7 140.74 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.235 1.414 . . . . 0.0 108.982 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.2 m -88.94 115.14 26.28 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 127.816 2.446 . . . . 0.0 106.612 178.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -57.91 -16.96 13.83 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.211 1.404 . . . . 0.0 113.586 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 61.8 t -53.32 -56.06 9.98 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 CA-C-N 118.913 0.779 . . . . 0.0 110.663 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 1.9 t -124.66 -23.12 4.43 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -177.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.87 35.35 4.03 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 108.395 -1.882 . . . . 0.0 108.395 -178.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -111.0 147.59 34.4 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 119.054 1.427 . . . . 0.0 113.563 -178.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -68.34 144.51 54.76 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.992 0.917 . . . . 0.0 112.657 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -70.1 26.77 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.499 1 C-N-CA 131.862 4.065 . . . . 0.0 111.471 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 7.0 ptm -74.08 176.3 6.66 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.767 1.167 . . . . 0.0 112.814 -177.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.3 p -141.18 148.33 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 125.1 1.36 . . . . 0.0 107.981 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -110.59 109.32 19.57 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.484 1.913 . . . . 0.0 106.477 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 9.2 mm -99.29 150.06 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 O-C-N 121.055 -1.028 . . . . 0.0 111.191 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -125.67 106.52 9.78 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.206 2.202 . . . . 0.0 110.077 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -87.46 110.25 20.17 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 177.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.468 HG12 ' HB3' ' A' ' 182' ' ' TYR . 31.3 m -125.17 168.42 17.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 C-N-CA 125.186 1.394 . . . . 0.0 109.041 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 51.6 t -89.07 146.5 24.79 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 104.432 -2.432 . . . . 0.0 104.432 177.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -91.19 18.74 50.43 Favored Glycine 0 C--O 1.226 -0.401 0 CA-C-O 117.023 -1.987 . . . . 0.0 116.688 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.722 0 CA-C-N 119.433 1.617 . . . . 0.0 109.075 -179.308 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo . . . . . 0 CA--C 1.542 0.899 0 CA-C-O 119.905 -0.123 . . . . 0.0 112.033 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . 0.438 ' CB ' HG22 ' A' ' 235' ' ' ILE . 14.7 p -147.34 145.97 29.51 Favored 'General case' 0 C--O 1.239 0.52 0 O-C-N 120.482 -1.387 . . . . 0.0 112.369 -177.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 81.3 p -149.91 166.14 30.47 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.163 0.985 . . . . 0.0 110.99 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.9 mp -104.07 154.36 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 126.072 1.749 . . . . 0.0 108.118 178.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 43.4 mm-40 -103.11 -49.98 3.61 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 125.202 1.401 . . . . 0.0 110.66 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 59.8 p-90 -158.04 155.88 30.1 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.572 1.149 . . . . 0.0 109.109 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 60.9 t -153.97 132.64 2.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 125.809 1.644 . . . . 0.0 107.411 179.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.3 167.34 17.98 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.851 0.86 . . . . 0.0 111.342 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -75.96 132.99 40.56 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 4.6 t -112.42 -31.36 6.84 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.463 1.505 . . . . 0.0 112.705 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -132.49 -175.75 3.86 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 124.249 1.02 . . . . 0.0 108.357 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 55.1 mt -47.26 -47.87 9.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 123.567 0.747 . . . . 0.0 112.631 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -132.88 19.34 4.16 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.229 1.012 . . . . 0.0 111.2 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 18.4 t -116.75 145.33 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.813 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -177.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -125.02 164.53 19.96 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -136.18 148.19 48.02 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.48 146.53 30.58 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.387 1.475 . . . . 0.0 108.942 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -129.63 120.12 24.69 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 2.4 m -115.98 143.51 25.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.8 p -119.91 127.51 52.76 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 127.175 2.19 . . . . 0.0 111.911 -176.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.513 HD11 HD13 ' A' ' 238' ' ' LEU . 15.1 pt -134.04 146.64 60.72 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 177.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -71.45 -36.42 6.84 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 123.151 2.567 . . . . 0.0 111.323 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -59.02 -28.23 66.2 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.81 1.244 . . . . 0.0 114.304 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.513 HD13 HD11 ' A' ' 235' ' ' ILE . 3.1 tp -60.83 -32.49 71.88 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 121.45 -0.781 . . . . 0.0 111.367 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 7.3 m -59.56 -13.64 10.05 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.587 1.155 . . . . 0.0 113.448 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.88 -35.59 75.13 Favored 'General case' 0 C--O 1.227 -0.095 0 CA-C-N 119.58 1.082 . . . . 0.0 110.307 179.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.18 125.63 29.7 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -48.27 -42.29 30.26 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.128 1.371 . . . . 0.0 112.459 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.57 -32.27 73.76 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.415 -0.803 . . . . 0.0 112.496 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 25.4 mt -96.14 -7.63 35.38 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.835 1.654 . . . . 0.0 113.298 -178.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -67.52 108.53 2.88 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.094 2.158 . . . . 0.0 110.172 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 9.9 mmmt . . . . . 0 N--CA 1.47 0.543 0 CA-C-N 118.945 0.793 . . . . 0.0 110.246 -179.729 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.466 0.34 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.52 -38.32 80.69 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.212 0.46 . . . . 0.0 110.221 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 23.1 tp -73.94 -34.96 64.51 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.377 1.071 . . . . 0.0 109.383 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.63 HD23 HD11 ' A' ' 243' ' ' LEU . 28.6 mt -60.16 -55.18 37.03 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.23 0.923 . . . . 0.0 110.049 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 96.3 m -67.09 -40.34 86.95 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.295 -0.878 . . . . 0.0 111.018 -178.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.2 ttpt -59.38 -43.94 92.85 Favored 'General case' 0 C--O 1.226 -0.159 0 O-C-N 121.081 -1.012 . . . . 0.0 109.984 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 55.3 m -54.02 -43.92 70.53 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 124.352 1.061 . . . . 0.0 110.347 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -57.02 -50.33 73.06 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.522 0.601 . . . . 0.0 109.924 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.47 -54.69 21.13 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.565 0.697 . . . . 0.0 111.735 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -55.12 -44.4 74.96 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.224 1.01 . . . . 0.0 110.914 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.48 -51.87 48.39 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-O 117.797 -1.557 . . . . 0.0 109.366 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.469 ' HA ' HD12 ' A' ' 109' ' ' ILE . 41.0 t -54.86 -45.16 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 119.966 1.883 . . . . 0.0 109.683 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.0 pttm -61.83 -34.85 76.69 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 119.804 -0.759 . . . . 0.0 111.183 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 39.0 m -71.28 -44.17 65.74 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.579 0.752 . . . . 0.0 109.558 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.469 HD12 ' HA ' ' A' ' 106' ' ' VAL . 22.3 mt -57.49 -55.53 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -63.27 -29.24 70.61 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 118.782 -0.628 . . . . 0.0 112.348 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -70.18 -48.95 55.03 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.354 0.979 . . . . 0.0 111.898 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.46 ' HA ' ' HE2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -75.71 -43.91 44.71 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 123.562 0.745 . . . . 0.0 112.129 -178.037 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 14.2 mt -65.27 -28.25 69.21 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 118.193 -0.908 . . . . 0.0 112.671 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -51.91 -28.8 17.55 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -48.88 -69.86 0.11 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -146.48 179.01 7.84 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 126.152 1.781 . . . . 0.0 108.454 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 59.8 m -87.14 166.67 14.8 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 35.4 pt -120.39 155.95 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.446 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -148.22 139.79 23.66 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 123.61 0.764 . . . . 0.0 110.383 -178.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.461 ' CZ ' ' HA ' ' A' ' 220' ' ' TRP . 7.1 t80 -137.07 120.88 17.46 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.58 1.152 . . . . 0.0 110.304 178.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -82.97 101.94 11.4 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.513 1.525 . . . . 0.0 109.509 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.419 ' HB2' ' CE1' ' A' ' 120' ' ' TYR . . . -87.86 81.15 7.63 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 127.956 2.502 . . . . 0.0 106.794 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.52 -90.49 0.38 Allowed Glycine 0 CA--C 1.534 1.24 0 O-C-N 121.301 -0.874 . . . . 0.0 111.926 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -107.68 -28.57 9.64 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 127.053 2.141 . . . . 0.0 112.844 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -99.55 157.65 16.3 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.1 mp -126.88 128.4 70.78 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.424 ' CD1' HG11 ' A' ' 221' ' ' VAL . 44.0 m-85 -101.43 119.03 38.14 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -116.21 123.24 47.27 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -115.92 132.48 56.63 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.556 0.743 . . . . 0.0 110.302 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 66.7 m -112.27 148.18 38.57 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 124.247 1.019 . . . . 0.0 109.145 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.78 85.96 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 124.38 3.387 . . . . 0.0 115.151 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.21 30.76 40.57 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-O 117.944 -1.476 . . . . 0.0 112.981 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 3.9 mp -117.15 -73.62 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.455 0 CA-C-N 119.191 1.495 . . . . 0.0 110.247 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.406 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 37.4 mt-10 -163.39 166.25 23.09 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.03 2.132 . . . . 0.0 108.583 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -135.6 123.6 22.79 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.568 1.547 . . . . 0.0 107.568 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 17.8 m -144.47 164.04 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 126.8 2.04 . . . . 0.0 111.103 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -117.84 127.19 53.63 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 177.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -136.53 162.41 33.19 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 125.39 1.476 . . . . 0.0 111.224 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -92.63 160.56 14.95 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.751 0 CA-C-N 119.185 0.902 . . . . 0.0 111.722 -179.294 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 . . . . . 0 CA--C 1.532 0.284 0 CA-C-O 121.174 0.512 . . . . 0.0 109.626 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -149.04 112.0 4.87 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 126.268 1.827 . . . . 0.0 108.471 178.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 82.6 mt -99.07 -26.89 14.07 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 160.96 161.01 11.13 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -127.34 108.53 21.26 Favored Pre-proline 0 C--O 1.239 0.509 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 86.2 Cg_endo -72.32 -179.62 4.18 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 124.447 3.432 . . . . 0.0 109.825 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -122.39 159.76 26.85 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.063 0.545 . . . . 0.0 110.851 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.62 -54.0 11.85 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -68.72 64.6 0.12 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 126.751 2.02 . . . . 0.0 112.71 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 5.6 p -47.02 -34.34 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 C-N-CA 125.759 1.624 . . . . 0.0 111.846 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -63.84 -32.98 74.68 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.022 1.329 . . . . 0.0 112.026 -178.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -80.69 -14.21 58.34 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 122.748 0.419 . . . . 0.0 110.096 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 44.4 mtp180 -83.3 177.97 8.28 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 121.071 -1.018 . . . . 0.0 109.509 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -132.85 150.36 52.17 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.381 1.072 . . . . 0.0 108.201 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -138.22 161.2 37.47 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.193 1.797 . . . . 0.0 107.688 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -126.87 149.99 49.48 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 122.889 0.476 . . . . 0.0 110.606 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 32.1 tp -107.47 111.01 23.1 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.876 1.271 . . . . 0.0 108.659 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.46 HD23 ' HB2' ' A' ' 184' ' ' SER . 2.9 mm? -118.47 -179.75 3.88 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.944 1.298 . . . . 0.0 110.45 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -137.84 154.4 49.51 Favored 'General case' 0 N--CA 1.458 -0.037 0 C-N-CA 124.875 1.27 . . . . 0.0 109.467 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -140.45 -178.16 5.37 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 126.678 1.991 . . . . 0.0 107.421 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -66.11 -5.71 10.83 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.868 1.267 . . . . 0.0 113.417 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 56.0 t -107.6 -24.49 4.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 126.794 2.038 . . . . 0.0 113.656 -178.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 144.24 -173.02 25.12 Favored Glycine 0 N--CA 1.444 -0.774 0 O-C-N 121.841 -0.537 . . . . 0.0 112.052 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -79.06 158.42 27.86 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 121.716 0.769 . . . . 0.0 109.297 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.452 ' HB3' HG12 ' A' ' 207' ' ' VAL . 42.0 p90 -155.74 162.85 40.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.331 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 96.7 mt -104.23 136.42 37.62 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.073 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.46 ' HB2' HD23 ' A' ' 175' ' ' LEU . 46.2 t -102.22 129.34 48.59 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 125.414 1.485 . . . . 0.0 108.374 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -121.33 113.98 20.68 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.88 119.0 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 104.512 -2.403 . . . . 0.0 104.512 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 9.0 mt -109.2 105.63 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 177.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -101.32 -153.43 26.03 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 23.1 t 67.86 26.65 7.55 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.993 0.917 . . . . 0.0 111.932 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -82.2 -60.32 2.16 Favored Glycine 0 CA--C 1.525 0.691 0 O-C-N 120.51 -1.369 . . . . 0.0 110.543 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 153.83 -174.14 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.608 1 C-N-CA 131.893 4.077 . . . . 0.0 106.384 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 51.8 mm -105.9 143.3 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 129.561 3.144 . . . . 0.0 112.205 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.2 m -93.56 118.15 30.98 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 128.345 2.658 . . . . 0.0 107.207 177.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.5 -30.89 54.77 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.818 1.247 . . . . 0.0 113.331 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 44.1 t -45.32 -56.28 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 125.019 1.328 . . . . 0.0 113.031 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 6.6 t -123.46 -23.02 4.89 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 124.701 1.201 . . . . 0.0 113.85 -177.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 94.97 34.66 6.1 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 107.263 -2.335 . . . . 0.0 107.263 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -103.09 150.38 23.67 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 117.998 0.899 . . . . 0.0 110.922 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -74.03 139.65 44.88 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 122.544 0.337 . . . . 0.0 111.697 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -67.47 29.0 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.559 1 C-N-CA 135.799 5.64 . . . . 0.0 110.208 177.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 1.9 ptm -74.46 -176.81 2.85 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.17 1.388 . . . . 0.0 111.955 -177.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.2 p -153.6 146.69 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 O-C-N 121.087 -1.008 . . . . 0.0 110.753 -178.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -104.32 104.77 14.71 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.595 1.558 . . . . 0.0 109.522 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 8.7 mm -93.8 123.1 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -105.15 99.61 9.22 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 127.312 2.245 . . . . 0.0 109.333 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -82.17 110.72 17.63 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.76 1.224 . . . . 0.0 108.849 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.452 HG12 ' HB3' ' A' ' 182' ' ' TYR . 19.0 m -124.72 164.73 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 125.456 1.502 . . . . 0.0 107.46 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 46.3 t -83.91 146.09 28.23 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 119.909 -1.745 . . . . 0.0 107.562 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -86.75 3.76 86.77 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-O 118.774 -1.015 . . . . 0.0 113.108 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.726 0 N-CA-C 107.905 -2.078 . . . . 0.0 107.905 -179.069 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 N--CA 1.455 -0.774 0 N-CA-C 111.598 -0.193 . . . . 0.0 111.598 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 5.0 p -151.74 146.5 25.8 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.654 1.182 . . . . 0.0 109.086 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 17.0 p -149.89 172.23 15.5 Favored 'General case' 0 C--O 1.225 -0.201 0 O-C-N 121.757 -0.589 . . . . 0.0 112.246 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.416 HG21 HG23 ' A' ' 221' ' ' VAL . 5.8 mt -122.14 146.06 27.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 126.863 2.065 . . . . 0.0 106.555 177.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -95.35 -47.67 6.2 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.343 1.457 . . . . 0.0 110.525 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . 0.461 ' HA ' ' CZ ' ' A' ' 120' ' ' TYR . 56.2 p-90 -162.88 158.51 22.62 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 125.459 1.504 . . . . 0.0 108.948 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.424 HG11 ' CD1' ' A' ' 127' ' ' TYR . 49.7 t -152.94 135.02 5.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 126.189 1.796 . . . . 0.0 106.366 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.79 168.76 17.5 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.006 1.322 . . . . 0.0 110.347 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -75.61 141.67 42.82 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 124.104 0.962 . . . . 0.0 108.638 178.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . 0.437 HG21 ' HG3' ' A' ' 230' ' ' GLU . 10.2 t -118.83 -31.98 4.64 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.955 1.302 . . . . 0.0 112.3 179.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.429 ' HG3' HG23 ' A' ' 224' ' ' THR . 4.8 mttm -135.22 -176.59 4.31 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 120.806 -1.184 . . . . 0.0 109.067 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 36.5 mt -48.15 -47.22 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 123.864 0.866 . . . . 0.0 112.29 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -130.62 21.47 5.09 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.265 1.026 . . . . 0.0 111.894 -178.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 16.6 t -122.62 143.0 36.95 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.584 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -178.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -121.68 162.52 20.59 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.57 1.548 . . . . 0.0 107.131 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . 0.437 ' HG3' HG21 ' A' ' 224' ' ' THR . 13.3 mt-10 -131.46 138.28 48.95 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 125.416 1.486 . . . . 0.0 107.209 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -135.78 132.39 36.69 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.569 1.148 . . . . 0.0 109.522 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -109.08 108.0 18.53 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 48.3 t -100.73 138.23 25.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.3 p -120.94 130.29 53.8 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 126.286 1.835 . . . . 0.0 112.427 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -138.67 143.34 37.5 Favored Pre-proline 0 N--CA 1.467 0.394 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 176.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -73.3 -33.32 7.27 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.948 2.432 . . . . 0.0 112.963 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -64.25 -17.77 63.92 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.56 0.744 . . . . 0.0 112.811 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 5.9 tp -68.16 -29.51 68.42 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 121.174 -0.954 . . . . 0.0 110.044 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 14.4 m -62.99 -9.98 12.05 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.664 0.786 . . . . 0.0 112.961 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -60.89 -31.24 70.73 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.196 0.907 . . . . 0.0 109.721 178.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -88.64 127.22 35.56 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 124.196 0.998 . . . . 0.0 109.331 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -47.0 -49.33 21.04 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 126.047 1.739 . . . . 0.0 113.475 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.63 HD11 HD23 ' A' ' 98' ' ' LEU . 41.8 mt -65.05 -28.81 69.73 Favored 'General case' 0 C--O 1.231 0.115 0 O-C-N 121.332 -0.855 . . . . 0.0 112.983 -178.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 11.5 mt -95.75 -17.52 21.16 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.101 0.96 . . . . 0.0 112.7 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -62.31 135.53 57.5 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 129.321 3.048 . . . . 0.0 109.445 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt . . . . . 0 CA--C 1.513 -0.474 0 C-N-CA 124.154 0.982 . . . . 0.0 112.12 -179.711 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.311 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.07 -50.97 69.82 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 57.2 tp -63.79 -39.86 95.26 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.569 1.148 . . . . 0.0 110.678 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.8 mt -60.1 -54.28 47.76 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 119.277 0.944 . . . . 0.0 108.65 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.3 m -58.31 -49.32 77.58 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.121 0.486 . . . . 0.0 110.152 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -60.88 -40.74 94.16 Favored 'General case' 0 C--O 1.232 0.164 0 O-C-N 121.206 -0.934 . . . . 0.0 111.776 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 54.4 m -52.3 -48.74 65.21 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.574 0.75 . . . . 0.0 110.842 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -58.89 -47.6 84.38 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 117.966 0.348 . . . . 0.0 110.659 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.45 -55.81 24.11 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 122.504 1.145 . . . . 0.0 113.876 -177.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -64.34 -38.44 91.05 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-N 113.645 -1.616 . . . . 0.0 111.521 -177.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.25 -52.78 41.15 Favored Glycine 0 N--CA 1.44 -1.045 0 N-CA-C 107.95 -2.06 . . . . 0.0 107.95 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 56.0 t -56.92 -47.92 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 119.306 1.553 . . . . 0.0 110.541 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.6 pttm -59.1 -35.52 73.56 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.847 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 52.5 m -79.29 -36.36 39.85 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.308 1.043 . . . . 0.0 111.067 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 21.8 mt -57.85 -54.27 34.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -60.84 -29.39 69.47 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.481 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -68.24 -41.05 81.74 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 120.144 1.338 . . . . 0.0 111.593 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.463 ' HA ' ' HE2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -79.07 -37.42 38.9 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 117.991 0.36 . . . . 0.0 111.75 -179.371 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 17.2 mt -74.17 -25.83 59.95 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 118.685 -0.674 . . . . 0.0 111.903 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -54.82 -20.12 7.95 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.454 0.57 . . . . 0.0 112.167 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -64.62 -72.77 0.14 Allowed 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.694 1.197 . . . . 0.0 109.036 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -147.42 -175.55 4.89 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.386 1.474 . . . . 0.0 111.522 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 62.6 m -87.71 175.4 7.89 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.604 -0.685 . . . . 0.0 109.439 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 27.4 pt -132.73 161.22 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 126.324 1.85 . . . . 0.0 108.774 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -154.74 142.73 20.15 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 122.759 0.423 . . . . 0.0 110.401 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -134.37 123.74 24.61 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.478 0.711 . . . . 0.0 110.499 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -86.66 98.7 11.26 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.19 81.06 5.56 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 128.407 2.683 . . . . 0.0 107.336 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 58.47 -112.93 4.39 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 124.388 0.994 . . . . 0.0 111.054 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -77.28 -12.8 59.99 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.852 1.261 . . . . 0.0 113.375 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -115.74 158.24 23.12 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 124.414 1.086 . . . . 0.0 112.642 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.573 HD13 ' H ' ' A' ' 140' ' ' GLY . 4.8 mp -133.38 126.36 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 N-CA-C 103.577 -2.749 . . . . 0.0 103.577 177.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -110.54 123.36 49.79 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -117.96 129.63 55.72 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.714 0.806 . . . . 0.0 110.008 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -119.52 133.2 55.79 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 123.722 0.809 . . . . 0.0 110.923 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.513 ' HB3' HD13 ' A' ' 133' ' ' ILE . 16.3 m -112.41 156.1 42.7 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 123.737 0.815 . . . . 0.0 111.075 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -63.77 78.46 0.15 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 125.084 3.856 . . . . 0.0 114.203 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 67.51 60.19 6.06 Favored Glycine 0 CA--C 1.525 0.677 0 O-C-N 120.971 -1.081 . . . . 0.0 111.688 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.513 HD13 ' HB3' ' A' ' 130' ' ' CYS . 3.5 mp -130.86 -71.44 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -165.73 168.95 15.65 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 125.45 1.5 . . . . 0.0 109.449 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -130.81 121.95 26.25 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 176.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.8 m -144.76 164.94 12.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 118.916 0.78 . . . . 0.0 111.083 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -120.95 132.2 54.79 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.726 1.211 . . . . 0.0 108.727 178.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -138.51 162.74 33.77 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.122 1.369 . . . . 0.0 112.437 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 55.5 t60 -103.15 108.8 20.14 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.573 ' H ' HD13 ' A' ' 126' ' ' ILE . . . . . . . . 0 C--N 1.331 0.301 0 O-C-N 121.603 -0.686 . . . . 0.0 112.107 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 . . . . . 0 N--CA 1.449 -0.487 0 CA-C-O 122.795 1.283 . . . . 0.0 108.436 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.518 ' N ' HH21 ' A' ' 200' ' ' ARG . 0.0 OUTLIER -149.38 110.35 4.34 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 179.005 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mp -93.92 -27.53 16.32 Favored 'General case' 0 C--O 1.219 -0.55 0 O-C-N 125.794 1.934 . . . . 0.0 107.315 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 163.63 163.23 15.97 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 5.4 mtpt -127.66 110.13 20.68 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -78.04 -173.08 1.68 Allowed 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 124.954 3.769 . . . . 0.0 110.4 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -129.32 149.18 51.22 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 125.277 1.431 . . . . 0.0 109.58 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.74 -41.4 71.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.668 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 31.4 m-20 -71.7 65.02 0.48 Allowed 'General case' 0 C--O 1.236 0.383 0 C-N-CA 126.383 1.873 . . . . 0.0 110.977 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.4 p -52.3 -32.0 15.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 124.904 1.282 . . . . 0.0 110.663 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -63.93 -22.39 66.9 Favored 'General case' 0 N--CA 1.461 0.105 0 C-N-CA 124.695 1.198 . . . . 0.0 112.544 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -97.85 -18.27 18.82 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.522 1.129 . . . . 0.0 110.877 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.4 mtp-105 -81.02 142.21 33.61 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -103.73 148.98 25.42 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 178.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -134.25 -176.47 4.21 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.48 1.512 . . . . 0.0 109.587 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -135.41 153.46 51.79 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.329 1.051 . . . . 0.0 109.331 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 22.9 tp -115.05 98.97 7.11 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.697 1.599 . . . . 0.0 106.861 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.462 HD23 ' HB2' ' A' ' 184' ' ' SER . 2.7 mm? -105.33 -179.8 4.05 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 181' ' ' TYR . 2.5 p90 -145.65 163.01 36.2 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -140.75 -178.44 5.54 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.406 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -62.07 -14.41 36.01 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.528 1.131 . . . . 0.0 111.107 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 57.9 t -98.04 -39.12 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 125.495 1.518 . . . . 0.0 111.395 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 161.3 -173.83 37.77 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 123.431 0.539 . . . . 0.0 112.152 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 176' ' ' TYR . 25.9 m-85 -77.72 160.34 28.5 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 118.387 1.094 . . . . 0.0 110.72 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -158.84 168.5 26.64 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.325 1.45 . . . . 0.0 110.813 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 89.1 mt -108.89 141.46 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.462 ' HB2' HD23 ' A' ' 175' ' ' LEU . 15.6 t -111.41 137.32 49.35 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.394 1.077 . . . . 0.0 109.585 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -129.13 111.53 13.04 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.482 1.513 . . . . 0.0 108.381 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.2 mp -94.93 116.7 36.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 103.928 -2.619 . . . . 0.0 103.928 178.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 12.4 mt -105.1 106.95 21.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -103.66 -152.22 22.85 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 75.19 33.39 0.71 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.218 1.007 . . . . 0.0 110.127 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -113.87 159.18 13.83 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 107.615 -2.194 . . . . 0.0 107.615 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -66.72 167.82 10.55 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.354 1.062 . . . . 0.0 109.892 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.0 mm -87.13 142.33 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 C-N-CA 124.282 1.033 . . . . 0.0 108.795 178.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.1 m -88.81 110.76 21.31 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 104.204 -2.517 . . . . 0.0 104.204 177.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -47.68 -40.02 18.92 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 125.503 1.521 . . . . 0.0 111.637 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 33.4 t -38.45 -56.62 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.228 -0.055 0 C-N-CA 128.024 2.53 . . . . 0.0 113.366 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 10.8 t -124.42 -28.86 3.58 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 105.23 35.31 3.17 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -107.35 149.95 27.27 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 118.278 1.039 . . . . 0.0 110.23 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -77.48 152.25 34.26 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 119.02 0.827 . . . . 0.0 111.176 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.518 HH21 ' N ' ' A' ' 159' ' ' ARG . 30.7 mmm-85 -71.1 27.78 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 131.471 3.908 . . . . 0.0 110.795 177.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 8.1 ptm -75.59 178.43 6.02 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.343 1.057 . . . . 0.0 111.312 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.33 151.28 14.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 125.22 1.408 . . . . 0.0 108.745 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -107.45 106.38 16.75 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.937 2.095 . . . . 0.0 106.703 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 16.2 mm -101.29 144.58 12.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -125.48 121.22 33.11 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.441 1.496 . . . . 0.0 108.914 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -99.04 108.76 21.5 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.658 1.183 . . . . 0.0 108.985 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 3.8 m -126.91 169.77 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 122.101 0.953 . . . . 0.0 109.506 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 42.0 t -95.25 144.08 26.13 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 104.39 -2.448 . . . . 0.0 104.39 177.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -99.85 10.0 60.35 Favored Glycine 0 N--CA 1.461 0.324 0 CA-C-O 117.736 -1.591 . . . . 0.0 115.016 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.497 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.595 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo . . . . . 0 CA--C 1.542 0.912 0 CA-C-O 119.657 -0.226 . . . . 0.0 111.95 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 4.8 p -161.8 147.06 13.28 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 120.45 -1.406 . . . . 0.0 112.809 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 19.2 p -151.22 160.23 43.95 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.501 1.12 . . . . 0.0 110.37 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 233' ' ' VAL . 4.3 mt -100.75 153.55 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 125.894 1.678 . . . . 0.0 108.018 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -98.93 -50.21 4.27 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.184 0.994 . . . . 0.0 111.798 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 63.9 p-90 -159.11 154.52 25.7 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.142 1.377 . . . . 0.0 107.353 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 59.7 t -150.2 130.09 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.03 167.83 26.98 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 118.147 0.43 . . . . 0.0 111.086 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -80.77 137.32 36.24 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 1.8 t -112.96 -39.32 4.26 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.705 -0.622 . . . . 0.0 110.74 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -121.65 -174.82 2.95 Favored 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 124.185 0.994 . . . . 0.0 109.595 -177.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 72.8 mt -56.51 -41.73 73.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.528 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -131.52 12.3 4.93 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.15 1.78 . . . . 0.0 112.815 -178.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 21.0 t -116.59 146.19 21.34 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 CA-C-N 118.72 0.691 . . . . 0.0 109.611 -178.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -123.5 161.64 24.47 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -127.99 142.13 51.33 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 106.376 -1.712 . . . . 0.0 106.376 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -150.78 131.82 14.32 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.465 1.106 . . . . 0.0 109.013 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -121.17 122.65 40.46 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.3 0.64 . . . . 0.0 109.635 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' A' ' 218' ' ' ILE . 4.6 m -106.47 156.44 7.06 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-N 118.676 0.671 . . . . 0.0 109.339 178.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.54 115.62 19.8 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 125.584 1.554 . . . . 0.0 109.166 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 10.6 pt -128.26 145.22 54.79 Favored Pre-proline 0 N--CA 1.448 -0.536 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.05 -41.43 5.19 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.004 1.803 . . . . 0.0 111.128 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -55.69 -17.57 6.14 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 117.589 2.44 . . . . 0.0 117.589 -177.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.443 HD22 ' CD1' ' A' ' 244' ' ' LEU . 44.2 mt -72.84 -30.12 63.76 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 120.781 1.628 . . . . 0.0 108.912 178.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 22.3 m -61.65 -11.65 12.61 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.563 0.745 . . . . 0.0 112.649 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 -67.53 -18.08 64.9 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-O 122.222 1.011 . . . . 0.0 109.664 177.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 29.8 mt -101.01 118.64 37.41 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 127.97 2.508 . . . . 0.0 106.787 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -46.75 -46.46 20.41 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.141 1.376 . . . . 0.0 112.732 -178.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 1.1 mp -65.59 -27.24 68.28 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.443 ' CD1' HD22 ' A' ' 238' ' ' LEU . 9.4 mt -102.39 -3.78 26.52 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.381 1.073 . . . . 0.0 111.609 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -68.94 113.71 6.59 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 127.84 2.456 . . . . 0.0 110.689 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.226 -0.178 0 CA-C-O 118.746 -0.645 . . . . 0.0 110.7 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.17 -47.98 71.4 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 42.3 tp -65.44 -37.44 86.91 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 117.645 -1.169 . . . . 0.0 110.662 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 64.1 mt -61.95 -55.01 33.91 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.55 1.068 . . . . 0.0 109.678 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 89.8 m -57.99 -49.59 76.32 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.389 1.875 . . . . 0.0 110.168 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 23.6 ttpt -62.09 -47.55 84.11 Favored 'General case' 0 N--CA 1.444 -0.741 0 O-C-N 121.341 -0.85 . . . . 0.0 109.698 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.6 m -52.74 -47.14 67.59 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 118.726 0.693 . . . . 0.0 110.765 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -58.7 -50.46 73.81 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 118.228 0.467 . . . . 0.0 109.971 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.83 -61.19 2.45 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -61.25 -38.32 86.26 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.641 0.776 . . . . 0.0 110.99 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.6 -53.24 45.35 Favored Glycine 0 CA--C 1.52 0.376 0 CA-C-O 117.904 -1.498 . . . . 0.0 109.401 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.518 ' HA ' HD12 ' A' ' 109' ' ' ILE . 39.3 t -57.74 -40.76 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 119.434 1.617 . . . . 0.0 109.251 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -58.69 -41.39 86.15 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 28.2 m -70.76 -40.1 72.87 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 125.133 1.373 . . . . 0.0 110.557 -177.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.555 HD13 ' CD1' ' A' ' 206' ' ' TYR . 18.0 mt -61.48 -55.95 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -62.55 -32.39 73.34 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.821 -0.609 . . . . 0.0 111.488 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -60.83 -40.12 91.61 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 118.632 0.651 . . . . 0.0 111.029 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.3 tptm -81.13 -37.99 27.94 Favored 'General case' 0 CA--C 1.519 -0.247 0 O-C-N 122.064 -0.398 . . . . 0.0 110.793 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 40.4 mt -69.12 -26.61 64.99 Favored 'General case' 0 C--O 1.221 -0.412 0 O-C-N 121.443 -0.786 . . . . 0.0 109.992 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.16 -30.87 50.85 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.628 1.171 . . . . 0.0 111.339 179.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -56.24 -63.9 1.04 Allowed 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.489 1.116 . . . . 0.0 111.946 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -151.37 175.59 12.09 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 126.319 1.848 . . . . 0.0 110.336 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 85.7 m -87.53 161.4 17.8 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 106.959 -1.496 . . . . 0.0 106.959 178.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 42.3 pt -112.42 155.01 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 124.846 1.258 . . . . 0.0 108.143 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -148.98 137.37 21.0 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 125.185 1.394 . . . . 0.0 108.27 -178.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -140.85 126.94 19.51 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.307 1.043 . . . . 0.0 111.652 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -80.39 99.46 7.96 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.047 1.339 . . . . 0.0 109.122 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.98 79.97 5.79 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 178.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 58.71 -119.83 19.53 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -63.74 -35.91 82.12 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.91 0.884 . . . . 0.0 112.955 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -99.86 164.36 12.06 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 119.126 0.875 . . . . 0.0 111.651 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.516 HD13 ' H ' ' A' ' 140' ' ' GLY . 4.2 mp -129.43 129.13 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 103.824 -2.658 . . . . 0.0 103.824 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.418 ' CG ' HG11 ' A' ' 221' ' ' VAL . 10.6 m-85 -105.39 122.95 47.02 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 125.634 1.574 . . . . 0.0 106.871 -178.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -118.5 126.49 52.13 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -122.88 137.37 54.96 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.531 0.732 . . . . 0.0 111.26 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.554 ' HB3' HD13 ' A' ' 133' ' ' ILE . 27.4 m -117.12 153.37 49.7 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.613 1.165 . . . . 0.0 111.488 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -62.61 84.53 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.643 1 C-N-CA 125.428 4.085 . . . . 0.0 116.266 -177.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.36 32.56 55.14 Favored Glycine 0 CA--C 1.531 1.093 0 O-C-N 120.749 -1.22 . . . . 0.0 112.853 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.554 HD13 ' HB3' ' A' ' 130' ' ' CYS . 4.5 mp -115.56 -69.92 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.306 0 CA-C-N 117.956 0.878 . . . . 0.0 109.104 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -168.44 168.34 11.25 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.533 1.133 . . . . 0.0 110.632 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -132.38 120.22 21.74 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 177.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.2 m -140.56 163.85 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 124.924 1.29 . . . . 0.0 110.575 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -135.04 126.55 28.68 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -138.08 162.86 33.07 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 126.604 1.962 . . . . 0.0 109.08 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -102.87 120.02 39.87 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.516 ' H ' HD13 ' A' ' 126' ' ' ILE . . . . . . . . 0 CA--C 1.534 1.231 0 C-N-CA 127.21 2.338 . . . . 0.0 107.919 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 . . . . . 0 C--O 1.226 -0.147 0 CA-C-O 121.675 0.75 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 5.8 mpp_? -149.37 133.33 17.09 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 48.3 mt -110.87 -21.75 11.88 Favored 'General case' 0 C--O 1.22 -0.476 0 O-C-N 124.181 0.926 . . . . 0.0 109.195 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 155.53 163.97 12.69 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -126.63 114.3 22.8 Favored Pre-proline 0 C--O 1.236 0.352 0 CA-C-O 118.849 -0.595 . . . . 0.0 109.914 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -71.24 -173.89 1.05 Allowed 'Trans proline' 0 CA--C 1.544 1.004 0 C-N-CA 125.091 3.861 . . . . 0.0 109.567 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -120.8 163.83 17.54 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.932 0.872 . . . . 0.0 111.974 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.75 -36.56 59.85 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.116 177.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -89.57 65.71 7.05 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.476 1.91 . . . . 0.0 110.895 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.9 p -45.76 -36.72 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 123.146 0.578 . . . . 0.0 111.851 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -61.86 -37.9 86.24 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 125.488 1.515 . . . . 0.0 112.532 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -71.56 -23.61 61.78 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 124.972 1.309 . . . . 0.0 110.671 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 9.5 mtp-105 -79.53 138.92 37.67 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -101.41 139.78 36.61 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -122.89 -178.32 3.91 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 126.493 1.917 . . . . 0.0 111.802 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -131.49 154.01 49.18 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.908 1.283 . . . . 0.0 109.968 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 28.4 tp -116.75 107.69 14.96 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.264 1.826 . . . . 0.0 106.368 178.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.601 HD23 ' HB2' ' A' ' 184' ' ' SER . 1.7 mm? -118.58 -178.25 3.49 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 126.258 1.823 . . . . 0.0 109.564 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -145.33 164.81 30.3 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.236 0.615 . . . . 0.0 111.27 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.7 178.56 7.06 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 128.005 2.522 . . . . 0.0 107.417 178.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -59.69 -18.9 46.01 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.489 1.116 . . . . 0.0 111.822 -177.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 76.8 t -92.05 -38.6 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 125.429 1.491 . . . . 0.0 111.297 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 163.46 -168.06 37.94 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 118.764 0.711 . . . . 0.0 112.194 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.405 ' CD2' ' HB3' ' A' ' 243' ' ' LEU . 6.4 m-30 -78.48 161.92 26.73 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.579 0.704 . . . . 0.0 110.234 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.402 ' HB3' HG12 ' A' ' 207' ' ' VAL . 32.3 p90 -159.32 161.87 35.89 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.25 1.42 . . . . 0.0 110.38 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 95.3 mt -100.96 146.08 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.601 ' HB2' HD23 ' A' ' 175' ' ' LEU . 6.7 t -119.7 132.88 55.77 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.492 1.117 . . . . 0.0 108.364 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -126.79 107.71 10.38 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.978 2.111 . . . . 0.0 108.939 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.487 HD11 ' HG3' ' A' ' 203' ' ' GLU . 1.7 mp -90.6 114.14 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 104.481 -2.415 . . . . 0.0 104.481 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 7.2 mt -98.1 106.68 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.49 -153.49 24.82 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 77.07 20.85 1.17 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.585 1.154 . . . . 0.0 109.58 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -84.95 146.16 21.95 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.12 137.71 58.04 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 125.851 1.66 . . . . 0.0 108.44 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 25.3 mm -62.37 139.32 21.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 CA-C-O 122.218 1.009 . . . . 0.0 112.227 -178.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 5.6 t -79.2 116.35 19.42 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 128.381 2.672 . . . . 0.0 109.802 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.08 -17.0 56.16 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.904 0.881 . . . . 0.0 112.907 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 42.0 t -69.11 -52.47 33.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 125.742 1.617 . . . . 0.0 112.235 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . 0.4 HG22 HG21 ' A' ' 226' ' ' ILE . 3.8 t -123.38 -40.44 2.37 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.971 1.308 . . . . 0.0 113.832 -178.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 117.03 21.66 4.46 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.301 1.429 . . . . 0.0 110.596 -178.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -88.7 151.31 22.51 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.868 1.834 . . . . 0.0 110.729 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -71.59 153.61 42.01 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 5.8 ttt-85 -74.52 28.58 0.08 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 127.519 2.328 . . . . 0.0 110.011 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 7.6 ptm -73.03 172.17 11.5 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 122.424 1.106 . . . . 0.0 111.315 -176.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.2 p -143.17 143.95 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 C-N-CA 124.414 1.086 . . . . 0.0 108.092 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.487 ' HG3' HD11 ' A' ' 186' ' ' ILE . 11.2 tt0 -100.56 106.96 18.53 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 178.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 23.6 mm -100.98 146.25 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 O-C-N 120.756 -1.215 . . . . 0.0 108.713 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.458 HE22 ' HG2' ' A' ' 203' ' ' GLU . 17.1 mm-40 -125.48 134.53 52.02 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.796 -1.186 . . . . 0.0 107.796 177.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . 0.555 ' CD1' HD13 ' A' ' 109' ' ' ILE . 43.4 m-85 -106.06 110.05 22.19 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.402 HG12 ' HB3' ' A' ' 182' ' ' TYR . 29.9 m -124.7 162.58 26.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 45.5 t -83.03 143.51 30.56 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -87.48 23.67 11.9 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-O 117.285 -1.842 . . . . 0.0 113.187 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.341 0.83 0 C-N-CA 126.256 1.884 . . . . 0.0 109.911 -179.643 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo . . . . . 0 CA--C 1.547 1.13 0 N-CA-C 109.97 -0.819 . . . . 0.0 109.97 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.2 p -163.9 139.3 6.22 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 129.731 3.212 . . . . 0.0 105.409 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 77.4 p -151.3 175.46 12.19 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.536 1.062 . . . . 0.0 110.819 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.433 ' HA ' ' HA ' ' A' ' 233' ' ' VAL . 3.2 mt -115.48 143.05 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 104.073 -2.565 . . . . 0.0 104.073 176.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -94.35 -48.31 6.21 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.722 1.209 . . . . 0.0 112.421 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 -156.84 151.85 26.11 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.815 1.646 . . . . 0.0 108.499 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.493 HG23 ' HB2' ' A' ' 231' ' ' ALA . 6.8 p -155.71 120.44 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 177.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -148.85 158.38 44.12 Favored 'General case' 0 C--O 1.235 0.342 0 O-C-N 121.563 -0.711 . . . . 0.0 110.849 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -65.84 130.44 43.29 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 12.1 t -107.96 -33.61 7.16 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 125.842 1.657 . . . . 0.0 112.605 -178.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 7.1 mttt -132.17 -175.88 3.89 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.4 HG21 HG22 ' A' ' 196' ' ' THR . 1.1 mm -38.72 -56.92 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 124.896 1.278 . . . . 0.0 113.319 -177.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 2.5 m -133.32 17.61 4.04 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.775 1.63 . . . . 0.0 109.81 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.64 141.75 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -121.53 163.7 18.43 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.457 1.103 . . . . 0.0 108.474 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -138.16 132.36 31.81 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 178.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.493 ' HB2' HG23 ' A' ' 221' ' ' VAL . . . -136.57 140.04 42.61 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.158 1.383 . . . . 0.0 108.141 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -118.92 116.98 27.62 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 218' ' ' ILE . 1.3 m -107.0 151.85 8.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.8 p -126.75 136.83 52.94 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 123.461 0.704 . . . . 0.0 111.857 -178.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -141.21 142.55 27.48 Favored Pre-proline 0 N--CA 1.452 -0.336 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -66.79 -47.54 2.62 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.855 2.37 . . . . 0.0 112.002 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -53.41 -24.48 12.61 Favored 'General case' 0 CA--C 1.527 0.091 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 10.7 tp -61.11 -29.9 70.04 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 119.266 0.939 . . . . 0.0 111.409 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 9.2 m -62.0 -12.26 17.75 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.999 0.919 . . . . 0.0 112.602 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.99 -24.65 66.06 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.245 0.93 . . . . 0.0 110.121 178.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -89.14 117.21 27.96 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 178.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 -46.79 -44.18 18.93 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 126.281 1.833 . . . . 0.0 114.105 -178.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.405 ' HB3' ' CD2' ' A' ' 181' ' ' TYR . 60.2 mt -70.23 -31.43 68.83 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.448 -1.407 . . . . 0.0 113.017 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 14.3 mt -84.29 -20.7 31.69 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.124 0.97 . . . . 0.0 112.583 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -55.72 141.16 39.28 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 128.914 2.886 . . . . 0.0 111.538 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 34.5 mmtt . . . . . 0 C--O 1.236 0.39 0 C-N-CA 125.378 1.471 . . . . 0.0 109.616 179.233 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.527 ' HA ' HD12 ' A' ' 98' ' ' LEU . 0.3 OUTLIER . . . . . 0 CA--C 1.531 0.216 0 CA-C-O 119.385 -0.341 . . . . 0.0 111.035 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.43 -45.96 92.1 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 55.3 tp -66.38 -38.07 86.71 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 118.396 -0.811 . . . . 0.0 109.905 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.527 HD12 ' HA ' ' A' ' 95' ' ' THR . 20.7 mt -59.74 -54.81 41.98 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 24.5 m -60.7 -38.53 85.34 Favored 'General case' 0 C--O 1.239 0.551 0 O-C-N 121.449 -0.782 . . . . 0.0 111.77 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -65.28 -48.19 74.04 Favored 'General case' 0 CA--C 1.519 -0.247 0 O-C-N 121.056 -1.027 . . . . 0.0 109.993 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 69.2 m -51.95 -47.81 64.59 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.352 1.061 . . . . 0.0 110.667 -178.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.411 HD21 ' HB2' ' A' ' 172' ' ' PHE . 3.4 tm? -58.51 -49.48 77.21 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 117.847 0.294 . . . . 0.0 110.912 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -62.89 -57.35 11.09 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 122.243 1.02 . . . . 0.0 113.153 -177.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -60.41 -41.6 94.22 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.797 -178.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -62.71 -53.21 42.9 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-O 117.781 -1.566 . . . . 0.0 111.418 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.515 ' HA ' HD12 ' A' ' 109' ' ' ILE . 47.8 t -58.34 -42.53 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 120.562 2.181 . . . . 0.0 109.0 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.84 -30.98 71.69 Favored 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 119.181 -1.007 . . . . 0.0 112.499 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.429 ' CG2' ' HB3' ' A' ' 237' ' ' GLU . 52.6 m -72.32 -40.75 67.24 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 126.042 1.737 . . . . 0.0 108.385 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.515 HD12 ' HA ' ' A' ' 106' ' ' VAL . 18.1 mt -60.66 -55.06 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 178.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -60.91 -28.0 68.6 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-O 117.876 -1.059 . . . . 0.0 111.657 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -62.07 -49.38 76.17 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.22 1.008 . . . . 0.0 111.337 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.473 ' HA ' ' HE2' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -85.26 -39.28 17.93 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -177.765 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 16.2 mt -66.38 -25.78 66.95 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 119.009 -0.519 . . . . 0.0 112.26 -179.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -52.44 -28.75 21.3 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -51.18 -74.77 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.821 1.648 . . . . 0.0 111.67 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -147.68 176.68 9.9 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.804 1.642 . . . . 0.0 109.126 -178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 33.4 m -86.21 163.06 18.0 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.635 0.731 . . . . 0.0 109.147 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 37.6 pt -118.63 160.29 18.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 126.134 1.774 . . . . 0.0 109.395 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -158.05 139.62 13.7 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -130.54 127.2 38.61 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 123.584 0.753 . . . . 0.0 110.052 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -85.39 101.66 12.78 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.26 1.024 . . . . 0.0 108.439 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.26 80.07 7.65 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 104.681 -2.34 . . . . 0.0 104.681 178.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.73 -99.63 0.37 Allowed Glycine 0 CA--C 1.531 1.08 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -95.25 -25.85 16.19 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.742 1.617 . . . . 0.0 114.031 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -99.01 152.35 19.91 Favored 'General case' 0 CA--C 1.513 -0.451 0 O-C-N 121.302 -0.874 . . . . 0.0 108.752 -178.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.465 HD13 ' H ' ' A' ' 140' ' ' GLY . 5.2 mp -124.67 124.6 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -100.99 119.3 38.54 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 103.212 -2.884 . . . . 0.0 103.212 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -118.4 124.7 48.33 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.157 0.983 . . . . 0.0 110.891 -177.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -124.03 135.03 53.32 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -178.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.578 ' HB3' HD13 ' A' ' 133' ' ' ILE . 16.1 m -111.18 155.97 41.79 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 125.546 1.538 . . . . 0.0 112.808 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -67.97 81.31 0.49 Allowed 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 124.864 3.71 . . . . 0.0 114.474 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 72.98 54.55 7.0 Favored Glycine 0 CA--C 1.529 0.922 0 O-C-N 121.207 -0.933 . . . . 0.0 112.862 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.578 HD13 ' HB3' ' A' ' 130' ' ' CYS . 3.6 mp -131.04 -72.02 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -167.16 167.82 14.02 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.757 1.623 . . . . 0.0 109.068 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -128.54 126.14 39.75 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 176.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.8 m -141.53 164.0 19.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 124.591 1.157 . . . . 0.0 110.55 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -126.36 125.81 42.85 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -139.4 162.96 33.77 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.091 0.957 . . . . 0.0 110.636 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 61.8 t60 -110.19 109.35 19.81 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 101.993 -3.336 . . . . 0.0 101.993 177.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.465 ' H ' HD13 ' A' ' 126' ' ' ILE . . . . . . . . 0 CA--C 1.53 1.012 0 C-N-CA 126.191 1.853 . . . . 0.0 109.959 -178.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 . . . . . 0 N--CA 1.445 -0.692 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -134.59 141.78 46.74 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 177.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 59.7 mt -120.17 -29.06 4.96 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 125.454 1.721 . . . . 0.0 107.042 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 160.62 159.18 9.73 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 36.1 mtmt -128.57 114.66 19.49 Favored Pre-proline 0 CA--C 1.537 0.444 0 O-C-N 122.021 -0.694 . . . . 0.0 109.998 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -75.6 -167.98 0.49 Allowed 'Trans proline' 0 CA--C 1.537 0.63 1 C-N-CA 125.806 4.338 . . . . 0.0 110.336 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -131.93 157.56 43.7 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.328 1.451 . . . . 0.0 108.91 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.89 -38.29 73.05 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.878 0.371 . . . . 0.0 110.503 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 33.7 m-20 -76.15 64.73 2.03 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.703 1.601 . . . . 0.0 110.293 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 6.1 p -52.04 -30.32 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 124.212 1.005 . . . . 0.0 111.172 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -71.32 -26.03 62.66 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.531 1.132 . . . . 0.0 113.804 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -77.32 -23.68 50.95 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 122.901 0.481 . . . . 0.0 112.174 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -92.42 160.32 15.14 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.964 0.411 . . . . 0.0 109.909 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -114.38 161.48 17.87 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.411 ' HB2' HD21 ' A' ' 102' ' ' LEU . 49.4 m-85 -138.11 170.43 16.05 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.738 1.215 . . . . 0.0 109.621 -177.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -112.57 151.32 30.19 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 21.9 tp -121.3 98.35 5.94 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -110.16 178.46 4.39 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -155.0 163.3 40.51 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -141.08 -171.03 3.18 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -55.27 -23.82 25.02 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.087 1.355 . . . . 0.0 112.406 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.5 t -81.87 -65.91 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 177.48 -170.58 43.1 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -77.55 157.62 30.26 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.566 0.746 . . . . 0.0 111.838 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.452 ' HB3' HG12 ' A' ' 207' ' ' VAL . 48.7 p90 -156.09 173.77 16.34 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 126.735 2.014 . . . . 0.0 108.585 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 93.8 mt -114.29 141.69 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 177.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 21.3 t -109.91 128.71 55.53 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.059 1.343 . . . . 0.0 107.923 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -124.07 107.39 11.23 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.862 1.265 . . . . 0.0 108.459 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.6 mp -91.05 128.65 42.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 7.6 mt -118.9 106.72 19.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -93.88 -152.56 29.41 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 108.443 -1.863 . . . . 0.0 108.443 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 69.7 m 79.15 25.49 0.46 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.201 2.2 . . . . 0.0 115.768 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -89.64 -156.02 31.44 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 107.58 -2.208 . . . . 0.0 107.58 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -123.17 144.13 49.56 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 39.8 mm -60.82 134.55 26.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -79.62 109.63 14.18 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 127.131 2.172 . . . . 0.0 105.489 177.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -55.04 -19.5 7.2 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.847 2.059 . . . . 0.0 113.189 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 50.1 t -60.47 -54.52 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 126.968 2.107 . . . . 0.0 111.567 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 4.8 t -124.09 -25.42 4.18 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -177.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 99.59 35.72 4.55 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 108.239 -1.945 . . . . 0.0 108.239 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -113.27 151.29 31.29 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 117.933 0.867 . . . . 0.0 110.669 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 57.5 mp0 -75.26 141.41 43.49 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 123.976 0.91 . . . . 0.0 112.735 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . 0.297 7.9 ttt85 -70.05 30.98 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 130.885 3.674 . . . . 0.0 112.797 178.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 5.1 ptm -74.75 177.36 6.22 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.125 0.97 . . . . 0.0 110.472 -179.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.2 p -143.65 152.97 16.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 125.283 1.433 . . . . 0.0 107.98 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -114.65 112.57 23.08 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 15.7 mm -98.24 141.96 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -124.62 111.46 15.66 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.663 1.585 . . . . 0.0 107.985 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -92.56 109.03 20.43 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.701 1.6 . . . . 0.0 110.369 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.452 HG12 ' HB3' ' A' ' 182' ' ' TYR . 34.9 m -124.79 167.82 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.211 1.005 . . . . 0.0 109.837 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 45.5 t -96.46 132.73 41.72 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 103.541 -2.763 . . . . 0.0 103.541 177.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -98.36 32.49 6.89 Favored Glycine 0 N--CA 1.463 0.456 0 C-N-CA 124.541 1.067 . . . . 0.0 111.01 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.169 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.276 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo . . . . . 0 N--CA 1.456 -0.731 0 N-CA-C 115.429 1.281 . . . . 0.0 115.429 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -164.12 151.03 11.63 Favored 'General case' 0 C--O 1.241 0.624 0 O-C-N 120.863 -1.148 . . . . 0.0 109.1 -178.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 36.7 p -151.81 160.64 43.49 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.839 0.855 . . . . 0.0 110.579 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 4.1 mt -106.48 148.55 10.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -93.82 -53.98 3.8 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.672 0.789 . . . . 0.0 110.95 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 63.4 p-90 -155.17 155.03 33.2 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.859 1.264 . . . . 0.0 108.113 -178.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 56.3 t -150.58 129.66 3.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.84 162.18 32.15 Favored 'General case' 0 C--O 1.233 0.209 0 O-C-N 122.19 -0.319 . . . . 0.0 111.174 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -72.53 128.79 36.66 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 104.574 -2.38 . . . . 0.0 104.574 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 9.9 t -106.15 -37.17 6.68 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 124.833 1.253 . . . . 0.0 109.981 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 34.2 mttt -133.31 -176.45 4.14 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 123.782 0.833 . . . . 0.0 109.975 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 69.3 mt -46.38 -49.43 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.188 0.995 . . . . 0.0 112.322 -178.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.99 21.23 5.83 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 124.112 0.965 . . . . 0.0 110.362 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 7.9 t -120.1 141.4 40.49 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.61 0 CA-C-N 118.64 0.654 . . . . 0.0 111.61 -177.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -122.97 158.37 30.61 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -129.73 134.46 47.63 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -137.32 119.33 15.38 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 125.427 1.491 . . . . 0.0 109.932 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -108.42 124.66 50.74 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 12.5 m -116.31 156.58 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.481 0 C-N-CA 122.47 0.308 . . . . 0.0 110.665 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.3 p -123.85 123.89 41.45 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 124.39 1.076 . . . . 0.0 110.263 -178.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 2.2 pt -133.44 134.52 23.92 Favored Pre-proline 0 C--O 1.237 0.4 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 177.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.54 -27.82 45.83 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.233 2.622 . . . . 0.0 113.304 -178.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . 0.429 ' HB3' ' CG2' ' A' ' 108' ' ' THR . 28.2 mp0 -64.59 -28.65 69.78 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 -178.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 66.6 mt -61.23 -29.23 69.7 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 118.587 -1.245 . . . . 0.0 110.652 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 21.7 m -58.86 -16.35 16.95 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 118.806 0.73 . . . . 0.0 112.256 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -60.11 -38.4 82.91 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 118.91 0.777 . . . . 0.0 109.663 178.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -79.61 122.47 26.56 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -47.33 -44.88 24.05 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 126.26 1.824 . . . . 0.0 113.34 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.43 -33.59 76.05 Favored 'General case' 0 C--O 1.226 -0.176 0 O-C-N 121.341 -0.849 . . . . 0.0 112.694 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 27.2 mt -92.88 -4.99 51.89 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.231 1.012 . . . . 0.0 113.054 -178.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -71.61 117.06 12.71 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 127.625 2.37 . . . . 0.0 112.978 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 32.6 mmtm . . . . . 0 CA--C 1.516 -0.352 0 C-N-CA 123.216 0.606 . . . . 0.0 110.709 178.424 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.171 0 CA-C-O 118.554 -0.736 . . . . 0.0 112.078 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.82 -49.23 76.01 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 52.8 tp -65.1 -35.6 81.64 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.492 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.498 HD23 HD11 ' A' ' 243' ' ' LEU . 43.3 mt -63.24 -55.01 28.48 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.44 1.018 . . . . 0.0 108.791 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 88.9 m -57.25 -46.36 83.1 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 125.045 1.338 . . . . 0.0 110.254 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.71 -50.2 70.08 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 118.231 -0.89 . . . . 0.0 109.666 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 47.6 m -52.53 -46.9 66.94 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 124.159 0.984 . . . . 0.0 110.532 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -59.49 -50.33 74.33 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 118.3 0.5 . . . . 0.0 110.003 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.1 -61.5 2.22 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.219 0.608 . . . . 0.0 112.313 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.44 -37.98 79.5 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.487 0.315 . . . . 0.0 110.231 -178.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.09 -53.25 38.16 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-O 117.583 -1.676 . . . . 0.0 110.706 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.55 ' HA ' HD12 ' A' ' 109' ' ' ILE . 37.3 t -57.12 -45.19 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 119.671 1.736 . . . . 0.0 109.087 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -62.96 -34.36 77.33 Favored 'General case' 0 C--O 1.223 -0.311 0 C-N-CA 118.815 -1.154 . . . . 0.0 111.573 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 86.2 m -70.89 -36.96 72.97 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.444 0.698 . . . . 0.0 109.53 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.55 HD12 ' HA ' ' A' ' 106' ' ' VAL . 13.7 mt -61.81 -55.4 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 179.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -64.3 -27.85 69.32 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -64.51 -30.82 71.85 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.443 1.02 . . . . 0.0 111.646 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.68 -46.61 6.54 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 123.835 0.854 . . . . 0.0 110.56 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.9 mt -59.98 -27.58 66.97 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -55.03 -24.83 26.63 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -62.85 -62.44 1.72 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.48 0.712 . . . . 0.0 110.872 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -148.42 171.03 16.7 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 123.97 0.908 . . . . 0.0 110.868 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 69.8 m -87.07 166.14 15.25 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 35.4 pt -117.92 156.44 19.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 125.372 1.469 . . . . 0.0 108.613 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.3 138.29 21.27 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 125.389 1.475 . . . . 0.0 109.278 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -136.7 113.36 10.21 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 123.634 0.773 . . . . 0.0 111.44 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -79.82 99.59 7.58 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.29 79.62 8.99 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 178.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 60.13 -105.83 0.87 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -77.99 -34.32 50.87 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.685 0.794 . . . . 0.0 112.981 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 52.4 m95 -99.79 167.82 10.3 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 118.952 0.797 . . . . 0.0 110.293 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.3 mp -136.88 153.81 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.503 ' CD1' HG11 ' A' ' 221' ' ' VAL . 98.9 m-85 -133.68 120.15 20.27 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.766 2.027 . . . . 0.0 106.221 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -117.15 121.29 40.85 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -119.06 139.43 51.76 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 124.216 1.007 . . . . 0.0 109.895 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.607 ' HB3' HD13 ' A' ' 133' ' ' ILE . 20.8 m -115.77 157.38 44.73 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 126.663 1.985 . . . . 0.0 111.687 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -64.21 76.68 0.17 Allowed 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 124.723 3.615 . . . . 0.0 114.626 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 68.54 56.87 8.92 Favored Glycine 0 CA--C 1.533 1.161 0 O-C-N 120.72 -1.238 . . . . 0.0 112.792 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.607 HD13 ' HB3' ' A' ' 130' ' ' CYS . 3.9 mp -128.12 -71.24 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.131 0 C-N-CA 126.198 1.799 . . . . 0.0 106.153 179.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -164.42 169.97 16.61 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 126.963 2.105 . . . . 0.0 109.521 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -133.38 124.84 27.89 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 178.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 33.9 m -142.65 163.71 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 123.99 0.916 . . . . 0.0 112.043 -178.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -125.43 124.67 41.95 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.757 1.623 . . . . 0.0 107.017 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -139.34 162.45 34.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 119.451 1.023 . . . . 0.0 111.43 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 63.1 t60 -85.37 160.97 19.66 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 177.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.595 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -178.674 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 . . . . . 0 CA--C 1.532 0.271 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -148.7 134.18 18.61 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.5 mp -109.85 -23.73 11.22 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 160.79 159.22 9.78 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-N 119.436 1.016 . . . . 0.0 111.891 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.38 108.46 41.71 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 123.918 0.887 . . . . 0.0 109.631 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.4 166.73 23.88 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.286 2.657 . . . . 0.0 110.058 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -96.75 156.55 16.3 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -76.02 -35.14 59.65 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.728 1.211 . . . . 0.0 113.149 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -84.85 66.73 9.83 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 124.369 1.068 . . . . 0.0 110.534 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.5 p -46.04 -28.6 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -71.16 -31.2 67.4 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 124.823 1.249 . . . . 0.0 111.737 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -87.84 -14.1 40.4 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.138 1.775 . . . . 0.0 110.24 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -75.97 158.38 32.02 Favored 'General case' 0 CA--C 1.521 -0.165 0 O-C-N 120.921 -1.112 . . . . 0.0 108.865 178.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -109.9 149.25 30.18 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -143.37 169.28 17.96 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 127.025 2.13 . . . . 0.0 108.606 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -128.13 154.01 46.23 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.082 0.953 . . . . 0.0 110.043 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 23.9 tp -114.25 108.52 17.05 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.555 HD23 ' HB2' ' A' ' 184' ' ' SER . 1.9 mm? -118.2 -179.83 3.89 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.226 1.41 . . . . 0.0 109.297 -178.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -149.33 156.79 42.62 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -141.52 -178.12 5.48 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 177.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -60.86 -13.13 13.58 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.331 -0.856 . . . . 0.0 111.464 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 69.0 t -83.09 -45.25 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 O-C-N 120.796 -1.19 . . . . 0.0 110.435 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 154.53 -165.56 31.99 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 108.082 -2.007 . . . . 0.0 108.082 -178.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.441 ' CD2' ' HB3' ' A' ' 243' ' ' LEU . 3.4 m-30 -78.56 160.72 27.46 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 118.239 1.019 . . . . 0.0 110.22 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.439 ' CB ' HG12 ' A' ' 207' ' ' VAL . 45.7 p90 -158.64 161.72 37.2 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.503 1.121 . . . . 0.0 111.371 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 95.8 mt -101.4 144.1 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.555 ' HB2' HD23 ' A' ' 175' ' ' LEU . 29.7 t -114.29 133.01 55.95 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -123.46 108.55 12.8 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -85.84 127.61 40.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.8 mt -115.59 105.23 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 102.874 -3.01 . . . . 0.0 102.874 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -110.76 -152.04 12.74 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 108.379 -1.888 . . . . 0.0 108.379 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 75.26 23.74 1.52 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.389 1.076 . . . . 0.0 110.945 178.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -95.08 173.64 31.89 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.98 163.88 26.72 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 44.0 mm -86.23 141.43 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 125.619 1.568 . . . . 0.0 111.623 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.2 m -87.23 118.75 26.86 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 127.724 2.41 . . . . 0.0 108.383 178.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -54.06 -32.24 54.02 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.075 2.15 . . . . 0.0 113.335 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 43.8 t -50.91 -55.42 7.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 125.542 1.537 . . . . 0.0 112.772 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 13.6 t -123.93 -33.28 3.16 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 108.05 34.73 2.69 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -178.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -104.82 152.65 22.33 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.916 1.358 . . . . 0.0 110.438 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -76.96 146.2 37.65 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 118.773 0.715 . . . . 0.0 109.559 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . 0.373 4.8 ptp180 -71.62 29.34 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 128.176 2.59 . . . . 0.0 113.558 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 7.8 ptm -72.59 174.31 7.7 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 122.15 0.976 . . . . 0.0 111.643 -176.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.4 p -142.25 150.17 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 124.065 0.946 . . . . 0.0 109.346 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -111.06 106.23 15.23 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 17.0 mm -90.31 150.59 3.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -125.76 100.03 6.23 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 126.916 2.087 . . . . 0.0 110.173 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -84.81 108.68 17.6 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 178.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.439 HG12 ' CB ' ' A' ' 182' ' ' TYR . 26.1 m -125.38 164.11 25.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 124.243 1.017 . . . . 0.0 108.674 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 42.6 t -82.92 146.51 28.8 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 177.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -93.04 13.42 67.74 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-O 118.997 -0.891 . . . . 0.0 112.456 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.977 0 N-CA-C 106.443 -2.663 . . . . 0.0 106.443 -177.239 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo . . . . . 0 N--CA 1.456 -0.731 0 N-CA-C 114.305 0.848 . . . . 0.0 114.305 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 2.9 p -164.33 142.7 7.1 Favored 'General case' 0 N--CA 1.463 0.201 0 O-C-N 120.934 -1.104 . . . . 0.0 109.678 -178.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 7.9 p -148.8 165.5 31.29 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.47 0.577 . . . . 0.0 111.132 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 3.4 mt -101.96 154.48 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 125.298 1.439 . . . . 0.0 107.372 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -105.0 -44.86 4.69 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.121 0.968 . . . . 0.0 113.573 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 67.0 p-90 -163.68 151.88 13.31 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.999 1.319 . . . . 0.0 107.718 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.503 HG11 ' CD1' ' A' ' 127' ' ' TYR . 87.9 t -151.89 129.2 2.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 C-N-CA 124.879 1.272 . . . . 0.0 109.22 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 1.5 ppt_? -163.48 160.5 23.34 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.752 0.706 . . . . 0.0 110.495 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -67.09 131.25 45.45 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 14.9 t -104.07 -33.15 8.87 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.948 1.299 . . . . 0.0 111.361 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 56.8 mttt -131.36 -175.04 3.57 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 125.049 1.34 . . . . 0.0 108.332 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 67.5 mt -52.27 -43.88 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -129.95 8.3 5.22 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.649 0.78 . . . . 0.0 112.227 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 21.5 t -105.81 142.34 19.07 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -178.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -121.55 166.36 14.31 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 124.72 1.208 . . . . 0.0 108.104 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -136.91 144.29 43.39 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -148.65 119.02 7.33 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 123.364 0.666 . . . . 0.0 109.608 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -103.5 123.07 46.22 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 2.3 m -119.98 152.44 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 2.8 p -126.6 135.93 51.87 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 3.9 pt -139.82 146.17 46.02 Favored Pre-proline 0 C--O 1.236 0.362 0 C-N-CA 125.564 1.545 . . . . 0.0 107.029 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -74.03 -24.82 14.63 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.201 1.934 . . . . 0.0 112.973 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 49.6 mp0 -66.02 -28.18 68.68 Favored 'General case' 0 CA--C 1.518 -0.286 0 O-C-N 120.43 -1.418 . . . . 0.0 114.355 -178.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.409 HD22 ' CD1' ' A' ' 244' ' ' LEU . 58.9 mt -63.32 -25.13 68.16 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 118.902 -1.119 . . . . 0.0 110.682 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 20.9 m -63.0 -15.12 55.27 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 119.163 0.892 . . . . 0.0 111.051 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -69.5 -31.77 70.22 Favored 'General case' 0 C--N 1.341 0.206 0 O-C-N 121.186 -0.946 . . . . 0.0 109.358 178.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.445 HD13 ' HA ' ' A' ' 241' ' ' LEU . 3.1 mm? -78.21 120.75 23.44 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 178.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 33.0 tp10 -46.05 -48.47 16.86 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.766 2.026 . . . . 0.0 115.795 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.498 HD11 HD23 ' A' ' 98' ' ' LEU . 20.0 mt -69.52 -34.44 74.27 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.148 -0.97 . . . . 0.0 112.786 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.409 ' CD1' HD22 ' A' ' 238' ' ' LEU . 3.2 mt -84.71 -10.35 57.36 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.266 1.026 . . . . 0.0 112.717 -178.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -61.25 123.73 18.56 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.179 2.192 . . . . 0.0 111.015 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 16.2 mmtp . . . . . 0 C--O 1.237 0.443 0 C-N-CA 123.319 0.648 . . . . 0.0 109.677 178.759 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.468 ' HA ' HD12 ' A' ' 98' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.462 0.138 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.88 -52.64 64.86 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 42.0 tp -68.36 -34.95 77.0 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 118.416 -0.802 . . . . 0.0 110.373 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.468 HD12 ' HA ' ' A' ' 95' ' ' THR . 31.8 mt -60.36 -54.37 46.42 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 60.4 m -61.9 -45.26 94.5 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.656 -0.652 . . . . 0.0 109.8 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.9 -47.31 83.16 Favored 'General case' 0 C--N 1.346 0.415 0 O-C-N 120.854 -1.154 . . . . 0.0 109.416 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.405 ' HA ' HD12 ' A' ' 241' ' ' LEU . 72.3 m -54.14 -51.17 65.13 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.579 1.152 . . . . 0.0 110.323 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -57.98 -47.92 81.54 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 123.288 0.367 . . . . 0.0 110.56 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -69.17 -59.58 2.93 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -177.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.46 -37.32 85.46 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.451 ' HA3' HD11 ' A' ' 183' ' ' ILE . . . -56.15 -52.65 47.99 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.519 ' HA ' HD12 ' A' ' 109' ' ' ILE . 41.3 t -56.69 -46.02 82.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 119.381 1.59 . . . . 0.0 110.475 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.3 ptmt -63.61 -31.63 72.86 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 118.714 -0.66 . . . . 0.0 111.878 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.3 m -76.43 -37.89 56.36 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.38 1.072 . . . . 0.0 109.104 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.558 HD13 ' CD1' ' A' ' 206' ' ' TYR . 24.6 mt -62.16 -55.34 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -62.15 -28.37 69.6 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 118.272 -0.87 . . . . 0.0 111.497 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -68.67 -50.3 52.16 Favored 'General case' 0 N--CA 1.457 -0.085 0 CA-C-N 119.028 0.831 . . . . 0.0 111.135 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.05 -44.8 45.64 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 30.8 mt -64.33 -26.12 68.34 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-O 119.068 -0.491 . . . . 0.0 111.929 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -51.63 -27.06 10.26 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.3 1.04 . . . . 0.0 112.872 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -52.58 -68.09 0.2 Allowed 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.544 1.538 . . . . 0.0 112.489 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -152.9 -179.13 7.38 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.597 1.559 . . . . 0.0 111.536 -178.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 64.1 m -86.65 175.42 8.29 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 35.7 pt -140.73 160.19 24.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 125.306 1.442 . . . . 0.0 109.746 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.32 144.2 25.38 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 123.878 0.871 . . . . 0.0 110.081 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.537 ' CE1' ' HB2' ' A' ' 122' ' ' ALA . 8.8 t80 -135.04 131.16 36.71 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.091 0.956 . . . . 0.0 109.461 178.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.4 ' HA ' HG13 ' A' ' 126' ' ' ILE . 57.0 tt0 -91.43 109.71 21.0 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 124.915 1.286 . . . . 0.0 108.029 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.537 ' HB2' ' CE1' ' A' ' 120' ' ' TYR . . . -102.39 80.09 1.91 Allowed 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.15 1.78 . . . . 0.0 110.86 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.82 -85.99 0.07 OUTLIER Glycine 0 CA--C 1.529 0.913 0 O-C-N 120.711 -1.243 . . . . 0.0 113.1 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -109.77 -32.62 7.01 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.407 1.083 . . . . 0.0 111.235 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 69.2 m95 -99.81 152.76 19.76 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 118.933 0.788 . . . . 0.0 110.323 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.483 HD13 ' H ' ' A' ' 140' ' ' GLY . 4.8 mp -122.19 138.22 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -113.97 130.62 56.51 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -132.86 125.04 29.09 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.358 0.526 . . . . 0.0 110.57 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -116.06 140.65 49.06 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.823 1.249 . . . . 0.0 110.82 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 6.5 m -121.37 151.9 56.9 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 124.354 1.062 . . . . 0.0 109.925 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -65.69 84.86 0.23 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 124.374 3.383 . . . . 0.0 116.108 -177.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.21 32.07 36.38 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-O 118.041 -1.422 . . . . 0.0 112.714 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.8 mp -114.67 -72.59 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -172.05 173.74 4.28 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.737 1.215 . . . . 0.0 109.364 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -129.47 126.9 39.74 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.0 m -142.05 163.97 18.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 124.383 1.073 . . . . 0.0 111.487 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -123.93 118.93 28.17 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -137.78 163.43 31.39 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 125.869 1.667 . . . . 0.0 111.361 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -94.77 135.39 36.31 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 177.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.483 ' H ' HD13 ' A' ' 126' ' ' ILE . . . . . . . . 0 CA--C 1.529 0.914 0 O-C-N 121.126 -0.984 . . . . 0.0 111.89 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 . . . . . 0 C--O 1.236 0.385 0 CA-C-O 120.587 0.232 . . . . 0.0 110.513 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 19.2 tpp180 -148.11 113.19 5.5 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.425 1.49 . . . . 0.0 110.527 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 60.3 mt -97.91 -41.59 7.94 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 157.89 175.06 28.39 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.439 ' N ' HG22 ' A' ' 187' ' ' ILE . 6.0 ptmm? -130.36 127.83 22.54 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -70.35 179.1 4.27 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.036 3.157 . . . . 0.0 108.771 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -123.47 162.06 23.62 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 121.321 -0.862 . . . . 0.0 110.425 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -73.04 -50.06 25.17 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.126 0.97 . . . . 0.0 111.037 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -77.55 64.96 2.98 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 126.072 1.749 . . . . 0.0 111.734 -177.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.4 p -50.14 -32.43 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.464 1.105 . . . . 0.0 111.133 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -62.38 -37.24 84.98 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.402 1.481 . . . . 0.0 110.752 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -84.54 -15.21 46.6 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.849 1.26 . . . . 0.0 112.018 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 67.4 mtp180 -79.65 134.29 36.42 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -89.96 149.55 22.53 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -135.65 166.3 23.55 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.913 1.685 . . . . 0.0 107.149 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -122.79 153.57 39.36 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 48.1 tp -116.63 100.74 8.04 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.58 1.552 . . . . 0.0 109.524 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -117.67 178.68 4.31 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 125.175 1.39 . . . . 0.0 107.449 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -153.98 161.09 42.23 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 121.85 -0.531 . . . . 0.0 111.048 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -138.78 176.24 8.86 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 126.649 1.98 . . . . 0.0 107.501 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -59.91 -16.87 33.0 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 126.169 1.788 . . . . 0.0 111.987 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.469 ' CG1' ' HE3' ' A' ' 246' ' ' LYS . 99.3 t -86.41 -37.55 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 124.293 1.037 . . . . 0.0 110.196 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 155.51 -178.94 31.85 Favored Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -78.43 165.53 23.68 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.222 1.009 . . . . 0.0 108.718 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.479 ' HB3' HG12 ' A' ' 207' ' ' VAL . 36.8 p90 -158.95 169.75 23.63 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 122.779 0.431 . . . . 0.0 109.922 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.451 HD11 ' HA3' ' A' ' 105' ' ' GLY . 96.7 mt -109.48 124.74 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 35.3 t -91.54 129.52 37.5 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -125.64 107.26 10.4 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -90.15 125.68 43.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 103.711 -2.7 . . . . 0.0 103.711 177.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.439 HG22 ' N ' ' A' ' 162' ' ' LYS . 6.3 mt -113.74 112.75 41.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.73 -160.3 25.76 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 124.945 1.26 . . . . 0.0 112.554 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 84.25 56.64 0.01 OUTLIER 'General case' 0 C--O 1.239 0.529 0 C-N-CA 128.291 2.636 . . . . 0.0 108.421 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -134.05 149.62 19.8 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-O 121.651 0.584 . . . . 0.0 112.773 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -58.68 140.01 55.25 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 128.325 2.65 . . . . 0.0 109.995 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 21.7 mm -69.16 137.03 25.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 121.16 0.505 . . . . 0.0 111.21 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.3 m -85.33 104.06 14.82 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -53.99 -28.87 40.58 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.123 0.969 . . . . 0.0 112.593 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 45.5 t -42.95 -48.76 1.2 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 125.882 1.673 . . . . 0.0 111.207 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 10.0 t -124.36 -35.21 2.81 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.294 1.038 . . . . 0.0 113.241 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 105.94 36.15 2.82 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.564 1.554 . . . . 0.0 109.238 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -114.37 152.24 31.79 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 118.463 1.131 . . . . 0.0 111.535 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -66.1 163.29 17.82 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 4.9 mmt85 -89.29 28.4 1.25 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 130.648 3.579 . . . . 0.0 112.452 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 6.1 ptm -73.32 175.31 7.01 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 121.763 2.074 . . . . 0.0 111.042 -177.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.81 153.01 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 125.289 1.436 . . . . 0.0 107.24 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -115.48 114.65 25.3 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.798 1.639 . . . . 0.0 106.951 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 12.0 mm -106.07 144.79 14.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.324 1.049 . . . . 0.0 109.138 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -125.65 98.46 5.58 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.609 1.564 . . . . 0.0 112.601 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . 0.558 ' CD1' HD13 ' A' ' 109' ' ' ILE . 54.4 m-85 -73.06 111.48 8.21 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.571 1.148 . . . . 0.0 108.003 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.479 HG12 ' HB3' ' A' ' 182' ' ' TYR . 25.4 m -125.24 163.63 25.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 C-N-CA 124.932 1.293 . . . . 0.0 109.018 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 48.7 t -85.12 146.7 27.0 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -102.03 22.39 38.28 Favored Glycine 0 N--CA 1.463 0.443 0 C-N-CA 124.361 0.981 . . . . 0.0 112.042 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.833 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 -178.283 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo . . . . . 0 N--CA 1.458 -0.601 0 N-CA-C 109.866 -0.859 . . . . 0.0 109.866 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 2.3 p -171.19 145.57 2.24 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 126.961 2.104 . . . . 0.0 108.317 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 13.9 p -149.88 172.42 15.2 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.849 0.86 . . . . 0.0 110.207 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.462 HG21 HG23 ' A' ' 221' ' ' VAL . 4.1 mt -122.36 136.08 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 125.997 1.719 . . . . 0.0 107.27 177.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -77.61 -59.37 2.81 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.425 1.49 . . . . 0.0 107.94 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . 0.473 ' HA ' ' CE1' ' A' ' 120' ' ' TYR . 68.1 p-90 -159.88 162.57 34.62 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.38 1.472 . . . . 0.0 109.259 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.462 HG23 HG21 ' A' ' 218' ' ' ILE . 47.3 t -154.43 138.67 9.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 178.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.27 163.3 20.09 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.998 0.919 . . . . 0.0 110.474 178.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -71.53 143.12 50.05 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 178.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . 0.516 HG21 ' HG3' ' A' ' 230' ' ' GLU . 9.4 t -118.67 -35.95 3.59 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.541 1.136 . . . . 0.0 111.547 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.423 ' HG3' HG23 ' A' ' 224' ' ' THR . 10.7 mttt -129.51 -175.98 3.76 Favored 'General case' 0 C--O 1.22 -0.485 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 56.5 mt -53.35 -43.31 51.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -129.56 14.54 6.0 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.512 0.725 . . . . 0.0 112.159 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 15.8 t -115.84 142.7 28.03 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -177.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -123.76 159.8 28.69 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.362 1.065 . . . . 0.0 109.037 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . 0.516 ' HG3' HG21 ' A' ' 224' ' ' THR . 25.3 mt-10 -126.77 136.74 52.81 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.885 1.674 . . . . 0.0 107.824 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -137.27 146.66 45.0 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 125.814 1.646 . . . . 0.0 109.038 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -135.5 108.04 7.4 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' A' ' 218' ' ' ILE . 2.8 m -101.15 149.63 6.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 124.542 1.137 . . . . 0.0 108.622 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.12 128.6 46.45 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.94 0.896 . . . . 0.0 112.39 -178.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -131.83 147.88 67.71 Favored Pre-proline 0 C--O 1.234 0.249 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 177.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -72.45 -43.55 0.97 Allowed 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.225 1.95 . . . . 0.0 110.512 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -54.46 -23.92 18.12 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 125.424 1.49 . . . . 0.0 113.39 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 5.4 tp -62.24 -32.8 73.53 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 121.229 -0.919 . . . . 0.0 110.432 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 9.0 m -61.6 -12.3 15.18 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.666 1.186 . . . . 0.0 112.469 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.83 -31.28 70.7 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 123.391 0.676 . . . . 0.0 109.344 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 101' ' ' THR . 4.3 mm? -82.49 122.15 27.68 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 177.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -47.35 -44.36 23.88 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.823 1.649 . . . . 0.0 112.841 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 1.1 tp -68.06 -30.71 69.98 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 120.975 -1.078 . . . . 0.0 113.704 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 19.2 mt -93.61 -5.0 49.77 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.876 1.671 . . . . 0.0 111.841 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -67.22 119.77 12.66 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.004 1.321 . . . . 0.0 109.944 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.469 ' HE3' ' CG1' ' A' ' 179' ' ' VAL . 13.3 mmmm . . . . . 0 CA--C 1.532 0.276 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.421 ' HA ' HD12 ' A' ' 98' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.462 0.159 0 CA-C-O 119.468 -0.301 . . . . 0.0 110.353 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.22 -51.17 69.06 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.782 0.833 . . . . 0.0 108.942 178.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 35.4 tp -67.22 -40.03 86.36 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.826 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 95' ' ' THR . 41.4 mt -59.66 -54.55 45.07 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 119.514 1.052 . . . . 0.0 109.889 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 52.5 m -62.68 -44.84 95.23 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.132 0.973 . . . . 0.0 110.358 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.4 tmmm? -60.83 -50.92 71.47 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.713 -0.617 . . . . 0.0 109.934 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.1 m -53.82 -44.29 70.11 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 123.873 0.869 . . . . 0.0 109.862 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.12 -45.9 92.78 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.689 0.677 . . . . 0.0 109.76 178.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.87 -61.7 2.32 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 124.573 1.149 . . . . 0.0 113.71 -178.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.98 -34.46 78.15 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 119.118 -0.468 . . . . 0.0 110.558 -178.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.34 -53.08 48.58 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.595 ' HA ' HD12 ' A' ' 109' ' ' ILE . 40.3 t -57.52 -51.57 68.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-N 118.909 1.355 . . . . 0.0 111.471 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 7.6 pttp -60.39 -33.68 72.82 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.849 -179.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 35.5 m -76.33 -30.89 57.84 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 122.235 0.214 . . . . 0.0 111.095 -178.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.595 HD12 ' HA ' ' A' ' 106' ' ' VAL . 16.1 mt -61.83 -54.97 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -62.45 -33.5 74.94 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.901 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -60.23 -35.56 75.73 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.178 0.899 . . . . 0.0 110.942 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.1 tptp -80.27 -53.67 6.43 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 28.8 mt -57.02 -28.79 62.8 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -178.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -49.35 -26.0 2.84 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.881 1.272 . . . . 0.0 112.908 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -61.33 -63.3 1.33 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.181 0.992 . . . . 0.0 112.511 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.7 mmm-85 -154.62 178.82 9.67 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.088 1.755 . . . . 0.0 110.049 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 63.4 m -86.62 174.05 9.14 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 38.5 pt -127.92 157.54 39.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 125.762 1.625 . . . . 0.0 108.778 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -151.57 145.23 24.98 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.847 1.259 . . . . 0.0 109.609 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -140.23 120.91 14.31 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.191 0.596 . . . . 0.0 111.551 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -79.22 104.61 9.96 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 178.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.06 79.97 3.6 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 57.8 -109.14 1.66 Allowed Glycine 0 CA--C 1.53 1.023 0 C-N-CA 123.992 0.806 . . . . 0.0 111.121 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -72.27 -35.96 68.87 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 118.704 -0.665 . . . . 0.0 112.281 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -99.8 168.68 9.75 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 119.336 0.971 . . . . 0.0 112.702 -177.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.4 mp -136.51 133.82 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 N-CA-C 104.059 -2.571 . . . . 0.0 104.059 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -111.68 119.98 40.49 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -117.88 124.78 49.15 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.256 0.622 . . . . 0.0 109.437 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -117.78 136.22 53.54 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.436 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.451 ' HB3' HD13 ' A' ' 133' ' ' ILE . 17.8 m -113.78 154.61 45.79 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 124.184 0.994 . . . . 0.0 111.241 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -61.99 80.56 0.09 OUTLIER 'Trans proline' 0 C--N 1.351 0.661 1 C-N-CA 125.409 4.072 . . . . 0.0 116.383 -177.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 72.95 41.74 47.57 Favored Glycine 0 CA--C 1.529 0.934 0 O-C-N 120.836 -1.165 . . . . 0.0 111.258 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.451 HD13 ' HB3' ' A' ' 130' ' ' CYS . 3.9 mp -122.93 -69.43 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.32 0 CA-C-N 118.207 1.004 . . . . 0.0 108.553 179.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -164.29 169.62 17.28 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.235 1.014 . . . . 0.0 109.849 -178.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -133.06 118.32 18.63 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 176.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.7 m -135.85 164.63 31.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 125.229 1.412 . . . . 0.0 112.327 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -125.23 123.29 39.22 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.546 1.938 . . . . 0.0 108.514 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -138.31 162.56 34.06 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.561 1.145 . . . . 0.0 110.987 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -105.54 130.59 53.56 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 178.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.512 0 N-CA-C 108.476 -1.85 . . . . 0.0 108.476 -178.605 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 . . . . . 0 N--CA 1.452 -0.363 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -149.36 115.95 5.88 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 178.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 26.5 mt -100.14 -24.81 14.48 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 159.89 161.72 11.59 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-O 122.545 1.081 . . . . 0.0 112.199 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.416 ' N ' HG22 ' A' ' 187' ' ' ILE . 38.9 ttpt -124.02 109.46 29.67 Favored Pre-proline 0 N--CA 1.43 -1.429 0 C-N-CA 125.01 1.324 . . . . 0.0 111.737 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -74.86 157.23 43.49 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 123.726 2.951 . . . . 0.0 109.223 177.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -92.73 157.54 16.39 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.791 -0.568 . . . . 0.0 109.54 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.62 -47.8 74.38 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.3 0.64 . . . . 0.0 111.572 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -74.74 64.89 1.29 Allowed 'General case' 0 N--CA 1.461 0.102 0 C-N-CA 126.701 2.001 . . . . 0.0 113.162 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.4 p -47.55 -31.82 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 124.382 1.073 . . . . 0.0 112.969 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -64.85 -32.44 74.15 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 122.401 1.095 . . . . 0.0 112.283 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -87.78 -15.1 37.88 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.165 1.386 . . . . 0.0 111.173 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -80.74 133.58 35.69 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -98.78 149.2 23.11 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -134.41 169.98 16.43 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.087 1.355 . . . . 0.0 108.565 -178.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -120.77 152.97 37.65 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 122.908 0.483 . . . . 0.0 109.791 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 14.2 tp -110.59 110.62 21.4 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 125.417 1.487 . . . . 0.0 107.384 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.575 HD23 ' HB2' ' A' ' 184' ' ' SER . 2.6 mm? -123.65 -179.23 4.28 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 127.316 2.246 . . . . 0.0 108.595 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -144.69 167.97 21.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.435 0.636 . . . . 0.0 111.005 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -140.64 -176.11 4.53 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 126.734 2.014 . . . . 0.0 107.646 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -64.04 -11.87 33.36 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 121.386 -0.821 . . . . 0.0 112.965 -177.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 85.0 t -106.23 -36.42 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 124.62 1.168 . . . . 0.0 112.485 -178.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 169.4 -173.62 43.74 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 119.389 0.995 . . . . 0.0 112.476 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.419 ' CD2' ' HB3' ' A' ' 243' ' ' LEU . 5.1 m-30 -79.97 162.97 24.62 Favored 'General case' 0 C--O 1.241 0.654 0 O-C-N 122.107 -0.643 . . . . 0.0 110.125 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -159.22 168.96 25.18 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.501 -1.227 . . . . 0.0 112.053 -179.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 92.1 mt -104.74 127.5 59.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.575 ' HB2' HD23 ' A' ' 175' ' ' LEU . 22.5 t -100.07 115.08 28.93 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.915 1.286 . . . . 0.0 108.802 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -111.83 107.01 15.91 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -89.54 111.84 23.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.447 0 N-CA-C 103.455 -2.795 . . . . 0.0 103.455 177.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.416 HG22 ' N ' ' A' ' 162' ' ' LYS . 6.7 mt -95.87 106.64 18.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.01 -157.42 26.29 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.0 t 85.29 3.61 0.62 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 127.667 2.387 . . . . 0.0 108.679 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -63.74 136.78 41.5 Favored Glycine 0 N--CA 1.435 -1.411 0 N-CA-C 108.256 -1.937 . . . . 0.0 108.256 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.26 148.25 27.9 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.469 1.108 . . . . 0.0 108.842 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.8 mm -70.37 130.76 34.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 122.863 1.316 . . . . 0.0 113.893 -177.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.3 m -85.46 107.5 17.45 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 128.448 2.699 . . . . 0.0 108.171 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -53.74 -18.38 3.09 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 127.963 2.505 . . . . 0.0 113.436 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 18.0 t -56.24 -54.77 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 125.935 1.694 . . . . 0.0 109.805 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 13.3 t -123.75 -29.68 3.67 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.189 0.996 . . . . 0.0 112.49 -178.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 104.6 35.75 3.21 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -115.48 160.1 20.35 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.282 1.541 . . . . 0.0 111.9 -178.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -77.54 151.43 34.53 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 118.867 0.758 . . . . 0.0 112.996 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -71.0 28.65 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.667 1 C-N-CA 132.129 4.172 . . . . 0.0 109.988 177.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 7.0 ptm -73.47 173.78 9.15 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 122.617 1.199 . . . . 0.0 112.002 -176.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.08 147.04 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 124.488 1.115 . . . . 0.0 108.733 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -106.83 104.37 14.04 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 125.635 1.574 . . . . 0.0 107.241 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 12.6 mm -93.24 147.21 5.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -126.84 101.75 6.73 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.008 1.723 . . . . 0.0 107.638 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . 0.509 ' CD1' HD13 ' A' ' 109' ' ' ILE . 40.9 m-85 -84.34 111.15 19.17 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 6.4 m -125.13 168.13 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.718 0.77 . . . . 0.0 109.605 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 49.8 t -87.88 142.15 28.03 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -88.49 -0.69 81.89 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-O 118.464 -1.187 . . . . 0.0 113.07 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.739 0 N-CA-C 107.31 -2.316 . . . . 0.0 107.31 -178.234 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo . . . . . 0 N--CA 1.451 -0.987 0 N-CA-C 110.973 -0.433 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 19.0 p -160.21 147.7 16.34 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 120.624 -1.298 . . . . 0.0 108.951 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 82.8 p -148.04 166.43 27.79 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.632 0.773 . . . . 0.0 109.31 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 3.4 mt -105.47 149.51 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 177.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -99.1 -44.95 6.09 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.653 0.781 . . . . 0.0 112.29 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 66.9 p-90 -163.63 155.12 16.79 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.15 1.78 . . . . 0.0 107.51 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 59.1 t -151.96 131.54 3.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 C-N-CA 125.565 1.546 . . . . 0.0 107.479 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.78 163.43 36.73 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.185 0.902 . . . . 0.0 111.848 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -77.74 129.07 35.03 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 104.02 -2.585 . . . . 0.0 104.02 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . 0.435 HG23 ' HG3' ' A' ' 225' ' ' LYS . 9.8 t -108.55 -28.33 9.37 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.886 1.275 . . . . 0.0 113.089 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.435 ' HG3' HG23 ' A' ' 224' ' ' THR . 59.1 mttt -135.9 -176.05 4.17 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 124.468 1.107 . . . . 0.0 108.621 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 68.9 mt -47.86 -47.49 12.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.591 -0.732 . . . . 0.0 112.365 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 3.7 t -133.06 18.08 4.11 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.131 1.373 . . . . 0.0 111.372 -178.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 22.0 t -114.96 142.48 27.64 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -178.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -121.29 162.94 19.38 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.202 1.401 . . . . 0.0 107.226 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -135.47 143.57 45.93 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 179.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -142.8 150.14 39.57 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -137.6 122.41 18.79 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 104.33 -2.47 . . . . 0.0 104.33 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 3.5 m -119.09 150.74 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -178.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.3 p -120.94 132.82 55.17 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.149 0.98 . . . . 0.0 111.608 -178.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 6.6 pt -138.32 154.85 74.09 Favored Pre-proline 0 N--CA 1.453 -0.278 0 C-N-CA 125.317 1.447 . . . . 0.0 109.205 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -76.08 -49.93 0.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.256 2.638 . . . . 0.0 112.296 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -53.01 -15.83 0.9 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 118.002 2.593 . . . . 0.0 118.002 -176.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 22.9 mt -77.52 -26.89 51.51 Favored 'General case' 0 CA--C 1.517 -0.308 0 O-C-N 120.958 -1.089 . . . . 0.0 109.648 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 5.8 m -56.13 -21.37 22.07 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.112 0.965 . . . . 0.0 111.724 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -59.49 -36.07 75.34 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.635 1.174 . . . . 0.0 109.347 178.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.58 125.2 30.24 Favored 'General case' 0 CA--C 1.521 -0.164 0 O-C-N 120.941 -1.1 . . . . 0.0 108.322 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -47.49 -48.83 26.94 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -178.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.419 ' HB3' ' CD2' ' A' ' 181' ' ' TYR . 22.5 mt -68.58 -26.87 65.6 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -178.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 13.8 mt -91.97 -13.47 31.02 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.219 0.608 . . . . 0.0 112.291 -178.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -58.15 141.83 49.15 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 128.283 2.633 . . . . 0.0 113.061 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp . . . . . 0 C--N 1.33 -0.257 0 C-N-CA 127.659 2.383 . . . . 0.0 110.093 179.532 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.549 HG22 HD12 ' A' ' 98' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--O 1.233 0.222 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.89 -39.26 93.78 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 56.4 tp -63.58 -38.26 90.46 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.549 HD12 HG22 ' A' ' 95' ' ' THR . 64.8 mt -59.37 -54.55 45.45 Favored 'General case' 0 C--N 1.345 0.381 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.0 m -64.06 -45.98 86.38 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.889 0.476 . . . . 0.0 111.755 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.54 -47.61 79.07 Favored 'General case' 0 CA--C 1.516 -0.362 0 O-C-N 121.397 -0.815 . . . . 0.0 109.632 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 91.7 m -55.15 -47.3 75.31 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.358 0.663 . . . . 0.0 110.703 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -56.73 -47.0 80.97 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 123.438 0.462 . . . . 0.0 110.007 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.37 -56.93 6.05 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.854 0.835 . . . . 0.0 112.52 -178.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -56.96 -42.04 79.41 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 125.058 1.343 . . . . 0.0 110.651 -178.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.68 -52.79 39.53 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-O 117.673 -1.626 . . . . 0.0 109.594 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.452 ' HA ' HD12 ' A' ' 109' ' ' ILE . 50.8 t -55.89 -45.62 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 120.155 1.978 . . . . 0.0 110.485 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.2 pttp -61.3 -35.83 78.43 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.193 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 51.8 m -75.14 -36.69 61.54 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.898 0.879 . . . . 0.0 110.301 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.452 HD12 ' HA ' ' A' ' 106' ' ' VAL . 20.0 mt -59.17 -55.04 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -60.0 -34.22 73.03 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 124.066 0.854 . . . . 0.0 111.726 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -63.42 -37.75 88.51 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -178.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.8 mmmt -86.07 -42.79 13.64 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 19.2 mt -61.73 -29.19 69.95 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-O 117.808 -1.092 . . . . 0.0 111.685 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -47.83 -30.79 4.32 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.704 2.002 . . . . 0.0 111.807 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -64.85 -70.34 0.24 Allowed 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 122.813 0.445 . . . . 0.0 111.544 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -145.35 -178.62 6.16 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.628 1.171 . . . . 0.0 112.275 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 60.2 m -86.82 171.2 11.05 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 27.3 pt -121.91 160.35 23.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 127.087 2.155 . . . . 0.0 107.41 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -156.4 134.8 11.47 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.043 0.537 . . . . 0.0 111.957 -178.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -132.09 121.21 23.45 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.65 0.78 . . . . 0.0 110.562 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -87.95 99.44 12.14 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.41 80.71 6.72 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 127.363 2.265 . . . . 0.0 108.952 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.17 -111.53 4.08 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 108.158 -1.977 . . . . 0.0 108.158 -179.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -85.88 -24.4 26.67 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -100.53 159.4 15.18 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 119.551 1.069 . . . . 0.0 111.851 -178.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.2 mp -132.73 140.9 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.456 ' CD1' HG11 ' A' ' 221' ' ' VAL . 88.5 m-85 -121.72 119.55 32.09 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -107.5 116.44 31.94 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.189 0.595 . . . . 0.0 110.087 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -109.27 129.19 55.52 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 122.03 -0.419 . . . . 0.0 110.673 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.41 ' HB3' HD13 ' A' ' 133' ' ' ILE . 52.3 m -110.95 155.9 41.68 Favored Pre-proline 0 N--CA 1.446 -0.641 0 C-N-CA 127.266 2.226 . . . . 0.0 113.312 -178.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.26 70.75 0.15 Allowed 'Trans proline' 0 CA--C 1.542 0.904 1 C-N-CA 125.647 4.231 . . . . 0.0 114.717 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 68.57 57.51 8.06 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 120.466 -1.396 . . . . 0.0 110.911 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.41 HD13 ' HB3' ' A' ' 130' ' ' CYS . 2.0 mp -124.65 -71.72 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.303 0 CA-C-N 118.333 1.067 . . . . 0.0 109.251 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -175.21 138.29 0.42 Allowed 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -109.8 125.22 52.5 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.984 0.811 . . . . 0.0 109.722 -176.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 20.0 m -142.9 163.97 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.795 1.238 . . . . 0.0 111.637 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -122.13 129.6 52.48 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.222 1.409 . . . . 0.0 108.266 178.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -139.13 162.96 33.67 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.017 0.927 . . . . 0.0 112.074 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 53.1 t60 -84.85 160.87 20.1 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 177.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.653 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 -179.517 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 . . . . . 0 CA--C 1.516 -0.335 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -140.86 134.01 29.46 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 58.7 mt -119.92 -26.25 5.65 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 125.286 1.616 . . . . 0.0 108.031 178.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 156.13 154.61 7.05 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 119.543 1.065 . . . . 0.0 111.096 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -117.57 109.95 41.23 Favored Pre-proline 0 C--O 1.236 0.347 0 C-N-CA 124.138 0.975 . . . . 0.0 108.412 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -73.3 -169.44 0.52 Allowed 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 124.003 3.135 . . . . 0.0 109.445 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -126.86 156.32 41.55 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.833 1.253 . . . . 0.0 108.549 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.44 -45.29 39.61 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.361 0.664 . . . . 0.0 111.247 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -74.9 65.75 1.45 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.602 1.561 . . . . 0.0 111.518 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.3 p -45.55 -35.09 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 124.762 1.225 . . . . 0.0 112.52 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -63.9 -36.43 83.91 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -178.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -74.31 -15.84 60.95 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.746 0.819 . . . . 0.0 113.046 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 20.5 mtp-105 -78.22 178.17 7.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 122.096 0.951 . . . . 0.0 110.097 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -127.27 144.6 51.01 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 178.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -132.22 165.95 22.97 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -123.89 147.74 47.42 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 16.0 tp -114.58 98.06 6.66 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -112.25 -179.26 3.63 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 127.856 2.463 . . . . 0.0 106.757 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -149.4 165.22 32.72 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.617 0.722 . . . . 0.0 109.446 178.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -135.88 179.64 6.22 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 126.654 1.981 . . . . 0.0 110.513 -178.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.26 -18.75 63.89 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.904 1.282 . . . . 0.0 109.656 178.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 25.6 t -87.24 -25.3 6.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 129.771 3.228 . . . . 0.0 111.805 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 132.87 -167.95 23.07 Favored Glycine 0 N--CA 1.444 -0.779 0 O-C-N 121.279 -0.888 . . . . 0.0 111.701 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -77.71 163.31 26.29 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 121.841 -0.8 . . . . 0.0 110.367 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -160.73 167.36 27.03 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.635 1.174 . . . . 0.0 111.082 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 83.9 mt -106.15 138.28 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 17.4 t -113.01 135.15 54.09 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.041 0.937 . . . . 0.0 109.052 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -127.22 110.88 13.32 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 125.815 1.646 . . . . 0.0 108.57 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -93.52 111.49 24.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 7.5 mt -98.45 108.28 21.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 179.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -94.63 -153.28 30.14 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 66.6 m 66.19 54.73 0.94 Allowed 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.208 1.003 . . . . 0.0 112.912 178.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.423 ' HA3' ' HB3' ' A' ' 200' ' ' ARG . . . -102.02 -137.84 9.83 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -140.58 128.8 22.32 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 177.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 28.8 mm -60.21 132.3 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 121.911 0.862 . . . . 0.0 111.743 -178.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 3.0 m -84.92 111.34 19.58 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 128.101 2.56 . . . . 0.0 109.245 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.76 -19.58 11.73 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.125 1.77 . . . . 0.0 113.774 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 60.9 t -56.62 -51.75 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 124.652 1.181 . . . . 0.0 110.33 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 13.9 t -125.12 -25.1 3.89 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 99.0 35.51 4.79 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 107.556 -2.218 . . . . 0.0 107.556 -178.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -103.98 152.52 21.91 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 118.519 1.16 . . . . 0.0 113.732 -178.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -78.42 138.94 38.74 Favored 'General case' 0 C--N 1.335 -0.052 0 C-N-CA 124.025 0.93 . . . . 0.0 109.152 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.423 ' HB3' ' HA3' ' A' ' 190' ' ' GLY 0.3 34.3 ttt180 -69.94 30.52 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 130.705 3.602 . . . . 0.0 113.598 178.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 5.2 ptm -74.18 171.92 12.71 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.056 -1.028 . . . . 0.0 109.216 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.77 148.79 22.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 C-N-CA 124.679 1.191 . . . . 0.0 107.819 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -110.17 116.39 31.43 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 14.4 mm -103.97 141.08 20.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -124.43 110.09 14.1 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 126.067 1.747 . . . . 0.0 109.774 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -87.31 110.85 20.51 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.479 1.111 . . . . 0.0 108.875 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 11.2 m -123.11 163.66 21.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 46.1 t -88.07 146.58 25.38 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -97.86 16.91 59.62 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-O 117.914 -1.492 . . . . 0.0 113.057 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.077 0 C-N-CA 126.646 2.07 . . . . 0.0 113.875 179.507 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo . . . . . 0 CA--C 1.539 0.753 0 N-CA-C 110.145 -0.752 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 4.6 p -166.88 148.27 6.02 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 127.055 2.142 . . . . 0.0 107.34 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 10.4 p -154.39 165.97 34.72 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.182 1.393 . . . . 0.0 109.556 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 4.9 mt -108.54 153.81 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 126.567 1.947 . . . . 0.0 106.592 178.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -101.1 -52.21 3.33 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 123.44 0.696 . . . . 0.0 110.484 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 58.9 p-90 -157.07 157.32 34.36 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -178.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.456 HG11 ' CD1' ' A' ' 127' ' ' TYR . 91.3 t -153.16 122.56 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -178.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.22 167.5 29.6 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.511 1.05 . . . . 0.0 110.784 178.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -73.07 132.05 42.85 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 6.7 t -109.35 -38.59 5.45 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.427 1.091 . . . . 0.0 110.22 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 6.7 mttt -130.92 178.57 6.57 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 73.1 mt -49.51 -46.98 20.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -126.19 22.32 7.24 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 6.5 t -122.86 138.64 52.25 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.545 0 O-C-N 121.191 -0.943 . . . . 0.0 110.081 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -120.97 162.26 20.2 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -132.53 145.71 51.35 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.24 119.36 8.26 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.218 1.007 . . . . 0.0 108.471 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -107.36 126.93 53.08 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 4.0 m -118.14 154.38 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-N 117.717 0.235 . . . . 0.0 110.797 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 2.3 p -121.56 124.82 45.31 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.33 1.052 . . . . 0.0 110.911 -177.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 2.3 pt -136.84 129.49 17.29 Favored Pre-proline 0 N--CA 1.444 -0.728 0 CA-C-N 114.922 -1.035 . . . . 0.0 108.831 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -64.85 -31.12 57.82 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.065 2.51 . . . . 0.0 113.388 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -64.25 -14.13 53.74 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -177.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 44.6 mt -76.88 -31.03 56.48 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 120.475 -1.391 . . . . 0.0 109.908 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 15.6 m -55.88 -12.06 1.24 Allowed 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -70.42 -32.04 69.48 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 121.497 -0.752 . . . . 0.0 110.043 179.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.9 mt -80.71 123.16 27.96 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.669 1.988 . . . . 0.0 106.671 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -47.51 -48.09 27.44 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.074 1.349 . . . . 0.0 114.081 -178.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 56.1 mt -66.65 -32.53 73.91 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 119.298 0.954 . . . . 0.0 112.847 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 15.9 mt -91.68 -5.57 53.53 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -65.31 134.42 53.54 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 127.55 2.34 . . . . 0.0 110.3 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt . . . . . 0 CA--C 1.511 -0.554 0 C-N-CA 125.214 1.406 . . . . 0.0 111.146 179.872 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 CA--C 1.522 -0.133 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.54 -43.63 84.53 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 53.1 tp -68.28 -36.7 79.79 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-O 118.459 -0.782 . . . . 0.0 109.401 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.456 HD23 HD11 ' A' ' 243' ' ' LEU . 60.5 mt -60.26 -54.69 42.78 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 118.935 0.789 . . . . 0.0 109.694 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 50.9 m -58.78 -49.12 78.87 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.314 1.046 . . . . 0.0 109.845 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.22 -44.69 96.86 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 118.095 -0.955 . . . . 0.0 110.905 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 63.0 m -52.33 -49.3 64.54 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 119.286 0.948 . . . . 0.0 110.682 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -55.38 -50.73 68.94 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 122.744 0.417 . . . . 0.0 110.101 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.36 -55.49 15.63 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 115.151 1.538 . . . . 0.0 115.151 -178.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -64.94 -38.1 89.84 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.497 1.119 . . . . 0.0 110.648 -177.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.551 ' HA3' HD11 ' A' ' 183' ' ' ILE . . . -61.03 -52.57 51.42 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.526 ' HA ' HD12 ' A' ' 109' ' ' ILE . 54.2 t -57.37 -44.88 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 118.671 1.236 . . . . 0.0 109.72 178.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -61.7 -35.78 79.02 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 118.53 -1.268 . . . . 0.0 111.643 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 59.3 m -65.64 -46.43 79.22 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -178.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 106' ' ' VAL . 19.3 mt -56.92 -54.96 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 CA-C-O 121.568 0.699 . . . . 0.0 109.738 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -64.61 -27.81 69.19 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -62.61 -42.73 99.75 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -83.25 -43.16 16.37 Favored 'General case' 0 C--N 1.341 0.234 0 O-C-N 121.278 -0.889 . . . . 0.0 113.038 -179.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.4 mt -62.87 -27.38 69.31 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.099 0.863 . . . . 0.0 113.243 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -44.38 -33.86 1.8 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.484 1.514 . . . . 0.0 113.825 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -64.43 -69.5 0.28 Allowed 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.909 1.283 . . . . 0.0 113.944 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 -140.07 172.58 12.55 Favored 'General case' 0 CA--C 1.518 -0.27 0 O-C-N 121.097 -1.002 . . . . 0.0 112.979 -177.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 37.7 m -87.13 160.7 18.45 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 178.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 34.9 pt -114.37 157.03 15.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 124.906 1.282 . . . . 0.0 107.544 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -151.4 134.29 15.75 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 123.801 0.84 . . . . 0.0 109.263 -178.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.615 ' CE1' ' HB2' ' A' ' 122' ' ' ALA . 21.7 t80 -133.16 120.95 21.87 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 123.741 0.817 . . . . 0.0 111.615 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -84.48 101.41 12.02 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.542 1.137 . . . . 0.0 108.614 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.615 ' HB2' ' CE1' ' A' ' 120' ' ' TYR . . . -94.75 80.34 3.76 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.04 -124.65 20.51 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -70.97 -31.2 67.69 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 48.0 m95 -99.83 152.02 20.61 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 118.546 0.612 . . . . 0.0 110.344 -178.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.7 mp -125.15 144.73 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 104.481 -2.415 . . . . 0.0 104.481 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -122.12 119.68 32.04 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -178.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -113.63 126.51 55.35 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.918 0.887 . . . . 0.0 109.091 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -124.98 126.77 45.97 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.424 0.69 . . . . 0.0 109.801 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.461 ' HB3' HD13 ' A' ' 133' ' ' ILE . 15.0 m -104.46 155.96 36.57 Favored Pre-proline 0 CA--C 1.532 0.257 0 C-N-CA 123.929 0.892 . . . . 0.0 111.47 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -63.13 83.25 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 124.385 3.39 . . . . 0.0 114.597 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.38 42.96 63.81 Favored Glycine 0 CA--C 1.526 0.77 0 O-C-N 120.776 -1.202 . . . . 0.0 113.079 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.461 HD13 ' HB3' ' A' ' 130' ' ' CYS . 3.6 mp -122.7 -70.25 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -161.86 168.52 22.9 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.849 1.259 . . . . 0.0 110.611 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -132.42 126.84 34.07 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 104.459 -2.422 . . . . 0.0 104.459 177.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.2 m -144.81 164.17 13.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 124.999 1.32 . . . . 0.0 112.321 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -130.24 118.77 21.86 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -137.9 162.82 33.04 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.871 1.668 . . . . 0.0 111.23 -178.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -94.08 148.29 22.32 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.524 0 C-N-CA 125.301 1.429 . . . . 0.0 110.343 -179.69 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 . . . . . 0 C--O 1.235 0.298 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -145.45 136.87 25.08 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 124.69 1.196 . . . . 0.0 107.926 178.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.1 mp -116.15 -27.74 6.8 Favored 'General case' 0 C--O 1.221 -0.444 0 O-C-N 125.486 1.741 . . . . 0.0 107.277 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 157.3 163.45 12.55 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -126.97 110.24 21.92 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 124.03 0.932 . . . . 0.0 111.428 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -71.96 177.57 6.91 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.907 3.071 . . . . 0.0 109.274 178.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -121.1 146.67 46.49 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.31 -45.94 76.3 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.171 1.388 . . . . 0.0 112.178 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.432 HD22 ' CD ' ' A' ' 169' ' ' GLU . 48.8 m-20 -73.41 67.13 1.0 Allowed 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 127.581 2.353 . . . . 0.0 110.249 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.5 p -44.82 -32.74 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 O-C-N 121.196 -0.94 . . . . 0.0 113.385 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -65.25 -31.74 73.05 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 119.186 0.903 . . . . 0.0 111.671 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.432 ' CD ' HD22 ' A' ' 166' ' ' ASN . 98.0 mt-10 -71.74 -30.56 65.74 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 124.03 0.932 . . . . 0.0 110.049 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 25.7 mtt180 -69.08 152.46 45.17 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -114.06 143.12 45.29 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -129.63 168.06 17.02 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.159 1.384 . . . . 0.0 112.072 -177.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -133.62 154.67 50.71 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 124.884 1.274 . . . . 0.0 111.265 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 57.5 tp -109.23 98.63 8.03 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 127.28 2.232 . . . . 0.0 110.252 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.42 HD23 ' HB2' ' A' ' 184' ' ' SER . 2.1 mm? -112.17 -179.26 3.63 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 127.649 2.38 . . . . 0.0 108.581 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -141.7 166.29 25.15 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.188 0.518 . . . . 0.0 111.461 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -139.28 179.99 6.21 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 127.313 2.245 . . . . 0.0 108.39 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -57.4 -19.25 22.11 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.477 1.111 . . . . 0.0 112.389 -178.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 40.7 t -92.6 -54.84 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 O-C-N 120.651 -1.281 . . . . 0.0 110.43 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 178.7 -153.52 12.78 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -178.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.405 ' CD2' HD13 ' A' ' 243' ' ' LEU . 6.3 m-30 -86.64 168.79 13.29 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 122.43 1.109 . . . . 0.0 110.772 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -158.57 176.09 12.84 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.014 1.725 . . . . 0.0 109.559 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.551 HD11 ' HA3' ' A' ' 105' ' ' GLY . 89.3 mt -110.95 138.27 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 176.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.42 ' HB2' HD23 ' A' ' 175' ' ' LEU . 14.2 t -100.96 128.53 46.95 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -129.15 110.03 11.66 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -92.42 135.66 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 104.604 -2.369 . . . . 0.0 104.604 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 3.8 mt -112.74 106.2 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 104.782 -2.303 . . . . 0.0 104.782 176.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -99.32 -155.49 28.65 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.5 t 68.72 56.19 0.45 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-O 122.516 1.151 . . . . 0.0 111.766 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -131.82 157.07 22.23 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 128.401 2.905 . . . . 0.0 106.396 177.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -72.62 150.91 42.64 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.219 1.007 . . . . 0.0 112.273 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.9 mm -65.99 136.23 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-O 121.274 0.559 . . . . 0.0 110.379 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.5 m -79.87 115.52 19.5 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.707 2.003 . . . . 0.0 106.979 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -55.06 -21.7 13.39 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.863 1.265 . . . . 0.0 112.957 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 31.6 t -51.44 -61.16 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.205 0 C-N-CA 126.966 2.106 . . . . 0.0 112.24 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . 0.544 HG22 HG21 ' A' ' 226' ' ' ILE . 5.1 t -125.69 -24.12 3.9 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.318 1.047 . . . . 0.0 113.762 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 105.61 34.87 3.2 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -178.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -98.91 149.72 22.65 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 118.851 1.326 . . . . 0.0 112.112 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -74.71 141.04 44.52 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.942 0.897 . . . . 0.0 110.737 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -66.64 27.71 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 131.269 3.828 . . . . 0.0 113.882 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 8.2 ptm -75.14 177.09 6.7 Favored 'General case' 0 C--N 1.319 -0.743 0 O-C-N 120.788 -1.195 . . . . 0.0 111.787 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.0 p -147.18 153.62 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 126.612 1.965 . . . . 0.0 106.408 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -116.77 117.63 30.3 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.801 1.24 . . . . 0.0 108.324 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 9.2 mm -102.25 148.53 7.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -126.09 103.73 7.87 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 128.274 2.63 . . . . 0.0 108.97 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . 0.432 ' CD1' HD13 ' A' ' 109' ' ' ILE . 35.0 m-85 -83.25 109.8 17.54 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.967 1.307 . . . . 0.0 108.706 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 5.8 m -125.17 163.4 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 47.5 t -84.76 139.83 31.69 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 178.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -86.97 -0.07 85.87 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 118.369 -1.239 . . . . 0.0 112.7 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.678 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 -178.72 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo . . . . . 0 N--CA 1.454 -0.806 0 CA-C-O 120.085 -0.048 . . . . 0.0 112.003 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.7 p -158.66 148.94 19.78 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.283 1.433 . . . . 0.0 108.751 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 1.7 p -152.62 170.51 20.04 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.423 1.089 . . . . 0.0 110.365 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 4.8 mt -113.17 154.37 14.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 126.406 1.883 . . . . 0.0 107.291 178.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -104.38 -46.6 4.35 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.886 0.875 . . . . 0.0 111.527 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -160.93 155.63 23.71 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.972 1.709 . . . . 0.0 107.781 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 59.9 t -154.05 123.56 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 125.68 1.592 . . . . 0.0 106.999 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -154.13 161.68 41.71 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 118.913 0.779 . . . . 0.0 111.21 179.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -69.18 136.99 52.9 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . 0.636 HG23 ' HG3' ' A' ' 225' ' ' LYS . 2.0 t -119.2 -28.75 5.37 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.199 1.0 . . . . 0.0 111.866 -179.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.636 ' HG3' HG23 ' A' ' 224' ' ' THR . 7.5 mttm -134.98 -176.66 4.32 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 124.123 0.969 . . . . 0.0 108.709 178.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.544 HG21 HG22 ' A' ' 196' ' ' THR . 1.9 mm -50.41 -48.98 25.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 123.346 0.659 . . . . 0.0 112.133 -178.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -128.13 23.56 6.04 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.373 1.469 . . . . 0.0 111.63 -178.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 14.1 t -127.47 146.37 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 CA-C-O 122.045 0.926 . . . . 0.0 110.367 -178.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -126.14 161.84 26.73 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . 0.48 ' CD ' HG21 ' A' ' 224' ' ' THR . 10.9 mt-10 -134.35 141.32 46.85 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -140.09 140.12 36.01 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 125.31 1.444 . . . . 0.0 110.233 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -120.47 114.35 21.65 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 2.5 m -107.87 148.1 12.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.4 p -122.17 135.93 54.84 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 123.567 0.747 . . . . 0.0 111.927 -178.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -140.6 152.25 65.68 Favored Pre-proline 0 N--CA 1.451 -0.402 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.074 177.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -74.91 -50.86 0.13 Allowed 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.496 2.797 . . . . 0.0 111.995 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -52.98 -27.13 17.69 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 117.606 -1.188 . . . . 0.0 113.911 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 238' ' ' LEU . 9.8 tp -59.23 -25.39 63.98 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 120.538 1.517 . . . . 0.0 112.258 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 3.4 m -64.74 -9.2 18.47 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.805 0.842 . . . . 0.0 111.963 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 42.5 p-10 -60.29 -40.3 89.95 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 125.337 1.455 . . . . 0.0 109.418 178.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -83.7 123.91 30.32 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 124.78 1.232 . . . . 0.0 108.591 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -47.18 -47.89 23.93 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.749 2.02 . . . . 0.0 113.31 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.456 HD11 HD23 ' A' ' 98' ' ' LEU . 40.6 mt -65.6 -20.09 66.17 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -178.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 5.2 mt -107.1 -11.75 15.56 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.176 1.39 . . . . 0.0 112.249 -178.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -63.29 131.12 47.3 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 128.479 2.712 . . . . 0.0 110.082 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt . . . . . 0 N--CA 1.465 0.285 0 C-N-CA 124.237 1.015 . . . . 0.0 110.017 179.764 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.211 0.053 . . . . 0.0 111.012 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.54 -43.4 89.24 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 13.0 tp -69.71 -36.18 75.7 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.239 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.561 HD23 HD11 ' A' ' 243' ' ' LEU . 62.3 mt -59.13 -54.72 43.83 Favored 'General case' 0 C--N 1.343 0.288 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 20.7 m -65.37 -42.29 92.88 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 121.559 -0.713 . . . . 0.0 110.938 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.29 -42.4 95.39 Favored 'General case' 0 C--N 1.341 0.214 0 O-C-N 120.874 -1.141 . . . . 0.0 110.472 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 80.3 m -56.59 -46.45 80.81 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.776 0.83 . . . . 0.0 109.805 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -59.79 -45.14 93.25 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 118.233 0.47 . . . . 0.0 110.604 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -65.19 -61.11 2.33 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 122.26 1.029 . . . . 0.0 112.013 -178.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -62.3 -36.89 83.53 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.369 -178.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -65.6 -53.35 32.18 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-O 118.114 -1.381 . . . . 0.0 110.149 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.646 ' HA ' HD12 ' A' ' 109' ' ' ILE . 45.4 t -58.28 -44.16 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 119.913 1.857 . . . . 0.0 109.957 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.7 ptmt -64.74 -32.94 74.85 Favored 'General case' 0 C--O 1.226 -0.168 0 C-N-CA 119.604 -0.839 . . . . 0.0 111.695 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.6 m -76.08 -33.78 59.53 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 123.441 0.696 . . . . 0.0 109.738 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.646 HD12 ' HA ' ' A' ' 106' ' ' VAL . 16.6 mt -62.75 -55.52 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 178.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -61.92 -28.57 69.62 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 117.948 -1.025 . . . . 0.0 112.39 -179.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.64 -38.16 86.68 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.963 1.256 . . . . 0.0 112.656 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.416 ' HE3' ' CD ' ' A' ' 237' ' ' GLU . 0.6 OUTLIER -95.48 -37.48 10.88 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.491 -0.755 . . . . 0.0 110.847 179.538 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 15.8 mt -62.64 -28.35 69.86 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 118.66 0.664 . . . . 0.0 110.734 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -50.15 -34.71 23.23 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.613 1.165 . . . . 0.0 113.536 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -55.5 -61.74 2.15 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.735 1.214 . . . . 0.0 112.554 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -151.61 174.59 13.27 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.86 1.664 . . . . 0.0 110.761 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 56.7 m -86.61 170.94 11.4 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 114.006 -1.452 . . . . 0.0 108.684 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 29.6 pt -127.78 162.82 32.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 126.272 1.829 . . . . 0.0 109.004 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.72 145.28 22.24 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -136.87 125.7 24.09 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -88.88 108.04 19.32 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.075 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.37 80.3 3.93 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 178.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 58.75 -107.92 1.35 Allowed Glycine 0 CA--C 1.53 0.989 0 O-C-N 121.807 -0.558 . . . . 0.0 111.713 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -81.47 -17.88 47.2 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.546 1.938 . . . . 0.0 113.715 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 65.8 m95 -111.88 157.39 20.68 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 123.406 0.682 . . . . 0.0 110.121 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.2 mp -133.3 136.84 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -113.33 129.95 56.4 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -121.55 125.61 47.19 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 123.682 0.793 . . . . 0.0 110.885 -178.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -124.77 129.94 51.43 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.899 0.857 . . . . 0.0 110.63 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.524 ' HB3' HD13 ' A' ' 133' ' ' ILE . 2.1 m -111.18 156.41 41.07 Favored Pre-proline 0 C--N 1.33 -0.262 0 C-N-CA 125.303 1.441 . . . . 0.0 110.314 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -64.36 82.04 0.16 Allowed 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.775 2.983 . . . . 0.0 114.097 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 69.79 50.14 31.8 Favored Glycine 0 CA--C 1.533 1.209 0 O-C-N 120.785 -1.197 . . . . 0.0 113.683 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.524 HD13 ' HB3' ' A' ' 130' ' ' CYS . 3.4 mp -125.18 -68.28 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 119.042 1.421 . . . . 0.0 108.508 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -165.72 159.3 16.14 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 124.906 1.282 . . . . 0.0 109.213 179.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -122.96 123.07 40.08 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 104.554 -2.387 . . . . 0.0 104.554 176.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 16.6 m -143.37 163.98 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 123.485 0.714 . . . . 0.0 110.654 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -123.77 117.91 25.99 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -139.76 163.37 32.79 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 118.937 0.79 . . . . 0.0 112.039 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -90.07 154.99 19.37 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.273 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.468 0 O-C-N 120.674 -1.266 . . . . 0.0 111.583 179.61 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 . . . . . 0 N--CA 1.466 0.363 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.96 104.94 3.48 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.697 1.199 . . . . 0.0 109.414 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.3 mp -90.99 -28.59 17.91 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 162.76 156.77 8.68 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.7 mtpt -122.29 110.06 32.77 Favored Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 123.697 0.799 . . . . 0.0 108.997 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -79.73 170.12 17.34 Favored 'Trans proline' 0 N--CA 1.456 -0.698 1 C-N-CA 125.736 4.291 . . . . 0.0 109.133 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -105.7 159.72 15.76 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 123.036 0.534 . . . . 0.0 110.703 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -72.99 -43.39 62.25 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -73.39 64.01 0.8 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.416 1.486 . . . . 0.0 110.279 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.4 p -53.51 -29.48 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 O-C-N 120.653 -1.279 . . . . 0.0 110.821 178.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -63.13 -28.04 69.79 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.897 1.679 . . . . 0.0 112.748 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -88.57 -19.78 25.88 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 125.405 1.482 . . . . 0.0 112.462 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -77.77 154.68 31.74 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -107.85 149.45 28.25 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -137.13 173.99 11.09 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 126.681 1.992 . . . . 0.0 109.24 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -132.99 153.93 50.99 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.411 1.085 . . . . 0.0 110.455 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 25.1 tp -115.05 98.55 6.87 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 127.03 2.132 . . . . 0.0 108.53 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -110.09 -178.88 3.63 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.33 1.452 . . . . 0.0 110.079 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -135.22 153.85 51.79 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.952 0.901 . . . . 0.0 109.04 177.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -130.46 175.41 8.99 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 128.087 2.555 . . . . 0.0 107.866 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -56.76 -16.86 7.26 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 129.099 2.96 . . . . 0.0 111.252 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 67.4 t -99.55 -50.42 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 126.803 2.041 . . . . 0.0 108.859 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 170.04 -161.46 34.65 Favored Glycine 0 C--N 1.336 0.553 0 CA-C-N 119.1 0.864 . . . . 0.0 112.339 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 -77.16 156.0 31.89 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 117.751 0.776 . . . . 0.0 110.891 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -157.35 166.63 32.54 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.21 1.004 . . . . 0.0 112.03 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 96.6 mt -105.34 142.06 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 15.9 t -111.24 138.58 47.52 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.238 1.415 . . . . 0.0 107.849 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -130.06 109.3 10.74 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 124.606 1.162 . . . . 0.0 108.402 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.8 mp -93.77 117.47 37.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 6.4 mt -108.12 106.38 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -125.01 142.82 14.14 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 108.111 -1.996 . . . . 0.0 108.111 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 22.7 t 162.83 25.21 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 129.949 3.3 . . . . 0.0 106.968 -178.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -99.0 159.31 20.12 Favored Glycine 0 CA--C 1.505 -0.549 0 O-C-N 120.328 -1.482 . . . . 0.0 111.55 -178.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.44 167.17 15.28 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 178.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 35.0 mm -84.07 135.82 24.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 O-C-N 121.177 -0.952 . . . . 0.0 111.955 -178.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -81.51 104.32 11.85 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 177.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -50.94 -31.69 18.51 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.553 1.141 . . . . 0.0 111.593 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.441 HG23 ' H ' ' A' ' 195' ' ' VAL . 18.8 t -47.77 -47.33 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 128.72 2.808 . . . . 0.0 112.752 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 7.5 t -124.51 -39.69 2.29 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 110.57 36.16 1.95 Allowed Glycine 0 C--N 1.335 0.512 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -178.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -128.24 154.16 46.16 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 118.995 1.397 . . . . 0.0 110.567 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -66.16 168.26 8.79 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.102 0.561 . . . . 0.0 110.204 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -87.75 30.8 0.8 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 130.259 3.424 . . . . 0.0 110.335 177.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 5.9 ptm -72.58 175.42 6.36 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 120.576 -1.327 . . . . 0.0 111.815 -177.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.1 p -139.93 152.04 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 125.215 1.406 . . . . 0.0 109.19 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -114.27 104.08 11.72 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.511 1.924 . . . . 0.0 107.179 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 13.4 mm -91.69 143.7 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -124.72 99.31 6.1 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.624 1.57 . . . . 0.0 107.118 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . 0.52 ' CD1' HD13 ' A' ' 109' ' ' ILE . 25.8 m-85 -78.86 110.2 13.83 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 179.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 4.5 m -123.8 160.58 27.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 124.649 1.18 . . . . 0.0 108.678 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 53.5 t -82.41 141.26 32.92 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 179.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -90.16 3.34 82.33 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-O 118.421 -1.21 . . . . 0.0 114.916 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.585 0 C-N-CA 124.688 1.137 . . . . 0.0 111.967 -179.204 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo . . . . . 0 CA--C 1.536 0.585 0 N-CA-C 114.624 0.971 . . . . 0.0 114.624 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . 0.431 ' CB ' HG22 ' A' ' 235' ' ' ILE . 4.9 p -173.46 156.28 3.0 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.021 -1.049 . . . . 0.0 113.245 -177.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 20.5 p -155.31 172.95 17.34 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.892 1.277 . . . . 0.0 108.255 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 7.5 mt -114.77 148.12 17.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 126.399 1.88 . . . . 0.0 108.465 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -89.37 -51.69 5.42 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.959 0.903 . . . . 0.0 110.961 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 64.8 p-90 -161.53 160.81 29.52 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.42 1.888 . . . . 0.0 107.189 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 88.0 t -148.92 127.89 3.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 125.586 1.555 . . . . 0.0 107.361 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -158.77 159.4 35.13 Favored 'General case' 0 C--O 1.239 0.522 0 O-C-N 121.392 -0.818 . . . . 0.0 112.012 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -67.48 135.12 52.56 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 177.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 8.8 t -109.51 -36.64 5.92 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.86 -0.525 . . . . 0.0 111.138 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 14.5 mttt -129.22 -175.48 3.58 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 124.274 1.03 . . . . 0.0 108.625 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 73.3 mt -51.19 -41.9 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -133.1 9.89 4.14 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.154 0.982 . . . . 0.0 112.453 -178.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 15.0 t -109.28 142.49 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.683 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -177.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -119.76 158.91 25.56 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.216 1.406 . . . . 0.0 107.586 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -136.38 141.86 43.71 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -144.61 121.04 10.99 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.339 1.056 . . . . 0.0 111.337 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -95.05 110.08 22.05 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 105.523 -2.029 . . . . 0.0 105.523 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 61.9 t -101.41 129.5 52.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -114.73 122.02 45.13 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.101 1.36 . . . . 0.0 111.913 -178.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.431 HG22 ' CB ' ' A' ' 216' ' ' SER . 10.8 pt -132.3 139.26 34.3 Favored Pre-proline 0 N--CA 1.453 -0.312 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -66.84 -34.63 29.91 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 121.762 1.641 . . . . 0.0 111.37 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . 0.416 ' CD ' ' HE3' ' A' ' 112' ' ' LYS . 75.4 mm-40 -54.53 -32.66 58.64 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 126.571 1.949 . . . . 0.0 115.023 -178.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.427 HD11 ' HB3' ' A' ' 206' ' ' TYR . 43.5 mt -59.91 -29.47 68.38 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.766 1.166 . . . . 0.0 112.353 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 33.8 m -59.04 -11.85 4.01 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.938 0.895 . . . . 0.0 112.471 179.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -59.87 -25.68 65.25 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 118.668 -0.682 . . . . 0.0 111.106 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -97.27 132.24 43.21 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.904 1.282 . . . . 0.0 108.15 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -46.99 -46.89 21.99 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.297 1.839 . . . . 0.0 112.062 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.561 HD11 HD23 ' A' ' 98' ' ' LEU . 69.1 mt -58.13 -45.25 87.66 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 6.0 mt -91.32 1.19 57.29 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.478 1.511 . . . . 0.0 113.221 -177.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -71.24 111.76 6.84 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.311 1.044 . . . . 0.0 108.935 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 5.5 mmmt . . . . . 0 C--O 1.24 0.586 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.543 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.407 ' HA ' HD12 ' A' ' 98' ' ' LEU . 1.1 p . . . . . 0 C--O 1.235 0.331 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.0 -35.94 80.03 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 42.1 tp -74.72 -36.79 62.69 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 121.281 -0.887 . . . . 0.0 109.425 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 95' ' ' THR . 86.9 mt -59.53 -55.66 31.71 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.433 1.093 . . . . 0.0 111.048 -179.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 37.0 m -68.69 -40.89 79.83 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.29 -0.881 . . . . 0.0 111.007 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.12 -42.95 91.81 Favored 'General case' 0 C--N 1.341 0.201 0 O-C-N 121.579 -0.701 . . . . 0.0 109.681 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 53.7 m -56.18 -49.19 74.73 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 123.848 0.859 . . . . 0.0 109.904 178.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -57.97 -49.22 77.57 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 122.405 0.282 . . . . 0.0 110.643 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -66.59 -59.61 3.46 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -177.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -60.37 -37.8 81.9 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 123.079 0.552 . . . . 0.0 110.415 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.98 -51.97 55.23 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.542 ' HA ' HD12 ' A' ' 109' ' ' ILE . 39.0 t -56.93 -43.64 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 119.538 1.669 . . . . 0.0 108.081 177.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.4 tttt -57.76 -39.05 76.49 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 122.11 -0.368 . . . . 0.0 110.583 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.6 m -70.37 -37.41 74.58 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 126.149 1.78 . . . . 0.0 110.342 -178.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.542 HD12 ' HA ' ' A' ' 106' ' ' VAL . 12.2 mt -63.92 -55.02 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -61.45 -28.23 69.13 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.801 -0.619 . . . . 0.0 112.48 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -64.26 -53.82 43.07 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.036 1.334 . . . . 0.0 109.962 178.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -80.36 -39.52 28.37 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.4 mt -61.04 -28.59 69.17 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 118.534 0.606 . . . . 0.0 112.338 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -51.34 -31.05 20.59 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -49.32 -72.01 0.06 Allowed 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.131 1.372 . . . . 0.0 112.92 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -149.06 178.67 8.5 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.529 1.532 . . . . 0.0 109.846 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 86.3 m -86.72 159.17 19.25 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 40.5 pt -115.44 160.65 14.69 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 C-N-CA 124.806 1.243 . . . . 0.0 110.021 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -156.07 149.03 24.21 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.649 -178.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.445 ' CE1' ' HB2' ' A' ' 122' ' ' ALA . 6.0 t80 -141.14 136.52 31.96 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.71 1.204 . . . . 0.0 110.633 178.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -95.04 102.37 14.17 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.733 1.213 . . . . 0.0 108.194 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.445 ' HB2' ' CE1' ' A' ' 120' ' ' TYR . . . -86.69 80.71 8.46 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 127.746 2.418 . . . . 0.0 106.622 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.65 -102.11 0.59 Allowed Glycine 0 CA--C 1.528 0.864 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -93.6 -20.15 20.48 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.667 1.187 . . . . 0.0 112.376 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 56.6 m95 -99.49 158.4 15.76 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 123.823 0.849 . . . . 0.0 111.0 -178.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.584 HD13 ' H ' ' A' ' 140' ' ' GLY . 4.6 mp -131.59 141.57 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 N-CA-C 104.912 -2.255 . . . . 0.0 104.912 178.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.5 ' CD1' HG11 ' A' ' 221' ' ' VAL . 68.9 m-85 -124.38 121.31 34.57 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 126.188 1.795 . . . . 0.0 107.983 -179.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -114.81 119.44 36.64 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 125.887 1.675 . . . . 0.0 110.716 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -111.54 135.74 51.7 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 13.3 m -117.18 153.76 49.88 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 123.69 0.796 . . . . 0.0 109.928 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -67.17 74.1 0.5 Allowed 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 125.142 3.895 . . . . 0.0 115.877 -177.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.35 39.11 9.29 Favored Glycine 0 CA--C 1.526 0.764 0 O-C-N 121.465 -0.772 . . . . 0.0 113.32 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 3.1 mp -121.06 -66.96 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 118.199 1.0 . . . . 0.0 109.239 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -167.46 169.12 12.45 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.19 1.396 . . . . 0.0 109.525 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -135.49 117.18 14.99 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 104.245 -2.502 . . . . 0.0 104.245 176.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 31.8 m -145.15 165.48 11.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 126.529 1.932 . . . . 0.0 109.644 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.41 ' HB3' ' CD1' ' A' ' 127' ' ' TYR . 18.0 pt20 -124.22 130.38 52.42 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 177.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -138.82 163.15 32.98 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.503 1.521 . . . . 0.0 109.373 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -93.59 108.41 20.13 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.584 ' H ' HD13 ' A' ' 126' ' ' ILE . . . . . . . . 0 CA--C 1.523 0.573 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 -179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 . . . . . 0 CA--C 1.528 0.103 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -147.73 137.14 22.46 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.2 mp -120.22 -30.93 4.52 Favored 'General case' 0 C--O 1.221 -0.4 0 C-N-CA 125.525 1.53 . . . . 0.0 108.315 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 167.28 162.41 18.96 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-N 119.61 1.095 . . . . 0.0 111.39 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm -125.54 108.31 26.34 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 124.78 1.232 . . . . 0.0 108.516 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -81.64 167.05 17.17 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.83 3.02 . . . . 0.0 110.92 178.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -110.56 145.1 38.39 Favored 'General case' 0 CA--C 1.513 -0.481 0 C-N-CA 124.752 1.221 . . . . 0.0 112.036 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.4 -40.33 90.55 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 124.356 1.035 . . . . 0.0 109.596 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -76.4 64.34 2.11 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 126.173 1.789 . . . . 0.0 109.348 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.9 p -47.06 -32.46 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 119.763 1.165 . . . . 0.0 111.91 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -63.99 -26.67 68.68 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.899 1.68 . . . . 0.0 112.619 -178.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.0 -25.91 56.21 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.428 0.691 . . . . 0.0 110.568 178.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 65.4 mtp180 -81.04 165.24 21.85 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 122.067 0.937 . . . . 0.0 110.884 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -123.46 147.68 46.93 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -130.42 165.44 22.58 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 125.318 1.447 . . . . 0.0 107.866 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -130.83 153.36 49.17 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 118.012 0.369 . . . . 0.0 110.447 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 45.9 tp -108.41 103.23 12.33 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.305 1.442 . . . . 0.0 108.471 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.525 HD23 ' HB2' ' A' ' 184' ' ' SER . 2.9 mm? -114.63 -179.51 3.65 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 126.653 1.981 . . . . 0.0 109.073 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -142.17 160.47 40.17 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.693 0.797 . . . . 0.0 110.824 179.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -139.97 -175.46 4.24 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.368 2.267 . . . . 0.0 108.084 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -58.48 -18.49 29.33 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 120.292 -1.505 . . . . 0.0 114.361 -178.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 42.4 t -98.84 -44.99 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 122.964 0.506 . . . . 0.0 111.648 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 175.2 -159.86 28.29 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 118.659 0.663 . . . . 0.0 111.729 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -85.38 158.76 20.16 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -154.97 166.41 33.65 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.61 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 98.2 mt -105.77 128.7 59.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.525 ' HB2' HD23 ' A' ' 175' ' ' LEU . 43.8 t -92.95 130.71 38.44 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.216 1.406 . . . . 0.0 108.299 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -126.0 112.77 16.29 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 177.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.14 112.2 26.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 11.1 mt -99.84 106.53 19.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 103.426 -2.805 . . . . 0.0 103.426 178.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -101.37 -153.18 25.88 Favored Glycine 0 CA--C 1.52 0.364 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 60.96 43.18 11.86 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.499 0.72 . . . . 0.0 112.153 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -86.56 -106.59 0.8 Allowed Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 105.027 -3.229 . . . . 0.0 105.027 178.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -157.9 162.63 38.33 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 129.095 2.958 . . . . 0.0 104.545 178.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.6 mm -85.62 142.28 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.3 m -97.97 105.6 17.77 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 127.746 2.418 . . . . 0.0 104.584 177.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -50.39 -27.0 5.58 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.311 1.844 . . . . 0.0 112.902 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 21.6 t -43.0 -56.55 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 126.819 2.048 . . . . 0.0 110.866 179.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 9.2 t -123.65 -25.61 4.31 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.867 1.267 . . . . 0.0 112.774 -178.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 99.27 35.04 4.87 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 107.541 -2.224 . . . . 0.0 107.541 -178.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -106.62 150.46 26.18 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 118.851 1.326 . . . . 0.0 112.747 -178.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -78.91 141.97 37.16 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.274 0.559 . . . . 0.0 109.722 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 -67.56 29.71 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.519 1 C-N-CA 133.64 4.776 . . . . 0.0 114.625 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 9.5 ptm -74.43 178.99 4.87 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.433 1.493 . . . . 0.0 112.051 -178.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.23 150.46 15.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 124.853 1.261 . . . . 0.0 109.199 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -110.74 103.58 12.14 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.445 2.298 . . . . 0.0 107.553 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 9.4 mm -93.48 146.8 6.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -125.58 105.34 8.95 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.952 2.101 . . . . 0.0 108.004 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . 0.431 ' CE2' HG21 ' A' ' 233' ' ' VAL . 58.4 m-85 -84.77 110.58 18.9 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 12.5 m -125.36 167.19 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 124.015 0.926 . . . . 0.0 109.101 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 36.7 t -93.69 135.21 35.21 Favored 'General case' 0 C--N 1.333 -0.127 0 O-C-N 120.153 -1.592 . . . . 0.0 107.233 178.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -83.84 8.65 65.39 Favored Glycine 0 N--CA 1.464 0.509 0 CA-C-O 118.77 -1.017 . . . . 0.0 114.349 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.954 0 CA-C-O 118.23 -1.317 . . . . 0.0 114.273 -179.584 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 CA--C 1.535 0.541 0 N-CA-C 110.778 -0.508 . . . . 0.0 110.778 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 11.2 p -162.13 154.17 19.06 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 120.645 -1.284 . . . . 0.0 109.686 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 41.7 p -151.38 163.79 38.16 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.392 0.677 . . . . 0.0 110.426 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.438 HG13 HG12 ' A' ' 233' ' ' VAL . 4.1 mt -110.54 143.03 21.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 125.145 1.378 . . . . 0.0 107.423 178.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -95.11 -51.72 4.52 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.199 1.4 . . . . 0.0 110.786 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 -161.21 156.57 24.41 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.429 1.491 . . . . 0.0 109.658 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.5 HG11 ' CD1' ' A' ' 127' ' ' TYR . 7.3 t -151.03 144.98 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 C-N-CA 127.894 2.478 . . . . 0.0 106.228 -178.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.24 168.47 15.18 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.602 1.161 . . . . 0.0 109.146 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -83.57 131.12 35.0 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 103.383 -2.821 . . . . 0.0 103.383 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . 0.478 HG23 ' HG3' ' A' ' 225' ' ' LYS . 9.8 t -109.87 -28.68 8.64 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 124.245 1.018 . . . . 0.0 113.177 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.515 ' HE3' HG11 ' A' ' 228' ' ' VAL . 10.2 mttt -133.92 -175.6 3.89 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 70.0 mt -54.39 -49.52 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -123.01 20.56 9.94 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 124.042 0.937 . . . . 0.0 110.76 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.515 HG11 ' HE3' ' A' ' 225' ' ' LYS . 13.5 t -121.73 144.73 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 CA-C-N 118.578 0.626 . . . . 0.0 110.38 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -123.33 165.47 16.93 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 125.983 1.713 . . . . 0.0 108.434 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . 0.42 ' HG3' HG21 ' A' ' 224' ' ' THR . 25.7 mt-10 -131.31 147.01 52.53 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 126.086 1.754 . . . . 0.0 106.981 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -151.35 120.6 6.79 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.84 0.856 . . . . 0.0 109.373 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -108.79 113.45 26.41 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 123.588 0.755 . . . . 0.0 109.389 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . 0.438 HG12 HG13 ' A' ' 218' ' ' ILE . 6.7 m -104.12 152.2 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -118.91 116.34 26.26 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.68 -1.145 . . . . 0.0 108.452 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -124.83 122.47 25.6 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-O 117.935 -1.031 . . . . 0.0 109.282 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -57.38 -38.45 94.47 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.249 2.633 . . . . 0.0 111.427 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -59.18 -28.66 66.83 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 10.2 tp -58.59 -33.25 69.77 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 121.48 -0.762 . . . . 0.0 111.638 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 15.3 m -59.21 -11.13 3.47 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.141 0.976 . . . . 0.0 112.996 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -61.79 -32.01 72.27 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 120.128 1.331 . . . . 0.0 109.877 178.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -85.05 124.5 31.81 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -47.73 -48.11 29.83 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.239 2.215 . . . . 0.0 113.101 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 59.7 mt -67.97 -19.41 64.94 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.061 -1.025 . . . . 0.0 113.185 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 11.4 mt -105.36 -5.91 20.04 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.82 1.248 . . . . 0.0 111.686 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -71.64 139.69 49.38 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 128.606 2.762 . . . . 0.0 112.189 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 16.8 mmtm . . . . . 0 N--CA 1.463 0.187 0 C-N-CA 127.894 2.478 . . . . 0.0 112.698 179.598 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.52 -0.183 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.03 -40.84 95.11 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 35.6 tp -67.98 -35.99 79.27 Favored 'General case' 0 C--N 1.343 0.306 0 CA-C-O 117.514 -1.232 . . . . 0.0 109.233 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.7 mt -62.05 -55.04 33.14 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.942 1.246 . . . . 0.0 107.963 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 53.5 m -60.05 -47.16 87.01 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.097 0.959 . . . . 0.0 110.346 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.16 -45.25 94.25 Favored 'General case' 0 N--CA 1.462 0.128 0 O-C-N 121.099 -1.001 . . . . 0.0 109.808 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.5 m -53.92 -43.11 69.46 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 124.706 1.202 . . . . 0.0 109.684 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.22 -52.08 67.2 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 118.341 0.519 . . . . 0.0 110.218 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -64.95 -51.47 61.61 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -178.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -63.14 -42.08 99.41 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.777 -178.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.38 -52.51 52.18 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 107.872 -2.091 . . . . 0.0 107.872 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.415 HG23 HD13 ' A' ' 183' ' ' ILE . 17.9 t -54.81 -51.99 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 124.614 1.166 . . . . 0.0 110.954 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 31.5 pttt -62.33 -32.2 72.94 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 119.966 -0.693 . . . . 0.0 111.484 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 59.9 m -76.61 -33.2 58.42 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 19.6 mt -63.49 -56.03 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -60.36 -36.92 79.15 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 118.063 -0.97 . . . . 0.0 111.669 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -54.86 -43.83 73.45 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.832 0.742 . . . . 0.0 111.806 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.9 tptt -82.38 -40.95 20.6 Favored 'General case' 0 CA--C 1.517 -0.326 0 O-C-N 122.027 -0.421 . . . . 0.0 111.566 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 44.5 mt -60.65 -29.47 69.29 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 119.135 -0.46 . . . . 0.0 111.512 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -55.38 -15.66 2.82 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.038 0.935 . . . . 0.0 112.729 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -64.63 -66.85 0.49 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.253 1.021 . . . . 0.0 109.676 178.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 18.6 mmt85 -151.47 -179.49 7.43 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.894 1.678 . . . . 0.0 111.85 -178.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 64.9 m -86.12 161.32 18.94 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 38.7 pt -121.63 162.68 20.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 125.722 1.609 . . . . 0.0 108.281 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -156.89 142.62 17.7 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.374 1.07 . . . . 0.0 109.433 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -136.38 132.6 35.75 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.213 1.005 . . . . 0.0 110.65 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -81.44 98.44 8.23 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.66 83.04 4.8 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.122 1.369 . . . . 0.0 107.78 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.12 -98.15 0.18 Allowed Glycine 0 C--N 1.336 0.53 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -100.45 -26.56 13.82 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.349 1.06 . . . . 0.0 113.716 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -103.1 132.2 49.53 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 118.932 0.787 . . . . 0.0 110.467 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.488 HD13 ' H ' ' A' ' 140' ' ' GLY . 3.3 mp -96.2 127.86 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 103.643 -2.725 . . . . 0.0 103.643 178.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.401 ' CG ' HG11 ' A' ' 221' ' ' VAL . 11.3 m-85 -100.84 120.35 40.0 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -179.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -116.11 125.07 51.87 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 125.167 1.387 . . . . 0.0 110.394 -178.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -121.51 129.07 52.69 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.508 0.723 . . . . 0.0 112.018 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 22.7 m -107.76 151.01 40.96 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 123.624 0.77 . . . . 0.0 111.301 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -66.23 80.25 0.3 Allowed 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 125.275 3.983 . . . . 0.0 116.82 -177.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.87 31.19 27.07 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 117.803 -1.554 . . . . 0.0 112.007 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 3.0 mp -117.18 -71.99 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 119.444 1.622 . . . . 0.0 109.817 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.507 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 16.2 pt-20 -163.22 166.63 23.03 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.927 1.691 . . . . 0.0 110.435 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -130.56 119.91 23.25 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 105.731 -1.952 . . . . 0.0 105.731 177.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.7 m -144.22 164.08 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 125.109 1.364 . . . . 0.0 110.724 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -125.65 122.84 37.56 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -138.72 162.15 35.42 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 123.924 0.89 . . . . 0.0 108.907 178.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -96.04 118.45 32.66 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.488 ' H ' HD13 ' A' ' 126' ' ' ILE . . . . . . . . 0 CA--C 1.528 0.904 0 C-N-CA 125.026 1.298 . . . . 0.0 110.267 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 122.504 1.145 . . . . 0.0 110.029 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -148.65 143.81 26.76 Favored 'General case' 0 CA--C 1.512 -0.484 0 C-N-CA 126.371 1.868 . . . . 0.0 107.046 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 42.7 mt -129.79 -31.67 1.95 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.566 1.547 . . . . 0.0 107.689 177.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 159.34 158.66 9.24 Favored Glycine 0 C--N 1.341 0.823 0 O-C-N 120.587 -1.32 . . . . 0.0 113.459 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -117.41 108.93 42.7 Favored Pre-proline 0 C--O 1.239 0.529 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.507 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 91.5 Cg_endo -72.04 165.09 33.65 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 124.16 3.24 . . . . 0.0 109.371 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -109.99 148.82 30.94 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 123.476 0.71 . . . . 0.0 110.281 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -68.15 -48.46 65.3 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 125.777 1.923 . . . . 0.0 109.788 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -74.98 65.47 1.44 Allowed 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.207 1.403 . . . . 0.0 113.443 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.0 p -47.8 -31.66 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.29 1.036 . . . . 0.0 111.925 178.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -72.65 -30.11 64.01 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -178.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -73.66 -18.16 61.06 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.963 0.505 . . . . 0.0 109.842 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -105.81 165.47 11.16 Favored 'General case' 0 C--N 1.342 0.268 0 O-C-N 121.603 -0.686 . . . . 0.0 109.824 178.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -120.84 156.3 32.24 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -130.0 171.14 13.1 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.405 1.482 . . . . 0.0 108.715 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -113.7 153.44 28.97 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 123.691 0.796 . . . . 0.0 110.057 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 56.8 tp -121.63 102.51 8.28 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.594 1.558 . . . . 0.0 107.759 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.424 HD23 ' HB2' ' A' ' 184' ' ' SER . 2.3 mm? -112.5 -178.6 3.44 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 127.299 2.24 . . . . 0.0 109.996 -178.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -142.57 161.14 38.82 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.599 0.76 . . . . 0.0 110.346 177.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -140.92 178.68 7.19 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 127.637 2.375 . . . . 0.0 106.909 178.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.29 -17.81 22.32 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.435 1.494 . . . . 0.0 113.337 -178.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 90.0 t -93.92 -31.83 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 124.787 1.235 . . . . 0.0 111.917 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 156.19 -170.46 33.86 Favored Glycine 0 N--CA 1.448 -0.553 0 O-C-N 121.305 -0.872 . . . . 0.0 112.762 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.425 ' CE2' ' HG ' ' A' ' 243' ' ' LEU . 3.7 m-30 -78.76 160.73 27.28 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.401 ' HB3' HG12 ' A' ' 207' ' ' VAL . 30.7 p90 -164.33 157.96 18.18 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.273 1.029 . . . . 0.0 111.831 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.415 HD13 HG23 ' A' ' 106' ' ' VAL . 76.2 mt -96.03 138.82 20.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.899 1.28 . . . . 0.0 107.8 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.424 ' HB2' HD23 ' A' ' 175' ' ' LEU . 30.1 t -105.12 120.89 42.62 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 126.087 1.755 . . . . 0.0 107.973 179.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -114.89 107.49 15.48 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.905 1.682 . . . . 0.0 108.355 179.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -89.79 124.14 42.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 178.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.7 mt -114.27 105.69 19.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 104.94 -2.244 . . . . 0.0 104.94 177.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -98.18 -152.22 27.86 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 105.99 -2.844 . . . . 0.0 105.99 178.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 20.1 m 81.33 18.51 0.44 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 177.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -90.58 -142.19 9.78 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 108.354 -1.899 . . . . 0.0 108.354 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -124.5 163.82 21.05 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.4 mm -81.41 142.71 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.191 0.996 . . . . 0.0 112.012 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -85.93 122.63 30.25 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.722 1.609 . . . . 0.0 109.129 178.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.45 -28.4 63.29 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.761 1.225 . . . . 0.0 111.896 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 58.6 t -57.62 -54.95 24.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.549 1.139 . . . . 0.0 113.165 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 14.0 t -122.72 -36.64 2.87 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 116.164 1.912 . . . . 0.0 116.164 -176.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 111.81 23.51 5.58 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -99.07 150.95 21.48 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.763 0.825 . . . . 0.0 109.742 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -74.91 151.88 38.88 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.955 0.883 . . . . 0.0 108.922 178.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -71.27 29.75 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 130.021 3.329 . . . . 0.0 110.276 177.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 8.0 ptm -73.84 175.58 7.15 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.284 1.834 . . . . 0.0 111.778 -177.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.52 150.34 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 124.294 1.038 . . . . 0.0 108.628 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -111.93 104.17 12.44 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.242 1.817 . . . . 0.0 106.412 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 10.2 mm -96.75 144.02 11.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 O-C-N 120.848 -1.157 . . . . 0.0 109.289 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -124.29 127.67 47.99 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.292 1.037 . . . . 0.0 109.22 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -102.43 113.11 26.17 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 118.565 -0.731 . . . . 0.0 110.823 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.401 HG12 ' HB3' ' A' ' 182' ' ' TYR . 4.5 m -127.61 162.26 33.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 16.2 t -91.89 138.26 31.7 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 104.381 -2.451 . . . . 0.0 104.381 177.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -95.33 12.97 67.5 Favored Glycine 0 CA--C 1.522 0.483 0 CA-C-O 118.726 -1.041 . . . . 0.0 112.462 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.171 0 CA-C-N 118.16 0.98 . . . . 0.0 111.666 -178.721 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo . . . . . 0 N--CA 1.451 -0.98 0 N-CA-C 110.879 -0.469 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 18.2 p -170.8 146.94 2.67 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.171 1.788 . . . . 0.0 109.842 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 29.3 p -154.84 147.7 24.5 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.504 1.122 . . . . 0.0 110.487 178.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.447 HG13 HG12 ' A' ' 233' ' ' VAL . 3.2 mt -85.64 144.85 8.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -90.34 -55.75 3.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.869 1.267 . . . . 0.0 108.683 178.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 66.1 p-90 -154.63 158.14 39.23 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.328 1.051 . . . . 0.0 110.105 -178.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.612 HG23 ' HB2' ' A' ' 231' ' ' ALA . 7.2 p -156.16 134.91 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 177.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -159.64 159.91 33.64 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 118.545 0.611 . . . . 0.0 110.683 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -67.59 133.36 49.27 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 178.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . 0.644 HG23 ' HG3' ' A' ' 225' ' ' LYS . 2.3 t -111.82 -34.32 6.05 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.937 1.295 . . . . 0.0 111.592 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.644 ' HG3' HG23 ' A' ' 224' ' ' THR . 7.7 mttm -134.73 -176.5 4.25 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 97.6 mt -50.06 -47.67 23.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 C-N-CA 124.681 1.192 . . . . 0.0 111.669 -178.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -127.7 20.5 6.58 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.582 0.753 . . . . 0.0 110.232 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 13.6 t -122.75 147.71 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 O-C-N 120.925 -1.109 . . . . 0.0 110.067 -177.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -127.92 163.58 24.16 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -135.35 133.05 38.36 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 178.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.612 ' HB2' HG23 ' A' ' 221' ' ' VAL . . . -135.91 149.08 48.82 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.208 1.803 . . . . 0.0 107.981 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -135.72 124.36 23.73 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 118.862 0.756 . . . . 0.0 110.049 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . 0.447 HG12 HG13 ' A' ' 218' ' ' ILE . 15.3 m -106.97 153.08 8.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 121.338 0.59 . . . . 0.0 109.682 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.02 121.62 39.32 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 178.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -132.82 145.36 56.77 Favored Pre-proline 0 N--CA 1.45 -0.432 0 O-C-N 124.469 1.106 . . . . 0.0 110.809 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.71 -42.26 1.24 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.812 2.341 . . . . 0.0 112.317 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -56.89 -25.48 57.03 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -178.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 9.6 tp -64.58 -29.69 70.71 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 121.403 -0.811 . . . . 0.0 112.374 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 11.4 m -58.39 -12.47 3.85 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.464 1.106 . . . . 0.0 112.449 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -64.11 -27.02 68.8 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 119.42 1.009 . . . . 0.0 111.239 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.27 124.86 35.79 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 -47.85 -48.35 31.07 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.706 1.203 . . . . 0.0 113.904 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.425 ' HG ' ' CE2' ' A' ' 181' ' ' TYR . 1.6 mp -61.12 -31.84 71.54 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 13.4 mt -93.73 -17.9 22.68 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.859 1.264 . . . . 0.0 113.167 -178.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -61.4 146.83 46.97 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 128.18 2.592 . . . . 0.0 110.411 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt . . . . . 0 C--N 1.328 -0.352 0 C-N-CA 125.361 1.464 . . . . 0.0 111.977 -179.16 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.45 -44.35 89.16 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 118.809 -0.615 . . . . 0.0 110.759 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 58.6 tp -74.26 -38.35 63.47 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-O 117.913 -1.041 . . . . 0.0 109.416 178.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 16.1 mt -58.92 -54.51 46.29 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.597 1.089 . . . . 0.0 110.746 -177.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 16.9 m -64.54 -36.18 83.37 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 118.703 -1.199 . . . . 0.0 110.762 -179.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.74 -49.86 76.06 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 89.6 m -51.44 -46.52 63.03 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.345 1.058 . . . . 0.0 110.586 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -58.77 -50.08 75.27 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.82 0.737 . . . . 0.0 110.524 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -67.95 -59.1 3.53 Favored 'General case' 0 C--O 1.227 -0.114 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -58.89 -38.14 78.18 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.21 1.004 . . . . 0.0 110.392 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.22 -52.65 50.47 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.478 ' HA ' HD12 ' A' ' 109' ' ' ILE . 51.6 t -57.72 -44.53 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 118.882 1.341 . . . . 0.0 109.974 179.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -60.47 -35.49 76.01 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.458 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 88.4 m -75.74 -34.95 60.34 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 122.771 0.428 . . . . 0.0 110.335 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.478 HD12 ' HA ' ' A' ' 106' ' ' VAL . 26.1 mt -63.36 -55.59 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -62.04 -33.51 74.51 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 118.433 -0.794 . . . . 0.0 112.753 -178.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -65.8 -37.95 87.66 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 118.834 0.743 . . . . 0.0 111.354 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.8 tptt -84.76 -38.46 19.6 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 118.761 -0.638 . . . . 0.0 111.157 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 16.8 mt -65.06 -25.81 67.97 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.845 0.748 . . . . 0.0 111.256 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -53.17 -24.66 11.27 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.059 1.344 . . . . 0.0 111.459 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -65.96 -65.79 0.63 Allowed 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 118.132 -0.937 . . . . 0.0 111.71 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -147.43 175.32 10.91 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 120.276 1.398 . . . . 0.0 112.863 -178.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 79.0 m -86.44 163.9 17.3 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 43.1 pt -121.8 159.46 24.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 124.587 1.155 . . . . 0.0 109.86 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -157.06 140.22 15.48 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 122.914 0.486 . . . . 0.0 111.847 -178.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -138.73 129.9 26.94 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 119.804 -0.759 . . . . 0.0 109.995 176.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -83.46 98.56 9.59 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.996 1.319 . . . . 0.0 107.547 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -85.95 80.56 8.84 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.494 1.918 . . . . 0.0 106.545 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.44 -99.42 0.33 Allowed Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -92.38 -30.75 15.62 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 118.423 1.112 . . . . 0.0 113.43 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -100.21 155.18 17.9 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 119.109 0.868 . . . . 0.0 110.548 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.687 HD13 ' H ' ' A' ' 140' ' ' GLY . 4.0 mp -122.13 144.59 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 104.003 -2.591 . . . . 0.0 104.003 179.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -128.88 120.0 25.43 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -110.06 126.02 53.56 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.966 1.706 . . . . 0.0 109.423 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -115.13 136.09 53.49 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.498 ' HB3' HD13 ' A' ' 133' ' ' ILE . 17.1 m -118.97 148.8 45.46 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 123.528 0.731 . . . . 0.0 111.066 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -64.63 91.33 0.19 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 125.079 3.853 . . . . 0.0 114.586 -178.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.82 28.44 58.98 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-O 118.045 -1.42 . . . . 0.0 114.265 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.498 HD13 ' HB3' ' A' ' 130' ' ' CYS . 4.1 mp -115.14 -71.58 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 119.654 1.727 . . . . 0.0 108.43 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.406 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 15.8 pt-20 -171.43 174.6 4.4 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.449 1.5 . . . . 0.0 110.072 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.416 ' CD1' HD12 ' A' ' 160' ' ' LEU . 1.2 t80 -136.54 120.26 17.3 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 177.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.9 m -145.41 164.99 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 126.494 1.917 . . . . 0.0 110.336 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -117.37 131.97 56.68 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 119.461 1.028 . . . . 0.0 110.498 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -137.68 162.31 34.19 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.547 1.067 . . . . 0.0 108.781 176.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -102.24 109.93 21.75 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.687 ' H ' HD13 ' A' ' 126' ' ' ILE . . . . . . . . 0 CA--C 1.528 0.888 0 C-N-CA 125.426 1.489 . . . . 0.0 109.788 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 . . . . . 0 CA--C 1.531 0.225 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.27 113.06 5.41 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 117.37 -1.3 . . . . 0.0 109.248 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.416 HD12 ' CD1' ' A' ' 135' ' ' PHE . 43.4 mt -102.02 -30.46 11.18 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.936 1.244 . . . . 0.0 108.982 178.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 161.99 161.31 11.81 Favored Glycine 0 CA--C 1.503 -0.668 0 CA-C-O 122.396 0.998 . . . . 0.0 110.758 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -123.91 109.39 29.95 Favored Pre-proline 0 N--CA 1.426 -1.631 0 C-N-CA 125.262 1.425 . . . . 0.0 109.307 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 85.3 Cg_endo -70.52 177.77 5.75 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.664 2.909 . . . . 0.0 108.745 178.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -120.55 152.11 38.52 Favored 'General case' 0 CA--C 1.517 -0.312 0 O-C-N 121.64 -0.663 . . . . 0.0 111.363 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -67.04 -49.69 64.37 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 122.945 0.498 . . . . 0.0 110.142 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -79.18 65.02 4.24 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.606 0.763 . . . . 0.0 110.47 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.3 p -48.8 -33.35 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 125.26 1.424 . . . . 0.0 111.229 179.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -65.5 -30.93 71.75 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 126.131 1.773 . . . . 0.0 111.621 -178.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -88.76 -11.3 45.38 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.698 1.199 . . . . 0.0 111.692 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.442 HH22 HG12 ' A' ' 187' ' ' ILE . 50.6 ttt180 -81.53 177.23 9.06 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.025 1.33 . . . . 0.0 108.686 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -133.29 149.8 51.92 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 121.261 -0.9 . . . . 0.0 109.34 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -136.63 169.87 17.01 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 127.592 2.357 . . . . 0.0 110.091 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -123.62 154.63 39.05 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.806 0.842 . . . . 0.0 110.349 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 12.4 tp -119.09 105.1 11.08 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 122.383 1.087 . . . . 0.0 109.621 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 3.4 mt -119.09 176.67 5.19 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 128.227 2.611 . . . . 0.0 107.738 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -154.68 164.36 38.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.714 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.71 -175.43 3.82 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.388 1.875 . . . . 0.0 110.313 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -66.81 -1.81 4.34 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.875 1.67 . . . . 0.0 113.442 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.407 ' CG1' ' HE3' ' A' ' 246' ' ' LYS . 30.6 t -112.82 -44.21 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 124.741 1.216 . . . . 0.0 109.519 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 175.56 -175.52 47.26 Favored Glycine 0 N--CA 1.446 -0.67 0 O-C-N 121.274 -0.891 . . . . 0.0 111.943 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -82.17 163.71 21.75 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.455 ' HB3' HG12 ' A' ' 207' ' ' VAL . 45.7 p90 -154.4 172.37 17.84 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 74.6 mt -113.9 129.81 69.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 35.0 t -91.59 124.22 35.59 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -123.15 107.54 11.85 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.5 mp -93.39 117.89 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 104.281 -2.488 . . . . 0.0 104.281 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.442 HG12 HH22 ' A' ' 170' ' ' ARG . 4.3 mt -104.89 105.83 19.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 178.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -104.19 -156.38 23.82 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.793 1.664 . . . . 0.0 109.409 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.1 t 64.02 43.47 5.16 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.586 1.155 . . . . 0.0 110.36 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -91.57 -64.09 1.16 Allowed Glycine 0 CA--C 1.529 0.937 0 N-CA-C 107.987 -2.045 . . . . 0.0 107.987 179.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 157.29 179.98 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.379 1 C-N-CA 132.086 4.155 . . . . 0.0 105.792 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.5 mm -105.59 143.39 16.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 127.756 2.423 . . . . 0.0 112.107 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.4 m -95.73 101.13 12.78 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 128.11 2.564 . . . . 0.0 104.312 176.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -48.73 -31.32 6.73 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.258 1.823 . . . . 0.0 112.658 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 60.0 t -39.16 -54.11 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 127.268 2.227 . . . . 0.0 110.574 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 11.3 t -123.5 -26.95 4.13 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.404 1.082 . . . . 0.0 111.787 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.33 35.18 4.24 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 -178.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -110.67 148.69 31.74 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 118.498 1.149 . . . . 0.0 113.108 -178.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -73.8 148.09 42.8 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.274 0.559 . . . . 0.0 112.156 179.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -70.06 27.01 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.425 1 C-N-CA 134.844 5.258 . . . . 0.0 109.87 177.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 2.8 ptm -74.64 178.78 5.14 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.383 1.473 . . . . 0.0 113.336 -176.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.1 p -150.74 136.45 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 123.279 0.631 . . . . 0.0 110.642 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -98.79 109.22 22.01 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.744 1.217 . . . . 0.0 109.213 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 11.1 mm -97.49 147.88 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 O-C-N 121.627 -0.671 . . . . 0.0 109.853 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -125.7 105.4 8.96 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 128.092 2.557 . . . . 0.0 109.106 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -87.76 114.17 24.12 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 120.65 -1.281 . . . . 0.0 108.951 178.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.455 HG12 ' HB3' ' A' ' 182' ' ' TYR . 4.6 m -124.49 165.01 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 41.9 t -84.63 145.86 27.79 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 120.418 -1.426 . . . . 0.0 107.36 178.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -90.89 6.14 81.91 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-O 117.341 -1.81 . . . . 0.0 115.362 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.957 0 CA-C-N 119.026 1.413 . . . . 0.0 114.952 179.542 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo . . . . . 0 N--CA 1.452 -0.913 0 N-CA-C 109.575 -0.971 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 28.1 p -154.68 147.61 24.56 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 119.992 -1.693 . . . . 0.0 111.374 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 20.6 p -151.05 161.59 42.44 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.541 1.136 . . . . 0.0 110.145 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 3.6 mt -100.64 154.53 4.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 125.311 1.444 . . . . 0.0 109.386 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -102.27 -51.69 3.31 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 124.783 1.233 . . . . 0.0 109.844 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 64.5 p-90 -155.92 154.09 30.65 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.067 0.947 . . . . 0.0 109.255 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 90.9 t -147.73 137.7 16.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.63 168.53 19.8 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 122.842 0.457 . . . . 0.0 111.207 -178.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -86.86 133.67 33.6 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 177.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 14.8 t -109.21 -32.22 7.28 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.528 1.131 . . . . 0.0 112.214 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -136.86 -175.97 4.21 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.668 1.187 . . . . 0.0 108.84 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 78.3 mt -48.76 -45.05 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.585 0.754 . . . . 0.0 112.479 -178.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -130.19 12.54 5.59 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.112 0.965 . . . . 0.0 112.265 -178.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 17.5 t -114.14 140.29 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 O-C-N 122.116 -0.365 . . . . 0.0 110.127 -176.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -120.66 166.97 12.95 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 125.18 1.392 . . . . 0.0 108.445 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -137.89 148.65 45.54 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.505 1.522 . . . . 0.0 108.822 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -148.93 145.49 27.42 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 125.789 1.636 . . . . 0.0 110.273 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -132.84 122.89 25.11 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 178.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 5.5 m -116.29 154.81 17.8 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.1 p -120.76 124.05 44.17 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.517 1.127 . . . . 0.0 110.302 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -132.8 122.98 17.97 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 124.238 1.015 . . . . 0.0 109.261 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -58.19 -40.83 73.07 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 124.014 3.143 . . . . 0.0 113.406 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -61.05 -19.62 61.6 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.615 0.766 . . . . 0.0 112.101 -178.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 8.6 tp -66.94 -28.87 68.64 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 120.432 -1.418 . . . . 0.0 110.715 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 21.4 m -62.33 -11.85 17.69 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.746 0.818 . . . . 0.0 111.942 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.08 -21.39 66.14 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.046 0.839 . . . . 0.0 110.122 178.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -98.12 121.01 39.53 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 177.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -47.99 -46.13 32.35 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 126.071 1.749 . . . . 0.0 112.704 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.42 -37.54 87.23 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 120.809 -1.182 . . . . 0.0 112.127 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 22.1 mt -85.21 -5.73 59.31 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.32 1.048 . . . . 0.0 112.252 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -68.95 156.41 38.62 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.822 1.249 . . . . 0.0 110.428 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.407 ' HE3' ' CG1' ' A' ' 179' ' ' VAL . 2.9 mmmt . . . . . 0 C--N 1.325 -0.498 0 C-N-CA 126.225 1.81 . . . . 0.0 109.279 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.384 0 CA-C-O 118.777 -0.63 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.55 -42.65 92.89 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.505 1.048 . . . . 0.0 109.481 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.5 tp -68.88 -36.8 78.51 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-O 117.276 -1.345 . . . . 0.0 109.28 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 98.8 mt -58.67 -54.55 45.82 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 120.265 1.393 . . . . 0.0 108.533 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.2 m -58.93 -46.88 86.88 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.808 0.843 . . . . 0.0 111.457 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.09 -41.94 94.51 Favored 'General case' 0 N--CA 1.463 0.197 0 O-C-N 120.343 -1.473 . . . . 0.0 111.014 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 37.6 m -52.4 -46.94 66.51 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.135 1.374 . . . . 0.0 110.771 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -56.51 -50.99 70.19 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.309 0.504 . . . . 0.0 110.098 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -63.02 -58.0 8.78 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -178.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.09 -39.33 78.32 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.343 -177.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.78 -52.57 41.19 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.54 ' HA ' HD12 ' A' ' 109' ' ' ILE . 43.6 t -54.46 -51.07 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-N 119.032 1.416 . . . . 0.0 110.682 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.6 pttp -56.86 -35.14 68.52 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.448 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 77.2 m -80.34 -29.03 37.97 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.113 0.965 . . . . 0.0 111.947 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.54 HD12 ' HA ' ' A' ' 106' ' ' VAL . 16.7 mt -63.27 -54.39 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 104.677 -2.342 . . . . 0.0 104.677 177.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -61.13 -30.69 70.53 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 118.44 -0.79 . . . . 0.0 111.199 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -56.37 -47.57 78.62 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.478 1.036 . . . . 0.0 111.084 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -84.14 -37.9 21.36 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 24.9 mt -65.97 -26.56 67.62 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 118.931 -0.557 . . . . 0.0 112.161 -179.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -56.83 -20.9 25.17 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -64.64 -66.81 0.49 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.517 0.727 . . . . 0.0 109.485 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -153.51 -179.7 8.01 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.04 1.736 . . . . 0.0 110.306 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 56.0 m -86.63 172.82 9.95 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.287 0.635 . . . . 0.0 109.694 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 34.0 pt -129.8 164.37 32.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 126.654 1.982 . . . . 0.0 109.046 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -158.74 150.33 20.86 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 122.831 0.452 . . . . 0.0 110.225 -179.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -141.5 127.38 19.32 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.631 0.772 . . . . 0.0 109.882 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -84.07 102.23 12.37 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 122.054 0.93 . . . . 0.0 109.404 179.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.27 80.57 6.84 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 127.864 2.466 . . . . 0.0 107.15 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 60.75 -114.69 6.85 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -76.74 -28.81 55.9 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.829 0.852 . . . . 0.0 112.548 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -99.95 163.46 12.43 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 119.073 0.851 . . . . 0.0 110.89 -178.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.524 HD13 ' H ' ' A' ' 140' ' ' GLY . 4.5 mp -136.55 130.56 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -110.05 119.99 41.05 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -108.04 126.42 52.71 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 118.437 -0.792 . . . . 0.0 109.909 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -117.55 130.49 56.44 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.292 0.951 . . . . 0.0 110.094 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.462 ' HB3' HD13 ' A' ' 133' ' ' ILE . 21.4 m -110.83 156.6 40.44 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 128.427 2.691 . . . . 0.0 113.937 -178.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -68.19 72.42 0.83 Allowed 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 124.79 3.66 . . . . 0.0 114.404 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.84 62.06 3.77 Favored Glycine 0 N--CA 1.448 -0.517 0 O-C-N 121.186 -0.947 . . . . 0.0 111.285 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.462 HD13 ' HB3' ' A' ' 130' ' ' CYS . 2.5 mp -131.03 -72.31 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-O 118.325 -0.845 . . . . 0.0 109.235 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -173.65 136.9 0.59 Allowed 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 119.646 1.112 . . . . 0.0 108.15 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -108.27 124.3 50.1 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 121.04 1.745 . . . . 0.0 106.32 -175.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 18.3 m -145.04 165.06 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 125.257 1.423 . . . . 0.0 111.428 -178.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -122.02 133.4 54.8 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.479 1.512 . . . . 0.0 108.193 178.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -138.96 162.87 33.82 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.127 1.371 . . . . 0.0 112.667 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 42.6 t60 -92.76 122.66 35.38 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.524 ' H ' HD13 ' A' ' 126' ' ' ILE . . . . . . . . 0 N--CA 1.454 -0.145 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 -178.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 . . . . . 0 CA--C 1.52 -0.197 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.67 135.86 23.84 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 178.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.1 mp -125.7 -36.36 2.43 Favored 'General case' 0 C--O 1.221 -0.445 0 C-N-CA 126.478 1.911 . . . . 0.0 106.905 177.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 172.75 152.43 8.65 Favored Glycine 0 C--N 1.34 0.795 0 CA-C-N 119.391 0.996 . . . . 0.0 112.705 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 29.3 mtmt -123.28 109.33 31.32 Favored Pre-proline 0 C--O 1.239 0.513 0 N-CA-C 106.125 -1.805 . . . . 0.0 106.125 177.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -75.35 -172.95 1.43 Allowed 'Trans proline' 0 N--CA 1.459 -0.519 1 C-N-CA 126.174 4.583 . . . . 0.0 111.425 -178.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -124.39 152.41 43.25 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 123.762 0.825 . . . . 0.0 108.965 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.11 -46.18 65.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.066 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 -68.88 65.36 0.13 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 127.366 2.267 . . . . 0.0 111.166 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.8 p -48.51 -34.06 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 124.662 1.185 . . . . 0.0 111.746 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -59.64 -32.21 70.24 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 125.46 1.504 . . . . 0.0 113.184 -178.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -84.61 -22.61 29.91 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.767 1.227 . . . . 0.0 112.787 -178.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.404 HH22 ' HG3' ' A' ' 185' ' ' GLU . 66.6 mtp180 -74.82 139.71 43.43 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -97.22 143.3 28.15 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 179.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -133.59 165.84 23.97 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 124.21 1.004 . . . . 0.0 109.777 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -123.45 142.73 50.7 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.944 0.897 . . . . 0.0 109.965 -178.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 58.9 tp -102.28 100.95 11.18 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.062 1.745 . . . . 0.0 107.584 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.584 HD23 ' HB2' ' A' ' 184' ' ' SER . 2.9 mm? -107.78 -178.84 3.74 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.301 1.44 . . . . 0.0 109.147 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 181' ' ' TYR . 1.7 p90 -139.97 156.88 46.43 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -134.97 175.0 9.98 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 126.879 2.072 . . . . 0.0 107.446 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -64.21 -13.97 52.36 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 124.548 1.139 . . . . 0.0 112.699 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 99.6 t -97.65 -34.93 4.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 125.856 1.662 . . . . 0.0 112.459 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 163.93 -174.65 40.09 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 176' ' ' TYR . 3.6 m-30 -78.41 166.21 22.9 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -165.66 164.19 19.08 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.354 0.662 . . . . 0.0 111.395 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 67.7 mt -102.43 132.41 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.584 ' HB2' HD23 ' A' ' 175' ' ' LEU . 23.3 t -100.81 127.27 47.33 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.581 1.553 . . . . 0.0 107.954 179.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.404 ' HG3' HH22 ' A' ' 170' ' ' ARG . 26.4 tt0 -124.21 112.47 17.09 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.39 1.876 . . . . 0.0 109.617 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -96.94 116.23 38.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 178.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 5.3 mt -105.22 108.64 25.44 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -106.58 -153.21 19.83 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 108.023 -2.031 . . . . 0.0 108.023 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 85.44 32.13 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.352 1.861 . . . . 0.0 111.237 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -111.53 165.17 12.09 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 125.537 1.541 . . . . 0.0 111.093 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.62 157.17 38.45 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.7 mm -78.1 134.87 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 C-N-CA 125.387 1.475 . . . . 0.0 110.769 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.35 115.03 18.75 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.918 1.687 . . . . 0.0 106.685 178.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -60.37 -22.21 63.03 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.161 1.384 . . . . 0.0 112.219 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 59.8 t -53.73 -48.51 60.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 C-N-CA 125.192 1.397 . . . . 0.0 111.249 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 11.7 t -125.2 -43.27 1.95 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 117.62 35.15 1.1 Allowed Glycine 0 CA--C 1.532 1.139 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 -177.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -111.08 150.67 29.05 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.612 1.706 . . . . 0.0 111.598 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -73.03 143.3 47.57 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.446 0.641 . . . . 0.0 109.388 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 7.0 ttp180 -67.6 29.45 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.4 1 C-N-CA 132.184 4.194 . . . . 0.0 113.564 179.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 6.0 ptm -73.51 175.78 6.72 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.216 -0.927 . . . . 0.0 113.062 -177.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 8.8 p -142.13 151.41 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 124.7 1.2 . . . . 0.0 108.483 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -110.78 115.25 29.23 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 179.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 8.5 mm -106.12 140.06 25.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -125.44 109.0 12.21 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.604 1.562 . . . . 0.0 109.108 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -89.48 115.27 26.78 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 120.636 -1.29 . . . . 0.0 110.413 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 5.2 m -124.62 165.99 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 124.015 0.926 . . . . 0.0 108.525 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 48.8 t -85.39 143.09 28.83 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 121.033 -1.042 . . . . 0.0 108.331 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -86.91 7.18 81.28 Favored Glycine 0 CA--C 1.52 0.395 0 CA-C-O 116.831 -2.094 . . . . 0.0 116.829 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.827 0 CA-C-N 120.249 2.024 . . . . 0.0 111.593 -178.579 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo . . . . . 0 N--CA 1.45 -1.031 0 N-CA-C 109.047 -1.174 . . . . 0.0 109.047 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.5 p -171.42 150.39 2.86 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 121.021 -1.049 . . . . 0.0 110.078 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.9 p -151.85 159.1 43.97 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.862 1.265 . . . . 0.0 109.325 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.429 ' HA ' ' HA ' ' A' ' 233' ' ' VAL . 4.3 mt -102.31 152.56 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 126.416 1.886 . . . . 0.0 107.996 178.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -97.6 -50.95 4.29 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.467 1.107 . . . . 0.0 111.447 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 58.2 p-90 -160.02 155.24 25.02 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.336 1.454 . . . . 0.0 107.84 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 52.9 t -151.46 118.75 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 125.672 1.589 . . . . 0.0 106.769 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.98 167.49 26.54 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 118.51 0.596 . . . . 0.0 111.459 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -73.81 134.69 43.41 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 1.4 t -112.34 -37.36 5.01 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.172 0.989 . . . . 0.0 110.732 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 16.4 mttm -131.61 -175.19 3.63 Favored 'General case' 0 CA--C 1.506 -0.749 0 C-N-CA 124.054 0.942 . . . . 0.0 109.689 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 71.0 mt -53.16 -48.51 54.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.923 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -126.84 22.56 6.78 Favored 'General case' 0 C--O 1.226 -0.135 0 C-N-CA 124.66 1.184 . . . . 0.0 110.777 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 12.3 t -123.38 144.33 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.518 0 C-N-CA 120.328 -0.549 . . . . 0.0 109.57 -178.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -125.15 158.93 32.7 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.496 1.519 . . . . 0.0 107.379 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -127.72 137.47 52.48 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -142.34 125.64 16.54 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.88 1.672 . . . . 0.0 110.686 -177.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -118.97 116.96 27.55 Favored 'General case' 0 C--O 1.237 0.436 0 O-C-N 121.721 -0.612 . . . . 0.0 110.659 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 218' ' ' ILE . 3.6 m -101.5 154.3 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.1 p -124.01 125.57 44.79 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 1.2 pt -136.5 141.03 34.12 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -67.68 -43.34 5.57 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.831 2.354 . . . . 0.0 112.386 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -56.69 -18.23 11.64 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -178.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 3.9 tp -70.18 -22.16 62.98 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 120.06 -1.65 . . . . 0.0 112.171 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 15.9 m -70.48 -9.31 56.23 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.623 1.169 . . . . 0.0 112.259 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -57.29 -35.86 70.34 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.203 1.001 . . . . 0.0 108.535 178.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -92.55 124.33 36.5 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -46.89 -47.92 21.3 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 128.416 2.686 . . . . 0.0 111.815 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.432 ' HB3' ' CD2' ' A' ' 181' ' ' TYR . 25.3 mt -62.09 -44.46 96.61 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.752 -178.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 8.2 mp -78.66 -8.33 58.56 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -70.02 141.39 52.91 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.688 1.595 . . . . 0.0 110.722 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 10.3 mmmm . . . . . 0 C--N 1.328 -0.33 0 C-N-CA 124.126 0.971 . . . . 0.0 109.409 179.489 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 118.661 -0.685 . . . . 0.0 111.552 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.42 -51.22 69.63 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.651 -1.241 . . . . 0.0 107.651 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 53.7 tp -61.35 -38.25 86.27 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 117.728 -1.13 . . . . 0.0 110.383 179.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.6 mt -60.94 -54.37 45.87 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 119.627 1.103 . . . . 0.0 109.365 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 26.4 m -58.86 -49.01 79.34 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.241 1.416 . . . . 0.0 110.303 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.4 ttmm -58.7 -49.85 76.07 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 52.9 m -52.61 -45.34 66.52 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 123.964 0.905 . . . . 0.0 110.127 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -57.32 -49.8 74.96 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.711 0.687 . . . . 0.0 109.482 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.17 -61.38 2.17 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.904 0.881 . . . . 0.0 112.5 -178.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.25 -39.03 78.11 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 125.153 1.381 . . . . 0.0 111.739 -178.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -65.32 -52.72 37.79 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-O 117.985 -1.453 . . . . 0.0 109.935 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.536 ' HA ' HD12 ' A' ' 109' ' ' ILE . 52.2 t -58.77 -42.89 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 119.689 1.745 . . . . 0.0 110.691 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.9 ptmm? -62.06 -35.9 80.02 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.968 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.4 m -72.89 -40.13 65.81 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.317 1.047 . . . . 0.0 109.67 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.536 HD12 ' HA ' ' A' ' 106' ' ' VAL . 20.4 mt -58.48 -54.71 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -57.18 -37.73 72.58 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 118.011 -0.995 . . . . 0.0 111.432 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -63.69 -37.41 87.26 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.102 0.865 . . . . 0.0 111.399 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.43 -32.56 62.68 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.768 -0.582 . . . . 0.0 111.636 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.0 mt -83.73 -25.11 30.85 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 117.884 0.311 . . . . 0.0 111.362 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -47.82 -35.45 10.18 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.185 1.394 . . . . 0.0 111.552 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -60.62 -67.04 0.44 Allowed 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 125.329 1.452 . . . . 0.0 111.928 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 77.5 mmt-85 -150.05 171.73 16.39 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.815 1.189 . . . . 0.0 111.936 -178.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 62.1 m -86.71 152.62 22.38 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 178.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 28.7 pt -106.41 161.32 5.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 125.779 1.632 . . . . 0.0 109.74 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -151.73 134.57 15.64 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.635 1.574 . . . . 0.0 108.694 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.406 ' CB ' ' HB ' ' A' ' 218' ' ' ILE . 12.2 t80 -138.61 127.6 23.91 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.114 0.966 . . . . 0.0 111.139 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -81.99 106.78 14.18 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.533 1.133 . . . . 0.0 108.83 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -100.54 79.99 2.16 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 178.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.66 -125.59 20.24 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -67.05 -34.59 78.03 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.308 0.643 . . . . 0.0 112.046 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -99.96 163.88 12.25 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 119.132 0.878 . . . . 0.0 111.637 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.1 mp -128.98 140.92 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 104.886 -2.264 . . . . 0.0 104.886 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.416 ' CG ' HG11 ' A' ' 221' ' ' VAL . 10.5 m-85 -114.82 120.07 38.76 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 125.841 1.656 . . . . 0.0 107.961 -177.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -113.46 122.66 47.99 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -122.25 135.13 54.7 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 123.855 0.862 . . . . 0.0 110.7 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.506 ' HB3' HD13 ' A' ' 133' ' ' ILE . 16.4 m -109.09 158.25 34.84 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 126.675 1.99 . . . . 0.0 112.59 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -63.9 74.46 0.17 Allowed 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 124.738 3.625 . . . . 0.0 114.457 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 72.78 50.68 13.18 Favored Glycine 0 CA--C 1.532 1.126 0 O-C-N 120.093 -1.63 . . . . 0.0 114.085 179.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.506 HD13 ' HB3' ' A' ' 130' ' ' CYS . 3.6 mp -124.31 -65.98 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 125.352 1.461 . . . . 0.0 108.091 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -166.64 168.48 14.44 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 127.416 2.286 . . . . 0.0 110.837 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -134.57 121.72 21.35 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 19.5 m -143.03 163.79 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 125.008 1.323 . . . . 0.0 111.821 -178.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -126.19 128.07 46.67 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.608 1.163 . . . . 0.0 110.124 178.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -138.09 162.92 32.93 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.555 1.942 . . . . 0.0 110.929 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -91.69 160.76 15.2 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 120.867 -1.146 . . . . 0.0 109.357 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.953 0 C-N-CA 124.842 1.21 . . . . 0.0 111.045 -179.128 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 . . . . . 0 C--O 1.228 -0.033 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -148.93 140.28 23.26 Favored 'General case' 0 CA--C 1.507 -0.697 0 O-C-N 120.819 -1.176 . . . . 0.0 109.474 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 41.0 mt -118.07 -24.37 7.05 Favored 'General case' 0 C--O 1.219 -0.51 0 O-C-N 125.391 1.682 . . . . 0.0 109.378 179.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 163.38 164.12 17.72 Favored Glycine 0 C--N 1.34 0.757 0 O-C-N 121.056 -1.028 . . . . 0.0 111.1 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.414 ' N ' HG22 ' A' ' 187' ' ' ILE . 49.0 mtpt -127.89 109.58 20.25 Favored Pre-proline 0 CA--C 1.533 0.31 0 C-N-CA 124.374 1.07 . . . . 0.0 110.519 178.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -72.09 172.58 14.44 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 123.945 3.097 . . . . 0.0 111.127 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -111.43 152.32 27.52 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.705 0.802 . . . . 0.0 111.083 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -68.01 -44.25 76.97 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.807 1.243 . . . . 0.0 111.986 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -78.15 65.36 3.51 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.482 1.113 . . . . 0.0 111.456 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.8 p -47.23 -33.91 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 124.532 1.133 . . . . 0.0 111.86 178.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -67.45 -36.19 80.69 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.951 1.3 . . . . 0.0 112.726 -178.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -86.28 -1.39 57.45 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 125.503 1.521 . . . . 0.0 110.917 -178.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 18.3 ttt-85 -93.24 146.94 23.32 Favored 'General case' 0 N--CA 1.441 -0.876 0 O-C-N 120.399 -1.438 . . . . 0.0 110.634 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -102.69 147.85 26.32 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.597 0.759 . . . . 0.0 110.656 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -138.04 175.48 9.54 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.873 2.069 . . . . 0.0 109.371 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -137.6 133.68 34.68 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.513 0.725 . . . . 0.0 112.52 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 35.1 tp -92.07 106.36 18.4 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.633 1.173 . . . . 0.0 109.377 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.492 HD23 ' HB2' ' A' ' 184' ' ' SER . 2.8 mm? -113.38 -179.25 3.59 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 125.775 1.63 . . . . 0.0 109.412 179.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -136.42 162.74 32.2 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.098 0.959 . . . . 0.0 110.092 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -138.89 178.81 6.88 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 127.666 2.386 . . . . 0.0 107.711 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -63.46 -14.31 49.4 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 121.706 -0.621 . . . . 0.0 111.659 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 5.0 t -97.5 -47.72 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 125.279 1.432 . . . . 0.0 112.101 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 172.6 -162.29 33.98 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.281 -1.127 . . . . 0.0 110.281 -178.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -84.32 163.33 19.67 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 117.993 0.897 . . . . 0.0 110.359 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -156.88 165.14 37.04 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.29 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 62.7 mt -105.26 120.2 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.492 ' HB2' HD23 ' A' ' 175' ' ' LEU . 39.8 t -89.93 136.31 33.12 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 124.707 1.203 . . . . 0.0 107.931 178.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -131.44 113.16 13.37 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 125.129 1.372 . . . . 0.0 107.652 178.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.48 107.03 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.414 HG22 ' N ' ' A' ' 162' ' ' LYS . 7.2 mt -94.01 105.81 17.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 178.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -111.57 -152.34 12.17 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 126.676 2.084 . . . . 0.0 109.715 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 76.73 40.54 0.2 Allowed 'General case' 0 C--O 1.237 0.416 0 C-N-CA 127.166 2.186 . . . . 0.0 108.305 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -108.7 173.25 17.43 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-O 121.978 0.766 . . . . 0.0 112.793 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . 0.504 ' H ' ' NE ' ' A' ' 200' ' ' ARG . 30.6 m-20 -80.97 141.28 34.61 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 179.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 43.5 mm -69.2 136.53 26.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 124.951 1.3 . . . . 0.0 112.046 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -87.52 110.33 20.26 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 128.335 2.654 . . . . 0.0 107.744 178.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -55.94 -18.49 9.25 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 127.691 2.396 . . . . 0.0 114.101 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 25.3 t -60.48 -46.28 95.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 124.985 1.314 . . . . 0.0 110.575 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 5.7 t -123.1 -37.52 2.7 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.514 1.126 . . . . 0.0 113.133 -178.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 104.12 35.89 3.29 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 108.079 -2.008 . . . . 0.0 108.079 -178.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -122.18 163.45 19.53 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.71 1.255 . . . . 0.0 110.813 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -77.2 151.71 35.1 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -178.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.504 ' NE ' ' H ' ' A' ' 191' ' ' ASP . 27.0 ptt85 -76.61 28.71 0.13 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 129.352 3.061 . . . . 0.0 111.852 177.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 6.6 ptm -72.77 175.52 6.4 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.956 0.903 . . . . 0.0 112.286 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.2 p -142.34 146.86 21.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 124.977 1.311 . . . . 0.0 109.978 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -105.18 104.04 13.69 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.831 1.652 . . . . 0.0 107.678 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 24.4 mm -91.26 152.01 3.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 O-C-N 120.896 -1.127 . . . . 0.0 109.432 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -127.36 104.83 8.13 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.342 1.857 . . . . 0.0 110.586 178.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . 0.446 ' CD1' HD13 ' A' ' 109' ' ' ILE . 42.9 m-85 -84.48 108.59 17.35 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 177.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 11.6 m -125.01 166.88 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 48.0 t -91.77 138.35 31.63 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 178.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -87.4 3.26 86.6 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-O 118.56 -1.133 . . . . 0.0 112.601 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.686 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -178.802 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo . . . . . 0 N--CA 1.449 -1.138 0 N-CA-C 109.401 -1.038 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.1 146.38 26.89 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.864 1.666 . . . . 0.0 108.782 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 80.4 p -147.18 162.3 39.16 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 118.784 0.72 . . . . 0.0 110.357 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.433 ' CG1' HG12 ' A' ' 233' ' ' VAL . 3.4 mt -107.28 139.63 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 105.013 -2.218 . . . . 0.0 105.013 177.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -88.48 -47.71 8.13 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.417 1.087 . . . . 0.0 111.45 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 68.6 p-90 -159.25 154.21 24.93 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 126.047 1.739 . . . . 0.0 108.66 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.483 HG23 ' HB2' ' A' ' 231' ' ' ALA . 6.1 p -155.78 128.82 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -156.3 162.54 40.09 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 122.895 0.478 . . . . 0.0 111.119 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -68.76 133.42 48.33 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 178.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . 0.4 HG23 ' HG3' ' A' ' 225' ' ' LYS . 12.0 t -109.48 -31.11 7.63 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 123.909 0.884 . . . . 0.0 111.882 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.4 ' HG3' HG23 ' A' ' 224' ' ' THR . 7.1 mttm -138.65 -175.85 4.27 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.043 1.337 . . . . 0.0 108.024 178.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 76.3 mt -45.1 -49.39 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 1.8 t -132.96 18.96 4.12 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.169 0.988 . . . . 0.0 111.168 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 18.5 t -113.79 141.69 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -123.96 163.62 20.97 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.805 1.242 . . . . 0.0 107.725 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -142.76 133.55 25.4 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.483 ' HB2' HG23 ' A' ' 221' ' ' VAL . . . -134.89 145.26 48.07 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 125.669 1.588 . . . . 0.0 107.986 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -124.29 123.29 39.9 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . 0.433 HG12 ' CG1' ' A' ' 218' ' ' ILE . 6.3 m -113.92 154.81 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -179.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 2.1 p -125.37 126.3 44.8 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 123.76 0.824 . . . . 0.0 112.079 -178.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -131.38 145.94 59.81 Favored Pre-proline 0 C--O 1.234 0.254 0 O-C-N 124.357 1.035 . . . . 0.0 108.258 176.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -66.52 -47.85 2.71 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.786 2.324 . . . . 0.0 109.255 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -53.31 -23.61 9.64 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 -178.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 7.4 tp -66.39 -30.27 70.61 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 121.11 -0.994 . . . . 0.0 111.147 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 2.8 m -60.25 -13.08 10.72 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.058 0.943 . . . . 0.0 112.706 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.33 -25.79 67.76 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 118.901 0.773 . . . . 0.0 111.389 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' A' ' 241' ' ' LEU . 4.1 mm? -88.94 126.42 35.39 Favored 'General case' 0 C--O 1.225 -0.229 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -47.4 -44.65 24.59 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.631 1.972 . . . . 0.0 113.064 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 48.1 mt -72.93 -21.72 60.84 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 120.681 -1.262 . . . . 0.0 113.864 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 13.2 mt -100.46 -13.14 18.82 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.538 1.535 . . . . 0.0 112.654 -178.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -61.25 136.29 58.01 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 129.263 3.025 . . . . 0.0 110.742 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt . . . . . 0 N--CA 1.464 0.236 0 C-N-CA 125.703 1.601 . . . . 0.0 110.079 179.238 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 CA--C 1.517 -0.296 0 CA-C-O 118.755 -0.64 . . . . 0.0 112.089 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.91 -38.61 79.3 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 49.9 tp -70.25 -38.24 75.1 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 117.865 -1.064 . . . . 0.0 109.519 177.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.5 mt -61.75 -55.24 32.33 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.94 1.245 . . . . 0.0 109.376 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 18.3 m -60.12 -46.45 89.59 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.93 1.692 . . . . 0.0 111.211 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.9 ttpt -66.84 -41.9 86.66 Favored 'General case' 0 C--N 1.341 0.208 0 O-C-N 120.103 -1.623 . . . . 0.0 110.544 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 27.0 m -53.73 -50.49 65.83 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.795 0.838 . . . . 0.0 110.028 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -55.05 -50.38 69.26 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.133 0.573 . . . . 0.0 111.015 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.77 -58.49 7.82 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 122.487 1.136 . . . . 0.0 112.807 -178.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.0 mm100 -58.87 -40.63 84.92 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.915 1.286 . . . . 0.0 111.27 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.0 -53.03 39.86 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 109.171 -1.571 . . . . 0.0 109.171 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.472 ' HA ' HD12 ' A' ' 109' ' ' ILE . 42.3 t -55.12 -47.58 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 119.46 1.63 . . . . 0.0 110.482 179.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.4 pttm -62.1 -34.23 75.94 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.364 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 84.0 m -75.63 -35.96 60.33 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.472 HD12 ' HA ' ' A' ' 106' ' ' VAL . 21.0 mt -59.24 -54.3 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -58.45 -34.14 70.51 Favored 'General case' 0 C--O 1.225 -0.198 0 O-C-N 123.852 0.72 . . . . 0.0 111.447 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -56.18 -48.13 76.95 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.181 0.593 . . . . 0.0 111.496 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.483 ' HE3' ' HA ' ' A' ' 215' ' ' PRO . 27.0 mmmt -80.96 -40.8 23.86 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 121.565 -0.709 . . . . 0.0 111.255 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 13.0 mt -61.59 -31.62 71.69 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-O 118.364 -0.827 . . . . 0.0 112.25 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -51.53 -28.14 12.81 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.031 0.932 . . . . 0.0 113.337 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -59.65 -63.11 1.42 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.981 0.912 . . . . 0.0 111.72 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 7.3 mmt85 -154.65 -176.95 6.16 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.395 1.478 . . . . 0.0 110.805 -178.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 67.3 m -86.29 174.32 9.15 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 177.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 30.9 pt -129.47 161.42 38.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 126.573 1.949 . . . . 0.0 107.246 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -153.35 142.62 21.52 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -136.97 117.23 13.52 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.346 0.659 . . . . 0.0 109.892 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -85.24 98.43 10.49 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.83 80.77 7.09 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 128.634 2.774 . . . . 0.0 108.02 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 60.16 -112.09 4.17 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 108.581 -1.808 . . . . 0.0 108.581 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -80.77 -24.65 38.47 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -100.45 159.33 15.23 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 119.957 1.253 . . . . 0.0 111.031 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.0 mp -134.88 132.22 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 N-CA-C 103.904 -2.628 . . . . 0.0 103.904 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -118.59 121.3 39.87 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -109.26 121.1 44.45 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -111.25 128.3 55.89 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.196 0.522 . . . . 0.0 110.669 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.483 ' HB3' HD13 ' A' ' 133' ' ' ILE . 54.7 m -110.14 153.21 43.37 Favored Pre-proline 0 N--CA 1.439 -1.002 0 C-N-CA 126.894 2.077 . . . . 0.0 113.308 -178.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -68.96 74.34 0.95 Allowed 'Trans proline' 0 C--N 1.349 0.573 1 C-N-CA 125.356 4.037 . . . . 0.0 113.692 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.13 51.77 6.65 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-O 119.04 -0.866 . . . . 0.0 113.812 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.483 HD13 ' HB3' ' A' ' 130' ' ' CYS . 2.6 mp -124.83 -72.16 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.299 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 177.73 145.28 0.11 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -109.87 131.98 54.57 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 124.757 1.223 . . . . 0.0 109.098 -175.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.5 m -144.82 164.53 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 125.318 1.447 . . . . 0.0 111.581 -177.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -123.19 126.29 46.71 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 105.25 -2.129 . . . . 0.0 105.25 177.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -138.36 162.99 32.98 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.87 1.214 . . . . 0.0 111.235 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -84.98 157.73 20.7 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 177.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.926 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -179.439 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 . . . . . 0 CA--C 1.512 -0.499 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.3 116.18 12.3 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 49.0 mt -98.05 -26.81 14.48 Favored 'General case' 0 C--O 1.22 -0.448 0 O-C-N 124.413 1.07 . . . . 0.0 110.91 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 155.17 155.17 7.2 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 119.028 0.831 . . . . 0.0 111.54 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -114.74 109.97 47.17 Favored Pre-proline 0 N--CA 1.451 -0.4 0 C-N-CA 125.246 1.418 . . . . 0.0 108.766 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -74.52 -177.55 3.41 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.801 2.334 . . . . 0.0 107.319 178.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -128.95 134.67 48.29 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-N 118.819 0.736 . . . . 0.0 110.532 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -49.61 -45.98 48.71 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 125.869 1.98 . . . . 0.0 109.808 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -73.21 65.05 0.8 Allowed 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.522 1.529 . . . . 0.0 110.297 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 5.9 p -50.76 -31.23 9.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 121.035 -1.041 . . . . 0.0 112.659 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -63.42 -26.88 68.94 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -177.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -86.74 -23.09 25.62 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.67 1.588 . . . . 0.0 112.826 -179.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 30.2 mtp85 -73.34 150.71 41.65 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -103.71 144.19 31.79 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -138.93 159.26 42.57 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.96 1.304 . . . . 0.0 108.749 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -120.11 153.74 35.72 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.738 0.815 . . . . 0.0 109.994 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 35.5 tp -114.26 98.01 6.68 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.777 1.631 . . . . 0.0 106.995 179.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -107.92 -178.54 3.64 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.693 1.997 . . . . 0.0 108.547 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -141.22 158.06 44.4 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.024 0.53 . . . . 0.0 110.853 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -132.09 -178.7 5.02 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.681 1.992 . . . . 0.0 108.435 179.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.14 -14.42 17.05 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.186 1.394 . . . . 0.0 113.136 -178.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 16.0 t -107.24 -41.87 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 124.37 1.068 . . . . 0.0 111.279 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 177.34 -172.34 45.15 Favored Glycine 0 C--N 1.336 0.537 0 O-C-N 121.104 -0.998 . . . . 0.0 114.573 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 5.0 m-30 -77.28 158.36 30.26 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 122.337 1.065 . . . . 0.0 108.514 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -157.04 160.5 39.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.2 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 92.5 mt -100.19 132.11 46.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 22.7 t -102.06 126.15 48.92 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 125.406 1.482 . . . . 0.0 111.971 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -123.17 111.6 16.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.725 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -93.26 119.04 40.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 177.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 9.1 mt -104.7 106.55 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 178.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.63 -153.1 24.54 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 124.771 1.177 . . . . 0.0 110.57 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 71.3 47.87 0.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.716 2.006 . . . . 0.0 107.946 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -115.04 162.91 12.27 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 108.886 -1.685 . . . . 0.0 108.886 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.05 159.11 30.11 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.0 mm -79.6 137.84 20.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 124.674 1.19 . . . . 0.0 110.604 178.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.3 m -90.09 108.65 19.86 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 128.047 2.539 . . . . 0.0 106.635 178.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -53.93 -25.88 22.62 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.051 1.34 . . . . 0.0 113.486 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 40.0 t -49.6 -47.26 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 125.254 1.422 . . . . 0.0 112.024 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 11.2 t -124.3 -38.99 2.37 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.278 1.031 . . . . 0.0 111.653 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 110.5 34.96 2.16 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 107.923 -2.071 . . . . 0.0 107.923 -177.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -106.28 154.8 20.23 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 120.175 1.988 . . . . 0.0 111.403 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -76.25 148.41 37.63 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 123.523 0.729 . . . . 0.0 111.723 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 38.6 mtt180 -69.91 27.23 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 130.564 3.546 . . . . 0.0 112.442 178.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 6.4 ptm -74.38 175.29 7.82 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.473 1.033 . . . . 0.0 110.683 -178.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.13 149.84 18.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 124.972 1.309 . . . . 0.0 107.484 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -109.19 112.79 25.15 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.355 1.462 . . . . 0.0 107.345 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 13.3 mm -105.99 139.49 27.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 39.1 mm-40 -124.73 126.71 46.11 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.479 1.112 . . . . 0.0 109.88 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -100.41 111.2 23.44 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.301 1.04 . . . . 0.0 110.512 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 3.5 m -124.21 163.43 24.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 123.742 0.817 . . . . 0.0 109.769 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 52.7 t -88.87 134.21 34.02 Favored 'General case' 0 N--CA 1.461 0.09 0 O-C-N 120.633 -1.292 . . . . 0.0 110.204 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -84.59 10.37 62.19 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 124.34 0.971 . . . . 0.0 114.032 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.17 0 N-CA-C 106.965 -2.454 . . . . 0.0 106.965 -177.988 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.483 ' HA ' ' HE3' ' A' ' 112' ' ' LYS . 55.4 Cg_endo . . . . . 0 N--CA 1.451 -1.024 0 N-CA-C 111.102 -0.384 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 4.2 p -174.85 151.83 1.46 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.212 1.405 . . . . 0.0 110.66 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.4 p -151.09 158.58 44.22 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.865 1.266 . . . . 0.0 109.222 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 4.3 mt -98.1 151.93 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 125.65 1.58 . . . . 0.0 110.084 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -97.07 -50.34 4.64 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 124.691 1.197 . . . . 0.0 112.031 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 63.9 p-90 -159.69 156.09 27.17 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -178.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 61.7 t -153.76 129.16 1.59 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 125.792 1.637 . . . . 0.0 107.198 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -160.62 163.68 32.42 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.198 0.599 . . . . 0.0 111.189 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -69.39 144.21 53.45 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . 0.409 HG23 ' HG3' ' A' ' 225' ' ' LYS . 9.0 t -119.18 -35.8 3.53 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 121.084 -1.01 . . . . 0.0 110.521 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.409 ' HG3' HG23 ' A' ' 224' ' ' THR . 21.0 mttm -127.65 -175.11 3.37 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 83.3 mt -55.7 -44.63 77.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.731 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 1.1 t -125.16 10.16 8.08 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.579 0.752 . . . . 0.0 112.492 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 10.6 t -114.74 143.77 23.76 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.793 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -177.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -122.39 162.22 22.01 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -132.54 143.53 49.79 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -145.89 146.27 31.03 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.638 1.575 . . . . 0.0 108.842 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -135.44 130.25 34.49 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 8.8 m -114.43 155.6 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.627 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 178.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.04 125.27 44.25 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 1.5 pt -134.72 146.22 58.06 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -75.22 -35.98 2.68 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.413 2.076 . . . . 0.0 112.566 -178.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -62.89 -17.58 61.84 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 -177.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 18.4 mt -73.18 -29.31 62.75 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.88 1.218 . . . . 0.0 110.264 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 10.1 m -57.1 -15.86 6.32 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.11 0.964 . . . . 0.0 112.903 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -62.01 -31.05 71.39 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.139 0.975 . . . . 0.0 109.173 177.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -86.34 124.28 32.52 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 106.052 -1.832 . . . . 0.0 106.052 178.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -47.23 -48.67 24.19 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 127.003 2.121 . . . . 0.0 113.608 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 32.9 mt -67.01 -26.18 66.67 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 12.8 mt -99.31 2.64 45.63 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.095 1.758 . . . . 0.0 111.582 -178.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -77.67 114.56 16.63 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.614 1.566 . . . . 0.0 111.733 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp . . . . . 0 N--CA 1.465 0.279 0 C-N-CA 124.018 0.927 . . . . 0.0 109.529 178.208 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.55 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -148.78 76.74 1.36 Allowed 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 73.8 m -139.33 147.77 42.01 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 123.141 0.576 . . . . 0.0 111.625 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -87.13 168.36 13.33 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.194 0.998 . . . . 0.0 110.572 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.3 t -70.93 -41.37 71.26 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 117.696 -1.145 . . . . 0.0 113.945 -178.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -54.4 -40.36 68.15 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 120.297 1.408 . . . . 0.0 110.225 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.1 tmtm? -54.26 -55.16 30.9 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.631 1.172 . . . . 0.0 108.025 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.428 ' HA ' HD12 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -64.53 -37.17 86.61 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 124.06 0.944 . . . . 0.0 112.078 179.006 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.71 -50.26 74.56 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 61.1 tp -69.54 -34.61 74.48 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 118.33 -0.843 . . . . 0.0 110.748 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 95' ' ' THR . 17.3 mt -61.38 -54.38 44.39 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.8 m -57.52 -50.52 72.79 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.157 0.983 . . . . 0.0 110.368 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.7 -50.29 72.61 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 118.651 -0.69 . . . . 0.0 111.038 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 21.9 m -52.2 -45.21 65.13 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 124.282 1.033 . . . . 0.0 110.309 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -60.56 -51.38 69.67 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.356 0.98 . . . . 0.0 108.767 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -59.03 -60.25 4.17 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.44 -30.92 67.89 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.199 -176.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.76 -52.29 51.64 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.506 ' HA ' HD12 ' A' ' 109' ' ' ILE . 42.1 t -56.75 -48.62 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 118.361 1.08 . . . . 0.0 109.794 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.43 -30.92 70.87 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 119.037 -1.065 . . . . 0.0 113.487 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 44.4 m -78.19 -34.2 49.62 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.506 HD12 ' HA ' ' A' ' 106' ' ' VAL . 21.7 mt -60.02 -54.74 30.63 Favored 'Isoleucine or valine' 0 C--O 1.23 0.072 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -58.11 -29.85 65.82 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.781 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -69.75 -39.81 76.5 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.294 0.952 . . . . 0.0 112.189 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.2 tptt -84.77 -34.2 22.85 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 120.744 -1.223 . . . . 0.0 110.426 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 15.9 mt -65.95 -30.28 70.82 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 118.497 -0.763 . . . . 0.0 109.802 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -48.36 -35.05 11.75 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.466 1.107 . . . . 0.0 112.209 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -49.0 -66.07 0.46 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.51 1.524 . . . . 0.0 113.328 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -158.0 -177.85 6.87 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 128.178 2.591 . . . . 0.0 108.777 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 58.5 m -86.67 167.21 14.71 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 42.3 pt -115.69 156.99 16.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -154.18 141.76 19.85 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 122.555 0.342 . . . . 0.0 111.225 -178.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -140.44 125.75 18.78 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.649 0.78 . . . . 0.0 111.205 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -84.27 105.76 15.37 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.64 80.23 4.79 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.27 -103.24 0.98 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -93.2 -23.08 18.67 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.457 1.103 . . . . 0.0 113.742 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -100.58 156.9 17.04 Favored 'General case' 0 CA--C 1.517 -0.326 0 O-C-N 121.606 -0.684 . . . . 0.0 110.111 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.8 mp -127.89 135.33 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.43 ' CD1' HG11 ' A' ' 221' ' ' VAL . 63.1 m-85 -115.5 124.87 52.17 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -120.9 120.07 34.45 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 123.291 0.636 . . . . 0.0 110.301 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -110.9 131.2 55.25 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.657 0.741 . . . . 0.0 109.922 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.45 ' HB3' HD13 ' A' ' 133' ' ' ILE . 36.1 m -110.08 157.24 38.43 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 124.398 1.079 . . . . 0.0 112.697 -178.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -63.6 76.68 0.14 Allowed 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 125.042 3.828 . . . . 0.0 113.612 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 66.18 60.66 6.15 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 125.01 1.291 . . . . 0.0 112.228 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.45 HD13 ' HB3' ' A' ' 130' ' ' CYS . 3.2 mp -130.57 -71.46 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -164.88 164.71 20.82 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 126.455 1.902 . . . . 0.0 110.278 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -131.18 119.35 21.75 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 22.5 m -143.92 164.89 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 123.899 0.88 . . . . 0.0 110.761 -178.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -120.59 129.48 53.77 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.632 1.173 . . . . 0.0 109.014 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -138.93 162.87 33.81 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.19 1.396 . . . . 0.0 112.089 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -89.09 160.91 16.81 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 176.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 138.68 -161.81 25.81 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -149.06 167.55 25.56 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 126.495 1.918 . . . . 0.0 108.579 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.5 p -127.96 149.31 32.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -105.2 104.39 14.12 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 103.624 -2.732 . . . . 0.0 103.624 177.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.8 p -53.86 -31.85 51.02 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 120.744 1.611 . . . . 0.0 112.125 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -53.09 -46.28 68.59 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.25 1.42 . . . . 0.0 111.051 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 40.3 p -97.77 -33.95 11.08 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 123.835 0.854 . . . . 0.0 112.043 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 86.94 22.32 46.2 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 127.74 2.591 . . . . 0.0 111.763 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -124.32 154.77 39.8 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 119.082 1.441 . . . . 0.0 112.229 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 9.5 mm -70.51 166.45 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 125.128 1.371 . . . . 0.0 108.907 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 12.4 m -60.78 -55.52 24.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 178.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -164.41 157.51 17.49 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 127.884 2.474 . . . . 0.0 107.124 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 39.6 mtm-85 -74.68 176.78 6.64 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -140.99 103.72 4.53 Favored 'General case' 0 C--O 1.232 0.165 0 O-C-N 120.954 -1.091 . . . . 0.0 112.73 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -77.85 -19.5 54.75 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.413 1.085 . . . . 0.0 112.878 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 16.0 m -82.58 -41.16 19.91 Favored 'General case' 0 C--O 1.238 0.458 0 O-C-N 121.286 -0.884 . . . . 0.0 110.464 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 94.4 mt -77.36 72.96 3.93 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.883 1.673 . . . . 0.0 109.75 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 57.4 t -75.08 120.01 23.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 123.674 0.79 . . . . 0.0 109.895 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -146.96 151.74 37.49 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.971 1.708 . . . . 0.0 108.374 178.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -147.03 129.21 15.62 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 54.3 mt -112.94 -21.98 10.85 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.828 0.74 . . . . 0.0 109.753 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 155.98 157.8 8.48 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -126.46 117.73 23.07 Favored Pre-proline 0 CA--C 1.536 0.41 0 O-C-N 122.044 -0.68 . . . . 0.0 111.003 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -77.01 -171.17 1.07 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 1 C-N-CA 126.316 4.677 . . . . 0.0 108.845 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -129.5 152.86 48.57 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.312 1.045 . . . . 0.0 109.04 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -73.76 -29.71 62.37 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.26 1.024 . . . . 0.0 110.578 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -88.28 64.66 7.71 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 124.708 1.203 . . . . 0.0 108.361 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.6 p -50.07 -31.59 7.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 124.92 1.288 . . . . 0.0 112.093 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -61.5 -32.89 72.94 Favored 'General case' 0 CA--C 1.522 -0.116 0 C-N-CA 123.931 0.892 . . . . 0.0 111.986 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -80.64 -28.28 36.98 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.338 1.055 . . . . 0.0 110.82 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 9.4 mtp-105 -72.92 137.3 45.48 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -99.12 144.75 27.9 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -128.7 173.89 9.91 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 126.326 1.85 . . . . 0.0 108.639 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -131.71 154.09 49.36 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.375 0.67 . . . . 0.0 109.389 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 23.1 tp -118.27 100.65 7.64 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.344 1.058 . . . . 0.0 109.061 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -109.24 -179.89 3.97 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 181' ' ' TYR . 4.0 p90 -149.95 163.51 37.9 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 121.142 -0.974 . . . . 0.0 108.978 177.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -140.58 -178.14 5.38 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -59.33 -22.52 61.39 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.694 1.198 . . . . 0.0 111.729 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.449 HG12 ' HE3' ' A' ' 246' ' ' LYS . 48.3 t -88.85 -35.86 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 125.762 1.625 . . . . 0.0 111.965 -178.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 160.19 178.95 34.64 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 121.743 -0.265 . . . . 0.0 112.789 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 176' ' ' TYR . 20.1 m-85 -78.01 155.71 30.56 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 123.893 0.877 . . . . 0.0 108.98 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -155.72 156.72 35.37 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.31 0.644 . . . . 0.0 111.395 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 92.7 mt -97.15 133.82 37.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 12.3 t -101.32 127.14 48.07 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.495 1.518 . . . . 0.0 108.294 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -122.54 107.28 11.82 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.604 1.562 . . . . 0.0 107.807 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -93.3 115.47 32.19 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.5 mt -99.64 106.59 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 104.778 -2.305 . . . . 0.0 104.778 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -99.72 -152.86 27.24 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 108.771 -1.731 . . . . 0.0 108.771 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 69.66 47.7 0.63 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-O 123.049 1.404 . . . . 0.0 107.875 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -116.79 158.24 14.59 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 107.803 -2.119 . . . . 0.0 107.803 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -74.42 159.15 32.69 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.168 0.987 . . . . 0.0 108.704 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 34.1 mm -83.03 126.38 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 177.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.2 m -75.37 111.75 10.97 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 127.065 2.146 . . . . 0.0 107.072 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -56.23 -27.45 54.93 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.626 1.17 . . . . 0.0 112.49 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 57.9 t -49.3 -50.67 15.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 125.036 1.334 . . . . 0.0 110.847 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 6.5 t -125.57 -32.35 2.89 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 116.644 2.09 . . . . 0.0 116.644 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 106.9 35.86 2.68 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -178.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -116.68 152.14 34.89 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 118.261 1.03 . . . . 0.0 111.764 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -74.81 146.45 42.03 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.571 0.748 . . . . 0.0 112.908 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -72.6 29.11 0.06 Allowed 'General case' 0 C--O 1.223 -0.322 1 C-N-CA 132.055 4.142 . . . . 0.0 112.308 178.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 5.8 ptm -75.77 177.52 6.83 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 120.197 -1.565 . . . . 0.0 110.341 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 5.9 p -147.94 148.85 15.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 125.158 1.383 . . . . 0.0 108.452 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -104.73 121.97 44.71 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 177.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 17.7 mm -114.1 131.22 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -114.54 125.0 53.3 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.304 1.042 . . . . 0.0 109.068 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -97.77 112.72 24.51 Favored 'General case' 0 C--O 1.239 0.553 0 C-N-CA 123.685 0.794 . . . . 0.0 109.72 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 5.1 m -124.08 161.46 26.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 44.1 t -90.25 142.68 27.48 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -84.4 2.39 87.93 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-O 117.753 -1.581 . . . . 0.0 114.906 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 62.6 56.5 21.09 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 106.97 -2.452 . . . . 0.0 106.97 -178.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.93 137.37 29.4 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -179.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -82.18 -13.04 57.75 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.503 0.668 . . . . 0.0 110.653 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 50.5 p -156.23 172.26 18.77 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 119.845 -1.784 . . . . 0.0 111.682 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 125.57 174.22 13.86 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 127.041 2.258 . . . . 0.0 112.221 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -85.43 -113.85 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 124.194 3.263 . . . . 0.0 107.733 178.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.6 p -150.33 142.11 23.72 Favored 'General case' 0 C--O 1.237 0.405 0 O-C-N 120.047 -1.658 . . . . 0.0 111.554 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 40.7 p -147.86 160.98 42.19 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.776 1.23 . . . . 0.0 110.244 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 4.0 mt -100.08 153.71 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 126.536 1.935 . . . . 0.0 107.865 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -97.62 -48.55 5.2 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 124.492 1.117 . . . . 0.0 112.618 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 52.8 p-90 -163.96 159.46 20.83 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.43 HG11 ' CD1' ' A' ' 127' ' ' TYR . 91.0 t -152.8 129.15 1.84 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.586 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.14 167.35 29.39 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.289 0.95 . . . . 0.0 112.547 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -77.41 132.63 38.6 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.581 1.552 . . . . 0.0 107.653 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 7.5 t -110.84 -33.74 6.44 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.573 1.149 . . . . 0.0 110.918 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -132.53 -175.18 3.67 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 124.645 1.178 . . . . 0.0 108.985 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 60.9 mt -56.64 -45.05 82.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -125.58 18.33 8.1 Favored 'General case' 0 C--N 1.334 -0.108 0 C-N-CA 124.185 0.994 . . . . 0.0 111.102 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 15.8 t -121.65 143.3 34.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 CA-C-N 118.309 0.504 . . . . 0.0 110.387 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -124.47 161.32 26.32 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.152 1.381 . . . . 0.0 107.666 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -132.07 134.49 45.57 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 126.04 1.736 . . . . 0.0 106.534 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -140.22 145.3 37.22 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.919 1.688 . . . . 0.0 109.07 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -133.69 128.62 35.37 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 119.263 -0.398 . . . . 0.0 111.57 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 3.8 m -112.35 152.69 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.57 115.36 20.71 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.808 1.243 . . . . 0.0 107.775 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 18.5 pt -127.14 152.25 75.61 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.879 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.63 -45.43 0.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.819 2.346 . . . . 0.0 112.366 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -53.32 -28.51 28.77 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 116.751 2.13 . . . . 0.0 116.751 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.4 HD22 ' CD1' ' A' ' 244' ' ' LEU . 59.2 mt -64.42 -28.98 70.05 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 120.33 1.423 . . . . 0.0 110.323 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 12.3 m -60.61 -11.72 8.04 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -69.85 -31.52 69.41 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.96 121.63 25.71 Favored 'General case' 0 C--O 1.225 -0.199 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -47.13 -42.6 19.63 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.906 1.683 . . . . 0.0 113.47 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.86 -29.57 64.51 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.4 ' CD1' HD22 ' A' ' 238' ' ' LEU . 17.3 mt -96.49 -5.45 39.45 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.299 1.04 . . . . 0.0 111.832 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -64.3 116.77 6.36 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.895 1.678 . . . . 0.0 108.577 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.449 ' HE3' HG12 ' A' ' 179' ' ' VAL . 3.8 mmmm -77.26 161.21 28.31 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 178.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.3 -11.5 59.57 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -127.71 33.12 4.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.104 1.362 . . . . 0.0 110.552 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.017 0 C-N-CA 125.615 1.566 . . . . 0.0 109.043 178.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.706 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.09 126.51 18.8 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.888 0.875 . . . . 0.0 110.141 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.2 t -151.39 109.44 3.71 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 50.84 31.63 6.29 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.523 1.129 . . . . 0.0 110.824 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.5 m -46.23 -54.17 9.3 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 127.343 2.257 . . . . 0.0 113.702 -177.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -64.51 -38.21 90.21 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 118.33 0.514 . . . . 0.0 111.555 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -61.05 -46.29 91.32 Favored 'General case' 0 C--N 1.342 0.265 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.85 -34.04 73.97 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.754 0.706 . . . . 0.0 110.955 178.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.56 -43.15 97.57 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 119.119 0.872 . . . . 0.0 109.395 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 65.7 tp -64.2 -32.36 73.91 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-O 118.406 -0.807 . . . . 0.0 109.61 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.04 -54.36 39.3 Favored 'General case' 0 C--N 1.345 0.377 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 25.3 m -60.79 -48.14 83.13 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.159 0.984 . . . . 0.0 110.877 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.86 -48.84 79.95 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 121.024 -1.048 . . . . 0.0 110.036 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 53.8 m -54.11 -46.09 72.03 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 123.535 0.734 . . . . 0.0 110.055 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -56.22 -48.47 76.41 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.515 0.326 . . . . 0.0 110.432 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.16 -52.96 16.26 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -58.14 -40.29 80.95 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.344 1.058 . . . . 0.0 110.983 -178.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -66.58 -52.35 35.34 Favored Glycine 0 C--O 1.223 -0.537 0 N-CA-C 108.776 -1.729 . . . . 0.0 108.776 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.415 ' HA ' HD12 ' A' ' 109' ' ' ILE . 24.5 t -53.25 -46.88 57.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 118.76 1.28 . . . . 0.0 110.988 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.6 ptmm? -62.44 -34.2 76.32 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.1 m -77.66 -36.45 51.34 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.916 0.887 . . . . 0.0 110.371 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.415 HD12 ' HA ' ' A' ' 106' ' ' VAL . 23.5 mt -60.22 -54.71 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -61.53 -28.19 69.14 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.112 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -66.29 -45.41 80.5 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 120.586 -1.321 . . . . 0.0 113.0 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -76.92 -39.43 50.84 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 18.3 mt -66.22 -28.41 68.72 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-O 118.721 -0.657 . . . . 0.0 112.147 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -56.77 -18.57 13.16 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.54 0.736 . . . . 0.0 112.607 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -68.01 -74.71 0.11 Allowed 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 7.1 mmm180 -143.06 -179.65 6.5 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.281 1.432 . . . . 0.0 111.402 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 85.3 m -86.59 174.91 8.6 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 32.7 pt -128.67 159.99 39.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 127.043 2.137 . . . . 0.0 107.299 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -155.81 135.25 12.39 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.855 1.262 . . . . 0.0 108.975 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -130.79 126.16 35.62 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.666 1.186 . . . . 0.0 109.076 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -88.88 104.15 16.67 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.26 1.024 . . . . 0.0 109.365 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.59 80.74 4.3 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 128.337 2.655 . . . . 0.0 106.552 178.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 59.97 -113.34 5.24 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -78.0 -22.54 49.18 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.192 0.997 . . . . 0.0 112.835 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -105.15 161.72 14.01 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 123.625 0.77 . . . . 0.0 111.917 -178.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.4 mp -135.61 134.75 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 104.131 -2.544 . . . . 0.0 104.131 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.405 ' CD1' ' HB3' ' A' ' 137' ' ' GLN . 94.4 m-85 -114.86 119.65 37.29 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 103.991 -2.596 . . . . 0.0 103.991 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -111.02 116.46 31.22 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.382 0.673 . . . . 0.0 109.396 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -106.66 129.23 54.6 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.52 ' HB3' HD13 ' A' ' 133' ' ' ILE . 20.8 m -114.75 155.49 46.17 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 126.665 1.986 . . . . 0.0 113.835 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.27 80.73 1.57 Allowed 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 124.115 3.21 . . . . 0.0 113.37 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.44 45.31 18.93 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-O 118.2 -1.333 . . . . 0.0 112.961 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.52 HD13 ' HB3' ' A' ' 130' ' ' CYS . 3.0 mp -120.84 -72.3 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 119.459 1.63 . . . . 0.0 109.913 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -179.2 141.91 0.18 Allowed 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -109.17 125.69 52.46 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -177.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 33.3 m -144.61 164.33 13.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 114.123 -1.399 . . . . 0.0 111.575 -177.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.405 ' HB3' ' CD1' ' A' ' 127' ' ' TYR . 6.6 pt20 -123.0 130.57 52.97 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.649 1.179 . . . . 0.0 108.286 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -138.25 162.89 33.15 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.402 1.481 . . . . 0.0 111.338 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.495 ' H ' ' CD1' ' A' ' 156' ' ' LEU . 74.3 t60 -91.06 161.56 15.06 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.916 1.686 . . . . 0.0 107.391 178.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 126.57 -158.65 20.71 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-N 120.099 1.318 . . . . 0.0 110.769 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.57 167.26 28.62 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 121.668 -0.901 . . . . 0.0 109.488 177.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.8 p -123.16 141.15 44.54 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 C-N-CA 124.034 0.934 . . . . 0.0 108.79 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -86.72 113.94 22.99 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 13.5 p -59.86 -17.72 38.85 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.831 1.252 . . . . 0.0 112.799 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -68.8 -35.37 76.93 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 126.984 2.114 . . . . 0.0 113.399 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 30.6 p -124.88 -36.29 2.58 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 93.92 34.82 6.33 Favored Glycine 0 C--N 1.334 0.447 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -124.36 141.96 51.66 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 125.166 1.386 . . . . 0.0 108.863 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 9.4 mm -71.73 161.24 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 8.6 m -58.8 -42.23 84.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 O-C-N 121.505 -0.747 . . . . 0.0 110.672 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -172.91 164.1 5.01 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 126.596 1.959 . . . . 0.0 107.383 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -75.75 167.78 21.25 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 178.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -127.27 99.54 5.7 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -84.35 -20.03 32.68 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 118.514 -0.755 . . . . 0.0 112.121 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 6.0 t -75.02 -42.52 57.21 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 120.349 1.431 . . . . 0.0 109.462 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.495 ' CD1' ' H ' ' A' ' 139' ' ' HIS . 54.5 mt -72.6 123.3 22.92 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 15.7 m -131.56 105.03 9.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -124.09 160.76 27.03 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.491 1.516 . . . . 0.0 107.275 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 9.6 tpp180 -143.36 110.46 5.68 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.9 mp -98.43 -34.46 10.63 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 177.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 160.05 163.92 14.34 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 119.266 0.939 . . . . 0.0 111.537 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -118.82 109.78 39.25 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 124.264 1.026 . . . . 0.0 110.201 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -77.93 174.93 11.81 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 123.298 2.665 . . . . 0.0 111.118 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -126.35 146.23 50.13 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.25 -37.93 75.04 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 126.664 1.985 . . . . 0.0 111.428 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -73.25 65.36 0.83 Allowed 'General case' 0 C--O 1.233 0.227 0 C-N-CA 126.098 1.759 . . . . 0.0 109.967 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.4 p -48.84 -31.22 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 125.048 1.339 . . . . 0.0 112.206 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -71.18 -31.61 67.85 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 124.899 1.28 . . . . 0.0 112.862 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -76.65 -12.95 60.08 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.715 1.206 . . . . 0.0 113.167 -178.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -107.63 152.54 24.15 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.598 1.159 . . . . 0.0 110.526 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -105.02 156.61 17.89 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.267 1.427 . . . . 0.0 108.306 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -136.83 163.91 29.53 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.46 1.504 . . . . 0.0 108.738 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -114.72 153.7 29.81 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.236 0.614 . . . . 0.0 110.106 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 16.9 tp -118.39 98.79 6.44 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.432 1.493 . . . . 0.0 107.79 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -110.35 -178.99 3.65 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 126.875 2.07 . . . . 0.0 108.564 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -144.88 163.31 34.5 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 121.35 0.595 . . . . 0.0 110.057 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -137.69 -177.59 4.87 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.791 1.636 . . . . 0.0 108.046 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -60.55 -17.54 46.67 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.164 1.386 . . . . 0.0 111.56 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 87.7 t -86.0 -56.98 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 128.511 2.724 . . . . 0.0 110.484 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 168.76 -165.17 38.68 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -78.39 166.49 22.58 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 117.523 0.662 . . . . 0.0 109.683 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -159.85 171.59 19.18 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.167 0.987 . . . . 0.0 110.384 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 79.7 mt -107.42 138.11 35.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 32.9 t -107.07 134.11 50.69 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 125.393 1.477 . . . . 0.0 108.408 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -130.23 111.45 12.42 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.369 1.068 . . . . 0.0 108.214 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.6 mp -93.41 132.17 38.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 10.3 mt -122.18 115.2 45.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -110.68 -152.52 13.01 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 125.796 1.665 . . . . 0.0 111.603 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 4.6 t 71.58 35.25 1.49 Allowed 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.65 1.58 . . . . 0.0 114.434 178.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -87.58 -112.42 1.02 Allowed Glycine 0 CA--C 1.526 0.768 0 N-CA-C 108.44 -1.864 . . . . 0.0 108.44 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -154.55 150.83 28.17 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 129.825 3.25 . . . . 0.0 103.589 178.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.8 mm -72.9 137.57 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 O-C-N 120.053 -1.654 . . . . 0.0 111.999 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.6 m -81.4 116.08 21.05 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 128.489 2.716 . . . . 0.0 107.001 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -57.72 -29.16 64.51 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 124.624 1.17 . . . . 0.0 112.105 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 14.5 t -51.81 -50.67 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 126.423 1.889 . . . . 0.0 113.878 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 14.7 t -124.0 -31.97 3.31 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.15 34.74 3.86 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 -178.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -109.14 155.64 20.78 Favored 'General case' 0 C--N 1.343 0.324 0 C-N-CA 123.957 0.903 . . . . 0.0 110.182 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -75.72 144.4 41.55 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 125.197 1.399 . . . . 0.0 110.832 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . 0.269 26.1 mtp85 -69.04 29.18 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 130.053 3.341 . . . . 0.0 112.524 178.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 8.4 ptm -74.71 177.99 5.75 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.141 0.976 . . . . 0.0 112.022 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.3 p -145.78 152.72 13.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 125.504 1.522 . . . . 0.0 109.174 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -112.18 101.81 10.03 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 126.938 2.095 . . . . 0.0 106.921 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 9.1 mm -94.36 146.31 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.458 HE22 ' HG2' ' A' ' 230' ' ' GLU . 16.2 mp0 -126.32 114.43 18.24 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 127.298 2.239 . . . . 0.0 109.574 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -93.62 115.71 28.19 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 12.5 m -125.02 165.62 21.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 42.1 t -87.04 140.68 29.31 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -95.47 18.06 58.12 Favored Glycine 0 CA--C 1.523 0.532 0 CA-C-O 118.596 -1.114 . . . . 0.0 112.706 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 68.13 -149.18 49.87 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 107.771 -2.131 . . . . 0.0 107.771 -178.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 41.5 m -73.49 81.35 1.45 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.236 1.018 . . . . 0.0 108.33 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -132.02 60.67 1.67 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 12.6 m -52.97 123.62 12.06 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 123.882 0.873 . . . . 0.0 109.929 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 163.52 -168.25 38.07 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.68 -75.37 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 123.553 2.835 . . . . 0.0 110.488 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 3.8 p -173.05 152.42 2.32 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.863 1.665 . . . . 0.0 110.914 -178.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 4.7 p -150.85 166.36 30.79 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.533 1.533 . . . . 0.0 109.108 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.476 HG12 HG12 ' A' ' 233' ' ' VAL . 5.1 mt -108.68 153.73 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 126.098 1.759 . . . . 0.0 110.614 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -94.44 -56.29 2.86 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 124.46 1.104 . . . . 0.0 111.155 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 -160.73 156.05 24.76 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 126.324 1.85 . . . . 0.0 106.903 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 58.0 t -151.33 125.94 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 125.731 1.612 . . . . 0.0 108.369 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -162.54 164.18 27.01 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 118.21 0.459 . . . . 0.0 110.874 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -65.81 141.9 58.13 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . 0.486 HG23 ' HG3' ' A' ' 225' ' ' LYS . 1.8 t -123.79 -30.64 3.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 118.457 0.571 . . . . 0.0 111.897 179.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.486 ' HG3' HG23 ' A' ' 224' ' ' THR . 11.3 mttt -124.4 -175.87 3.37 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 77.0 mt -59.28 -47.36 90.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.88 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 1.8 t -118.93 15.02 13.37 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.651 0.78 . . . . 0.0 112.703 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 14.2 t -122.38 148.7 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.705 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.546 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -125.42 166.1 17.21 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . 0.458 ' HG2' HE22 ' A' ' 205' ' ' GLN . 4.3 mt-10 -133.02 144.47 50.1 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 124.667 1.187 . . . . 0.0 108.464 178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -144.96 118.95 9.35 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.19 1.396 . . . . 0.0 109.915 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -106.13 124.11 49.06 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 104.98 -2.23 . . . . 0.0 104.98 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . 0.476 HG12 HG12 ' A' ' 218' ' ' ILE . 3.0 m -119.38 153.76 21.92 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 2.1 p -122.55 138.27 54.63 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 122.236 1.017 . . . . 0.0 110.856 -178.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -143.69 148.14 41.86 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 114.609 -1.178 . . . . 0.0 108.142 178.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.28 -36.11 3.44 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 121.597 1.531 . . . . 0.0 112.208 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -59.86 -20.74 58.85 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 116.618 2.081 . . . . 0.0 116.618 -177.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 32.9 mt -71.24 -26.64 63.0 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.899 1.681 . . . . 0.0 110.52 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 27.5 m -59.57 -12.52 6.73 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.877 0.871 . . . . 0.0 111.845 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -62.39 -35.77 80.23 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.772 0.829 . . . . 0.0 110.171 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -87.87 130.9 34.75 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -47.81 -48.64 30.43 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.516 1.926 . . . . 0.0 112.779 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 66.0 mt -65.34 -25.67 67.7 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 15.4 mt -99.74 -7.54 25.42 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.746 0.818 . . . . 0.0 113.175 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -62.54 112.86 2.65 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 128.212 2.605 . . . . 0.0 112.743 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -66.69 151.71 46.85 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -94.5 -22.34 18.3 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.52 0.728 . . . . 0.0 111.521 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.29 35.36 4.56 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 129.117 2.967 . . . . 0.0 109.935 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 C--O 1.247 0.967 0 C-N-CA 125.917 1.687 . . . . 0.0 110.326 179.426 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.935 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.66 161.24 23.5 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.129 0.965 . . . . 0.0 109.785 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.9 p -154.09 107.56 2.93 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.759 1.224 . . . . 0.0 109.423 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -72.42 121.71 20.01 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 177.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.9 m -70.15 -20.91 63.13 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.119 1.368 . . . . 0.0 114.511 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -75.37 -49.68 18.27 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 120.702 -1.249 . . . . 0.0 108.663 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -53.65 -50.85 64.88 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.45 ' HA ' HD12 ' A' ' 98' ' ' LEU . 1.1 p -66.75 -36.17 81.83 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 123.256 0.622 . . . . 0.0 112.524 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.09 -38.97 93.3 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 22.8 tp -74.0 -40.96 62.57 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 117.519 -1.229 . . . . 0.0 109.367 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' ' 95' ' ' THR . 36.2 mt -57.87 -54.09 50.88 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.738 1.154 . . . . 0.0 110.407 -177.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 78.2 m -61.81 -38.07 86.73 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.503 -0.748 . . . . 0.0 111.215 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.39 -48.2 76.35 Favored 'General case' 0 C--N 1.341 0.201 0 O-C-N 120.091 -1.631 . . . . 0.0 109.424 178.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 77.2 m -52.82 -48.43 66.97 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.12 1.368 . . . . 0.0 109.941 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -59.38 -43.92 92.84 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.797 0.439 . . . . 0.0 111.933 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -71.98 -52.79 15.36 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -63.22 -41.22 99.09 Favored 'General case' 0 C--O 1.216 -0.698 0 C-N-CA 124.856 1.263 . . . . 0.0 109.661 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.04 -50.9 62.32 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.435 ' HA ' HD12 ' A' ' 109' ' ' ILE . 36.4 t -58.24 -45.88 88.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 118.591 1.195 . . . . 0.0 110.425 179.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 8.0 ptmt -61.92 -34.66 76.47 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.783 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 99.6 m -77.67 -28.53 51.16 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.679 0.792 . . . . 0.0 109.783 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.435 HD12 ' HA ' ' A' ' 106' ' ' VAL . 19.8 mt -69.61 -55.03 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 178.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -55.7 -36.99 67.76 Favored 'General case' 0 CA--C 1.527 0.083 0 O-C-N 123.644 0.59 . . . . 0.0 110.565 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -63.25 -38.66 92.02 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.258 1.023 . . . . 0.0 111.95 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.0 tptp -82.63 -38.78 23.04 Favored 'General case' 0 CA--C 1.518 -0.273 0 O-C-N 121.149 -0.969 . . . . 0.0 111.114 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 31.8 mt -70.26 -24.6 63.09 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 122.437 0.295 . . . . 0.0 111.305 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -50.93 -29.71 12.87 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.132 1.373 . . . . 0.0 111.096 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -64.87 -64.51 0.85 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.315 1.046 . . . . 0.0 113.176 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 86.7 mmt-85 -150.46 177.17 10.25 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.684 1.194 . . . . 0.0 110.479 -177.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 74.4 m -86.47 175.99 8.08 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 46.2 pt -129.33 157.74 42.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 124.926 1.29 . . . . 0.0 108.473 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -156.46 139.79 15.7 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.014 0.926 . . . . 0.0 110.668 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.476 ' CE1' ' HB2' ' A' ' 122' ' ' ALA . 4.9 t80 -136.84 124.14 21.9 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -81.07 98.79 8.15 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.997 1.719 . . . . 0.0 108.24 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.476 ' HB2' ' CE1' ' A' ' 120' ' ' TYR . . . -91.86 79.76 5.28 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.19 -85.37 0.06 OUTLIER Glycine 0 CA--C 1.521 0.458 0 C-N-CA 124.67 1.129 . . . . 0.0 113.183 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -106.8 -32.18 8.07 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.447 1.099 . . . . 0.0 112.895 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -104.93 128.24 53.11 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 123.679 0.791 . . . . 0.0 110.96 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.9 mp -98.24 157.1 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 103.794 -2.669 . . . . 0.0 103.794 177.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -135.34 121.95 20.77 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 103.955 -2.609 . . . . 0.0 103.955 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -119.25 117.65 29.18 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.8 1.64 . . . . 0.0 110.741 -178.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -110.67 137.7 48.0 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.415 1.486 . . . . 0.0 109.453 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.489 ' HB3' HD13 ' A' ' 133' ' ' ILE . 11.7 m -120.83 151.81 55.2 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 123.718 0.807 . . . . 0.0 111.506 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -60.53 85.35 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.662 1 C-N-CA 125.767 4.311 . . . . 0.0 115.044 -177.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 74.43 33.05 57.06 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 117.964 -1.464 . . . . 0.0 113.207 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.489 HD13 ' HB3' ' A' ' 130' ' ' CYS . 3.8 mp -115.65 -72.49 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 119.537 1.668 . . . . 0.0 109.222 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.489 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 9.1 pt-20 -168.88 169.36 9.83 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.12 1.768 . . . . 0.0 109.115 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -134.23 120.79 20.45 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 33.8 m -139.47 163.39 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.807 1.243 . . . . 0.0 110.993 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -118.82 125.07 48.73 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -138.24 162.3 34.66 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.962 0.801 . . . . 0.0 110.704 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -89.96 160.58 16.32 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 177.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 143.13 -158.59 27.26 Favored Glycine 0 N--CA 1.464 0.565 0 O-C-N 120.031 -1.668 . . . . 0.0 109.685 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.11 159.99 32.49 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.777 1.231 . . . . 0.0 108.671 177.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.7 p -110.24 149.06 13.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -103.61 101.59 11.45 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 17.7 p -48.25 -25.94 1.75 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 127.836 2.454 . . . . 0.0 114.209 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 39.8 mmtt -68.42 -32.22 72.11 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.299 1.44 . . . . 0.0 113.096 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 23.8 p -118.91 -27.77 5.7 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 84.29 31.63 24.79 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 124.67 1.129 . . . . 0.0 112.243 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -125.8 156.06 40.1 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.597 1.159 . . . . 0.0 111.055 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 15.0 mm -76.55 149.49 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 29.3 m -62.9 -43.97 99.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -149.42 -171.77 3.97 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.786 1.634 . . . . 0.0 107.755 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.22 105.48 5.04 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 178.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.437 ' CG ' HD12 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -70.83 120.45 16.44 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 120.768 -1.208 . . . . 0.0 108.881 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -79.66 -24.44 41.83 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.269 0.628 . . . . 0.0 110.869 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 2.6 p -74.0 -21.47 59.97 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 126.004 1.722 . . . . 0.0 112.642 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.437 HD12 ' CG ' ' A' ' 153' ' ' ASP . 29.3 mt -96.1 83.45 3.63 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 122.598 1.19 . . . . 0.0 109.413 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 65.1 t -84.66 124.07 39.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 125.249 1.42 . . . . 0.0 107.346 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -154.6 156.8 37.19 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.544 1.537 . . . . 0.0 108.221 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -149.07 129.52 13.88 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.047 -1.658 . . . . 0.0 110.7 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 43.4 mt -109.02 -30.63 7.98 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 120.053 1.297 . . . . 0.0 108.525 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 165.68 164.36 20.99 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -128.66 109.63 18.87 Favored Pre-proline 0 C--O 1.236 0.356 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.489 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 69.2 Cg_endo -73.36 176.72 8.85 Favored 'Trans proline' 0 C--O 1.236 0.39 1 C-N-CA 125.458 4.105 . . . . 0.0 110.783 -179.542 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -123.13 144.39 49.37 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 124.114 0.966 . . . . 0.0 109.58 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -67.11 -43.53 82.23 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 124.953 1.408 . . . . 0.0 109.6 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -74.3 64.81 1.14 Allowed 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.285 1.434 . . . . 0.0 110.411 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.2 p -50.95 -28.83 6.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 126.855 2.062 . . . . 0.0 111.333 178.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -72.97 -30.44 63.84 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.497 1.119 . . . . 0.0 112.524 -178.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -75.98 -23.01 55.29 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -96.58 173.6 7.26 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -133.31 165.39 24.92 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -135.71 169.79 16.99 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.743 1.217 . . . . 0.0 110.245 -177.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -113.23 153.65 28.01 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 48.7 tp -123.11 99.07 6.18 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.009 1.723 . . . . 0.0 106.784 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -108.36 175.56 5.43 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -140.5 160.56 39.73 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 123.001 1.382 . . . . 0.0 109.609 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -140.79 178.23 7.49 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 126.294 1.838 . . . . 0.0 106.544 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -73.2 10.78 0.87 Allowed 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 125.479 1.512 . . . . 0.0 114.199 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 59.6 t -116.76 -37.25 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 125.879 1.672 . . . . 0.0 109.827 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 164.04 -176.04 40.09 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -86.68 163.19 17.5 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.534 ' HB3' HG12 ' A' ' 207' ' ' VAL . 43.5 p90 -156.36 161.52 40.14 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.633 0.773 . . . . 0.0 110.667 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 86.6 mt -102.08 130.74 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 12.9 t -97.38 126.9 42.91 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.485 1.114 . . . . 0.0 108.704 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -122.13 108.89 13.86 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -90.28 108.88 20.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 N-CA-C 103.68 -2.711 . . . . 0.0 103.68 178.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 12.2 mt -94.62 105.92 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 103.331 -2.841 . . . . 0.0 103.331 177.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -99.28 -152.72 27.52 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 107.765 -2.134 . . . . 0.0 107.765 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 5.2 t 70.22 51.64 0.38 Allowed 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -178.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -93.29 -162.78 36.62 Favored Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 106.375 -2.69 . . . . 0.0 106.375 177.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -127.64 136.17 51.26 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 100.585 -3.858 . . . . 0.0 100.585 177.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 33.2 mm -60.36 138.95 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 119.552 1.069 . . . . 0.0 109.924 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.06 112.01 24.25 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.829 2.052 . . . . 0.0 106.376 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -51.12 -29.02 12.14 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.183 1.793 . . . . 0.0 115.795 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 24.5 t -42.22 -51.92 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.126 1.37 . . . . 0.0 111.108 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 13.2 t -123.76 -34.07 3.08 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.532 0.733 . . . . 0.0 109.334 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 106.48 35.46 2.86 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -112.51 158.86 19.39 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-N 118.852 1.326 . . . . 0.0 110.689 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -68.12 143.53 55.39 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.649 1.58 . . . . 0.0 114.869 -178.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . 0.258 24.1 ttp180 -77.22 28.76 0.14 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 130.508 3.523 . . . . 0.0 113.524 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 8.1 ptm -73.82 176.91 5.9 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.072 -1.017 . . . . 0.0 111.365 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.46 149.27 19.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 125.801 1.64 . . . . 0.0 106.733 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -111.39 114.19 27.16 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 9.5 mm -102.26 138.99 24.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -118.15 96.93 5.54 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 126.729 2.011 . . . . 0.0 107.698 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -80.83 111.13 17.01 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.247 1.019 . . . . 0.0 108.545 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.534 HG12 ' HB3' ' A' ' 182' ' ' TYR . 33.5 m -124.53 164.98 22.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 124.653 1.181 . . . . 0.0 108.383 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . 0.439 ' O ' ' HE2' ' A' ' 246' ' ' LYS . 41.8 t -85.8 142.22 29.1 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -90.54 16.99 56.57 Favored Glycine 0 C--O 1.227 -0.294 0 CA-C-O 118.067 -1.407 . . . . 0.0 115.15 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 57.57 -5.08 0.04 OUTLIER Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.812 1.673 . . . . 0.0 117.071 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 7.6 t -82.69 160.54 22.37 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 119.702 1.751 . . . . 0.0 108.88 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -73.57 -53.59 10.16 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.659 0.783 . . . . 0.0 111.821 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.85 163.01 38.39 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.662 0.744 . . . . 0.0 111.497 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 150.05 -174.27 29.53 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 128.181 2.8 . . . . 0.0 107.287 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -75.85 -110.3 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 124.085 3.19 . . . . 0.0 110.983 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . 0.405 ' CB ' HG22 ' A' ' 235' ' ' ILE . 3.8 p -156.01 148.61 23.86 Favored 'General case' 0 C--O 1.237 0.442 0 O-C-N 120.094 -1.629 . . . . 0.0 109.853 -178.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.7 p -151.01 168.5 24.38 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.895 0.878 . . . . 0.0 112.122 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.436 HG12 HG12 ' A' ' 233' ' ' VAL . 3.2 mt -109.63 152.01 11.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 126.505 1.922 . . . . 0.0 109.465 178.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -98.42 -51.83 3.84 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 126.063 1.745 . . . . 0.0 109.592 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 65.3 p-90 -159.87 158.67 31.34 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.607 1.163 . . . . 0.0 109.306 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 97.1 t -153.42 134.9 5.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 126.153 1.781 . . . . 0.0 107.459 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -165.7 162.64 18.86 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.367 0.667 . . . . 0.0 111.662 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -68.48 140.87 55.72 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 178.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 13.1 t -120.65 -30.07 4.57 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.865 1.266 . . . . 0.0 112.681 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 43.2 mttt -131.25 -175.63 3.76 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 72.8 mt -46.68 -49.49 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 6.8 t -133.25 17.82 4.06 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.986 0.514 . . . . 0.0 111.276 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 23.1 t -109.62 143.31 19.97 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -122.68 161.95 22.89 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -131.69 144.55 51.08 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 178.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -144.77 141.33 29.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.893 1.277 . . . . 0.0 109.585 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -124.01 116.26 22.55 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . 0.436 HG12 HG12 ' A' ' 218' ' ' ILE . 1.1 m -110.36 144.54 18.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -121.83 123.6 42.16 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.666 1.586 . . . . 0.0 110.757 -178.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.405 HG22 ' CB ' ' A' ' 216' ' ' SER . 3.6 pt -131.65 147.62 66.77 Favored Pre-proline 0 C--N 1.331 -0.231 0 C-N-CA 123.892 0.877 . . . . 0.0 108.695 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -70.18 -43.04 2.51 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.766 1.644 . . . . 0.0 111.924 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -55.77 -23.85 32.17 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -177.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.613 HD22 ' CD1' ' A' ' 244' ' ' LEU . 20.1 mt -65.28 -26.71 68.2 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 116.982 -1.887 . . . . 0.0 111.07 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 18.9 m -61.7 -11.75 13.35 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.618 0.645 . . . . 0.0 112.29 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -61.08 -22.89 65.04 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.718 0.807 . . . . 0.0 109.798 177.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -98.11 130.58 44.89 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 126.594 1.958 . . . . 0.0 109.743 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -51.65 -47.76 63.62 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.844 1.258 . . . . 0.0 112.637 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.59 -35.85 80.85 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.104 -0.998 . . . . 0.0 113.438 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.613 ' CD1' HD22 ' A' ' 238' ' ' LEU . 17.9 mt -89.89 -14.94 33.17 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -178.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -58.68 112.72 1.72 Allowed 'General case' 0 C--O 1.236 0.345 0 C-N-CA 128.204 2.601 . . . . 0.0 111.731 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.439 ' HE2' ' O ' ' A' ' 208' ' ' CYS . 39.2 mmtt -79.3 159.51 27.19 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -88.62 -64.57 1.13 Allowed 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -142.07 59.32 1.47 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.428 0.632 . . . . 0.0 111.034 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 30.5 t70 . . . . . 0 C--O 1.246 0.889 0 C-N-CA 125.175 1.39 . . . . 0.0 109.58 178.199 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.175 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.46 120.98 13.83 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 54.6 p -160.47 134.78 7.33 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 50.71 22.99 1.23 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.716 1.206 . . . . 0.0 113.504 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.7 m -48.27 -39.81 22.72 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 129.374 3.07 . . . . 0.0 114.202 -178.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -66.69 -44.99 80.25 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 123.788 0.835 . . . . 0.0 109.169 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.412 ' HE2' HD11 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -60.49 -43.9 96.5 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.482 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.531 ' HA ' HD12 ' A' ' 98' ' ' LEU . 0.6 OUTLIER -64.1 -34.66 78.56 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.776 1.171 . . . . 0.0 110.708 177.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.5 -42.61 95.72 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 32.5 tp -69.85 -36.89 75.91 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.44 1.096 . . . . 0.0 110.507 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.531 HD12 ' HA ' ' A' ' 95' ' ' THR . 22.4 mt -61.41 -54.89 37.67 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 119.005 0.821 . . . . 0.0 109.083 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 56.1 m -65.38 -40.26 93.26 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 121.453 -0.779 . . . . 0.0 111.257 -179.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -45.37 93.89 Favored 'General case' 0 C--O 1.222 -0.382 0 O-C-N 121.207 -0.933 . . . . 0.0 109.169 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 42.2 m -52.28 -48.9 65.05 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.171 0.989 . . . . 0.0 109.741 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -58.3 -48.9 79.02 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.886 0.474 . . . . 0.0 110.863 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -67.82 -56.33 9.57 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -177.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.427 ' HA ' ' HE3' ' A' ' 107' ' ' LYS . 2.8 mm-40 -55.83 -44.25 77.75 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.806 1.642 . . . . 0.0 109.678 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.34 -52.99 49.29 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-O 118.001 -1.444 . . . . 0.0 110.212 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.412 ' HA ' HD12 ' A' ' 109' ' ' ILE . 43.0 t -55.85 -43.36 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-N 119.893 1.846 . . . . 0.0 110.91 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.427 ' HE3' ' HA ' ' A' ' 104' ' ' GLN . 6.6 ptpt -66.01 -33.81 76.65 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 119.38 -0.928 . . . . 0.0 111.165 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 65.5 m -72.9 -39.24 66.51 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 106' ' ' VAL . 22.7 mt -61.06 -55.76 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -61.29 -35.42 77.29 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 118.292 -0.861 . . . . 0.0 112.67 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -62.21 -33.85 75.34 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.813 0.733 . . . . 0.0 111.887 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.527 ' HA ' ' HE2' ' A' ' 112' ' ' LYS . 0.6 OUTLIER -87.62 -38.27 16.06 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 117.87 -1.062 . . . . 0.0 110.333 179.047 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 29.5 mt -65.74 -25.17 67.16 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.904 1.229 . . . . 0.0 110.338 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -51.47 -30.08 18.54 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.119 1.768 . . . . 0.0 111.558 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -65.51 -66.75 0.51 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.426 1.49 . . . . 0.0 113.083 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.6 mmt180 -144.56 173.36 11.87 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 124.456 1.102 . . . . 0.0 110.743 -178.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 78.6 m -86.07 163.34 17.97 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 48.3 pt -118.92 154.5 21.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -178.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -151.87 144.49 24.24 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.909 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -140.74 122.34 15.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.425 178.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -81.6 100.07 9.2 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.69 80.03 6.67 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 104.389 -2.449 . . . . 0.0 104.389 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 65.97 -109.02 2.65 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -81.32 -36.36 29.84 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -99.84 146.0 27.11 Favored 'General case' 0 CA--C 1.512 -0.486 0 O-C-N 121.635 -0.666 . . . . 0.0 110.388 -178.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.5 mp -110.21 153.4 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -131.9 119.3 20.98 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -121.15 120.49 35.4 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.315 1.046 . . . . 0.0 111.676 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -111.27 140.66 45.66 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.003 1.321 . . . . 0.0 111.065 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.507 ' HB3' HD13 ' A' ' 133' ' ' ILE . 50.3 m -123.12 152.77 64.06 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.497 1.119 . . . . 0.0 111.371 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -63.73 86.28 0.14 Allowed 'Trans proline' 0 C--N 1.35 0.649 1 C-N-CA 125.548 4.165 . . . . 0.0 115.7 -178.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 72.51 34.96 59.84 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 118.751 -1.027 . . . . 0.0 112.278 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.507 HD13 ' HB3' ' A' ' 130' ' ' CYS . 4.4 mp -118.59 -71.62 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.344 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -168.81 172.65 7.66 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.523 1.529 . . . . 0.0 110.314 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -137.21 119.75 15.99 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 31.8 m -139.22 163.54 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 124.528 1.131 . . . . 0.0 111.059 -178.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -121.05 124.43 44.8 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.968 1.307 . . . . 0.0 107.92 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -138.65 162.28 35.03 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.961 0.904 . . . . 0.0 111.469 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.595 ' H ' ' CD1' ' A' ' 156' ' ' LEU . 60.1 t60 -92.08 160.91 14.99 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 176.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 138.14 -160.19 25.34 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -148.98 162.21 40.36 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 125.418 1.487 . . . . 0.0 110.182 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 p -131.97 146.95 32.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 C-N-CA 125.277 1.431 . . . . 0.0 107.487 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -106.02 121.82 44.89 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 177.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 35.6 p -54.07 -13.34 0.78 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 127.487 2.315 . . . . 0.0 115.559 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt -78.98 -24.9 43.48 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -178.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 26.8 p -128.77 -33.64 2.02 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 123.936 0.895 . . . . 0.0 111.971 -178.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.86 31.16 36.49 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.632 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 -121.59 146.24 47.17 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 21.9 mm -65.23 152.41 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 26.6 m -58.45 -45.84 89.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 122.877 0.471 . . . . 0.0 109.759 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -164.32 108.58 0.96 Allowed 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -56.12 126.55 26.53 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.565 0.62 . . . . 0.0 110.394 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.96 104.84 5.71 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 126.488 1.915 . . . . 0.0 108.058 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -81.96 -23.88 35.83 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.026 0.931 . . . . 0.0 113.497 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 66.5 m -67.81 -36.53 80.57 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.469 -0.769 . . . . 0.0 112.63 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.595 ' CD1' ' H ' ' A' ' 139' ' ' HIS . 44.9 mt -72.66 132.79 44.16 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.599 1.159 . . . . 0.0 108.933 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 25.7 m -128.95 119.84 50.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 123.149 0.579 . . . . 0.0 109.489 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -149.45 155.36 40.28 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.84 1.656 . . . . 0.0 108.084 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 33.1 ttt85 -148.49 102.14 3.3 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 81.6 mt -79.37 -30.8 42.71 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 119.387 0.994 . . . . 0.0 108.495 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 169.45 156.35 10.74 Favored Glycine 0 N--CA 1.439 -1.129 0 CA-C-O 121.899 0.721 . . . . 0.0 111.345 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.62 109.04 44.05 Favored Pre-proline 0 N--CA 1.444 -0.76 0 C-N-CA 124.481 1.112 . . . . 0.0 108.674 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -77.22 -168.36 0.58 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.438 2.759 . . . . 0.0 109.038 178.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -126.5 151.09 48.28 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 124.724 1.21 . . . . 0.0 108.047 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -74.81 -28.69 60.81 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.973 0.892 . . . . 0.0 109.445 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -89.32 65.24 7.15 Favored 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 126.148 1.779 . . . . 0.0 106.297 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.2 p -45.22 -32.79 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 123.911 0.884 . . . . 0.0 111.973 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -65.48 -26.34 67.89 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.996 2.119 . . . . 0.0 112.875 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.68 -25.83 49.79 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.742 0.817 . . . . 0.0 110.337 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -75.96 177.74 6.79 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.725 0.81 . . . . 0.0 109.267 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -131.52 155.74 46.91 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -139.73 160.15 40.54 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.993 0.917 . . . . 0.0 109.49 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -117.24 153.57 32.67 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 18.5 tp -119.84 98.34 6.05 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -106.05 172.53 6.76 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 181' ' ' TYR . 2.5 p90 -147.21 162.76 38.24 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.934 0.873 . . . . 0.0 109.021 178.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -139.54 178.17 7.41 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 125.682 1.593 . . . . 0.0 109.44 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -68.38 2.2 2.47 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.081 1.353 . . . . 0.0 111.928 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 90.8 t -109.66 -38.96 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 126.14 1.776 . . . . 0.0 110.177 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 166.37 -175.81 41.73 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 176' ' ' TYR . 16.6 m-85 -88.33 164.86 15.35 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 117.962 0.881 . . . . 0.0 109.327 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.468 ' HB3' HG12 ' A' ' 207' ' ' VAL . 46.6 p90 -158.92 163.7 36.31 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.704 0.802 . . . . 0.0 109.965 179.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 95.2 mt -107.21 131.8 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 22.6 t -100.69 137.34 39.22 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.405 0.682 . . . . 0.0 109.312 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -131.22 116.05 17.14 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.513 1.125 . . . . 0.0 108.082 178.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -92.84 120.75 42.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 178.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.1 mt -107.66 106.7 21.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -108.92 -152.68 15.28 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 125.977 1.751 . . . . 0.0 109.199 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 80.42 22.8 0.41 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.956 1.702 . . . . 0.0 112.634 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -91.89 -154.05 30.41 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.24 166.15 10.85 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 179.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 36.7 mm -88.7 140.74 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.235 1.414 . . . . 0.0 108.982 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.2 m -88.94 115.14 26.28 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 127.816 2.446 . . . . 0.0 106.612 178.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -57.91 -16.96 13.83 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.211 1.404 . . . . 0.0 113.586 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 61.8 t -53.32 -56.06 9.98 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 CA-C-N 118.913 0.779 . . . . 0.0 110.663 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 1.9 t -124.66 -23.12 4.43 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -177.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.87 35.35 4.03 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 108.395 -1.882 . . . . 0.0 108.395 -178.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -111.0 147.59 34.4 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 119.054 1.427 . . . . 0.0 113.563 -178.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -68.34 144.51 54.76 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.992 0.917 . . . . 0.0 112.657 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -70.1 26.77 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.499 1 C-N-CA 131.862 4.065 . . . . 0.0 111.471 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 7.0 ptm -74.08 176.3 6.66 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.767 1.167 . . . . 0.0 112.814 -177.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.3 p -141.18 148.33 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 125.1 1.36 . . . . 0.0 107.981 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -110.59 109.32 19.57 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.484 1.913 . . . . 0.0 106.477 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 9.2 mm -99.29 150.06 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 O-C-N 121.055 -1.028 . . . . 0.0 111.191 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -125.67 106.52 9.78 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.206 2.202 . . . . 0.0 110.077 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -87.46 110.25 20.17 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 177.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.468 HG12 ' HB3' ' A' ' 182' ' ' TYR . 31.3 m -125.17 168.42 17.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 C-N-CA 125.186 1.394 . . . . 0.0 109.041 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 51.6 t -89.07 146.5 24.79 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 104.432 -2.432 . . . . 0.0 104.432 177.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -91.19 18.74 50.43 Favored Glycine 0 C--O 1.226 -0.401 0 CA-C-O 117.023 -1.987 . . . . 0.0 116.688 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 58.5 48.62 83.25 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-N 119.433 1.617 . . . . 0.0 109.075 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 71.5 m -149.13 166.52 28.53 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.52 1.528 . . . . 0.0 108.57 -178.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -123.87 -3.28 8.18 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 8.7 t -150.74 148.54 28.67 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 118.816 0.734 . . . . 0.0 109.695 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 125.79 175.43 14.19 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.263 0.935 . . . . 0.0 114.286 178.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -81.23 -115.83 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 124.536 3.491 . . . . 0.0 112.033 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . 0.438 ' CB ' HG22 ' A' ' 235' ' ' ILE . 14.7 p -147.34 145.97 29.51 Favored 'General case' 0 C--O 1.239 0.52 0 O-C-N 120.482 -1.387 . . . . 0.0 112.369 -177.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 81.3 p -149.91 166.14 30.47 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.163 0.985 . . . . 0.0 110.99 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 2.9 mp -104.07 154.36 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 126.072 1.749 . . . . 0.0 108.118 178.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 43.4 mm-40 -103.11 -49.98 3.61 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 125.202 1.401 . . . . 0.0 110.66 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 59.8 p-90 -158.04 155.88 30.1 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.572 1.149 . . . . 0.0 109.109 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 60.9 t -153.97 132.64 2.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 125.809 1.644 . . . . 0.0 107.411 179.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.3 167.34 17.98 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.851 0.86 . . . . 0.0 111.342 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -75.96 132.99 40.56 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 4.6 t -112.42 -31.36 6.84 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.463 1.505 . . . . 0.0 112.705 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -132.49 -175.75 3.86 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 124.249 1.02 . . . . 0.0 108.357 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 55.1 mt -47.26 -47.87 9.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 123.567 0.747 . . . . 0.0 112.631 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -132.88 19.34 4.16 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.229 1.012 . . . . 0.0 111.2 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 18.4 t -116.75 145.33 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.813 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -177.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -125.02 164.53 19.96 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -136.18 148.19 48.02 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.48 146.53 30.58 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.387 1.475 . . . . 0.0 108.942 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -129.63 120.12 24.69 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 2.4 m -115.98 143.51 25.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.8 p -119.91 127.51 52.76 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 127.175 2.19 . . . . 0.0 111.911 -176.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.513 HD11 HD13 ' A' ' 238' ' ' LEU . 15.1 pt -134.04 146.64 60.72 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 177.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -71.45 -36.42 6.84 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 123.151 2.567 . . . . 0.0 111.323 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -59.02 -28.23 66.2 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.81 1.244 . . . . 0.0 114.304 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.513 HD13 HD11 ' A' ' 235' ' ' ILE . 3.1 tp -60.83 -32.49 71.88 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 121.45 -0.781 . . . . 0.0 111.367 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 7.3 m -59.56 -13.64 10.05 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.587 1.155 . . . . 0.0 113.448 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.88 -35.59 75.13 Favored 'General case' 0 C--O 1.227 -0.095 0 CA-C-N 119.58 1.082 . . . . 0.0 110.307 179.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.18 125.63 29.7 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -48.27 -42.29 30.26 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.128 1.371 . . . . 0.0 112.459 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.57 -32.27 73.76 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.415 -0.803 . . . . 0.0 112.496 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 25.4 mt -96.14 -7.63 35.38 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.835 1.654 . . . . 0.0 113.298 -178.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -67.52 108.53 2.88 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.094 2.158 . . . . 0.0 110.172 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 9.9 mmmt -71.45 159.43 34.52 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.945 0.793 . . . . 0.0 110.246 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -97.34 -76.16 0.52 Allowed 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.866 0.866 . . . . 0.0 109.059 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -144.89 39.18 1.22 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.632 1.173 . . . . 0.0 110.243 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.011 0 CA-C-O 116.779 -1.581 . . . . 0.0 110.607 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.059 0 N-CA-C 106.805 -2.518 . . . . 0.0 106.805 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.96 -173.76 1.67 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 p -66.34 93.3 0.22 Allowed 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.642 1.177 . . . . 0.0 108.675 179.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -62.54 -49.7 74.26 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.162 1.385 . . . . 0.0 110.87 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.3 m -52.57 -47.9 66.55 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.346 1.059 . . . . 0.0 111.775 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -57.11 -48.78 77.79 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 123.973 0.909 . . . . 0.0 110.553 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.65 -57.43 11.98 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 118.107 -0.949 . . . . 0.0 108.648 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.28 -40.76 68.14 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 119.05 0.841 . . . . 0.0 112.134 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.52 -38.32 80.69 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.212 0.46 . . . . 0.0 110.221 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 23.1 tp -73.94 -34.96 64.51 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.377 1.071 . . . . 0.0 109.383 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.63 HD23 HD11 ' A' ' 243' ' ' LEU . 28.6 mt -60.16 -55.18 37.03 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.23 0.923 . . . . 0.0 110.049 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 96.3 m -67.09 -40.34 86.95 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.295 -0.878 . . . . 0.0 111.018 -178.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.2 ttpt -59.38 -43.94 92.85 Favored 'General case' 0 C--O 1.226 -0.159 0 O-C-N 121.081 -1.012 . . . . 0.0 109.984 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 55.3 m -54.02 -43.92 70.53 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 124.352 1.061 . . . . 0.0 110.347 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -57.02 -50.33 73.06 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.522 0.601 . . . . 0.0 109.924 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.47 -54.69 21.13 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.565 0.697 . . . . 0.0 111.735 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -55.12 -44.4 74.96 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.224 1.01 . . . . 0.0 110.914 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.48 -51.87 48.39 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-O 117.797 -1.557 . . . . 0.0 109.366 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.469 ' HA ' HD12 ' A' ' 109' ' ' ILE . 41.0 t -54.86 -45.16 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 119.966 1.883 . . . . 0.0 109.683 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.0 pttm -61.83 -34.85 76.69 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 119.804 -0.759 . . . . 0.0 111.183 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 39.0 m -71.28 -44.17 65.74 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.579 0.752 . . . . 0.0 109.558 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.469 HD12 ' HA ' ' A' ' 106' ' ' VAL . 22.3 mt -57.49 -55.53 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -63.27 -29.24 70.61 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 118.782 -0.628 . . . . 0.0 112.348 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -70.18 -48.95 55.03 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.354 0.979 . . . . 0.0 111.898 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.46 ' HA ' ' HE2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -75.71 -43.91 44.71 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 123.562 0.745 . . . . 0.0 112.129 -178.037 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 14.2 mt -65.27 -28.25 69.21 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 118.193 -0.908 . . . . 0.0 112.671 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -51.91 -28.8 17.55 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -48.88 -69.86 0.11 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -146.48 179.01 7.84 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 126.152 1.781 . . . . 0.0 108.454 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 59.8 m -87.14 166.67 14.8 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 35.4 pt -120.39 155.95 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.446 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -148.22 139.79 23.66 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 123.61 0.764 . . . . 0.0 110.383 -178.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.461 ' CZ ' ' HA ' ' A' ' 220' ' ' TRP . 7.1 t80 -137.07 120.88 17.46 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.58 1.152 . . . . 0.0 110.304 178.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -82.97 101.94 11.4 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.513 1.525 . . . . 0.0 109.509 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.419 ' HB2' ' CE1' ' A' ' 120' ' ' TYR . . . -87.86 81.15 7.63 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 127.956 2.502 . . . . 0.0 106.794 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.52 -90.49 0.38 Allowed Glycine 0 CA--C 1.534 1.24 0 O-C-N 121.301 -0.874 . . . . 0.0 111.926 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -107.68 -28.57 9.64 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 127.053 2.141 . . . . 0.0 112.844 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -99.55 157.65 16.3 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.1 mp -126.88 128.4 70.78 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.424 ' CD1' HG11 ' A' ' 221' ' ' VAL . 44.0 m-85 -101.43 119.03 38.14 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -116.21 123.24 47.27 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -115.92 132.48 56.63 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.556 0.743 . . . . 0.0 110.302 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 66.7 m -112.27 148.18 38.57 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 124.247 1.019 . . . . 0.0 109.145 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.78 85.96 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 124.38 3.387 . . . . 0.0 115.151 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.21 30.76 40.57 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-O 117.944 -1.476 . . . . 0.0 112.981 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 3.9 mp -117.15 -73.62 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.455 0 CA-C-N 119.191 1.495 . . . . 0.0 110.247 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.406 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 37.4 mt-10 -163.39 166.25 23.09 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.03 2.132 . . . . 0.0 108.583 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -135.6 123.6 22.79 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.568 1.547 . . . . 0.0 107.568 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 17.8 m -144.47 164.04 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 126.8 2.04 . . . . 0.0 111.103 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -117.84 127.19 53.63 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 177.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -136.53 162.41 33.19 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 125.39 1.476 . . . . 0.0 111.224 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.546 ' H ' ' CD1' ' A' ' 156' ' ' LEU . 80.9 t60 -92.63 160.56 14.95 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 177.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 135.44 -159.13 24.01 Favored Glycine 0 C--N 1.34 0.751 0 CA-C-N 119.185 0.902 . . . . 0.0 111.722 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.33 167.25 30.82 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 128.37 2.668 . . . . 0.0 105.527 177.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.6 p -114.41 152.33 16.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -100.2 103.33 14.78 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 178.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 39.6 p -51.13 -24.19 3.88 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 115.825 1.787 . . . . 0.0 115.825 -178.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 38.9 mmtt -66.55 -27.44 67.75 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.976 0.91 . . . . 0.0 113.171 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.9 p -126.42 -40.93 1.92 Allowed 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.283 1.433 . . . . 0.0 112.524 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 96.41 29.69 8.19 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 125.544 1.545 . . . . 0.0 110.609 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -102.66 140.52 36.82 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.393 1.077 . . . . 0.0 109.909 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 14.5 mm -81.04 134.28 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 20.4 m -65.57 -10.83 11.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 -178.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -138.51 105.72 5.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 119.174 0.897 . . . . 0.0 111.063 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -82.7 65.9 8.05 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.325 0.512 . . . . 0.0 110.655 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 27.1 53.58 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 129.017 2.927 . . . . 0.0 114.788 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -60.55 -35.03 75.03 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.363 -1.29 . . . . 0.0 111.732 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 5.8 m -125.44 -21.01 4.62 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 115.478 1.658 . . . . 0.0 115.478 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.546 ' CD1' ' H ' ' A' ' 139' ' ' HIS . 9.2 mt -82.53 153.44 25.54 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 120.497 1.499 . . . . 0.0 109.382 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 44.7 t -147.25 119.38 1.72 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 124.336 1.054 . . . . 0.0 109.494 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -147.09 165.84 28.7 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.221 1.809 . . . . 0.0 109.626 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -149.04 112.0 4.87 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 126.268 1.827 . . . . 0.0 108.471 178.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 82.6 mt -99.07 -26.89 14.07 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 160.96 161.01 11.13 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -127.34 108.53 21.26 Favored Pre-proline 0 C--O 1.239 0.509 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 86.2 Cg_endo -72.32 -179.62 4.18 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 124.447 3.432 . . . . 0.0 109.825 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -122.39 159.76 26.85 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.063 0.545 . . . . 0.0 110.851 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.62 -54.0 11.85 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -68.72 64.6 0.12 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 126.751 2.02 . . . . 0.0 112.71 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 5.6 p -47.02 -34.34 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 C-N-CA 125.759 1.624 . . . . 0.0 111.846 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -63.84 -32.98 74.68 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.022 1.329 . . . . 0.0 112.026 -178.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -80.69 -14.21 58.34 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 122.748 0.419 . . . . 0.0 110.096 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 44.4 mtp180 -83.3 177.97 8.28 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 121.071 -1.018 . . . . 0.0 109.509 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -132.85 150.36 52.17 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.381 1.072 . . . . 0.0 108.201 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -138.22 161.2 37.47 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.193 1.797 . . . . 0.0 107.688 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -126.87 149.99 49.48 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 122.889 0.476 . . . . 0.0 110.606 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 32.1 tp -107.47 111.01 23.1 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.876 1.271 . . . . 0.0 108.659 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.46 HD23 ' HB2' ' A' ' 184' ' ' SER . 2.9 mm? -118.47 -179.75 3.88 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.944 1.298 . . . . 0.0 110.45 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -137.84 154.4 49.51 Favored 'General case' 0 N--CA 1.458 -0.037 0 C-N-CA 124.875 1.27 . . . . 0.0 109.467 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -140.45 -178.16 5.37 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 126.678 1.991 . . . . 0.0 107.421 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -66.11 -5.71 10.83 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.868 1.267 . . . . 0.0 113.417 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 56.0 t -107.6 -24.49 4.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 126.794 2.038 . . . . 0.0 113.656 -178.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 144.24 -173.02 25.12 Favored Glycine 0 N--CA 1.444 -0.774 0 O-C-N 121.841 -0.537 . . . . 0.0 112.052 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -79.06 158.42 27.86 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 121.716 0.769 . . . . 0.0 109.297 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.452 ' HB3' HG12 ' A' ' 207' ' ' VAL . 42.0 p90 -155.74 162.85 40.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.331 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 96.7 mt -104.23 136.42 37.62 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.073 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.46 ' HB2' HD23 ' A' ' 175' ' ' LEU . 46.2 t -102.22 129.34 48.59 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 125.414 1.485 . . . . 0.0 108.374 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -121.33 113.98 20.68 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.88 119.0 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 104.512 -2.403 . . . . 0.0 104.512 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 9.0 mt -109.2 105.63 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 177.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -101.32 -153.43 26.03 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 23.1 t 67.86 26.65 7.55 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.993 0.917 . . . . 0.0 111.932 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -82.2 -60.32 2.16 Favored Glycine 0 CA--C 1.525 0.691 0 O-C-N 120.51 -1.369 . . . . 0.0 110.543 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 153.83 -174.14 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.608 1 C-N-CA 131.893 4.077 . . . . 0.0 106.384 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 51.8 mm -105.9 143.3 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 129.561 3.144 . . . . 0.0 112.205 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.2 m -93.56 118.15 30.98 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 128.345 2.658 . . . . 0.0 107.207 177.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.5 -30.89 54.77 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.818 1.247 . . . . 0.0 113.331 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 44.1 t -45.32 -56.28 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 125.019 1.328 . . . . 0.0 113.031 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 6.6 t -123.46 -23.02 4.89 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 124.701 1.201 . . . . 0.0 113.85 -177.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 94.97 34.66 6.1 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 107.263 -2.335 . . . . 0.0 107.263 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -103.09 150.38 23.67 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 117.998 0.899 . . . . 0.0 110.922 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -74.03 139.65 44.88 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 122.544 0.337 . . . . 0.0 111.697 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -67.47 29.0 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.559 1 C-N-CA 135.799 5.64 . . . . 0.0 110.208 177.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 1.9 ptm -74.46 -176.81 2.85 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.17 1.388 . . . . 0.0 111.955 -177.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.2 p -153.6 146.69 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 O-C-N 121.087 -1.008 . . . . 0.0 110.753 -178.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -104.32 104.77 14.71 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.595 1.558 . . . . 0.0 109.522 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 8.7 mm -93.8 123.1 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -105.15 99.61 9.22 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 127.312 2.245 . . . . 0.0 109.333 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -82.17 110.72 17.63 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.76 1.224 . . . . 0.0 108.849 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.452 HG12 ' HB3' ' A' ' 182' ' ' TYR . 19.0 m -124.72 164.73 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 125.456 1.502 . . . . 0.0 107.46 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 46.3 t -83.91 146.09 28.23 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 119.909 -1.745 . . . . 0.0 107.562 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -86.75 3.76 86.77 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-O 118.774 -1.015 . . . . 0.0 113.108 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 70.23 -126.05 15.75 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 107.905 -2.078 . . . . 0.0 107.905 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 12.6 m -73.06 -163.51 0.14 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.705 0.765 . . . . 0.0 109.981 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 2.6 m120 58.54 57.82 3.63 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.056 1.343 . . . . 0.0 109.814 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 1.3 p -64.68 93.85 0.11 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.345 0.658 . . . . 0.0 110.886 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -118.79 -162.53 12.14 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 127.376 2.417 . . . . 0.0 108.206 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -68.87 -91.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 124.073 3.182 . . . . 0.0 111.598 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 5.0 p -151.74 146.5 25.8 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.654 1.182 . . . . 0.0 109.086 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 17.0 p -149.89 172.23 15.5 Favored 'General case' 0 C--O 1.225 -0.201 0 O-C-N 121.757 -0.589 . . . . 0.0 112.246 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.416 HG21 HG23 ' A' ' 221' ' ' VAL . 5.8 mt -122.14 146.06 27.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 126.863 2.065 . . . . 0.0 106.555 177.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -95.35 -47.67 6.2 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.343 1.457 . . . . 0.0 110.525 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . 0.461 ' HA ' ' CZ ' ' A' ' 120' ' ' TYR . 56.2 p-90 -162.88 158.51 22.62 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 125.459 1.504 . . . . 0.0 108.948 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.424 HG11 ' CD1' ' A' ' 127' ' ' TYR . 49.7 t -152.94 135.02 5.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 126.189 1.796 . . . . 0.0 106.366 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.79 168.76 17.5 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.006 1.322 . . . . 0.0 110.347 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -75.61 141.67 42.82 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 124.104 0.962 . . . . 0.0 108.638 178.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . 0.437 HG21 ' HG3' ' A' ' 230' ' ' GLU . 10.2 t -118.83 -31.98 4.64 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.955 1.302 . . . . 0.0 112.3 179.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.429 ' HG3' HG23 ' A' ' 224' ' ' THR . 4.8 mttm -135.22 -176.59 4.31 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 120.806 -1.184 . . . . 0.0 109.067 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 36.5 mt -48.15 -47.22 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 123.864 0.866 . . . . 0.0 112.29 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -130.62 21.47 5.09 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.265 1.026 . . . . 0.0 111.894 -178.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 16.6 t -122.62 143.0 36.95 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.584 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -178.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -121.68 162.52 20.59 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.57 1.548 . . . . 0.0 107.131 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . 0.437 ' HG3' HG21 ' A' ' 224' ' ' THR . 13.3 mt-10 -131.46 138.28 48.95 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 125.416 1.486 . . . . 0.0 107.209 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -135.78 132.39 36.69 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.569 1.148 . . . . 0.0 109.522 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -109.08 108.0 18.53 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 48.3 t -100.73 138.23 25.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.3 p -120.94 130.29 53.8 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 126.286 1.835 . . . . 0.0 112.427 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -138.67 143.34 37.5 Favored Pre-proline 0 N--CA 1.467 0.394 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 176.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -73.3 -33.32 7.27 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.948 2.432 . . . . 0.0 112.963 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -64.25 -17.77 63.92 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.56 0.744 . . . . 0.0 112.811 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 5.9 tp -68.16 -29.51 68.42 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 121.174 -0.954 . . . . 0.0 110.044 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 14.4 m -62.99 -9.98 12.05 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.664 0.786 . . . . 0.0 112.961 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -60.89 -31.24 70.73 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.196 0.907 . . . . 0.0 109.721 178.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -88.64 127.22 35.56 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 124.196 0.998 . . . . 0.0 109.331 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -47.0 -49.33 21.04 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 126.047 1.739 . . . . 0.0 113.475 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.63 HD11 HD23 ' A' ' 98' ' ' LEU . 41.8 mt -65.05 -28.81 69.73 Favored 'General case' 0 C--O 1.231 0.115 0 O-C-N 121.332 -0.855 . . . . 0.0 112.983 -178.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 11.5 mt -95.75 -17.52 21.16 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.101 0.96 . . . . 0.0 112.7 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -62.31 135.53 57.5 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 129.321 3.048 . . . . 0.0 109.445 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -101.69 155.75 17.92 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 124.154 0.982 . . . . 0.0 112.12 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -70.68 -60.46 2.24 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 123.781 0.675 . . . . 0.0 109.337 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 50.02 29.67 3.62 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.634 1.574 . . . . 0.0 111.738 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 21.7 t70 . . . . . 0 C--O 1.261 1.695 0 C-N-CA 129.382 3.073 . . . . 0.0 106.464 -179.163 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.99 0 N-CA-C 108.2 -1.96 . . . . 0.0 108.2 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.54 -59.32 5.41 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 119.081 1.441 . . . . 0.0 109.99 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.1 t -167.33 166.46 14.6 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 126.209 1.804 . . . . 0.0 106.29 178.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 61.4 m-80 54.22 7.5 0.14 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.172 2.189 . . . . 0.0 114.529 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.8 m -56.1 -30.51 62.17 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.993 1.317 . . . . 0.0 113.64 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -70.7 -24.7 62.71 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.648 -0.658 . . . . 0.0 111.085 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.87 -47.55 65.63 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 105.585 -2.005 . . . . 0.0 105.585 177.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -32.92 74.51 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 118.887 0.767 . . . . 0.0 110.262 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.07 -50.97 69.82 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 57.2 tp -63.79 -39.86 95.26 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.569 1.148 . . . . 0.0 110.678 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.8 mt -60.1 -54.28 47.76 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 119.277 0.944 . . . . 0.0 108.65 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.3 m -58.31 -49.32 77.58 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.121 0.486 . . . . 0.0 110.152 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -60.88 -40.74 94.16 Favored 'General case' 0 C--O 1.232 0.164 0 O-C-N 121.206 -0.934 . . . . 0.0 111.776 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 54.4 m -52.3 -48.74 65.21 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.574 0.75 . . . . 0.0 110.842 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -58.89 -47.6 84.38 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 117.966 0.348 . . . . 0.0 110.659 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.45 -55.81 24.11 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 122.504 1.145 . . . . 0.0 113.876 -177.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -64.34 -38.44 91.05 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-N 113.645 -1.616 . . . . 0.0 111.521 -177.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.25 -52.78 41.15 Favored Glycine 0 N--CA 1.44 -1.045 0 N-CA-C 107.95 -2.06 . . . . 0.0 107.95 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 56.0 t -56.92 -47.92 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 119.306 1.553 . . . . 0.0 110.541 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.6 pttm -59.1 -35.52 73.56 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.847 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 52.5 m -79.29 -36.36 39.85 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.308 1.043 . . . . 0.0 111.067 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 21.8 mt -57.85 -54.27 34.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -60.84 -29.39 69.47 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.481 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -68.24 -41.05 81.74 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 120.144 1.338 . . . . 0.0 111.593 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.463 ' HA ' ' HE2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -79.07 -37.42 38.9 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 117.991 0.36 . . . . 0.0 111.75 -179.371 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 17.2 mt -74.17 -25.83 59.95 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 118.685 -0.674 . . . . 0.0 111.903 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -54.82 -20.12 7.95 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.454 0.57 . . . . 0.0 112.167 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -64.62 -72.77 0.14 Allowed 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.694 1.197 . . . . 0.0 109.036 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -147.42 -175.55 4.89 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.386 1.474 . . . . 0.0 111.522 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 62.6 m -87.71 175.4 7.89 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.604 -0.685 . . . . 0.0 109.439 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 27.4 pt -132.73 161.22 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 126.324 1.85 . . . . 0.0 108.774 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -154.74 142.73 20.15 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 122.759 0.423 . . . . 0.0 110.401 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -134.37 123.74 24.61 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.478 0.711 . . . . 0.0 110.499 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -86.66 98.7 11.26 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.19 81.06 5.56 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 128.407 2.683 . . . . 0.0 107.336 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 58.47 -112.93 4.39 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 124.388 0.994 . . . . 0.0 111.054 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -77.28 -12.8 59.99 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.852 1.261 . . . . 0.0 113.375 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -115.74 158.24 23.12 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 124.414 1.086 . . . . 0.0 112.642 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.573 HD13 ' H ' ' A' ' 140' ' ' GLY . 4.8 mp -133.38 126.36 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 N-CA-C 103.577 -2.749 . . . . 0.0 103.577 177.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -110.54 123.36 49.79 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -117.96 129.63 55.72 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.714 0.806 . . . . 0.0 110.008 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -119.52 133.2 55.79 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 123.722 0.809 . . . . 0.0 110.923 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.513 ' HB3' HD13 ' A' ' 133' ' ' ILE . 16.3 m -112.41 156.1 42.7 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 123.737 0.815 . . . . 0.0 111.075 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -63.77 78.46 0.15 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 125.084 3.856 . . . . 0.0 114.203 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 67.51 60.19 6.06 Favored Glycine 0 CA--C 1.525 0.677 0 O-C-N 120.971 -1.081 . . . . 0.0 111.688 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.513 HD13 ' HB3' ' A' ' 130' ' ' CYS . 3.5 mp -130.86 -71.44 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -165.73 168.95 15.65 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 125.45 1.5 . . . . 0.0 109.449 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -130.81 121.95 26.25 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 176.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.8 m -144.76 164.94 12.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 118.916 0.78 . . . . 0.0 111.083 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -120.95 132.2 54.79 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.726 1.211 . . . . 0.0 108.727 178.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -138.51 162.74 33.77 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.122 1.369 . . . . 0.0 112.437 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 55.5 t60 -103.15 108.8 20.14 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.573 ' H ' HD13 ' A' ' 126' ' ' ILE . . . -176.12 -160.21 23.14 Favored Glycine 0 C--N 1.331 0.301 0 O-C-N 121.603 -0.686 . . . . 0.0 112.107 -179.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -141.99 157.48 44.89 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.764 1.225 . . . . 0.0 108.072 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.6 p -121.15 152.35 24.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -104.89 120.25 40.98 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 119.096 0.862 . . . . 0.0 108.982 178.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.8 p -58.06 -8.61 1.1 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.032 1.733 . . . . 0.0 114.065 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 30.7 mmtt -88.21 -29.59 20.36 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.271 1.029 . . . . 0.0 112.936 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.7 p -117.98 -48.29 2.56 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.088 0.555 . . . . 0.0 110.603 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 95.38 33.12 6.64 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 123.948 0.785 . . . . 0.0 111.783 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -125.1 161.18 27.37 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 126.879 2.072 . . . . 0.0 107.46 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 20.8 mm -85.31 142.75 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 124.234 1.013 . . . . 0.0 109.32 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 30.5 m -57.91 -38.72 67.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 117.857 -1.068 . . . . 0.0 113.755 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 38.8 p-10 159.7 177.79 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 130.149 3.38 . . . . 0.0 109.561 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 49.0 ttt180 81.56 70.05 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 128.993 2.917 . . . . 0.0 111.263 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -101.23 -82.12 0.47 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.812 2.445 . . . . 0.0 112.732 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -51.5 -34.41 35.81 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 117.857 2.54 . . . . 0.0 117.857 -178.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.51 -19.46 57.03 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -177.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 75.4 mt -113.76 91.53 3.67 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 15.4 m -74.62 108.34 6.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 C-N-CA 124.604 1.162 . . . . 0.0 111.613 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -141.27 151.48 43.71 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 122.795 1.283 . . . . 0.0 108.436 178.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.518 ' N ' HH21 ' A' ' 200' ' ' ARG . 0.0 OUTLIER -149.38 110.35 4.34 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 179.005 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mp -93.92 -27.53 16.32 Favored 'General case' 0 C--O 1.219 -0.55 0 O-C-N 125.794 1.934 . . . . 0.0 107.315 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 163.63 163.23 15.97 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 5.4 mtpt -127.66 110.13 20.68 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -78.04 -173.08 1.68 Allowed 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 124.954 3.769 . . . . 0.0 110.4 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -129.32 149.18 51.22 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 125.277 1.431 . . . . 0.0 109.58 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.74 -41.4 71.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.668 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 31.4 m-20 -71.7 65.02 0.48 Allowed 'General case' 0 C--O 1.236 0.383 0 C-N-CA 126.383 1.873 . . . . 0.0 110.977 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.4 p -52.3 -32.0 15.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 124.904 1.282 . . . . 0.0 110.663 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -63.93 -22.39 66.9 Favored 'General case' 0 N--CA 1.461 0.105 0 C-N-CA 124.695 1.198 . . . . 0.0 112.544 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -97.85 -18.27 18.82 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.522 1.129 . . . . 0.0 110.877 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.4 mtp-105 -81.02 142.21 33.61 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -103.73 148.98 25.42 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 178.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -134.25 -176.47 4.21 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.48 1.512 . . . . 0.0 109.587 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -135.41 153.46 51.79 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.329 1.051 . . . . 0.0 109.331 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 22.9 tp -115.05 98.97 7.11 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.697 1.599 . . . . 0.0 106.861 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.462 HD23 ' HB2' ' A' ' 184' ' ' SER . 2.7 mm? -105.33 -179.8 4.05 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 181' ' ' TYR . 2.5 p90 -145.65 163.01 36.2 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -140.75 -178.44 5.54 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.406 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -62.07 -14.41 36.01 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.528 1.131 . . . . 0.0 111.107 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 57.9 t -98.04 -39.12 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 125.495 1.518 . . . . 0.0 111.395 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 161.3 -173.83 37.77 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 123.431 0.539 . . . . 0.0 112.152 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 176' ' ' TYR . 25.9 m-85 -77.72 160.34 28.5 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 118.387 1.094 . . . . 0.0 110.72 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -158.84 168.5 26.64 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.325 1.45 . . . . 0.0 110.813 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 89.1 mt -108.89 141.46 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.462 ' HB2' HD23 ' A' ' 175' ' ' LEU . 15.6 t -111.41 137.32 49.35 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.394 1.077 . . . . 0.0 109.585 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -129.13 111.53 13.04 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.482 1.513 . . . . 0.0 108.381 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.2 mp -94.93 116.7 36.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 103.928 -2.619 . . . . 0.0 103.928 178.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 12.4 mt -105.1 106.95 21.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -103.66 -152.22 22.85 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 75.19 33.39 0.71 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.218 1.007 . . . . 0.0 110.127 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -113.87 159.18 13.83 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 107.615 -2.194 . . . . 0.0 107.615 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -66.72 167.82 10.55 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.354 1.062 . . . . 0.0 109.892 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.0 mm -87.13 142.33 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 C-N-CA 124.282 1.033 . . . . 0.0 108.795 178.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.1 m -88.81 110.76 21.31 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 104.204 -2.517 . . . . 0.0 104.204 177.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -47.68 -40.02 18.92 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 125.503 1.521 . . . . 0.0 111.637 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 33.4 t -38.45 -56.62 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.228 -0.055 0 C-N-CA 128.024 2.53 . . . . 0.0 113.366 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 10.8 t -124.42 -28.86 3.58 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 105.23 35.31 3.17 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -107.35 149.95 27.27 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 118.278 1.039 . . . . 0.0 110.23 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -77.48 152.25 34.26 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 119.02 0.827 . . . . 0.0 111.176 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.518 HH21 ' N ' ' A' ' 159' ' ' ARG . 30.7 mmm-85 -71.1 27.78 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 131.471 3.908 . . . . 0.0 110.795 177.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 8.1 ptm -75.59 178.43 6.02 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.343 1.057 . . . . 0.0 111.312 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.33 151.28 14.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 125.22 1.408 . . . . 0.0 108.745 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -107.45 106.38 16.75 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.937 2.095 . . . . 0.0 106.703 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 16.2 mm -101.29 144.58 12.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -125.48 121.22 33.11 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.441 1.496 . . . . 0.0 108.914 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -99.04 108.76 21.5 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.658 1.183 . . . . 0.0 108.985 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 3.8 m -126.91 169.77 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 122.101 0.953 . . . . 0.0 109.506 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 42.0 t -95.25 144.08 26.13 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 104.39 -2.448 . . . . 0.0 104.39 177.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -99.85 10.0 60.35 Favored Glycine 0 N--CA 1.461 0.324 0 CA-C-O 117.736 -1.591 . . . . 0.0 115.016 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 66.69 54.18 23.79 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.5 m -132.35 128.81 38.46 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -73.11 -19.38 61.16 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.801 0.728 . . . . 0.0 112.819 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 6.3 t -157.72 177.31 11.52 Favored 'General case' 0 C--O 1.242 0.661 0 O-C-N 121.22 -0.925 . . . . 0.0 110.725 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.88 178.4 16.35 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 126.195 1.855 . . . . 0.0 115.941 178.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -78.93 -104.96 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.912 1 C-N-CA 126.03 4.487 . . . . 0.0 111.95 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 4.8 p -161.8 147.06 13.28 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 120.45 -1.406 . . . . 0.0 112.809 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 19.2 p -151.22 160.23 43.95 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.501 1.12 . . . . 0.0 110.37 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 233' ' ' VAL . 4.3 mt -100.75 153.55 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 125.894 1.678 . . . . 0.0 108.018 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -98.93 -50.21 4.27 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.184 0.994 . . . . 0.0 111.798 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 63.9 p-90 -159.11 154.52 25.7 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.142 1.377 . . . . 0.0 107.353 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 59.7 t -150.2 130.09 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.03 167.83 26.98 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 118.147 0.43 . . . . 0.0 111.086 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -80.77 137.32 36.24 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 1.8 t -112.96 -39.32 4.26 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.705 -0.622 . . . . 0.0 110.74 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -121.65 -174.82 2.95 Favored 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 124.185 0.994 . . . . 0.0 109.595 -177.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 72.8 mt -56.51 -41.73 73.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.528 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -131.52 12.3 4.93 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.15 1.78 . . . . 0.0 112.815 -178.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 21.0 t -116.59 146.19 21.34 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 CA-C-N 118.72 0.691 . . . . 0.0 109.611 -178.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -123.5 161.64 24.47 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -127.99 142.13 51.33 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 106.376 -1.712 . . . . 0.0 106.376 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -150.78 131.82 14.32 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.465 1.106 . . . . 0.0 109.013 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -121.17 122.65 40.46 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.3 0.64 . . . . 0.0 109.635 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' A' ' 218' ' ' ILE . 4.6 m -106.47 156.44 7.06 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-N 118.676 0.671 . . . . 0.0 109.339 178.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.54 115.62 19.8 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 125.584 1.554 . . . . 0.0 109.166 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 10.6 pt -128.26 145.22 54.79 Favored Pre-proline 0 N--CA 1.448 -0.536 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.05 -41.43 5.19 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.004 1.803 . . . . 0.0 111.128 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -55.69 -17.57 6.14 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 117.589 2.44 . . . . 0.0 117.589 -177.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.443 HD22 ' CD1' ' A' ' 244' ' ' LEU . 44.2 mt -72.84 -30.12 63.76 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 120.781 1.628 . . . . 0.0 108.912 178.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 22.3 m -61.65 -11.65 12.61 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.563 0.745 . . . . 0.0 112.649 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 -67.53 -18.08 64.9 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-O 122.222 1.011 . . . . 0.0 109.664 177.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 29.8 mt -101.01 118.64 37.41 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 127.97 2.508 . . . . 0.0 106.787 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -46.75 -46.46 20.41 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.141 1.376 . . . . 0.0 112.732 -178.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 1.1 mp -65.59 -27.24 68.28 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.443 ' CD1' HD22 ' A' ' 238' ' ' LEU . 9.4 mt -102.39 -3.78 26.52 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.381 1.073 . . . . 0.0 111.609 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -68.94 113.71 6.59 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 127.84 2.456 . . . . 0.0 110.689 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.49 170.15 16.74 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -62.63 -29.21 70.45 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.122 0.487 . . . . 0.0 109.748 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -87.12 54.9 3.33 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.735 1.614 . . . . 0.0 108.478 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.257 1.483 0 C-N-CA 125.242 1.417 . . . . 0.0 111.823 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.751 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.88 127.37 32.39 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.9 t -164.22 175.62 9.95 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.715 1.206 . . . . 0.0 108.265 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.4 m120 54.73 37.79 28.97 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.916 1.686 . . . . 0.0 110.139 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.3 m -53.0 -35.11 59.02 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 120.947 -1.096 . . . . 0.0 113.48 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -72.03 -21.21 61.57 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.123 -0.985 . . . . 0.0 111.017 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.521 ' HE3' ' HA ' ' A' ' 94' ' ' LYS . 0.1 OUTLIER -73.02 -57.08 4.29 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 178.043 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -55.75 -39.41 71.15 Favored 'General case' 0 C--O 1.226 -0.178 0 O-C-N 123.797 0.686 . . . . 0.0 110.7 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.17 -47.98 71.4 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 42.3 tp -65.44 -37.44 86.91 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 117.645 -1.169 . . . . 0.0 110.662 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 64.1 mt -61.95 -55.01 33.91 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.55 1.068 . . . . 0.0 109.678 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 89.8 m -57.99 -49.59 76.32 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.389 1.875 . . . . 0.0 110.168 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 23.6 ttpt -62.09 -47.55 84.11 Favored 'General case' 0 N--CA 1.444 -0.741 0 O-C-N 121.341 -0.85 . . . . 0.0 109.698 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.6 m -52.74 -47.14 67.59 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 118.726 0.693 . . . . 0.0 110.765 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -58.7 -50.46 73.81 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 118.228 0.467 . . . . 0.0 109.971 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.83 -61.19 2.45 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -61.25 -38.32 86.26 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.641 0.776 . . . . 0.0 110.99 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.6 -53.24 45.35 Favored Glycine 0 CA--C 1.52 0.376 0 CA-C-O 117.904 -1.498 . . . . 0.0 109.401 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.518 ' HA ' HD12 ' A' ' 109' ' ' ILE . 39.3 t -57.74 -40.76 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 119.434 1.617 . . . . 0.0 109.251 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -58.69 -41.39 86.15 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 28.2 m -70.76 -40.1 72.87 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 125.133 1.373 . . . . 0.0 110.557 -177.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.555 HD13 ' CD1' ' A' ' 206' ' ' TYR . 18.0 mt -61.48 -55.95 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -62.55 -32.39 73.34 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.821 -0.609 . . . . 0.0 111.488 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -60.83 -40.12 91.61 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 118.632 0.651 . . . . 0.0 111.029 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.3 tptm -81.13 -37.99 27.94 Favored 'General case' 0 CA--C 1.519 -0.247 0 O-C-N 122.064 -0.398 . . . . 0.0 110.793 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 40.4 mt -69.12 -26.61 64.99 Favored 'General case' 0 C--O 1.221 -0.412 0 O-C-N 121.443 -0.786 . . . . 0.0 109.992 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.16 -30.87 50.85 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.628 1.171 . . . . 0.0 111.339 179.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -56.24 -63.9 1.04 Allowed 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.489 1.116 . . . . 0.0 111.946 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -151.37 175.59 12.09 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 126.319 1.848 . . . . 0.0 110.336 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 85.7 m -87.53 161.4 17.8 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 106.959 -1.496 . . . . 0.0 106.959 178.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 42.3 pt -112.42 155.01 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 124.846 1.258 . . . . 0.0 108.143 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -148.98 137.37 21.0 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 125.185 1.394 . . . . 0.0 108.27 -178.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -140.85 126.94 19.51 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.307 1.043 . . . . 0.0 111.652 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -80.39 99.46 7.96 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.047 1.339 . . . . 0.0 109.122 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.98 79.97 5.79 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 178.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 58.71 -119.83 19.53 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -63.74 -35.91 82.12 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.91 0.884 . . . . 0.0 112.955 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -99.86 164.36 12.06 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 119.126 0.875 . . . . 0.0 111.651 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.516 HD13 ' H ' ' A' ' 140' ' ' GLY . 4.2 mp -129.43 129.13 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 103.824 -2.658 . . . . 0.0 103.824 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.418 ' CG ' HG11 ' A' ' 221' ' ' VAL . 10.6 m-85 -105.39 122.95 47.02 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 125.634 1.574 . . . . 0.0 106.871 -178.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -118.5 126.49 52.13 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -122.88 137.37 54.96 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.531 0.732 . . . . 0.0 111.26 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.554 ' HB3' HD13 ' A' ' 133' ' ' ILE . 27.4 m -117.12 153.37 49.7 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.613 1.165 . . . . 0.0 111.488 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -62.61 84.53 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.643 1 C-N-CA 125.428 4.085 . . . . 0.0 116.266 -177.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.36 32.56 55.14 Favored Glycine 0 CA--C 1.531 1.093 0 O-C-N 120.749 -1.22 . . . . 0.0 112.853 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.554 HD13 ' HB3' ' A' ' 130' ' ' CYS . 4.5 mp -115.56 -69.92 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.306 0 CA-C-N 117.956 0.878 . . . . 0.0 109.104 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -168.44 168.34 11.25 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.533 1.133 . . . . 0.0 110.632 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -132.38 120.22 21.74 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 177.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.2 m -140.56 163.85 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 124.924 1.29 . . . . 0.0 110.575 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -135.04 126.55 28.68 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -138.08 162.86 33.07 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 126.604 1.962 . . . . 0.0 109.08 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.458 ' H ' HD13 ' A' ' 156' ' ' LEU . 78.9 t60 -102.87 120.02 39.87 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.516 ' H ' HD13 ' A' ' 126' ' ' ILE . . . -178.76 -159.87 23.84 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 127.21 2.338 . . . . 0.0 107.919 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.07 159.05 42.77 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.957 1.879 . . . . 0.0 111.933 178.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.2 p -94.75 155.91 3.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 124.69 1.196 . . . . 0.0 109.611 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 48.2 m-20 -101.48 97.95 8.35 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 101.031 -3.692 . . . . 0.0 101.031 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 82.6 p -57.99 -19.4 30.55 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 40.5 mmtt -67.66 -45.9 73.92 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 121.137 -0.977 . . . . 0.0 110.961 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 35.0 p -99.51 -38.33 8.82 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 125.329 1.452 . . . . 0.0 112.512 -178.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 95.28 32.25 7.13 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 126.079 1.8 . . . . 0.0 112.108 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -125.35 160.94 28.12 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.914 1.686 . . . . 0.0 110.332 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 11.4 mm -86.18 146.1 6.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 123.202 0.601 . . . . 0.0 110.04 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 32.8 m -61.13 -20.22 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.408 1.483 . . . . 0.0 113.877 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -169.5 -179.36 3.39 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 127.735 2.414 . . . . 0.0 108.356 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -102.33 -77.61 0.55 Allowed 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 103.011 -2.959 . . . . 0.0 103.011 176.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -156.25 133.99 11.03 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.888 0.875 . . . . 0.0 108.659 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -85.03 -62.36 1.56 Allowed 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.5 m -126.7 32.68 5.1 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.886 2.074 . . . . 0.0 112.512 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.458 HD13 ' H ' ' A' ' 139' ' ' HIS . 34.9 mt -120.54 138.48 53.83 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 120.266 -1.521 . . . . 0.0 110.785 -177.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.3 p -143.97 121.49 5.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 118.863 0.756 . . . . 0.0 109.386 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -148.39 160.39 43.07 Favored 'General case' 0 C--O 1.226 -0.147 0 C-N-CA 123.883 0.873 . . . . 0.0 110.867 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 5.8 mpp_? -149.37 133.33 17.09 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 48.3 mt -110.87 -21.75 11.88 Favored 'General case' 0 C--O 1.22 -0.476 0 O-C-N 124.181 0.926 . . . . 0.0 109.195 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 155.53 163.97 12.69 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -126.63 114.3 22.8 Favored Pre-proline 0 C--O 1.236 0.352 0 CA-C-O 118.849 -0.595 . . . . 0.0 109.914 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -71.24 -173.89 1.05 Allowed 'Trans proline' 0 CA--C 1.544 1.004 0 C-N-CA 125.091 3.861 . . . . 0.0 109.567 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -120.8 163.83 17.54 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.932 0.872 . . . . 0.0 111.974 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.75 -36.56 59.85 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.116 177.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -89.57 65.71 7.05 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.476 1.91 . . . . 0.0 110.895 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.9 p -45.76 -36.72 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 123.146 0.578 . . . . 0.0 111.851 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -61.86 -37.9 86.24 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 125.488 1.515 . . . . 0.0 112.532 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -71.56 -23.61 61.78 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 124.972 1.309 . . . . 0.0 110.671 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 9.5 mtp-105 -79.53 138.92 37.67 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -101.41 139.78 36.61 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -122.89 -178.32 3.91 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 126.493 1.917 . . . . 0.0 111.802 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -131.49 154.01 49.18 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.908 1.283 . . . . 0.0 109.968 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 28.4 tp -116.75 107.69 14.96 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.264 1.826 . . . . 0.0 106.368 178.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.601 HD23 ' HB2' ' A' ' 184' ' ' SER . 1.7 mm? -118.58 -178.25 3.49 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 126.258 1.823 . . . . 0.0 109.564 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -145.33 164.81 30.3 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.236 0.615 . . . . 0.0 111.27 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.7 178.56 7.06 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 128.005 2.522 . . . . 0.0 107.417 178.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -59.69 -18.9 46.01 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.489 1.116 . . . . 0.0 111.822 -177.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 76.8 t -92.05 -38.6 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 125.429 1.491 . . . . 0.0 111.297 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 163.46 -168.06 37.94 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 118.764 0.711 . . . . 0.0 112.194 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.405 ' CD2' ' HB3' ' A' ' 243' ' ' LEU . 6.4 m-30 -78.48 161.92 26.73 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.579 0.704 . . . . 0.0 110.234 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.402 ' HB3' HG12 ' A' ' 207' ' ' VAL . 32.3 p90 -159.32 161.87 35.89 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.25 1.42 . . . . 0.0 110.38 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 95.3 mt -100.96 146.08 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.601 ' HB2' HD23 ' A' ' 175' ' ' LEU . 6.7 t -119.7 132.88 55.77 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.492 1.117 . . . . 0.0 108.364 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -126.79 107.71 10.38 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.978 2.111 . . . . 0.0 108.939 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.487 HD11 ' HG3' ' A' ' 203' ' ' GLU . 1.7 mp -90.6 114.14 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 104.481 -2.415 . . . . 0.0 104.481 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 7.2 mt -98.1 106.68 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.49 -153.49 24.82 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 77.07 20.85 1.17 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.585 1.154 . . . . 0.0 109.58 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -84.95 146.16 21.95 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.12 137.71 58.04 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 125.851 1.66 . . . . 0.0 108.44 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 25.3 mm -62.37 139.32 21.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 CA-C-O 122.218 1.009 . . . . 0.0 112.227 -178.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 5.6 t -79.2 116.35 19.42 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 128.381 2.672 . . . . 0.0 109.802 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.08 -17.0 56.16 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.904 0.881 . . . . 0.0 112.907 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 42.0 t -69.11 -52.47 33.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 125.742 1.617 . . . . 0.0 112.235 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . 0.4 HG22 HG21 ' A' ' 226' ' ' ILE . 3.8 t -123.38 -40.44 2.37 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.971 1.308 . . . . 0.0 113.832 -178.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 117.03 21.66 4.46 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.301 1.429 . . . . 0.0 110.596 -178.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -88.7 151.31 22.51 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.868 1.834 . . . . 0.0 110.729 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -71.59 153.61 42.01 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 5.8 ttt-85 -74.52 28.58 0.08 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 127.519 2.328 . . . . 0.0 110.011 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 7.6 ptm -73.03 172.17 11.5 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 122.424 1.106 . . . . 0.0 111.315 -176.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.2 p -143.17 143.95 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 C-N-CA 124.414 1.086 . . . . 0.0 108.092 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.487 ' HG3' HD11 ' A' ' 186' ' ' ILE . 11.2 tt0 -100.56 106.96 18.53 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 178.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 23.6 mm -100.98 146.25 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 O-C-N 120.756 -1.215 . . . . 0.0 108.713 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.458 HE22 ' HG2' ' A' ' 203' ' ' GLU . 17.1 mm-40 -125.48 134.53 52.02 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.796 -1.186 . . . . 0.0 107.796 177.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . 0.555 ' CD1' HD13 ' A' ' 109' ' ' ILE . 43.4 m-85 -106.06 110.05 22.19 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.402 HG12 ' HB3' ' A' ' 182' ' ' TYR . 29.9 m -124.7 162.58 26.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 45.5 t -83.03 143.51 30.56 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -87.48 23.67 11.9 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-O 117.285 -1.842 . . . . 0.0 113.187 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 71.2 -74.19 0.68 Allowed Glycine 0 C--N 1.341 0.83 0 C-N-CA 126.256 1.884 . . . . 0.0 109.911 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 60.8 m -51.6 123.45 9.99 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.377 1.871 . . . . 0.0 107.09 178.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -74.68 2.78 9.11 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.049 1.339 . . . . 0.0 113.22 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 4.0 t -131.26 154.95 47.94 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.021 1.328 . . . . 0.0 109.495 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 132.28 177.72 15.08 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.68 1.61 . . . . 0.0 112.1 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -80.15 -101.97 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.13 0 C-N-CA 123.743 2.962 . . . . 0.0 109.97 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.2 p -163.9 139.3 6.22 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 129.731 3.212 . . . . 0.0 105.409 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 77.4 p -151.3 175.46 12.19 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.536 1.062 . . . . 0.0 110.819 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.433 ' HA ' ' HA ' ' A' ' 233' ' ' VAL . 3.2 mt -115.48 143.05 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 104.073 -2.565 . . . . 0.0 104.073 176.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -94.35 -48.31 6.21 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.722 1.209 . . . . 0.0 112.421 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 -156.84 151.85 26.11 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.815 1.646 . . . . 0.0 108.499 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.493 HG23 ' HB2' ' A' ' 231' ' ' ALA . 6.8 p -155.71 120.44 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 177.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -148.85 158.38 44.12 Favored 'General case' 0 C--O 1.235 0.342 0 O-C-N 121.563 -0.711 . . . . 0.0 110.849 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -65.84 130.44 43.29 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 12.1 t -107.96 -33.61 7.16 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 125.842 1.657 . . . . 0.0 112.605 -178.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 7.1 mttt -132.17 -175.88 3.89 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.4 HG21 HG22 ' A' ' 196' ' ' THR . 1.1 mm -38.72 -56.92 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 124.896 1.278 . . . . 0.0 113.319 -177.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 2.5 m -133.32 17.61 4.04 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.775 1.63 . . . . 0.0 109.81 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.64 141.75 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -121.53 163.7 18.43 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.457 1.103 . . . . 0.0 108.474 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -138.16 132.36 31.81 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 178.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.493 ' HB2' HG23 ' A' ' 221' ' ' VAL . . . -136.57 140.04 42.61 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.158 1.383 . . . . 0.0 108.141 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -118.92 116.98 27.62 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 218' ' ' ILE . 1.3 m -107.0 151.85 8.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.8 p -126.75 136.83 52.94 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 123.461 0.704 . . . . 0.0 111.857 -178.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -141.21 142.55 27.48 Favored Pre-proline 0 N--CA 1.452 -0.336 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -66.79 -47.54 2.62 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.855 2.37 . . . . 0.0 112.002 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -53.41 -24.48 12.61 Favored 'General case' 0 CA--C 1.527 0.091 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 10.7 tp -61.11 -29.9 70.04 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 119.266 0.939 . . . . 0.0 111.409 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 9.2 m -62.0 -12.26 17.75 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.999 0.919 . . . . 0.0 112.602 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.99 -24.65 66.06 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.245 0.93 . . . . 0.0 110.121 178.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -89.14 117.21 27.96 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 178.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 -46.79 -44.18 18.93 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 126.281 1.833 . . . . 0.0 114.105 -178.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.405 ' HB3' ' CD2' ' A' ' 181' ' ' TYR . 60.2 mt -70.23 -31.43 68.83 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.448 -1.407 . . . . 0.0 113.017 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 14.3 mt -84.29 -20.7 31.69 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.124 0.97 . . . . 0.0 112.583 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -55.72 141.16 39.28 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 128.914 2.886 . . . . 0.0 111.538 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 34.5 mmtt -103.5 176.49 5.13 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.378 1.471 . . . . 0.0 109.616 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -101.77 -69.63 0.78 Allowed 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 53.03 25.44 4.08 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.356 1.463 . . . . 0.0 110.94 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 3.0 t70 . . . . . 0 C--O 1.246 0.88 0 C-N-CA 127.096 2.158 . . . . 0.0 108.057 179.745 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.366 0 N-CA-C 108.149 -1.981 . . . . 0.0 108.149 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.5 -29.81 68.11 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 119.443 1.621 . . . . 0.0 109.216 178.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 70.6 m -142.14 164.38 30.33 Favored 'General case' 0 C--O 1.246 0.909 0 C-N-CA 131.658 3.983 . . . . 0.0 102.953 177.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -120.63 118.06 29.17 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 58.6 m -52.41 -37.4 56.56 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 124.396 1.078 . . . . 0.0 109.077 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -58.82 -40.63 84.74 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 127.757 2.423 . . . . 0.0 110.746 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? -62.33 -50.49 71.43 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.527 ' HA ' HD12 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -62.52 -37.24 85.28 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.021 0.528 . . . . 0.0 111.035 178.741 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.43 -45.96 92.1 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 55.3 tp -66.38 -38.07 86.71 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 118.396 -0.811 . . . . 0.0 109.905 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.527 HD12 ' HA ' ' A' ' 95' ' ' THR . 20.7 mt -59.74 -54.81 41.98 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 24.5 m -60.7 -38.53 85.34 Favored 'General case' 0 C--O 1.239 0.551 0 O-C-N 121.449 -0.782 . . . . 0.0 111.77 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -65.28 -48.19 74.04 Favored 'General case' 0 CA--C 1.519 -0.247 0 O-C-N 121.056 -1.027 . . . . 0.0 109.993 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 69.2 m -51.95 -47.81 64.59 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.352 1.061 . . . . 0.0 110.667 -178.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.411 HD21 ' HB2' ' A' ' 172' ' ' PHE . 3.4 tm? -58.51 -49.48 77.21 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 117.847 0.294 . . . . 0.0 110.912 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -62.89 -57.35 11.09 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 122.243 1.02 . . . . 0.0 113.153 -177.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -60.41 -41.6 94.22 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.797 -178.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -62.71 -53.21 42.9 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-O 117.781 -1.566 . . . . 0.0 111.418 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.515 ' HA ' HD12 ' A' ' 109' ' ' ILE . 47.8 t -58.34 -42.53 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 120.562 2.181 . . . . 0.0 109.0 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.84 -30.98 71.69 Favored 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 119.181 -1.007 . . . . 0.0 112.499 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.429 ' CG2' ' HB3' ' A' ' 237' ' ' GLU . 52.6 m -72.32 -40.75 67.24 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 126.042 1.737 . . . . 0.0 108.385 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.515 HD12 ' HA ' ' A' ' 106' ' ' VAL . 18.1 mt -60.66 -55.06 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 178.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -60.91 -28.0 68.6 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-O 117.876 -1.059 . . . . 0.0 111.657 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -62.07 -49.38 76.17 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.22 1.008 . . . . 0.0 111.337 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.473 ' HA ' ' HE2' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -85.26 -39.28 17.93 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -177.765 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 16.2 mt -66.38 -25.78 66.95 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 119.009 -0.519 . . . . 0.0 112.26 -179.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -52.44 -28.75 21.3 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -51.18 -74.77 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.821 1.648 . . . . 0.0 111.67 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -147.68 176.68 9.9 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.804 1.642 . . . . 0.0 109.126 -178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 33.4 m -86.21 163.06 18.0 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.635 0.731 . . . . 0.0 109.147 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 37.6 pt -118.63 160.29 18.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 126.134 1.774 . . . . 0.0 109.395 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -158.05 139.62 13.7 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -130.54 127.2 38.61 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 123.584 0.753 . . . . 0.0 110.052 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -85.39 101.66 12.78 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.26 1.024 . . . . 0.0 108.439 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.26 80.07 7.65 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 104.681 -2.34 . . . . 0.0 104.681 178.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.73 -99.63 0.37 Allowed Glycine 0 CA--C 1.531 1.08 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -95.25 -25.85 16.19 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.742 1.617 . . . . 0.0 114.031 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -99.01 152.35 19.91 Favored 'General case' 0 CA--C 1.513 -0.451 0 O-C-N 121.302 -0.874 . . . . 0.0 108.752 -178.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.465 HD13 ' H ' ' A' ' 140' ' ' GLY . 5.2 mp -124.67 124.6 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -100.99 119.3 38.54 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 103.212 -2.884 . . . . 0.0 103.212 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -118.4 124.7 48.33 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.157 0.983 . . . . 0.0 110.891 -177.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -124.03 135.03 53.32 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -178.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.578 ' HB3' HD13 ' A' ' 133' ' ' ILE . 16.1 m -111.18 155.97 41.79 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 125.546 1.538 . . . . 0.0 112.808 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -67.97 81.31 0.49 Allowed 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 124.864 3.71 . . . . 0.0 114.474 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 72.98 54.55 7.0 Favored Glycine 0 CA--C 1.529 0.922 0 O-C-N 121.207 -0.933 . . . . 0.0 112.862 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.578 HD13 ' HB3' ' A' ' 130' ' ' CYS . 3.6 mp -131.04 -72.02 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -167.16 167.82 14.02 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.757 1.623 . . . . 0.0 109.068 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -128.54 126.14 39.75 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 176.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.8 m -141.53 164.0 19.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 124.591 1.157 . . . . 0.0 110.55 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -126.36 125.81 42.85 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -139.4 162.96 33.77 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.091 0.957 . . . . 0.0 110.636 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.559 ' H ' HD13 ' A' ' 156' ' ' LEU . 61.8 t60 -110.19 109.35 19.81 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 101.993 -3.336 . . . . 0.0 101.993 177.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.465 ' H ' HD13 ' A' ' 126' ' ' ILE . . . -168.78 -159.64 14.92 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.191 1.853 . . . . 0.0 109.959 -178.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -141.02 167.26 22.61 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 118.856 1.328 . . . . 0.0 112.684 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.467 HG23 ' C ' ' A' ' 148' ' ' GLU . 8.9 p -133.16 150.42 32.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 125.747 1.619 . . . . 0.0 107.878 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 63.2 t-20 -103.49 121.75 43.49 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 16.6 p -60.9 -27.4 68.14 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 33.3 mmtt -61.29 -33.12 73.05 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -178.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.8 p -110.05 -47.33 3.33 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 125.025 1.33 . . . . 0.0 109.497 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 90.56 32.22 9.59 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 125.325 1.44 . . . . 0.0 110.793 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.467 ' C ' HG23 ' A' ' 142' ' ' VAL . 11.9 pt-20 -124.68 145.62 49.57 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 125.668 1.587 . . . . 0.0 108.881 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 6.5 mm -66.0 149.26 11.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 125.299 1.439 . . . . 0.0 110.464 -177.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 24.3 m -59.98 -43.39 92.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 124.197 0.999 . . . . 0.0 111.096 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 74.3 m-80 -151.52 151.29 31.41 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 125.005 1.322 . . . . 0.0 108.103 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -79.75 -155.97 0.11 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.553 1.141 . . . . 0.0 109.725 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -67.04 90.53 0.19 Allowed 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.651 -1.281 . . . . 0.0 111.06 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -76.54 -67.1 0.73 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 49.8 m -126.54 -15.53 5.55 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.742 1.217 . . . . 0.0 113.479 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.559 HD13 ' H ' ' A' ' 139' ' ' HIS . 56.7 mt -83.45 81.8 8.56 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 120.743 -1.223 . . . . 0.0 109.995 -178.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 71.4 t -77.06 110.05 12.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -145.72 137.26 25.06 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.639 1.176 . . . . 0.0 109.029 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -134.59 141.78 46.74 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 177.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 59.7 mt -120.17 -29.06 4.96 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 125.454 1.721 . . . . 0.0 107.042 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 160.62 159.18 9.73 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 36.1 mtmt -128.57 114.66 19.49 Favored Pre-proline 0 CA--C 1.537 0.444 0 O-C-N 122.021 -0.694 . . . . 0.0 109.998 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -75.6 -167.98 0.49 Allowed 'Trans proline' 0 CA--C 1.537 0.63 1 C-N-CA 125.806 4.338 . . . . 0.0 110.336 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -131.93 157.56 43.7 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.328 1.451 . . . . 0.0 108.91 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.89 -38.29 73.05 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.878 0.371 . . . . 0.0 110.503 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 33.7 m-20 -76.15 64.73 2.03 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.703 1.601 . . . . 0.0 110.293 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 6.1 p -52.04 -30.32 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 124.212 1.005 . . . . 0.0 111.172 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -71.32 -26.03 62.66 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.531 1.132 . . . . 0.0 113.804 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -77.32 -23.68 50.95 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 122.901 0.481 . . . . 0.0 112.174 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -92.42 160.32 15.14 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.964 0.411 . . . . 0.0 109.909 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -114.38 161.48 17.87 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.411 ' HB2' HD21 ' A' ' 102' ' ' LEU . 49.4 m-85 -138.11 170.43 16.05 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.738 1.215 . . . . 0.0 109.621 -177.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -112.57 151.32 30.19 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 21.9 tp -121.3 98.35 5.94 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -110.16 178.46 4.39 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -155.0 163.3 40.51 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -141.08 -171.03 3.18 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -55.27 -23.82 25.02 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.087 1.355 . . . . 0.0 112.406 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.5 t -81.87 -65.91 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 177.48 -170.58 43.1 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -77.55 157.62 30.26 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.566 0.746 . . . . 0.0 111.838 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.452 ' HB3' HG12 ' A' ' 207' ' ' VAL . 48.7 p90 -156.09 173.77 16.34 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 126.735 2.014 . . . . 0.0 108.585 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 93.8 mt -114.29 141.69 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 177.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 21.3 t -109.91 128.71 55.53 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.059 1.343 . . . . 0.0 107.923 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -124.07 107.39 11.23 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.862 1.265 . . . . 0.0 108.459 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.6 mp -91.05 128.65 42.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 7.6 mt -118.9 106.72 19.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -93.88 -152.56 29.41 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 108.443 -1.863 . . . . 0.0 108.443 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 69.7 m 79.15 25.49 0.46 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.201 2.2 . . . . 0.0 115.768 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -89.64 -156.02 31.44 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 107.58 -2.208 . . . . 0.0 107.58 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -123.17 144.13 49.56 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 39.8 mm -60.82 134.55 26.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -79.62 109.63 14.18 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 127.131 2.172 . . . . 0.0 105.489 177.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -55.04 -19.5 7.2 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.847 2.059 . . . . 0.0 113.189 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 50.1 t -60.47 -54.52 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 126.968 2.107 . . . . 0.0 111.567 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 4.8 t -124.09 -25.42 4.18 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -177.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 99.59 35.72 4.55 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 108.239 -1.945 . . . . 0.0 108.239 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -113.27 151.29 31.29 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 117.933 0.867 . . . . 0.0 110.669 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 57.5 mp0 -75.26 141.41 43.49 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 123.976 0.91 . . . . 0.0 112.735 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . 0.297 7.9 ttt85 -70.05 30.98 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 130.885 3.674 . . . . 0.0 112.797 178.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 5.1 ptm -74.75 177.36 6.22 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.125 0.97 . . . . 0.0 110.472 -179.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.2 p -143.65 152.97 16.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 125.283 1.433 . . . . 0.0 107.98 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -114.65 112.57 23.08 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 15.7 mm -98.24 141.96 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -124.62 111.46 15.66 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.663 1.585 . . . . 0.0 107.985 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -92.56 109.03 20.43 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.701 1.6 . . . . 0.0 110.369 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.452 HG12 ' HB3' ' A' ' 182' ' ' TYR . 34.9 m -124.79 167.82 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.211 1.005 . . . . 0.0 109.837 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 45.5 t -96.46 132.73 41.72 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 103.541 -2.763 . . . . 0.0 103.541 177.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -98.36 32.49 6.89 Favored Glycine 0 N--CA 1.463 0.456 0 C-N-CA 124.541 1.067 . . . . 0.0 111.01 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 58.14 -147.44 38.26 Favored Glycine 0 CA--C 1.533 1.169 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 25.6 m -63.16 80.16 0.02 OUTLIER 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.659 1.584 . . . . 0.0 113.871 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.29 59.4 1.56 Allowed 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.119 1.367 . . . . 0.0 108.421 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 9.6 m -54.21 147.22 13.53 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 121.377 -0.827 . . . . 0.0 109.145 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 131.96 -161.06 23.77 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-O 119.163 -0.798 . . . . 0.0 112.525 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -67.1 -95.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 124.483 3.455 . . . . 0.0 115.429 -178.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -164.12 151.03 11.63 Favored 'General case' 0 C--O 1.241 0.624 0 O-C-N 120.863 -1.148 . . . . 0.0 109.1 -178.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 36.7 p -151.81 160.64 43.49 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.839 0.855 . . . . 0.0 110.579 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 4.1 mt -106.48 148.55 10.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -93.82 -53.98 3.8 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.672 0.789 . . . . 0.0 110.95 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 63.4 p-90 -155.17 155.03 33.2 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.859 1.264 . . . . 0.0 108.113 -178.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 56.3 t -150.58 129.66 3.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.84 162.18 32.15 Favored 'General case' 0 C--O 1.233 0.209 0 O-C-N 122.19 -0.319 . . . . 0.0 111.174 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -72.53 128.79 36.66 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 104.574 -2.38 . . . . 0.0 104.574 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 9.9 t -106.15 -37.17 6.68 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 124.833 1.253 . . . . 0.0 109.981 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 34.2 mttt -133.31 -176.45 4.14 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 123.782 0.833 . . . . 0.0 109.975 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 69.3 mt -46.38 -49.43 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.188 0.995 . . . . 0.0 112.322 -178.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.99 21.23 5.83 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 124.112 0.965 . . . . 0.0 110.362 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 7.9 t -120.1 141.4 40.49 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.61 0 CA-C-N 118.64 0.654 . . . . 0.0 111.61 -177.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -122.97 158.37 30.61 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -129.73 134.46 47.63 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -137.32 119.33 15.38 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 125.427 1.491 . . . . 0.0 109.932 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -108.42 124.66 50.74 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 12.5 m -116.31 156.58 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.481 0 C-N-CA 122.47 0.308 . . . . 0.0 110.665 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.3 p -123.85 123.89 41.45 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 124.39 1.076 . . . . 0.0 110.263 -178.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 2.2 pt -133.44 134.52 23.92 Favored Pre-proline 0 C--O 1.237 0.4 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 177.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.54 -27.82 45.83 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.233 2.622 . . . . 0.0 113.304 -178.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.429 ' HB3' ' CG2' ' A' ' 108' ' ' THR . 28.2 mp0 -64.59 -28.65 69.78 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 -178.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 66.6 mt -61.23 -29.23 69.7 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 118.587 -1.245 . . . . 0.0 110.652 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 21.7 m -58.86 -16.35 16.95 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 118.806 0.73 . . . . 0.0 112.256 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -60.11 -38.4 82.91 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 118.91 0.777 . . . . 0.0 109.663 178.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -79.61 122.47 26.56 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -47.33 -44.88 24.05 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 126.26 1.824 . . . . 0.0 113.34 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.43 -33.59 76.05 Favored 'General case' 0 C--O 1.226 -0.176 0 O-C-N 121.341 -0.849 . . . . 0.0 112.694 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 27.2 mt -92.88 -4.99 51.89 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.231 1.012 . . . . 0.0 113.054 -178.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -71.61 117.06 12.71 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 127.625 2.37 . . . . 0.0 112.978 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 32.6 mmtm -79.54 150.56 31.1 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 123.216 0.606 . . . . 0.0 110.709 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -144.05 -13.89 0.62 Allowed 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 124.865 1.266 . . . . 0.0 111.56 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -120.64 21.32 11.57 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 127.206 2.202 . . . . 0.0 110.183 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 . . . . . 0 C--O 1.252 1.189 0 CA-C-O 116.613 -1.661 . . . . 0.0 111.126 179.642 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.658 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -147.37 -143.69 0.14 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 128.885 2.874 . . . . 0.0 104.583 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.0 t -79.21 63.6 3.89 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 120.008 1.276 . . . . 0.0 107.69 178.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -65.76 -53.35 41.66 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.825 1.65 . . . . 0.0 109.888 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.9 m -50.79 -43.09 58.61 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.475 1.91 . . . . 0.0 112.947 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -60.96 -50.02 75.08 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 118.528 0.604 . . . . 0.0 110.234 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -52.99 -53.43 50.14 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -178.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.37 -37.63 65.19 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 118.554 -0.736 . . . . 0.0 112.078 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.82 -49.23 76.01 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 52.8 tp -65.1 -35.6 81.64 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.492 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.498 HD23 HD11 ' A' ' 243' ' ' LEU . 43.3 mt -63.24 -55.01 28.48 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.44 1.018 . . . . 0.0 108.791 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 88.9 m -57.25 -46.36 83.1 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 125.045 1.338 . . . . 0.0 110.254 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.71 -50.2 70.08 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 118.231 -0.89 . . . . 0.0 109.666 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 47.6 m -52.53 -46.9 66.94 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 124.159 0.984 . . . . 0.0 110.532 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -59.49 -50.33 74.33 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 118.3 0.5 . . . . 0.0 110.003 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.1 -61.5 2.22 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.219 0.608 . . . . 0.0 112.313 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.44 -37.98 79.5 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.487 0.315 . . . . 0.0 110.231 -178.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.09 -53.25 38.16 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-O 117.583 -1.676 . . . . 0.0 110.706 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.55 ' HA ' HD12 ' A' ' 109' ' ' ILE . 37.3 t -57.12 -45.19 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 119.671 1.736 . . . . 0.0 109.087 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -62.96 -34.36 77.33 Favored 'General case' 0 C--O 1.223 -0.311 0 C-N-CA 118.815 -1.154 . . . . 0.0 111.573 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 86.2 m -70.89 -36.96 72.97 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.444 0.698 . . . . 0.0 109.53 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.55 HD12 ' HA ' ' A' ' 106' ' ' VAL . 13.7 mt -61.81 -55.4 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 179.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -64.3 -27.85 69.32 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -64.51 -30.82 71.85 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.443 1.02 . . . . 0.0 111.646 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.68 -46.61 6.54 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 123.835 0.854 . . . . 0.0 110.56 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.9 mt -59.98 -27.58 66.97 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -55.03 -24.83 26.63 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -62.85 -62.44 1.72 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.48 0.712 . . . . 0.0 110.872 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -148.42 171.03 16.7 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 123.97 0.908 . . . . 0.0 110.868 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 69.8 m -87.07 166.14 15.25 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 35.4 pt -117.92 156.44 19.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 125.372 1.469 . . . . 0.0 108.613 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.3 138.29 21.27 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 125.389 1.475 . . . . 0.0 109.278 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -136.7 113.36 10.21 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 123.634 0.773 . . . . 0.0 111.44 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -79.82 99.59 7.58 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.29 79.62 8.99 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 178.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 60.13 -105.83 0.87 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -77.99 -34.32 50.87 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.685 0.794 . . . . 0.0 112.981 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 52.4 m95 -99.79 167.82 10.3 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 118.952 0.797 . . . . 0.0 110.293 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.3 mp -136.88 153.81 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.503 ' CD1' HG11 ' A' ' 221' ' ' VAL . 98.9 m-85 -133.68 120.15 20.27 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.766 2.027 . . . . 0.0 106.221 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -117.15 121.29 40.85 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -119.06 139.43 51.76 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 124.216 1.007 . . . . 0.0 109.895 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.607 ' HB3' HD13 ' A' ' 133' ' ' ILE . 20.8 m -115.77 157.38 44.73 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 126.663 1.985 . . . . 0.0 111.687 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -64.21 76.68 0.17 Allowed 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 124.723 3.615 . . . . 0.0 114.626 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 68.54 56.87 8.92 Favored Glycine 0 CA--C 1.533 1.161 0 O-C-N 120.72 -1.238 . . . . 0.0 112.792 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.607 HD13 ' HB3' ' A' ' 130' ' ' CYS . 3.9 mp -128.12 -71.24 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.131 0 C-N-CA 126.198 1.799 . . . . 0.0 106.153 179.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -164.42 169.97 16.61 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 126.963 2.105 . . . . 0.0 109.521 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -133.38 124.84 27.89 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 178.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 33.9 m -142.65 163.71 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 123.99 0.916 . . . . 0.0 112.043 -178.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -125.43 124.67 41.95 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.757 1.623 . . . . 0.0 107.017 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -139.34 162.45 34.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 119.451 1.023 . . . . 0.0 111.43 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 63.1 t60 -85.37 160.97 19.66 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 177.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 133.09 -159.06 23.43 Favored Glycine 0 N--CA 1.465 0.595 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.97 167.54 29.1 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 124.949 1.3 . . . . 0.0 109.584 178.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.0 p -112.66 148.95 15.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.3 113.01 26.28 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 178.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 58.9 p -53.77 -30.82 46.31 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.918 1.287 . . . . 0.0 112.972 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp -47.04 -45.12 21.24 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 127.79 2.436 . . . . 0.0 112.965 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.7 p -120.22 -41.27 2.64 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 127.331 2.252 . . . . 0.0 112.926 -177.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 100.04 35.47 4.51 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 125.871 1.701 . . . . 0.0 110.467 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.1 148.63 41.37 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.755 1.222 . . . . 0.0 111.503 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 34.2 mm -78.73 144.68 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 103.24 -2.874 . . . . 0.0 103.24 177.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 32.5 m -66.66 -6.46 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 36.61 84.1 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 128.978 2.911 . . . . 0.0 110.471 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -140.85 -34.64 0.5 Allowed 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -178.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -93.28 66.97 4.07 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -60.37 -57.02 14.56 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.162 1.385 . . . . 0.0 112.641 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 4.5 m -59.54 -15.41 17.95 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 115.764 1.765 . . . . 0.0 115.764 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 13.8 mt -84.23 57.32 4.17 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.252 0.933 . . . . 0.0 108.921 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 10.8 m -85.48 148.08 5.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 124.005 0.922 . . . . 0.0 109.61 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -151.85 176.98 10.89 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 128.561 2.744 . . . . 0.0 107.477 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -148.7 134.18 18.61 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.5 mp -109.85 -23.73 11.22 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 160.79 159.22 9.78 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-N 119.436 1.016 . . . . 0.0 111.891 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.38 108.46 41.71 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 123.918 0.887 . . . . 0.0 109.631 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.4 166.73 23.88 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.286 2.657 . . . . 0.0 110.058 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -96.75 156.55 16.3 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -76.02 -35.14 59.65 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.728 1.211 . . . . 0.0 113.149 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -84.85 66.73 9.83 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 124.369 1.068 . . . . 0.0 110.534 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.5 p -46.04 -28.6 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -71.16 -31.2 67.4 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 124.823 1.249 . . . . 0.0 111.737 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -87.84 -14.1 40.4 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.138 1.775 . . . . 0.0 110.24 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -75.97 158.38 32.02 Favored 'General case' 0 CA--C 1.521 -0.165 0 O-C-N 120.921 -1.112 . . . . 0.0 108.865 178.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -109.9 149.25 30.18 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -143.37 169.28 17.96 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 127.025 2.13 . . . . 0.0 108.606 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -128.13 154.01 46.23 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.082 0.953 . . . . 0.0 110.043 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 23.9 tp -114.25 108.52 17.05 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.555 HD23 ' HB2' ' A' ' 184' ' ' SER . 1.9 mm? -118.2 -179.83 3.89 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.226 1.41 . . . . 0.0 109.297 -178.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -149.33 156.79 42.62 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -141.52 -178.12 5.48 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 177.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -60.86 -13.13 13.58 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.331 -0.856 . . . . 0.0 111.464 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 69.0 t -83.09 -45.25 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 O-C-N 120.796 -1.19 . . . . 0.0 110.435 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 154.53 -165.56 31.99 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 108.082 -2.007 . . . . 0.0 108.082 -178.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.441 ' CD2' ' HB3' ' A' ' 243' ' ' LEU . 3.4 m-30 -78.56 160.72 27.46 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 118.239 1.019 . . . . 0.0 110.22 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.439 ' CB ' HG12 ' A' ' 207' ' ' VAL . 45.7 p90 -158.64 161.72 37.2 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.503 1.121 . . . . 0.0 111.371 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 95.8 mt -101.4 144.1 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.555 ' HB2' HD23 ' A' ' 175' ' ' LEU . 29.7 t -114.29 133.01 55.95 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -123.46 108.55 12.8 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -85.84 127.61 40.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.8 mt -115.59 105.23 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 102.874 -3.01 . . . . 0.0 102.874 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -110.76 -152.04 12.74 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 108.379 -1.888 . . . . 0.0 108.379 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 75.26 23.74 1.52 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.389 1.076 . . . . 0.0 110.945 178.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -95.08 173.64 31.89 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.98 163.88 26.72 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 44.0 mm -86.23 141.43 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 125.619 1.568 . . . . 0.0 111.623 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.2 m -87.23 118.75 26.86 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 127.724 2.41 . . . . 0.0 108.383 178.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -54.06 -32.24 54.02 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.075 2.15 . . . . 0.0 113.335 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 43.8 t -50.91 -55.42 7.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 125.542 1.537 . . . . 0.0 112.772 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 13.6 t -123.93 -33.28 3.16 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 108.05 34.73 2.69 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -178.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -104.82 152.65 22.33 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.916 1.358 . . . . 0.0 110.438 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -76.96 146.2 37.65 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 118.773 0.715 . . . . 0.0 109.559 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . 0.373 4.8 ptp180 -71.62 29.34 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 128.176 2.59 . . . . 0.0 113.558 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 7.8 ptm -72.59 174.31 7.7 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 122.15 0.976 . . . . 0.0 111.643 -176.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.4 p -142.25 150.17 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 124.065 0.946 . . . . 0.0 109.346 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -111.06 106.23 15.23 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 17.0 mm -90.31 150.59 3.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -125.76 100.03 6.23 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 126.916 2.087 . . . . 0.0 110.173 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -84.81 108.68 17.6 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 178.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.439 HG12 ' CB ' ' A' ' 182' ' ' TYR . 26.1 m -125.38 164.11 25.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 124.243 1.017 . . . . 0.0 108.674 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 42.6 t -82.92 146.51 28.8 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 177.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -93.04 13.42 67.74 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-O 118.997 -0.891 . . . . 0.0 112.456 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 68.85 -155.97 53.49 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 106.443 -2.663 . . . . 0.0 106.443 -177.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 16.0 m -70.43 85.48 0.6 Allowed 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.15 0.98 . . . . 0.0 109.393 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -145.74 60.65 1.27 Allowed 'General case' 0 C--O 1.233 0.22 0 C-N-CA 126.418 1.887 . . . . 0.0 108.02 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 12.8 m -59.72 104.84 0.31 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.319 1.448 . . . . 0.0 111.506 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.421 ' H ' ' HG3' ' A' ' 236' ' ' PRO . . . -175.21 -163.39 28.14 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 125.284 1.421 . . . . 0.0 110.426 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -68.95 -92.5 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.641 2.894 . . . . 0.0 114.305 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 2.9 p -164.33 142.7 7.1 Favored 'General case' 0 N--CA 1.463 0.201 0 O-C-N 120.934 -1.104 . . . . 0.0 109.678 -178.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 7.9 p -148.8 165.5 31.29 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.47 0.577 . . . . 0.0 111.132 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 3.4 mt -101.96 154.48 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 125.298 1.439 . . . . 0.0 107.372 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -105.0 -44.86 4.69 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.121 0.968 . . . . 0.0 113.573 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 67.0 p-90 -163.68 151.88 13.31 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.999 1.319 . . . . 0.0 107.718 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.503 HG11 ' CD1' ' A' ' 127' ' ' TYR . 87.9 t -151.89 129.2 2.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 C-N-CA 124.879 1.272 . . . . 0.0 109.22 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 1.5 ppt_? -163.48 160.5 23.34 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.752 0.706 . . . . 0.0 110.495 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -67.09 131.25 45.45 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 14.9 t -104.07 -33.15 8.87 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.948 1.299 . . . . 0.0 111.361 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 56.8 mttt -131.36 -175.04 3.57 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 125.049 1.34 . . . . 0.0 108.332 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 67.5 mt -52.27 -43.88 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -129.95 8.3 5.22 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.649 0.78 . . . . 0.0 112.227 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 21.5 t -105.81 142.34 19.07 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -178.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -121.55 166.36 14.31 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 124.72 1.208 . . . . 0.0 108.104 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -136.91 144.29 43.39 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -148.65 119.02 7.33 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 123.364 0.666 . . . . 0.0 109.608 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -103.5 123.07 46.22 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 2.3 m -119.98 152.44 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 2.8 p -126.6 135.93 51.87 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 3.9 pt -139.82 146.17 46.02 Favored Pre-proline 0 C--O 1.236 0.362 0 C-N-CA 125.564 1.545 . . . . 0.0 107.029 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.421 ' HG3' ' H ' ' A' ' 214' ' ' GLY . 97.4 Cg_endo -74.03 -24.82 14.63 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.201 1.934 . . . . 0.0 112.973 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 49.6 mp0 -66.02 -28.18 68.68 Favored 'General case' 0 CA--C 1.518 -0.286 0 O-C-N 120.43 -1.418 . . . . 0.0 114.355 -178.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.409 HD22 ' CD1' ' A' ' 244' ' ' LEU . 58.9 mt -63.32 -25.13 68.16 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 118.902 -1.119 . . . . 0.0 110.682 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 20.9 m -63.0 -15.12 55.27 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 119.163 0.892 . . . . 0.0 111.051 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -69.5 -31.77 70.22 Favored 'General case' 0 C--N 1.341 0.206 0 O-C-N 121.186 -0.946 . . . . 0.0 109.358 178.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.445 HD13 ' HA ' ' A' ' 241' ' ' LEU . 3.1 mm? -78.21 120.75 23.44 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 178.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 33.0 tp10 -46.05 -48.47 16.86 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.766 2.026 . . . . 0.0 115.795 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.498 HD11 HD23 ' A' ' 98' ' ' LEU . 20.0 mt -69.52 -34.44 74.27 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.148 -0.97 . . . . 0.0 112.786 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.409 ' CD1' HD22 ' A' ' 238' ' ' LEU . 3.2 mt -84.71 -10.35 57.36 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.266 1.026 . . . . 0.0 112.717 -178.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -61.25 123.73 18.56 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.179 2.192 . . . . 0.0 111.015 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 16.2 mmtp -78.52 167.26 21.55 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.319 0.648 . . . . 0.0 109.677 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -65.99 -48.26 71.8 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 123.704 0.802 . . . . 0.0 111.183 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 48.0 48.72 17.89 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 126.299 1.84 . . . . 0.0 110.788 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 0.989 0 C-N-CA 126.351 1.86 . . . . 0.0 110.004 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.673 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -140.63 157.43 45.47 Favored 'General case' 0 CA--C 1.523 -0.077 0 CA-C-N 118.58 1.19 . . . . 0.0 110.258 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.2 p -112.12 15.97 20.34 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.177 2.191 . . . . 0.0 111.211 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -60.21 90.45 0.02 OUTLIER 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.677 1.591 . . . . 0.0 111.286 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.6 t -77.93 -41.6 35.86 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 118.808 0.731 . . . . 0.0 109.778 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.508 ' CD ' ' H ' ' A' ' 93' ' ' GLU . 8.8 mp0 -53.27 -41.58 65.68 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 127.095 2.158 . . . . 0.0 110.887 -178.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.8 tmtm? -60.56 -59.17 5.82 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.468 ' HA ' HD12 ' A' ' 98' ' ' LEU . 0.9 OUTLIER -59.48 -36.89 76.88 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 179.36 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.88 -52.64 64.86 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 42.0 tp -68.36 -34.95 77.0 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 118.416 -0.802 . . . . 0.0 110.373 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.468 HD12 ' HA ' ' A' ' 95' ' ' THR . 31.8 mt -60.36 -54.37 46.42 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 60.4 m -61.9 -45.26 94.5 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.656 -0.652 . . . . 0.0 109.8 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.9 -47.31 83.16 Favored 'General case' 0 C--N 1.346 0.415 0 O-C-N 120.854 -1.154 . . . . 0.0 109.416 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.405 ' HA ' HD12 ' A' ' 241' ' ' LEU . 72.3 m -54.14 -51.17 65.13 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.579 1.152 . . . . 0.0 110.323 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -57.98 -47.92 81.54 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 123.288 0.367 . . . . 0.0 110.56 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -69.17 -59.58 2.93 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -177.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.46 -37.32 85.46 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.451 ' HA3' HD11 ' A' ' 183' ' ' ILE . . . -56.15 -52.65 47.99 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.519 ' HA ' HD12 ' A' ' 109' ' ' ILE . 41.3 t -56.69 -46.02 82.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 119.381 1.59 . . . . 0.0 110.475 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.3 ptmt -63.61 -31.63 72.86 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 118.714 -0.66 . . . . 0.0 111.878 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.3 m -76.43 -37.89 56.36 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.38 1.072 . . . . 0.0 109.104 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.558 HD13 ' CD1' ' A' ' 206' ' ' TYR . 24.6 mt -62.16 -55.34 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -62.15 -28.37 69.6 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 118.272 -0.87 . . . . 0.0 111.497 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -68.67 -50.3 52.16 Favored 'General case' 0 N--CA 1.457 -0.085 0 CA-C-N 119.028 0.831 . . . . 0.0 111.135 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.05 -44.8 45.64 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 30.8 mt -64.33 -26.12 68.34 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-O 119.068 -0.491 . . . . 0.0 111.929 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -51.63 -27.06 10.26 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.3 1.04 . . . . 0.0 112.872 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -52.58 -68.09 0.2 Allowed 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.544 1.538 . . . . 0.0 112.489 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -152.9 -179.13 7.38 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.597 1.559 . . . . 0.0 111.536 -178.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 64.1 m -86.65 175.42 8.29 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 35.7 pt -140.73 160.19 24.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 125.306 1.442 . . . . 0.0 109.746 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.412 ' CD2' HG11 ' A' ' 142' ' ' VAL . 0.2 OUTLIER -150.32 144.2 25.38 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 123.878 0.871 . . . . 0.0 110.081 -179.607 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.537 ' CE1' ' HB2' ' A' ' 122' ' ' ALA . 8.8 t80 -135.04 131.16 36.71 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.091 0.956 . . . . 0.0 109.461 178.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.4 ' HA ' HG13 ' A' ' 126' ' ' ILE . 57.0 tt0 -91.43 109.71 21.0 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 124.915 1.286 . . . . 0.0 108.029 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.537 ' HB2' ' CE1' ' A' ' 120' ' ' TYR . . . -102.39 80.09 1.91 Allowed 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.15 1.78 . . . . 0.0 110.86 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.82 -85.99 0.07 OUTLIER Glycine 0 CA--C 1.529 0.913 0 O-C-N 120.711 -1.243 . . . . 0.0 113.1 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -109.77 -32.62 7.01 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.407 1.083 . . . . 0.0 111.235 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 69.2 m95 -99.81 152.76 19.76 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 118.933 0.788 . . . . 0.0 110.323 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.483 HD13 ' H ' ' A' ' 140' ' ' GLY . 4.8 mp -122.19 138.22 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -113.97 130.62 56.51 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -132.86 125.04 29.09 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.358 0.526 . . . . 0.0 110.57 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -116.06 140.65 49.06 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.823 1.249 . . . . 0.0 110.82 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 6.5 m -121.37 151.9 56.9 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 124.354 1.062 . . . . 0.0 109.925 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -65.69 84.86 0.23 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 124.374 3.383 . . . . 0.0 116.108 -177.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.21 32.07 36.38 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-O 118.041 -1.422 . . . . 0.0 112.714 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.8 mp -114.67 -72.59 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -172.05 173.74 4.28 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.737 1.215 . . . . 0.0 109.364 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -129.47 126.9 39.74 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.0 m -142.05 163.97 18.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 124.383 1.073 . . . . 0.0 111.487 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -123.93 118.93 28.17 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -137.78 163.43 31.39 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 125.869 1.667 . . . . 0.0 111.361 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.443 ' H ' ' CD1' ' A' ' 156' ' ' LEU . 70.5 t60 -94.77 135.39 36.31 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 177.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.483 ' H ' HD13 ' A' ' 126' ' ' ILE . . . 148.84 141.27 3.43 Favored Glycine 0 CA--C 1.529 0.914 0 O-C-N 121.126 -0.984 . . . . 0.0 111.89 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -91.13 167.94 11.99 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.715 0.806 . . . . 0.0 111.524 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.412 HG11 ' CD2' ' A' ' 119' ' ' PHE . 4.4 p -131.9 150.48 33.87 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 C-N-CA 124.7 1.2 . . . . 0.0 108.316 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -105.04 111.11 23.77 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 30.9 p -52.77 -29.13 25.54 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.18 1.392 . . . . 0.0 113.052 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 39.3 mmtt -59.59 -30.4 68.65 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.312 1.445 . . . . 0.0 113.056 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 25.5 p -124.99 -47.45 1.79 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.068 0.947 . . . . 0.0 112.39 -177.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 102.44 35.03 3.97 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.056 1.312 . . . . 0.0 110.987 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -120.56 149.88 41.75 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.273 1.029 . . . . 0.0 109.638 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 8.7 mm -79.14 157.92 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 179.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 15.6 m -65.53 -42.95 94.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 123.882 0.873 . . . . 0.0 110.218 179.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -157.43 154.43 28.78 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.484 2.313 . . . . 0.0 107.009 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 15.1 mmt180 -103.07 95.96 6.48 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 104.528 -2.397 . . . . 0.0 104.528 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -70.92 92.11 0.9 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 122.61 1.195 . . . . 0.0 114.097 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -71.81 -17.35 62.16 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.119 0.968 . . . . 0.0 112.476 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.52 -10.69 59.17 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.272 1.429 . . . . 0.0 110.371 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.443 ' CD1' ' H ' ' A' ' 139' ' ' HIS . 69.8 mt -111.26 101.49 9.97 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 126.949 2.1 . . . . 0.0 108.041 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.6 m -97.54 119.22 45.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -142.58 162.87 34.36 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.268 0.627 . . . . 0.0 110.513 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 19.2 tpp180 -148.11 113.19 5.5 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.425 1.49 . . . . 0.0 110.527 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 60.3 mt -97.91 -41.59 7.94 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 157.89 175.06 28.39 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.439 ' N ' HG22 ' A' ' 187' ' ' ILE . 6.0 ptmm? -130.36 127.83 22.54 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -70.35 179.1 4.27 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.036 3.157 . . . . 0.0 108.771 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -123.47 162.06 23.62 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 121.321 -0.862 . . . . 0.0 110.425 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -73.04 -50.06 25.17 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.126 0.97 . . . . 0.0 111.037 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -77.55 64.96 2.98 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 126.072 1.749 . . . . 0.0 111.734 -177.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.4 p -50.14 -32.43 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.464 1.105 . . . . 0.0 111.133 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -62.38 -37.24 84.98 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.402 1.481 . . . . 0.0 110.752 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -84.54 -15.21 46.6 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.849 1.26 . . . . 0.0 112.018 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 67.4 mtp180 -79.65 134.29 36.42 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -89.96 149.55 22.53 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -135.65 166.3 23.55 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.913 1.685 . . . . 0.0 107.149 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -122.79 153.57 39.36 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 48.1 tp -116.63 100.74 8.04 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.58 1.552 . . . . 0.0 109.524 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -117.67 178.68 4.31 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 125.175 1.39 . . . . 0.0 107.449 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -153.98 161.09 42.23 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 121.85 -0.531 . . . . 0.0 111.048 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -138.78 176.24 8.86 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 126.649 1.98 . . . . 0.0 107.501 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -59.91 -16.87 33.0 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 126.169 1.788 . . . . 0.0 111.987 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.469 ' CG1' ' HE3' ' A' ' 246' ' ' LYS . 99.3 t -86.41 -37.55 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 124.293 1.037 . . . . 0.0 110.196 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 155.51 -178.94 31.85 Favored Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -78.43 165.53 23.68 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.222 1.009 . . . . 0.0 108.718 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.479 ' HB3' HG12 ' A' ' 207' ' ' VAL . 36.8 p90 -158.95 169.75 23.63 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 122.779 0.431 . . . . 0.0 109.922 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.451 HD11 ' HA3' ' A' ' 105' ' ' GLY . 96.7 mt -109.48 124.74 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 35.3 t -91.54 129.52 37.5 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -125.64 107.26 10.4 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -90.15 125.68 43.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 103.711 -2.7 . . . . 0.0 103.711 177.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.439 HG22 ' N ' ' A' ' 162' ' ' LYS . 6.3 mt -113.74 112.75 41.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.73 -160.3 25.76 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 124.945 1.26 . . . . 0.0 112.554 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 84.25 56.64 0.01 OUTLIER 'General case' 0 C--O 1.239 0.529 0 C-N-CA 128.291 2.636 . . . . 0.0 108.421 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -134.05 149.62 19.8 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-O 121.651 0.584 . . . . 0.0 112.773 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -58.68 140.01 55.25 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 128.325 2.65 . . . . 0.0 109.995 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 21.7 mm -69.16 137.03 25.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 121.16 0.505 . . . . 0.0 111.21 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.3 m -85.33 104.06 14.82 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -53.99 -28.87 40.58 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.123 0.969 . . . . 0.0 112.593 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 45.5 t -42.95 -48.76 1.2 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 125.882 1.673 . . . . 0.0 111.207 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 10.0 t -124.36 -35.21 2.81 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.294 1.038 . . . . 0.0 113.241 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 105.94 36.15 2.82 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.564 1.554 . . . . 0.0 109.238 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -114.37 152.24 31.79 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 118.463 1.131 . . . . 0.0 111.535 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -66.1 163.29 17.82 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 4.9 mmt85 -89.29 28.4 1.25 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 130.648 3.579 . . . . 0.0 112.452 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 6.1 ptm -73.32 175.31 7.01 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 121.763 2.074 . . . . 0.0 111.042 -177.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.81 153.01 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 125.289 1.436 . . . . 0.0 107.24 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -115.48 114.65 25.3 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.798 1.639 . . . . 0.0 106.951 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 12.0 mm -106.07 144.79 14.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.324 1.049 . . . . 0.0 109.138 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -125.65 98.46 5.58 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.609 1.564 . . . . 0.0 112.601 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . 0.558 ' CD1' HD13 ' A' ' 109' ' ' ILE . 54.4 m-85 -73.06 111.48 8.21 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.571 1.148 . . . . 0.0 108.003 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.479 HG12 ' HB3' ' A' ' 182' ' ' TYR . 25.4 m -125.24 163.63 25.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 C-N-CA 124.932 1.293 . . . . 0.0 109.018 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 48.7 t -85.12 146.7 27.0 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -102.03 22.39 38.28 Favored Glycine 0 N--CA 1.463 0.443 0 C-N-CA 124.361 0.981 . . . . 0.0 112.042 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 67.53 -142.0 39.78 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 50.9 m -74.48 -149.71 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 127.206 2.202 . . . . 0.0 111.066 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 15.9 m120 53.55 51.62 14.84 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.991 1.716 . . . . 0.0 110.777 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -41.39 100.14 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 128.107 2.563 . . . . 0.0 111.867 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -118.99 175.96 15.9 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 126.824 2.154 . . . . 0.0 110.138 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -64.18 -67.9 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.822 2.348 . . . . 0.0 109.866 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 2.3 p -171.19 145.57 2.24 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 126.961 2.104 . . . . 0.0 108.317 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 13.9 p -149.88 172.42 15.2 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.849 0.86 . . . . 0.0 110.207 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.462 HG21 HG23 ' A' ' 221' ' ' VAL . 4.1 mt -122.36 136.08 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 125.997 1.719 . . . . 0.0 107.27 177.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -77.61 -59.37 2.81 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.425 1.49 . . . . 0.0 107.94 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . 0.473 ' HA ' ' CE1' ' A' ' 120' ' ' TYR . 68.1 p-90 -159.88 162.57 34.62 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.38 1.472 . . . . 0.0 109.259 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.462 HG23 HG21 ' A' ' 218' ' ' ILE . 47.3 t -154.43 138.67 9.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 178.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.27 163.3 20.09 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.998 0.919 . . . . 0.0 110.474 178.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -71.53 143.12 50.05 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 178.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . 0.516 HG21 ' HG3' ' A' ' 230' ' ' GLU . 9.4 t -118.67 -35.95 3.59 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.541 1.136 . . . . 0.0 111.547 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.423 ' HG3' HG23 ' A' ' 224' ' ' THR . 10.7 mttt -129.51 -175.98 3.76 Favored 'General case' 0 C--O 1.22 -0.485 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 56.5 mt -53.35 -43.31 51.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -129.56 14.54 6.0 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.512 0.725 . . . . 0.0 112.159 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 15.8 t -115.84 142.7 28.03 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -177.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -123.76 159.8 28.69 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.362 1.065 . . . . 0.0 109.037 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . 0.516 ' HG3' HG21 ' A' ' 224' ' ' THR . 25.3 mt-10 -126.77 136.74 52.81 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.885 1.674 . . . . 0.0 107.824 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -137.27 146.66 45.0 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 125.814 1.646 . . . . 0.0 109.038 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -135.5 108.04 7.4 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' A' ' 218' ' ' ILE . 2.8 m -101.15 149.63 6.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 124.542 1.137 . . . . 0.0 108.622 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.12 128.6 46.45 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.94 0.896 . . . . 0.0 112.39 -178.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -131.83 147.88 67.71 Favored Pre-proline 0 C--O 1.234 0.249 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 177.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -72.45 -43.55 0.97 Allowed 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.225 1.95 . . . . 0.0 110.512 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -54.46 -23.92 18.12 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 125.424 1.49 . . . . 0.0 113.39 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 5.4 tp -62.24 -32.8 73.53 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 121.229 -0.919 . . . . 0.0 110.432 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 9.0 m -61.6 -12.3 15.18 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.666 1.186 . . . . 0.0 112.469 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.83 -31.28 70.7 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 123.391 0.676 . . . . 0.0 109.344 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 101' ' ' THR . 4.3 mm? -82.49 122.15 27.68 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 177.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -47.35 -44.36 23.88 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.823 1.649 . . . . 0.0 112.841 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 1.1 tp -68.06 -30.71 69.98 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 120.975 -1.078 . . . . 0.0 113.704 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 19.2 mt -93.61 -5.0 49.77 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.876 1.671 . . . . 0.0 111.841 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -67.22 119.77 12.66 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.004 1.321 . . . . 0.0 109.944 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.469 ' HE3' ' CG1' ' A' ' 179' ' ' VAL . 13.3 mmmm -71.3 174.27 6.69 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -78.31 -10.48 59.69 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.597 -0.689 . . . . 0.0 110.062 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -129.17 34.86 4.35 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 129.663 3.185 . . . . 0.0 110.148 -178.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 . . . . . 0 C--O 1.245 0.865 0 C-N-CA 125.65 1.58 . . . . 0.0 111.823 179.002 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.145 0 N-CA-C 108.841 -1.704 . . . . 0.0 108.841 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -117.94 90.4 3.32 Favored 'General case' 0 C--N 1.334 -0.09 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.0 m 60.43 24.6 14.17 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.757 0.823 . . . . 0.0 112.316 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 21.4 m120 51.8 47.39 24.88 Favored 'General case' 0 C--N 1.344 0.342 0 C-N-CA 125.736 1.614 . . . . 0.0 107.701 -177.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.9 p -47.17 -38.04 11.17 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 126.576 1.95 . . . . 0.0 112.334 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -68.86 -32.21 71.72 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.641 1.576 . . . . 0.0 110.79 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.06 -52.76 9.51 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 178.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.421 ' HA ' HD12 ' A' ' 98' ' ' LEU . 0.6 OUTLIER -56.86 -39.35 74.14 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 119.767 1.167 . . . . 0.0 110.353 179.048 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.22 -51.17 69.06 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.782 0.833 . . . . 0.0 108.942 178.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 35.4 tp -67.22 -40.03 86.36 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.826 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 95' ' ' THR . 41.4 mt -59.66 -54.55 45.07 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 119.514 1.052 . . . . 0.0 109.889 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 52.5 m -62.68 -44.84 95.23 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.132 0.973 . . . . 0.0 110.358 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.4 tmmm? -60.83 -50.92 71.47 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.713 -0.617 . . . . 0.0 109.934 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.1 m -53.82 -44.29 70.11 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 123.873 0.869 . . . . 0.0 109.862 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.12 -45.9 92.78 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.689 0.677 . . . . 0.0 109.76 178.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.87 -61.7 2.32 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 124.573 1.149 . . . . 0.0 113.71 -178.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.98 -34.46 78.15 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 119.118 -0.468 . . . . 0.0 110.558 -178.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.34 -53.08 48.58 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.595 ' HA ' HD12 ' A' ' 109' ' ' ILE . 40.3 t -57.52 -51.57 68.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-N 118.909 1.355 . . . . 0.0 111.471 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 7.6 pttp -60.39 -33.68 72.82 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.849 -179.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 35.5 m -76.33 -30.89 57.84 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 122.235 0.214 . . . . 0.0 111.095 -178.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.595 HD12 ' HA ' ' A' ' 106' ' ' VAL . 16.1 mt -61.83 -54.97 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -62.45 -33.5 74.94 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.901 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -60.23 -35.56 75.73 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.178 0.899 . . . . 0.0 110.942 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.1 tptp -80.27 -53.67 6.43 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 28.8 mt -57.02 -28.79 62.8 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -178.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -49.35 -26.0 2.84 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.881 1.272 . . . . 0.0 112.908 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -61.33 -63.3 1.33 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.181 0.992 . . . . 0.0 112.511 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.7 mmm-85 -154.62 178.82 9.67 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.088 1.755 . . . . 0.0 110.049 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 63.4 m -86.62 174.05 9.14 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 38.5 pt -127.92 157.54 39.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 125.762 1.625 . . . . 0.0 108.778 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -151.57 145.23 24.98 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.847 1.259 . . . . 0.0 109.609 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -140.23 120.91 14.31 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.191 0.596 . . . . 0.0 111.551 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -79.22 104.61 9.96 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 178.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.06 79.97 3.6 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 57.8 -109.14 1.66 Allowed Glycine 0 CA--C 1.53 1.023 0 C-N-CA 123.992 0.806 . . . . 0.0 111.121 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -72.27 -35.96 68.87 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 118.704 -0.665 . . . . 0.0 112.281 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -99.8 168.68 9.75 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 119.336 0.971 . . . . 0.0 112.702 -177.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.4 mp -136.51 133.82 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 N-CA-C 104.059 -2.571 . . . . 0.0 104.059 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -111.68 119.98 40.49 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -117.88 124.78 49.15 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.256 0.622 . . . . 0.0 109.437 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -117.78 136.22 53.54 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.436 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.451 ' HB3' HD13 ' A' ' 133' ' ' ILE . 17.8 m -113.78 154.61 45.79 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 124.184 0.994 . . . . 0.0 111.241 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -61.99 80.56 0.09 OUTLIER 'Trans proline' 0 C--N 1.351 0.661 1 C-N-CA 125.409 4.072 . . . . 0.0 116.383 -177.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 72.95 41.74 47.57 Favored Glycine 0 CA--C 1.529 0.934 0 O-C-N 120.836 -1.165 . . . . 0.0 111.258 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.451 HD13 ' HB3' ' A' ' 130' ' ' CYS . 3.9 mp -122.93 -69.43 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.32 0 CA-C-N 118.207 1.004 . . . . 0.0 108.553 179.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -164.29 169.62 17.28 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.235 1.014 . . . . 0.0 109.849 -178.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -133.06 118.32 18.63 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 176.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.7 m -135.85 164.63 31.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 125.229 1.412 . . . . 0.0 112.327 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -125.23 123.29 39.22 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.546 1.938 . . . . 0.0 108.514 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -138.31 162.56 34.06 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.561 1.145 . . . . 0.0 110.987 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.457 ' H ' ' CD1' ' A' ' 156' ' ' LEU . 84.0 t60 -105.54 130.59 53.56 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 178.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 164.28 -159.15 31.99 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 108.476 -1.85 . . . . 0.0 108.476 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.89 159.72 43.55 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 118.757 1.279 . . . . 0.0 109.916 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.2 p -115.26 160.2 14.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 124.498 1.119 . . . . 0.0 108.578 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -105.49 110.06 22.26 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 104.24 -2.504 . . . . 0.0 104.24 177.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 17.5 p -55.27 -26.23 38.76 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 120.367 1.44 . . . . 0.0 112.762 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -61.43 -56.42 20.43 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 123.863 0.865 . . . . 0.0 111.694 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 36.6 p -93.54 -30.21 15.11 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.686 1.594 . . . . 0.0 113.332 -177.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.87 27.22 51.19 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 126.027 1.775 . . . . 0.0 112.604 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.54 151.8 38.02 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.42 1.088 . . . . 0.0 109.579 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 12.4 mm -71.23 150.97 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 29.3 m -66.5 -22.69 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 176.08 149.31 0.12 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.632 2.773 . . . . 0.0 107.519 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -88.23 114.5 24.91 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 119.443 1.019 . . . . 0.0 108.516 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.62 82.74 5.69 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -65.09 -17.4 64.43 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.344 0.657 . . . . 0.0 112.052 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 19.1 m -67.22 -10.21 48.19 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.842 1.657 . . . . 0.0 112.117 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.457 ' CD1' ' H ' ' A' ' 139' ' ' HIS . 71.1 mt -104.3 133.01 49.93 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 104.268 -2.493 . . . . 0.0 104.268 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.9 m -128.88 116.39 40.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -144.51 154.92 43.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.073 1.349 . . . . 0.0 109.163 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -149.36 115.95 5.88 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 178.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 26.5 mt -100.14 -24.81 14.48 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 159.89 161.72 11.59 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-O 122.545 1.081 . . . . 0.0 112.199 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.416 ' N ' HG22 ' A' ' 187' ' ' ILE . 38.9 ttpt -124.02 109.46 29.67 Favored Pre-proline 0 N--CA 1.43 -1.429 0 C-N-CA 125.01 1.324 . . . . 0.0 111.737 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -74.86 157.23 43.49 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 123.726 2.951 . . . . 0.0 109.223 177.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -92.73 157.54 16.39 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.791 -0.568 . . . . 0.0 109.54 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.62 -47.8 74.38 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.3 0.64 . . . . 0.0 111.572 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -74.74 64.89 1.29 Allowed 'General case' 0 N--CA 1.461 0.102 0 C-N-CA 126.701 2.001 . . . . 0.0 113.162 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.4 p -47.55 -31.82 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 124.382 1.073 . . . . 0.0 112.969 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -64.85 -32.44 74.15 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 122.401 1.095 . . . . 0.0 112.283 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -87.78 -15.1 37.88 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.165 1.386 . . . . 0.0 111.173 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -80.74 133.58 35.69 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -98.78 149.2 23.11 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -134.41 169.98 16.43 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.087 1.355 . . . . 0.0 108.565 -178.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -120.77 152.97 37.65 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 122.908 0.483 . . . . 0.0 109.791 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 14.2 tp -110.59 110.62 21.4 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 125.417 1.487 . . . . 0.0 107.384 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.575 HD23 ' HB2' ' A' ' 184' ' ' SER . 2.6 mm? -123.65 -179.23 4.28 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 127.316 2.246 . . . . 0.0 108.595 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -144.69 167.97 21.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.435 0.636 . . . . 0.0 111.005 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -140.64 -176.11 4.53 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 126.734 2.014 . . . . 0.0 107.646 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -64.04 -11.87 33.36 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 121.386 -0.821 . . . . 0.0 112.965 -177.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 85.0 t -106.23 -36.42 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 124.62 1.168 . . . . 0.0 112.485 -178.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 169.4 -173.62 43.74 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 119.389 0.995 . . . . 0.0 112.476 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.419 ' CD2' ' HB3' ' A' ' 243' ' ' LEU . 5.1 m-30 -79.97 162.97 24.62 Favored 'General case' 0 C--O 1.241 0.654 0 O-C-N 122.107 -0.643 . . . . 0.0 110.125 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -159.22 168.96 25.18 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.501 -1.227 . . . . 0.0 112.053 -179.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 92.1 mt -104.74 127.5 59.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.575 ' HB2' HD23 ' A' ' 175' ' ' LEU . 22.5 t -100.07 115.08 28.93 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.915 1.286 . . . . 0.0 108.802 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -111.83 107.01 15.91 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -89.54 111.84 23.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.447 0 N-CA-C 103.455 -2.795 . . . . 0.0 103.455 177.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.416 HG22 ' N ' ' A' ' 162' ' ' LYS . 6.7 mt -95.87 106.64 18.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.01 -157.42 26.29 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.0 t 85.29 3.61 0.62 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 127.667 2.387 . . . . 0.0 108.679 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -63.74 136.78 41.5 Favored Glycine 0 N--CA 1.435 -1.411 0 N-CA-C 108.256 -1.937 . . . . 0.0 108.256 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.26 148.25 27.9 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.469 1.108 . . . . 0.0 108.842 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.8 mm -70.37 130.76 34.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 122.863 1.316 . . . . 0.0 113.893 -177.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.3 m -85.46 107.5 17.45 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 128.448 2.699 . . . . 0.0 108.171 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -53.74 -18.38 3.09 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 127.963 2.505 . . . . 0.0 113.436 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 18.0 t -56.24 -54.77 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 125.935 1.694 . . . . 0.0 109.805 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 13.3 t -123.75 -29.68 3.67 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.189 0.996 . . . . 0.0 112.49 -178.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 104.6 35.75 3.21 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -115.48 160.1 20.35 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.282 1.541 . . . . 0.0 111.9 -178.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -77.54 151.43 34.53 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 118.867 0.758 . . . . 0.0 112.996 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -71.0 28.65 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.667 1 C-N-CA 132.129 4.172 . . . . 0.0 109.988 177.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 7.0 ptm -73.47 173.78 9.15 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 122.617 1.199 . . . . 0.0 112.002 -176.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.08 147.04 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 124.488 1.115 . . . . 0.0 108.733 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -106.83 104.37 14.04 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 125.635 1.574 . . . . 0.0 107.241 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 12.6 mm -93.24 147.21 5.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -126.84 101.75 6.73 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.008 1.723 . . . . 0.0 107.638 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . 0.509 ' CD1' HD13 ' A' ' 109' ' ' ILE . 40.9 m-85 -84.34 111.15 19.17 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 6.4 m -125.13 168.13 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.718 0.77 . . . . 0.0 109.605 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 49.8 t -87.88 142.15 28.03 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -88.49 -0.69 81.89 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-O 118.464 -1.187 . . . . 0.0 113.07 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 61.11 57.33 19.09 Favored Glycine 0 C--N 1.339 0.739 0 N-CA-C 107.31 -2.316 . . . . 0.0 107.31 -178.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 11.7 m -135.62 143.54 45.61 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -73.38 -37.46 65.99 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 119.566 -0.254 . . . . 0.0 111.255 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 75.8 p -148.78 -176.02 5.17 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 118.53 0.604 . . . . 0.0 110.693 -178.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 121.94 -179.82 16.14 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 124.047 0.832 . . . . 0.0 115.087 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -78.88 -113.67 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 124.053 3.169 . . . . 0.0 110.973 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 19.0 p -160.21 147.7 16.34 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 120.624 -1.298 . . . . 0.0 108.951 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 82.8 p -148.04 166.43 27.79 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.632 0.773 . . . . 0.0 109.31 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 3.4 mt -105.47 149.51 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 177.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -99.1 -44.95 6.09 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.653 0.781 . . . . 0.0 112.29 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 66.9 p-90 -163.63 155.12 16.79 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.15 1.78 . . . . 0.0 107.51 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 59.1 t -151.96 131.54 3.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 C-N-CA 125.565 1.546 . . . . 0.0 107.479 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.78 163.43 36.73 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.185 0.902 . . . . 0.0 111.848 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -77.74 129.07 35.03 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 104.02 -2.585 . . . . 0.0 104.02 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . 0.435 HG23 ' HG3' ' A' ' 225' ' ' LYS . 9.8 t -108.55 -28.33 9.37 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.886 1.275 . . . . 0.0 113.089 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.435 ' HG3' HG23 ' A' ' 224' ' ' THR . 59.1 mttt -135.9 -176.05 4.17 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 124.468 1.107 . . . . 0.0 108.621 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 68.9 mt -47.86 -47.49 12.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.591 -0.732 . . . . 0.0 112.365 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 3.7 t -133.06 18.08 4.11 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.131 1.373 . . . . 0.0 111.372 -178.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 22.0 t -114.96 142.48 27.64 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -178.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -121.29 162.94 19.38 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.202 1.401 . . . . 0.0 107.226 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -135.47 143.57 45.93 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 179.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -142.8 150.14 39.57 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -137.6 122.41 18.79 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 104.33 -2.47 . . . . 0.0 104.33 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 3.5 m -119.09 150.74 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -178.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.3 p -120.94 132.82 55.17 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.149 0.98 . . . . 0.0 111.608 -178.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 6.6 pt -138.32 154.85 74.09 Favored Pre-proline 0 N--CA 1.453 -0.278 0 C-N-CA 125.317 1.447 . . . . 0.0 109.205 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -76.08 -49.93 0.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.256 2.638 . . . . 0.0 112.296 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -53.01 -15.83 0.9 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 118.002 2.593 . . . . 0.0 118.002 -176.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 22.9 mt -77.52 -26.89 51.51 Favored 'General case' 0 CA--C 1.517 -0.308 0 O-C-N 120.958 -1.089 . . . . 0.0 109.648 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 5.8 m -56.13 -21.37 22.07 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.112 0.965 . . . . 0.0 111.724 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -59.49 -36.07 75.34 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.635 1.174 . . . . 0.0 109.347 178.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.58 125.2 30.24 Favored 'General case' 0 CA--C 1.521 -0.164 0 O-C-N 120.941 -1.1 . . . . 0.0 108.322 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -47.49 -48.83 26.94 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -178.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.419 ' HB3' ' CD2' ' A' ' 181' ' ' TYR . 22.5 mt -68.58 -26.87 65.6 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -178.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 13.8 mt -91.97 -13.47 31.02 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.219 0.608 . . . . 0.0 112.291 -178.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -58.15 141.83 49.15 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 128.283 2.633 . . . . 0.0 113.061 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp -115.72 172.02 7.39 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 127.659 2.383 . . . . 0.0 110.093 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -70.04 -33.01 71.41 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.658 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -87.4 55.22 3.43 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.813 1.645 . . . . 0.0 107.4 179.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 38.2 t70 . . . . . 0 C--O 1.249 1.027 0 C-N-CA 124.775 1.23 . . . . 0.0 110.489 179.851 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.884 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.13 -161.7 0.43 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.3 m -57.65 164.41 2.06 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.048 0.939 . . . . 0.0 110.813 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -56.29 142.76 36.55 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.51 1.124 . . . . 0.0 108.193 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.3 m -52.62 -30.68 32.64 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.241 1.016 . . . . 0.0 113.106 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -70.54 -51.44 28.65 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 123.872 0.869 . . . . 0.0 108.952 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -54.06 -50.89 65.73 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.549 HG22 HD12 ' A' ' 98' ' ' LEU . 0.7 OUTLIER -65.72 -32.72 74.42 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 179.844 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.89 -39.26 93.78 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 56.4 tp -63.58 -38.26 90.46 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.549 HD12 HG22 ' A' ' 95' ' ' THR . 64.8 mt -59.37 -54.55 45.45 Favored 'General case' 0 C--N 1.345 0.381 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.0 m -64.06 -45.98 86.38 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.889 0.476 . . . . 0.0 111.755 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.54 -47.61 79.07 Favored 'General case' 0 CA--C 1.516 -0.362 0 O-C-N 121.397 -0.815 . . . . 0.0 109.632 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 91.7 m -55.15 -47.3 75.31 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.358 0.663 . . . . 0.0 110.703 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -56.73 -47.0 80.97 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 123.438 0.462 . . . . 0.0 110.007 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.37 -56.93 6.05 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.854 0.835 . . . . 0.0 112.52 -178.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -56.96 -42.04 79.41 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 125.058 1.343 . . . . 0.0 110.651 -178.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.68 -52.79 39.53 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-O 117.673 -1.626 . . . . 0.0 109.594 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.452 ' HA ' HD12 ' A' ' 109' ' ' ILE . 50.8 t -55.89 -45.62 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 120.155 1.978 . . . . 0.0 110.485 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.2 pttp -61.3 -35.83 78.43 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.193 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 51.8 m -75.14 -36.69 61.54 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.898 0.879 . . . . 0.0 110.301 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.452 HD12 ' HA ' ' A' ' 106' ' ' VAL . 20.0 mt -59.17 -55.04 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -60.0 -34.22 73.03 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 124.066 0.854 . . . . 0.0 111.726 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -63.42 -37.75 88.51 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -178.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.8 mmmt -86.07 -42.79 13.64 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 19.2 mt -61.73 -29.19 69.95 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-O 117.808 -1.092 . . . . 0.0 111.685 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -47.83 -30.79 4.32 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.704 2.002 . . . . 0.0 111.807 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -64.85 -70.34 0.24 Allowed 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 122.813 0.445 . . . . 0.0 111.544 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -145.35 -178.62 6.16 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.628 1.171 . . . . 0.0 112.275 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 60.2 m -86.82 171.2 11.05 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 27.3 pt -121.91 160.35 23.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 127.087 2.155 . . . . 0.0 107.41 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -156.4 134.8 11.47 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.043 0.537 . . . . 0.0 111.957 -178.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -132.09 121.21 23.45 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.65 0.78 . . . . 0.0 110.562 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -87.95 99.44 12.14 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.41 80.71 6.72 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 127.363 2.265 . . . . 0.0 108.952 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.17 -111.53 4.08 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 108.158 -1.977 . . . . 0.0 108.158 -179.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -85.88 -24.4 26.67 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -100.53 159.4 15.18 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 119.551 1.069 . . . . 0.0 111.851 -178.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.2 mp -132.73 140.9 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.456 ' CD1' HG11 ' A' ' 221' ' ' VAL . 88.5 m-85 -121.72 119.55 32.09 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -107.5 116.44 31.94 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.189 0.595 . . . . 0.0 110.087 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -109.27 129.19 55.52 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 122.03 -0.419 . . . . 0.0 110.673 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.41 ' HB3' HD13 ' A' ' 133' ' ' ILE . 52.3 m -110.95 155.9 41.68 Favored Pre-proline 0 N--CA 1.446 -0.641 0 C-N-CA 127.266 2.226 . . . . 0.0 113.312 -178.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.26 70.75 0.15 Allowed 'Trans proline' 0 CA--C 1.542 0.904 1 C-N-CA 125.647 4.231 . . . . 0.0 114.717 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 68.57 57.51 8.06 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 120.466 -1.396 . . . . 0.0 110.911 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.41 HD13 ' HB3' ' A' ' 130' ' ' CYS . 2.0 mp -124.65 -71.72 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.303 0 CA-C-N 118.333 1.067 . . . . 0.0 109.251 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -175.21 138.29 0.42 Allowed 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -109.8 125.22 52.5 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.984 0.811 . . . . 0.0 109.722 -176.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 20.0 m -142.9 163.97 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.795 1.238 . . . . 0.0 111.637 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -122.13 129.6 52.48 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.222 1.409 . . . . 0.0 108.266 178.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -139.13 162.96 33.67 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.017 0.927 . . . . 0.0 112.074 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 53.1 t60 -84.85 160.87 20.1 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 177.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 136.62 -159.42 24.49 Favored Glycine 0 C--N 1.338 0.653 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -152.24 167.12 29.61 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 128.126 2.57 . . . . 0.0 106.792 178.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.4 p -128.32 150.92 34.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 119.456 1.025 . . . . 0.0 109.544 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -106.03 106.89 17.62 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 178.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 13.5 p -52.22 -29.29 21.99 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.676 1.191 . . . . 0.0 112.597 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 43.2 mmtt -57.12 -27.93 62.25 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 127.465 2.306 . . . . 0.0 113.044 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.2 p -122.98 -47.73 2.03 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 124.609 1.164 . . . . 0.0 110.075 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 100.84 28.16 7.11 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.404 1.478 . . . . 0.0 110.15 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -124.83 147.44 48.75 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 124.688 1.195 . . . . 0.0 110.317 -179.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 9.4 mm -70.4 148.26 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 21.6 m -70.62 -10.75 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 121.57 -0.706 . . . . 0.0 112.517 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -161.29 169.29 22.4 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 125.976 1.71 . . . . 0.0 109.38 -179.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 89.2 mtm-85 -94.32 -31.71 13.93 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 120.412 1.46 . . . . 0.0 108.379 177.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 56.49 36.47 27.61 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.596 1.558 . . . . 0.0 109.066 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -47.87 -27.89 2.35 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 128.025 2.53 . . . . 0.0 114.495 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 49.5 m -59.57 -34.46 72.73 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.497 -0.752 . . . . 0.0 111.136 178.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 69.1 mt -81.23 66.28 6.7 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.453 1.501 . . . . 0.0 108.703 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 3.0 p -74.08 107.75 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -122.71 158.36 30.27 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 125.703 1.601 . . . . 0.0 107.395 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -140.86 134.01 29.46 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 58.7 mt -119.92 -26.25 5.65 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 125.286 1.616 . . . . 0.0 108.031 178.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 156.13 154.61 7.05 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 119.543 1.065 . . . . 0.0 111.096 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -117.57 109.95 41.23 Favored Pre-proline 0 C--O 1.236 0.347 0 C-N-CA 124.138 0.975 . . . . 0.0 108.412 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -73.3 -169.44 0.52 Allowed 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 124.003 3.135 . . . . 0.0 109.445 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -126.86 156.32 41.55 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.833 1.253 . . . . 0.0 108.549 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.44 -45.29 39.61 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.361 0.664 . . . . 0.0 111.247 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -74.9 65.75 1.45 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.602 1.561 . . . . 0.0 111.518 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.3 p -45.55 -35.09 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 124.762 1.225 . . . . 0.0 112.52 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -63.9 -36.43 83.91 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -178.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -74.31 -15.84 60.95 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.746 0.819 . . . . 0.0 113.046 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 20.5 mtp-105 -78.22 178.17 7.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 122.096 0.951 . . . . 0.0 110.097 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -127.27 144.6 51.01 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 178.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -132.22 165.95 22.97 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -123.89 147.74 47.42 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 16.0 tp -114.58 98.06 6.66 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -112.25 -179.26 3.63 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 127.856 2.463 . . . . 0.0 106.757 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -149.4 165.22 32.72 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.617 0.722 . . . . 0.0 109.446 178.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -135.88 179.64 6.22 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 126.654 1.981 . . . . 0.0 110.513 -178.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.26 -18.75 63.89 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.904 1.282 . . . . 0.0 109.656 178.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 25.6 t -87.24 -25.3 6.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 129.771 3.228 . . . . 0.0 111.805 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 132.87 -167.95 23.07 Favored Glycine 0 N--CA 1.444 -0.779 0 O-C-N 121.279 -0.888 . . . . 0.0 111.701 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -77.71 163.31 26.29 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 121.841 -0.8 . . . . 0.0 110.367 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -160.73 167.36 27.03 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.635 1.174 . . . . 0.0 111.082 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 83.9 mt -106.15 138.28 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 17.4 t -113.01 135.15 54.09 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.041 0.937 . . . . 0.0 109.052 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -127.22 110.88 13.32 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 125.815 1.646 . . . . 0.0 108.57 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -93.52 111.49 24.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 7.5 mt -98.45 108.28 21.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 179.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -94.63 -153.28 30.14 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 66.6 m 66.19 54.73 0.94 Allowed 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.208 1.003 . . . . 0.0 112.912 178.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.423 ' HA3' ' HB3' ' A' ' 200' ' ' ARG . . . -102.02 -137.84 9.83 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -140.58 128.8 22.32 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 177.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 28.8 mm -60.21 132.3 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 121.911 0.862 . . . . 0.0 111.743 -178.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 3.0 m -84.92 111.34 19.58 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 128.101 2.56 . . . . 0.0 109.245 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.76 -19.58 11.73 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.125 1.77 . . . . 0.0 113.774 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 60.9 t -56.62 -51.75 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 124.652 1.181 . . . . 0.0 110.33 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 13.9 t -125.12 -25.1 3.89 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 99.0 35.51 4.79 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 107.556 -2.218 . . . . 0.0 107.556 -178.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -103.98 152.52 21.91 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 118.519 1.16 . . . . 0.0 113.732 -178.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -78.42 138.94 38.74 Favored 'General case' 0 C--N 1.335 -0.052 0 C-N-CA 124.025 0.93 . . . . 0.0 109.152 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.423 ' HB3' ' HA3' ' A' ' 190' ' ' GLY 0.3 34.3 ttt180 -69.94 30.52 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 130.705 3.602 . . . . 0.0 113.598 178.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 5.2 ptm -74.18 171.92 12.71 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.056 -1.028 . . . . 0.0 109.216 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.77 148.79 22.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 C-N-CA 124.679 1.191 . . . . 0.0 107.819 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -110.17 116.39 31.43 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 14.4 mm -103.97 141.08 20.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -124.43 110.09 14.1 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 126.067 1.747 . . . . 0.0 109.774 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -87.31 110.85 20.51 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.479 1.111 . . . . 0.0 108.875 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 11.2 m -123.11 163.66 21.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 46.1 t -88.07 146.58 25.38 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -97.86 16.91 59.62 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-O 117.914 -1.492 . . . . 0.0 113.057 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 45.5 28.39 2.33 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 126.646 2.07 . . . . 0.0 113.875 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.0 151.49 19.49 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.08 -1.247 . . . . 0.0 108.375 -179.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -61.22 -42.46 98.64 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 122.983 0.513 . . . . 0.0 111.613 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 57.7 m -161.91 176.93 10.3 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 128.862 2.865 . . . . 0.0 107.474 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 149.1 176.41 22.36 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 121.071 -1.018 . . . . 0.0 113.018 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -79.1 -99.14 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 124.322 3.348 . . . . 0.0 110.145 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 4.6 p -166.88 148.27 6.02 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 127.055 2.142 . . . . 0.0 107.34 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 10.4 p -154.39 165.97 34.72 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.182 1.393 . . . . 0.0 109.556 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 4.9 mt -108.54 153.81 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 126.567 1.947 . . . . 0.0 106.592 178.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -101.1 -52.21 3.33 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 123.44 0.696 . . . . 0.0 110.484 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 58.9 p-90 -157.07 157.32 34.36 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -178.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.456 HG11 ' CD1' ' A' ' 127' ' ' TYR . 91.3 t -153.16 122.56 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -178.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.22 167.5 29.6 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.511 1.05 . . . . 0.0 110.784 178.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -73.07 132.05 42.85 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 6.7 t -109.35 -38.59 5.45 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.427 1.091 . . . . 0.0 110.22 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 6.7 mttt -130.92 178.57 6.57 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 73.1 mt -49.51 -46.98 20.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -126.19 22.32 7.24 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 6.5 t -122.86 138.64 52.25 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.545 0 O-C-N 121.191 -0.943 . . . . 0.0 110.081 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -120.97 162.26 20.2 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -132.53 145.71 51.35 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.24 119.36 8.26 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.218 1.007 . . . . 0.0 108.471 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -107.36 126.93 53.08 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 4.0 m -118.14 154.38 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-N 117.717 0.235 . . . . 0.0 110.797 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 2.3 p -121.56 124.82 45.31 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.33 1.052 . . . . 0.0 110.911 -177.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 2.3 pt -136.84 129.49 17.29 Favored Pre-proline 0 N--CA 1.444 -0.728 0 CA-C-N 114.922 -1.035 . . . . 0.0 108.831 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -64.85 -31.12 57.82 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.065 2.51 . . . . 0.0 113.388 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -64.25 -14.13 53.74 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -177.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 44.6 mt -76.88 -31.03 56.48 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 120.475 -1.391 . . . . 0.0 109.908 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 15.6 m -55.88 -12.06 1.24 Allowed 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -70.42 -32.04 69.48 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 121.497 -0.752 . . . . 0.0 110.043 179.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.9 mt -80.71 123.16 27.96 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.669 1.988 . . . . 0.0 106.671 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -47.51 -48.09 27.44 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.074 1.349 . . . . 0.0 114.081 -178.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 56.1 mt -66.65 -32.53 73.91 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 119.298 0.954 . . . . 0.0 112.847 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 15.9 mt -91.68 -5.57 53.53 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -65.31 134.42 53.54 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 127.55 2.34 . . . . 0.0 110.3 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -107.24 152.45 24.08 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 125.214 1.406 . . . . 0.0 111.146 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -89.98 -47.27 7.96 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.231 -0.895 . . . . 0.0 113.211 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -146.43 26.59 1.16 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -177.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 30.0 t70 . . . . . 0 C--O 1.242 0.675 0 CA-C-O 117.869 -1.062 . . . . 0.0 108.342 179.04 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.373 0 N-CA-C 106.675 -2.57 . . . . 0.0 106.675 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.75 57.72 3.52 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 104.535 -2.395 . . . . 0.0 104.535 177.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . 0.273 14.4 m -58.12 -11.41 2.56 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.996 2.118 . . . . 0.0 115.765 -177.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -68.55 -48.8 63.32 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 176.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 75.4 m -62.05 -35.87 79.9 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 125.053 1.341 . . . . 0.0 110.41 178.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -62.98 -34.85 78.4 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.547 -0.721 . . . . 0.0 111.004 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -78.12 -48.12 16.68 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 118.303 -0.856 . . . . 0.0 109.319 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.2 p -57.15 -31.62 65.55 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-N 118.999 0.818 . . . . 0.0 111.632 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.54 -43.63 84.53 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 53.1 tp -68.28 -36.7 79.79 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-O 118.459 -0.782 . . . . 0.0 109.401 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.456 HD23 HD11 ' A' ' 243' ' ' LEU . 60.5 mt -60.26 -54.69 42.78 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 118.935 0.789 . . . . 0.0 109.694 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 50.9 m -58.78 -49.12 78.87 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.314 1.046 . . . . 0.0 109.845 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.22 -44.69 96.86 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 118.095 -0.955 . . . . 0.0 110.905 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 63.0 m -52.33 -49.3 64.54 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 119.286 0.948 . . . . 0.0 110.682 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -55.38 -50.73 68.94 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 122.744 0.417 . . . . 0.0 110.101 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.36 -55.49 15.63 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 115.151 1.538 . . . . 0.0 115.151 -178.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -64.94 -38.1 89.84 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.497 1.119 . . . . 0.0 110.648 -177.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.551 ' HA3' HD11 ' A' ' 183' ' ' ILE . . . -61.03 -52.57 51.42 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.526 ' HA ' HD12 ' A' ' 109' ' ' ILE . 54.2 t -57.37 -44.88 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 118.671 1.236 . . . . 0.0 109.72 178.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -61.7 -35.78 79.02 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 118.53 -1.268 . . . . 0.0 111.643 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 59.3 m -65.64 -46.43 79.22 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -178.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 106' ' ' VAL . 19.3 mt -56.92 -54.96 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 CA-C-O 121.568 0.699 . . . . 0.0 109.738 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -64.61 -27.81 69.19 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -62.61 -42.73 99.75 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -83.25 -43.16 16.37 Favored 'General case' 0 C--N 1.341 0.234 0 O-C-N 121.278 -0.889 . . . . 0.0 113.038 -179.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.4 mt -62.87 -27.38 69.31 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.099 0.863 . . . . 0.0 113.243 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -44.38 -33.86 1.8 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.484 1.514 . . . . 0.0 113.825 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -64.43 -69.5 0.28 Allowed 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.909 1.283 . . . . 0.0 113.944 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 -140.07 172.58 12.55 Favored 'General case' 0 CA--C 1.518 -0.27 0 O-C-N 121.097 -1.002 . . . . 0.0 112.979 -177.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 37.7 m -87.13 160.7 18.45 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 178.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 34.9 pt -114.37 157.03 15.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 124.906 1.282 . . . . 0.0 107.544 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -151.4 134.29 15.75 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 123.801 0.84 . . . . 0.0 109.263 -178.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.615 ' CE1' ' HB2' ' A' ' 122' ' ' ALA . 21.7 t80 -133.16 120.95 21.87 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 123.741 0.817 . . . . 0.0 111.615 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -84.48 101.41 12.02 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.542 1.137 . . . . 0.0 108.614 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.615 ' HB2' ' CE1' ' A' ' 120' ' ' TYR . . . -94.75 80.34 3.76 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.04 -124.65 20.51 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -70.97 -31.2 67.69 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 48.0 m95 -99.83 152.02 20.61 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 118.546 0.612 . . . . 0.0 110.344 -178.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.7 mp -125.15 144.73 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 104.481 -2.415 . . . . 0.0 104.481 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -122.12 119.68 32.04 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -178.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -113.63 126.51 55.35 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.918 0.887 . . . . 0.0 109.091 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -124.98 126.77 45.97 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.424 0.69 . . . . 0.0 109.801 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.461 ' HB3' HD13 ' A' ' 133' ' ' ILE . 15.0 m -104.46 155.96 36.57 Favored Pre-proline 0 CA--C 1.532 0.257 0 C-N-CA 123.929 0.892 . . . . 0.0 111.47 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -63.13 83.25 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 124.385 3.39 . . . . 0.0 114.597 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.38 42.96 63.81 Favored Glycine 0 CA--C 1.526 0.77 0 O-C-N 120.776 -1.202 . . . . 0.0 113.079 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.461 HD13 ' HB3' ' A' ' 130' ' ' CYS . 3.6 mp -122.7 -70.25 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -161.86 168.52 22.9 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.849 1.259 . . . . 0.0 110.611 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -132.42 126.84 34.07 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 104.459 -2.422 . . . . 0.0 104.459 177.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.2 m -144.81 164.17 13.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 124.999 1.32 . . . . 0.0 112.321 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -130.24 118.77 21.86 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -137.9 162.82 33.04 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.871 1.668 . . . . 0.0 111.23 -178.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.453 ' H ' HD13 ' A' ' 156' ' ' LEU . 80.9 t60 -94.08 148.29 22.32 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 142.18 -170.62 24.92 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 125.301 1.429 . . . . 0.0 110.343 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.93 167.51 21.96 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 121.082 -1.246 . . . . 0.0 109.492 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.2 p -107.67 132.75 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 178.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -87.37 115.03 24.5 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 67.2 p -57.06 -22.41 38.95 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.018 0.927 . . . . 0.0 113.376 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.54 -49.42 76.4 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 124.344 1.058 . . . . 0.0 111.332 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 49.2 p -113.57 -22.64 10.2 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -176.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 79.31 34.78 31.63 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.453 1.025 . . . . 0.0 111.374 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -122.06 148.39 44.91 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.469 1.108 . . . . 0.0 109.742 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 24.0 mm -75.62 153.89 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 15.9 m -58.69 -34.76 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.315 1.046 . . . . 0.0 113.042 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 61.7 m-80 -155.18 152.69 29.69 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.77 1.628 . . . . 0.0 109.657 -179.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 -106.57 103.99 13.57 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 177.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 38.58 81.57 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 127.737 2.415 . . . . 0.0 111.729 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -60.95 -79.65 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 65.8 p -126.83 -1.42 6.64 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.753 1.621 . . . . 0.0 110.418 177.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.453 HD13 ' H ' ' A' ' 139' ' ' HIS . 67.6 mt -82.18 74.63 9.15 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 126.855 2.062 . . . . 0.0 111.135 -177.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 16.4 m -74.79 116.91 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 178.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -148.56 151.51 35.19 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.603 1.161 . . . . 0.0 108.691 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -145.45 136.87 25.08 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 124.69 1.196 . . . . 0.0 107.926 178.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.1 mp -116.15 -27.74 6.8 Favored 'General case' 0 C--O 1.221 -0.444 0 O-C-N 125.486 1.741 . . . . 0.0 107.277 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 157.3 163.45 12.55 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -126.97 110.24 21.92 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 124.03 0.932 . . . . 0.0 111.428 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -71.96 177.57 6.91 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.907 3.071 . . . . 0.0 109.274 178.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -121.1 146.67 46.49 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.31 -45.94 76.3 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.171 1.388 . . . . 0.0 112.178 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.432 HD22 ' CD ' ' A' ' 169' ' ' GLU . 48.8 m-20 -73.41 67.13 1.0 Allowed 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 127.581 2.353 . . . . 0.0 110.249 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.5 p -44.82 -32.74 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 O-C-N 121.196 -0.94 . . . . 0.0 113.385 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -65.25 -31.74 73.05 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 119.186 0.903 . . . . 0.0 111.671 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.432 ' CD ' HD22 ' A' ' 166' ' ' ASN . 98.0 mt-10 -71.74 -30.56 65.74 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 124.03 0.932 . . . . 0.0 110.049 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 25.7 mtt180 -69.08 152.46 45.17 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -114.06 143.12 45.29 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -129.63 168.06 17.02 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.159 1.384 . . . . 0.0 112.072 -177.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -133.62 154.67 50.71 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 124.884 1.274 . . . . 0.0 111.265 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 57.5 tp -109.23 98.63 8.03 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 127.28 2.232 . . . . 0.0 110.252 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.42 HD23 ' HB2' ' A' ' 184' ' ' SER . 2.1 mm? -112.17 -179.26 3.63 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 127.649 2.38 . . . . 0.0 108.581 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -141.7 166.29 25.15 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.188 0.518 . . . . 0.0 111.461 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -139.28 179.99 6.21 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 127.313 2.245 . . . . 0.0 108.39 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -57.4 -19.25 22.11 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.477 1.111 . . . . 0.0 112.389 -178.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 40.7 t -92.6 -54.84 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 O-C-N 120.651 -1.281 . . . . 0.0 110.43 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 178.7 -153.52 12.78 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -178.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.405 ' CD2' HD13 ' A' ' 243' ' ' LEU . 6.3 m-30 -86.64 168.79 13.29 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 122.43 1.109 . . . . 0.0 110.772 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -158.57 176.09 12.84 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.014 1.725 . . . . 0.0 109.559 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.551 HD11 ' HA3' ' A' ' 105' ' ' GLY . 89.3 mt -110.95 138.27 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 176.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.42 ' HB2' HD23 ' A' ' 175' ' ' LEU . 14.2 t -100.96 128.53 46.95 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -129.15 110.03 11.66 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -92.42 135.66 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 104.604 -2.369 . . . . 0.0 104.604 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 3.8 mt -112.74 106.2 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 104.782 -2.303 . . . . 0.0 104.782 176.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -99.32 -155.49 28.65 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.5 t 68.72 56.19 0.45 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-O 122.516 1.151 . . . . 0.0 111.766 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -131.82 157.07 22.23 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 128.401 2.905 . . . . 0.0 106.396 177.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -72.62 150.91 42.64 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.219 1.007 . . . . 0.0 112.273 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.9 mm -65.99 136.23 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-O 121.274 0.559 . . . . 0.0 110.379 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.5 m -79.87 115.52 19.5 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.707 2.003 . . . . 0.0 106.979 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -55.06 -21.7 13.39 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.863 1.265 . . . . 0.0 112.957 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 31.6 t -51.44 -61.16 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.205 0 C-N-CA 126.966 2.106 . . . . 0.0 112.24 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . 0.544 HG22 HG21 ' A' ' 226' ' ' ILE . 5.1 t -125.69 -24.12 3.9 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.318 1.047 . . . . 0.0 113.762 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 105.61 34.87 3.2 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -178.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -98.91 149.72 22.65 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 118.851 1.326 . . . . 0.0 112.112 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -74.71 141.04 44.52 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.942 0.897 . . . . 0.0 110.737 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -66.64 27.71 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 131.269 3.828 . . . . 0.0 113.882 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 8.2 ptm -75.14 177.09 6.7 Favored 'General case' 0 C--N 1.319 -0.743 0 O-C-N 120.788 -1.195 . . . . 0.0 111.787 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.0 p -147.18 153.62 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 126.612 1.965 . . . . 0.0 106.408 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -116.77 117.63 30.3 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.801 1.24 . . . . 0.0 108.324 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 9.2 mm -102.25 148.53 7.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -126.09 103.73 7.87 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 128.274 2.63 . . . . 0.0 108.97 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . 0.432 ' CD1' HD13 ' A' ' 109' ' ' ILE . 35.0 m-85 -83.25 109.8 17.54 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.967 1.307 . . . . 0.0 108.706 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 5.8 m -125.17 163.4 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 47.5 t -84.76 139.83 31.69 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 178.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -86.97 -0.07 85.87 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 118.369 -1.239 . . . . 0.0 112.7 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 58.71 59.24 11.15 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 3.6 m -138.3 148.73 44.96 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -64.17 -47.51 79.55 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -178.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 85.3 p -151.0 -176.15 5.42 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.06 0.944 . . . . 0.0 109.497 -179.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 129.95 172.55 13.17 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 124.804 1.192 . . . . 0.0 112.673 178.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -75.63 -104.06 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.745 2.963 . . . . 0.0 112.003 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.7 p -158.66 148.94 19.78 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.283 1.433 . . . . 0.0 108.751 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 1.7 p -152.62 170.51 20.04 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.423 1.089 . . . . 0.0 110.365 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 4.8 mt -113.17 154.37 14.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 126.406 1.883 . . . . 0.0 107.291 178.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -104.38 -46.6 4.35 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.886 0.875 . . . . 0.0 111.527 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -160.93 155.63 23.71 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.972 1.709 . . . . 0.0 107.781 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 59.9 t -154.05 123.56 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 125.68 1.592 . . . . 0.0 106.999 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -154.13 161.68 41.71 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 118.913 0.779 . . . . 0.0 111.21 179.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -69.18 136.99 52.9 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . 0.636 HG23 ' HG3' ' A' ' 225' ' ' LYS . 2.0 t -119.2 -28.75 5.37 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.199 1.0 . . . . 0.0 111.866 -179.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.636 ' HG3' HG23 ' A' ' 224' ' ' THR . 7.5 mttm -134.98 -176.66 4.32 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 124.123 0.969 . . . . 0.0 108.709 178.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.544 HG21 HG22 ' A' ' 196' ' ' THR . 1.9 mm -50.41 -48.98 25.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 123.346 0.659 . . . . 0.0 112.133 -178.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -128.13 23.56 6.04 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.373 1.469 . . . . 0.0 111.63 -178.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 14.1 t -127.47 146.37 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 CA-C-O 122.045 0.926 . . . . 0.0 110.367 -178.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -126.14 161.84 26.73 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . 0.48 ' CD ' HG21 ' A' ' 224' ' ' THR . 10.9 mt-10 -134.35 141.32 46.85 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -140.09 140.12 36.01 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 125.31 1.444 . . . . 0.0 110.233 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -120.47 114.35 21.65 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 2.5 m -107.87 148.1 12.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.4 p -122.17 135.93 54.84 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 123.567 0.747 . . . . 0.0 111.927 -178.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -140.6 152.25 65.68 Favored Pre-proline 0 N--CA 1.451 -0.402 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.074 177.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -74.91 -50.86 0.13 Allowed 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.496 2.797 . . . . 0.0 111.995 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -52.98 -27.13 17.69 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 117.606 -1.188 . . . . 0.0 113.911 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 238' ' ' LEU . 9.8 tp -59.23 -25.39 63.98 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 120.538 1.517 . . . . 0.0 112.258 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 3.4 m -64.74 -9.2 18.47 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.805 0.842 . . . . 0.0 111.963 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 42.5 p-10 -60.29 -40.3 89.95 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 125.337 1.455 . . . . 0.0 109.418 178.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -83.7 123.91 30.32 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 124.78 1.232 . . . . 0.0 108.591 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -47.18 -47.89 23.93 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.749 2.02 . . . . 0.0 113.31 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.456 HD11 HD23 ' A' ' 98' ' ' LEU . 40.6 mt -65.6 -20.09 66.17 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -178.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 5.2 mt -107.1 -11.75 15.56 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.176 1.39 . . . . 0.0 112.249 -178.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -63.29 131.12 47.3 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 128.479 2.712 . . . . 0.0 110.082 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt -100.5 166.48 10.9 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.237 1.015 . . . . 0.0 110.017 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -81.27 -8.83 59.82 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -178.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.17 30.52 4.77 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.67 1.188 . . . . 0.0 112.294 -177.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.252 1.198 0 C-N-CA 125.036 1.334 . . . . 0.0 107.423 177.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.917 0 CA-C-O 119.196 -0.78 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -118.16 -30.38 5.31 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 13.5 p -149.85 -74.29 0.17 Allowed 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -76.77 37.2 0.18 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.679 1.592 . . . . 0.0 109.57 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.7 t -64.5 -42.23 95.95 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 128.159 2.583 . . . . 0.0 110.607 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -65.36 -22.68 66.83 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 121.785 -0.572 . . . . 0.0 111.97 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.489 ' HE2' HD21 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -64.67 -56.39 14.09 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 178.14 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.72 -34.6 78.23 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 123.199 0.6 . . . . 0.0 111.012 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.54 -43.4 89.24 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 13.0 tp -69.71 -36.18 75.7 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.239 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.561 HD23 HD11 ' A' ' 243' ' ' LEU . 62.3 mt -59.13 -54.72 43.83 Favored 'General case' 0 C--N 1.343 0.288 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 20.7 m -65.37 -42.29 92.88 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 121.559 -0.713 . . . . 0.0 110.938 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.29 -42.4 95.39 Favored 'General case' 0 C--N 1.341 0.214 0 O-C-N 120.874 -1.141 . . . . 0.0 110.472 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 80.3 m -56.59 -46.45 80.81 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.776 0.83 . . . . 0.0 109.805 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -59.79 -45.14 93.25 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 118.233 0.47 . . . . 0.0 110.604 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -65.19 -61.11 2.33 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 122.26 1.029 . . . . 0.0 112.013 -178.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -62.3 -36.89 83.53 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.369 -178.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -65.6 -53.35 32.18 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-O 118.114 -1.381 . . . . 0.0 110.149 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.646 ' HA ' HD12 ' A' ' 109' ' ' ILE . 45.4 t -58.28 -44.16 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 119.913 1.857 . . . . 0.0 109.957 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.7 ptmt -64.74 -32.94 74.85 Favored 'General case' 0 C--O 1.226 -0.168 0 C-N-CA 119.604 -0.839 . . . . 0.0 111.695 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.6 m -76.08 -33.78 59.53 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 123.441 0.696 . . . . 0.0 109.738 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.646 HD12 ' HA ' ' A' ' 106' ' ' VAL . 16.6 mt -62.75 -55.52 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 178.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -61.92 -28.57 69.62 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 117.948 -1.025 . . . . 0.0 112.39 -179.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.64 -38.16 86.68 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.963 1.256 . . . . 0.0 112.656 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.416 ' HE3' ' CD ' ' A' ' 237' ' ' GLU . 0.6 OUTLIER -95.48 -37.48 10.88 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.491 -0.755 . . . . 0.0 110.847 179.538 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 15.8 mt -62.64 -28.35 69.86 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 118.66 0.664 . . . . 0.0 110.734 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -50.15 -34.71 23.23 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.613 1.165 . . . . 0.0 113.536 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -55.5 -61.74 2.15 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.735 1.214 . . . . 0.0 112.554 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -151.61 174.59 13.27 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.86 1.664 . . . . 0.0 110.761 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 56.7 m -86.61 170.94 11.4 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 114.006 -1.452 . . . . 0.0 108.684 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 29.6 pt -127.78 162.82 32.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 126.272 1.829 . . . . 0.0 109.004 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.72 145.28 22.24 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -136.87 125.7 24.09 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -88.88 108.04 19.32 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.075 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.37 80.3 3.93 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 178.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 58.75 -107.92 1.35 Allowed Glycine 0 CA--C 1.53 0.989 0 O-C-N 121.807 -0.558 . . . . 0.0 111.713 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -81.47 -17.88 47.2 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.546 1.938 . . . . 0.0 113.715 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 65.8 m95 -111.88 157.39 20.68 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 123.406 0.682 . . . . 0.0 110.121 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.2 mp -133.3 136.84 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -113.33 129.95 56.4 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -121.55 125.61 47.19 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 123.682 0.793 . . . . 0.0 110.885 -178.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -124.77 129.94 51.43 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.899 0.857 . . . . 0.0 110.63 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.524 ' HB3' HD13 ' A' ' 133' ' ' ILE . 2.1 m -111.18 156.41 41.07 Favored Pre-proline 0 C--N 1.33 -0.262 0 C-N-CA 125.303 1.441 . . . . 0.0 110.314 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -64.36 82.04 0.16 Allowed 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.775 2.983 . . . . 0.0 114.097 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 69.79 50.14 31.8 Favored Glycine 0 CA--C 1.533 1.209 0 O-C-N 120.785 -1.197 . . . . 0.0 113.683 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.524 HD13 ' HB3' ' A' ' 130' ' ' CYS . 3.4 mp -125.18 -68.28 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 119.042 1.421 . . . . 0.0 108.508 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -165.72 159.3 16.14 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 124.906 1.282 . . . . 0.0 109.213 179.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -122.96 123.07 40.08 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 104.554 -2.387 . . . . 0.0 104.554 176.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 16.6 m -143.37 163.98 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 123.485 0.714 . . . . 0.0 110.654 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -123.77 117.91 25.99 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -139.76 163.37 32.79 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 118.937 0.79 . . . . 0.0 112.039 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -90.07 154.99 19.37 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.273 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 144.19 -162.95 27.85 Favored Glycine 0 C--N 1.334 0.468 0 O-C-N 120.674 -1.266 . . . . 0.0 111.583 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -145.35 160.78 41.01 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 126.601 1.96 . . . . 0.0 107.013 178.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.478 HG23 ' C ' ' A' ' 148' ' ' GLU . 9.6 p -126.97 156.57 38.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -100.56 109.79 21.9 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 2.0 p -60.92 -7.85 2.71 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.783 0.833 . . . . 0.0 113.079 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -83.15 -26.99 30.41 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 125.808 1.643 . . . . 0.0 112.095 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.7 p -121.67 -48.65 2.15 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 124.154 0.982 . . . . 0.0 112.482 -178.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 108.1 21.98 7.45 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.963 1.268 . . . . 0.0 113.08 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.478 ' C ' HG23 ' A' ' 142' ' ' VAL . 8.5 pt-20 -124.51 152.25 43.65 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 119.275 1.537 . . . . 0.0 112.069 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 5.5 mm -69.19 153.87 8.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 C-N-CA 124.96 1.304 . . . . 0.0 108.853 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 12.7 m -60.0 -53.63 45.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.97 1.308 . . . . 0.0 109.542 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -158.59 159.92 35.99 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.08 1.752 . . . . 0.0 109.623 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 -83.37 153.68 24.43 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 178.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 28.7 p-10 -128.05 81.65 2.04 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 127.375 2.27 . . . . 0.0 111.555 -178.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -50.64 -38.08 44.15 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.615 1.566 . . . . 0.0 114.546 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 16.5 m -73.24 -5.82 41.9 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 33.3 mt -124.26 37.21 4.46 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.755 1.222 . . . . 0.0 112.161 -177.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 8.1 p -74.81 138.63 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-O 121.89 0.852 . . . . 0.0 110.15 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -135.56 172.08 13.52 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 128.327 2.651 . . . . 0.0 108.051 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.96 104.94 3.48 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.697 1.199 . . . . 0.0 109.414 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.3 mp -90.99 -28.59 17.91 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 162.76 156.77 8.68 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.7 mtpt -122.29 110.06 32.77 Favored Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 123.697 0.799 . . . . 0.0 108.997 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -79.73 170.12 17.34 Favored 'Trans proline' 0 N--CA 1.456 -0.698 1 C-N-CA 125.736 4.291 . . . . 0.0 109.133 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -105.7 159.72 15.76 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 123.036 0.534 . . . . 0.0 110.703 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -72.99 -43.39 62.25 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -73.39 64.01 0.8 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.416 1.486 . . . . 0.0 110.279 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.4 p -53.51 -29.48 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 O-C-N 120.653 -1.279 . . . . 0.0 110.821 178.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -63.13 -28.04 69.79 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.897 1.679 . . . . 0.0 112.748 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -88.57 -19.78 25.88 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 125.405 1.482 . . . . 0.0 112.462 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -77.77 154.68 31.74 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -107.85 149.45 28.25 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -137.13 173.99 11.09 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 126.681 1.992 . . . . 0.0 109.24 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -132.99 153.93 50.99 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.411 1.085 . . . . 0.0 110.455 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 25.1 tp -115.05 98.55 6.87 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 127.03 2.132 . . . . 0.0 108.53 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -110.09 -178.88 3.63 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.33 1.452 . . . . 0.0 110.079 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -135.22 153.85 51.79 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.952 0.901 . . . . 0.0 109.04 177.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -130.46 175.41 8.99 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 128.087 2.555 . . . . 0.0 107.866 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -56.76 -16.86 7.26 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 129.099 2.96 . . . . 0.0 111.252 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 67.4 t -99.55 -50.42 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 126.803 2.041 . . . . 0.0 108.859 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 170.04 -161.46 34.65 Favored Glycine 0 C--N 1.336 0.553 0 CA-C-N 119.1 0.864 . . . . 0.0 112.339 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 -77.16 156.0 31.89 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 117.751 0.776 . . . . 0.0 110.891 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -157.35 166.63 32.54 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.21 1.004 . . . . 0.0 112.03 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 96.6 mt -105.34 142.06 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 15.9 t -111.24 138.58 47.52 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.238 1.415 . . . . 0.0 107.849 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -130.06 109.3 10.74 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 124.606 1.162 . . . . 0.0 108.402 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.8 mp -93.77 117.47 37.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 6.4 mt -108.12 106.38 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -125.01 142.82 14.14 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 108.111 -1.996 . . . . 0.0 108.111 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 22.7 t 162.83 25.21 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 129.949 3.3 . . . . 0.0 106.968 -178.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -99.0 159.31 20.12 Favored Glycine 0 CA--C 1.505 -0.549 0 O-C-N 120.328 -1.482 . . . . 0.0 111.55 -178.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.44 167.17 15.28 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 178.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 35.0 mm -84.07 135.82 24.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 O-C-N 121.177 -0.952 . . . . 0.0 111.955 -178.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -81.51 104.32 11.85 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 177.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -50.94 -31.69 18.51 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.553 1.141 . . . . 0.0 111.593 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.441 HG23 ' H ' ' A' ' 195' ' ' VAL . 18.8 t -47.77 -47.33 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 128.72 2.808 . . . . 0.0 112.752 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 7.5 t -124.51 -39.69 2.29 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 110.57 36.16 1.95 Allowed Glycine 0 C--N 1.335 0.512 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -178.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -128.24 154.16 46.16 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 118.995 1.397 . . . . 0.0 110.567 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -66.16 168.26 8.79 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.102 0.561 . . . . 0.0 110.204 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -87.75 30.8 0.8 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 130.259 3.424 . . . . 0.0 110.335 177.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 5.9 ptm -72.58 175.42 6.36 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 120.576 -1.327 . . . . 0.0 111.815 -177.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.1 p -139.93 152.04 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 125.215 1.406 . . . . 0.0 109.19 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -114.27 104.08 11.72 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.511 1.924 . . . . 0.0 107.179 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 13.4 mm -91.69 143.7 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -124.72 99.31 6.1 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.624 1.57 . . . . 0.0 107.118 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . 0.52 ' CD1' HD13 ' A' ' 109' ' ' ILE . 25.8 m-85 -78.86 110.2 13.83 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 179.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 4.5 m -123.8 160.58 27.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 124.649 1.18 . . . . 0.0 108.678 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 53.5 t -82.41 141.26 32.92 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 179.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -90.16 3.34 82.33 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-O 118.421 -1.21 . . . . 0.0 114.916 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 56.5 75.52 0.24 Allowed Glycine 0 CA--C 1.523 0.585 0 C-N-CA 124.688 1.137 . . . . 0.0 111.967 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 6.7 t -157.29 163.52 38.63 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 178.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -63.91 -61.28 2.39 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.111 0.965 . . . . 0.0 113.148 -178.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 3.3 t -158.12 163.06 37.98 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 149.34 167.53 14.08 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 126.013 1.768 . . . . 0.0 111.261 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -65.08 -92.22 0.0 OUTLIER 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 124.882 3.721 . . . . 0.0 114.624 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . 0.431 ' CB ' HG22 ' A' ' 235' ' ' ILE . 4.9 p -173.46 156.28 3.0 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.021 -1.049 . . . . 0.0 113.245 -177.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 20.5 p -155.31 172.95 17.34 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.892 1.277 . . . . 0.0 108.255 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 7.5 mt -114.77 148.12 17.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 126.399 1.88 . . . . 0.0 108.465 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -89.37 -51.69 5.42 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.959 0.903 . . . . 0.0 110.961 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 64.8 p-90 -161.53 160.81 29.52 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.42 1.888 . . . . 0.0 107.189 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 88.0 t -148.92 127.89 3.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 125.586 1.555 . . . . 0.0 107.361 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -158.77 159.4 35.13 Favored 'General case' 0 C--O 1.239 0.522 0 O-C-N 121.392 -0.818 . . . . 0.0 112.012 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -67.48 135.12 52.56 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 177.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 8.8 t -109.51 -36.64 5.92 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.86 -0.525 . . . . 0.0 111.138 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 14.5 mttt -129.22 -175.48 3.58 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 124.274 1.03 . . . . 0.0 108.625 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 73.3 mt -51.19 -41.9 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -133.1 9.89 4.14 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.154 0.982 . . . . 0.0 112.453 -178.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 15.0 t -109.28 142.49 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.683 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -177.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -119.76 158.91 25.56 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.216 1.406 . . . . 0.0 107.586 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -136.38 141.86 43.71 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -144.61 121.04 10.99 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.339 1.056 . . . . 0.0 111.337 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -95.05 110.08 22.05 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 105.523 -2.029 . . . . 0.0 105.523 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 61.9 t -101.41 129.5 52.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -114.73 122.02 45.13 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.101 1.36 . . . . 0.0 111.913 -178.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.431 HG22 ' CB ' ' A' ' 216' ' ' SER . 10.8 pt -132.3 139.26 34.3 Favored Pre-proline 0 N--CA 1.453 -0.312 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -66.84 -34.63 29.91 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 121.762 1.641 . . . . 0.0 111.37 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.416 ' CD ' ' HE3' ' A' ' 112' ' ' LYS . 75.4 mm-40 -54.53 -32.66 58.64 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 126.571 1.949 . . . . 0.0 115.023 -178.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.427 HD11 ' HB3' ' A' ' 206' ' ' TYR . 43.5 mt -59.91 -29.47 68.38 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.766 1.166 . . . . 0.0 112.353 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 33.8 m -59.04 -11.85 4.01 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.938 0.895 . . . . 0.0 112.471 179.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -59.87 -25.68 65.25 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 118.668 -0.682 . . . . 0.0 111.106 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -97.27 132.24 43.21 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.904 1.282 . . . . 0.0 108.15 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -46.99 -46.89 21.99 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.297 1.839 . . . . 0.0 112.062 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.561 HD11 HD23 ' A' ' 98' ' ' LEU . 69.1 mt -58.13 -45.25 87.66 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 6.0 mt -91.32 1.19 57.29 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.478 1.511 . . . . 0.0 113.221 -177.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -71.24 111.76 6.84 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.311 1.044 . . . . 0.0 108.935 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 5.5 mmmt -63.7 146.47 53.76 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -92.49 -55.73 3.29 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-O 117.279 -1.343 . . . . 0.0 110.702 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 46.18 58.55 4.39 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.198 1.399 . . . . 0.0 107.468 -177.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 9.4 t0 . . . . . 0 C--O 1.248 1.015 0 CA-C-N 112.399 -2.182 . . . . 0.0 110.795 -177.969 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' A' ' 90' ' ' SER . . . . . . . . 0 N--CA 1.477 1.406 0 N-CA-C 108.121 -1.991 . . . . 0.0 108.121 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 65.02 -16.63 0.09 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 127.053 2.141 . . . . 0.0 113.929 -178.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.43 ' H ' ' C ' ' A' ' 88' ' ' GLY . 5.5 p -63.97 83.59 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 130.817 3.647 . . . . 0.0 109.785 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -114.09 -18.83 11.58 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.854 1.261 . . . . 0.0 111.622 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 70.0 m -56.23 -26.35 51.0 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.921 1.289 . . . . 0.0 114.291 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -78.72 -44.2 24.05 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 120.426 -1.422 . . . . 0.0 107.185 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.5 tptm -56.8 -53.54 56.69 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.407 ' HA ' HD12 ' A' ' 98' ' ' LEU . 1.1 p -60.94 -38.89 87.42 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 119.613 1.097 . . . . 0.0 112.12 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.0 -35.94 80.03 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 42.1 tp -74.72 -36.79 62.69 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 121.281 -0.887 . . . . 0.0 109.425 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 95' ' ' THR . 86.9 mt -59.53 -55.66 31.71 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.433 1.093 . . . . 0.0 111.048 -179.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 37.0 m -68.69 -40.89 79.83 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.29 -0.881 . . . . 0.0 111.007 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.12 -42.95 91.81 Favored 'General case' 0 C--N 1.341 0.201 0 O-C-N 121.579 -0.701 . . . . 0.0 109.681 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 53.7 m -56.18 -49.19 74.73 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 123.848 0.859 . . . . 0.0 109.904 178.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -57.97 -49.22 77.57 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 122.405 0.282 . . . . 0.0 110.643 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -66.59 -59.61 3.46 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -177.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -60.37 -37.8 81.9 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 123.079 0.552 . . . . 0.0 110.415 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.98 -51.97 55.23 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.542 ' HA ' HD12 ' A' ' 109' ' ' ILE . 39.0 t -56.93 -43.64 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 119.538 1.669 . . . . 0.0 108.081 177.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.4 tttt -57.76 -39.05 76.49 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 122.11 -0.368 . . . . 0.0 110.583 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.6 m -70.37 -37.41 74.58 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 126.149 1.78 . . . . 0.0 110.342 -178.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.542 HD12 ' HA ' ' A' ' 106' ' ' VAL . 12.2 mt -63.92 -55.02 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -61.45 -28.23 69.13 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.801 -0.619 . . . . 0.0 112.48 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -64.26 -53.82 43.07 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.036 1.334 . . . . 0.0 109.962 178.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -80.36 -39.52 28.37 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.4 mt -61.04 -28.59 69.17 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 118.534 0.606 . . . . 0.0 112.338 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -51.34 -31.05 20.59 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -49.32 -72.01 0.06 Allowed 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.131 1.372 . . . . 0.0 112.92 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -149.06 178.67 8.5 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.529 1.532 . . . . 0.0 109.846 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 86.3 m -86.72 159.17 19.25 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 40.5 pt -115.44 160.65 14.69 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 C-N-CA 124.806 1.243 . . . . 0.0 110.021 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -156.07 149.03 24.21 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.649 -178.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.445 ' CE1' ' HB2' ' A' ' 122' ' ' ALA . 6.0 t80 -141.14 136.52 31.96 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.71 1.204 . . . . 0.0 110.633 178.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -95.04 102.37 14.17 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.733 1.213 . . . . 0.0 108.194 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.445 ' HB2' ' CE1' ' A' ' 120' ' ' TYR . . . -86.69 80.71 8.46 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 127.746 2.418 . . . . 0.0 106.622 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.65 -102.11 0.59 Allowed Glycine 0 CA--C 1.528 0.864 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -93.6 -20.15 20.48 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.667 1.187 . . . . 0.0 112.376 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.5 ' HH2' HD22 ' A' ' 156' ' ' LEU . 56.6 m95 -99.49 158.4 15.76 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 123.823 0.849 . . . . 0.0 111.0 -178.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.584 HD13 ' H ' ' A' ' 140' ' ' GLY . 4.6 mp -131.59 141.57 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 N-CA-C 104.912 -2.255 . . . . 0.0 104.912 178.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.5 ' CD1' HG11 ' A' ' 221' ' ' VAL . 68.9 m-85 -124.38 121.31 34.57 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 126.188 1.795 . . . . 0.0 107.983 -179.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -114.81 119.44 36.64 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 125.887 1.675 . . . . 0.0 110.716 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -111.54 135.74 51.7 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 13.3 m -117.18 153.76 49.88 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 123.69 0.796 . . . . 0.0 109.928 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -67.17 74.1 0.5 Allowed 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 125.142 3.895 . . . . 0.0 115.877 -177.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.35 39.11 9.29 Favored Glycine 0 CA--C 1.526 0.764 0 O-C-N 121.465 -0.772 . . . . 0.0 113.32 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 3.1 mp -121.06 -66.96 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 118.199 1.0 . . . . 0.0 109.239 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -167.46 169.12 12.45 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.19 1.396 . . . . 0.0 109.525 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -135.49 117.18 14.99 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 104.245 -2.502 . . . . 0.0 104.245 176.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 31.8 m -145.15 165.48 11.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 126.529 1.932 . . . . 0.0 109.644 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.41 ' HB3' ' CD1' ' A' ' 127' ' ' TYR . 18.0 pt20 -124.22 130.38 52.42 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 177.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -138.82 163.15 32.98 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.503 1.521 . . . . 0.0 109.373 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -93.59 108.41 20.13 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.584 ' H ' HD13 ' A' ' 126' ' ' ILE . . . 175.08 151.56 8.61 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.417 ' HD2' ' H ' ' A' ' 141' ' ' ARG . 0.0 OUTLIER -125.78 167.0 15.79 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.452 1.126 . . . . 0.0 111.578 -179.313 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.3 p -95.68 150.89 4.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 C-N-CA 124.948 1.299 . . . . 0.0 110.965 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -105.57 132.59 51.54 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 104.459 -2.422 . . . . 0.0 104.459 176.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 19.2 p -69.76 -13.57 62.35 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -71.22 -49.28 45.0 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 119.163 0.892 . . . . 0.0 111.52 -177.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 67.7 p -108.29 -21.34 12.8 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.791 0.836 . . . . 0.0 112.384 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.34 29.75 43.76 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.634 -0.537 . . . . 0.0 113.372 179.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -124.65 160.2 29.03 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.762 1.225 . . . . 0.0 110.105 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.8 mp -84.11 159.0 3.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 29.4 m -68.96 -58.22 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.641 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -164.2 169.35 17.77 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 127.674 2.39 . . . . 0.0 106.681 178.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -127.85 104.57 7.89 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 103.808 -2.664 . . . . 0.0 103.808 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -63.83 113.25 3.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 126.198 1.799 . . . . 0.0 112.217 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -63.82 -6.36 5.7 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.805 1.642 . . . . 0.0 112.631 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.6 t -87.93 -15.93 35.25 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.645 1.978 . . . . 0.0 110.348 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.5 HD22 ' HH2' ' A' ' 125' ' ' TRP . 26.9 mt -125.41 53.22 1.56 Allowed 'General case' 0 C--N 1.338 0.081 0 C-N-CA 125.78 1.632 . . . . 0.0 109.172 -178.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 15.0 m -86.03 145.96 7.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 C-N-CA 124.486 1.114 . . . . 0.0 110.681 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -151.03 175.43 12.1 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 126.223 1.809 . . . . 0.0 108.581 -179.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -147.73 137.14 22.46 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.2 mp -120.22 -30.93 4.52 Favored 'General case' 0 C--O 1.221 -0.4 0 C-N-CA 125.525 1.53 . . . . 0.0 108.315 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 167.28 162.41 18.96 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-N 119.61 1.095 . . . . 0.0 111.39 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm -125.54 108.31 26.34 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 124.78 1.232 . . . . 0.0 108.516 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -81.64 167.05 17.17 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.83 3.02 . . . . 0.0 110.92 178.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -110.56 145.1 38.39 Favored 'General case' 0 CA--C 1.513 -0.481 0 C-N-CA 124.752 1.221 . . . . 0.0 112.036 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.4 -40.33 90.55 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 124.356 1.035 . . . . 0.0 109.596 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -76.4 64.34 2.11 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 126.173 1.789 . . . . 0.0 109.348 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.9 p -47.06 -32.46 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 119.763 1.165 . . . . 0.0 111.91 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -63.99 -26.67 68.68 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.899 1.68 . . . . 0.0 112.619 -178.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.0 -25.91 56.21 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.428 0.691 . . . . 0.0 110.568 178.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 65.4 mtp180 -81.04 165.24 21.85 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 122.067 0.937 . . . . 0.0 110.884 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -123.46 147.68 46.93 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -130.42 165.44 22.58 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 125.318 1.447 . . . . 0.0 107.866 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -130.83 153.36 49.17 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 118.012 0.369 . . . . 0.0 110.447 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 45.9 tp -108.41 103.23 12.33 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.305 1.442 . . . . 0.0 108.471 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.525 HD23 ' HB2' ' A' ' 184' ' ' SER . 2.9 mm? -114.63 -179.51 3.65 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 126.653 1.981 . . . . 0.0 109.073 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -142.17 160.47 40.17 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.693 0.797 . . . . 0.0 110.824 179.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -139.97 -175.46 4.24 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.368 2.267 . . . . 0.0 108.084 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -58.48 -18.49 29.33 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 120.292 -1.505 . . . . 0.0 114.361 -178.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 42.4 t -98.84 -44.99 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 122.964 0.506 . . . . 0.0 111.648 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 175.2 -159.86 28.29 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 118.659 0.663 . . . . 0.0 111.729 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -85.38 158.76 20.16 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -154.97 166.41 33.65 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.61 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 98.2 mt -105.77 128.7 59.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.525 ' HB2' HD23 ' A' ' 175' ' ' LEU . 43.8 t -92.95 130.71 38.44 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.216 1.406 . . . . 0.0 108.299 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -126.0 112.77 16.29 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 177.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.14 112.2 26.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 11.1 mt -99.84 106.53 19.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 103.426 -2.805 . . . . 0.0 103.426 178.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -101.37 -153.18 25.88 Favored Glycine 0 CA--C 1.52 0.364 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 60.96 43.18 11.86 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.499 0.72 . . . . 0.0 112.153 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -86.56 -106.59 0.8 Allowed Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 105.027 -3.229 . . . . 0.0 105.027 178.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -157.9 162.63 38.33 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 129.095 2.958 . . . . 0.0 104.545 178.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.6 mm -85.62 142.28 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.3 m -97.97 105.6 17.77 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 127.746 2.418 . . . . 0.0 104.584 177.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -50.39 -27.0 5.58 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.311 1.844 . . . . 0.0 112.902 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 21.6 t -43.0 -56.55 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 126.819 2.048 . . . . 0.0 110.866 179.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 9.2 t -123.65 -25.61 4.31 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.867 1.267 . . . . 0.0 112.774 -178.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 99.27 35.04 4.87 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 107.541 -2.224 . . . . 0.0 107.541 -178.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -106.62 150.46 26.18 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 118.851 1.326 . . . . 0.0 112.747 -178.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -78.91 141.97 37.16 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.274 0.559 . . . . 0.0 109.722 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 -67.56 29.71 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.519 1 C-N-CA 133.64 4.776 . . . . 0.0 114.625 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 9.5 ptm -74.43 178.99 4.87 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.433 1.493 . . . . 0.0 112.051 -178.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.23 150.46 15.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 124.853 1.261 . . . . 0.0 109.199 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -110.74 103.58 12.14 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.445 2.298 . . . . 0.0 107.553 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 9.4 mm -93.48 146.8 6.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -125.58 105.34 8.95 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.952 2.101 . . . . 0.0 108.004 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . 0.431 ' CE2' HG21 ' A' ' 233' ' ' VAL . 58.4 m-85 -84.77 110.58 18.9 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 12.5 m -125.36 167.19 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 124.015 0.926 . . . . 0.0 109.101 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 36.7 t -93.69 135.21 35.21 Favored 'General case' 0 C--N 1.333 -0.127 0 O-C-N 120.153 -1.592 . . . . 0.0 107.233 178.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -83.84 8.65 65.39 Favored Glycine 0 N--CA 1.464 0.509 0 CA-C-O 118.77 -1.017 . . . . 0.0 114.349 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 73.33 -6.77 13.92 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-O 118.23 -1.317 . . . . 0.0 114.273 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 2.8 p -79.82 156.88 27.2 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 119.368 1.584 . . . . 0.0 108.798 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -83.7 -29.31 27.67 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.231 1.013 . . . . 0.0 112.427 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 9.4 m -156.81 168.81 26.33 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 120.126 -1.609 . . . . 0.0 111.731 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 132.3 170.62 12.58 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 128.373 2.892 . . . . 0.0 111.168 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.06 -94.34 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 124.19 3.26 . . . . 0.0 110.778 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 11.2 p -162.13 154.17 19.06 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 120.645 -1.284 . . . . 0.0 109.686 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 41.7 p -151.38 163.79 38.16 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.392 0.677 . . . . 0.0 110.426 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.438 HG13 HG12 ' A' ' 233' ' ' VAL . 4.1 mt -110.54 143.03 21.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 125.145 1.378 . . . . 0.0 107.423 178.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -95.11 -51.72 4.52 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.199 1.4 . . . . 0.0 110.786 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 -161.21 156.57 24.41 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.429 1.491 . . . . 0.0 109.658 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.5 HG11 ' CD1' ' A' ' 127' ' ' TYR . 7.3 t -151.03 144.98 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 C-N-CA 127.894 2.478 . . . . 0.0 106.228 -178.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.24 168.47 15.18 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.602 1.161 . . . . 0.0 109.146 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -83.57 131.12 35.0 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 103.383 -2.821 . . . . 0.0 103.383 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . 0.478 HG23 ' HG3' ' A' ' 225' ' ' LYS . 9.8 t -109.87 -28.68 8.64 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 124.245 1.018 . . . . 0.0 113.177 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.515 ' HE3' HG11 ' A' ' 228' ' ' VAL . 10.2 mttt -133.92 -175.6 3.89 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 70.0 mt -54.39 -49.52 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -123.01 20.56 9.94 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 124.042 0.937 . . . . 0.0 110.76 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.515 HG11 ' HE3' ' A' ' 225' ' ' LYS . 13.5 t -121.73 144.73 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 CA-C-N 118.578 0.626 . . . . 0.0 110.38 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -123.33 165.47 16.93 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 125.983 1.713 . . . . 0.0 108.434 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . 0.42 ' HG3' HG21 ' A' ' 224' ' ' THR . 25.7 mt-10 -131.31 147.01 52.53 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 126.086 1.754 . . . . 0.0 106.981 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -151.35 120.6 6.79 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.84 0.856 . . . . 0.0 109.373 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -108.79 113.45 26.41 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 123.588 0.755 . . . . 0.0 109.389 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . 0.438 HG12 HG13 ' A' ' 218' ' ' ILE . 6.7 m -104.12 152.2 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -118.91 116.34 26.26 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.68 -1.145 . . . . 0.0 108.452 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -124.83 122.47 25.6 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-O 117.935 -1.031 . . . . 0.0 109.282 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -57.38 -38.45 94.47 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.249 2.633 . . . . 0.0 111.427 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -59.18 -28.66 66.83 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 10.2 tp -58.59 -33.25 69.77 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 121.48 -0.762 . . . . 0.0 111.638 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 15.3 m -59.21 -11.13 3.47 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.141 0.976 . . . . 0.0 112.996 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -61.79 -32.01 72.27 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 120.128 1.331 . . . . 0.0 109.877 178.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -85.05 124.5 31.81 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -47.73 -48.11 29.83 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.239 2.215 . . . . 0.0 113.101 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 59.7 mt -67.97 -19.41 64.94 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.061 -1.025 . . . . 0.0 113.185 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 11.4 mt -105.36 -5.91 20.04 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.82 1.248 . . . . 0.0 111.686 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -71.64 139.69 49.38 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 128.606 2.762 . . . . 0.0 112.189 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 16.8 mmtm -111.74 163.3 14.3 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 127.894 2.478 . . . . 0.0 112.698 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -124.64 -39.36 2.3 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -140.97 51.18 1.62 Allowed 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.149 0.98 . . . . 0.0 109.848 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.254 1.309 0 C-N-CA 125.431 1.492 . . . . 0.0 108.21 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.68 0 CA-C-O 118.746 -1.03 . . . . 0.0 112.669 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 51.31 7.64 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 128.641 2.776 . . . . 0.0 118.201 178.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.0 m -63.76 157.88 23.19 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 120.859 1.663 . . . . 0.0 112.057 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -54.15 -58.19 8.3 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.768 1.227 . . . . 0.0 110.642 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.6 m -62.68 -28.93 70.27 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.337 1.055 . . . . 0.0 112.245 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -69.19 -26.24 64.74 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 118.44 -0.791 . . . . 0.0 111.559 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 42.3 tptt -66.9 -55.26 15.43 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.28 -39.96 94.67 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 123.043 0.537 . . . . 0.0 110.103 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.03 -40.84 95.11 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 35.6 tp -67.98 -35.99 79.27 Favored 'General case' 0 C--N 1.343 0.306 0 CA-C-O 117.514 -1.232 . . . . 0.0 109.233 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.7 mt -62.05 -55.04 33.14 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.942 1.246 . . . . 0.0 107.963 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 53.5 m -60.05 -47.16 87.01 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.097 0.959 . . . . 0.0 110.346 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.16 -45.25 94.25 Favored 'General case' 0 N--CA 1.462 0.128 0 O-C-N 121.099 -1.001 . . . . 0.0 109.808 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.5 m -53.92 -43.11 69.46 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 124.706 1.202 . . . . 0.0 109.684 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.22 -52.08 67.2 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 118.341 0.519 . . . . 0.0 110.218 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -64.95 -51.47 61.61 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -178.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -63.14 -42.08 99.41 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.777 -178.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.38 -52.51 52.18 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 107.872 -2.091 . . . . 0.0 107.872 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.415 HG23 HD13 ' A' ' 183' ' ' ILE . 17.9 t -54.81 -51.99 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 124.614 1.166 . . . . 0.0 110.954 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 31.5 pttt -62.33 -32.2 72.94 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 119.966 -0.693 . . . . 0.0 111.484 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 59.9 m -76.61 -33.2 58.42 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 19.6 mt -63.49 -56.03 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -60.36 -36.92 79.15 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 118.063 -0.97 . . . . 0.0 111.669 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -54.86 -43.83 73.45 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.832 0.742 . . . . 0.0 111.806 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.9 tptt -82.38 -40.95 20.6 Favored 'General case' 0 CA--C 1.517 -0.326 0 O-C-N 122.027 -0.421 . . . . 0.0 111.566 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 44.5 mt -60.65 -29.47 69.29 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 119.135 -0.46 . . . . 0.0 111.512 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -55.38 -15.66 2.82 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.038 0.935 . . . . 0.0 112.729 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -64.63 -66.85 0.49 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.253 1.021 . . . . 0.0 109.676 178.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 18.6 mmt85 -151.47 -179.49 7.43 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.894 1.678 . . . . 0.0 111.85 -178.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 64.9 m -86.12 161.32 18.94 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 38.7 pt -121.63 162.68 20.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 125.722 1.609 . . . . 0.0 108.281 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -156.89 142.62 17.7 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.374 1.07 . . . . 0.0 109.433 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -136.38 132.6 35.75 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.213 1.005 . . . . 0.0 110.65 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -81.44 98.44 8.23 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.66 83.04 4.8 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.122 1.369 . . . . 0.0 107.78 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.12 -98.15 0.18 Allowed Glycine 0 C--N 1.336 0.53 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -100.45 -26.56 13.82 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.349 1.06 . . . . 0.0 113.716 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -103.1 132.2 49.53 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 118.932 0.787 . . . . 0.0 110.467 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.488 HD13 ' H ' ' A' ' 140' ' ' GLY . 3.3 mp -96.2 127.86 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 103.643 -2.725 . . . . 0.0 103.643 178.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.401 ' CG ' HG11 ' A' ' 221' ' ' VAL . 11.3 m-85 -100.84 120.35 40.0 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -179.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -116.11 125.07 51.87 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 125.167 1.387 . . . . 0.0 110.394 -178.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -121.51 129.07 52.69 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.508 0.723 . . . . 0.0 112.018 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 22.7 m -107.76 151.01 40.96 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 123.624 0.77 . . . . 0.0 111.301 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -66.23 80.25 0.3 Allowed 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 125.275 3.983 . . . . 0.0 116.82 -177.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.87 31.19 27.07 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 117.803 -1.554 . . . . 0.0 112.007 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 3.0 mp -117.18 -71.99 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 119.444 1.622 . . . . 0.0 109.817 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.507 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 16.2 pt-20 -163.22 166.63 23.03 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.927 1.691 . . . . 0.0 110.435 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -130.56 119.91 23.25 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 105.731 -1.952 . . . . 0.0 105.731 177.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.7 m -144.22 164.08 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 125.109 1.364 . . . . 0.0 110.724 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -125.65 122.84 37.56 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.459 ' HE2' HG21 ' A' ' 149' ' ' ILE . 31.2 p90 -138.72 162.15 35.42 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 123.924 0.89 . . . . 0.0 108.907 178.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.547 ' H ' HD13 ' A' ' 156' ' ' LEU . 76.4 t60 -96.04 118.45 32.66 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.488 ' H ' HD13 ' A' ' 126' ' ' ILE . . . -169.15 -167.51 29.84 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.026 1.298 . . . . 0.0 110.267 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -138.99 142.92 38.32 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.673 1.589 . . . . 0.0 107.783 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.5 p -94.91 149.94 4.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 119.633 1.106 . . . . 0.0 108.308 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -98.06 92.88 5.99 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 102.377 -3.194 . . . . 0.0 102.377 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 27.8 p -52.5 -25.37 10.08 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.82 1.248 . . . . 0.0 114.117 -178.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -52.5 -40.33 62.28 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 125.09 1.356 . . . . 0.0 111.124 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.0 p -117.81 -48.07 2.58 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.896 1.279 . . . . 0.0 112.045 -178.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 118.11 24.91 3.14 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 117.979 -1.456 . . . . 0.0 113.84 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -124.77 155.54 39.19 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 121.163 2.481 . . . . 0.0 111.963 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.459 HG21 ' HE2' ' A' ' 138' ' ' PHE . 10.7 mm -69.31 158.05 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 123.919 0.888 . . . . 0.0 109.532 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 7.6 m -66.68 -33.21 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 125.09 1.356 . . . . 0.0 113.701 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -145.5 159.1 43.6 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.127 1.371 . . . . 0.0 110.03 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -113.68 124.79 53.15 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.451 1.5 . . . . 0.0 111.737 -178.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 8.68 61.32 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.172 1 C-N-CA 131.728 4.011 . . . . 0.0 113.904 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -59.72 -79.98 0.02 OUTLIER 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.882 1.673 . . . . 0.0 112.866 -178.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 42.3 m -112.31 -29.51 7.51 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.04 0.936 . . . . 0.0 110.7 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.547 HD13 ' H ' ' A' ' 139' ' ' HIS . 68.8 mt -61.35 133.62 56.04 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.3 p -127.64 119.79 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 123.887 0.875 . . . . 0.0 110.957 -178.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -154.82 155.56 34.65 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 124.707 1.203 . . . . 0.0 110.029 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -148.65 143.81 26.76 Favored 'General case' 0 CA--C 1.512 -0.484 0 C-N-CA 126.371 1.868 . . . . 0.0 107.046 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 42.7 mt -129.79 -31.67 1.95 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.566 1.547 . . . . 0.0 107.689 177.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 159.34 158.66 9.24 Favored Glycine 0 C--N 1.341 0.823 0 O-C-N 120.587 -1.32 . . . . 0.0 113.459 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -117.41 108.93 42.7 Favored Pre-proline 0 C--O 1.239 0.529 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.507 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 91.5 Cg_endo -72.04 165.09 33.65 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 124.16 3.24 . . . . 0.0 109.371 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -109.99 148.82 30.94 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 123.476 0.71 . . . . 0.0 110.281 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -68.15 -48.46 65.3 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 125.777 1.923 . . . . 0.0 109.788 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -74.98 65.47 1.44 Allowed 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.207 1.403 . . . . 0.0 113.443 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.0 p -47.8 -31.66 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.29 1.036 . . . . 0.0 111.925 178.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -72.65 -30.11 64.01 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -178.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -73.66 -18.16 61.06 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.963 0.505 . . . . 0.0 109.842 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -105.81 165.47 11.16 Favored 'General case' 0 C--N 1.342 0.268 0 O-C-N 121.603 -0.686 . . . . 0.0 109.824 178.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -120.84 156.3 32.24 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -130.0 171.14 13.1 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.405 1.482 . . . . 0.0 108.715 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -113.7 153.44 28.97 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 123.691 0.796 . . . . 0.0 110.057 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 56.8 tp -121.63 102.51 8.28 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.594 1.558 . . . . 0.0 107.759 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.424 HD23 ' HB2' ' A' ' 184' ' ' SER . 2.3 mm? -112.5 -178.6 3.44 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 127.299 2.24 . . . . 0.0 109.996 -178.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -142.57 161.14 38.82 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.599 0.76 . . . . 0.0 110.346 177.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -140.92 178.68 7.19 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 127.637 2.375 . . . . 0.0 106.909 178.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.29 -17.81 22.32 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.435 1.494 . . . . 0.0 113.337 -178.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 90.0 t -93.92 -31.83 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 124.787 1.235 . . . . 0.0 111.917 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 156.19 -170.46 33.86 Favored Glycine 0 N--CA 1.448 -0.553 0 O-C-N 121.305 -0.872 . . . . 0.0 112.762 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.425 ' CE2' ' HG ' ' A' ' 243' ' ' LEU . 3.7 m-30 -78.76 160.73 27.28 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.401 ' HB3' HG12 ' A' ' 207' ' ' VAL . 30.7 p90 -164.33 157.96 18.18 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.273 1.029 . . . . 0.0 111.831 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.415 HD13 HG23 ' A' ' 106' ' ' VAL . 76.2 mt -96.03 138.82 20.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.899 1.28 . . . . 0.0 107.8 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.424 ' HB2' HD23 ' A' ' 175' ' ' LEU . 30.1 t -105.12 120.89 42.62 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 126.087 1.755 . . . . 0.0 107.973 179.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -114.89 107.49 15.48 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.905 1.682 . . . . 0.0 108.355 179.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -89.79 124.14 42.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 178.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.7 mt -114.27 105.69 19.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 104.94 -2.244 . . . . 0.0 104.94 177.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -98.18 -152.22 27.86 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 105.99 -2.844 . . . . 0.0 105.99 178.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 20.1 m 81.33 18.51 0.44 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 177.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -90.58 -142.19 9.78 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 108.354 -1.899 . . . . 0.0 108.354 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -124.5 163.82 21.05 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.4 mm -81.41 142.71 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.191 0.996 . . . . 0.0 112.012 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -85.93 122.63 30.25 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.722 1.609 . . . . 0.0 109.129 178.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.45 -28.4 63.29 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.761 1.225 . . . . 0.0 111.896 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 58.6 t -57.62 -54.95 24.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.549 1.139 . . . . 0.0 113.165 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 14.0 t -122.72 -36.64 2.87 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 116.164 1.912 . . . . 0.0 116.164 -176.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 111.81 23.51 5.58 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -99.07 150.95 21.48 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.763 0.825 . . . . 0.0 109.742 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -74.91 151.88 38.88 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.955 0.883 . . . . 0.0 108.922 178.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -71.27 29.75 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 130.021 3.329 . . . . 0.0 110.276 177.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 8.0 ptm -73.84 175.58 7.15 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.284 1.834 . . . . 0.0 111.778 -177.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.52 150.34 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 124.294 1.038 . . . . 0.0 108.628 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -111.93 104.17 12.44 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.242 1.817 . . . . 0.0 106.412 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 10.2 mm -96.75 144.02 11.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 O-C-N 120.848 -1.157 . . . . 0.0 109.289 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -124.29 127.67 47.99 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.292 1.037 . . . . 0.0 109.22 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -102.43 113.11 26.17 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 118.565 -0.731 . . . . 0.0 110.823 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.401 HG12 ' HB3' ' A' ' 182' ' ' TYR . 4.5 m -127.61 162.26 33.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 16.2 t -91.89 138.26 31.7 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 104.381 -2.451 . . . . 0.0 104.381 177.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -95.33 12.97 67.5 Favored Glycine 0 CA--C 1.522 0.483 0 CA-C-O 118.726 -1.041 . . . . 0.0 112.462 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 71.31 -0.91 29.86 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-N 118.16 0.98 . . . . 0.0 111.666 -178.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 9.4 m -68.67 130.33 42.53 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -74.39 -19.72 60.32 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -155.63 175.07 14.39 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.214 1.406 . . . . 0.0 110.306 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 123.3 173.49 14.04 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.5 1.524 . . . . 0.0 113.861 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -79.93 -89.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 123.824 3.016 . . . . 0.0 110.879 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 18.2 p -170.8 146.94 2.67 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.171 1.788 . . . . 0.0 109.842 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 29.3 p -154.84 147.7 24.5 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.504 1.122 . . . . 0.0 110.487 178.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.447 HG13 HG12 ' A' ' 233' ' ' VAL . 3.2 mt -85.64 144.85 8.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -90.34 -55.75 3.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.869 1.267 . . . . 0.0 108.683 178.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 66.1 p-90 -154.63 158.14 39.23 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.328 1.051 . . . . 0.0 110.105 -178.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.612 HG23 ' HB2' ' A' ' 231' ' ' ALA . 7.2 p -156.16 134.91 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 177.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -159.64 159.91 33.64 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 118.545 0.611 . . . . 0.0 110.683 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -67.59 133.36 49.27 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 178.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . 0.644 HG23 ' HG3' ' A' ' 225' ' ' LYS . 2.3 t -111.82 -34.32 6.05 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.937 1.295 . . . . 0.0 111.592 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.644 ' HG3' HG23 ' A' ' 224' ' ' THR . 7.7 mttm -134.73 -176.5 4.25 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 97.6 mt -50.06 -47.67 23.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 C-N-CA 124.681 1.192 . . . . 0.0 111.669 -178.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -127.7 20.5 6.58 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.582 0.753 . . . . 0.0 110.232 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 13.6 t -122.75 147.71 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 O-C-N 120.925 -1.109 . . . . 0.0 110.067 -177.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -127.92 163.58 24.16 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -135.35 133.05 38.36 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 178.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.612 ' HB2' HG23 ' A' ' 221' ' ' VAL . . . -135.91 149.08 48.82 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.208 1.803 . . . . 0.0 107.981 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -135.72 124.36 23.73 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 118.862 0.756 . . . . 0.0 110.049 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . 0.447 HG12 HG13 ' A' ' 218' ' ' ILE . 15.3 m -106.97 153.08 8.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 121.338 0.59 . . . . 0.0 109.682 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.02 121.62 39.32 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 178.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -132.82 145.36 56.77 Favored Pre-proline 0 N--CA 1.45 -0.432 0 O-C-N 124.469 1.106 . . . . 0.0 110.809 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.71 -42.26 1.24 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.812 2.341 . . . . 0.0 112.317 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -56.89 -25.48 57.03 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -178.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 9.6 tp -64.58 -29.69 70.71 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 121.403 -0.811 . . . . 0.0 112.374 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 11.4 m -58.39 -12.47 3.85 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.464 1.106 . . . . 0.0 112.449 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -64.11 -27.02 68.8 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 119.42 1.009 . . . . 0.0 111.239 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.27 124.86 35.79 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 -47.85 -48.35 31.07 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.706 1.203 . . . . 0.0 113.904 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.425 ' HG ' ' CE2' ' A' ' 181' ' ' TYR . 1.6 mp -61.12 -31.84 71.54 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 13.4 mt -93.73 -17.9 22.68 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.859 1.264 . . . . 0.0 113.167 -178.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -61.4 146.83 46.97 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 128.18 2.592 . . . . 0.0 110.411 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -105.2 169.57 8.37 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.361 1.464 . . . . 0.0 111.977 -179.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -106.17 -5.83 19.01 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 125.376 1.471 . . . . 0.0 111.142 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -112.6 24.21 12.72 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.202 1.801 . . . . 0.0 109.784 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 12.1 t70 . . . . . 0 C--O 1.259 1.557 0 C-N-CA 126.868 2.067 . . . . 0.0 109.941 -179.495 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.874 0 N-CA-C 108.468 -1.853 . . . . 0.0 108.468 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.02 177.99 10.18 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.496 1.518 . . . . 0.0 107.943 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.2 m -71.81 82.25 0.89 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.843 0.857 . . . . 0.0 110.179 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -63.05 -40.38 97.52 Favored 'General case' 0 C--O 1.225 -0.234 0 O-C-N 120.819 -1.175 . . . . 0.0 110.828 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.1 m -60.07 -49.49 77.43 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.041 1.336 . . . . 0.0 111.566 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -61.05 -45.07 96.26 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.0 tptm -54.29 -52.99 59.71 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 118.452 -0.785 . . . . 0.0 109.379 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.5 p -58.52 -40.72 83.67 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.45 -44.35 89.16 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 118.809 -0.615 . . . . 0.0 110.759 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 58.6 tp -74.26 -38.35 63.47 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-O 117.913 -1.041 . . . . 0.0 109.416 178.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 16.1 mt -58.92 -54.51 46.29 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.597 1.089 . . . . 0.0 110.746 -177.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 16.9 m -64.54 -36.18 83.37 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 118.703 -1.199 . . . . 0.0 110.762 -179.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.74 -49.86 76.06 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 89.6 m -51.44 -46.52 63.03 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.345 1.058 . . . . 0.0 110.586 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -58.77 -50.08 75.27 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.82 0.737 . . . . 0.0 110.524 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -67.95 -59.1 3.53 Favored 'General case' 0 C--O 1.227 -0.114 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -58.89 -38.14 78.18 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.21 1.004 . . . . 0.0 110.392 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.22 -52.65 50.47 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.478 ' HA ' HD12 ' A' ' 109' ' ' ILE . 51.6 t -57.72 -44.53 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 118.882 1.341 . . . . 0.0 109.974 179.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -60.47 -35.49 76.01 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.458 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 88.4 m -75.74 -34.95 60.34 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 122.771 0.428 . . . . 0.0 110.335 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.478 HD12 ' HA ' ' A' ' 106' ' ' VAL . 26.1 mt -63.36 -55.59 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -62.04 -33.51 74.51 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 118.433 -0.794 . . . . 0.0 112.753 -178.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -65.8 -37.95 87.66 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 118.834 0.743 . . . . 0.0 111.354 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.8 tptt -84.76 -38.46 19.6 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 118.761 -0.638 . . . . 0.0 111.157 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 16.8 mt -65.06 -25.81 67.97 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.845 0.748 . . . . 0.0 111.256 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -53.17 -24.66 11.27 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.059 1.344 . . . . 0.0 111.459 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -65.96 -65.79 0.63 Allowed 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 118.132 -0.937 . . . . 0.0 111.71 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -147.43 175.32 10.91 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 120.276 1.398 . . . . 0.0 112.863 -178.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 79.0 m -86.44 163.9 17.3 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 43.1 pt -121.8 159.46 24.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 124.587 1.155 . . . . 0.0 109.86 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -157.06 140.22 15.48 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 122.914 0.486 . . . . 0.0 111.847 -178.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -138.73 129.9 26.94 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 119.804 -0.759 . . . . 0.0 109.995 176.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -83.46 98.56 9.59 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.996 1.319 . . . . 0.0 107.547 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -85.95 80.56 8.84 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.494 1.918 . . . . 0.0 106.545 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.44 -99.42 0.33 Allowed Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -92.38 -30.75 15.62 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 118.423 1.112 . . . . 0.0 113.43 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -100.21 155.18 17.9 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 119.109 0.868 . . . . 0.0 110.548 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.687 HD13 ' H ' ' A' ' 140' ' ' GLY . 4.0 mp -122.13 144.59 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 104.003 -2.591 . . . . 0.0 104.003 179.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -128.88 120.0 25.43 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -110.06 126.02 53.56 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.966 1.706 . . . . 0.0 109.423 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -115.13 136.09 53.49 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.498 ' HB3' HD13 ' A' ' 133' ' ' ILE . 17.1 m -118.97 148.8 45.46 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 123.528 0.731 . . . . 0.0 111.066 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -64.63 91.33 0.19 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 125.079 3.853 . . . . 0.0 114.586 -178.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.82 28.44 58.98 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-O 118.045 -1.42 . . . . 0.0 114.265 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.498 HD13 ' HB3' ' A' ' 130' ' ' CYS . 4.1 mp -115.14 -71.58 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 119.654 1.727 . . . . 0.0 108.43 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.406 ' HA ' ' HD2' ' A' ' 163' ' ' PRO . 15.8 pt-20 -171.43 174.6 4.4 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.449 1.5 . . . . 0.0 110.072 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.416 ' CD1' HD12 ' A' ' 160' ' ' LEU . 1.2 t80 -136.54 120.26 17.3 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 177.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.9 m -145.41 164.99 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 126.494 1.917 . . . . 0.0 110.336 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -117.37 131.97 56.68 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 119.461 1.028 . . . . 0.0 110.498 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -137.68 162.31 34.19 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.547 1.067 . . . . 0.0 108.781 176.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.528 ' H ' ' CD1' ' A' ' 156' ' ' LEU . 72.1 t60 -102.24 109.93 21.75 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.687 ' H ' HD13 ' A' ' 126' ' ' ILE . . . -170.42 -178.25 41.09 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.426 1.489 . . . . 0.0 109.788 -179.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -126.01 160.71 29.32 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.39 1.595 . . . . 0.0 110.886 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.6 p -117.41 157.42 18.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 C-N-CA 124.082 0.953 . . . . 0.0 108.572 179.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -105.26 99.81 9.42 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 177.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 40.0 p -53.25 -17.03 1.48 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.518 1.527 . . . . 0.0 113.558 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.79 -39.13 83.91 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 125.395 1.478 . . . . 0.0 111.835 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 44.3 p -132.23 -28.01 1.74 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 105.99 18.2 11.79 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.958 1.266 . . . . 0.0 115.501 179.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -97.41 147.81 23.83 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 118.85 1.325 . . . . 0.0 111.833 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 13.8 mm -74.12 154.64 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 178.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 27.1 m -68.73 -38.0 78.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.162 0.985 . . . . 0.0 110.753 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 26.2 t30 -175.75 148.78 0.9 Allowed 'General case' 0 C--O 1.235 0.313 0 C-N-CA 129.114 2.965 . . . . 0.0 106.45 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 30.4 mtp180 -97.19 155.08 17.0 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.029 0.832 . . . . 0.0 109.323 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -114.91 112.16 22.29 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -83.16 -13.59 55.22 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.914 0.864 . . . . 0.0 112.594 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 4.6 p -69.27 -42.33 75.68 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 127.994 2.518 . . . . 0.0 111.071 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.528 ' CD1' ' H ' ' A' ' 139' ' ' HIS . 34.2 mt -77.5 67.57 3.44 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 127.708 2.403 . . . . 0.0 110.582 -178.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 4.3 p -79.77 130.93 35.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -150.55 166.78 29.2 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 126.55 1.94 . . . . 0.0 107.859 178.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.27 113.06 5.41 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 117.37 -1.3 . . . . 0.0 109.248 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.416 HD12 ' CD1' ' A' ' 135' ' ' PHE . 43.4 mt -102.02 -30.46 11.18 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.936 1.244 . . . . 0.0 108.982 178.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 161.99 161.31 11.81 Favored Glycine 0 CA--C 1.503 -0.668 0 CA-C-O 122.396 0.998 . . . . 0.0 110.758 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -123.91 109.39 29.95 Favored Pre-proline 0 N--CA 1.426 -1.631 0 C-N-CA 125.262 1.425 . . . . 0.0 109.307 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 85.3 Cg_endo -70.52 177.77 5.75 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.664 2.909 . . . . 0.0 108.745 178.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -120.55 152.11 38.52 Favored 'General case' 0 CA--C 1.517 -0.312 0 O-C-N 121.64 -0.663 . . . . 0.0 111.363 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -67.04 -49.69 64.37 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 122.945 0.498 . . . . 0.0 110.142 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -79.18 65.02 4.24 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.606 0.763 . . . . 0.0 110.47 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.3 p -48.8 -33.35 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 125.26 1.424 . . . . 0.0 111.229 179.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -65.5 -30.93 71.75 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 126.131 1.773 . . . . 0.0 111.621 -178.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -88.76 -11.3 45.38 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.698 1.199 . . . . 0.0 111.692 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.442 HH22 HG12 ' A' ' 187' ' ' ILE . 50.6 ttt180 -81.53 177.23 9.06 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.025 1.33 . . . . 0.0 108.686 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -133.29 149.8 51.92 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 121.261 -0.9 . . . . 0.0 109.34 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -136.63 169.87 17.01 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 127.592 2.357 . . . . 0.0 110.091 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -123.62 154.63 39.05 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.806 0.842 . . . . 0.0 110.349 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 12.4 tp -119.09 105.1 11.08 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 122.383 1.087 . . . . 0.0 109.621 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 3.4 mt -119.09 176.67 5.19 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 128.227 2.611 . . . . 0.0 107.738 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -154.68 164.36 38.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.714 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.71 -175.43 3.82 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.388 1.875 . . . . 0.0 110.313 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -66.81 -1.81 4.34 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.875 1.67 . . . . 0.0 113.442 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.407 ' CG1' ' HE3' ' A' ' 246' ' ' LYS . 30.6 t -112.82 -44.21 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 124.741 1.216 . . . . 0.0 109.519 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 175.56 -175.52 47.26 Favored Glycine 0 N--CA 1.446 -0.67 0 O-C-N 121.274 -0.891 . . . . 0.0 111.943 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -82.17 163.71 21.75 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.455 ' HB3' HG12 ' A' ' 207' ' ' VAL . 45.7 p90 -154.4 172.37 17.84 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 74.6 mt -113.9 129.81 69.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 35.0 t -91.59 124.22 35.59 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -123.15 107.54 11.85 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.5 mp -93.39 117.89 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 104.281 -2.488 . . . . 0.0 104.281 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.442 HG12 HH22 ' A' ' 170' ' ' ARG . 4.3 mt -104.89 105.83 19.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 178.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -104.19 -156.38 23.82 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.793 1.664 . . . . 0.0 109.409 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.1 t 64.02 43.47 5.16 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.586 1.155 . . . . 0.0 110.36 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -91.57 -64.09 1.16 Allowed Glycine 0 CA--C 1.529 0.937 0 N-CA-C 107.987 -2.045 . . . . 0.0 107.987 179.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 157.29 179.98 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.379 1 C-N-CA 132.086 4.155 . . . . 0.0 105.792 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.5 mm -105.59 143.39 16.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 127.756 2.423 . . . . 0.0 112.107 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.4 m -95.73 101.13 12.78 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 128.11 2.564 . . . . 0.0 104.312 176.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -48.73 -31.32 6.73 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.258 1.823 . . . . 0.0 112.658 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 60.0 t -39.16 -54.11 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 127.268 2.227 . . . . 0.0 110.574 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 11.3 t -123.5 -26.95 4.13 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.404 1.082 . . . . 0.0 111.787 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.33 35.18 4.24 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 -178.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -110.67 148.69 31.74 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 118.498 1.149 . . . . 0.0 113.108 -178.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -73.8 148.09 42.8 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.274 0.559 . . . . 0.0 112.156 179.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -70.06 27.01 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.425 1 C-N-CA 134.844 5.258 . . . . 0.0 109.87 177.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 2.8 ptm -74.64 178.78 5.14 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.383 1.473 . . . . 0.0 113.336 -176.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.1 p -150.74 136.45 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 123.279 0.631 . . . . 0.0 110.642 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -98.79 109.22 22.01 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.744 1.217 . . . . 0.0 109.213 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 11.1 mm -97.49 147.88 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 O-C-N 121.627 -0.671 . . . . 0.0 109.853 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -125.7 105.4 8.96 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 128.092 2.557 . . . . 0.0 109.106 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -87.76 114.17 24.12 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 120.65 -1.281 . . . . 0.0 108.951 178.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.455 HG12 ' HB3' ' A' ' 182' ' ' TYR . 4.6 m -124.49 165.01 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 41.9 t -84.63 145.86 27.79 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 120.418 -1.426 . . . . 0.0 107.36 178.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -90.89 6.14 81.91 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-O 117.341 -1.81 . . . . 0.0 115.362 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 62.96 13.75 49.38 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-N 119.026 1.413 . . . . 0.0 114.952 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 46.8 m -96.79 153.84 17.64 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.139 1.376 . . . . 0.0 107.935 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -72.46 -35.48 68.25 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 115.273 1.583 . . . . 0.0 115.273 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 18.6 m -157.95 166.17 33.28 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.52 1.528 . . . . 0.0 109.273 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 144.42 175.05 17.21 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 115.647 1.019 . . . . 0.0 115.647 178.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -78.37 -118.26 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.913 1 C-N-CA 125.38 4.054 . . . . 0.0 109.575 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 28.1 p -154.68 147.61 24.56 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 119.992 -1.693 . . . . 0.0 111.374 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 20.6 p -151.05 161.59 42.44 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.541 1.136 . . . . 0.0 110.145 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 3.6 mt -100.64 154.53 4.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 125.311 1.444 . . . . 0.0 109.386 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -102.27 -51.69 3.31 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 124.783 1.233 . . . . 0.0 109.844 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 64.5 p-90 -155.92 154.09 30.65 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.067 0.947 . . . . 0.0 109.255 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 90.9 t -147.73 137.7 16.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.63 168.53 19.8 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 122.842 0.457 . . . . 0.0 111.207 -178.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -86.86 133.67 33.6 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 177.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 14.8 t -109.21 -32.22 7.28 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.528 1.131 . . . . 0.0 112.214 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -136.86 -175.97 4.21 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.668 1.187 . . . . 0.0 108.84 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 78.3 mt -48.76 -45.05 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.585 0.754 . . . . 0.0 112.479 -178.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -130.19 12.54 5.59 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.112 0.965 . . . . 0.0 112.265 -178.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 17.5 t -114.14 140.29 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 O-C-N 122.116 -0.365 . . . . 0.0 110.127 -176.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -120.66 166.97 12.95 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 125.18 1.392 . . . . 0.0 108.445 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -137.89 148.65 45.54 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.505 1.522 . . . . 0.0 108.822 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -148.93 145.49 27.42 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 125.789 1.636 . . . . 0.0 110.273 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -132.84 122.89 25.11 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 178.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 5.5 m -116.29 154.81 17.8 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.1 p -120.76 124.05 44.17 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.517 1.127 . . . . 0.0 110.302 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -132.8 122.98 17.97 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 124.238 1.015 . . . . 0.0 109.261 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -58.19 -40.83 73.07 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 124.014 3.143 . . . . 0.0 113.406 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -61.05 -19.62 61.6 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.615 0.766 . . . . 0.0 112.101 -178.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 8.6 tp -66.94 -28.87 68.64 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 120.432 -1.418 . . . . 0.0 110.715 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 21.4 m -62.33 -11.85 17.69 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.746 0.818 . . . . 0.0 111.942 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.08 -21.39 66.14 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.046 0.839 . . . . 0.0 110.122 178.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -98.12 121.01 39.53 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 177.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -47.99 -46.13 32.35 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 126.071 1.749 . . . . 0.0 112.704 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.42 -37.54 87.23 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 120.809 -1.182 . . . . 0.0 112.127 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 22.1 mt -85.21 -5.73 59.31 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.32 1.048 . . . . 0.0 112.252 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -68.95 156.41 38.62 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.822 1.249 . . . . 0.0 110.428 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.407 ' HE3' ' CG1' ' A' ' 179' ' ' VAL . 2.9 mmmt -96.35 -166.87 1.48 Allowed 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 126.225 1.81 . . . . 0.0 109.279 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -67.0 -27.99 67.88 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 53.45 31.78 12.79 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 128.19 2.596 . . . . 0.0 111.989 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 33.7 t70 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.739 -0.648 . . . . 0.0 112.598 -179.281 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.936 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 35.16 66.14 0.33 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 127.106 2.163 . . . . 0.0 114.018 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 71.6 m -140.16 147.1 39.65 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.728 1.211 . . . . 0.0 108.689 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -65.72 107.17 1.69 Allowed 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.8 m -50.69 -50.37 55.1 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 119.758 1.163 . . . . 0.0 112.531 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -63.92 -33.63 76.15 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.385 0.674 . . . . 0.0 112.241 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -59.24 -51.37 70.28 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 178.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.46 -37.15 74.87 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.043 0.937 . . . . 0.0 110.874 178.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.55 -42.65 92.89 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.505 1.048 . . . . 0.0 109.481 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.5 tp -68.88 -36.8 78.51 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-O 117.276 -1.345 . . . . 0.0 109.28 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 98.8 mt -58.67 -54.55 45.82 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 120.265 1.393 . . . . 0.0 108.533 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.2 m -58.93 -46.88 86.88 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.808 0.843 . . . . 0.0 111.457 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.09 -41.94 94.51 Favored 'General case' 0 N--CA 1.463 0.197 0 O-C-N 120.343 -1.473 . . . . 0.0 111.014 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 37.6 m -52.4 -46.94 66.51 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.135 1.374 . . . . 0.0 110.771 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -56.51 -50.99 70.19 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.309 0.504 . . . . 0.0 110.098 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -63.02 -58.0 8.78 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -178.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.09 -39.33 78.32 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.343 -177.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.78 -52.57 41.19 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.54 ' HA ' HD12 ' A' ' 109' ' ' ILE . 43.6 t -54.46 -51.07 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-N 119.032 1.416 . . . . 0.0 110.682 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.6 pttp -56.86 -35.14 68.52 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.448 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 77.2 m -80.34 -29.03 37.97 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.113 0.965 . . . . 0.0 111.947 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.54 HD12 ' HA ' ' A' ' 106' ' ' VAL . 16.7 mt -63.27 -54.39 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 104.677 -2.342 . . . . 0.0 104.677 177.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -61.13 -30.69 70.53 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 118.44 -0.79 . . . . 0.0 111.199 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -56.37 -47.57 78.62 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.478 1.036 . . . . 0.0 111.084 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -84.14 -37.9 21.36 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 24.9 mt -65.97 -26.56 67.62 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 118.931 -0.557 . . . . 0.0 112.161 -179.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -56.83 -20.9 25.17 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -64.64 -66.81 0.49 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.517 0.727 . . . . 0.0 109.485 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -153.51 -179.7 8.01 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.04 1.736 . . . . 0.0 110.306 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 56.0 m -86.63 172.82 9.95 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.287 0.635 . . . . 0.0 109.694 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 34.0 pt -129.8 164.37 32.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 126.654 1.982 . . . . 0.0 109.046 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.593 ' CE2' HG21 ' A' ' 142' ' ' VAL . 0.5 OUTLIER -158.74 150.33 20.86 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 122.831 0.452 . . . . 0.0 110.225 -179.222 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -141.5 127.38 19.32 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.631 0.772 . . . . 0.0 109.882 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -84.07 102.23 12.37 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 122.054 0.93 . . . . 0.0 109.404 179.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.27 80.57 6.84 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 127.864 2.466 . . . . 0.0 107.15 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 60.75 -114.69 6.85 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -76.74 -28.81 55.9 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.829 0.852 . . . . 0.0 112.548 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -99.95 163.46 12.43 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 119.073 0.851 . . . . 0.0 110.89 -178.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.524 HD13 ' H ' ' A' ' 140' ' ' GLY . 4.5 mp -136.55 130.56 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -110.05 119.99 41.05 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -108.04 126.42 52.71 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 118.437 -0.792 . . . . 0.0 109.909 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -117.55 130.49 56.44 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.292 0.951 . . . . 0.0 110.094 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.462 ' HB3' HD13 ' A' ' 133' ' ' ILE . 21.4 m -110.83 156.6 40.44 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 128.427 2.691 . . . . 0.0 113.937 -178.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -68.19 72.42 0.83 Allowed 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 124.79 3.66 . . . . 0.0 114.404 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.84 62.06 3.77 Favored Glycine 0 N--CA 1.448 -0.517 0 O-C-N 121.186 -0.947 . . . . 0.0 111.285 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.462 HD13 ' HB3' ' A' ' 130' ' ' CYS . 2.5 mp -131.03 -72.31 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-O 118.325 -0.845 . . . . 0.0 109.235 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -173.65 136.9 0.59 Allowed 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 119.646 1.112 . . . . 0.0 108.15 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -108.27 124.3 50.1 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 121.04 1.745 . . . . 0.0 106.32 -175.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 18.3 m -145.04 165.06 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 125.257 1.423 . . . . 0.0 111.428 -178.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -122.02 133.4 54.8 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.479 1.512 . . . . 0.0 108.193 178.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -138.96 162.87 33.82 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.127 1.371 . . . . 0.0 112.667 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 42.6 t60 -92.76 122.66 35.38 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.524 ' H ' HD13 ' A' ' 126' ' ' ILE . . . 169.97 -158.78 31.07 Favored Glycine 0 N--CA 1.454 -0.145 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 -178.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.6 165.59 34.12 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.593 HG21 ' CE2' ' A' ' 119' ' ' PHE . 5.3 p -107.11 154.52 8.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 178.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -106.16 102.18 11.61 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 104.14 -2.541 . . . . 0.0 104.14 176.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 2.3 p -47.58 -39.67 17.29 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 119.812 1.187 . . . . 0.0 113.205 -178.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 53.3 mmtt -56.3 -30.34 62.4 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 126.093 1.757 . . . . 0.0 114.488 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 29.2 p -113.14 -32.67 6.25 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.106 0.962 . . . . 0.0 110.593 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 84.1 26.54 40.3 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 126.015 1.769 . . . . 0.0 112.719 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -125.45 159.63 31.45 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.948 1.299 . . . . 0.0 110.996 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 24.3 mm -75.25 150.78 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 106.816 -1.549 . . . . 0.0 106.816 178.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 30.3 m -65.45 -29.61 47.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -165.61 174.87 9.39 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.925 1.29 . . . . 0.0 110.392 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -113.6 157.38 22.18 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -123.09 109.13 13.67 Favored 'General case' 0 CA--C 1.516 -0.337 0 O-C-N 120.853 -1.154 . . . . 0.0 113.337 -175.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 -83.11 -17.89 41.49 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.905 -0.497 . . . . 0.0 111.133 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 16.0 m -89.54 -42.53 11.38 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 120.874 -1.141 . . . . 0.0 111.004 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 72.9 mt -79.33 93.2 5.27 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.9 m -110.93 117.66 55.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 123.691 0.797 . . . . 0.0 111.127 -178.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -132.81 163.86 28.12 Favored 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 125.122 1.369 . . . . 0.0 109.181 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.67 135.86 23.84 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 178.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.1 mp -125.7 -36.36 2.43 Favored 'General case' 0 C--O 1.221 -0.445 0 C-N-CA 126.478 1.911 . . . . 0.0 106.905 177.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 172.75 152.43 8.65 Favored Glycine 0 C--N 1.34 0.795 0 CA-C-N 119.391 0.996 . . . . 0.0 112.705 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 29.3 mtmt -123.28 109.33 31.32 Favored Pre-proline 0 C--O 1.239 0.513 0 N-CA-C 106.125 -1.805 . . . . 0.0 106.125 177.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -75.35 -172.95 1.43 Allowed 'Trans proline' 0 N--CA 1.459 -0.519 1 C-N-CA 126.174 4.583 . . . . 0.0 111.425 -178.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -124.39 152.41 43.25 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 123.762 0.825 . . . . 0.0 108.965 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.11 -46.18 65.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.066 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 -68.88 65.36 0.13 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 127.366 2.267 . . . . 0.0 111.166 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.8 p -48.51 -34.06 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 124.662 1.185 . . . . 0.0 111.746 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -59.64 -32.21 70.24 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 125.46 1.504 . . . . 0.0 113.184 -178.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -84.61 -22.61 29.91 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.767 1.227 . . . . 0.0 112.787 -178.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.404 HH22 ' HG3' ' A' ' 185' ' ' GLU . 66.6 mtp180 -74.82 139.71 43.43 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -97.22 143.3 28.15 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 179.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -133.59 165.84 23.97 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 124.21 1.004 . . . . 0.0 109.777 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -123.45 142.73 50.7 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.944 0.897 . . . . 0.0 109.965 -178.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 58.9 tp -102.28 100.95 11.18 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.062 1.745 . . . . 0.0 107.584 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.584 HD23 ' HB2' ' A' ' 184' ' ' SER . 2.9 mm? -107.78 -178.84 3.74 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.301 1.44 . . . . 0.0 109.147 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 181' ' ' TYR . 1.7 p90 -139.97 156.88 46.43 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -134.97 175.0 9.98 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 126.879 2.072 . . . . 0.0 107.446 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -64.21 -13.97 52.36 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 124.548 1.139 . . . . 0.0 112.699 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 99.6 t -97.65 -34.93 4.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 125.856 1.662 . . . . 0.0 112.459 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 163.93 -174.65 40.09 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 176' ' ' TYR . 3.6 m-30 -78.41 166.21 22.9 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -165.66 164.19 19.08 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.354 0.662 . . . . 0.0 111.395 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 67.7 mt -102.43 132.41 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.584 ' HB2' HD23 ' A' ' 175' ' ' LEU . 23.3 t -100.81 127.27 47.33 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.581 1.553 . . . . 0.0 107.954 179.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.404 ' HG3' HH22 ' A' ' 170' ' ' ARG . 26.4 tt0 -124.21 112.47 17.09 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.39 1.876 . . . . 0.0 109.617 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -96.94 116.23 38.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 178.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 5.3 mt -105.22 108.64 25.44 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -106.58 -153.21 19.83 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 108.023 -2.031 . . . . 0.0 108.023 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 85.44 32.13 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.352 1.861 . . . . 0.0 111.237 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -111.53 165.17 12.09 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 125.537 1.541 . . . . 0.0 111.093 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.62 157.17 38.45 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.7 mm -78.1 134.87 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 C-N-CA 125.387 1.475 . . . . 0.0 110.769 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.35 115.03 18.75 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.918 1.687 . . . . 0.0 106.685 178.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -60.37 -22.21 63.03 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.161 1.384 . . . . 0.0 112.219 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 59.8 t -53.73 -48.51 60.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 C-N-CA 125.192 1.397 . . . . 0.0 111.249 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 11.7 t -125.2 -43.27 1.95 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 117.62 35.15 1.1 Allowed Glycine 0 CA--C 1.532 1.139 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 -177.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -111.08 150.67 29.05 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.612 1.706 . . . . 0.0 111.598 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -73.03 143.3 47.57 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.446 0.641 . . . . 0.0 109.388 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 7.0 ttp180 -67.6 29.45 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.4 1 C-N-CA 132.184 4.194 . . . . 0.0 113.564 179.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 6.0 ptm -73.51 175.78 6.72 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.216 -0.927 . . . . 0.0 113.062 -177.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 8.8 p -142.13 151.41 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 124.7 1.2 . . . . 0.0 108.483 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -110.78 115.25 29.23 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 179.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 8.5 mm -106.12 140.06 25.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -125.44 109.0 12.21 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.604 1.562 . . . . 0.0 109.108 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -89.48 115.27 26.78 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 120.636 -1.29 . . . . 0.0 110.413 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 5.2 m -124.62 165.99 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 124.015 0.926 . . . . 0.0 108.525 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 48.8 t -85.39 143.09 28.83 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 121.033 -1.042 . . . . 0.0 108.331 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -86.91 7.18 81.28 Favored Glycine 0 CA--C 1.52 0.395 0 CA-C-O 116.831 -2.094 . . . . 0.0 116.829 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 54.29 60.85 7.89 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 120.249 2.024 . . . . 0.0 111.593 -178.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.3 t -157.47 160.06 37.91 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.788 0.835 . . . . 0.0 109.76 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -70.31 -57.21 5.12 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 124.831 1.253 . . . . 0.0 114.259 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 91.9 p -149.84 167.88 25.33 Favored 'General case' 0 C--O 1.233 0.229 0 O-C-N 121.227 -0.921 . . . . 0.0 111.45 -178.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 152.55 168.61 16.87 Favored Glycine 0 CA--C 1.522 0.508 0 CA-C-O 119.161 -0.799 . . . . 0.0 111.352 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -70.91 -90.67 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 123.186 2.591 . . . . 0.0 109.047 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.5 p -171.42 150.39 2.86 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 121.021 -1.049 . . . . 0.0 110.078 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.9 p -151.85 159.1 43.97 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.862 1.265 . . . . 0.0 109.325 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.429 ' HA ' ' HA ' ' A' ' 233' ' ' VAL . 4.3 mt -102.31 152.56 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 126.416 1.886 . . . . 0.0 107.996 178.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -97.6 -50.95 4.29 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.467 1.107 . . . . 0.0 111.447 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 58.2 p-90 -160.02 155.24 25.02 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.336 1.454 . . . . 0.0 107.84 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 52.9 t -151.46 118.75 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 125.672 1.589 . . . . 0.0 106.769 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.98 167.49 26.54 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 118.51 0.596 . . . . 0.0 111.459 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -73.81 134.69 43.41 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 1.4 t -112.34 -37.36 5.01 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.172 0.989 . . . . 0.0 110.732 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 16.4 mttm -131.61 -175.19 3.63 Favored 'General case' 0 CA--C 1.506 -0.749 0 C-N-CA 124.054 0.942 . . . . 0.0 109.689 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 71.0 mt -53.16 -48.51 54.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.923 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -126.84 22.56 6.78 Favored 'General case' 0 C--O 1.226 -0.135 0 C-N-CA 124.66 1.184 . . . . 0.0 110.777 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 12.3 t -123.38 144.33 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.518 0 C-N-CA 120.328 -0.549 . . . . 0.0 109.57 -178.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -125.15 158.93 32.7 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.496 1.519 . . . . 0.0 107.379 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -127.72 137.47 52.48 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -142.34 125.64 16.54 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.88 1.672 . . . . 0.0 110.686 -177.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -118.97 116.96 27.55 Favored 'General case' 0 C--O 1.237 0.436 0 O-C-N 121.721 -0.612 . . . . 0.0 110.659 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 218' ' ' ILE . 3.6 m -101.5 154.3 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 1.1 p -124.01 125.57 44.79 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 1.2 pt -136.5 141.03 34.12 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -67.68 -43.34 5.57 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.831 2.354 . . . . 0.0 112.386 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -56.69 -18.23 11.64 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -178.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 3.9 tp -70.18 -22.16 62.98 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 120.06 -1.65 . . . . 0.0 112.171 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 15.9 m -70.48 -9.31 56.23 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.623 1.169 . . . . 0.0 112.259 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -57.29 -35.86 70.34 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.203 1.001 . . . . 0.0 108.535 178.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -92.55 124.33 36.5 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -46.89 -47.92 21.3 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 128.416 2.686 . . . . 0.0 111.815 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.432 ' HB3' ' CD2' ' A' ' 181' ' ' TYR . 25.3 mt -62.09 -44.46 96.61 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.752 -178.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 8.2 mp -78.66 -8.33 58.56 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -70.02 141.39 52.91 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.688 1.595 . . . . 0.0 110.722 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 10.3 mmmm -85.89 174.35 9.34 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.126 0.971 . . . . 0.0 109.409 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -102.98 -16.67 15.75 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.534 0.734 . . . . 0.0 111.754 179.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -123.15 50.15 1.59 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.403 1.481 . . . . 0.0 107.963 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 . . . . . 0 C--O 1.248 1.016 0 CA-C-N 114.219 -1.355 . . . . 0.0 108.78 178.679 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.672 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.78 179.1 6.87 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.202 1.001 . . . . 0.0 109.461 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.7 m -137.9 80.98 1.83 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 178.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.58 71.67 1.47 Allowed 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 17.1 m -54.9 -27.5 43.45 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.872 0.869 . . . . 0.0 112.979 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -70.93 -40.89 71.83 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.948 0.795 . . . . 0.0 110.412 179.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 43.9 tptt -65.67 -54.67 24.27 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.19 -34.29 70.21 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 118.661 -0.685 . . . . 0.0 111.552 179.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.42 -51.22 69.63 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.651 -1.241 . . . . 0.0 107.651 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 53.7 tp -61.35 -38.25 86.27 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 117.728 -1.13 . . . . 0.0 110.383 179.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.6 mt -60.94 -54.37 45.87 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 119.627 1.103 . . . . 0.0 109.365 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 26.4 m -58.86 -49.01 79.34 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.241 1.416 . . . . 0.0 110.303 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.4 ttmm -58.7 -49.85 76.07 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 52.9 m -52.61 -45.34 66.52 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 123.964 0.905 . . . . 0.0 110.127 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -57.32 -49.8 74.96 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.711 0.687 . . . . 0.0 109.482 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.17 -61.38 2.17 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.904 0.881 . . . . 0.0 112.5 -178.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.25 -39.03 78.11 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 125.153 1.381 . . . . 0.0 111.739 -178.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -65.32 -52.72 37.79 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-O 117.985 -1.453 . . . . 0.0 109.935 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.536 ' HA ' HD12 ' A' ' 109' ' ' ILE . 52.2 t -58.77 -42.89 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 119.689 1.745 . . . . 0.0 110.691 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.9 ptmm? -62.06 -35.9 80.02 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.968 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.4 m -72.89 -40.13 65.81 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.317 1.047 . . . . 0.0 109.67 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.536 HD12 ' HA ' ' A' ' 106' ' ' VAL . 20.4 mt -58.48 -54.71 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -57.18 -37.73 72.58 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 118.011 -0.995 . . . . 0.0 111.432 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -63.69 -37.41 87.26 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.102 0.865 . . . . 0.0 111.399 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.43 -32.56 62.68 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.768 -0.582 . . . . 0.0 111.636 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.0 mt -83.73 -25.11 30.85 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 117.884 0.311 . . . . 0.0 111.362 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -47.82 -35.45 10.18 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.185 1.394 . . . . 0.0 111.552 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -60.62 -67.04 0.44 Allowed 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 125.329 1.452 . . . . 0.0 111.928 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 77.5 mmt-85 -150.05 171.73 16.39 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.815 1.189 . . . . 0.0 111.936 -178.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 62.1 m -86.71 152.62 22.38 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 178.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 28.7 pt -106.41 161.32 5.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 125.779 1.632 . . . . 0.0 109.74 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -151.73 134.57 15.64 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.635 1.574 . . . . 0.0 108.694 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.406 ' CB ' ' HB ' ' A' ' 218' ' ' ILE . 12.2 t80 -138.61 127.6 23.91 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.114 0.966 . . . . 0.0 111.139 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -81.99 106.78 14.18 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.533 1.133 . . . . 0.0 108.83 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -100.54 79.99 2.16 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 178.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.66 -125.59 20.24 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -67.05 -34.59 78.03 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.308 0.643 . . . . 0.0 112.046 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -99.96 163.88 12.25 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 119.132 0.878 . . . . 0.0 111.637 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.1 mp -128.98 140.92 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 104.886 -2.264 . . . . 0.0 104.886 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.416 ' CG ' HG11 ' A' ' 221' ' ' VAL . 10.5 m-85 -114.82 120.07 38.76 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 125.841 1.656 . . . . 0.0 107.961 -177.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -113.46 122.66 47.99 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -122.25 135.13 54.7 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 123.855 0.862 . . . . 0.0 110.7 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.506 ' HB3' HD13 ' A' ' 133' ' ' ILE . 16.4 m -109.09 158.25 34.84 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 126.675 1.99 . . . . 0.0 112.59 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -63.9 74.46 0.17 Allowed 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 124.738 3.625 . . . . 0.0 114.457 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 72.78 50.68 13.18 Favored Glycine 0 CA--C 1.532 1.126 0 O-C-N 120.093 -1.63 . . . . 0.0 114.085 179.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.506 HD13 ' HB3' ' A' ' 130' ' ' CYS . 3.6 mp -124.31 -65.98 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 125.352 1.461 . . . . 0.0 108.091 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -166.64 168.48 14.44 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 127.416 2.286 . . . . 0.0 110.837 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -134.57 121.72 21.35 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 19.5 m -143.03 163.79 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 125.008 1.323 . . . . 0.0 111.821 -178.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -126.19 128.07 46.67 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.608 1.163 . . . . 0.0 110.124 178.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -138.09 162.92 32.93 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.555 1.942 . . . . 0.0 110.929 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.459 ' H ' HD13 ' A' ' 156' ' ' LEU . 13.1 t60 -91.69 160.76 15.2 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 120.867 -1.146 . . . . 0.0 109.357 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 135.52 -160.62 24.54 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.842 1.21 . . . . 0.0 111.045 -179.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.449 ' H ' HG22 ' A' ' 150' ' ' VAL . 0.4 OUTLIER -142.47 167.72 21.43 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.004 1.322 . . . . 0.0 110.183 179.462 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.9 p -128.75 146.29 34.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 CA-C-N 119.645 1.111 . . . . 0.0 111.198 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -95.12 106.39 18.4 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 25.7 p -60.06 -25.48 65.4 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.437 1.017 . . . . 0.0 113.299 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -55.75 -49.3 73.47 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.615 0.766 . . . . 0.0 112.077 -179.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 24.9 p -102.68 -36.17 8.41 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.798 1.239 . . . . 0.0 112.443 -178.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 92.12 35.96 6.5 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -179.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -124.14 148.34 47.27 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 118.266 1.033 . . . . 0.0 110.337 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 14.3 mm -69.95 156.14 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 179.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.449 HG22 ' H ' ' A' ' 141' ' ' ARG . 6.3 m -56.71 -29.32 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 124.705 1.202 . . . . 0.0 112.077 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -169.48 176.42 5.06 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 126.826 2.05 . . . . 0.0 107.168 179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -109.34 101.07 10.09 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 104.975 -2.231 . . . . 0.0 104.975 178.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.39 88.34 1.19 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -73.14 -23.57 60.48 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.187 -0.946 . . . . 0.0 110.516 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 3.8 m -71.85 3.74 3.95 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.141 1.776 . . . . 0.0 113.237 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.459 HD13 ' H ' ' A' ' 139' ' ' HIS . 43.1 mt -125.23 123.48 39.64 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.6 126.81 61.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 124.681 1.192 . . . . 0.0 108.028 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -151.53 162.6 40.68 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 126.798 2.039 . . . . 0.0 107.863 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -148.93 140.28 23.26 Favored 'General case' 0 CA--C 1.507 -0.697 0 O-C-N 120.819 -1.176 . . . . 0.0 109.474 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 41.0 mt -118.07 -24.37 7.05 Favored 'General case' 0 C--O 1.219 -0.51 0 O-C-N 125.391 1.682 . . . . 0.0 109.378 179.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 163.38 164.12 17.72 Favored Glycine 0 C--N 1.34 0.757 0 O-C-N 121.056 -1.028 . . . . 0.0 111.1 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.414 ' N ' HG22 ' A' ' 187' ' ' ILE . 49.0 mtpt -127.89 109.58 20.25 Favored Pre-proline 0 CA--C 1.533 0.31 0 C-N-CA 124.374 1.07 . . . . 0.0 110.519 178.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -72.09 172.58 14.44 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 123.945 3.097 . . . . 0.0 111.127 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -111.43 152.32 27.52 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.705 0.802 . . . . 0.0 111.083 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -68.01 -44.25 76.97 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.807 1.243 . . . . 0.0 111.986 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -78.15 65.36 3.51 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.482 1.113 . . . . 0.0 111.456 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.8 p -47.23 -33.91 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 124.532 1.133 . . . . 0.0 111.86 178.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -67.45 -36.19 80.69 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.951 1.3 . . . . 0.0 112.726 -178.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -86.28 -1.39 57.45 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 125.503 1.521 . . . . 0.0 110.917 -178.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 18.3 ttt-85 -93.24 146.94 23.32 Favored 'General case' 0 N--CA 1.441 -0.876 0 O-C-N 120.399 -1.438 . . . . 0.0 110.634 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -102.69 147.85 26.32 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.597 0.759 . . . . 0.0 110.656 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -138.04 175.48 9.54 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.873 2.069 . . . . 0.0 109.371 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -137.6 133.68 34.68 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.513 0.725 . . . . 0.0 112.52 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 35.1 tp -92.07 106.36 18.4 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.633 1.173 . . . . 0.0 109.377 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.492 HD23 ' HB2' ' A' ' 184' ' ' SER . 2.8 mm? -113.38 -179.25 3.59 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 125.775 1.63 . . . . 0.0 109.412 179.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -136.42 162.74 32.2 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.098 0.959 . . . . 0.0 110.092 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -138.89 178.81 6.88 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 127.666 2.386 . . . . 0.0 107.711 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -63.46 -14.31 49.4 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 121.706 -0.621 . . . . 0.0 111.659 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 5.0 t -97.5 -47.72 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 125.279 1.432 . . . . 0.0 112.101 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 172.6 -162.29 33.98 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.281 -1.127 . . . . 0.0 110.281 -178.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -84.32 163.33 19.67 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 117.993 0.897 . . . . 0.0 110.359 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -156.88 165.14 37.04 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.29 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 62.7 mt -105.26 120.2 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.492 ' HB2' HD23 ' A' ' 175' ' ' LEU . 39.8 t -89.93 136.31 33.12 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 124.707 1.203 . . . . 0.0 107.931 178.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -131.44 113.16 13.37 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 125.129 1.372 . . . . 0.0 107.652 178.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.48 107.03 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.414 HG22 ' N ' ' A' ' 162' ' ' LYS . 7.2 mt -94.01 105.81 17.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 178.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -111.57 -152.34 12.17 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 126.676 2.084 . . . . 0.0 109.715 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 76.73 40.54 0.2 Allowed 'General case' 0 C--O 1.237 0.416 0 C-N-CA 127.166 2.186 . . . . 0.0 108.305 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -108.7 173.25 17.43 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-O 121.978 0.766 . . . . 0.0 112.793 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . 0.504 ' H ' ' NE ' ' A' ' 200' ' ' ARG . 30.6 m-20 -80.97 141.28 34.61 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 179.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 43.5 mm -69.2 136.53 26.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 124.951 1.3 . . . . 0.0 112.046 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -87.52 110.33 20.26 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 128.335 2.654 . . . . 0.0 107.744 178.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -55.94 -18.49 9.25 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 127.691 2.396 . . . . 0.0 114.101 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 25.3 t -60.48 -46.28 95.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 124.985 1.314 . . . . 0.0 110.575 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 5.7 t -123.1 -37.52 2.7 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.514 1.126 . . . . 0.0 113.133 -178.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 104.12 35.89 3.29 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 108.079 -2.008 . . . . 0.0 108.079 -178.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -122.18 163.45 19.53 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.71 1.255 . . . . 0.0 110.813 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -77.2 151.71 35.1 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -178.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.504 ' NE ' ' H ' ' A' ' 191' ' ' ASP . 27.0 ptt85 -76.61 28.71 0.13 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 129.352 3.061 . . . . 0.0 111.852 177.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 6.6 ptm -72.77 175.52 6.4 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.956 0.903 . . . . 0.0 112.286 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.2 p -142.34 146.86 21.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 124.977 1.311 . . . . 0.0 109.978 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -105.18 104.04 13.69 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.831 1.652 . . . . 0.0 107.678 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 24.4 mm -91.26 152.01 3.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 O-C-N 120.896 -1.127 . . . . 0.0 109.432 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -127.36 104.83 8.13 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.342 1.857 . . . . 0.0 110.586 178.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . 0.446 ' CD1' HD13 ' A' ' 109' ' ' ILE . 42.9 m-85 -84.48 108.59 17.35 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 177.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 11.6 m -125.01 166.88 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 48.0 t -91.77 138.35 31.63 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 178.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -87.4 3.26 86.6 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-O 118.56 -1.133 . . . . 0.0 112.601 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 60.48 63.42 5.02 Favored Glycine 0 C--N 1.338 0.686 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 5.8 p -143.3 151.58 40.68 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 55.0 p30 -81.06 -19.27 44.13 Favored 'General case' 0 CA--C 1.522 -0.115 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -179.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 54.1 p -163.72 170.99 16.22 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 119.255 0.934 . . . . 0.0 110.697 -178.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 132.95 176.76 14.55 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 124.217 0.913 . . . . 0.0 113.708 178.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -80.02 -114.89 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 124.075 3.183 . . . . 0.0 109.401 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.1 146.38 26.89 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.864 1.666 . . . . 0.0 108.782 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 80.4 p -147.18 162.3 39.16 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 118.784 0.72 . . . . 0.0 110.357 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.433 ' CG1' HG12 ' A' ' 233' ' ' VAL . 3.4 mt -107.28 139.63 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 105.013 -2.218 . . . . 0.0 105.013 177.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -88.48 -47.71 8.13 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.417 1.087 . . . . 0.0 111.45 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 68.6 p-90 -159.25 154.21 24.93 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 126.047 1.739 . . . . 0.0 108.66 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.483 HG23 ' HB2' ' A' ' 231' ' ' ALA . 6.1 p -155.78 128.82 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -156.3 162.54 40.09 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 122.895 0.478 . . . . 0.0 111.119 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -68.76 133.42 48.33 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 178.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . 0.4 HG23 ' HG3' ' A' ' 225' ' ' LYS . 12.0 t -109.48 -31.11 7.63 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 123.909 0.884 . . . . 0.0 111.882 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.4 ' HG3' HG23 ' A' ' 224' ' ' THR . 7.1 mttm -138.65 -175.85 4.27 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.043 1.337 . . . . 0.0 108.024 178.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 76.3 mt -45.1 -49.39 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 1.8 t -132.96 18.96 4.12 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.169 0.988 . . . . 0.0 111.168 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 18.5 t -113.79 141.69 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -123.96 163.62 20.97 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.805 1.242 . . . . 0.0 107.725 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -142.76 133.55 25.4 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.483 ' HB2' HG23 ' A' ' 221' ' ' VAL . . . -134.89 145.26 48.07 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 125.669 1.588 . . . . 0.0 107.986 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -124.29 123.29 39.9 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . 0.433 HG12 ' CG1' ' A' ' 218' ' ' ILE . 6.3 m -113.92 154.81 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -179.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 2.1 p -125.37 126.3 44.8 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 123.76 0.824 . . . . 0.0 112.079 -178.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -131.38 145.94 59.81 Favored Pre-proline 0 C--O 1.234 0.254 0 O-C-N 124.357 1.035 . . . . 0.0 108.258 176.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -66.52 -47.85 2.71 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.786 2.324 . . . . 0.0 109.255 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -53.31 -23.61 9.64 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 -178.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 7.4 tp -66.39 -30.27 70.61 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 121.11 -0.994 . . . . 0.0 111.147 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 2.8 m -60.25 -13.08 10.72 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.058 0.943 . . . . 0.0 112.706 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.33 -25.79 67.76 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 118.901 0.773 . . . . 0.0 111.389 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' A' ' 241' ' ' LEU . 4.1 mm? -88.94 126.42 35.39 Favored 'General case' 0 C--O 1.225 -0.229 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -47.4 -44.65 24.59 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.631 1.972 . . . . 0.0 113.064 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 48.1 mt -72.93 -21.72 60.84 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 120.681 -1.262 . . . . 0.0 113.864 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 13.2 mt -100.46 -13.14 18.82 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.538 1.535 . . . . 0.0 112.654 -178.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -61.25 136.29 58.01 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 129.263 3.025 . . . . 0.0 110.742 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -112.9 -176.0 2.8 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.703 1.601 . . . . 0.0 110.079 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -69.53 -8.99 52.0 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.033 1.333 . . . . 0.0 111.31 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -122.7 31.36 6.11 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 127.382 2.273 . . . . 0.0 109.959 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.247 0.971 0 CA-C-O 117.345 -1.312 . . . . 0.0 111.711 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.037 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -99.89 -111.99 0.18 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 104.262 -2.496 . . . . 0.0 104.262 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.9 m -58.01 -13.12 4.04 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.479 1.112 . . . . 0.0 113.515 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -59.88 -37.64 79.92 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 177.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.3 t -72.79 -37.78 67.48 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 128.73 2.812 . . . . 0.0 110.101 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -63.59 -46.12 87.28 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -55.95 -55.19 35.65 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.1 p -62.7 -37.38 86.23 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 123.307 0.643 . . . . 0.0 112.089 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.91 -38.61 79.3 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 49.9 tp -70.25 -38.24 75.1 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 117.865 -1.064 . . . . 0.0 109.519 177.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.5 mt -61.75 -55.24 32.33 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.94 1.245 . . . . 0.0 109.376 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 18.3 m -60.12 -46.45 89.59 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.93 1.692 . . . . 0.0 111.211 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.9 ttpt -66.84 -41.9 86.66 Favored 'General case' 0 C--N 1.341 0.208 0 O-C-N 120.103 -1.623 . . . . 0.0 110.544 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 27.0 m -53.73 -50.49 65.83 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.795 0.838 . . . . 0.0 110.028 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -55.05 -50.38 69.26 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.133 0.573 . . . . 0.0 111.015 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.77 -58.49 7.82 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 122.487 1.136 . . . . 0.0 112.807 -178.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.0 mm100 -58.87 -40.63 84.92 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.915 1.286 . . . . 0.0 111.27 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.0 -53.03 39.86 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 109.171 -1.571 . . . . 0.0 109.171 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.472 ' HA ' HD12 ' A' ' 109' ' ' ILE . 42.3 t -55.12 -47.58 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 119.46 1.63 . . . . 0.0 110.482 179.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.4 pttm -62.1 -34.23 75.94 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.364 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 84.0 m -75.63 -35.96 60.33 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.472 HD12 ' HA ' ' A' ' 106' ' ' VAL . 21.0 mt -59.24 -54.3 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -58.45 -34.14 70.51 Favored 'General case' 0 C--O 1.225 -0.198 0 O-C-N 123.852 0.72 . . . . 0.0 111.447 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -56.18 -48.13 76.95 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.181 0.593 . . . . 0.0 111.496 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.483 ' HE3' ' HA ' ' A' ' 215' ' ' PRO . 27.0 mmmt -80.96 -40.8 23.86 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 121.565 -0.709 . . . . 0.0 111.255 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 13.0 mt -61.59 -31.62 71.69 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-O 118.364 -0.827 . . . . 0.0 112.25 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -51.53 -28.14 12.81 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.031 0.932 . . . . 0.0 113.337 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -59.65 -63.11 1.42 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.981 0.912 . . . . 0.0 111.72 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 7.3 mmt85 -154.65 -176.95 6.16 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.395 1.478 . . . . 0.0 110.805 -178.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 67.3 m -86.29 174.32 9.15 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 177.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 30.9 pt -129.47 161.42 38.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 126.573 1.949 . . . . 0.0 107.246 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -153.35 142.62 21.52 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -136.97 117.23 13.52 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.346 0.659 . . . . 0.0 109.892 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -85.24 98.43 10.49 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.83 80.77 7.09 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 128.634 2.774 . . . . 0.0 108.02 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 60.16 -112.09 4.17 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 108.581 -1.808 . . . . 0.0 108.581 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -80.77 -24.65 38.47 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -100.45 159.33 15.23 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 119.957 1.253 . . . . 0.0 111.031 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.0 mp -134.88 132.22 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 N-CA-C 103.904 -2.628 . . . . 0.0 103.904 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -118.59 121.3 39.87 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -109.26 121.1 44.45 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -111.25 128.3 55.89 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.196 0.522 . . . . 0.0 110.669 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.483 ' HB3' HD13 ' A' ' 133' ' ' ILE . 54.7 m -110.14 153.21 43.37 Favored Pre-proline 0 N--CA 1.439 -1.002 0 C-N-CA 126.894 2.077 . . . . 0.0 113.308 -178.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -68.96 74.34 0.95 Allowed 'Trans proline' 0 C--N 1.349 0.573 1 C-N-CA 125.356 4.037 . . . . 0.0 113.692 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.13 51.77 6.65 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-O 119.04 -0.866 . . . . 0.0 113.812 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.483 HD13 ' HB3' ' A' ' 130' ' ' CYS . 2.6 mp -124.83 -72.16 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.299 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 177.73 145.28 0.11 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -109.87 131.98 54.57 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 124.757 1.223 . . . . 0.0 109.098 -175.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.5 m -144.82 164.53 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 125.318 1.447 . . . . 0.0 111.581 -177.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -123.19 126.29 46.71 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 105.25 -2.129 . . . . 0.0 105.25 177.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -138.36 162.99 32.98 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.87 1.214 . . . . 0.0 111.235 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -84.98 157.73 20.7 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 177.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 136.76 -163.63 25.24 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.402 ' H ' HG22 ' A' ' 150' ' ' VAL . 0.6 OUTLIER -152.67 167.62 28.34 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 128.966 2.906 . . . . 0.0 107.137 178.462 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.2 p -122.32 146.56 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 123.721 0.809 . . . . 0.0 109.212 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -89.71 108.95 19.98 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 179.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 46.2 p -48.38 -33.15 8.63 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -178.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -66.31 -39.47 89.32 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -178.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 45.2 p -110.18 -21.92 12.02 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -177.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.25 35.54 70.07 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.064 1.316 . . . . 0.0 110.494 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -117.05 150.41 38.68 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 118.811 1.305 . . . . 0.0 109.288 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 12.2 mm -74.91 159.69 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 123.77 0.828 . . . . 0.0 109.166 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.402 HG22 ' H ' ' A' ' 141' ' ' ARG . 17.9 m -69.78 -37.42 73.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 125.446 1.498 . . . . 0.0 111.641 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -162.1 174.78 12.5 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 128.372 2.669 . . . . 0.0 107.298 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.37 124.57 45.85 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 101.464 -3.532 . . . . 0.0 101.464 176.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.44 89.26 7.79 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.575 0.703 . . . . 0.0 110.0 -177.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -57.72 -24.7 58.27 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.45 1.1 . . . . 0.0 110.059 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 5.5 m -80.5 -22.23 41.16 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 127.403 2.281 . . . . 0.0 113.63 -179.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 93.9 mt -98.13 89.36 4.49 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 19.6 m -95.54 105.07 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.189 -178.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -130.41 143.09 50.55 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 125.594 1.558 . . . . 0.0 106.921 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.3 116.18 12.3 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 49.0 mt -98.05 -26.81 14.48 Favored 'General case' 0 C--O 1.22 -0.448 0 O-C-N 124.413 1.07 . . . . 0.0 110.91 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 155.17 155.17 7.2 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 119.028 0.831 . . . . 0.0 111.54 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -114.74 109.97 47.17 Favored Pre-proline 0 N--CA 1.451 -0.4 0 C-N-CA 125.246 1.418 . . . . 0.0 108.766 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -74.52 -177.55 3.41 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.801 2.334 . . . . 0.0 107.319 178.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -128.95 134.67 48.29 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-N 118.819 0.736 . . . . 0.0 110.532 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -49.61 -45.98 48.71 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 125.869 1.98 . . . . 0.0 109.808 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -73.21 65.05 0.8 Allowed 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.522 1.529 . . . . 0.0 110.297 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 5.9 p -50.76 -31.23 9.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 121.035 -1.041 . . . . 0.0 112.659 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -63.42 -26.88 68.94 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -177.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -86.74 -23.09 25.62 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.67 1.588 . . . . 0.0 112.826 -179.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 30.2 mtp85 -73.34 150.71 41.65 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -103.71 144.19 31.79 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -138.93 159.26 42.57 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.96 1.304 . . . . 0.0 108.749 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -120.11 153.74 35.72 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.738 0.815 . . . . 0.0 109.994 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 35.5 tp -114.26 98.01 6.68 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.777 1.631 . . . . 0.0 106.995 179.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -107.92 -178.54 3.64 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.693 1.997 . . . . 0.0 108.547 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -141.22 158.06 44.4 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.024 0.53 . . . . 0.0 110.853 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -132.09 -178.7 5.02 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.681 1.992 . . . . 0.0 108.435 179.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.14 -14.42 17.05 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.186 1.394 . . . . 0.0 113.136 -178.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 16.0 t -107.24 -41.87 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 124.37 1.068 . . . . 0.0 111.279 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 177.34 -172.34 45.15 Favored Glycine 0 C--N 1.336 0.537 0 O-C-N 121.104 -0.998 . . . . 0.0 114.573 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 5.0 m-30 -77.28 158.36 30.26 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 122.337 1.065 . . . . 0.0 108.514 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -157.04 160.5 39.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.2 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 92.5 mt -100.19 132.11 46.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 22.7 t -102.06 126.15 48.92 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 125.406 1.482 . . . . 0.0 111.971 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -123.17 111.6 16.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.725 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 1.7 mp -93.26 119.04 40.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 177.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 9.1 mt -104.7 106.55 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 178.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.63 -153.1 24.54 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 124.771 1.177 . . . . 0.0 110.57 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 71.3 47.87 0.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.716 2.006 . . . . 0.0 107.946 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -115.04 162.91 12.27 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 108.886 -1.685 . . . . 0.0 108.886 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.05 159.11 30.11 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.0 mm -79.6 137.84 20.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 124.674 1.19 . . . . 0.0 110.604 178.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 1.3 m -90.09 108.65 19.86 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 128.047 2.539 . . . . 0.0 106.635 178.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -53.93 -25.88 22.62 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.051 1.34 . . . . 0.0 113.486 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 40.0 t -49.6 -47.26 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 125.254 1.422 . . . . 0.0 112.024 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 11.2 t -124.3 -38.99 2.37 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.278 1.031 . . . . 0.0 111.653 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 110.5 34.96 2.16 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 107.923 -2.071 . . . . 0.0 107.923 -177.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -106.28 154.8 20.23 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 120.175 1.988 . . . . 0.0 111.403 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -76.25 148.41 37.63 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 123.523 0.729 . . . . 0.0 111.723 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 38.6 mtt180 -69.91 27.23 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 130.564 3.546 . . . . 0.0 112.442 178.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 6.4 ptm -74.38 175.29 7.82 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.473 1.033 . . . . 0.0 110.683 -178.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.13 149.84 18.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 124.972 1.309 . . . . 0.0 107.484 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -109.19 112.79 25.15 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.355 1.462 . . . . 0.0 107.345 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 13.3 mm -105.99 139.49 27.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 39.1 mm-40 -124.73 126.71 46.11 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.479 1.112 . . . . 0.0 109.88 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -100.41 111.2 23.44 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.301 1.04 . . . . 0.0 110.512 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 3.5 m -124.21 163.43 24.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 123.742 0.817 . . . . 0.0 109.769 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 52.7 t -88.87 134.21 34.02 Favored 'General case' 0 N--CA 1.461 0.09 0 O-C-N 120.633 -1.292 . . . . 0.0 110.204 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -84.59 10.37 62.19 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 124.34 0.971 . . . . 0.0 114.032 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 63.03 -143.05 48.3 Favored Glycine 0 CA--C 1.533 1.17 0 N-CA-C 106.965 -2.454 . . . . 0.0 106.965 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 40.7 m -69.72 78.75 0.44 Allowed 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -140.93 64.9 1.41 Allowed 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 177.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 2.9 m -58.68 138.43 57.02 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 149.59 -167.08 29.76 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.238 0.923 . . . . 0.0 112.074 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.483 ' HA ' ' HE3' ' A' ' 112' ' ' LYS . 55.4 Cg_endo -67.22 -82.64 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 124.234 3.289 . . . . 0.0 111.102 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 4.2 p -174.85 151.83 1.46 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.212 1.405 . . . . 0.0 110.66 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.4 p -151.09 158.58 44.22 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.865 1.266 . . . . 0.0 109.222 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 4.3 mt -98.1 151.93 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 125.65 1.58 . . . . 0.0 110.084 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -97.07 -50.34 4.64 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 124.691 1.197 . . . . 0.0 112.031 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 63.9 p-90 -159.69 156.09 27.17 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -178.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 61.7 t -153.76 129.16 1.59 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 125.792 1.637 . . . . 0.0 107.198 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -160.62 163.68 32.42 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.198 0.599 . . . . 0.0 111.189 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -69.39 144.21 53.45 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . 0.409 HG23 ' HG3' ' A' ' 225' ' ' LYS . 9.0 t -119.18 -35.8 3.53 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 121.084 -1.01 . . . . 0.0 110.521 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.409 ' HG3' HG23 ' A' ' 224' ' ' THR . 21.0 mttm -127.65 -175.11 3.37 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 83.3 mt -55.7 -44.63 77.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.731 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 1.1 t -125.16 10.16 8.08 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.579 0.752 . . . . 0.0 112.492 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 10.6 t -114.74 143.77 23.76 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.793 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -177.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -122.39 162.22 22.01 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -132.54 143.53 49.79 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -145.89 146.27 31.03 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.638 1.575 . . . . 0.0 108.842 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -135.44 130.25 34.49 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 8.8 m -114.43 155.6 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.627 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 178.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.04 125.27 44.25 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 1.5 pt -134.72 146.22 58.06 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -75.22 -35.98 2.68 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.413 2.076 . . . . 0.0 112.566 -178.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -62.89 -17.58 61.84 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 -177.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 18.4 mt -73.18 -29.31 62.75 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.88 1.218 . . . . 0.0 110.264 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 10.1 m -57.1 -15.86 6.32 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.11 0.964 . . . . 0.0 112.903 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -62.01 -31.05 71.39 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.139 0.975 . . . . 0.0 109.173 177.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -86.34 124.28 32.52 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 106.052 -1.832 . . . . 0.0 106.052 178.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -47.23 -48.67 24.19 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 127.003 2.121 . . . . 0.0 113.608 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 32.9 mt -67.01 -26.18 66.67 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 12.8 mt -99.31 2.64 45.63 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.095 1.758 . . . . 0.0 111.582 -178.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -77.67 114.56 16.63 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.614 1.566 . . . . 0.0 111.733 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -69.2 173.44 5.64 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.018 0.927 . . . . 0.0 109.529 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . 0.42 ' C ' ' H ' ' A' ' 249' ' ' ASP . 36.9 t30 63.11 -13.01 0.08 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 127.793 2.437 . . . . 0.0 115.635 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -72.58 22.4 0.06 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 126.727 2.011 . . . . 0.0 111.729 178.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . 0.42 ' H ' ' C ' ' A' ' 247' ' ' ASN . 16.9 t70 . . . . . 0 C--O 1.244 0.776 0 C-N-CA 128.623 2.769 . . . . 0.0 109.552 179.501 . . . . . . . . 1 1 . 1 stop_ save_